Citrus Sinensis ID: 020235
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 329 | 2.2.26 [Sep-21-2011] | |||||||
| P51567 | 427 | Serine/threonine-protein | no | no | 0.978 | 0.754 | 0.851 | 1e-168 | |
| P51566 | 467 | Serine/threonine-protein | no | no | 0.984 | 0.693 | 0.796 | 1e-157 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.969 | 0.797 | 0.665 | 1e-129 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.951 | 0.453 | 0.472 | 6e-87 | |
| O35491 | 499 | Dual specificity protein | yes | no | 0.942 | 0.621 | 0.476 | 4e-83 | |
| P49760 | 499 | Dual specificity protein | yes | no | 0.945 | 0.623 | 0.475 | 6e-83 | |
| Q9HAZ1 | 481 | Dual specificity protein | no | no | 0.939 | 0.642 | 0.475 | 8e-80 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.951 | 0.376 | 0.457 | 2e-79 | |
| O35493 | 481 | Dual specificity protein | no | no | 0.939 | 0.642 | 0.466 | 7e-78 | |
| P49759 | 484 | Dual specificity protein | no | no | 0.939 | 0.638 | 0.459 | 3e-77 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 590 bits (1520), Expect = e-168, Method: Compositional matrix adjust.
Identities = 276/324 (85%), Positives = 305/324 (94%), Gaps = 2/324 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIR
Sbjct: 104 MGEGTFGQVLECWDRERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIR 163
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL MIHTD
Sbjct: 164 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTD 223
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSS+Y+K+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER DQ YIV
Sbjct: 224 LKPENILLVSSDYVKIPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIV 281
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ
Sbjct: 282 STRHYRAPEVILGLGWSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQ 341
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
MLK+VDRH+EKYVRRGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++Q
Sbjct: 342 QMLKKVDRHSEKYVRRGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQ 401
Query: 301 GLLRYDPTDRLTAREALRHPFFTR 324
GLLR+DP++R+TAREALRHPFF R
Sbjct: 402 GLLRFDPSERITAREALRHPFFAR 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 553 bits (1424), Expect = e-157, Method: Compositional matrix adjust.
Identities = 259/325 (79%), Positives = 289/325 (88%), Gaps = 1/325 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLEC+D + KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIR
Sbjct: 121 MGEGTFGQVLECFDNKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIR 180
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTD
Sbjct: 181 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTD 240
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSEYIK+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D NYIV
Sbjct: 241 LKPENILLVSSEYIKIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIV 300
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILG+GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP
Sbjct: 301 STRHYRAPEVILGVGWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPP 360
Query: 241 HMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
HM+ R DR +EKY RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL LL
Sbjct: 361 HMVLRADRRSEKYFRRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLL 420
Query: 300 QGLLRYDPTDRLTAREALRHPFFTR 324
QGLLRYDPT+R AREAL HPFFTR
Sbjct: 421 QGLLRYDPTERFKAREALNHPFFTR 445
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 460 bits (1183), Expect = e-129, Method: Compositional matrix adjust.
Identities = 215/323 (66%), Positives = 266/323 (82%), Gaps = 4/323 (1%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFG+VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG RCVQ++
Sbjct: 77 MGEGTFGRVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMK 136
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SL+DFL++N Y +FP+ LVR+ QLLE +A+MH+L ++HTD
Sbjct: 137 NWFDYRNHICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTD 196
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSE +K+PD K S + ++F+ +PKSSAIK+IDFGST + + IV
Sbjct: 197 LKPENILLVSSENVKLPDNKRS---AANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIV 253
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
TRHYR+PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+
Sbjct: 254 QTRHYRSPEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPE 313
Query: 241 HMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
HM ++ R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++ LL
Sbjct: 314 HMTRKASRGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLL 373
Query: 300 QGLLRYDPTDRLTAREALRHPFF 322
GLL YDP++RLTA EAL HPFF
Sbjct: 374 YGLLAYDPSERLTANEALDHPFF 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 320 bits (821), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 155/328 (47%), Positives = 227/328 (69%), Gaps = 15/328 (4%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQI 59
+G GTFG+V++C+D+ AIK+ R I KYREA++IE+ VLQ +A D N+C+Q+
Sbjct: 368 LGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREASLIELRVLQTIAHSDPTNENKCIQL 427
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
R++FDYR HICIV + G S++DFL+ NNY FP+ ++ +++QL + +AF+H L ++HT
Sbjct: 428 RDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHT 487
Query: 120 DLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
DLKPENVLLVS S I++P Y++ Y +++ S I++IDFGS T+E +
Sbjct: 488 DLKPENVLLVSNASRTIRLP-YRN---------YSQKVLNSCEIRLIDFGSATFEDEYHS 537
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL TG+ALFQTHE+ EHL MME++LGP
Sbjct: 538 SVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELFTGQALFQTHEDSEHLCMMEKILGP 597
Query: 238 LPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
++M+ R R ++++ + G++ +P ++SI + L L+ + A L
Sbjct: 598 FDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSINYLQSLQTLEQIFAVSSPEVAL-LL 656
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTR 324
LL+ + YDP R+TA+EAL HPFFT+
Sbjct: 657 DLLKKVFVYDPKRRITAKEALWHPFFTQ 684
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 308 bits (789), Expect = 4e-83, Method: Compositional matrix adjust.
Identities = 155/325 (47%), Positives = 218/325 (67%), Gaps = 15/325 (4%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 168 LGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 227
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 228 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 287
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 288 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 339
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 340 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPV 399
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + DH L L
Sbjct: 400 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEDHHQ--LFDL 454
Query: 299 LQGLLRYDPTDRLTAREALRHPFFT 323
++ +L Y+P RLT EAL+HPFF
Sbjct: 455 IENMLEYEPAKRLTLGEALQHPFFA 479
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 6e-83, Method: Compositional matrix adjust.
Identities = 155/326 (47%), Positives = 219/326 (67%), Gaps = 15/326 (4%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 169 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 228
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 229 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 288
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 289 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 340
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 341 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 400
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 401 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHHQ--LFDL 455
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 456 IESMLEYEPAKRLTLGEALQHPFFAR 481
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 297 bits (760), Expect = 8e-80, Method: Compositional matrix adjust.
Identities = 154/324 (47%), Positives = 216/324 (66%), Gaps = 15/324 (4%)
Query: 1 MGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEG FG+V+EC D M VA+KIV+ + +YREAA EI+VL+ L D RCVQ
Sbjct: 165 LGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREAARSEIQVLEHLNSTDPNSVFRCVQ 224
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ WFD+ H+CIVFE LG S YDF+++N++ F ID +R++A Q+ + I F+H + H
Sbjct: 225 MLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQIDHIRQMAYQICQSINFLHHNKLTH 284
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V S+Y V Y S + +D +R K++ IKV+DFGS TY+ +
Sbjct: 285 TDLKPENILFVKSDY--VVKYNSKM--KRD----ERTLKNTDIKVVDFGSATYDDEHHST 336
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +FQTH++ EHLAMMER+LGP+
Sbjct: 337 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFQTHDSKEHLAMMERILGPI 396
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
PQHM+++ + KY +LDW E +++ ++ K L+ ++ H D L L
Sbjct: 397 PQHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRRRCKP--LKEFMLCH-DEEHEKLFDL 451
Query: 299 LQGLLRYDPTDRLTAREALRHPFF 322
++ +L YDPT R+T EAL+HPFF
Sbjct: 452 VRRMLEYDPTQRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 150/328 (45%), Positives = 214/328 (65%), Gaps = 15/328 (4%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQI 59
+GEGTFG+V++ D ER +A+KI++ ++KYREAA +EI L+++A+ D + CV++
Sbjct: 485 LGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAAKLEINALEKIAQKDPHCDHLCVKM 544
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+WFDY H+CIVFE LG S++DFLR+NNY +P+D VR +A QL + F+HD + HT
Sbjct: 545 IDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLDQVRHMAYQLCYSVKFLHDNRLTHT 604
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLKPEN+L V S+Y ++K + R K++ +++IDFGS T++ + I
Sbjct: 605 DLKPENILFVDSDYTSHYNHKINREV--------RRVKNTDVRLIDFGSATFDHEHHSTI 656
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL G LFQTH+N EHLAMMER+LG +P
Sbjct: 657 VSTRHYRAPEVILELGWSQPCDVWSIGCILFELYLGITLFQTHDNREHLAMMERILGQIP 716
Query: 240 QHMLKR---VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
M + + KY G+LDW E +++ ++ K P + DH +L
Sbjct: 717 YRMARNHTLYSKTKTKYFYHGKLDWDEKSSAGRYVRDHCK-PLFLCQLSDSEDHC--ELF 773
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTR 324
L++ +L Y+P+ R+T EAL HPFF R
Sbjct: 774 SLIKKMLEYEPSSRITLGEALHHPFFDR 801
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 291 bits (744), Expect = 7e-78, Method: Compositional matrix adjust.
Identities = 151/324 (46%), Positives = 214/324 (66%), Gaps = 15/324 (4%)
Query: 1 MGEGTFGQVLECWDRERKEM-VAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEG FG+V+EC D + VA+KIV+ + +YREAA EI+VL+ L D RCVQ
Sbjct: 165 LGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREAARSEIQVLEHLNSTDPNSVFRCVQ 224
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ WFD+ H+CIVFE LG S YDF+++N++ F ID +R++A Q+ + I F+H + H
Sbjct: 225 MLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQIDHIRQMAYQICQSINFLHHNKLTH 284
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V S+Y V Y S + +D +R K++ IKV+DFGS TY+ +
Sbjct: 285 TDLKPENILFVKSDY--VVKYNSKM--KRD----ERTLKNTDIKVVDFGSATYDDEHHST 336
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +FQTH++ EHLAMMER+LGP+
Sbjct: 337 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFQTHDSKEHLAMMERILGPI 396
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P HM+++ + KY +LDW E +++ ++ K L+ ++ H D L L
Sbjct: 397 PAHMIQKTRK--RKYFHHNQLDWDEHSSAGRYVRRRCKP--LKEFMLCH-DEEHEKLFDL 451
Query: 299 LQGLLRYDPTDRLTAREALRHPFF 322
++ +L YDP R+T EAL+HPFF
Sbjct: 452 VRRMLEYDPARRITLDEALQHPFF 475
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49759|CLK1_HUMAN Dual specificity protein kinase CLK1 OS=Homo sapiens GN=CLK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 288 bits (738), Expect = 3e-77, Method: Compositional matrix adjust.
Identities = 149/324 (45%), Positives = 211/324 (65%), Gaps = 15/324 (4%)
Query: 1 MGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN-RCVQ 58
+GEG FG+V+EC D + VA+KIV+ + +Y EAA EI+VL+ L D RCVQ
Sbjct: 167 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 226
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ WF++ HICIVFE LG S YDF+++N + F +D +R++A Q+ + + F+H + H
Sbjct: 227 MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTH 286
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V S+Y + + K +D +R + IKV+DFGS TY+ +
Sbjct: 287 TDLKPENILFVQSDYTEAYNPK----IKRD----ERTLINPDIKVVDFGSATYDDEHHST 338
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +F TH++ EHLAMMER+LGPL
Sbjct: 339 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 398
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P+HM+++ + KY RLDW E +++ + K P + ++ Q V+H L L
Sbjct: 399 PKHMIQKTRK--RKYFHHDRLDWDEHSSAGRYVSRRCK-PLKEFMLSQDVEHER--LFDL 453
Query: 299 LQGLLRYDPTDRLTAREALRHPFF 322
+Q +L YDP R+T REAL+HPFF
Sbjct: 454 IQKMLEYDPAKRITLREALKHPFF 477
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 329 | ||||||
| 255540473 | 435 | afc, putative [Ricinus communis] gi|2235 | 1.0 | 0.756 | 0.920 | 0.0 | |
| 225456860 | 435 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.756 | 0.927 | 0.0 | |
| 224135977 | 427 | predicted protein [Populus trichocarpa] | 0.996 | 0.768 | 0.908 | 1e-180 | |
| 7211773 | 437 | protein kinase MK5 [Mesembryanthemum cry | 1.0 | 0.752 | 0.884 | 1e-176 | |
| 224121850 | 422 | predicted protein [Populus trichocarpa] | 0.984 | 0.767 | 0.898 | 1e-175 | |
| 356516617 | 425 | PREDICTED: serine/threonine-protein kina | 0.993 | 0.769 | 0.896 | 1e-175 | |
| 357461735 | 426 | Serine/threonine protein kinase AFC2 [Me | 0.993 | 0.767 | 0.893 | 1e-174 | |
| 356508738 | 425 | PREDICTED: serine/threonine-protein kina | 0.993 | 0.769 | 0.899 | 1e-174 | |
| 217074570 | 327 | unknown [Medicago truncatula] | 0.993 | 1.0 | 0.890 | 1e-174 | |
| 255647343 | 425 | unknown [Glycine max] | 0.993 | 0.769 | 0.896 | 1e-174 |
| >gi|255540473|ref|XP_002511301.1| afc, putative [Ricinus communis] gi|223550416|gb|EEF51903.1| afc, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 646 bits (1666), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/329 (92%), Positives = 317/329 (96%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGGNRCVQIR
Sbjct: 107 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGNRCVQIR 166
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLECIAFMHDL +IHTD
Sbjct: 167 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECIAFMHDLHLIHTD 226
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVS +Y+KVPDYK S +PKDSSYFKR+PKSSA+KVIDFGSTTYER DQNYIV
Sbjct: 227 LKPENILLVSPDYVKVPDYKGSTRSPKDSSYFKRVPKSSAVKVIDFGSTTYERQDQNYIV 286
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ
Sbjct: 287 STRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 346
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
HMLKR+DRHAEKYVRRGRLDWPEGA SRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQ
Sbjct: 347 HMLKRIDRHAEKYVRRGRLDWPEGATSRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQ 406
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP+DRLTAREALRHPFF RDHLRR
Sbjct: 407 GLLRYDPSDRLTAREALRHPFFARDHLRR 435
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456860|ref|XP_002279764.1| PREDICTED: serine/threonine-protein kinase AFC2 [Vitis vinifera] gi|297733679|emb|CBI14926.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 305/329 (92%), Positives = 316/329 (96%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVA+KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR
Sbjct: 106 MGEGTFGQVLECWDRERKEMVAVKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 165
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL +IHTD
Sbjct: 166 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRLIHTD 225
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVS EY+KVPDYK S +PKD SYFKR+PKSSAIKVIDFGSTTYER DQNYIV
Sbjct: 226 LKPENILLVSPEYVKVPDYKVSSRSPKDGSYFKRVPKSSAIKVIDFGSTTYERQDQNYIV 285
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ
Sbjct: 286 STRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 345
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
HMLKRVDRHAEKYVRRGRLDWPEGA SRESIK+V+KLPRLQNLIMQHVDHSAGDL HLLQ
Sbjct: 346 HMLKRVDRHAEKYVRRGRLDWPEGATSRESIKAVLKLPRLQNLIMQHVDHSAGDLIHLLQ 405
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP+DRLTA ALRHPFFTRDHLRR
Sbjct: 406 GLLRYDPSDRLTALGALRHPFFTRDHLRR 434
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135977|ref|XP_002322208.1| predicted protein [Populus trichocarpa] gi|222869204|gb|EEF06335.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 636 bits (1640), Expect = e-180, Method: Compositional matrix adjust.
Identities = 298/328 (90%), Positives = 316/328 (96%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY+EAAMIEIEVLQQL KHDKGGNRCVQIR
Sbjct: 99 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYKEAAMIEIEVLQQLGKHDKGGNRCVQIR 158
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPID VREI RQLLEC+AFMHDL MIHTD
Sbjct: 159 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDHVREIGRQLLECVAFMHDLHMIHTD 218
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSS+Y+KVPDYK+S +PKDSSY+KR+PKSSAIKVIDFGSTTYER DQNYIV
Sbjct: 219 LKPENILLVSSDYVKVPDYKNSTRSPKDSSYYKRVPKSSAIKVIDFGSTTYERQDQNYIV 278
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ
Sbjct: 279 STRHYRAPEVILGLGWSYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQ 338
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+MLKRVDRHAEK+VRRGRLDWPEGAASRESIK+V+KLPRLQNL+MQHVDHSAGDL HLLQ
Sbjct: 339 NMLKRVDRHAEKFVRRGRLDWPEGAASRESIKAVLKLPRLQNLVMQHVDHSAGDLIHLLQ 398
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLR 328
GLLRYDP DRLTAREALRHPFF +DH R
Sbjct: 399 GLLRYDPMDRLTAREALRHPFFAKDHRR 426
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7211773|gb|AAF40430.1| protein kinase MK5 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1604), Expect = e-176, Method: Compositional matrix adjust.
Identities = 291/329 (88%), Positives = 312/329 (94%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEI+VLQQL KHDKGG+RCVQIR
Sbjct: 109 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIDVLQQLGKHDKGGSRCVQIR 168
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLGSSLYDFLRKNNY FPIDLVRE RQLL+C+AFMHDL +IHTD
Sbjct: 169 NWFDYRNHICIVFEKLGSSLYDFLRKNNYGPFPIDLVRENGRQLLDCVAFMHDLHLIHTD 228
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPENVLLVSS+Y+K+ DYK +PKDSSY+K++PKSSAIKVIDFGSTTYERPDQNYIV
Sbjct: 229 LKPENVLLVSSDYVKIRDYKGFSRSPKDSSYYKKVPKSSAIKVIDFGSTTYERPDQNYIV 288
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCILVELC+GEALFQTHENLE LAMMERVLGPLPQ
Sbjct: 289 STRHYRAPEVILGLGWSYPCDVWSVGCILVELCSGEALFQTHENLEDLAMMERVLGPLPQ 348
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
HMLKRVDRHAEKYVRRGRLDWPEGAASRESI++V KL RLQNL+MQHVDHS GD HLLQ
Sbjct: 349 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIRAVTKLLRLQNLVMQHVDHSGGDFIHLLQ 408
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP+DRLTAREA+RHPFFTRD+LRR
Sbjct: 409 GLLRYDPSDRLTAREAVRHPFFTRDNLRR 437
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121850|ref|XP_002318688.1| predicted protein [Populus trichocarpa] gi|222859361|gb|EEE96908.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1598), Expect = e-175, Method: Compositional matrix adjust.
Identities = 291/324 (89%), Positives = 307/324 (94%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQ L KHDKG NRCVQIR
Sbjct: 99 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQNLGKHDKGSNRCVQIR 158
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTD
Sbjct: 159 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLRMIHTD 218
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSS+Y+KVPDYK+S +PKD SY+KR+PKSSAIKVIDFGSTTYER DQNYIV
Sbjct: 219 LKPENILLVSSDYVKVPDYKNSSRSPKDISYYKRVPKSSAIKVIDFGSTTYERQDQNYIV 278
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWS GCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ
Sbjct: 279 STRHYRAPEVILGLGWSYPCDIWSAGCILVELCTGEALFQTHENLEHLAMMERVLGPMPQ 338
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
H+LKRVDRHA KYVRRGRLDWPEGAASRES+K+V+KLPRLQNL+MQHVD SAGDL HLLQ
Sbjct: 339 HILKRVDRHAGKYVRRGRLDWPEGAASRESMKAVLKLPRLQNLVMQHVDQSAGDLIHLLQ 398
Query: 301 GLLRYDPTDRLTAREALRHPFFTR 324
GLLRYDP DRLTAREALRHPF +
Sbjct: 399 GLLRYDPLDRLTAREALRHPFLAK 422
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516617|ref|XP_003526990.1| PREDICTED: serine/threonine-protein kinase AFC2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-175, Method: Compositional matrix adjust.
Identities = 295/329 (89%), Positives = 311/329 (94%), Gaps = 2/329 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NRCVQIR
Sbjct: 99 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNRCVQIR 158
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL MIHTD
Sbjct: 159 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLHMIHTD 218
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER DQ YIV
Sbjct: 219 LKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIV 276
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ
Sbjct: 277 STRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQ 336
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
MLKRVDRHAEKYVRRGRLDWPEGAASRESIK+VMKLPRLQN+IMQHVDHSAGDL HLLQ
Sbjct: 337 QMLKRVDRHAEKYVRRGRLDWPEGAASRESIKAVMKLPRLQNIIMQHVDHSAGDLIHLLQ 396
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP +RLTAR+ALRH FFTRD LRR
Sbjct: 397 GLLRYDPFERLTARDALRHSFFTRDQLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357461735|ref|XP_003601149.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] gi|355490197|gb|AES71400.1| Serine/threonine protein kinase AFC2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1594), Expect = e-174, Method: Compositional matrix adjust.
Identities = 294/329 (89%), Positives = 311/329 (94%), Gaps = 2/329 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIK+VR IKKYREAAMIEIE+LQQL KHDKGGNRCVQIR
Sbjct: 100 MGEGTFGQVLECWDRERKEMVAIKVVRAIKKYREAAMIEIEMLQQLGKHDKGGNRCVQIR 159
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTD
Sbjct: 160 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLHMIHTD 219
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSEY+K+PDYKSS P S++KR+PKSSAIKVIDFGSTTYER +QNYIV
Sbjct: 220 LKPENILLVSSEYLKIPDYKSSSRAP--CSFYKRVPKSSAIKVIDFGSTTYERENQNYIV 277
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLG LPQ
Sbjct: 278 STRHYRAPEVILGLGWSYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGLLPQ 337
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+LKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL HLLQ
Sbjct: 338 QLLKRVDRHAEKYVRRGRLDWPEGANSRESIKAVMKLPRLQNLIMQHVDHSAGDLIHLLQ 397
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP +R+TAR+ALRHPFF RDHLRR
Sbjct: 398 GLLRYDPFERVTARDALRHPFFMRDHLRR 426
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356508738|ref|XP_003523111.1| PREDICTED: serine/threonine-protein kinase AFC2-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 618 bits (1593), Expect = e-174, Method: Compositional matrix adjust.
Identities = 296/329 (89%), Positives = 310/329 (94%), Gaps = 2/329 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL KHDKG NRCVQIR
Sbjct: 99 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLGKHDKGSNRCVQIR 158
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL MIHTD
Sbjct: 159 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLRMIHTD 218
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER DQ YIV
Sbjct: 219 LKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIV 276
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ
Sbjct: 277 STRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQ 336
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
MLKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGDL HLLQ
Sbjct: 337 QMLKRVDRHAEKYVRRGRLDWPEGAISRESIKAVMKLPRLQNLIMQHVDHSAGDLIHLLQ 396
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP +RLTAR+ALRH FF RDHLRR
Sbjct: 397 GLLRYDPFERLTARDALRHSFFMRDHLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074570|gb|ACJ85645.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 293/329 (89%), Positives = 310/329 (94%), Gaps = 2/329 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIK+VR IKKYREAAMIEIE+LQQL KHDKGGNRCVQIR
Sbjct: 1 MGEGTFGQVLECWDRERKEMVAIKVVRAIKKYREAAMIEIEMLQQLGKHDKGGNRCVQIR 60
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKNNYRSFPIDLVREI RQLLEC+AFMHDL MIHTD
Sbjct: 61 NWFDYRNHICIVFEKLGPSLYDFLRKNNYRSFPIDLVREIGRQLLECVAFMHDLHMIHTD 120
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSEY+K+PDYKSS P S++KR+PKSSAIKVIDFGSTTYER +QNYIV
Sbjct: 121 LKPENILLVSSEYLKIPDYKSSSRAP--CSFYKRVPKSSAIKVIDFGSTTYERENQNYIV 178
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCILVELCTGEALFQTHENLEHLAMMERVLG LPQ
Sbjct: 179 STRHYRAPEVILGLGWSYPCDVWSVGCILVELCTGEALFQTHENLEHLAMMERVLGLLPQ 238
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+LKRVDRHAEKYVRRGRLDWPEGA SRESIK+VMKLPRLQNLIMQHVDHSAGD HLLQ
Sbjct: 239 QLLKRVDRHAEKYVRRGRLDWPEGANSRESIKAVMKLPRLQNLIMQHVDHSAGDFIHLLQ 298
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP +R+TAR+ALRHPFF RDHLRR
Sbjct: 299 GLLRYDPFERVTARDALRHPFFMRDHLRR 327
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255647343|gb|ACU24138.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 617 bits (1591), Expect = e-174, Method: Compositional matrix adjust.
Identities = 295/329 (89%), Positives = 310/329 (94%), Gaps = 2/329 (0%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM+EIEVLQQL KHDKG NRCVQIR
Sbjct: 99 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMVEIEVLQQLGKHDKGSNRCVQIR 158
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVREI QLLEC+AFMHDL MIHTD
Sbjct: 159 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREIGWQLLECVAFMHDLHMIHTD 218
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVS EY+K+PDYKS+ +P SS+FKR+PKSSAIKVIDFGSTTYER DQ YIV
Sbjct: 219 LKPENILLVSPEYLKIPDYKSTTRSP--SSFFKRVPKSSAIKVIDFGSTTYEREDQTYIV 276
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP+PQ
Sbjct: 277 STRHYRAPEVILGLGWSYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPIPQ 336
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
MLKRVDRHAEKYVRRGRLDWPEGAASRESIK+VMKLPRLQN IMQHVDHSAGDL HLLQ
Sbjct: 337 QMLKRVDRHAEKYVRRGRLDWPEGAASRESIKAVMKLPRLQNTIMQHVDHSAGDLIHLLQ 396
Query: 301 GLLRYDPTDRLTAREALRHPFFTRDHLRR 329
GLLRYDP +RLTAR+ALRH FFTRD LRR
Sbjct: 397 GLLRYDPFERLTARDALRHSFFTRDQLRR 425
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 329 | ||||||
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.978 | 0.754 | 0.851 | 9.2e-155 | |
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.984 | 0.693 | 0.796 | 2.2e-144 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.969 | 0.797 | 0.665 | 9.8e-119 | |
| UNIPROTKB|E1B9Q2 | 500 | CLK2 "Uncharacterized protein" | 0.945 | 0.622 | 0.475 | 1.2e-79 | |
| UNIPROTKB|F1P919 | 612 | CLK2 "Uncharacterized protein" | 0.945 | 0.508 | 0.475 | 1.2e-79 | |
| UNIPROTKB|B1AVT0 | 497 | CLK2 "Dual-specificity protein | 0.945 | 0.625 | 0.475 | 1.2e-79 | |
| UNIPROTKB|P49760 | 499 | CLK2 "Dual specificity protein | 0.945 | 0.623 | 0.475 | 1.2e-79 | |
| UNIPROTKB|F1RLJ5 | 500 | CLK2 "Uncharacterized protein" | 0.945 | 0.622 | 0.475 | 1.2e-79 | |
| MGI|MGI:1098669 | 499 | Clk2 "CDC-like kinase 2" [Mus | 0.939 | 0.619 | 0.478 | 1.6e-79 | |
| POMBASE|SPAC1D4.11c | 690 | lkh1 "dual specificity protein | 0.951 | 0.453 | 0.472 | 2e-79 |
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1509 (536.3 bits), Expect = 9.2e-155, P = 9.2e-155
Identities = 276/324 (85%), Positives = 305/324 (94%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLECWDRERKEMVA+KIVRG+KKYREAAMIEIE+LQQL KHDKGGNRCVQIR
Sbjct: 104 MGEGTFGQVLECWDRERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIR 163
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI QLLEC+AFMHDL MIHTD
Sbjct: 164 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTD 223
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSS+Y+K+P+YK S +D Y KR+PKSSAIKVIDFGSTTYER DQ YIV
Sbjct: 224 LKPENILLVSSDYVKIPEYKGS-RLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIV 281
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILGLGW+YPCD+WSVGCI+VELCTGEALFQTHENLEHLAMMERVLGP PQ
Sbjct: 282 STRHYRAPEVILGLGWSYPCDVWSVGCIIVELCTGEALFQTHENLEHLAMMERVLGPFPQ 341
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
MLK+VDRH+EKYVRRGRLDWP+GA SR+S+K+V+KLPRLQNLIMQHVDHSAG+L +++Q
Sbjct: 342 QMLKKVDRHSEKYVRRGRLDWPDGATSRDSLKAVLKLPRLQNLIMQHVDHSAGELINMVQ 401
Query: 301 GLLRYDPTDRLTAREALRHPFFTR 324
GLLR+DP++R+TAREALRHPFF R
Sbjct: 402 GLLRFDPSERITAREALRHPFFAR 425
|
|
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
Identities = 259/325 (79%), Positives = 289/325 (88%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFGQVLEC+D + KE+VAIK++R I KYREAAMIEI+VLQ+L +HD GG+RCVQIR
Sbjct: 121 MGEGTFGQVLECFDNKNKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIR 180
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SLYDFLRKN+YRSFPIDLVRE+ RQLLE +A+MHDL +IHTD
Sbjct: 181 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTD 240
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSEYIK+PDYK KD SYFK +PKSSAIK+IDFGSTT+E D NYIV
Sbjct: 241 LKPENILLVSSEYIKIPDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIV 300
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
STRHYRAPEVILG+GW YPCD+WS+GCILVELC+GEALFQTHENLEHLAMMERVLGPLP
Sbjct: 301 STRHYRAPEVILGVGWNYPCDLWSIGCILVELCSGEALFQTHENLEHLAMMERVLGPLPP 360
Query: 241 HMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
HM+ R DR +EKY RRG +LDWPEGA SR+S+K+V KLPRL NLIMQHVDHSAGDL LL
Sbjct: 361 HMVLRADRRSEKYFRRGAKLDWPEGATSRDSLKAVWKLPRLPNLIMQHVDHSAGDLIDLL 420
Query: 300 QGLLRYDPTDRLTAREALRHPFFTR 324
QGLLRYDPT+R AREAL HPFFTR
Sbjct: 421 QGLLRYDPTERFKAREALNHPFFTR 445
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1169 (416.6 bits), Expect = 9.8e-119, P = 9.8e-119
Identities = 215/323 (66%), Positives = 266/323 (82%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MGEGTFG+VLECWDR+ KE VAIKI+R IKKYR+AAMIEI+VLQ+L K DKG RCVQ++
Sbjct: 77 MGEGTFGRVLECWDRDTKEYVAIKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMK 136
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
NWFDYRNHICIVFEKLG SL+DFL++N Y +FP+ LVR+ QLLE +A+MH+L ++HTD
Sbjct: 137 NWFDYRNHICIVFEKLGPSLFDFLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTD 196
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LLVSSE +K+PD K S + ++F+ +PKSSAIK+IDFGST + + IV
Sbjct: 197 LKPENILLVSSENVKLPDNKRSA---ANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIV 253
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
TRHYR+PEVILGLGW+Y CD+WS+GCIL ELCTGEALFQTH+NLEHLAMMER LGPLP+
Sbjct: 254 QTRHYRSPEVILGLGWSYQCDLWSIGCILFELCTGEALFQTHDNLEHLAMMERALGPLPE 313
Query: 241 HMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
HM ++ R AEKY RRG RL+WPEGA SRESI++V +L RL++++ +HVD++ LL
Sbjct: 314 HMTRKASRGAEKYFRRGCRLNWPEGANSRESIRAVKRLDRLKDMVSKHVDNTRSRFADLL 373
Query: 300 QGLLRYDPTDRLTAREALRHPFF 322
GLL YDP++RLTA EAL HPFF
Sbjct: 374 YGLLAYDPSERLTANEALDHPFF 396
|
|
| UNIPROTKB|E1B9Q2 CLK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 155/326 (47%), Positives = 219/326 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 169 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 228
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 229 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 288
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 289 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 340
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 341 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 400
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 401 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH--QLFDL 455
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 456 IESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1P919 CLK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 155/326 (47%), Positives = 219/326 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 281 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 340
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 341 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 400
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 401 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 452
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 453 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 512
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 513 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH--QLFDL 567
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 568 IESMLEYEPAKRLTLGEALQHPFFAR 593
|
|
| UNIPROTKB|B1AVT0 CLK2 "Dual-specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 155/326 (47%), Positives = 219/326 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 167 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 226
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 227 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 286
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 287 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 338
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 339 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 398
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 399 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH--QLFDL 453
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 454 IESMLEYEPAKRLTLGEALQHPFFAR 479
|
|
| UNIPROTKB|P49760 CLK2 "Dual specificity protein kinase CLK2" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 155/326 (47%), Positives = 219/326 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 169 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 228
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 229 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 288
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 289 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 340
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 341 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 400
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 401 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH--QLFDL 455
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 456 IESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| UNIPROTKB|F1RLJ5 CLK2 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 800 (286.7 bits), Expect = 1.2e-79, P = 1.2e-79
Identities = 155/326 (47%), Positives = 219/326 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 169 LGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 228
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 229 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 288
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 289 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 340
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 341 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 400
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + +H L L
Sbjct: 401 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEEHH--QLFDL 455
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L Y+P RLT EAL+HPFF R
Sbjct: 456 IESMLEYEPAKRLTLGEALQHPFFAR 481
|
|
| MGI|MGI:1098669 Clk2 "CDC-like kinase 2" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 799 (286.3 bits), Expect = 1.6e-79, P = 1.6e-79
Identities = 155/324 (47%), Positives = 218/324 (67%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V++C D R VA+KI++ ++KY+EAA +EI VL+++ + D N CVQ
Sbjct: 168 LGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLCVQ 227
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WFDY H+CI FE LG S +DFL+ NNY +PI VR +A QL + + F+HD + H
Sbjct: 228 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 287
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+S+Y + +L +D +R KS+A++V+DFGS T++ +
Sbjct: 288 TDLKPENILFVNSDY----ELTYNLEKKRD----ERSVKSTAVRVVDFGSATFDHEHHST 339
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IVSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E G LFQTH+N EHLAMMER+LGP+
Sbjct: 340 IVSTRHYRAPEVILELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPV 399
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P M+++ + +KY RGRLDW E ++ ++ K P + L + DH L L
Sbjct: 400 PSRMIRKTRK--QKYFYRGRLDWDENTSAGRYVRENCK-PLRRYLTSEAEDHH--QLFDL 454
Query: 299 LQGLLRYDPTDRLTAREALRHPFF 322
++ +L Y+P RLT EAL+HPFF
Sbjct: 455 IENMLEYEPAKRLTLGEALQHPFF 478
|
|
| POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 798 (286.0 bits), Expect = 2.0e-79, P = 2.0e-79
Identities = 155/328 (47%), Positives = 227/328 (69%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQI 59
+G GTFG+V++C+D+ AIK+ R I KYREA++IE+ VLQ +A D N+C+Q+
Sbjct: 368 LGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREASLIELRVLQTIAHSDPTNENKCIQL 427
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
R++FDYR HICIV + G S++DFL+ NNY FP+ ++ +++QL + +AF+H L ++HT
Sbjct: 428 RDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHT 487
Query: 120 DLKPENVLLVS--SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
DLKPENVLLVS S I++P Y++ Y +++ S I++IDFGS T+E +
Sbjct: 488 DLKPENVLLVSNASRTIRLP-YRN---------YSQKVLNSCEIRLIDFGSATFEDEYHS 537
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+VSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL TG+ALFQTHE+ EHL MME++LGP
Sbjct: 538 SVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVELFTGQALFQTHEDSEHLCMMEKILGP 597
Query: 238 LPQHMLKRVDRHAEKYVRR-GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
++M+ R R ++++ + G++ +P ++SI + L L+ + A L
Sbjct: 598 FDRNMISRSSRTSQRFFKSDGKVRYPLSNTPKKSINYLQSLQTLEQIFAVSSPEVAL-LL 656
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTR 324
LL+ + YDP R+TA+EAL HPFFT+
Sbjct: 657 DLLKKVFVYDPKRRITAKEALWHPFFTQ 684
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.12.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.12 | 0.976 |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | estExt_fgenesh4_pg.C_LG_XV0599 | hypothetical protein (428 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 329 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-71 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-63 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-57 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-53 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-49 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-48 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-43 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-37 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-35 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-35 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-34 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-34 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-32 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-32 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-30 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-30 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-28 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-28 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-27 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-27 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-27 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-26 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-26 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-25 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-25 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-24 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-24 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-23 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-22 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-20 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-20 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-19 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-16 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-13 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-12 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-12 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-12 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-08 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-04 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-04 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-04 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.001 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.001 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 0.003 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.003 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 7e-71
Identities = 96/326 (29%), Positives = 143/326 (43%), Gaps = 84/326 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
GEG+FG+V D++ ++VAIK+++ IKK RE + EI++L++L KH V++
Sbjct: 8 GEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPN----IVRL 62
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ F+ + + +V E G L+D L+K D R RQ+L + ++H ++H
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSKGIVH 120
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKPEN+LL + +K+ DFG P +
Sbjct: 121 RDLKPENILLDEDGH---------------------------VKLADFGLARQLDPGEKL 153
Query: 179 --IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
V T Y APEV+LG G+ DIWS+G IL EL TG+ F + L + +++
Sbjct: 154 TTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL--ELFKKIGK 211
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
P P PE S E+
Sbjct: 212 PKPP------------------FPPPEWDISPEAK------------------------- 228
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFF 322
L++ LL DP RLTA EAL+HPFF
Sbjct: 229 DLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 8e-63
Identities = 119/329 (36%), Positives = 181/329 (55%), Gaps = 33/329 (10%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN-RCVQI 59
+GEGTFG+V+E WDR+RKE A+KIVR + KY A IEI+ ++++ + D ++I
Sbjct: 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKI 196
Query: 60 RNWF-DYRNHICIVFEKLGSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAFMH-DL 114
+ +F + H+CIV K G L D++ K+ ++R +I Q + + H +L
Sbjct: 197 QRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLA-----QIIFQTGVALDYFHTEL 251
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++HTDLKPEN+L+ +S+ V D ++ P P +++ D G ER
Sbjct: 252 HLMHTDLKPENILMETSD--TVVDPVTNRALP---------PDPCRVRICDLGGCCDERH 300
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ IVSTRHYR+PEV+LGLGW Y D+WS+GCI+ EL TG+ L+ TH+NLEHL +ME+
Sbjct: 301 SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360
Query: 235 LGPLPQHMLKRVDRHAEK--YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
LG LP R + Y G+L + + + + ++ +I +
Sbjct: 361 LGRLPSEWAGRCGTEEARLLYNSAGQL---RPCTDPKHLARIARARPVREVIRDDL---- 413
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPF 321
L L+ GLL YD RL AR+ HP+
Sbjct: 414 --LCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 9e-57
Identities = 87/330 (26%), Positives = 143/330 (43%), Gaps = 84/330 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G G+FG V + + ++VA+KI++ K + A EI +L++L H V
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPNI----V 61
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + F+ ++H+ +V E G L+D+L + D ++IA Q+L + ++H +
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
IH DLKPEN+LL + +K+ DFG + +
Sbjct: 120 IHRDLKPENILLDENGVVKI---------------------------ADFGLAKKLLKSS 152
Query: 176 QNY--IVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ V T Y APEV+L G G+ D+WS+G IL EL TG+ F L+ L ++
Sbjct: 153 SSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
R+LGP D P+ ++ E
Sbjct: 213 RILGPPL------------------EFDEPKWSSGSE----------------------- 231
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ L++ L DP+ R TA E L+HP+F
Sbjct: 232 -EAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 2e-53
Identities = 102/333 (30%), Positives = 156/333 (46%), Gaps = 69/333 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMI--EIEVLQQLAKHDKGGNRCV 57
G+GTFG V ++E E+VAIK + KK+ E M E++ L++L +H V
Sbjct: 8 GDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEHPN----IV 61
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+++ F + + VFE + +LY ++ + F ++R I Q+L+ +A +H
Sbjct: 62 KLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF 121
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--STTYERPD 175
H DLKPEN LLVS + +K+ DFG RP
Sbjct: 122 HRDLKPEN-LLVSGPEV--------------------------VKIADFGLAREIRSRPP 154
Query: 176 QNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
VSTR YRAPE++L Y P DIW++GCI+ EL T LF ++ L +
Sbjct: 155 YTDYVSTRWYRAPEILLRSTS-YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213
Query: 234 VLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA--ASRESIKSVMKLPRL-QNLIMQHVD 289
VLG P Q DWPEG AS+ + P+ + Q +
Sbjct: 214 VLGTPTKQ-------------------DWPEGYKLASKLGF----RFPQFAPTSLHQLIP 250
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+++ + L++ +LR+DP R TA +AL+HP+F
Sbjct: 251 NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-49
Identities = 95/343 (27%), Positives = 153/343 (44%), Gaps = 90/343 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGNR 55
GEGT+G V + D++ E+VA+K +R GI A+ EI +L++L KH N
Sbjct: 8 GEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS---TALREISLLKEL-KHP---N- 59
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V++ + + +VFE L +L +L++ I QLL +A+ H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKKYL-DKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
++H DLKP+N +L++ + + +K+ DFG + + P
Sbjct: 119 ILHRDLKPQN-ILINRDGV--------------------------LKLADFGLARAFGIP 151
Query: 175 DQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ Y V T YRAPE++LG ++ DIWSVGCI E+ TG+ LF ++ L +
Sbjct: 152 LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211
Query: 232 ERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH--- 287
++LG P + WP V KLP + +
Sbjct: 212 FQILGTPTEE-------------------SWPG----------VTKLPDYKPTFPKFPPK 242
Query: 288 --------VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+D D LL +L+Y+P R++A+EAL+HP+F
Sbjct: 243 DLEKVLPRLDPEGID---LLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-48
Identities = 99/329 (30%), Positives = 159/329 (48%), Gaps = 58/329 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
GEG +G VL+C ++ E+VAIK + ++ A+ E++VL+QL +H+ V
Sbjct: 10 GEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN----IVN 64
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
++ F + + +VFE + +L + L + P D VR QLL+ IA+ H +IH
Sbjct: 65 LKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY--ERPDQ 176
D+KPEN +LVS +S +K+ DFG RP
Sbjct: 124 RDIKPEN-ILVS--------------------------ESGVLKLCDFGFARALRARPAS 156
Query: 177 NYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
V+TR YRAPE+++G + P D+W++GCI+ EL GE LF +++ L ++++
Sbjct: 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
LGPLP + + R + +PE + ES++ R + +
Sbjct: 217 CLGPLPPSHQELFSSNP----RFAGVAFPE-PSQPESLER-----RYPGKV-------SS 259
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
L+ LR DP +RLT E L+HP+F
Sbjct: 260 PALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-45
Identities = 98/337 (29%), Positives = 150/337 (44%), Gaps = 75/337 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEGT+G V + D+ E+VAIK ++ GI K A+ EI++L++L H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPK---TALREIKLLKEL-NHPN--- 59
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+++ + F ++ + +VFE + + LY ++ R P L++ QLL+ +AF H
Sbjct: 60 -IIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++H DLKPEN+L+ +K+ DFG
Sbjct: 118 GILHRDLKPENLLI---------------------------NTEGVLKLADFGLARSFGS 150
Query: 175 DQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
V TR YRAPE++LG G++ P DIWSVGCI EL + LF ++ L
Sbjct: 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK 210
Query: 231 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGA----ASRESIKSVMKLPRLQNLIM 285
+ R LG P P+ WP+ + S +P +
Sbjct: 211 IFRTLGTPDPEV-------------------WPKFTSLARNYKFSFPKKAGMP--LPKLF 249
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ A D LL +L YDP R+TA +AL HP+F
Sbjct: 250 PNASPQALD---LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 1e-43
Identities = 73/218 (33%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
GEG FG V D++ + VAIKI++ E + EIE+L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
F+ NH+ +V E G SL D L++N + D + I Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKPEN+LL S +K+ DFG + D++
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149
Query: 179 ---IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVEL 212
IV T Y APEV+LG G ++ DIWS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 6e-43
Identities = 95/330 (28%), Positives = 148/330 (44%), Gaps = 58/330 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+GEG G V + DRE E VA+K + R A+ EI+ LQ +H V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHP----YVV 62
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ + F + + +V E + S L + LR + R P V+ R LL+ +A+MH ++
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
H DLKP N+L+ + +K+ D+ + + Y +
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ--------------------- 160
Query: 176 QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
V+TR YRAPE++ G + D+W+VGCI EL G LF ++E LA++ R
Sbjct: 161 ----VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216
Query: 235 LG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
LG P + WP + + K + + ++
Sbjct: 217 LGTPNEE-------------------TWPGLTSLPDYNKITFP-ESKPIPLEEIFPDASP 256
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+ LL+GLL YDP+ RL+A EALRHP+FT
Sbjct: 257 EALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 89/336 (26%), Positives = 143/336 (42%), Gaps = 71/336 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-EIEVLQQLAKHDKGGN 54
GEG +G V + D VA+K VR GI + + EI +L+QL +
Sbjct: 8 GEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIP----LSTLREIALLKQLESFEH--P 61
Query: 55 RCVQIR----NWFDYRN-HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
V++ R + +VFE + L +L K P + ++++ RQLL +
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS- 168
F+H ++H DLKP+N+L+ S +K+ D+ + ++ F
Sbjct: 122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA-------------------RIYSFEMA 162
Query: 169 -TTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
T+ +V T YRAPEV+L + P D+WSVGCI EL LF+ +
Sbjct: 163 LTS--------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ 214
Query: 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRLQNLIMQ 286
L + V+G + +WP + R S S PR +
Sbjct: 215 LDKIFDVIGLPSEE------------------EWPRNVSLPRSSFPS--YTPRSFKSFVP 254
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ D LL+ +L ++P R++A EAL+HP+F
Sbjct: 255 EICEEGLD---LLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-36
Identities = 97/336 (28%), Positives = 164/336 (48%), Gaps = 72/336 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK---------IVRGIKKYREAAMIEIEVLQQLAKHDK 51
+GEG++G V +C +RE ++VAIK +++ I A+ EI +L+QL KH
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLKQL-KH-- 59
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V + F + + +VFE ++ + L KN R P L+++I Q L+ + F
Sbjct: 60 --PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFC 116
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 170
H IH D+KPEN+L+ K IK+ DFG +
Sbjct: 117 HKHNCIHRDVKPENILIT---------------------------KQGQIKLCDFGFARI 149
Query: 171 YERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
P +Y V+TR YRAPE+++G + P D+W++GC+ EL TG+ L+ +++
Sbjct: 150 LTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ 209
Query: 228 LAMMERVLGPL-PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
L ++ + LG L P+H +++ ++ + + PE +RE ++ K P + + +
Sbjct: 210 LYLIRKTLGDLIPRH--QQIFS-TNQFFKGLSIPEPE---TREPLE--SKFPNISSPALS 261
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
L+G L+ DPT+RL+ E L HP+F
Sbjct: 262 -----------FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (328), Expect = 2e-35
Identities = 93/351 (26%), Positives = 144/351 (41%), Gaps = 101/351 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCV 57
GEGT+GQV + +++ E+VA+K +R ++ +E A+ EI++LQ+L +H V
Sbjct: 8 GEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPITAIREIKLLQKL-RHPN----IV 61
Query: 58 QIRNWFDYRNHICIVFEKLGSSLY--------DF---LRKNNYRSFPIDLVREIARQLLE 106
++ IV K S+Y D L + F ++ +QLLE
Sbjct: 62 RL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCYMKQLLE 111
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
+ ++H ++H D+K N+L+ + L K+ DF
Sbjct: 112 GLQYLHSNGILHRDIKGSNILI---------NNDGVL------------------KLADF 144
Query: 167 G-STTYE---RPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 221
G + Y D V T YR PE++LG + D+WSVGCIL EL G+ +FQ
Sbjct: 145 GLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204
Query: 222 HENLEHLAMMERVLGP----------LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 271
LE L + + G + + Y RR RE
Sbjct: 205 STELEQLEKIFELCGSPTDENWPGVSKLPWF--ENLKPKKPYKRR----------LREFF 252
Query: 272 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
K ++ D SA D LL LL DP R++A +AL+H +F
Sbjct: 253 KHLI-------------DPSALD---LLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 87/333 (26%), Positives = 148/333 (44%), Gaps = 66/333 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA------AMIEIEVLQQLAKHDKGGNR 55
GEGT+ V + D+E +VAIK ++ ++ A+ EI++LQ+L KH
Sbjct: 9 GEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPN---- 63
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ + + F ++++I +VFE + + L ++ + P D ++ L + ++H
Sbjct: 64 IIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLRGLEYLHSNW 122
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
++H DLKP N LL++S+ + +K+ DFG + ++ P
Sbjct: 123 ILHRDLKPNN-LLIASDGV--------------------------LKLADFGLARSFGSP 155
Query: 175 DQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
++ V TR YRAPE++ G + D+WSVGCI EL +++ L +
Sbjct: 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215
Query: 232 ERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
LG P + +WP G S P + Q
Sbjct: 216 FEALGTPTEE-------------------NWP-GVTSLPDYVEFKPFPPTP--LKQIFPA 253
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
++ D LLQ LL +P R+TAR+AL HP+F+
Sbjct: 254 ASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-35
Identities = 94/327 (28%), Positives = 158/327 (48%), Gaps = 53/327 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+GEG +G VL+C +E KE+VAIK + ++ +E + E+++L+ L + + V
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN-----IV 63
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+++ F R + +VFE + ++ + L + P + VR QL++ I + H ++
Sbjct: 64 ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHWCHKNDIV 122
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+KPEN+L+ ++ +K+ D+ F E + N
Sbjct: 123 HRDIKPENLLISHNDVLKLCDF-------------------------GFARNLSEGSNAN 157
Query: 178 YI--VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
Y V+TR YR+PE++LG + D+WSVGCIL EL G+ LF ++ L +++VL
Sbjct: 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
GPLP +K + R L +P ++ L R I+ G L
Sbjct: 218 GPLPAEQMKLFYSNP----RFHGLRFP-------AVNHPQSLERRYLGILS------GVL 260
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFF 322
L++ LL+ +PTDR + L HP F
Sbjct: 261 LDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 94/347 (27%), Positives = 148/347 (42%), Gaps = 81/347 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
G G +G V D+ VAIK I +A I EI++L+ L +H+ N +
Sbjct: 9 GSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHE---N-IIG 63
Query: 59 IRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIAR----QLLECIA 109
+ + + N + IV E + + L+ ++ P L + + Q+L +
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFLYQILRGLK 117
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-- 167
++H +IH DLKP N+L+ S+ +K+ DFG
Sbjct: 118 YLHSANVIHRDLKPSNILVNSN---------------------------CDLKICDFGLA 150
Query: 168 --STTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 221
E Y+V TR YRAPE++L +T DIWSVGCI EL T + LF
Sbjct: 151 RGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209
Query: 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 281
+ ++ L ++ VLG + LK + +R +KS+ K P+ +
Sbjct: 210 RDYIDQLNLIVEVLGTPSEEDLKFI----------------TSEKARNYLKSLPKKPK-K 252
Query: 282 NL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
L + A D LL+ +L +DP R+TA EAL HP+ + H
Sbjct: 253 PLSKLFPGASPEAID---LLEKMLVFDPKKRITADEALAHPYLAQLH 296
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 92/347 (26%), Positives = 138/347 (39%), Gaps = 93/347 (26%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNRC 56
+GEGT+G V D E+VA+K VR + R+ I EI +L L +H
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RHPN----I 68
Query: 57 VQIRNWF--DYRNHICIVFE----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V+++ + + I +V E L S L N F V+ + QLL + +
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQY 123
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 169
+H+ +IH DLK N+L + +K+ DFG +
Sbjct: 124 LHENFIIHRDLKVSNLL---------------------------LTDKGCLKIADFGLAR 156
Query: 170 TYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
TY P + V T YRAPE++LG +T D+W+VGCIL EL + L +E
Sbjct: 157 TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE 216
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
L ++ ++LG + + WP LP + +
Sbjct: 217 QLDLIIQLLGTPNESI------------------WP----------GFSDLPLVGKFTLP 248
Query: 287 HVDHSAGDLTH-----------LLQGLLRYDPTDRLTAREALRHPFF 322
++ +L H LL LL YDP R TA EAL +F
Sbjct: 249 KQPYN--NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 97/329 (29%), Positives = 149/329 (45%), Gaps = 62/329 (18%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNRCV 57
GEGTF +VL+ R+ + AIK K ++ + EI+ L++L+ H N
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPH---PNILR 62
Query: 58 QIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
I FD + + +VFE + +LY+ + K R P V+ QLL+ + MH +
Sbjct: 63 LIEVLFDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS--TTYERP 174
H D+KPEN+L+ K +K+ DFGS Y +P
Sbjct: 122 FHRDIKPENILI----------------------------KDDILKLADFGSCRGIYSKP 153
Query: 175 DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
+STR YRAPE +L G + DIW+VGC+ E+ + LF L+ +A +
Sbjct: 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
VLG +LK+ + ++P K L +L + +
Sbjct: 214 VLGTPDAEVLKKFRKSRHM-----NYNFPS--------KKGTGLRKL----LPNASAEGL 256
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D LL+ LL YDP +R+TA++ALRHP+F
Sbjct: 257 D---LLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-33
Identities = 100/345 (28%), Positives = 148/345 (42%), Gaps = 76/345 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKG 52
+G+G +G V + DR KE+VA+K + + +RE I LQ+L H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFRE-----IMFLQELGDHPN- 68
Query: 53 GNRCVQIRNWFDYRNH--ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V++ N N I +VFE + + L+ +R N R I QLL+ + +
Sbjct: 69 ---IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED---VHKRYIMYQLLKALKY 122
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 167
+H +IH DLKP N+LL +S +K+ DFG
Sbjct: 123 IHSGNVIHRDLKPSNILL-------------------NSDCR--------VKLADFGLAR 155
Query: 168 -----STTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQT 221
E P V+TR YRAPE++LG T D+WSVGCIL E+ G+ LF
Sbjct: 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215
Query: 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 281
L L + V+GP ++ + P A +S+ S + P +
Sbjct: 216 TSTLNQLEKIIEVIGPPSAEDIESIKS-------------PFAATMLDSLPSRPRKPLDE 262
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ A D LL+ LL ++P RLTA EAL HP+ + H
Sbjct: 263 --LLPKASDDALD---LLKKLLVFNPNKRLTAEEALEHPYVAQFH 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 99/334 (29%), Positives = 153/334 (45%), Gaps = 69/334 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEGT+G V + ++ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP---STAIREISLLKEL-NHPN--- 60
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 61 -IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
++H DLKP+N LL+++E AIK+ DFG + +
Sbjct: 120 RVLHRDLKPQN-LLINTE--------------------------GAIKLADFGLARAFGV 152
Query: 174 PDQNYI--VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
P + Y V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L
Sbjct: 153 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHV 288
+ R LG P ++ WP G S K Q+ ++ +
Sbjct: 213 IFRTLGT-PDEVV-----------------WP-GVTSLPDYKPSFPKWARQDFSKVVPPL 253
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D D LL +L YDP R++A+ AL HPFF
Sbjct: 254 DEDGRD---LLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 69/334 (20%)
Query: 3 EGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCVQ 58
EGT+G V D++ E+VA+K ++ ++K +E ++ EI +L +L +H V
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHPN----IVT 68
Query: 59 IRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + I +V E + L + + + F V+ + QLL +A +HD +
Sbjct: 69 VKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
+H DLK N+L + +K+ DFG + Y P
Sbjct: 128 LHRDLKTSNLL---------------------------LNNRGILKICDFGLAREYGSPL 160
Query: 176 QNY--IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ Y +V T YRAPE++LG ++ D+WSVGCI EL T + LF ++ L +
Sbjct: 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
++LG P EK WP G + K N + +
Sbjct: 221 KLLG-TPT----------EK-------IWP-GFSELPGAKKKTFTKYPYNQLRKKFPA-- 259
Query: 293 GDLTH----LLQGLLRYDPTDRLTAREALRHPFF 322
L+ LL LL YDP R++A +AL+HP+F
Sbjct: 260 LSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 88/327 (26%), Positives = 149/327 (45%), Gaps = 55/327 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+GEGT+ V + +R E+VA+K + + A+ EI ++++L KH+ V+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHEN----IVR 62
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + N + +VFE + L ++ + + + V+ QLL+ IAF H+ ++
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVL 122
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKP+N+L+ +K+ D+ + ++ I V F +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFG--------------LARAFGIPVNTFSNE-------- 160
Query: 178 YIVSTRHYRAPEVILGLGWTYPC--DIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T YRAP+V+LG TY DIWSVGCI+ E+ TG LF N + L + R++
Sbjct: 161 --VVTLWYRAPDVLLG-SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIM 217
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
G + + + E + +P LQ L H+
Sbjct: 218 GTPTESTWPGISQLPEY-----KPTFPRYPPQ-----------DLQQLF----PHADPLG 257
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFF 322
LL LL+ +P R++A +AL+HP+F
Sbjct: 258 IDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 65/258 (25%), Positives = 111/258 (43%), Gaps = 54/258 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G+FG V D++ E++A+K + ++ EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QH----PNIVR 63
Query: 59 IR--NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H D+K N+L+ S +K+ DFG D
Sbjct: 122 IVHRDIKGANILVDSD---------------------------GVVKLADFGCAK-RLGD 153
Query: 176 QNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
T R APEVI G + DIWS+GC ++E+ TG+ + E +A
Sbjct: 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW--SELGNPMA 211
Query: 230 MMERVLG-----PLPQHM 242
+ ++ +P+H+
Sbjct: 212 ALYKIGSSGEPPEIPEHL 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 6e-31
Identities = 98/335 (29%), Positives = 161/335 (48%), Gaps = 70/335 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+GEG++G V++C +E ++VAIK K ++ AM EI +L+QL +H+ V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHEN----LV 63
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDL----VREIARQLLECIAFMHD 113
+ F + + +VFE + ++ D L K +P L VR+ Q+L I F H
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEK-----YPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 172
+IH D+KPEN+L VS +S +K+ DFG + T
Sbjct: 119 HNIIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFARTLA 151
Query: 173 RPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
P + Y V+TR YRAPE+++G + DIW+VGC++ E+ TGE LF +++ L
Sbjct: 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQH 287
+ + LG L + RH E + + + + M+LP ++ + + +
Sbjct: 212 HIIKCLGNL-------IPRHQEIF-------------QKNPLFAGMRLPEVKEIEPLEKR 251
Query: 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+G + L + LR DP DR ++ + L H FF
Sbjct: 252 FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 85/339 (25%), Positives = 134/339 (39%), Gaps = 71/339 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+GEG+FG+V DR+ VA+K++ K E + EI++L L
Sbjct: 8 LGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP----PNI 60
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIAFMHDL 114
V++ ++F + +V E + G SL D L+K + I Q+L + ++H
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 115 CMIHTDLKPENVLLVSSEY-IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+IH D+KPEN+LL +K+ D+ A + D GST+
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDF------------------GLAKLLPDPGSTSSIP 162
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPC---DIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ V T Y APEV+LGL Y DIWS+G L EL TG F+ +N +
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+++ LP L L + +
Sbjct: 223 TLKIILELPTPSLA------------------------------------SPLSPSNPEL 246
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 329
+ + LL+ LL DP +RL++ L H L+
Sbjct: 247 ISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKE 285
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 80/324 (24%), Positives = 132/324 (40%), Gaps = 83/324 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+G FG+V + + + VAIK+++ K+ +E + EI++L++ KH N V+
Sbjct: 9 GKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KH---PN-IVKYY 63
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ ++ + IV E G SL D L K+ ++ + + ++LL+ + ++H +IH
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE-RPDQN 177
D+K N+LL S +K+IDFG S +N
Sbjct: 123 DIKAANILLTS---------------------------DGEVKLIDFGLSAQLSDTKARN 155
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+V T ++ APEVI G + Y DIWS+G +EL G+ + E A+ +
Sbjct: 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKALFKIATNG 213
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
P L PE S E
Sbjct: 214 PP------------------GLRNPE-KWSDE-------------------------FKD 229
Query: 298 LLQGLLRYDPTDRLTAREALRHPF 321
L+ L+ +P R TA + L+HPF
Sbjct: 230 FLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 79/333 (23%), Positives = 130/333 (39%), Gaps = 72/333 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRC 56
+GEG+F V+ ++E + AIKI+ + +E IE EVL +L H G
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH-PG---I 64
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+++ F ++ V E L ++RK Y S R A ++L + ++H
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH DLKPEN+LL +IK+ D+ ++ +SS S + E+
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS------PESNKGDATNIDSQIEKNR 176
Query: 176 QN--YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
+ V T Y +PE++ D+W++GCI+ ++ TG+ F+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR------------- 223
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
G +++ E +P P ++LI
Sbjct: 224 --GSNEYLTFQKI-LKLE-------YSFPPNFP-----------PDAKDLI--------- 253
Query: 294 DLTHLLQGLLRYDPTDRLTA----REALRHPFF 322
+ LL DP DRL E HPFF
Sbjct: 254 ------EKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 94/334 (28%), Positives = 148/334 (44%), Gaps = 71/334 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGNR 55
GEGT+G V + D+ E+VA+K +R G+ A+ EI +L++L H
Sbjct: 8 GEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP---STAIREISLLKEL-NHPN---- 59
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V++ + N + +VFE L L ++ + L++ QLL+ IA+ H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
++H DLKP+N+L+ + A+K+ DFG + + P
Sbjct: 120 VLHRDLKPQNLLI---------------------------DREGALKLADFGLARAFGVP 152
Query: 175 DQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ Y V T YRAPE++LG Y P DIWS+GCI E+ LF ++ L
Sbjct: 153 VRTYTHEVVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHV 288
+ R LG + + WP G S K Q+L ++ ++
Sbjct: 212 IFRTLGTPDEDV------------------WP-GVTSLPDYKPTFPKWARQDLSKVVPNL 252
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D D LL +L YDP R++A+ AL+HP+F
Sbjct: 253 DEDGLD---LLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 81/329 (24%), Positives = 134/329 (40%), Gaps = 88/329 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 57
G+G+FG+VL ++ ++ A+K+++ I K +E E +L ++ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHP----FIV 56
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F + +V E G L+ L K F + R A +++ + ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLKPEN+LL + +IK+ D+ A ++ GS T
Sbjct: 115 IYRDLKPENILLDADGHIKLTDF------------------GLAKELSSEGSRTNT---- 152
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
T Y APEV+LG G+ D WS+G +L E+ TG+ F + E + E++L
Sbjct: 153 --FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEKIL- 206
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ L +PE + +
Sbjct: 207 -------------------KDPLRFPEFLSP--------------------------EAR 221
Query: 297 HLLQGLLRYDPTDRLTAREA---LRHPFF 322
L+ GLL+ DPT RL + A HPFF
Sbjct: 222 DLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 94/334 (28%), Positives = 158/334 (47%), Gaps = 68/334 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEGT+G V + +++ ++VA+K +R G+ A+ EI +L++L +H
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP---STAIREISLLKEL-QHPN--- 60
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSL---YDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V +++ + + ++FE L L D L K Y +LV+ Q+L+ I F
Sbjct: 61 -IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGILFC 117
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H DLKP+N+L+ + IK+ D+ + ++ I V + T+
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFG--------------LARAFGIPVRVY---TH 160
Query: 172 ERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
E V T YRAPEV+LG ++ P DIWS+G I E+ T + LF ++ L
Sbjct: 161 E-------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHV 288
+ R+LG P WP G S K+ + +L ++++
Sbjct: 214 IFRILGT-PTE-----------------DVWP-GVTSLPDYKNTFPKWKKGSLRSAVKNL 254
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D D LL+ +L YDP R++A++AL HP+F
Sbjct: 255 DEDGLD---LLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-28
Identities = 94/339 (27%), Positives = 148/339 (43%), Gaps = 70/339 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEGT+G+V + D+ ++VA+K R GI A+ EI +LQ L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP---TALREISLLQMLS-ESIYIV 64
Query: 55 RCVQIRNWFDYRNHICI--VFEKLGSSLYDFL---RKNNYRSFPIDLVREIARQLLECIA 109
R + + + + + VFE L S L F+ + R P ++ QLL+ +A
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 168
H ++H DLKP+N+L+ + + +K+ D G
Sbjct: 125 HCHKHGVMHRDLKPQNLLVDKQKGL--------------------------LKIADLGLG 158
Query: 169 TTYERPDQNYI--VSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHEN 224
+ P ++Y + T YRAPEV+LG Y P DIWSVGCI E+ + LF
Sbjct: 159 RAFSIPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217
Query: 225 LEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283
L+ L + ++LG P Q WP + R+ + P+ +
Sbjct: 218 LQQLLHIFKLLGTPTEQ-------------------VWPGVSKLRDWHEFPQWKPQDLSR 258
Query: 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ + D LLQ +LRYDP R++A+ AL HP+F
Sbjct: 259 AVPDLSPEGLD---LLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 85/331 (25%), Positives = 139/331 (41%), Gaps = 59/331 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD-----K 51
+G G +G V + D VA+K VR ++ + + E+ +L++L D +
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVR-VQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ C R D + +VFE + L +L K P + ++++ RQ L + F+
Sbjct: 67 LMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H C++H DLKPEN+L+ S +K+ D+ + Y +M +
Sbjct: 125 HANCIVHRDLKPENILVTSGGQVKLADFGLA------RIYSCQMALTP------------ 166
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+V T YRAPEV+L + P D+WSVGCI E+ + LF + + L +
Sbjct: 167 -------VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI 219
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
++G P+ DWP S PR + V
Sbjct: 220 FDLIGLPPED------------------DWPRDVTLPRGAFS----PRGPRPVQSVVPEI 257
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
LL +L ++P R++A AL+HPFF
Sbjct: 258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 94/338 (27%), Positives = 153/338 (45%), Gaps = 68/338 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMI--EIEVLQQLAKHDKGGNRCV 57
+G+G++G V D E VAIK + + ++ +A I EI++L+ L D V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-----IV 62
Query: 58 QIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE----IARQLLEC 107
+I++ ++++ I +VFE + S L+ ++ N+ DL E QLL
Sbjct: 63 EIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQFFLYQLLRA 115
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ ++H + H DLKP+N+L + +K+ D+ + D+ +AI D+
Sbjct: 116 LKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP--------TAIFWTDY- 166
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENL 225
V+TR YRAPE+ +T DIWS+GCI E+ TG+ LF +
Sbjct: 167 ------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214
Query: 226 EHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
L ++ +LG + RV + A +Y+ R P + K P L
Sbjct: 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP--------VPFSQKFPNADPLA 266
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
++ LL+ LL +DP DR TA EAL P+F
Sbjct: 267 LR-----------LLERLLAFDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 81/328 (24%), Positives = 129/328 (39%), Gaps = 78/328 (23%)
Query: 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCVQI 59
G +G+V + ++ AIK+++ R+ + E ++L Q V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-----SPYVVKL 58
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
F + ++ +V E L G L L N S D+ R +++ + ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKP+N+L+ S+ ++K+ D+ L S + + + +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDF--GL------SKVGLVRRQINLNDDEKEDKR-------- 160
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IV T Y APEVILG G + D WS+GCIL E G F H E +
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPF--HGETP-----EEIF--- 210
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
Q++L G+++WPE V +LI
Sbjct: 211 -QNILN------------GKIEWPED---------VEVSDEAIDLI-------------- 234
Query: 299 LQGLLRYDPTDRLTAR---EALRHPFFT 323
LL DP RL A+ E HPFF
Sbjct: 235 -SKLLVPDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-27
Identities = 92/351 (26%), Positives = 150/351 (42%), Gaps = 73/351 (20%)
Query: 2 GEGTFGQVLECW--DRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNR 55
G GT+G+V + + + + AIK +G K+ +A EI +L++L KH+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHEN---- 63
Query: 56 CVQIRNWF--DYRNHICIVFEKLGSSLYDFL------RKNNYRSFPIDLVREIARQLLEC 107
V + F + ++F+ + +D R+ S P +V+ + Q+L
Sbjct: 64 VVSLVEVFLEHADKSVYLLFD---YAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ ++H ++H DLKP N+L++ P+ +K+ D G
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEG-----------------------PERGVVKIGDLG 157
Query: 168 -STTYERP-----DQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQ 220
+ + P D + +V T YRAPE++LG +T DIW++GCI EL T E +F+
Sbjct: 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217
Query: 221 THE------NLEHLAMMER---VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 271
E N +ER VLG + + + E Y D+ S+
Sbjct: 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPE-Y-DTLMKDFKTKTYPSNSL 275
Query: 272 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
M+ H + LL+ LL YDPT R+TA EAL HP+F
Sbjct: 276 AKWMEK---------HKKPDSQGF-DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 93/342 (27%), Positives = 147/342 (42%), Gaps = 76/342 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRC 56
+GEGT+GQV + D++ E+VA+K VR + +E A+ EI++L+QL H N
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR-LDNEKEGFPITAIREIKILRQL-NHRNIVNLK 72
Query: 57 ---VQIRNWFDYRNH---ICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
++ D++ +VFE + L L ++ F D ++ +QLLE + +
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDHIKSFMKQLLEGLNY 131
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
H +H D+K N+LL + IK+ D+ + + S
Sbjct: 132 CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-------------------- 171
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLEHLA 229
RP N ++ T YR PE++LG P D+WS GCIL EL T + +FQ ++ L L
Sbjct: 172 --RPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228
Query: 230 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL----- 283
++ R+ G P P WP+ V+KLP +
Sbjct: 229 LISRLCGSPCPA-------------------VWPD----------VIKLPYFNTMKPKKQ 259
Query: 284 ----IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
+ + LL +L DP+ R TA EAL P+
Sbjct: 260 YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 87/343 (25%), Positives = 146/343 (42%), Gaps = 73/343 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCVQ 58
G G +G V D + VAIK I A + E+++L+ KHD +
Sbjct: 14 GSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDN----IIA 68
Query: 59 IRNWF----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
IR+ + +V + + S L+ + + + + +R QLL + ++H
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA 126
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
+IH DLKP N+L+ +++ D+ + +P + YF M T Y
Sbjct: 127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF--M-------------TEY 171
Query: 172 ERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
V+TR YRAPE++L L +T D+WSVGCI E+ LF + L +
Sbjct: 172 --------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKL 223
Query: 231 MERVLGPLPQHMLK-----RVDRHAEKYVRRGRLDWPE--GAASRESIKSVMKLPRLQNL 283
+ VLG + +L RV ++ + R+ + W + AS E++
Sbjct: 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD----------- 272
Query: 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
LL +L++DP +R+T +AL+HPF + H
Sbjct: 273 --------------LLSQMLQFDPEERITVEQALQHPFLAQYH 301
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-26
Identities = 90/332 (27%), Positives = 153/332 (46%), Gaps = 64/332 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRC 56
+GEGT+G V + DR E +A+K +R +++ E A+ EI +L+++ +H
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEM-QHGN----I 63
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V++++ + +VFE L L + + + L++ Q+L IA+ H +
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRV 123
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
+H DLKP+N+L+ ++A+K+ DFG + + P
Sbjct: 124 LHRDLKPQNLLIDRR--------------------------TNALKLADFGLARAFGIPV 157
Query: 176 QNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ + V T YRAPE++LG ++ P DIWSVGCI E+ + LF ++ L +
Sbjct: 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHVDH 290
R+LG + WP G S KS ++L ++ ++
Sbjct: 218 RILGTPNEET------------------WP-GVTSLPDYKSAFPKWPPKDLATVVPTLEP 258
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ D LL +LR DP+ R+TAR AL H +F
Sbjct: 259 AGVD---LLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-25
Identities = 82/357 (22%), Positives = 149/357 (41%), Gaps = 82/357 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYRE---------AAMIEIEVLQQ 45
+GEGT+G+V + +D ++VAIK V+ + K R+ + E++++ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 46 LAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 105
+ + G V + F I +V + + S L + + V+ I Q+L
Sbjct: 77 IKHENIMGLVDVYVEGDF-----INLVMDIMASDLKKVV--DRKIRLTESQVKCILLQIL 129
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIK 162
+ +H +H DL P N+ + S K+ D+ + + P + K +
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREE 189
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQT 221
+ T + V T YRAPE+++G + + D+WSVGCI EL TG+ LF
Sbjct: 190 M------TSK-------VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
Query: 222 HENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEG----------AASRES 270
++ L + +LG P +WP+ +
Sbjct: 237 ENEIDQLGRIFELLGTPNED-------------------NWPQAKKLPLYTEFTPRKPKD 277
Query: 271 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
+K++ +++ D LLQ LL+ +P +R++A+EAL+H +F D L
Sbjct: 278 LKTIFP-------------NASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPL 321
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 95/342 (27%), Positives = 148/342 (43%), Gaps = 85/342 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEGT+G V + +RE E+VA+K VR G+ +A+ EI +L++L KH
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP---SSALREICLLKEL-KH----K 59
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
V++ + + +VFE L + N P ++V+ QLL+ +AF H
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDP-EIVKSFMFQLLKGLAFCHSH 118
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
++H DLKP+N+L+ K+ +K+ DFG + +
Sbjct: 119 NVLHRDLKPQNLLI---------------------------NKNGELKLADFGLARAFGI 151
Query: 174 PDQNYI--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229
P + Y V T YR P+V+ G ++ D+WS GCI EL G LF ++ + L
Sbjct: 152 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211
Query: 230 MMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288
+ R+LG P + WP V KLP + M
Sbjct: 212 RIFRLLGTPTEE-------------------SWP----------GVSKLPDYKPYPMYPA 242
Query: 289 DHSAGDLT--------HLLQGLLRYDPTDRLTAREALRHPFF 322
S ++ LLQ LL +P R++A EAL+HP+F
Sbjct: 243 TTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 79/332 (23%), Positives = 137/332 (41%), Gaps = 93/332 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G+FG+V + ++ +K + +K RE A+ E+++L++L H N ++
Sbjct: 9 GKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP---N-IIK 63
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
F+ + +CIV E G L + +K + FP + + + QL + ++H
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
++H D+KP+N+ L +S + +K+ DFG S
Sbjct: 124 ILHRDIKPQNIFL-TSNGL--------------------------VKLGDFGISKVLSST 156
Query: 175 DQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM-- 230
+V T +Y +PE+ + Y DIWS+GC+L ELCT + F+ ENL LA+
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE-GENLLELALKI 215
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
++ P+P Y S E L+NL+
Sbjct: 216 LKGQYPPIPSQ-----------Y-------------SSE----------LRNLV------ 235
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
LL+ DP +R + + L+ PF
Sbjct: 236 ---------SSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 9e-25
Identities = 91/338 (26%), Positives = 149/338 (44%), Gaps = 67/338 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--------EAAMIEIEVLQQLAKHDK- 51
+G G +G V DR VAIK K YR + A E+ +L+ + KH+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK-----KLYRPFQSELFAKRAYRELRLLKHM-KHENV 76
Query: 52 -GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
G D + +V +G+ L ++ + D ++ + Q+L+ + +
Sbjct: 77 IGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKY 133
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H +IH DLKP N L V+ + +K++DFG
Sbjct: 134 IHAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGLAR 166
Query: 171 YERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
+ V TR YRAPEVIL + +T DIWSVGCI+ E+ TG+ LF+ H++L+ L
Sbjct: 167 QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM 226
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ +V G + ++++ S ++ V KLPR + + +
Sbjct: 227 EIMKVTGTPSKEFVQKLQ-------------------SEDAKNYVKKLPRFRKKDFRSLL 267
Query: 290 HSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+A L ++L+ +L D R+TA EAL HP+F H
Sbjct: 268 PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 84/338 (24%), Positives = 145/338 (42%), Gaps = 72/338 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKHDKGGNR 55
+G G FG V D+ + VAIK + +K + + E+++L+ L +H+
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKI--MKPFSTPVLAKRTYRELKLLKHL-RHEN---- 70
Query: 56 CVQIRNWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ + + F I V E LG+ L+ L R ++ Q+L + ++H
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++H DLKP N+L+ ++ +K+ DFG + P
Sbjct: 128 GVVHRDLKPSNILI---------------------------NENCDLKICDFGLARIQDP 160
Query: 175 DQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
VSTR+YRAPE++L + DIWS GCI E+ G+ LF +++ +++
Sbjct: 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-----LQNLIMQHV 288
+LG P ++ + S +++ V LP+ ++
Sbjct: 221 LLGTPPDDVINTI-------------------CSENTLRFVQSLPKREPVPFSEKF-KNA 260
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
D SA D LL+ +L +DP R++A EAL HP+ H
Sbjct: 261 DPSAID---LLEKMLVFDPQKRISAAEALAHPYLAPYH 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 95/338 (28%), Positives = 142/338 (42%), Gaps = 76/338 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCV 57
+G G +G V D+ E VAIK + R + + + A E+ +L+ + + G V
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDF----------LRKNNYRSFPIDLVREIARQLLEC 107
G DF L+K D V+ + Q+L
Sbjct: 83 F-------------TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ ++H +IH DLKP N L V+ + +K++DFG
Sbjct: 130 LKYIHSAGIIHRDLKPGN-LAVNED--------------------------CELKILDFG 162
Query: 168 STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ + V TR YRAPEVIL + + DIWSVGCI+ E+ TG+ LF+ + L+
Sbjct: 163 LARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 222
Query: 227 HLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLI 284
L + +V G P P+ + K D+ A+ Y IKS+ K PR + +
Sbjct: 223 QLTQILKVTGVPGPEFVQKLEDKAAKSY-----------------IKSLPKYPRKDFSTL 265
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
A D LL+ +L D RLTA EAL HP+F
Sbjct: 266 FPKASPQAVD---LLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 82/340 (24%), Positives = 140/340 (41%), Gaps = 62/340 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLA--------- 47
+GEGTFG+V + + +VA+K + + ++ A+ EI++L++L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 48 ----KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 103
+ DK + R + +V + L L + + ++ Q
Sbjct: 75 MAVERPDKSKRK----------RGSVYMVTPYMDHDLSGLLENPSVKLTESQ-IKCYMLQ 123
Query: 104 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 163
LLE I ++H+ ++H D+K N+L+ + +K+ D+ L P D PK
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDNQGILKIADF--GLARPYDGP--PPNPKG----- 174
Query: 164 IDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222
G R N +V TR YR PE++LG +T DIW +GC+ E+ T + Q
Sbjct: 175 ---GGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
+++ L ++ ++ G + WP G S + V
Sbjct: 231 SDIDQLHLIFKLCGTPTEE------------------TWP-GWRSLPGCEGVHSFTNYPR 271
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ + + LL LL DP RLTA +AL HP+F
Sbjct: 272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 85/333 (25%), Positives = 142/333 (42%), Gaps = 62/333 (18%)
Query: 1 MGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGG-- 53
+GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L +
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 54 ---NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
+ C R D + +VFE + L +L K P + ++++ QLL + F
Sbjct: 68 RLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H ++H DLKP+N+L+ SS IK+ D+ + ++ F
Sbjct: 126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------------------RIYSFQMAL 166
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+V T YRAPEV+L + P D+WSVGCI E+ + LF+ +++ L
Sbjct: 167 ------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK 220
Query: 231 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ V+G P + DWP A ++ + +D
Sbjct: 221 ILDVIGLPGEE-------------------DWPRDVALPRQAFHSKSAQPIEKFV-TDID 260
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D LL L ++P R++A AL HP+F
Sbjct: 261 ELGKD---LLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 72/270 (26%), Positives = 114/270 (42%), Gaps = 51/270 (18%)
Query: 64 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 123
D I +V E + S L+ + + D V+ Q+L + ++H ++H D+KP
Sbjct: 74 DPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131
Query: 124 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI---- 179
N LLV+S + +K+ DFG E PD++
Sbjct: 132 GN-LLVNSNCV--------------------------LKICDFGLARVEEPDESKHMTQE 164
Query: 180 VSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
V T++YRAPE+++G +T DIWSVGCI EL LFQ ++ L ++ +LG
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTP 224
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
++ A ++ R K P L L + + HL
Sbjct: 225 SLEAMRSACEGARAHILR----------------GPHKPPSLPVLYT-LSSQATHEAVHL 267
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
L +L +DP R++A +AL HP+ LR
Sbjct: 268 LCRMLVFDPDKRISAADALAHPYLDEGRLR 297
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 41/221 (18%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQ 58
G G FG V + + E + VAIK + K EA M EI++L+ L KH V+
Sbjct: 9 GRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KH----PNIVK 63
Query: 59 IRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + I+ E SL ++K FP LV Q+L+ +A++H+ +I
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVI 121
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY---ERP 174
H D+K N+L K +K+ DFG T
Sbjct: 122 HRDIKAANIL---------------------------TTKDGVVKLADFGVATKLNDVSK 154
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
D +V T ++ APEVI G + DIWS+GC ++EL TG
Sbjct: 155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 88/346 (25%), Positives = 141/346 (40%), Gaps = 85/346 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G +GQV +D + VAIK K R Q A H K R +++
Sbjct: 24 GSGAYGQVCSAFDTKTGRKVAIK-----KLSRPF---------QSAIHAKRTYRELRLLK 69
Query: 62 WFDYRNHIC------------------IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 103
D+ N I +V +G+ L + ++ + D ++ + Q
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC---QKLSDDHIQFLVYQ 126
Query: 104 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 163
+L + ++H +IH DLKP N+ + +K+ D+ + HT
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT------------------ 168
Query: 164 IDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 222
D T Y V+TR YRAPE++L + + DIWSVGCI+ EL TG+ LF
Sbjct: 169 -DDEMTGY--------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
Query: 223 ENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 281
++++ L + ++G P + + K A Y++ LP++
Sbjct: 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQ--------------------SLPQMP 259
Query: 282 NLIMQHVDHSAG-DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ V A LL+ +L DP R+TA EAL HP+ H
Sbjct: 260 KKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 54/258 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNRCV 57
G GTFG+V + + E++A+K +R I+ + E++VL+ L KH
Sbjct: 9 GGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELL-KHP------- 59
Query: 58 QIRNWFDY------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
N Y R + I E G +L + L + R ++R QLLE +A+
Sbjct: 60 ---NLVKYYGVEVHREKVYIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLLEGLAY 114
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H ++H D+KP N+ L + IK+ D+ + + +TT
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCA-------------------VKLKNNTTT 155
Query: 171 YERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTG----EALFQTHE 223
Q+ T Y APEVI G G DIWS+GC+++E+ TG L +
Sbjct: 156 MGEEVQSL-AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ 214
Query: 224 NLEHLAMMERVLGPLPQH 241
+ H+ + P+P
Sbjct: 215 IMFHVGAGHK--PPIPDS 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-23
Identities = 84/346 (24%), Positives = 149/346 (43%), Gaps = 83/346 (23%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 52
+G G +G V +D + VA+K I+ + YRE +L KH K
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL---------RLLKHMKH 75
Query: 53 GN-----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 107
N + N + +V +G+ L + ++ + D V+ + Q+L
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRG 132
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ ++H +IH DLKP N+ + + +K++DFG
Sbjct: 133 LKYIHSADIIHRDLKPSNLAV---------------------------NEDCELKILDFG 165
Query: 168 STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ + V+TR YRAPE++L + + DIWSVGCI+ EL TG LF ++++
Sbjct: 166 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 225
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL--QNLI 284
L ++ R++G +LK++ ++R I+S+ ++P++ N+
Sbjct: 226 QLKLILRLVGTPGAELLKKISSE----------------SARNYIQSLTQMPKMNFANVF 269
Query: 285 M----QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ VD LL+ +L D R+TA +AL H +F + H
Sbjct: 270 IGANPLAVD--------LLEKMLVLDSDKRITAAQALAHAYFAQYH 307
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 4e-23
Identities = 64/261 (24%), Positives = 113/261 (43%), Gaps = 39/261 (14%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G G FG+V + + A+K V R I + + I E E+L++ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HP----FIV 56
Query: 58 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F + +I ++ E LG L+ LR F R ++ ++H+ +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLKPEN+LL S+ Y+K+ D+ + K + G T+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFA-------------------KKLKSGQKTWT---- 151
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
T Y APE+IL G+ + D WS+G +L EL TG F ++ + + + +L
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE-DDEDPMEIYNDILK 208
Query: 237 PLPQHML-KRVDRHAEKYVRR 256
+ +D+ A+ +++
Sbjct: 209 GNGKLEFPNYIDKAAKDLIKQ 229
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 5e-23
Identities = 88/343 (25%), Positives = 151/343 (44%), Gaps = 77/343 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK--------IVRGIKKYREAAMIEIEVLQQLAKHDKG 52
+G G +G V +D ++ VA+K ++ + YRE +L KH K
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYREL---------RLLKHMKH 73
Query: 53 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 106
N + + + F + N + +V +G+ L + ++ + + V+ + QLL
Sbjct: 74 EN-VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQKLSDEHVQFLIYQLLR 129
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
+ ++H +IH DLKP NV + + ++++DF
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAV---------------------------NEDCELRILDF 162
Query: 167 GSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
G + V+TR YRAPE++L + + DIWSVGCI+ EL G+ALF ++ +
Sbjct: 163 GLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222
Query: 226 EHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
+ L +ME V P P+ + K HA KY++ LP +
Sbjct: 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQ--------------------SLPHMPQQD 262
Query: 285 MQHVDHSAGDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ + A L LL+ +L D R++A EAL HP+F++ H
Sbjct: 263 LKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 8e-23
Identities = 78/329 (23%), Positives = 124/329 (37%), Gaps = 89/329 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G+G+ G V + + ++ A+K V G +++R+ + E++ L+ + V+
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESPY----VVKC 64
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMI 117
F I IV E + G SL D L+K P ++ IARQ+L+ + ++H +I
Sbjct: 65 YGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER--- 173
H D+KP N+L+ S +K+ DFG S E
Sbjct: 123 HRDIKPSNLLINSKGEVKIA---------------------------DFGISKVLENTLD 155
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
+ V T Y +PE I G ++Y DIWS+G L+E G+ F +M+
Sbjct: 156 QCNTF-VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214
Query: 234 VL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
+ GP P P S E
Sbjct: 215 ICDGPPP--------------------SLPAEEFSPE----------------------- 231
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPF 321
+ L+ DP R +A E L+HPF
Sbjct: 232 --FRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 64/221 (28%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 54
+G+G FG+V C+D + +A+K V KK A EI++L+ L +H
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QH----E 64
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
R VQ + I E + G S+ D L+ Y + + R+ RQ+LE + ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHS 122
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H D+K N+L S+ +K+ D+ +S KR+ I S T +
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL---QTICS----SGTGMK 165
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ T ++ +PEVI G G+ D+WSVGC +VE+ T
Sbjct: 166 S----VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 2e-22
Identities = 81/347 (23%), Positives = 139/347 (40%), Gaps = 81/347 (23%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHD------ 50
+G+GTFG+V + ++ K++VA+K V ++ +E A+ EI++LQ L KH+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVL-MENEKEGFPITALREIKILQLL-KHENVVNLI 77
Query: 51 -------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 103
NR Y+ +VFE L L N F + ++++ +
Sbjct: 78 EICRTKATPYNR---------YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKM 127
Query: 104 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 163
LL + ++H ++H D+K N+L+ K +K+
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILIT---------------------------KDGILKL 160
Query: 164 IDFG-------STTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG 215
DFG S + V T YR PE++LG + P D+W GCI+ E+ T
Sbjct: 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 216 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 275
+ Q + L ++ ++ G + + VD K +++ P+G + +
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVD----KLELFKKMELPQGQKRKVKERLKP 276
Query: 276 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ L L+ LL DP R+ A AL H FF
Sbjct: 277 YVKDPHAL-------------DLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-22
Identities = 79/331 (23%), Positives = 132/331 (39%), Gaps = 91/331 (27%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMI---EIEVLQQLAKHDKGGN 54
+G G+FG V E + + + A+K V + +EA EI +L +L +H
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPN--- 63
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++HD
Sbjct: 64 -IVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+H D+K N+L+ ++ +K+ D+ + KS
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQ-----VVEFSFAKS--------------- 160
Query: 174 PDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ ++ APEVI G + DIWS+GC ++E+ TG+ + E + + +
Sbjct: 161 -----FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
Query: 233 R--VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
R L P+P H+ S E ++ I++
Sbjct: 216 RSKELPPIPDHL------------------------SDE----------AKDFILK---- 237
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
L+ DP+ R TA E L HPF
Sbjct: 238 -----------CLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-22
Identities = 93/329 (28%), Positives = 145/329 (44%), Gaps = 60/329 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNRC 56
+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNL-KH----ANI 65
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V + + + +VFE L S L +L N + V+ QLL +++ H +
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 125 LHRDLKPQNLLINEKGELKLADF--------GLARAKSVP-----------TKTYSNE-- 163
Query: 177 NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T YR P+V+LG ++ P D+W VGCIL E+ TG +F E L ++ R+L
Sbjct: 164 ---VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLL 220
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--RLQNLIMQHVDHSAG 293
G + WP G S E +S + P R Q LI H
Sbjct: 221 GTPTEE------------------TWP-GITSNEEFRSYL-FPQYRAQPLI-NHAPRLDT 259
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D LL LL Y+ R++A ALRH +F
Sbjct: 260 DGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 89/341 (26%), Positives = 151/341 (44%), Gaps = 69/341 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA---KHDKGGNRCV 57
+G G+FG V E + E VAIK V +Y+ ++ ++ L + D C
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECF 133
Query: 58 QI--RNWFDYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHD 113
+ +N F + +V E + +++ +++ N + P+ LV+ + QL +A++H
Sbjct: 134 KKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ H DLKP+N+L+ P + +K+ DFGS
Sbjct: 189 KFICHRDLKPQNLLI--------------------------DPNTHTLKLCDFGSAKNLL 222
Query: 174 PDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
Q +YI S R YRAPE++LG +T D+WS+GCI+ E+ G +F +++ L
Sbjct: 223 AGQRSVSYICS-RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV- 288
+ +VLG + LK ++ P A +K P ++ ++ V
Sbjct: 282 RIIQVLGTPTEDQLKEMN--------------PNYAD--------IKFPDVKPKDLKKVF 319
Query: 289 -DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ D + + L+Y+P RL EAL PFF D LR
Sbjct: 320 PKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF--DDLR 358
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 66/225 (29%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L I +H +IH DLKP N+++ S D + +K
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVVKS-----------------DCT----------LK 158
Query: 163 VIDFG-----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217
++DFG T++ Y+V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G
Sbjct: 159 ILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215
Query: 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR-RGRLDWPEGAASRESIKSVMK 276
LF ++++ + LG + R+ YV R + G + E V+
Sbjct: 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKY---AGYSFEELFPDVLF 272
Query: 277 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
P ++ H A LL +L DP R++ +AL+HP+
Sbjct: 273 PPDSES----HNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 86/324 (26%), Positives = 146/324 (45%), Gaps = 47/324 (14%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQI 59
GEG +G V + VAIK + + + + + EI++L++ + G +
Sbjct: 14 GEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIR 73
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
F+ N + IV E + + LY ++ + + D ++ Q+L + ++H ++H
Sbjct: 74 PPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILRGLKYIHSANVLHR 130
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLKP N+LL ++ +K+ D+ + + + + T Y
Sbjct: 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-------------TEY-------- 169
Query: 180 VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
V+TR YRAPE++L G+T DIWSVGCIL E+ + LF + L L ++ VLG
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSAGDLTH 297
Q L + +R IKS+ P++ N + + D A D
Sbjct: 230 SQEDLNCI----------------ISLRARNYIKSLPFKPKVPWNKLFPNADPKALD--- 270
Query: 298 LLQGLLRYDPTDRLTAREALRHPF 321
LL +L ++P R+T EAL HP+
Sbjct: 271 LLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 93/341 (27%), Positives = 151/341 (44%), Gaps = 70/341 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCV 57
+G G +G V + E E VAIK I +A + EI++L+ L H+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN----VI 67
Query: 58 QIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
I++ + N + IV+E + + L+ +R + ++ D + QLL + ++H
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH 125
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--STT 170
++H DLKP N+LL ++ +K+ DFG TT
Sbjct: 126 SANVLHRDLKPSNLLLNAN---------------------------CDLKICDFGLARTT 158
Query: 171 YERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
E+ D Y+V TR YRAPE++L +T D+WSVGCI EL + LF + +
Sbjct: 159 SEKGDFMTEYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ 217
Query: 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IM 285
L ++ +LG L + +R I+S+ PR Q+ +
Sbjct: 218 LKLITELLGS----------------PSEEDLGFIRNEKARRYIRSLPYTPR-QSFARLF 260
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
H + A D LL+ +L +DP+ R+T EAL HP+ H
Sbjct: 261 PHANPLAID---LLEKMLVFDPSKRITVEEALAHPYLASLH 298
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-20
Identities = 81/334 (24%), Positives = 136/334 (40%), Gaps = 97/334 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG G+V + DR + VAIK +R K+ +E + EI +++ KH I +
Sbjct: 28 GEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHP-------NIVD 79
Query: 62 WFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVRE----IARQLLECIAFMHD 113
++D + + +V E + G SL D + +N + + + R++L+ + ++H
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STT 170
+IH D+K +N+LL KD S +K+ DFG T
Sbjct: 135 QNVIHRDIKSDNILL-----------------SKDGS----------VKLADFGFAAQLT 167
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
E+ +N +V T ++ APEVI + DIWS+G + +E+ GE
Sbjct: 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE-------------- 213
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
P ++ R P A + K +P L+N +
Sbjct: 214 --------PPYL---------------REP-PLRALFLITTK---GIPPLKNP-----EK 241
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ + L L DP R +A E L+HPF +
Sbjct: 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-20
Identities = 83/348 (23%), Positives = 150/348 (43%), Gaps = 79/348 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMIEIEVLQQLAKHD--------- 50
+G G+ G V D + + VA+K IV + + A+ EI+++++L HD
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVL 71
Query: 51 --KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G + + + + + + IV E + + L + L + + R QLL +
Sbjct: 72 GPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGL 127
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++H ++H DLKP NV + + + + +K+ DFG
Sbjct: 128 KYIHSANVLHRDLKPANVFINTEDLV--------------------------LKIGDFGL 161
Query: 169 TTYERPD---QNYI---VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT 221
P + Y+ + T+ YR+P ++L +T D+W+ GCI E+ TG+ LF
Sbjct: 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG 221
Query: 222 HENLEHLAMMERVLGPLPQHMLKRVDRHA-----EKYVRRGRLDWPEGAASRESIKSVMK 276
LE M+ +L +P +++ DR+ +VR +G R ++ ++
Sbjct: 222 AHELE---QMQLILESVP--VVREEDRNELLNVIPSFVRN------DGGEPRRPLRDLLP 270
Query: 277 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
V+ A D L+ +L ++P DRLTA EAL HP+ +
Sbjct: 271 ----------GVNPEALD---FLEQILTFNPMDRLTAEEALMHPYMSC 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-19
Identities = 67/233 (28%), Positives = 107/233 (45%), Gaps = 55/233 (23%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L + ++H ++H DLKP N LLV+++ +K
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGN-LLVNAD--------------------------CELK 145
Query: 163 VIDFG-STTY-ERPDQN--YI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 214
+ DFG + + E P +N ++ V+TR YRAPE++L +T D+WSVGCIL EL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVRRGRLDWPEGAASRESIKS 273
+ +F+ + ++ L + +VLG + L R+ A+ Y+R L
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIR--SLPNIPK--------- 254
Query: 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
I + + A D LL+ LL +DPT R++ EAL HP+ H
Sbjct: 255 -KPFES----IFPNANPLALD---LLEKLLAFDPTKRISVEEALEHPYLAIWH 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 7e-19
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 37/226 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G+G++G V + + A+K V +K RE A+ EI +L + + +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN-----II 62
Query: 58 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDL 114
+ F N +CIV E L + K + P + I QLL + +H+
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++H DLK N+LLV+++ +K+ D S K + K+ A I
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGIS----------KVLKKNMAKTQI---------- 162
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 220
T HY APEV G ++Y DIWS+GC+L E+ T F+
Sbjct: 163 ------GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 66/221 (29%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L I +H +IH DLKP N+++ S +K+ D+ + +++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--------------LARTACT- 175
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
+F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ EL G +FQ
Sbjct: 176 --NFMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
++++ + LG + R+ YV R +P S E + P
Sbjct: 226 DHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV-ENRPQYP--GISFEELFPDWIFPSES- 281
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+ LL +L DP R++ EALRHP+ T
Sbjct: 282 ---ERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYIT 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 84/327 (25%), Positives = 140/327 (42%), Gaps = 56/327 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNRC 56
+GEGT+ V + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN----I 66
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V + + + +VFE L L +L + S + V+ QLL + + H +
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLKP+N+L+ +K+ D+ + ++ +I + TY
Sbjct: 126 LHRDLKPQNLLINERGELKLADFG--------------LARAKSIP-----TKTYSNE-- 164
Query: 177 NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T YR P+++LG ++ D+W VGCI E+ TG LF E L + R+L
Sbjct: 165 ---VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRIL 221
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
G + WP G S E KS + + H D
Sbjct: 222 GTPTEET------------------WP-GILSNEEFKSYNYPKYRADCLHNHAPRLDSDG 262
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFF 322
LL LL+++ R++A EA++HP+F
Sbjct: 263 AELLSKLLQFEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 75/340 (22%), Positives = 121/340 (35%), Gaps = 80/340 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAA-MIEIEVLQQLAKHDKGGNRCV 57
G G FG+V D++ ++ A+K++R IK+ + A E ++L
Sbjct: 10 GRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-------------A 56
Query: 58 QIRN-W-------FDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECI 108
+ W F H+ +V E + D + FP + R +L+ +
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLAL 114
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFK--RMPKSSAIKVI 164
+H L IH D+KP+N+L+ + +IK+ D+ ++ KD Y+ V+
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 165 DFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
+R N V T Y APEV+ G + CD WS+G IL E+ G F
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF---- 230
Query: 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283
Q ++ ++L
Sbjct: 231 -----------YSDTLQETYNKIINW------------------------------KESL 249
Query: 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLT-AREALRHPFF 322
+ + L+ LL DP DRL E HPFF
Sbjct: 250 RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-18
Identities = 66/226 (29%), Positives = 110/226 (48%), Gaps = 36/226 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR----GIK-KYREAAMI-----EIEVLQQLAKHD 50
+G G+FG V + E++A+K V K R+ +M+ EI +L++L +H+
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
VQ +H+ I E + G S+ L NNY +F LVR RQ+L+ +
Sbjct: 67 N----IVQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++H+ +IH D+K N+L+ + IK+ D+ S K++ +S T
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGIS----------KKLEANSLS-----TKT 165
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
RP + + + APEV+ +T DIWS+GC++VE+ TG
Sbjct: 166 NGARPS---LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 86/336 (25%), Positives = 139/336 (41%), Gaps = 71/336 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRC 56
+GEG++ V + + ++VA+K +R ++ E A+ E +L+ L KH
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLKDL-KH----ANI 65
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V + + + + +VFE L + L ++ + VR QLL +A+ H +
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRV 124
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--------S 168
+H DLKP+N LL+S + +K+ DFG S
Sbjct: 125 LHRDLKPQN-LLIS--------------------------ERGELKLADFGLARAKSVPS 157
Query: 169 TTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LE 226
TY N +V T YR P+V+LG ++ D+W VGCI E+ TG LF + +
Sbjct: 158 KTY----SNEVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED 212
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
L + RVLG + V + E P + PRL +
Sbjct: 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINH--------APRLDRIP-- 262
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
L L+Y+P R++A EA++HP+F
Sbjct: 263 -------HGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 68/310 (21%), Positives = 109/310 (35%), Gaps = 90/310 (29%)
Query: 17 RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76
+ +M+A V +K R MI+ E ++ F ++++ +V E L
Sbjct: 31 KSDMIAKNQVTNVKAERAIMMIQGE-----------SPYVAKLYYSFQSKDYLYLVMEYL 79
Query: 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIK 135
G ++ P D ++ +++ + +H +IH D+KPEN+L+ + ++K
Sbjct: 80 NGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLK 137
Query: 136 VPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 195
+ D+ S R E V T Y APE ILG+G
Sbjct: 138 LTDFGLS-----------RN--------------GLENKK---FVGTPDYLAPETILGVG 169
Query: 196 WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR 255
D WS+GC++ E G F P + +
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAET---------------PDAVFDNIL-------- 206
Query: 256 RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 313
R++WPE S P +LI + LL DP RL A
Sbjct: 207 SRRINWPEEVKEFCS-------PEAVDLINR---------------LLCMDPAKRLGANG 244
Query: 314 -REALRHPFF 322
+E HPFF
Sbjct: 245 YQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 3e-17
Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 172
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF
Sbjct: 173 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 223 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL- 280
+ ++ ++E++ P P+ M K++ YV + P+ A + P+L
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFM-KKLQPTVRNYVE----NRPKYAG--------LTFPKLF 268
Query: 281 -QNLIMQHVDHS---AGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
+L +H+ A LL +L DP R++ EAL+HP+
Sbjct: 269 PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+GEG++G V + +E ++VAIK+V +++ + + EI +L+Q V+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVP-VEEDLQEIIKEISILKQ-CDSP----YIVKYY 64
Query: 61 NWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + IV E G S+ D ++ N ++ + + I Q L+ + ++H IH
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHR 123
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
D+K N+LL K+ D+ S G T +N +
Sbjct: 124 DIKAGNILLNEEGQAKLADFGVS------------------------GQLTDTMAKRNTV 159
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
+ T + APEVI +G+ DIWS+G +E+ G+
Sbjct: 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 79/333 (23%), Positives = 128/333 (38%), Gaps = 96/333 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKGGNRCV 57
G+G+FG+V + D+ ++VAIK++ E A EIE +QQ L++ R
Sbjct: 10 GKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLSQC-----RSP 59
Query: 58 QIRNWF-----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
I ++ + + I+ E G S D L+ + I R++L + ++
Sbjct: 60 YITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILREVLLGLEYL 114
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H+ IH D+K N+LL +K+ D+ S S+ K F
Sbjct: 115 HEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----------TSTMSKRNTF----- 158
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
V T + APEVI G+ DIWS+G +EL GE L L M
Sbjct: 159 --------VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP------PLSDLHPM 204
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
RVL +P++ ++ + K+ + +
Sbjct: 205 -RVLFLIPKNNPPSLEGN--KFSKPFK--------------------------------- 228
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
D L L DP +R +A+E L+H F +
Sbjct: 229 --DFVSL---CLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 68/221 (30%), Positives = 105/221 (47%), Gaps = 36/221 (16%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L I +H +IH DLKP N+++ S +K+ D+ R +S
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-----------LARTAGTS--- 179
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
F T Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G LF
Sbjct: 180 ---FMMTPY--------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
Query: 223 ENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA-SRESIKSVMKLPRL 280
++++ ++E++ P P+ M K++ YV + P+ A S E + + P
Sbjct: 229 DHIDQWNKVIEQLGTPCPEFM-KKLQPTVRTYVE----NRPKYAGYSFEKLFPDVLFPAD 283
Query: 281 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
+H A LL +L D + R++ EAL+HP+
Sbjct: 284 S----EHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 4e-16
Identities = 84/334 (25%), Positives = 142/334 (42%), Gaps = 67/334 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV-----RGI--KKYREAAMIEIEVLQQLAKHDKGG 53
+GEG++ V + R ++VA+K++ G+ REA+++ K K
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLL---------KGLKHA 63
Query: 54 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
N V + + + + VFE + + L ++ ++ P + VR QLL +A++H
Sbjct: 64 N-IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIHG 121
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYE 172
++H DLKP+N+L+ SY +K+ DFG +
Sbjct: 122 QHILHRDLKPQNLLI---------------------SYL------GELKLADFGLARAKS 154
Query: 173 RPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ-THENLEHL 228
P Q Y V T YR P+V+LG ++ DIW GCI +E+ G+ F + E L
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214
Query: 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288
+ VLG + V + Y L + R K + + P+ ++L Q
Sbjct: 215 EKIWTVLGVPTEDTWPGVSK-LPNYKPEWFL-PCKPQQLRVVWKRLSRPPKAEDLASQ-- 270
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+L P DR++A++AL HP+F
Sbjct: 271 -------------MLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 67/252 (26%), Positives = 107/252 (42%), Gaps = 60/252 (23%)
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
P +V+ + Q+L+ I ++H ++H DLKP N+L++
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 145
Query: 152 FKRMPKSSAIKVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWS 204
P+ +K+ D G + + P D + +V T YRAPE++LG +T DIW+
Sbjct: 146 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201
Query: 205 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 264
+GCI EL T E +F + E + P H ++DR DW
Sbjct: 202 IGCIFAELLTSEPIFHCRQ--------EDIKTSNPFHH-DQLDRIFSVMGFPADKDW--- 249
Query: 265 AASRESIKSVMKLPRLQ--------------NLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310
E I+ + + P LQ + +H + LLQ LL DPT R
Sbjct: 250 ----EDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKR 305
Query: 311 LTAREALRHPFF 322
+T+ +AL+ P+F
Sbjct: 306 ITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 3e-15
Identities = 81/329 (24%), Positives = 144/329 (43%), Gaps = 60/329 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA----MIEIEVLQQLAKHDKGGNRC 56
+GEGT+ V + + + +VA+K +R ++ E A + E+ +L+ L KH
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDL-KHAN----I 66
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + + + +VFE L L ++ N S + V+ Q+L +A+ H
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRRK 124
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H DLKP+N+L+ +K+ D+ + K +P + TY
Sbjct: 125 VLHRDLKPQNLLINERGELKLADF--------GLARAKSVP-----------TKTYSNE- 164
Query: 176 QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
V T YR P+V+LG ++ D+W VGCI E+ +G LF + L ++ R+
Sbjct: 165 ----VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSAG 293
LG + WP G +S + K+ P+ + ++ H
Sbjct: 221 LGTPTEE------------------TWP-GISSNDEFKN-YNFPKYKPQPLINHAPRLDT 260
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ LL L+Y+ R++A EA++H +F
Sbjct: 261 EGIELLTKFLQYESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 74/331 (22%), Positives = 126/331 (38%), Gaps = 93/331 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G G+FG+V+ + + A+KI+ I K ++ + E +LQ + +H
Sbjct: 10 GTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP---FLVN 65
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ D N + +V E + G L+ LRK+ FP + R A Q++ + ++H L +
Sbjct: 66 LYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
++ DLKPEN+LL S Y IK+ DFG +
Sbjct: 123 VYRDLKPENLLLDSDGY---------------------------IKITDFGFAKRVKGRT 155
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ T Y APE+IL G+ D W++G ++ E+ G F + + E++L
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDD---NPIQIYEKILE 212
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
G++ +P D
Sbjct: 213 --------------------GKVRFP-----------------------SFFS---PDAK 226
Query: 297 HLLQGLLRYDPTDRL-----TAREALRHPFF 322
L++ LL+ D T RL + HP+F
Sbjct: 227 DLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 68/265 (25%), Positives = 120/265 (45%), Gaps = 39/265 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+G+G FG+V C+D + +A+K V+ K A EI++L+ L
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE----- 64
Query: 55 RCVQIRNWF-DYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
R VQ D +F + G S+ D L+ +Y + ++ R+ RQ+LE ++++
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQILEGVSYL 122
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H D+K N+L S +K+ D+ +S KR+ + I T
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGAS----------KRL------QTICLSGTGM 166
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ + T ++ +PEVI G G+ DIWSVGC +VE+ T + + E + A+
Sbjct: 167 KS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIF 219
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRR 256
+ P + V H +++R
Sbjct: 220 KIATQPTNPVLPPHVSDHCRDFLKR 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 70/268 (26%), Positives = 111/268 (41%), Gaps = 67/268 (25%)
Query: 63 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
F+ + H+C+V E + G L+ N + P+D+ R + + + ++H+ ++H DL
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVLALEYLHNYGIVHRDL 127
Query: 122 KPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
KP+N+L+ S +IK+ D+ K L + + Y + K T E D+
Sbjct: 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD-----------TREFLDKQ- 175
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+ T Y APEVIL G+ P D W++G IL E G F G
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF---------------FGDT 220
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P+ + + V ++WPEG + LP D L
Sbjct: 221 PEELFGQ--------VISDDIEWPEGDEA---------LP--------------ADAQDL 249
Query: 299 LQGLLRYDPTDRL---TAREALRHPFFT 323
+ LLR +P +RL A E +H FF
Sbjct: 250 ISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 5e-15
Identities = 81/327 (24%), Positives = 149/327 (45%), Gaps = 51/327 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKGGNRCVQ 58
+GEG++ V + + ++VA+K++R ++ A+ E +L+ L KH V
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHAN----IVL 67
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + + + +VFE + + L ++ K+ P + V+ QLL ++++H ++H
Sbjct: 68 LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIHQRYILH 126
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKP+N+L+ + +K+ D+ + ++ ++ S TY
Sbjct: 127 RDLKPQNLLISDTGELKLADFG--------------LARAKSVP-----SHTYSNE---- 163
Query: 179 IVSTRHYRAPEVILGLGWTYPC-DIWSVGCILVELCTGEALFQTHENLE-HLAMMERVLG 236
V T YR P+V+LG C D+W VGCI VE+ G A F ++++ L + VLG
Sbjct: 164 -VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLG 222
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ V P R ++ S L + N + +V+H+
Sbjct: 223 TPNEDTWPGVH------------SLPHFKPERFTLYSPKNLRQAWNK-LSYVNHA----E 265
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFT 323
L LL+ P +RL+A+ AL H +F+
Sbjct: 266 DLASKLLQCFPKNRLSAQAALSHEYFS 292
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 7e-15
Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 48/246 (19%)
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
P +V+ + Q+L+ I ++H ++H DLKP N+L++
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG------------------- 145
Query: 152 FKRMPKSSAIKVIDFG-STTYERP-----DQNYIVSTRHYRAPEVILGL-GWTYPCDIWS 204
P+ +K+ D G + + P D + +V T YRAPE++LG +T DIW+
Sbjct: 146 ----PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201
Query: 205 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 264
+GCI EL T E +F + E + P H ++DR DW +
Sbjct: 202 IGCIFAELLTSEPIFHCRQ--------EDIKTSNPYHH-DQLDRIFNVMGFPADKDWEDI 252
Query: 265 AASRESIKSVMKLPR--------LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316
E ++MK R L + +H HLLQ LL DP R+T+ +A
Sbjct: 253 KKMPEH-STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 311
Query: 317 LRHPFF 322
++ P+F
Sbjct: 312 MQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 68/269 (25%), Positives = 123/269 (45%), Gaps = 47/269 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+G+G FG+V C+D + +A K V+ K A EI++L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 55 RCVQIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
R VQ R+ + I E + G S+ D L+ Y + + R+ RQ+LE ++
Sbjct: 65 RIVQYYGCL--RDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMS 120
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++H ++H D+K N+L S+ +K+ D+ +S KR+ + I T
Sbjct: 121 YLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KRL------QTICMSGT 164
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
+ T ++ +PEVI G G+ D+WS+GC +VE+ T + + +E + +
Sbjct: 165 GIRS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219
Query: 230 MM--ERVLGPLPQHMLKRVDRHAEKYVRR 256
+ + LP H + HA ++
Sbjct: 220 KIATQPTNPQLPSH----ISEHARDFLGC 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 2e-14
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 55/230 (23%)
Query: 2 GEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD----- 50
GEG FG+V + ++ VA+K ++ ++ E ++++L H
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNIVKL 66
Query: 51 KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C + + IV E G L D+LRKN + + + A Q+ +
Sbjct: 67 LGV--CTE-------EEPLMIVMEYMPGGD-LLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ IH DL N L V + +K+ DFG
Sbjct: 117 EYLESKNFIHRDLAARNCL-VGENLV--------------------------VKISDFGL 149
Query: 169 TTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 214
+ D Y V R APE + +T D+WS G +L E+ T
Sbjct: 150 SRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 69/329 (20%), Positives = 117/329 (35%), Gaps = 79/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---EAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G V E VAIK + ++K + + E++ + Q H V+
Sbjct: 10 GVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCN-HPN----VVK 63
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLR-KNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
F + + +V L G SL D ++ ++ + +++L+ + ++H
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ 123
Query: 117 IHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
IH D+K N+LL +K+ D+ +SL D + R
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR-------------------- 163
Query: 175 DQNYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
V T + APEV+ G+ + DIWS G +EL TG A + + ++ +M
Sbjct: 164 --KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLT 219
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ P +KY + R+ I
Sbjct: 220 LQNDPPSL---ETGADYKKY----------SKSFRKMISLC------------------- 247
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
L+ DP+ R TA E L+H FF
Sbjct: 248 ---------LQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 34/237 (14%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-------LAKHDKGGN 54
G G FG+V ++ + A+K +R ++ M+E E + LA+ D
Sbjct: 10 GRGAFGEVRLVQKKDTGHIYAMKKLR------KSEMLEKEQVAHVRAERDILAEAD--NP 61
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR-EIARQLLECIAFMH 112
V++ F N++ ++ E L G + L K +F + R IA +L I +H
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETIL-AIDSIH 118
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
L IH D+KP+N+LL + +IK+ D+ + L + +++ + + +DF S
Sbjct: 119 KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 171 YERPD--QNY----------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
+ + V T Y APEV L G+ CD WS+G I+ E+ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-14
Identities = 71/248 (28%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+GT+G V D + +AIK + + R + E+ L + K N VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYVQPLHEEIA--LHSYLKHRN-IVQYL 71
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLR------KNNYRSFPIDLVREIARQLLECIAFMHD 113
I E++ G SL LR K+N + +Q+LE + ++HD
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNE-----QTIIFYTKQILEGLKYLHD 126
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H D+K +NVL+ ++Y S +K+ DFG T +R
Sbjct: 127 NQIVHRDIKGDNVLV--------------------NTY------SGVVKISDFG--TSKR 158
Query: 174 -----PDQNYIVSTRHYRAPEVI-LGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
P T Y APEVI G G+ P DIWS+GC +VE+ TG+ F E E
Sbjct: 159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF--IELGE 216
Query: 227 HLAMMERV 234
A M +V
Sbjct: 217 PQAAMFKV 224
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 4e-14
Identities = 60/295 (20%), Positives = 102/295 (34%), Gaps = 82/295 (27%)
Query: 2 GEGTFGQVLECW----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK---- 51
GEG FG+V + + VA+K ++ ++ RE + E ++++L H
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNIVRL 66
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C Q + IV E G L DFLRK+ + + ++A Q+ + +
Sbjct: 67 LGV--CTQ-------GEPLYIVTEYMPGGD-LLDFLRKHG-EKLTLKDLLQMALQIAKGM 115
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ +H DL N L+ + +K+ D FG
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISD---------------------------FGL 148
Query: 169 TTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
+ D Y + APE + +T D+WS G +L E+ T
Sbjct: 149 SRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQ----- 203
Query: 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMKL 277
P P + V + + G RL PE + + +M
Sbjct: 204 -------------PYPGMSNEEV----LELLEDGYRLPRPENCP--DELYELMLQ 239
|
Length = 258 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 65/245 (26%), Positives = 105/245 (42%), Gaps = 33/245 (13%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIE-VLQQLAKHDKGGNRCVQI 59
+GEG+FG+ L + A+K +R K E VL KH V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN----IVAF 63
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ F+ H+ IV E G L ++ + FP D + + Q+ + +H+ ++H
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
D+K +N+ L + +K+ D+ S+ +Y + TY
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY----------------ACTY------- 160
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLG 236
V T +Y PE+ + + DIWS+GCIL ELCT + FQ + +NL L + +
Sbjct: 161 -VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LKVCQGSYK 218
Query: 237 PLPQH 241
PLP H
Sbjct: 219 PLPSH 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-14
Identities = 38/161 (23%), Positives = 81/161 (50%), Gaps = 26/161 (16%)
Query: 88 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTP 146
Y +F ++ QLL ++++H+ +IH D+K N+L+ S+ + +++ D+
Sbjct: 96 KYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADF------- 148
Query: 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 206
+A ++ G+ E Q ++ T + APEV+ G + CD+WSVG
Sbjct: 149 -----------GAAARLAAKGTGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVG 195
Query: 207 CILVELCTGEALFQTHENLEHLAMMERVLG-----PLPQHM 242
C+++E+ T + + ++ HLA++ ++ +P+H+
Sbjct: 196 CVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL 236
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 5e-14
Identities = 78/340 (22%), Positives = 128/340 (37%), Gaps = 96/340 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMI-----EIEVLQQLAKH 49
+G+GT+G+V + EM+A+K V G R+ M+ EIE L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 50 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
+ VQ + ++ I E + G S+ LR Y F LVR Q+LE +
Sbjct: 69 N-----IVQYLGFETTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFTEQVLEGL 121
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
A++H ++H DLK +N+L+ + K+ D+ S +
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS----------------------D 159
Query: 169 TTYERPDQNYIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
Y+ + + + APEVI G++ DIWS+GC+++E+ G + + E
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR---RPWSDEE 216
Query: 227 HLAMM-----ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ 281
+A M +R P+P + + P
Sbjct: 217 AIAAMFKLGNKRSAPPIPPDVSMNLS--------------PVAL---------------- 246
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
L +P +R TARE L+HPF
Sbjct: 247 ---------------DFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 5e-14
Identities = 77/341 (22%), Positives = 125/341 (36%), Gaps = 94/341 (27%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+G +GQV ++ E+VA+K + + K E + E ++L K +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKSE----WL 63
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V++ F ++ + E + G L NN D R ++ E + +H+L
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
IH DLKPEN L+ +S +IK+ DFG +
Sbjct: 122 YIHRDLKPENFLIDASGHIKL---------------------------TDFGLSKGIVTY 154
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHENLEHLA 229
N +V + Y APEV+ G G+ + D WS+GC+L E G F +T ENL++
Sbjct: 155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
L P R ++ D
Sbjct: 215 ET---------------------------LQRPVYDDPRFNLS----------------D 231
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALR-HPFFTRDHLRR 329
+ +T L+ DP+ R + E ++ HPFF
Sbjct: 232 EAWDLITKLIN-----DPSRRFGSLEDIKNHPFFKEVDWNE 267
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 33/218 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G+G FG+ E +V K V R +K R A+ EI +L L +H +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN----II 62
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
N F N + I E G +LYD + + + F ++V Q++ ++++H +
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H D+K N+ L + IK+ D+ S K M ++
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGIS----KILGSEYSMAET------------------ 160
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+V T +Y +PE+ G+ + + DIW++GC+L EL T
Sbjct: 161 --VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 62/224 (27%), Positives = 109/224 (48%), Gaps = 39/224 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV------RGIKKYREAAMIEIEVLQQLAKHDKGGN 54
+G G FG+V C+D + +A+K V + K A EI++L+ L +HD
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHD---- 64
Query: 55 RCVQ----IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
R VQ +R+ + + I + + G S+ D L+ Y + ++ R RQ+L+ +++
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLKA--YGALTENVTRRYTRQILQGVSY 121
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H ++H D+K N+L S+ +K+ D+ +S KR I+ I T
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGAS----------KR------IQTICMSGTG 165
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ + T ++ +PEVI G G+ D+WSV C +VE+ T
Sbjct: 166 IKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 7e-14
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 44/224 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC-- 56
+G G G V + R +++A+K +R + ++ + E+++L +C
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----------KCNS 58
Query: 57 ---VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH- 112
V F I I E + D + K P ++ +IA +L+ + ++H
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+IH D+KP N+L+ S IK+ D+ S ++ S A
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----------GQLVNSLA------------ 156
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
V T Y APE I G ++ DIWS+G L+EL TG
Sbjct: 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 70/339 (20%), Positives = 132/339 (38%), Gaps = 85/339 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G FG+V C + +M A K + + +KK + + A+ E ++L++++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F+ ++ +C+V + G L + FP A Q++ + +H
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKPENVLL +++ D ++ G R
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKG-------------------GKKIKGR-- 154
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
T Y APEV+ G + + D +++GC L E+ G + F+ +
Sbjct: 155 ----AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK------------ 198
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
++V++ K R +++ ++ P D + +
Sbjct: 199 --------EKVEKEELK---------------RRTLEMAVEYP----------DKFSPEA 225
Query: 296 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 329
L + LL+ DP RL +A E HP F + RR
Sbjct: 226 KDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 43/229 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+GEG+FG+ + +E + IK I + K RE + E+ VL + KH V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN----IV 62
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q + F+ ++ IV + G LY + FP D + + Q+ + +HD +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI 122
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-----STTY 171
+H D+K +N+ L K IK+ DFG ++T
Sbjct: 123 LHRDIKSQNIFLT---------------------------KDGTIKLGDFGIARVLNSTV 155
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 220
E + T +Y +PE+ + DIW++GC+L E+CT + F+
Sbjct: 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 66/250 (26%), Positives = 109/250 (43%), Gaps = 40/250 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ---LAKHDKGGNRCV 57
+G+G +G V C + +++A+K V AA E E LQ+ L K K N
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ D N I I E + G S+ L N + P + + +Q+L+ +A++H+ C+
Sbjct: 67 YLGTCLD-DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 117 IHTDLKPENVLLVSSEYIKVPDYK-------SSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
+H D+K NV+L+ + IK+ D+ LH S+ K M
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMH------------- 169
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
T ++ APEVI G+ DIWS+GC + E+ TG+ + + L +
Sbjct: 170 -----------GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218
Query: 230 MMERVLGPLP 239
+ G +P
Sbjct: 219 YIGAHRGLMP 228
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 35/218 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G+G FG+V + ++E + A K++ + E M+EIE+L V++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHP-----YIVKL 74
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
F + + I+ E D + R ++ I RQ+LE + ++H + +IH
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHR 134
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLK NVLL IK+ D+ S K T +R D
Sbjct: 135 DLKAGNVLLTLDGDIKLADFGVSAKNVK----------------------TLQRRDS--F 170
Query: 180 VSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 212
+ T ++ APEV++ + Y DIWS+G L+E+
Sbjct: 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 77/331 (23%), Positives = 123/331 (37%), Gaps = 83/331 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G+G FG+V + +E A KI++ ++ E M+EI++L + KH V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPN----IVGL 67
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ Y N + I+ E D + R +R + RQ+LE + F+H +IH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLK N+LL +K+ D+ S ++
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVS------------------------AKNKSTLQKRDTF 163
Query: 180 VSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ T ++ APEV+ + Y DIWS+G L+EL E H L + ++ ++
Sbjct: 164 IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP---PHHELNPMRVLLKI 220
Query: 235 L-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
L P LD P +S
Sbjct: 221 LKSEPPT------------------LDQPSKWSS-------------------------- 236
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L+ L DP DR TA E L+HPF +
Sbjct: 237 SFNDFLKSCLVKDPDDRPTAAELLKHPFVSD 267
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 63/254 (24%), Positives = 104/254 (40%), Gaps = 74/254 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----------K 51
GEGT+G+V + ++ ++VAIKI+ I+ E E +L++ + H K
Sbjct: 15 GEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIK 74
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF---LRKNNYRSFPIDLVREIARQLLEC 107
+ W V E G S+ D LRK + + + I R+ L
Sbjct: 75 KNPPGNDDQLWL--------VMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRG 125
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+A++H+ +IH D+K +N+LL K++ +K++DFG
Sbjct: 126 LAYLHENKVIHRDIKGQNILLT---------------------------KNAEVKLVDFG 158
Query: 168 ------STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 216
ST R N + T ++ APEVI + D+WS+G +EL G+
Sbjct: 159 VSAQLDSTLGRR---NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
Query: 217 ----------ALFQ 220
ALF+
Sbjct: 216 PPLCDMHPMRALFK 229
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-13
Identities = 56/228 (24%), Positives = 98/228 (42%), Gaps = 38/228 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G GT+G V + D E+VAIK+++ ++ + +I EI +L++ +H V
Sbjct: 12 GSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFEIIQQEISMLKE-CRH----PNIVAY 65
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ R+ + IV E G SL D + + + R+ L+ +A++H+ IH
Sbjct: 66 FGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIH 124
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
D+K N+LL +K+ D+ S ++ KR
Sbjct: 125 RDIKGANILLTEDGDVKLADFGVS--AQLTATIAKR----------------------KS 160
Query: 179 IVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGE-ALFQTH 222
+ T ++ APEV G+ CDIW++G +EL + +F H
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 35/218 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G+G FG+V + ++E + A K++ + E M+EI++L + V++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN-----IVKL 67
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F Y N++ I+ E D + R +R + +Q LE + ++H+ +IH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLK N+L IK+ D+ S + T +R D
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTR----------------------TIQRRDS--F 163
Query: 180 VSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVEL 212
+ T ++ APEV++ + Y D+WS+G L+E+
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 8e-13
Identities = 83/329 (25%), Positives = 130/329 (39%), Gaps = 87/329 (26%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+G+FG+V + D KE+VAIKI+ E A EIE +QQ + R
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 61 NWFDY--RNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLC 115
+ Y + I+ E LG S D L+ P++ + I R++L+ + ++H
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSER 121
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
IH D+K NVLL +K+ D+ + G T +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQIK 157
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
+N V T + APEVI + + DIWS+G +EL GE + +L + RVL
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEP---PNSDLHPM----RVL 210
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+P++ P L+ Q+ +
Sbjct: 211 FLIPKN----------------------------------SPPTLEG---QY----SKPF 229
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTR 324
++ L DP R TA+E L+H F TR
Sbjct: 230 KEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 75/334 (22%), Positives = 125/334 (37%), Gaps = 94/334 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC---- 56
+G+GTFG+V+ ++ + A+KI++ +E + + EV L + N
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
++ F + +C V E G L+ L + R F D R +++ + ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFG--------------LCKEG----ISDGATM----- 152
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 233
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 211
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ + PR L +
Sbjct: 212 I-----------------------------------------RFPR--TL--------SP 220
Query: 294 DLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
+ LL GLL+ DP RL A+E + H FF
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 56/240 (23%), Positives = 100/240 (41%), Gaps = 44/240 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
+G+G+FG V + + +++ K I G +E + E+ +L++L KH V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPN----IV 62
Query: 58 QIRNWF-DYRNH-ICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ + D N + IV E + L +K + + + I QLL +
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYEC 121
Query: 112 HDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
H+ ++H DLKP N+ L ++ +K+ D+ + K + S
Sbjct: 122 HNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA----------KILGHDS------S 165
Query: 167 GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ TY V T +Y +PE + + + DIWS+GC++ ELC F L+
Sbjct: 166 FAKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 64/258 (24%), Positives = 116/258 (44%), Gaps = 39/258 (15%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G+FG+V L + E VAIK K ++ + + +++ + CV +
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNL 96
Query: 60 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
F +++ +V E +G + FLR+N + FP D+ A Q++ ++ L +++
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKPEN+LL +IK+ D+ + KV+D + TY
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFA-------------------KVVD--TRTYT------ 187
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-------EALFQTHENLEHLAMM 231
+ T Y APE++L +G D W++G + E+ G E L + LE +
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
Query: 232 ERVLGPLPQHMLKRVDRH 249
+ L +H++K++ H
Sbjct: 248 PKFLDNNCKHLMKKLLSH 265
|
Length = 340 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 54/204 (26%), Positives = 89/204 (43%), Gaps = 34/204 (16%)
Query: 88 NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHT 145
Y +F D+ R + + I +H L IH D+KP+N+L+ +IK+ D+ S H
Sbjct: 94 KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153
Query: 146 PKDSSYFKRMPKSSAIK---------VIDFGSTTYERPDQ------------NYIVSTRH 184
DS+Y++++ + + K +D + T DQ V T
Sbjct: 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213
Query: 185 YRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENL-------EHLAMMERV 234
Y APE+ L G+ CD WS+G I+ E G F +HE E L + +
Sbjct: 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDI 273
Query: 235 -LGPLPQHMLKRVDRHAEKYVRRG 257
L + +++R+ +AE + RG
Sbjct: 274 HLSVEAEDLIRRLITNAENRLGRG 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 67/259 (25%), Positives = 116/259 (44%), Gaps = 45/259 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---KGGNRCV 57
+G G FG+V + K + A+K +R ++ ++ +V A+ D + N V
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADNEWV 63
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRS-------FPIDLVREIARQLLECIAF 110
+R ++ +++ + F + D++ + S FP DL R +L +
Sbjct: 64 -VRLYYSFQDKDNLYF------VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVES 116
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKRM 155
+H + IH D+KP+N+L+ +IK+ D Y+S H +DS F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 156 PKSSA-------IKVIDF-GSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 207
A +K ++ + ++R + +V T +Y APEV+L G+T CD WSVG
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 208 ILVELCTGEALFQTHENLE 226
IL E+ G+ F LE
Sbjct: 237 ILYEMLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 65.2 bits (160), Expect = 3e-12
Identities = 53/230 (23%), Positives = 85/230 (36%), Gaps = 56/230 (24%)
Query: 2 GEGTFGQVLECW----DRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD----- 50
GEG FG+V + ++K VA+K ++ ++ E ++++L H
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNVVKL 66
Query: 51 KGGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C + + IV E + G L +LRKN + DL+ A Q+ +
Sbjct: 67 LGV--CTE-------EEPLYIVMEYMEGGD-LLSYLRKNRPKLSLSDLL-SFALQIARGM 115
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ IH DL N L V + +K+ DFG
Sbjct: 116 EYLESKNFIHRDLAARNCL-VGENLV--------------------------VKISDFGL 148
Query: 169 TTYERPDQNYIVSTRH--YR--APEVILGLGWTYPCDIWSVGCILVELCT 214
+ D Y R APE + +T D+WS G +L E+ T
Sbjct: 149 SRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 39/221 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKGGNRC 56
+G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDS--PYV 64
Query: 57 VQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ + + I+ E LG S D LR + F I + +++L+ + ++H
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLHSEK 121
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
IH D+K NVLL +K+ D+ + G T +
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVA------------------------GQLTDTQIK 157
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
+N V T + APEVI + DIWS+G +EL GE
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 43/228 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G+G+FG V + + K + A+K + + ++ RE A+ E VL +L +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-------DSSY 60
Query: 58 QIRNW--FDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
IR + F + + IV E L+ L+ R P D V Q+L +A +H
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++H D+K N+ L Y V K+ D G
Sbjct: 121 KILHRDIKSLNLFL--DAYDNV-------------------------KIGDLGVAKLLSD 153
Query: 175 DQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
+ N+ IV T +Y +PE+ + D+W++G +L E CTG+ F
Sbjct: 154 NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-12
Identities = 82/328 (25%), Positives = 124/328 (37%), Gaps = 83/328 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG V D++ +K+++ I E E Q L+K D
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEA-QLLSKLDHPA--I 64
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHD 113
V+ F R+ CI+ E G L L K+ ++ + V E QLL + +MH
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H DLK +N+ L + +K+ D+ S R+ S D +T
Sbjct: 125 RRILHRDLKAKNIFL-KNNLLKIGDFGVS-----------RLLMGSC----DLATT---- 164
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
T +Y +PE + G+ DIWS+GCIL E+C F+ L ++
Sbjct: 165 -----FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS--VVLRI 217
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
V GP P PE R N IMQ
Sbjct: 218 VEGPTPS--------------------LPE------------TYSRQLNSIMQS------ 239
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPF 321
+L DP+ R +A E LR+PF
Sbjct: 240 --------MLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-12
Identities = 57/256 (22%), Positives = 111/256 (43%), Gaps = 35/256 (13%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFV 62
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + ++ ++ +C+V + G L + F A ++ + +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKPEN+LL +I++ D ++H P+ + R
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR--------------------- 161
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ + +ER++
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217
Query: 236 GPLPQHMLKRVDRHAE 251
+ + ++ A
Sbjct: 218 KEVQEEYSEKFSPDAR 233
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 61/248 (24%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G G FG V C + +++V IK + + K R AA E +VL+ L+ + +
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN-----II 62
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + IV E G +L ++++K D + Q+L + +H +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI 122
Query: 117 IHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+H DLK +N+LL + + K+ D+ S K++ S Y
Sbjct: 123 LHRDLKTQNILLDKHKMVVKIGDFGIS-------------------KILSSKSKAYT--- 160
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM--MER 233
+V T Y +PE+ G + DIW++GC+L EL + + F+ NL L + M
Sbjct: 161 ---VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSG 216
Query: 234 VLGPLPQH 241
P+
Sbjct: 217 TFAPISDR 224
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 63/272 (23%), Positives = 103/272 (37%), Gaps = 61/272 (22%)
Query: 63 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
F ++C+V + G L+ L++ + ++ R A ++L + ++H L +++ DL
Sbjct: 70 FQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTP-------KDSSYFKRMPKSSAIKVIDFGSTTYERP 174
KPEN+LL S +I + D+ S + K R ++I F R
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFR- 188
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
N V T Y APEVI G G D W++G +L E+ G F+
Sbjct: 189 -SNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK-------------- 233
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
G+ E+ +++K S+
Sbjct: 234 -----------------------------GSNRDETFSNILKKEV---TFPGSPPVSS-S 260
Query: 295 LTHLLQGLLRYDPTDRL----TAREALRHPFF 322
L++ LL DP+ RL A E +HPFF
Sbjct: 261 ARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 19/147 (12%)
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD------------- 138
F DL R +L I +H + IH D+KP+N+L+ +IK+ D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 139 --YKSSLHTPKDS-SYFKRM--PKSSAIKVID-FGSTTYERPDQNYIVSTRHYRAPEVIL 192
Y+ H +DS + +K ++ ++R + +V T +Y APEV+L
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 193 GLGWTYPCDIWSVGCILVELCTGEALF 219
G+T CD WSVG IL E+ G+ F
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 64/261 (24%), Positives = 112/261 (42%), Gaps = 38/261 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+GEG+ G V ++ + VA+K + K+ R + V+ + H+ V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN----VVDMY 85
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
N + + + +V E L G +L D + + + + +L ++++H+ +IH
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLSVLRALSYLHNQGVIHR 142
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
D+K +++LL S IK+ D+ K E P + +
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSK------------------------EVPKRKSL 178
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
V T ++ APEVI L + DIWS+G +++E+ GE + N L M R+ LP
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP---PYFNEPPLQAMRRIRDNLP 235
Query: 240 QHMLKRVDRHAEKYVRRGRLD 260
+ D H V RG LD
Sbjct: 236 PRV---KDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 76/335 (22%), Positives = 125/335 (37%), Gaps = 94/335 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR----C 56
+G+GTFG+V+ ++ + A+KI++ +E + + EV L + N
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILK-----KEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
++ F ++ +C V E + G L+ L + R F D R +++ + ++H
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGK 115
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLK EN++L +IK+ D+ D++ K
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF-------------------- 155
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 233
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED 211
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ K PR +
Sbjct: 212 I-----------------------------------------KFPRTL----------SA 220
Query: 294 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 323
D LL GLL DP RL A+E +RH FFT
Sbjct: 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 75/280 (26%), Positives = 109/280 (38%), Gaps = 84/280 (30%)
Query: 70 CIVFEKLGSSLYDFLRKNNYRSFPIDL--VREIARQLLECIAFMHDLCMIHTDLKPENVL 127
C+V K S LY +L R P+ L V +ARQLL I ++H +IH D+K ENVL
Sbjct: 236 CLVLPKYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVL 292
Query: 128 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVST 182
++ P+D I + DFG+ + R P I T
Sbjct: 293 ---------------VNGPED------------ICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 183 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERVLGPLPQH 241
APEV+ G +T DIWS G ++ E A LF E ++L
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQIL------ 379
Query: 242 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG-------- 293
R+ R A+ +V ++P+ A SR L+ Q+ +A
Sbjct: 380 ---RIIRQAQVHVD----EFPQHAGSR--------------LVSQYRHRAARNRRPAYTR 418
Query: 294 -----------DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D+ +L+ L +D R +A E LR P F
Sbjct: 419 PAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458
|
Length = 461 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 58/237 (24%), Positives = 100/237 (42%), Gaps = 47/237 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G+FG+V + E AIK ++ + K + E +L +L+
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-----PFI 80
Query: 57 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F N + + E +G L+ LRK FP D+ + +L+ ++H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+I+ DLKPEN+LL + ++KV D+ + K++ PD
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDF----------GFAKKV------------------PD 170
Query: 176 QNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG------EALFQTHENL 225
+ + + T Y APEVI G D W++G +L E G + F+ +E +
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI 227
|
Length = 329 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 54/233 (23%)
Query: 2 GEGTFGQVLEC-WDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRC 56
GEG FG+V + + VA+K ++ ++ R+ + E V+++L H
Sbjct: 4 GEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPN----V 58
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN-NYRSFPI-------DLVREIARQLLE 106
V++ + +V E + G L D+LRK+ P DL+ A Q+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGD-LLDYLRKSRPVFPSPEKSTLSLKDLLS-FAIQIAK 116
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
+ ++ +H DL N L V + + +K+ DF
Sbjct: 117 GMEYLASKKFVHRDLAARNCL-VGEDLV--------------------------VKISDF 149
Query: 167 GSTTYERPDQNYIVSTR---HYR--APEVILGLGWTYPCDIWSVGCILVELCT 214
G + D Y T R APE + +T D+WS G +L E+ T
Sbjct: 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 74/338 (21%), Positives = 126/338 (37%), Gaps = 101/338 (29%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-------EAAMIEIEVLQQLAKHDKGG 53
+G+G+FG+VL + E+ A+K++ KK E M E VL KH
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHP--- 56
Query: 54 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
Q+ + F ++ + V E + G ++ R F R A +++ + F+
Sbjct: 57 -FLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFL 112
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H+ +I+ DLK +NVLL S +IK+ D+ M K I G TT
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFG--------------MCKEG----ILGGVTT- 153
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLA 229
+ T Y APE++ + D W++G +L E+ G++ F + L
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ + V P+ + S+E+
Sbjct: 209 LEDEVR--YPRWL------------------------SKEAKS----------------- 225
Query: 290 HSAGDLTHLLQGLLRYDPTDRL----TAREALR-HPFF 322
+L+ L +P RL T + ++ HPFF
Sbjct: 226 --------ILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 64/229 (27%), Positives = 98/229 (42%), Gaps = 55/229 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ----LAKHDKG---- 52
+G+G+FG+V + D +++VAIKI+ E A EIE +QQ L++ D
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 53 --GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLEC 107
G+ + W I+ E LG S D L P+D + I R++L+
Sbjct: 67 YYGSYLKDTKLW--------IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKG 113
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ ++H IH D+K NVLL +K+ D+ + G
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------G 149
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
T + +N V T + APEVI + DIWS+G +EL GE
Sbjct: 150 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 1 MGEGTFGQV-LECWDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
+GEG FG+V L +D E VA+K + G +++R EIE+L+ L H+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN--- 67
Query: 55 RCVQIRNWFD--YRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V+ + + + ++ E L S SL D+L+++ + L+ + Q+ + + ++
Sbjct: 68 -IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-FSSQICKGMDYL 125
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGSTT 170
IH DL N+L+ S + +K+ D+ + P+D Y+ + P S I
Sbjct: 126 GSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-------- 177
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ APE + ++ D+WS G L EL T
Sbjct: 178 --------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 96/335 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+VL + + A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F + + V + + G L+ L++ RSFP R A ++ + ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+I+ DLKPEN+LL S ++ + D+ K + K +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE--------------- 161
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
Y APEV+ + D W +G +L E+ G F + + E M +
Sbjct: 162 ------------YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYD 206
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH-VDHS 291
+L + L ++ + S
Sbjct: 207 NILN--------------------------------------------KPLRLKPNISVS 222
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALR----HPFF 322
A HLL+GLL+ D T RL A++ H FF
Sbjct: 223 A---RHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 84/347 (24%), Positives = 134/347 (38%), Gaps = 108/347 (31%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V++ R+ + + A+K +R + + E VL Q+ C
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV--------NC 52
Query: 57 ---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----NNYRSFPIDLVREIARQLLECI 108
V ++ F + +V + G L+ L++ + R+ R +LL +
Sbjct: 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCAL 106
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
+H +I+ DLKPEN+LL DY+ I + DFG
Sbjct: 107 ENLHKFNVIYRDLKPENILL---------DYQGH------------------IALCDFGL 139
Query: 169 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
D N T Y APE++LG G+T D W++G +L E+ TG
Sbjct: 140 CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG---------- 189
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285
LP + V+ K ++ L +P+G
Sbjct: 190 ------------LPPFYDENVNEMYRKILQE-PLRFPDG--------------------- 215
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHLRR 329
D A D LL GLL DPT RL A+E HPFF++ ++
Sbjct: 216 --FDRDAKD---LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKK 257
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 73/326 (22%), Positives = 129/326 (39%), Gaps = 84/326 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+GEG+ G V D+ VA+K + K+ R + V+ + +H V++
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN----IVEMY 82
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + + + +V E L G +L D + + + + +L+ ++F+H +IH
Sbjct: 83 SSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFLHAQGVIHR 139
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYERPDQ 176
D+K +++LL S +K+ DFG + E P +
Sbjct: 140 DIKSDSILLTSD---------------------------GRVKLSDFGFCAQVSKEVPRR 172
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+V T ++ APEVI L + DIWS+G +++E+ GE + N L M+R+
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP---PYFNEPPLQAMKRIRD 229
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
LP + ++ K PRL++ + +
Sbjct: 230 NLPPKL-----KNLHKVS-----------------------PRLRSFLDR---------- 251
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFF 322
+L DP R TA E L HPF
Sbjct: 252 -----MLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 58/236 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G GT+GQV + + ++ AIK++ + E +EI +L++ + H R
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----------R 73
Query: 61 NWFDY------------RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLEC 107
N Y + + +V E G+ S+ D ++ + D + I R++L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+A +H +IH D+K +NVLL +++ +K++DFG
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFG 166
Query: 168 -STTYERP--DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG 215
S +R +N + T ++ APEVI + Y DIWS+G +E+ G
Sbjct: 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 68/329 (20%), Positives = 128/329 (38%), Gaps = 88/329 (26%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
+G G +G V +VA+KI+ + + I E+ +L QL + + N
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQL-RQSQPPN---I 64
Query: 59 IRNWFDYRN--HICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHD 113
+ + Y + I+ E G S+ ++ PI + I R++L + ++H
Sbjct: 65 TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK 119
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ +IH D+K N+L+ ++ +K+ D+ + ++SS KR +T+
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KR--------------STF-- 161
Query: 174 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
V T ++ APEVI G + DIWS+G + E+ TG + +
Sbjct: 162 ------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------- 208
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
R + +P+ K PRL++ + +
Sbjct: 209 RAMMLIPKS----------------------------------KPPRLED------NGYS 228
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPF 321
L + L +P +RL+A E L+ +
Sbjct: 229 KLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 72/325 (22%), Positives = 129/325 (39%), Gaps = 78/325 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+GEG+ G V + ++VA+K + K+ R + V+ + +H+ V++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN----VVEMY 83
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
N + + + +V E L G +L D + + + + +L+ ++ +H +IH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNE---EQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
D+K +++LL +K+ D+ K E P + +
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSK------------------------EVPRRKSL 176
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
V T ++ APE+I L + DIWS+G +++E+ GE + L+ + M+
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------- 228
Query: 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
R + P P+L+NL V S L L
Sbjct: 229 ------------------RDNLP---------------PKLKNL--HKVSPS---LKGFL 250
Query: 300 QGLLRYDPTDRLTAREALRHPFFTR 324
LL DP R TA E L+HPF +
Sbjct: 251 DRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 9e-11
Identities = 78/339 (23%), Positives = 131/339 (38%), Gaps = 85/339 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+G FG+V C R +M A K + + IKK + +M E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFV 62
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + ++ ++ +C+V + G L + F + A ++L + +H
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++ DLKPEN+LL +I++ D ++ P+ S R
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--------------------- 161
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T Y APEV+ +T D W +GC++ E+ G++ F+ E+V
Sbjct: 162 ----VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR--------GRKEKV- 208
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+ + +RV E Y A E KS+ K+
Sbjct: 209 --KREEVDRRVLETEEVY----------SAKFSEEAKSICKM------------------ 238
Query: 296 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 329
LL DP RL A E RHPFF + +R
Sbjct: 239 ------LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 66/244 (27%), Positives = 111/244 (45%), Gaps = 35/244 (14%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G+G FG+V + W+ K VAIK ++ EA + E +++++L +HDK +
Sbjct: 14 LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVV 70
Query: 60 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I IV E +G SL DFL++ + + + + ++A Q+ + +A++ + IH
Sbjct: 71 S-----EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIK---------------- 168
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER-VLG 236
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
Query: 237 PLPQ 240
P PQ
Sbjct: 223 PCPQ 226
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 63/236 (26%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V + W+ K VA+K ++ E+ + E +++++L +HDK VQ+
Sbjct: 14 LGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKL-RHDK----LVQL 66
Query: 60 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I IV E + SL DFL+ R+ + + ++A Q+ +A++ + IH
Sbjct: 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ N+L+ K+ D+ + +D+ Y R IK
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIK---------------- 168
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G+FG V D E+VAIK K + E Q + K + +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVRFLQQLRH-P 75
Query: 61 NWFDY-----RNHIC-IVFEK-LGSS--LYDFLRKNNYRSFPIDLVREIA---RQLLECI 108
N +Y R H +V E LGS+ + + +K P+ V EIA L+ +
Sbjct: 76 NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK------PLQEV-EIAAICHGALQGL 128
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
A++H IH D+K N+LL + +K+ DFGS
Sbjct: 129 AYLHSHERIHRDIKAGNILLT---------------------------EPGTVKLADFGS 161
Query: 169 TTYERPDQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 212
+ P ++ V T ++ APEVIL + + D+WS+G +EL
Sbjct: 162 ASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (150), Expect = 1e-10
Identities = 64/248 (25%), Positives = 115/248 (46%), Gaps = 36/248 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAM-IEIEVLQQLAKHDKGGNRCV 57
+G G FG+V + +E K + RG+K+ ++ + IE+ V+++L KH
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYID 79
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI------DLVREIARQLLECIAFM 111
+ N + + +I + F G L +N + + + + +I RQLL +A+
Sbjct: 80 RFLNKANQKLYILMEFCDAGD-----LSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 112 HDLC-------MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 164
H+L ++H DLKP+N+ L S I+ H K ++ + K+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFL--STGIR--------HIGKITAQANNLNGRPIAKIG 184
Query: 165 DFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQ 220
DFG + + + V T +Y +PE++L +Y D+W++GCI+ ELC+G+ F
Sbjct: 185 DFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244
Query: 221 THENLEHL 228
N L
Sbjct: 245 KANNFSQL 252
|
Length = 1021 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 43/219 (19%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG V L W +RK VAIK +R E + E +V+ +L+ + VQ+
Sbjct: 12 IGSGQFGLVWLGYWLEKRK--VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQL 64
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
R+ IC+VFE + L D+LR F + + + + E +A++ +IH
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL N L+ ++ +KV DFG T + DQ Y
Sbjct: 124 RDLAARNCLV---------------------------GENQVVKVSDFGMTRFVLDDQ-Y 155
Query: 179 IVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVEL 212
ST + +PEV ++ D+WS G ++ E+
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 40/221 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G F V + +VA+K V+ K R+ + EI++L+QL H
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPN----V 64
Query: 57 VQIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
++ F N + IV E L + F K R P + + QL + M
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHF--KKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H D+KP NV + ++ +K+ D R F S T
Sbjct: 123 HSKRIMHRDIKPANVFITATGVVKLGDLG-----------LGRF----------FSSKTT 161
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212
+ +V T +Y +PE I G+ + DIWS+GC+L E+
Sbjct: 162 A---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 23/151 (15%)
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDS 149
FP L R +L I +H + IH D+KP+N+L+ +IK+ D+ + +S
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 150 SYFKR--------MPKS------SAIKVIDFGSTTYERPDQNY-------IVSTRHYRAP 188
Y+++ M S S + D T +R + + +V T +Y AP
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAP 217
Query: 189 EVILGLGWTYPCDIWSVGCILVELCTGEALF 219
EV+L G+T CD WSVG IL E+ G+ F
Sbjct: 218 EVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 68/257 (26%), Positives = 105/257 (40%), Gaps = 54/257 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+G+FG+V +VR I + ++VL++ + R R
Sbjct: 4 LGQGSFGKVF--------------LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMER 49
Query: 61 NWFDYRNHICIV-----FEKLGSSLY---DFLRKNNYRS-------FPIDLVREIARQLL 105
+ NH IV F+ G LY DFLR + + F + V+ +L
Sbjct: 50 DILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELA 108
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
+ +H L +I+ DLKPEN+LL +IK+ D+ S K+S ID
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------ID 150
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
Y T Y APEV+ G T D WS G ++ E+ TG FQ +
Sbjct: 151 HEKKAYS------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204
Query: 226 EHLAMMERVLGPLPQHM 242
E + M+ + +PQ +
Sbjct: 205 ETMTMILKAKLGMPQFL 221
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 78/326 (23%), Positives = 130/326 (39%), Gaps = 53/326 (16%)
Query: 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 63
G+ G+V + + V +KI G K +IE +LQ + H +++++
Sbjct: 77 GSEGRVFVATKPGQPDPVVLKI--GQKG---TTLIEAMLLQNV-NHPS----VIRMKDTL 126
Query: 64 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 123
C+V S LY +L K + R PID I +Q+LE + ++H +IH D+K
Sbjct: 127 VSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKT 185
Query: 124 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 183
EN+ + + + + D ++ + P V+ P + T
Sbjct: 186 ENIFINDVDQVCIGDLGAA-----------QFP------VVA--------PAFLGLAGTV 220
Query: 184 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHML 243
APEV+ + DIWS G +L E+ A T E V H+L
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML---AYPSTIFEDPPSTPEEYVKSC-HSHLL 276
Query: 244 KRVDR---HAEKYVRRGRLDWPEGAASRESIK--SVMKLPRLQNLIMQHVD-HSAGDLTH 297
K + H E++ R P R I+ S+ + P + Q V+ G+
Sbjct: 277 KIISTLKVHPEEFPRD-----PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF-- 329
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFT 323
L+ +L +D R +A E L +P F
Sbjct: 330 LVHKMLTFDAAMRPSAEEILNYPMFA 355
|
Length = 357 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.4 bits (143), Expect = 5e-10
Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQI 59
+G+G G V D + VAIK + K+ ++ +I EI V+++L + I
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPN--------I 78
Query: 60 RNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYE 172
+IH D+K +NVLL ++K+ DFG T E
Sbjct: 136 VIHRDIKSDNVLL---------------------------GMDGSVKLTDFGFCAQITPE 168
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 41/228 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+VL + + E A+K ++ I E M+E VL ++
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMH 112
+ F + H+ V E L G ++ K + DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+I+ DLK +NV+L +IK+ D+ M K + D ++T+
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFG--------------MCKENVFG--DNRASTF- 156
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 220
T Y APE++ GL +T+ D WS G +L E+ G++ F
Sbjct: 157 -------CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 7e-10
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 35/228 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREA-AMIEIEVLQQLAKHDKGGNRC 56
+G+G FG+V + +M A K + R KK E A++E E+L+++
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSP-----FI 55
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F+ + H+C+V + G L + R ++ V + Q+ I +H +
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ D+KPENVLL ++ D ++ G T +R
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD-------------------GKTITQR-- 154
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
T Y APE++ ++YP D +++GC + E+ G F+ H+
Sbjct: 155 ----AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-- 58
+G+GTFG+V+ ++ A+KI++ +E + + EV L + NR +Q
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILK-----KEVIVAKDEVAHTLTE-----NRVLQNS 52
Query: 59 -------IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
++ F + +C V E G L+ L + R F D R +++ + +
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDY 110
Query: 111 MH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
+H + +++ DLK EN++L +IK+ D+ KD + K
Sbjct: 111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-------------- 156
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEH 227
T Y APEV+ + D W +G ++ E+ G F Q HE L
Sbjct: 157 ----------CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 206
Query: 228 LAMME-----RVLGPLPQHML 243
L +ME R L P + +L
Sbjct: 207 LILMEEIRFPRTLSPEAKSLL 227
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 28/158 (17%)
Query: 63 FDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDL 121
F N+IC+ E + D + K P++++ +IA ++E + ++++ ++H D+
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
KP N+L+ S IK+ D+ S ++I+ + T+ V
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSG------------------ELINSIADTF--------VG 164
Query: 182 TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
T Y +PE I G +T D+WS+G ++EL G+ F
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF 202
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 63/248 (25%), Positives = 106/248 (42%), Gaps = 49/248 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 55
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D G
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILVEADGAW 62
Query: 56 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 109
V++ F + ++ ++ E L G + L K D + E A Q + I
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAID 115
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPD---------------YKSSLHTPKDSSYFKR 154
+H L IH D+KP+N+LL + ++K+ D Y++ H P F+
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 155 MPKSSAIKVIDFGSTTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211
M + T+++ + V T Y APEV + G+ CD WS+G I+ E
Sbjct: 176 MNSKRK-------AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 212 LCTGEALF 219
+ G F
Sbjct: 229 MLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 33/165 (20%)
Query: 63 FDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTD 120
F ++++ +V E G L L N Y F D+ + +L+ I +H + +H D
Sbjct: 70 FQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRD 127
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
+KPENVL+ + +IK+ D+ S+ + ++P V
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP-----------------------V 164
Query: 181 STRHYRAPEVILGL----GWTY--PCDIWSVGCILVELCTGEALF 219
T Y APEV+ + TY CD WS+G I E+ G + F
Sbjct: 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLA-----KHDKGGNR 55
+GEG G V +C + + A+K + ++ ++L++L K
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSCKSP----Y 60
Query: 56 CVQIRNWF--DYRNHICIVFEKLGS----SLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
V+ F + + I I E S+Y ++K R L + IA +L+ ++
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK-IAESVLKGLS 119
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++H +IH D+KP N+LL +K+ D+ S ++++ +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG------------------ELVNSLAG 161
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212
T+ T Y APE I G ++ D+WS+G L+E+
Sbjct: 162 TF--------TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 75/332 (22%), Positives = 129/332 (38%), Gaps = 86/332 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+GTFGQV + ++ + + A+K++ + I +E A E +L + +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 57 VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V ++ F + + +V + G L+ L+K F D + +L+ + +H
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKPEN+LL ++ +I + D+ S D+ TT
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDN------------------KTT----- 153
Query: 176 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
N T Y APEV+L G+T D WS+G ++ E+C G + F
Sbjct: 154 -NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF--------------- 197
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
Q M + + G++ +P+ S E
Sbjct: 198 YAEDTQQMYRN--------IAFGKVRFPKNVLSDEG------------------------ 225
Query: 295 LTHLLQGLLRYDPTDRL----TAREALRHPFF 322
++GLL +P RL A E HPFF
Sbjct: 226 -RQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 76/339 (22%), Positives = 131/339 (38%), Gaps = 85/339 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+G FG+V C R +M A K + + IKK + AM E ++L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFV 62
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + ++ ++ +C+V + G L + F + A ++ + +H
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPE-------------------GETIRGR-- 161
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
V T Y APEV+ +T+ D W +GC++ E+ G++ F+ + +ER
Sbjct: 162 ----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-- 215
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
RV E+Y + + E A S
Sbjct: 216 ---------RVKEDQEEYSEK----FSEAARS---------------------------- 234
Query: 296 THLLQGLLRYDPTDRL-----TAREALRHPFFTRDHLRR 329
+ + LL DP RL A E HPFF + +R
Sbjct: 235 --ICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 69/283 (24%), Positives = 123/283 (43%), Gaps = 40/283 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK---IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G+G++G+V R + IK + ++ R+AA E ++L QL KH N
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHP---NIVA 63
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+W + IV G LY L++ + P + V E Q+ + ++H+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLK +NV L + IKV D R+ ++ D ST
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLG-----------IARVLENQC----DMAST------- 161
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 235
++ T +Y +PE+ + Y D+W++GC + E+ T + F + +++ R++
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK---DMNSLVYRIIE 216
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 278
G LP M K + + PE R S+KS+++ P
Sbjct: 217 GKLPP-MPKDYSPELGELIATMLSKRPE---KRPSVKSILRQP 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 50/229 (21%)
Query: 1 MGEGTFGQV-LECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHD---- 50
+GEG FG+V L C+D EMVA+K ++ ++ EI +L+ L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 51 -----KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLL 105
+ G + +Q+ + + LGS L D+L K+ + L A+Q+
Sbjct: 72 KGCCSEQGGKGLQL----------IMEYVPLGS-LRDYLPKHKLNLAQLLL---FAQQIC 117
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
E +A++H IH DL NVLL + +K+ D+ + P+ Y+ +V +
Sbjct: 118 EGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY---------RVRE 168
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
G S + A E + ++Y D+WS G L EL T
Sbjct: 169 DGD------------SPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 60/289 (20%), Positives = 123/289 (42%), Gaps = 43/289 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI- 59
+G GT+GQV + + ++ AIK++ E EI +L++ + H
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 60 -RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+N + + +V E G+ S+ D ++ + + + I R++L ++ +H +I
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVI 133
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP-- 174
H D+K +NVLL +++ +K++DFG S +R
Sbjct: 134 HRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQLDRTVG 166
Query: 175 DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
+N + T ++ APEVI + + D+WS+G +E+ G + L
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF 226
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 278
++ R P P+ K+ + + ++ + + + R + + +MK P
Sbjct: 227 LIPR--NPAPRLKSKKWSKKFQSFIESCLV---KNHSQRPTTEQLMKHP 270
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 59/239 (24%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQI 59
+G+G G V D + VAIK + ++ ++ +I EI V+++ N+ I
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE--------NKNPNI 78
Query: 60 RNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQ 135
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYE 172
+IH D+K +N+LL ++K+ DFG T E
Sbjct: 136 VIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITPE 168
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 59/245 (24%), Positives = 102/245 (41%), Gaps = 38/245 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+VL + + A+K+++ +K ++ M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F + V + + G L+ L++ RSFP R A ++ + ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKPEN+LL S ++ + D+ I D +T
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLC---------------KEGIAQSDTTTT------ 155
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF---QTHENLEHLAMME 232
T Y APEVI + D W +G +L E+ G F E +++
Sbjct: 156 ---FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 233 RVLGP 237
VL P
Sbjct: 213 LVLRP 217
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 4e-09
Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQI 59
+G+G G V D + VAI+ + ++ ++ +I EI V+++ N+ I
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE--------NKNPNI 79
Query: 60 RNWFDYR---NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQ 136
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYE 172
+IH D+K +N+LL ++K+ DFG T E
Sbjct: 137 VIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITPE 169
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ ++ +V T ++ APEV+ + DIWS+G + +E+ GE + L L ++
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 76/335 (22%), Positives = 121/335 (36%), Gaps = 94/335 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRC 56
+G+GTFG+V+ ++ A+KI+R I K A + E VLQ +H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHP----FL 57
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
++ F + +C V E G L+ L + R F + R +++ + ++H
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ D+K EN++L +IK+ D+ D + K
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-------------------- 155
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMMER 233
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 211
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ P R PE +
Sbjct: 212 IRFP--------------------RTLSPEAKS--------------------------- 224
Query: 294 DLTHLLQGLLRYDPTDRL-----TAREALRHPFFT 323
LL GLL+ DP RL A+E + H FF
Sbjct: 225 ----LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 52/226 (23%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF 63
G G C D + E V IK + R E +L+ + H +Q++ F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-NHPS----IIQLKGTF 152
Query: 64 DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKP 123
Y C++ + + LY +L R+ I + I R +L I ++H+ +IH D+K
Sbjct: 153 TYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKA 210
Query: 124 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR 183
EN+ + + P D + + DFG+ + I + +
Sbjct: 211 ENIFI---------------NHPGD------------VCLGDFGAACFPVD----INANK 239
Query: 184 HY--------RAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQ 220
+Y APE++ + DIWS G +L E+ T +LF+
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 6e-09
Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 59/230 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKI--VRGIKKYREAAMI--EIEVLQQL---------- 46
+G GTFG+V DR + A+K+ + + + ++ + E VL+++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 47 AKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLL 105
+HD+ + ++ E + G L+ +LR N F A +++
Sbjct: 69 TEHDQ---------------RFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIV 111
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
+ ++H +++ DLKPEN+LL +IK+ D+ A K+ D
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDF------------------GFAKKLRD 153
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
T + T Y APEVI G D W++G ++ E+ G
Sbjct: 154 RTWT---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-09
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G+G FG+V + W+ + VAIK ++ EA + E +V+++L +H+K VQ+
Sbjct: 14 LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK----LVQL 66
Query: 60 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I IV E + SL DFL+ + + + ++A Q+ +A++ + +H
Sbjct: 67 YAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 126 RDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIK---------------- 168
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 169 ------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 57/235 (24%), Positives = 96/235 (40%), Gaps = 35/235 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCV 57
+GEG+FG++ + E IK + K K +EA+ E+ +L ++ KH V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPN----IV 62
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
F + IV E G L + + F D + Q+ + +HD +
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 117 IHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+H D+K +N+ L + + K+ D+ + DS
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIA-RQLNDSMELAYT-------------------- 161
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
V T +Y +PE+ + DIWS+GC+L ELCT + F+ + NL L +
Sbjct: 162 ---CVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 37/229 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G+G FG+V C R +M A K + + IKK + AM E +L+++
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFV 62
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 114
V + ++ ++ +C+V + F N + D R I A +L + +
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+++ DLKPEN+LL +I++ D ++ P+ G T R
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE-------------------GETVRGR- 161
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
V T Y APEVI +T+ D W +GC++ E+ G++ F+ +
Sbjct: 162 -----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G+FG V + E+VA+K + + + + + E++ LQQL KH
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPN----T 83
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + + + +V E S D L + +++ I L+ +A++H M
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSHNM 142
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+K N+LL + +K+ DFGS + P
Sbjct: 143 IHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSSP-A 174
Query: 177 NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 212
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 67/323 (20%), Positives = 123/323 (38%), Gaps = 78/323 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+GEG+ G V ++ VA+K++ K+ R + V+ + +H V++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEMY 84
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + ++ E L G +L D + + I V E +L+ + ++H +IH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIHR 141
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
D+K +++LL +K+ D+ KD P + +
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDV------------------------PKRKSL 177
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
V T ++ APEVI + DIWS+G +++E+ GE + + P
Sbjct: 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---------------P 222
Query: 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
+KR+ R P + I V++ L
Sbjct: 223 VQAMKRL-----------RDSPPPKLKNAHKISPVLR--------------------DFL 251
Query: 300 QGLLRYDPTDRLTAREALRHPFF 322
+ +L +P +R TA+E L HPF
Sbjct: 252 ERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 51/234 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+GT+G+V + +++ A+KI+ I E E +L+ L+ H V+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN----VVKFY 81
Query: 61 NWF---DYRN--HICIVFEKL-GSSLYD----FLRKNNYRSFPIDLVREIARQLLECIAF 110
+ D +N + +V E G S+ D FL++ PI + I + L +
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEALMGLQH 139
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST- 169
+H IH D+K N+LL + +K++DFG +
Sbjct: 140 LHVNKTIHRDVKGNNILLTT---------------------------EGGVKLVDFGVSA 172
Query: 170 --TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 216
T R +N V T + APEVI L + CD+WS+G +EL G+
Sbjct: 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 70/250 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+GT+G+V + +++ + A+KI+ I E E +LQ L H V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN----VVKFY 85
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC--------IAF-- 110
F Y+ + G L+ L N S V E+ + LL C I++
Sbjct: 86 GMF-YKADKLV-----GGQLWLVLELCNGGS-----VTELVKGLLICGQRLDEAMISYIL 134
Query: 111 ---------MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 161
+H+ +IH D+K N+LL + +
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTT---------------------------EGGV 167
Query: 162 KVIDFGST---TYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELC 213
K++DFG + T R +N V T + APEVI + CD+WS+G +EL
Sbjct: 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227
Query: 214 TGE-ALFQTH 222
G+ LF H
Sbjct: 228 DGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 65/319 (20%), Positives = 129/319 (40%), Gaps = 77/319 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G++ +VL ++ ++ A+K+V+ + + + ++ + + + V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 61 NWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ F + + +V E + G ++ R+ R P + R A ++ + F+H+ +I+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 119 TDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
DLK +NVLL + +IK+ DY K L +S F P
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP------------------- 160
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -NYI-------APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI-------------- 198
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+ D + E Y+ + L+ P +++PR ++ HV
Sbjct: 199 ------ITDNPDMNTEDYLFQVILEKP------------IRIPRFLSVKASHV------- 233
Query: 296 THLLQGLLRYDPTDRLTAR 314
L+G L DP +RL +
Sbjct: 234 ---LKGFLNKDPKERLGCQ 249
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 46/224 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQI 59
+G+G G V D + VAIK + ++ ++ +I EI V+++ N+ I
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE--------NKHPNI 78
Query: 60 RNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
N+ D + + +V E L G SL D + + I V R+ L+ + F+H
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQ 135
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH D+K +N+LL ++K+ DFG P+
Sbjct: 136 VIHRDIKSDNILL---------------------------GMDGSVKLTDFGFCAQITPE 168
Query: 176 QN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
Q+ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 37/232 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V + + AIK ++ + E M+E VL +H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREI--ARQLLECIAFMHDL 114
+ F + ++ V E L F ++ ++ DL R A +++ + F+H
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+++ DLK +N+LL + +IK+ D+ M K + + D + T+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFG--------------MCKENMLG--DAKTCTF--- 156
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
T Y APE++LG + D WS G +L E+ G++ F H+ E
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 52/229 (22%), Positives = 97/229 (42%), Gaps = 39/229 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMI-EIEVLQQLAKHDKGGNRCV 57
G+G FG+V R+ K+M A+K + ++K ++ E +LQ+L H V
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NH----PFLV 63
Query: 58 QIRNWFDYRNHICIVFE-KLGSSL-YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ F ++ +V + LG L Y +K F + V+ +++ + ++H
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH D+KP+N+LL ++ + D+ + D+ +T+
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-----------------TTST---- 159
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224
T Y APEV+ G++ D WS+G E G+ ++ H
Sbjct: 160 ----SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 57/248 (22%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIE------IEVLQQLAKHDKGG 53
+G G FG V L W + VAIK++R E AM E +V+ +L+ H
Sbjct: 12 LGSGQFGVVHLGKWRGKID--VAIKMIR------EGAMSEDDFIEEAKVMMKLS-HPN-- 60
Query: 54 NRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
VQ+ + I IV E + + L ++LR+ + + + ++ + E + ++
Sbjct: 61 --LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE 117
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
IH DL N LV + + +KV DFG Y
Sbjct: 118 SNGFIHRDLAARNC-LVGEDNV--------------------------VKVSDFGLARYV 150
Query: 173 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
DQ Y S + PEV ++ D+WS G ++ E+ + + +E +
Sbjct: 151 LDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKM--PYERFSN 207
Query: 228 LAMMERVL 235
++E V
Sbjct: 208 SEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 35/241 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNR 55
+G G FG+V ++ + A+KI+R +A M+E E + + A+ D
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILVEADSLW 62
Query: 56 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQL-----LECIA 109
V++ F + ++ ++ E L G + L K D + E Q + I
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAID 115
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYK--SSLHTPKDSSYFKRMPKS--SAIKVID 165
+H L IH D+KP+N+LL S ++K+ D+ + L + +++ + S S +
Sbjct: 116 SIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN 175
Query: 166 FGST----TYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 218
S T++R + V T Y APEV + G+ CD WS+G I+ E+ G
Sbjct: 176 MNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 219 F 219
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 34/153 (22%)
Query: 67 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPE 124
I I E + G SL L+K P +++ +I+ +L + ++ + ++H D+KP
Sbjct: 72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 125 NVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVST 182
N+L+ S IK+ D+ S L DS N V T
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLI---DSM-------------------------ANSFVGT 161
Query: 183 RHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
R Y +PE + G +T DIWS+G LVE+ G
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 57/234 (24%), Positives = 100/234 (42%), Gaps = 41/234 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAA--MIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+VL + ++ A+K++ + I K +E M E VL + KH
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F + + V + + G L+ L++ R F R A ++ + ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+++ DLKPEN+LL S +I + D+ K ++ +S F P+
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE--------------- 161
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
Y APEV+ + D W +G +L E+ G F + E
Sbjct: 162 ------------YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G F +V ++ VA+K V+ + K R+ + EI++L+QL +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN-----V 64
Query: 57 VQIRNWFDYRNHICIVFEKLG----SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
++ + F N + IV E S + + +K R P V + QL + MH
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMH 123
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
++H D+KP NV + ++ +K+ D R F S T
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLG-----------LGRF----------FSSKTTA 162
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 163 ---AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 5e-08
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 45/221 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G+FG V D E+VAIK K + E Q + K K R ++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIK------KMSYSGKQSNEKWQDIIKEVKFLQR-IKHP 85
Query: 61 NWFDY-----RNHIC-IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
N +Y R H +V E S D L + +++ I L+ +A++H
Sbjct: 86 NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHSH 144
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
MIH D+K N+LL + +K+ DFGS + P
Sbjct: 145 NMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIASP 177
Query: 175 DQNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 212
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 33/162 (20%)
Query: 86 KNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144
K + F + + I Q++ + ++H + ++H DL P N++L +
Sbjct: 104 KEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD------------ 151
Query: 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDI 202
+ + DFG ++P+ +V T Y PE++ + D+
Sbjct: 152 ---------------KVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADV 196
Query: 203 WSVGCILVELCTGEALFQTHENLEHLAM--MERVLGPLPQHM 242
W+ GCIL ++CT + F + N+ LA +E V PLP+ M
Sbjct: 197 WAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 30/170 (17%)
Query: 63 FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
F N++ +V + +G L L K R P D+ R +++ I +H L +H D+
Sbjct: 70 FQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
KP+NVLL + +I++ D+ S L +D + +SS V
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSV------------------AVG 165
Query: 182 TRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 226
T Y +PE++ G+G P CD WS+G + E+ GE F +E
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 57/242 (23%), Positives = 99/242 (40%), Gaps = 41/242 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ + E AIK ++ E M+E VL +H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + H+ V E L F +++ R F R A +++ + F+H +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117
Query: 117 IHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
I+ DLK +NVLL +IK+ D+ K +++ +S F
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--------------------- 156
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 231
T Y APE++ G + D WS G +L E+ G++ F + + L +
Sbjct: 157 ------CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 232 ER 233
+R
Sbjct: 211 DR 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 58/262 (22%), Positives = 102/262 (38%), Gaps = 65/262 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD--KGGNRCVQ 58
+G G FG V + + ++A+K +R + E E + L D + C
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRST-------VDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 59 IRNWFDYRNH-----IC-----IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
I ++ IC I +K +Y+ L+ P +++ +IA ++ +
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEILGKIAVATVKAL 120
Query: 109 AFM-HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
++ +L +IH D+KP N+LL ++ IK+ DFG
Sbjct: 121 NYLKEELKIIHRDVKPSNILL---------------------------DRNGNIKLCDFG 153
Query: 168 STTYERPDQNYIVSTRH-----YRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALF 219
+ + I TR Y APE I G+ D+WS+G L E+ TG+ +
Sbjct: 154 ISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210
Query: 220 QTHENL-EHLAMMERVLGPLPQ 240
++ + L + V G P
Sbjct: 211 PKWNSVFDQLTQV--VKGDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 53/228 (23%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 54
+G G++ +VL ++ + + A+K+V+ + + ++ E V +Q + H G +
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
C Q + R I + G ++ R+ R P + R + ++ + ++H+
Sbjct: 63 SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
+I+ DLK +NVLL S +IK+ DY K L +S F P
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP--------------- 160
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
NYI APE++ G + + D W++G ++ E+ G + F
Sbjct: 161 -----NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 47/186 (25%)
Query: 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 139
L+D L+K V++I RQL+E + +H +IH D+K ENVL
Sbjct: 96 LFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL------------ 141
Query: 140 KSSLHTPKDSSYFKRMPKSSAIKVIDFG-------STTYERPDQNYIVSTRHYRAPEVIL 192
Y + + I + D+G + Y+ T Y +PE I
Sbjct: 142 -----------YDRAKDR---IYLCDYGLCKIIGTPSCYDG--------TLDYFSPEKIK 179
Query: 193 GLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHA 250
G + D W+VG + EL TG+ F+ E L+ ++++R LP +K V ++A
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP--FIKNVSKNA 237
Query: 251 EKYVRR 256
+V+
Sbjct: 238 NDFVQS 243
|
Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 41/237 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDKGGNRC 56
+G G FG+V + ++ A+KI+ + + A E +VL G N+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN------GDNQW 62
Query: 57 VQIRNW-FDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ ++ F N++ +V + +G L L K R P D+ R +++ I +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H D+KP+N+L+ + +I++ D+ S L +D +
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV----------------------- 158
Query: 175 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALFQTHENLE 226
+ V T Y +PE++ G G P CD WS+G + E+ GE F +E
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 50/218 (22%), Positives = 94/218 (43%), Gaps = 40/218 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G G V + + + ++A+K++ + ++ M E+E+L + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-----PYIIG 63
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
F N I I E + G SL + YR P ++ IA +++ + ++ L ++
Sbjct: 64 FYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLWSLKIL 117
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+KP N+L+ + +K+ D+ S ++++ + TY
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVS------------------TQLVNSIAKTY------ 153
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
V T Y APE I G + D+WS+G +EL G
Sbjct: 154 --VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 56/228 (24%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 1 MGEGTFGQVLEC----WDRERKEM-VAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGG 53
+G G FG+V+E + M VA+K+++ REA M E++++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 54 NRCVQIRNWFDYRNH---ICIVFEKLG-SSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
I N I ++ E L +FLR+ ++ + + Q+ + +A
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
F+ IH DL NVLL + +K+ DFG
Sbjct: 156 FLASKNCIHRDLAARNVLLTHGK---------------------------IVKICDFGLA 188
Query: 170 TYERPDQNYIV--STR---HYRAPEVILGLGWTYPCDIWSVGCILVEL 212
D NY+V + R + APE I +T+ D+WS G +L E+
Sbjct: 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 59/241 (24%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+VL + A+K+++ KK + M E VL + KH
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F + V + + G L+ L++ R F R A ++ I ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+I+ DLKPEN+LL S ++ + D+ K + + +S F P+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPE--------------- 161
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF------QTHENLE 226
Y APEV+ + D W +G +L E+ G F Q ++N+
Sbjct: 162 ------------YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209
Query: 227 H 227
H
Sbjct: 210 H 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV----RGIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G+FG V D E+VAIK + + + + + E+ LQ+L +H
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPN----T 77
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+Q R + + +V E S D L + +++ + L+ +A++H M
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHSHNM 136
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+K N+LL + +K+ DFGS + P
Sbjct: 137 IHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMAP-A 168
Query: 177 NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVEL 212
N V T ++ APEVIL + + D+WS+G +EL
Sbjct: 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 34/236 (14%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V + ++ K VAIK ++ EA + E +++QL +H R V++
Sbjct: 14 LGAGQFGEVWMGYYNGHTK--VAIKSLKQGSMSPEAFLAEANLMKQL-QH----PRLVRL 66
Query: 60 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ I I+ E + + SL DFL+ I+ + ++A Q+ E +AF+ IH
Sbjct: 67 -YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ N+L+ + K+ D+ + +D+ Y R IK
Sbjct: 126 RDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIK---------------- 168
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE I +T D+WS G +L E+ T G + N E + +ER
Sbjct: 169 ------WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 34/236 (14%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V + +++ K VA+K ++ EA + E V++ L +HDK V++
Sbjct: 14 LGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHDK----LVKL 66
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + I I+ E + SL DFL+ + P+ + + + Q+ E +AF+ IH
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ N+L+ +S K+ D+ + +D+ Y R IK
Sbjct: 126 RDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIK---------------- 168
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE I +T D+WS G +L+E+ T G + N E + +ER
Sbjct: 169 ------WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 62/241 (25%), Positives = 100/241 (41%), Gaps = 44/241 (18%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG V L W + K VAIK + E + E +V+ +L+ H K VQ+
Sbjct: 12 LGSGQFGVVHLGKWRAQIK--VAIKAINEGAMSEEDFIEEAKVMMKLS-HPK----LVQL 64
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + IV E + L ++LR+ D++ + + + E + ++ IH
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL N LVSS + +KV DFG T Y D+ Y
Sbjct: 124 RDLAARNC-LVSSTGV--------------------------VKVSDFGMTRYVLDDE-Y 155
Query: 179 IVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232
S+ + PEV ++ D+WS G ++ E+ T G+ F+ N E + M+
Sbjct: 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
Query: 233 R 233
R
Sbjct: 216 R 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 73/334 (21%), Positives = 135/334 (40%), Gaps = 83/334 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIE--VLQQLAKHD--KGGN 54
+G G++ +VL ++ + + A+K+++ + + ++ E V + + H G +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
C Q + R I F G ++ R+ R P + R + ++ + F+H+
Sbjct: 63 SCFQTES----RLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER 115
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+I+ DLK +NVLL + +IK+ DY M K I+ D ST P
Sbjct: 116 GIIYRDLKLDNVLLDAEGHIKLTDYG--------------MCK-EGIRPGDTTSTFCGTP 160
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
NYI APE++ G + + D W++G ++ E+ G + F ++
Sbjct: 161 --NYI-------APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDN------- 204
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
D++ E Y+ + L+ +++PR ++ V
Sbjct: 205 -----------PDQNTEDYLFQVILEKQ------------IRIPRSLSVKASSV------ 235
Query: 295 LTHLLQGLLRYDPTDRLTA------REALRHPFF 322
L+G L DP +RL R+ HPFF
Sbjct: 236 ----LKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 56/259 (21%), Positives = 95/259 (36%), Gaps = 83/259 (32%)
Query: 96 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155
+++ I RQ+L + +H ++H D+KP+N++
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF--------------------------S 289
Query: 156 PKSSAIKVIDFGSTT------------------YERPDQNYIVSTRHYRAPEVILGLG-- 195
S + K+ID G+ Y P+Q YI+ST+ AP +
Sbjct: 290 EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQ-YIMSTQTPSAPSAPVATALS 348
Query: 196 ---WTYPC----DIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDR 248
W DI+S G I +++ F + +L R LKR D
Sbjct: 349 PVLWQLNLPDRFDIYSAGLIFLQMA-----FPNLRSDSNLIQFNR--------QLKRNDY 395
Query: 249 HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308
+ R ++ R + V+ L D AG LL+ ++R+
Sbjct: 396 DLVAW--RKLVEPRASPDLRRGFE-VLDL-----------DGGAG--WELLKSMMRFKGR 439
Query: 309 DRLTAREALRHPFFTRDHL 327
R++A+ AL HP+F R+ L
Sbjct: 440 QRISAKAALAHPYFDREGL 458
|
Length = 566 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 56/226 (24%), Positives = 94/226 (41%), Gaps = 36/226 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G F +V VA+K V+ K R + EI++L+QL +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN-----V 64
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHD 113
++ F N + IV E L ++ K R P V + QL + MH
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H D+KP NV + ++ +K+ D +F K++A
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLG-------RFFSS--KTTA------------- 162
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F
Sbjct: 163 --AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 27/121 (22%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
+++ + +H + IH D+KP+N+LL S ++K+ D+ + + +M + ++
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------KMDANGMVR 199
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEAL 218
T PD Y +PEV+ G + CD WSVG L E+ G+
Sbjct: 200 C----DTAVGTPD---------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
Query: 219 F 219
F
Sbjct: 247 F 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 71/338 (21%), Positives = 136/338 (40%), Gaps = 77/338 (22%)
Query: 4 GTFGQVLEC--WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR- 60
G+ G+V C E+++ V +K V G K EI++L+ + + I
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR----EIDILKTI-------SHRAIINL 151
Query: 61 -NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + +++ +C+V K L+ ++ ++ P++ I R+LLE +A++H +IH
Sbjct: 152 IHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHR 209
Query: 120 DLKPENVLLVSSEYIKVPDYKS------SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
D+K EN+ L E + D+ + TP+ +
Sbjct: 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW---------------------- 247
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALF--QTHENLEHLAM 230
T +PE++ + DIWS G +L E+ LF Q + L
Sbjct: 248 ------SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301
Query: 231 MERVLG--PL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
+ R + PL PQ+ + +H ++Y R + ++ + R + M
Sbjct: 302 IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY-----------TIPPVIRKYGMHM- 349
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
D+ +L+ +L +D R +A++ L P FT+
Sbjct: 350 -------DVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380
|
Length = 392 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 54/227 (23%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G G FG+V + +++ A+K++ IK+ A E + A V
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----SPWVV 106
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ F ++ +V E + G L + + +NY P R +++ + +H +
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNY-DVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KP+N+LL S ++K+ D+ + + +M K ++
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM----------KMNKEGMVRC------------- 200
Query: 177 NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 219
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 7e-07
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 94/304 (30%)
Query: 25 IVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDF 83
I++G++K E + + ++ + V + + + + +V + G L+
Sbjct: 22 ILKGLRKSSEYSRERLTIIPHCVPN------MVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75
Query: 84 LRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143
+ K + + P + V+ A +++ + +H ++ DL P N+LL +I++
Sbjct: 76 ISK--FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL------- 126
Query: 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 203
+YF R S + D + Y APEV T CD W
Sbjct: 127 ------TYFSRW------------SEVEDSCDGEAV--ENMYCAPEVGGISEETEACDWW 166
Query: 204 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPE 263
S+G IL EL TG+ L + H P
Sbjct: 167 SLGAILFELLTGKTLVECH---------------------------------------PS 187
Query: 264 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA-----LR 318
G + ++ I + V A LLQ LL+++PT+RL A A
Sbjct: 188 GINTHTTLN-----------IPEWVSEEARS---LLQQLLQFNPTERLGAGVAGVEDIKS 233
Query: 319 HPFF 322
HPFF
Sbjct: 234 HPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 45/242 (18%)
Query: 1 MGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V W+ K VA+K ++ EA + E +++++L +HDK VQ+
Sbjct: 14 LGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKL-RHDK----LVQL 66
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I IV E + SL DFL+ + + + ++A Q+ E +A++ IH
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126
Query: 119 TDLKPENVLLVSSEYIKVPDY------KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
DL N+L+ + K+ D+ + +T ++ + + P IK
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA---KFP----IK---------- 169
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 231
+ APE +T D+WS G +L E+ T G + N E L +
Sbjct: 170 ------------WTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217
Query: 232 ER 233
ER
Sbjct: 218 ER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 52/229 (22%), Positives = 102/229 (44%), Gaps = 39/229 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G GT+G V + + E+ AIK+++ ++ + A+++ E++ + K K N
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEII--MMKDCKHSNIVAYFG 73
Query: 61 NWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCMI 117
++ R+ + I E G SL D + + P+ + ++R+ L+ + ++H +
Sbjct: 74 SYLR-RDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+K N+LL + ++K+ D+ S +T +R
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQ---------------------ITATIAKRKS-- 165
Query: 178 YIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGE-ALFQTH 222
+ T ++ APEV G+ CDIW+VG +EL + +F H
Sbjct: 166 -FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 1 MGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V E W+ VA+K ++ + + E +++++L +H K +Q+
Sbjct: 14 LGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKL-RHPK----LIQL 66
Query: 60 RNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
I IV E K GS L ++L+ R+ + + ++A Q+ +A++ I
Sbjct: 67 YAVCTLEEPIYIVTELMKYGS-LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DL NVL+ + KV D+ + K+ Y R IK
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLA-RVIKEDIYEAREGAKFPIK--------------- 169
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE L ++ D+WS G +L E+ T G + N E L +++
Sbjct: 170 -------WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ 219
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 32/152 (21%)
Query: 71 IVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVL 127
I E + +SL F +K + + P D++ +IA +++ + ++H L +IH D+KP NVL
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 128 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRA 187
+ + +K+ D+ S + S K ID G + Y A
Sbjct: 137 INRNGQVKLCDFGISGYL-----------VDSVAKTIDAGC--------------KPYMA 171
Query: 188 PEVILG----LGWTYPCDIWSVGCILVELCTG 215
PE I G+ D+WS+G ++EL TG
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATG 203
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 51/227 (22%), Positives = 98/227 (43%), Gaps = 38/227 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G G FG+V + +++ A+K++ IK+ A E + A V
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN----SPWVV 106
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ F ++ +V E + G L + + +NY P + +++ + +H + +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNY-DVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KP+N+LL ++K+ D+ + + +M ++ ++
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCM----------KMDETGMVRC------------- 200
Query: 177 NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALF 219
+ V T Y +PEV+ G + CD WSVG L E+ G+ F
Sbjct: 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 68/255 (26%)
Query: 1 MGEGTFGQVLECWDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 55
+G G FG V++ + VA+K ++ I ++ + E V+ QL
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 56 CVQIRNWFDYRNHICIV----------------FEKLGSSLYDFLRKNNYRSFPIDLVRE 99
+H CIV LG L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 100 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159
+A Q+ +A++ +H DL NVLLV+ K+ D+ S S Y++
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR------ 153
Query: 160 AIKVIDFGSTTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 217
+TT R P + Y APE I ++ D+WS G L E + G
Sbjct: 154 --------ATTAGRWPLKWY--------APECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 218 LFQTHENLEHLAMME 232
+ + E +AM+E
Sbjct: 198 PYGEMKGAEVIAMLE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G G V + + ++A K++ IK R + E++VL H+ V
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYIVG 67
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
F I I E + G SL L++ + P +++ +++ +L +A++ + I
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 118 -HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF----- 162
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
V TR Y +PE + G ++ DIWS+G LVEL G
Sbjct: 163 ---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIG 198
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 53/229 (23%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ F + +C + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 176 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
V T Y APEV+ G + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 60/245 (24%), Positives = 103/245 (42%), Gaps = 46/245 (18%)
Query: 1 MGEGTFGQVLECWDRERK--EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G FG V + + +K + VA+KI +K ++ E+L + N Q
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKI---LKNDNNDPALKDELL-------REANVMQQ 52
Query: 59 IRNWFDYRN-HIC------IVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
+ N + R IC +V E +LG L FL+KN + + E+ Q+ +
Sbjct: 53 LDNPYIVRMIGICEAESWMLVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGMK 109
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++ + +H DL NVLLV+ Y K+ D+ S D +Y+K T
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK-------------AKT 156
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHL 228
+ P + Y APE + ++ D+WS G ++ E G+ ++ + E
Sbjct: 157 HGKWPVKWY--------APECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
Query: 229 AMMER 233
M+E
Sbjct: 209 QMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 3e-06
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 56/241 (23%)
Query: 3 EGTFGQVLECWDR------ERKEMVAI------KIVRGIKKY-----REAAMIEIEVLQ- 44
G FG++ C R E + V K R I K R A +E E+L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217
Query: 45 QLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN--NYRSFP-IDLVREIA 101
H+ ++I + ++ +K LY F+ +++ P + R I
Sbjct: 218 GRLNHEN----ILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIM 273
Query: 102 RQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 161
+QLL + ++HD +IH D+K EN+ L D K L
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNC-------DGKIVLG----------------- 309
Query: 162 KVIDFGS-TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217
DFG+ +E+ + + V T +PE++ G G+ DIWS G IL+++ + +
Sbjct: 310 ---DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366
Query: 218 L 218
Sbjct: 367 C 367
|
Length = 501 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 39/226 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP----FL 63
Query: 57 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 113
Q+ + F + + V E + G +Y + ++ + EI+ L F+H
Sbjct: 64 TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLF----FLHR 119
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEHMVD----GVTT--- 158
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
T Y APE+I + D W+ G +L E+ G+ F
Sbjct: 159 ---RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 57/245 (23%), Positives = 108/245 (44%), Gaps = 41/245 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYR--EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G FG+V C R ++ A K + + +KK + E AM+E +L ++ H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV--HSR---FI 55
Query: 57 VQIRNWFDYRNHICIVFEKLGSS-----LYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V + F + +C+V + +Y+ +N FP Q++ + +
Sbjct: 56 VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGLEHL 113
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H +I+ DLKPENVLL + +++ D A+++ D S T
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDL------------------GLAVELKDGQSKT- 154
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAM 230
+ Y T + APE++ G + + D +++G L E+ F+ E +E+ +
Sbjct: 155 ----KGY-AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 209
Query: 231 MERVL 235
+R+L
Sbjct: 210 KQRIL 214
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 42/236 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ +E + A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
Q+ F + + V E + G L ++K+ R F R A ++ + F+HD
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+I+ DLK +NVLL + K+ D+ K + K +S F
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF-------------------- 156
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228
T Y APE++ + + D W++G +L E+ G A F+ EN + L
Sbjct: 157 -------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA-ENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 57/236 (24%), Positives = 104/236 (44%), Gaps = 33/236 (13%)
Query: 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
+G G FG+V + ++ K VA+K ++ +A + E +++ L +HDK V++
Sbjct: 14 LGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTL-QHDK----LVRL 66
Query: 60 RNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I I+ E + SL DFL+ + + + + + Q+ E +A++ IH
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL+ NVL+ S K+ D+ + +D+ Y R IK
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIK---------------- 169
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE I +T D+WS G +L E+ T G+ + N + ++ ++R
Sbjct: 170 ------WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 41/230 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMI--EIEVLQQLAKHDKGGNRC 56
+G G FG+V + ++ A+KI+ + K E A E +VL G R
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV------NGDRRW 62
Query: 57 V-QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ + F N++ +V + +G L L K R P D+ R +++ I +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVLAIDSVHQL 121
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H D+KP+NVLL + +I++ D+ S L D +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV----------------------- 158
Query: 175 DQNYIVSTRHYRAPEVIL----GLGWTYP-CDIWSVGCILVELCTGEALF 219
N V T Y +PE++ G G P CD WS+G + E+ GE F
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 37/223 (16%)
Query: 1 MGEGTFGQV-LECWD---RERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNR 55
+G+G FG V L +D E+VA+K ++ ++ EIE+L+ L +HD
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDN---- 66
Query: 56 CVQIRN--WFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V+ + + R ++ +V E L SL D+L+K+ R L+ A Q+ + + ++
Sbjct: 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYASQICKGMEYLG 125
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-RMPKSSAIKVIDFGSTTY 171
+H DL N+L+ S +K+ D+ + P+D Y+K R P S I
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPI---------- 175
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ APE + ++ D+WS G +L EL T
Sbjct: 176 ------------FWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 49/205 (23%), Positives = 81/205 (39%), Gaps = 57/205 (27%)
Query: 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138
SL D LRK+ F I + + A Q+ + ++ IH DL N+LL S + +K+ D
Sbjct: 81 SLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGD 140
Query: 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVIL 192
+ + +P++ + +Y V H + APE +
Sbjct: 141 FGLM----------RALPQN----------------EDHY-VMEEHLKVPFAWCAPESLR 173
Query: 193 GLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE 251
+++ D+W G L E+ T GE E G +LK++D+ E
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGE---------------EPWAGLSGSQILKKIDKEGE 218
Query: 252 KYVRRGRLDWPEGAASRESIKSVMK 276
RL+ PE A + I +VM
Sbjct: 219 ------RLERPE--ACPQDIYNVML 235
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 37/245 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ + E+ AIK+++ + + M E +L AKH
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP----FL 58
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ F ++ + V E + G L ++++ R F R A ++ + F+H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+I+ DLK +N+LL + + K+ D+ M K + G TT
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFG--------------MCKEGILN----GVTT----- 153
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT--HENLEHLAMMER 233
T Y APE++ L + D W++G ++ E+ G+ F+ ++L + +
Sbjct: 154 -TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212
Query: 234 VLGPL 238
VL P+
Sbjct: 213 VLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G GT+G V + + E+ A+KI++ ++ + ++I+ E+ + K K N
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIF--MVKECKHCNIVAYFG 73
Query: 61 NWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCMI 117
++ R + I E G SL D + + P+ + + R+ L+ +A++H +
Sbjct: 74 SYLS-REKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+K N+LL + +K+ D+ A K+ +T +R
Sbjct: 129 HRDIKGANILLTDNGDVKLADF------------------GVAAKIT---ATIAKRKS-- 165
Query: 178 YIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVEL 212
+ T ++ APEV G+ CDIW+VG +EL
Sbjct: 166 -FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 32/238 (13%)
Query: 1 MGEGTFGQVLECWDRERKEM--VAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G FG V + + RK+ VAIK+++ K R+ M E E++ QL
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-----PYI 57
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V++ + + ++ G L FL + V E+ Q+ + ++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DL NVLLV+ Y K+ D+ S D SY+K + + P +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK-------------ARSAGKWPLK 163
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMER 233
Y APE I ++ D+WS G + E G+ ++ + E ++ +E+
Sbjct: 164 WY--------APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 52/229 (22%), Positives = 101/229 (44%), Gaps = 36/229 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G G FG+V C + +M A+K + +K+ A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 62 MSYA--FHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMHNRF 117
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLKP N+LL ++++ D + + K+ P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA------CDFSKKKPHAS---------------- 155
Query: 176 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHE 223
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+
Sbjct: 156 ----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGG 53
+G+G+FG+V+ + E+ AIKI +KK E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKI---LKKDVIIQDDDVECTMVEKRVLALPGK----P 60
Query: 54 NRCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAF 110
Q+ + F + + V E + G +Y + ++ + EIA L F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLF----F 116
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+H +I+ DLK +NV+L + +IK+ D+ K ++ K + F P
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP----------- 165
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
+YI APE+I + D W+ G +L E+ G+ F
Sbjct: 166 ---------DYI-------APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 52/246 (21%), Positives = 92/246 (37%), Gaps = 61/246 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLAKHD-- 50
+GEG FG+V++ K V +K +E A + E +L+Q+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTV-AVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKN----------------------N 88
K C Q D + + + K GS L FLR++ +
Sbjct: 67 KLYGACSQ-----DGPLLLIVEYAKYGS-LRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 89 YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148
R+ + + A Q+ + ++ ++ ++H DL NVL+ +K+ D+ S ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 208
SY KR +K + A E + +T D+WS G +
Sbjct: 181 DSYVKRSKGRIPVK----------------------WMAIESLFDHIYTTQSDVWSFGVL 218
Query: 209 LVELCT 214
L E+ T
Sbjct: 219 LWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 41/252 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ + E+ AIKI++ + E M+E VL K
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----FL 63
Query: 57 VQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHD 113
Q+ + F + + V E + G +Y + ++ + EIA L F+H
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF----FLHS 119
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+I+ DLK +NV+L S +IK+ D+ M K + G TT
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFG--------------MCKENMWD----GVTT--- 158
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL-AMME 232
T Y APE+I + D W+ G +L E+ G+A F+ + E ++ME
Sbjct: 159 ---KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215
Query: 233 RVLGPLPQHMLK 244
+ P+ M K
Sbjct: 216 HNVA-YPKSMSK 226
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 39/246 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRC---V 57
+G GT GQV + ++ ++A+K +R E I +++ L HD C V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHD-----CPYIV 77
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CM 116
+ +F + + I E + + L D L K P D++ ++ +++ + ++ + +
Sbjct: 78 KCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGV 136
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY---ER 173
IH D+KP N+LL +S +K+ D+ S R+ S A K G Y ER
Sbjct: 137 IHRDVKPSNILLDASGNVKLCDFGIS----------GRLVDSKA-KTRSAGCAAYMAPER 185
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
D RA D+WS+G LVEL TG+ F ++ +
Sbjct: 186 IDPPDPNPKYDIRA-------------DVWSLGISLVELATGQ--FPYKNCKTEFEVLTK 230
Query: 234 VLGPLP 239
+L P
Sbjct: 231 ILQEEP 236
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 34/224 (15%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQ-----LAKHDKGGNR 55
+G G FG+VL ++ E+ AIK +KK A E+E L + +
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKA---LKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + F +H+C V E D + + F A ++ + ++H+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGG--DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+++ DLK +N+LL + ++K+ D+ + K + FG T
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFG--------------LCKEG----MGFGDRT----- 158
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219
+ T + APEV+ +T D W +G ++ E+ GE+ F
Sbjct: 159 -STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR-GIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G G V + + ++A K++ IK R + E++VL H+ V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPYIVG 67
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
F I I E + G SL L+K P ++ +++ +++ + ++ + I
Sbjct: 68 FYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 118 -HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
H D+KP N+L+ S IK+ D+ S ++ID + ++
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSG------------------QLIDSMANSF----- 162
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
V TR Y +PE + G ++ DIWS+G LVE+ G
Sbjct: 163 ---VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 43/185 (23%), Positives = 75/185 (40%), Gaps = 43/185 (23%)
Query: 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136
G ++ L + + F D VR + +++ + +H L +++ D+K EN+LL S ++ +
Sbjct: 89 GGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVL 146
Query: 137 PDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG 193
D+ K L K+ +Y F T Y APE+I G
Sbjct: 147 TDFGLSKEFLSEEKERTY-------------SFCGTI-------------EYMAPEIIRG 180
Query: 194 -LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER-----------VLGPLPQH 241
G D WS+G ++ EL TG + F + + R +GP Q
Sbjct: 181 KGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQD 240
Query: 242 MLKRV 246
+L ++
Sbjct: 241 LLHKL 245
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 31/117 (26%)
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+H +I+ DLKPEN+LL + ++K+ D+ K S+H G
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE---------------------G 154
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224
+ T+ T Y APE+++ G D WS+G ++ ++ TG F T EN
Sbjct: 155 TVTHT------FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF-TAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 26/140 (18%)
Query: 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138
SL FLR+N+ + LV + R + + ++ ++ +H DL N+L+ S+ KV D
Sbjct: 91 SLDKFLRENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 139 YKSSLHT-PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 197
+ S +++Y + K + APE I +T
Sbjct: 150 FGLSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKFT 186
Query: 198 YPCDIWSVGCILVELCT-GE 216
D+WS G ++ E+ + GE
Sbjct: 187 SASDVWSFGIVMWEVMSYGE 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 37/138 (26%), Positives = 57/138 (41%), Gaps = 29/138 (21%)
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H L +I+ D+K EN+LL S+ ++ + D+ S +F
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---------------------EFHEDE 159
Query: 171 YERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEH 227
ER T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 160 VERAYS--FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
Query: 228 LAMMERVLG---PLPQHM 242
+ R+L P PQ M
Sbjct: 218 AEISRRILKSEPPYPQEM 235
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 34/125 (27%), Positives = 53/125 (42%), Gaps = 25/125 (20%)
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H M+H DLK N+ L+ + IK+ D+ S S +D S+
Sbjct: 185 VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS-------------LDVASS- 230
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
T +Y APE+ ++ D+WS+G IL EL T F+ E +
Sbjct: 231 --------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I 279
Query: 231 MERVL 235
M++VL
Sbjct: 280 MQQVL 284
|
Length = 478 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 61/253 (24%), Positives = 107/253 (42%), Gaps = 57/253 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAK------HDKGGN 54
+G G FG V++ + VAIK+++ E +M E E +++ AK H+K
Sbjct: 12 LGTGQFG-VVKYGKWRGQYDVAIKMIK------EGSMSEDEFIEE-AKVMMKLSHEK--- 60
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSS-LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
VQ+ + I IV E + + L ++LR++ R P L+ E+ + + E +A++
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLES 118
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
IH DL N L+ +KV DFG + Y
Sbjct: 119 KQFIHRDLAARNCLVDD---------------------------QGCVKVSDFGLSRYVL 151
Query: 174 PDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA---LFQTHEN 224
D+ Y S + PEV+L ++ D+W+ G ++ E+ + G+ F E
Sbjct: 152 DDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210
Query: 225 LEHLAMMERVLGP 237
+E ++ R+ P
Sbjct: 211 VEKVSQGLRLYRP 223
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 25/132 (18%)
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
F VR +++ + +H L +I+ D+K EN+LL S ++ + D+ S
Sbjct: 102 FTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK-------- 153
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCIL 209
+F + ER T Y APEVI G G D WS+G +
Sbjct: 154 -------------EFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 210 VELCTGEALFQT 221
EL TG + F
Sbjct: 199 FELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 41/141 (29%), Positives = 64/141 (45%), Gaps = 29/141 (20%)
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
Q+L + +H MIH D+K N+LL S+ +K+ D+ F +M +A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG-----------FSKM--YAATV 197
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
D G T T +Y APE+ ++ D++S+G +L EL T + F
Sbjct: 198 SDDVGRT---------FCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG- 247
Query: 223 ENLEHLAMMERVLG----PLP 239
EN+E + M + L PLP
Sbjct: 248 ENMEEV--MHKTLAGRYDPLP 266
|
Length = 496 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 40/225 (17%)
Query: 1 MGEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHD--KG 52
+GEG FG+V C +D E E VA+K ++ A + EIE+L+ L + K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 53 GNRCVQIRNWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREI--ARQLLECIA 109
C + D N I ++ E L S SL ++L +N + I+L +++ A Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++ +H DL NVL+ S +K+ D+ + D Y+ T
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY----------------T 167
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ D S + APE ++ + D+WS G L EL T
Sbjct: 168 VKDDLD-----SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 34/119 (28%), Positives = 57/119 (47%), Gaps = 23/119 (19%)
Query: 99 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMP 156
++ARQ+L IA++H ++H D+KP N+L+ S++ +K+ D+ S L D P
Sbjct: 172 DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-------P 224
Query: 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215
+S++ I + S D N+ G Y DIWS+G ++E G
Sbjct: 225 CNSSVGTIAYMSPERINTDLNH--------------GAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 55/222 (24%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGG 53
+G G FG+V C R +R+ VAIK ++ +K R + E ++ Q +
Sbjct: 12 IGAGEFGEV--CSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN--- 66
Query: 54 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ + + IV E + SL FLRK++ + I LV + R + + ++
Sbjct: 67 --IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV-GMLRGIASGMKYLS 123
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSS--LHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
D+ +H DL N+L+ S+ KV D+ S L +++Y R K
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK------------- 170
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212
+ R + APE I +T D+WS G ++ E+
Sbjct: 171 ---------IPIR-WTAPEAIAYRKFTSASDVWSYGIVMWEV 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 6e-04
Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 51/235 (21%)
Query: 1 MGEGTFGQVL--ECWD---RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHD---K 51
+GEG FG+V EC++ + K +VA+K ++ R+ E E+L L +H+ K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVK 71
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDFLRKNNYRSF-------PIDLVR----E 99
CV+ + + +VFE + L FLR + + P +L +
Sbjct: 72 FYGVCVE-------GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 100 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159
IA+Q+ + ++ +H DL N L+ + +K+ D+ S
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR---------------- 168
Query: 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
D ST Y R + ++ R + PE I+ +T D+WS+G +L E+ T
Sbjct: 169 -----DVYSTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 6e-04
Identities = 54/234 (23%), Positives = 98/234 (41%), Gaps = 36/234 (15%)
Query: 1 MGEGTFGQVLECWDRE--RKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 55
+G G FG+V + RKE+ VAIK ++ +K R+ + E ++ Q + H+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN----- 67
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYD-FLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+++ I+ E + + D +LR ++ LV + R + + ++ D+
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV-GMLRGIAAGMKYLSDM 126
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI-DFGSTTYER 173
+H DL N+L+ S+ KV D+ S +V+ D TY
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLS-------------------RVLEDDPEGTYTT 167
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 226
+ + APE I +T D+WS G ++ E+ + GE + N E
Sbjct: 168 SGGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 46/176 (26%)
Query: 93 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152
+ R + Q+L+ +A H+ ++H DLKP+N+++ +
Sbjct: 78 AGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTG-------------------- 116
Query: 153 KRMPKSSAIKVIDFGSTT----YERPDQNYI------VSTRHYRAPEVILGLGWTYPCDI 202
KV+DFG T D + + T Y APE + G T D+
Sbjct: 117 ----VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 203 WSVGCILVELCTGEALFQTHENLEHLAMMERVLGP----LPQ----HMLKRVDRHA 250
++ G I +E TG+ + Q E ++ + L P LP H L +V R A
Sbjct: 173 YAWGLIFLECLTGQRVVQGASVAE---ILYQQLSPVDVSLPPWIAGHPLGQVLRKA 225
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 50/229 (21%), Positives = 93/229 (40%), Gaps = 48/229 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
+G+G +G V + R +A+K +R K+ + M E+++L H V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDIL-----HKAVSPYIV 62
Query: 58 QIRNWFDYRN--HICIVFEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-H 112
F ++C+ + GS LY P D++R I +++ + F+
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+ +IH D+KP NVL+ + +K+ D+ S + + K++
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN------------- 161
Query: 173 RPDQNYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCTG 215
+ + Y APE I G +T D+WS+G ++E+ G
Sbjct: 162 -------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 30/109 (27%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 108 IAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS--SAIKVID 165
I ++H ++H DLKP+N+LL + + D+ +++ FK++ + I V +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI--------FKKLEEEDLLDIDVDE 177
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
IV T Y APE +LG+ + DI+++G IL ++ T
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 66/266 (24%), Positives = 102/266 (38%), Gaps = 58/266 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G+G FG V+ R +K VA+K ++ +A + E V+ L +H VQ+
Sbjct: 14 IGKGEFGDVMLGDYRGQK--VAVKCLKDDSTAAQAFLAEASVMTTL-RHPN----LVQLL 66
Query: 61 NWFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
N + IV E + SL D+LR + A + E + ++ + +H
Sbjct: 67 GVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DL NV LVS + + KV DFG Q+
Sbjct: 127 DLAARNV-LVSEDLVA--------------------------KVSDFGLAKEASQGQDSG 159
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
+ APE + ++ D+WS G +L E+ + RV P P
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------------FGRV--PYP 201
Query: 240 QHMLKRVDRHAEK-YVRRGRLDWPEG 264
+ LK V H EK Y R++ PEG
Sbjct: 202 RIPLKDVVPHVEKGY----RMEAPEG 223
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 14/50 (28%), Positives = 34/50 (68%)
Query: 94 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143
I++++ + RQ+L + +H + ++H D+KPEN+L+ +K+ D+ +++
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAV 357
|
Length = 507 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 34/142 (23%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL-AKHD----KGGNRCVQ 58
G FG+V + ++ A+K+V+ +A MI ++ Q+ A+ D V
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVK------KADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ N++ +V E L G + L Y F ++ + ++ + ++H +I
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHRHGII 126
Query: 118 HTDLKPENVLLVSSEYIKVPDY 139
H DLKP+N+L+ + +IK+ D+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 32/137 (23%), Positives = 58/137 (42%), Gaps = 25/137 (18%)
Query: 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138
SL D +R++ P + Q+ + + ++ + M+H +L N+LL S +++ D
Sbjct: 94 SLLDHVRQHRDSLDP-QRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIAD 152
Query: 139 YK-SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT 197
+ + L P D YF K+ IK + A E IL +T
Sbjct: 153 FGVADLLYPDDKKYFYSEHKTP-IK----------------------WMALESILFGRYT 189
Query: 198 YPCDIWSVGCILVELCT 214
+ D+WS G + E+ +
Sbjct: 190 HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 50/225 (22%)
Query: 1 MGEGTFGQVLE-CWDRERKEMVAIKIV-RGIKKYREAAMIEIEVLQQLAKHDK------- 51
+G G FG+V E W + VAIKI+ ++ E++ L++L +H
Sbjct: 14 LGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAV 70
Query: 52 -GGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V I I + EK SL FLR + P+ + ++A Q+ E +A+
Sbjct: 71 CSVGEPVYI---------ITELMEK--GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 111 MHDLCMIHTDLKPENVLLVSSEYI-KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
+ + IH DL N+ LV + + KV D+ + K+ Y + I
Sbjct: 120 LEEQNSIHRDLAARNI-LVGEDLVCKVADFGLA-RLIKEDVY---LSSDKKIPY------ 168
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ APE ++ D+WS G +L E+ T
Sbjct: 169 --------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 45/225 (20%)
Query: 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGG 53
+G G FG+V C R +R+ VAIK ++ +K R + E ++ Q +
Sbjct: 12 IGAGEFGEV--CRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPN--- 66
Query: 54 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ + + I+ E + +L FLR+N+ + I LV + R + + ++
Sbjct: 67 --IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLV-GMLRGIAAGMKYLS 123
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
++ +H DL N+L+ S+ KV D+ S D+S
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS---------------------- 161
Query: 173 RPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVEL 212
D Y S + APE I +T D+WS G ++ E+
Sbjct: 162 --DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 19/161 (11%)
Query: 95 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154
D+++ +A ++ + ++H IH+DL N L + +K+ DY +L + Y +
Sbjct: 100 DVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159
Query: 155 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
+ ++ + P+ +V R +L T +IWS+G + EL T
Sbjct: 160 DCHAVPLRWLA--------PE---LVEIRGQD----LLPKDQTKKSNIWSLGVTMWELFT 204
Query: 215 -GEALFQTHENLEHLA--MMERVLG-PLPQHMLKRVDRHAE 251
+ + + + L + E+ + P PQ LK DR E
Sbjct: 205 AADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 48/232 (20%), Positives = 90/232 (38%), Gaps = 27/232 (11%)
Query: 96 LVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155
L+ I L + ++H IH ++K ++L +S + + S L+ S +
Sbjct: 102 LIGNILFGALRGLNYLHQNGYIHRNIKASHIL-ISGDGLVSLSGLSHLY-----SLVRNG 155
Query: 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELC 213
K+ + Y+ P + S + +PE++ G+ DI+SVG EL
Sbjct: 156 QKAKVV---------YDFP--QFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204
Query: 214 TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG---AASRES 270
TG FQ + L ++++ GP + E ++ + G +
Sbjct: 205 TGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262
Query: 271 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ M RL+ + + +L++ L+ DP R +A L H FF
Sbjct: 263 MTQTMTSERLRTPSSKTF---SPAFQNLVELCLQQDPEKRPSASSLLSHAFF 311
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 329 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.44 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.97 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.79 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.54 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.53 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.99 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.79 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.52 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.51 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.2 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.05 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.71 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.68 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.61 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.53 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.45 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.38 | |
| PLN02236 | 344 | choline kinase | 96.35 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.14 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.93 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.83 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.35 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.16 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.84 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.51 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 93.46 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.31 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 92.9 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-60 Score=401.23 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=213.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.|-+|..+.||+.||||++++.. .......+|+++|+++ +||+|++++++|+..+..|+|
T Consensus 180 LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-----~HP~IV~~~d~f~~~ds~YmV 254 (475)
T KOG0615|consen 180 LGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-----SHPNIVRIKDFFEVPDSSYMV 254 (475)
T ss_pred ecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-----CCCCEEEEeeeeecCCceEEE
Confidence 799999999999999999999999997432 1223356899999999 779999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ ||+|.+++..+. .+.+...+.+++||+.|+.|||++||+||||||+|||+..+
T Consensus 255 lE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~-------------------- 312 (475)
T KOG0615|consen 255 LEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND-------------------- 312 (475)
T ss_pred EEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC--------------------
Confidence 9999 999999998875 68888999999999999999999999999999999999653
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC---CCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.....+||+|||+|+..+... .+.||||.|.|||++.+.. +..++|+|||||++|.+++|.+||.......
T Consensus 313 ----~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 313 ----AEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ----CcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 356789999999999886554 6789999999999998775 3458899999999999999999998754433
Q ss_pred -HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 227 -HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
...+|.+....+-+ ..+..++.+..+||.+||+.
T Consensus 389 sl~eQI~~G~y~f~p---------------------------------------------~~w~~Iseea~dlI~~mL~V 423 (475)
T KOG0615|consen 389 SLKEQILKGRYAFGP---------------------------------------------LQWDRISEEALDLINWMLVV 423 (475)
T ss_pred cHHHHHhcCcccccC---------------------------------------------hhhhhhhHHHHHHHHHhhEe
Confidence 44444443322221 22345778999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCcC
Q 020235 306 DPTDRLTAREALRHPFFTRDHLR 328 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~~~~ 328 (329)
||++|||++++|+||||+...++
T Consensus 424 dP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 424 DPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred CcccCcCHHHHhcChhhhccccc
Confidence 99999999999999999976643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-57 Score=403.70 Aligned_cols=302 Identities=39% Similarity=0.690 Sum_probs=254.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhh-CCCCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
||+|+||.|-+|++..|++.||||+++.......+...|+.+|..+..+ ..+..|+++++++|...+|+|||+|.+..+
T Consensus 194 LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~N 273 (586)
T KOG0667|consen 194 LGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTN 273 (586)
T ss_pred ecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhh
Confidence 7999999999999999999999999998888888899999999999843 345568999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|+++++.+...+++...++.++.|++.||.+||+.||+|+||||+|||+.+. ...
T Consensus 274 LYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-------------------------~r~ 328 (586)
T KOG0667|consen 274 LYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-------------------------KRS 328 (586)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-------------------------CcC
Confidence 9999999888899999999999999999999999999999999999999653 334
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (329)
.+|+||||.|+......-..+.+..|+|||++.+.+|+.+.||||||||++||.+|.+.|.+.+..+++..|.+++|.+|
T Consensus 329 ~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp 408 (586)
T KOG0667|consen 329 RIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPP 408 (586)
T ss_pred ceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCC
Confidence 79999999999888877778899999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhhhhhhhh-cCCcCCCCCCC------chHHH------hhhccch-hhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 240 QHMLKRVDRHAEKYVR-RGRLDWPEGAA------SRESI------KSVMKLP-RLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 240 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
..+++........+.. .+......... +.+.. ......| ................|.|||.+||.+
T Consensus 409 ~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~ 488 (586)
T KOG0667|consen 409 PKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEW 488 (586)
T ss_pred HHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhcc
Confidence 9999887776544444 22222111111 00110 1112233 333333333345667799999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCc
Q 020235 306 DPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
||.+|+|+.++|+||||+...+
T Consensus 489 dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 489 DPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred CchhcCCHHHHhcCcccccccc
Confidence 9999999999999999996543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=376.94 Aligned_cols=247 Identities=26% Similarity=0.466 Sum_probs=210.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec--cchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc-eEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-ICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~-~~lv~e~~- 76 (329)
||+|..|+||+|.++.|++.+|+|.+. .......+..+|++++... .+|+|+.+++.|...+. +.++||||
T Consensus 87 lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-----~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 87 LGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-----QSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred cccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-----CCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 799999999999999999999999994 3455677888999999888 66999999999999884 99999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.+++...+ ++++..+.+++.++++||.|||. .+|+||||||+|||+
T Consensus 162 gGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv--------------------------- 212 (364)
T KOG0581|consen 162 GGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV--------------------------- 212 (364)
T ss_pred CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---------------------------
Confidence 999999998764 69999999999999999999995 999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC--chhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~--~~~~~~~~~~ 232 (329)
...+.|||||||.+...... ..+++||..|||||.+.+..|+.++||||||++++|+++|+.||... .....+..+.
T Consensus 213 NskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~ 292 (364)
T KOG0581|consen 213 NSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC 292 (364)
T ss_pred ccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH
Confidence 56677999999999866544 46789999999999999999999999999999999999999999764 1222333333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhcc-CchhHHHHHHHHhcccCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD-HSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
..+..+|+. .+. ..|++|++||..||++||.+|+
T Consensus 293 ~Iv~~ppP~---------------------------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~ 327 (364)
T KOG0581|consen 293 AIVDEPPPR---------------------------------------------LPEGEFSPEFRSFVSCCLRKDPSERP 327 (364)
T ss_pred HHhcCCCCC---------------------------------------------CCcccCCHHHHHHHHHHhcCCcccCC
Confidence 333222211 122 3788999999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q 020235 312 TAREALRHPFFTRDH 326 (329)
Q Consensus 312 t~~~ll~hp~f~~~~ 326 (329)
|+.|+++|||+++-+
T Consensus 328 s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 328 SAKQLLQHPFIKKFE 342 (364)
T ss_pred CHHHHhcCHHHhhcc
Confidence 999999999998643
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-57 Score=377.95 Aligned_cols=315 Identities=61% Similarity=1.047 Sum_probs=281.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhC-CCCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
||+|.||.|-.+++..++..||||+++...+.++.++.|++++.++.... ++...++.+.++|+..++.|+|+|.+|.+
T Consensus 97 lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S 176 (415)
T KOG0671|consen 97 LGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLS 176 (415)
T ss_pred hcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChh
Confidence 69999999999999999999999999988888899999999999997765 55567999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
+.+++..+...+++...++.+.+|++.+++|||+.+++|-||||+|||+.+....+....+.. .+..+..++.
T Consensus 177 ~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~-------~~~~r~~ks~ 249 (415)
T KOG0671|consen 177 TFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK-------VCFIRPLKST 249 (415)
T ss_pred HHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc-------cceeccCCCc
Confidence 999999988889999999999999999999999999999999999999988777666555433 2333346678
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (329)
.++++|||.|.......+..+.|.+|+|||++.+.+.+.++||||+||||+|+.+|...|++.++.+...++++++||+|
T Consensus 250 ~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P 329 (415)
T KOG0671|consen 250 AIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIP 329 (415)
T ss_pred ceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCc
Confidence 89999999999988888889999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+..+.. ..++...+.+.|++.....+ ...+...+.+........+.....+.|||++||..||.+|+|+.|+|.|
T Consensus 330 ~~mi~r~~--~~Kyf~~~rldw~e~~~~~~-~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 330 SRMIKKTR--KEKYFRRGRLDWPEVSSKGK-SKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHhhhhh--hHhhhhcccccCcccccccc-chhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence 99888765 67777888999998776665 5666666777777766666677789999999999999999999999999
Q ss_pred CCCCCC
Q 020235 320 PFFTRD 325 (329)
Q Consensus 320 p~f~~~ 325 (329)
|||+.-
T Consensus 407 pFF~~~ 412 (415)
T KOG0671|consen 407 PFFARL 412 (415)
T ss_pred HHhhcC
Confidence 999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-56 Score=392.38 Aligned_cols=241 Identities=32% Similarity=0.550 Sum_probs=220.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc----chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|||++||.+++..+|+.||+|++.+ ....++...+|+++-..+ .||||++++.+|++.+++|+|+|+|
T Consensus 26 LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-----~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 26 LGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-----KHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-----CCCcEEeeeeEeecCCceEEEEEec
Confidence 7999999999999999999999999985 456678888999999999 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
.++|..++++. +.++|..++.++.|++.||.|||+++|+|||||..|+++
T Consensus 101 ~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL--------------------------- 151 (592)
T KOG0575|consen 101 HRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL--------------------------- 151 (592)
T ss_pred CCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---------------------------
Confidence 99999999855 379999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.+..|||+|||+|.....+ ..+.+|||.|.|||++...+++..+||||+||+||.|++|++||+..+-.+.+..|.
T Consensus 152 ~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik 231 (592)
T KOG0575|consen 152 NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK 231 (592)
T ss_pred cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH
Confidence 77889999999999988744 356899999999999999999999999999999999999999999988888888877
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
......|. ..|.+++|||.+||+.||.+|||
T Consensus 232 ~~~Y~~P~-------------------------------------------------~ls~~A~dLI~~lL~~~P~~Rps 262 (592)
T KOG0575|consen 232 LNEYSMPS-------------------------------------------------HLSAEAKDLIRKLLRPNPSERPS 262 (592)
T ss_pred hcCccccc-------------------------------------------------ccCHHHHHHHHHHhcCCcccCCC
Confidence 76655553 45778999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 020235 313 AREALRHPFFTR 324 (329)
Q Consensus 313 ~~~ll~hp~f~~ 324 (329)
+++||.|+||++
T Consensus 263 l~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 263 LDEVLDHPFFKS 274 (592)
T ss_pred HHHHhcCHhhhC
Confidence 999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-55 Score=368.55 Aligned_cols=245 Identities=29% Similarity=0.512 Sum_probs=215.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.||+++.+.|++.+|+|++++.. +.......|..++..+ .||+|+.+...|++...+|+|++|+
T Consensus 33 iGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-----~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 33 IGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-----KHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-----CCCcEeeeEEecccCCeEEEEEecc
Confidence 799999999999999999999999998532 3455667799999997 7799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|...|.+.+ .+++..++.++.+|+.||.|||++||+||||||+|||+
T Consensus 108 ~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL--------------------------- 158 (357)
T KOG0598|consen 108 NGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL--------------------------- 158 (357)
T ss_pred CCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---------------------------
Confidence 999999999876 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+..++++|+|||+++..... ..+.+||+.|||||++.+.+|+..+|+||||+++|+|++|.+||.+.+.......+.
T Consensus 159 d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 159 DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 67788999999999844333 355799999999999999999999999999999999999999999988777766666
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
+.-.+.++ ...+.+++|+++++|+.||++|+
T Consensus 239 ~~k~~~~p------------------------------------------------~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 239 KGKLPLPP------------------------------------------------GYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCcCCCCC------------------------------------------------ccCCHHHHHHHHHHhccCHHHhcC
Confidence 54322221 23567899999999999999996
Q ss_pred ---CHHHHhcCCCCCCCCc
Q 020235 312 ---TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~ 327 (329)
++.++.+||||.+.+.
T Consensus 271 ~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 271 GPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred CCCChHHhhcCcccccCCH
Confidence 6899999999998863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=354.21 Aligned_cols=269 Identities=31% Similarity=0.569 Sum_probs=225.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
+|+|+||.||+|+++.||+.||||++... ..-++-+++|+.+++++ .|+|++.++++|.-...++||+|||.
T Consensus 10 vGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-----kH~NLVnLiEVFrrkrklhLVFE~~d 84 (396)
T KOG0593|consen 10 VGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-----KHENLVNLIEVFRRKRKLHLVFEYCD 84 (396)
T ss_pred cccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-----ccchHHHHHHHHHhcceeEEEeeecc
Confidence 69999999999999999999999998643 34467789999999999 55999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.++.+-+.+.. .+++...++.+++|++.|+.|+|+++|+||||||+|||+ ..
T Consensus 85 hTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi---------------------------t~ 136 (396)
T KOG0593|consen 85 HTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI---------------------------TQ 136 (396)
T ss_pred hHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE---------------------------ec
Confidence 88888888865 469999999999999999999999999999999999999 56
Q ss_pred CCCeEEeeCCCCcccCC-CC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERP-DQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~-~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.+||||||+|+.... .. .-++.|.-|+|||.+.+ -+|++.+||||+||++.||++|.+.|.+..+.++...|..
T Consensus 137 ~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 137 NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 66799999999987763 33 33678999999999998 5799999999999999999999999999999999999999
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcC---CCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLD---WPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
.+|.+.+....- |..++.+. .|+. +..++... -....+..+.||+.+||..||.+|
T Consensus 217 tLG~L~prhq~i-------F~~N~~F~Gv~lP~~-------------~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 217 TLGNLIPRHQSI-------FSSNPFFHGVRLPEP-------------EHPEPLER-KYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred HHcccCHHHHHH-------hccCCceeeeecCCC-------------CCccchhh-hcccchHHHHHHHHHHhcCCcccc
Confidence 999988754332 22222221 1110 01111111 123456789999999999999999
Q ss_pred CCHHHHhcCCCCC
Q 020235 311 LTAREALRHPFFT 323 (329)
Q Consensus 311 ~t~~~ll~hp~f~ 323 (329)
++.++++.||||.
T Consensus 276 ~sc~qll~H~yFd 288 (396)
T KOG0593|consen 276 LSCEQLLHHPYFD 288 (396)
T ss_pred ccHHHHhcChHHH
Confidence 9999999999994
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=377.93 Aligned_cols=245 Identities=30% Similarity=0.494 Sum_probs=215.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+|++|++|+++.+++.||||++.+. +...+...+|-.+|.++. +||.|++|+..|+++..+|+|+||+
T Consensus 81 lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~----~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 81 LGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLS----GHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred eccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhh----CCCCeEEEEEEeecccceEEEEEec
Confidence 79999999999999999999999998742 233455667888888884 7899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.++|.+.+ .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 157 ~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL--------------------------- 207 (604)
T KOG0592|consen 157 PNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL--------------------------- 207 (604)
T ss_pred CCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---------------------------
Confidence 999999999875 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC----------------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCC
Q 020235 156 PKSSAIKVIDFGSTTYERPD----------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF 219 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 219 (329)
+++++++|+|||.|...++. ...++||..|.+||++.....++.+|+|+|||++|+|+.|.+||
T Consensus 208 d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 208 DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 55556666666665443321 13478999999999999999999999999999999999999999
Q ss_pred CCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHH
Q 020235 220 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299 (329)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 299 (329)
.+.++.-.++.|..+...+|+ ..++.++|||
T Consensus 288 ra~NeyliFqkI~~l~y~fp~-------------------------------------------------~fp~~a~dLv 318 (604)
T KOG0592|consen 288 RAANEYLIFQKIQALDYEFPE-------------------------------------------------GFPEDARDLI 318 (604)
T ss_pred ccccHHHHHHHHHHhcccCCC-------------------------------------------------CCCHHHHHHH
Confidence 999999999999998777664 3456899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 300 QGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 300 ~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
+++|..||.+|+|+.+|.+||||.+++.
T Consensus 319 ~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 319 KKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred HHHHccCccccccHHHHhhCcccccCCh
Confidence 9999999999999999999999998864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=374.20 Aligned_cols=273 Identities=32% Similarity=0.553 Sum_probs=226.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-ceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-~~~lv~e~~~ 77 (329)
||.|+||.||+|..+.++..||||.|+..- ...-..++|+..+.++ +.|+||+++.+++.+.+ ++++|||||.
T Consensus 18 lGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kl----n~hpniikL~Evi~d~~~~L~fVfE~Md 93 (538)
T KOG0661|consen 18 LGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL----NPHPNIIKLKEVIRDNDRILYFVFEFMD 93 (538)
T ss_pred hcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhc----CCCCcchhhHHHhhccCceEeeeHHhhh
Confidence 799999999999999999999999998532 2233446799999998 34899999999999887 9999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+|+++++.. .+.+++..++.|++||++||+|+|++|++|||+||+|||+ ..
T Consensus 94 ~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi---------------------------~~ 145 (538)
T KOG0661|consen 94 CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI---------------------------SG 145 (538)
T ss_pred hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe---------------------------cc
Confidence 9999999987 4789999999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+..+||+|||+|+...... ..++.|.=|+|||++.... |+.+.|+||+||+++|+.+-++.|.|.++.+++..|.++
T Consensus 146 ~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 146 NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 5679999999998766554 4468899999999998765 889999999999999999999999999999999999999
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
+|.+....|...-..+.... +.+|. ...-.+... ....+.++.++|.+||.|||++||||.
T Consensus 226 LGtP~~~~~~eg~~La~~mn----f~~P~-----------~~~~~l~~L----~p~~s~~~~~li~~ll~WDP~kRpTA~ 286 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMN----FRFPQ-----------VKPSPLKDL----LPNASSEAASLIERLLAWDPDKRPTAS 286 (538)
T ss_pred hCCCccccchhHHHHHHHhc----cCCCc-----------CCCCChHHh----CcccCHHHHHHHHHHhcCCCccCccHH
Confidence 99987766655322222111 11111 000111111 223678899999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
++|+||||+.
T Consensus 287 ~al~~pffq~ 296 (538)
T KOG0661|consen 287 QALQHPFFQV 296 (538)
T ss_pred HHhcCccccc
Confidence 9999999974
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-53 Score=340.57 Aligned_cols=272 Identities=28% Similarity=0.500 Sum_probs=233.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|.||.||+|++..||+.||||.++.... ....+.+|+..++.+ .|+||+.+.++|-..+.+.||+||+.
T Consensus 10 lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-----~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 10 LGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-----KHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-----cCcchhhhhhhccCCCceEEEEEecc
Confidence 7999999999999999999999999985432 356788999999999 56999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+|...++... ..++...++.++.+++.||+|||++.|.||||||.|+|+ ..
T Consensus 85 tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi---------------------------s~ 136 (318)
T KOG0659|consen 85 TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI---------------------------SS 136 (318)
T ss_pred ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE---------------------------cC
Confidence 99999998765 568999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCCC---cccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~---~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.+||+|||+|+....... ..+-|.=|+|||.+.|. .|+..+|+||.||++.||+.|.+.|.+.++.++...+.+
T Consensus 137 ~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~ 216 (318)
T KOG0659|consen 137 DGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR 216 (318)
T ss_pred CCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH
Confidence 56689999999987776542 23678889999999986 599999999999999999999999999999999999999
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.+|.+.++.|+.+.+..+..... .+ +.+.... .....+.++.||+.+||..||.+|+||
T Consensus 217 ~LGTP~~~~WP~~~~lpdY~~~~-~~----------------P~~~~~~----lf~aas~d~ldLl~~m~~ynP~~Rita 275 (318)
T KOG0659|consen 217 ALGTPTPDQWPEMTSLPDYVKIQ-QF----------------PKPPLNN----LFPAASSDALDLLSKMLTYNPKKRITA 275 (318)
T ss_pred HcCCCCcccCccccccccHHHHh-cC----------------CCCcccc----ccccccHHHHHHHHhhhccCchhcccH
Confidence 99999999888877755543322 11 1111111 234567778999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.|+|+||||++-.
T Consensus 276 ~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 276 SQALKHPYFKSLP 288 (318)
T ss_pred HHHhcchhhhcCC
Confidence 9999999999643
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-53 Score=344.90 Aligned_cols=243 Identities=27% Similarity=0.447 Sum_probs=219.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.|.+++.+.+|..+|+|++++.. +..+....|..+++.+ .||+++++.+.+.+.+.+++||||.
T Consensus 52 lGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-----~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 52 LGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-----SHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred eccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-----cCceeEEEEEeeccCCeEEEEEecc
Confidence 799999999999999999999999998543 3456667899999988 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|.+++++.+ +++++.++.++.|++.||+|||+.+|++||+||+|||+
T Consensus 127 ~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl--------------------------- 177 (355)
T KOG0616|consen 127 PGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL--------------------------- 177 (355)
T ss_pred CCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---------------------------
Confidence 999999999865 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.+||+|||+|+......-+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||.+.++...+..|.+.-
T Consensus 178 D~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~ 257 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK 257 (355)
T ss_pred ccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc
Confidence 66778999999999988888778899999999999999999999999999999999999999999988877777666644
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC----
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---- 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---- 311 (329)
-.+| ...+.+++|||+++|++|-.+|.
T Consensus 258 v~fP-------------------------------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlk 288 (355)
T KOG0616|consen 258 VKFP-------------------------------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLK 288 (355)
T ss_pred ccCC-------------------------------------------------cccCHHHHHHHHHHHhhhhHhhhcCcC
Confidence 3333 34677899999999999999994
Q ss_pred -CHHHHhcCCCCCCCC
Q 020235 312 -TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -t~~~ll~hp~f~~~~ 326 (329)
...++..||||++++
T Consensus 289 nG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 289 NGVEDIKNHPWFKGVD 304 (355)
T ss_pred CCccccccCccccccc
Confidence 578999999999875
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=356.57 Aligned_cols=274 Identities=28% Similarity=0.384 Sum_probs=225.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|.-|+||+|+.+.++..+|+|+|.+.. +...++..|.+||..+ .||+++.|+..|+++...|+|||||
T Consensus 85 LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-----DHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 85 LGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-----DHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred cCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-----CCCccchhhheeeccceeEEEEecC
Confidence 799999999999999999999999998543 3345566788899988 7799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|..+.+++.++.+++..++.++.+++.||+|||-.||++|||||+|||+.++|.++++||-++.....+.+.....
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~ 239 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSS 239 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccC
Confidence 9999999999998999999999999999999999999999999999999999999999999999887764433222110
Q ss_pred C-----CCCCeE---Ee----------------eCCCC--------cccCCCCCcccccCCCCchhHHhcCCCCCccchH
Q 020235 156 P-----KSSAIK---VI----------------DFGST--------TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIW 203 (329)
Q Consensus 156 ~-----~~~~~~---l~----------------Dfg~~--------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 203 (329)
. ....+. +. |.+.. ...+......+||..|.|||++.+++.+.++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWW 319 (459)
T KOG0610|consen 240 SPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWW 319 (459)
T ss_pred CCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHH
Confidence 0 000011 11 11110 1111112457899999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHH
Q 020235 204 SVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283 (329)
Q Consensus 204 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
+||+++|||+.|..||.+.+..+++.++....-.+|..
T Consensus 320 tfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~------------------------------------------ 357 (459)
T KOG0610|consen 320 TFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE------------------------------------------ 357 (459)
T ss_pred HHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC------------------------------------------
Confidence 99999999999999999999888777665544333321
Q ss_pred HhhhccCchhHHHHHHHHhcccCCCCCCC----HHHHhcCCCCCCCC
Q 020235 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLT----AREALRHPFFTRDH 326 (329)
Q Consensus 284 ~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~~ll~hp~f~~~~ 326 (329)
..++.+++|||+++|.+||.+|+. |+||.+||||+.+|
T Consensus 358 -----~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 358 -----PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred -----CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 246789999999999999999997 99999999999886
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=356.31 Aligned_cols=252 Identities=29% Similarity=0.510 Sum_probs=215.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++.++..||||.+.+. .+..+....|+.+++.+ .|+||+.++++.++++.+|+|||||
T Consensus 18 iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-----~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-----KHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred ccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-----CCcceeeEEEEEecCCeEEEEEEeCC
Confidence 79999999999999999999999999754 34556678899999999 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
||+|.+++++.+ .+++..++..+.|++.||++||+++|+||||||+|||++.+.. .+
T Consensus 93 gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~---------------------~~ 149 (429)
T KOG0595|consen 93 GGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR---------------------ND 149 (429)
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC---------------------CC
Confidence 999999999875 7999999999999999999999999999999999999965410 01
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
....+||+|||+|+...+.. .+.+|++.|||||++....|+.|+|+||+|+++|++++|++||...+..+....+.+.
T Consensus 150 ~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~ 229 (429)
T KOG0595|consen 150 TSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG 229 (429)
T ss_pred CCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc
Confidence 12679999999999888765 6689999999999999999999999999999999999999999988887776655543
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..-.|. .....+....+++...|+.||..|.+..
T Consensus 230 ~~~~~~----------------------------------------------~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 230 NEIVPV----------------------------------------------LPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred ccccCc----------------------------------------------hhhhccCchhhhhhHHHhcCccccCchH
Confidence 322111 1123455677888899999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
+-+.|+++....
T Consensus 264 ~~~~~~~l~~~p 275 (429)
T KOG0595|consen 264 DFFDHPFLAANP 275 (429)
T ss_pred HhhhhhhcccCc
Confidence 988998887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=363.34 Aligned_cols=273 Identities=29% Similarity=0.491 Sum_probs=229.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|.||.||+|++..||+.||+|.++.+. .......+|+.||+++ +|+||++|.+...+. ..+|+||||
T Consensus 125 IGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-----~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 125 IGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-----DHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred hcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-----CCCcccceeeEEEecCCceEEEEEec
Confidence 799999999999999999999999998543 4456667899999999 779999999988766 689999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|..+|.-++.... -.+++.+++.++.||+.||+|||++||.|||||.+|||+
T Consensus 200 MdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi--------------------------- 251 (560)
T KOG0600|consen 200 MDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI--------------------------- 251 (560)
T ss_pred ccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---------------------------
Confidence 9999999888754 469999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.+||+|||+|+++.... ...+-|.=|+|||++.+. .|+..+|+||.|||+.||+.|++.|++.++.+++..
T Consensus 252 dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~k 331 (560)
T KOG0600|consen 252 DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHK 331 (560)
T ss_pred cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHH
Confidence 666779999999999776655 334668889999999987 599999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
|.+++|.+.++.|. +.+....-....... ....+.+.....+....+|+..||..||.+|
T Consensus 332 IfklcGSP~e~~W~-~~kLP~~~~~kp~~~-------------------y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 332 IFKLCGSPTEDYWP-VSKLPHATIFKPQQP-------------------YKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred HHHHhCCCChhccc-cccCCcccccCCCCc-------------------ccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 99999999988877 322221111111111 1112222345677889999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
.||.++|+|+||+.+.
T Consensus 392 ~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 392 GTASSALQSEYFTTEP 407 (560)
T ss_pred ccHHHHhcCcccccCC
Confidence 9999999999996554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-52 Score=362.55 Aligned_cols=273 Identities=29% Similarity=0.456 Sum_probs=219.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.||+|+.+.||..+|+|++++.. ........|-.+|... .++.|++++..|++...+||||||+
T Consensus 149 IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-----ds~~vVKLyYsFQD~~~LYLiMEyl 223 (550)
T KOG0605|consen 149 IGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-----DSPWVVKLYYSFQDKEYLYLIMEYL 223 (550)
T ss_pred eccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-----CCCcEEEEEEEecCCCeeEEEEEec
Confidence 799999999999999999999999998643 3345555677777765 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc-c
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK-R 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 154 (329)
||++.-+|.+.+ .+++..++.++.+++.|++.+|+.|++||||||+|+|++..|.++++|||++.-.-+...... +
T Consensus 224 PGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 224 PGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred CCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 999999999876 799999999999999999999999999999999999999999999999999854433322110 0
Q ss_pred ----CC-CCCCeEEeeCCCC--cccCCC---------------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHH
Q 020235 155 ----MP-KSSAIKVIDFGST--TYERPD---------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 155 ----~~-~~~~~~l~Dfg~~--~~~~~~---------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 212 (329)
.. .....+-.||... ...... ....+|||-|+|||++.+.+|+..+|+||||||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 00 0111233334321 010000 0235899999999999999999999999999999999
Q ss_pred HhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 213 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+.|.+||.+.++.+.+..|......+. +|+ ....+
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~---------------------fP~------------------------~~~~s 416 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLK---------------------FPE------------------------EVDLS 416 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhcc---------------------CCC------------------------cCccc
Confidence 999999999999988888777542221 111 12356
Q ss_pred hHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 020235 293 GDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 326 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t---~~~ll~hp~f~~~~ 326 (329)
++++|||.+||+ ||++|+. +.||.+||||++++
T Consensus 417 ~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 417 DEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 789999999999 9999994 89999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-51 Score=361.40 Aligned_cols=242 Identities=31% Similarity=0.503 Sum_probs=208.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----h--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----K--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.|++|++..++..||+|+++.. . ...+...+|+.++..+. .||||+++++++.+...+++|||
T Consensus 25 lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~----~HpnI~~l~ev~~t~~~~~ivmE 100 (370)
T KOG0583|consen 25 LGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLR----SHPNIIRLLEVFATPTKIYIVME 100 (370)
T ss_pred ecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhc----cCCCEeEEEEEEecCCeEEEEEE
Confidence 79999999999999999999999987653 1 23445557998888883 36899999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ ||+|.+++... .++.+..+++++.|++.|++|||++||+||||||+|||+
T Consensus 101 y~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill------------------------- 153 (370)
T KOG0583|consen 101 YCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL------------------------- 153 (370)
T ss_pred ecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe-------------------------
Confidence 99 89999999984 379999999999999999999999999999999999999
Q ss_pred cCCCC-CCeEEeeCCCCcccC-C--CCCcccccCCCCchhHHhcCC-CC-CccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 154 RMPKS-SAIKVIDFGSTTYER-P--DQNYIVSTRHYRAPEVILGLG-WT-YPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~-~~~~l~Dfg~~~~~~-~--~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.+ ..+||+|||++.... . .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+
T Consensus 154 --d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l 231 (370)
T KOG0583|consen 154 --DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL 231 (370)
T ss_pred --cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH
Confidence 555 889999999999773 2 236689999999999999988 86 889999999999999999999988666655
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc-hhHHHHHHHHhcccC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS-AGDLTHLLQGLLRYD 306 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ll~~~l~~d 306 (329)
...+.+..-..| ... |.++++|+++||..|
T Consensus 232 ~~ki~~~~~~~p-------------------------------------------------~~~~S~~~~~Li~~mL~~~ 262 (370)
T KOG0583|consen 232 YRKIRKGEFKIP-------------------------------------------------SYLLSPEARSLIEKMLVPD 262 (370)
T ss_pred HHHHhcCCccCC-------------------------------------------------CCcCCHHHHHHHHHHcCCC
Confidence 555444322222 223 778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTR 324 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~ 324 (329)
|.+|+|+.++++||||+.
T Consensus 263 P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 263 PSTRITLLEILEHPWFQK 280 (370)
T ss_pred cccCCCHHHHhhChhhcc
Confidence 999999999999999997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=337.71 Aligned_cols=277 Identities=28% Similarity=0.464 Sum_probs=230.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
|++|+||.||+|+++.|+..||+|.++-. ....-..++|+.++.++ .|+||+.+.++.... +.+|+||||
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-----~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-----RHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-----CCCCeeeeEEEEeccccceeeeeHHH
Confidence 68999999999999999999999999743 24456778999999999 579999999887644 579999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|..+|.+++.... +++...+++.++.|++.||.|||...|+||||||+|+|+
T Consensus 159 ~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm--------------------------- 210 (419)
T KOG0663|consen 159 VEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL--------------------------- 210 (419)
T ss_pred HHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee---------------------------
Confidence 9999999998865 679999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
...+.+||+|||+|+.++.+. ...+-|.-|+|||++.+.. |+...|+||+|||+.+|+++++.|.+....++...|
T Consensus 211 ~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I 290 (419)
T KOG0663|consen 211 SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI 290 (419)
T ss_pred ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH
Confidence 556679999999999887764 4456788999999999865 899999999999999999999999999999999999
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.+.+|.+++..|+.+.+....- ...++. .+.-.++..++... .+....+|++.+|..||.+|.
T Consensus 291 f~llGtPte~iwpg~~~lp~~k----~~~f~~-----------~pyn~lr~kF~~~~--lse~g~~Lln~llt~dP~kR~ 353 (419)
T KOG0663|consen 291 FKLLGTPSEAIWPGYSELPAVK----KMTFSE-----------HPYNNLRKKFGALS--LSEQGFDLLNKLLTYDPGKRI 353 (419)
T ss_pred HHHhCCCccccCCCccccchhh----ccccCC-----------CCchhhhhhccccc--cchhHHHHHHHHhccCccccc
Confidence 9999999988877654433110 011111 01111222222111 568899999999999999999
Q ss_pred CHHHHhcCCCCCCCCc
Q 020235 312 TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 t~~~ll~hp~f~~~~~ 327 (329)
||.+.|+|+||.+..+
T Consensus 354 tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 354 TAEDGLKHEYFRETPL 369 (419)
T ss_pred cHHHhhcccccccCCC
Confidence 9999999999998653
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=362.11 Aligned_cols=243 Identities=28% Similarity=0.439 Sum_probs=213.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+-|.||.|....+++.||||.|... ...++....|+.++... .|+||+.+++.|-..+.+|+||||+ ||
T Consensus 281 igqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-----~H~NiVnfl~Sylv~deLWVVMEym~gg 355 (550)
T KOG0578|consen 281 IGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-----HHPNIVNFLDSYLVGDELWVVMEYMEGG 355 (550)
T ss_pred hccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-----cchHHHHHHHHhcccceeEEEEeecCCC
Confidence 69999999999999999999999999754 34466778899999888 6699999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+.+.... +++.++..++.+++.||+|||.+||+|||||.+|||+ ..+
T Consensus 356 sLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL---------------------------~~~ 405 (550)
T KOG0578|consen 356 SLTDVVTKTR---MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL---------------------------TMD 405 (550)
T ss_pred chhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe---------------------------ccC
Confidence 9999998764 9999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.+||+|||++....+.. .+.+|||.|||||++....|++++||||||++++||+.|.+||...++....+.|...-
T Consensus 406 g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng 485 (550)
T KOG0578|consen 406 GSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 485 (550)
T ss_pred CcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC
Confidence 679999999998776654 56789999999999999999999999999999999999999999877766655554432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+ .- ...+..|..++|||.+||+.||++|++|.+
T Consensus 486 ~P-~l---------------------------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~e 519 (550)
T KOG0578|consen 486 TP-KL---------------------------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKE 519 (550)
T ss_pred CC-Cc---------------------------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHH
Confidence 22 10 113467899999999999999999999999
Q ss_pred HhcCCCCCC
Q 020235 316 ALRHPFFTR 324 (329)
Q Consensus 316 ll~hp~f~~ 324 (329)
||+||||+.
T Consensus 520 LL~HpFl~~ 528 (550)
T KOG0578|consen 520 LLEHPFLKM 528 (550)
T ss_pred HhcChhhhh
Confidence 999999964
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=340.39 Aligned_cols=271 Identities=30% Similarity=0.523 Sum_probs=228.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec---cchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-----CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-----~~~~~lv 72 (329)
||.|+||.|+.|.++.||+.||||.+. ......++.++|+.+++.+ .|+||+.+.+++.. -+.+|+|
T Consensus 30 iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-----~HeNIi~l~di~~p~~~~~f~DvYiV 104 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-----RHENIIGLLDIFRPPSRDKFNDVYLV 104 (359)
T ss_pred ccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-----cCCCcceEEeecccccccccceeEEe
Confidence 799999999999999999999999987 2345567888999999999 46999999998876 3579999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+|+++.+|...++.+. .++..-+...++|++.||.|+|+.+++|||+||.|+++
T Consensus 105 ~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~------------------------ 158 (359)
T KOG0660|consen 105 FELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL------------------------ 158 (359)
T ss_pred hhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheee------------------------
Confidence 9999999999998864 59999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCC-----CCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERP-----DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.+..+||||||+|+.... ..+..+.|.-|+|||++.. ..|+...||||+|||+.||++|++.|.|.+..+
T Consensus 159 ---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 159 ---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred ---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 6677789999999987743 2255678999999998864 469999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhHHHhhh-hhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 227 HLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
++..|.+.+|.++++....+. +.+..|+.+-. ..+. ..........++.+.||+++||+.
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp-~~p~------------------~~f~~~fp~a~p~AidLlekmL~f 296 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLP-QIPK------------------QPFSSIFPNANPLAIDLLEKMLVF 296 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCC-CCCC------------------CCHHHHcCCCCHHHHHHHHHHhcc
Confidence 999999999999988888765 33333433311 0000 001122335678899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~ 324 (329)
||.+|+|++|+|+||||+.
T Consensus 297 dP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 297 DPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CccccCCHHHHhcChhhhh
Confidence 9999999999999999975
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=337.57 Aligned_cols=276 Identities=32% Similarity=0.529 Sum_probs=229.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCc-eeeeccccccCC------ceE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRN------HIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~-i~~l~~~~~~~~------~~~ 70 (329)
||+|+||+||+|+.+.+|+.||+|.++.... ......+|+.+++.+.+ +| |+.+++++.+.+ .++
T Consensus 19 lGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~-----~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSH-----ANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred hCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCC-----CcceEEEEeeeeecccccccceEE
Confidence 6999999999999999999999999985433 56677899999999944 55 999999998877 899
Q ss_pred EEeecCCCCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCC
Q 020235 71 IVFEKLGSSLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148 (329)
Q Consensus 71 lv~e~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 148 (329)
+||||+.-+|..++..... ..++...++.++.|++.||+|||+++|+||||||+|||+
T Consensus 94 lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi-------------------- 153 (323)
T KOG0594|consen 94 LVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI-------------------- 153 (323)
T ss_pred EEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE--------------------
Confidence 9999999999999987553 357889999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 149 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
++.+.+||+|||+|+...-+. ...++|.-|+|||++.+. .|+...||||+||+++||+++++.|.+..+
T Consensus 154 -------~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 154 -------SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred -------CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 556778999999988655332 345788899999999987 699999999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.++...|.+.+|.+.+..|+.+....+.-. ....|+ .......+ ....+.+..|++.+||+
T Consensus 227 ~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~--~f~~~~----------------~~~~l~~~-~~~~~~~~~dll~~~L~ 287 (323)
T KOG0594|consen 227 IDQLFRIFRLLGTPNEKDWPGVSSLPDYKA--PFPKWP----------------GPKDLSSI-LPKLDPDGIELLSKLLQ 287 (323)
T ss_pred HHHHHHHHHHcCCCCccCCCCccccccccc--cCcCCC----------------CccchHHh-ccccCccHHHHHHHHhc
Confidence 999999999999999988887665443322 111111 11111111 12234679999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCc
Q 020235 305 YDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
.+|.+|.||+.+++||||.+...
T Consensus 288 y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 288 YDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCcccCcCHHHHhcChhhccccc
Confidence 99999999999999999998754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-51 Score=363.74 Aligned_cols=241 Identities=29% Similarity=0.550 Sum_probs=212.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+-|.|-+|++..||+.+|||++.+. ........+|+.+|+.+ .|||++.+++++++..++|+|.||+
T Consensus 20 LG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-----~HpnVl~LydVwe~~~~lylvlEyv 94 (786)
T KOG0588|consen 20 LGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-----EHPNVLRLYDVWENKQHLYLVLEYV 94 (786)
T ss_pred ccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-----cCCCeeeeeeeeccCceEEEEEEec
Confidence 79999999999999999999999999753 23456678899999999 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|.+++.+++ ++++..+.+++.|++.|+.|||..+|+|||+||+|+|+
T Consensus 95 ~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL--------------------------- 145 (786)
T KOG0588|consen 95 PGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL--------------------------- 145 (786)
T ss_pred CCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---------------------------
Confidence 999999999876 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+....+||+|||.|....++. .+.||+|+|.|||++.+.+|. .++||||.|||+|.|++|++||.+.+-...+..+.
T Consensus 146 d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~ 225 (786)
T KOG0588|consen 146 DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ 225 (786)
T ss_pred hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 455559999999999877776 678999999999999999985 89999999999999999999998765544444333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+. .+..| ..++.++.|||++||.+||++|+|
T Consensus 226 ~G-----------------------~f~MP--------------------------s~Is~eaQdLLr~ml~VDp~~RiT 256 (786)
T KOG0588|consen 226 RG-----------------------VFEMP--------------------------SNISSEAQDLLRRMLDVDPSTRIT 256 (786)
T ss_pred cC-----------------------cccCC--------------------------CcCCHHHHHHHHHHhccCcccccc
Confidence 32 22222 356889999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 020235 313 AREALRHPFFTR 324 (329)
Q Consensus 313 ~~~ll~hp~f~~ 324 (329)
.++|++|||+..
T Consensus 257 ~~eI~kHP~l~g 268 (786)
T KOG0588|consen 257 TEEILKHPFLSG 268 (786)
T ss_pred HHHHhhCchhhc
Confidence 999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-52 Score=330.76 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=214.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|.|+.|+++.++.||+.+|+|+++.. ....+...+|+.|...+ .||||+++.+.+......|+|+|++
T Consensus 19 igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-----qHP~IvrL~~ti~~~~~~ylvFe~m~ 93 (355)
T KOG0033|consen 19 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESFHYLVFDLVT 93 (355)
T ss_pred HccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-----CCCcEeehhhhhcccceeEEEEeccc
Confidence 79999999999999999999999998732 22345566788888777 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
|++|..-|.+. .-.++..+..++.|++.||+|+|.+||+|||+||+|+++-+. +
T Consensus 94 G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK------------------------~ 147 (355)
T KOG0033|consen 94 GGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK------------------------A 147 (355)
T ss_pred chHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec------------------------c
Confidence 88887666543 247888999999999999999999999999999999999543 4
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.-.+||+|||++...+... ...+|||+|||||++...+|+..+|||+.||++|-|+.|.+||.+.+....+++|.+.
T Consensus 148 ~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g 227 (355)
T KOG0033|consen 148 KGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG 227 (355)
T ss_pred CCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 55679999999998777443 4578999999999999999999999999999999999999999987777777777765
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
-...|+ ..++++++++++|+++||..||.+|+|+.
T Consensus 228 ~yd~~~---------------------------------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~ 262 (355)
T KOG0033|consen 228 AYDYPS---------------------------------------------PEWDTVTPEAKSLIRRMLTVNPKKRITAD 262 (355)
T ss_pred ccCCCC---------------------------------------------cccCcCCHHHHHHHHHHhccChhhhccHH
Confidence 433332 12467888999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
|+|+|||+.+.+
T Consensus 263 EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 263 EALKHPWICNRE 274 (355)
T ss_pred HHhCCchhcchH
Confidence 999999998864
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=354.65 Aligned_cols=241 Identities=29% Similarity=0.510 Sum_probs=210.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+++.+.|.+.||+|.+.+... ......+|++++..+ .||||+.++++|++..++|+|+||+.
T Consensus 10 iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-----kHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 10 IGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-----KHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-----CCcchhhHHHhhcccceEEEEehhhh
Confidence 6999999999999999999999999875433 334567899999999 66999999999999999999999996
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|+|..++.... .+++..+..+.++++.||.|||+.+|.|||+||.|||+ .+
T Consensus 85 g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---------------------------~~ 135 (808)
T KOG0597|consen 85 GDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---------------------------EK 135 (808)
T ss_pred hhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---------------------------cC
Confidence 69999998765 79999999999999999999999999999999999999 78
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
++.+|+||||+|+...... +..-|||.|||||++.+.+|+..+|+|||||++||+++|++||....-......|..-
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d 215 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD 215 (808)
T ss_pred CCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC
Confidence 8889999999998777655 3457999999999999999999999999999999999999999765444444444332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
...+| .+.+..|.+|+..+|.+||.+|+|..
T Consensus 216 ~v~~p-------------------------------------------------~~~S~~f~nfl~gLL~kdP~~RltW~ 246 (808)
T KOG0597|consen 216 PVKPP-------------------------------------------------STASSSFVNFLQGLLIKDPAQRLTWT 246 (808)
T ss_pred CCCCc-------------------------------------------------ccccHHHHHHHHHHhhcChhhcccHH
Confidence 22222 24678899999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
+++.|||.++
T Consensus 247 ~Ll~HpF~k~ 256 (808)
T KOG0597|consen 247 DLLGHPFWKG 256 (808)
T ss_pred HHhcChHHhh
Confidence 9999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=343.23 Aligned_cols=247 Identities=32% Similarity=0.490 Sum_probs=201.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--ceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--~~~lv~e~~- 76 (329)
||+|+||.||++.++.+|...|+|.+..... ..+...+|+.++..+ .||+|+++++...... .++++|||+
T Consensus 25 lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-----~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 25 LGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-----NHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred ccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-----CCCCEEeeCCccccccCeeeEeeeeccC
Confidence 7999999999999999999999999875421 145578899999999 4799999999855544 699999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|.+++.+..+ .+++..+++++.|++.||.|||++||+|+||||+|||++.
T Consensus 100 ~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~-------------------------- 152 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDP-------------------------- 152 (313)
T ss_pred CCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeC--------------------------
Confidence 9999999999776 7999999999999999999999999999999999999942
Q ss_pred CCCCeEEeeCCCCcccCC-----C-CCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCC-chhHHH
Q 020235 157 KSSAIKVIDFGSTTYERP-----D-QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~-----~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~ 228 (329)
.++.+||+|||.+..... . .....||+.|||||++.. ...+.++|||||||++.+|+||..||... ...+..
T Consensus 153 ~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~ 232 (313)
T KOG0198|consen 153 SNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEAL 232 (313)
T ss_pred CCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHH
Confidence 156799999998876663 1 134689999999999995 23345999999999999999999999763 222211
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.... ..++.+...+.++++||.+||..||+
T Consensus 233 ~~ig~~~-----------------------------------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~ 265 (313)
T KOG0198|consen 233 LLIGRED-----------------------------------------------SLPEIPDSLSDEAKDFLRKCFKRDPE 265 (313)
T ss_pred HHHhccC-----------------------------------------------CCCCCCcccCHHHHHHHHHHhhcCcc
Confidence 1111100 01123455788999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRDH 326 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~~ 326 (329)
+||||+++|+|||.++..
T Consensus 266 ~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 266 KRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCcCHHHHhhChhhhccc
Confidence 999999999999998754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-50 Score=328.76 Aligned_cols=233 Identities=29% Similarity=0.457 Sum_probs=203.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeecc-ccccCCc-eEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRNH-ICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~-~~~~~~~-~~lv~e~ 75 (329)
||.|+||+||+|.+..+|..||+|.+.. +.+.++....|+.+|+++ .||||++++. .|..++. ++||||+
T Consensus 27 IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-----~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 27 IGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-----NHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-----CCchHHHHHHHhhhccchhhHHHHHh
Confidence 6999999999999999999999999874 345677888999999999 7799999998 6666665 9999999
Q ss_pred C-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh--cC--CcccCCCCCcEEEeeccccccCCCcCccCCCCC
Q 020235 76 L-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD--LC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148 (329)
Q Consensus 76 ~-~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~--~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 148 (329)
| +|+|...++. ..++.+++..+++++.|++.||..+|+ .. |.||||||.||++
T Consensus 102 c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl-------------------- 161 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL-------------------- 161 (375)
T ss_pred hcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE--------------------
Confidence 9 9999999974 344679999999999999999999998 44 9999999999999
Q ss_pred CCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 149 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.+||.|||+++...... .+.+|||.||+||++.+.+|+.++|||||||++|||+.-++||.+.+-.
T Consensus 162 -------~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~ 234 (375)
T KOG0591|consen 162 -------TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL 234 (375)
T ss_pred -------cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH
Confidence 566779999999998877665 4578999999999999999999999999999999999999999998877
Q ss_pred HHHHHHHHHhCC-CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
+....|.+..-+ +|+ +.+|..+..+|..|+.
T Consensus 235 ~L~~KI~qgd~~~~p~------------------------------------------------~~YS~~l~~li~~ci~ 266 (375)
T KOG0591|consen 235 SLCKKIEQGDYPPLPD------------------------------------------------EHYSTDLRELINMCIA 266 (375)
T ss_pred HHHHHHHcCCCCCCcH------------------------------------------------HHhhhHHHHHHHHHcc
Confidence 777777775332 332 3467789999999999
Q ss_pred cCCCCCCCH
Q 020235 305 YDPTDRLTA 313 (329)
Q Consensus 305 ~dP~~R~t~ 313 (329)
.||+.||+.
T Consensus 267 vd~~~RP~t 275 (375)
T KOG0591|consen 267 VDPEQRPDT 275 (375)
T ss_pred CCcccCCCc
Confidence 999999984
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=358.04 Aligned_cols=243 Identities=26% Similarity=0.416 Sum_probs=210.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.|++|..+.+++.+|||.+++. ....+..+.|..|+..+. .||+++.++..|++.+++|+||||+
T Consensus 376 LGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~----~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 376 LGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN----RHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred eccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc----cCCeEeecccccccCCeEEEEEEec
Confidence 79999999999999999999999999863 344566677888887773 6899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||++..+.+. ..+++..++.++.+|+.||+|||++||+|||||.+|||+
T Consensus 452 ~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL--------------------------- 501 (694)
T KOG0694|consen 452 AGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL--------------------------- 501 (694)
T ss_pred CCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---------------------------
Confidence 8884443333 369999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+..+++||+|||+++..- ...++.+|||.|||||++.+..|+..+|+|||||+||+|+.|..||.+.++.+.+..|.
T Consensus 502 D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~ 581 (694)
T KOG0694|consen 502 DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV 581 (694)
T ss_pred cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 677889999999997432 33467899999999999999999999999999999999999999999999888777666
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
......| .-.|.++.++|+++|++||++|+.
T Consensus 582 ~d~~~yP-------------------------------------------------~~ls~ea~~il~~ll~k~p~kRLG 612 (694)
T KOG0694|consen 582 NDEVRYP-------------------------------------------------RFLSKEAIAIMRRLLRKNPEKRLG 612 (694)
T ss_pred cCCCCCC-------------------------------------------------CcccHHHHHHHHHHhccCcccccC
Confidence 5332222 345778999999999999999995
Q ss_pred -----HHHHhcCCCCCCCC
Q 020235 313 -----AREALRHPFFTRDH 326 (329)
Q Consensus 313 -----~~~ll~hp~f~~~~ 326 (329)
+.+|.+||||+..+
T Consensus 613 ~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 613 SGERDAEDIKKHPFFRSID 631 (694)
T ss_pred CCCCCchhhhhCCccccCC
Confidence 58889999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=340.34 Aligned_cols=263 Identities=25% Similarity=0.372 Sum_probs=210.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh--HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||.|.-++||+|+...++..||||+++..+.+ -+...+|+..+..+ +||||+.++..|..+..+|+||+++ +
T Consensus 34 IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-----~HPNIv~~~~sFvv~~~LWvVmpfMa~ 108 (516)
T KOG0582|consen 34 IGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-----DHPNIVTYHCSFVVDSELWVVMPFMAG 108 (516)
T ss_pred EeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-----CCCCcceEEEEEEecceeEEeehhhcC
Confidence 68999999999999999999999999854433 46778899999888 7799999999999999999999999 9
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|++.+++.......+++..+..++.+++.||.|||.+|.+|||||+.|||++.+|.+++.|||.+.++-.+.
T Consensus 109 GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G-------- 180 (516)
T KOG0582|consen 109 GSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG-------- 180 (516)
T ss_pred CcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC--------
Confidence 999999998776789999999999999999999999999999999999999777776666666554432211
Q ss_pred CCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.=...+| .+.+||+.|||||++..+ +|+.|+||||||++..||++|+.||....++... +.++.
T Consensus 181 --~R~~~rf----------~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLq 246 (516)
T KOG0582|consen 181 --DRQVTRF----------NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQ 246 (516)
T ss_pred --ceeeEee----------ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhc
Confidence 0011111 345899999999997654 6999999999999999999999999865554433 34444
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+.+|....... .. ......+.+|+.++..||+.||.+||||++
T Consensus 247 n~pp~~~t~~~--------------------~~-----------------d~~k~~~ksf~e~i~~CL~kDP~kRptAsk 289 (516)
T KOG0582|consen 247 NDPPTLLTSGL--------------------DK-----------------DEDKKFSKSFREMIALCLVKDPSKRPTASK 289 (516)
T ss_pred CCCCCcccccC--------------------Ch-----------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHH
Confidence 55442210000 00 001345668999999999999999999999
Q ss_pred HhcCCCCCCCCc
Q 020235 316 ALRHPFFTRDHL 327 (329)
Q Consensus 316 ll~hp~f~~~~~ 327 (329)
+|+|+||+....
T Consensus 290 Llkh~FFk~~k~ 301 (516)
T KOG0582|consen 290 LLKHAFFKKAKS 301 (516)
T ss_pred HhccHHHhhccc
Confidence 999999998654
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=340.54 Aligned_cols=270 Identities=30% Similarity=0.511 Sum_probs=215.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|+++.+++.||+|+++... .......+|+.++..+ .|+||+++++++.+++..++||||+.+
T Consensus 13 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (288)
T cd07871 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-----KHANIVTLHDIIHTERCLTLVFEYLDS 87 (288)
T ss_pred EecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeEEEEEeCCCc
Confidence 699999999999999999999999987432 2234566899999888 569999999999999999999999977
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+ +.+
T Consensus 88 ~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---------------------------~~~ 139 (288)
T cd07871 88 DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---------------------------NEK 139 (288)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---------------------------CCC
Confidence 9999987643 357899999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++|+|||.+....... ....|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+....+.+.
T Consensus 140 ~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (288)
T cd07871 140 GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219 (288)
T ss_pred CCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 668888998876443222 33467899999999876 45889999999999999999999999998888888888888
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.++.+.++...+..... . ...+. ...... .......+.++.|||++||++||.+|||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~-~---~~~~~--------------~~~~~~-~~~~~~~~~~~~dll~~mL~~dp~~R~t~~ 280 (288)
T cd07871 220 LGTPTEETWPGITSNEEFR-S---YLFPQ--------------YRAQPL-INHAPRLDTDGIDLLSSLLLYETKSRISAE 280 (288)
T ss_pred hCCCChHHhhccccchhhh-c---cccCc--------------cCCCch-HHhCCCCCHHHHHHHHHhcCcCcccCCCHH
Confidence 8888887776543321110 0 00000 000000 011234567899999999999999999999
Q ss_pred HHhcCCCC
Q 020235 315 EALRHPFF 322 (329)
Q Consensus 315 ~ll~hp~f 322 (329)
|+++||||
T Consensus 281 ~~l~hp~f 288 (288)
T cd07871 281 AALRHSYF 288 (288)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=346.23 Aligned_cols=250 Identities=34% Similarity=0.555 Sum_probs=217.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|.||.||+|+.+.||+.+|+|.+.+... ......+|+.++.++. .|||++.+++.|++.+.+++|||+|
T Consensus 43 lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~----~hpniv~l~~~~e~~~~~~lvmEL~ 118 (382)
T KOG0032|consen 43 LGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLS----GHPNIVQLKDAFEDPDSVYLVMELC 118 (382)
T ss_pred hCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhcc----CCCCEEEEEEEEEcCCeEEEEEEec
Confidence 7999999999999999999999999975433 2357788999999993 3799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|.+.+... .+++..+..++.|++.++.|||+.|++|||+||+|+|+....
T Consensus 119 ~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~----------------------- 172 (382)
T KOG0032|consen 119 EGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD----------------------- 172 (382)
T ss_pred CCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc-----------------------
Confidence 99999999987 299999999999999999999999999999999999996532
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+..++++|||++....+.. ...+||+.|+|||++.+.+|+..+||||+|+++|.|++|.+||.+.+.......+..
T Consensus 173 ~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 234689999999999888743 567999999999999999999999999999999999999999998887666654444
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
....++.+ .++.++..+++||+.||..||.+|+||
T Consensus 253 ~~~~f~~~---------------------------------------------~w~~is~~akd~i~~ll~~dp~~R~ta 287 (382)
T KOG0032|consen 253 GDFDFTSE---------------------------------------------PWDDISESAKDFIRKLLEFDPRKRLTA 287 (382)
T ss_pred CCCCCCCC---------------------------------------------CccccCHHHHHHHHHhcccCcccCCCH
Confidence 33222222 234578899999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
.++|+|||+++.
T Consensus 288 ~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 288 AQALQHPWIKSI 299 (382)
T ss_pred HHHhcCccccCC
Confidence 999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-50 Score=323.96 Aligned_cols=246 Identities=30% Similarity=0.515 Sum_probs=212.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||.|..+.|-++.++.||+.+|+|++.-. ....+....|+.++.++ .+||+|+++.++++++..+++
T Consensus 25 lgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv----~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 25 LGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQV----MGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHh----cCCCcEEEeeeeccCcchhhh
Confidence 68899999999999999999999998621 12235556799999998 488999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|+|.| .|.|.|++...- .+++...++++.|++.|++|||..+|+||||||+|||+
T Consensus 101 VFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---------------------- 156 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---------------------- 156 (411)
T ss_pred hhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee----------------------
Confidence 99999 999999998764 69999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc------CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.+..++|+|||+++...+.. ...+|||+|+|||.+.. .+|+..+|+||+||+||.|+.|.+||--.
T Consensus 157 -----ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 157 -----DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred -----ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 778889999999999888876 45799999999999964 35899999999999999999999999766
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
..+-+...|++.-..+.++- |...+...+|||++|
T Consensus 232 kQmlMLR~ImeGkyqF~spe---------------------------------------------Wadis~~~KdLIsrl 266 (411)
T KOG0599|consen 232 KQMLMLRMIMEGKYQFRSPE---------------------------------------------WADISATVKDLISRL 266 (411)
T ss_pred HHHHHHHHHHhcccccCCcc---------------------------------------------hhhccccHHHHHHHH
Confidence 66666666666433332221 345677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
|++||.+|+|+.|+|+||||.+
T Consensus 267 LqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 267 LQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HeeCchhcccHHHHhcChHHHH
Confidence 9999999999999999999954
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=333.37 Aligned_cols=270 Identities=31% Similarity=0.526 Sum_probs=218.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~e~ 75 (329)
+|+|+||.||+|...++++.||||.+-.+.. ...+|++++..+ .||||+++..+|... -...+||||
T Consensus 32 iG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r---~knrEl~im~~l-----~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 32 IGSGSFGVVYQAKLRETEEEVAIKKVLQDKR---YKNRELQIMRKL-----DHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EeecccceEEEEEEcCCCceeEEEEecCCCC---cCcHHHHHHHhc-----CCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 5999999999999999999999999875433 445699999977 779999998877532 267899999
Q ss_pred CCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 76 LGSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 76 ~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++.+|.+.++.. ....++.-.++-+.+||+.||.|||+.||+||||||+|+|++
T Consensus 104 mP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD------------------------ 159 (364)
T KOG0658|consen 104 MPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD------------------------ 159 (364)
T ss_pred chHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc------------------------
Confidence 999999999842 235689999999999999999999999999999999999996
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
...+.+||||||.|+...+.. .++.=|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|.|.+..++...
T Consensus 160 --~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e 237 (364)
T KOG0658|consen 160 --PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE 237 (364)
T ss_pred --CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence 345789999999999776654 334568899999999886 599999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
|.+.+|.++.+-....... +.+.......... +..-.....+++..||+.++|+++|.+|
T Consensus 238 Iik~lG~Pt~e~I~~mn~~---y~~~~~p~ik~~~-----------------~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 238 IIKVLGTPTREDIKSMNPN---YTEFKFPQIKAHP-----------------WHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHHHhCCCCHHHHhhcCcc---cccccCccccccc-----------------ceeecccCCCHHHHHHHHHHhccChhhc
Confidence 9999999887644432221 1111100000000 0001234567889999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 020235 311 LTAREALRHPFFTR 324 (329)
Q Consensus 311 ~t~~~ll~hp~f~~ 324 (329)
.|+.|+++||||..
T Consensus 298 ~~~~~~l~h~fFde 311 (364)
T KOG0658|consen 298 LSALEALAHPFFDE 311 (364)
T ss_pred CCHHHHhcchhhHH
Confidence 99999999999974
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=357.12 Aligned_cols=303 Identities=38% Similarity=0.700 Sum_probs=224.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhC-CCCCceeeeccccccC-CceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYR-NHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~l~~~~~~~-~~~~lv~e~~~~ 78 (329)
||+|+||+||+|.+..+++.||||+++...........|+.++..+.+.. ..+.+++.+.+++..+ .+.|+||+++++
T Consensus 137 lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~ 216 (467)
T PTZ00284 137 LGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGP 216 (467)
T ss_pred EEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCC
Confidence 69999999999999999999999999754444455667888888886643 2345688888887754 589999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+|.+++.+.. .+++..++.++.|++.||+|||+ .||+||||||+|||++..+....... .... ...
T Consensus 217 ~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~--~~~~---------~~~ 283 (467)
T PTZ00284 217 CLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT--NRAL---------PPD 283 (467)
T ss_pred CHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc--cccc---------CCC
Confidence 9999987754 68999999999999999999998 59999999999999976543211110 0000 023
Q ss_pred CCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
...+||+|||.+..........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+.+..+.
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~ 363 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence 35699999998876555556678999999999999999999999999999999999999999998888888889999999
Q ss_pred CChhHHHhhhh-hhhhhh-hcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 238 LPQHMLKRVDR-HAEKYV-RRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 238 ~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+|..+...... ....+. ..+... ................... ......+.|||.+||++||++|||++|
T Consensus 364 ~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 364 LPSEWAGRCGTEEARLLYNSAGQLR---PCTDPKHLARIARARPVRE------VIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred CCHHHHhhccchhHHHHhhhccccc---ccCCHHHHHhhhcccchhh------hhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 98877654211 111111 111110 0000000100000000000 012456889999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+|+||||.+.
T Consensus 435 ~L~Hp~~~~~ 444 (467)
T PTZ00284 435 MTTHPYVLKY 444 (467)
T ss_pred HhcCcccccc
Confidence 9999999874
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=338.19 Aligned_cols=243 Identities=26% Similarity=0.352 Sum_probs=204.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++.+.+.+..++||||+
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-----SHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-----CCCcHhhhHhhhccCCeEEEEEeCC
Confidence 799999999999999999999999986432 2234566788888888 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||+|||++|++||||||+|||+
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli--------------------------- 134 (291)
T cd05612 84 PGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL--------------------------- 134 (291)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---------------------------
Confidence 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 135 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 214 (291)
T cd05612 135 DKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK 214 (291)
T ss_pred CCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 45567999999998876655555679999999999999889999999999999999999999998766544433332211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC---
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT--- 312 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t--- 312 (329)
.. .....+..++++|++||+.||.+|++
T Consensus 215 ~~-------------------------------------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 245 (291)
T cd05612 215 LE-------------------------------------------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMK 245 (291)
T ss_pred cC-------------------------------------------------CCccCCHHHHHHHHHHcCCCHHHccCCcc
Confidence 11 11234668999999999999999995
Q ss_pred --HHHHhcCCCCCCCC
Q 020235 313 --AREALRHPFFTRDH 326 (329)
Q Consensus 313 --~~~ll~hp~f~~~~ 326 (329)
++++++||||+..+
T Consensus 246 ~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 246 NGADDVKNHRWFKSVD 261 (291)
T ss_pred CCHHHHhcCccccCCC
Confidence 99999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=343.68 Aligned_cols=243 Identities=26% Similarity=0.434 Sum_probs=201.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|+++... .......+|+.++..+ .|++|+.+++.+...+..++||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~ 77 (323)
T cd05571 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-----RHPFLTALKYSFQTHDRLCFVMEYA 77 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCCEEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999987432 2234456788888777 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll--------------------------- 128 (323)
T cd05571 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML--------------------------- 128 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---------------------------
Confidence 899999988754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 129 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 45567899999988643221 234579999999999999899999999999999999999999998755543332221
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
..... .+...+.++.+||++||+.||++||
T Consensus 209 ~~~~~-------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 209 MEEIR-------------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 11000 1124567899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
++.++++||||++.+
T Consensus 240 ~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 240 GGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=344.07 Aligned_cols=243 Identities=28% Similarity=0.422 Sum_probs=204.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|+||+++++.+.+++..++||||+
T Consensus 26 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 100 (329)
T PTZ00263 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-----SHPFIVNMMCSFQDENRVYFLLEFV 100 (329)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEcCCEEEEEEcCC
Confidence 699999999999999999999999987432 2234566788888888 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+.+.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 101 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll--------------------------- 151 (329)
T PTZ00263 101 VGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL--------------------------- 151 (329)
T ss_pred CCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---------------------------
Confidence 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.+..
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~ 231 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231 (329)
T ss_pred CCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Confidence 55667999999998876665556689999999999999899999999999999999999999998765544333222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC---
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT--- 312 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t--- 312 (329)
... +...+..+.+||++||+.||.+|++
T Consensus 232 ~~~-------------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~ 262 (329)
T PTZ00263 232 LKF-------------------------------------------------PNWFDGRARDLVKGLLQTDHTKRLGTLK 262 (329)
T ss_pred cCC-------------------------------------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 000 1224567899999999999999997
Q ss_pred --HHHHhcCCCCCCCC
Q 020235 313 --AREALRHPFFTRDH 326 (329)
Q Consensus 313 --~~~ll~hp~f~~~~ 326 (329)
++++++||||++.+
T Consensus 263 ~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 263 GGVADVKNHPYFHGAN 278 (329)
T ss_pred CCHHHHhcCCccCCCC
Confidence 79999999998754
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=333.32 Aligned_cols=272 Identities=33% Similarity=0.606 Sum_probs=213.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|+||+++++.+...+..++||||+.
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-----KQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred ecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-----CCccccchhhhEecCCEEEEEEecCC
Confidence 699999999999999999999999987432 2234566788888888 56999999999999999999999995
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.
T Consensus 84 ~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---------------------------~~ 135 (287)
T cd07848 84 KNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---------------------------SH 135 (287)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------cC
Confidence 55555554432 368999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+....+.+
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (287)
T cd07848 136 NDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQK 215 (287)
T ss_pred CCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5668899999887653322 234689999999999988899999999999999999999999998888777788888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..++++.+.+.......... ...++... .............+.++.+||++||++||++|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-------------~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~ 278 (287)
T cd07848 216 VLGPLPAEQMKLFYSNPRFH----GLRFPAVN-------------HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT 278 (287)
T ss_pred hhCCCCHHHHHhhhccchhc----ccccCccc-------------CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence 88888876655332211000 00011000 00001111223467889999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
+++++||||
T Consensus 279 ~~~l~hp~f 287 (287)
T cd07848 279 EQCLNHPAF 287 (287)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=337.96 Aligned_cols=243 Identities=31% Similarity=0.496 Sum_probs=201.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++.. .........|+.++..+ .|+||+++++.+.+.+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-----NCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCcEeceeeEEecCCeEEEEEcCC
Confidence 79999999999999999999999998742 22234456788888877 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili--------------------------- 126 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL--------------------------- 126 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---------------------------
Confidence 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 127 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~ 206 (312)
T cd05585 127 DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206 (312)
T ss_pred CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH
Confidence 45567999999988753222 234579999999999999899999999999999999999999998755443333222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
+... ..+...+..+.++|.+||+.||++||
T Consensus 207 ~~~~-------------------------------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 207 QEPL-------------------------------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCC-------------------------------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 1100 01124567899999999999999997
Q ss_pred --CHHHHhcCCCCCCCC
Q 020235 312 --TAREALRHPFFTRDH 326 (329)
Q Consensus 312 --t~~~ll~hp~f~~~~ 326 (329)
++.++++||||++.+
T Consensus 238 ~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 238 YNGAQEIKNHPFFSQLS 254 (312)
T ss_pred CCCHHHHHcCCCcCCCC
Confidence 589999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-48 Score=335.07 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|.+.... .......+|+.++..+ .|++++.+.+.+.+.+..++||||+
T Consensus 8 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-----NSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-----CCCcEEEEEEEEccCCeEEEEEEec
Confidence 799999999999999999999999986432 1223456788888888 5689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+.+.......+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill--------------------------- 135 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL--------------------------- 135 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---------------------------
Confidence 8999988876544568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05631 136 DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR 215 (285)
T ss_pred CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH
Confidence 455668999999887643322 345789999999999998999999999999999999999999987544322211111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
..... ........+..+.+|+++||+.||++|||
T Consensus 216 ~~~~~---------------------------------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 216 RVKED---------------------------------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred Hhhcc---------------------------------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 11000 01112346778999999999999999997
Q ss_pred ----HHHHhcCCCCCCCCc
Q 020235 313 ----AREALRHPFFTRDHL 327 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~~ 327 (329)
++++++||||.+.+.
T Consensus 251 ~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05631 251 RGNGAAGVKQHPIFKNINF 269 (285)
T ss_pred CCCCHHHHhcCHhhcCCCH
Confidence 899999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=320.58 Aligned_cols=267 Identities=26% Similarity=0.446 Sum_probs=221.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+|+.|-.|.+..||..+|||++.+.. ..+.+..+|++++.+. .+|+||+.++++|+++...|||||.+ ||
T Consensus 86 LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~C----qgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 86 LGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQC----QGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred hcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHh----cCCccHHHHHHHhcccceEEEEEecccCc
Confidence 799999999999999999999999998653 3467888999999887 58899999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+.|.+.. .+++..+.+++.+++.||+|||.+||+|||+||+|||.... +..
T Consensus 162 plLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p------------------------n~v 215 (463)
T KOG0607|consen 162 PLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP------------------------NKV 215 (463)
T ss_pred hHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC------------------------CCc
Confidence 9999998764 59999999999999999999999999999999999999543 344
Q ss_pred CCeEEeeCCCCcccCC----------CCCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 159 SAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
.-+|||||.+..-... +-.+.+|+..|||||+... .-|+.+.|.|||||++|-|++|.+||.+..
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C 295 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC 295 (463)
T ss_pred CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence 5689999987642211 1134578889999998852 248999999999999999999999999876
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+ +|.-..+.....+..+-.-+..|++.+|+. .|..+|.+.+|+++.+|
T Consensus 296 g~d--------CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdk----------------------dWahIS~eakdlisnLl 345 (463)
T KOG0607|consen 296 GAD--------CGWDRGEVCRVCQNKLFESIQEGKYEFPDK----------------------DWAHISSEAKDLISNLL 345 (463)
T ss_pred CCc--------CCccCCCccHHHHHHHHHHHhccCCcCChh----------------------hhHHhhHHHHHHHHHHH
Confidence 543 233344444444454555556677777763 24568899999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 304 RYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
..||..|.+|.++++|||++...+
T Consensus 346 vrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 346 VRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred hccHHhhhhhhhccCCccccccch
Confidence 999999999999999999987643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=333.99 Aligned_cols=277 Identities=25% Similarity=0.422 Sum_probs=209.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+++.||+|+++... .......+|+.++..+ .|+||+++++++.++...++||||+++
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~ 87 (303)
T cd07869 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLTLVFEYVHT 87 (303)
T ss_pred EEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-----CCCCcCeEEEEEecCCeEEEEEECCCc
Confidence 699999999999999999999999987432 2234556788998888 669999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+ ..+
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---------------------------~~~ 139 (303)
T cd07869 88 DLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---------------------------SDT 139 (303)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCC
Confidence 9999887643 358899999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCch-hHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAMMER 233 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~ 233 (329)
+.++|+|||.+....... ....||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+..+ .+....+..
T Consensus 140 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (303)
T cd07869 140 GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219 (303)
T ss_pred CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 568888998876433221 335688999999998764 578899999999999999999999987544 344555555
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.++...+........ +.... .. ......+..... ....+..+.+|+++||+.||++|||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~-~~~~~-~~-------------~~~~~~~~~~~~--~~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 220 VLGTPNEDTWPGVHSLPH-FKPER-FT-------------LYSPKNLRQAWN--KLSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred HhCCCChhhccchhhccc-ccccc-cc-------------ccCCccHHHHhh--ccCCChHHHHHHHHHhccCchhccCH
Confidence 555555444333221100 00000 00 000111111100 11245679999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
.++++||||++...
T Consensus 283 ~~~l~h~~f~~~~~ 296 (303)
T cd07869 283 QAALSHEYFSDLPP 296 (303)
T ss_pred HHHhcCcccccCCh
Confidence 99999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=339.44 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=203.7
Q ss_pred CCCccceEEEEEEecCCC-ceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.++ ..||+|.+.... .......+|+.++..+ .||||+++++++.+++..++||||
T Consensus 38 ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~~~lv~Ey 112 (340)
T PTZ00426 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-----NHPFCVNLYGSFKDESYLYLVLEF 112 (340)
T ss_pred EeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCCcceEEEEEeCCEEEEEEeC
Confidence 699999999999877665 689999986432 2234556788888888 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 113 ~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl-------------------------- 164 (340)
T PTZ00426 113 VIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL-------------------------- 164 (340)
T ss_pred CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE--------------------------
Confidence 9 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.+.
T Consensus 165 -~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 243 (340)
T PTZ00426 165 -DKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG 243 (340)
T ss_pred -CCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence 4556789999999887665555668999999999999988999999999999999999999999876655444433321
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC---
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL--- 311 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~--- 311 (329)
.... +...+..+.++|++||+.||++|+
T Consensus 244 ~~~~-------------------------------------------------p~~~~~~~~~li~~~l~~dp~~R~~~~ 274 (340)
T PTZ00426 244 IIYF-------------------------------------------------PKFLDNNCKHLMKKLLSHDLTKRYGNL 274 (340)
T ss_pred CCCC-------------------------------------------------CCCCCHHHHHHHHHHcccCHHHcCCCC
Confidence 1111 123456789999999999999996
Q ss_pred --CHHHHhcCCCCCCCC
Q 020235 312 --TAREALRHPFFTRDH 326 (329)
Q Consensus 312 --t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 275 ~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 275 KKGAQNVKEHPWFGNID 291 (340)
T ss_pred CCCHHHHHcCCCcCCCC
Confidence 899999999998764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-47 Score=335.77 Aligned_cols=273 Identities=31% Similarity=0.501 Sum_probs=212.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv 72 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+ .|+||+++++++... ...|+|
T Consensus 8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-----RHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-----CCCCEeeecceEeccCCCCCceEEEE
Confidence 69999999999999999999999998632 12234567899999888 569999999887533 358999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|||++++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 83 ~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll------------------------ 136 (338)
T cd07859 83 FELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA------------------------ 136 (338)
T ss_pred EecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE------------------------
Confidence 9999889999997654 58999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 137 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 137 ---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred ---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 455668888888876432211 23468999999999876 5689999999999999999999999998887
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
......+....+.++......+..... .+...-... ...+ ..+.....+..+.++|.+||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~--------------~~~~-----~~~~~~~~~~~~~~li~~~l 274 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKK--------------QPVP-----FSQKFPNADPLALRLLERLL 274 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhccc--------------CCCc-----hHHhcCCCChHHHHHHHHHc
Confidence 777777777788877766555432110 110000000 0000 00112235678899999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
+.||++|||++++++||||++..
T Consensus 275 ~~~P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 275 AFDPKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred CcCcccCCCHHHHhcCchhhhcC
Confidence 99999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=328.83 Aligned_cols=271 Identities=29% Similarity=0.485 Sum_probs=207.8
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-----cCCceEE
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----YRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-----~~~~~~l 71 (329)
||+|+||.||+|++.. +++.||+|.++... .......+|+.++..+.. ..|+||+++++++. .....++
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~hpniv~~~~~~~~~~~~~~~~~~l 86 (290)
T cd07862 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSRTDRETKLTL 86 (290)
T ss_pred eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcc--cCCCCcceEEEEEecccCCCCCcEEE
Confidence 7999999999999854 46889999887432 223345567777776632 25699999998774 3457999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 87 v~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~----------------------- 143 (290)
T cd07862 87 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----------------------- 143 (290)
T ss_pred EEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE-----------------------
Confidence 999998899999987655568999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||+.|+|||.+.+..++.++|+|||||++|+|++|++||.+.+..+...
T Consensus 144 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 219 (290)
T cd07862 144 ----TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 219 (290)
T ss_pred ----cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence 455668999999886544332 34568999999999998889999999999999999999999999888877777
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....+.+.+..+.......... + .+.............+..+.+++.+||+.||++
T Consensus 220 ~i~~~~~~~~~~~~~~~~~~~~~~-------~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 277 (290)
T cd07862 220 KILDVIGLPGEEDWPRDVALPRQA-------F---------------HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 277 (290)
T ss_pred HHHHHhCCCChhhchhhhcccchh-------c---------------cCCCCCCHHHHccCCCHHHHHHHHHHhccCchh
Confidence 777766654433222211100000 0 000000111122346778999999999999999
Q ss_pred CCCHHHHhcCCCC
Q 020235 310 RLTAREALRHPFF 322 (329)
Q Consensus 310 R~t~~~ll~hp~f 322 (329)
|||+.++|+||||
T Consensus 278 R~s~~~~l~hp~f 290 (290)
T cd07862 278 RISAYSALSHPYF 290 (290)
T ss_pred cCCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=336.95 Aligned_cols=243 Identities=27% Similarity=0.445 Sum_probs=200.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|++|+.+++.+.+.+..++||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~Ey~ 77 (328)
T cd05593 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-----RHPFLTSLKYSFQTKDRLCFVMEYV 77 (328)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999987432 2234556677777777 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll--------------------------- 128 (328)
T cd05593 78 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML--------------------------- 128 (328)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---------------------------
Confidence 999998887654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 129 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~ 208 (328)
T cd05593 129 DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (328)
T ss_pred CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc
Confidence 45567899999987653222 134578999999999998889999999999999999999999998765543332221
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
..... .+...+.++.+||++||+.||++|+
T Consensus 209 ~~~~~-------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 209 MEDIK-------------------------------------------------FPRTLSADAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred cCCcc-------------------------------------------------CCCCCCHHHHHHHHHHcCCCHHHcCC
Confidence 11000 1124567899999999999999997
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
|+.++++||||.+.+
T Consensus 240 ~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 240 GGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 899999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=307.72 Aligned_cols=243 Identities=25% Similarity=0.452 Sum_probs=215.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|-||.||+|+.+.++..||+|++.+.+ ....+..+|++|-..+ .||||.+++++|.+...+||++||.
T Consensus 30 LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-----~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 30 LGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-----RHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred ccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-----CCccHHhhhhheeccceeEEEEEec
Confidence 799999999999999999999999987533 2345566788887777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
.|.++..+.......+++.....++.|++.||.|+|.++++||||||+|+|++
T Consensus 105 ~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg-------------------------- 158 (281)
T KOG0580|consen 105 PRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG-------------------------- 158 (281)
T ss_pred CCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC--------------------------
Confidence 99999999976667899999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
..+.++|+|||.+...... +.+.+||.-|.+||...+..++..+|+|++|++.|+++.|.+||.+....+.++.|.+.
T Consensus 159 -~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~ 237 (281)
T KOG0580|consen 159 -SAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV 237 (281)
T ss_pred -CCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc
Confidence 5566899999988766433 46689999999999999999999999999999999999999999998888888888876
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.-..| ..++..+.|+|++||.++|.+|.+..
T Consensus 238 ~~~~p-------------------------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~ 268 (281)
T KOG0580|consen 238 DLKFP-------------------------------------------------STISGGAADLISRLLVKNPIERLALT 268 (281)
T ss_pred cccCC-------------------------------------------------cccChhHHHHHHHHhccCccccccHH
Confidence 55444 35678899999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
|++.|||+..
T Consensus 269 ~v~~hpwI~a 278 (281)
T KOG0580|consen 269 EVMDHPWIVA 278 (281)
T ss_pred HHhhhHHHHh
Confidence 9999999865
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-47 Score=334.63 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=199.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... ........|..++..+ ..|++|+++++++.+.+..|+||||+
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~iv~~~~~~~~~~~~~iv~Ey~ 78 (320)
T cd05590 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLYCCFQTPDRLFFVMEFV 78 (320)
T ss_pred eeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc----cCCCchhceeeEEEcCCEEEEEEcCC
Confidence 799999999999999999999999987432 1223344566666554 35799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 79 ~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli--------------------------- 129 (320)
T cd05590 79 NGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL--------------------------- 129 (320)
T ss_pred CCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---------------------------
Confidence 899999887754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 130 DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 4556689999998764322 1234578999999999998889999999999999999999999998766554443332
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..... +...+..+.++|++||+.||++|+|
T Consensus 210 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 210 NDEVVY-------------------------------------------------PTWLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred cCCCCC-------------------------------------------------CCCCCHHHHHHHHHHcccCHHHCCC
Confidence 211111 1234668999999999999999999
Q ss_pred H------HHHhcCCCCCCCC
Q 020235 313 A------REALRHPFFTRDH 326 (329)
Q Consensus 313 ~------~~ll~hp~f~~~~ 326 (329)
+ +++++||||++..
T Consensus 241 ~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 241 SLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCCHHHHHcCCCcCCCC
Confidence 8 9999999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=331.49 Aligned_cols=282 Identities=26% Similarity=0.478 Sum_probs=206.2
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++ .+++.||+|.+.... ......+|+.++..+ .|+||+++++.+.. +..++++|||+
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLREL-----KHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhc-----CCCCCcceeeeEecCCCcEEEEEEecc
Confidence 799999999999975 467899999987432 344567899999988 66999999998853 46789999999
Q ss_pred CCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 77 GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 77 ~~~l~~~l~~~~-------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+...+
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~----------------- 145 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----------------- 145 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC-----------------
Confidence 889999886421 12488999999999999999999999999999999999995432
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
.....++|+|||.+....... ....||+.|+|||++.+. .++.++|+|||||++|+|++|++||.+.
T Consensus 146 ------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 146 ------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 345679999999987654321 235789999999999874 5889999999999999999999999754
Q ss_pred ch---------hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 223 EN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 223 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
.. ......+.+..+.++...++..............+.. . ..................+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~---------~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07868 220 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRR--N---------TYTNCSLIKYMEKHKVKPDS 288 (317)
T ss_pred cccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhc--c---------ccCcccccchHHhcCCCCCh
Confidence 32 2445566666676666555544322111000000000 0 00000001111111123456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~hp~f 322 (329)
.+.|||.+||++||.+|||++|+|+||||
T Consensus 289 ~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 78999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=332.62 Aligned_cols=246 Identities=27% Similarity=0.467 Sum_probs=221.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|.|+.|-+|++..||..||||++.+.+ ........|+.-++.+ .||||+++|++.++...+|||+|+-
T Consensus 26 lG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-----QHpNiVRLYEViDTQTKlyLiLELGD 100 (864)
T KOG4717|consen 26 LGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-----QHPNIVRLYEVIDTQTKLYLILELGD 100 (864)
T ss_pred hcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-----cCcCeeeeeehhcccceEEEEEEecC
Confidence 799999999999999999999999997643 4456677898888888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|+++|-+.. ..+++..+++++.||+.|+.|+|+..+|||||||+|+.+. .
T Consensus 101 ~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--------------------------E 153 (864)
T KOG4717|consen 101 GGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--------------------------E 153 (864)
T ss_pred CchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--------------------------e
Confidence 999999998765 5699999999999999999999999999999999999885 4
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+-+.|||+|||++..+.+.. .+.+|+..|.|||++.+..|+ +++||||||||+|.|++|++||+.+++.+..-+|+.
T Consensus 154 KlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD 233 (864)
T KOG4717|consen 154 KLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD 233 (864)
T ss_pred ecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc
Confidence 66789999999998887776 568999999999999999998 889999999999999999999999999988888777
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.-...|+ .++.+++|||..||+.||++|.|.
T Consensus 234 CKYtvPs-------------------------------------------------hvS~eCrdLI~sMLvRdPkkRAsl 264 (864)
T KOG4717|consen 234 CKYTVPS-------------------------------------------------HVSKECRDLIQSMLVRDPKKRASL 264 (864)
T ss_pred ccccCch-------------------------------------------------hhhHHHHHHHHHHHhcCchhhccH
Confidence 6555543 568899999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
+++..|+|++....
T Consensus 265 EeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 265 EEIVSTSWLQAGDR 278 (864)
T ss_pred HHHhccccccCCCC
Confidence 99999999987654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=337.98 Aligned_cols=275 Identities=27% Similarity=0.484 Sum_probs=217.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~~lv 72 (329)
||+|+||.||+|.+..+++.||+|.+... ........+|+.++..+ .|+||+++++++...+ ..++|
T Consensus 8 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-----KHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-----CCCCcCCHhheecCCCccccceEEEE
Confidence 79999999999999999999999998642 12234567888888888 5699999999998776 89999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|||++++|.+.+.... .+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus 83 ~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili------------------------ 136 (372)
T cd07853 83 TELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV------------------------ 136 (372)
T ss_pred eeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE------------------------
Confidence 9999888988886643 68999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 137 ---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 213 (372)
T cd07853 137 ---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213 (372)
T ss_pred ---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH
Confidence 455678888988886544322 234678899999999875 478999999999999999999999999888888
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+..+..+...+....+....+........+. ...........+.++.+||.+||+.||
T Consensus 214 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~mL~~dP 276 (372)
T cd07853 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPS-----------------LPVLYTLSSQATHEAVHLLCRMLVFDP 276 (372)
T ss_pred HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCc-----------------hHHhcccCCCCCHHHHHHHHHhCCCCh
Confidence 888888888776654444333333332221111110 000111223457789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 020235 308 TDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~~~ 326 (329)
++|||+.++++||||.+..
T Consensus 277 ~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 277 DKRISAADALAHPYLDEGR 295 (372)
T ss_pred hhCcCHHHHhcCHhhCCCc
Confidence 9999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=346.42 Aligned_cols=270 Identities=28% Similarity=0.528 Sum_probs=209.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--------CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------~~~~~lv 72 (329)
||+|+||.||+|.+..+++.||||++.... ....+|+.++..+ .|+||+++++++.. ...+++|
T Consensus 74 LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-----~h~niv~l~~~~~~~~~~~~~~~~~l~lv 145 (440)
T PTZ00036 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNL-----NHINIIFLKDYYYTECFKKNEKNIFLNVV 145 (440)
T ss_pred EEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhc-----CCCCCcceeeeEeecccccCCCceEEEEE
Confidence 699999999999999999999999886432 2334688899888 56999998876532 2257899
Q ss_pred eecCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||+++++.+++.. .....+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 146 mE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~-------------------- 205 (440)
T PTZ00036 146 MEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDP-------------------- 205 (440)
T ss_pred EecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcC--------------------
Confidence 99998888888764 22346899999999999999999999999999999999999942
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
....++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 206 ------~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 279 (440)
T PTZ00036 206 ------NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279 (440)
T ss_pred ------CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 22458999999987554332 345789999999998764 689999999999999999999999999888888
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+..+.++.+.+......... ..++. .........++...+.++.+||.+||++||
T Consensus 280 ~~~i~~~~~~p~~~~~~~~~~~~~~------~~~~~--------------~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 280 LVRIIQVLGTPTEDQLKEMNPNYAD------IKFPD--------------VKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHHHhCCCCHHHHHHhchhhhc------ccCCc--------------cCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 8888888887766544432111100 00110 000111122234567789999999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q 020235 308 TDRLTAREALRHPFFTR 324 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~ 324 (329)
.+|||+.|+++||||.+
T Consensus 340 ~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 340 LKRLNPIEALADPFFDD 356 (440)
T ss_pred hHCcCHHHHhCChhHHh
Confidence 99999999999999975
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=341.73 Aligned_cols=270 Identities=22% Similarity=0.368 Sum_probs=205.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|.++.+++.||+|... .....+|+.++..+ .|+||+++++++......++|+|+++++|
T Consensus 100 lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~lv~e~~~~~L 169 (391)
T PHA03212 100 FTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAI-----NHPSIIQLKGTFTYNKFTCLILPRYKTDL 169 (391)
T ss_pred EcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhC-----CCCCCCCEeEEEEECCeeEEEEecCCCCH
Confidence 699999999999999999999999754 23457899999998 56999999999999999999999998899
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
..++.... .+++..++.++.|++.||.|||++||+||||||+|||+ ..++.
T Consensus 170 ~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---------------------------~~~~~ 220 (391)
T PHA03212 170 YCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---------------------------NHPGD 220 (391)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---------------------------cCCCC
Confidence 99987654 68999999999999999999999999999999999999 45566
Q ss_pred eEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc-------hhHHHH
Q 020235 161 IKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE-------NLEHLA 229 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-------~~~~~~ 229 (329)
++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...+ ......
T Consensus 221 vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~ 300 (391)
T PHA03212 221 VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIK 300 (391)
T ss_pred EEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHH
Confidence 8999999986533221 23579999999999999899999999999999999999998875432 233455
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhh-h--cCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYV-R--RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
.+.+..+..|.+............. . ......+.. .+.... ....+.++.+||.+||++|
T Consensus 301 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~-----~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 301 LIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGS------------RPLWTN-----LYELPIDLEYLICKMLAFD 363 (391)
T ss_pred HHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCC------------CCCHHH-----HhhhhhhHHHHHHHHhcCC
Confidence 5566666655432111111111000 0 000000000 000000 0123557899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~~ 326 (329)
|++||||.|+|+||||++..
T Consensus 364 P~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hhhCCCHHHHhcChhhccCC
Confidence 99999999999999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=334.92 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=200.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|+++... .......+|+.++..+ .|+|++++++.+...+..|+||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (323)
T cd05595 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVMEYA 77 (323)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCEEEEEEeCC
Confidence 799999999999999999999999987432 2223445677888777 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll--------------------------- 128 (323)
T cd05595 78 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--------------------------- 128 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---------------------------
Confidence 999998887654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus 129 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 129 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 455668888888876432221 33568999999999998889999999999999999999999998765544333222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
..... .+...+.++.++|.+||+.||++|+
T Consensus 209 ~~~~~-------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 209 MEEIR-------------------------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred cCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHhCC
Confidence 11100 1124567899999999999999998
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
++.++++||||.+.+
T Consensus 240 ~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 240 GGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.23 Aligned_cols=244 Identities=27% Similarity=0.409 Sum_probs=197.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++... ..|++++++++.+.+.+.+|+||||+
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~E~~ 78 (316)
T cd05620 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA----WENPFLTHLYCTFQTKEHLFFVMEFL 78 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCCccCeeEEEEeCCEEEEEECCC
Confidence 799999999999999999999999987432 1223344555555443 25699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.... .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 79 ~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~--------------------------- 129 (316)
T cd05620 79 NGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML--------------------------- 129 (316)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---------------------------
Confidence 899999987753 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+.... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~ 209 (316)
T cd05620 130 DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR 209 (316)
T ss_pred CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 455668888888876422 12234578999999999999899999999999999999999999998766544333322
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..... .....+.++.++|++||+.||++|+|
T Consensus 210 ~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 210 VDTPH-------------------------------------------------YPRWITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred hCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 11100 11224668999999999999999999
Q ss_pred H-HHHhcCCCCCCCC
Q 020235 313 A-REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-~~ll~hp~f~~~~ 326 (329)
+ +++++||||++.+
T Consensus 241 ~~~~~~~h~~f~~~~ 255 (316)
T cd05620 241 VVGNIRGHPFFKTIN 255 (316)
T ss_pred ChHHHHcCCCcCCCC
Confidence 7 5888999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=331.63 Aligned_cols=244 Identities=27% Similarity=0.390 Sum_probs=197.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++... ........|..++... ..|++|+++++.+..++..++||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~i~~~~~~~~~~~~~~lv~e~~ 78 (316)
T cd05592 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA----WEHPFLTHLFCTFQTKEHLFFVMEYL 78 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEcCC
Confidence 799999999999999999999999987432 1122334455544433 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 79 ~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill--------------------------- 129 (316)
T cd05592 79 NGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL--------------------------- 129 (316)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---------------------------
Confidence 999999987654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 130 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 209 (316)
T cd05592 130 DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209 (316)
T ss_pred CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4556789999998864322 1234578999999999999889999999999999999999999998766544433322
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..... .+...+.++.++|.+||+.||++|++
T Consensus 210 ~~~~~-------------------------------------------------~~~~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 210 NDRPH-------------------------------------------------FPRWISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred cCCCC-------------------------------------------------CCCCCCHHHHHHHHHHccCCHHHcCC
Confidence 21111 11235668899999999999999998
Q ss_pred H-HHHhcCCCCCCCC
Q 020235 313 A-REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-~~ll~hp~f~~~~ 326 (329)
+ .++++||||...+
T Consensus 241 ~~~~l~~h~~~~~~~ 255 (316)
T cd05592 241 VDGDIRQHPFFRGID 255 (316)
T ss_pred ChHHHHcCcccCCCC
Confidence 6 5888999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=329.14 Aligned_cols=243 Identities=26% Similarity=0.395 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh---------------HHhHHHHHHHHHHHHhhCCCCCceeeecccccc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~ 65 (329)
||+|.||.|-+|++..+++.||||++.+.+.. .+...+|+.+++++ .|+||++|+++.++
T Consensus 105 iG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-----~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 105 IGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-----HHPNVVKLIEVLDD 179 (576)
T ss_pred hcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-----CCcCeeEEEEeecC
Confidence 79999999999999999999999999743211 24667899999999 66999999999997
Q ss_pred C--CceEEEeecC-CCCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 66 R--NHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 66 ~--~~~~lv~e~~-~~~l~~~l~~~~~~~-l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
. +.+|+|+||| .|.+.+. ..... +++.+++.++..++.||.|||.+||+||||||+|+|++
T Consensus 180 P~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~------------ 244 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS------------ 244 (576)
T ss_pred cccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc------------
Confidence 5 5899999999 6665432 22234 89999999999999999999999999999999999994
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--------CcccccCCCCchhHHhcC---CC-CCccchHhHHHHH
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGL---GW-TYPCDIWSVGCIL 209 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~---~~-~~~~DiwslG~~l 209 (329)
.++.+||.|||.+....... ...+|||.|+|||...+. .+ +.+.||||+||+|
T Consensus 245 ---------------~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 245 ---------------SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred ---------------CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 45667888888776442111 336899999999999873 33 5788999999999
Q ss_pred HHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhcc
Q 020235 210 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289 (329)
Q Consensus 210 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
|.|+.|+.||.+....+.+..|....-.+|. ..
T Consensus 310 YCllfG~~PF~~~~~~~l~~KIvn~pL~fP~-----------------------------------------------~p 342 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFELELFDKIVNDPLEFPE-----------------------------------------------NP 342 (576)
T ss_pred HHhhhccCCcccchHHHHHHHHhcCcccCCC-----------------------------------------------cc
Confidence 9999999999987777777666654333332 11
Q ss_pred CchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 290 ~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
.....++|||.+||++||++|+|+.+|..|||..+.
T Consensus 343 e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 343 EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 345689999999999999999999999999998865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=337.15 Aligned_cols=242 Identities=28% Similarity=0.423 Sum_probs=206.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||.|+||.||+|.+..|++.||+|++.... ..-.....|+.++.++ .+++|..+++.+-.+..+|++|||| |
T Consensus 21 IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-----~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 21 IGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-----DSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-----CcchHHhhhhheeecccHHHHHHHhcC
Confidence 799999999999999999999999998543 2335566788999888 5589999999999999999999999 9
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|++.+.++... .+++..+..++.+++.||.|||+++.+|||||+.|||+ ..
T Consensus 96 Gsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~---------------------------s~ 146 (467)
T KOG0201|consen 96 GSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL---------------------------SE 146 (467)
T ss_pred cchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeE---------------------------ec
Confidence 99999998865 45888899999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+.++++|||.+....... ..++||+.|||||++.+..|+.++||||||++.++|++|.+|+....++.....|-+
T Consensus 147 ~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk- 225 (467)
T KOG0201|consen 147 SGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK- 225 (467)
T ss_pred cCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-
Confidence 5679999999987666543 567999999999999998999999999999999999999999987665322111111
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
+.++......+..+++||..||.+||+.||||.
T Consensus 226 -----------------------------------------------~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~ 258 (467)
T KOG0201|consen 226 -----------------------------------------------SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAK 258 (467)
T ss_pred -----------------------------------------------CCCCccccccCHHHHHHHHHHhhcCcccCcCHH
Confidence 111122345788999999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
++|+|+|+++
T Consensus 259 ~LLKh~FIk~ 268 (467)
T KOG0201|consen 259 ELLKHKFIKR 268 (467)
T ss_pred HHhhhHHHHh
Confidence 9999999986
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=334.78 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=206.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|+.++..+ .|++|+++++.+.+.+..|+||||+
T Consensus 9 ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-----KSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-----CCCCCccEEEEEEcCCEEEEEEeCC
Confidence 699999999999999999999999987432 1234456688887777 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--------------------------- 134 (333)
T cd05600 84 PGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI--------------------------- 134 (333)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------------
Confidence 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 135 ~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 214 (333)
T cd05600 135 DASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK 214 (333)
T ss_pred CCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc
Confidence 45667999999998876665556789999999999999899999999999999999999999998766655444333221
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.... .+... ......+.++.++|.+||+.+|++|+|+.+
T Consensus 215 ~~~~---------------------~~~~~--------------------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ 253 (333)
T cd05600 215 ETLQ---------------------RPVYD--------------------DPRFNLSDEAWDLITKLINDPSRRFGSLED 253 (333)
T ss_pred cccc---------------------CCCCC--------------------ccccccCHHHHHHHHHHhhChhhhcCCHHH
Confidence 1100 00000 000235678999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||++.+
T Consensus 254 ll~h~~~~~~~ 264 (333)
T cd05600 254 IKNHPFFKEVD 264 (333)
T ss_pred HHhCcccCCCC
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=324.91 Aligned_cols=271 Identities=30% Similarity=0.527 Sum_probs=207.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-----CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-----RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-----~~~~~lv 72 (329)
||+|+||+||+|+++.+++.||+|.++... .......+|+.++..+.+ ..|+||+++++++.. ....++|
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~ni~~~~~~~~~~~~~~~~~~~lv 85 (288)
T cd07863 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA--FDHPNIVRLMDVCATSRTDRETKVTLV 85 (288)
T ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhh--cCCCCeeeeeeeeccccCCCCceEEEE
Confidence 799999999999999999999999987432 122345568888777743 257999999988764 3468999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||++.++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 86 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili------------------------ 141 (288)
T cd07863 86 FEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV------------------------ 141 (288)
T ss_pred EcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------------------
Confidence 99998899999987654568999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|+|||||++|+|++|++||.+....+....
T Consensus 142 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 142 ---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred ---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 455668889998887654332 334688999999999988899999999999999999999999988777766666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....+......+...... +.... .+.............+..+.++|.+||+.||++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~------------~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 219 IFDLIGLPPEDDWPRDVTL------------PRGAF----------SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHhCCCChhhCcccccc------------ccccc----------CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 6666554443222210000 00000 0000001112223456789999999999999999
Q ss_pred CCHHHHhcCCCC
Q 020235 311 LTAREALRHPFF 322 (329)
Q Consensus 311 ~t~~~ll~hp~f 322 (329)
||+.+++.||||
T Consensus 277 ~t~~~~l~hp~f 288 (288)
T cd07863 277 ISAFRALQHPFF 288 (288)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=331.44 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=200.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+.+++++.+.+..|+||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~----~~hp~i~~~~~~~~~~~~~~lv~E~~ 78 (321)
T cd05591 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA----AKHPFLTALHCCFQTKDRLFFVMEYV 78 (321)
T ss_pred cccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCeEEEEEeCC
Confidence 799999999999999999999999987432 2223345566666554 35799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|...+.... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 79 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill--------------------------- 129 (321)
T cd05591 79 NGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL--------------------------- 129 (321)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---------------------------
Confidence 899999987654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~ 209 (321)
T cd05591 130 DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESIL 209 (321)
T ss_pred CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 45567899999987643222 234568999999999998889999999999999999999999998776655444333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
...... +...+.++.++|.+||+.||++|+
T Consensus 210 ~~~~~~-------------------------------------------------p~~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 210 HDDVLY-------------------------------------------------PVWLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred cCCCCC-------------------------------------------------CCCCCHHHHHHHHHHhccCHHHcCC
Confidence 211111 112456899999999999999999
Q ss_pred ------CHHHHhcCCCCCCCC
Q 020235 312 ------TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ------t~~~ll~hp~f~~~~ 326 (329)
++.++++||||.+.+
T Consensus 241 ~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCCCHHHHhcCCccCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=333.40 Aligned_cols=281 Identities=27% Similarity=0.458 Sum_probs=217.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
||+|+||.||+|.++.+|+.||+|++... ........+|+.++..+ .|+||+++++++...+ .+|+
T Consensus 29 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~~l 103 (359)
T cd07876 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-----NHKNIISLLNVFTPQKSLEEFQDVYL 103 (359)
T ss_pred eecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccCCCccccceeEE
Confidence 79999999999999999999999998642 23345566788888888 6799999999886543 5799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+++++.+.+.. .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 104 v~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~----------------------- 156 (359)
T cd07876 104 VMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 156 (359)
T ss_pred EEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE-----------------------
Confidence 999998888887754 48899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 157 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 157 ----KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred ----CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455678999999886543322 34578999999999999899999999999999999999999999988888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.++.............+..... .++... ... ..... ............+..+++||.+||+.||++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~---~~~~~-~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 305 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRP-QYPGIS--FEE---LFPDW-IFPSESERDKLKTSQARDLLSKMLVIDPDK 305 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCC-CCCCcc--hhh---hcccc-ccccccccccccchhHHHHHHHHhccCccc
Confidence 88888888887777666555544433211 111100 000 00000 000001112234677999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
|||+.|+++||||..
T Consensus 306 R~t~~e~l~hp~~~~ 320 (359)
T cd07876 306 RISVDEALRHPYITV 320 (359)
T ss_pred CCCHHHHhcCchhhh
Confidence 999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=327.63 Aligned_cols=274 Identities=26% Similarity=0.473 Sum_probs=217.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|+++.+++.||+|.++... .......+|+.++..+ .|+|++++++++..++..++||||+.+
T Consensus 14 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 88 (309)
T cd07872 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIVHTDKSLTLVFEYLDK 88 (309)
T ss_pred ecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-----CCCCcceEEEEEeeCCeEEEEEeCCCC
Confidence 799999999999999999999999987432 2233456788888888 569999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.+
T Consensus 89 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---------------------------~~~ 140 (309)
T cd07872 89 DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---------------------------NER 140 (309)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCC
Confidence 9999887654 358899999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++|+|||.+....... ....+|+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.+.
T Consensus 141 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 220 (309)
T cd07872 141 GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220 (309)
T ss_pred CCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 668899999876543222 234678899999998764 5789999999999999999999999988888888888888
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.++...|+.......... . ..+.. .... ........+.++.++|.+||+.||.+|||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~-~---~~~~~--------------~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 281 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKN-Y---NFPKY--------------KPQP-LINHAPRLDTEGIELLTKFLQYESKKRISAE 281 (309)
T ss_pred hCCCCHHHHhhhcchhhhhh-h---hcCcc--------------CCCc-hhhhccCCCHHHHHHHHHhccCChhhCCCHH
Confidence 88887777665433221110 0 00000 0000 0011234577899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
++++||||+...
T Consensus 282 e~l~h~~~~~~~ 293 (309)
T cd07872 282 EAMKHAYFRSLG 293 (309)
T ss_pred HHhcChhhhhcc
Confidence 999999998755
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=331.69 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++... ........|..++..+. ++++++.+++++.+.+.+|+||||+
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (324)
T cd05587 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG----KPPFLTQLHSCFQTMDRLYFVMEYV 83 (324)
T ss_pred EeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcC----CCCceeeeEEEEEcCCEEEEEEcCC
Confidence 799999999999999999999999987432 22334456666666552 4467889999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill--------------------------- 134 (324)
T cd05587 84 NGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--------------------------- 134 (324)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---------------------------
Confidence 999999997654 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
..++.++|+|||.+.... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 455678999999876432 12234578999999999999899999999999999999999999998766554444333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+..+.+++++||+.||.+|++
T Consensus 215 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~ 245 (324)
T cd05587 215 EHNVSY-------------------------------------------------PKSLSKEAVSICKGLLTKHPAKRLG 245 (324)
T ss_pred cCCCCC-------------------------------------------------CCCCCHHHHHHHHHHhhcCHHHcCC
Confidence 221111 1235678999999999999999998
Q ss_pred H-----HHHhcCCCCCCCC
Q 020235 313 A-----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-----~~ll~hp~f~~~~ 326 (329)
+ +++++||||++.+
T Consensus 246 ~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 246 CGPTGERDIREHAFFRRID 264 (324)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 6 8999999998764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=331.05 Aligned_cols=271 Identities=27% Similarity=0.507 Sum_probs=213.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||+||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+++++++... ...++
T Consensus 23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-----KHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred cccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-----CCCchhhhhhhhcccccccccCcEEE
Confidence 799999999999999999999999987432 2234456788888888 569999999887543 45799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
++++++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 98 ~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~----------------------- 151 (343)
T cd07878 98 VTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV----------------------- 151 (343)
T ss_pred EeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE-----------------------
Confidence 9999999999888653 59999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 152 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07878 152 ----NEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR 227 (343)
T ss_pred ----CCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 45567899999998876666566789999999999977 4688999999999999999999999998887777888
Q ss_pred HHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+..+......+.... ..+...- ...+ .. .........+..+.+||.+||+.||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------------~~----~~~~~~~~~~~~~~~li~~mL~~dp~~ 288 (343)
T cd07878 228 IMEVVGTPSPEVLKKISSEHARKYIQSL-PHMP--------------QQ----DLKKIFRGANPLAIDLLEKMLVLDSDK 288 (343)
T ss_pred HHHHhCCCCHHHHHhcchhhHHHHhhcc-cccc--------------ch----hHHHhccCCCHHHHHHHHHHcCCChhh
Confidence 88877777666554432211 1111100 0000 00 001112234567899999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||+.++++||||.+.
T Consensus 289 R~s~~ell~hp~~~~~ 304 (343)
T cd07878 289 RISASEALAHPYFSQY 304 (343)
T ss_pred CCCHHHHhcCcchhcc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=328.95 Aligned_cols=244 Identities=25% Similarity=0.386 Sum_probs=197.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... ........|..++... ..||+|+++++.+.+.+.+++||||+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~ey~ 78 (316)
T cd05619 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHLYCTFQTKENLFFVMEYL 78 (316)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhc----cCCCcCcceEEEEEeCCEEEEEEeCC
Confidence 799999999999999999999999987532 1223344555555443 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~--------------------------- 129 (316)
T cd05619 79 NGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL--------------------------- 129 (316)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---------------------------
Confidence 999999998653 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
..+..++|+|||.+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~ 209 (316)
T cd05619 130 DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209 (316)
T ss_pred CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4556689999998764321 2234578999999999999889999999999999999999999998766544433322
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+..+.++|.+||+.||++|++
T Consensus 210 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 210 MDNPCY-------------------------------------------------PRWLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred hCCCCC-------------------------------------------------CccCCHHHHHHHHHHhccCHhhcCC
Confidence 111000 1124567899999999999999999
Q ss_pred HH-HHhcCCCCCCCC
Q 020235 313 AR-EALRHPFFTRDH 326 (329)
Q Consensus 313 ~~-~ll~hp~f~~~~ 326 (329)
+. ++++||||++.+
T Consensus 241 ~~~~l~~h~~~~~~~ 255 (316)
T cd05619 241 VKGDIRQHPFFREID 255 (316)
T ss_pred ChHHHHcCcccCCCC
Confidence 96 899999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=333.94 Aligned_cols=243 Identities=26% Similarity=0.424 Sum_probs=198.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... ........|+.++..+ .|++|+.+.+.+.+.+..++||||+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-----~hp~i~~~~~~~~~~~~~~lv~E~~ 77 (325)
T cd05594 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHDRLCFVMEYA 77 (325)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999987432 1223445566777666 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|..++.... .+++..+..++.|++.||.|||+ .||+||||||+|||+
T Consensus 78 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll-------------------------- 129 (325)
T cd05594 78 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML-------------------------- 129 (325)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE--------------------------
Confidence 899998887654 68999999999999999999997 799999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+
T Consensus 130 -~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i 208 (325)
T cd05594 130 -DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208 (325)
T ss_pred -CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH
Confidence 45567899999987643222 23456999999999999888999999999999999999999999876554333222
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... .+...+.++.+||++||+.||++|+
T Consensus 209 ~~~~~~-------------------------------------------------~p~~~~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 209 LMEEIR-------------------------------------------------FPRTLSPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred hcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhcCHHHhC
Confidence 111100 1123567899999999999999997
Q ss_pred -----CHHHHhcCCCCCCCC
Q 020235 312 -----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -----t~~~ll~hp~f~~~~ 326 (329)
|+.++++||||++..
T Consensus 240 ~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 240 GGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCHHHHhcCCCcCCCC
Confidence 999999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=335.90 Aligned_cols=273 Identities=22% Similarity=0.299 Sum_probs=197.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|+++... ........|..++..+ .|++|+++++.+.+...+|+||||+
T Consensus 9 LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-----~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-----DSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred EEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCeEEEEEcCC
Confidence 699999999999999999999999987432 2223455677777777 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++.+++.|||++...........-
T Consensus 84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~- 160 (363)
T cd05628 84 PGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY- 160 (363)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc-
Confidence 999999998754 6899999999999999999999999999999999999976666555555554332111000000
Q ss_pred CCCCCeEEeeCCCCccc------------CCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 156 PKSSAIKVIDFGSTTYE------------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
.........|+...... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 00000000011000000 000123479999999999999899999999999999999999999998876
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+....+........ ++. ....+.+++++|.+|+
T Consensus 241 ~~~~~~~i~~~~~~~~---------------------~p~------------------------~~~~s~~~~~li~~l~ 275 (363)
T cd05628 241 PQETYKKVMNWKETLI---------------------FPP------------------------EVPISEKAKDLILRFC 275 (363)
T ss_pred HHHHHHHHHcCcCccc---------------------CCC------------------------cCCCCHHHHHHHHHHc
Confidence 6555444433211100 000 1125678999999877
Q ss_pred ccCCC---CCCCHHHHhcCCCCCCCCc
Q 020235 304 RYDPT---DRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 304 ~~dP~---~R~t~~~ll~hp~f~~~~~ 327 (329)
. +|. .||+++++++||||++.+.
T Consensus 276 ~-~~~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 276 C-EWEHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred C-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence 5 444 4589999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=332.17 Aligned_cols=281 Identities=27% Similarity=0.447 Sum_probs=217.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+|++.+++++... ..+|+
T Consensus 32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~~~~~~~~~~~~l 106 (364)
T cd07875 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQKSLEEFQDVYI 106 (364)
T ss_pred eecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-----CCCCccccceeecccccccccCeEEE
Confidence 79999999999999999999999998742 22345566788888877 568999998877543 36899
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+++++.+.+.. .+++..+..++.|++.||+|||++||+||||||+||++
T Consensus 107 v~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----------------------- 159 (364)
T cd07875 107 VMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 159 (364)
T ss_pred EEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE-----------------------
Confidence 999998888888864 47889999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 160 ----~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 160 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred ----CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455679999999987654432 33578999999999999899999999999999999999999999988888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.+.++....+......+...... +.. ...+.. ... .............+..+++||.+||+.||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~---~~~-~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPK-YAG--YSFEKL---FPD-VLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCC-cCC--CChHhh---Ccc-ccccccccccccccHHHHHHHHHhcCcCccc
Confidence 888888877777777665555444332110 000 000000 000 0000001112234567999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
|||+.++|+||||..
T Consensus 309 R~t~~e~L~hp~~~~ 323 (364)
T cd07875 309 RISVDEALQHPYINV 323 (364)
T ss_pred CCCHHHHhcCccccc
Confidence 999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=322.34 Aligned_cols=249 Identities=23% Similarity=0.366 Sum_probs=198.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||++.++.+++.||+|.+..... .......|+.++..+ +|++++.+.+.+...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-----HSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-----CCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 7999999999999999999999999874321 123445688888888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+.+... ....+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili------------------------- 130 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL------------------------- 130 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------------------
Confidence 99998887542 22468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...........
T Consensus 131 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 208 (280)
T cd05608 131 --DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 208 (280)
T ss_pred --CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 455668999999886543322 234689999999999998999999999999999999999999976433211111
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.......+ .......+..+.+++.+||+.||++|
T Consensus 209 ~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R 243 (280)
T cd05608 209 LKQRILNDS---------------------------------------------VTYPDKFSPASKSFCEALLAKDPEKR 243 (280)
T ss_pred HHHhhcccC---------------------------------------------CCCcccCCHHHHHHHHHHhcCCHHHh
Confidence 111000000 01123457789999999999999999
Q ss_pred C-----CHHHHhcCCCCCCCC
Q 020235 311 L-----TAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~-----t~~~ll~hp~f~~~~ 326 (329)
+ |++++++||||++.+
T Consensus 244 ~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 244 LGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred cCCCCCCHHHHhcChhhhcCC
Confidence 9 889999999998854
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=328.94 Aligned_cols=244 Identities=25% Similarity=0.377 Sum_probs=199.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... ........|..++..+ ..|++|+++++++.+.+..++||||+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~----~~h~~i~~~~~~~~~~~~~~lv~e~~ 78 (318)
T cd05570 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALA----GKHPFLTQLHSCFQTKDRLFFVMEYV 78 (318)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhc----cCCCCccceeeEEEcCCEEEEEEcCC
Confidence 799999999999999999999999987432 2233445566666655 25799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.+.. .+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 79 ~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill--------------------------- 129 (318)
T cd05570 79 NGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL--------------------------- 129 (318)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---------------------------
Confidence 999999987754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 130 DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 4556688899988754221 1233468999999999999899999999999999999999999998765544333222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..... .+...+..+.+||++||+.||++|||
T Consensus 210 ~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 210 EDEVR-------------------------------------------------YPRWLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred cCCCC-------------------------------------------------CCCcCCHHHHHHHHHHccCCHHHcCC
Confidence 11000 11235678999999999999999999
Q ss_pred H-----HHHhcCCCCCCCC
Q 020235 313 A-----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-----~~ll~hp~f~~~~ 326 (329)
+ .++++||||++.+
T Consensus 241 ~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 241 CLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 9 9999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=309.97 Aligned_cols=253 Identities=28% Similarity=0.498 Sum_probs=211.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||-|-.|.|-.|.++.||+.+|+|++.-.. .+.+|++.--.. +.|+||+.++++|+. ...+.+|||.+
T Consensus 70 LG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~----s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 70 LGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMA----SGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhh----cCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 789999999999999999999999987432 345566554343 478999999999874 35788999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|.+.+...+...+.+.++..|+.|+..|+.|||+.+|+||||||+|+|+...
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t------------------------ 197 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT------------------------ 197 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC------------------------
Confidence 9999999999988899999999999999999999999999999999999999654
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+-.+||+|||+|+...... .+.+-||.|.|||++-.+.|+...|+||+||++|-|++|.+||.+....
T Consensus 198 ~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~-------- 269 (400)
T KOG0604|consen 198 SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-------- 269 (400)
T ss_pred CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--------
Confidence 467779999999999877433 5567899999999999999999999999999999999999999875432
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.+++.|..+ +..+.+.+|+ +.|+.+|.+.+|+|+.+|..+|.+|+|+
T Consensus 270 ---aispgMk~r--------I~~gqy~FP~----------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI 316 (400)
T KOG0604|consen 270 ---AISPGMKRR--------IRTGQYEFPE----------------------PEWSCVSEAAKDLIRKLLKTEPTERLTI 316 (400)
T ss_pred ---cCChhHHhH--------hhccCccCCC----------------------hhHhHHHHHHHHHHHHHhcCCchhheeH
Confidence 233333332 2334455544 2256788999999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.+++.|||+++.+
T Consensus 317 ~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 317 EEVMDHPWINQYE 329 (400)
T ss_pred HHhhcCchhcccc
Confidence 9999999998754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=328.64 Aligned_cols=244 Identities=25% Similarity=0.361 Sum_probs=198.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++.... .......|..++..+ ..+++++.+++++.+.+..++||||+
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~E~~ 83 (323)
T cd05616 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS----GKPPFLTQLHSCFQTMDRLYFVMEYV 83 (323)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCeEeeEEEEEecCCEEEEEEcCC
Confidence 7999999999999999999999999875321 122334455555444 35688999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill--------------------------- 134 (323)
T cd05616 84 NGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--------------------------- 134 (323)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---------------------------
Confidence 899999987754 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus 135 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 214 (323)
T cd05616 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 214 (323)
T ss_pred CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45567899999987643221 234578999999999999999999999999999999999999998766655444433
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+.++.+++.+||+.||++|++
T Consensus 215 ~~~~~~-------------------------------------------------p~~~s~~~~~li~~~l~~~p~~R~~ 245 (323)
T cd05616 215 EHNVAY-------------------------------------------------PKSMSKEAVAICKGLMTKHPGKRLG 245 (323)
T ss_pred hCCCCC-------------------------------------------------CCcCCHHHHHHHHHHcccCHHhcCC
Confidence 321111 1235678999999999999999997
Q ss_pred H-----HHHhcCCCCCCCC
Q 020235 313 A-----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-----~~ll~hp~f~~~~ 326 (329)
+ .++++||||+..+
T Consensus 246 ~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 246 CGPEGERDIKEHAFFRYID 264 (323)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 4 8999999998654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.36 Aligned_cols=281 Identities=26% Similarity=0.447 Sum_probs=215.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||+|.+..+++.||+|.+... ........+|+.++..+ .|+||+++++++... ...++
T Consensus 25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~~l 99 (355)
T cd07874 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKSLEEFQDVYL 99 (355)
T ss_pred eeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-----CCCchhceeeeeeccccccccceeEE
Confidence 79999999999999999999999998742 22345566788888888 569999999887643 35799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+.+++.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||+
T Consensus 100 v~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill----------------------- 152 (355)
T cd07874 100 VMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 152 (355)
T ss_pred EhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE-----------------------
Confidence 999998888887764 48899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+...
T Consensus 153 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 153 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred ----CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 455678999999987654432 34578999999999999899999999999999999999999999988877777
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.+..+.+.........+...... +....... ... ..............+..+.+||.+||+.||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPK-YAGLTFPK-----LFP-DSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCc-cccccchh-----hcc-ccccccccccccccchHHHHHHHHHhcCCchh
Confidence 777777776666666655544444332110 00000000 000 00000001112234567899999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
|||+.|+++||||..
T Consensus 302 Rps~~ell~hp~~~~ 316 (355)
T cd07874 302 RISVDEALQHPYINV 316 (355)
T ss_pred cCCHHHHhcCcchhc
Confidence 999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=329.08 Aligned_cols=252 Identities=21% Similarity=0.374 Sum_probs=195.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++.... .......|..++..+ ..|++|+.+++++.+.+..|+||||+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~----~~hp~Iv~~~~~~~~~~~~~lv~e~~ 78 (329)
T cd05588 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFLVGLHSCFQTESRLFFVIEFV 78 (329)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCCCCceEEEEEcCCEEEEEEeCC
Confidence 7999999999999999999999999974321 223345666666665 35799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus 79 ~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili--------------------------- 129 (329)
T cd05588 79 SGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL--------------------------- 129 (329)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---------------------------
Confidence 999998887653 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
..++.++|+|||.+.... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......+..
T Consensus 130 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~---- 205 (329)
T cd05588 130 DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP---- 205 (329)
T ss_pred CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccc----
Confidence 455668999999876421 2223457999999999999989999999999999999999999999632111000
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
....... ........ ....+...+..+.++|++||+.||.+|+|
T Consensus 206 ---~~~~~~~-------~~~~~~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~ 249 (329)
T cd05588 206 ---DQNTEDY-------LFQVILEK--------------------------QIRIPRSLSVKASSVLKGFLNKDPKERLG 249 (329)
T ss_pred ---cccchHH-------HHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCC
Confidence 0000000 00000000 01112345678999999999999999987
Q ss_pred ------HHHHhcCCCCCCC
Q 020235 313 ------AREALRHPFFTRD 325 (329)
Q Consensus 313 ------~~~ll~hp~f~~~ 325 (329)
++++++||||...
T Consensus 250 ~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 250 CHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred CCCCCCHHHHhcCCCCCCC
Confidence 7899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=336.21 Aligned_cols=273 Identities=25% Similarity=0.393 Sum_probs=200.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|++.... .......+|+.++..+ .|++|+++++.+.+++..++||||+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-----DNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred EEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceEEEEEcCCeEEEEECCC
Confidence 799999999999999999999999987432 2233455688888887 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc--cc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY--FK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~--~~ 153 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+++.|||++......... ..
T Consensus 84 ~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 161 (364)
T cd05599 84 PGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR 161 (364)
T ss_pred CCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccc
Confidence 999999998754 6899999999999999999999999999999999999977777777777665433211100 00
Q ss_pred cCCCCCCeEEeeCCCCcccCC------------CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 154 RMPKSSAIKVIDFGSTTYERP------------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
........-.+++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~ 241 (364)
T cd05599 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241 (364)
T ss_pred cccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCC
Confidence 000000000000000000000 00124699999999999998999999999999999999999999987
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..+....+....... ..+. ....+..+.++|++
T Consensus 242 ~~~~~~~~~i~~~~~~~---------------------~~~~------------------------~~~~s~~~~~li~~ 276 (364)
T cd05599 242 DNPQETYRKIINWKETL---------------------QFPD------------------------EVPLSPEAKDLIKR 276 (364)
T ss_pred CCHHHHHHHHHcCCCcc---------------------CCCC------------------------CCCCCHHHHHHHHH
Confidence 66554433332211000 0000 11356789999999
Q ss_pred hcccCCCCCCC---HHHHhcCCCCCCCC
Q 020235 302 LLRYDPTDRLT---AREALRHPFFTRDH 326 (329)
Q Consensus 302 ~l~~dP~~R~t---~~~ll~hp~f~~~~ 326 (329)
||. +|.+|++ +.++++||||+..+
T Consensus 277 ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 277 LCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred Hcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 997 9999998 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=328.04 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++... ...+....|..++..+.. ..|+||+++++++.+.+..|+||||+
T Consensus 7 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~--l~hp~i~~~~~~~~~~~~~~lv~E~~ 84 (324)
T cd05589 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANS--ERHPFLVNLFACFQTEDHVCFVMEYA 84 (324)
T ss_pred EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccc--cCCCChhceeeEEEcCCEEEEEEcCC
Confidence 799999999999999999999999987432 122344456555544422 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|...+... .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 85 ~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill--------------------------- 134 (324)
T cd05589 85 AGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL--------------------------- 134 (324)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---------------------------
Confidence 89998888653 59999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45567888999887643221 234578999999999999889999999999999999999999998766554433332
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
...... +...+..+.++|.+||+.||++||
T Consensus 215 ~~~~~~-------------------------------------------------p~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 215 NDEVRY-------------------------------------------------PRFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred hCCCCC-------------------------------------------------CCCCCHHHHHHHHHHhhcCHhHcCC
Confidence 211111 123567889999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
++.++++||||++.+
T Consensus 246 ~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 246 SGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred CCCCCHHHHhhCCCcCCCC
Confidence 799999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=335.22 Aligned_cols=274 Identities=24% Similarity=0.370 Sum_probs=199.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|++.... ........|+.++..+ .|++|+++++.+.+.+.+++||||+
T Consensus 9 LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-----CCCCeeeeEEEEecCCEEEEEEecC
Confidence 799999999999999999999999987432 2234556788888877 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCC--CCccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD--SSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~--~~~~~ 153 (329)
+++|.+++.+.. .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+++.|||++...... .....
T Consensus 84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~ 161 (381)
T cd05626 84 PGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQ 161 (381)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccccc
Confidence 999999998754 6899999999999999999999999999999999999987777777777765322110 00000
Q ss_pred cC-----------CCCCCeEEeeCCCC-------cccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHH
Q 020235 154 RM-----------PKSSAIKVIDFGST-------TYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 154 ~~-----------~~~~~~~l~Dfg~~-------~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 212 (329)
.. ........+.++.. .... ......+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~el 241 (381)
T cd05626 162 KGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241 (381)
T ss_pred ccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHH
Confidence 00 00000000111100 0000 001235799999999999998899999999999999999
Q ss_pred HhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 213 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 213 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
++|..||...+..+....+....... ..+ .....+
T Consensus 242 ltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------~~~------------------------~~~~~s 276 (381)
T cd05626 242 LVGQPPFLAPTPTETQLKVINWENTL---------------------HIP------------------------PQVKLS 276 (381)
T ss_pred HhCCCCCcCCCHHHHHHHHHcccccc---------------------CCC------------------------CCCCCC
Confidence 99999998766544333222111100 000 012356
Q ss_pred hHHHHHHHHhcc--cCCCCCCCHHHHhcCCCCCCCC
Q 020235 293 GDLTHLLQGLLR--YDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 293 ~~~~~ll~~~l~--~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
.++.+||.+|+. .+|..|+|++++++||||++..
T Consensus 277 ~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 277 PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 789999999654 4555699999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=326.52 Aligned_cols=288 Identities=22% Similarity=0.327 Sum_probs=205.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|+++.++..+|+|.+... ........+|+.++..+ .|+|++++++++..++..++||||+ +
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (331)
T cd06649 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEISICMEHMDG 87 (331)
T ss_pred ecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEEEEEeecCCC
Confidence 79999999999999999999999998743 22345677899999888 6699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.|++.||.|||++ +|+|+||||+||++ +
T Consensus 88 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---------------------------~ 138 (331)
T cd06649 88 GSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---------------------------N 138 (331)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---------------------------c
Confidence 99999998754 589999999999999999999986 69999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+....
T Consensus 139 ~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~ 218 (331)
T cd06649 139 SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPV 218 (331)
T ss_pred CCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 4556888899887654332 234578999999999998889999999999999999999999998765544322211110
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCC---CchHHHhhhccchhhHHH-Hh-hhccCchhHHHHHHHHhcccCCCCC
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGA---ASRESIKSVMKLPRLQNL-IM-QHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
................ .......... ........... .+... .+ .....++.++.+||.+||++||++|
T Consensus 219 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~R 292 (331)
T cd06649 219 VDGEEGEPHSISPRPR----PPGRPVSGHGMDSRPAMAIFELLD--YIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAER 292 (331)
T ss_pred cccccCCccccCcccc----cccccccccccccccchhHHHHHH--HHHhCCCcCCCCccccHHHHHHHHHHccCCcccC
Confidence 0000000000000000 0000000000 00000000000 00000 00 0112367789999999999999999
Q ss_pred CCHHHHhcCCCCCCCCcC
Q 020235 311 LTAREALRHPFFTRDHLR 328 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~~~ 328 (329)
||+.++++||||++.+.+
T Consensus 293 pt~~ell~h~~~~~~~~~ 310 (331)
T cd06649 293 ADLKMLMNHTFIKRSEVE 310 (331)
T ss_pred CCHHHHhcChHHhhcccc
Confidence 999999999999876553
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=328.79 Aligned_cols=243 Identities=27% Similarity=0.419 Sum_probs=195.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHH-HHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~-l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|.++.+|+.||+|++...... ......|... +..+ .|+||+++++.+.+.+..++||||
T Consensus 3 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-----~hp~iv~~~~~~~~~~~~~lv~e~ 77 (323)
T cd05575 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTADKLYFVLDY 77 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-----CCCCCCCeeEEEEeCCEEEEEEcC
Confidence 79999999999999999999999998743211 1222333332 2333 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|..++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll-------------------------- 129 (323)
T cd05575 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL-------------------------- 129 (323)
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE--------------------------
Confidence 9 999999987754 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 208 (323)
T cd05575 130 -DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208 (323)
T ss_pred -CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 4556789999998764322 123457899999999999989999999999999999999999999876554433332
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... .....+..+.++|++||+.||.+||
T Consensus 209 ~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~R~ 239 (323)
T cd05575 209 LNKPLR-------------------------------------------------LKPNISVSARHLLEGLLQKDRTKRL 239 (323)
T ss_pred HcCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhhcCHHhCC
Confidence 221100 0123467899999999999999999
Q ss_pred CH----HHHhcCCCCCCCC
Q 020235 312 TA----REALRHPFFTRDH 326 (329)
Q Consensus 312 t~----~~ll~hp~f~~~~ 326 (329)
++ .++++||||....
T Consensus 240 ~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 240 GAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 97 6999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=333.58 Aligned_cols=273 Identities=27% Similarity=0.405 Sum_probs=197.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|+++... ........|..++..+ .|++++++++.+.+++..++||||+
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-----DSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred EEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-----CCCCccchhhheecCCeEEEEEcCC
Confidence 799999999999999999999999987432 2234456678888777 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||++.............
T Consensus 84 ~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 161 (350)
T cd05573 84 PGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYL 161 (350)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccc
Confidence 999999998763 68999999999999999999999999999999999999655544444444333222111000000
Q ss_pred CCCCCe-EEeeCC----CCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAI-KVIDFG----STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~-~l~Dfg----~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
...... ...... .............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~ 241 (350)
T cd05573 162 NDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241 (350)
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHH
Confidence 000000 000000 000000011234689999999999999999999999999999999999999987665544433
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....... ..+. ....+..+.+||.+||. ||.+|
T Consensus 242 i~~~~~~~---------------------~~p~------------------------~~~~~~~~~~li~~ll~-dp~~R 275 (350)
T cd05573 242 IINWKESL---------------------RFPP------------------------DPPVSPEAIDLICRLLC-DPEDR 275 (350)
T ss_pred HhccCCcc---------------------cCCC------------------------CCCCCHHHHHHHHHHcc-Chhhc
Confidence 33311110 0000 11246789999999998 99999
Q ss_pred CC-HHHHhcCCCCCCCC
Q 020235 311 LT-AREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t-~~~ll~hp~f~~~~ 326 (329)
++ ++++++||||++..
T Consensus 276 ~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 276 LGSFEEIKSHPFFKGID 292 (350)
T ss_pred CCCHHHHhcCCCcCCCC
Confidence 99 99999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=327.29 Aligned_cols=252 Identities=27% Similarity=0.417 Sum_probs=217.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc----chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.||||.||-|+.+.||+.+|.|.+.+ .......++.|..++..+ +.++|+.+...|++.+.+|+|+..|
T Consensus 193 lGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-----~s~FiVslaYAfeTkd~LClVLtlM 267 (591)
T KOG0986|consen 193 LGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-----SSPFIVSLAYAFETKDALCLVLTLM 267 (591)
T ss_pred EecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-----ccCcEEEEeeeecCCCceEEEEEee
Confidence 7999999999999999999999998753 223456677899999999 5589999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.-.|.+.+...+++..+..++.+|+.||.+||..+||+||+||+|||+
T Consensus 268 NGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL--------------------------- 320 (591)
T KOG0986|consen 268 NGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL--------------------------- 320 (591)
T ss_pred cCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---------------------------
Confidence 9999999998877889999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+..+++.|.|+|+|....... ...+||.+|||||++..+.|+...|+|||||++|+|+.|+.||...........+.+
T Consensus 321 Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr 400 (591)
T KOG0986|consen 321 DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR 400 (591)
T ss_pred ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH
Confidence 677889999999998655443 445899999999999999999999999999999999999999987665544444444
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
..-.. ...+.++.|++++++++.+|++||++|+
T Consensus 401 r~~~~---------------------------------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 401 RTLED---------------------------------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HHhcc---------------------------------------------hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 32221 2233457789999999999999999998
Q ss_pred ---CHHHHhcCCCCCCCCcCC
Q 020235 312 ---TAREALRHPFFTRDHLRR 329 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~~~ 329 (329)
+++++.+||||++.|.||
T Consensus 436 rg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 436 RGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred CCcCcchhhhCcccccCCHhH
Confidence 578999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=336.34 Aligned_cols=272 Identities=27% Similarity=0.427 Sum_probs=200.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|++.... ........|+.++..+ .|++|+++++.+.+.+.+++||||+
T Consensus 9 LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-----~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-----CCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 799999999999999999999999987432 2234556788888887 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC--Cccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS--SYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~--~~~~ 153 (329)
+++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.+|.+++.|||++....... ....
T Consensus 84 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 84 PGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 899999997754 68999999999999999999999999999999999999877777777777653221100 0000
Q ss_pred cCCCCCCeEEeeCCC---------------------CcccC-CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 154 RMPKSSAIKVIDFGS---------------------TTYER-PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~---------------------~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
. .........+|.. ..... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 162 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 S-GDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred c-ccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 0 0000000000000 00000 00123479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc
Q 020235 212 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291 (329)
Q Consensus 212 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
|++|+.||.+.+..+....+.......+ .+ .....
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~p------------------------~~~~~ 275 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLH---------------------IP------------------------PQAKL 275 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcC---------------------CC------------------------CcccC
Confidence 9999999987665544333322111100 00 01235
Q ss_pred hhHHHHHHHHhcccCCCCCCC---HHHHhcCCCCCCCC
Q 020235 292 AGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTRDH 326 (329)
Q Consensus 292 ~~~~~~ll~~~l~~dP~~R~t---~~~ll~hp~f~~~~ 326 (329)
++++.++|.+|+ .||++|++ +.++++||||+..+
T Consensus 276 s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 276 SPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred CHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 678999999876 59999997 99999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=333.68 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=200.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|+.++..+ .|++|+.+++.+.+++..++||||+
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-----~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-----NSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCEEEEEEcCC
Confidence 699999999999999999999999986422 2223455688888777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 126 ~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl--------------------------- 175 (370)
T cd05596 126 PGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--------------------------- 175 (370)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---------------------------
Confidence 99999998764 48999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC----CCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL----GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+....
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 456678999999887554322 345799999999998754 378999999999999999999999987665444
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+...... ..++. ....+..+.+||++||+.+|
T Consensus 256 ~~~i~~~~~~---------------------~~~~~------------------------~~~~s~~~~~li~~~L~~~p 290 (370)
T cd05596 256 YSKIMDHKNS---------------------LTFPD------------------------DIEISKQAKDLICAFLTDRE 290 (370)
T ss_pred HHHHHcCCCc---------------------CCCCC------------------------cCCCCHHHHHHHHHHccChh
Confidence 4333321111 01110 12357789999999999999
Q ss_pred CC--CCCHHHHhcCCCCCCCC
Q 020235 308 TD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~--R~t~~~ll~hp~f~~~~ 326 (329)
++ |+|++++++||||++..
T Consensus 291 ~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 291 VRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred hccCCCCHHHHhcCcccCCCC
Confidence 98 99999999999998754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=321.11 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=203.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||++.+..+++.||+|++..... ......+|+.++..+ .|++++.+++.+.+++..++||||+
T Consensus 8 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred EecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-----CCCCEeeeeeeecCCCeEEEEEecc
Confidence 6999999999999999999999999874321 123456788888888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~--------------------------- 135 (285)
T cd05605 83 NGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--------------------------- 135 (285)
T ss_pred CCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---------------------------
Confidence 8999988876544568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|++.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+..
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05605 136 DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215 (285)
T ss_pred CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH
Confidence 455678899999887543322 234789999999999988899999999999999999999999987554332222222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
.....+ ......++..+.+||.+||..||++||
T Consensus 216 ~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05605 216 RVKEDQ---------------------------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGC 250 (285)
T ss_pred Hhhhcc---------------------------------------------cccCcccCHHHHHHHHHHccCCHHHhcCC
Confidence 111000 011234567899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCcC
Q 020235 312 ---TAREALRHPFFTRDHLR 328 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~~ 328 (329)
|++++++||||...+.+
T Consensus 251 ~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 251 RGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred CCCCHHHHhcCcCccCCCHH
Confidence 89999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.17 Aligned_cols=248 Identities=22% Similarity=0.392 Sum_probs=195.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+.+++++.+.+..++||||+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~~~~~~~~~~~~~lv~E~~ 78 (329)
T cd05618 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIEYV 78 (329)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhc----CCCCcCCceeeEEEeCCEEEEEEeCC
Confidence 799999999999999999999999987432 1223344566665554 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 79 ~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili--------------------------- 129 (329)
T cd05618 79 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--------------------------- 129 (329)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---------------------------
Confidence 899998887654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH-----H
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-----H 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~ 227 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||....... .
T Consensus 130 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~ 209 (329)
T cd05618 130 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 209 (329)
T ss_pred CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCccccc
Confidence 4566789999998864322 2234578999999999999899999999999999999999999995321100 0
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+. ..... ...+...+..+.++|++||+.||
T Consensus 210 ~~~~~~~-------------------i~~~~--------------------------~~~p~~~~~~~~~ll~~~L~~dP 244 (329)
T cd05618 210 EDYLFQV-------------------ILEKQ--------------------------IRIPRSLSVKAASVLKSFLNKDP 244 (329)
T ss_pred HHHHHHH-------------------HhcCC--------------------------CCCCCCCCHHHHHHHHHHhcCCH
Confidence 0000000 00000 01123456789999999999999
Q ss_pred CCCCC------HHHHhcCCCCCCCC
Q 020235 308 TDRLT------AREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~R~t------~~~ll~hp~f~~~~ 326 (329)
++|+| ++++++||||++.+
T Consensus 245 ~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 245 KERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 99998 47999999998753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=315.53 Aligned_cols=316 Identities=34% Similarity=0.598 Sum_probs=238.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCC---CCceeeecccccc----CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKG---GNRCVQIRNWFDY----RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~---~~~i~~l~~~~~~----~~~~~lv~ 73 (329)
||.|.|+|||+|++..+.+.||+|+.+......+.++.|+.+|+++..+... ...|++|++.|.- +.|+|+|+
T Consensus 86 LGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVf 165 (590)
T KOG1290|consen 86 LGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVF 165 (590)
T ss_pred ccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEe
Confidence 7999999999999999999999999998888888999999999999887633 3479999999983 56999999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccc-------------------
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEY------------------- 133 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~------------------- 133 (329)
|++|.+|..+|.....+.++...++.|++||+.||.||| ..||+|-||||+|||+-....
T Consensus 166 EvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~ 245 (590)
T KOG1290|consen 166 EVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKM 245 (590)
T ss_pred hhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCC
Confidence 999999999999988899999999999999999999999 678999999999999832100
Q ss_pred ----------------------------------------cccCCCc-----------------------Ccc-C-----
Q 020235 134 ----------------------------------------IKVPDYK-----------------------SSL-H----- 144 (329)
Q Consensus 134 ----------------------------------------~~~~~~~-----------------------~~~-~----- 144 (329)
..+.+.+ ... .
T Consensus 246 s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~ 325 (590)
T KOG1290|consen 246 SPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDS 325 (590)
T ss_pred CcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhccccccc
Confidence 0000000 000 0
Q ss_pred ---------CCCC----------------------CC--ccc------------------cCCCCCCeEEeeCCCCcccC
Q 020235 145 ---------TPKD----------------------SS--YFK------------------RMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 145 ---------~~~~----------------------~~--~~~------------------~~~~~~~~~l~Dfg~~~~~~ 173 (329)
..++ +. ..+ .......|||+|||.|....
T Consensus 326 ~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~ 405 (590)
T KOG1290|consen 326 NENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH 405 (590)
T ss_pred ccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh
Confidence 0000 00 000 01123468999999999877
Q ss_pred CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC------chhHHHHHHHHHhCCCChhHHHhhh
Q 020235 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH------ENLEHLAMMERVLGPLPQHMLKRVD 247 (329)
Q Consensus 174 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (329)
..-..-+.|..|+|||++.+.+|+..+||||++|++|||+||...|... .+.+.+..|.+++|..|..+.-.-.
T Consensus 406 khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk 485 (590)
T KOG1290|consen 406 KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGK 485 (590)
T ss_pred hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCc
Confidence 7666668899999999999999999999999999999999999888432 4678899999999999987655433
Q ss_pred hhhhhhhhcCCcCCCC---CCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 248 RHAEKYVRRGRLDWPE---GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 248 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
-..+-|...|.+.--. .+--.+...+-+.. .......+.|||.-||+.+|++|+||.+.|+|||++.
T Consensus 486 ~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~----------s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~ 555 (590)
T KOG1290|consen 486 YSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEW----------SEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNP 555 (590)
T ss_pred chHhhhccccceecccccCCCcHHHHHHHHhCC----------CHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccC
Confidence 3333343344332111 00011111111111 1234567999999999999999999999999999996
Q ss_pred CC
Q 020235 325 DH 326 (329)
Q Consensus 325 ~~ 326 (329)
.-
T Consensus 556 ~~ 557 (590)
T KOG1290|consen 556 VA 557 (590)
T ss_pred CC
Confidence 53
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=323.51 Aligned_cols=282 Identities=26% Similarity=0.490 Sum_probs=204.8
Q ss_pred CCCccceEEEEEEecC--CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc--cCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRE--RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~--~~~~~~lv~e~~ 76 (329)
||+|+||+||+|..+. ++..||+|.+.... ......+|+.++..+ .|+|++++++++. .+...++||||+
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLREL-----KHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhC-----CCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 7999999999999654 56889999987432 234567899999888 5699999999874 456789999999
Q ss_pred CCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 77 GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 77 ~~~l~~~l~~~~-------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++++.+++.... ...+++..++.++.|++.||.|||++||+||||||+||++..++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~----------------- 145 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----------------- 145 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC-----------------
Confidence 889988886321 12478889999999999999999999999999999999995432
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
..++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 146 ------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 146 ------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 345679999999987654322 234689999999999774 4789999999999999999999999754
Q ss_pred ch---------hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 223 EN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 223 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
.. ......+....+......|................. ........+...........+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 288 (317)
T cd07867 220 QEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFR-----------RTTYANSSLIKYMEKHKVKPDS 288 (317)
T ss_pred cccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhc-----------ccccCCchhhhhhhcccCCCCh
Confidence 32 233444555566555555544332211100000000 0001111111112222234566
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~hp~f 322 (329)
.+.++|.+||+.||.+|||++|+|+||||
T Consensus 289 ~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 289 KVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 79999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=326.47 Aligned_cols=243 Identities=24% Similarity=0.416 Sum_probs=198.8
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .+++.||+|+++... ........|+.++..+ .|+||+++++.+..++..++|
T Consensus 4 lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~~lv 78 (323)
T cd05584 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-----KHPFIVDLIYAFQTGGKLYLI 78 (323)
T ss_pred eeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-----CCCchhceeeEEecCCeEEEE
Confidence 799999999999864 468899999987432 2223456788888888 569999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----------------------- 133 (323)
T cd05584 79 LEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL----------------------- 133 (323)
T ss_pred EeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-----------------------
Confidence 9999 899999997754 57889999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.....
T Consensus 134 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~ 209 (323)
T cd05584 134 ----DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209 (323)
T ss_pred ----CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH
Confidence 45567899999987643222 23357899999999999888999999999999999999999999876554433
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+....... +...+..+.++|++||+.||+
T Consensus 210 ~~~~~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 210 DKILKGKLNL-------------------------------------------------PPYLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred HHHHcCCCCC-------------------------------------------------CCCCCHHHHHHHHHHcccCHh
Confidence 3322211111 123466899999999999999
Q ss_pred CCC-----CHHHHhcCCCCCCCC
Q 020235 309 DRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 309 ~R~-----t~~~ll~hp~f~~~~ 326 (329)
+|+ ++.++++||||....
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCC
Confidence 999 899999999998653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=325.06 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|+++.... .......|..++..+ .++++++.+++++.+.+..|+||||+
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv~Ey~ 83 (323)
T cd05615 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ----DKPPFLTQLHSCFQTVDRLYFVMEYV 83 (323)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhc----cCCCchhheeeEEecCCEEEEEEcCC
Confidence 6999999999999999999999999874321 123344566666555 34578888999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill--------------------------- 134 (323)
T cd05615 84 NGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML--------------------------- 134 (323)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---------------------------
Confidence 899999997754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 135 ~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (323)
T cd05615 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (323)
T ss_pred CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45567899999987643322 234568999999999999889999999999999999999999998766554444333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+..+.+++.+||+.||.+|++
T Consensus 215 ~~~~~~-------------------------------------------------p~~~~~~~~~li~~~l~~~p~~R~~ 245 (323)
T cd05615 215 EHNVSY-------------------------------------------------PKSLSKEAVSICKGLMTKHPSKRLG 245 (323)
T ss_pred hCCCCC-------------------------------------------------CccCCHHHHHHHHHHcccCHhhCCC
Confidence 321111 1234567899999999999999997
Q ss_pred -----HHHHhcCCCCCCCC
Q 020235 313 -----AREALRHPFFTRDH 326 (329)
Q Consensus 313 -----~~~ll~hp~f~~~~ 326 (329)
..++++||||...+
T Consensus 246 ~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 246 CGPEGERDIREHAFFRRID 264 (323)
T ss_pred CCCCCHHHHhcCcccCCCC
Confidence 47899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=318.69 Aligned_cols=251 Identities=23% Similarity=0.401 Sum_probs=199.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+++++.+|+.||+|.+..... .......|++++..+ .|+||+++.+.++++...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-----NSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-----CCCcEEEEEEEEecCCeEEEEEecC
Confidence 7999999999999999999999999864221 223445688888888 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili--------------------------- 128 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL--------------------------- 128 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---------------------------
Confidence 9999998876555568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+..
T Consensus 129 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05607 129 DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208 (277)
T ss_pred cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH
Confidence 445668899999876554322 234688999999999988899999999999999999999999976432211111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.... .... .....++.+++++|++||+.||++|||+
T Consensus 209 ~~~~-------------------~~~~-------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~ 244 (277)
T cd05607 209 RTLE-------------------DEVK-------------------------FEHQNFTEESKDICRLFLAKKPEDRLGS 244 (277)
T ss_pred Hhhc-------------------cccc-------------------------cccccCCHHHHHHHHHHhccCHhhCCCC
Confidence 0000 0000 0012356789999999999999999999
Q ss_pred ----HHHhcCCCCCCCCc
Q 020235 314 ----REALRHPFFTRDHL 327 (329)
Q Consensus 314 ----~~ll~hp~f~~~~~ 327 (329)
.++++||||+..+.
T Consensus 245 ~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 245 REKNDDPRKHEFFKTINF 262 (277)
T ss_pred ccchhhhhcChhhcCCCH
Confidence 67889999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=334.74 Aligned_cols=271 Identities=25% Similarity=0.397 Sum_probs=198.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|++..... ......+|+.++..+ .|++|+++++.+.+.+..|+||||+
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-----DSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred EeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCeeEEEEeCC
Confidence 6999999999999999999999999864321 224455688887776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC--cc-
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS--YF- 152 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~--~~- 152 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+++.|||++........ ..
T Consensus 84 ~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 161 (377)
T cd05629 84 PGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161 (377)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence 999999997653 689999999999999999999999999999999999998877777777776642211000 00
Q ss_pred ---------ccCCCCCCe-------------EEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHH
Q 020235 153 ---------KRMPKSSAI-------------KVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 210 (329)
Q Consensus 153 ---------~~~~~~~~~-------------~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 210 (329)
......... .+.+++.+... .....+||+.|+|||++.+..++.++|||||||++|
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 000000000 00011100000 001246999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 211 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
+|++|..||.+.+..+....+...... ..+++ ...
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------~~~p~------------------------~~~ 274 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRET---------------------LYFPD------------------------DIH 274 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCc---------------------cCCCC------------------------CCC
Confidence 999999999876654443333221100 00110 123
Q ss_pred chhHHHHHHHHhcccCCCCC---CCHHHHhcCCCCCCCC
Q 020235 291 SAGDLTHLLQGLLRYDPTDR---LTAREALRHPFFTRDH 326 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R---~t~~~ll~hp~f~~~~ 326 (329)
.+.++.+||++||+ +|.+| +|+.++++||||++.+
T Consensus 275 ~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 275 LSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 56789999999998 77765 5999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=326.87 Aligned_cols=242 Identities=29% Similarity=0.530 Sum_probs=218.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc-eEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-ICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~-~~lv~e~~ 76 (329)
+|.|+||.+++++++..++.+|+|.++.. ...+..+..|+.++.++ .||||+.+.+.|..++. ++|||+||
T Consensus 12 iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-----~hP~iv~y~ds~~~~~~~l~Ivm~Y~ 86 (426)
T KOG0589|consen 12 VGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-----LHPNIVEYKDSFEEDGQLLCIVMEYC 86 (426)
T ss_pred cCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-----cCCCeeeeccchhcCCceEEEEEeec
Confidence 69999999999999999999999999743 34455778899999998 66999999999998887 99999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||++.+.+.+..+..+++..+.+++.|++.|++|||+..|.|||||+.||++
T Consensus 87 eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl--------------------------- 139 (426)
T KOG0589|consen 87 EGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL--------------------------- 139 (426)
T ss_pred CCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc---------------------------
Confidence 9999999998777789999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++..++|.|||+|+..++.. .+.+||+.||+||++.+.+|+.++|||||||++|+|++-+.+|.+.+.......+.
T Consensus 140 tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~ 219 (426)
T KOG0589|consen 140 TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN 219 (426)
T ss_pred cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh
Confidence 566778999999999888775 55789999999999999999999999999999999999999999999888888777
Q ss_pred HHh-CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 233 RVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 233 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
+.. .|.| ..++.+++.+|..||..+|+.||
T Consensus 220 ~~~~~Plp-------------------------------------------------~~ys~el~~lv~~~l~~~P~~RP 250 (426)
T KOG0589|consen 220 RGLYSPLP-------------------------------------------------SMYSSELRSLVKSMLRKNPEHRP 250 (426)
T ss_pred hccCCCCC-------------------------------------------------ccccHHHHHHHHHHhhcCCccCC
Confidence 765 3333 34678999999999999999999
Q ss_pred CHHHHhcCCCCC
Q 020235 312 TAREALRHPFFT 323 (329)
Q Consensus 312 t~~~ll~hp~f~ 323 (329)
++.++|.+|...
T Consensus 251 sa~~LL~~P~l~ 262 (426)
T KOG0589|consen 251 SALELLRRPHLL 262 (426)
T ss_pred CHHHHhhChhhh
Confidence 999999998765
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=330.00 Aligned_cols=246 Identities=27% Similarity=0.450 Sum_probs=194.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|++..... .......|..++.... ...|++|+.++..+.+.+..++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~--~~~~p~i~~~~~~~~~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTL--LDESPFIVGLKFSFQTDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhc--cCCCCcCcceEEEEecCCeEEEEEcCC
Confidence 7999999999999999999999999864221 1122233445554442 125799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 79 ~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili--------------------------- 129 (330)
T cd05586 79 SGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL--------------------------- 129 (330)
T ss_pred CCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---------------------------
Confidence 899999987654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
..++.++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 130 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 130 DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 45567899999987643222 2345799999999999765 4789999999999999999999999876554433322
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
......++ ....+..+.+||++||+.||.+||
T Consensus 210 ~~~~~~~~------------------------------------------------~~~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 210 AFGKVRFP------------------------------------------------KNVLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred HcCCCCCC------------------------------------------------CccCCHHHHHHHHHHcCCCHHHCC
Confidence 21111110 012466889999999999999998
Q ss_pred ----CHHHHhcCCCCCCC
Q 020235 312 ----TAREALRHPFFTRD 325 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~ 325 (329)
++.++++||||++.
T Consensus 242 ~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 242 GAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCHHHHhcCccccCC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=320.36 Aligned_cols=275 Identities=27% Similarity=0.481 Sum_probs=214.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+++.||+|.++... .......+|+.++..+ .|+||+++++++..++..++||||+++
T Consensus 14 lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nI~~~~~~~~~~~~~~lv~e~~~~ 88 (301)
T cd07873 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLTLVFEYLDK 88 (301)
T ss_pred eccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-----CCCCcceEEEEEecCCeEEEEEecccc
Confidence 799999999999999999999999986432 2234566789999888 569999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 89 ~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---------------------------~~~ 140 (301)
T cd07873 89 DLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---------------------------NER 140 (301)
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---------------------------CCC
Confidence 9999887643 358899999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
..++|+|||.+....... ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 141 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~ 220 (301)
T cd07873 141 GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRI 220 (301)
T ss_pred CcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 568888888876543222 234568899999998764 4788999999999999999999999988877777777777
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.++...|+...+... +. ....+. .............+..+++||.+||+.||.+|||++
T Consensus 221 ~~~~~~~~~~~~~~~~~-~~---~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 281 (301)
T cd07873 221 LGTPTEETWPGILSNEE-FK---SYNYPK---------------YRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281 (301)
T ss_pred cCCCChhhchhhhcccc-cc---ccccCc---------------cccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 77766655544322110 00 000000 000001112234677899999999999999999999
Q ss_pred HHhcCCCCCCCCc
Q 020235 315 EALRHPFFTRDHL 327 (329)
Q Consensus 315 ~ll~hp~f~~~~~ 327 (329)
++++||||+.-..
T Consensus 282 eil~h~~f~~~~~ 294 (301)
T cd07873 282 EAMKHPYFHCLGE 294 (301)
T ss_pred HHhcCcccccccc
Confidence 9999999987553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=316.51 Aligned_cols=239 Identities=27% Similarity=0.461 Sum_probs=210.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|.||.|-+|.....|+.||||.++++. .....+.+|++|+..+ +||||+.++++|+..+.+.|||||.
T Consensus 61 LGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-----NHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 61 LGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-----NHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred hcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-----CCCceeehhhhhcCCceEEEEEEec
Confidence 799999999999999999999999998543 2334566899999999 7799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|.|++++.+.+ .+++..++.++.|+++|+.|||+++++|||||.+|||+
T Consensus 136 S~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL--------------------------- 186 (668)
T KOG0611|consen 136 SGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL--------------------------- 186 (668)
T ss_pred CCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---------------------------
Confidence 999999999875 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.|..+||+|||++..+.... .+++|++-|.+||++.+.+|. +.+|.|||||++|.|+.|..||.+.+-..+..+|.
T Consensus 187 D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs 266 (668)
T KOG0611|consen 187 DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS 266 (668)
T ss_pred cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh
Confidence 677889999999998777665 568999999999999999985 99999999999999999999999988776666555
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+....-| +...++.-||+.||.+||++|.|
T Consensus 267 ~GaYrEP--------------------------------------------------~~PSdA~gLIRwmLmVNP~RRAT 296 (668)
T KOG0611|consen 267 RGAYREP--------------------------------------------------ETPSDASGLIRWMLMVNPERRAT 296 (668)
T ss_pred cccccCC--------------------------------------------------CCCchHHHHHHHHHhcCcccchh
Confidence 5321111 12345777999999999999999
Q ss_pred HHHHhcCCCCC
Q 020235 313 AREALRHPFFT 323 (329)
Q Consensus 313 ~~~ll~hp~f~ 323 (329)
+.++-.|=|++
T Consensus 297 ieDiAsHWWvN 307 (668)
T KOG0611|consen 297 IEDIASHWWVN 307 (668)
T ss_pred HHHHhhhheee
Confidence 99999998875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=322.06 Aligned_cols=238 Identities=28% Similarity=0.388 Sum_probs=196.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh---HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-~~~lv~e~~ 76 (329)
||+|+||+||++.++.+. .||+|++...... ...+.+|+.++..+ .||||+++++.+.... .+++||||+
T Consensus 49 iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDESRKAFRREASLLSRL-----RHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred cccCCceeEEEEEeCCce-eEEEEEecchhcChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 699999999999887543 2999999853322 45788899999998 6799999999999887 799999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~-i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+|+|.+++.......++...+..++.+++.|++|||+++ |+||||||+|||+
T Consensus 123 ~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv-------------------------- 176 (362)
T KOG0192|consen 123 PGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV-------------------------- 176 (362)
T ss_pred CCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE--------------------------
Confidence 999999998854457999999999999999999999999 9999999999999
Q ss_pred CCCCC-CeEEeeCCCCcccCC---CCCcccccCCCCchhHHh--cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 155 MPKSS-AIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 155 ~~~~~-~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.+. ++||+|||+++.... ......||..|||||++. ...|+.++||||||+++|||+||..||.+.......
T Consensus 177 -~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~ 255 (362)
T KOG0192|consen 177 -DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA 255 (362)
T ss_pred -cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 5564 899999999976664 334468999999999999 568999999999999999999999999987764333
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+... +..| .++......+..+|..||..||+
T Consensus 256 ~~v~~~-~~Rp----------------------------------------------~~p~~~~~~l~~l~~~CW~~dp~ 288 (362)
T KOG0192|consen 256 SAVVVG-GLRP----------------------------------------------PIPKECPPHLSSLMERCWLVDPS 288 (362)
T ss_pred HHHHhc-CCCC----------------------------------------------CCCccCCHHHHHHHHHhCCCCCC
Confidence 332211 1111 01123566889999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+||++.+++.
T Consensus 289 ~RP~f~ei~~ 298 (362)
T KOG0192|consen 289 RRPSFLEIVS 298 (362)
T ss_pred cCCCHHHHHH
Confidence 9999988763
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=335.07 Aligned_cols=272 Identities=25% Similarity=0.382 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|++|+++++.+.+++.+++||||+
T Consensus 9 lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-----DNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred EEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999986432 2234556788888888 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCC--CCccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD--SSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~--~~~~~ 153 (329)
+++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||++....-. .....
T Consensus 84 ~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~ 161 (376)
T cd05598 84 PGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (376)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccc
Confidence 999999998754 6899999999999999999999999999999999999976666666666554211000 00000
Q ss_pred cCCCCCCeEEeeC---------------CCCcc---cCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC
Q 020235 154 RMPKSSAIKVIDF---------------GSTTY---ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215 (329)
Q Consensus 154 ~~~~~~~~~l~Df---------------g~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 215 (329)
.. ........+. ..... ........+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 162 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 162 KG-DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred cc-cccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 0000000000 00000 00001234799999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHH
Q 020235 216 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295 (329)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (329)
+.||.+.+..+....+.......+ . ......+..+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~---------------------~------------------------~~~~~~s~~~ 275 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLH---------------------I------------------------PSQAKLSREA 275 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCcccc---------------------C------------------------CCCCCCCHHH
Confidence 999987665443332221100000 0 0012356789
Q ss_pred HHHHHHhcccCCCCCC---CHHHHhcCCCCCCCC
Q 020235 296 THLLQGLLRYDPTDRL---TAREALRHPFFTRDH 326 (329)
Q Consensus 296 ~~ll~~~l~~dP~~R~---t~~~ll~hp~f~~~~ 326 (329)
.++|.+|+ .+|.+|+ |+.++++||||+..+
T Consensus 276 ~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 276 SDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999976 5999999 999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=330.31 Aligned_cols=246 Identities=24% Similarity=0.423 Sum_probs=198.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... ........|+.++..+ .|++|+++++.+.+++..++||||+
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05621 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFCAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCEEEEEEcCC
Confidence 699999999999999999999999986422 1233455677777776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++... .+++.++..++.|++.||+|||++||+||||||+|||+
T Consensus 126 ~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl--------------------------- 175 (370)
T cd05621 126 PGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL--------------------------- 175 (370)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---------------------------
Confidence 99999999764 48999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCC----CCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+....
T Consensus 176 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~ 255 (370)
T cd05621 176 DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255 (370)
T ss_pred CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence 456679999999987654322 3457999999999998653 77899999999999999999999987665544
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+......+ .++. ....+..+++++..||+.+|
T Consensus 256 ~~~i~~~~~~~---------------------~~p~------------------------~~~~s~~~~~li~~~L~~~~ 290 (370)
T cd05621 256 YSKIMDHKNSL---------------------NFPE------------------------DVEISKHAKNLICAFLTDRE 290 (370)
T ss_pred HHHHHhCCccc---------------------CCCC------------------------cccCCHHHHHHHHHHccCch
Confidence 44333211110 0110 11356789999999998666
Q ss_pred CC--CCCHHHHhcCCCCCCCC
Q 020235 308 TD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~--R~t~~~ll~hp~f~~~~ 326 (329)
.+ |+|+.++++||||+...
T Consensus 291 ~r~~R~~~~e~l~hp~~~~~~ 311 (370)
T cd05621 291 VRLGRNGVEEIKQHPFFKNDQ 311 (370)
T ss_pred hccCCCCHHHHhcCcccCCCC
Confidence 54 88999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=316.24 Aligned_cols=245 Identities=26% Similarity=0.436 Sum_probs=208.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++++|+.+|||.+.- ....++..+|+.++.+. ..++++++++.+=....+|+||||| .|+
T Consensus 41 LGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC-----~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQC-----KSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred hcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHc-----CCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 7999999999999999999999999884 45577888999999988 5699999999988888999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
+.++++..+ +++++..+..++...+.||+|||...=+|||||..|||+ ...+
T Consensus 115 iSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---------------------------NT~G 166 (502)
T KOG0574|consen 115 ISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---------------------------NTDG 166 (502)
T ss_pred HHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---------------------------cccc
Confidence 999998755 679999999999999999999999999999999999999 4556
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
+.||+|||.+....... ++..|||.|||||++...+|+.++||||||++..+|+.|++||....++..+..|-..
T Consensus 167 ~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~-- 244 (502)
T KOG0574|consen 167 IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTK-- 244 (502)
T ss_pred hhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCC--
Confidence 67888888887666543 5678999999999999999999999999999999999999999876554433332221
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
|+|.. .. ++..|++|.||+++||.++|++|.||.++
T Consensus 245 PPPTF------------------~K--------------------------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L 280 (502)
T KOG0574|consen 245 PPPTF------------------KK--------------------------PEEWSSEFNDFIRSCLIKKPEERKTALRL 280 (502)
T ss_pred CCCCC------------------CC--------------------------hHhhhhHHHHHHHHHhcCCHHHHHHHHHH
Confidence 11110 00 12357789999999999999999999999
Q ss_pred hcCCCCCCC
Q 020235 317 LRHPFFTRD 325 (329)
Q Consensus 317 l~hp~f~~~ 325 (329)
++|||+++-
T Consensus 281 ~~H~FiknA 289 (502)
T KOG0574|consen 281 CEHTFIKNA 289 (502)
T ss_pred hhhhhhcCC
Confidence 999999874
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=325.80 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=194.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHH-HHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+|+.||+|++..... .......|... +..+ .|+||+++++.+...+..++||||
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~hp~iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05604 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-----KHPFLVGLHYSFQTTEKLYFVLDF 77 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-----CCCCCccEEEEEecCCEEEEEEcC
Confidence 7999999999999999999999999874321 12223334333 2233 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|...+.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll-------------------------- 129 (325)
T cd05604 78 VNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL-------------------------- 129 (325)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE--------------------------
Confidence 9 899998887654 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~ 208 (325)
T cd05604 130 -DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208 (325)
T ss_pred -CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH
Confidence 4556789999998764322 123457899999999999988999999999999999999999999876654433332
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... .....+..+.++|++||+.||.+||
T Consensus 209 ~~~~~~-------------------------------------------------~~~~~~~~~~~ll~~ll~~~p~~R~ 239 (325)
T cd05604 209 LHKPLV-------------------------------------------------LRPGASLTAWSILEELLEKDRQRRL 239 (325)
T ss_pred HcCCcc-------------------------------------------------CCCCCCHHHHHHHHHHhccCHHhcC
Confidence 221000 0123566789999999999999999
Q ss_pred CH----HHHhcCCCCCCCC
Q 020235 312 TA----REALRHPFFTRDH 326 (329)
Q Consensus 312 t~----~~ll~hp~f~~~~ 326 (329)
++ .++++||||++..
T Consensus 240 ~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 240 GAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHhcCCCcCCCC
Confidence 76 5999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=323.68 Aligned_cols=243 Identities=26% Similarity=0.418 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHH-HHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEV-LQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~-l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|+++.+++.||+|++...... ......|... +..+ .|+||+++++.+.+.+..++||||
T Consensus 3 lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~Iv~~~~~~~~~~~~~lv~e~ 77 (325)
T cd05602 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-----KHPFLVGLHFSFQTADKLYFVLDY 77 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-----CCCCCCceeEEEEcCCeEEEEEeC
Confidence 79999999999999999999999998743211 1122223222 2333 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 78 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili-------------------------- 129 (325)
T cd05602 78 INGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL-------------------------- 129 (325)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE--------------------------
Confidence 9 899999998754 58899999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+
T Consensus 130 -~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (325)
T cd05602 130 -DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208 (325)
T ss_pred -CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 4556789999998764322 123457999999999999989999999999999999999999999876655443333
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... .....+..+.++|++||+.||.+|+
T Consensus 209 ~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~R~ 239 (325)
T cd05602 209 LNKPLQ-------------------------------------------------LKPNITNSARHLLEGLLQKDRTKRL 239 (325)
T ss_pred HhCCcC-------------------------------------------------CCCCCCHHHHHHHHHHcccCHHHCC
Confidence 221100 1124567899999999999999999
Q ss_pred CHH----HHhcCCCCCCCC
Q 020235 312 TAR----EALRHPFFTRDH 326 (329)
Q Consensus 312 t~~----~ll~hp~f~~~~ 326 (329)
++. ++++|+||...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 240 GAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred CCCCCHHHHhcCcccCCCC
Confidence 876 899999997643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=322.49 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=196.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++.... .......|..++..+ ..|++|+.+++++.+.+.+++||||+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (327)
T cd05617 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQA----SSNPFLVGLHSCFQTTSRLFLVIEYV 78 (327)
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhh----cCCCCEeeEEEEEEeCCEEEEEEeCC
Confidence 7999999999999999999999999975321 223345677766666 35689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 79 ~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili--------------------------- 129 (327)
T cd05617 79 NGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL--------------------------- 129 (327)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---------------------------
Confidence 999998887654 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH---HHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE---HLA 229 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~ 229 (329)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||....... ...
T Consensus 130 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~ 209 (327)
T cd05617 130 DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209 (327)
T ss_pred eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHH
Confidence 4556689999998764321 2234579999999999999899999999999999999999999996422110 000
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+... ......+...+..+.++|++||+.||++
T Consensus 210 ~~~~~~~---------------------------------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~ 244 (327)
T cd05617 210 YLFQVIL---------------------------------------------EKPIRIPRFLSVKASHVLKGFLNKDPKE 244 (327)
T ss_pred HHHHHHH---------------------------------------------hCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 0000000 0000112345678999999999999999
Q ss_pred CCC------HHHHhcCCCCCCCC
Q 020235 310 RLT------AREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t------~~~ll~hp~f~~~~ 326 (329)
|++ +.++++||||+..+
T Consensus 245 R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 245 RLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred cCCCCCCCCHHHHHcCCCCCCCC
Confidence 998 47999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.19 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=194.0
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .+++.||+|++.... ........|..++..+. .|++|+.+++.+..++..++|
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~~~~~~lv 83 (332)
T cd05614 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVR----QSPFLVTLHYAFQTEAKLHLI 83 (332)
T ss_pred EeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhcc----CCCCcccEEEEEecCCEEEEE
Confidence 799999999999864 578999999986422 12234556777777763 568999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili----------------------- 138 (332)
T cd05614 84 LDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL----------------------- 138 (332)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE-----------------------
Confidence 9999 899999997654 68999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 139 ----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 139 ----DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred ----CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 455678999999887543221 235789999999999875 47899999999999999999999996532211
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+...... .........+..+.++|.+||+.|
T Consensus 215 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~~li~~~l~~d 249 (332)
T cd05614 215 TQSEVSRRILK---------------------------------------------CDPPFPSFIGPEAQDLLHKLLRKD 249 (332)
T ss_pred CHHHHHHHHhc---------------------------------------------CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 11111110000 000112345678999999999999
Q ss_pred CCCCC-----CHHHHhcCCCCCCCC
Q 020235 307 PTDRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~-----t~~~ll~hp~f~~~~ 326 (329)
|++|| +++++++||||++..
T Consensus 250 p~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 250 PKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999 788999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=329.89 Aligned_cols=271 Identities=24% Similarity=0.382 Sum_probs=198.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ .|++++++++.+.+.+.+++||||+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-----DGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999987432 2234455677777776 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc-ccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY-FKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 154 (329)
+++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+++.|||++......... ...
T Consensus 84 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~ 161 (360)
T cd05627 84 PGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYR 161 (360)
T ss_pred CCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccccc
Confidence 999999997754 6899999999999999999999999999999999999977776666666655433211000 000
Q ss_pred CCCCCCeEEeeCCCCccc------------CCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 155 MPKSSAIKVIDFGSTTYE------------RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
..... .-.++...... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus 162 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 162 NLTHN--PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccC--CcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 00000 00000000000 00011347999999999999999999999999999999999999999876
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
+.......+....... .++. ....+..++++|.+|
T Consensus 240 ~~~~~~~~i~~~~~~~---------------------~~p~------------------------~~~~s~~~~~li~~l 274 (360)
T cd05627 240 TPQETYRKVMNWKETL---------------------VFPP------------------------EVPISEKAKDLILRF 274 (360)
T ss_pred CHHHHHHHHHcCCCce---------------------ecCC------------------------CCCCCHHHHHHHHHh
Confidence 6654443333211000 0000 012567899999997
Q ss_pred cccCCCCCC---CHHHHhcCCCCCCCC
Q 020235 303 LRYDPTDRL---TAREALRHPFFTRDH 326 (329)
Q Consensus 303 l~~dP~~R~---t~~~ll~hp~f~~~~ 326 (329)
+. ||.+|+ +++++++||||++.+
T Consensus 275 ~~-~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 275 CT-DSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred cc-ChhhcCCCCCHHHHhcCCCCCCCC
Confidence 74 999998 489999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=325.56 Aligned_cols=243 Identities=28% Similarity=0.467 Sum_probs=200.1
Q ss_pred CCCccceEEEEEEe---cCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWD---RERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||++++ +.+|+.||+|++..... .......|+.++..+ .|+||+++++.+.+++..|+|||
T Consensus 4 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-----NHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred eeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCEEEEEEc
Confidence 79999999999986 35789999999874321 233455688888887 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 79 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~------------------------- 131 (318)
T cd05582 79 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL------------------------- 131 (318)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE-------------------------
Confidence 99 899999997653 68999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+..+....
T Consensus 132 --~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~ 209 (318)
T cd05582 132 --DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209 (318)
T ss_pred --CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH
Confidence 455678999999887554332 335689999999999988899999999999999999999999987665544433
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..... +...+..+.++|++||+.||++|
T Consensus 210 i~~~~~~~-------------------------------------------------p~~~~~~~~~li~~~l~~~P~~R 240 (318)
T cd05582 210 ILKAKLGM-------------------------------------------------PQFLSPEAQSLLRALFKRNPANR 240 (318)
T ss_pred HHcCCCCC-------------------------------------------------CCCCCHHHHHHHHHHhhcCHhHc
Confidence 32211111 12346689999999999999999
Q ss_pred CC-----HHHHhcCCCCCCCC
Q 020235 311 LT-----AREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t-----~~~ll~hp~f~~~~ 326 (329)
|| +.++++||||....
T Consensus 241 ~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 241 LGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCCCCCCHHHHhCCCCcCCCC
Confidence 99 77899999998753
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=327.38 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=198.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|+++.... .......|..++..+ .|++++.+++.+.+.+..++||||+
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-----NSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred EEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeEEEEECCC
Confidence 6999999999999999999999999875332 233445666776665 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 84 ~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll--------------------------- 135 (330)
T cd05601 84 PGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI--------------------------- 135 (330)
T ss_pred CCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---------------------------
Confidence 999999998753 368999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHh------cCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..||...+..
T Consensus 136 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 215 (330)
T cd05601 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215 (330)
T ss_pred CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH
Confidence 455678999999887554332 2346899999999987 445789999999999999999999999876554
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+...... ..++. ....+..+.+||++||+
T Consensus 216 ~~~~~i~~~~~~---------------------~~~~~------------------------~~~~~~~~~~li~~ll~- 249 (330)
T cd05601 216 KTYNNIMNFQRF---------------------LKFPE------------------------DPKVSSDFLDLIQSLLC- 249 (330)
T ss_pred HHHHHHHcCCCc---------------------cCCCC------------------------CCCCCHHHHHHHHHHcc-
Confidence 443333221100 00100 12356789999999998
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||++|||++++++||||+..+
T Consensus 250 ~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 250 GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ChhhCCCHHHHhCCCCcCCCC
Confidence 999999999999999998743
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=317.11 Aligned_cols=250 Identities=27% Similarity=0.424 Sum_probs=200.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|.+.... ........|+.++..+ .|++++.+.+.+.+.+..++||||+
T Consensus 8 ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-----NSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-----CCCCeeeeeEEEecCCEEEEEEEec
Confidence 799999999999999999999999886432 1123456788888888 5689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++.++..++.|++.||.|||+.|++|+||||+||++
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~--------------------------- 135 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL--------------------------- 135 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---------------------------
Confidence 8999999876554568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|+..|+|||++.+..++.++|+||+||++|+|++|..||..............
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~ 215 (285)
T cd05630 136 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215 (285)
T ss_pred CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh
Confidence 455668999999886543322 234789999999999988899999999999999999999999976432211111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
.....+ .......+..+.+|+++||+.||++|||
T Consensus 216 ~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 216 LVKEVQ---------------------------------------------EEYSEKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred hhhhhh---------------------------------------------hhcCccCCHHHHHHHHHHhhcCHHHccCC
Confidence 100000 0112345678999999999999999999
Q ss_pred ----HHHHhcCCCCCCCCc
Q 020235 313 ----AREALRHPFFTRDHL 327 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~~ 327 (329)
++++++||||++.+.
T Consensus 251 ~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 251 QGGGAREVKEHPLFKQINF 269 (285)
T ss_pred CCCchHHHHcChhhhccCH
Confidence 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=329.00 Aligned_cols=244 Identities=26% Similarity=0.395 Sum_probs=214.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.||-|++..+.+.||||.|+...+. =..+++|+..+.++ .|||.+.+.++|-.+...|||||||
T Consensus 34 IGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-----~HPntieYkgCyLre~TaWLVMEYC 108 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-----RHPNTIEYKGCYLREHTAWLVMEYC 108 (948)
T ss_pred hcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-----cCCCcccccceeeccchHHHHHHHH
Confidence 79999999999999999999999999854322 24567899999999 6699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
-|+..|++.-.. +++.+-.+..|+.+.+.||.|||+.+.+|||||..|||+ .
T Consensus 109 lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL---------------------------s 160 (948)
T KOG0577|consen 109 LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL---------------------------S 160 (948)
T ss_pred hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe---------------------------c
Confidence 888889987654 578999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+.|||+|||.|....+.. .++|||.|||||++.. ..|+.++||||||+++.+|+.+++|+.+.+.+...+.|.+
T Consensus 161 e~g~VKLaDFGSAsi~~PAn-sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 161 EPGLVKLADFGSASIMAPAN-SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred CCCeeeeccccchhhcCchh-cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 56679999999998777654 5699999999999973 4699999999999999999999999999999999999988
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+-.|.-. ....|+.|+.|+..||++=|.+|||.
T Consensus 240 NesPtLq-----------------------------------------------s~eWS~~F~~Fvd~CLqKipqeRpts 272 (948)
T KOG0577|consen 240 NESPTLQ-----------------------------------------------SNEWSDYFRNFVDSCLQKIPQERPTS 272 (948)
T ss_pred cCCCCCC-----------------------------------------------CchhHHHHHHHHHHHHhhCcccCCcH
Confidence 7655321 12356789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
+++|.|+|+.++
T Consensus 273 e~ll~H~fv~R~ 284 (948)
T KOG0577|consen 273 EELLKHRFVLRE 284 (948)
T ss_pred HHHhhcchhccC
Confidence 999999999765
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=280.40 Aligned_cols=272 Identities=30% Similarity=0.502 Sum_probs=226.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|.||+||+|+++.|++.||+|.++.+ +.....+++|+-+++.+ .|.||+++++....++.+.+|+|+|.
T Consensus 10 igegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-----khknivrl~dvlhsdkkltlvfe~cd 84 (292)
T KOG0662|consen 10 IGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_pred hcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-----hhcceeehhhhhccCceeEEeHHHhh
Confidence 79999999999999999999999999853 34467789999999999 45899999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
-+|..+...-+ ..++...++..+.|++.||.|+|++++.|||+||+|.|| ..
T Consensus 85 qdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---------------------------n~ 136 (292)
T KOG0662|consen 85 QDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---------------------------NR 136 (292)
T ss_pred HHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---------------------------cc
Confidence 99999988755 358999999999999999999999999999999999999 56
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (329)
++.+|++|||+++-.+-+. +..+-|.-|++|.++.+.. |+...|+||.||++.|+.. |++.|.+.+..++...|.
T Consensus 137 ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif 216 (292)
T KOG0662|consen 137 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_pred CCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHH
Confidence 6778888888887655443 3345688899999999875 7899999999999999985 889999999999999999
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+.+|.+.++.|+.+....+.-. +| .......-.+........-+|+++++|.-+|..|++
T Consensus 217 ~~lg~p~ed~wps~t~lpdyk~------yp--------------~ypattswsqivp~lns~grdllqkll~cnp~qris 276 (292)
T KOG0662|consen 217 RLLGTPTEDQWPSMTKLPDYKP------YP--------------IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS 276 (292)
T ss_pred HHhCCCccccCCccccCCCCcc------cC--------------CccccchHHHHhhhhcchhHHHHHHHhccCcccccC
Confidence 9999999888776544332110 11 111111112223345567899999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
|+++++||||.+-
T Consensus 277 aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 277 AEAALQHPYFSDF 289 (292)
T ss_pred HHHHhcCcccccc
Confidence 9999999999863
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=321.39 Aligned_cols=243 Identities=26% Similarity=0.372 Sum_probs=193.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHH-HHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIE-VLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~-~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|+++.+++.||+|++..... .......|.. ++..+ .|+||+++++.+.+.+..++||||
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv~e~ 77 (321)
T cd05603 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-----KHPFLVGLHYSFQTAEKLYFVLDY 77 (321)
T ss_pred eeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCEEEEEEcC
Confidence 7999999999999999999999999874321 1222333333 23333 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|...+.... .+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 78 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll-------------------------- 129 (321)
T cd05603 78 VNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL-------------------------- 129 (321)
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE--------------------------
Confidence 9 899988887643 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+
T Consensus 130 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i 208 (321)
T cd05603 130 -DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208 (321)
T ss_pred -CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH
Confidence 45567899999987643221 23457899999999999888999999999999999999999999876544433322
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
..... +.+...+..+.++|.+||+.||.+|+
T Consensus 209 ~~~~~-------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~ 239 (321)
T cd05603 209 LHKPL-------------------------------------------------QLPGGKTVAACDLLVGLLHKDQRRRL 239 (321)
T ss_pred hcCCC-------------------------------------------------CCCCCCCHHHHHHHHHHccCCHhhcC
Confidence 21100 01123466799999999999999999
Q ss_pred CH----HHHhcCCCCCCCC
Q 020235 312 TA----REALRHPFFTRDH 326 (329)
Q Consensus 312 t~----~~ll~hp~f~~~~ 326 (329)
++ .++++||||...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 240 GAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHhCCCCcCCCC
Confidence 75 4999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=311.86 Aligned_cols=270 Identities=30% Similarity=0.499 Sum_probs=209.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|++|.||+|.++.+++.||+|.++... .......+|+.++..+ .|+|++++++.+.+++..++||||+.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-----QHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred ecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-----CCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 799999999999999999999999986432 2234567788888888 57999999999999999999999998
Q ss_pred CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~--------------------------- 135 (285)
T cd07861 83 MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID--------------------------- 135 (285)
T ss_pred CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---------------------------
Confidence 78988887533 24689999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.++|+|||.+....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+....+....+.
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~ 215 (285)
T cd07861 136 NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215 (285)
T ss_pred CCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 45567888888776443322 223568889999998764 47889999999999999999999999877776666666
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+..+...++......+...... .+ ............+.++.++|++||+.||++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 275 (285)
T cd07861 216 RILGTPTEDVWPGVTSLPDYKNTFP--KW------------------KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275 (285)
T ss_pred HHhCCCChhhhhcchhhHHHHhhcc--cc------------------CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC
Confidence 6666665555443332211100000 00 000111112346788999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
+.+|++||||
T Consensus 276 ~~~ll~~~~~ 285 (285)
T cd07861 276 AKKALNHPYF 285 (285)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=306.93 Aligned_cols=244 Identities=28% Similarity=0.469 Sum_probs=211.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|.||.|-+|+.+.||+.+|+|++++. .......+.|-.+++.. .||++..+...|++.+++|+||||.
T Consensus 176 LGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-----~HPFLt~LKYsFQt~drlCFVMeya 250 (516)
T KOG0690|consen 176 LGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-----RHPFLTSLKYSFQTQDRLCFVMEYA 250 (516)
T ss_pred hcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-----cCcHHHHhhhhhccCceEEEEEEEc
Confidence 79999999999999999999999999852 34455566788888777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.|.-.+++.. .+++...+.+..++++||.|||+++|++||+|.+|.|+
T Consensus 251 nGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL--------------------------- 301 (516)
T KOG0690|consen 251 NGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL--------------------------- 301 (516)
T ss_pred cCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---------------------------
Confidence 999998888754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
++++++||+|||+++..- ......+|||.|+|||++....|+..+|+|.+||++|+|++|+.||.+.+....+.-|.
T Consensus 302 DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl 381 (516)
T KOG0690|consen 302 DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL 381 (516)
T ss_pred ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH
Confidence 788899999999987432 23367899999999999999999999999999999999999999999877665554433
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
-.--. ++.+.+++++.|+..+|.+||.+|+
T Consensus 382 ~ed~k-------------------------------------------------FPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 382 MEDLK-------------------------------------------------FPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred hhhcc-------------------------------------------------CCccCCHHHHHHHHHHhhcChHhhcC
Confidence 32211 2346788999999999999999998
Q ss_pred ----CHHHHhcCCCCCCCCc
Q 020235 312 ----TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~~ 327 (329)
.|.++.+|+||.+++-
T Consensus 413 gGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 413 GGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred CCchhHHHHHhhhhhccCCH
Confidence 4899999999998863
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=320.94 Aligned_cols=286 Identities=21% Similarity=0.326 Sum_probs=203.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.++..+|+|++... ........+|+.++..+ .|+||+++++++.+.+..++||||+ +
T Consensus 13 lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 87 (333)
T cd06650 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEISICMEHMDG 87 (333)
T ss_pred ccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-----CCCcccceeEEEEECCEEEEEEecCCC
Confidence 79999999999999999999999988743 22345677899999888 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+|||+ +
T Consensus 88 ~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---------------------------~ 138 (333)
T cd06650 88 GSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---------------------------N 138 (333)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---------------------------c
Confidence 99999998754 589999999999999999999975 79999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.++.++|+|||.+...... .....|+..|+|||++.+..++.++|+|||||++|+|++|+.||...........+....
T Consensus 139 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 139 SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred CCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc
Confidence 4556899999988654332 234578999999999998889999999999999999999999997654432221111111
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCC---CCchHHHhhhccchhhHHHHhhh-ccCchhHHHHHHHHhcccCCCCCC
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEG---AASRESIKSVMKLPRLQNLIMQH-VDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...+...... .... -.......+... ..........+ .....+.. ....+.++.+||.+||++||++||
T Consensus 219 ~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 219 EGDPAESETS--PRPR-PPGRPLSSYGPDSRPPMAIFELLDYI----VNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred cCCccccccC--cccC-CccchhhhhcccccccccHHHHHHHH----hcCCCccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 0000000000 0000 000000000000 00000000000 00000111 123567899999999999999999
Q ss_pred CHHHHhcCCCCCCCCc
Q 020235 312 TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 t~~~ll~hp~f~~~~~ 327 (329)
|+.++++||||+....
T Consensus 292 t~~ell~h~~~~~~~~ 307 (333)
T cd06650 292 DLKQLMVHAFIKRSEA 307 (333)
T ss_pred CHHHHhhCHHHhcCcc
Confidence 9999999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=311.34 Aligned_cols=269 Identities=30% Similarity=0.484 Sum_probs=207.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.++.+|+.+|+|.++... .......+|+.++..+ .|+|++++++++.+.+..++|+||++
T Consensus 8 l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-----CCCCeeeHHHHhccCCceEEEEecCC
Confidence 699999999999999999999999987432 2234556788888888 56999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .
T Consensus 83 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---------------------------~ 134 (284)
T cd07839 83 QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---------------------------K 134 (284)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---------------------------C
Confidence 89988887643 3589999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCC-CCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~ 232 (329)
++.++|+|||.+....... ....++..|+|||.+.+.. ++.++|+|||||++|+|++|..|+ .+.+..+....+.
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (284)
T cd07839 135 NGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 214 (284)
T ss_pred CCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHH
Confidence 5568888888776543322 2245688999999987754 689999999999999999988775 4455556666777
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+..+...+.......+.. .. ..++ ......+.....+.++.++|.+||+.||.+|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~-~~--~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t 274 (284)
T cd07839 215 RLLGTPTEESWPGVSKLPDYK-PY--PMYP-----------------ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274 (284)
T ss_pred HHhCCCChHHhHHhhhccccc-cc--CCCC-----------------CcchhhhhcccCCHHHHHHHHHHhcCChhhcCC
Confidence 777776665555433322110 00 0000 000001122346788999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
++++++||||
T Consensus 275 ~~~il~h~~f 284 (284)
T cd07839 275 AEEALQHPYF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=324.27 Aligned_cols=244 Identities=27% Similarity=0.447 Sum_probs=191.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+ .|+||+++++++...+.+++||||+ +
T Consensus 82 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-----NHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred ccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-----CCCCcceeeeEeccCCeEEEEEecCCC
Confidence 79999999999999999999999998643 23345667899999888 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+. ...++..+..++.|++.||.|||++||+||||||+|||+ +.
T Consensus 157 ~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---------------------------~~ 203 (353)
T PLN00034 157 GSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---------------------------NS 203 (353)
T ss_pred Cccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---------------------------cC
Confidence 887532 246778888999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+..++|+|||.+....... ....||..|+|||++.. ...+.++|||||||++|+|++|+.||......+...
T Consensus 204 ~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~ 283 (353)
T PLN00034 204 AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS 283 (353)
T ss_pred CCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH
Confidence 5678999999887544322 34578999999998753 224568999999999999999999997432211111
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.......+ .......+.++.+||.+||+.||++
T Consensus 284 ~~~~~~~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~~~P~~ 318 (353)
T PLN00034 284 LMCAICMSQP---------------------------------------------PEAPATASREFRHFISCCLQREPAK 318 (353)
T ss_pred HHHHHhccCC---------------------------------------------CCCCCccCHHHHHHHHHHccCChhh
Confidence 1111000000 0011245678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||+.|+++||||.+...
T Consensus 319 Rpt~~ell~hp~~~~~~~ 336 (353)
T PLN00034 319 RWSAMQLLQHPFILRAQP 336 (353)
T ss_pred CcCHHHHhcCcccccCCc
Confidence 999999999999998753
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.49 Aligned_cols=246 Identities=24% Similarity=0.429 Sum_probs=197.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|..++..+ .|++|+++++.+.+++..++||||+
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-----~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 699999999999999999999999986422 1223345677777766 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 126 ~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll--------------------------- 175 (371)
T cd05622 126 PGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--------------------------- 175 (371)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---------------------------
Confidence 89999999764 48999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCC----CCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 456679999999987654322 3457999999999997643 78899999999999999999999987666544
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+......+ .++. ....+..++++|..||+.++
T Consensus 256 ~~~i~~~~~~~---------------------~~~~------------------------~~~~s~~~~~li~~~L~~~~ 290 (371)
T cd05622 256 YSKIMNHKNSL---------------------TFPD------------------------DNDISKEAKNLICAFLTDRE 290 (371)
T ss_pred HHHHHcCCCcc---------------------cCCC------------------------cCCCCHHHHHHHHHHcCChh
Confidence 44433221111 0000 12467789999999998444
Q ss_pred CC--CCCHHHHhcCCCCCCCC
Q 020235 308 TD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~--R~t~~~ll~hp~f~~~~ 326 (329)
.+ |++++++++||||++..
T Consensus 291 ~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 291 VRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred hhcCCCCHHHHhcCcccCCCC
Confidence 43 78999999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=318.93 Aligned_cols=300 Identities=18% Similarity=0.239 Sum_probs=198.6
Q ss_pred CCCc--cceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+| +|++||++.++.+|+.||+|+++... .......+|+.++..+ .|+||+++++++.+++..++||||
T Consensus 6 ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred ccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEECCEEEEEEec
Confidence 6888 78999999999999999999987432 2234555688888777 669999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.......+++..++.++.|++.||+|||++||+|+||||+||+++.++.+++.+|+....
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~---------- 150 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS---------- 150 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc----------
Confidence 9 89999999765445689999999999999999999999999999999999997666555555432211
Q ss_pred CCCCCCeEEeeCCCCcc-cCCCCCcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTY-ERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
++++|.... .........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 151 --------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~- 221 (327)
T cd08227 151 --------MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE- 221 (327)
T ss_pred --------cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH-
Confidence 111111110 0011122356778999999976 3588999999999999999999999976544332221
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...+..+... ...................+............................+..+.+||++||+.||++||
T Consensus 222 -~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 299 (327)
T cd08227 222 -KLNGTVPCLL-DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARP 299 (327)
T ss_pred -HhcCCccccc-cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcC
Confidence 1222222110 00000000000000000000000000000000000011111122345677899999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q 020235 312 TAREALRHPFFTRDH 326 (329)
Q Consensus 312 t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++..
T Consensus 300 t~~ell~~p~f~~~~ 314 (327)
T cd08227 300 SASTLLNHSFFKQIK 314 (327)
T ss_pred CHHHHhcChhhhhcc
Confidence 999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=310.91 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=202.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.+..+++.+|+|.+.... .......+|+.++..+ .|++++.+.+.+.+++..++||||+
T Consensus 8 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-----NSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-----CCcCceeEEEEEecCCEEEEEEEec
Confidence 799999999999999999999999986432 1223456788888888 5689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||++
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili--------------------------- 135 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL--------------------------- 135 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---------------------------
Confidence 8899988876544569999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.........+..
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~ 215 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215 (285)
T ss_pred CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 455668999999886543322 335789999999999888899999999999999999999999987554333222222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
....... ......+.++.+|+..||+.||++|||
T Consensus 216 ~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05632 216 RVLETEE---------------------------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGC 250 (285)
T ss_pred hhhcccc---------------------------------------------ccCccCCHHHHHHHHHHccCCHhHcCCC
Confidence 1111000 011235667899999999999999999
Q ss_pred ----HHHHhcCCCCCCCCc
Q 020235 313 ----AREALRHPFFTRDHL 327 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~~ 327 (329)
++++++||||++..+
T Consensus 251 ~~~~~~~l~~~~~~~~~~~ 269 (285)
T cd05632 251 QEEGAGEVKRHPFFRNMNF 269 (285)
T ss_pred cccChHHHHcChhhhcCCH
Confidence 899999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=321.78 Aligned_cols=270 Identities=24% Similarity=0.381 Sum_probs=195.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|.++.+++.||+|+.... ....|..++..+ .|+||+++++++...+..++||+++.++|
T Consensus 74 lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~l 143 (357)
T PHA03209 74 LTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNV-----NHPSVIRMKDTLVSGAITCMVLPHYSSDL 143 (357)
T ss_pred ecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhC-----CCCCCcChhheEEeCCeeEEEEEccCCcH
Confidence 79999999999999999999999975432 335688888888 66999999999999999999999998899
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+ .....
T Consensus 144 ~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---------------------------~~~~~ 195 (357)
T PHA03209 144 YTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---------------------------NDVDQ 195 (357)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCCCC
Confidence 99987644 468999999999999999999999999999999999999 45566
Q ss_pred eEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCC-CCCCchh---------HHH
Q 020235 161 IKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL-FQTHENL---------EHL 228 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~---------~~~ 228 (329)
++|+|||.+....... ....||..|+|||++.+..++.++|+|||||++|+|+++..| |...... ...
T Consensus 196 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l 275 (357)
T PHA03209 196 VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHL 275 (357)
T ss_pred EEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHH
Confidence 8999999887543322 345689999999999998999999999999999999985544 4332111 112
Q ss_pred HHHHHHhCCCChhHHHh-hhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 229 AMMERVLGPLPQHMLKR-VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
..+....+..|..+... .......+...... ...+...... ......+.++.+||.+||+.||
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dP 339 (357)
T PHA03209 276 LKIISTLKVHPEEFPRDPGSRLVRGFIEYASL---------------ERQPYTRYPC-FQRVNLPIDGEFLVHKMLTFDA 339 (357)
T ss_pred HHHHHHhccChhhcCCCCccHHHHHHHhhccc---------------CCCcccccHH-HhccCCCchHHHHHHHHHcCCc
Confidence 22222223222211100 00000001000000 0000000000 0012345678899999999999
Q ss_pred CCCCCHHHHhcCCCCCC
Q 020235 308 TDRLTAREALRHPFFTR 324 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~ 324 (329)
.+||||.|+|+||||++
T Consensus 340 ~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 340 AMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccCcCHHHHhcCchhcc
Confidence 99999999999999986
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=323.46 Aligned_cols=270 Identities=23% Similarity=0.417 Sum_probs=202.7
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|... .++..||+|.+... ....+|+.++..+ .|+||+++++.+......++|||++++
T Consensus 100 Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 170 (392)
T PHA03207 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTI-----SHRAIINLIHAYRWKSTVCMVMPKYKC 170 (392)
T ss_pred ecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhc-----CCCCccceeeeEeeCCEEEEEehhcCC
Confidence 799999999999764 45678999987643 2345799999988 569999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ ...
T Consensus 171 ~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---------------------------~~~ 221 (392)
T PHA03207 171 DLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---------------------------DEP 221 (392)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------------cCC
Confidence 999999554 368999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch---hHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN---LEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~~~~ 230 (329)
+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ......
T Consensus 222 ~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~ 301 (392)
T PHA03207 222 ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS 301 (392)
T ss_pred CCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH
Confidence 678899999886543322 235789999999999998999999999999999999999999977543 333444
Q ss_pred HHHHhCCCChhHHH----hhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 231 MERVLGPLPQHMLK----RVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 231 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
+.+..+..+..... ........+.......+ ..+.. ......+.++.++|++||+.|
T Consensus 302 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~-----~~~~~~~~~~~~li~~ml~~d 362 (392)
T PHA03207 302 IIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPY--------------TIPPV-----IRKYGMHMDVEYLIAKMLTFD 362 (392)
T ss_pred HHHHhccCccccCCccchhHHHHHHhhcccccCCc--------------cccch-----hhccCcchhHHHHHHHHhccC
Confidence 44444433322110 11111111110000000 00000 001134567899999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCCc
Q 020235 307 PTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~~~ 327 (329)
|++|||+.++|+||||.+...
T Consensus 363 p~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 363 QEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hhhCCCHHHHhhCchhhccch
Confidence 999999999999999987653
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=315.67 Aligned_cols=249 Identities=26% Similarity=0.409 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+++++.+++.||+|++.... ........|..++..+ .|++|+.+++.+.+++++|+||||+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-----DRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCeEEEEEecC
Confidence 699999999999999999999999987422 1223345566676665 6689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 84 ~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill--------------------------- 135 (331)
T cd05597 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL--------------------------- 135 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---------------------------
Confidence 999999997643 368999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
..++.++|+|||.+....... ....||+.|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~ 215 (331)
T cd05597 136 DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH
Confidence 455679999999886543322 22468999999999973 347789999999999999999999998765544
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+....... ..+ ......+..++++|++||..+
T Consensus 216 ~~~~i~~~~~~~---------------------~~~-----------------------~~~~~~~~~~~~li~~ll~~~ 251 (331)
T cd05597 216 TYGKIMNHKEHF---------------------QFP-----------------------PDVTDVSEEAKDLIRRLICSP 251 (331)
T ss_pred HHHHHHcCCCcc---------------------cCC-----------------------CccCCCCHHHHHHHHHHccCc
Confidence 333322211000 000 001235678999999998765
Q ss_pred CCC--CCCHHHHhcCCCCCCCC
Q 020235 307 PTD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~--R~t~~~ll~hp~f~~~~ 326 (329)
+.+ |+++.++++||||++..
T Consensus 252 ~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 252 ETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred ccccCCCCHHHHhcCCCCCCCC
Confidence 444 78999999999998753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=306.38 Aligned_cols=270 Identities=33% Similarity=0.532 Sum_probs=212.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|++|.||+|.++.+++.||+|.++.... .......|+.++..+ .|+|++++++++.+++..++||||+.
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred ecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-----CCCCCcchhhhcccCCcEEEEeeccc
Confidence 6999999999999999999999998874321 234567799999988 56999999999999999999999997
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.......+++.++..++.|++.||+|||+.|++|+||+|+||++ +.
T Consensus 83 ~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---------------------------~~ 135 (284)
T cd07860 83 QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---------------------------NT 135 (284)
T ss_pred cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CC
Confidence 789999877555578999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+..++|+|||.+....... ....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+.+
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 136 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred CCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 5568888888876543322 2235678899999887644 57889999999999999999999998877777777777
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+..+..+++...........-. .+. ...........+..++++|.+||+.||++|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 275 (284)
T cd07860 216 TLGTPDEVVWPGVTSLPDYKPSFP--KWA------------------RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA 275 (284)
T ss_pred HhCCCChhhhhhhhHHHHHHhhcc--ccc------------------ccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH
Confidence 777776665554333211111000 000 000111123456789999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
+++++||||
T Consensus 276 ~~~l~~~~f 284 (284)
T cd07860 276 KAALAHPFF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.85 Aligned_cols=281 Identities=26% Similarity=0.448 Sum_probs=216.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+|++++++++... ...|+
T Consensus 24 lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~l 98 (353)
T cd07850 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-----NHKNIIGLLNVFTPQKSLEEFQDVYL 98 (353)
T ss_pred eccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-----CCCCCcceeeeeccCCCccccCcEEE
Confidence 79999999999999999999999998632 22234556788888888 568999999887543 36799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||++++|.+.+... +++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 99 v~e~~~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~----------------------- 151 (353)
T cd07850 99 VMELMDANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 151 (353)
T ss_pred EEeccCCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE-----------------------
Confidence 9999988999888652 8899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+......
T Consensus 152 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 152 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred ----CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 455668888888887554432 23467889999999999899999999999999999999999999888888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....+.++.++.+.+......+....... ... ......................+..+.++|.+||+.||++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKY-AGY-----SFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCC-CCc-----chhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 8888888888887777665555544332111 000 0000000000000000002234667899999999999999
Q ss_pred CCCHHHHhcCCCCC
Q 020235 310 RLTAREALRHPFFT 323 (329)
Q Consensus 310 R~t~~~ll~hp~f~ 323 (329)
|||+.++|+||||+
T Consensus 302 R~t~~eiL~~~~~~ 315 (353)
T cd07850 302 RISVDDALQHPYIN 315 (353)
T ss_pred CcCHHHHhcChhHh
Confidence 99999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=326.30 Aligned_cols=268 Identities=27% Similarity=0.361 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|.+..+++.||+|... .....+|+.++..+ .|+||+++++++..++..++||+++.++|
T Consensus 177 Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L-----~HpnIv~l~~~~~~~~~~~lv~e~~~~~L 246 (461)
T PHA03211 177 LTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRL-----SHPAVLALLDVRVVGGLTCLVLPKYRSDL 246 (461)
T ss_pred EccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEEEEEEccCCCH
Confidence 689999999999999999999999643 22356799999998 66999999999999999999999998899
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++.+++.++.|++.||.|||++||+||||||+|||+ ..+..
T Consensus 247 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---------------------------~~~~~ 298 (461)
T PHA03211 247 YTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---------------------------NGPED 298 (461)
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---------------------------CCCCC
Confidence 99887643 368999999999999999999999999999999999999 44556
Q ss_pred eEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch-------hHHH
Q 020235 161 IKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN-------LEHL 228 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-------~~~~ 228 (329)
++|+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++|..|+.+... ....
T Consensus 299 vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l 378 (461)
T PHA03211 299 ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378 (461)
T ss_pred EEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHH
Confidence 8888888876543321 234689999999999998999999999999999999998866543211 1122
Q ss_pred HHHHHHhCC----CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 229 AMMERVLGP----LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 229 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
..+.+..+. ++......+............... ...+. + .. ....+..+.+||.+||+
T Consensus 379 ~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------------~~~~~---~-~~-~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 379 LRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA-------------YTRPA---W-TR-YYKLDLDVEYLVCRALT 440 (461)
T ss_pred HHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc-------------cCCcc---h-hh-hccccchHHHHHHHHcc
Confidence 222222111 111000000000000000000000 00000 0 00 11345679999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCC
Q 020235 305 YDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~ 324 (329)
.||.+|||+.|+|+||||++
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999976
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.29 Aligned_cols=247 Identities=25% Similarity=0.473 Sum_probs=204.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||.|+||.||+|.++.++-..|.|.+.. .......++-|++||... .||+|+.+++.|-.++.+|++.||| ||
T Consensus 40 LGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-----dHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 40 LGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-----DHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred hcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-----CChHHHHHHHHHhccCceEEEEeecCCc
Confidence 7999999999999999999999998863 334456677899999888 6799999999999999999999999 66
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
.+..++-.-+ +.+.+.++..+++|++.||+|||+++|+|||||..|||+..+
T Consensus 115 AVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld--------------------------- 166 (1187)
T KOG0579|consen 115 AVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD--------------------------- 166 (1187)
T ss_pred hHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec---------------------------
Confidence 6666665543 679999999999999999999999999999999999999544
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++|+|||.+...... +..+.|||.|||||+... .+|+.++||||||++|.+|+.+.+|-...+++..+..
T Consensus 167 GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK 246 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 246 (1187)
T ss_pred CcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH
Confidence 45888888887654433 245789999999999864 4799999999999999999999999977777665554
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+.-.| -+ ..+...+..|.||+..||.+||..|
T Consensus 247 iaKSePP---TL-------------------------------------------lqPS~Ws~~F~DfLk~cL~Knp~~R 280 (1187)
T KOG0579|consen 247 IAKSEPP---TL-------------------------------------------LQPSHWSRSFSDFLKRCLVKNPRNR 280 (1187)
T ss_pred HhhcCCC---cc-------------------------------------------cCcchhhhHHHHHHHHHHhcCCccC
Confidence 4443211 10 0123457789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
|+++++++||||++..
T Consensus 281 p~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 281 PPAAQLLKHPFVQNAP 296 (1187)
T ss_pred CCHHHHhhCcccccCC
Confidence 9999999999999653
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=303.68 Aligned_cols=244 Identities=23% Similarity=0.420 Sum_probs=194.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~lv~e 74 (329)
||+|+||.||+|.++.+++.||+|++............|+.++..+. .|+|++++.+.+... ...++|||
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 89 (272)
T cd06637 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNPPGMDDQLWLVME 89 (272)
T ss_pred eeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhc----CCCCeeeEeeEEeecCCCCCCcEEEEEEE
Confidence 69999999999999999999999998765555566777888887772 468999999987642 46899999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||++
T Consensus 90 ~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili------------------------- 144 (272)
T cd06637 90 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL------------------------- 144 (272)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE-------------------------
Confidence 99 8899999987554568999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..+..++|+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++|+|++|..||......
T Consensus 145 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~ 222 (272)
T cd06637 145 --TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 222 (272)
T ss_pred --CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 44556888899887654322 234568899999999863 35788999999999999999999999654432
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+... .. ... .....+..+.+|+.+||..
T Consensus 223 ~~~~~~~~~--~~--------------------~~~-------------------------~~~~~~~~~~~li~~~l~~ 255 (272)
T cd06637 223 RALFLIPRN--PA--------------------PRL-------------------------KSKKWSKKFQSFIESCLVK 255 (272)
T ss_pred HHHHHHhcC--CC--------------------CCC-------------------------CCCCcCHHHHHHHHHHcCC
Confidence 222111100 00 000 0123456899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 020235 306 DPTDRLTAREALRHPFF 322 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f 322 (329)
||.+|||+.+++.||||
T Consensus 256 ~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 256 NHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=304.47 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=193.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++.+..+++.+|+|.+.... ........|..++..+.. ..|++++.+++.+..++..++||||+
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhh--CCCCcEeEEEEEEecCCeEEEEEecC
Confidence 799999999999999999999999886432 112223344444443322 35689999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 80 ~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~--------------------------- 130 (279)
T cd05633 80 NGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL--------------------------- 130 (279)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---------------------------
Confidence 899999987654 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHh-cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|+..|+|||.+. +..++.++|+||+||++|+|++|..||........ ..+.+
T Consensus 131 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~ 209 (279)
T cd05633 131 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDR 209 (279)
T ss_pred CCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHH
Confidence 445568888888876443222 3346899999999986 45688999999999999999999999975432111 01111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
.....+ ...+...+..+.++|++||..||++|+
T Consensus 210 ~~~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 244 (279)
T cd05633 210 MTLTVN---------------------------------------------VELPDSFSPELKSLLEGLLQRDVSKRLGC 244 (279)
T ss_pred HhhcCC---------------------------------------------cCCccccCHHHHHHHHHHhcCCHHHhcCC
Confidence 100000 001233567899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCcC
Q 020235 312 ---TAREALRHPFFTRDHLR 328 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~~ 328 (329)
|+.++++||||++.+..
T Consensus 245 ~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 245 LGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred CCCCHHHHHhCccccCCCHh
Confidence 69999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=314.18 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+++++.+++.+|+|++..... .......|..++..+ .|++++.+++.+.+.+..++||||+
T Consensus 9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred EEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCCEEEEEEecc
Confidence 7999999999999999999999999864221 122244566665555 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili--------------------------- 135 (332)
T cd05623 84 VGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--------------------------- 135 (332)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---------------------------
Confidence 999999998743 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+..+
T Consensus 136 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~ 215 (332)
T cd05623 136 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (332)
T ss_pred CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH
Confidence 455678999999876443221 23479999999999873 357899999999999999999999998766554
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+....... .++ ......+..+++||++||+.+
T Consensus 216 ~~~~i~~~~~~~---------------------~~p-----------------------~~~~~~s~~~~~li~~ll~~~ 251 (332)
T cd05623 216 TYGKIMNHKERF---------------------QFP-----------------------AQVTDVSEDAKDLIRRLICSR 251 (332)
T ss_pred HHHHHhCCCccc---------------------cCC-----------------------CccccCCHHHHHHHHHHccCh
Confidence 443332211000 000 001235778999999999765
Q ss_pred CCC--CCCHHHHhcCCCCCCCC
Q 020235 307 PTD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~--R~t~~~ll~hp~f~~~~ 326 (329)
|.+ |+|++++++||||.+.+
T Consensus 252 ~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 252 EHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred hhhcCCCCHHHHhCCCCcCCCC
Confidence 555 68999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=292.33 Aligned_cols=248 Identities=24% Similarity=0.397 Sum_probs=202.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+-|.||+++.+.+|...|||.++.. ....++.++.+.++..- +..|+|++++++|..+..+++.||.++.
T Consensus 100 lGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s----~dcpyIV~c~GyFi~n~dV~IcMelMs~ 175 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVQCFGYFITNTDVFICMELMST 175 (391)
T ss_pred hcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhc----cCCCeeeeeeeEEeeCchHHHHHHHHHH
Confidence 79999999999999999999999999853 33455666666666544 3579999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+..++.+-. +++++..+-++...++.||.||. ++||+|||+||+|||+ +.
T Consensus 176 C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---------------------------De 227 (391)
T KOG0983|consen 176 CAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---------------------------DE 227 (391)
T ss_pred HHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---------------------------cc
Confidence 8888888755 46999999999999999999999 6789999999999999 56
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.+.+||||||.+....... +...|.+.|||||.+.-. .|+.++||||||+++++|+||+.||.+.+.. +..+.
T Consensus 228 ~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~lt 305 (391)
T KOG0983|consen 228 RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLT 305 (391)
T ss_pred CCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHH
Confidence 6779999999998776654 446799999999999643 5999999999999999999999999986543 22222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+++...|+.+ ......|..|.+|+..||++|+.+||.
T Consensus 306 kvln~ePP~L-------------------------------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~ 342 (391)
T KOG0983|consen 306 KVLNEEPPLL-------------------------------------------PGHMGFSPDFQSFVKDCLTKDHRKRPK 342 (391)
T ss_pred HHHhcCCCCC-------------------------------------------CcccCcCHHHHHHHHHHhhcCcccCcc
Confidence 2222222111 001237889999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
-.++|+|||+..-
T Consensus 343 Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 343 YNKLLEHPFIKRY 355 (391)
T ss_pred hHHHhcCcceeec
Confidence 9999999998753
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=305.16 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=200.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+|+.||+|.+.... ........|+.++..+ .|++++.+++.++..+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-----SSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-----CCCCEeeeeeEEecCCeEEEEEecC
Confidence 799999999999999999999999986422 1233445788888888 4699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~--------------------------- 128 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL--------------------------- 128 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---------------------------
Confidence 8999999987654568999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.+
T Consensus 129 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 208 (277)
T cd05577 129 DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208 (277)
T ss_pred CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh
Confidence 455668888988876543322 234577889999999888889999999999999999999999976543211111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
..... ........+..+.++|++||+.||++||
T Consensus 209 ~~~~~---------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 243 (277)
T cd05577 209 RTLEM---------------------------------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGC 243 (277)
T ss_pred ccccc---------------------------------------------cccCCccCCHHHHHHHHHHccCChhHccCC
Confidence 10000 0011234567899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCcC
Q 020235 312 ---TAREALRHPFFTRDHLR 328 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~~ 328 (329)
|+.++++||||++.+.+
T Consensus 244 ~~~~~~~ll~h~~~~~~~~~ 263 (277)
T cd05577 244 RGGSADEVREHPLFKDLNWR 263 (277)
T ss_pred CcccHHHHHhChhhhcCChh
Confidence 89999999999887764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=310.13 Aligned_cols=275 Identities=30% Similarity=0.460 Sum_probs=212.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||.|+||.||+|.++.+|+.||+|.++.... ......+|+.++..+ .|++++++++++... +..++||||
T Consensus 15 ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-----RHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-----CCCCCcceEEEEecCCCCeEEEEEec
Confidence 6999999999999999999999999874322 123445788889888 568999999988654 568999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++|.+++.... ..+++.++..++.|++.||+|||+.|++|+||||+||+++
T Consensus 90 ~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~-------------------------- 142 (309)
T cd07845 90 CEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-------------------------- 142 (309)
T ss_pred CCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC--------------------------
Confidence 9889999987643 4689999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
.+..++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+....+
T Consensus 143 -~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~ 221 (309)
T cd07845 143 -DKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221 (309)
T ss_pred -CCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 45568888888876554321 22345778999999876 45789999999999999999999999998888888888
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
....+..+..+++........ +....+.... ... .......+..+.++|++||++||++||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------~~~----~~~~~~~~~~~~~li~~ml~~dp~~R~ 282 (309)
T cd07845 222 IQLLGTPNESIWPGFSDLPLV----GKFTLPKQPY-----------NNL----KHKFPWLSEAGLRLLNFLLMYDPKKRA 282 (309)
T ss_pred HHhcCCCChhhchhhhccccc----ccccccCCCC-----------Cch----HHhccccCHHHHHHHHHHhcCChhhCc
Confidence 888877766665544332210 0000000000 000 011123467899999999999999999
Q ss_pred CHHHHhcCCCCCCCCc
Q 020235 312 TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 t~~~ll~hp~f~~~~~ 327 (329)
|+.++++||||++..+
T Consensus 283 t~~~il~h~~f~~~~~ 298 (309)
T cd07845 283 TAEEALESSYFKEKPL 298 (309)
T ss_pred CHHHHhcChhhccCCC
Confidence 9999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=304.95 Aligned_cols=271 Identities=34% Similarity=0.577 Sum_probs=213.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.++.+|+.||+|++.... .......+|+.++..+ .|++++++++++..++..++|+||++
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (286)
T cd07832 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-----QHPYVVKLLDVFPHGSGFVLVMEYMP 82 (286)
T ss_pred cccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-----CCCCCcceeeEEecCCeeEEEecccC
Confidence 699999999999999999999999987432 2245667788888888 46999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .
T Consensus 83 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---------------------------~ 134 (286)
T cd07832 83 SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---------------------------A 134 (286)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---------------------------C
Confidence 99999987654 4689999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+..++|+|||.+....... ....|+..|+|||.+.+. .++.++|||||||++|+|++|.+||.+.++......+.
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 135 DGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214 (286)
T ss_pred CCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence 5668889998877554432 234688899999998754 46899999999999999999999998887777777777
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...+.+....+....+..+. ....++... ...........+..+.++|.+||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 215 RTLGTPNEETWPGLTSLPDY----NKITFPESK---------------PIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred HHcCCCChHHHhhccCcchh----hcccCCCCC---------------cchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 77776665555443321111 000010000 00011122345678999999999999999999
Q ss_pred HHHHhcCCCCC
Q 020235 313 AREALRHPFFT 323 (329)
Q Consensus 313 ~~~ll~hp~f~ 323 (329)
++++++||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999995
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=307.01 Aligned_cols=246 Identities=36% Similarity=0.589 Sum_probs=197.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHh---HHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~---~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.+..+++.||+|++......... ..+|+.++..+ .|++|+++++++.+....++|||++
T Consensus 7 lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 7 LGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-----RHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-----TBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-----cccccccccccccccccccccccccc
Confidence 79999999999999999999999999865433322 24488888888 4689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..+..++.|++.||.+||++|++|+||||+||++ .
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---------------------------~ 132 (260)
T PF00069_consen 82 GGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---------------------------D 132 (260)
T ss_dssp TEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---------------------------S
T ss_pred cccccccccccc--cccccccccccccccccccccccccccccccccccccc---------------------------c
Confidence 669999998432 68999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCccc---CCCCCcccccCCCCchhHHh-cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYE---RPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.++|+|||.+... ........++..|+|||++. +..++.++|+||||+++|+|++|..||......+....+.
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 6677899999998753 22224457888999999998 7788999999999999999999999998763333333333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+......... ..........+.++|.+||+.||++|||
T Consensus 213 ~~~~~~~~~~------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~ 250 (260)
T PF00069_consen 213 KILKRPLPSS------------------------------------------SQQSREKSEELRDLIKKMLSKDPEQRPS 250 (260)
T ss_dssp HHHHTHHHHH------------------------------------------TTSHTTSHHHHHHHHHHHSSSSGGGSTT
T ss_pred hccccccccc------------------------------------------ccccchhHHHHHHHHHHHccCChhHCcC
Confidence 3221110000 0000112368999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
+.++++||||
T Consensus 251 ~~~l~~~~~~ 260 (260)
T PF00069_consen 251 AEELLKHPWF 260 (260)
T ss_dssp HHHHHTSGGG
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=303.52 Aligned_cols=270 Identities=29% Similarity=0.475 Sum_probs=205.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|++|.||+|.++.+++.||+|.+..... ......+|+.++..+ .|++|+++++++.+.+..++||||+++
T Consensus 13 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07844 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-----KHANIVTLHDIIHTKKTLTLVFEYLDT 87 (291)
T ss_pred EeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-----CCcceeeEEEEEecCCeEEEEEecCCC
Confidence 6999999999999999999999999864321 223456799999888 568999999999999999999999977
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||+++ .+
T Consensus 88 ~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~---------------------------~~ 139 (291)
T cd07844 88 DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS---------------------------ER 139 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEc---------------------------CC
Confidence 9999987654 3689999999999999999999999999999999999994 45
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCc-hhHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE-NLEHLAMMER 233 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~ 233 (329)
+.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.. ..+....+.+
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 219 (291)
T cd07844 140 GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFR 219 (291)
T ss_pred CCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 568888888775433221 22346788999999876 457899999999999999999999997765 4455555666
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch--hHHHHHHHHhcccCCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~l~~dP~~R~ 311 (329)
..+.+.+..+.............. . . .....+.. .....+ ..+.+++.+||+.||++||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~----~--~---------~~~~~~~~----~~~~~~~~~~~~~li~~~L~~~p~~Rp 280 (291)
T cd07844 220 VLGTPTEETWPGVSSNPEFKPYSF----P--F---------YPPRPLIN----HAPRLDRIPHGEELALKFLQYEPKKRI 280 (291)
T ss_pred hcCCCChhhhhhhhhccccccccc----c--c---------cCChhHHH----hCcCCCCchhHHHHHHHHhccCccccc
Confidence 666666655554433211111100 0 0 00000111 111223 6789999999999999999
Q ss_pred CHHHHhcCCCC
Q 020235 312 TAREALRHPFF 322 (329)
Q Consensus 312 t~~~ll~hp~f 322 (329)
|+.++++||||
T Consensus 281 s~~e~l~~~~f 291 (291)
T cd07844 281 SAAEAMKHPYF 291 (291)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=305.97 Aligned_cols=272 Identities=28% Similarity=0.463 Sum_probs=209.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh------HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|.++.+++.||+|.++..... ......|+.++..+ .|++++++++++.+.+..++|||
T Consensus 8 lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-----KHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-----CCCCChhhhheeecCCEEEEEEc
Confidence 68999999999999999999999998754322 33445688888877 56999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 75 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 75 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
|++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~------------------------- 136 (298)
T cd07841 83 FMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA------------------------- 136 (298)
T ss_pred ccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc-------------------------
Confidence 99999999997653 3689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.++.++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.+....
T Consensus 137 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~ 214 (298)
T cd07841 137 --SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGK 214 (298)
T ss_pred --CCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHH
Confidence 45568888888876554322 22356778999998865 3578999999999999999999999988777766666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+.+....+............... .... ........+..+.++|.+||++||++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R 273 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPF-----------------PPTP----LKQIFPAASDDALDLLQRLLTLNPNKR 273 (298)
T ss_pred HHHHcCCCchhhhhhccccccccccccc-----------------CCcc----hhhhcccccHHHHHHHHHHhcCCcccC
Confidence 6666655554444332221111000000 0000 011123456789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||++..
T Consensus 274 ~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 274 ITARQALEHPYFSNDP 289 (298)
T ss_pred cCHHHHhhCccccCCC
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=312.55 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=195.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+++++.+++.||+|++.... ........|..++..+ .|++|+.+++.+.+.+..|+||||+
T Consensus 9 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-----DCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 799999999999999999999999987422 1122344566666555 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 84 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill--------------------------- 135 (331)
T cd05624 84 VGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL--------------------------- 135 (331)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---------------------------
Confidence 999999998743 368999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+
T Consensus 136 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~ 215 (331)
T cd05624 136 DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215 (331)
T ss_pred cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH
Confidence 455678999999886554332 23468999999999876 457889999999999999999999998765544
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+......+ .++ ......+..++++|.+||+.+
T Consensus 216 ~~~~i~~~~~~~---------------------~~p-----------------------~~~~~~~~~~~~li~~ll~~~ 251 (331)
T cd05624 216 TYGKIMNHEERF---------------------QFP-----------------------SHITDVSEEAKDLIQRLICSR 251 (331)
T ss_pred HHHHHHcCCCcc---------------------cCC-----------------------CccccCCHHHHHHHHHHccCc
Confidence 333322211000 000 001235678999999999976
Q ss_pred CCC--CCCHHHHhcCCCCCCCC
Q 020235 307 PTD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~--R~t~~~ll~hp~f~~~~ 326 (329)
+.+ |++++++++||||+..+
T Consensus 252 ~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 252 ERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred hhhcCCCCHHHHhcCCCcCCCC
Confidence 655 56999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=299.00 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=193.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHH----hHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|.++....... ....|..++ .....|+|++++++.+..++..++|+||+
T Consensus 4 l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~----~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (260)
T cd05611 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIM----MIQGESPYVAKLYYSFQSKDYLYLVMEYL 79 (260)
T ss_pred CCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHH----hhcCCCCCeeeeeeeEEcCCeEEEEEecc
Confidence 7999999999999999999999999874322111 112222222 22236799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 80 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~--------------------------- 130 (260)
T cd05611 80 NGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--------------------------- 130 (260)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---------------------------
Confidence 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..+..++|+|||.+..... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 131 ~~~~~~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 131 DQTGHLKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred CCCCcEEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc
Confidence 4456689999998765433 233468889999999988888999999999999999999999998765544333222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH--
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 313 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~-- 313 (329)
...+. ......+..+.++|.+||+.||++|||+
T Consensus 210 ~~~~~---------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 244 (260)
T cd05611 210 INWPE---------------------------------------------EVKEFCSPEAVDLINRLLCMDPAKRLGANG 244 (260)
T ss_pred cCCCC---------------------------------------------cccccCCHHHHHHHHHHccCCHHHccCCCc
Confidence 00000 0012356789999999999999999954
Q ss_pred -HHHhcCCCCCCCC
Q 020235 314 -REALRHPFFTRDH 326 (329)
Q Consensus 314 -~~ll~hp~f~~~~ 326 (329)
.|++.||||++.+
T Consensus 245 ~~~~l~~~~~~~~~ 258 (260)
T cd05611 245 YQEIKSHPFFKSIN 258 (260)
T ss_pred HHHHHcChHhhcCC
Confidence 7999999998865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=316.73 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=212.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|-||+||-+.++.+|+.||||++.+ ..+.......|+.|+..+ .||.|+.+...|++.+.+|+|||.+.
T Consensus 572 LGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-----~HPGiV~le~M~ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 572 LGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-----HHPGIVNLECMFETPERVFVVMEKLH 646 (888)
T ss_pred ccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-----CCCCeeEEEEeecCCceEEEEehhhc
Confidence 7999999999999999999999999874 334556778899999999 66999999999999999999999997
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|++.+.|-.....++++..-+.++.|++.||.|||-++|+|+||||+|||+.+. +.
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~------------------------~~ 702 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA------------------------SP 702 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC------------------------CC
Confidence 777777765555689999999999999999999999999999999999999543 45
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
-..+||||||+|++.+... ...+|||.|+|||++..++|...-|+||.||++|.-++|..||.-..+. ..+|
T Consensus 703 FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQI---- 776 (888)
T KOG4236|consen 703 FPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQI---- 776 (888)
T ss_pred CCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHh----
Confidence 6789999999999887764 5678999999999999999999999999999999999999999643322 1122
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+..+.+|.. -|.+++..+.|||..+|++.=.+|-|.+.
T Consensus 777 -------------------QNAaFMyPp~----------------------PW~eis~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 777 -------------------QNAAFMYPPN----------------------PWSEISPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred -------------------hccccccCCC----------------------chhhcCHHHHHHHHHHHHHHHHHhcchHh
Confidence 2222333221 13557889999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
.|.|||+++..
T Consensus 816 ~lsh~Wlq~yq 826 (888)
T KOG4236|consen 816 SLSHPWLQDYQ 826 (888)
T ss_pred hccchhhhcch
Confidence 99999998754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=326.29 Aligned_cols=244 Identities=23% Similarity=0.235 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCC-CceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRER-KEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||.|++|.||+|.+..+ +..||+|.+.... ........|+.++..+ .|+||+++++.+..++..|+||||+ +
T Consensus 75 lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~~~~~~~~~~~~~lv~E~~~g 149 (478)
T PTZ00267 75 VGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-----DHFGIVKHFDDFKSDDKLLLIMEYGSG 149 (478)
T ss_pred EEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEECCEEEEEEECCCC
Confidence 68999999999998877 7889999765432 2334556788888887 6799999999999999999999999 9
Q ss_pred CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 78 SSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 78 ~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++|.+.+... ....+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 150 g~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll--------------------------- 202 (478)
T PTZ00267 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--------------------------- 202 (478)
T ss_pred CCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---------------------------
Confidence 9999988642 22458899999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 203 ~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~ 282 (478)
T PTZ00267 203 MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ 282 (478)
T ss_pred CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 455678999999987654322 335699999999999998899999999999999999999999987655443333
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+...... ......+..+.++|.+||+.||++|
T Consensus 283 ~~~~~~~------------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R 314 (478)
T PTZ00267 283 VLYGKYD------------------------------------------------PFPCPVSSGMKALLDPLLSKNPALR 314 (478)
T ss_pred HHhCCCC------------------------------------------------CCCccCCHHHHHHHHHHhccChhhC
Confidence 2221100 0012356689999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 020235 311 LTAREALRHPFFTR 324 (329)
Q Consensus 311 ~t~~~ll~hp~f~~ 324 (329)
||+++++.|||++.
T Consensus 315 ps~~~~l~~~~~~~ 328 (478)
T PTZ00267 315 PTTQQLLHTEFLKY 328 (478)
T ss_pred cCHHHHHhCHHHHH
Confidence 99999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=302.34 Aligned_cols=244 Identities=25% Similarity=0.435 Sum_probs=193.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc------cCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------YRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~------~~~~~~lv~e 74 (329)
||+|+||.||+|.++.+++.+|+|++............|..++..+ ..|+|++++++++. ..+..+++||
T Consensus 24 lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e 99 (282)
T cd06636 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKY----SHHRNIATYYGAFIKKSPPGHDDQLWLVME 99 (282)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHh----cCCCcEEEEeeehhcccccCCCCEEEEEEE
Confidence 6999999999999999999999999876544455566777777776 25689999999885 3467899999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||++
T Consensus 100 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili------------------------- 154 (282)
T cd06636 100 FCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL------------------------- 154 (282)
T ss_pred eCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------------------
Confidence 99 8899999987655568899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..+..++|+|||.+...... .....|++.|+|||.+.. ..++.++|+|||||++|+|++|..||......
T Consensus 155 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~ 232 (282)
T cd06636 155 --TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM 232 (282)
T ss_pred --CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH
Confidence 44556899999987654322 234568899999999863 35788999999999999999999999754433
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+.. ..+. .. ....++..+.+||++||+.
T Consensus 233 ~~~~~~~~---~~~~-------------------~~-------------------------~~~~~~~~~~~li~~cl~~ 265 (282)
T cd06636 233 RALFLIPR---NPPP-------------------KL-------------------------KSKKWSKKFIDFIEGCLVK 265 (282)
T ss_pred hhhhhHhh---CCCC-------------------CC-------------------------cccccCHHHHHHHHHHhCC
Confidence 22211111 0000 00 0123566899999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 020235 306 DPTDRLTAREALRHPFF 322 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f 322 (329)
||.+|||+.++++||||
T Consensus 266 ~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 266 NYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ChhhCcCHHHHhcCCCC
Confidence 99999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=313.48 Aligned_cols=298 Identities=32% Similarity=0.583 Sum_probs=234.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCC-CCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
.|.|-|++|-.|.+..-|+.||||+++.+....+.-++|+++|+.|..... ...+++.++..|...+|+|+|||.+..+
T Consensus 440 ~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslN 519 (752)
T KOG0670|consen 440 TGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLN 519 (752)
T ss_pred cccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhch
Confidence 489999999999999999999999999888888889999999999977643 3357999999999999999999999999
Q ss_pred HHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 80 LYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 80 l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
|.+.|...+ ..+|...+++.++.||+.||..|..+||+|.||||+|||+. ...
T Consensus 520 LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--------------------------E~k 573 (752)
T KOG0670|consen 520 LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--------------------------ESK 573 (752)
T ss_pred HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--------------------------cCc
Confidence 999998743 35688999999999999999999999999999999999995 345
Q ss_pred CCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
..+||||||.|.....+. ..+.-+..|+|||++.|.+|+...|+||.||+||+|.||+..|.+..+-.++.-.+.+-|+
T Consensus 574 ~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 678999999999887766 3345667899999999999999999999999999999999999999999999999999999
Q ss_pred CChhHHHhhhhhhhhhhhcCCcC-CCCCCCchHHHhhhcc----chhhHHHHhh------hccCchhHHHHHHHHhcccC
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLD-WPEGAASRESIKSVMK----LPRLQNLIMQ------HVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~------~~~~~~~~~~~ll~~~l~~d 306 (329)
+|..|..+-+=.-.-|...--+- ......+......++. ...+...+-. ........+++||.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 99887665321111111110000 0111111111111110 0111111111 01123457999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTR 324 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~ 324 (329)
|++|+|+.++|.||||+.
T Consensus 734 P~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 734 PEKRITVNQALKHPFITE 751 (752)
T ss_pred hhhcCCHHHHhcCCcccC
Confidence 999999999999999985
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=302.22 Aligned_cols=271 Identities=29% Similarity=0.483 Sum_probs=211.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.+|+|.++.... ......+|+.++..+ .|+|++.+++++... +..++||||
T Consensus 13 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-----QHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-----CCCCEEEEEEEEEecCCCcEEEEehh
Confidence 7999999999999999999999999874322 223446788888888 569999999988777 899999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 88 ~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili--------------------------- 139 (293)
T cd07843 88 VEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--------------------------- 139 (293)
T ss_pred cCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---------------------------
Confidence 9779999988754 358999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 140 NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 455668889998877554431 2345788899999987654 689999999999999999999999988888888888
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC-chhHHHHHHHHhcccCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~dP~~R 310 (329)
....+.+++..|........... ..+... ....+... +... .+..+.++|++||+.||++|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-----------~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R 281 (293)
T cd07843 220 FKLLGTPTEKIWPGFSELPGAKK----KTFTKY-----------PYNQLRKK---FPALSLSDNGFDLLNRLLTYDPAKR 281 (293)
T ss_pred HHHhCCCchHHHHHhhccchhcc----cccccc-----------cchhhhcc---ccccCCChHHHHHHHHHhccCcccc
Confidence 88887777666655432211110 000000 00001111 1111 47789999999999999999
Q ss_pred CCHHHHhcCCCC
Q 020235 311 LTAREALRHPFF 322 (329)
Q Consensus 311 ~t~~~ll~hp~f 322 (329)
||+.|+++||||
T Consensus 282 ~t~~ell~~~~f 293 (293)
T cd07843 282 ISAEDALKHPYF 293 (293)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=303.56 Aligned_cols=243 Identities=28% Similarity=0.459 Sum_probs=203.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++.+..+++.||+|.+.... .......+|+.++..+ .|+||+++++.+..++..++||||+
T Consensus 9 ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-----RHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred eecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-----CCCCccceeeEEEcCCeEEEEEecC
Confidence 689999999999999999999999986432 2345566788888888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|.||++
T Consensus 84 ~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili--------------------------- 134 (290)
T cd05580 84 PGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL--------------------------- 134 (290)
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---------------------------
Confidence 999999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++.++|+|||.+...........|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+....
T Consensus 135 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (290)
T cd05580 135 DSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214 (290)
T ss_pred CCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 45566899999998876665555678999999999988888899999999999999999999998765433333222111
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC----
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---- 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---- 311 (329)
.+. ....+..+.++|++||+.||.+|+
T Consensus 215 ~~~-------------------------------------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~ 245 (290)
T cd05580 215 VRF-------------------------------------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLK 245 (290)
T ss_pred ccC-------------------------------------------------CccCCHHHHHHHHHHccCCHHHccCccc
Confidence 111 122456889999999999999999
Q ss_pred -CHHHHhcCCCCCCCC
Q 020235 312 -TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -t~~~ll~hp~f~~~~ 326 (329)
+++++++||||++..
T Consensus 246 ~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 246 NGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHHHcCcccccCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=309.09 Aligned_cols=236 Identities=25% Similarity=0.350 Sum_probs=203.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|-||.||.+.++.+ ..||+|.++...-..+...+|+++++.+ .|++|+++++++..+..++|||||+ .|+
T Consensus 214 LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L-----~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKL-----RHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred hcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhC-----cccCeEEEEEEEecCCceEEEEEecccCc
Confidence 79999999999998864 3699999987666667788999999999 6699999999999988999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.++|+...+..++..+.+.++.||+.|++||++++++||||-..|||+ +.+.
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---------------------------~~~~ 340 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---------------------------DEDL 340 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---------------------------ccCc
Confidence 9999998666789999999999999999999999999999999999999 5666
Q ss_pred CeEEeeCCCCcccCCCCC-ccc---ccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQN-YIV---STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~-~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||+|+....+.- ... -+..|+|||.+....++.+||||||||+||||+| |+.||.+....+....+.+.
T Consensus 341 ~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G 420 (468)
T KOG0197|consen 341 VVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG 420 (468)
T ss_pred eEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc
Confidence 789999999984443331 112 2457999999999999999999999999999998 99999998888887777765
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..=+ .++.+++.+.++|..||..+|++|||++
T Consensus 421 yRlp------------------------------------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~ 452 (468)
T KOG0197|consen 421 YRLP------------------------------------------------RPEGCPDEVYELMKSCWHEDPEDRPTFE 452 (468)
T ss_pred CcCC------------------------------------------------CCCCCCHHHHHHHHHHhhCCcccCCCHH
Confidence 3211 1234677899999999999999999998
Q ss_pred HHh
Q 020235 315 EAL 317 (329)
Q Consensus 315 ~ll 317 (329)
.+.
T Consensus 453 ~L~ 455 (468)
T KOG0197|consen 453 TLR 455 (468)
T ss_pred HHH
Confidence 765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=298.84 Aligned_cols=241 Identities=28% Similarity=0.441 Sum_probs=195.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|++|.||+|.+..+++.||+|.+..... ......+|+.++..+ .|++|+++++++.++...++|+|
T Consensus 10 lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-----QHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEccCCeEEEEEE
Confidence 6999999999999999999999998864221 123456688888777 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+.+.... .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 85 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv------------------------- 137 (263)
T cd06625 85 YMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR------------------------- 137 (263)
T ss_pred ECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-------------------------
Confidence 99 899999998754 58899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+....
T Consensus 138 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 215 (263)
T cd06625 138 --DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215 (263)
T ss_pred --cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH
Confidence 455668899999876443321 224577899999999998899999999999999999999999976544332
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
.......... .+.....+..+.++|++||..+|
T Consensus 216 ~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p 248 (263)
T cd06625 216 IFKIATQPTN-----------------------------------------------PQLPSHVSPDARNFLRRTFVENA 248 (263)
T ss_pred HHHHhccCCC-----------------------------------------------CCCCccCCHHHHHHHHHHhhcCc
Confidence 2221111000 01123456789999999999999
Q ss_pred CCCCCHHHHhcCCCC
Q 020235 308 TDRLTAREALRHPFF 322 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f 322 (329)
.+|||+.++++||||
T Consensus 249 ~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 249 KKRPSAEELLRHFFV 263 (263)
T ss_pred ccCCCHHHHhhCCCC
Confidence 999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=307.18 Aligned_cols=274 Identities=25% Similarity=0.390 Sum_probs=202.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|++|+||+|.+..+++.||+|.+..... .......|+.++..+ .|++|+++++.+.+++..++||||+
T Consensus 9 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-----DHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred ecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-----CCCCchhheeeeecCCEEEEEEEec
Confidence 6999999999999999999999999875322 234566788888877 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.+++.|||++.............
T Consensus 84 ~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 163 (316)
T cd05574 84 PGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKA 163 (316)
T ss_pred CCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccc
Confidence 8999999987655578999999999999999999999999999999999999777776677766554432221110000
Q ss_pred CCCCCeE--EeeCCCC---cccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIK--VIDFGST---TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~--l~Dfg~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
....... ....+.. ...........||..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 243 (316)
T cd05574 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSN 243 (316)
T ss_pred cccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH
Confidence 0000000 0000000 0001111234688999999999988899999999999999999999999987665443332
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.......+ . ....+..+.++|.+||..||++|
T Consensus 244 ~~~~~~~~~-----------------------~------------------------~~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 244 ILKKEVTFP-----------------------G------------------------SPPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred HhcCCccCC-----------------------C------------------------ccccCHHHHHHHHHHccCCHhHC
Confidence 221111100 0 01146789999999999999999
Q ss_pred CC----HHHHhcCCCCCCCC
Q 020235 311 LT----AREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t----~~~ll~hp~f~~~~ 326 (329)
|| +.++++||||++..
T Consensus 277 ~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 277 LGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CCchhhHHHHHcCchhhcCC
Confidence 99 99999999998753
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=324.65 Aligned_cols=244 Identities=23% Similarity=0.265 Sum_probs=194.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--------ce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--------HI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--------~~ 69 (329)
||+|+||+||+|++..+++.||+|++.... .......+|+..+..+ .|+++++++..+...+ .+
T Consensus 40 LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-----~h~~iv~~~~~~~~~~~~~~~~~~~i 114 (496)
T PTZ00283 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-----DFFSIVKCHEDFAKKDPRNPENVLMI 114 (496)
T ss_pred EecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-----CCCcEEEeecceecccccCcccceEE
Confidence 799999999999999999999999986432 2234455677766665 6688999887665322 47
Q ss_pred EEEeecC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 70 CIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 70 ~lv~e~~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
++||||+ +++|.+++... ....+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 115 ~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl------------------ 176 (496)
T PTZ00283 115 ALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL------------------ 176 (496)
T ss_pred EEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE------------------
Confidence 8999999 99999999753 22468999999999999999999999999999999999999
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
..++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 177 ---------~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 177 ---------CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred ---------eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 45567899999988654322 2345799999999999998899999999999999999999999987
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..+....+.... . .......+..+.+++.+
T Consensus 248 ~~~~~~~~~~~~~~--~----------------------------------------------~~~~~~~~~~l~~li~~ 279 (496)
T PTZ00283 248 ENMEEVMHKTLAGR--Y----------------------------------------------DPLPPSISPEMQEIVTA 279 (496)
T ss_pred CCHHHHHHHHhcCC--C----------------------------------------------CCCCCCCCHHHHHHHHH
Confidence 65443332221110 0 00122456789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
||+.||++|||+.++++|||++.
T Consensus 280 ~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 280 LLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HcccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=300.42 Aligned_cols=270 Identities=30% Similarity=0.568 Sum_probs=202.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|++.... ...+....|+.++..+ .|+|++++++.+...+..++||||+
T Consensus 9 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-----KHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-----CCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 699999999999999999999999886432 1234456788888888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++.+..++.... .+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~--------------------------- 134 (286)
T cd07847 84 HTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT--------------------------- 134 (286)
T ss_pred ccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---------------------------
Confidence 666655554432 589999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~ 214 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214 (286)
T ss_pred CCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 44568888888876554332 234577889999998764 57899999999999999999999999877776666666
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+............ ..+........+ .............+..+.+|+.+||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 276 (286)
T cd07847 215 KTLGDLIPRHQQIFST--NQFFKGLSIPEP----------------ETREPLESKFPNISSPALSFLKGCLQMDPTERLS 276 (286)
T ss_pred HHhCCCChHHhhhccc--ccccccccCCCc----------------ccccCHHHHhccCCHHHHHHHHHHhcCCccccCC
Confidence 6665544322111100 000000000000 0000011122345778999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
+.+++.||||
T Consensus 277 ~~eil~~~~f 286 (286)
T cd07847 277 CEELLEHPYF 286 (286)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=295.08 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=199.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|++|.||+|.++.+++.||+|.+... .........|+.++..+ .|+|++++++.+.+.+..++||||+
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-----DSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-----CCCCeehheeeeccCCEEEEEEEeCC
Confidence 68999999999999999999999998632 33455667788888887 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.......++...+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~--------------------------- 135 (256)
T cd08529 83 NGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD--------------------------- 135 (256)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---------------------------
Confidence 99999999876556789999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+....... ....|++.|+|||++.+..++.++|+|||||++++|++|+.||...+.......+.+
T Consensus 136 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08529 136 AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215 (256)
T ss_pred CCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 45568888888876544332 234678899999999988899999999999999999999999987664433322221
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...+ .....++.++.+++++||+.+|++||++
T Consensus 216 ~~~~------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 247 (256)
T cd08529 216 GVFP------------------------------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDT 247 (256)
T ss_pred CCCC------------------------------------------------CCccccCHHHHHHHHHHccCCcccCcCH
Confidence 1100 0011345689999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++|||+
T Consensus 248 ~~ll~~~~~ 256 (256)
T cd08529 248 FQLLRNPSL 256 (256)
T ss_pred HHHhhCCCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=301.93 Aligned_cols=272 Identities=32% Similarity=0.522 Sum_probs=205.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc-----eEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-----ICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~-----~~lv 72 (329)
||+|+||.||+|.+..+++.||+|.++.... ......+|+.++..+. +|++++++++++..... .++|
T Consensus 9 lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS----ESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred ecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHcc----CCCCccceeeeEeecCCCCCceEEEE
Confidence 6999999999999999999999998764321 2345677888888883 45889999998876655 8999
Q ss_pred eecCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|||+.+++.+++.... ...+++..++.++.|++.||.|||++|++|+||+|+||+++.
T Consensus 85 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~------------------- 145 (295)
T cd07837 85 FEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDK------------------- 145 (295)
T ss_pred eeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEec-------------------
Confidence 9999778988887532 235799999999999999999999999999999999999943
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+..++|+|||.+....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..
T Consensus 146 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~ 218 (295)
T cd07837 146 -------QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL 218 (295)
T ss_pred -------CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 15568899999876543322 22356788999998875 35789999999999999999999999987777
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+..+..+...++...+...... .+ ..............+..+.+||.+||..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~---------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 277 (295)
T cd07837 219 QQLLHIFKLLGTPTEQVWPGVSKLRDWHE------FP---------------QWKPQDLSRAVPDLSPEGLDLLQKMLRY 277 (295)
T ss_pred HHHHHHHHHhCCCChhhCcchhhccchhh------cC---------------cccchhHHHhccccCHHHHHHHHHHccC
Confidence 76666666655554444332222111000 00 0000011111234677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 020235 306 DPTDRLTAREALRHPFFT 323 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~ 323 (329)
||.+|||+.++++||||+
T Consensus 278 ~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhcCCHHHHhcCCCcC
Confidence 999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.06 Aligned_cols=269 Identities=31% Similarity=0.537 Sum_probs=208.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++.... ......+|+.++..+ ..|+|++++++++.+. +..++||||+
T Consensus 7 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l----~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL----SPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred ccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhc----CCCCCccceEEEEecCCCCcEEEEEecC
Confidence 6999999999999999999999999874321 122334577766666 2478999999999887 8999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l---------------------------~ 134 (282)
T cd07831 83 DMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI---------------------------K 134 (282)
T ss_pred CccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE---------------------------c
Confidence 779998887643 358999999999999999999999999999999999999 3
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
. +.++|+|||.+....... ....++..|+|||.+.. ..++.++|+|||||++|+|++|.+||.+.+..+....+..
T Consensus 135 ~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~ 213 (282)
T cd07831 135 D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHD 213 (282)
T ss_pred C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHH
Confidence 4 678999999887554332 23457889999998755 4468899999999999999999999998888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+..+..+........ .....++.. ....+.......+..+.++|.+||+.||++|||+
T Consensus 214 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 273 (282)
T cd07831 214 VLGTPDAEVLKKFRKSR-----HMNYNFPSK---------------KGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273 (282)
T ss_pred HcCCCCHHHHHhhcccc-----cccccCccc---------------ccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence 88877766533221110 000111110 0001111223457899999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||||
T Consensus 274 ~~~l~~~~~ 282 (282)
T cd07831 274 KQALRHPYF 282 (282)
T ss_pred HHHhhCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=299.73 Aligned_cols=249 Identities=25% Similarity=0.452 Sum_probs=197.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.+..++..+|+|.+.... .......+|+.++..+ .|+|++++++.+..++..++|+||+ ++
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~~v~e~~~~~ 87 (282)
T cd06643 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWILIEFCAGG 87 (282)
T ss_pred cccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-----CCCCeeeEEEEEeeCCEEEEEEEecCCC
Confidence 799999999999999999999999986432 3344566788888887 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|..++.+.. ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .+
T Consensus 88 ~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---------------------------~~ 139 (282)
T cd06643 88 AVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---------------------------LD 139 (282)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---------------------------cC
Confidence 9888876533 3689999999999999999999999999999999999994 45
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++|+|||.+...... .....++..|+|||++. ...++.++|+|||||++|+|++|++||...+..+....
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 219 (282)
T cd06643 140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219 (282)
T ss_pred CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence 56888888877543322 12346888999999984 33477899999999999999999999977655443333
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.....+.. ..+..++..+.+||.+||..||.+|
T Consensus 220 ~~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 253 (282)
T cd06643 220 IAKSEPPTL----------------------------------------------AQPSRWSSEFKDFLKKCLEKNVDAR 253 (282)
T ss_pred HhhcCCCCC----------------------------------------------CCccccCHHHHHHHHHHccCChhhC
Confidence 222111100 0012345689999999999999999
Q ss_pred CCHHHHhcCCCCCCCCcC
Q 020235 311 LTAREALRHPFFTRDHLR 328 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~~~ 328 (329)
||+.++++||||+....+
T Consensus 254 p~~~~il~~~~~~~~~~~ 271 (282)
T cd06643 254 WTTTQLLQHPFVTVNSNK 271 (282)
T ss_pred cCHHHHhcCCCEeccCCC
Confidence 999999999999876543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=303.05 Aligned_cols=281 Identities=26% Similarity=0.396 Sum_probs=200.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||++.+..++..+|+|.+... ........+|+.++..+ .|+||+++++.+.+++..++||||+ +
T Consensus 9 lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ey~~~ 83 (308)
T cd06615 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-----NSPYIVGFYGAFYSDGEISICMEHMDG 83 (308)
T ss_pred ccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCEEEEEeeccCC
Confidence 79999999999999999999999988643 22334567788888888 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~--------------------------- 134 (308)
T cd06615 84 GSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN--------------------------- 134 (308)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---------------------------
Confidence 99999998753 68999999999999999999997 6999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.+..++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (308)
T cd06615 135 SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPV 214 (308)
T ss_pred cCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcc
Confidence 4455788888877543322 234578899999999988889999999999999999999999997655332221111110
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
...+... ... . ........+......+.......... ... ....++.++++|+.+||..||++|||+.+
T Consensus 215 ~~~~~~~---~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 283 (308)
T cd06615 215 SEGEAKE---SHR---P-VSGHPPDSPRPMAIFELLDYIVNEPP--PKL--PSGAFSDEFQDFVDKCLKKNPKERADLKE 283 (308)
T ss_pred ccccccC---Ccc---c-ccCCCCCccchhhHHHHHHHHhcCCC--ccC--cCcccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000000 000 0 00000000000000000000000000 000 01125678999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||.+..
T Consensus 284 ll~~~~~~~~~ 294 (308)
T cd06615 284 LTKHPFIKRAE 294 (308)
T ss_pred HhcChhhhhcc
Confidence 99999998753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=290.06 Aligned_cols=287 Identities=29% Similarity=0.493 Sum_probs=221.7
Q ss_pred CCCccceEEEEEEecCCC----ceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERK----EMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv 72 (329)
||+|.||.||+|..+.+. +.+|||.++... .....+.+|+.++..+ .|+|++.+..+|-. +..++++
T Consensus 32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-----~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-----KHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-----cCCcchhHHHHHhccCceEEEE
Confidence 689999999999766553 378999987542 3456678899999999 56999999998887 7899999
Q ss_pred eecCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+||...+|..+|+-.. .+.++...++.++.|++.|+.|||++=|.||||||.|||+--+|
T Consensus 107 fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg----------------- 169 (438)
T KOG0666|consen 107 FDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG----------------- 169 (438)
T ss_pred ehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC-----------------
Confidence 9999999999997422 24689999999999999999999999999999999999996655
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
...+.|||+|+|+++....+-. ..+-|.-|+|||++.+.. |+++.|+||.|||+.||++-.+.|.+.
T Consensus 170 ------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 170 ------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred ------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 5678999999999987765432 235577899999999875 899999999999999999999999664
Q ss_pred c---------hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 223 E---------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 223 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
. ..+...+|.+++|.+..+-|+.+....+.......+.. .......+....+. ...-++
T Consensus 244 E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~-----------~~~~n~sL~~~~~~-~k~k~~ 311 (438)
T KOG0666|consen 244 EEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRR-----------HYYDNVSLHKYYHK-HKVKDP 311 (438)
T ss_pred hhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHH-----------hhcCcchHHHHHHH-hcCCCc
Confidence 2 23567789999999988887776554432111100000 00000011111111 122345
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
...+|+.+||++||.+|+|++++++|+||++.++
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~l 345 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALEHPYFTEDPL 345 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhcccccccCCC
Confidence 5899999999999999999999999999998764
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=294.56 Aligned_cols=242 Identities=25% Similarity=0.421 Sum_probs=194.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~e~~ 76 (329)
||.|++|.||++.++.+++.||+|.+.... ...+....|+.++..+ .|++++++.+.+.. +...+++||++
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-----KHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeecCCCCEEEEEeccc
Confidence 689999999999999999999999986432 2234556677777777 56899999887764 45689999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++.++..++.+++.||.+||+.|++|+||||+||+++
T Consensus 83 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~-------------------------- 136 (257)
T cd08223 83 EGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT-------------------------- 136 (257)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe--------------------------
Confidence 89999999875545689999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.+..++|+|||.+...... .....+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.
T Consensus 137 -~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 215 (257)
T cd08223 137 -RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII 215 (257)
T ss_pred -cCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 4556888888887654322 133467889999999998889999999999999999999999997655433322222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.. ..+ ......+..+.+++.+||+.||++|||
T Consensus 216 ~~--~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~ 247 (257)
T cd08223 216 EG--KLP----------------------------------------------PMPKDYSPELGELIATMLSKRPEKRPS 247 (257)
T ss_pred hc--CCC----------------------------------------------CCccccCHHHHHHHHHHhccCcccCCC
Confidence 11 110 001235668999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
+.++++||||
T Consensus 248 ~~~~l~~~~~ 257 (257)
T cd08223 248 VKSILRQPYI 257 (257)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=298.57 Aligned_cols=270 Identities=31% Similarity=0.510 Sum_probs=211.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||.|++|.||+|.++.+|..||+|++.... ........|+.++..+ .|++++++++++.+++..+++|||++
T Consensus 7 l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-----NHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred ecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-----CCCCccCHhheeccCCeEEEEEeccC
Confidence 699999999999999999999999987432 2234566788888888 56999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||++ ..
T Consensus 82 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~---------------------------~~ 134 (283)
T cd07835 82 LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---------------------------DR 134 (283)
T ss_pred cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---------------------------cC
Confidence 899999887554468999999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....++..|+|||++.+. .++.++|+||||+++|+|++|++||...+.......+.+
T Consensus 135 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 135 EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred CCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5668888888876543222 223568889999988764 468899999999999999999999988777666666666
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.+....+.......+......... ...........+..+.++|.+||+.||++|||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 274 (283)
T cd07835 215 TLGTPDEDVWPGVTSLPDYKPTFPKWA--------------------RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA 274 (283)
T ss_pred HhCCCChHHhhhhhhchhhhhhccccc--------------------ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 666666555544322211110000000 000111233466789999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||||
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.51 Aligned_cols=275 Identities=30% Similarity=0.479 Sum_probs=212.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||.|++|+||++.++.+++.||+|.+.... ........|+.++..+ .|+|++++++++.+.+..++||||++
T Consensus 10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-----QHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred ecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-----cCCCEeeEEEEEecCCeEEEEEeccc
Confidence 689999999999999999999999986432 2234566788888888 56999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+.+.......+++..++.++.|++.||+|||++|++|+||+|+||+++. .
T Consensus 85 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~--------------------------~ 138 (294)
T PLN00009 85 LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR--------------------------R 138 (294)
T ss_pred ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC--------------------------C
Confidence 88988887655445688899999999999999999999999999999999953 2
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+..++|+|||.+....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~ 218 (294)
T PLN00009 139 TNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFR 218 (294)
T ss_pred CCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3458899999886543322 234578899999998764 578999999999999999999999988777777766666
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.++...|.......+...... .+. .. .........+..+.+++.+||+.||++|||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~--------------~~----~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 219 ILGTPNEETWPGVTSLPDYKSAFP--KWP--------------PK----DLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred HhCCCChhhccccccchhhhhhcc--cCC--------------CC----CHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 666655555443222111100000 000 00 0001123467789999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.++++||||.+..
T Consensus 279 ~~~l~~~~~~~~~ 291 (294)
T PLN00009 279 RAALEHEYFKDLG 291 (294)
T ss_pred HHHhcCchHhHHh
Confidence 9999999998753
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=307.71 Aligned_cols=290 Identities=26% Similarity=0.429 Sum_probs=208.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhH---------------HhHHHHHHHHHHHHhhCCCCCceeeecccccc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------------EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~---------------~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~ 65 (329)
||+|+||+||+|.++.+++.||+|+++...... ....+|+.++..+ .|+|++++++++..
T Consensus 17 ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-----KHENIMGLVDVYVE 91 (335)
T ss_pred ccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-----CCcceeeeeEEEec
Confidence 799999999999999999999999987432211 1356788888888 56999999999999
Q ss_pred CCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 66 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 66 ~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
++..++|||++.++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+++.|||.+...
T Consensus 92 ~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 92 GDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred CCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 99999999999889999997653 5899999999999999999999999999999999999966555555555444322
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
..+........ +.+. ..........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+.
T Consensus 170 ~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 170 GYPPYSDTLSK--------DETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ccccccccccc--------cccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11100000000 0000 000111223467889999998764 468999999999999999999999998888
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.+....+....+.++...+.......... . +... .. ..........+..+.++|.+||+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~---~~~~-------------~~----~~~~~~~~~~~~~~~~li~~~l~ 298 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYT-E---FTPR-------------KP----KDLKTIFPNASDDAIDLLQSLLK 298 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhccccc-c---cCcC-------------Cc----ccHHHhCcCCChHHHHHHHHHcC
Confidence 77777777777665554333221100000 0 0000 00 00111123456789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCcC
Q 020235 305 YDPTDRLTAREALRHPFFTRDHLR 328 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~~~ 328 (329)
.||++|||+++++.||||++...+
T Consensus 299 ~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 299 LNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CCchhccCHHHHhcCcccCCCCCC
Confidence 999999999999999999987654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=307.62 Aligned_cols=273 Identities=26% Similarity=0.491 Sum_probs=214.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc------eEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH------ICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~------~~l 71 (329)
||+|++|.||+|++..+++.||+|++... ........+|+.++..+ .|++++++.+++...+. .++
T Consensus 23 ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-----DHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred eccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-----cCCCHHHHHHHhhccccccccccEEE
Confidence 69999999999999999999999987642 22334566788888888 56899999888776554 999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+++++++|.+++... .+++..++.++.|++.||+|||+.|++|+||||+||++
T Consensus 98 v~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill----------------------- 151 (343)
T cd07851 98 VTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----------------------- 151 (343)
T ss_pred EEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-----------------------
Confidence 9999999999998763 58999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..++.++|+|||.+...........++..|+|||.+.+. .++.++|+|||||++|++++|+.||.+.+.......
T Consensus 152 ----~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~ 227 (343)
T cd07851 152 ----NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR 227 (343)
T ss_pred ----CCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 445668999999887765555556788899999998763 578999999999999999999999988877777777
Q ss_pred HHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.+++.++.++.... ..+....... ..+ .........+..+.++|++||..||++
T Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~----~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 228 IMNLVGTPDEELLQKISSESARNYIQSLPQM---------------PKK----DFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHHhcCCCCHHHHhhccchhHHHHHHhcccc---------------CCC----CHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 77777777776655543211 1111000000 000 001112235778999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||+.+|++||||.+-+.
T Consensus 289 Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 289 RITAAEALAHPYLAEYHD 306 (343)
T ss_pred CCCHHHHhcCCCccccCC
Confidence 999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=296.03 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|++|.||+|.++.+++.+|+|++.... ...+...+|+.++..+ .|++++++.+.+.+++..++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-----NHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-----CCCCEeeeeeeEEcCCccEEEEecC
Confidence 799999999999999999999999986432 2345566788888777 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv--------------------------- 126 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL--------------------------- 126 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---------------------------
Confidence 899999998754 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc--hhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE--NLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~ 231 (329)
+.+..++|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+
T Consensus 127 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 206 (262)
T cd05572 127 DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDI 206 (262)
T ss_pred cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHH
Confidence 44566899999988765443 233468889999999988889999999999999999999999997655 22222111
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... . ..+...+..+.++|.+||+.||++|+
T Consensus 207 ~~~~~~---------------------~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~ 239 (262)
T cd05572 207 LKGNGK---------------------L--------------------------EFPNYIDKAAKDLIKQLLRRNPEERL 239 (262)
T ss_pred hccCCC---------------------C--------------------------CCCcccCHHHHHHHHHHccCChhhCc
Confidence 110000 0 01122356899999999999999999
Q ss_pred C-----HHHHhcCCCCCCC
Q 020235 312 T-----AREALRHPFFTRD 325 (329)
Q Consensus 312 t-----~~~ll~hp~f~~~ 325 (329)
| +.|+++||||++-
T Consensus 240 ~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 240 GNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred CCcccCHHHHhcChhhhCC
Confidence 9 9999999999874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=297.40 Aligned_cols=270 Identities=30% Similarity=0.512 Sum_probs=210.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||.|++|.||+|.++.+|+.||+|.++... ........|+.++..+ .|+|++++++.+.+.+..++||||+.+
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-----KHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-----cCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 689999999999999999999999987532 2244566788888888 569999999999999999999999977
Q ss_pred CHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+|.+++.... ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---------------------------~~ 135 (284)
T cd07836 83 DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---------------------------NK 135 (284)
T ss_pred cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---------------------------CC
Confidence 9999887643 2358999999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+.+
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 136 RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 5568888888876443221 234568889999998764 468899999999999999999999998887777777777
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
....+....++.+.... .+.. ..+. .............+..+.+++.+||+.||.+|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~-~~~~----~~~~---------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 275 (284)
T cd07836 216 IMGTPTESTWPGISQLP-EYKP----TFPR---------------YPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275 (284)
T ss_pred HhCCCChhhHHHHhcCc-hhcc----cccC---------------CChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH
Confidence 76666555544433111 0100 0000 00011112223456789999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||||
T Consensus 276 ~~~l~~~~f 284 (284)
T cd07836 276 HDALQHPWF 284 (284)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=302.72 Aligned_cols=272 Identities=27% Similarity=0.511 Sum_probs=205.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--------ce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--------HI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--------~~ 69 (329)
||+|+||.||+|.++.+++.||+|.+.... .......+|+.++..+ .|++++++++++.... ..
T Consensus 20 lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~~ 94 (310)
T cd07865 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKATPYNRYKGSF 94 (310)
T ss_pred eecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-----CCCCccceEEEEecccccccCCCceE
Confidence 699999999999999999999999886422 1233445788888888 5689999998876543 46
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++||||+++++.+.+.... ..+++..++.++.|++.||+|||++|++|+||||+||+++
T Consensus 95 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~-------------------- 153 (310)
T cd07865 95 YLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT-------------------- 153 (310)
T ss_pred EEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEC--------------------
Confidence 9999999889988887643 3589999999999999999999999999999999999994
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
.+..++|+|||.+....... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+
T Consensus 154 -------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~ 226 (310)
T cd07865 154 -------KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQG 226 (310)
T ss_pred -------CCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 45567778888775443221 1235678899999987654 68899999999999999999999998
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+.......+.+..+..+.++++....... +. ....+... .......+ .....+..+.+||.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~--~~~~~~~l-----------~~~~~~~~~~dli~~ 289 (310)
T cd07865 227 NTEQHQLTLISQLCGSITPEVWPGVDKLEL-FK---KMELPQGQ--KRKVKERL-----------KPYVKDPHALDLIDK 289 (310)
T ss_pred CCHHHHHHHHHHHhCCCChhhcccccchhh-hh---hccCCCcc--chhhHHhc-----------ccccCCHHHHHHHHH
Confidence 887777778888888887766554322110 00 00000000 00000000 001235678999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f 322 (329)
||+.||++|||++++++||||
T Consensus 290 ~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 290 LLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HhcCChhhccCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=297.39 Aligned_cols=250 Identities=26% Similarity=0.402 Sum_probs=193.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|.+..... .......|..++..+.. ..|++++.+.+.+...+..++||||+
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHh--CCCCcEeeeeeeeecCCEEEEEEecC
Confidence 7999999999999999999999999874321 11223334444444322 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..++.++.|++.||.|||+.+++|+||||+||++
T Consensus 80 ~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili--------------------------- 130 (278)
T cd05606 80 NGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--------------------------- 130 (278)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---------------------------
Confidence 999999887653 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..++.++|+|||.+...... .....|+..|+|||.+.+. .++.++|+||+||++|+|++|+.||..............
T Consensus 131 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 131 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 210 (278)
T ss_pred CCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH
Confidence 44556888888887644322 2345789999999998754 588999999999999999999999976432111100000
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
.... ....+...+..+.+++.+||..||.+|+
T Consensus 211 ~~~~----------------------------------------------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~ 244 (278)
T cd05606 211 TLTM----------------------------------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGC 244 (278)
T ss_pred hhcc----------------------------------------------CCCCCCcCCHHHHHHHHHHhhcCHHhccCC
Confidence 0000 0011223567899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCCc
Q 020235 312 ---TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~~ 327 (329)
|+.++++||||++.+.
T Consensus 245 ~~~~~~~ll~~~~~~~~~~ 263 (278)
T cd05606 245 LGRGAQEVKEHPFFRSLDW 263 (278)
T ss_pred CCCCHHHHHhCccccCCCc
Confidence 9999999999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=288.12 Aligned_cols=280 Identities=28% Similarity=0.488 Sum_probs=220.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--------CCce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------~~~~ 69 (329)
+|+|.||.||+|+.+.+++.||+|++-. ........++|+.++..+. |+|++.+++.+.+ ...+
T Consensus 25 igqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-----Henv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 25 IGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-----HENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred cCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-----chhHHHHHHHHhhccCCccccccee
Confidence 6999999999999999999999997643 3455677889999999994 4777777776653 2358
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|+||.+|..+|.-++.... .+++...+++++.+++.||.|+|...|.|||+|+.|+||
T Consensus 100 ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI--------------------- 157 (376)
T KOG0669|consen 100 YLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI--------------------- 157 (376)
T ss_pred eeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE---------------------
Confidence 9999999999999998753 469999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
++++.++|+|||.++...... ...+-|..|++||.+.+. .|+++.|+|..||++.+|++|.+.+++
T Consensus 158 ------t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 158 ------TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred ------cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 566778888888885433222 234558899999999886 589999999999999999999999999
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
..+...+.-|..++|+.+.++|+.+....-.-.-. ..+.+.... ..+.+...++. -.++..||+.+
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie-~ePl~~~~~-----------rkv~n~~kp~~--kd~~a~dLle~ 297 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIE-LEPLPKGQK-----------RKVKNRLKPYV--KDDEALDLLEK 297 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhcc-CCCCCcchh-----------hhhhhhccccc--CChhHHHHHHH
Confidence 99999999999999999999998875533221110 000111000 01111111111 24578899999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
||..||.+|++++++++|.||..+..
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HhccCcccCcchHhhhchhhhhcCCc
Confidence 99999999999999999999987653
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=298.55 Aligned_cols=247 Identities=29% Similarity=0.486 Sum_probs=197.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.++.++..+|+|.+.... ........|+.++..+ .|++++++++.+.++...++||||+ ++
T Consensus 13 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd06611 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-----KHPNIVGLYEAYFYENKLWILIEFCDGG 87 (280)
T ss_pred hcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEecCCeEEEEeeccCCC
Confidence 699999999999999899999999987432 2334566788888888 5699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++ ..+
T Consensus 88 ~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---------------------------~~~ 139 (280)
T cd06611 88 ALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---------------------------TLD 139 (280)
T ss_pred cHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---------------------------CCC
Confidence 9999987643 368999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++|+|||.+...... .....|++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.......
T Consensus 140 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~ 219 (280)
T cd06611 140 GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219 (280)
T ss_pred CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH
Confidence 66888888876544322 233468889999999863 3467899999999999999999999977554433322
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+... ..+. . ......+..+.++|.+||+.||++|
T Consensus 220 ~~~~--~~~~------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~~R 253 (280)
T cd06611 220 ILKS--EPPT------------------L--------------------------DQPSKWSSSFNDFLKSCLVKDPDDR 253 (280)
T ss_pred HhcC--CCCC------------------c--------------------------CCcccCCHHHHHHHHHHhccChhhC
Confidence 2211 0000 0 0012345689999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||++..
T Consensus 254 ps~~~il~~~~~~~~~ 269 (280)
T cd06611 254 PTAAELLKHPFVSDQS 269 (280)
T ss_pred cCHHHHhcChhhcccc
Confidence 9999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=300.91 Aligned_cols=244 Identities=26% Similarity=0.422 Sum_probs=197.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.+..+++.+|+|.+.... .......+|+.++..+ .|+|++++++.+..+...++||||+ ++
T Consensus 28 lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~v~~~~~~~~~~~~~~lv~e~~~~~ 102 (296)
T cd06654 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (296)
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-----CCCCEeeEEEEEEeCCEEEEeecccCCC
Confidence 699999999999999999999999887533 2345566788888777 6699999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++.++..++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 103 ~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---------------------------~~~ 152 (296)
T cd06654 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---------------------------GMD 152 (296)
T ss_pred CHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---------------------------cCC
Confidence 999998764 48899999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~- 231 (296)
T cd06654 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN- 231 (296)
T ss_pred CCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-
Confidence 568888888876543322 2346888999999999888899999999999999999999999765543222111110
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+..+ . +....++..+.+++.+||..||++|||+.+
T Consensus 232 ~~~~---------------------~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 266 (296)
T cd06654 232 GTPE---------------------L------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (296)
T ss_pred CCCC---------------------C------------------------CCccccCHHHHHHHHHHCcCCcccCcCHHH
Confidence 0000 0 001234567899999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||...
T Consensus 267 il~~~~~~~~ 276 (296)
T cd06654 267 LLQHQFLKIA 276 (296)
T ss_pred HhhChhhhcc
Confidence 9999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=302.37 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=194.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.+..+++.||+|.+... .........|+.++..+ .|++++++++.+...+..++||||+ +
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-----DSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 79999999999999999999999998643 22334567788888888 6699999999999999999999999 7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++..+. .+++..+..++.|++.||.|||+.|++|+||||+||++ ..
T Consensus 84 ~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---------------------------~~ 130 (279)
T cd06619 84 GSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---------------------------NT 130 (279)
T ss_pred CChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---------------------------CC
Confidence 7775431 47888999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 158 SSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
++.++|+|||.+...... .....||..|+|||.+.+..++.++|+|||||++|+|++|+.||..........
T Consensus 131 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~------- 203 (279)
T cd06619 131 RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL------- 203 (279)
T ss_pred CCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-------
Confidence 566899999988754433 244578999999999998889999999999999999999999996532211000
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
.+....... ........ .....+.++.+++.+||+.||++|||++++
T Consensus 204 -~~~~~~~~~-------~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~ei 250 (279)
T cd06619 204 -MPLQLLQCI-------VDEDPPVL-------------------------PVGQFSEKFVHFITQCMRKQPKERPAPENL 250 (279)
T ss_pred -chHHHHHHH-------hccCCCCC-------------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHH
Confidence 000000000 00000000 012345689999999999999999999999
Q ss_pred hcCCCCCCCCcC
Q 020235 317 LRHPFFTRDHLR 328 (329)
Q Consensus 317 l~hp~f~~~~~~ 328 (329)
++||||...+.+
T Consensus 251 l~~~~~~~~~~~ 262 (279)
T cd06619 251 MDHPFIVQYNDG 262 (279)
T ss_pred hcCcccccccCc
Confidence 999999877643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=305.16 Aligned_cols=272 Identities=28% Similarity=0.499 Sum_probs=213.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
||+|+||.||+|.+..++..||+|++... ........+|+.++..+ .|+||+++++.+.... ..++
T Consensus 23 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----KHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred eeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCccceeeeecCCccccccceEEE
Confidence 79999999999999999999999988532 22234566788988888 5689999999887554 4699
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||++++++|.+++... .+++..++.++.|++.||.|||+.||+|+||||+||++
T Consensus 98 v~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill----------------------- 151 (343)
T cd07880 98 VMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV----------------------- 151 (343)
T ss_pred EEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-----------------------
Confidence 9999999999888753 58999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..++.++|+|||.+...........+++.|+|||.+.+ ..++.++|+|||||++|++++|..||.+.+.......
T Consensus 152 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 152 ----NEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred ----cCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 44566899999998876655555577889999999876 3578999999999999999999999998877777777
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+..+..+...+........ ....+... ...........+..+.++|.+||+.||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 228 IMKVTGTPSKEFVQKLQSEDAKNY-----------------VKKLPRFR-KKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HHHhcCCCCHHHHHhhcchhHHHH-----------------HHhccccC-cchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 777777766665554432211000 00000000 011122234567789999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||+.++++||||+..
T Consensus 290 ~t~~~~l~~~~~~~~ 304 (343)
T cd07880 290 ITAAEALAHPYFEEF 304 (343)
T ss_pred CCHHHHhcCccHhhh
Confidence 999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=301.40 Aligned_cols=282 Identities=28% Similarity=0.489 Sum_probs=206.7
Q ss_pred CCCccceEEEEEEecC--CCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECWDRE--RKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||.||+|.++. +++.||+|.+... ........+|+.++..+ .|++++++++++.+. +..++|
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-----KHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-----CCCCccceEEEEeCCCCceEEEE
Confidence 7999999999999988 8999999998752 22335567788888888 569999999999888 889999
Q ss_pred eecCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
||++++++.+.+.... ...+++..++.++.|++.||+|||+.+++|+||||+||+++.++
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~----------------- 145 (316)
T cd07842 83 FDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG----------------- 145 (316)
T ss_pred EeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC-----------------
Confidence 9999888888876432 13588999999999999999999999999999999999996532
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
..++.++|+|||.+....... ....++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.
T Consensus 146 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 146 ------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 336778899999877543322 234678889999988764 5789999999999999999999999765
Q ss_pred chh---------HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 223 ENL---------EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 223 ~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
+.. .....+...++......+....+..+........... .+....+.... ......+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~~~~ 287 (316)
T cd07842 220 EAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTK-----------TYPSNSLAKWM-EKHKKPDS 287 (316)
T ss_pred cccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCC-----------CCCCccHHHHH-HhccCCCH
Confidence 432 2334444555555554444333322111100000000 00001111111 11135678
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~hp~f 322 (329)
.+.+++.+||+.||++|||+.++++||||
T Consensus 288 ~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 288 QGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 89999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=306.35 Aligned_cols=271 Identities=29% Similarity=0.519 Sum_probs=204.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~ 73 (329)
||+|+||.||+|.++.+|+.||+|.++.. ........+|+.++..+ .|+|++++++++... ...++|+
T Consensus 13 lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-----KHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCcCchhheeecccccccceEEEEe
Confidence 68999999999999999999999998632 22334566788888888 468999998876543 4689999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|++++++.+.+... .+++..++.++.|++.||+|||+.|++|+||||+||+++
T Consensus 88 e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~------------------------ 140 (336)
T cd07849 88 ELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN------------------------ 140 (336)
T ss_pred hhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC------------------------
Confidence 99988998888654 589999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.++.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+...
T Consensus 141 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 141 ---TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred ---CCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 45567778887765443221 22467889999998765 458899999999999999999999998877777
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
....+....+..+.+.+........ .+.... ....... ........+..+.++|++||+.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 278 (336)
T cd07849 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSL------------------PFKPKVP-WNKLFPNADPKALDLLDKMLTF 278 (336)
T ss_pred HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhc------------------CcCCccc-HHHHhcccCcHHHHHHHHHcCC
Confidence 7777777776655544333222110 110000 0000000 0011223577899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~ 325 (329)
||++|||+.++++||||++.
T Consensus 279 dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 279 NPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred ChhhCcCHHHHhcCcccccc
Confidence 99999999999999999764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=332.15 Aligned_cols=244 Identities=27% Similarity=0.438 Sum_probs=208.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---c-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---I-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.|.+++++.|++.||.|++++ . ......+..|-.++..- +.+=|+.++..|++++++|+||||+
T Consensus 83 IGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-----ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 83 IGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-----NSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred hcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-----CcHHHHHHHHHhcCccceEEEEecc
Confidence 7999999999999999999999999985 1 23345556676777555 4577999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|..++.+.. .+|+..++.|+.+|+.||+-||+.|+|||||||+|||+
T Consensus 158 pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl--------------------------- 208 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL--------------------------- 208 (1317)
T ss_pred cCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---------------------------
Confidence 999999999876 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+..++++|+|||.+.....+. +..+|||-|.|||++.. ..|+...|+||+||++|+|+.|.+||...+-.+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 778889999999988777554 45689999999999973 358999999999999999999999998877777
Q ss_pred HHHHHHHHh--CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 227 HLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 227 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
++..|+..- -.+|+ ...+|..++|||+++++
T Consensus 289 TY~KIm~hk~~l~FP~-----------------------------------------------~~~VSeeakdLI~~ll~ 321 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPD-----------------------------------------------ETDVSEEAKDLIEALLC 321 (1317)
T ss_pred HHHHHhchhhhcCCCc-----------------------------------------------ccccCHHHHHHHHHHhc
Confidence 766666541 12221 12478899999999887
Q ss_pred cCCCCCCC---HHHHhcCCCCCCCC
Q 020235 305 YDPTDRLT---AREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~t---~~~ll~hp~f~~~~ 326 (329)
+|+.|.. +.++..||||.+.+
T Consensus 322 -~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 322 -DREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred -ChhhhcccccHHHHHhCccccCCC
Confidence 5999998 99999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=296.54 Aligned_cols=243 Identities=27% Similarity=0.435 Sum_probs=199.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|++|.||+|.+..+++.||+|++.... .......+|+.++..+ .|+|++++.+.+.++...++|+|++ +
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-----RSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-----CCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 699999999999999999999999987532 2234556788888888 4699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++ ..
T Consensus 84 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---------------------------~~ 133 (274)
T cd06609 84 GSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---------------------------SE 133 (274)
T ss_pred CcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---------------------------CC
Confidence 8999999864 58999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
++.++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 213 (274)
T cd06609 134 EGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKN 213 (274)
T ss_pred CCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhc
Confidence 566888888887655433 23456888999999999888999999999999999999999999765543322222211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC-chhHHHHHHHHhcccCCCCCCCH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+. .... ++..+.+++.+||..||++|||+
T Consensus 214 ~~~~------------------------------------------------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~ 245 (274)
T cd06609 214 NPPS------------------------------------------------LEGNKFSKPFKDFVSLCLNKDPKERPSA 245 (274)
T ss_pred CCCC------------------------------------------------CcccccCHHHHHHHHHHhhCChhhCcCH
Confidence 1000 0011 45679999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+++++||||++..
T Consensus 246 ~~il~~~~~~~~~ 258 (274)
T cd06609 246 KELLKHKFIKKAK 258 (274)
T ss_pred HHHhhChhhcCCC
Confidence 9999999998764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=304.98 Aligned_cols=273 Identities=30% Similarity=0.531 Sum_probs=209.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv 72 (329)
||.|+||+||+|.+..+++.||+|.+... ........+|+.++..+ .|+|++++++++... ...++|
T Consensus 13 lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-----DHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCccchHHheecccccccCcEEEE
Confidence 69999999999999999999999988642 22234556788888887 569999999887644 358999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+||++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++
T Consensus 88 ~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~----------------------- 142 (337)
T cd07858 88 YELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN----------------------- 142 (337)
T ss_pred EeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc-----------------------
Confidence 9999889999987654 689999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.+..++|+|||.+....... ....++..|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.+.....
T Consensus 143 ----~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 218 (337)
T cd07858 143 ----ANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL 218 (337)
T ss_pred ----CCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH
Confidence 45568888888876544331 23467889999998875 45889999999999999999999999988777777
Q ss_pred HHHHHHhCCCChhHHHhhhh-hhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 229 AMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
..+....++.+++.+..... ....+... ....+ ...........+..+.++|++||+.||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P 279 (337)
T cd07858 219 KLITELLGSPSEEDLGFIRNEKARRYIRS-----------------LPYTP--RQSFARLFPHANPLAIDLLEKMLVFDP 279 (337)
T ss_pred HHHHHHhCCCChHHhhhcCchhhhHHHHh-----------------cCccc--ccCHHHHcccCCHHHHHHHHHHhcCCh
Confidence 77777777776654432111 00111000 00000 000011123467889999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 020235 308 TDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~~~ 326 (329)
++|||++++++||||+..+
T Consensus 280 ~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 280 SKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhccCHHHHHcCcchhhhc
Confidence 9999999999999998643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=304.69 Aligned_cols=245 Identities=27% Similarity=0.457 Sum_probs=193.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+||-+.||+|..... +.+|+|.+.. +......+..|+..|.++. ++.+|++++++--.++.+|+|||+-.
T Consensus 369 iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLk----g~~~IIqL~DYEv~d~~lYmvmE~Gd 443 (677)
T KOG0596|consen 369 IGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLK----GHDKIIQLYDYEVTDGYLYMVMECGD 443 (677)
T ss_pred hcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhc----CCceEEEEeeeeccCceEEEEeeccc
Confidence 79999999999976544 4566676542 3445667788999999994 66899999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+|..+|++... .++.-.++.+..||+.|+.++|++||||.||||.|+|+.
T Consensus 444 ~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV---------------------------- 494 (677)
T KOG0596|consen 444 IDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV---------------------------- 494 (677)
T ss_pred ccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE----------------------------
Confidence 999999998662 234348899999999999999999999999999999983
Q ss_pred CCCeEEeeCCCCcccCCCCC-----cccccCCCCchhHHhcC-----------CCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 158 SSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGL-----------GWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
.+.+||||||.|....++.. ..+||+.||+||.+... ..+.++||||||||||+|+.|++||..
T Consensus 495 kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 495 KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 46799999999988777653 35899999999999632 267899999999999999999999964
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
... .+..+..+..|-. ...++.. ..-.++.+++..
T Consensus 575 ~~n--~~aKl~aI~~P~~------------------~Iefp~~-------------------------~~~~~li~~mK~ 609 (677)
T KOG0596|consen 575 IIN--QIAKLHAITDPNH------------------EIEFPDI-------------------------PENDELIDVMKC 609 (677)
T ss_pred HHH--HHHHHHhhcCCCc------------------cccccCC-------------------------CCchHHHHHHHH
Confidence 221 2222333222211 1111110 011238999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
||.+||++|||+.+||+|||++-
T Consensus 610 CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 610 CLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HHhcCcccCCCcHHHhcCccccc
Confidence 99999999999999999999976
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=306.02 Aligned_cols=273 Identities=27% Similarity=0.513 Sum_probs=211.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~ 73 (329)
||.|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|++|+++++++.. ...+++||
T Consensus 13 lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-----KHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-----CCCCccCHHHhccccCCCCceEEEEE
Confidence 699999999999999999999999987432 2334566788888888 56999999888763 35789999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
||++++|.+++.... .+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus 88 e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~------------------------ 141 (334)
T cd07855 88 DLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN------------------------ 141 (334)
T ss_pred ehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc------------------------
Confidence 999889999987653 589999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.++.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 142 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~ 218 (334)
T cd07855 142 ---EDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV 218 (334)
T ss_pred ---CCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH
Confidence 45567888888775432211 23467889999999876 45889999999999999999999999988887
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.....+....+.++...+....... ..+... ++. ... ..........+..+.++|++||+
T Consensus 219 ~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~----~~~--------------~~~-~~~~~~~~~~~~~~~~li~~~l~ 279 (334)
T cd07855 219 HQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN----LPR--------------KQP-VPWSKIFPKASPEALDLLSQMLQ 279 (334)
T ss_pred HHHHHHHHHhCCChhHhhhhhchhhHHHHHhh----ccc--------------CCC-CCHHHHcccCCHHHHHHHHHHcc
Confidence 7777788888877776655433211 111100 000 000 00011123457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 020235 305 YDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
.||++|||++++++||||.+..
T Consensus 280 ~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 280 FDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred CChhhCcCHHHHHhChhhhhcc
Confidence 9999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=306.19 Aligned_cols=240 Identities=21% Similarity=0.331 Sum_probs=184.0
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-CceEEE
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-~~~~lv 72 (329)
||+|+||.||+|.+ +.++..||+|+++... .......+|+.++..+. .|+||+++++.+... +.+++|
T Consensus 15 lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~~~~~lv 90 (338)
T cd05102 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIG----NHLNVVNLLGACTKPNGPLMVI 90 (338)
T ss_pred eccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhc----cCcceeeEEeEecCCCCceEEE
Confidence 79999999999975 3446789999987432 22345678988888883 468999999987654 468999
Q ss_pred eecC-CCCHHHHHHhCC------------------------------------------------------------CCC
Q 020235 73 FEKL-GSSLYDFLRKNN------------------------------------------------------------YRS 91 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~------------------------------------------------------------~~~ 91 (329)
|||+ +|+|.+++.... ...
T Consensus 91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (338)
T cd05102 91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP 170 (338)
T ss_pred EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence 9999 999999997532 124
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcc
Q 020235 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 92 l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
+++..+..++.|++.||.|||++||+||||||+|||+ +.+..++|+|||.+..
T Consensus 171 l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---------------------------~~~~~~kl~DfG~a~~ 223 (338)
T cd05102 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---------------------------SENNVVKICDFGLARD 223 (338)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---------------------------cCCCcEEEeecccccc
Confidence 6778889999999999999999999999999999999 4455688899998865
Q ss_pred cCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHh
Q 020235 172 ERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKR 245 (329)
Q Consensus 172 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (329)
..... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+........ +..+
T Consensus 224 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~------ 296 (338)
T cd05102 224 IYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-GTRM------ 296 (338)
T ss_pred cccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhc-CCCC------
Confidence 43222 12345678999999999899999999999999999997 99999765432221111110 0000
Q ss_pred hhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 246 VDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+.++.+++.+||+.||++|||+.++++
T Consensus 297 ----------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 ----------------------------------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ----------------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001234567999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=298.78 Aligned_cols=247 Identities=26% Similarity=0.459 Sum_probs=195.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||.|+||.||++++..+++.+|+|.+.... ........|+.++..+ .|+|++++++.+..++..++||||+ ++
T Consensus 20 lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (292)
T cd06644 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-----NHPYIVKLLGAFYWDGKLWIMIEFCPGG 94 (292)
T ss_pred ecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence 799999999999999999999999987432 2344556788888777 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++..++.+.. ..+++..+..++.|++.+|.|||+.|++|+||||+||++ ..+
T Consensus 95 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---------------------------~~~ 146 (292)
T cd06644 95 AVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---------------------------TLD 146 (292)
T ss_pred cHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---------------------------cCC
Confidence 8888876543 358999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++|+|||.+....... ....+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......
T Consensus 147 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 226 (292)
T cd06644 147 GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226 (292)
T ss_pred CCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 568888888776433221 23467889999999853 3467899999999999999999999976554332222
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+. ..+. .......+.++.++|.+||+.||++|
T Consensus 227 ~~~~--~~~~--------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 260 (292)
T cd06644 227 IAKS--EPPT--------------------------------------------LSQPSKWSMEFRDFLKTALDKHPETR 260 (292)
T ss_pred HhcC--CCcc--------------------------------------------CCCCcccCHHHHHHHHHHhcCCcccC
Confidence 2111 0000 00012345679999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||...+
T Consensus 261 p~~~~il~~~~~~~~~ 276 (292)
T cd06644 261 PSAAQLLEHPFVSSVT 276 (292)
T ss_pred cCHHHHhcCccccccc
Confidence 9999999999998754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=298.95 Aligned_cols=249 Identities=22% Similarity=0.370 Sum_probs=198.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.+..+++.||+|.++.. ........+|+.++..+ .|+|++++++.+...+..++||||+ +
T Consensus 9 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-----VSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-----CCCcHHhhhhheecCCeEEEEEeecCC
Confidence 79999999999999999999999988642 22235667788888887 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 78 SSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 78 ~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++|.+++.... ...+++..+..++.|++.||.|||+ .|++|+||||+||++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~--------------------------- 136 (286)
T cd06622 84 GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV--------------------------- 136 (286)
T ss_pred CCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE---------------------------
Confidence 89998887631 2358999999999999999999996 599999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcC------CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
..+..++|+|||.+...... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.........
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 137 NGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216 (286)
T ss_pred CCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence 44567899999988654322 2345678899999998654 3578999999999999999999999765443333
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.......+. .....++.++.+||++||+.+|+
T Consensus 217 ~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 251 (286)
T cd06622 217 AQLSAIVDGDPP---------------------------------------------TLPSGYSDDAQDFVAKCLNKIPN 251 (286)
T ss_pred HHHHHHhhcCCC---------------------------------------------CCCcccCHHHHHHHHHHcccCcc
Confidence 332222211110 01123567899999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRDH 326 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~~ 326 (329)
+|||+.++++||||....
T Consensus 252 ~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 252 RRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred cCCCHHHHhcChhhhhcc
Confidence 999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=300.26 Aligned_cols=244 Identities=29% Similarity=0.451 Sum_probs=198.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||.|++|.||++.+..+++.||+|.+.... .......+|+.++..+ .|+|++.+++.+..++..++|+||+ ++
T Consensus 27 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-----KNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-----CCCceeeeeeeEecCceEEEEEEecCCC
Confidence 689999999999999999999999886432 2345566788888887 5699999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++.++..++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---------------------------~~~ 151 (296)
T cd06655 102 SLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---------------------------GMD 151 (296)
T ss_pred cHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---------------------------CCC
Confidence 999988764 48999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~ 231 (296)
T cd06655 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231 (296)
T ss_pred CCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 568888888876544332 23468889999999998889999999999999999999999998765543322221110
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+. .+....++..+.++|++||..||++|||+.+
T Consensus 232 ~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ 265 (296)
T cd06655 232 TPE----------------------------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKE 265 (296)
T ss_pred Ccc----------------------------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHH
Confidence 000 0011235668999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
++.||||+..
T Consensus 266 il~~~~~~~~ 275 (296)
T cd06655 266 LLQHPFLKLA 275 (296)
T ss_pred HhhChHhhhc
Confidence 9999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=297.54 Aligned_cols=235 Identities=16% Similarity=0.166 Sum_probs=190.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv 72 (329)
||+|+++.||++.+ +|+.||+|.++..... .+...+|+.++.++ .|+||+++++++.+ ....++|
T Consensus 28 i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 28 IKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-----DSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred EeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-----CCCCEEEEeeeEEecccCCCceEEE
Confidence 58999999999976 6889999998754332 24455899999998 56899999998866 4578999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||+ +|+|.+++.... .+++.....++.+++.||.|||+ .+++||||||+||++
T Consensus 101 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---------------------- 156 (283)
T PHA02988 101 LEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---------------------- 156 (283)
T ss_pred EEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE----------------------
Confidence 9999 999999998753 68889999999999999999998 599999999999999
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.++.++|+|||.+...........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 157 -----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 157 -----TENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred -----CCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 55667899999988765554455678999999999976 57899999999999999999999999876655444
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+......++ .+...+..+.+|+.+||+.||+
T Consensus 232 ~~i~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~cl~~dp~ 264 (283)
T PHA02988 232 DLIINKNNSLK-----------------------------------------------LPLDCPLEIKCIVEACTSHDSI 264 (283)
T ss_pred HHHHhcCCCCC-----------------------------------------------CCCcCcHHHHHHHHHHhcCCcc
Confidence 33322111110 0113456899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||++++++
T Consensus 265 ~Rps~~ell~ 274 (283)
T PHA02988 265 KRPNIKEILY 274 (283)
T ss_pred cCcCHHHHHH
Confidence 9999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.15 Aligned_cols=245 Identities=26% Similarity=0.440 Sum_probs=197.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.+..++..||+|.+.... ...+...+|+.++..+ .|+|++++++.+..++..++||||+ ++
T Consensus 30 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-----HHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred ccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-----CCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 799999999999999999999999886432 2344566788888777 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++ +.+
T Consensus 105 ~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---------------------------~~~ 154 (292)
T cd06658 105 ALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---------------------------TSD 154 (292)
T ss_pred cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---------------------------cCC
Confidence 999888653 48999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+....
T Consensus 155 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~ 234 (292)
T cd06658 155 GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNL 234 (292)
T ss_pred CCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC
Confidence 568888888775432221 23468889999999988889999999999999999999999997655443332222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+... .....+..+.+++.+||..||++|||+.+
T Consensus 235 ~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 268 (292)
T cd06658 235 PPRVK----------------------------------------------DSHKVSSVLRGFLDLMLVREPSQRATAQE 268 (292)
T ss_pred CCccc----------------------------------------------cccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 11000 01134567899999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||....
T Consensus 269 il~~~~~~~~~ 279 (292)
T cd06658 269 LLQHPFLKLAG 279 (292)
T ss_pred HhhChhhhccC
Confidence 99999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=292.26 Aligned_cols=242 Identities=27% Similarity=0.455 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||++.+..+++.||+|.+... ........+|+.+++.+ .|++++++.+.+...+..++|+||+
T Consensus 8 lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-----KHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-----CCCCeeeeEeeecCCCeEEEEEecCC
Confidence 79999999999999999999999998642 23345667788888888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.......+++.++..++.|++.||.|||++|++|+||+|+||++ +
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---------------------------~ 135 (256)
T cd08218 83 GGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---------------------------T 135 (256)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---------------------------c
Confidence 8999999987554468899999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+....... ....|++.|+|||.+.+...+.++|+|||||++++|++|+.||...+..+....+..
T Consensus 136 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08218 136 KDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215 (256)
T ss_pred CCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc
Confidence 45568999999886554332 234578899999999888889999999999999999999999976554433222211
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+..+ ......+.++.++|.+||+.+|++||++
T Consensus 216 --~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (256)
T cd08218 216 --GSYP----------------------------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSV 247 (256)
T ss_pred --CCCC----------------------------------------------CCcccCCHHHHHHHHHHhhCChhhCcCH
Confidence 1110 0012346689999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||||
T Consensus 248 ~~vl~~~~~ 256 (256)
T cd08218 248 NSILEKNFI 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=294.56 Aligned_cols=240 Identities=29% Similarity=0.472 Sum_probs=192.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~ 70 (329)
||+|++|.||+|.+..+++.+|+|.+..... ..+...+|+.++..+ .|++++++++++...+..+
T Consensus 8 ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-----QHENIVQYLGSSLDADHLN 82 (267)
T ss_pred eecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCCccE
Confidence 6899999999999998999999998863221 123456788888888 5699999999999999999
Q ss_pred EEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+||||+ +++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~-------------------- 140 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVD-------------------- 140 (267)
T ss_pred EEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEc--------------------
Confidence 999999 889999998753 689999999999999999999999999999999999994
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCC---------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQ 220 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (329)
.+..++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.
T Consensus 141 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 141 -------NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred -------CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 4455777777766544321 112357889999999988888999999999999999999999998
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
..+.......+.....+ ......+..+.++|+
T Consensus 214 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~ 245 (267)
T cd06628 214 DCTQLQAIFKIGENASP------------------------------------------------EIPSNISSEAIDFLE 245 (267)
T ss_pred CccHHHHHHHHhccCCC------------------------------------------------cCCcccCHHHHHHHH
Confidence 65443322221111000 011235668999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCC
Q 020235 301 GLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~hp~f 322 (329)
+||+.||.+|||+.++++||||
T Consensus 246 ~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 246 KTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=301.43 Aligned_cols=245 Identities=27% Similarity=0.438 Sum_probs=196.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.+..+++.||+|.+.... ........|+.++..+ .|++++++++.+..++..++||||+ ++
T Consensus 27 lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (297)
T cd06656 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWVVMEYLAGG 101 (297)
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCEEEEeecccCCC
Confidence 799999999999999999999999987433 2334556787777776 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++.++..++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 102 ~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---------------------------~~~ 151 (297)
T cd06656 102 SLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---------------------------GMD 151 (297)
T ss_pred CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---------------------------CCC
Confidence 999998764 48999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+....... ....+++.|+|||.+.+..++.++|+|||||++|++++|..||.+.+.......+...
T Consensus 152 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~- 230 (297)
T cd06656 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN- 230 (297)
T ss_pred CCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-
Confidence 668888888876544332 2346888999999999888999999999999999999999999764432211110000
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+..+ .......+..+.+|+.+||+.||++|||+.+
T Consensus 231 ~~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 265 (297)
T cd06656 231 GTPE---------------------------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKE 265 (297)
T ss_pred CCCC---------------------------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000 0001234567899999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||....
T Consensus 266 il~~~~~~~~~ 276 (297)
T cd06656 266 LLQHPFLKLAK 276 (297)
T ss_pred HhcCchhcccc
Confidence 99999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=304.50 Aligned_cols=271 Identities=28% Similarity=0.511 Sum_probs=209.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||+|.++.+++.||+|.+... ........+|+.++..+ .|+|++++++++... ...++
T Consensus 23 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~~l 97 (342)
T cd07879 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-----QHENVIGLLDVFTSAVSGDEFQDFYL 97 (342)
T ss_pred eeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-----CCCCccchhheecccccCCCCceEEE
Confidence 69999999999999999999999988642 22234566788888888 569999999988654 35699
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|++++..++..... ..+++..+..++.|++.||+|||+.|++||||||+||++
T Consensus 98 v~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll----------------------- 150 (342)
T cd07879 98 VMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV----------------------- 150 (342)
T ss_pred EecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-----------------------
Confidence 99999778776653 258999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..++.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......
T Consensus 151 ----~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~ 226 (342)
T cd07879 151 ----NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 226 (342)
T ss_pred ----CCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45567999999988766554455678889999999876 4588999999999999999999999998777777777
Q ss_pred HHHHhCCCChhHHHhhhhhhhh-hhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+....+..++.+.+........ +... ... .............+..+.+||++||+.||++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 287 (342)
T cd07879 227 ILKVTGVPGPEFVQKLEDKAAKSYIKS------------------LPK-YPRKDFSTLFPKASPQAVDLLEKMLELDVDK 287 (342)
T ss_pred HHHhcCCCCHHHHHHhcccchHHHHhh------------------cCC-cccchHHHHhcCCCHHHHHHHHHHcCCChhh
Confidence 7777776666655544332111 1000 000 0000011112245678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|||+++++.||||.+..
T Consensus 288 R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 288 RLTATEALEHPYFDSFR 304 (342)
T ss_pred CcCHHHHhcCcchhhcc
Confidence 99999999999998753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.09 Aligned_cols=279 Identities=23% Similarity=0.309 Sum_probs=191.9
Q ss_pred CCCccceEEEEEEecCCC-ceEEE------------------EEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc
Q 020235 1 MGEGTFGQVLECWDRERK-EMVAI------------------KIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-~~vai------------------K~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~ 61 (329)
||+|+||+||+|..+... ...+. |.+...........+|+.++..+ .|+||+++++
T Consensus 156 LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~ 230 (501)
T PHA03210 156 LPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-----NHENILKIEE 230 (501)
T ss_pred ecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-----CCCCcCcEeE
Confidence 799999999998765332 11221 22222222344566788888888 6799999999
Q ss_pred ccccCCceEEEeecCCCCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 62 WFDYRNHICIVFEKLGSSLYDFLRKNN---YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 62 ~~~~~~~~~lv~e~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
++.+.+..++|++++++++.+++.... ........++.++.|++.||.|||++||+||||||+|||+
T Consensus 231 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---------- 300 (501)
T PHA03210 231 ILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---------- 300 (501)
T ss_pred EEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----------
Confidence 999999999999999889988886532 1223456788899999999999999999999999999999
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 214 (329)
..++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++
T Consensus 301 -----------------~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~ 363 (501)
T PHA03210 301 -----------------NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363 (501)
T ss_pred -----------------CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 455679999999987654432 23579999999999999899999999999999999999
Q ss_pred CCC-CCCCC--chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc
Q 020235 215 GEA-LFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291 (329)
Q Consensus 215 g~~-p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
|.. ||... ........+....+....++.....+ ...++....+.... ..+...+. ....
T Consensus 364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~i~~~~~~~~~--------------~~~~~~~~--~~~~ 426 (501)
T PHA03210 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCK-LFDYIDSAEIDHAG--------------HSVPPLIR--NLGL 426 (501)
T ss_pred CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHH-HHHHhhhhhcccCc--------------cchhhHHH--hcCC
Confidence 875 44332 22233333333333222111000000 00111110000000 00000110 1124
Q ss_pred hhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCcC
Q 020235 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328 (329)
Q Consensus 292 ~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~~ 328 (329)
+..+.++|.+||++||.+|||+.|+|+||||.+...+
T Consensus 427 ~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~ 463 (501)
T PHA03210 427 PADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEE 463 (501)
T ss_pred ChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCch
Confidence 5678999999999999999999999999999986543
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=294.98 Aligned_cols=243 Identities=24% Similarity=0.396 Sum_probs=191.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|++..+++.||+|.++.... ......+|+.++..+ .|++++++++.+...+..++||||+ ++
T Consensus 17 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-----~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-----KHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred hCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 6999999999999999999999999875432 223455677777777 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... .+++.+++.++.|++.||.|||+.|++|+||||+||++ ..+
T Consensus 92 ~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---------------------------~~~ 142 (267)
T cd06645 92 SLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---------------------------TDN 142 (267)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCC
Confidence 9999987654 68999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
..++|+|||.+....... ....|+..|+|||.+. ...++.++|+|||||++|+|++|..||.............
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~ 222 (267)
T cd06645 143 GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT 222 (267)
T ss_pred CCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhh
Confidence 568888888876443221 3357899999999985 3458899999999999999999999996544332211111
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.. ...++.. .....++..+.+++.+||+.||++|||
T Consensus 223 ~~-~~~~~~~-------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~ 258 (267)
T cd06645 223 KS-NFQPPKL-------------------------------------------KDKMKWSNSFHHFVKMALTKNPKKRPT 258 (267)
T ss_pred cc-CCCCCcc-------------------------------------------cccCCCCHHHHHHHHHHccCCchhCcC
Confidence 10 0000000 000124567899999999999999999
Q ss_pred HHHHhcCCC
Q 020235 313 AREALRHPF 321 (329)
Q Consensus 313 ~~~ll~hp~ 321 (329)
++++++|||
T Consensus 259 ~~~ll~~~~ 267 (267)
T cd06645 259 AEKLLQHPF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=291.62 Aligned_cols=242 Identities=26% Similarity=0.460 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.++.+++.+|+|.++.... .+...+|+.++..+ .|++++++++.+.+....++++|++ +++
T Consensus 11 i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQC-----DSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred hcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhC-----CCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 6899999999999998899999999875433 66777888888888 6699999999999999999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++ ..++
T Consensus 85 L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~---------------------------~~~~ 136 (256)
T cd06612 85 VSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL---------------------------NEEG 136 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---------------------------CCCC
Confidence 999987643 468999999999999999999999999999999999999 4455
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+..
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~--- 213 (256)
T cd06612 137 QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN--- 213 (256)
T ss_pred cEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---
Confidence 68888888877544332 334578899999999988899999999999999999999999976444322111100
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+. . .......+..+.+++.+||+.||++|||+.++
T Consensus 214 ~~~~-------------------~------------------------~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~i 250 (256)
T cd06612 214 KPPP-------------------T------------------------LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQL 250 (256)
T ss_pred CCCC-------------------C------------------------CCchhhcCHHHHHHHHHHHhcChhhCcCHHHH
Confidence 0000 0 00012345679999999999999999999999
Q ss_pred hcCCCC
Q 020235 317 LRHPFF 322 (329)
Q Consensus 317 l~hp~f 322 (329)
++||||
T Consensus 251 l~~~~~ 256 (256)
T cd06612 251 LQHPFI 256 (256)
T ss_pred hcCCCC
Confidence 999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=297.16 Aligned_cols=272 Identities=26% Similarity=0.428 Sum_probs=202.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+++.||+|.+.... .......+|+.++..+ .|+|++++++++.+++..++||||+++
T Consensus 13 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~lv~e~~~~ 87 (291)
T cd07870 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-----KHANIVLLHDIIHTKETLTFVFEYMHT 87 (291)
T ss_pred EEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-----CCCCEeEEEEEEecCCeEEEEEecccC
Confidence 699999999999999999999999986432 2223456788888888 568999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 88 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---------------------------~~~ 139 (291)
T cd07870 88 DLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---------------------------SYL 139 (291)
T ss_pred CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---------------------------cCC
Confidence 8888776543 357888899999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCch-hHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAMMER 233 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~ 233 (329)
+.++|+|||.+....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+. .+....+..
T Consensus 140 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 219 (291)
T cd07870 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219 (291)
T ss_pred CcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence 668899999876433221 234578899999998764 478899999999999999999999976543 344444555
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.++...+.......+..........+ .... .... ....+..+.+++.+||+.||++|||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~-~~~~-~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKP---------------QQLR-VVWK-RLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCC---------------cchh-hhcc-ccCCChHHHHHHHHHhCcCcccCcCH
Confidence 55655555444333211110000000000 0000 0000 00125678999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.+++.||||
T Consensus 283 ~~~l~h~~~ 291 (291)
T cd07870 283 QDALLHPYF 291 (291)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=293.60 Aligned_cols=241 Identities=28% Similarity=0.450 Sum_probs=191.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+ .+++.+|+|.+.... .......+|+.++..+ .|+|++++.+++.+.+..++|+
T Consensus 8 ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 8 LGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-----KHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred EeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-----CCCCEeeEeeEeecCCeEEEEE
Confidence 69999999999986 478899999886422 1123456688888877 5689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.+.. .+++..+..++.|++.||+|||+.|++|+||+|+||++++
T Consensus 82 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---------------------- 137 (265)
T cd06631 82 EFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP---------------------- 137 (265)
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC----------------------
Confidence 999 999999997754 5889999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCC---------CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 153 KRMPKSSAIKVIDFGSTTYERP---------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
++.++|+|||.+..... ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus 138 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 138 -----NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred -----CCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 44567777776643211 1123457889999999998889999999999999999999999997655
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
.......+....+..+ .....++..+.++|++||
T Consensus 213 ~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l 246 (265)
T cd06631 213 RLAAMFYIGAHRGLMP----------------------------------------------RLPDSFSAAAIDFVTSCL 246 (265)
T ss_pred hHHHHHHhhhccCCCC----------------------------------------------CCCCCCCHHHHHHHHHHh
Confidence 4433322222111111 012345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 020235 304 RYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f 322 (329)
..+|++|||+.++++||||
T Consensus 247 ~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 247 TRDQHERPSALQLLRHDFL 265 (265)
T ss_pred cCCcccCCCHHHHhcCCCC
Confidence 9999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=296.10 Aligned_cols=270 Identities=33% Similarity=0.594 Sum_probs=214.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|++|.||+|.+..+++.+|+|.++.... .......|+.++..+ .|++++++++++.+++..++|+||++
T Consensus 7 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-----NHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred eecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-----cCCCcchHHHhhccCCCEEEEEeccC
Confidence 6899999999999999999999999874322 245566788888888 46999999999999999999999997
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||++ +.
T Consensus 82 ~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---------------------------~~ 133 (283)
T cd05118 82 TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---------------------------NT 133 (283)
T ss_pred CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---------------------------CC
Confidence 79999887754 468999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+..++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+....+.+
T Consensus 134 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~ 213 (283)
T cd05118 134 EGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFR 213 (283)
T ss_pred CCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5668999999886555433 224577889999998876 688999999999999999999999988887777777777
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+...+..+............. .+... ... .....+..+..+.+||.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~--------------~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 274 (283)
T cd05118 214 TLGTPDPEVWPKFTSLARNYKFS----FPKKA--------------GMP-LPKLFPNASPQALDLLSQMLHYDPHKRITA 274 (283)
T ss_pred HcCCCchHhcccchhhhhhhhhh----hcccc--------------ccC-HHHhhhhhCHHHHHHHHHHhccCcccCcCH
Confidence 66666555555443322211111 00000 000 011223457889999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.+++.||||
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=330.17 Aligned_cols=262 Identities=24% Similarity=0.426 Sum_probs=198.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~ 75 (329)
||+|+||+||+|.++.++..||+|++... ......+..|+.++..+ .|++|++++++|.. ...+|+||||
T Consensus 21 LG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-----~HPNIVrl~d~f~de~~~~lyIVMEY 95 (1021)
T PTZ00266 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-----KHKNIVRYIDRFLNKANQKLYILMEF 95 (1021)
T ss_pred EecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEecCCCEEEEEEeC
Confidence 79999999999999999999999998742 23345667899999998 56999999998743 4579999999
Q ss_pred C-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 76 L-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDL-------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 76 ~-~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~-------~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
+ +++|.++|.... ...+++..++.++.||+.||.|||+. +|+|+||||+|||+...... +.+..
T Consensus 96 ~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~-lg~i~----- 169 (1021)
T PTZ00266 96 CDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH-IGKIT----- 169 (1021)
T ss_pred CCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc-ccccc-----
Confidence 9 899999997521 23689999999999999999999984 49999999999999643210 00000
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
...........++|+|||++....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 170 ----~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 ----AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ----ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 000111334568999999987654332 345799999999999653 478999999999999999999999976
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..............++ ....+..+.+||..
T Consensus 246 ~~~~~qli~~lk~~p~lp------------------------------------------------i~~~S~eL~dLI~~ 277 (1021)
T PTZ00266 246 ANNFSQLISELKRGPDLP------------------------------------------------IKGKSKELNILIKN 277 (1021)
T ss_pred CCcHHHHHHHHhcCCCCC------------------------------------------------cCCCCHHHHHHHHH
Confidence 554332221111100000 01245689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
||+.+|.+|||+.++|.||||+..
T Consensus 278 ~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 278 LLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HhcCChhHCcCHHHHhccHHHhhc
Confidence 999999999999999999999754
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=299.49 Aligned_cols=244 Identities=24% Similarity=0.459 Sum_probs=198.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.+..+++.||+|.+... ........+|+.++..+ .|+|++++++.+..++..++|+||+ ++
T Consensus 29 ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred cCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-----CCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 79999999999999999999999998642 22344566788777777 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..++.++.|++.||.|||+.|++|+||||+||++ +.+
T Consensus 104 ~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---------------------------~~~ 153 (297)
T cd06659 104 ALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---------------------------TLD 153 (297)
T ss_pred CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---------------------------ccC
Confidence 999887663 48999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..+....+...
T Consensus 154 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~- 232 (297)
T cd06659 154 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS- 232 (297)
T ss_pred CcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc-
Confidence 67899999987644332 23356889999999999888999999999999999999999999865554433222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. .......+..+.++|++||+.+|++|||+.+
T Consensus 233 --~~~~-------------------------------------------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ 267 (297)
T cd06659 233 --PPPK-------------------------------------------LKNAHKISPVLRDFLERMLTREPQERATAQE 267 (297)
T ss_pred --CCCC-------------------------------------------ccccCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence 0000 0001234567899999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||.+-
T Consensus 268 ll~~~~~~~~ 277 (297)
T cd06659 268 LLDHPFLLQT 277 (297)
T ss_pred HhhChhhccC
Confidence 9999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.13 Aligned_cols=271 Identities=27% Similarity=0.487 Sum_probs=210.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||++.+..+++.||+|++.... .......+|+.++..+ .|+||+++.+++... +..++
T Consensus 25 lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~l 99 (345)
T cd07877 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSLEEFNDVYL 99 (345)
T ss_pred eeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-----CCCcccceeeeeeecccccccccEEE
Confidence 699999999999999999999999986432 2234556788888888 568999998887543 45789
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
++++++++|.+++... .+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 100 v~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----------------------- 153 (345)
T cd07877 100 VTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----------------------- 153 (345)
T ss_pred EehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE-----------------------
Confidence 9999999998888653 48999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..++.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......
T Consensus 154 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~ 229 (345)
T cd07877 154 ----NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229 (345)
T ss_pred ----cCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 45566899999988766555555678899999999876 4678999999999999999999999988777777777
Q ss_pred HHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+..++.+...+..... .+.... ....... ........+..+.++|.+||+.||.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dp~~ 290 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQSL---------------TQMPKMN----FANVFIGANPLAVDLLEKMLVLDSDK 290 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHHHh---------------cccCCcc----hhhhcCCCCHHHHHHHHHHcCCChhh
Confidence 777777666666554432111 110000 0000000 00111235678999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|+|+.++++||||++-
T Consensus 291 R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 291 RITAAQALAHAYFAQY 306 (345)
T ss_pred cCCHHHHhcChhhhhc
Confidence 9999999999999853
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=293.79 Aligned_cols=240 Identities=25% Similarity=0.405 Sum_probs=189.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.++.++..+|+|.+....... .|......+ ..|++++++++.+...+..++||||+ +++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~----~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLM----KDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHh----hcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 599999999999999999999999987432111 123222222 25799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||++.. +.
T Consensus 96 L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~---------------------------~~ 146 (267)
T PHA03390 96 LFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR---------------------------AK 146 (267)
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC---------------------------CC
Confidence 999998764 6899999999999999999999999999999999999943 33
Q ss_pred -CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH-HHHHHHHhCC
Q 020235 160 -AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH-LAMMERVLGP 237 (329)
Q Consensus 160 -~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~ 237 (329)
.++|+|||.+...... ....|+..|+|||++.+..++.++|+||||+++|+|++|..||........ ...+......
T Consensus 147 ~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 225 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK 225 (267)
T ss_pred CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc
Confidence 6889999987655433 234688899999999988899999999999999999999999975433221 1111110000
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-HHHH
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT-AREA 316 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t-~~~l 316 (329)
........+..+.+||.+||+.||.+|++ ++++
T Consensus 226 ----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 259 (267)
T PHA03390 226 ----------------------------------------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEI 259 (267)
T ss_pred ----------------------------------------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHH
Confidence 00111246778999999999999999996 5999
Q ss_pred hcCCCCCC
Q 020235 317 LRHPFFTR 324 (329)
Q Consensus 317 l~hp~f~~ 324 (329)
|+||||++
T Consensus 260 l~h~~~~~ 267 (267)
T PHA03390 260 IKHPFLKI 267 (267)
T ss_pred hcCCcccC
Confidence 99999974
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=292.98 Aligned_cols=245 Identities=29% Similarity=0.493 Sum_probs=198.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++++..+++.+|+|.+..... ......+|+.++..+ .|+|++++++.+..++..++++|++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-----QSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-----CCcchhHHHHheecCcEEEEEEecC
Confidence 7999999999999999999999999874332 344556677777777 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~--------------------------- 126 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI--------------------------- 126 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---------------------------
Confidence 889999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC-----------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 156 PKSSAIKVIDFGSTTYERPD-----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.+..++|+|||.+...... .....++..|+|||.......+.++|+||||+++|++++|..||...+.
T Consensus 127 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 44556888888877644322 1234678889999999888889999999999999999999999987655
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.+....+...... ++. ....+..+.+++++||+
T Consensus 207 ~~~~~~~~~~~~~-----------------------~~~------------------------~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 207 EEIFQNILNGKIE-----------------------WPE------------------------DVEVSDEAIDLISKLLV 239 (265)
T ss_pred HHHHHHHhcCCcC-----------------------CCc------------------------cccCCHHHHHHHHHHhc
Confidence 4433332221101 110 00135689999999999
Q ss_pred cCCCCCCCH---HHHhcCCCCCCCC
Q 020235 305 YDPTDRLTA---REALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~t~---~~ll~hp~f~~~~ 326 (329)
.+|++|||+ .++++||||++.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccCCC
Confidence 999999999 9999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=296.05 Aligned_cols=250 Identities=23% Similarity=0.442 Sum_probs=193.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+|+.||+|+++... ........|...+.+. .+|+|++++++.+..++..+++|||+.+
T Consensus 9 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (283)
T cd06617 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS----VDCPYTVTFYGALFREGDVWICMEVMDT 84 (283)
T ss_pred ecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHH----cCCCCeeeeeEEEecCCcEEEEhhhhcc
Confidence 699999999999999999999999987532 1223444455543333 3679999999999999999999999988
Q ss_pred CHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 79 SLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 79 ~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|.+++... ....+++..++.++.|++.||+|||++ +++|+||||+||++
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~--------------------------- 137 (283)
T cd06617 85 SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI--------------------------- 137 (283)
T ss_pred cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---------------------------
Confidence 998888652 224689999999999999999999997 99999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc----CCCCCccchHhHHHHHHHHHhCCCCCCCCch-hHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~ 228 (329)
+.+..++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... .+..
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 217 (283)
T cd06617 138 NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL 217 (283)
T ss_pred CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH
Confidence 455678999999887544322 23467889999998865 4568899999999999999999999964221 1111
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..... +..+ ..+ ...++.++.++|.+||..+|+
T Consensus 218 ~~~~~--~~~~--------------------~~~-------------------------~~~~~~~l~~li~~~l~~~p~ 250 (283)
T cd06617 218 KQVVE--EPSP--------------------QLP-------------------------AEKFSPEFQDFVNKCLKKNYK 250 (283)
T ss_pred HHHHh--cCCC--------------------CCC-------------------------ccccCHHHHHHHHHHccCChh
Confidence 11111 0000 000 112467899999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCcC
Q 020235 309 DRLTAREALRHPFFTRDHLR 328 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~~~~ 328 (329)
+|||+.++++||||.....+
T Consensus 251 ~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 251 ERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred hCcCHHHHhcCchhhhcccc
Confidence 99999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=291.01 Aligned_cols=243 Identities=26% Similarity=0.392 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.+..+++.+|+|.+.... ........|+.+++.+ .|++++++++.+..++..++||||+
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-----SHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred ecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-----CCCchhheeeeEecCCEEEEEEecCC
Confidence 699999999999999999999999986432 2345566788888888 5689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.......+++..+..++.+++.+|.|||++|++|+||+|+||+++.
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~-------------------------- 136 (256)
T cd08220 83 GGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDK-------------------------- 136 (256)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC--------------------------
Confidence 889999998765456899999999999999999999999999999999999942
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 137 HKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred CCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 23457899999887554332 2356788999999998888899999999999999999999999776544333222211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... +.....+..+.+++.+||..||++|||+.
T Consensus 217 ~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 248 (256)
T cd08220 217 TFA------------------------------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLS 248 (256)
T ss_pred CCC------------------------------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHH
Confidence 000 00123466899999999999999999999
Q ss_pred HHhcCCCC
Q 020235 315 EALRHPFF 322 (329)
Q Consensus 315 ~ll~hp~f 322 (329)
++++||||
T Consensus 249 ~ll~~p~~ 256 (256)
T cd08220 249 QIMAQPIC 256 (256)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=295.51 Aligned_cols=270 Identities=31% Similarity=0.536 Sum_probs=204.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|.+..... ..+....|+.++..+ .|++++++++++.+++..++|+||+
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-----RHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-----CCcchhhHHHhcccCCeEEEEEecCC
Confidence 7999999999999998999999998764222 234556788888887 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++.+..+..... .+++.+++.++.|++.||.|||+.|++|+||+|+||++ +
T Consensus 84 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---------------------------~ 134 (286)
T cd07846 84 HTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---------------------------S 134 (286)
T ss_pred ccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------------C
Confidence 667766655432 48999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.+..++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.+.+..+....+.
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~ 214 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214 (286)
T ss_pred CCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 55678999999876543322 234578899999998764 46789999999999999999999998877777777777
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+.+............ .... ...+.. .... .........+..+.+|+++||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~-------------~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 276 (286)
T cd07846 215 KCLGNLIPRHQEIFQKNP--LFAG--MRLPEV-------------KEIE-PLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276 (286)
T ss_pred HHhCCCchhhHHHhccch--Hhhc--cccccc-------------cCcc-hHHHhCCCcCHHHHHHHHHHhcCCcccchh
Confidence 766655433221110000 0000 000000 0000 011112346778999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
+.++++||||
T Consensus 277 ~~~il~~~~~ 286 (286)
T cd07846 277 SSQLLHHEFF 286 (286)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.47 Aligned_cols=272 Identities=34% Similarity=0.645 Sum_probs=210.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.++.+++.||+|.++.. ........+|+.++..+ .|++++++.+.+.+++..++||||++
T Consensus 9 i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~iv~e~~~ 83 (288)
T cd07833 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-----RHENIVNLKEAFRRKGRLYLVFEYVE 83 (288)
T ss_pred ecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-----CCCCeeehhheEEECCEEEEEEecCC
Confidence 69999999999999999999999988642 22345677899999888 46999999999999999999999995
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.
T Consensus 84 ~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---------------------------~~ 135 (288)
T cd07833 84 RTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---------------------------SE 135 (288)
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---------------------------CC
Confidence 45545444433 358999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+..++|+|||.+....... ....++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+....+.
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 215 (288)
T cd07833 136 SGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ 215 (288)
T ss_pred CCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 6678999999887655433 234678889999999888 78899999999999999999999999877777777777
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...+++++............. + ...++ ..............++..+.+||++||..||++|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~---~-~~~~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 278 (288)
T cd07833 216 KCLGPLPPSHQELFSSNPRFA---G-VAFPE-------------PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278 (288)
T ss_pred HHhCCCCHHHhhhcccCcccc---c-cccCC-------------CCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc
Confidence 777777765443322110000 0 00000 000011111122334788999999999999999999
Q ss_pred HHHHhcCCCC
Q 020235 313 AREALRHPFF 322 (329)
Q Consensus 313 ~~~ll~hp~f 322 (329)
++++++||||
T Consensus 279 ~~~il~~~~f 288 (288)
T cd07833 279 CDELLQHPYF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=304.24 Aligned_cols=273 Identities=29% Similarity=0.521 Sum_probs=214.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~~lv 72 (329)
||+|++|.||+|.+..+++.||+|.+... ....+...+|+.++..+ .|++++++.+++.... ..|+|
T Consensus 8 ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-----RHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred ecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-----CCcchhhhhhhhcccCcccccceEEE
Confidence 69999999999999989999999988743 22345667788888888 4699999999988765 89999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|+|++++|.+++.+.. .+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 83 ~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili------------------------ 136 (330)
T cd07834 83 TELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV------------------------ 136 (330)
T ss_pred ecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------------------
Confidence 9999888999887654 78999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|++||.+.+..
T Consensus 137 ---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~ 213 (330)
T cd07834 137 ---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213 (330)
T ss_pred ---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH
Confidence 445668888888876554432 234678889999999887 7899999999999999999999999998888
Q ss_pred HHHHHHHHHhCCCChhHHHhhhh-hhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
+....+....+.++...+..... ....+... . .........+.....+..+.++|++||+
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~ 274 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKS------------------L-PKKPKKPLSKLFPGASPEAIDLLEKMLV 274 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhh------------------c-ccCCcchhHHhcccCCHHHHHHHHHHcc
Confidence 88888888877776654442110 00111110 0 0000011111223467789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 020235 305 YDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
+||++|||+.++++||||++..
T Consensus 275 ~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 275 FDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred CChhhCCCHHHHHhCccHHhhc
Confidence 9999999999999999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=294.05 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=194.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~lv~e 74 (329)
||+|++|.||+|.++.+++.+|+|++............|+.++..+. .|+|++++++.+.+. ...++|||
T Consensus 14 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~----~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS----NHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhc----CCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 68999999999999999999999998866555667778888888872 468999999998654 35899999
Q ss_pred cC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 75 KL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+ +++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~----------------------- 146 (275)
T cd06608 90 LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL----------------------- 146 (275)
T ss_pred cCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE-----------------------
Confidence 99 889999987533 3468999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-----CCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
+.+..++|+|||.+....... ....|+..|+|||++... .++.++|+|||||++|+|++|+.||....
T Consensus 147 ----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 147 ----TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred ----ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 445668888888876443222 345688899999998643 36788999999999999999999997654
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
.......+... . +.. . ......+..+.++|++||
T Consensus 223 ~~~~~~~~~~~--~-~~~-------------------~------------------------~~~~~~~~~~~~li~~~l 256 (275)
T cd06608 223 PMRALFKIPRN--P-PPT-------------------L------------------------KSPENWSKKFNDFISECL 256 (275)
T ss_pred hHHHHHHhhcc--C-CCC-------------------C------------------------CchhhcCHHHHHHHHHHh
Confidence 43322222111 0 000 0 001124568999999999
Q ss_pred ccCCCCCCCHHHHhcCCCC
Q 020235 304 RYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f 322 (329)
..||++|||+.++++|||+
T Consensus 257 ~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 257 IKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=294.20 Aligned_cols=245 Identities=29% Similarity=0.438 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.++..||+|.+.... .......+|+.++..+ .|++++++++.+.+++..++||||+ +
T Consensus 12 lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred cccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 799999999999999999999999987432 2334556687777777 6699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++.++..++.|++.||.|||+.+++|+||+|+||+++ .
T Consensus 87 ~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---------------------------~ 136 (277)
T cd06640 87 GSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---------------------------E 136 (277)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---------------------------C
Confidence 9999998763 589999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~- 215 (277)
T cd06640 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK- 215 (277)
T ss_pred CCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc-
Confidence 4567888888775443322 234578889999999888899999999999999999999999976544322211110
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ +......+..+.+++.+||+.+|++|||+.
T Consensus 216 --~~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06640 216 --NNP---------------------------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAK 248 (277)
T ss_pred --CCC---------------------------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHH
Confidence 000 001122456788999999999999999999
Q ss_pred HHhcCCCCCCCCcC
Q 020235 315 EALRHPFFTRDHLR 328 (329)
Q Consensus 315 ~ll~hp~f~~~~~~ 328 (329)
++++||||.+...+
T Consensus 249 ~il~~~~~~~~~~~ 262 (277)
T cd06640 249 ELLKHKFIVKNAKK 262 (277)
T ss_pred HHHhChHhhhcchh
Confidence 99999999877653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=295.11 Aligned_cols=246 Identities=25% Similarity=0.416 Sum_probs=192.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.+|+|.+............|+.++..+. .|+|++++++++... +..++||||
T Consensus 30 l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~----~h~ni~~~~~~~~~~~~~~~~~~~lv~ey 105 (291)
T cd06639 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLP----NHPNVVKFYGMFYKADKLVGGQLWLVLEL 105 (291)
T ss_pred eecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhc----CCCCeEEEEEEEEeccccCCCeeEEEEEE
Confidence 68999999999999999999999998754444556667888877773 468999999987643 468999999
Q ss_pred C-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 76 L-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 76 ~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+ +++|.+++... ....+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus 106 ~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili------------------------ 161 (291)
T cd06639 106 CNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL------------------------ 161 (291)
T ss_pred CCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE------------------------
Confidence 9 89999988642 23468999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-----CCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-----WTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
..+..++|+|||.+....... ....|+..|+|||.+.... ++.++|+|||||++|+|++|+.||...+.
T Consensus 162 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 162 ---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred ---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 445568999999876543322 3346788999999986532 67899999999999999999999976544
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
......+.+ ..+.. . ......+..+.++|.+||+
T Consensus 239 ~~~~~~~~~---~~~~~-------------------~------------------------~~~~~~~~~l~~li~~~l~ 272 (291)
T cd06639 239 VKTLFKIPR---NPPPT-------------------L------------------------LHPEKWCRSFNHFISQCLI 272 (291)
T ss_pred HHHHHHHhc---CCCCC-------------------C------------------------CcccccCHHHHHHHHHHhh
Confidence 332222111 10000 0 0012244579999999999
Q ss_pred cCCCCCCCHHHHhcCCCCC
Q 020235 305 YDPTDRLTAREALRHPFFT 323 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~ 323 (329)
.||++|||+.++++||||+
T Consensus 273 ~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 273 KDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cChhhCcCHHHHhcCcccC
Confidence 9999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=303.40 Aligned_cols=290 Identities=16% Similarity=0.192 Sum_probs=191.9
Q ss_pred CCCc--cceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||.| +||+||+|.+..+|+.||+|++.... ...+...+|+.++..+ .|+||+++++++..++..++|+||
T Consensus 6 ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~~~~~~v~e~ 80 (328)
T cd08226 6 IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-----RHPNIMTSWTVFTTGSWLWVISPF 80 (328)
T ss_pred hCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEeeeEecCCceEEEEec
Confidence 4555 99999999999999999999987432 2234455677776666 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ ++++.+++.+.....+++..+..++.|++.||+|||+.|++||||||+||++..++.
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--------------------- 139 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--------------------- 139 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc---------------------
Confidence 9 889999998765456899999999999999999999999999999999999965544
Q ss_pred CCCCCCeEEeeCCCCcccCC----------CCCcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 155 MPKSSAIKVIDFGSTTYERP----------DQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~----------~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
++++||+.+..... ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...
T Consensus 140 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 140 ------VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ------EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 45555543211110 01112345679999999764 4789999999999999999999999875
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhcc-chhhHHHHhhhccCchhHHHHHHHH
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK-LPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
................+.......... ... ......+. ............. ...............+..+.+||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 290 (328)
T cd08226 214 LRTQMLLQKLKGPPYSPLDITTFPCEE-SRM-KNSQSGVD-SGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL 290 (328)
T ss_pred ChHHHHHHHhcCCCCCCccccccchhh-hhh-ccchhhhh-cccccchhccccccccccccccchhhhhhhHHHHHHHHH
Confidence 543332222211111110000000000 000 00000000 0000000000000 0000000011123457789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
||+.||++|||++++++||||++.
T Consensus 291 ~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 291 CLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred HccCCcccCCCHHHHhhCHHHHHH
Confidence 999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=317.52 Aligned_cols=237 Identities=30% Similarity=0.419 Sum_probs=193.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc-ccc------CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-FDY------RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~-~~~------~~~~~lv 72 (329)
|.+|||+.||+|.+...|..||+|++-. ++.......+|+.+++.| .+|+||+.+++. ... .-.+.|+
T Consensus 45 LAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L----~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 45 LAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLL----SGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHh----cCCCceeeEeccccccccCCCceeEEEee
Confidence 6799999999999999889999998864 344456677899999999 578999999993 221 2368999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|||| ||.|-+++......+|++.++++|+.+++.|+.+||.+. |+|||||-+|||+
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl--------------------- 179 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL--------------------- 179 (738)
T ss_pred hhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE---------------------
Confidence 9999 799999999765567999999999999999999999887 9999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC-C-----------cccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHh
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ-N-----------YIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~-----------~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~ 214 (329)
..++..||||||.++-.-... + ...-|+.|+|||.+. +.+++.|+|||||||+||-|+.
T Consensus 180 ------s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy 253 (738)
T KOG1989|consen 180 ------SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY 253 (738)
T ss_pred ------cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence 566679999999986433322 1 124589999999885 6679999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
...||....... +-++.+.+|. ...++..
T Consensus 254 ~t~PFe~sg~la---------------------------Ilng~Y~~P~------------------------~p~ys~~ 282 (738)
T KOG1989|consen 254 FTTPFEESGKLA---------------------------ILNGNYSFPP------------------------FPNYSDR 282 (738)
T ss_pred hCCCcCcCccee---------------------------EEeccccCCC------------------------CccHHHH
Confidence 999997532211 1233344433 2457889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+++||+.||+.||.+||++.+++.+
T Consensus 283 l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 283 LKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred HHHHHHHHhccCcccCCCHHHHHHH
Confidence 9999999999999999999988764
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=301.33 Aligned_cols=271 Identities=25% Similarity=0.443 Sum_probs=199.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-------------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------------- 66 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------------- 66 (329)
||.|+||.||+|.++.+++.||+|.+.... .......+|+.++..+ .|++++++++.+...
T Consensus 13 Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 87 (342)
T cd07854 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVYEVLGPSGSDLTEDVGSLTE 87 (342)
T ss_pred ecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-----CCCcchhhHhhhcccccccccccccccc
Confidence 799999999999999999999999886432 2334567789998888 568999998776543
Q ss_pred -CceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 67 -NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 67 -~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
...++||||++++|.+++... .+++..++.++.|++.||+|||+.|++|+||||+||+++.
T Consensus 88 ~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~--------------- 149 (342)
T cd07854 88 LNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINT--------------- 149 (342)
T ss_pred cceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcC---------------
Confidence 358999999988998888653 5899999999999999999999999999999999999952
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCC
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 218 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p 218 (329)
.+..++|+|||.+....... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus 150 -----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 218 (342)
T cd07854 150 -----------EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218 (342)
T ss_pred -----------CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCC
Confidence 23457888888876543221 22357888999998765 4578999999999999999999999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.......................... ...............+.++.+|
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRND-------------------GGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhc-------------------ccccCCCHHHHccCCCHHHHHH
Confidence 988777665555444332222222111111000000000 0000000111123466789999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 299 LQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
|++||+.||++|||+.++++||||+.
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcccc
Confidence 99999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=291.71 Aligned_cols=246 Identities=26% Similarity=0.479 Sum_probs=195.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||++.+..+++.||+|.++... ........|+.++..+ .|++++++++++.+.+..++|+
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-----NHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred ecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-----CCCceehhhceeccCCeEEEEE
Confidence 799999999999999999999999987422 1235567788888888 5699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.+.. .+++..+..++.|++.||+|||++|++|+||+|+||+++.+
T Consensus 83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~--------------------- 139 (268)
T cd06630 83 EWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDST--------------------- 139 (268)
T ss_pred eccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC---------------------
Confidence 999 899999998754 68999999999999999999999999999999999999432
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 140 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~ 214 (268)
T cd06630 140 -----GQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS 214 (268)
T ss_pred -----CCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc
Confidence 2347888888876543321 2346788999999998888999999999999999999999999654332
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+.+...... ........+..+.+++.+||+.
T Consensus 215 ~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~~i~~~l~~ 250 (268)
T cd06630 215 NHLALIFKIASATT--------------------------------------------APSIPEHLSPGLRDVTLRCLEL 250 (268)
T ss_pred chHHHHHHHhccCC--------------------------------------------CCCCchhhCHHHHHHHHHHcCC
Confidence 22211111100000 0001123466899999999999
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 020235 306 DPTDRLTAREALRHPFFT 323 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~ 323 (329)
||++|||+.++++||||+
T Consensus 251 ~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 251 QPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CcccCcCHHHHhcCcccC
Confidence 999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=291.42 Aligned_cols=269 Identities=31% Similarity=0.555 Sum_probs=214.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|++|.||+|.+..+++.||+|++... .........|+.++..+ .|++++++++++.+.+..++|+|+++
T Consensus 7 ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-----KHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred ccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-----CCCCHHHHHhhhhcCCceEEEecCcC
Confidence 69999999999999999999999998753 22334556788888887 46999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||++ ..
T Consensus 82 ~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---------------------------~~ 133 (282)
T cd07829 82 MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---------------------------NR 133 (282)
T ss_pred cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---------------------------cC
Confidence 89999998753 358999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....++..|+|||.+... .++.++|+|||||++|++++|..||.+.+..+....+.+
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~ 213 (282)
T cd07829 134 DGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213 (282)
T ss_pred CCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH
Confidence 5668888988876554332 223456789999998776 788999999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+...+..+........ + ......+.. ... .......+..+.++|++||+.||++|||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~--------------~~~----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 273 (282)
T cd07829 214 ILGTPTEESWPGVTKLPD-Y-KPTFPKFPP--------------KDL----EKVLPRLDPEGIDLLSKMLQYNPAKRISA 273 (282)
T ss_pred HhCCCcHHHHHhhccccc-c-cccccccCc--------------cch----HHhcccccHHHHHHHHHhhccCcccCCCH
Confidence 888777766665443320 0 000000000 000 01112336789999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.+++.||||
T Consensus 274 ~~~l~~p~~ 282 (282)
T cd07829 274 KEALKHPYF 282 (282)
T ss_pred HHHhhCcCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=292.41 Aligned_cols=272 Identities=32% Similarity=0.557 Sum_probs=210.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|++|+||+|....+++.||+|.+..... ......+|+..+..+ ..|++++.+++.+.+++..++||||+++
T Consensus 7 ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (283)
T cd07830 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKL----NEHPNIVKLKEVFRENDELYFVFEYMEG 82 (283)
T ss_pred eccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhc----cCCCCchhHHHHhhcCCcEEEEEecCCC
Confidence 7999999999999998999999998864322 122334577777766 2379999999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++.+.+.......+++.++..++.|++.+|.|||++|++|+||+|+||++ +.+
T Consensus 83 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---------------------------~~~ 135 (283)
T cd07830 83 NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---------------------------SGP 135 (283)
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---------------------------cCC
Confidence 99999987654568999999999999999999999999999999999999 456
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++|+|||.+....... ....++..|+|||.+.+ ..++.++|+||||+++++|++|++||.+....+....+....
T Consensus 136 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 215 (283)
T cd07830 136 EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVL 215 (283)
T ss_pred CCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhc
Confidence 678899998887554432 23467889999998754 457899999999999999999999999888878888888887
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
++++...+........... ..++... ... ........+..+.++|++||+.||++|||+.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~----~~~~~~~-----------~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 216 GTPTKQDWPEGYKLASKLG----FRFPQFA-----------PTS----LHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CCCChhhhhhHhhhhcccc----ccccccc-----------ccc----HHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 7776655443222111110 0000000 000 01111223678999999999999999999999
Q ss_pred HhcCCCC
Q 020235 316 ALRHPFF 322 (329)
Q Consensus 316 ll~hp~f 322 (329)
++.||||
T Consensus 277 i~~~~~~ 283 (283)
T cd07830 277 ALQHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=291.81 Aligned_cols=242 Identities=25% Similarity=0.415 Sum_probs=197.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.||+|.++.+++.||+|++.... ...+....|+.++..+ .|+|++++++.+.+++..++|+||+
T Consensus 8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-----NHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-----CCCChHHHHHhhcCCCeEEEEEeCC
Confidence 699999999999999999999999987432 2345667788888888 6699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++
T Consensus 83 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~--------------------------- 133 (258)
T cd05578 83 LGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL--------------------------- 133 (258)
T ss_pred CCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---------------------------
Confidence 99999999876 368999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.+..++|+|||.+....... ....|+..|+|||.+....++.++|+||||+++|+|++|..||...+.... ..+.+
T Consensus 134 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 212 (258)
T cd05578 134 DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQIRA 212 (258)
T ss_pred cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HHHHH
Confidence 455668889998877654432 335678899999999988899999999999999999999999987554211 11111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..... ....+...+..+.++|++||+.||.+|||+
T Consensus 213 ~~~~~---------------------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 213 KQETA---------------------------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred Hhccc---------------------------------------------cccCcccCcHHHHHHHHHHccCChhHcCCc
Confidence 10000 001112345689999999999999999999
Q ss_pred --HHHhcCCCC
Q 020235 314 --REALRHPFF 322 (329)
Q Consensus 314 --~~ll~hp~f 322 (329)
.++++||||
T Consensus 248 ~~~~l~~~~~~ 258 (258)
T cd05578 248 NLKDLKNHPYF 258 (258)
T ss_pred cHHHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=293.36 Aligned_cols=244 Identities=27% Similarity=0.455 Sum_probs=197.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|++|.||++.++.+++.+|+|.+.... ...+...+|+.++..+ .|++++++++.+...+..++++||+ ++
T Consensus 27 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-----~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-----CCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 799999999999999999999999886432 2234566788888877 5699999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||++ +.+
T Consensus 102 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---------------------------~~~ 151 (285)
T cd06648 102 ALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---------------------------TSD 151 (285)
T ss_pred CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---------------------------cCC
Confidence 999998873 58999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++|+|||.+....... ....|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+....
T Consensus 152 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~ 231 (285)
T cd06648 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL 231 (285)
T ss_pred CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC
Confidence 568888888765433221 23468889999999988889999999999999999999999997755543333222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. ......+..+.+++++||+.||++|||+.+
T Consensus 232 ~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 265 (285)
T cd06648 232 PPKL----------------------------------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAE 265 (285)
T ss_pred CCCC----------------------------------------------cccccCCHHHHHHHHHHcccChhhCcCHHH
Confidence 0000 001124568999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||++.
T Consensus 266 il~~~~~~~~ 275 (285)
T cd06648 266 LLNHPFLAKA 275 (285)
T ss_pred HccCcccccC
Confidence 9999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=298.70 Aligned_cols=244 Identities=27% Similarity=0.414 Sum_probs=211.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.|.+|..+.|.+.+|||+++++ ....+..+.|..+|..-. --|++++++..|++-+.+|+||||+
T Consensus 357 lGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~----kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 357 LGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG----KPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCC----CCchHHHHHHHhhhhhheeeEEEEe
Confidence 79999999999999999999999999853 233444556666665542 3378999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|...+++-+ .+.++.+..++.+++.||-|||++||++||||.+||++
T Consensus 433 nGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL--------------------------- 483 (683)
T KOG0696|consen 433 NGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML--------------------------- 483 (683)
T ss_pred cCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---------------------------
Confidence 999999998875 68899999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+..+++||+|||.++..--+ ..+.+|||-|+|||++..++|+..+|+||+||+||||+.|++||.+.+..+.++.|.
T Consensus 484 d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 484 DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 67788999999998744332 256799999999999999999999999999999999999999999999999888888
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+.....| ...|.++.+++...|.+.|.+|+.
T Consensus 564 ehnvsyP-------------------------------------------------KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHNVSYP-------------------------------------------------KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HccCcCc-------------------------------------------------ccccHHHHHHHHHHhhcCCccccC
Confidence 7654443 345778999999999999999985
Q ss_pred H-----HHHhcCCCCCCCC
Q 020235 313 A-----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-----~~ll~hp~f~~~~ 326 (329)
+ +++-.||||..+.
T Consensus 595 cg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 595 CGPEGERDIREHPFFRRID 613 (683)
T ss_pred CCCccccchhhCcchhhcc
Confidence 4 6888999998764
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=309.69 Aligned_cols=243 Identities=26% Similarity=0.404 Sum_probs=208.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|.|+.|.+|++..|+..||||++.+... ......+|+.+++.+ .||||++++.+.++...+|+||||+
T Consensus 64 ig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-----~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 64 IGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-----NHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-----CCcceeeeeeeeeecceeEEEEEecc
Confidence 7999999999999999999999999986432 334467899999999 7799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|.+.+++.+.+ ++.+..++.++.|+++|++|||+++|+|||||.+|||+ +
T Consensus 139 ~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---------------------------~ 189 (596)
T KOG0586|consen 139 GGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---------------------------D 189 (596)
T ss_pred CchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---------------------------c
Confidence 999999999876 68889999999999999999999999999999999999 6
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||++....... .+.+|++.|.|||++.+..|. +.+|+||||+++|.|++|.+||.+.+-.+.....
T Consensus 190 ~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-- 267 (596)
T KOG0586|consen 190 ENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-- 267 (596)
T ss_pred cccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--
Confidence 77789999999998877654 568999999999999999875 9999999999999999999999875543321111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
-.+++..+ .-++.++.++|+++|..+|.+|+|+
T Consensus 268 ---------------------l~gk~rIp--------------------------~~ms~dce~lLrk~lvl~Pskr~~~ 300 (596)
T KOG0586|consen 268 ---------------------LRGKYRIP--------------------------FYMSCDCEDLLRKFLVLNPSKRGPC 300 (596)
T ss_pred ---------------------eeeeeccc--------------------------ceeechhHHHHHHhhccCccccCCH
Confidence 11111111 1346789999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+++..|+|...-+
T Consensus 301 dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 301 DQIMKDRWRNDLL 313 (596)
T ss_pred HHhhhhcccchhh
Confidence 9999999987644
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=290.09 Aligned_cols=238 Identities=21% Similarity=0.316 Sum_probs=193.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.+++.||+|++...........+|+.++..+ .|++++++++++..++..+++|||+ +++
T Consensus 14 ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (263)
T cd05052 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYIITEFMTYGN 88 (263)
T ss_pred cCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-----CCCChhheEEEEcCCCCcEEEEEeCCCCc
Confidence 7999999999999999999999999886555556677899988888 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||++. .+.
T Consensus 89 L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---------------------------~~~ 141 (263)
T cd05052 89 LLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---------------------------ENH 141 (263)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---------------------------CCC
Confidence 99999876555689999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCCC----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 142 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 221 (263)
T cd05052 142 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG 221 (263)
T ss_pred cEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 678888887765443221 1223567999999998889999999999999999998 99999775544333222211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ ......+..+.+++.+||+.||++|||+.
T Consensus 222 ~~~------------------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 253 (263)
T cd05052 222 YRM------------------------------------------------ERPEGCPPKVYELMRACWQWNPSDRPSFA 253 (263)
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 000 01123567899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 254 ~l~~ 257 (263)
T cd05052 254 EIHQ 257 (263)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.69 Aligned_cols=245 Identities=24% Similarity=0.431 Sum_probs=190.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc-----ccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~-----~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.+|+|+++...........|+.++..+. .|+|++++++.+ ..++..++||||
T Consensus 26 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 101 (286)
T cd06638 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS----DHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101 (286)
T ss_pred eccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHh----cCCCeeeeeeeeeecccCCCCeEEEEEee
Confidence 79999999999999999999999998754444455667888888773 468999999876 345679999999
Q ss_pred C-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 76 L-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 76 ~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+ +++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||++.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~----------------------- 158 (286)
T cd06638 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT----------------------- 158 (286)
T ss_pred cCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC-----------------------
Confidence 9 99999988642 224588899999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
.+..++|+|||.+...... .....|+..|+|||++.. ..++.++|+|||||++|+|++|+.||...+.
T Consensus 159 ----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 159 ----TEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred ----CCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 4556888999887654322 133468899999999853 3478899999999999999999999976543
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
......+... ..+. .......+..+.++|.+||+
T Consensus 235 ~~~~~~~~~~--~~~~--------------------------------------------~~~~~~~~~~~~~li~~~l~ 268 (286)
T cd06638 235 MRALFKIPRN--PPPT--------------------------------------------LHQPELWSNEFNDFIRKCLT 268 (286)
T ss_pred hHHHhhcccc--CCCc--------------------------------------------ccCCCCcCHHHHHHHHHHcc
Confidence 2221111100 0000 00011235679999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 020235 305 YDPTDRLTAREALRHPFF 322 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f 322 (329)
.||++|||+.++++|+||
T Consensus 269 ~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 269 KDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCcccCCCHHHHhhcccC
Confidence 999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=293.07 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=190.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|++++++++.+...+..++||||+ ++
T Consensus 17 lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-----KHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred eecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-----CCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 699999999999999999999999987432 2234556788888877 6699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... .+++..+..++.|++.||+|||+.||+|+||+|+||++ ..+
T Consensus 92 ~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---------------------------~~~ 142 (267)
T cd06646 92 SLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---------------------------TDN 142 (267)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---------------------------CCC
Confidence 9999987653 68999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++|+|||.+...... .....|+..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 143 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~ 222 (267)
T cd06646 143 GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS 222 (267)
T ss_pred CCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee
Confidence 56888888887654322 133468889999999853 347789999999999999999999996543322111100
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..... + + .. ......+..+.++|++||+.||++|||
T Consensus 223 ~~~~~-~----------------------~----------------~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 223 KSNFQ-P----------------------P----------------KL-----KDKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred cCCCC-C----------------------C----------------CC-----ccccccCHHHHHHHHHHhhCChhhCcC
Confidence 00000 0 0 00 001234678999999999999999999
Q ss_pred HHHHhcCCC
Q 020235 313 AREALRHPF 321 (329)
Q Consensus 313 ~~~ll~hp~ 321 (329)
++++++|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=290.76 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=196.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||.|+||+||+|....++..+|+|++.... .......+|+..+..+ .|++++++++.+...+..++|||++ +
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (267)
T cd06610 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-----NHPNVVKYYTSFVVGDELWLVMPYLSG 83 (267)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-----CCCCEEEEEEEEeeCCEEEEEEeccCC
Confidence 689999999999999899999999986432 2345567788888777 5689999999999999999999999 9
Q ss_pred CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~--------------------------- 136 (267)
T cd06610 84 GSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG--------------------------- 136 (267)
T ss_pred CcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---------------------------
Confidence 999999986432 4589999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.+..++|+|||.+....... ....|+..|+|||.+... .++.++|+|||||++|+|++|+.||...+.....
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 216 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence 44567888888765444322 224688899999998876 6889999999999999999999999765543322
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
....+. .+.. .+. .......+..+.+++.+||+.||+
T Consensus 217 ~~~~~~---~~~~-------------------~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~ 253 (267)
T cd06610 217 MLTLQN---DPPS-------------------LET---------------------GADYKKYSKSFRKMISLCLQKDPS 253 (267)
T ss_pred HHHhcC---CCCC-------------------cCC---------------------ccccccccHHHHHHHHHHcCCChh
Confidence 221111 0000 000 000124567899999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 020235 309 DRLTAREALRHPFF 322 (329)
Q Consensus 309 ~R~t~~~ll~hp~f 322 (329)
+|||+.++++||||
T Consensus 254 ~Rp~~~~ll~~p~~ 267 (267)
T cd06610 254 KRPTAEELLKHKFF 267 (267)
T ss_pred hCcCHHHHhhCCCC
Confidence 99999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=297.42 Aligned_cols=272 Identities=27% Similarity=0.508 Sum_probs=213.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~e~~ 76 (329)
||.|+||.||+|.++.+++.||+|++... .........|+.++..+ .|||++++.+++.. ....++++|++
T Consensus 18 ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~lv~e~~ 92 (328)
T cd07856 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-----RHENIISLSDIFISPLEDIYFVTELL 92 (328)
T ss_pred ecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-----CCCCeeeEeeeEecCCCcEEEEeehh
Confidence 68999999999999999999999987532 22345566788988888 56999999998865 56899999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|..++... .+++..+..++.|++.||.|||+.|++|+||+|+||++ +
T Consensus 93 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---------------------------~ 142 (328)
T cd07856 93 GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---------------------------N 142 (328)
T ss_pred ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---------------------------C
Confidence 88999888753 48888999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.++.++|+|||.+...........++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.........+.+..
T Consensus 143 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~ 222 (328)
T cd07856 143 ENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLL 222 (328)
T ss_pred CCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5566899999988766554455577889999998765 568899999999999999999999998887777777788888
Q ss_pred CCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 236 GPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
+.++.++......... .+.... ...... .........+..+.++|++||+.+|++|||++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 283 (328)
T cd07856 223 GTPPDDVINTICSENTLRFVQSL------------------PKREPV-PFSEKFKNADPSAIDLLEKMLVFDPQKRISAA 283 (328)
T ss_pred CCCCHHHHHhccchhhHHHHhhc------------------cccCCC-cHHHHcCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 8888776554322110 000000 000000 00011224567899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
+++.||||...+
T Consensus 284 ell~~~~~~~~~ 295 (328)
T cd07856 284 EALAHPYLAPYH 295 (328)
T ss_pred HHhcCCcccccc
Confidence 999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.30 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=192.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++.++.+++.||+|.+.... ........|+.++..+ .|+||+++++.+..++..++||||+
T Consensus 9 l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 9 ISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-----ENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-----CCCCeeeeEEEEecCCEEEEEEecC
Confidence 689999999999999999999999987432 1234455677777776 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++
T Consensus 84 ~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~----------------------- 138 (305)
T cd05609 84 EGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG----------------------- 138 (305)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-----------------------
Confidence 899999997754 689999999999999999999999999999999999995544
Q ss_pred CCCCCeEEeeCCCCcccCC------------------CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCC
Q 020235 156 PKSSAIKVIDFGSTTYERP------------------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 217 (329)
.++|+|||.+..... ......++..|+|||.+....++.++|+|||||++|+|++|..
T Consensus 139 ----~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 139 ----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred ----CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 456666665432110 0012356788999999988889999999999999999999999
Q ss_pred CCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHH
Q 020235 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297 (329)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
||.+.+..+............+. .....+..+.+
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~ 248 (305)
T cd05609 215 PFFGDTPEELFGQVISDDIEWPE----------------------------------------------GDEALPADAQD 248 (305)
T ss_pred CCCCCCHHHHHHHHHhcccCCCC----------------------------------------------ccccCCHHHHH
Confidence 99876554433332221111110 00124667999
Q ss_pred HHHHhcccCCCCCCC---HHHHhcCCCCCCC
Q 020235 298 LLQGLLRYDPTDRLT---AREALRHPFFTRD 325 (329)
Q Consensus 298 ll~~~l~~dP~~R~t---~~~ll~hp~f~~~ 325 (329)
+|.+||+.||++||| +.++++||||...
T Consensus 249 li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 249 LISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 999999999999997 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=297.31 Aligned_cols=274 Identities=27% Similarity=0.449 Sum_probs=208.3
Q ss_pred CCCccceEEEEEEecCC--CceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc----cCCceEE
Q 020235 1 MGEGTFGQVLECWDRER--KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----YRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~----~~~~~~l 71 (329)
||+|+||.||++++..+ +..||+|.+.... .......+|+.++..+ ..|+||+++++... ....+++
T Consensus 8 lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~~~~~~~~~~~~~~~~ 83 (332)
T cd07857 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHF----RGHKNITCLYDMDIVFPGNFNELYL 83 (332)
T ss_pred ccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHh----cCCCChheeeeeeeeccccCCcEEE
Confidence 79999999999999988 8899999987421 2234566788888877 24688999987643 2356899
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
++++++++|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 84 ~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---------------------- 139 (332)
T cd07857 84 YEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---------------------- 139 (332)
T ss_pred EEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc----------------------
Confidence 99999889999987643 689999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
.++.++|+|||.+...... .....||..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+
T Consensus 140 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 140 -----ADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred -----CCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 4456778888877543321 123468899999998876 468899999999999999999999999888
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
.......+....+.++.+.+..................+ .. .........+..+.+++.+||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~----~~~~~~~~~~~~~~~li~~~l 276 (332)
T cd07857 215 YVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIP--------------KK----PFESIFPNANPLALDLLEKLL 276 (332)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccC--------------Cc----chHhhCCCCCHHHHHHHHHHc
Confidence 888888888888887766655443321110000000000 00 000112234678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
+.||++|||+.+++.||||++-
T Consensus 277 ~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 277 AFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred cCCcccCCCHHHHhcChhhhhh
Confidence 9999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=296.13 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=194.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||++.++.+++.+|+|.+.... .......+|+.++.++. .|+|++++++++..++..+++||+++.
T Consensus 12 lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~----~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS----DCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred hCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhc----CCCCEeeeeeEEecCCcEEEEEecccC
Confidence 799999999999999999999999987432 23345567877777762 468999999999999999999999977
Q ss_pred CHHHHHH---hCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 79 SLYDFLR---KNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 79 ~l~~~l~---~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
++.++.. ......+++..+..++.|++.||+|||+. +++||||||+||+++
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~------------------------- 142 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD------------------------- 142 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc-------------------------
Confidence 7665443 22234689999999999999999999974 999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
.++.++|+|||.+....... ....|+..|+|||++.+. .++.++|+|||||++|+|++|+.||.... ....
T Consensus 143 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~ 218 (288)
T cd06616 143 --RNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFD 218 (288)
T ss_pred --cCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHH
Confidence 44568999999876443322 334678899999999876 58899999999999999999999997543 1222
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+.....++.. .......++.++.+|+++||+.||++
T Consensus 219 ~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~ 257 (288)
T cd06616 219 QLTQVVKGDPPIL-----------------------------------------SNSEEREFSPSFVNFINLCLIKDESK 257 (288)
T ss_pred HHhhhcCCCCCcC-----------------------------------------CCcCCCccCHHHHHHHHHHccCChhh
Confidence 2222221111000 00001235678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||+.++++||||.+...
T Consensus 258 Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 258 RPKYKELLEHPFIKDYEE 275 (288)
T ss_pred CcCHHHHhcChhhhchhh
Confidence 999999999999987544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=293.34 Aligned_cols=270 Identities=29% Similarity=0.483 Sum_probs=208.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|+||.||+|.+..+++.+|+|.+.... ........|+.++..+ .|++++++++++.+. +..++|+||
T Consensus 7 l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-----RHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCeeeheeeEecCCCCcEEEEecc
Confidence 699999999999999999999999998542 2334566788889888 569999999999887 899999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++|.+++.... ..+++.+++.++.|++.||.|||+.|++|+||+|+||++
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~--------------------------- 133 (287)
T cd07840 82 MDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI--------------------------- 133 (287)
T ss_pred ccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---------------------------
Confidence 9779998887653 368999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......
T Consensus 134 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~ 213 (287)
T cd07840 134 NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEK 213 (287)
T ss_pred cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 445668888888876554432 234567789999987654 578999999999999999999999998887777777
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC-chhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.++...+......... ... ................ ++..+.+++++||+.||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 274 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWF--ENL-----------------KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKK 274 (287)
T ss_pred HHHHhCCCchhhccccccchhh--hhc-----------------cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhh
Confidence 7777666655444332221000 000 0000000111111122 4788999999999999999
Q ss_pred CCCHHHHhcCCCC
Q 020235 310 RLTAREALRHPFF 322 (329)
Q Consensus 310 R~t~~~ll~hp~f 322 (329)
|||+.++++||||
T Consensus 275 Rp~~~~~l~~~~~ 287 (287)
T cd07840 275 RISADQALQHEYF 287 (287)
T ss_pred CcCHHHHhhCcCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=291.24 Aligned_cols=271 Identities=30% Similarity=0.506 Sum_probs=203.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc-----eEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-----ICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~-----~~lv 72 (329)
||+|+||.||+|.++.+++.||+|.++.... .......|+.++..+.. ..|++++++++.+.+... .+++
T Consensus 7 l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~~~~~~~~~~l~ 84 (287)
T cd07838 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES--FEHPNIVRLLDVCHGPRTDRELKLTLV 84 (287)
T ss_pred ecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhc--cCCCCcceEEEEEeeccCCCCceeEEE
Confidence 6899999999999998899999999874321 22344567777777732 257999999999987766 9999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+++++|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||++
T Consensus 85 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili------------------------ 140 (287)
T cd07838 85 FEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV------------------------ 140 (287)
T ss_pred ehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE------------------------
Confidence 99997789999887554468999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|.+||......+....
T Consensus 141 ---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~ 217 (287)
T cd07838 141 ---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK 217 (287)
T ss_pred ---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH
Confidence 455678999999876654332 234578889999999988899999999999999999999999988777666666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+.....-+....... ...... ... ..........+..+.++|.+||+.||++|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (287)
T cd07838 218 IFDVIGLPSEEEWPRNVSLP-----------------RSSFPS-YTP----RSFKSFVPEICEEGLDLLKKMLTFNPHKR 275 (287)
T ss_pred HHHHcCCCChHhcCCCcccc-----------------hhhccc-ccc----cchhhhhhhhhHHHHHHHHHHhccCCccC
Confidence 55544332211111000000 000000 000 00011112346788999999999999999
Q ss_pred CCHHHHhcCCCC
Q 020235 311 LTAREALRHPFF 322 (329)
Q Consensus 311 ~t~~~ll~hp~f 322 (329)
||+.++++||||
T Consensus 276 p~~~~il~~~~~ 287 (287)
T cd07838 276 ISAFEALQHPYF 287 (287)
T ss_pred CCHHHHhcCcCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=289.42 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=191.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.++.++..||+|.+.... .......+|+.++..+ .|+||+++++++..++..++|+||+ ++
T Consensus 16 lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-----KHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred EecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-----CCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 699999999999999999999999876433 2344567788888887 5699999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 79 SLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 79 ~l~~~l~~~~~~~l--~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|.+++.... ..+ ++..+..++.|++.||.|||+.||+|+||||+||+++.
T Consensus 91 ~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~-------------------------- 143 (268)
T cd06624 91 SLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT-------------------------- 143 (268)
T ss_pred CHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC--------------------------
Confidence 9999998643 234 78888999999999999999999999999999999942
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
....++|+|||.+....... ....|++.|+|||.+.... ++.++|+||||+++|+|++|..||...+........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~ 223 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK 223 (268)
T ss_pred CCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh
Confidence 23468999999876543221 2345788999999987643 789999999999999999999999653321111000
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... .+..+...+..+.+++++||+.+|++||
T Consensus 224 ~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 257 (268)
T cd06624 224 VGMFKI----------------------------------------------HPEIPESLSAEAKNFILRCFEPDPDKRA 257 (268)
T ss_pred hhhhcc----------------------------------------------CCCCCcccCHHHHHHHHHHcCCCchhCC
Confidence 000000 0011223566799999999999999999
Q ss_pred CHHHHhcCCCC
Q 020235 312 TAREALRHPFF 322 (329)
Q Consensus 312 t~~~ll~hp~f 322 (329)
|+.++++||||
T Consensus 258 t~~~ll~~~~~ 268 (268)
T cd06624 258 SAHDLLQDPFL 268 (268)
T ss_pred CHHHHHhCCCC
Confidence 99999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.76 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=198.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.+|+|.+.... .......+|+.++..+ .|+|++++++.+...+..++++|++ +
T Consensus 9 ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-----NSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-----CCCchhhhheeeecCCEEEEEEEecCC
Confidence 699999999999999999999999987532 3345567788888877 4799999999999999999999999 7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||||+||++ +
T Consensus 84 ~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~---------------------------~ 135 (265)
T cd06605 84 GSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV---------------------------N 135 (265)
T ss_pred CcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE---------------------------C
Confidence 99999998753 468999999999999999999999 999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch--hHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~ 233 (329)
.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+. ......+..
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 215 (265)
T cd06605 136 SRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY 215 (265)
T ss_pred CCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH
Confidence 45668999999886553322 225678899999999998899999999999999999999999965421 111111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.....+. ..+ ....+..+.++|.+||..||++|||+
T Consensus 216 ~~~~~~~-------------------~~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~ 251 (265)
T cd06605 216 IVNEPPP-------------------RLP-------------------------SGKFSPDFQDFVNLCLIKDPRERPSY 251 (265)
T ss_pred HhcCCCC-------------------CCC-------------------------hhhcCHHHHHHHHHHcCCCchhCcCH
Confidence 1111000 000 01146679999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.+++.||||++-+
T Consensus 252 ~~ll~~~~~~~~~ 264 (265)
T cd06605 252 KELLEHPFIKKYE 264 (265)
T ss_pred HHHhhCchhhccc
Confidence 9999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=286.26 Aligned_cols=242 Identities=29% Similarity=0.471 Sum_probs=199.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||.|+||.||.+++..+++.+|+|.+... ........+|+.++..+ .|+|++++++++.+.+..+++|||+
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-----QHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred ecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-----CCCCeeEEEeEEecCCeEEEEEEecC
Confidence 69999999999999999999999987642 33345567888888888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.+.....+++.++..++.|++.+|.|||+.|++|+||+|+||+++
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~--------------------------- 135 (256)
T cd08221 83 GGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT--------------------------- 135 (256)
T ss_pred CCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---------------------------
Confidence 89999999876445689999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+....... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..
T Consensus 136 ~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08221 136 KAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215 (256)
T ss_pred CCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 44568888888776543322 345688999999999888888999999999999999999999977555443333221
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+..+. .....+..+.+++.+||..||++|||+
T Consensus 216 --~~~~~----------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~ 247 (256)
T cd08221 216 --GNYTP----------------------------------------------VVSVYSSELISLVHSLLQQDPEKRPTA 247 (256)
T ss_pred --CCCCC----------------------------------------------CccccCHHHHHHHHHHcccCcccCCCH
Confidence 11110 012346679999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++|||+
T Consensus 248 ~~ll~~~~l 256 (256)
T cd08221 248 DEVLDQPLL 256 (256)
T ss_pred HHHhhCcCC
Confidence 999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=311.36 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=203.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||.|.||+||-|++..|+...|||.+... ....+..+.|+.+-..+. |.||+++++.+..+++.-|+||-. ||
T Consensus 583 LGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-----HkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-----HKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred eecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-----hHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 79999999999999999999999998743 334556667888888884 489999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 79 SLYDFLRKNNYRSF--PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 79 ~l~~~l~~~~~~~l--~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|.++++...+ ++ +++++-.+.+|++.||.|||.+.|||||||-+|+|+. .
T Consensus 658 SLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--------------------------T 710 (1226)
T KOG4279|consen 658 SLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--------------------------T 710 (1226)
T ss_pred cHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--------------------------e
Confidence 99999998774 56 7889999999999999999999999999999999995 2
Q ss_pred CCCCeEEeeCCCCcccC---CCCCcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCCchhHH--HH
Q 020235 157 KSSAIKVIDFGSTTYER---PDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEH--LA 229 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~ 229 (329)
-.+.+||.|||-++... +-..++.||..|||||++... +|+.++|||||||++.||+||++||.-...... ++
T Consensus 711 ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk 790 (1226)
T KOG4279|consen 711 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK 790 (1226)
T ss_pred ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh
Confidence 34668999999886543 334677899999999999865 499999999999999999999999964322211 11
Q ss_pred -HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 230 -MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 230 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
.+.+... ++++..+.+++.||.+|+.+||.
T Consensus 791 VGmyKvHP-------------------------------------------------~iPeelsaeak~FilrcFepd~~ 821 (1226)
T KOG4279|consen 791 VGMYKVHP-------------------------------------------------PIPEELSAEAKNFILRCFEPDPC 821 (1226)
T ss_pred hcceecCC-------------------------------------------------CCcHHHHHHHHHHHHHHcCCCcc
Confidence 1112222 23345677899999999999999
Q ss_pred CCCCHHHHhcCCCCCCCCc
Q 020235 309 DRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~~~ 327 (329)
.||+|.++|+.||++..+.
T Consensus 822 ~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 822 DRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred cCccHHHhccCcccccCCC
Confidence 9999999999999987643
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=288.67 Aligned_cols=241 Identities=29% Similarity=0.464 Sum_probs=188.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch------hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv 72 (329)
||+|+||.||+|.+..++..||+|.+.... .......+|+.++..+ .|+|++++++.+.+ ....+++
T Consensus 10 lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-----QHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred ecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-----CCCCeeeEEEEEEcCCCCEEEEE
Confidence 699999999999999999999999886321 1234456788888888 56999999998765 3678999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+||+ +++|.+++.... .+++..++.++.|++.||.|||+.+++|+||+|+||+++
T Consensus 85 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~---------------------- 140 (266)
T cd06651 85 MEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRD---------------------- 140 (266)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC----------------------
Confidence 9999 889999998754 589999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+..++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 141 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~ 215 (266)
T cd06651 141 -----SAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM 215 (266)
T ss_pred -----CCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH
Confidence 4556888888877543221 12245788999999999888999999999999999999999999765433
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+... ...+ ......+..+.+++ +||..
T Consensus 216 ~~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~li-~~~~~ 247 (266)
T cd06651 216 AAIFKIATQ-PTNP----------------------------------------------QLPSHISEHARDFL-GCIFV 247 (266)
T ss_pred HHHHHHhcC-CCCC----------------------------------------------CCchhcCHHHHHHH-HHhcC
Confidence 222211110 0000 01122456788888 67888
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 020235 306 DPTDRLTAREALRHPFFT 323 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~ 323 (329)
+|++|||++++++||||+
T Consensus 248 ~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 248 EARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ChhhCcCHHHHhcCcccc
Confidence 999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=307.05 Aligned_cols=245 Identities=23% Similarity=0.404 Sum_probs=207.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-----chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc--eEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH--ICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~--~~lv~ 73 (329)
||+|+|-+||+|.+..+|..||.-.++. .....+++..|+.+|+.| .|+||++++++|.+... +.+|+
T Consensus 48 LGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-----~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 48 LGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-----KHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred cccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-----CCCceeeeeeheecCCCceeeeee
Confidence 7999999999999999999999876652 333457788899999999 67999999999987654 89999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|.+ .|+|..+..+.+ .++..+++.|+.||+.||.|||++. |+|||||.+||+|.
T Consensus 123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--------------------- 179 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--------------------- 179 (632)
T ss_pred ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---------------------
Confidence 999 999999999875 7999999999999999999999886 99999999999994
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
-..+.|||.|+|+|....... ...+|||.|||||.+. +.|+..+||||||++++||+|+..||.-......++
T Consensus 180 -----G~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 180 -----GNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred -----CCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 345789999999999777654 4468999999999988 679999999999999999999999998766654433
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.++.....+..+.++ ..+++++||.+||.. .++
T Consensus 254 --KKV~SGiKP~sl~kV--------------------------------------------~dPevr~fIekCl~~-~~~ 286 (632)
T KOG0584|consen 254 --KKVTSGIKPAALSKV--------------------------------------------KDPEVREFIEKCLAT-KSE 286 (632)
T ss_pred --HHHHcCCCHHHhhcc--------------------------------------------CCHHHHHHHHHHhcC-chh
Confidence 233334444333322 246799999999999 999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|+||.|+|.||||..+.
T Consensus 287 R~sa~eLL~d~Ff~~d~ 303 (632)
T KOG0584|consen 287 RLSAKELLKDPFFDEDG 303 (632)
T ss_pred ccCHHHHhhChhhcccc
Confidence 99999999999999873
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=296.09 Aligned_cols=270 Identities=26% Similarity=0.445 Sum_probs=200.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--------CCce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------~~~~ 69 (329)
||+|+||.||+|.++.+++.+|+|++..... ......+|+.++..+ .|++++++++.+.. ...+
T Consensus 16 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-----KHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred eccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-----CCCCccchhhheecccccccccCceE
Confidence 6999999999999999999999998864221 123456788888888 56899999887643 3357
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++|++|+++++...+.... ..+++.+++.++.|++.||+|||++|++|+||||+||++++++.
T Consensus 91 ~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~---------------- 153 (311)
T cd07866 91 YMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---------------- 153 (311)
T ss_pred EEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC----------------
Confidence 9999999888888876543 46999999999999999999999999999999999999965554
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--------------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHh
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--------------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--------------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~ 214 (329)
++|+|||.+....... ....+++.|+|||.+.+. .++.++|+|||||++|+|++
T Consensus 154 -----------~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~ 222 (311)
T cd07866 154 -----------LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222 (311)
T ss_pred -----------EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh
Confidence 5555555543322111 223568889999988764 47899999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|++||.+.+.......+....+.+++..++............ ... .............+..
T Consensus 223 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----------------~~~~~~~~~~~~~~~~ 283 (311)
T cd07866 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVH---SFT----------------NYPRTLEERFGKLGPE 283 (311)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccc---cCC----------------CCCccHHHHcccCChh
Confidence 999999888877777777777666554443321111100000 000 0000011112334578
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~hp~f 322 (329)
+.+||++||+.||++|||+.++++||||
T Consensus 284 ~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.64 Aligned_cols=241 Identities=31% Similarity=0.459 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.+..++..||+|.++... .......+|+.++..+ .|+|++++++.+..++..++||||+ +
T Consensus 12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-----CCCccHhhhcccccCCceEEEEEccCC
Confidence 699999999999999999999999987432 2334566788888777 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++ .
T Consensus 87 ~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---------------------------~ 136 (277)
T cd06642 87 GSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---------------------------E 136 (277)
T ss_pred CcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---------------------------C
Confidence 8999988653 589999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...........+...
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06642 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 216 (277)
T ss_pred CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC
Confidence 4557888888776543322 2245788899999999888999999999999999999999999754432221111000
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+ .......+..+.+++.+||+.+|++|||+.
T Consensus 217 ---~~---------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 248 (277)
T cd06642 217 ---SP---------------------------------------------PTLEGQYSKPFKEFVEACLNKDPRFRPTAK 248 (277)
T ss_pred ---CC---------------------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHH
Confidence 00 001123456799999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
++++||||..
T Consensus 249 ~il~~~~~~~ 258 (277)
T cd06642 249 ELLKHKFITR 258 (277)
T ss_pred HHHHhHHHHH
Confidence 9999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=287.67 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=194.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||++.++.+++.+|+|.++.. ....+....|..++..+ .|+|++++.+.+.+++..++||||+ +
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-----KHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 69999999999999999999999998632 23345566788888777 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++ +.
T Consensus 83 ~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---------------------------~~ 135 (255)
T cd08219 83 GDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---------------------------TQ 135 (255)
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---------------------------CC
Confidence 999999876555568999999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+..++++|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.+.
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 215 (255)
T cd08219 136 NGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQG 215 (255)
T ss_pred CCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcC
Confidence 5568888888876544322 2356888999999999888999999999999999999999999875544333322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+..+.++|.+||+.||++|||+.
T Consensus 216 ~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 247 (255)
T cd08219 216 SYK------------------------------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSAT 247 (255)
T ss_pred CCC------------------------------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHH
Confidence 100 00123456789999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++-
T Consensus 248 ~il~~ 252 (255)
T cd08219 248 TILSR 252 (255)
T ss_pred HHhhc
Confidence 99863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=294.38 Aligned_cols=245 Identities=26% Similarity=0.393 Sum_probs=197.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.+..+++.||+|.+.... .......+|+.++..+ .|+|++++.+++.+.+..++||||+
T Consensus 23 lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-----RHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 699999999999999999999999886322 2234566788888887 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+++.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ .
T Consensus 98 ~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---------------------------~ 149 (307)
T cd06607 98 LGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---------------------------T 149 (307)
T ss_pred CCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---------------------------C
Confidence 888888886543 358999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+....+. ....++..|+|||++. ...++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 150 ~~~~~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~ 228 (307)
T cd06607 150 EPGTVKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (307)
T ss_pred CCCCEEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc
Confidence 5567899999988655433 3346788999999875 34578999999999999999999999987655443332221
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.. .+. .+ ....+..+.++|++||..||++|||+
T Consensus 229 ~~--~~~--------------------~~-------------------------~~~~~~~~~~li~~~l~~~p~~Rp~~ 261 (307)
T cd06607 229 ND--SPT--------------------LS-------------------------SNDWSDYFRNFVDSCLQKIPQDRPSS 261 (307)
T ss_pred CC--CCC--------------------CC-------------------------chhhCHHHHHHHHHHhcCChhhCcCH
Confidence 10 000 00 01234578999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.+++.||||....
T Consensus 262 ~~il~~~~~~~~~ 274 (307)
T cd06607 262 EELLKHRFVLRER 274 (307)
T ss_pred HHHhcChhhcccC
Confidence 9999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=289.52 Aligned_cols=245 Identities=28% Similarity=0.434 Sum_probs=191.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~ 69 (329)
||+|+||.||+|.+..+++.+|+|.++.... ..+....|+.++..+ .|++++++++++...+..
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-----DHLNIVQYLGFETTEEYL 83 (272)
T ss_pred ecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-----CCCCcceEEEEeccCCce
Confidence 7999999999999999999999998753211 112345677777777 569999999999999999
Q ss_pred EEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCC
Q 020235 70 CIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148 (329)
Q Consensus 70 ~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 148 (329)
++||||+ +++|.+++.+.. .++...+..++.|++.||.|||++|++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~-------------------- 141 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV-------------------- 141 (272)
T ss_pred EEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE--------------------
Confidence 9999999 999999998763 68999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 149 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
..++.++|+|||.+....... ....|+..|+|||.+.... ++.++|+||||+++|++++|..||..
T Consensus 142 -------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 142 -------DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred -------cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 445668888888876543221 2245788999999988654 78999999999999999999999975
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+.......+...... ...+. .....++..+.++|.+
T Consensus 215 ~~~~~~~~~~~~~~~~---------------------~~~~~----------------------~~~~~~~~~~~~li~~ 251 (272)
T cd06629 215 EEAIAAMFKLGNKRSA---------------------PPIPP----------------------DVSMNLSPVALDFLNA 251 (272)
T ss_pred cchHHHHHHhhccccC---------------------CcCCc----------------------cccccCCHHHHHHHHH
Confidence 4443222111110000 00000 0112356789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f 322 (329)
||..+|++|||++++++||||
T Consensus 252 ~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 252 CFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HhcCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=292.66 Aligned_cols=270 Identities=30% Similarity=0.497 Sum_probs=205.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---------- 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~---------- 67 (329)
||+|+||.||+|.++.+++.||+|.++... ........|+.++..+ .|+|++++++++.+..
T Consensus 15 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-----NHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred ecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-----CCCCeeeeeheecCcchhhhccccCC
Confidence 689999999999999999999999987432 2234455688888888 5699999998887654
Q ss_pred ceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 68 HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 68 ~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
..++|+||+++++...+.... ..+++..+..++.|++.||.|||+.||+|+||||+||++
T Consensus 90 ~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili------------------- 149 (302)
T cd07864 90 AFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL------------------- 149 (302)
T ss_pred cEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE-------------------
Confidence 899999999778888887643 368999999999999999999999999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|+|++|++||...
T Consensus 150 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 150 --------NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred --------CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 455668888888876543322 123457789999988754 4689999999999999999999999887
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
+..+....+.+..+..+...++.+.+........... .............+..+.+++.+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~li~~~ 282 (302)
T cd07864 222 QELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKK-------------------QYRRRLREEFSFIPTPALDLLDHM 282 (302)
T ss_pred ChHHHHHHHHHHhCCCChhhccccccccccccccccc-------------------ccccchhhhcCCCCHHHHHHHHHH
Confidence 7777777788877766655544332211100000000 000011111223567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f 322 (329)
|+.||++|||+.+++.||||
T Consensus 283 l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 283 LTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=292.59 Aligned_cols=246 Identities=26% Similarity=0.393 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.+..++..||+|.+..... .......|+.++..+ .|++++.+++++.+....++||||+
T Consensus 29 lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-----KHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCEEEEEEecC
Confidence 6999999999999999999999999864221 223456788888887 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+++.+++.... ..+++.++..++.|++.||.|||++|++|+||+|+||++ .
T Consensus 104 ~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---------------------------~ 155 (313)
T cd06633 104 LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---------------------------T 155 (313)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---------------------------C
Confidence 888888887644 358999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+..... .....|+..|+|||.+. ...++.++|+|||||++|+|++|..||...+.......+..
T Consensus 156 ~~~~~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 234 (313)
T cd06633 156 EPGQVKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234 (313)
T ss_pred CCCCEEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 456689999998764432 23457888999999985 34578899999999999999999999977655443333222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.. .+. ......+..+.+|+.+||+.+|.+|||+
T Consensus 235 ~~--~~~---------------------------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~ 267 (313)
T cd06633 235 ND--SPT---------------------------------------------LQSNEWTDSFRGFVDYCLQKIPQERPAS 267 (313)
T ss_pred cC--CCC---------------------------------------------CCccccCHHHHHHHHHHccCChhhCcCH
Confidence 11 000 0011234578999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
.++++||||.....
T Consensus 268 ~~~l~~~~~~~~~~ 281 (313)
T cd06633 268 AELLRHDFVRRDRP 281 (313)
T ss_pred HHHhcCcccCCCch
Confidence 99999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=286.14 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=197.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||++.++.+|..+|+|.+.... ...+...+|+.++..+ .|+|++++++.+...+..++|+||+
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-----KHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred ecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-----CCCChhhhhheeccCCeEEEEEecCC
Confidence 689999999999999999999999986431 2344566788888888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++++
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~------------------------- 137 (257)
T cd08225 83 GGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN------------------------- 137 (257)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC-------------------------
Confidence 9999999987554568999999999999999999999999999999999999432
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
...++|+|||.+....... ....|++.|+|||.+....++.++|+||||+++++|++|..||...+.......+..
T Consensus 138 -~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (257)
T cd08225 138 -GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216 (257)
T ss_pred -CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 2346889998887654432 224588899999999888899999999999999999999999976544332221111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+..+ ......+.++.++|++||..+|++|||+
T Consensus 217 --~~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 248 (257)
T cd08225 217 --GYFA----------------------------------------------PISPNFSRDLRSLISQLFKVSPRDRPSI 248 (257)
T ss_pred --ccCC----------------------------------------------CCCCCCCHHHHHHHHHHhccChhhCcCH
Confidence 0000 0012345679999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||||
T Consensus 249 ~~ll~~~~~ 257 (257)
T cd08225 249 TSILKRPFL 257 (257)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.55 Aligned_cols=241 Identities=28% Similarity=0.461 Sum_probs=188.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||.||++.+..++..||+|.+.... .......+|+.++..+ .|++++++++.+.+. ..+++|
T Consensus 10 l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-----LHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred EecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-----CCCCeeeEEeEeccCCCceEEEE
Confidence 689999999999999999999999886321 1234556788888888 569999999988653 568899
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---------------------- 140 (265)
T cd06652 85 MEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---------------------- 140 (265)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec----------------------
Confidence 9999 899999998654 588999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCC------CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERP------DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+..++|+|||.+..... ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||......
T Consensus 141 -----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 215 (265)
T cd06652 141 -----SVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM 215 (265)
T ss_pred -----CCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH
Confidence 445577777777654321 112345788999999998888999999999999999999999999764433
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.... +....... +..+...+..+.++|++||.
T Consensus 216 ~~~~---~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~i~~~l~- 247 (265)
T cd06652 216 AAIF---KIATQPTN--------------------------------------------PVLPPHVSDHCRDFLKRIFV- 247 (265)
T ss_pred HHHH---HHhcCCCC--------------------------------------------CCCchhhCHHHHHHHHHHhc-
Confidence 2221 11111000 00012345678999999995
Q ss_pred CCCCCCCHHHHhcCCCCC
Q 020235 306 DPTDRLTAREALRHPFFT 323 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~ 323 (329)
+|++|||++++++|||+.
T Consensus 248 ~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 248 EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.25 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=196.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||++.+..+++.||+|++.... .......+|+.++..+ .|++++++++.+...+..++||||+ +
T Consensus 13 ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-----RSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred cCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-----CCCCcceEeeeEecCCEEEEEEecCCC
Confidence 799999999999999999999999876432 2345667888888887 5699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.+++.+|.|||+ .+++|+||+|+||++ .
T Consensus 88 ~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---------------------------~ 138 (284)
T cd06620 88 GSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---------------------------N 138 (284)
T ss_pred CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---------------------------C
Confidence 89999887643 68999999999999999999996 689999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCC-CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.+..++|+|||.+..... ......|+..|+|||++.+..++.++|+|||||++|++++|..||......+...
T Consensus 139 ~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------ 212 (284)
T cd06620 139 SRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------ 212 (284)
T ss_pred CCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------
Confidence 456688888888754322 2234578999999999988889999999999999999999999997644321000
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
..+..... .............+ ....+..+.+|+.+||+.||++|||+.+
T Consensus 213 -~~~~~~~~----~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 213 -DDPMGILD----LLQQIVQEPPPRLP-------------------------SSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred -hhhhHHHH----HHHHHhhccCCCCC-------------------------chhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 00000000 00000000000000 0124567899999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||.+.
T Consensus 263 ~~~~~~~~~~ 272 (284)
T cd06620 263 LCAMPPFIQA 272 (284)
T ss_pred HhcCcccccc
Confidence 9999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=291.30 Aligned_cols=244 Identities=27% Similarity=0.463 Sum_probs=196.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.++.++..||+|.+.... .......+|+.++..+ .|++++++++.+...+..++||||+ ++
T Consensus 28 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred cCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-----CCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 799999999999999999999999876322 2344566788888877 5699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..+..++.|++.||+|||+.|++|+||+|+||++ +.+
T Consensus 103 ~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---------------------------~~~ 152 (292)
T cd06657 103 ALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---------------------------THD 152 (292)
T ss_pred cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCC
Confidence 998887653 48999999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+...... .....|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+.......+....
T Consensus 153 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 153 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred CCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence 56888888876543322 123467889999999988888999999999999999999999998755544333222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. ......+..+.+++.+||+.||.+|||+.+
T Consensus 233 ~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ 266 (292)
T cd06657 233 PPKL----------------------------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266 (292)
T ss_pred Cccc----------------------------------------------CCcccCCHHHHHHHHHHHhCCcccCcCHHH
Confidence 0000 001224567889999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||...
T Consensus 267 ll~~~~~~~~ 276 (292)
T cd06657 267 LLKHPFLAKA 276 (292)
T ss_pred HhcChHHhcc
Confidence 9999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.23 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=196.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.+..+++.+|+|++.... .......+|+.++..+ .|++++++++.+.+.+..+++|||+ ++
T Consensus 11 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~l~~e~~~~~ 85 (262)
T cd06613 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-----RHPNIVAYFGSYLRRDKLWIVMEYCGGG 85 (262)
T ss_pred ecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-----CCCChhceEEEEEeCCEEEEEEeCCCCC
Confidence 689999999999999999999999987532 2345667788888888 6799999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.+
T Consensus 86 ~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---------------------------~~~ 137 (262)
T cd06613 86 SLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---------------------------TED 137 (262)
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---------------------------CCC
Confidence 9999887652 368999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++|+|||.+...... .....++..|+|||.+... .++.++|+||||+++|+|++|..||...+.......+.
T Consensus 138 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 138 GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred CCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 66888888887654432 1334678899999999876 78899999999999999999999997755443332222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...-..+. .......+.++.+++++||..||.+|||
T Consensus 218 ~~~~~~~~--------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt 253 (262)
T cd06613 218 KSNFPPPK--------------------------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPT 253 (262)
T ss_pred hccCCCcc--------------------------------------------ccchhhhhHHHHHHHHHHcCCChhhCCC
Confidence 11000000 0001124567899999999999999999
Q ss_pred HHHHhcCCC
Q 020235 313 AREALRHPF 321 (329)
Q Consensus 313 ~~~ll~hp~ 321 (329)
+.+++.|||
T Consensus 254 ~~~il~~~~ 262 (262)
T cd06613 254 ATKLLQHPF 262 (262)
T ss_pred HHHHhcCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.54 Aligned_cols=241 Identities=29% Similarity=0.463 Sum_probs=195.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|++|.||+|.++.+++.||+|.+.... ........|+.++..+ .|++++++++++.++...++++|
T Consensus 8 ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-----QHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred eeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-----CCCCchheeeeEecCCeEEEEEE
Confidence 699999999999999899999999886432 1334566788888777 56999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.+.. .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 83 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~------------------------- 135 (258)
T cd06632 83 LVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV------------------------- 135 (258)
T ss_pred ecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-------------------------
Confidence 99 889999998754 58899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.+..++|+|||.+....... ....|+..|+|||.+.... ++.++|+|||||++|+|++|+.||......+....
T Consensus 136 --~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~ 213 (258)
T cd06632 136 --DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213 (258)
T ss_pred --CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence 445668888988876543332 3456888999999988766 88999999999999999999999976443222211
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+... ... ...+...+..+.+++++||+.||++|
T Consensus 214 ~~~~-~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 246 (258)
T cd06632 214 IGRS-KEL----------------------------------------------PPIPDHLSDEAKDFILKCLQRDPSLR 246 (258)
T ss_pred HHhc-ccC----------------------------------------------CCcCCCcCHHHHHHHHHHhhcCcccC
Confidence 1110 000 01122356789999999999999999
Q ss_pred CCHHHHhcCCCC
Q 020235 311 LTAREALRHPFF 322 (329)
Q Consensus 311 ~t~~~ll~hp~f 322 (329)
||+.++++|||+
T Consensus 247 p~~~~~l~~~~~ 258 (258)
T cd06632 247 PTAAELLEHPFV 258 (258)
T ss_pred cCHHHHhcCCCC
Confidence 999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=292.20 Aligned_cols=244 Identities=21% Similarity=0.314 Sum_probs=185.5
Q ss_pred CCCccceEEEEEEecC----------------CCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc
Q 020235 1 MGEGTFGQVLECWDRE----------------RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~ 62 (329)
||+|+||.||+|.+.. ++..||+|++... ........+|+.++..+ .|+||++++++
T Consensus 13 lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~ 87 (304)
T cd05096 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-----KDPNIIRLLGV 87 (304)
T ss_pred ecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEE
Confidence 7999999999998542 3457999998753 22345677899988888 56999999999
Q ss_pred cccCCceEEEeecC-CCCHHHHHHhCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCC
Q 020235 63 FDYRNHICIVFEKL-GSSLYDFLRKNNY-----------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPE 124 (329)
Q Consensus 63 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~-----------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~ 124 (329)
+.+.+..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||+.||+|+||||+
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~ 167 (304)
T cd05096 88 CVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchh
Confidence 99999999999999 9999999865321 23577889999999999999999999999999999
Q ss_pred cEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCc
Q 020235 125 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYP 199 (329)
Q Consensus 125 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~ 199 (329)
|||+ +.++.++|+|||.+....... ....++..|+|||++....++.+
T Consensus 168 Nill---------------------------~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 220 (304)
T cd05096 168 NCLV---------------------------GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220 (304)
T ss_pred heEE---------------------------cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch
Confidence 9999 455668888888876543322 12345778999999998889999
Q ss_pred cchHhHHHHHHHHHh--CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccc
Q 020235 200 CDIWSVGCILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 277 (329)
Q Consensus 200 ~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
+|||||||++|+|++ +..||...+..+............... .
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------------~----------------- 265 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQ------------------V----------------- 265 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccc------------------c-----------------
Confidence 999999999999986 567887655444333222211000000 0
Q ss_pred hhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
........+..+.+|+.+||+.||++|||+.++.
T Consensus 266 ------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 266 ------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred ------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 0000123456899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=288.40 Aligned_cols=254 Identities=23% Similarity=0.379 Sum_probs=193.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~~ 76 (329)
||.|++|.||+|.++.+++.+|+|.+.... .......+|++++..+ .|+||+++++++.+ .+.+++||||+
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-----KSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred eccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 699999999999999999999999987432 2345677898888888 56999999998754 34789999999
Q ss_pred -CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++.. .....+++..+..++.|++.||.|||+.|++|+||+|+||+++
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~------------------------ 139 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT------------------------ 139 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe------------------------
Confidence 8999988764 2234588999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch--hHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~ 230 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ......
T Consensus 140 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (287)
T cd06621 140 ---RKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL 216 (287)
T ss_pred ---cCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH
Confidence 44558888988876443322 234577889999999988899999999999999999999999976422 000000
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
........+... + .. .......+..+.+||.+||+.||++|
T Consensus 217 ~~~~~~~~~~~~-------------------~-------------------~~-~~~~~~~~~~~~~li~~~l~~~p~~R 257 (287)
T cd06621 217 LSYIVNMPNPEL-------------------K-------------------DE-PGNGIKWSEEFKDFIKQCLEKDPTRR 257 (287)
T ss_pred HHHHhcCCchhh-------------------c-------------------cC-CCCCCchHHHHHHHHHHHcCCCcccC
Confidence 000000000000 0 00 00001235678999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||+.|+++||||++.
T Consensus 258 pt~~eil~~~~~~~~ 272 (287)
T cd06621 258 PTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCHHHHHhCcccccc
Confidence 999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=282.94 Aligned_cols=239 Identities=31% Similarity=0.521 Sum_probs=198.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+||.||++.+..+++.+|+|+++.... .......|+.++..+ .|++++.+++.++.++..++|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-----NHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-----CCCcHHHHHHHeecCCeeEEEEecC
Confidence 7999999999999998899999999875322 334667788888888 4699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~--------------------------- 126 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL--------------------------- 126 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE---------------------------
Confidence 999999998764 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
..+..++|+|||.+...... .....++..|+|||.+.+...+.++|+||||+++|++++|..||...+.......+.
T Consensus 127 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 206 (250)
T cd05123 127 DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL 206 (250)
T ss_pred cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 44556899999988765443 234567889999999988888999999999999999999999997655433222222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+...+ .+...+..+.+++++||..||++|||
T Consensus 207 ~~~~~-------------------------------------------------~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 207 KDPLR-------------------------------------------------FPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred cCCCC-------------------------------------------------CCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 21000 11223567899999999999999999
Q ss_pred H---HHHhcCCCC
Q 020235 313 A---REALRHPFF 322 (329)
Q Consensus 313 ~---~~ll~hp~f 322 (329)
+ .++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=288.51 Aligned_cols=247 Identities=22% Similarity=0.387 Sum_probs=196.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.+..+++.||+|.++.. ........+|+.++..+.+ ..|++++++++.+..+...++||||+ +
T Consensus 9 l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~--~~~~~vi~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06917 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ--SQPPNITKYYGSYLKGPRLWIIMEYAEG 86 (277)
T ss_pred eeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhcc--CCCCCeeeEeeeeeeCCEEEEEEecCCC
Confidence 68999999999999999999999988643 2234556778888888843 34799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++ .
T Consensus 87 ~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---------------------------~ 136 (277)
T cd06917 87 GSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---------------------------N 136 (277)
T ss_pred CcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---------------------------C
Confidence 9999998764 589999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+.++|+|||.+....... ....|+..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~ 216 (277)
T cd06917 137 TGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216 (277)
T ss_pred CCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc
Confidence 5568888888876554332 33468889999998865 3578999999999999999999999976443221111100
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
. .++ ..+ ....+.++.+++.+||+.||++|||+
T Consensus 217 ~---~~~-------------------~~~-------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~ 249 (277)
T cd06917 217 S---KPP-------------------RLE-------------------------DNGYSKLLREFVAACLDEEPKERLSA 249 (277)
T ss_pred C---CCC-------------------CCC-------------------------cccCCHHHHHHHHHHcCCCcccCcCH
Confidence 0 000 000 01245689999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
.++++||||++..
T Consensus 250 ~~il~~~~~~~~~ 262 (277)
T cd06917 250 EELLKSKWIKAHS 262 (277)
T ss_pred HHHhhChHhhccc
Confidence 9999999997643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=287.35 Aligned_cols=237 Identities=20% Similarity=0.275 Sum_probs=185.3
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++ ..+..||+|.++... .......+|+..+..+ .|+|++++++++..++..++||||
T Consensus 13 ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~ 87 (266)
T cd05064 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-----DHSNIVRLEGVITRGNTMMIVTEY 87 (266)
T ss_pred ecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEecCCCcEEEEEe
Confidence 799999999999875 446789999987542 2234556788888777 579999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++.+++.++.|++.||+|||++|++|+||||+||+++
T Consensus 88 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~------------------------- 141 (266)
T cd05064 88 MSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVN------------------------- 141 (266)
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEc-------------------------
Confidence 9 889999998743 3689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
.+..++++|||.+....... ....++..|+|||.+.+..++.++|||||||++|++++ |..||...+..+...
T Consensus 142 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 142 --SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred --CCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 44556777777654432221 11234568999999999899999999999999999775 999998765544333
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..... .+...+..+.+++.+||+.+|++
T Consensus 220 ~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~c~~~~p~~ 251 (266)
T cd05064 220 AVEDGFRLP------------------------------------------------APRNCPNLLHQLMLDCWQKERGE 251 (266)
T ss_pred HHHCCCCCC------------------------------------------------CCCCCCHHHHHHHHHHcCCCchh
Confidence 332211000 01234567999999999999999
Q ss_pred CCCHHHHhc
Q 020235 310 RLTAREALR 318 (329)
Q Consensus 310 R~t~~~ll~ 318 (329)
|||++++++
T Consensus 252 RP~~~~i~~ 260 (266)
T cd05064 252 RPRFSQIHS 260 (266)
T ss_pred CCCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=292.86 Aligned_cols=245 Identities=27% Similarity=0.445 Sum_probs=196.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.+..+++.||+|.+... ....+...+|+.++..+ .|+|++++++.+...+..++|+||+ ++
T Consensus 27 lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (293)
T cd06647 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-----KHPNIVNYLDSYLVGDELWVVMEYLAGG 101 (293)
T ss_pred ecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-----CCCCeeehhheeeeCCcEEEEEecCCCC
Confidence 69999999999999889999999998643 23345567788887777 5699999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.+. .+++..+..++.|++.||.|||++|++|+||+|+||++ ..+
T Consensus 102 ~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili---------------------------~~~ 151 (293)
T cd06647 102 SLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---------------------------GMD 151 (293)
T ss_pred cHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE---------------------------cCC
Confidence 999998764 48899999999999999999999999999999999999 445
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..++|+|||.+....... ....|++.|+|||.+....++.++|+|||||++|++++|..||...+.......+..
T Consensus 152 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-- 229 (293)
T cd06647 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-- 229 (293)
T ss_pred CCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--
Confidence 568888888775443322 234688899999999888889999999999999999999999976544322111100
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+..+ . .......+..+.+++++||..+|++|||+++
T Consensus 230 ~~~~--------------------~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 265 (293)
T cd06647 230 NGTP--------------------E------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 265 (293)
T ss_pred CCCC--------------------C------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 0000 0 0001234567999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
++.||||+...
T Consensus 266 il~h~~~~~~~ 276 (293)
T cd06647 266 LLQHPFLKIAK 276 (293)
T ss_pred HhcCHHHhcCc
Confidence 99999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.55 Aligned_cols=240 Identities=23% Similarity=0.347 Sum_probs=185.7
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.. ..++..||+|+++... ...+...+|+.++..+. .||||+++++.+.+++..++||
T Consensus 43 LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~----~HpnIv~l~~~~~~~~~~~lv~ 118 (375)
T cd05104 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG----NHINIVNLLGACTVGGPTLVIT 118 (375)
T ss_pred ecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhc----CCcceeeeeeeeccCCcceeee
Confidence 79999999999974 3556789999987432 23455678999888873 4699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------------------------------------------------
Q 020235 74 EKL-GSSLYDFLRKNN---------------------------------------------------------------- 88 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~---------------------------------------------------------------- 88 (329)
||+ +|+|.+++....
T Consensus 119 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (375)
T cd05104 119 EYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198 (375)
T ss_pred hhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccc
Confidence 999 999999997532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 89 ---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 89 ---------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
...+++..+..++.|++.||.|||++||+||||||+|||++ .+.
T Consensus 199 ~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---------------------------~~~ 251 (375)
T cd05104 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---------------------------HGR 251 (375)
T ss_pred cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---------------------------CCC
Confidence 12467788999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCCC-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 233 (329)
.++|+|||.+........ ...++..|+|||++.+..++.++|+|||||++|+|++ |..||..............
T Consensus 252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~ 331 (375)
T cd05104 252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK 331 (375)
T ss_pred cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH
Confidence 688888888765433221 1234567999999999899999999999999999998 8899976443222111111
Q ss_pred -HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 234 -VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.... ..+...+.++.+|+.+||+.||++|||
T Consensus 332 ~~~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs 363 (375)
T cd05104 332 EGYRM------------------------------------------------LSPECAPSEMYDIMKSCWDADPLKRPT 363 (375)
T ss_pred hCccC------------------------------------------------CCCCCCCHHHHHHHHHHccCChhHCcC
Confidence 0000 001123567999999999999999999
Q ss_pred HHHHhcC
Q 020235 313 AREALRH 319 (329)
Q Consensus 313 ~~~ll~h 319 (329)
+.++++.
T Consensus 364 ~~eil~~ 370 (375)
T cd05104 364 FKQIVQL 370 (375)
T ss_pred HHHHHHH
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.15 Aligned_cols=240 Identities=24% Similarity=0.336 Sum_probs=184.9
Q ss_pred CCCccceEEEEEEecCCC-----ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+..++ ..||+|.++... .......+|+.++..+. .|+||+++++.+...+.+++||
T Consensus 46 LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~----~h~nIv~~~~~~~~~~~~~lv~ 121 (374)
T cd05106 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG----QHKNIVNLLGACTHGGPVLVIT 121 (374)
T ss_pred ecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhc----cCCceeeEeeEecCCCCeEEeH
Confidence 799999999999865443 579999987432 23345677888888772 4699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------------------------------------------------
Q 020235 74 EKL-GSSLYDFLRKNN---------------------------------------------------------------- 88 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~---------------------------------------------------------------- 88 (329)
||+ +++|.+++....
T Consensus 122 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (374)
T cd05106 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEE 201 (374)
T ss_pred hhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchh
Confidence 999 999999986421
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEe
Q 020235 89 ----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 164 (329)
Q Consensus 89 ----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 164 (329)
..++++..+.+++.|++.||.|||++||+||||||+|||++ .+..++|+
T Consensus 202 ~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---------------------------~~~~~kL~ 254 (374)
T cd05106 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---------------------------DGRVAKIC 254 (374)
T ss_pred ccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---------------------------CCCeEEEe
Confidence 12467888999999999999999999999999999999994 44568888
Q ss_pred eCCCCcccCCCCC-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCC
Q 020235 165 DFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPL 238 (329)
Q Consensus 165 Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (329)
|||.+........ ...++..|+|||++....++.++|||||||++|+|++ |+.||...................
T Consensus 255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~ 334 (374)
T cd05106 255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334 (374)
T ss_pred eceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence 8888765433221 1234567999999988889999999999999999997 999997644322221111110000
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+.++.+++.+||+.||++|||+.++++
T Consensus 335 -----------------------------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 335 -----------------------------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------------------------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001124568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.62 Aligned_cols=236 Identities=28% Similarity=0.417 Sum_probs=197.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
+|.|+|+.|-.+.+..|++.+++|++... .....+|..++... ..|+|++++.+.+.++.+.|+|||.+ |+-
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~----~~h~niv~~~~v~~~~~~~~~v~e~l~g~e 402 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLV----RDHPNIVKSHDVYEDGKEIYLVMELLDGGE 402 (612)
T ss_pred cCCCCccceeeeeccccccchhheecccc---ccccccccchhhhh----cCCCcceeecceecCCceeeeeehhccccH
Confidence 68999999999999999999999998854 23344566666665 36799999999999999999999999 777
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
+.+.+.... .....+..|+.+|+.|+.|||++|++|||+||+|||+. ...+
T Consensus 403 ll~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--------------------------~~~g 453 (612)
T KOG0603|consen 403 LLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--------------------------GSAG 453 (612)
T ss_pred HHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--------------------------CCCC
Confidence 777776654 33377778999999999999999999999999999993 1345
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (329)
+++|||||.++..+......+-|..|.|||++...+|+.++|+||||++||+|++|+.||...... ..+.+..+..+
T Consensus 454 ~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~ 530 (612)
T KOG0603|consen 454 HLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK 530 (612)
T ss_pred cEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc
Confidence 699999999998877755556788999999999999999999999999999999999999875443 22233222221
Q ss_pred hhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+...+|.+++|||++||+.||.+|+|+.+++.|
T Consensus 531 -----------------------------------------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 -----------------------------------------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----------------------------------------------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 114578899999999999999999999999999
Q ss_pred CCC
Q 020235 320 PFF 322 (329)
Q Consensus 320 p~f 322 (329)
|||
T Consensus 564 ~w~ 566 (612)
T KOG0603|consen 564 PWF 566 (612)
T ss_pred cch
Confidence 999
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.39 Aligned_cols=243 Identities=29% Similarity=0.439 Sum_probs=195.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||++.++.++..||+|++.... .......+|+.++..+ .|++++++++.+..+...++||||+ +
T Consensus 12 ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred EeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-----CCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 699999999999999899999999876432 2234566788888777 6699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++..+..++.|++.+|.+||+.|++|+||+|+||++ +.
T Consensus 87 ~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---------------------------~~ 136 (277)
T cd06641 87 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---------------------------SE 136 (277)
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---------------------------CC
Confidence 8999988753 48999999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
++.++|+|||.+....... ....++..|+|||.+.....+.++|+|||||++|+|++|..||...........+...
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06641 137 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN 216 (277)
T ss_pred CCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC
Confidence 5568888888875443321 2346788899999998888899999999999999999999999764433222211110
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ .....++..+.+++.+||+.+|++||++.
T Consensus 217 --~~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 248 (277)
T cd06641 217 --NPP----------------------------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAK 248 (277)
T ss_pred --CCC----------------------------------------------CCCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 000 00123456799999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
++++||||.+.-
T Consensus 249 ~~l~~~~~~~~~ 260 (277)
T cd06641 249 ELLKHKFIVRFA 260 (277)
T ss_pred HHHhCHHHhhhh
Confidence 999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=288.18 Aligned_cols=263 Identities=28% Similarity=0.413 Sum_probs=194.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... ........|..++..+. .|+|++++++++...+..++|||++
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd05581 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN----GHPGIIKLYYTFQDEENLYFVLEYA 84 (280)
T ss_pred ecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcc----cCCCchhHHHHhcCCceEEEEEcCC
Confidence 699999999999999999999999986422 22345566777777772 3799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||++.+++.+++.|||.+...........
T Consensus 85 ~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~-- 160 (280)
T cd05581 85 PNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES-- 160 (280)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc--
Confidence 999999998764 699999999999999999999999999999999999996655555555544432211110000
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.......++..............++..|+|||......++.++|+||||++++++++|..||...+.......+....
T Consensus 161 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 161 --NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred --CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 000000001111111111123457889999999988888999999999999999999999998765433332222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH--
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-- 313 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~-- 313 (329)
...+ ...+..+.+||++||+.||++|||+
T Consensus 239 ~~~~-------------------------------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 239 YSFP-------------------------------------------------PNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred CCCC-------------------------------------------------CccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1111 2235678999999999999999999
Q ss_pred --HHHhcCCCC
Q 020235 314 --REALRHPFF 322 (329)
Q Consensus 314 --~~ll~hp~f 322 (329)
.++++||||
T Consensus 270 ~~~~ll~~~~~ 280 (280)
T cd05581 270 GYDELKAHPFF 280 (280)
T ss_pred CHHHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.81 Aligned_cols=242 Identities=24% Similarity=0.421 Sum_probs=194.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc--cCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~--~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+..+++.||+|.+... ....+....|+.++..+ .|++++++++.+. .+...+++|||
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-----KHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-----CCCccceeeeeeecCCCCEEEEEehh
Confidence 69999999999999999999999998642 23344566788888888 5689999988664 34578999999
Q ss_pred C-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 76 L-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMH-----DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 76 ~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH-----~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+ +++|.+++... ....+++..++.++.|++.||.||| +.+++|+||+|+||++
T Consensus 83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili------------------- 143 (265)
T cd08217 83 CEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL------------------- 143 (265)
T ss_pred ccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE-------------------
Confidence 9 89999999763 2246899999999999999999999 8999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
..+..++|+|||.+....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 144 --------~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 215 (265)
T cd08217 144 --------DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ 215 (265)
T ss_pred --------ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH
Confidence 445678888998887654433 234688999999999888889999999999999999999999987653
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
......+.... .+ ......+..+.+++++||+
T Consensus 216 ~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~l~~~~l~ 247 (265)
T cd08217 216 LQLASKIKEGK--FR----------------------------------------------RIPYRYSSELNEVIKSMLN 247 (265)
T ss_pred HHHHHHHhcCC--CC----------------------------------------------CCccccCHHHHHHHHHHcc
Confidence 33222221110 00 0112345689999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 020235 305 YDPTDRLTAREALRHPFF 322 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f 322 (329)
.+|++|||+.++++|||+
T Consensus 248 ~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 248 VDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCcccCCCHHHHhhCCCC
Confidence 999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=284.83 Aligned_cols=246 Identities=28% Similarity=0.482 Sum_probs=199.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|++|.||+|.++.+++.||+|++.... .......+|+..+..+ .|++++++++.+...+..++||||+ +
T Consensus 9 i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-----ESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 689999999999999999999999987543 2356677788888888 4699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.|++.||+|||+ .|++|+||+|+||++ .
T Consensus 84 ~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---------------------------~ 134 (264)
T cd06623 84 GSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---------------------------N 134 (264)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---------------------------C
Confidence 99999998753 68999999999999999999999 999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+....... ....++..|+|||.+....++.++|+||||+++|+|++|..||...+.......+..
T Consensus 135 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 214 (264)
T cd06623 135 SKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA 214 (264)
T ss_pred CCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH
Confidence 55668888888877554333 234678899999999888889999999999999999999999976542111111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC-chhHHHHHHHHhcccCCCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... ...... .+..+.++|++||..+|++|||
T Consensus 215 ~~~~~~---------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~ 249 (264)
T cd06623 215 ICDGPP---------------------------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPS 249 (264)
T ss_pred HhcCCC---------------------------------------------CCCCcccCCHHHHHHHHHHccCChhhCCC
Confidence 111100 000112 5678999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
+.++++||||++-
T Consensus 250 ~~~ll~~~~~~~~ 262 (264)
T cd06623 250 AAELLQHPFIKKA 262 (264)
T ss_pred HHHHHhCHHHHhc
Confidence 9999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=268.99 Aligned_cols=242 Identities=24% Similarity=0.298 Sum_probs=191.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~e 74 (329)
||+|||+-||++.+..++..+|+|++.+.. ...+..++|+...+++ .+||+++++++.-.+ ...||+++
T Consensus 29 LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-----~s~~vl~l~dh~l~~~~D~~~~~yll~P 103 (302)
T KOG2345|consen 29 LGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-----NSPNVLRLVDHQLREEKDGKHEAYLLLP 103 (302)
T ss_pred ecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-----CCcchHHHHHHHHHhhccCceeEEEEee
Confidence 799999999999999999999999998654 5567788999999999 669999998875432 35999999
Q ss_pred cC-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 75 KL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|+ .|+|.+.+.+.. +..+++.++++|+.++..||.+||+.. ++||||||.|||+.
T Consensus 104 yy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls-------------------- 163 (302)
T KOG2345|consen 104 YYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS-------------------- 163 (302)
T ss_pred hhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec--------------------
Confidence 99 999999998632 235899999999999999999999998 99999999999994
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCCc------------ccccCCCCchhHHhcCC---CCCccchHhHHHHHHHHHh
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNY------------IVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~------------~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~ 214 (329)
....++|+|||.+....-.... ..-|..|+|||.+..+. .+.++|||||||++|.|+.
T Consensus 164 -------~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 164 -------DSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred -------CCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence 4566899999988654433211 12377899999997653 6799999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|..||... .+ .|. .....+.++.+.+|+. ..++..
T Consensus 237 ~~sPfe~~---------~~-~Gg-----------SlaLAv~n~q~s~P~~------------------------~~yse~ 271 (302)
T KOG2345|consen 237 GESPFERI---------YQ-QGG-----------SLALAVQNAQISIPNS------------------------SRYSEA 271 (302)
T ss_pred cCCcchHH---------hh-cCC-----------eEEEeeeccccccCCC------------------------CCccHH
Confidence 99999421 00 000 0111223344444442 236788
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+.++|..||+.||.+|||+.+++.+
T Consensus 272 l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 272 LHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999999999999864
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.30 Aligned_cols=275 Identities=19% Similarity=0.221 Sum_probs=193.1
Q ss_pred ccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 4 GTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 4 G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
|++|.||.++.+.+++.||+|+++.. .........|+.++..+ .|+||+++++.+.+.+..+++|||+ +++
T Consensus 11 ~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-----QHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred cCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 46778888888889999999998753 23345677888888888 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||+|||+++|+|+||||+||+++.++.
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~-------------------------- 139 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK-------------------------- 139 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--------------------------
Confidence 999998755456899999999999999999999999999999999999965554
Q ss_pred CeEEeeCCCCcccCCC----------CCcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 160 AIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
++|+|||.+...... .....++..|+|||++... .++.++|+|||||++|+|++|..||........
T Consensus 140 -~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~ 218 (314)
T cd08216 140 -VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218 (314)
T ss_pred -eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 555555544322111 1223567789999999764 588999999999999999999999986544322
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
. +....+..+..+........ .......... ..................+.++.+|+.+||+.||
T Consensus 219 ~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 283 (314)
T cd08216 219 L--LEKVRGTVPCLLDKSTYPLY-----EDSMSQSRSS--------NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP 283 (314)
T ss_pred H--HHHHhccCccccccCchhhh-----cCCcCccccc--------ccccchhhhhhcchhhHHHHHHHHHHHHHhhcCC
Confidence 2 22222222211100000000 0000000000 0000000011111122356789999999999999
Q ss_pred CCCCCHHHHhcCCCCCCC
Q 020235 308 TDRLTAREALRHPFFTRD 325 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~~ 325 (329)
++|||+.++++||||+..
T Consensus 284 ~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 284 ESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CcCcCHHHHhcCchHhhh
Confidence 999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.66 Aligned_cols=237 Identities=21% Similarity=0.342 Sum_probs=186.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.+|+|.+... ........+|+.++..+ .|+|++++++++...+..++||||+ +
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred cCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 79999999999999999999999987642 22345667888888887 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .
T Consensus 78 ~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---------------------------~ 129 (252)
T cd05084 78 GDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---------------------------E 129 (252)
T ss_pred CcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---------------------------C
Confidence 99999997643 3589999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCCCc-----ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 231 (329)
+..++|+|||.+......... ...+..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+
T Consensus 130 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~ 209 (252)
T cd05084 130 KNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209 (252)
T ss_pred CCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH
Confidence 455777787776543322111 112346999999988889999999999999999997 88999654433222211
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... ......+..+.+++.+||+.||++||
T Consensus 210 ~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 241 (252)
T cd05084 210 EQGVRL------------------------------------------------PCPELCPDAVYRLMERCWEYDPGQRP 241 (252)
T ss_pred HcCCCC------------------------------------------------CCcccCCHHHHHHHHHHcCCChhhCc
Confidence 110000 00123456899999999999999999
Q ss_pred CHHHHhc
Q 020235 312 TAREALR 318 (329)
Q Consensus 312 t~~~ll~ 318 (329)
|+.++++
T Consensus 242 s~~~~~~ 248 (252)
T cd05084 242 SFSTVHQ 248 (252)
T ss_pred CHHHHHH
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=292.92 Aligned_cols=273 Identities=32% Similarity=0.499 Sum_probs=206.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|+||.||+|.+..+++.+|+|.+... ........+|+.++..+ ..|+||+++++++... ...++||||
T Consensus 15 lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l----~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL----GDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred hcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHh----cCCCCccceeeeeccCCCceEEEEecc
Confidence 79999999999999989999999987531 22334456788888777 2458999999987643 468999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++|.+++... .+++..++.++.|++.||.|||+.||+|+||||+||+++
T Consensus 91 ~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~-------------------------- 141 (337)
T cd07852 91 METDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN-------------------------- 141 (337)
T ss_pred cccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc--------------------------
Confidence 988999988764 588889999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCCC--------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.++.++|+|||.+....... ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+....+
T Consensus 142 -~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 142 -SDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred -CCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 45567888888775433221 23467889999998765 457899999999999999999999998887777
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+....+..+...+............ ..+....... ........+.++.++|.+||+.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~ 282 (337)
T cd07852 221 QLEKIIEVIGPPSAEDIESIKSPFAATML-----------------DSLPSRPRKP-LDELLPKASDDALDLLKKLLVFN 282 (337)
T ss_pred HHHHHHHHhCCCCHHHHHHHHhhhHHHhh-----------------hhcccccccc-hhhhccCCCHHHHHHHHHhccCC
Confidence 77777777766665544433221111000 0000000000 11112236788999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~ 325 (329)
|++|||+.++++||||++.
T Consensus 283 P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 283 PNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred cccccCHHHHhhChhhhhh
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=286.99 Aligned_cols=246 Identities=28% Similarity=0.471 Sum_probs=199.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|++|.||++.+..++..||+|.+............|+..+..+ .|+|++++++.+...+..++|+||+ +++
T Consensus 27 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 101 (286)
T cd06614 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-----KHPNIVDYYDSYLVGDELWVVMEYMDGGS 101 (286)
T ss_pred ccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-----CCCCeeEEEEEEEECCEEEEEEeccCCCc
Confidence 6899999999999998899999999886544455667888888888 5689999999999999999999999 799
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..++...+..++.|++.||.|||+.|++|+||+|+||++ ..++
T Consensus 102 L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---------------------------~~~~ 153 (286)
T cd06614 102 LTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---------------------------SKDG 153 (286)
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---------------------------cCCC
Confidence 999998753 368999999999999999999999999999999999999 4455
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+...
T Consensus 154 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-- 231 (286)
T cd06614 154 SVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-- 231 (286)
T ss_pred CEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc--
Confidence 68888888765443321 2345778899999998888999999999999999999999999765544322222110
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+. . .....++..+.++|++||+.+|.+|||+.++
T Consensus 232 ~~~~--------------------~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i 267 (286)
T cd06614 232 GIPP--------------------L------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267 (286)
T ss_pred CCCC--------------------C------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 0000 0 0011245679999999999999999999999
Q ss_pred hcCCCCCCC
Q 020235 317 LRHPFFTRD 325 (329)
Q Consensus 317 l~hp~f~~~ 325 (329)
++||||++.
T Consensus 268 l~~~~~~~~ 276 (286)
T cd06614 268 LQHPFLKKA 276 (286)
T ss_pred hhChHhhcc
Confidence 999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=283.24 Aligned_cols=237 Identities=22% Similarity=0.336 Sum_probs=190.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+. ++..||+|.+.......+...+|+.++..+ .|++++++++.+...+..+++||++ +++
T Consensus 14 lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05072 14 LGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTL-----QHDKLVRLYAVVTKEEPIYIITEYMAKGS 87 (261)
T ss_pred cCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCcEEEEecCCCCc
Confidence 799999999999865 456799998876555566778899999888 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||+|||+.+++|+||||+||+++ .+.
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---------------------------~~~ 140 (261)
T cd05072 88 LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---------------------------ESL 140 (261)
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---------------------------CCC
Confidence 99999875555688999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+.+.
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05072 141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG 220 (261)
T ss_pred cEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence 57888888876543322 12235667999999988889999999999999999998 99999775544433322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+.++.+++.+||..||++|||++
T Consensus 221 ~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 252 (261)
T cd05072 221 YRM------------------------------------------------PRMENCPDELYDIMKTCWKEKAEERPTFD 252 (261)
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 100 00123456899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 253 ~i~~ 256 (261)
T cd05072 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.13 Aligned_cols=239 Identities=23% Similarity=0.303 Sum_probs=190.0
Q ss_pred CCCccceEEEEEEecCCC-----ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.....+ ..||+|.+.... .......+|+.++..+ .|++++++++++......+++|
T Consensus 13 lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-----QHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred ccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-----CCcccceEEEEEcCCCceEEEE
Confidence 799999999999876554 689999986432 2334566788888887 5699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 74 EKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~--------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
||+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~--------- 158 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG--------- 158 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---------
Confidence 999 8999999976421 3578889999999999999999999999999999999994
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.+..++|+|||.+....... ....+++.|+|||.+....++.++|+|||||++|+|+
T Consensus 159 ------------------~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~ 220 (283)
T cd05048 159 ------------------EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIF 220 (283)
T ss_pred ------------------CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHH
Confidence 45568888888876432221 2235678899999998888999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+ |..||.+.+..+....+.+...+ ......+
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~ 252 (283)
T cd05048 221 SYGLQPYYGFSNQEVIEMIRSRQLL------------------------------------------------PCPEDCP 252 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------------CCcccCC
Confidence 8 99999876654433322221100 0112456
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.++.+|+.+||+.||.+|||+++++++
T Consensus 253 ~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 253 ARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=301.58 Aligned_cols=235 Identities=23% Similarity=0.334 Sum_probs=192.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+.|.||+++.+ ++.||||+++. ....++.-|.++ .|+||+.+.+++.....+||||||| .|.
T Consensus 132 lGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkL-----kH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKL-----KHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhc-----cCcceeeEeeeecCCceeEEeeecccccc
Confidence 799999999999665 57899998763 223355567777 6699999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|+..|+... .+.......|..+|+.|++|||.+.|+|||||.-|||| ..+.
T Consensus 199 L~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI---------------------------s~~d 249 (904)
T KOG4721|consen 199 LYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI---------------------------SYDD 249 (904)
T ss_pred HHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe---------------------------eccc
Confidence 999999865 78889999999999999999999999999999999999 4556
Q ss_pred CeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 160 AIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
.|||+|||-++....-. -.++||..|||||++..++.+.|+|||||||+||||+||..||.+-+....+..+..+.-
T Consensus 250 ~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL- 328 (904)
T KOG4721|consen 250 VVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL- 328 (904)
T ss_pred eEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc-
Confidence 68888888887655443 346899999999999999999999999999999999999999976554433222221111
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
....+.+..+-|+-||++||+-.|..||+++++|
T Consensus 329 ----------------------------------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil 362 (904)
T KOG4721|consen 329 ----------------------------------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQIL 362 (904)
T ss_pred ----------------------------------------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHH
Confidence 1112345667788999999999999999999999
Q ss_pred cCCCCCC
Q 020235 318 RHPFFTR 324 (329)
Q Consensus 318 ~hp~f~~ 324 (329)
.|-=+..
T Consensus 363 ~HldIa~ 369 (904)
T KOG4721|consen 363 LHLDIAS 369 (904)
T ss_pred HHHhhcC
Confidence 9954433
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=281.80 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=189.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++..+. +..+|+|.+............|+.++..+ .|++++++++++...+..++||||+ +++
T Consensus 12 lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 12 LGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKL-----SHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred ecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHC-----CCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 7999999999998765 45799998875554456677899999988 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ .+.
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---------------------------~~~ 137 (256)
T cd05114 86 LLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---------------------------STG 137 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---------------------------CCC
Confidence 999987643 2588999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.+.
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~ 217 (256)
T cd05114 138 VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217 (256)
T ss_pred eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence 57888888776432221 12234567999999988889999999999999999999 89999876654444333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .+...+..+.+++.+||+.||++|||++
T Consensus 218 ~~~~------------------------------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~ 249 (256)
T cd05114 218 FRLY------------------------------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFA 249 (256)
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 1100 0112345789999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 250 ~l~~ 253 (256)
T cd05114 250 ELLR 253 (256)
T ss_pred HHHH
Confidence 9985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.96 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=196.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++.+..++..+|+|.+.... .......+|+.++..+ .|+|++++++++.+++..++||||+
T Consensus 33 lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 107 (317)
T cd06635 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-----KHPNSIEYKGCYLREHTAWLVMEYC 107 (317)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeCCeEEEEEeCC
Confidence 799999999999999999999999986432 1223556788888877 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+++.+.+.... ..+++.++..++.|++.||.|||+.|++|+||+|+||++ .
T Consensus 108 ~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---------------------------~ 159 (317)
T cd06635 108 LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---------------------------T 159 (317)
T ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---------------------------C
Confidence 778888876543 358999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+...... ....|+..|+|||.+. ...++.++|+|||||++|+|++|..||...+.......+..
T Consensus 160 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 160 EPGQVKLADFGSASIASPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred CCCCEEEecCCCccccCCc-ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 4566888999887654332 3446888999999984 34578999999999999999999999976554443333222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...+.. .....+..+.+++.+||+.+|.+|||+
T Consensus 239 ~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~ 271 (317)
T cd06635 239 NESPTL-----------------------------------------------QSNEWSDYFRNFVDSCLQKIPQDRPTS 271 (317)
T ss_pred ccCCCC-----------------------------------------------CCccccHHHHHHHHHHccCCcccCcCH
Confidence 111100 011245678999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
.++++|||+.....
T Consensus 272 ~~il~~~~~~~~~~ 285 (317)
T cd06635 272 EELLKHMFVLRERP 285 (317)
T ss_pred HHHHhChhhhccCc
Confidence 99999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=285.92 Aligned_cols=238 Identities=23% Similarity=0.342 Sum_probs=189.6
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+. .+++.||+|+++.... ......+|+.++..+ .|++++++++++......++||
T Consensus 13 lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-----QHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred ccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-----CCCCchheeeEEecCCCeEEEE
Confidence 799999999999874 3467899999875332 245677899998888 5689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 74 EKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
||+ +++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~----------- 156 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG----------- 156 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc-----------
Confidence 999 999999997643 13478889999999999999999999999999999999994
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 214 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 214 (329)
.+..++|+|||.+....... ....+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 157 ----------------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~ 220 (280)
T cd05049 157 ----------------YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTY 220 (280)
T ss_pred ----------------CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhc
Confidence 45667888888775432211 22345678999999999899999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|..||.+.+..+....+...... ......+..
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~ 252 (280)
T cd05049 221 GKQPWYGLSNEEVIECITQGRLL------------------------------------------------QRPRTCPSE 252 (280)
T ss_pred CCCCCCCCCHHHHHHHHHcCCcC------------------------------------------------CCCCCCCHH
Confidence 99999776554433332211100 001235678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
+.+++++||+.||++|||+.++++
T Consensus 253 ~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 253 VYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=281.77 Aligned_cols=237 Identities=23% Similarity=0.329 Sum_probs=189.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.++ ++..+|+|++...........+|+.++..+ .|++++++++++...+..++||||+ +++
T Consensus 12 lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 12 LGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-----SHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred hccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 799999999999886 456799999875444455677898988888 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++ .++
T Consensus 86 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---------------------------~~~ 137 (256)
T cd05059 86 LLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---------------------------EDN 137 (256)
T ss_pred HHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---------------------------CCC
Confidence 999997654 2689999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCCC----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..+....+...
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05059 138 VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217 (256)
T ss_pred cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC
Confidence 688888887765433221 1123457999999998889999999999999999998 89999765554433322211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+.++.+++.+||..+|++|||+.
T Consensus 218 ~~~------------------------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 249 (256)
T cd05059 218 YRL------------------------------------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFK 249 (256)
T ss_pred CcC------------------------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 100 01123567899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++.
T Consensus 250 ~~l~~ 254 (256)
T cd05059 250 KLLSQ 254 (256)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=281.62 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=189.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.+.. +..+|+|.+............|+.++..+ .|++++++++++...+..++||||+ +++
T Consensus 12 lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 12 LGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKL-----SHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred ecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcC-----CCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 7999999999998764 44699998875544456677888888888 5699999999999889999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++.++..++.|++.||.|||+.|++|+||||+||++ +.+.
T Consensus 86 l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---------------------------~~~~ 137 (256)
T cd05113 86 LLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---------------------------DDQG 137 (256)
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---------------------------cCCC
Confidence 999997644 268999999999999999999999999999999999999 4455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+.+.
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05113 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217 (256)
T ss_pred CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcC
Confidence 68888888776443322 11234567999999988889999999999999999998 99999765544333322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .....+..+.+++.+||+.||.+|||+.
T Consensus 218 ~~~~------------------------------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 249 (256)
T cd05113 218 LRLY------------------------------------------------RPHLASEKVYAIMYSCWHEKAEERPTFQ 249 (256)
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 1100 0112456899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
+++++
T Consensus 250 ~ll~~ 254 (256)
T cd05113 250 QLLSS 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=278.30 Aligned_cols=242 Identities=29% Similarity=0.505 Sum_probs=199.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|++|.||++.+..+++.+++|++..... ......+|+..+..+ .+++++++.+.+...+..++++||+ ++
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-----KHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 6899999999999998999999999875433 456677888888888 4699999999999999999999999 79
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.+
T Consensus 83 ~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i---------------------------~~~ 134 (253)
T cd05122 83 SLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL---------------------------TSD 134 (253)
T ss_pred cHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE---------------------------ccC
Confidence 9999998753 368999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......... .
T Consensus 135 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~ 212 (253)
T cd05122 135 GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--N 212 (253)
T ss_pred CeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--c
Confidence 678999999887666553 456788899999999888889999999999999999999999976543332222211 0
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+. .+ ....++..+.+++.+||+.||++|||+.++
T Consensus 213 ~~~~--------------------~~------------------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 213 GPPG--------------------LR------------------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred CCCC--------------------cC------------------------cccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 0000 00 001135679999999999999999999999
Q ss_pred hcCCC
Q 020235 317 LRHPF 321 (329)
Q Consensus 317 l~hp~ 321 (329)
++|||
T Consensus 249 l~~~~ 253 (253)
T cd05122 249 LKHPF 253 (253)
T ss_pred hcCCC
Confidence 99999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=280.15 Aligned_cols=239 Identities=24% Similarity=0.372 Sum_probs=195.0
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccchhh--HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+... +..||+|.+...... ......|+..+..+ .|++++++++++.+....++||||
T Consensus 3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-----GHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred cccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-----CCCChheeeeeecCCCceEEEEEe
Confidence 79999999999999865 889999998854332 46667788888888 469999999999999999999999
Q ss_pred C-CCCHHHHHHhCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 76 L-GSSLYDFLRKNN-------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 76 ~-~~~l~~~l~~~~-------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+ +++|.+++.... ...+++..+..++.|++.||+|||++|++|+||+|+||++
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili------------------- 138 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV------------------- 138 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE-------------------
Confidence 9 999999998751 2468999999999999999999999999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 221 (329)
+.+..++|+|||.+...... .....++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 139 --------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 139 --------GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred --------CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 45566888888888765543 223456788999999988889999999999999999998 6999987
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
....+....+... .. .......+.++.+++.+
T Consensus 211 ~~~~~~~~~~~~~--~~----------------------------------------------~~~~~~~~~~~~~li~~ 242 (262)
T cd00192 211 LSNEEVLEYLRKG--YR----------------------------------------------LPKPEYCPDELYELMLS 242 (262)
T ss_pred CCHHHHHHHHHcC--CC----------------------------------------------CCCCccCChHHHHHHHH
Confidence 6544333322220 00 00112346789999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 020235 302 LLRYDPTDRLTAREALRH 319 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~h 319 (329)
||+.||++|||+.+++++
T Consensus 243 ~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 243 CWQLDPEDRPTFSELVER 260 (262)
T ss_pred HccCCcccCcCHHHHHHh
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=281.58 Aligned_cols=243 Identities=30% Similarity=0.468 Sum_probs=193.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||++.+..+++.||+|.++.... .......|+.++..+ .|++|+++++.+.+.+..++|+||+
T Consensus 8 lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-----KHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-----CCCChhheeeeEecCCEEEEEEecCC
Confidence 7999999999999998999999999875433 345667788888888 5689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~--------------------------- 133 (264)
T cd06626 83 GGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD--------------------------- 133 (264)
T ss_pred CCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---------------------------
Confidence 899999998753 578999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCCC-------cccccCCCCchhHHhcCC---CCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 157 KSSAIKVIDFGSTTYERPDQN-------YIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~-------~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.+..++|+|||.+........ ...++..|+|||.+.+.. ++.++|+||||+++|++++|+.||...+...
T Consensus 134 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~ 213 (264)
T cd06626 134 HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF 213 (264)
T ss_pred CCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH
Confidence 455678888887765443221 245788999999998766 7899999999999999999999997653222
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
........ +..+. .+. ....+..+.+++.+||+.|
T Consensus 214 ~~~~~~~~-~~~~~--------------------~~~------------------------~~~~~~~~~~li~~~l~~~ 248 (264)
T cd06626 214 QIMFHVGA-GHKPP--------------------IPD------------------------SLQLSPEGKDFLDRCLESD 248 (264)
T ss_pred HHHHHHhc-CCCCC--------------------CCc------------------------ccccCHHHHHHHHHHccCC
Confidence 11111110 11100 000 1123667889999999999
Q ss_pred CCCCCCHHHHhcCCCC
Q 020235 307 PTDRLTAREALRHPFF 322 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f 322 (329)
|++|||+.++++|||+
T Consensus 249 p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 249 PKKRPTASELLQHPFV 264 (264)
T ss_pred cccCCCHHHHhcCCCC
Confidence 9999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=280.38 Aligned_cols=242 Identities=28% Similarity=0.513 Sum_probs=198.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||.|+||.||++.+..+++.||+|++.... ........|++++..+ .|++++++.+.+..+...++|+|++
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-----NHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-----CCCChhheEEEEecCCEEEEEEEecC
Confidence 689999999999999999999999987532 3445667788888888 4689999999999889999999999
Q ss_pred CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 ~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++.+.. ...+++..+..++.+++.||.+||++|++|+||+|+||+++
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~------------------------- 137 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT------------------------- 137 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc-------------------------
Confidence 889999998743 35689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
.+..++|+|||.+....... ....|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+..+....+
T Consensus 138 --~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 215 (258)
T cd08215 138 --SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKI 215 (258)
T ss_pred --CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHH
Confidence 45568888888876554432 3346888999999998888999999999999999999999999765543333222
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.+.. .+ ......+..+.+++.+||..+|++||
T Consensus 216 ~~~~--~~----------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp 247 (258)
T cd08215 216 LKGQ--YP----------------------------------------------PIPSQYSSELRNLVSSLLQKDPEERP 247 (258)
T ss_pred hcCC--CC----------------------------------------------CCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 2110 00 01123456899999999999999999
Q ss_pred CHHHHhcCCCC
Q 020235 312 TAREALRHPFF 322 (329)
Q Consensus 312 t~~~ll~hp~f 322 (329)
|+.++++||||
T Consensus 248 ~~~~ll~~~~~ 258 (258)
T cd08215 248 SIAQILQSPFI 258 (258)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=287.20 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=193.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++.++.++..+|+|.+... ........+|+.++..+ .|++++++.+++......++||||+
T Consensus 23 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 97 (308)
T cd06634 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREHTAWLVMEYC 97 (308)
T ss_pred eeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCcccEEEEEEcCCeeEEEEEcc
Confidence 68999999999999999999999998632 12233456788888887 5689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+++.+.+.... ..+++.++..++.|++.||.|||+.+++|+||+|+||++ .
T Consensus 98 ~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~---------------------------~ 149 (308)
T cd06634 98 LGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL---------------------------S 149 (308)
T ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE---------------------------C
Confidence 778888776543 358999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+...... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.+
T Consensus 150 ~~~~~kl~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 228 (308)
T cd06634 150 EPGLVKLGDFGSASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228 (308)
T ss_pred CCCcEEECCcccceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh
Confidence 4556888888887654432 23467889999999853 4578899999999999999999999976544333222221
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...+.. .....+..+.++|++||+.+|++|||+
T Consensus 229 ~~~~~~-----------------------------------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~ 261 (308)
T cd06634 229 NESPAL-----------------------------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTS 261 (308)
T ss_pred cCCCCc-----------------------------------------------CcccccHHHHHHHHHHhhCCcccCCCH
Confidence 110000 012345678999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
.++++|||+...
T Consensus 262 ~~ll~~~~~~~~ 273 (308)
T cd06634 262 EVLLKHRFVLRE 273 (308)
T ss_pred HHHhhCcccccc
Confidence 999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=282.51 Aligned_cols=237 Identities=23% Similarity=0.334 Sum_probs=191.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.++. +..+|+|.+..... .......|+.++..+ .|++++++++++.+.+..++||||+ ++
T Consensus 14 ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (261)
T cd05148 14 LGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-----RHKHLISLFAVCSVGEPVYIITELMEKG 87 (261)
T ss_pred hccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-----CCcchhheeeeEecCCCeEEEEeecccC
Confidence 6999999999999987 88899999875443 345667788888877 5699999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++....+..+++..+..++.|++.||+|||++|++|+||||+||+++ .+
T Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---------------------------~~ 140 (261)
T cd05148 88 SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---------------------------ED 140 (261)
T ss_pred CHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---------------------------CC
Confidence 999999876556789999999999999999999999999999999999994 45
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
..++|+|||.+....... ....++..|+|||.+....++.++|+||||+++|+|++ |+.||...+..+....+...
T Consensus 141 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05148 141 LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG 220 (261)
T ss_pred ceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence 567888888776543322 12234567999999988889999999999999999998 89999776554443333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+..+.+++.+||+.||++|||+.
T Consensus 221 ~~~------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 252 (261)
T cd05148 221 YRM------------------------------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFK 252 (261)
T ss_pred CcC------------------------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 100 01124567899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05148 253 ALRE 256 (261)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=281.55 Aligned_cols=228 Identities=25% Similarity=0.369 Sum_probs=182.0
Q ss_pred ccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHH
Q 020235 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYD 82 (329)
Q Consensus 4 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~ 82 (329)
|.+|.||+|+++.+++.||+|.++.... ...|...+... .++|++++++++...+..++||||+ +++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPH-----CVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhc-----CCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence 8999999999999999999999875432 12232222222 5699999999999999999999999 899999
Q ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeE
Q 020235 83 FLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162 (329)
Q Consensus 83 ~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (329)
++.+.. .+++..+..++.|++.||+|||++|++|+||||+||++ +.++.++
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---------------------------~~~~~~~ 125 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---------------------------DDRGHIQ 125 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---------------------------cCCCCEE
Confidence 987654 58999999999999999999999999999999999999 4455688
Q ss_pred EeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhH
Q 020235 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHM 242 (329)
Q Consensus 163 l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 242 (329)
++|||.+...........++..|+|||.+.+..++.++|+||+|+++|+|++|..|+....... ..
T Consensus 126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~----- 191 (237)
T cd05576 126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NT----- 191 (237)
T ss_pred EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------cc-----
Confidence 8999877655554444456778999999988888999999999999999999998874311100 00
Q ss_pred HHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH-----HHHh
Q 020235 243 LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA-----REAL 317 (329)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~-----~~ll 317 (329)
.... ..+...+..+.++|++||+.||++|+|+ ++++
T Consensus 192 -------------~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~ 232 (237)
T cd05576 192 -------------HTTL--------------------------NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIK 232 (237)
T ss_pred -------------cccc--------------------------CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHH
Confidence 0000 0112356789999999999999999986 9999
Q ss_pred cCCCC
Q 020235 318 RHPFF 322 (329)
Q Consensus 318 ~hp~f 322 (329)
+||||
T Consensus 233 ~h~~~ 237 (237)
T cd05576 233 SHPFF 237 (237)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=277.03 Aligned_cols=279 Identities=27% Similarity=0.473 Sum_probs=227.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
+|.|.- .|--|.+..+++.||+|.+.. .....+++.+|...+..+ .|+|+++++.+|.... .+|+
T Consensus 25 ~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-----~~~nii~l~n~ftP~~~l~~~~e~y~ 98 (369)
T KOG0665|consen 25 IGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-----NHKNIISLLNVFTPQKTLEEFQEVYL 98 (369)
T ss_pred cCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-----cccceeeeeeccCccccHHHHHhHHH
Confidence 466776 788888888999999998753 233456778899999999 6699999999997543 6899
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||++..+|...+.. .++...++.+++|++.|+.|||+.||+||||||+||++
T Consensus 99 v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv----------------------- 151 (369)
T KOG0665|consen 99 VMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 151 (369)
T ss_pred HHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee-----------------------
Confidence 999999999999984 47888999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
.....+||.|||.|...+..- +..+.|..|+|||++.+-.+...+||||+||++.+|++|+..|.+.+..+++.
T Consensus 152 ----~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ 227 (369)
T KOG0665|consen 152 ----NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWN 227 (369)
T ss_pred ----cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHH
Confidence 555668999999998777662 45678999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+.+|.+.+....++++....|..+... +.. -.....+++-..... .+.....+.-++|++.+||..||++
T Consensus 228 ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~-y~~-----~~f~~~fpD~~f~~~-~e~~~~~~~~ardll~~MLvi~pe~ 300 (369)
T KOG0665|consen 228 KIIEQLGTPDPSFMKQLQPTVRNYVENRPQ-YQA-----ISFSELFPDSLFPVV-LEGSKLDCSLARDLLSKMLVIDPEK 300 (369)
T ss_pred HHHHHhcCCCHHHHHHhhHHHHHHhhcChH-hhc-----cchhhhCCccccccc-ccCCccchHHHHHHHHHhhccChhh
Confidence 999999999999999999999888774211 000 011111111111111 1112345667999999999999999
Q ss_pred CCCHHHHhcCCCCC
Q 020235 310 RLTAREALRHPFFT 323 (329)
Q Consensus 310 R~t~~~ll~hp~f~ 323 (329)
|.+++++|+||||+
T Consensus 301 Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 301 RISVDDALRHPYIK 314 (369)
T ss_pred cccHHHHhcCCeee
Confidence 99999999999996
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=282.76 Aligned_cols=242 Identities=21% Similarity=0.294 Sum_probs=190.8
Q ss_pred CCCccceEEEEEEecC-----CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|++|.||+|.++. ++..||+|.++... .......+|+.++..+ .|++++++++++.+.+..++||
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~ 88 (277)
T cd05036 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-----NHQNIVRLIGVSFERLPRFILL 88 (277)
T ss_pred CCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCCcEEEE
Confidence 7999999999999987 77899999876432 2234567788888887 5699999999998888999999
Q ss_pred ecC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 74 EKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
||+ +++|.+++..... ..+++.++..++.|++.||+|||+++++|+||||+||+++.++
T Consensus 89 e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~--------------- 153 (277)
T cd05036 89 ELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG--------------- 153 (277)
T ss_pred ecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC---------------
Confidence 999 9999999976431 2478899999999999999999999999999999999996532
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 221 (329)
....++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 154 ---------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 154 ---------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred ---------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 23458999999887553222 12233567999999998889999999999999999997 9999987
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+.......+...... ..+...+..+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~i~~ 256 (277)
T cd05036 225 RTNQEVMEFVTGGGRL------------------------------------------------DPPKGCPGPVYRIMTD 256 (277)
T ss_pred CCHHHHHHHHHcCCcC------------------------------------------------CCCCCCCHHHHHHHHH
Confidence 6554332222111000 0012345678999999
Q ss_pred hcccCCCCCCCHHHHhcC
Q 020235 302 LLRYDPTDRLTAREALRH 319 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~h 319 (329)
||+.||++|||+.+|++|
T Consensus 257 cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 257 CWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCCcccCcCHHHHHHH
Confidence 999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=281.11 Aligned_cols=237 Identities=24% Similarity=0.346 Sum_probs=191.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|++|.||+|.+.. ++.||+|.++..........+|+.++..+ .|+|++++++++...+..++|||++ +++
T Consensus 14 lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (261)
T cd05068 14 LGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKL-----RHPKLIQLYAVCTLEEPIYIVTELMKYGS 87 (261)
T ss_pred ecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHC-----CCCCccceeEEEecCCCeeeeeecccCCc
Confidence 6999999999998754 56799999886554556677899999888 5689999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++....+..+++..+..++.|++.||.+||+.|++|+||||+||++ ..+.
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---------------------------~~~~ 140 (261)
T cd05068 88 LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV---------------------------GENN 140 (261)
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE---------------------------cCCC
Confidence 9999987555568999999999999999999999999999999999999 4455
Q ss_pred CeEEeeCCCCcccCCCC-Cccc---ccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ-NYIV---STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~-~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... .... .+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.......+.+.
T Consensus 141 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05068 141 ICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220 (261)
T ss_pred CEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 68888888876554322 1112 2347999999988889999999999999999999 99999876554433333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... + .....+..+.+++.+||+.+|++|||+.
T Consensus 221 ~~~-~-----------------------------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~ 252 (261)
T cd05068 221 YRM-P-----------------------------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFE 252 (261)
T ss_pred CCC-C-----------------------------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHH
Confidence 100 0 0123456899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05068 253 TLQW 256 (261)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.88 Aligned_cols=243 Identities=30% Similarity=0.423 Sum_probs=198.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||.|.||.||.|.+..||...|+|.++... +.-....+|+.++..+ +|||+++++++--....++|.||||
T Consensus 1243 Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-----nHpNlV~YyGVEvHRekv~IFMEyC~ 1317 (1509)
T KOG4645|consen 1243 IGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-----NHPNLVRYYGVEVHREKVYIFMEYCE 1317 (1509)
T ss_pred cCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-----cCccccccCceeecHHHHHHHHHHhc
Confidence 699999999999999999999999987432 3345566799999999 7799999999988888999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|.+.+...+ ..++.....+..|++.|++|||++|||||||||.||+++.+|
T Consensus 1318 ~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g------------------------ 1371 (1509)
T KOG4645|consen 1318 GGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG------------------------ 1371 (1509)
T ss_pred cCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC------------------------
Confidence 999999998764 578888889999999999999999999999999999995544
Q ss_pred CCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.+|+.|||.|....... ....||+.|||||++.+. +...+.|||||||++.||+||+.||...+..-
T Consensus 1372 ---~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~ 1448 (1509)
T KOG4645|consen 1372 ---LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW 1448 (1509)
T ss_pred ---cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh
Confidence 56666666665444332 245799999999999864 56789999999999999999999997665543
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
.+..-.. .|.. +++++..|.+.+|||.+||+.|
T Consensus 1449 aIMy~V~-~gh~----------------------------------------------Pq~P~~ls~~g~dFle~Cl~~d 1481 (1509)
T KOG4645|consen 1449 AIMYHVA-AGHK----------------------------------------------PQIPERLSSEGRDFLEHCLEQD 1481 (1509)
T ss_pred HHHhHHh-ccCC----------------------------------------------CCCchhhhHhHHHHHHHHHhcC
Confidence 2221111 1111 1233457889999999999999
Q ss_pred CCCCCCHHHHhcCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTR 324 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~ 324 (329)
|++|+|+.|+++|.|-+.
T Consensus 1482 P~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1482 PKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred chhhhHHHHHHHhhcccc
Confidence 999999999999998764
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=278.68 Aligned_cols=235 Identities=22% Similarity=0.317 Sum_probs=184.7
Q ss_pred CCCccceEEEEEEe--cCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+ +.++..+|+|+++... ...+....|+.++..+ .|+++++++++++ ....++||||
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~-~~~~~lv~e~ 76 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-----DNPYIVRMIGICE-AESWMLVMEL 76 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEc-CCCcEEEEec
Confidence 79999999999965 4567899999986432 2345567788888887 6699999998875 4567999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||||.||++
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill-------------------------- 128 (257)
T cd05116 77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL-------------------------- 128 (257)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE--------------------------
Confidence 9 889999997653 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
..+..++|+|||.+........ ...++..|+|||.+....++.++|+|||||++|+|++ |..||.+.+..+.
T Consensus 129 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 207 (257)
T cd05116 129 -VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV 207 (257)
T ss_pred -cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4455688888888765433321 1223568999999988888999999999999999998 9999987655443
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+...+ ..+...+.++.++|++||+.||
T Consensus 208 ~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~~~~~p 239 (257)
T cd05116 208 TQMIESGERM------------------------------------------------ECPQRCPPEMYDLMKLCWTYGV 239 (257)
T ss_pred HHHHHCCCCC------------------------------------------------CCCCCCCHHHHHHHHHHhccCc
Confidence 3333221100 0012356789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+++|..
T Consensus 240 ~~Rp~~~~i~~ 250 (257)
T cd05116 240 DERPGFAVVEL 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=276.69 Aligned_cols=240 Identities=30% Similarity=0.458 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|++|.||++.++.+++.||+|.+.... .......+|++++..+ .|++++++.+++.+++..+++||++
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-----KHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred EcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-----CCCCccEEEEEEEeCCEEEEEEecCC
Confidence 689999999999999999999999987543 2445667788888888 5689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.+.. .+++..+..++.|++.||.+||+.|++|+||+|+||++ .
T Consensus 83 ~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---------------------------~ 133 (254)
T cd06627 83 NGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT---------------------------T 133 (254)
T ss_pred CCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---------------------------C
Confidence 889999998763 68999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCCC---cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+........ ...++..|+|||...+..++.++|+||||+++|+|++|..||...+.......+..
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 213 (254)
T cd06627 134 KDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213 (254)
T ss_pred CCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc
Confidence 456688899988876554432 34678899999999887888999999999999999999999976543322211111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
... .......+..+.+++.+||..+|++|||+
T Consensus 214 --~~~----------------------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 245 (254)
T cd06627 214 --DDH----------------------------------------------PPLPEGISPELKDFLMQCFQKDPNLRPTA 245 (254)
T ss_pred --cCC----------------------------------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCH
Confidence 000 00112346789999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.+++.||||
T Consensus 246 ~~~l~~~~~ 254 (254)
T cd06627 246 KQLLKHPWI 254 (254)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.28 Aligned_cols=236 Identities=26% Similarity=0.362 Sum_probs=187.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+. ++..+|+|.++......+...+|+.++..+ .|++++++++++. ....+++|||+ +++
T Consensus 14 ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 14 LGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-----RHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred eccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-----CCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 799999999999876 456799999886555556678899999888 5689999998875 45689999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++ .+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---------------------------~~~ 139 (260)
T cd05070 87 LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---------------------------DGL 139 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---------------------------CCc
Confidence 99999875545689999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05070 140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG 219 (260)
T ss_pred eEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 67888888876543322 11234567999999988889999999999999999999 89999776554433332211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
. .. +.....+..+.+++.+||..||++|||++
T Consensus 220 ~-~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 251 (260)
T cd05070 220 Y-RM-----------------------------------------------PCPQDCPISLHELMLQCWKKDPEERPTFE 251 (260)
T ss_pred C-CC-----------------------------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHH
Confidence 0 00 01123456899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 252 ~l~~ 255 (260)
T cd05070 252 YLQS 255 (260)
T ss_pred HHHH
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=277.53 Aligned_cols=236 Identities=22% Similarity=0.317 Sum_probs=190.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|... |+.||+|.+.......+....|+.++..+ .|++++++++++.+.+..++|||++ +++
T Consensus 14 ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 14 IGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTL-----RHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred eecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhc-----CCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 689999999999764 78899999986554456777899988888 5689999999999999999999999 789
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||+++ .++
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---------------------------~~~ 139 (256)
T cd05039 87 LVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---------------------------EDL 139 (256)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---------------------------CCC
Confidence 99999876545689999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPL 238 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (329)
.++|+|||.+...........++..|+|||.+....++.++|+||||+++|++++ |..||......+....+......
T Consensus 140 ~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~- 218 (256)
T cd05039 140 VAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM- 218 (256)
T ss_pred CEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC-
Confidence 6888888888765433333344567999999988889999999999999999997 99999765443322221110000
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+..+.++|++||..+|++|||+.++++
T Consensus 219 -----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 -----------------------------------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -----------------------------------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001234568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=307.91 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=211.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-----cCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----YRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-----~~~~~~lv~e~ 75 (329)
+|.|.+|.||++.++.+++..|+|++.......++...|.++++.. ++|||++.++++|. .++.+||||||
T Consensus 27 ig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~----~~hpnv~~fyg~~~k~~~~~~DqLWLVMEf 102 (953)
T KOG0587|consen 27 IGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKY----SHHPNVATFYGAFIKKDPGNGDQLWLVMEF 102 (953)
T ss_pred EeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhc----cCCCCcceEEEEEEEecCCCCCeEEEEeec
Confidence 5899999999999999999999999988877788888888888777 57899999999886 35689999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
| ||++.|+++...+.++.+..+..|+...+.||.+||...++|||||-.|||+
T Consensus 103 C~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL-------------------------- 156 (953)
T KOG0587|consen 103 CGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL-------------------------- 156 (953)
T ss_pred cCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE--------------------------
Confidence 9 9999999998777889999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-----CCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-----WTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
..+..|||+|||.+....... .+.+|||.|||||++...+ |+..+|+||||++..+|.-|.+|+-..-++-
T Consensus 157 -T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 157 -TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred -eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 677789999999987665543 5678999999999998653 7889999999999999999999996544432
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
.+......+|+.+.. +++.+..|.|||+.||.+|
T Consensus 236 ---aLF~IpRNPPPkLkr-------------------------------------------p~kWs~~FndFIs~cL~Kd 269 (953)
T KOG0587|consen 236 ---ALFLIPRNPPPKLKR-------------------------------------------PKKWSKKFNDFISTCLVKD 269 (953)
T ss_pred ---hhccCCCCCCccccc-------------------------------------------hhhHHHHHHHHHHHHHhhc
Confidence 233333333322110 2345778999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~~ 326 (329)
-++||+..++|+|||+++..
T Consensus 270 ~e~RP~~~~ll~hpFi~e~~ 289 (953)
T KOG0587|consen 270 YEQRPSTEELLKHPFITEQP 289 (953)
T ss_pred cccCcchhhhccCCcccccc
Confidence 99999999999999998543
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.73 Aligned_cols=236 Identities=27% Similarity=0.358 Sum_probs=186.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+..++ .||+|+++..........+|+.++..+ .|++++++++.+. ....++||||+ +++
T Consensus 14 lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 14 LGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred cCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhC-----CCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 799999999999887654 599999886444455677899988888 5689999988775 45689999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||+++ .+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---------------------------~~~ 139 (262)
T cd05071 87 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---------------------------ENL 139 (262)
T ss_pred HHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---------------------------CCC
Confidence 99999875445688999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCCC----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+........ ...++..|+|||...+..++.++|+|||||++|+|++ |..||.+....+....+...
T Consensus 140 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~ 219 (262)
T cd05071 140 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 219 (262)
T ss_pred cEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence 688888888765443321 2345667999999988889999999999999999999 88999765543332222110
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
. ..+ .....+..+.+++.+||+.||++|||+.
T Consensus 220 ~-~~~-----------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~ 251 (262)
T cd05071 220 Y-RMP-----------------------------------------------CPPECPESLHDLMCQCWRKEPEERPTFE 251 (262)
T ss_pred C-CCC-----------------------------------------------CccccCHHHHHHHHHHccCCcccCCCHH
Confidence 0 000 0123456789999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 252 ~~~~ 255 (262)
T cd05071 252 YLQA 255 (262)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=277.45 Aligned_cols=235 Identities=23% Similarity=0.317 Sum_probs=186.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc-ccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~-~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||++..+ +..+|+|.++.. ...+...+|+.++..+ .|++++++++++ .+++..++||||+ ++
T Consensus 14 lg~g~~~~v~~~~~~--~~~~~~k~~~~~-~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~lv~e~~~~~ 85 (256)
T cd05082 14 IGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 85 (256)
T ss_pred ecccCCCeEEEEEEc--CCcEEEEEeCCC-chHHHHHHHHHHHHhC-----CCCCeeeEEEEEEcCCCceEEEEECCCCC
Confidence 699999999999664 678999998743 3345667888888888 568999999864 5567899999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.......+++..+..++.|++.||+|||++|++|+||||+||++ +.+
T Consensus 86 ~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---------------------------~~~ 138 (256)
T cd05082 86 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---------------------------SED 138 (256)
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---------------------------cCC
Confidence 99999987654568899999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
+.++|+|||.+...........++..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+.+...+
T Consensus 139 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 218 (256)
T cd05082 139 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 218 (256)
T ss_pred CcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC
Confidence 66888888887755444333445667999999988889999999999999999997 99999765443332222111000
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
......+..+.+++.+||+.||++|||+.+++
T Consensus 219 ------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 219 ------------------------------------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLR 250 (256)
T ss_pred ------------------------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 01123466899999999999999999999997
Q ss_pred c
Q 020235 318 R 318 (329)
Q Consensus 318 ~ 318 (329)
+
T Consensus 251 ~ 251 (256)
T cd05082 251 E 251 (256)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=282.40 Aligned_cols=238 Identities=24% Similarity=0.351 Sum_probs=187.4
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||++.. ..++..+|+|.+.... .......+|+.++..+ .|++++++++++...+..++|||
T Consensus 13 lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e 87 (288)
T cd05093 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVEGDPLIMVFE 87 (288)
T ss_pred cCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCccEEEEE
Confidence 79999999999985 3345679999887432 3345677888888888 56999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCc
Q 020235 75 KL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 142 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~-----------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~ 142 (329)
|+ +++|.+++.... ...+++.++..++.|++.||+|||++|++||||||+||+++
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~------------- 154 (288)
T cd05093 88 YMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG------------- 154 (288)
T ss_pred cCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc-------------
Confidence 99 899999997532 12489999999999999999999999999999999999994
Q ss_pred cCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CC
Q 020235 143 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 216 (329)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 216 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |.
T Consensus 155 --------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~ 220 (288)
T cd05093 155 --------------ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220 (288)
T ss_pred --------------cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 45567888888776443222 22345678999999998889999999999999999998 99
Q ss_pred CCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHH
Q 020235 217 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296 (329)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
.||...+..+....+.... .+ ......+.++.
T Consensus 221 ~p~~~~~~~~~~~~i~~~~--~~----------------------------------------------~~~~~~~~~l~ 252 (288)
T cd05093 221 QPWYQLSNNEVIECITQGR--VL----------------------------------------------QRPRTCPKEVY 252 (288)
T ss_pred CCCCCCCHHHHHHHHHcCC--cC----------------------------------------------CCCCCCCHHHH
Confidence 9997765543332222110 00 00123566899
Q ss_pred HHHHHhcccCCCCCCCHHHHhc
Q 020235 297 HLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 297 ~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
+|+.+||+.||.+|||+.++++
T Consensus 253 ~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 253 DLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=277.76 Aligned_cols=236 Identities=26% Similarity=0.371 Sum_probs=187.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|++|.||+|.+..++ .+|+|.+...........+|+.++..+ .|++++++++++. .+..++||||+ +++
T Consensus 14 ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05069 14 LGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKL-----RHDKLVPLYAVVS-EEPIYIVTEFMGKGS 86 (260)
T ss_pred ecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhC-----CCCCeeeEEEEEc-CCCcEEEEEcCCCCC
Confidence 799999999999887654 599998875554556677899999888 5689999988875 45689999999 789
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++ +.+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---------------------------~~~~ 139 (260)
T cd05069 87 LLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---------------------------GDNL 139 (260)
T ss_pred HHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---------------------------cCCC
Confidence 9999987554568899999999999999999999999999999999999 4456
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....+....+...
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05069 140 VCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG 219 (260)
T ss_pred eEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 68888888876543322 12345667999999988889999999999999999999 99999875544433322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ + .....+..+.+++++||..||++|||++
T Consensus 220 ~~~-~-----------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05069 220 YRM-P-----------------------------------------------CPQGCPESLHELMKLCWKKDPDERPTFE 251 (260)
T ss_pred CCC-C-----------------------------------------------CCcccCHHHHHHHHHHccCCcccCcCHH
Confidence 000 0 0122456799999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 252 ~i~~ 255 (260)
T cd05069 252 YIQS 255 (260)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.22 Aligned_cols=240 Identities=22% Similarity=0.283 Sum_probs=185.4
Q ss_pred CCCccceEEEEEEecCCCc--eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.++. .+|+|.++.. ........+|+.++..+. .|+|++++++++.+++..++||||+
T Consensus 15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e~~ 90 (303)
T cd05088 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYLYLAIEYA 90 (303)
T ss_pred ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhc----CCCCcceEEEEECCCCCceEEEEeC
Confidence 7999999999999887775 4577776532 223345667888888872 4689999999999999999999999
Q ss_pred -CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 77 -GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 77 -~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
+++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 91 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili------------- 157 (303)
T cd05088 91 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------------- 157 (303)
T ss_pred CCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe-------------
Confidence 899999997542 1247889999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
+.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 158 --------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 223 (303)
T cd05088 158 --------------GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223 (303)
T ss_pred --------------cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCC
Confidence 445568888888875332211 11223567999999988889999999999999999998 9999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.... . . ......+..+.++
T Consensus 224 ~~~~~~~~~~~~~~~~~---~---------------------~------------------------~~~~~~~~~~~~l 255 (303)
T cd05088 224 YCGMTCAELYEKLPQGY---R---------------------L------------------------EKPLNCDDEVYDL 255 (303)
T ss_pred cccCChHHHHHHHhcCC---c---------------------C------------------------CCCCCCCHHHHHH
Confidence 97655433322211100 0 0 0011245678999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
+.+||+.||++|||+++++++
T Consensus 256 i~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 256 MRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=281.21 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=188.7
Q ss_pred CCCccceEEEEEEecC-----CCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-----RKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|..+. .+..||+|.+..... ......+|+.++..+ .|++++++++.+.+.+..++||
T Consensus 14 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~ 88 (288)
T cd05061 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-----TCHHVVRLLGVVSKGQPTLVVM 88 (288)
T ss_pred ecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCcEEEE
Confidence 7999999999997652 345899998764332 233456677778777 5689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 74 EKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
||+ +++|.+++.... ....+...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~--------------- 153 (288)
T cd05061 89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA--------------- 153 (288)
T ss_pred eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---------------
Confidence 999 999999997532 12345678889999999999999999999999999999994
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..|
T Consensus 154 ------------~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p 221 (288)
T cd05061 154 ------------HDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQP 221 (288)
T ss_pred ------------CCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCC
Confidence 45567888888776433221 12234667999999988889999999999999999998 7889
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.. +..+ . .....+..+.++
T Consensus 222 ~~~~~~~~~~~~~~~--~~~~--------------------~--------------------------~~~~~~~~~~~l 253 (288)
T cd05061 222 YQGLSNEQVLKFVMD--GGYL--------------------D--------------------------QPDNCPERVTDL 253 (288)
T ss_pred CCCCCHHHHHHHHHc--CCCC--------------------C--------------------------CCCCCCHHHHHH
Confidence 976554433222111 0000 0 011235679999
Q ss_pred HHHhcccCCCCCCCHHHHhc------CCCCCCCC
Q 020235 299 LQGLLRYDPTDRLTAREALR------HPFFTRDH 326 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~------hp~f~~~~ 326 (329)
+++||+.||++|||+.++++ ||||.++.
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 254 MRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred HHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 99999999999999999987 99998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=280.71 Aligned_cols=239 Identities=22% Similarity=0.324 Sum_probs=184.8
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++ .++..||+|.+.... .......+|+.++..+ .|+|++++++++..++..++||
T Consensus 14 ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~iv~~~~~~~~~~~~~lv~ 88 (277)
T cd05062 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVSQGQPTLVIM 88 (277)
T ss_pred eccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEcCCCCeEEEE
Confidence 699999999999864 235689999886432 2334566788888777 6699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 74 EKL-GSSLYDFLRKNNY--------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~--------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
||+ +++|.+++..... ..++...+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~--------------- 153 (277)
T cd05062 89 ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA--------------- 153 (277)
T ss_pred ecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---------------
Confidence 999 8999999976321 2356778899999999999999999999999999999994
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..|
T Consensus 154 ------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p 221 (277)
T cd05062 154 ------------EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 221 (277)
T ss_pred ------------CCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCC
Confidence 45567888888776433221 12245678999999998889999999999999999998 7899
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+.......+... ..+ ......+..+.++
T Consensus 222 ~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~~~~~~~l 253 (277)
T cd05062 222 YQGMSNEQVLRFVMEG--GLL----------------------------------------------DKPDNCPDMLFEL 253 (277)
T ss_pred CCCCCHHHHHHHHHcC--CcC----------------------------------------------CCCCCCCHHHHHH
Confidence 9765544333222111 000 0012345679999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
+.+||+.||++|||+.+++++
T Consensus 254 i~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 254 MRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=277.42 Aligned_cols=236 Identities=27% Similarity=0.369 Sum_probs=189.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|..+ +++.||+|.+...........+|+.++..+ .|++++++++++. .+..+++||++ +++
T Consensus 14 ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 86 (260)
T cd05067 14 LGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQL-----QHPRLVRLYAVVT-QEPIYIITEYMENGS 86 (260)
T ss_pred eccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhc-----CCcCeeeEEEEEc-cCCcEEEEEcCCCCC
Confidence 799999999999865 467899999886555566778899999888 5689999998864 46789999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++....+..++..++..++.|++.||.|||+.|++|+||||+||+++ .+.
T Consensus 87 L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---------------------------~~~ 139 (260)
T cd05067 87 LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---------------------------ETL 139 (260)
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---------------------------CCC
Confidence 99999876556789999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+....++.++|+||||+++|++++ |+.||.+.+..+....+...
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05067 140 CCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG 219 (260)
T ss_pred CEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence 68888888876544221 12345668999999988889999999999999999999 99999876554433332221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+.++.+++.+||..||++|||++
T Consensus 220 ~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 251 (260)
T cd05067 220 YRM------------------------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFE 251 (260)
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 110 00123456799999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 252 ~l~~ 255 (260)
T cd05067 252 YLRS 255 (260)
T ss_pred HHHH
Confidence 9875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=276.42 Aligned_cols=235 Identities=25% Similarity=0.360 Sum_probs=185.3
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+..++ ..+|+|.+..... ..+....|+.++..+ .|++++++++++. .+..++||||
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-----DHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred cCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEc-CCceEEEEEe
Confidence 799999999999876554 7899999875443 445667788888887 5699999999775 4578999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++
T Consensus 77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~------------------------- 129 (257)
T cd05060 77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV------------------------- 129 (257)
T ss_pred CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc-------------------------
Confidence 9 889999998754 689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCc------ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+......... ..++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 130 --~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~ 207 (257)
T cd05060 130 --NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV 207 (257)
T ss_pred --CCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 4455778888877654333211 123457999999988889999999999999999998 9999976555433
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+... . ......+..+.+++.+||..||
T Consensus 208 ~~~~~~~~~-~-----------------------------------------------~~~~~~~~~l~~li~~cl~~~p 239 (257)
T cd05060 208 IAMLESGER-L-----------------------------------------------PRPEECPQEIYSIMLSCWKYRP 239 (257)
T ss_pred HHHHHcCCc-C-----------------------------------------------CCCCCCCHHHHHHHHHHhcCCh
Confidence 332221100 0 0112356689999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 240 ~~Rp~~~~l~~ 250 (257)
T cd05060 240 EDRPTFSELES 250 (257)
T ss_pred hhCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=276.15 Aligned_cols=242 Identities=31% Similarity=0.479 Sum_probs=197.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|++|.||+|.++.+++.|++|++.... ...+...+|+.++..+ .|++++++++.+... +..++|+|+
T Consensus 8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-----QHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 689999999999999999999999987543 3356667788888888 579999999999888 899999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.+.. .+++..+..++.|++.+|.|||+.|++|+||+|+||++
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i-------------------------- 134 (260)
T cd06606 83 VSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV-------------------------- 134 (260)
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE--------------------------
Confidence 9 999999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..+..++|+|||.+....... ....++..|+|||.+.+...+.++|+||||+++|+|++|..||...+... .
T Consensus 135 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~ 211 (260)
T cd06606 135 -DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--A 211 (260)
T ss_pred -cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H
Confidence 445678889998876554432 33568889999999988889999999999999999999999997655211 1
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+...... ..........+..+.+++.+||+.||++
T Consensus 212 ~~~~~~~~--------------------------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~ 247 (260)
T cd06606 212 ALYKIGSS--------------------------------------------GEPPEIPEHLSEEAKDFLRKCLRRDPKK 247 (260)
T ss_pred HHHhcccc--------------------------------------------CCCcCCCcccCHHHHHHHHHhCcCChhh
Confidence 11111000 0000112234678999999999999999
Q ss_pred CCCHHHHhcCCCC
Q 020235 310 RLTAREALRHPFF 322 (329)
Q Consensus 310 R~t~~~ll~hp~f 322 (329)
|||+.++++||||
T Consensus 248 Rp~~~~ll~~~~~ 260 (260)
T cd06606 248 RPTADELLQHPFL 260 (260)
T ss_pred CCCHHHHhhCCCC
Confidence 9999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=281.07 Aligned_cols=239 Identities=21% Similarity=0.317 Sum_probs=187.2
Q ss_pred CCCccceEEEEEEec----CCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|.+. .++..+|+|.+..... ......+|+.++..+ .|+|++++++++..++..++|||
T Consensus 13 lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-----HHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred ccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCCeeeEEEEEecCCceEEEEE
Confidence 799999999999853 4567899999874322 224566788888888 56999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 75 KL-GSSLYDFLRKNN---------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~---------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
|+ +++|.+++.... ...+++.++..++.|++.||.|||++|++|+||||+||+++
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~--------- 158 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG--------- 158 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---------
Confidence 99 899999986421 12477888999999999999999999999999999999994
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus 159 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 220 (283)
T cd05090 159 ------------------EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIF 220 (283)
T ss_pred ------------------CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 44568888888886543321 2234566799999998888999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+ |..||.+.+.......+.... .+ ..+...+
T Consensus 221 ~~g~~p~~~~~~~~~~~~~~~~~-~~-----------------------------------------------~~~~~~~ 252 (283)
T cd05090 221 SFGLQPYYGFSNQEVIEMVRKRQ-LL-----------------------------------------------PCSEDCP 252 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCC-cC-----------------------------------------------CCCCCCC
Confidence 8 999997755433322222110 00 0112345
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+.+++.+||+.||++||++.+++++
T Consensus 253 ~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 253 PRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 689999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=295.17 Aligned_cols=245 Identities=26% Similarity=0.423 Sum_probs=210.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||-|+||.|=++..+....-+|+|++++. ....+....|-.++... ..++|+++|..|.++..+|++||-|
T Consensus 428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-----~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-----RSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-----CchHHHHHHHHhccchhhhhhHHhh
Confidence 79999999999987765556899998853 34456666788888777 4699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||.++..++..+ .++...++.++..++.|++|||++||++|||||+|.+++.+
T Consensus 503 lGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~------------------------ 556 (732)
T KOG0614|consen 503 LGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNR------------------------ 556 (732)
T ss_pred cCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccC------------------------
Confidence 999999998865 68999999999999999999999999999999999999544
Q ss_pred CCCCCeEEeeCCCCcccCCCCC--cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQN--YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+-+||.|||+|+....... +++|||.|.|||++...+.+.++|.||||+++|||++|.+||.+.+++..++.|.+
T Consensus 557 ---Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 557 ---GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred ---CceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 4588889999887766553 46999999999999999999999999999999999999999999999988887777
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
.+.-+ .++..+.....++|+++...+|.+|+.
T Consensus 634 Gid~i-----------------------------------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~ 666 (732)
T KOG0614|consen 634 GIDKI-----------------------------------------------EFPRRITKTATDLIKKLCRDNPTERLGY 666 (732)
T ss_pred hhhhh-----------------------------------------------hcccccchhHHHHHHHHHhcCcHhhhcc
Confidence 54211 112346678899999999999999985
Q ss_pred ----HHHHhcCCCCCCCC
Q 020235 313 ----AREALRHPFFTRDH 326 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~ 326 (329)
+.++-.|.||.+=+
T Consensus 667 ~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 667 QKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ccCChHHHHhhhhhhcCC
Confidence 89999999998643
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=288.00 Aligned_cols=241 Identities=21% Similarity=0.304 Sum_probs=183.3
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-cCCceEEE
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-~~~~~~lv 72 (329)
||.|+||.||+|+.. .+++.||+|+++... ........|+.++..+. .|+||+++++++. .+..++++
T Consensus 15 lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~----~h~niv~~~~~~~~~~~~~~~v 90 (337)
T cd05054 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG----HHLNVVNLLGACTKPGGPLMVI 90 (337)
T ss_pred cccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhc----cCcchhheeeeEecCCCCEEEE
Confidence 799999999999753 345789999987432 22345567888887772 4689999998775 44678999
Q ss_pred eecC-CCCHHHHHHhCCC-----------------------------------------------------------CCC
Q 020235 73 FEKL-GSSLYDFLRKNNY-----------------------------------------------------------RSF 92 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~-----------------------------------------------------------~~l 92 (329)
|||+ +++|.+++..... ..+
T Consensus 91 ~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 170 (337)
T cd05054 91 VEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPL 170 (337)
T ss_pred EecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCC
Confidence 9999 9999999865321 257
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc
Q 020235 93 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 93 ~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
++..+..++.|++.||.|||++||+||||||+||+++ .+..++|+|||.+...
T Consensus 171 ~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---------------------------~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 171 TLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---------------------------ENNVVKICDFGLARDI 223 (337)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---------------------------CCCcEEEeccccchhc
Confidence 8889999999999999999999999999999999994 4456888999988754
Q ss_pred CCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhh
Q 020235 173 RPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRV 246 (329)
Q Consensus 173 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (329)
.... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+......+....
T Consensus 224 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--------- 294 (337)
T cd05054 224 YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR--------- 294 (337)
T ss_pred ccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC---------
Confidence 3322 12345678999999999999999999999999999998 99999764332211111000000
Q ss_pred hhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 247 DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.......+.++.+++.+||+.+|++|||+.++++|
T Consensus 295 --------------------------------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 --------------------------------------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred --------------------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00012345689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.74 Aligned_cols=250 Identities=24% Similarity=0.422 Sum_probs=190.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+++.||+|.++... ........|+.++... ..|++++++++++.++...++||||+++
T Consensus 23 lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~----~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 98 (296)
T cd06618 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS----HDCPYIVKCYGYFITDSDVFICMELMST 98 (296)
T ss_pred eeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhc----cCCCchHhhheeeecCCeEEEEeeccCc
Confidence 689999999999999999999999987432 2233445565555444 2579999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||++ +.
T Consensus 99 ~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---------------------------~~ 150 (296)
T cd06618 99 CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---------------------------DA 150 (296)
T ss_pred CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---------------------------cC
Confidence 8888876643 368999999999999999999997 699999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC----CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+..++|+|||.+....... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... ...+
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~ 228 (296)
T cd06618 151 SGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVL 228 (296)
T ss_pred CCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHH
Confidence 5568888888876543222 2235778899999987653 788999999999999999999999653221 1111
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.+....... ..+ ....++.++.+|+.+||..||++||
T Consensus 229 ~~~~~~~~~-------------------~~~------------------------~~~~~~~~l~~li~~~l~~~p~~Rp 265 (296)
T cd06618 229 TKILQEEPP-------------------SLP------------------------PNEGFSPDFCSFVDLCLTKDHRKRP 265 (296)
T ss_pred HHHhcCCCC-------------------CCC------------------------CCCCCCHHHHHHHHHHccCChhhCC
Confidence 111111000 000 0012456799999999999999999
Q ss_pred CHHHHhcCCCCCCCCc
Q 020235 312 TAREALRHPFFTRDHL 327 (329)
Q Consensus 312 t~~~ll~hp~f~~~~~ 327 (329)
|+.++++||||.....
T Consensus 266 ~~~~il~~~~~~~~~~ 281 (296)
T cd06618 266 KYRELLQHPFIRRYET 281 (296)
T ss_pred CHHHHhcChhhhccch
Confidence 9999999999987543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.69 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=189.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|.++.. .........|+.++..+ .|++++++++.+.+.+..++|+||+
T Consensus 10 l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-----NHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-----CCcceeeeeeeEEECCeEEEEEEec
Confidence 68999999999999999999999987531 22334566788888888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++... ....+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~------------------------ 140 (267)
T cd08228 85 DAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT------------------------ 140 (267)
T ss_pred CCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc------------------------
Confidence 88999888642 223578999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch--hHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN--LEHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~ 228 (329)
.+..++|+|||.+....... ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 141 ---~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08228 141 ---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217 (267)
T ss_pred ---CCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH
Confidence 44558888888776544322 234678899999999988899999999999999999999999965332 1111
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.. .+ .++. .....+..+.+++++||..+|+
T Consensus 218 ~~~~~-~~-~~~~---------------------------------------------~~~~~~~~~~~li~~cl~~~p~ 250 (267)
T cd08228 218 QKIEQ-CD-YPPL---------------------------------------------PTEHYSEKLRELVSMCIYPDPD 250 (267)
T ss_pred HHHhc-CC-CCCC---------------------------------------------ChhhcCHHHHHHHHHHCCCCcc
Confidence 11111 01 1000 0112456799999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+.++++.
T Consensus 251 ~Rp~~~~vl~~ 261 (267)
T cd08228 251 QRPDIGYVHQI 261 (267)
T ss_pred cCcCHHHHHHH
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=275.67 Aligned_cols=237 Identities=26% Similarity=0.339 Sum_probs=191.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++. ++.+|+|.+............|+.++..+ .|++++++++++......++|||++ +++
T Consensus 14 ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 87 (261)
T cd05034 14 LGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMSPEAFLQEAQIMKKL-----RHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87 (261)
T ss_pred eccCcceEEEEEEEcC-CceEEEEEecCCccCHHHHHHHHHHHhhC-----CCCCEeeeeeeeecCCceEEEEeccCCCC
Confidence 6999999999998764 57799999886555566778899999888 5699999999999989999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.+++.||.|||++|++|+||||+||++ ..+.
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili---------------------------~~~~ 140 (261)
T cd05034 88 LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---------------------------GENL 140 (261)
T ss_pred HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE---------------------------cCCC
Confidence 9999987655568999999999999999999999999999999999999 4456
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.+.......+...
T Consensus 141 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~ 220 (261)
T cd05034 141 VCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220 (261)
T ss_pred CEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 67888888776544221 11234567999999998889999999999999999998 99999776554433332221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .....+..+.+++.+||+.||++|||++
T Consensus 221 ~~~~------------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 252 (261)
T cd05034 221 YRMP------------------------------------------------RPPNCPEELYDLMLQCWDKDPEERPTFE 252 (261)
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 1000 0112345789999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 253 ~l~~ 256 (261)
T cd05034 253 YLQS 256 (261)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=281.82 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=193.7
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .+|+.||+|+++... ...+....|+.++..+. +|++|+.+++.++.+...++|
T Consensus 8 lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcc----cCCChhceeeEeecCCeEEEE
Confidence 699999999999874 478999999987422 22345567888887773 468999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 84 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~----------------------- 138 (290)
T cd05613 84 LDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL----------------------- 138 (290)
T ss_pred EecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE-----------------------
Confidence 9999 899999998754 68899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....|+..|+|||.+... .++.++|+||||+++|+|++|..||......
T Consensus 139 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 139 ----DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ----CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 455678999999876543322 234588899999998753 4678999999999999999999999643322
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+.+..... ........+..+.+++++||+.
T Consensus 215 ~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~~~ll~~~l~~ 249 (290)
T cd05613 215 NSQAEISRRILKS---------------------------------------------EPPYPQEMSALAKDIIQRLLMK 249 (290)
T ss_pred ccHHHHHHHhhcc---------------------------------------------CCCCCccCCHHHHHHHHHHhcC
Confidence 1111111110000 0001123456789999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCCC
Q 020235 306 DPTDRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~-----t~~~ll~hp~f~~~~ 326 (329)
||++|+ ++.+++.||||+..+
T Consensus 250 ~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 250 DPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CHHHhcCCCCCCHHHHHcCcccccCC
Confidence 999997 899999999998865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.98 Aligned_cols=237 Identities=21% Similarity=0.267 Sum_probs=184.4
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|.+..++. .||+|.++.. .........|+.++..+ .|+||+++++++... ..+++++
T Consensus 15 lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~g~~~~~-~~~~v~e 88 (316)
T cd05108 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS-TVQLITQ 88 (316)
T ss_pred eecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEcCC-Cceeeee
Confidence 7999999999998876655 3899998643 23345667788888877 669999999988764 5778999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +|+|.+++.... ..++...+..++.|++.||+|||++||+||||||+||++
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill------------------------- 142 (316)
T cd05108 89 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV------------------------- 142 (316)
T ss_pred cCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe-------------------------
Confidence 99 999999998754 358889999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCC-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
..+..++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 143 --~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~ 220 (316)
T cd05108 143 --KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 220 (316)
T ss_pred --cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 4455688888888875543321 1223567999999998889999999999999999997 9999976544332
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
.. +......++ .....+.++.+++.+||..||
T Consensus 221 ~~-~~~~~~~~~-----------------------------------------------~~~~~~~~~~~li~~cl~~~p 252 (316)
T cd05108 221 SS-ILEKGERLP-----------------------------------------------QPPICTIDVYMIMVKCWMIDA 252 (316)
T ss_pred HH-HHhCCCCCC-----------------------------------------------CCCCCCHHHHHHHHHHccCCh
Confidence 11 111100000 012245578899999999999
Q ss_pred CCCCCHHHHhcC
Q 020235 308 TDRLTAREALRH 319 (329)
Q Consensus 308 ~~R~t~~~ll~h 319 (329)
.+|||+.+++.+
T Consensus 253 ~~Rps~~~l~~~ 264 (316)
T cd05108 253 DSRPKFRELIIE 264 (316)
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=275.76 Aligned_cols=240 Identities=27% Similarity=0.446 Sum_probs=189.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+ .|++++++++.+.+. +..+++
T Consensus 10 lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-----RHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred EccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-----CCCCcceEEEEEEcCCCCEEEEE
Confidence 69999999999999999999999987532 12234556788888888 568999999988653 568999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+||+ +++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 85 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---------------------- 140 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---------------------- 140 (264)
T ss_pred EEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc----------------------
Confidence 9999 889999998654 588999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+..++|+|||.+...... .....|+..|+|||.+.+...+.++|+|||||++|+|++|+.||......
T Consensus 141 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 215 (264)
T cd06653 141 -----SAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM 215 (264)
T ss_pred -----CCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH
Confidence 4455777788777543221 12345788999999999888899999999999999999999999765433
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.... +....... +..+...+..+.+++++||+
T Consensus 216 ~~~~---~~~~~~~~--------------------------------------------~~~p~~~~~~~~~~i~~~l~- 247 (264)
T cd06653 216 AAIF---KIATQPTK--------------------------------------------PMLPDGVSDACRDFLKQIFV- 247 (264)
T ss_pred HHHH---HHHcCCCC--------------------------------------------CCCCcccCHHHHHHHHHHhc-
Confidence 3222 21111100 01123456789999999999
Q ss_pred CCCCCCCHHHHhcCCCC
Q 020235 306 DPTDRLTAREALRHPFF 322 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f 322 (329)
+|.+|||+.++++|||.
T Consensus 248 ~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 248 EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CcccCccHHHHhcCCCC
Confidence 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=279.53 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=185.9
Q ss_pred CCCccceEEEEEEecCCCc-------eEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKE-------MVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~-------~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|.++.++. .+|+|.+..... ..+....|..++..+ .|+|++++++++..+...++|
T Consensus 3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-----~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-----SHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-----CCCChhheeeEEEeCCCcEEE
Confidence 7999999999999865543 488888764322 234456677777766 679999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... ..+++.++..++.|++.||.|||++||+|+||||+||++++++..+..
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~-------------- 142 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTG-------------- 142 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccC--------------
Confidence 9999 899999997654 358999999999999999999999999999999999999776543332
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCC-CCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~ 229 (329)
....++++|||.+...... ....++..|+|||++.+. .++.++|+|||||++|+|++|. .||...+......
T Consensus 143 -----~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~ 216 (258)
T cd05078 143 -----NPPFIKLSDPGISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216 (258)
T ss_pred -----CCceEEecccccccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH
Confidence 2234799999988655432 334678899999999864 5789999999999999999985 6665433322111
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
....... .+...+.++.+++.+||+.||++
T Consensus 217 -~~~~~~~-------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~ 246 (258)
T cd05078 217 -FYEDRHQ-------------------------------------------------LPAPKWTELANLINQCMDYEPDF 246 (258)
T ss_pred -HHHcccc-------------------------------------------------CCCCCcHHHHHHHHHHhccChhh
Confidence 1110000 11223457899999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||++++++.
T Consensus 247 Rps~~~il~~ 256 (258)
T cd05078 247 RPSFRAIIRD 256 (258)
T ss_pred CCCHHHHHHh
Confidence 9999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=278.25 Aligned_cols=238 Identities=24% Similarity=0.349 Sum_probs=187.2
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||++.++.. +..||+|.+.... .......+|+.++..+ .|++++++++++......++||
T Consensus 14 lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred ecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-----CCCceeEEEEEEcCCCCcEEEE
Confidence 69999999999988643 4789999986432 2234556788888777 6689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 74 EKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
||+ +++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||||+||++
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---------------- 152 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---------------- 152 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE----------------
Confidence 999 899999997532 1236788999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
+.++.++|+|||.+....... ....++..|+|||.+....++.++|+|||||++|++++ |..|
T Consensus 153 -----------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 221 (277)
T cd05032 153 -----------AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221 (277)
T ss_pred -----------cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCC
Confidence 445668888888776443221 22346778999999988889999999999999999998 9999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|...+..+....+.. +.. .. .+...+..+.++
T Consensus 222 ~~~~~~~~~~~~~~~--~~~--------------------~~--------------------------~~~~~~~~~~~l 253 (277)
T cd05032 222 YQGLSNEEVLKFVID--GGH--------------------LD--------------------------LPENCPDKLLEL 253 (277)
T ss_pred CccCCHHHHHHHHhc--CCC--------------------CC--------------------------CCCCCCHHHHHH
Confidence 977555443332221 000 00 012245689999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 020235 299 LQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~ 318 (329)
+.+||+.+|++|||+.++++
T Consensus 254 i~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 254 MRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHcCCChhhCCCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=281.32 Aligned_cols=240 Identities=23% Similarity=0.373 Sum_probs=186.9
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||++.+ ..++..||+|.++... ...+....|+.++..+. .|+||+++++.+...+..++||
T Consensus 43 ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~ 118 (302)
T cd05055 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG----NHENIVNLLGACTIGGPILVIT 118 (302)
T ss_pred eeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhcc----CCCCcceEEEEEecCCceEEEE
Confidence 69999999999975 3445689999887432 22345677888888872 4689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.......+++.++..++.|++.||.|||+++++|+||||+||+++
T Consensus 119 e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~----------------------- 175 (302)
T cd05055 119 EYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT----------------------- 175 (302)
T ss_pred EcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc-----------------------
Confidence 999 89999999875544589999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+
T Consensus 176 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~ 251 (302)
T cd05055 176 ----HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS 251 (302)
T ss_pred ----CCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH
Confidence 44567888888776443222 12345678999999998889999999999999999998 999997654433
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
........ +..+ ......+..+.+++.+||..+
T Consensus 252 ~~~~~~~~-~~~~----------------------------------------------~~~~~~~~~~~~li~~cl~~~ 284 (302)
T cd05055 252 KFYKLIKE-GYRM----------------------------------------------AQPEHAPAEIYDIMKTCWDAD 284 (302)
T ss_pred HHHHHHHc-CCcC----------------------------------------------CCCCCCCHHHHHHHHHHcCCC
Confidence 22211110 0000 001224568999999999999
Q ss_pred CCCCCCHHHHhc
Q 020235 307 PTDRLTAREALR 318 (329)
Q Consensus 307 P~~R~t~~~ll~ 318 (329)
|++|||+.++++
T Consensus 285 p~~Rpt~~ell~ 296 (302)
T cd05055 285 PLKRPTFKQIVQ 296 (302)
T ss_pred chhCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=273.91 Aligned_cols=242 Identities=28% Similarity=0.424 Sum_probs=195.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||.|+||.||++.++.+++.+|+|.+.... .......+|+.+++.+ .|++++++.+.+.+....++|+||+
T Consensus 8 i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-----NHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred ecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-----CCCCchhhhhhhccCCEEEEEehhcC
Confidence 689999999999999999999999987432 2344556777778777 4689999999999999999999999
Q ss_pred CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 ~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++.+. ....+++..+..++.|++.||.|||+.|++|+||+|+||++.
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~------------------------- 137 (256)
T cd08530 83 FGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV------------------------- 137 (256)
T ss_pred CCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe-------------------------
Confidence 89999998762 124588999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 138 --~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 138 --ANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred --cCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 44568888888876554432 234678899999999888899999999999999999999999987655433222211
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.. .+ ......+.++.+++.+||+.+|++|||+
T Consensus 216 ~~--~~----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (256)
T cd08530 216 GK--YP----------------------------------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNC 247 (256)
T ss_pred CC--CC----------------------------------------------CCchhhCHHHHHHHHHHcCCCcccCCCH
Confidence 11 00 0011245679999999999999999999
Q ss_pred HHHhcCCCC
Q 020235 314 REALRHPFF 322 (329)
Q Consensus 314 ~~ll~hp~f 322 (329)
.++++||++
T Consensus 248 ~~~l~~p~~ 256 (256)
T cd08530 248 DKILASPAV 256 (256)
T ss_pred HHHhcCCCC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=279.38 Aligned_cols=239 Identities=20% Similarity=0.250 Sum_probs=185.9
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||++.+..+ ++.||+|.++.... .......|..++..+ .|++|+++++++.+....++++
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-----QHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred hCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcCCCceEEEE
Confidence 79999999999987543 57899999874322 234455677777776 5699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 74 EKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
+|+ +++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||++.
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~--------- 158 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF--------- 158 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---------
Confidence 999 899999986321 12478888999999999999999999999999999999994
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.+..++|+|||.+....... ....+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 159 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 159 ------------------DKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred ------------------CCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 44568888888776443222 2234567899999998888999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+ |..||.+....+....+...... ......+
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~ 252 (283)
T cd05091 221 SYGLQPYCGYSNQDVIEMIRNRQVL------------------------------------------------PCPDDCP 252 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------------CCCCCCC
Confidence 8 88999775554433322221100 0112356
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+.+++.+||+.+|++|||++++++.
T Consensus 253 ~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 253 AWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=282.02 Aligned_cols=240 Identities=22% Similarity=0.289 Sum_probs=185.6
Q ss_pred CCCccceEEEEEEecCCCc--eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|..+.++. .+++|.++.. ........+|+.++.++. .|++++++++.+...+..++|+||+
T Consensus 10 lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (297)
T cd05089 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLG----HHPNIINLLGACENRGYLYIAIEYA 85 (297)
T ss_pred ecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhc----CCCchhheEEEEccCCcceEEEEec
Confidence 7999999999999877764 4688887632 223345667888887773 4689999999999999999999999
Q ss_pred -CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 77 -GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 77 -~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
+++|.+++.... ...+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill------------- 152 (297)
T cd05089 86 PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV------------- 152 (297)
T ss_pred CCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE-------------
Confidence 899999997532 1247888999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCc--ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
+.+..++|+|||.+......... ...+..|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus 153 --------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~p 218 (297)
T cd05089 153 --------------GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218 (297)
T ss_pred --------------CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 44556788888887543221111 122456999999998889999999999999999997 9999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.+.... .....++..+.+|
T Consensus 219 f~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~l 250 (297)
T cd05089 219 YCGMTCAELYEKLPQGYRM------------------------------------------------EKPRNCDDEVYEL 250 (297)
T ss_pred CCCCCHHHHHHHHhcCCCC------------------------------------------------CCCCCCCHHHHHH
Confidence 9776554333222111000 0012356789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
+.+||+.||.+|||++++++.
T Consensus 251 i~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 251 MRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=274.64 Aligned_cols=236 Identities=23% Similarity=0.337 Sum_probs=183.7
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++ .++..||+|++.... ...+...+|+.++..+ .|+++++++++++. ...++||||+
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~ii~~~~~~~~-~~~~lv~e~~ 76 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-----DNPYIVRMIGVCEA-EALMLVMEMA 76 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEcC-CCeEEEEEeC
Confidence 799999999999765 445679999887432 2234567888999888 56999999998764 5789999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~-------------------------- 129 (257)
T cd05115 77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV-------------------------- 129 (257)
T ss_pred CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc--------------------------
Confidence 899999987543 3689999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
.+..++|+|||.+........ ...++..|+|||.+....++.++|+|||||++|++++ |..||.+....+..
T Consensus 130 -~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 208 (257)
T cd05115 130 -NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208 (257)
T ss_pred -CCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH
Confidence 455678888887764433221 1123567999999988889999999999999999996 99999876544332
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+... .+.+...+.++.+++.+||..||+
T Consensus 209 ~~~~~~~~------------------------------------------------~~~~~~~~~~l~~li~~c~~~~~~ 240 (257)
T cd05115 209 SFIEQGKR------------------------------------------------LDCPAECPPEMYALMKDCWIYKWE 240 (257)
T ss_pred HHHHCCCC------------------------------------------------CCCCCCCCHHHHHHHHHHcCCChh
Confidence 22211100 001123467899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+||++.++.+
T Consensus 241 ~Rp~~~~i~~ 250 (257)
T cd05115 241 DRPNFAKVEE 250 (257)
T ss_pred hCcCHHHHHH
Confidence 9999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=276.25 Aligned_cols=238 Identities=22% Similarity=0.326 Sum_probs=187.6
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+ ...||+|.++... ........|+.++..+ .|++++++++.+...+..++|||+
T Consensus 12 lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~iv~e~ 86 (266)
T cd05033 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-----DHPNIIRLEGVVTKSRPVMIITEY 86 (266)
T ss_pred ecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCcceEeEEEecCCceEEEEEc
Confidence 69999999999988654 4589999886432 2344566788888888 569999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~------------------------- 140 (266)
T cd05033 87 MENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN------------------------- 140 (266)
T ss_pred CCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc-------------------------
Confidence 9 889999997754 3689999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
.+..++|+|||.+........ ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.........
T Consensus 141 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~ 218 (266)
T cd05033 141 --SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218 (266)
T ss_pred --CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH
Confidence 455678888887776542111 1234567999999998889999999999999999998 99999765444333
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+.... + .....+..+.+++.+||+.+|+
T Consensus 219 ~~~~~~~~~-~-----------------------------------------------~~~~~~~~l~~li~~cl~~~p~ 250 (266)
T cd05033 219 KAVEDGYRL-P-----------------------------------------------PPMDCPSALYQLMLDCWQKDRN 250 (266)
T ss_pred HHHHcCCCC-C-----------------------------------------------CCCCCCHHHHHHHHHHcCCCcc
Confidence 222211000 0 0123456799999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+.+++++
T Consensus 251 ~Rp~~~ei~~~ 261 (266)
T cd05033 251 ERPTFSQIVST 261 (266)
T ss_pred cCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=276.52 Aligned_cols=239 Identities=26% Similarity=0.386 Sum_probs=188.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.+|+|.+... ........+|+.++..+ .|+|++++++.+..++..+++||++
T Consensus 10 ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-----cCCchhhhhheeEeCCeEEEEEEec
Confidence 79999999999999999999999987632 22334566788888888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~------------------------ 140 (267)
T cd08229 85 DAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT------------------------ 140 (267)
T ss_pred CCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc------------------------
Confidence 88999998742 224589999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh--HHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL--EHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~ 228 (329)
.++.++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... ...
T Consensus 141 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08229 141 ---ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred ---CCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh
Confidence 44568888888776543322 2346888999999998888999999999999999999999999653321 111
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.....+ + ......+..+.+++.+||..||+
T Consensus 218 ~~~~~~~~~-~----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~ 250 (267)
T cd08229 218 KKIEQCDYP-P----------------------------------------------LPSDHYSEELRQLVNMCINPDPE 250 (267)
T ss_pred hhhhcCCCC-C----------------------------------------------CCcccccHHHHHHHHHhcCCCcc
Confidence 111110000 0 00123566899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||+.+|++
T Consensus 251 ~Rpt~~~i~~ 260 (267)
T cd08229 251 KRPDITYVYD 260 (267)
T ss_pred cCCCHHHHHH
Confidence 9999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=274.06 Aligned_cols=238 Identities=22% Similarity=0.295 Sum_probs=187.8
Q ss_pred CCCccceEEEEEEecC-CC--ceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRE-RK--EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~--~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|++|.||+|.+.. .+ ..||+|.++.... ..+...+|+.++..+ .|+|++++++.+.+ ...++|||+
T Consensus 3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-----DHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-----CCCCccceeEEEcC-CeEEEEEEe
Confidence 7999999999998865 33 3699999875433 345667788888888 56999999999888 899999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+.+.......+++..+..++.|++.||.|||+.|++|+||||+||+++.
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~------------------------ 132 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS------------------------ 132 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEec------------------------
Confidence 9 999999998754346899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 133 ---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 209 (257)
T cd05040 133 ---DDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI 209 (257)
T ss_pred ---CCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4557777777765443321 12346678999999998889999999999999999998 9999976655544
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.......+ .....+..+.+++.+||+.+|
T Consensus 210 ~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~~~li~~~l~~~p 242 (257)
T cd05040 210 LKKIDKEGERLE-----------------------------------------------RPEACPQDIYNVMLQCWAHNP 242 (257)
T ss_pred HHHHHhcCCcCC-----------------------------------------------CCccCCHHHHHHHHHHCCCCc
Confidence 333322110000 012245679999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 243 ~~Rps~~~~~~ 253 (257)
T cd05040 243 ADRPTFAALRE 253 (257)
T ss_pred ccCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=309.30 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=183.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|+++.. ........+|+.++..+ .|||++++++++.+++..++||||+
T Consensus 10 LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-----~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-----IHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-----CCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 69999999999999999999999998742 22345677899998888 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 77 -GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 77 -~~~l~~~l~~~~---------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
|++|.+++.... ...++...+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-------------- 150 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-------------- 150 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC--------------
Confidence 999999987521 12355677889999999999999999999999999999995544
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccC---------------------CCCCcccccCCCCchhHHhcCCCCCccchHhH
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYER---------------------PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSV 205 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (329)
.++|+|||.+.... ......+||+.|+|||.+.+..++.++|||||
T Consensus 151 -------------~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSL 217 (932)
T PRK13184 151 -------------EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217 (932)
T ss_pred -------------CEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHH
Confidence 45555555554331 01122468999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHh
Q 020235 206 GCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285 (329)
Q Consensus 206 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
||++|+|++|..||...+....... ... ..|..+
T Consensus 218 GVILyELLTG~~PF~~~~~~ki~~~--~~i-~~P~~~------------------------------------------- 251 (932)
T PRK13184 218 GVILYQMLTLSFPYRRKKGRKISYR--DVI-LSPIEV------------------------------------------- 251 (932)
T ss_pred HHHHHHHHHCCCCCCCcchhhhhhh--hhc-cChhhc-------------------------------------------
Confidence 9999999999999976433221110 000 000000
Q ss_pred hhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 286 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
......+..+.+++.+||+.||++|++..+.+
T Consensus 252 ~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 252 APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 00123556789999999999999998765544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=276.32 Aligned_cols=241 Identities=29% Similarity=0.465 Sum_probs=189.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||++.+..++..+++|+++.. .........|..++..+ .|+|++++++.+.+....++|+|
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-----DHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred ecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-----CCCcHHHHHHHHhcCCceEEEEE
Confidence 79999999999999888777777766531 11223445577777776 57999999999999999999999
Q ss_pred cC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 75 KL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 75 ~~-~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+ +++|.+++.. .....+++..++.++.|++.||.|||+.|++|+||+|+||++.+
T Consensus 83 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~--------------------- 141 (260)
T cd08222 83 YCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN--------------------- 141 (260)
T ss_pred eCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec---------------------
Confidence 99 8899988864 22246899999999999999999999999999999999999932
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 142 -------~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~ 214 (260)
T cd08222 142 -------NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVV 214 (260)
T ss_pred -------CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence 238888998876543322 2345788999999998888889999999999999999999999764443322
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.. +..+. .....+.++.++|.+||+.||+
T Consensus 215 ~~~~~--~~~~~----------------------------------------------~~~~~~~~~~~li~~~l~~~p~ 246 (260)
T cd08222 215 LRIVE--GPTPS----------------------------------------------LPETYSRQLNSIMQSMLNKDPS 246 (260)
T ss_pred HHHHc--CCCCC----------------------------------------------CcchhcHHHHHHHHHHhcCChh
Confidence 22111 11110 0123456889999999999999
Q ss_pred CCCCHHHHhcCCCC
Q 020235 309 DRLTAREALRHPFF 322 (329)
Q Consensus 309 ~R~t~~~ll~hp~f 322 (329)
+|||+.++++||||
T Consensus 247 ~Rp~~~~il~~~~~ 260 (260)
T cd08222 247 LRPSAAEILRNPFI 260 (260)
T ss_pred hCcCHHHHhhCCCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=280.30 Aligned_cols=238 Identities=27% Similarity=0.407 Sum_probs=186.7
Q ss_pred CCCccceEEEEEEec----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|... ..+..|+||.++... ...+...+|+..+..+ .|+||+++++++...+..++|+|
T Consensus 7 ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 7 IGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-----RHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-----SBTTBE-EEEEEESSSSEEEEEE
T ss_pred EccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-----ccccccccccccccccccccccc
Confidence 699999999999988 446789999996422 2356778898888888 56999999999998888999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.......++...+..++.|++.||.|||+++++|++|+++||+++
T Consensus 82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~------------------------ 137 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD------------------------ 137 (259)
T ss_dssp --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE------------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc------------------------
Confidence 99 89999999987445799999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..+||+|||.+....... ....+...|+|||.+....++.++||||||+++|++++ |+.||...+..+.
T Consensus 138 ---~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 138 ---SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ---TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45668888888887653222 22345678999999999889999999999999999999 7899987665554
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+.... ......+..+.++|.+||..||
T Consensus 215 ~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~C~~~~p 246 (259)
T PF07714_consen 215 IEKLKQGQRL------------------------------------------------PIPDNCPKDIYSLIQQCWSHDP 246 (259)
T ss_dssp HHHHHTTEET------------------------------------------------TSBTTSBHHHHHHHHHHT-SSG
T ss_pred cccccccccc------------------------------------------------eeccchhHHHHHHHHHHcCCCh
Confidence 4443221111 0122356789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 247 ~~RPs~~~i~~ 257 (259)
T PF07714_consen 247 EKRPSFQEILQ 257 (259)
T ss_dssp GGS--HHHHHH
T ss_pred hhCcCHHHHHh
Confidence 99999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=277.00 Aligned_cols=239 Identities=18% Similarity=0.261 Sum_probs=182.7
Q ss_pred CCCccceEEEEEEecCCCc--eEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCce
Q 020235 1 MGEGTFGQVLECWDRERKE--MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~ 69 (329)
||+|+||.||+|.+..++. .+|+|.++.. ........+|..++..+ .|+||+++++.+.. ....
T Consensus 7 ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-----DHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEccCCcccCCCCc
Confidence 7999999999999887765 6899987643 23345566788888887 56899999876532 2357
Q ss_pred EEEeecC-CCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 70 CIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 70 ~lv~e~~-~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
+++|||+ +++|.+++... ....+++..+..++.|++.||+|||++||+|+||||+||++
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---------------- 145 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---------------- 145 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE----------------
Confidence 9999999 89999887532 12347899999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
..+..++|+|||.+....... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..|
T Consensus 146 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 146 -----------NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred -----------cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 445668888888876543322 12245668999999998889999999999999999999 8999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+....+....+...... ......+..+.++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~~l 246 (272)
T cd05075 215 YPGVENSEIYDYLRQGNRL------------------------------------------------KQPPDCLDGLYSL 246 (272)
T ss_pred CCCCCHHHHHHHHHcCCCC------------------------------------------------CCCCCCCHHHHHH
Confidence 9765544332222211000 0012345678999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
+.+||+.||++|||+.+++++
T Consensus 247 i~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 247 MSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=279.99 Aligned_cols=240 Identities=22% Similarity=0.328 Sum_probs=186.8
Q ss_pred CCCccceEEEEEEecCCC-----ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERK-----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||++..+..+ ..+|+|.+.... .......+|+.++..+. .|+|++++++++..++..+++|
T Consensus 20 ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~li~ 95 (293)
T cd05053 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGVCTQEGPLYVVV 95 (293)
T ss_pred ecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhc----CCCCeeeEEEEEcCCCCeEEEE
Confidence 699999999999876443 789999987432 22344667888887772 4689999999999999999999
Q ss_pred ecC-CCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 74 EKL-GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 74 e~~-~~~l~~~l~~~--------------~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
||+ +++|.+++... ....+++..+..++.|++.||+|||+.||+|+||||+||+++
T Consensus 96 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~--------- 166 (293)
T cd05053 96 EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT--------- 166 (293)
T ss_pred EeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---------
Confidence 999 89999999752 234588999999999999999999999999999999999994
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.++.++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+++
T Consensus 167 ------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 228 (293)
T cd05053 167 ------------------EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228 (293)
T ss_pred ------------------CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHh
Confidence 44567888888876543321 1122456799999998888999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+ |..||.+....+....+...... ..+...+
T Consensus 229 ~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~ 260 (293)
T cd05053 229 TLGGSPYPGIPVEELFKLLKEGYRM------------------------------------------------EKPQNCT 260 (293)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcC------------------------------------------------CCCCCCC
Confidence 7 99999765544433222111000 0012345
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+.+|+.+||..||++|||+.+++++
T Consensus 261 ~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 261 QELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=257.19 Aligned_cols=275 Identities=26% Similarity=0.514 Sum_probs=214.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~~-~ 77 (329)
+|.|-|+.||.+.+..+.+.++||+++.. ..+...+|+.++..+ .+++||+.++++..+. ....||+|+. .
T Consensus 46 ~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL----~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n 119 (338)
T KOG0668|consen 46 VGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNL----RGGPNIIKLLDIVKDPESKTPSLIFEYVNN 119 (338)
T ss_pred HcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhc----cCCCCeeehhhhhcCccccCchhHhhhhcc
Confidence 69999999999999999999999998843 356778999999999 4789999999999875 4688999999 5
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+...+.. .++...++.++.+++.||+||||+||.|||+||.|++|+ ..
T Consensus 120 ~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--------------------------h~ 168 (338)
T KOG0668|consen 120 TDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--------------------------HE 168 (338)
T ss_pred ccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--------------------------hh
Confidence 55544432 477888999999999999999999999999999999996 35
Q ss_pred CCCeEEeeCCCCcccCCCCCc--ccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCC-CCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF-QTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~~~ 233 (329)
...++|||+|+|.+..+.... .+.+..|.-||.+-.- .|+..-|+|||||++..|+..+.|| .+.++.++...|.+
T Consensus 169 ~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak 248 (338)
T KOG0668|consen 169 LRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK 248 (338)
T ss_pred hceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence 567999999999988887754 4567789999988754 5889999999999999999988776 57788888999999
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC-chhHHHHHHHHhcccCCCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH-SAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ll~~~l~~dP~~R~t 312 (329)
++|.- ++ .....+|.-. . ....+++............+...+.. .++++.||+.++|..|-.+|+|
T Consensus 249 VLGt~--el----~~Yl~KY~i~----L---dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT 315 (338)
T KOG0668|consen 249 VLGTD--EL----YAYLNKYQID----L---DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT 315 (338)
T ss_pred HhChH--HH----HHHHHHHccC----C---ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc
Confidence 88762 11 1122221111 0 11122333333333344444333333 4588999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
|.|++.||||...
T Consensus 316 akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 AKEAMAHPYFAPV 328 (338)
T ss_pred hHHHhcCchHHHH
Confidence 9999999999753
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=279.48 Aligned_cols=238 Identities=23% Similarity=0.355 Sum_probs=186.6
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||.|+||.||+|.+. .++..+++|.+..... ..+...+|+.++..+ .|++++++++++...+..++|||
T Consensus 13 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e 87 (291)
T cd05094 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-----QHEHIVKFYGVCGDGDPLIMVFE 87 (291)
T ss_pred ecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccCCceEEEEe
Confidence 799999999999854 3456799998874332 234567788888887 56999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCC
Q 020235 75 KL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 139 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~ 139 (329)
|+ +++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---------- 157 (291)
T cd05094 88 YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---------- 157 (291)
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc----------
Confidence 99 999999997642 12478899999999999999999999999999999999994
Q ss_pred cCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh
Q 020235 140 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 214 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++
T Consensus 158 -----------------~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 220 (291)
T cd05094 158 -----------------ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220 (291)
T ss_pred -----------------cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 45567888888776443321 23356778999999998889999999999999999998
Q ss_pred -CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 215 -GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 215 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
|..||...+..+....+... ..+ ......+.
T Consensus 221 ~g~~p~~~~~~~~~~~~~~~~--~~~----------------------------------------------~~~~~~~~ 252 (291)
T cd05094 221 YGKQPWFQLSNTEVIECITQG--RVL----------------------------------------------ERPRVCPK 252 (291)
T ss_pred CCCCCCCCCCHHHHHHHHhCC--CCC----------------------------------------------CCCccCCH
Confidence 99999765554332221110 000 00112456
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.+.+++.+||+.||++|||+.++++
T Consensus 253 ~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 253 EVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHcccChhhCcCHHHHHH
Confidence 7999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=290.21 Aligned_cols=240 Identities=21% Similarity=0.276 Sum_probs=184.6
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+... +..||+|+++... ...+...+|+.++..+. .||||+++++++.+.+..++||
T Consensus 45 LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~----~HpnIv~l~~~~~~~~~~~lv~ 120 (400)
T cd05105 45 LGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG----PHLNIVNLLGACTKSGPIYIIT 120 (400)
T ss_pred ecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcC----CCCCeeeEEEEEccCCceEEEE
Confidence 79999999999987433 3479999986432 23456778999988882 3799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------------------------------------------------
Q 020235 74 EKL-GSSLYDFLRKNN---------------------------------------------------------------- 88 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~---------------------------------------------------------------- 88 (329)
||+ +|+|.+++....
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (400)
T cd05105 121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY 200 (400)
T ss_pred EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence 999 999999886531
Q ss_pred ------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 89 ------------------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 89 ------------------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
...+++..+..++.|++.||+|||+.+++|+||||+|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~--------- 271 (400)
T cd05105 201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA--------- 271 (400)
T ss_pred hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---------
Confidence 12467778889999999999999999999999999999994
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|+
T Consensus 272 ------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 333 (400)
T cd05105 272 ------------------QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF 333 (400)
T ss_pred ------------------CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 45568899999886543221 2234677899999999888999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+ |..||..................+ ......+
T Consensus 334 t~g~~P~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~ 366 (400)
T cd05105 334 SLGGTPYPGMIVDSTFYNKIKSGYRM-----------------------------------------------AKPDHAT 366 (400)
T ss_pred HCCCCCCcccchhHHHHHHHhcCCCC-----------------------------------------------CCCccCC
Confidence 7 999997543222111110000000 0012345
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
..+.+++.+||+.||++|||+.++.+
T Consensus 367 ~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 367 QEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 68999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=277.25 Aligned_cols=236 Identities=23% Similarity=0.294 Sum_probs=182.3
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.+..++. .||+|.++... .......+|..++..+ .|+|++.+++++.. ...+++++
T Consensus 15 lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~-~~~~l~~~ 88 (279)
T cd05109 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-----GSPYVCRLLGICLT-STVQLVTQ 88 (279)
T ss_pred cCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-----CCCCCceEEEEEcC-CCcEEEEE
Confidence 7999999999999877766 48999886432 2344556677777766 56899999988765 45789999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++.++..++.|++.||.|||++|++|+||||+||++.
T Consensus 89 ~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~------------------------ 143 (279)
T cd05109 89 LMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK------------------------ 143 (279)
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc------------------------
Confidence 99 899999997643 3589999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCC-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQN-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|+|++ |..||........
T Consensus 144 ---~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05109 144 ---SPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220 (279)
T ss_pred ---CCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 445588888888775543321 1234567999999988889999999999999999998 9999976544332
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.... ..+ .....+..+.+++.+||..||
T Consensus 221 ~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~li~~~l~~dp 252 (279)
T cd05109 221 PDLLEKGE-RLP-----------------------------------------------QPPICTIDVYMIMVKCWMIDS 252 (279)
T ss_pred HHHHHCCC-cCC-----------------------------------------------CCccCCHHHHHHHHHHcCCCh
Confidence 22211110 000 012345678999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.+++.
T Consensus 253 ~~Rp~~~~l~~ 263 (279)
T cd05109 253 ECRPRFRELVD 263 (279)
T ss_pred hhCcCHHHHHH
Confidence 99999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=273.44 Aligned_cols=238 Identities=25% Similarity=0.370 Sum_probs=191.3
Q ss_pred CCCccceEEEEEEecCCC----ceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERK----EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||.|+||.||++.+..++ ..||+|.++.... .......|+..+..+ .|++++++++.+.+.+..+++||
T Consensus 7 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 7 LGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-----DHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred eccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCeeEEEEe
Confidence 699999999999998766 8999999875433 355667788888888 56899999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.......+++..+..++.|++.||++||+.|++|+||||+||+++
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~------------------------ 137 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG------------------------ 137 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc------------------------
Confidence 99 89999999875533389999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCc----ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNY----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
.+..++|+|||.+......... ..++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.....
T Consensus 138 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~ 214 (258)
T smart00219 138 ---ENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL 214 (258)
T ss_pred ---cCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4456788888887655443211 236678999999987789999999999999999998 88999765544433
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+.... ......+.++.+++.+||..||+
T Consensus 215 ~~~~~~~~~------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~ 246 (258)
T smart00219 215 EYLKKGYRL------------------------------------------------PKPENCPPEIYKLMLQCWAEDPE 246 (258)
T ss_pred HHHhcCCCC------------------------------------------------CCCCcCCHHHHHHHHHHCcCChh
Confidence 332221100 00122466899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||+.++++
T Consensus 247 ~Rpt~~~ll~ 256 (258)
T smart00219 247 DRPTFSELVE 256 (258)
T ss_pred hCcCHHHHHh
Confidence 9999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=271.66 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=188.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||.|+||.||+|.+.. ++.||+|.++.... .......|+.++..+ .|++++++++++.+....++|||++ +
T Consensus 3 lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 3 IGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-----DHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred cccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 7999999999999887 89999998875332 345667788888887 5689999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..+..++.+++.+|.|||+++++|+||||+||++ +.
T Consensus 77 ~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---------------------------~~ 128 (251)
T cd05041 77 GSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---------------------------GE 128 (251)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---------------------------cC
Confidence 99999997643 358899999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 231 (329)
+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...........+
T Consensus 129 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~ 208 (251)
T cd05041 129 NNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208 (251)
T ss_pred CCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH
Confidence 5668888888876544221 11223557999999988889999999999999999998 88999765543322222
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... ......+..+.+++.+||+.+|++||
T Consensus 209 ~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 240 (251)
T cd05041 209 ESGYRM------------------------------------------------PAPQLCPEEIYRLMLQCWAYDPENRP 240 (251)
T ss_pred hcCCCC------------------------------------------------CCCccCCHHHHHHHHHHhccChhhCc
Confidence 111000 00123456899999999999999999
Q ss_pred CHHHHhc
Q 020235 312 TAREALR 318 (329)
Q Consensus 312 t~~~ll~ 318 (329)
|+.++++
T Consensus 241 ~~~ell~ 247 (251)
T cd05041 241 SFSEIYN 247 (251)
T ss_pred CHHHHHH
Confidence 9999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=275.51 Aligned_cols=239 Identities=22% Similarity=0.290 Sum_probs=184.5
Q ss_pred CCCccceEEEEEEecCCCc--eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKE--MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~--~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.++. .+|+|.++.. .........|+.++..+. .|+|++++++++...+..++||||+
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG----HHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhc----cCCCeeeEEEEEecCCCceEEEEeC
Confidence 7999999999999988775 4688887632 233455667888888873 4689999999999999999999999
Q ss_pred -CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 77 -GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 77 -~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
+++|.+++.... ...+++.++..++.|++.||+|||+.|++|+||||+||++
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili------------- 145 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------------- 145 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE-------------
Confidence 899999997532 1247889999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
..+..++|+|||++....... .....+..|+|||++....++.++|+|||||++|+|++ |..|
T Consensus 146 --------------~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 146 --------------GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred --------------cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 455668888888775322111 11123557999999988889999999999999999997 9999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+..... . ......+.++.++
T Consensus 212 f~~~~~~~~~~~~~~~~~----------------------~--------------------------~~~~~~~~~~~~l 243 (270)
T cd05047 212 YCGMTCAELYEKLPQGYR----------------------L--------------------------EKPLNCDDEVYDL 243 (270)
T ss_pred ccccCHHHHHHHHhCCCC----------------------C--------------------------CCCCcCCHHHHHH
Confidence 976544332222111000 0 0011245678999
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 020235 299 LQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~ 318 (329)
+.+||..||.+|||+.++++
T Consensus 244 i~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 244 MRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHHHcccChhhCCCHHHHHH
Confidence 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=273.47 Aligned_cols=237 Identities=26% Similarity=0.388 Sum_probs=188.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.+.. +..+|+|++............|+.++..+ .|++++++++.+......++||||+ +++
T Consensus 12 ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 12 IGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKL-----SHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred ecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhC-----CCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 6999999999998764 66899999875544456677899999888 5689999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.+|++||+.+++|+||||+||+++ .+.
T Consensus 86 L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---------------------------~~~ 137 (256)
T cd05112 86 LSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---------------------------ENQ 137 (256)
T ss_pred HHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---------------------------CCC
Confidence 999987644 3578999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.+.
T Consensus 138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 217 (256)
T cd05112 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG 217 (256)
T ss_pred eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC
Confidence 67888888776443221 12234568999999988889999999999999999998 99999765544333322211
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .....+..+.+|+++||+.+|++|||+.
T Consensus 218 ~~~~------------------------------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~ 249 (256)
T cd05112 218 FRLY------------------------------------------------KPRLASQSVYELMQHCWKERPEDRPSFS 249 (256)
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence 0000 0112356799999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
+++++
T Consensus 250 ~~l~~ 254 (256)
T cd05112 250 LLLHQ 254 (256)
T ss_pred HHHHh
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.64 Aligned_cols=238 Identities=24% Similarity=0.363 Sum_probs=185.9
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||++.. ..++..+|+|.+.... .......+|+.++..+ .|+||+++++++...+..+++||
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-----QHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred cCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-----CCCCCceEEEEEecCCceEEEEe
Confidence 79999999999974 3356789999876432 3345667788888888 56899999999999999999999
Q ss_pred cC-CCCHHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 75 KL-GSSLYDFLRKNNY-------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~-------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
|+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~----------- 156 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG----------- 156 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc-----------
Confidence 99 8999999976431 2478899999999999999999999999999999999994
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 214 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 214 (329)
.+..++|+|||.+....... ....+++.|+|||.+.+..++.++|+|||||++|+|++
T Consensus 157 ----------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 220 (280)
T cd05092 157 ----------------QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTY 220 (280)
T ss_pred ----------------CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 44567888888775433221 22345678999999998889999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|.+||......+....+...... ......+..
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~ 252 (280)
T cd05092 221 GKQPWYQLSNTEAIECITQGREL------------------------------------------------ERPRTCPPE 252 (280)
T ss_pred CCCCCccCCHHHHHHHHHcCccC------------------------------------------------CCCCCCCHH
Confidence 99999765544332222111000 001234567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
+.+++.+||+.||.+|||+.++++
T Consensus 253 ~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 253 VYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHccCChhhCCCHHHHHH
Confidence 999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=278.79 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=190.5
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .++..||+|.++... ...+....|+.++..+ .+|++++.+.+.+..+...++|
T Consensus 8 ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~~~~~~~~~~~~~lv 83 (288)
T cd05583 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV----RRCPFLVTLHYAFQTDTKLHLI 83 (288)
T ss_pred eccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhc----cCCcchhhhheeeecCCEEEEE
Confidence 699999999999864 467889999987432 1234455688888777 3568999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.+|.|||+.|++|+||+|+||++
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~----------------------- 138 (288)
T cd05583 84 LDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL----------------------- 138 (288)
T ss_pred EecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE-----------------------
Confidence 9999 889999987643 58999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..+..++|+|||.+....... ....|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+..
T Consensus 139 ----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 139 ----DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ----CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 445668899999876543322 2245788999999987654 678999999999999999999999643221
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+.+.. . ... .......+..+.+++.+||+.
T Consensus 215 ~~~~~~~~~~------------------~-~~~--------------------------~~~~~~~~~~l~~li~~~l~~ 249 (288)
T cd05583 215 NSQSEISRRI------------------L-KSK--------------------------PPFPKTMSAEARDFIQKLLEK 249 (288)
T ss_pred chHHHHHHHH------------------H-ccC--------------------------CCCCcccCHHHHHHHHHHhcC
Confidence 1111111100 0 000 001123456789999999999
Q ss_pred CCCCCCC---HHHHhcCCCCCCCC
Q 020235 306 DPTDRLT---AREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~t---~~~ll~hp~f~~~~ 326 (329)
||++||| +.++++||||++.+
T Consensus 250 ~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 250 DPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred CHhhccCcchHHHHhcCcccccCC
Confidence 9999998 56779999998865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=307.59 Aligned_cols=136 Identities=22% Similarity=0.373 Sum_probs=120.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|++..+++.||+|+++... ........|+.++..+ .|++|++++..+...+.+|+||||+
T Consensus 12 LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-----KSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-----CCCCcCeEEEEEEECCEEEEEEeCC
Confidence 699999999999999999999999987432 2234556677777776 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+..++.+++.|||++.
T Consensus 87 ~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999997654 58999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=275.78 Aligned_cols=243 Identities=21% Similarity=0.331 Sum_probs=188.8
Q ss_pred CCCccceEEEEEEecCCC------ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERK------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||++.++... +.+|+|.+.... .......+|+.++..+ .|++|+++++++.+.+..++|
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-----NHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred cccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-----CCCCeeeEeeeecCCCCeEEE
Confidence 799999999999886543 689999876432 3345667788888888 669999999999999999999
Q ss_pred eecC-CCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 73 FEKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
|||+ +++|.+++.... ...+++.++..++.|++.||.|||+.+++|+||||+||+++.++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~------------- 144 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGY------------- 144 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCC-------------
Confidence 9999 899999997532 234788999999999999999999999999999999999965431
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
+....++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 145 ---------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~ 215 (269)
T cd05044 145 ---------DADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215 (269)
T ss_pred ---------CCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCc
Confidence 123368888988876443221 12245678999999998889999999999999999998 999997
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
..+..+....+.... .+ ......+..+.+++.
T Consensus 216 ~~~~~~~~~~~~~~~-~~-----------------------------------------------~~~~~~~~~~~~li~ 247 (269)
T cd05044 216 ALNNQEVLQHVTAGG-RL-----------------------------------------------QKPENCPDKIYQLMT 247 (269)
T ss_pred ccCHHHHHHHHhcCC-cc-----------------------------------------------CCcccchHHHHHHHH
Confidence 655544332221100 00 011234567899999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 020235 301 GLLRYDPTDRLTAREALR 318 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~ 318 (329)
+||+.+|++|||++++++
T Consensus 248 ~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 248 NCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHcCCCcccCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=272.12 Aligned_cols=251 Identities=22% Similarity=0.369 Sum_probs=200.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||.|+||+|++..++.+|+..|||.++... +..++.+.|.....+- .+.|+|+++++..=.++..|+.||++..
T Consensus 72 iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks----~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS----SNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred hcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh----cCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 699999999999999999999999998643 3455666676666554 4779999999998888999999999987
Q ss_pred CHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 79 SLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 79 ~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
++..+... -....++++.+-.|....+.||+||. ...|+|||+||+|||+
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl-------------------------- 201 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL-------------------------- 201 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE--------------------------
Confidence 77655542 22246899999999999999999999 5679999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+..+.+||||||.+......- +.-.|...|||||.+.. .+|+.++|+||||++|||++||..||.+-+ +.+.+
T Consensus 202 -dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeq 278 (361)
T KOG1006|consen 202 -DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQ 278 (361)
T ss_pred -ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHH
Confidence 556679999999987665543 33478899999999974 358999999999999999999999997633 35666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.++...-|+.+.. + ...-+++..+..||..||.+|-+.|
T Consensus 279 l~~Vv~gdpp~l~~-----------------~-----------------------~~~~~~s~~~~~fintCl~Kd~~~R 318 (361)
T KOG1006|consen 279 LCQVVIGDPPILLF-----------------D-----------------------KECVHYSFSMVRFINTCLIKDRSDR 318 (361)
T ss_pred HHHHHcCCCCeecC-----------------c-----------------------ccccccCHHHHHHHHHHhhcccccC
Confidence 66665433321110 0 0012467889999999999999999
Q ss_pred CCHHHHhcCCCCCC
Q 020235 311 LTAREALRHPFFTR 324 (329)
Q Consensus 311 ~t~~~ll~hp~f~~ 324 (329)
|...+++.+||+..
T Consensus 319 pky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 319 PKYDDLKKFPFYRM 332 (361)
T ss_pred cchhhhhcCchhhh
Confidence 99999999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=273.36 Aligned_cols=234 Identities=21% Similarity=0.298 Sum_probs=185.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++. .+++.||+|.++.. .......+|+.++..+ .|++++++++.+... ..++||||+ +++
T Consensus 14 lg~g~~g~v~~~~--~~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~-----~~~~i~~~~~~~~~~-~~~~v~e~~~~~~ 84 (254)
T cd05083 14 IGEGEFGAVLQGE--YTGQKVAVKNIKCD-VTAQAFLEETAVMTKL-----HHKNLVRLLGVILHN-GLYIVMELMSKGN 84 (254)
T ss_pred eccCCCCceEecc--cCCCceEEEeecCc-chHHHHHHHHHHHHhC-----CCCCcCeEEEEEcCC-CcEEEEECCCCCC
Confidence 7999999999985 46788999998753 2345677888888887 568999999988654 479999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.|++||||||+||+++ .++
T Consensus 85 L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---------------------------~~~ 137 (254)
T cd05083 85 LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---------------------------EDG 137 (254)
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---------------------------CCC
Confidence 99999876545689999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPL 238 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 238 (329)
.++|+|||.+............+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+..+....+.+.....
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 217 (254)
T cd05083 138 VAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME 217 (254)
T ss_pred cEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC
Confidence 6888888887654433333344567999999988889999999999999999997 999997655433322221110000
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.....+..+.+++++||+.+|++|||++++++
T Consensus 218 ------------------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 ------------------------------------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------------------------------------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01234568899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=274.78 Aligned_cols=239 Identities=20% Similarity=0.272 Sum_probs=183.5
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------c
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------H 68 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~ 68 (329)
||+|+||.||+|....+ +..||+|+++... ........|+..+..+ .|++++++++.+.... .
T Consensus 7 lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-----DHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred cCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEeeeccCCccccCcc
Confidence 79999999999987653 4789999987432 2234566788888777 5689999998775544 3
Q ss_pred eEEEeecC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 69 ICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 69 ~~lv~e~~-~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
.++++||+ +++|..++.... ...+++..+..++.|++.||.|||+++++|+||||+||++
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~--------------- 146 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML--------------- 146 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---------------
Confidence 89999999 899999985432 2358899999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCC
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 217 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 217 (329)
+.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++ |..
T Consensus 147 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 147 ------------REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred ------------CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 445567888888876443322 11234567999999988889999999999999999999 899
Q ss_pred CCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHH
Q 020235 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297 (329)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
||.+.+..+....+.... . . ......+..+.+
T Consensus 215 p~~~~~~~~~~~~~~~~~--~--------------------~--------------------------~~~~~~~~~~~~ 246 (273)
T cd05035 215 PYPGVENHEIYDYLRHGN--R--------------------L--------------------------KQPEDCLDELYD 246 (273)
T ss_pred CCCCCCHHHHHHHHHcCC--C--------------------C--------------------------CCCcCCCHHHHH
Confidence 997755443322221110 0 0 001235668999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 020235 298 LLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 298 ll~~~l~~dP~~R~t~~~ll~h 319 (329)
++.+||+.||++|||+.+++++
T Consensus 247 li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 247 LMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=296.32 Aligned_cols=194 Identities=28% Similarity=0.427 Sum_probs=170.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc--chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~lv 72 (329)
||+|+||.||+++++.||+.||||..+. .....+...+|+++++++ +|+||++++++-++.. ...+|
T Consensus 21 LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-----nh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 21 LGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-----NHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred hcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-----CchhhhhhcccCCccccCcccccceEE
Confidence 7999999999999999999999999874 235567788999999999 5799999999877544 67999
Q ss_pred eecC-CCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKL-GSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~-~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||| ||+|...+.+ .+..++++.+++.++..+..||.|||.+||+||||||+||++....
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge------------------ 157 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE------------------ 157 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC------------------
Confidence 9999 9999999986 3346799999999999999999999999999999999999985432
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.....||||||.|+....+. ...+||+.|.+||++.. ..|+..+|.|||||++|+.+||..||...
T Consensus 158 -----dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 158 -----DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred -----CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 345668999999999887766 55789999999999994 67899999999999999999999999654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=291.02 Aligned_cols=237 Identities=24% Similarity=0.331 Sum_probs=189.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||++++-. .||||+++-. ....+.+.+|+.++++- -|.||+-+.+++..... .||+.+|
T Consensus 400 IGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-----RH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 400 IGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-----RHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred eccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhc-----chhhheeeehhhcCCce-eeeehhcc
Confidence 7999999999998864 3999999743 33556677899999888 45899999999998887 9999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
|.+|+.+++... ..+.+.....|+.|+++|+.|||.++|+|+|||..||++ .
T Consensus 471 GsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---------------------------~ 522 (678)
T KOG0193|consen 471 GSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---------------------------H 522 (678)
T ss_pred Cchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---------------------------c
Confidence 889999998655 458999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.+..|+|+|||++....... ....|...|||||++... +|+..+||||||+++|||++|..||...+....+
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi 602 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII 602 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE
Confidence 66889999999986544332 334677889999999753 6999999999999999999999999854443333
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
.++.+.. +.+++ .........++++|+..||..+++
T Consensus 603 fmVGrG~--l~pd~------------------------------------------s~~~s~~pk~mk~Ll~~C~~~~~~ 638 (678)
T KOG0193|consen 603 FMVGRGY--LMPDL------------------------------------------SKIRSNCPKAMKRLLSDCWKFDRE 638 (678)
T ss_pred EEecccc--cCccc------------------------------------------hhhhccCHHHHHHHHHHHHhcCcc
Confidence 2222211 11110 001123455899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+||++.+||.
T Consensus 639 eRP~F~~il~ 648 (678)
T KOG0193|consen 639 ERPLFPQLLS 648 (678)
T ss_pred cCccHHHHHH
Confidence 9999998876
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=279.63 Aligned_cols=240 Identities=20% Similarity=0.303 Sum_probs=185.2
Q ss_pred CCCccceEEEEEEecC-------CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRE-------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|.+.. ++..+|+|.+.... ........|+.++..+ ..|++++++++.+...+..++
T Consensus 26 lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l----~~h~~i~~~~~~~~~~~~~~l 101 (307)
T cd05098 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINLLGACTQDGPLYV 101 (307)
T ss_pred eccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHh----cCCCCEeeEEEEEecCCceEE
Confidence 7999999999998643 23579999987532 2234566788888777 246899999999999999999
Q ss_pred EeecC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~--------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +++|.+++..... ..++..++..++.|++.||+|||+.|++|+||||+||+++
T Consensus 102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~------- 174 (307)
T cd05098 102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT------- 174 (307)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc-------
Confidence 99999 8899999986421 2478889999999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 175 --------------------~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~e 234 (307)
T cd05098 175 --------------------EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 234 (307)
T ss_pred --------------------CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHH
Confidence 45568888888876443211 11123467999999998889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+.+..+....+...... .....
T Consensus 235 l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 266 (307)
T cd05098 235 IFTLGGSPYPGVPVEELFKLLKEGHRM------------------------------------------------DKPSN 266 (307)
T ss_pred HHcCCCCCCCcCCHHHHHHHHHcCCCC------------------------------------------------CCCCc
Confidence 998 88999764443322222111000 00123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+.++.+++.+||..+|++|||+.+++++
T Consensus 267 ~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 267 CTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 46689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=286.60 Aligned_cols=241 Identities=22% Similarity=0.305 Sum_probs=185.9
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|++. .+++.||+|+++... .......+|+.++..+. .|+||+.+++.+...+..++||
T Consensus 45 lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~----~H~niv~~~~~~~~~~~~~iv~ 120 (401)
T cd05107 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLG----PHLNIVNLLGACTKGGPIYIIT 120 (401)
T ss_pred ccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcC----CCCCeEEEEEEEccCCCcEEEE
Confidence 799999999999864 345689999997532 22345677999998882 3699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC---------------------------------------------------------------
Q 020235 74 EKL-GSSLYDFLRKNNY--------------------------------------------------------------- 89 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~--------------------------------------------------------------- 89 (329)
||+ +|+|.+++.+...
T Consensus 121 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (401)
T cd05107 121 EYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVK 200 (401)
T ss_pred eccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhh
Confidence 999 9999999975321
Q ss_pred ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 90 ---------------------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 90 ---------------------------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
..+++..+..++.|++.||.|||+.+++|+||||+|||++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~------- 273 (401)
T cd05107 201 YADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC------- 273 (401)
T ss_pred hhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe-------
Confidence 1356677888999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++|+|||.+...... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 274 --------------------~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e 333 (401)
T cd05107 274 --------------------EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333 (401)
T ss_pred --------------------CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHH
Confidence 4456888888887643221 122356788999999998889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||......+........ ..+ ...+..
T Consensus 334 ~l~~g~~P~~~~~~~~~~~~~~~~--~~~---------------------------------------------~~~p~~ 366 (401)
T cd05107 334 IFTLGGTPYPELPMNEQFYNAIKR--GYR---------------------------------------------MAKPAH 366 (401)
T ss_pred HHHcCCCCCCCCCchHHHHHHHHc--CCC---------------------------------------------CCCCCC
Confidence 998 88999764433221111110 000 001123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+.++.+++.+||..+|.+|||++++++.
T Consensus 367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 46789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=271.26 Aligned_cols=239 Identities=26% Similarity=0.423 Sum_probs=188.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+|+.||+|.++.. ........+|+.++..+ .|++++++++.+...+..++||||+
T Consensus 10 lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-----~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (267)
T cd08224 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-----DHPNVIKYLASFIENNELNIVLELA 84 (267)
T ss_pred eccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-----CCCCeeeeeeeeecCCeEEEEEecC
Confidence 69999999999999999999999988632 22345667888888888 5689999999999999999999999
Q ss_pred -CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++... ....+++.++..++.+++.||.|||+.|++|+||+|+||++
T Consensus 85 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~------------------------- 139 (267)
T cd08224 85 DAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI------------------------- 139 (267)
T ss_pred CCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE-------------------------
Confidence 89999998752 23458899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh--HHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL--EHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~ 228 (329)
+.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|++|+.||...... +..
T Consensus 140 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08224 140 --TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred --CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH
Confidence 445568888888776443221 2346788899999999888999999999999999999999999653311 111
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+... ..+ ..+ ....+..+.++|.+||..+|+
T Consensus 218 ~~~~~~--~~~--------------------~~~-------------------------~~~~~~~~~~~i~~cl~~~p~ 250 (267)
T cd08224 218 KKIEKC--DYP--------------------PLP-------------------------ADHYSEELRDLVSRCINPDPE 250 (267)
T ss_pred hhhhcC--CCC--------------------CCC-------------------------hhhcCHHHHHHHHHHcCCCcc
Confidence 111100 000 000 013456799999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||+.++++
T Consensus 251 ~Rp~~~~il~ 260 (267)
T cd08224 251 KRPDISYVLQ 260 (267)
T ss_pred cCCCHHHHHH
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.65 Aligned_cols=237 Identities=22% Similarity=0.325 Sum_probs=185.7
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|..+.++. .+|+|.+... .........|+.++..+ .|+|++++.+++.+.+..++||||
T Consensus 13 lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~ 87 (268)
T cd05063 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-----SHHNIIRLEGVVTKFKPAMIITEY 87 (268)
T ss_pred ecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCCCeeEEEEEEccCCCcEEEEEc
Confidence 7999999999999876654 7999988643 22344566788777777 568999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++.++..++.|++.||+|||+.|++|+||||+||+++
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~------------------------- 141 (268)
T cd05063 88 MENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN------------------------- 141 (268)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc-------------------------
Confidence 9 889999997643 4589999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCc------ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+......... ...+..|+|||.+....++.++|+|||||++|++++ |+.||...+..+.
T Consensus 142 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~ 219 (268)
T cd05063 142 --SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV 219 (268)
T ss_pred --CCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 4455777888877544322111 112456999999988889999999999999999997 9999976555443
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.... ..|. ....+.++.+++.+||+.+|
T Consensus 220 ~~~i~~~~-~~~~-----------------------------------------------~~~~~~~~~~li~~c~~~~p 251 (268)
T cd05063 220 MKAINDGF-RLPA-----------------------------------------------PMDCPSAVYQLMLQCWQQDR 251 (268)
T ss_pred HHHHhcCC-CCCC-----------------------------------------------CCCCCHHHHHHHHHHcCCCc
Confidence 33332211 1100 11245678999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++||++.++++
T Consensus 252 ~~Rp~~~~i~~ 262 (268)
T cd05063 252 ARRPRFVDIVN 262 (268)
T ss_pred ccCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=275.12 Aligned_cols=242 Identities=23% Similarity=0.313 Sum_probs=180.8
Q ss_pred CCCccceEEEEEEecCC------------------------CceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCc
Q 020235 1 MGEGTFGQVLECWDRER------------------------KEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNR 55 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~------------------------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~ 55 (329)
||+|+||.||++....+ ...||+|++..... .......|+.++..+ .|+|
T Consensus 3 lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-----~h~n 77 (274)
T cd05076 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-----SHIH 77 (274)
T ss_pred cCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-----CCCC
Confidence 79999999999975322 23689998864322 123444566666666 6799
Q ss_pred eeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccc
Q 020235 56 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYI 134 (329)
Q Consensus 56 i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~ 134 (329)
|+++++++...+..++||||+ +++|..++.... ..+++..+..++.|++.||+|||++||+||||||+||+++..+..
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcc
Confidence 999999999999999999999 889988887643 368999999999999999999999999999999999999654310
Q ss_pred ccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHH
Q 020235 135 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~ 213 (329)
......++++|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|+++
T Consensus 157 --------------------~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 157 --------------------EGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred --------------------cCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 012334799999987543322 23357788999998875 45889999999999999985
Q ss_pred -hCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 -TGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 -~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
+|..||......+....... .... ....+
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~-~~~~-------------------------------------------------~~~~~ 245 (274)
T cd05076 216 FDGEVPLKERTPSEKERFYEK-KHRL-------------------------------------------------PEPSC 245 (274)
T ss_pred hCCCCCccccChHHHHHHHHh-ccCC-------------------------------------------------CCCCC
Confidence 69999976543322111110 0000 01123
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+.++|.+||+.+|++|||+.+++++
T Consensus 246 ~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 246 KELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 468899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=271.07 Aligned_cols=236 Identities=25% Similarity=0.365 Sum_probs=186.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||++.+.. +..+|+|.+...........+|+.++..+ .|++++++.+.+.. ...+++|||+ +++
T Consensus 14 lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~-~~~~~v~e~~~~~~ 86 (260)
T cd05073 14 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVTK-EPIYIITEFMAKGS 86 (260)
T ss_pred ecCccceEEEEEEecC-CccEEEEecCCChhHHHHHHHHHHHHHhc-----CCCCcceEEEEEcC-CCeEEEEEeCCCCc
Confidence 6999999999998654 55699998876555556677899998888 56899999988877 7889999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++ ....
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i---------------------------~~~~ 139 (260)
T cd05073 87 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---------------------------SASL 139 (260)
T ss_pred HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE---------------------------cCCC
Confidence 9999987555568888999999999999999999999999999999999 4455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||++....++.++|+|||||++|++++ |..||.+.+.......+.+.
T Consensus 140 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 219 (260)
T cd05073 140 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219 (260)
T ss_pred cEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence 67888888776443221 12234567999999988889999999999999999998 99999875544332222111
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... +.....+.++.+++.+||+.||++|||+.
T Consensus 220 ~~~------------------------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 251 (260)
T cd05073 220 YRM------------------------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFE 251 (260)
T ss_pred CCC------------------------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHH
Confidence 000 00123456799999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 252 ~l~~ 255 (260)
T cd05073 252 YIQS 255 (260)
T ss_pred HHHH
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=297.89 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=171.0
Q ss_pred CCCccceEEEEEEecCC----CceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc------cccCCceE
Q 020235 1 MGEGTFGQVLECWDRER----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~------~~~~~~~~ 70 (329)
||+|+||.||+|++..+ +..||+|.+..... . |......+.+. .+.++..+... ...+...+
T Consensus 140 LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~-----e~~~~e~l~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 140 LGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-V-----EIWMNERVRRA--CPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred EeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-h-----HHHHHHHHHhh--chhhHHHHHHhhhcccccccCCceE
Confidence 79999999999999988 89999998763221 1 11111122111 00111111111 24567899
Q ss_pred EEeecC-CCCHHHHHHhCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeec
Q 020235 71 IVFEKL-GSSLYDFLRKNNYR------------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~------------------~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~ 131 (329)
+|+||+ +++|.+++...... ......+..++.|++.||.|||++||+||||||+|||++.
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~- 290 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE- 290 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeC-
Confidence 999999 88999998754210 0123456789999999999999999999999999999942
Q ss_pred cccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC----CCcccccCCCCchhHHhcCC------------
Q 020235 132 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----QNYIVSTRHYRAPEVILGLG------------ 195 (329)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~------------ 195 (329)
.+..++|+|||.+...... .....+|+.|+|||.+....
T Consensus 291 -------------------------~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~ 345 (566)
T PLN03225 291 -------------------------GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVAT 345 (566)
T ss_pred -------------------------CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccc
Confidence 3456899999998754322 23457899999999775322
Q ss_pred ----------CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCC
Q 020235 196 ----------WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGA 265 (329)
Q Consensus 196 ----------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (329)
++.++|||||||++|+|+++..|+. +....+.......+.....+.......
T Consensus 346 ~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~~~~~~---------------- 407 (566)
T PLN03225 346 ALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYDLVAWRKLVEPR---------------- 407 (566)
T ss_pred cccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCcHHHHHHhhccc----------------
Confidence 3345699999999999998766543 232233322222222111111111000
Q ss_pred CchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 266 ASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
..+.... .....+.......|||.+||+.||++|||++++|+||||++...
T Consensus 408 ----------~~~~~~~-~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 408 ----------ASPDLRR-GFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred ----------cchhhhh-hhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 0000000 00111233456789999999999999999999999999988654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=276.27 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=187.7
Q ss_pred CCCccceEEEEEEecCCC----------------ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccc
Q 020235 1 MGEGTFGQVLECWDRERK----------------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~ 62 (329)
||+|+||.||+|.+..++ ..||+|.+.... .......+|+.++..+ .|+++++++++
T Consensus 13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~ 87 (296)
T cd05051 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-----SDPNIARLLGV 87 (296)
T ss_pred ccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-----CCCCEeEEEEE
Confidence 799999999999876543 568999987532 3345667799999988 56999999999
Q ss_pred cccCCceEEEeecC-CCCHHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecc
Q 020235 63 FDYRNHICIVFEKL-GSSLYDFLRKNN---------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 63 ~~~~~~~~lv~e~~-~~~l~~~l~~~~---------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~ 132 (329)
+..++..+++||++ +++|.+++.+.. ...+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~--- 164 (296)
T cd05051 88 CTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--- 164 (296)
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeec---
Confidence 99999999999999 899999997643 12588999999999999999999999999999999999994
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHH
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 207 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||
T Consensus 165 ------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 165 ------------------------KNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220 (296)
T ss_pred ------------------------CCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH
Confidence 44567888888776433221 2234567899999998888999999999999
Q ss_pred HHHHHHh--CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHh
Q 020235 208 ILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285 (329)
Q Consensus 208 ~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
++|+|++ +..||...+..+....+........ .... .
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~-----------------------~ 259 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG------------------RQIY-----------------------L 259 (296)
T ss_pred HHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc------------------cccc-----------------------C
Confidence 9999998 7788876554443332222110000 0000 0
Q ss_pred hhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 286 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+.++.+++.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 260 PRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 001234568999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=268.50 Aligned_cols=236 Identities=23% Similarity=0.339 Sum_probs=185.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||++... ++..+|+|.++... ........|+.++..+ .|+|++++++++...+..++||||+ +
T Consensus 3 ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 3 LGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQY-----DHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred cCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEecCCccEEEEECCCC
Confidence 799999999999865 57889999876432 2234566788888877 6699999999999999999999999 9
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..+..++.+++.+|.|+|+.|++|+||||+||+++ .
T Consensus 77 ~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---------------------------~ 128 (250)
T cd05085 77 GDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---------------------------E 128 (250)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---------------------------C
Confidence 99999987644 3578999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 232 (329)
+..++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|++++ |..||...........+.
T Consensus 129 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~ 208 (250)
T cd05085 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE 208 (250)
T ss_pred CCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Confidence 4557788888775433221 11233567999999988888999999999999999998 999997655443322221
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..... ......+..+.+++.+||..+|++|||
T Consensus 209 ~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 209 KGYRM------------------------------------------------SCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred cCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 11000 001234568999999999999999999
Q ss_pred HHHHhc
Q 020235 313 AREALR 318 (329)
Q Consensus 313 ~~~ll~ 318 (329)
+.++++
T Consensus 241 ~~~l~~ 246 (250)
T cd05085 241 FSELQK 246 (250)
T ss_pred HHHHHH
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=299.76 Aligned_cols=237 Identities=23% Similarity=0.373 Sum_probs=200.1
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+-. ...+.||||.++... .....+.+|++++..+ .|+||+++++++..++-+|+|+
T Consensus 494 LGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-----~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 494 LGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-----QHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred hcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-----cCCCeEEEEEEEccCCeeEEEE
Confidence 799999999999753 334689999998543 3567889999999999 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------CCC----CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 74 EKL-GSSLYDFLRKNN--------YRS----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------~~~----l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
||+ .|||.+||.... +.. ++..+.+.|+.||+.|+.||-++.+|||||-..|+||
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV------------ 636 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV------------ 636 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee------------
Confidence 999 999999998421 222 7788999999999999999999999999999999999
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCc-----ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 214 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 214 (329)
..+..|||+|||+++......-+ ..-..+|||||.+....++.++||||+||+|||+++
T Consensus 637 ---------------ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsy 701 (774)
T KOG1026|consen 637 ---------------GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSY 701 (774)
T ss_pred ---------------ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhcc
Confidence 56777899999988755444322 223568999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|+.||.+..+.+.++.+.+..- + ..++..+.+
T Consensus 702 G~QPy~glSn~EVIe~i~~g~l-L-----------------------------------------------~~Pe~CP~~ 733 (774)
T KOG1026|consen 702 GKQPYYGLSNQEVIECIRAGQL-L-----------------------------------------------SCPENCPTE 733 (774)
T ss_pred ccCcccccchHHHHHHHHcCCc-c-----------------------------------------------cCCCCCCHH
Confidence 9999999998888777666321 1 123457789
Q ss_pred HHHHHHHhcccCCCCCCCHHHHh
Q 020235 295 LTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
+.+||..||+.+|++||+++||-
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHHH
Confidence 99999999999999999999873
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=274.64 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=183.5
Q ss_pred CCCccceEEEEEEe----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEE
Q 020235 1 MGEGTFGQVLECWD----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv 72 (329)
||.|+||+||++.. ..++..||+|.++... .......+|+.++..+ .|+|++++++++.. ....++|
T Consensus 12 lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-----YHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred cccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCCceEEEE
Confidence 79999999988753 3567899999987532 2345567788888888 56999999987654 3468999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++... .+++.++..++.|++.||.|||++|++|+||||+||++
T Consensus 87 ~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili----------------------- 140 (283)
T cd05080 87 MEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL----------------------- 140 (283)
T ss_pred ecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE-----------------------
Confidence 9999 89999999764 49999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..+..++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|..||......
T Consensus 141 ----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 216 (283)
T cd05080 141 ----DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216 (283)
T ss_pred ----cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch
Confidence 445668888888876544322 1123456799999998888999999999999999999999998653321
Q ss_pred HHHHHHHHH-hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERV-LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
....... .+........ + ....+ .........+..+.+++.+||+
T Consensus 217 --~~~~~~~~~~~~~~~~~~---~----~~~~~-------------------------~~~~~~~~~~~~~~~li~~cl~ 262 (283)
T cd05080 217 --FEEMIGPKQGQMTVVRLI---E----LLERG-------------------------MRLPCPKNCPQEVYILMKNCWE 262 (283)
T ss_pred --hhhhhcccccccchhhhh---h----hhhcC-------------------------CCCCCCCCCCHHHHHHHHHHhc
Confidence 0000000 0000000000 0 00000 0001123456789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 020235 305 YDPTDRLTAREALR 318 (329)
Q Consensus 305 ~dP~~R~t~~~ll~ 318 (329)
.||++|||++++++
T Consensus 263 ~~p~~Rps~~~i~~ 276 (283)
T cd05080 263 TEAKFRPTFRSLIP 276 (283)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=271.56 Aligned_cols=242 Identities=20% Similarity=0.239 Sum_probs=181.3
Q ss_pred CCCccceEEEEEEecCC------------CceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC
Q 020235 1 MGEGTFGQVLECWDRER------------KEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~------------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~ 67 (329)
||+|+||.||++....+ ...+|+|.+..... .......|+.++..+ .||||+++++++....
T Consensus 3 lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-----~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-----SHKHIVLLYGVCVRDV 77 (262)
T ss_pred cccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCC
Confidence 79999999999975322 23689998764322 223445566677766 6799999999999889
Q ss_pred ceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 68 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 68 ~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
..++||||+ +++|..++.... ..+++..+..++.|++.||+|||++|++|+||||+|||+..++..
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~------------ 144 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGID------------ 144 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCcc------------
Confidence 999999999 888888887543 358999999999999999999999999999999999999654310
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh-cCCCCCccchHhHHHHHHHHH-hCCCCCCCCch
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELC-TGEALFQTHEN 224 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~ 224 (329)
......++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||.....
T Consensus 145 --------~~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 145 --------GECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred --------CCCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 012234899999988654322 2346788899999887 456889999999999999998 58888865433
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.+... ..... .. .....+.++.+||.+||+
T Consensus 216 ~~~~~-~~~~~-----------------------~~--------------------------~~~~~~~~~~~li~~cl~ 245 (262)
T cd05077 216 AEKER-FYEGQ-----------------------CM--------------------------LVTPSCKELADLMTHCMN 245 (262)
T ss_pred hHHHH-HHhcC-----------------------cc--------------------------CCCCChHHHHHHHHHHcC
Confidence 22111 00000 00 011234578899999999
Q ss_pred cCCCCCCCHHHHhcC
Q 020235 305 YDPTDRLTAREALRH 319 (329)
Q Consensus 305 ~dP~~R~t~~~ll~h 319 (329)
.||.+|||+.+++++
T Consensus 246 ~dp~~Rp~~~~il~~ 260 (262)
T cd05077 246 YDPNQRPFFRAIMRD 260 (262)
T ss_pred CChhhCcCHHHHHHh
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=281.57 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=182.1
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEE
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv 72 (329)
||.|+||.||+|.+ ..+++.||+|+++... .......+|+.++..+. +|+||+++++.+.. +...++|
T Consensus 15 lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~~~~~~~~~~~~~~lv 90 (343)
T cd05103 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACTKPGGPLMVI 90 (343)
T ss_pred ccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhcc----CCccHhhhcceeecCCCceEEE
Confidence 79999999999984 3567899999987432 22345678999888883 45899999987754 4578999
Q ss_pred eecC-CCCHHHHHHhCCC--------------------------------------------------------------
Q 020235 73 FEKL-GSSLYDFLRKNNY-------------------------------------------------------------- 89 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~-------------------------------------------------------------- 89 (329)
|||+ +++|.+++.....
T Consensus 91 ~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (343)
T cd05103 91 VEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQED 170 (343)
T ss_pred EeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhh
Confidence 9999 9999999875321
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeC
Q 020235 90 ---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166 (329)
Q Consensus 90 ---~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Df 166 (329)
..++...+..++.|++.||.|||++||+|+||||+||++ ..+..++|+||
T Consensus 171 ~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---------------------------~~~~~~kl~df 223 (343)
T cd05103 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---------------------------SENNVVKICDF 223 (343)
T ss_pred hhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---------------------------cCCCcEEEEec
Confidence 135677888899999999999999999999999999999 44566899999
Q ss_pred CCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCCh
Q 020235 167 GSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQ 240 (329)
Q Consensus 167 g~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (329)
|.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||............... +.
T Consensus 224 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--- 299 (343)
T cd05103 224 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GT--- 299 (343)
T ss_pred ccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-cC---
Confidence 9886543221 12234567999999988889999999999999999997 99999764322111110000 00
Q ss_pred hHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
... .....+..+.+++.+||+.||++|||+.++++|
T Consensus 300 -----------------~~~--------------------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 300 -----------------RMR--------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----------------CCC--------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 011234578999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=276.50 Aligned_cols=239 Identities=21% Similarity=0.319 Sum_probs=184.2
Q ss_pred CCCccceEEEEEEecC-------CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRE-------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|.+.. ....+|+|.++... ........|+.++..+ ..|+||+++++++...+..++
T Consensus 20 lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~~~~~~~~~~~l 95 (314)
T cd05099 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLI----GKHKNIINLLGVCTQEGPLYV 95 (314)
T ss_pred ecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhc----cCCCCeeeEEEEEccCCceEE
Confidence 7999999999997632 34579999887432 2234456787777776 246999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
+|||+ +++|.+++.... ...+++.++..++.|++.||.|||++|++|+||||+||+++
T Consensus 96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~------- 168 (314)
T cd05099 96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT------- 168 (314)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc-------
Confidence 99999 899999997632 13478889999999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 169 --------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~e 228 (314)
T cd05099 169 --------------------EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWE 228 (314)
T ss_pred --------------------CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHH
Confidence 45568888888876543221 11223457999999998889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+....+....+..... ......
T Consensus 229 l~~~g~~p~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~ 260 (314)
T cd05099 229 IFTLGGSPYPGIPVEELFKLLREGHR------------------------------------------------MDKPSN 260 (314)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCC------------------------------------------------CCCCCC
Confidence 999 8999976554443332221100 000123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.+.++.+++.+||..||++|||+.++++
T Consensus 261 ~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 261 CTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 4568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=274.68 Aligned_cols=238 Identities=19% Similarity=0.322 Sum_probs=185.1
Q ss_pred CCCccceEEEEEEecC-----CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+.. ....+|+|.+.... .......+|+.++..+ .|+||+++++.+...+..++++
T Consensus 8 lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-----NHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred ccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-----CCCCEeeEEEEEecCCCcEEEE
Confidence 7999999999998753 23578999876432 2234567788888888 5699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEee
Q 020235 74 EKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~----------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~ 130 (329)
||+ +++|.+++.... ...+++.++..++.|++.||.|||+.|++|+||||+||++.
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~- 161 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA- 161 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEc-
Confidence 999 899999986521 12477889999999999999999999999999999999994
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhH
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 205 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||
T Consensus 162 --------------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl 215 (290)
T cd05045 162 --------------------------EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSF 215 (290)
T ss_pred --------------------------CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHH
Confidence 45568888888876443221 12245668999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 206 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 206 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
|+++|+|++ |..||.+.........+.+....
T Consensus 216 G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------- 248 (290)
T cd05045 216 GVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM----------------------------------------------- 248 (290)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------------------------------------
Confidence 999999998 99999765543322221111000
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+.++.+++.+||+.||++|||++++++
T Consensus 249 -~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 249 -ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001234568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=271.07 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=184.7
Q ss_pred CCCccceEEEEEEecCCC----------ceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceE
Q 020235 1 MGEGTFGQVLECWDRERK----------EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~ 70 (329)
||+|+||.||++.++.++ ..+++|.+...........+|+.++..+ .|++++++++.+.. ...+
T Consensus 3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-----SHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred ccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-----CCcchhheeeEEec-CCcE
Confidence 799999999999998776 3588888765443356667788888777 56999999998877 7789
Q ss_pred EEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+||||+ +++|.+++.... ..++...+..++.|++.||.|||++||+|+||||+||+++.++..
T Consensus 77 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~--------------- 140 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN--------------- 140 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc---------------
Confidence 999999 899999998754 258999999999999999999999999999999999999654310
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHh-CCCCCCCCchhH
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCT-GEALFQTHENLE 226 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (329)
......++|+|||.+..... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+..+
T Consensus 141 -----~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 141 -----EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred -----cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 01223689999999876544 2334567789999999876 68899999999999999999 578886543221
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
..... ..... . .......+.+++.+||..|
T Consensus 215 ~~~~~-~~~~~---------------------~----------------------------~~~~~~~~~~li~~~l~~~ 244 (259)
T cd05037 215 KERFY-QDQHR---------------------L----------------------------PMPDCAELANLINQCWTYD 244 (259)
T ss_pred HHHHH-hcCCC---------------------C----------------------------CCCCchHHHHHHHHHhccC
Confidence 11100 00000 0 0111257899999999999
Q ss_pred CCCCCCHHHHhc
Q 020235 307 PTDRLTAREALR 318 (329)
Q Consensus 307 P~~R~t~~~ll~ 318 (329)
|.+|||+.++++
T Consensus 245 p~~Rpt~~~il~ 256 (259)
T cd05037 245 PTKRPSFRAILR 256 (259)
T ss_pred hhhCCCHHHHHH
Confidence 999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=276.01 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=185.0
Q ss_pred CCCccceEEEEEEecCCC--------------ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc
Q 020235 1 MGEGTFGQVLECWDRERK--------------EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD 64 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~--------------~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~ 64 (329)
||+|+||.||+|++..++ ..||+|.++.. ........+|+.++..+ .|++++++++++.
T Consensus 13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~i~~~~~~~~ 87 (295)
T cd05097 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-----KNPNIIRLLGVCV 87 (295)
T ss_pred cCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCcCeEEEEEc
Confidence 799999999999876432 35899998743 22344567899999988 5699999999999
Q ss_pred cCCceEEEeecC-CCCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccc
Q 020235 65 YRNHICIVFEKL-GSSLYDFLRKNN----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEY 133 (329)
Q Consensus 65 ~~~~~~lv~e~~-~~~l~~~l~~~~----------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~ 133 (329)
..+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~---- 163 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG---- 163 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc----
Confidence 999999999999 899999996532 11367888999999999999999999999999999999994
Q ss_pred cccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHH
Q 020235 134 IKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCI 208 (329)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~ 208 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||+
T Consensus 164 -----------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~ 220 (295)
T cd05097 164 -----------------------NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVT 220 (295)
T ss_pred -----------------------CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHH
Confidence 44557888888776432221 12244678999999988889999999999999
Q ss_pred HHHHHh--CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhh
Q 020235 209 LVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286 (329)
Q Consensus 209 l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
+|+|++ +..||...+..+....+.+..... ....+ ..
T Consensus 221 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~------------------~~~~~-----------------------~~ 259 (295)
T cd05097 221 LWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQ------------------GRQIY-----------------------LS 259 (295)
T ss_pred HHHHHHcCCCCCCcccChHHHHHHHHHhhhhc------------------ccccc-----------------------CC
Confidence 999988 667887655444333222211000 00000 00
Q ss_pred hccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 287 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.....+..+.+|+++||+.||++|||++++++
T Consensus 260 ~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 260 QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01224568999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=276.44 Aligned_cols=240 Identities=19% Similarity=0.297 Sum_probs=185.2
Q ss_pred CCCccceEEEEEEec-------CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDR-------ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|+.. .++..||+|.+... .........|+.++..+ ..|+||+++++.+...+..++
T Consensus 23 lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~i~~~~~~~~~~~~~~l 98 (304)
T cd05101 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIINLLGACTQDGPLYV 98 (304)
T ss_pred eeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhh----ccCCCchheeEEEecCCceEE
Confidence 699999999999752 23457999988643 22334567788888777 246899999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +++|.+++.... ...++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~------- 171 (304)
T cd05101 99 IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT------- 171 (304)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc-------
Confidence 99999 889999998642 12467788999999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.++.++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+
T Consensus 172 --------------------~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 231 (304)
T cd05101 172 --------------------ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231 (304)
T ss_pred --------------------CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHH
Confidence 44567888888876543321 11234567999999988889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+....+....+...... .....
T Consensus 232 l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 263 (304)
T cd05101 232 IFTLGGSPYPGIPVEELFKLLKEGHRM------------------------------------------------DKPAN 263 (304)
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCcC------------------------------------------------CCCCC
Confidence 998 88898765444333222111000 00123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.+++.+||..+|++|||+.++++.
T Consensus 264 ~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 264 CTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 46689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=271.13 Aligned_cols=237 Identities=23% Similarity=0.333 Sum_probs=186.2
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.++ ..+|+|.++.. ........+|+.++..+ .|+|++++++++.+++..++||||
T Consensus 12 lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred ecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCccEEEEEc
Confidence 799999999999886554 37999988643 22345667788888877 569999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 87 ~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~------------------------- 140 (267)
T cd05066 87 MENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN------------------------- 140 (267)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC-------------------------
Confidence 9 889999998754 3579999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+........ ...++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..+.
T Consensus 141 --~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~ 218 (267)
T cd05066 141 --SNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV 218 (267)
T ss_pred --CCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH
Confidence 445677888887765433221 1122457999999998889999999999999999886 9999976555443
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+.... + .....+..+.+++.+||+.+|
T Consensus 219 ~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~li~~~l~~~p 250 (267)
T cd05066 219 IKAIEEGYRL-P-----------------------------------------------APMDCPAALHQLMLDCWQKDR 250 (267)
T ss_pred HHHHhCCCcC-C-----------------------------------------------CCCCCCHHHHHHHHHHcccCc
Confidence 3322221100 0 011245678999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+|||+.++++
T Consensus 251 ~~Rp~~~~i~~ 261 (267)
T cd05066 251 NERPKFEQIVS 261 (267)
T ss_pred hhCCCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=272.24 Aligned_cols=236 Identities=21% Similarity=0.249 Sum_probs=178.3
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||.|+||+||+|.+..+++ .+++|.+..... .......|+..+..+ .|+||+++++++. +...++++|
T Consensus 15 lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-----~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-----DHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred cCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-----CCCCcceEEEEEC-CCccEEEEE
Confidence 7999999999999877776 477787653211 122334455555555 6799999999875 455788999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 89 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili------------------------- 142 (279)
T cd05111 89 LSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL------------------------- 142 (279)
T ss_pred eCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE-------------------------
Confidence 99 899999998644 358999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+.+..++|+|||.+....+.. ....++..|+|||.+.+..++.++|+|||||++|++++ |..||.+......
T Consensus 143 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~ 220 (279)
T cd05111 143 --KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV 220 (279)
T ss_pred --cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 445568888888876543322 12346678999999988889999999999999999998 9999977554332
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.... .++ .....+.++.+++.+||..||
T Consensus 221 ~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~li~~c~~~~p 252 (279)
T cd05111 221 PDLLEKGE-RLA-----------------------------------------------QPQICTIDVYMVMVKCWMIDE 252 (279)
T ss_pred HHHHHCCC-cCC-----------------------------------------------CCCCCCHHHHHHHHHHcCCCc
Confidence 22111100 000 001234568889999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 253 ~~Rps~~el~~ 263 (279)
T cd05111 253 NVRPTFKELAN 263 (279)
T ss_pred ccCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=271.23 Aligned_cols=237 Identities=22% Similarity=0.362 Sum_probs=185.8
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|..+.+++ .||+|.+... .........|+.++..+ .|+|++++.+++.++...++||||
T Consensus 12 lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~lv~e~ 86 (269)
T cd05065 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNIIHLEGVVTKSRPVMIITEF 86 (269)
T ss_pred ecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCcCcceEEEEECCCCceEEEEec
Confidence 7999999999999887664 5999998743 23345667788888887 569999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~------------------------- 140 (269)
T cd05065 87 MENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVN------------------------- 140 (269)
T ss_pred CCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEc-------------------------
Confidence 9 889999987654 3589999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC------ccc--ccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN------YIV--STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
.+..++|+|||.+........ ... .+..|+|||.+.+..++.++|+|||||++|++++ |..||...+..
T Consensus 141 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~ 218 (269)
T cd05065 141 --SNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ 218 (269)
T ss_pred --CCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH
Confidence 455677788877654332211 011 1346999999998889999999999999999886 99999765544
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.... ..+ .....+..+.+++.+||..
T Consensus 219 ~~~~~i~~~~-~~~-----------------------------------------------~~~~~~~~~~~li~~~l~~ 250 (269)
T cd05065 219 DVINAIEQDY-RLP-----------------------------------------------PPMDCPTALHQLMLDCWQK 250 (269)
T ss_pred HHHHHHHcCC-cCC-----------------------------------------------CcccCCHHHHHHHHHHcCC
Confidence 3333222111 000 0112456788999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
+|.+|||+.++++
T Consensus 251 ~p~~Rp~~~~i~~ 263 (269)
T cd05065 251 DRNARPKFGQIVS 263 (269)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=271.44 Aligned_cols=240 Identities=20% Similarity=0.306 Sum_probs=186.4
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+.+.+ .+.+|+|.+..... ......+|+.++..+ .|++++++++++.+.+..++||
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-----SHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred ecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-----CCcceeeeEEEECCCCcceEEE
Confidence 69999999999997643 46799998864332 245677899999888 5689999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 74 EKL-GSSLYDFLRKNNY-------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~-------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
||+ +++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||++..
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~--------------- 152 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS--------------- 152 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeC---------------
Confidence 999 8999999986542 15899999999999999999999999999999999999944
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
...++++|||.+....... ....++..|+|||.+.+...+.++|+||||+++|++++ |..||.
T Consensus 153 ------------~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~ 220 (275)
T cd05046 153 ------------QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFY 220 (275)
T ss_pred ------------CCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 4456777777765332211 22356778999999988888899999999999999998 888996
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
..........+... ...++ .....+..+.+++.
T Consensus 221 ~~~~~~~~~~~~~~-----------------------~~~~~------------------------~~~~~~~~l~~~i~ 253 (275)
T cd05046 221 GLSDEEVLNRLQAG-----------------------KLELP------------------------VPEGCPSRLYKLMT 253 (275)
T ss_pred ccchHHHHHHHHcC-----------------------CcCCC------------------------CCCCCCHHHHHHHH
Confidence 54433322211110 00000 01234568999999
Q ss_pred HhcccCCCCCCCHHHHhcC
Q 020235 301 GLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~h 319 (329)
+||+.||++|||+.++++.
T Consensus 254 ~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 254 RCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHcCCCcccCCCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=282.13 Aligned_cols=188 Identities=28% Similarity=0.389 Sum_probs=163.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh-HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-ceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-~~~lv~e~~-~ 77 (329)
||+|+||.||++....+ ..||||.+...... ..++..|+.++.++ .|+|+++++++|.+.+ +.+||+||+ .
T Consensus 83 ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-----~H~Nlv~LlGyC~e~~~~~~LVYEym~n 156 (361)
T KOG1187|consen 83 IGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRL-----RHPNLVKLLGYCLEGGEHRLLVYEYMPN 156 (361)
T ss_pred eecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcC-----CCcCcccEEEEEecCCceEEEEEEccCC
Confidence 79999999999987654 88999988865544 55689999999999 5799999999999988 599999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~---i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
|+|.+.+.......+++....+|+.+++.||+|||... |+||||||+|||+
T Consensus 157 GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL-------------------------- 210 (361)
T KOG1187|consen 157 GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL-------------------------- 210 (361)
T ss_pred CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE--------------------------
Confidence 99999998765337899999999999999999999754 9999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCC-CCCcc---cccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 155 MPKSSAIKVIDFGSTTYERP-DQNYI---VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~-~~~~~---~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.+...||+|||+|..... ..... .||..|+|||.+.....+.++|||||||++.|+++|+.+...
T Consensus 211 -D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 211 -DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred -CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 6778899999999965544 33222 799999999999888899999999999999999999988864
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=269.54 Aligned_cols=241 Identities=20% Similarity=0.219 Sum_probs=179.7
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|... .++..+|+|.++.... ......+|+.++..+ .|+|++++++.+.+....++||||+
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-----QHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCCcEEEEECC
Confidence 799999999999754 4567899998875432 234566788888888 5699999999999989999999999
Q ss_pred -CCCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 77 -GSSLYDFLRKNNY---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 77 -~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+++|.+++..... ...++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~----------------------- 134 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT----------------------- 134 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc-----------------------
Confidence 8999999975321 2356677889999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC-------CCCCccchHhHHHHHHHHHh-CCCCC
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVELCT-GEALF 219 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~l~~-g~~p~ 219 (329)
.+..++|+|||.+....... ....++..|+|||++.+. .++.++|+||||+++|+|++ |..||
T Consensus 135 ----~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 210 (269)
T cd05087 135 ----ADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210 (269)
T ss_pred ----CCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 44567888888775433221 223567789999998642 35789999999999999996 99999
Q ss_pred CCCchhHHHHHHHHH-hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 220 QTHENLEHLAMMERV-LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 220 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
......+........ ....+. +......+..+.++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~l 246 (269)
T cd05087 211 RHLSDEQVLTYTVREQQLKLPK--------------------------------------------PRLKLPLSDRWYEV 246 (269)
T ss_pred CCCChHHHHHHHhhcccCCCCC--------------------------------------------CccCCCCChHHHHH
Confidence 765544322211110 000000 00011245678899
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 020235 299 LQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~ 318 (329)
++.|+ .+|++|||+++|+.
T Consensus 247 ~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 247 MQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHh-cCcccCCCHHHHHH
Confidence 99999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=270.05 Aligned_cols=241 Identities=23% Similarity=0.278 Sum_probs=179.5
Q ss_pred CCCccceEEEEEEecC--CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRE--RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~--~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.... ....+|+|.+.... .......+|+.++..+ .|+||+++++.+......++||||+
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-----NHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-----CCCCcceEEEEECCCCceEEEEEeC
Confidence 7999999999996532 34578899876332 2234456788877776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 77 -GSSLYDFLRKNNY---RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 77 -~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+++|.+++..... ...++..+..++.|++.||+|||++||+||||||+||++
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill------------------------ 133 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL------------------------ 133 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe------------------------
Confidence 8999999986432 224677889999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhc-------CCCCCccchHhHHHHHHHHHh-CCCCC
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEALF 219 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~p~ 219 (329)
+.+..++|+|||.+....... ....++..|+|||++.. ..++.++|+|||||++|+|++ |..||
T Consensus 134 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 210 (269)
T cd05042 134 ---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210 (269)
T ss_pred ---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC
Confidence 445568888888875432221 22345667999999853 346789999999999999999 78899
Q ss_pred CCCchhHHHHHHHHHhC-CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 220 QTHENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 220 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
....+.+.......... .++. +......+..+.++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~~~ 246 (269)
T cd05042 211 PDLSDEQVLKQVVREQDIKLPK--------------------------------------------PQLDLKYSDRWYEV 246 (269)
T ss_pred CcCCHHHHHHHHhhccCccCCC--------------------------------------------CcccccCCHHHHHH
Confidence 76555443332222111 1110 00112355678889
Q ss_pred HHHhcccCCCCCCCHHHHhc
Q 020235 299 LQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~ 318 (329)
+..|| .||++|||+++|++
T Consensus 247 ~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 247 MQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHh-cCcccccCHHHHHH
Confidence 99998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=272.78 Aligned_cols=238 Identities=21% Similarity=0.323 Sum_probs=184.5
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||.|+||.||+|.+. .++..+|+|++.... .......+|+.++..+ .|++++++++++..++..++||
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 87 (288)
T cd05050 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DHPNIVKLLGVCAVGKPMCLLF 87 (288)
T ss_pred ccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-----CCCchheEEEEEcCCCccEEEE
Confidence 799999999999875 367889999887432 2234566788888888 6699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecc
Q 020235 74 EKL-GSSLYDFLRKNN--------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~ 132 (329)
||+ +++|.+++.... ...+++..++.++.|++.||+|||++|++|+||||+||+++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~--- 164 (288)
T cd05050 88 EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG--- 164 (288)
T ss_pred ecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEec---
Confidence 999 889999997432 12367888999999999999999999999999999999994
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHH
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 207 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (329)
.+..++|+|||.+....... .....+..|+|||.+.+..++.++|+|||||
T Consensus 165 ------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (288)
T cd05050 165 ------------------------ENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGV 220 (288)
T ss_pred ------------------------CCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHH
Confidence 44557778888765433221 1223456799999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhh
Q 020235 208 ILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286 (329)
Q Consensus 208 ~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
++|+|++ |..||.+.+..+....+... ... .
T Consensus 221 il~el~~~~~~p~~~~~~~~~~~~~~~~--~~~----------------------------------------------~ 252 (288)
T cd05050 221 VLWEIFSYGMQPYYGMAHEEVIYYVRDG--NVL----------------------------------------------S 252 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHhcC--CCC----------------------------------------------C
Confidence 9999997 88898765544332222110 000 0
Q ss_pred hccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 287 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 253 CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 01234568999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=271.68 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=185.2
Q ss_pred CCCccceEEEEEEe----cCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECWD----RERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||.||+|.. +.++..||+|.++.. ........+|+.++..+ .|+|++++.+++... ...++|
T Consensus 12 lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05079 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTEDGGNGIKLI 86 (284)
T ss_pred cCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-----CCCCeeeeeeEEecCCCCceEEE
Confidence 79999999999974 466889999998743 22345667899998888 569999999988765 578999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.+.. ..+++..+..++.|++.||+|||++|++|+||||+||+++
T Consensus 87 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---------------------- 143 (284)
T cd05079 87 MEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---------------------- 143 (284)
T ss_pred EEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc----------------------
Confidence 9999 999999997643 3589999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|+|||||++|+|+++..|......
T Consensus 144 -----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~- 217 (284)
T cd05079 144 -----SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT- 217 (284)
T ss_pred -----CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc-
Confidence 44557777887776443322 123466789999999888899999999999999999998776533111
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
...+..++.+.+.... ... .....+. ........+..+.+|+.+||+.
T Consensus 218 ----~~~~~~~~~~~~~~~~--~~~-~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~ 265 (284)
T cd05079 218 ----LFLKMIGPTHGQMTVT--RLV-RVLEEGK-------------------------RLPRPPNCPEEVYQLMRKCWEF 265 (284)
T ss_pred ----hhhhhcccccccccHH--HHH-HHHHcCc-------------------------cCCCCCCCCHHHHHHHHHHccC
Confidence 1111112211111000 000 0000000 0011234577899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 020235 306 DPTDRLTAREALRH 319 (329)
Q Consensus 306 dP~~R~t~~~ll~h 319 (329)
||++|||+.+++++
T Consensus 266 ~p~~Rpt~~~il~~ 279 (284)
T cd05079 266 QPSKRTTFQNLIEG 279 (284)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=269.06 Aligned_cols=237 Identities=24% Similarity=0.315 Sum_probs=184.2
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||.|+||.||+|.+..+ ...||+|...... ...+....|+.++..+ .|+|++++++++.+ ...++||||
T Consensus 14 lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~-~~~~lv~e~ 87 (270)
T cd05056 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-----DHPHIVKLIGVITE-NPVWIVMEL 87 (270)
T ss_pred eCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-----CCCchhceeEEEcC-CCcEEEEEc
Confidence 69999999999987644 3568999876432 3345667788888888 56899999998875 457899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.+++.||.|||+.|++|+||||+||+++
T Consensus 88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~------------------------- 141 (270)
T cd05056 88 APLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS------------------------- 141 (270)
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe-------------------------
Confidence 9 899999997644 3589999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
.+..++|+|||.+....... ....++..|+|||.+....++.++|+||||+++|++++ |..||...+..+...
T Consensus 142 --~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~ 219 (270)
T cd05056 142 --SPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG 219 (270)
T ss_pred --cCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 44557888888776443322 11233467999999988889999999999999999986 999997765544332
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+.... ......+..+.+++.+||..+|++
T Consensus 220 ~~~~~~~~------------------------------------------------~~~~~~~~~~~~li~~~l~~~P~~ 251 (270)
T cd05056 220 RIENGERL------------------------------------------------PMPPNCPPTLYSLMTKCWAYDPSK 251 (270)
T ss_pred HHHcCCcC------------------------------------------------CCCCCCCHHHHHHHHHHcCCChhh
Confidence 22211000 001234568999999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||+.+++..
T Consensus 252 Rpt~~~~~~~ 261 (270)
T cd05056 252 RPRFTELKAQ 261 (270)
T ss_pred CcCHHHHHHH
Confidence 9999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=263.99 Aligned_cols=278 Identities=29% Similarity=0.478 Sum_probs=225.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~~lv 72 (329)
||-|+||.||-+.+..+|+.||+|++.... ...+...+|+.++..+ .|.|+...+++.+... .+|++
T Consensus 61 IGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-----kHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-----RHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred ccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-----ccccHHHHHHhcCCCCchHHHHHHHH
Confidence 799999999999999999999999986422 2356677899988888 4478888888877543 57889
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+|.+..+|..+|.... .++..-++..++|++.||.|||+.+|.||||||.|.|+
T Consensus 136 TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV------------------------ 189 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV------------------------ 189 (449)
T ss_pred HHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe------------------------
Confidence 9999999998887653 68888999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCCC----cccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQN----YIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~~----~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
..|..+||||||+++..+.+.. ..+-|..|+|||++.+.. |+...||||.||++.|++.++..|+..++.+.
T Consensus 190 ---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ 266 (449)
T KOG0664|consen 190 ---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ 266 (449)
T ss_pred ---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence 6677899999999998776652 245688999999999864 89999999999999999999999999999999
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...|..++|.+.-+-.....+-++..+-++....|+... ++.... .++-.-+..+++.+||..||
T Consensus 267 L~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~v-------LYtlsS--------~~~~~heav~~~~~~l~~d~ 331 (449)
T KOG0664|consen 267 LQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQR-------LYKIAS--------PDDKNHEAVDLLQKLLHFDP 331 (449)
T ss_pred HHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccc-------eeeecC--------CcccchHHHHHHHHHhCCCC
Confidence 999999999988877777777777666665444433110 000000 01122357788999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCc
Q 020235 308 TDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~~~~ 327 (329)
++|++.++++.|++..+--+
T Consensus 332 dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 332 DKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred cccccHhhhcccccccccce
Confidence 99999999999999876443
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=272.51 Aligned_cols=245 Identities=22% Similarity=0.345 Sum_probs=184.3
Q ss_pred CCCccceEEEEEEecC----------------CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccc
Q 020235 1 MGEGTFGQVLECWDRE----------------RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~----------------~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~ 62 (329)
||+|+||.||+|.+.. ++..+|+|.++... .......+|+.++..+ .|+++++++++
T Consensus 13 lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-----~~~~i~~~~~~ 87 (296)
T cd05095 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-----KDPNIIRLLAV 87 (296)
T ss_pred ccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEE
Confidence 7999999999996543 34579999987432 2345677899998888 56999999999
Q ss_pred cccCCceEEEeecC-CCCHHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecc
Q 020235 63 FDYRNHICIVFEKL-GSSLYDFLRKNNY---------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 63 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~---------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~ 132 (329)
+...+..++||||+ +++|.+++..... ..+++.++..++.|++.||+|||+.|++|+||||+||+++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~--- 164 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG--- 164 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEc---
Confidence 99999999999999 8999999976431 2366788999999999999999999999999999999994
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHH
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 207 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (329)
.+..++|+|||.+....... ....++..|+|||...+..++.++|+|||||
T Consensus 165 ------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~ 220 (296)
T cd05095 165 ------------------------KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220 (296)
T ss_pred ------------------------CCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHH
Confidence 45568888888876543322 1223456899999988888999999999999
Q ss_pred HHHHHHh--CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHh
Q 020235 208 ILVELCT--GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285 (329)
Q Consensus 208 ~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
++|+|++ |..||...+..+......+.... ...... .
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~-----------------------~ 259 (296)
T cd05095 221 TLWEILTLCKEQPYSQLSDEQVIENTGEFFRD------------------QGRQVY-----------------------L 259 (296)
T ss_pred HHHHHHHhCCCCCccccChHHHHHHHHHHHhh------------------cccccc-----------------------C
Confidence 9999998 77888765443332211110000 000000 0
Q ss_pred hhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 286 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
......+..+.+|+.+||+.||++|||+.++++
T Consensus 260 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 260 PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001224568999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.41 Aligned_cols=237 Identities=19% Similarity=0.230 Sum_probs=177.7
Q ss_pred CCCccceEEEEEEecC---CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-cCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-~~~~~~lv~e 74 (329)
||+|+||.||+|.+.. ++..+|+|.+.... .......+|..++..+ .|++++++++++. .++..++|||
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-----SHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred ccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-----CCCCcceEEEEeecCCCCcEEEEe
Confidence 7999999999998653 34679999875322 2234556777777776 6699999999654 4567899999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.... ...++..+..++.|++.||+|||+.+++|+||||+||+++
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~------------------------ 132 (262)
T cd05058 78 YMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD------------------------ 132 (262)
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc------------------------
Confidence 99 899999997643 2467778889999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
.+..++|+|||.+....... ....++..|+|||.+....++.++|||||||++|+|++ |.+||...+..
T Consensus 133 ---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~ 209 (262)
T cd05058 133 ---ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF 209 (262)
T ss_pred ---CCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 44557778888775433211 12245668999999988889999999999999999999 56677654433
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.... .+ . .....+..+.+++.+||..
T Consensus 210 ~~~~~~~~~~--~~--------------------~--------------------------~~~~~~~~~~~li~~cl~~ 241 (262)
T cd05058 210 DITVYLLQGR--RL--------------------L--------------------------QPEYCPDPLYEVMLSCWHP 241 (262)
T ss_pred HHHHHHhcCC--CC--------------------C--------------------------CCCcCCHHHHHHHHHHcCC
Confidence 3222111100 00 0 0112356799999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
+|++|||+.++++
T Consensus 242 ~p~~Rp~~~~il~ 254 (262)
T cd05058 242 KPEMRPTFSELVS 254 (262)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.79 Aligned_cols=240 Identities=20% Similarity=0.292 Sum_probs=184.9
Q ss_pred CCCccceEEEEEEecCC-------CceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRER-------KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|++... +..||+|.++.. ........+|+.++.++. .|+||+++++.+...+..++
T Consensus 20 ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~l 95 (334)
T cd05100 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG----KHKNIINLLGACTQDGPLYV 95 (334)
T ss_pred eccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhc----CCCCeeeeeEEEccCCceEE
Confidence 79999999999986432 236899987742 223456677888888772 46899999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
++||+ +++|.+++.+.. ...++..++..++.|++.||+|||++|++|+||||+||+++
T Consensus 96 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~------- 168 (334)
T cd05100 96 LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT------- 168 (334)
T ss_pred EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc-------
Confidence 99999 889999997632 12467788899999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++|+|||.+....... ....++..|+|||++.+..++.++|+|||||++|+
T Consensus 169 --------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 228 (334)
T cd05100 169 --------------------EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228 (334)
T ss_pred --------------------CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHH
Confidence 44567888888776443321 11223467999999999889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+.+..+....+...... .....
T Consensus 229 l~~~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 260 (334)
T cd05100 229 IFTLGGSPYPGIPVEELFKLLKEGHRM------------------------------------------------DKPAN 260 (334)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------------CCCCC
Confidence 998 88999775544433322211000 00123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.+++.+||+.+|++|||+.+++++
T Consensus 261 ~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 261 CTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 45678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.78 Aligned_cols=238 Identities=25% Similarity=0.368 Sum_probs=194.3
Q ss_pred CCCccceEEEEEEecCCCc---e-EEEEEecc----chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKE---M-VAIKIVRG----IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~-vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+++.+..+. . ||+|..+. ........++|..++.++ .|+||++++++.....-+++|
T Consensus 165 LGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-----~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 165 LGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-----NHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred eecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEcCCCccEEE
Confidence 7999999999999876532 3 89998874 234456778899999998 779999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||+| ||+|.++|..... .++..+..+++.+.+.||+|||+++++||||-..|+|+.
T Consensus 240 mEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---------------------- 296 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---------------------- 296 (474)
T ss_pred EEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec----------------------
Confidence 9999 9999999998763 599999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--C-cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--N-YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..+||+|||++....... . ..--+..|+|||.+....|+.++||||+||++||+++ |..||.+....+.
T Consensus 297 -----~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v 371 (474)
T KOG0194|consen 297 -----KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV 371 (474)
T ss_pred -----CCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence 44457888888876554211 1 1123468999999999899999999999999999998 8899999888776
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.....+.+. +......+..++.+||..||
T Consensus 372 ~~kI~~~~~r~~~-----------------------------------------------~~~~p~~~~~~~~~c~~~~p 404 (474)
T KOG0194|consen 372 KAKIVKNGYRMPI-----------------------------------------------PSKTPKELAKVMKQCWKKDP 404 (474)
T ss_pred HHHHHhcCccCCC-----------------------------------------------CCCCHHHHHHHHHHhccCCh
Confidence 6666443222211 12345678889999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
+.|||+.++.+
T Consensus 405 ~~R~tm~~i~~ 415 (474)
T KOG0194|consen 405 EDRPTMSTIKK 415 (474)
T ss_pred hhccCHHHHHH
Confidence 99999987753
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=268.80 Aligned_cols=236 Identities=22% Similarity=0.299 Sum_probs=184.7
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|.++.+|. .+|+|.+..... ......+|+.++..+ .|+|++++++++.+ ...++|||
T Consensus 15 ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~-~~~~~v~e 88 (279)
T cd05057 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-----DHPHVVRLLGICLS-SQVQLITQ 88 (279)
T ss_pred ecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEec-CceEEEEe
Confidence 7999999999999876664 589998765432 335566788888888 56999999998877 78999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||||+||+++
T Consensus 89 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~------------------------ 143 (279)
T cd05057 89 LMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK------------------------ 143 (279)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEc------------------------
Confidence 99 999999998754 3589999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCc-----ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+......... ..++..|+|||.+....++.++|+|||||++|++++ |..||.+....+.
T Consensus 144 ---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 220 (279)
T cd05057 144 ---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220 (279)
T ss_pred ---CCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 4455788888877655433211 123567999999988889999999999999999998 9999987654433
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.... ..+ .....+..+.+++.+||..||
T Consensus 221 ~~~~~~~~-~~~-----------------------------------------------~~~~~~~~~~~~~~~~l~~~p 252 (279)
T cd05057 221 PDLLEKGE-RLP-----------------------------------------------QPPICTIDVYMVLVKCWMIDA 252 (279)
T ss_pred HHHHhCCC-CCC-----------------------------------------------CCCCCCHHHHHHHHHHcCCCh
Confidence 22222110 000 011245578899999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+|||+.++++
T Consensus 253 ~~Rp~~~~l~~ 263 (279)
T cd05057 253 ESRPTFKELIN 263 (279)
T ss_pred hhCCCHHHHHH
Confidence 99999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=265.98 Aligned_cols=241 Identities=20% Similarity=0.379 Sum_probs=185.9
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccchh-----------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGIKK-----------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH 68 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~ 68 (329)
||+|+||.||++.++. +++.+|+|.+..... .......|+.++... ..|+|++.+++.+..++.
T Consensus 8 ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~----~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ----LRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhc----CCCCCeeeEEeeEccCCe
Confidence 7999999999999987 678999998763211 112233455544432 267999999999999999
Q ss_pred eEEEeecC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 69 ICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 69 ~~lv~e~~-~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
.+++|||+ +++|.+++.. .....+++..++.++.|++.+|.|||+ .|++|+||+|+||++
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---------------- 147 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---------------- 147 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE----------------
Confidence 99999999 8899988854 223468999999999999999999996 789999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
..+..++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 148 -----------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 148 -----------GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred -----------CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 445668889999887655442 3346888999999999888999999999999999999999999765
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
+.......+........ .....+..+.+++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~c 249 (269)
T cd08528 217 NMLSLATKIVEAVYEPL-----------------------------------------------PEGMYSEDVTDVITSC 249 (269)
T ss_pred CHHHHHHHHhhccCCcC-----------------------------------------------CcccCCHHHHHHHHHH
Confidence 44333222221110000 0113456899999999
Q ss_pred cccCCCCCCCHHHHhcC
Q 020235 303 LRYDPTDRLTAREALRH 319 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~h 319 (329)
|+.||++|||+.++.++
T Consensus 250 l~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 250 LTPDAEARPDIIQVSAM 266 (269)
T ss_pred CCCCCccCCCHHHHHHH
Confidence 99999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=267.98 Aligned_cols=238 Identities=18% Similarity=0.263 Sum_probs=184.6
Q ss_pred CCCccceEEEEEEecC----CCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE----RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~----~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~ 73 (329)
||+|+||.||+|.+.. ++..||+|.+... ........+|..++..+ .|+|++++++++.. +...++++
T Consensus 14 i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-----~h~ni~~~~~~~~~~~~~~~~~~ 88 (280)
T cd05043 14 LQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-----SHQNILPILHVCIEDGEPPFVLY 88 (280)
T ss_pred ecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCCCCEEEE
Confidence 6999999999999876 3578999988743 22345566788888877 67999999987654 57889999
Q ss_pred ecC-CCCHHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 74 EKL-GSSLYDFLRKNNY------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
+++ +++|.+++..... ..+++..+..++.|++.||.|||+.+++|+||||+||++.
T Consensus 89 ~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~----------------- 151 (280)
T cd05043 89 PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID----------------- 151 (280)
T ss_pred EcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc-----------------
Confidence 999 8999999976421 3588999999999999999999999999999999999994
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
.+..++|+|||.++...+.. ....++..|+|||.+.+..++.++|||||||++|++++ |+.||.
T Consensus 152 ----------~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 221 (280)
T cd05043 152 ----------EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYV 221 (280)
T ss_pred ----------CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcC
Confidence 44667888888876443322 11235667999999998889999999999999999998 999997
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
..+..+....+..... + ......+.++.+++.
T Consensus 222 ~~~~~~~~~~~~~~~~-~-----------------------------------------------~~~~~~~~~~~~li~ 253 (280)
T cd05043 222 EIDPFEMAAYLKDGYR-L-----------------------------------------------AQPINCPDELFAVMA 253 (280)
T ss_pred cCCHHHHHHHHHcCCC-C-----------------------------------------------CCCCcCCHHHHHHHH
Confidence 7554433222111100 0 001123567899999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 020235 301 GLLRYDPTDRLTAREALR 318 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~ 318 (329)
+||+.||++|||+.++++
T Consensus 254 ~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 254 CCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHcCCChhhCCCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=264.51 Aligned_cols=248 Identities=23% Similarity=0.412 Sum_probs=195.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+|+.|.+++.+.|.+.+|+|++++.-.+ -+....|..+..+. .++|+++-++..|+++..+++|.||.
T Consensus 258 igrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~a----sn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 258 IGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred ecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhc----cCCCeEEehhhhhcccceEEEEEEEe
Confidence 69999999999999999999999998753221 22333455554444 68899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.-.+.+.+ .++++-++.+..++..||+|||+.||++||+|.+|+|+
T Consensus 334 ~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvll--------------------------- 384 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL--------------------------- 384 (593)
T ss_pred cCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---------------------------
Confidence 999887777665 79999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC--chh--HHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH--ENL--EHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~--~~~--~~~ 228 (329)
+..+++||+|+|.++..-. ..++.+|||.|.|||++.+..|+..+|+|+|||++++|+.|+.||.-- ++. ..-
T Consensus 385 daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nte 464 (593)
T KOG0695|consen 385 DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTE 464 (593)
T ss_pred ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchh
Confidence 6677789999998864332 336789999999999999999999999999999999999999999521 111 000
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.++. -. .++++ +...|-.+..+++..|.+||.
T Consensus 465 dylfqvi-------------------le----------------kqiri----------prslsvkas~vlkgflnkdp~ 499 (593)
T KOG0695|consen 465 DYLFQVI-------------------LE----------------KQIRI----------PRSLSVKASHVLKGFLNKDPK 499 (593)
T ss_pred HHHHHHH-------------------hh----------------hcccc----------cceeehhhHHHHHHhhcCCcH
Confidence 1111110 00 01111 223455677789999999999
Q ss_pred CCC------CHHHHhcCCCCCCCC
Q 020235 309 DRL------TAREALRHPFFTRDH 326 (329)
Q Consensus 309 ~R~------t~~~ll~hp~f~~~~ 326 (329)
+|+ ..+++..||||..+.
T Consensus 500 erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 500 ERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred HhcCCCcccchhhhhcchhhhhCC
Confidence 997 478999999998653
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.42 Aligned_cols=271 Identities=25% Similarity=0.383 Sum_probs=204.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||-|+||+|.+|+...|...+|.|.+++.+ ........|-.||... ..+-|++|+..|++.+.+|+||+|+
T Consensus 637 iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-----Dn~WVVrLyySFQDkdnLYFVMdYI 711 (1034)
T KOG0608|consen 637 IGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-----DNEWVVRLYYSFQDKDNLYFVMDYI 711 (1034)
T ss_pred ecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-----CCcceEEEEEEeccCCceEEEEecc
Confidence 799999999999999999999999987532 2223334577777777 5688999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCc-cCCCCC-CCccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS-LHTPKD-SSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~-~~~~~~-~~~~~ 153 (329)
||++..+|.+.+ .+++..++.++.+|..|+++.|+.|++||||||+||||+++|.+|++|||+- ...+.+ ++++.
T Consensus 712 PGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 712 PGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred CCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 999999999876 6899999999999999999999999999999999999999999999999864 222322 33332
Q ss_pred cCCCCCCeEE---------eeCCCC---------cccCC-CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh
Q 020235 154 RMPKSSAIKV---------IDFGST---------TYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 154 ~~~~~~~~~l---------~Dfg~~---------~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 214 (329)
++.+... .|.+.+ ..... .....+||+.|+|||++...+|+...|+||.||+||+|+.
T Consensus 790 ---~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 790 ---EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ---CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 1111111 111111 00000 0134589999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|++||....+.+....+......+. -..-.+.|.+
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~---------------------------------------------~~~~~~ls~e 901 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLH---------------------------------------------IPYQGNLSKE 901 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccc---------------------------------------------cccccccCHH
Confidence 9999987666544332222111000 0011346788
Q ss_pred HHHHHHHhcccCCCCCC---CHHHHhcCCCCCCCCc
Q 020235 295 LTHLLQGLLRYDPTDRL---TAREALRHPFFTRDHL 327 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~---t~~~ll~hp~f~~~~~ 327 (329)
+.++|.++ +-+++.|+ .+++|..||||+.+..
T Consensus 902 ~~~li~kL-c~sad~RLGkng~d~vKaHpfFkgIDf 936 (1034)
T KOG0608|consen 902 ALDLIQKL-CCSADSRLGKNGADQVKAHPFFKGIDF 936 (1034)
T ss_pred HHHHHHHH-hcChhhhhcccchhhhhcCccccccch
Confidence 99999874 45789998 4788999999998753
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=266.63 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=180.7
Q ss_pred CCCccceEEEEEEe----cCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc--cCCceEEEe
Q 020235 1 MGEGTFGQVLECWD----RERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~--~~~~~~lv~ 73 (329)
||+|+||.||++.. ..++..||+|.+.... .......+|+.++..+ .|+|++++.+++. +....++||
T Consensus 12 lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred ccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEccCCCCceEEEE
Confidence 79999999999974 4678899999986433 2234567898988888 5699999988654 345789999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 87 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~----------------------- 142 (284)
T cd05081 87 EYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE----------------------- 142 (284)
T ss_pred EecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEEC-----------------------
Confidence 999 899999997643 3589999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCCCc------ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQNY------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.+..++|+|||.+......... ..++..|+|||.+.+..++.++|+|||||++|+|++|..|+......
T Consensus 143 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~- 217 (284)
T cd05081 143 ----SENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE- 217 (284)
T ss_pred ----CCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-
Confidence 4455777777777654332211 12334599999998888999999999999999999988776432211
Q ss_pred HHHHHHHHhCCCC--hhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 227 HLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 227 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
. .+..+... ........+ ..... . ........+..+.+|+.+||.
T Consensus 218 ~----~~~~~~~~~~~~~~~~~~~----~~~~~-~------------------------~~~~~~~~~~~~~~li~~cl~ 264 (284)
T cd05081 218 F----MRMMGNDKQGQMIVYHLIE----LLKNN-G------------------------RLPAPPGCPAEIYAIMKECWN 264 (284)
T ss_pred h----hhhcccccccccchHHHHH----HHhcC-C------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence 0 11111100 000000000 00000 0 000123356789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 020235 305 YDPTDRLTAREALR 318 (329)
Q Consensus 305 ~dP~~R~t~~~ll~ 318 (329)
.+|++|||+.++++
T Consensus 265 ~~p~~Rpt~~ei~~ 278 (284)
T cd05081 265 NDPSQRPSFSELAL 278 (284)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=269.88 Aligned_cols=237 Identities=22% Similarity=0.269 Sum_probs=181.6
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||++.+..++. .+|+|.+..... ......+|+.++..+ .|+|++++++++... ..+++++
T Consensus 15 lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-----DHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred cccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEcCC-Cceeeeh
Confidence 7999999999999887775 578898764322 223456788887777 669999999988654 4678999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++
T Consensus 89 ~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~------------------------ 143 (303)
T cd05110 89 LMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK------------------------ 143 (303)
T ss_pred hcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec------------------------
Confidence 99 899999987643 3588999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
.+..++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+.
T Consensus 144 ---~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~ 220 (303)
T cd05110 144 ---SPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220 (303)
T ss_pred ---CCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 44568888888886543322 12234678999999998889999999999999999997 8999976443222
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.. ...++ .....+..+.+++.+||..+|
T Consensus 221 ~~~~~~-~~~~~-----------------------------------------------~~~~~~~~~~~li~~c~~~~p 252 (303)
T cd05110 221 PDLLEK-GERLP-----------------------------------------------QPPICTIDVYMVMVKCWMIDA 252 (303)
T ss_pred HHHHHC-CCCCC-----------------------------------------------CCCCCCHHHHHHHHHHcCCCh
Confidence 111111 00000 011234578899999999999
Q ss_pred CCCCCHHHHhcC
Q 020235 308 TDRLTAREALRH 319 (329)
Q Consensus 308 ~~R~t~~~ll~h 319 (329)
++|||++++++.
T Consensus 253 ~~Rp~~~~l~~~ 264 (303)
T cd05110 253 DSRPKFKELAAE 264 (303)
T ss_pred hhCcCHHHHHHH
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=262.95 Aligned_cols=242 Identities=21% Similarity=0.228 Sum_probs=178.3
Q ss_pred CCCccceEEEEEEecCC--CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRER--KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||++....+ ...+++|.++... .......+|..++..+ .|+|++++++.+.+....++||||+
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-----QHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-----CCcchhheEEEecCCCccEEEEecC
Confidence 79999999999975433 3456777765432 2345667777777777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++.+.. ....++..++.++.|++.||+|||+.+++|+||||+|||+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~------------------------- 132 (268)
T cd05086 78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL------------------------- 132 (268)
T ss_pred CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE-------------------------
Confidence 899999998642 2346677888999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhc-------CCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
..+..++|+|||.+...... .....++..|+|||++.. ..++.++|+|||||++|+|++ |..||.
T Consensus 133 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 210 (268)
T cd05086 133 --TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210 (268)
T ss_pred --cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Confidence 44556888888876532211 123467889999999853 235788999999999999997 577887
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
..+..+....+...... .... +......+..+.+++.
T Consensus 211 ~~~~~~~~~~~~~~~~~----------------------~~~~---------------------~~~~~~~~~~~~~l~~ 247 (268)
T cd05086 211 HLSDREVLNHVIKDQQV----------------------KLFK---------------------PQLELPYSERWYEVLQ 247 (268)
T ss_pred CCCHHHHHHHHHhhccc----------------------ccCC---------------------CccCCCCcHHHHHHHH
Confidence 65554433332211100 0000 0011234567888999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 020235 301 GLLRYDPTDRLTAREALR 318 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~ 318 (329)
.|| .+|++|||++++++
T Consensus 248 ~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 248 FCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHh-hCcccCCCHHHHHH
Confidence 999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=270.47 Aligned_cols=313 Identities=24% Similarity=0.382 Sum_probs=213.0
Q ss_pred CCCccceEEEEEEecC---CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|.|++||++.+.. .++.||+|.+... ....+...|++.+..+. ++.||+.+.+.+..++.+.+|+||+
T Consensus 44 igeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~g----G~~ni~~~~~~~rnnd~v~ivlp~~~ 118 (418)
T KOG1167|consen 44 IGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLG----GSDNIIKLNGCFRNNDQVAIVLPYFE 118 (418)
T ss_pred ccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhc----cchhhhcchhhhccCCeeEEEecccC
Confidence 6999999999999887 7899999998853 44667889999999994 6689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeec-cccccCCCcCccC-CC----CCCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLH-TP----KDSS 150 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~-~~~~~~~~~~~~~-~~----~~~~ 150 (329)
.....++... ++...++.++..++.||.++|++||+||||||+|+|++.. +...+.|||++.. .. ..+.
T Consensus 119 H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~ 193 (418)
T KOG1167|consen 119 HDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSR 193 (418)
T ss_pred ccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhh
Confidence 7777777754 7889999999999999999999999999999999999764 6677899998872 11 1111
Q ss_pred cc---ccCC-CCCCeEEeeC-------CCCcccCCCC----CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHh
Q 020235 151 YF---KRMP-KSSAIKVIDF-------GSTTYERPDQ----NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 151 ~~---~~~~-~~~~~~l~Df-------g~~~~~~~~~----~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~ 214 (329)
.. +... ....+--..+ |.....+... -...||++|+|||++.+.+ .++++||||.||++..+++
T Consensus 194 ~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls 273 (418)
T KOG1167|consen 194 SYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS 273 (418)
T ss_pred hhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc
Confidence 10 0000 0000000000 1111001111 2357999999999998765 6899999999999999999
Q ss_pred CCCCCCC-CchhHHHHHHHHHhCCCChhHHHhhhhhhhh--hhhc-CCcCCCCCCCchHHH--hhhccchhhHHHHhhhc
Q 020235 215 GEALFQT-HENLEHLAMMERVLGPLPQHMLKRVDRHAEK--YVRR-GRLDWPEGAASRESI--KSVMKLPRLQNLIMQHV 288 (329)
Q Consensus 215 g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 288 (329)
++.||.. .++.+.+.++....|+..- .. ....... +... .....++.....+.. ....+.+..........
T Consensus 274 ~~~PFf~a~dd~~al~ei~tifG~~~m--rk-~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~ 350 (418)
T KOG1167|consen 274 RRYPFFKAKDDADALAEIATIFGSAEM--RK-CAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGS 350 (418)
T ss_pred cccccccCccccchHHHHHHHhChHHH--HH-HhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecccc
Confidence 9988754 4667778888887776321 11 1111111 0000 000001111111111 01111111101122223
Q ss_pred cCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 289 ~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
+..+..+.||+.+||+.||.+|+||+++|.||||...+
T Consensus 351 d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 351 DVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 34556899999999999999999999999999998654
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.50 Aligned_cols=238 Identities=23% Similarity=0.358 Sum_probs=195.9
Q ss_pred CCCccceEEEEEEecCCC-----ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERK-----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||.+....-. ..||+|.++.. ......+++|..++..+ .||||+++++++-+....+|++
T Consensus 700 lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-----~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 700 LGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-----DHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred eccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-----CCcceeeEEEeecCCCCcEEEe
Confidence 799999999999886443 34999998754 44567778899999999 7799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 74 EKL-GSSLYDFLRKNN-----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~-----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
||| ||+|..||+..+ ...++......++.+++.|.+||++++++||||-..|+|+
T Consensus 775 eyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL------------------- 835 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL------------------- 835 (1025)
T ss_pred hhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee-------------------
Confidence 999 999999999752 2458889999999999999999999999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCCCcc-----cccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI-----VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 221 (329)
+....+||+|||+|+......-+. .-...|||||.+....++.++|||||||++||+++ |..||.+
T Consensus 836 --------~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 836 --------DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred --------cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 455678999999998433332111 12458999999999899999999999999999998 9999999
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.++.+......+. +.+..| .-+.+.+.++|.+
T Consensus 908 ~~n~~v~~~~~~g----------------------gRL~~P--------------------------~~CP~~ly~lM~~ 939 (1025)
T KOG1095|consen 908 RSNFEVLLDVLEG----------------------GRLDPP--------------------------SYCPEKLYQLMLQ 939 (1025)
T ss_pred cchHHHHHHHHhC----------------------CccCCC--------------------------CCCChHHHHHHHH
Confidence 8887665533331 111221 2356678899999
Q ss_pred hcccCCCCCCCHHHHhc
Q 020235 302 LLRYDPTDRLTAREALR 318 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~ 318 (329)
||+.+|++||++..+++
T Consensus 940 CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 940 CWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HccCChhhCccHHHHHh
Confidence 99999999999999886
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=265.27 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=186.1
Q ss_pred CCCccceEEEEEEec----CCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEE
Q 020235 1 MGEGTFGQVLECWDR----ERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv 72 (329)
||+|+||.||+|... .++..+|+|.++.... ......+|+.++..+ .|++++++++++.. ....++|
T Consensus 12 ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-----~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-----DHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred eccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-----CCCChheEEeeeecCCCCceEEE
Confidence 699999999999864 3478999999885544 256677888888887 56899999988876 5689999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 87 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~----------------------- 142 (284)
T cd05038 87 MEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV----------------------- 142 (284)
T ss_pred EecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE-----------------------
Confidence 9999 899999997654 258999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.+..++|+|||.+........ ...++..|+|||.+....++.++|+||||+++|+|++|..|+......
T Consensus 143 ----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 218 (284)
T cd05038 143 ----ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218 (284)
T ss_pred ----cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccch
Confidence 4556788888888876553221 123455699999998888999999999999999999999998653221
Q ss_pred HHHHHHHHHhCCCCh-hHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERVLGPLPQ-HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
. ....++... .......+... .... . ......+.++.+++.+||+
T Consensus 219 ~-----~~~~~~~~~~~~~~~~~~~~~---~~~~--~------------------------~~~~~~~~~~~~li~~cl~ 264 (284)
T cd05038 219 F-----LRMIGIAQGQMIVTRLLELLK---EGER--L------------------------PRPPSCPDEVYDLMKLCWE 264 (284)
T ss_pred h-----ccccccccccccHHHHHHHHH---cCCc--C------------------------CCCccCCHHHHHHHHHHhc
Confidence 1 001111000 00000000000 0000 0 0012234679999999999
Q ss_pred cCCCCCCCHHHHhc
Q 020235 305 YDPTDRLTAREALR 318 (329)
Q Consensus 305 ~dP~~R~t~~~ll~ 318 (329)
.||++|||+.++++
T Consensus 265 ~~p~~Rpt~~ei~~ 278 (284)
T cd05038 265 AEPQDRPSFADLIL 278 (284)
T ss_pred cChhhCCCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.86 Aligned_cols=262 Identities=26% Similarity=0.358 Sum_probs=178.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-------------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------------- 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------------- 65 (329)
||.||||.||+|+++-+|+.||||++... ........+|+..+.++ +||||++++..+..
T Consensus 487 LGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-----nHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 487 LGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-----NHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred hcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-----CCcceeeeehhhhccCCcccccccccc
Confidence 79999999999999999999999999854 44456677899999999 66888887765500
Q ss_pred -----------------------------------------------------------------C--------------
Q 020235 66 -----------------------------------------------------------------R-------------- 66 (329)
Q Consensus 66 -----------------------------------------------------------------~-------------- 66 (329)
+
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence 0
Q ss_pred ---------------------------CceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 020235 67 ---------------------------NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118 (329)
Q Consensus 67 ---------------------------~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H 118 (329)
..+||-|||| ...+.++++++. ..-....+++++.+|+.||.|+|++||+|
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEGLaYIH~~giIH 720 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEGLAYIHDQGIIH 720 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHHHHHHHhCceee
Confidence 1258999999 666666666654 11146788999999999999999999999
Q ss_pred cCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC-CCCcccccCCCCchhHHhcCC--
Q 020235 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLG-- 195 (329)
Q Consensus 119 ~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-- 195 (329)
|||||.||++++++.+++.|||++--.-.... .......+.+.....+. ..+..+||..|+|||++.+..
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~-------~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLE-------SIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhh-------hHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999996555444444443321100000 00000000111111111 124468999999999998765
Q ss_pred -CCCccchHhHHHHHHHHHhCCCCCCCC-chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhh
Q 020235 196 -WTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 273 (329)
Q Consensus 196 -~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
|+.|+|+||||+++|||+. ||... .....+..+.+ +.+|.+ .
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~--g~iP~~--~----------------------------- 837 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRK--GSIPEP--A----------------------------- 837 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhccc--CCCCCC--c-----------------------------
Confidence 9999999999999999974 56542 22222333332 222221 0
Q ss_pred hccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 020235 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323 (329)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~ 323 (329)
.++...-..-..+|+.||+.||.+||||.|+|+|.||.
T Consensus 838 ------------~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 838 ------------DFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred ------------ccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 00111123456799999999999999999999999997
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=265.99 Aligned_cols=246 Identities=16% Similarity=0.246 Sum_probs=172.5
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccchhhH--H-h------HHHHHHHHHHHHhhCCCCCceeeeccccccCC-
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIKKYR--E-A------AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN- 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~--~-~------~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~- 67 (329)
||+|+||.||+|.+..+ +..+|+|+........ + . ...++..+..+ ....|++++.+++......
T Consensus 20 LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~--~~~~h~~i~~~~~~~~~~~~ 97 (294)
T PHA02882 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI--HNIDHLGIPKYYGCGSFKRC 97 (294)
T ss_pred EecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh--ccCCCCCCCcEEEeeeEecC
Confidence 79999999999998877 6678888644221110 0 0 00111122222 2236688888887654432
Q ss_pred ---ceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 68 ---HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 68 ---~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
..+++++++..++.+.+.... ..++..++.++.|++.||+|||+++|+||||||+|||+
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---------------- 159 (294)
T PHA02882 98 RMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---------------- 159 (294)
T ss_pred CceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----------------
Confidence 457888988778888877643 46788899999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCC----------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 214 (329)
+.+..++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 160 -----------~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~ 228 (294)
T PHA02882 160 -----------DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAG 228 (294)
T ss_pred -----------cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 44556889999988654221 122468999999999999999999999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|..||.+...........+. ++...+ ..+... ....+..
T Consensus 229 g~~P~~~~~~~~~~~~~~~~------~~~~~~--------~~~~~~---------------------------~~~~~~~ 267 (294)
T PHA02882 229 IKLPWKGFGHNGNLIHAAKC------DFIKRL--------HEGKIK---------------------------IKNANKF 267 (294)
T ss_pred CCCCCCccccchHHHHHhHH------HHHHHh--------hhhhhc---------------------------cCCCCHH
Confidence 99999875332211111110 000000 000000 1123567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhc
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
+.+++..|++.+|++||+..++++
T Consensus 268 ~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 268 IYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999999875
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.41 Aligned_cols=239 Identities=18% Similarity=0.231 Sum_probs=182.1
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------c
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------H 68 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~ 68 (329)
||+|+||.||+|..+ .+++.||+|++... ....+...+|+.++..+ .|++++++++++.... .
T Consensus 7 ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-----DHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred ccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-----CCCCcceEEEEEccCCCCCcccc
Confidence 799999999999865 35789999988743 22345567788888888 5699999999775432 3
Q ss_pred eEEEeecC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 69 ICIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 69 ~~lv~e~~-~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
.+++++|+ +++|.+++.... ...++...+..++.|++.||+|||+.||+|+||||+||++
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili--------------- 146 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML--------------- 146 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE---------------
Confidence 47889999 899988875321 1247888999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCC
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 217 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 217 (329)
..+..++|+|||.+....... ....+++.|++||.+....++.++|+|||||++|+|++ |+.
T Consensus 147 ------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 147 ------------NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred ------------cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 445668888888876543221 22345568999999998889999999999999999998 889
Q ss_pred CCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHH
Q 020235 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297 (329)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
||.+.+..+....+.... .+ .. ....+..+.+
T Consensus 215 p~~~~~~~~~~~~~~~~~-~~---------------------~~--------------------------~~~~~~~~~~ 246 (273)
T cd05074 215 PYAGVENSEIYNYLIKGN-RL---------------------KQ--------------------------PPDCLEDVYE 246 (273)
T ss_pred CCCCCCHHHHHHHHHcCC-cC---------------------CC--------------------------CCCCCHHHHH
Confidence 997655433222211100 00 00 1124568999
Q ss_pred HHHHhcccCCCCCCCHHHHhcC
Q 020235 298 LLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 298 ll~~~l~~dP~~R~t~~~ll~h 319 (329)
++.+||..+|++|||+.+++++
T Consensus 247 l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 247 LMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=270.96 Aligned_cols=237 Identities=22% Similarity=0.337 Sum_probs=204.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||.|-||.||.+.++.-.--||||.++.+.-...++++|..+++.+ .|||+++++++|..+.-.|||+||| .|+
T Consensus 275 LGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-----kHpNLVqLLGVCT~EpPFYIiTEfM~yGN 349 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTHEPPFYIITEFMCYGN 349 (1157)
T ss_pred cCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-----cCccHHHHhhhhccCCCeEEEEecccCcc
Confidence 7999999999999998888999999998877889999999999999 6699999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.++|++.+...++.-..+.++.||.+|+.||.+++++||||-..|+|+ ..+.
T Consensus 350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV---------------------------gEnh 402 (1157)
T KOG4278|consen 350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---------------------------GENH 402 (1157)
T ss_pred HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc---------------------------cccc
Confidence 9999998776678888889999999999999999999999999999999 5777
Q ss_pred CeEEeeCCCCcccCCCCCc-ccc---cCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQNY-IVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.||++|||+++....+.-+ ..| ...|+|||.+..+-++.++|||+|||+||+++| |..||.+.+-...+.-+++.
T Consensus 403 iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg 482 (1157)
T KOG4278|consen 403 IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG 482 (1157)
T ss_pred eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc
Confidence 8999999999888776522 223 457999999999999999999999999999998 99999987665444333332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.. +.-++.+.+.+.+||+.||+|+|..||+++
T Consensus 483 yR------------------------------------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFa 514 (1157)
T KOG4278|consen 483 YR------------------------------------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFA 514 (1157)
T ss_pred cc------------------------------------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHH
Confidence 10 011234667899999999999999999998
Q ss_pred HHh
Q 020235 315 EAL 317 (329)
Q Consensus 315 ~ll 317 (329)
++-
T Consensus 515 eiH 517 (1157)
T KOG4278|consen 515 EIH 517 (1157)
T ss_pred HHH
Confidence 874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=250.93 Aligned_cols=238 Identities=36% Similarity=0.608 Sum_probs=192.3
Q ss_pred cceEEEEEEecCCCceEEEEEeccchhh--HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHH
Q 020235 5 TFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 81 (329)
Q Consensus 5 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~ 81 (329)
+||.||+|.+..+++.+|+|++...... .+....|+..+..+ .+++++++.+.+......++++|++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-----KHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-----CCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999988999999998753322 46677788888888 6689999999999989999999999 66999
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCe
Q 020235 82 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 161 (329)
Q Consensus 82 ~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (329)
+++.... .++...+..++.+++.+|.+||+.+++|+||+|.||++ ..+..+
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---------------------------~~~~~~ 126 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---------------------------DEDGHV 126 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---------------------------CCCCcE
Confidence 9998754 38999999999999999999999999999999999999 455678
Q ss_pred EEeeCCCCcccCCC--CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH-HHHHHHHhCCC
Q 020235 162 KVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH-LAMMERVLGPL 238 (329)
Q Consensus 162 ~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~ 238 (329)
+|+|||.+...... .....++..|++||.+....++.++|+||||++++++++|..||........ ...+.......
T Consensus 127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~ 206 (244)
T smart00220 127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF 206 (244)
T ss_pred EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC
Confidence 99999988766553 2445678899999999988889999999999999999999999976333222 21111111110
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.. .....+..+.+++.+||..||++|||+.++++
T Consensus 207 ~~----------------------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 207 PP----------------------------------------------PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cc----------------------------------------------ccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00 00114568999999999999999999999999
Q ss_pred CCCC
Q 020235 319 HPFF 322 (329)
Q Consensus 319 hp~f 322 (329)
||||
T Consensus 241 ~~~~ 244 (244)
T smart00220 241 HPFF 244 (244)
T ss_pred CCCC
Confidence 9997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=272.41 Aligned_cols=262 Identities=21% Similarity=0.357 Sum_probs=175.8
Q ss_pred CCCccceEEEEEEec----------------CCCceEEEEEeccchhh---------------HHhHHHHHHHHHHHHhh
Q 020235 1 MGEGTFGQVLECWDR----------------ERKEMVAIKIVRGIKKY---------------REAAMIEIEVLQQLAKH 49 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~----------------~~~~~vaiK~~~~~~~~---------------~~~~~~e~~~l~~l~~~ 49 (329)
||+|+||+||++... ..++.||||.+...... .+....|+..+..+.+.
T Consensus 153 LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~ 232 (507)
T PLN03224 153 LGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRN 232 (507)
T ss_pred eecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcc
Confidence 799999999999642 33567999998642211 11223466666667554
Q ss_pred CCCCCceeeecccccc--------CCceEEEeecC-CCCHHHHHHhCCC----------------------CCCCHHHHH
Q 020235 50 DKGGNRCVQIRNWFDY--------RNHICIVFEKL-GSSLYDFLRKNNY----------------------RSFPIDLVR 98 (329)
Q Consensus 50 ~~~~~~i~~l~~~~~~--------~~~~~lv~e~~-~~~l~~~l~~~~~----------------------~~l~~~~~~ 98 (329)
...+.+++.+.+++.. .+..++||||+ +++|.+++..... ..+++..++
T Consensus 233 ~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~ 312 (507)
T PLN03224 233 PIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIK 312 (507)
T ss_pred cchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHH
Confidence 4444556777776642 35689999999 9999999874211 123566788
Q ss_pred HHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--
Q 020235 99 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 176 (329)
Q Consensus 99 ~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-- 176 (329)
.++.|++.+|.|||+.+|+||||||+|||+ ..+..++|+|||.+.......
T Consensus 313 ~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---------------------------~~~~~~kL~DFGla~~~~~~~~~ 365 (507)
T PLN03224 313 GVMRQVLTGLRKLHRIGIVHRDIKPENLLV---------------------------TVDGQVKIIDFGAAVDMCTGINF 365 (507)
T ss_pred HHHHHHHHHHHHHHHCCeecCCCchHhEEE---------------------------CCCCcEEEEeCcCccccccCCcc
Confidence 999999999999999999999999999999 445668999999886543322
Q ss_pred C--cccccCCCCchhHHhcCC--------------------CC--CccchHhHHHHHHHHHhCCC-CCCCCchhHHHHHH
Q 020235 177 N--YIVSTRHYRAPEVILGLG--------------------WT--YPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMM 231 (329)
Q Consensus 177 ~--~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwslG~~l~~l~~g~~-p~~~~~~~~~~~~~ 231 (329)
. ...+|+.|+|||.+.... ++ .+.|+||+||++|+|+++.. ||.+...... .+
T Consensus 366 ~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~--~~ 443 (507)
T PLN03224 366 NPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT--EL 443 (507)
T ss_pred CccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh--HH
Confidence 1 123478999999986432 12 34799999999999999875 7753221110 00
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC---C
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP---T 308 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP---~ 308 (329)
.. .......| . . .......++ ..+..++..+||+.+||+.+| .
T Consensus 444 ~~-~~~~~~~~-r-------~-~~~~~~~~~------------------------~~d~~s~~~~dLi~~LL~~~~~~~~ 489 (507)
T PLN03224 444 RQ-YDNDLNRW-R-------M-YKGQKYDFS------------------------LLDRNKEAGWDLACKLITKRDQANR 489 (507)
T ss_pred hh-ccchHHHH-H-------h-hcccCCCcc------------------------cccccChHHHHHHHHHhccCCCCcc
Confidence 00 00000000 0 0 000001110 134467889999999999876 7
Q ss_pred CCCCHHHHhcCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRD 325 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~ 325 (329)
+|+|++|+|+||||..+
T Consensus 490 ~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 490 GRLSVGQALSHRFFLPE 506 (507)
T ss_pred cCCCHHHHhCCCCcCCC
Confidence 89999999999999764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=283.28 Aligned_cols=248 Identities=24% Similarity=0.292 Sum_probs=190.2
Q ss_pred CCCccceEE-EEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQV-LECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V-~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
+|.|+.|+| |++... |+.||||.+-. ...+.+.+|+..+..- ..|+||+++++.-.+..+.||+.|.|..+
T Consensus 517 lG~Gs~Gt~Vf~G~ye--~R~VAVKrll~--e~~~~A~rEi~lL~eS----D~H~NviRyyc~E~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 517 LGYGSNGTVVFRGVYE--GREVAVKRLLE--EFFDFAQREIQLLQES----DEHPNVIRYYCSEQDRQFLYIALELCACS 588 (903)
T ss_pred cccCCCCcEEEEEeeC--CceehHHHHhh--HhHHHHHHHHHHHHhc----cCCCceEEEEeeccCCceEEEEehHhhhh
Confidence 477777765 999764 78999998763 3456678898888766 47799999999999999999999999999
Q ss_pred HHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 80 LYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 80 l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|.+++... ..........+..+.|++.||++||+.+|+||||||+||||..+. ...
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~----------------------~~~ 646 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS----------------------ADG 646 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC----------------------CCc
Confidence 99999874 111111134577899999999999999999999999999996532 134
Q ss_pred CCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC-CCCCCCCchhHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENLEHLAM 230 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~ 230 (329)
...++|.|||+++...... +...||.+|+|||.+....-..++||+||||++|+.++| ..||...-..+ .+
T Consensus 647 ~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~N 724 (903)
T KOG1027|consen 647 TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--AN 724 (903)
T ss_pred ceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hh
Confidence 5778999999998877665 335689999999999998888999999999999999985 89997532211 11
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
|......+ ..+. .....++.|||++|+.++|..|
T Consensus 725 Il~~~~~L---------------------------------------~~L~-------~~~d~eA~dLI~~ml~~dP~~R 758 (903)
T KOG1027|consen 725 ILTGNYTL---------------------------------------VHLE-------PLPDCEAKDLISRMLNPDPQLR 758 (903)
T ss_pred hhcCccce---------------------------------------eeec-------cCchHHHHHHHHHhcCCCcccC
Confidence 11110000 0000 0011178999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
|||.+||.||||=+.+
T Consensus 759 Psa~~VL~HPlFW~~e 774 (903)
T KOG1027|consen 759 PSATDVLNHPLFWDSE 774 (903)
T ss_pred CCHHHHhCCCccCChH
Confidence 9999999999996544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=259.11 Aligned_cols=250 Identities=24% Similarity=0.287 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC----CceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----NHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~----~~~~lv~e~~ 76 (329)
||+|.||.||++.++ |..||||++... ......+|.+++..+.- .|+||..++..-..+ ..+|||++|.
T Consensus 219 IGkGRyGEVwrG~wr--Ge~VAVKiF~sr--dE~SWfrEtEIYqTvmL---RHENILgFIaaD~~~~gs~TQLwLvTdYH 291 (513)
T KOG2052|consen 219 IGKGRFGEVWRGRWR--GEDVAVKIFSSR--DERSWFRETEIYQTVML---RHENILGFIAADNKDNGSWTQLWLVTDYH 291 (513)
T ss_pred ecCccccceeecccc--CCceEEEEeccc--chhhhhhHHHHHHHHHh---ccchhhhhhhccccCCCceEEEEEeeecc
Confidence 699999999999887 677999999843 35667889999888765 568998887765443 2799999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cC---CcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-----LC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-----~~---i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
.|+|+|+|.+. .++.....+++..++.||++||. +| |+|||||..|||+
T Consensus 292 e~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV------------------- 349 (513)
T KOG2052|consen 292 EHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV------------------- 349 (513)
T ss_pred cCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE-------------------
Confidence 99999999985 59999999999999999999993 33 9999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCchhHHhcCC----C--CCccchHhHHHHHHHHHh
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG----W--TYPCDIWSVGCILVELCT 214 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~~l~~l~~ 214 (329)
.+++.+-|+|+|+|...... .+..+||.+|||||++...- + -..+||||||+++||++.
T Consensus 350 --------Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 350 --------KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred --------ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 45566777888877554443 24569999999999997542 2 267999999999999986
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc--h
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS--A 292 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 292 (329)
+..- + . ..+...-+.+++....-+.|++.+++-..++++.++..+... .
T Consensus 422 Rc~~--g---------------g------------i~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l 472 (513)
T KOG2052|consen 422 RCES--G---------------G------------IVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPAL 472 (513)
T ss_pred Hhhc--C---------------C------------EehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHH
Confidence 4221 0 0 000011224455556667888888888888888887777643 4
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHH
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+..+|+.||..||.-|.||-.+
T Consensus 473 ~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 473 RVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHHHHHHHhhcCCchhhhHHHHH
Confidence 568889999999999999987443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.68 Aligned_cols=237 Identities=23% Similarity=0.346 Sum_probs=208.2
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEecc--chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||.|.||.|++++.+..| ..||||.++. .++.+..++.|..|+.++ .||||++|.++....+-+.||+||
T Consensus 637 IGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-----dHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 637 IGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-----DHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-----CCCcEEEEEEEEecCceeEEEhhh
Confidence 799999999999988666 4799999984 356677888999999999 779999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
| .|+|..||+.++++ +...++..++..|+.|+.||-+.++|||||-..|||+
T Consensus 712 MENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV-------------------------- 764 (996)
T KOG0196|consen 712 MENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV-------------------------- 764 (996)
T ss_pred hhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee--------------------------
Confidence 9 99999999998854 8999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCcc----cc--cCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNYI----VS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+.+..+|+.|||+++..+++.... .| +.+|+|||.+....++.++||||+|++|||.++ |.-||=...+.+.
T Consensus 765 -NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 765 -NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred -ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 677889999999998776665322 22 358999999999999999999999999999886 9999988888888
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
++.+++...-+|+ ..+...+..|+..||++|-
T Consensus 844 IkaIe~gyRLPpP------------------------------------------------mDCP~aL~qLMldCWqkdR 875 (996)
T KOG0196|consen 844 IKAIEQGYRLPPP------------------------------------------------MDCPAALYQLMLDCWQKDR 875 (996)
T ss_pred HHHHHhccCCCCC------------------------------------------------CCCcHHHHHHHHHHHHHHh
Confidence 8888887654332 2356689999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+||++.||+.
T Consensus 876 ~~RP~F~qiV~ 886 (996)
T KOG0196|consen 876 NRRPKFAQIVS 886 (996)
T ss_pred hcCCCHHHHHH
Confidence 99999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=264.60 Aligned_cols=235 Identities=22% Similarity=0.340 Sum_probs=191.6
Q ss_pred CCCccceEEEEEEecCC--C--ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRER--K--EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--~--~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||.|-||.||.+.+..- | --||||.-+.+ ....+.++.|..+++.+ .||||+++++++.+ .-+|+|||
T Consensus 397 iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-----dHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 397 IGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-----DHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred hcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-----CCcchhheeeeeec-cceeEEEe
Confidence 79999999999987533 2 35889987642 34467778899999999 77999999999864 56999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ -|.|..++.... ..++......+++|+..||.|||+..+|||||-..|||+.
T Consensus 471 L~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs------------------------ 525 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS------------------------ 525 (974)
T ss_pred cccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec------------------------
Confidence 99 999999999865 4689999999999999999999999999999999999994
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCc--ccc--cCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNY--IVS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
....|||+|||+++..+.+.-+ ..| +..|||||.+.-..++.++|||.|||++||+++ |..||++-.+.+.+
T Consensus 526 ---Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 526 ---SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred ---CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 4456888888888877766522 122 347999999999999999999999999999986 99999987766554
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+++.-.. ++++.+.+.+..++.+||.+||.
T Consensus 603 ~~iEnGeRl------------------------------------------------P~P~nCPp~LYslmskcWayeP~ 634 (974)
T KOG4257|consen 603 GHIENGERL------------------------------------------------PCPPNCPPALYSLMSKCWAYEPS 634 (974)
T ss_pred EEecCCCCC------------------------------------------------CCCCCCChHHHHHHHHHhccCcc
Confidence 444432211 22345677899999999999999
Q ss_pred CCCCHHHHh
Q 020235 309 DRLTAREAL 317 (329)
Q Consensus 309 ~R~t~~~ll 317 (329)
+||++.++.
T Consensus 635 kRPrftei~ 643 (974)
T KOG4257|consen 635 KRPRFTEIK 643 (974)
T ss_pred cCCcHHHHH
Confidence 999987764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.47 Aligned_cols=250 Identities=23% Similarity=0.269 Sum_probs=181.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e~~ 76 (329)
+|+|+||.||+|.. +++.||||++... .++.+..|..|..... -.|+||+++++.-+-.. .++||++|.
T Consensus 218 i~~Grfg~V~KaqL--~~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~---m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 218 IGRGRFGCVWKAQL--DNRLVAVKIFPEQ--EKQSFQNEKNIYSLPG---MKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hhcCccceeehhhc--cCceeEEEecCHH--HHHHHHhHHHHHhccC---ccchhHHHhhchhccCCccccceeEEeeec
Confidence 68999999999954 5699999998843 3556666766665542 26789999988876554 899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---------cCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD---------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~---------~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
.|+|.++|..+- +++....+++..|+.||+|||+ ..|+|||||..|||+
T Consensus 291 ~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv------------------ 349 (534)
T KOG3653|consen 291 PKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV------------------ 349 (534)
T ss_pred cCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE------------------
Confidence 999999999874 9999999999999999999995 359999999999999
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCC-C-----CCccchHhHHHHHHHHHhC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG-W-----TYPCDIWSVGCILVELCTG 215 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~~l~~l~~g 215 (329)
..+..+.|+|||+|....+.. ...+||.+|||||++.+.- + -.+.||||+|.++|||+++
T Consensus 350 ---------K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SR 420 (534)
T KOG3653|consen 350 ---------KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASR 420 (534)
T ss_pred ---------ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 455668889999987666543 2368999999999998742 1 1468999999999999997
Q ss_pred CCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhcc--Cchh
Q 020235 216 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD--HSAG 293 (329)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 293 (329)
..-+......+...-.+..+|..| +.+.+..++-..+.++.++..+. ....
T Consensus 421 C~~~~~~~vp~Yqlpfe~evG~hP---------------------------t~e~mq~~VV~kK~RP~~p~~W~~h~~~~ 473 (534)
T KOG3653|consen 421 CTDADPGPVPEYQLPFEAEVGNHP---------------------------TLEEMQELVVRKKQRPKIPDAWRKHAGMA 473 (534)
T ss_pred cccccCCCCCcccCchhHHhcCCC---------------------------CHHHHHHHHHhhccCCCChhhhhcCccHH
Confidence 665532111111111122333332 12222222222222322222222 2345
Q ss_pred HHHHHHHHhcccCCCCCCCHH
Q 020235 294 DLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~ 314 (329)
-+++.++.||..||+.|+||.
T Consensus 474 ~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 474 VLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHHHHcCCchhhhhhhH
Confidence 689999999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=255.22 Aligned_cols=250 Identities=24% Similarity=0.450 Sum_probs=194.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh--------HHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~l 71 (329)
||.|||+.||+|.+...++.||+|+-..++.+ .+.+.+|..|-+.+ .||.|++++++|.- .+..|-
T Consensus 471 LGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-----DHpRIVKlYDyfslDtdsFCT 545 (775)
T KOG1151|consen 471 LGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-----DHPRIVKLYDYFSLDTDSFCT 545 (775)
T ss_pred hccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-----Ccceeeeeeeeeeecccccee
Confidence 79999999999999999999999986433322 23445677777777 77999999999984 467999
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc--CCcccCCCCCcEEEeeccccccCCCcCccCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~--~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 148 (329)
|+||| |.+|.=++.... .+++..++.|+.|++.||.||... .|+|=||||.|||+.+.
T Consensus 546 VLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G----------------- 606 (775)
T KOG1151|consen 546 VLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG----------------- 606 (775)
T ss_pred eeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-----------------
Confidence 99999 888887787754 799999999999999999999954 59999999999999543
Q ss_pred CCccccCCCCCCeEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcC----CCCCccchHhHHHHHHHHHh
Q 020235 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGL----GWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 149 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~l~~ 214 (329)
...+.+||+|||++++.+.+. +...||--|++||.+... .++.++||||.||++|..+.
T Consensus 607 -------tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY 679 (775)
T KOG1151|consen 607 -------TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY 679 (775)
T ss_pred -------cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence 456779999999998887765 234688889999987643 37899999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|+.||........+ +.... .+......+|. -..++.+
T Consensus 680 GrKPFGhnqsQQdI--LqeNT-----------------IlkAtEVqFP~------------------------KPvVsse 716 (775)
T KOG1151|consen 680 GRKPFGHNQSQQDI--LQENT-----------------ILKATEVQFPP------------------------KPVVSSE 716 (775)
T ss_pred cCCCCCCchhHHHH--Hhhhc-----------------hhcceeccCCC------------------------CCccCHH
Confidence 99999653221111 11100 00000011111 1357889
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
+.+||++||++--+.|+...++-.||+|.-
T Consensus 717 AkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 717 AKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred HHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 999999999999999999999999999965
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=227.75 Aligned_cols=204 Identities=22% Similarity=0.426 Sum_probs=165.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||.|+||.|=+.++..+|+..|+|.++..- ...+..++|+.+.... ...|+++.+++.+-.+..+|+.||.+..
T Consensus 54 lGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~----~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 54 LGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRT----VDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccC----CCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 799999999999999999999999987432 2334445566655443 3679999999999899999999999988
Q ss_pred CHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 79 SLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 79 ~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|..+... ..+..+++..+-+|+..++.||.|||++ .++|||+||+|||+
T Consensus 130 Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI--------------------------- 182 (282)
T KOG0984|consen 130 SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI--------------------------- 182 (282)
T ss_pred hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---------------------------
Confidence 88887764 2335689999999999999999999965 69999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc----CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+..+++|+||||.+......- +...|...|||||.+.. .+|+-++||||||++++||++++.||.+-. ..+.
T Consensus 183 n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~ 260 (282)
T KOG0984|consen 183 NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQ 260 (282)
T ss_pred ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHH
Confidence 667789999999998776654 22468889999999964 369999999999999999999999997532 2344
Q ss_pred HHHHHhCC
Q 020235 230 MMERVLGP 237 (329)
Q Consensus 230 ~~~~~~~~ 237 (329)
++.++...
T Consensus 261 qLkqvVee 268 (282)
T KOG0984|consen 261 QLKQVVEE 268 (282)
T ss_pred HHHHHhcC
Confidence 44454433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=256.02 Aligned_cols=242 Identities=22% Similarity=0.321 Sum_probs=196.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|-||.|.+|.-.. +.+||+|+++... ..+..+.+|+.+|.++ .||||+.+.+++..++.+++|+||+ .
T Consensus 546 iGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-----khPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 546 IGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRL-----KHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred hcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhcc-----CCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 7999999999997654 6899999998533 3456788999999999 5599999999999999999999999 9
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|+|.+|+.+..-..+.-....+++.|+++|++||.+.+++|||+.+.|+|+ ++
T Consensus 620 GDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---------------------------~~ 672 (807)
T KOG1094|consen 620 GDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---------------------------DG 672 (807)
T ss_pred CcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---------------------------cC
Confidence 999999998642333455667899999999999999999999999999999 78
Q ss_pred CCCeEEeeCCCCcccCCCCCc-----ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH--hCCCCCCCCchhHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQNY-----IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC--TGEALFQTHENLEHLAM 230 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~--~g~~p~~~~~~~~~~~~ 230 (329)
+..+||+|||.++.......+ .+-+.+|||||.+.-..++.++|+|++|+++||++ +...||....+.+...+
T Consensus 673 e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 673 EFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred cccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 888999999999855544432 23467899999999999999999999999999986 58899987777665555
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
........+.. ..+..+.-+...+.++|..||..|-++|
T Consensus 753 ~~~~~~~~~~~-----------------------------------------~~l~~P~~cp~~lyelml~Cw~~es~~R 791 (807)
T KOG1094|consen 753 AGEFFRDQGRQ-----------------------------------------VVLSRPPACPQGLYELMLRCWRRESEQR 791 (807)
T ss_pred hhhhcCCCCcc-----------------------------------------eeccCCCcCcHHHHHHHHHHhchhhhcC
Confidence 44443222110 0111123456678899999999999999
Q ss_pred CCHHHH
Q 020235 311 LTAREA 316 (329)
Q Consensus 311 ~t~~~l 316 (329)
||++++
T Consensus 792 PsFe~l 797 (807)
T KOG1094|consen 792 PSFEQL 797 (807)
T ss_pred CCHHHH
Confidence 999998
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=259.23 Aligned_cols=237 Identities=22% Similarity=0.302 Sum_probs=194.0
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.|+++.++..+ -.||||.++.... .-..+++|+.++..+ .|+++++||++.-+ .-+.+|||+
T Consensus 118 LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-----~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 118 LGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-----QHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred hcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-----cCcceeEEeeeecc-chhhHHhhh
Confidence 799999999999887543 4699999985433 356778999999999 66999999999877 678899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ .|+|.+.|+......+-......++.||+.|+.||.+++++||||-..|+|+.+
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas------------------------ 247 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS------------------------ 247 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc------------------------
Confidence 9 999999999854456788889999999999999999999999999999999943
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCccc------ccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNYIV------STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~~~------gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
...|||+|||+.+........++ -...|.|||.+....++.++|+|++||++|||++ |..||.+......
T Consensus 248 ---prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 248 ---PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred ---cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 44588888888776655543322 1336999999999999999999999999999998 8899999888766
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
++.+.... .+.. ++.++.++.+++.+||..+|
T Consensus 325 L~~iD~~e----------------------rLpR--------------------------Pk~csedIY~imk~cWah~p 356 (1039)
T KOG0199|consen 325 LKNIDAGE----------------------RLPR--------------------------PKYCSEDIYQIMKNCWAHNP 356 (1039)
T ss_pred HHhccccc----------------------cCCC--------------------------CCCChHHHHHHHHHhccCCc
Confidence 65544211 1111 23467889999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+|||+..|.+
T Consensus 357 aDRptFsair~ 367 (1039)
T KOG0199|consen 357 ADRPTFSAIRE 367 (1039)
T ss_pred cccccHHHHHH
Confidence 99999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=257.38 Aligned_cols=190 Identities=29% Similarity=0.504 Sum_probs=166.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh-----H----HhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-----R----EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----~----~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.|++|.++.....|+||.+.+..-- + ...-.|++||..+..+ .|+||++++++|++++..||
T Consensus 569 lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~--sH~NIlKlLdfFEddd~yyl 646 (772)
T KOG1152|consen 569 LGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKH--SHENILKLLDFFEDDDYYYL 646 (772)
T ss_pred ccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhc--CccchhhhhheeecCCeeEE
Confidence 79999999999999999999999998753211 1 1223599999999753 57999999999999999999
Q ss_pred EeecC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 72 VFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 72 v~e~~--~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+||.. |.+|.++|..+. .+++..++.|+.|++.|+.+||++||+|||||-+|+++
T Consensus 647 ~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv--------------------- 703 (772)
T KOG1152|consen 647 ETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV--------------------- 703 (772)
T ss_pred EecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEE---------------------
Confidence 99998 789999999875 79999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++.++|||||.+......+ -..+||..|.|||++.++.| +..-|||+||+++|.++....||.+
T Consensus 704 ------d~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 704 ------DSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ------ecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 667779999999988655444 45789999999999999987 5788999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=287.19 Aligned_cols=179 Identities=20% Similarity=0.283 Sum_probs=147.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.++..||+|.+..... ....|+..+.++ .||||+++++++.+.+..++||||+ +++
T Consensus 698 ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l-----~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~ 769 (968)
T PLN00113 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKL-----QHPNIVKLIGLCRSEKGAYLIHEYIEGKN 769 (968)
T ss_pred EccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhC-----CCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence 6999999999999999999999998864322 223457777777 6799999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH---DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH---~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
|.+++.. +++..+..++.|++.||+||| +.+|+||||||+||+++.+
T Consensus 770 L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~------------------------- 819 (968)
T PLN00113 770 LSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGK------------------------- 819 (968)
T ss_pred HHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCC-------------------------
Confidence 9999953 788999999999999999999 6799999999999999533
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
...+++ ++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 820 --~~~~~~-~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 820 --DEPHLR-LSLPGLLCTD-TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred --CceEEE-eccccccccC-CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 333333 4443322211 223678899999999988999999999999999999999999953
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=261.10 Aligned_cols=250 Identities=25% Similarity=0.394 Sum_probs=199.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh-HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
+|+|.||.||+|+++.+++..|+|+++..... -.....|+-++... .|+||+.+++.+-..+.+|++|||| ||
T Consensus 23 vgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-----~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 23 VGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-----RHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred ecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-----CCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 69999999999999999999999999854322 23334465556555 6799999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+...-.+ ++++-++...+.+.+.+|+|||++|=+|||||-.|||+ ...
T Consensus 98 slQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanill---------------------------td~ 148 (829)
T KOG0576|consen 98 SLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL---------------------------TDE 148 (829)
T ss_pred cccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceee---------------------------ccc
Confidence 9988877654 79999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++++|||.+......- ....||+.|||||+... ..|...+|+|++|+...++..-++|....-++.....+.
T Consensus 149 gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT 228 (829)
T KOG0576|consen 149 GDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT 228 (829)
T ss_pred CceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence 668888888877655432 45689999999998863 358999999999999999998888876544443333222
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+ -+..|+... ...+.+..|.+|++.+|..+|++|||
T Consensus 229 k-S~~qpp~lk-------------------------------------------Dk~kws~~fh~fvK~altknpKkRpt 264 (829)
T KOG0576|consen 229 K-SGFQPPTLK-------------------------------------------DKTKWSEFFHNFVKGALTKNPKKRPT 264 (829)
T ss_pred c-cCCCCCccc-------------------------------------------CCccchHHHHHHHHHHhcCCCccCCC
Confidence 2 222221110 02345778999999999999999999
Q ss_pred HHHHhcCCCCCCCCcC
Q 020235 313 AREALRHPFFTRDHLR 328 (329)
Q Consensus 313 ~~~ll~hp~f~~~~~~ 328 (329)
++.+|+|||..+..-|
T Consensus 265 aeklL~h~fvs~~l~~ 280 (829)
T KOG0576|consen 265 AEKLLQHPFVSQTLSR 280 (829)
T ss_pred hhhheeceeeccchhh
Confidence 9999999999876443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=255.57 Aligned_cols=239 Identities=25% Similarity=0.401 Sum_probs=189.4
Q ss_pred CCCccceEEEEEEec---C----CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDR---E----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|.||.|+++.-+ . ....||||.++... ...+....|+.++..+. .|+|++.+.+.+...+.+++
T Consensus 304 lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g----~H~niv~llG~~t~~~~~~~ 379 (609)
T KOG0200|consen 304 LGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELG----KHPNIVNLLGACTQDGPLYV 379 (609)
T ss_pred eecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhc----CCcchhhheeeeccCCceEE
Confidence 799999999999743 1 14579999887432 34567778999999984 57899999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC------C--------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN------Y--------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~------~--------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
|+||+ .|+|.++++..+ . ..++......+..|++.|++||++..++|||+-..|||+
T Consensus 380 v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi-------- 451 (609)
T KOG0200|consen 380 IVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI-------- 451 (609)
T ss_pred EEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe--------
Confidence 99999 999999998754 0 127888999999999999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCc----ccc--cCCCCchhHHhcCCCCCccchHhHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY----IVS--TRHYRAPEVILGLGWTYPCDIWSVGCILV 210 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~----~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~ 210 (329)
..+..+||+|||+++.......+ ..| ...|||||.+....|+.++||||+|+++|
T Consensus 452 -------------------~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~ 512 (609)
T KOG0200|consen 452 -------------------TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW 512 (609)
T ss_pred -------------------cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence 56677999999999855444322 122 23599999999999999999999999999
Q ss_pred HHHh-CCCCCCCCc-hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhc
Q 020235 211 ELCT-GEALFQTHE-NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288 (329)
Q Consensus 211 ~l~~-g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (329)
|+++ |..||.+.. ..+....+.+.. .... +
T Consensus 513 EifsLG~~PYp~~~~~~~l~~~l~~G~----------------------r~~~--------------------------P 544 (609)
T KOG0200|consen 513 EIFTLGGTPYPGIPPTEELLEFLKEGN----------------------RMEQ--------------------------P 544 (609)
T ss_pred HHhhCCCCCCCCCCcHHHHHHHHhcCC----------------------CCCC--------------------------C
Confidence 9998 899998733 222222122111 1111 2
Q ss_pred cCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 289 ~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
...+.++.++++.||..+|++||++.++.+
T Consensus 545 ~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 545 EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 345778999999999999999999988753
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=274.34 Aligned_cols=200 Identities=19% Similarity=0.227 Sum_probs=153.7
Q ss_pred CceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 67 NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 67 ~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
..++++||+++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+...+.+++.|||......
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 4578889988999999997543 468999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCC-------------------CCcccccCCCCchhHHhcCCCCCccchHhHHH
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-------------------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGC 207 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (329)
. +.+..++++|||.+...... .....||+.|||||++.+..++.++|||||||
T Consensus 132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence 2 33467899999998643210 01135788999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhh
Q 020235 208 ILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 287 (329)
Q Consensus 208 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
++|||++|.+|+..... ....+... ..|+..
T Consensus 204 iL~ELl~~~~~~~~~~~--~~~~~~~~--~~~~~~--------------------------------------------- 234 (793)
T PLN00181 204 LLFELFCPVSSREEKSR--TMSSLRHR--VLPPQI--------------------------------------------- 234 (793)
T ss_pred HHHHHhhCCCchhhHHH--HHHHHHHh--hcChhh---------------------------------------------
Confidence 99999998888643211 11111110 011000
Q ss_pred ccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 288 ~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
........+++.+||+.||.+|||+.++++||||.+.
T Consensus 235 -~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 -LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred -hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0012345678899999999999999999999999763
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.01 Aligned_cols=236 Identities=21% Similarity=0.268 Sum_probs=191.3
Q ss_pred CCCccceEEEEEEecCCC----ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERK----EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||++.+--.| .+||+|++.... +...+.+.|+.++..+ .|+|++++++++.... +-||++
T Consensus 704 LGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-----dHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 704 LGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-----DHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred eccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-----CCchHHHHhhhcccch-HHHHHH
Confidence 799999999999875444 479999887433 3467788899999999 7799999999998765 889999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ .|+|.++++..+ ..+-....+.|..||++|+.|||.++++||||-..|+|+
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV------------------------- 831 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV------------------------- 831 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee-------------------------
Confidence 99 999999999865 468889999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCcc---cc--cCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNYI---VS--TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~~---~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
....++||+|||+++...++...+ .| .+.|||-|.+....|++++||||+||++||++| |..|+.+....+.
T Consensus 832 --ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 832 --KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred --cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 455678999999998777665321 22 447999999999999999999999999999998 9999987655443
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...++... .+. .+...+-++.-++.+||..|+
T Consensus 910 ~dlle~ge----------------------RLs--------------------------qPpiCtiDVy~~mvkCwmid~ 941 (1177)
T KOG1025|consen 910 PDLLEKGE----------------------RLS--------------------------QPPICTIDVYMVMVKCWMIDA 941 (1177)
T ss_pred hHHHhccc----------------------cCC--------------------------CCCCccHHHHHHHHHHhccCc
Confidence 22222111 011 123456778889999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
+.||+++++.+
T Consensus 942 ~~rp~fkel~~ 952 (1177)
T KOG1025|consen 942 DSRPTFKELAE 952 (1177)
T ss_pred ccCccHHHHHH
Confidence 99999988753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=224.92 Aligned_cols=191 Identities=25% Similarity=0.349 Sum_probs=160.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc-ccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-WFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~-~~~~~~~~~lv~e~~-~~ 78 (329)
||+|.||.+-+|+++.++..+|+|.+.........+.+|...-..+. .|.||+..++ .|++.+..++++||+ .|
T Consensus 32 lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls----~H~hIi~tY~vaFqt~d~YvF~qE~aP~g 107 (378)
T KOG1345|consen 32 LGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLS----PHQHIIDTYEVAFQTSDAYVFVQEFAPRG 107 (378)
T ss_pred hcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeec----cchhhhHHHHHHhhcCceEEEeeccCccc
Confidence 69999999999999999999999998866666667777777665553 4456666654 588889999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+-+... ++.+...++++.|+++||.|+|++++||||||.+||||.+. ..
T Consensus 108 dL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-------------------------df 159 (378)
T KOG1345|consen 108 DLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-------------------------DF 159 (378)
T ss_pred hhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-------------------------Cc
Confidence 999888775 48999999999999999999999999999999999999653 34
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-----CCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
.++||||||.+...+......--+..|.+||+.... ...+.+|+|.||+++|..++|.+||+.+.
T Consensus 160 ~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~ 229 (378)
T KOG1345|consen 160 YRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS 229 (378)
T ss_pred cEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh
Confidence 589999999998776665555556779999988632 25788999999999999999999998643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-31 Score=216.83 Aligned_cols=208 Identities=39% Similarity=0.618 Sum_probs=179.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|++|.||++....+++.+++|++..... ......+|+..+..+ .+++++++++++......++++|++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-----NHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-----CCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 7999999999999988899999999885443 246678899999888 3489999999999989999999999 6
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..++...+..++.+++.+|++||+.|++|+||+|.||++.. .
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~--------------------------~ 128 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--------------------------D 128 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeC--------------------------C
Confidence 99999998753 35899999999999999999999999999999999999942 1
Q ss_pred CCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
...++|+|||.+...... .....+...|++||..... ..+.++|+|+||++++++
T Consensus 129 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 129 NGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred CCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence 567899999988766554 2345677889999999887 788999999999999998
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.+++.+|++.||++|||+
T Consensus 188 -----------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~ 208 (215)
T cd00180 188 -----------------------------------------------------------PELKDLIRKMLQKDPEKRPSA 208 (215)
T ss_pred -----------------------------------------------------------HHHHHHHHHHhhCCcccCcCH
Confidence 046779999999999999999
Q ss_pred HHHhcCC
Q 020235 314 REALRHP 320 (329)
Q Consensus 314 ~~ll~hp 320 (329)
.++++|+
T Consensus 209 ~~l~~~~ 215 (215)
T cd00180 209 KEILEHL 215 (215)
T ss_pred HHHhhCC
Confidence 9999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=205.81 Aligned_cols=192 Identities=36% Similarity=0.591 Sum_probs=162.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|++|.||++....+++.+|+|.+..... ......+|+..+..+ .+++++++++.+......++++|++ +
T Consensus 7 i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-----~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 7 LGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-----KHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCChhhheeeeecCCceEEEEeccCC
Confidence 6899999999999998899999999875432 356667788888888 5689999999998889999999999 7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++..... .+++..+..++.+++.+|.+||+++++|+|++|.||++ +.
T Consensus 82 ~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v---------------------------~~ 133 (225)
T smart00221 82 GDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL---------------------------GM 133 (225)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---------------------------cC
Confidence 799999987541 17899999999999999999999999999999999999 44
Q ss_pred CCCeEEeeCCCCcccCCCC----CcccccCCCCchhHH-hcCCCCCccchHhHHHHHHHHHhCCCCCCC-Cchh
Q 020235 158 SSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVI-LGLGWTYPCDIWSVGCILVELCTGEALFQT-HENL 225 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~-~~~~ 225 (329)
+..++|+|||.+....... ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. .+..
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 134 DGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 5678999999887655432 445678889999998 566788899999999999999999999976 3443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=204.09 Aligned_cols=168 Identities=23% Similarity=0.271 Sum_probs=124.6
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|+|.+++.... ..+++.+++.++.|++.||.|||+++ ||+|||++ .
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~---------------------------~ 46 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLT---------------------------W 46 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEc---------------------------C
Confidence 68899998643 46999999999999999999999998 99999994 4
Q ss_pred CCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh-HHHHHHHHHhC
Q 020235 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL-EHLAMMERVLG 236 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~ 236 (329)
++.+++ ||.+....... ..||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....
T Consensus 47 ~~~~~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~ 122 (176)
T smart00750 47 DGLLKL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP 122 (176)
T ss_pred ccceee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc
Confidence 455666 77776554432 26889999999999999999999999999999999999999654332 11111111111
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch--hHHHHHHHHhcccCCCCCCCHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA--GDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
...... . +.....+ ..+.+++.+||..||++|||+.
T Consensus 123 ~~~~~~----------------------------------~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~ 160 (176)
T smart00750 123 ADDPRD----------------------------------R--------SNLESVSAARSFADFMRVCASRLPQRREAAN 160 (176)
T ss_pred cCCccc----------------------------------c--------ccHHHHHhhhhHHHHHHHHHhcccccccCHH
Confidence 100000 0 0001112 2689999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++++|+|+...
T Consensus 161 ~ll~~~~~~~~ 171 (176)
T smart00750 161 HYLAHCRALFA 171 (176)
T ss_pred HHHHHHHHHHH
Confidence 99999997643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=200.71 Aligned_cols=195 Identities=25% Similarity=0.336 Sum_probs=169.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.+|.+.+..+++.||||.-. .+....+..-|....+.+. +.+.|+..+.+...+.+-.||+|++|.+|
T Consensus 36 IGeGsFG~lf~G~Nl~nne~VAIKfEP-rkS~APQLrdEYr~YKlL~----g~~GIP~vYYFGqeG~~NiLVidLLGPSL 110 (449)
T KOG1165|consen 36 IGEGSFGVLFLGKNLYNNEPVAIKFEP-RKSEAPQLRDEYRTYKLLG----GTEGIPQVYYFGQEGKYNILVIDLLGPSL 110 (449)
T ss_pred cccCcceeeecccccccCceEEEEecc-ccCCcchHHHHHHHHHHHc----CCCCCCceeeeccccchhhhhhhhhCcCH
Confidence 799999999999999999999999644 3334455667888888884 55889999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.|++.--+ +.++...+.-++.||+.-++++|++.+++|||||+|+||.+.+. .....
T Consensus 111 EDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~----------------------k~~n~ 167 (449)
T KOG1165|consen 111 EDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGT----------------------KDANV 167 (449)
T ss_pred HHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCC----------------------CCCce
Confidence 99987644 67999999999999999999999999999999999999987653 44566
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
+.|+|||.|+..-++. ....||.+||+-....+.+.+.+.|+-|||-++++++.|.+||++..
T Consensus 168 IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 168 IHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred EEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 8999999998765554 33579999999999999999999999999999999999999998753
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=203.38 Aligned_cols=237 Identities=17% Similarity=0.200 Sum_probs=176.8
Q ss_pred CCccceEEEEEEecCC-----CceEEEEEeccchhh--HHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEe
Q 020235 2 GEGTFGQVLECWDRER-----KEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVF 73 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~ 73 (329)
-+|.||.||.+.+++. .+.|-+|.++..... ....+.|--.+..+ .|+|+....++... ....+.++
T Consensus 293 qEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-----sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 293 QEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-----SHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred hcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-----cCCCccceeEEEeeccCcceEEE
Confidence 4799999999966533 234556666533221 12222233333333 57999988887654 45788889
Q ss_pred ecC-CCCHHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 74 EKL-GSSLYDFLRK------NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 74 e~~-~~~l~~~l~~------~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
++. -|+|..|+.. ...+.++..+...++.|++.|++|||+.|++|.||-..|.+|
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI------------------ 429 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI------------------ 429 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee------------------
Confidence 999 7899999982 222446777888999999999999999999999999999999
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCCCccc-----ccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV-----STRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~-----gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
++...+||+|=.+++-.-+..-... .+..||+||.+..+.|+..+|+|||||++|||+| |+.||.
T Consensus 430 ---------dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Pya 500 (563)
T KOG1024|consen 430 ---------DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYA 500 (563)
T ss_pred ---------hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcc
Confidence 5557788888888765444332222 3557999999999999999999999999999998 999998
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
.-++.++...+.....- +.+-.+++++..++-
T Consensus 501 eIDPfEm~~ylkdGyRl------------------------------------------------aQP~NCPDeLf~vMa 532 (563)
T KOG1024|consen 501 EIDPFEMEHYLKDGYRL------------------------------------------------AQPFNCPDELFTVMA 532 (563)
T ss_pred ccCHHHHHHHHhcccee------------------------------------------------cCCCCCcHHHHHHHH
Confidence 88887766555443211 011245678999999
Q ss_pred HhcccCCCCCCCHHHHhc
Q 020235 301 GLLRYDPTDRLTAREALR 318 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~ 318 (329)
-||..+|++||+.+|+..
T Consensus 533 cCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 533 CCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHhcCcccCCCHHHHHH
Confidence 999999999999999864
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=188.55 Aligned_cols=195 Identities=27% Similarity=0.382 Sum_probs=164.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.+|++.+..+|..||||.-+... .......|..+...+. +...++.+..+..+..+-.+||+.+|.+|
T Consensus 23 iGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~----~g~GiP~i~~y~~e~~ynvlVMdLLGPsL 97 (341)
T KOG1163|consen 23 IGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQ----GGVGIPHIRHYGTEKDYNVLVMDLLGPSL 97 (341)
T ss_pred ecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhc----cCCCCchhhhhccccccceeeeeccCccH
Confidence 799999999999999999999999866433 3445567888887774 44678888888888999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.--. +.++..+++-++-|++..++|+|.++++||||||+|+|+.-. .-...
T Consensus 98 EdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlg------------------------rh~~k 152 (341)
T KOG1163|consen 98 EDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLG------------------------RHCNK 152 (341)
T ss_pred HHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccc------------------------cccce
Confidence 99886432 468999999999999999999999999999999999999432 23456
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.+||||+|+..-+.. ....||.+|.+-....+...+.+.|+-|+|.++.++-.|..||++....
T Consensus 153 l~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 153 LYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred EEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 8999999997654433 3457999999998888888899999999999999999999999986543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-26 Score=202.27 Aligned_cols=202 Identities=28% Similarity=0.350 Sum_probs=164.2
Q ss_pred CCCccceEEEEEEecCCC-ceEEEEEeccchhh-HHhHHHHHHHHHHHHhhCCCCCceeeecccc-ccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~-~~~~~~~lv~e~~~ 77 (329)
||+|+||.||.|.+..++ ..+|+|........ ......|..++..+.. ..+..+++.+++.. ..+...++||+.+|
T Consensus 26 iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~iVM~l~G 104 (322)
T KOG1164|consen 26 IGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNFIVMSLLG 104 (322)
T ss_pred ccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeEEEEeccC
Confidence 799999999999988775 67899987643221 1256778999988865 23446788888888 57889999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+|.++........++...+.+++.|++.+|.+||+.|++||||||+|+++...+. ..
T Consensus 105 ~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~----------------------~~ 162 (322)
T KOG1164|consen 105 PSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR----------------------SE 162 (322)
T ss_pred ccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC----------------------cc
Confidence 99999887665567999999999999999999999999999999999999954320 12
Q ss_pred CCCeEEeeCCCCc--ccC--------CC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 158 SSAIKVIDFGSTT--YER--------PD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 158 ~~~~~l~Dfg~~~--~~~--------~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
...+.|+|||+++ ..- +. .....||..|.++....+...+.+.|+||++.++.++..|..||.+...
T Consensus 163 ~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 163 VRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 2568999999998 311 11 1234599999999999999999999999999999999999999977654
Q ss_pred h
Q 020235 225 L 225 (329)
Q Consensus 225 ~ 225 (329)
.
T Consensus 243 ~ 243 (322)
T KOG1164|consen 243 T 243 (322)
T ss_pred c
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=228.09 Aligned_cols=252 Identities=21% Similarity=0.293 Sum_probs=178.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec----cchhhHHh---HHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREA---AMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~~~~~~~---~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
+|+|++|.|+.+........++.|..+ ......+. ...|+-+-..+ .|++++.....+.+.....-+|
T Consensus 326 ~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-----~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 326 LGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-----SHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred eeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-----cCCchhhhHHHHhhcccchhhh
Confidence 588999988888877666666666543 11111111 11122222223 5677766666655554444449
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|||.++|..++.+.. .+....+..++.|++.|++|+|+.||.|||+||+|+++
T Consensus 401 E~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~------------------------- 453 (601)
T KOG0590|consen 401 EYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV------------------------- 453 (601)
T ss_pred hcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE-------------------------
Confidence 999449999998763 58888999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..++.+||||||.+.....+. ...+|+.+|+|||++.+..|+ ...||||.|+++..|++|+.||..+...
T Consensus 454 --~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 454 --TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred --ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 456679999999987554332 335789999999999999998 5579999999999999999999765543
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+... ....+. .+. +........+.......+.+|.+||++
T Consensus 532 ~~~~--~~~~~~----------------------~~~----------------~~~~~~~~~~~~lp~~~~~~~~~~l~~ 571 (601)
T KOG0590|consen 532 DNSF--KTNNYS----------------------DQR----------------NIFEGPNRLLSLLPRETRIIIYRMLQL 571 (601)
T ss_pred ccch--hhhccc----------------------ccc----------------ccccChHHHHHhchhhHHHHHHHHccC
Confidence 2211 000000 000 000000011123445788899999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||.+|.|+.+|++.+||++++
T Consensus 572 ~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 572 DPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ChhheecHHHHhhChHhhhcc
Confidence 999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-27 Score=212.74 Aligned_cols=238 Identities=25% Similarity=0.385 Sum_probs=190.1
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
+|+|+||.|++++.- ..+..+|.|..++... .+.....|..++..+ +.++.++.++..++++...+++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~----~~~~f~v~lhyafqt~~kl~l~ld 77 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFV----HNTPFLVKLHYAFQTDGKLYLILD 77 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhc----cCCCceeeeeeeeccccchhHhhh
Confidence 699999999998642 3467788888764221 112334466666666 357899999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+. |+++...+.... ...+...+.+..+++.+++++|+.|++|+|+|++||++
T Consensus 78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill------------------------- 130 (612)
T KOG0603|consen 78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL------------------------- 130 (612)
T ss_pred hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee-------------------------
Confidence 99 889888877654 56778888999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.++++++.|||.++..-..... +||..|||||++. +....+|+||+|+++|+|++|..||.+ +....|.+
T Consensus 131 --d~~Ghi~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~ 201 (612)
T KOG0603|consen 131 --LLEGHIKLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK 201 (612)
T ss_pred --cccCccccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh
Confidence 55666777888887765554433 8999999999998 678999999999999999999999987 44555555
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
..-..|. ..+..+.+++..++..+|..|..
T Consensus 202 ~~~~~p~-------------------------------------------------~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 202 AELEMPR-------------------------------------------------ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hccCCch-------------------------------------------------hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 4334443 34557888999999999999985
Q ss_pred ----HHHHhcCCCCCCCCc
Q 020235 313 ----AREALRHPFFTRDHL 327 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~~ 327 (329)
+.++++|+||...+.
T Consensus 233 ~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 233 GPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred CcchhHHHhccchheeeeH
Confidence 579999999987653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=185.63 Aligned_cols=195 Identities=21% Similarity=0.302 Sum_probs=119.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhH----HhHHHHHHHHHHHHh---------h-CCCCC-ceeeecc---c
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAK---------H-DKGGN-RCVQIRN---W 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~---------~-~~~~~-~i~~l~~---~ 62 (329)
||.|+++.||.|++..|++.+|+|+........ +...+|......+.. + .-..| -++++.+ +
T Consensus 20 i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~ 99 (288)
T PF14531_consen 20 IGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPF 99 (288)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SE
T ss_pred cccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcc
Confidence 689999999999999999999999876332211 111222211111000 0 00001 0111111 1
Q ss_pred cccC---C-----ceEEEeecCCCCHHHHHHh---CCCC--CCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEe
Q 020235 63 FDYR---N-----HICIVFEKLGSSLYDFLRK---NNYR--SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129 (329)
Q Consensus 63 ~~~~---~-----~~~lv~e~~~~~l~~~l~~---~~~~--~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~ 129 (329)
+... + ..+++|+-+.++|.+++.. .... .+...+-..+..|++..+++||+.|++|+||+|+|+++
T Consensus 100 ~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll- 178 (288)
T PF14531_consen 100 FERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL- 178 (288)
T ss_dssp EEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-
T ss_pred eecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE-
Confidence 1111 1 3478899999999888763 1111 12233345567899999999999999999999999999
Q ss_pred eccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC--------CCCCccc
Q 020235 130 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL--------GWTYPCD 201 (329)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~D 201 (329)
+.++.+.|.||+.....+........+..|.+||..... .++.+.|
T Consensus 179 --------------------------~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D 232 (288)
T PF14531_consen 179 --------------------------DQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATD 232 (288)
T ss_dssp ---------------------------TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred --------------------------cCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence 556678888887765544433223345679999988543 3788999
Q ss_pred hHhHHHHHHHHHhCCCCCCCC
Q 020235 202 IWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 202 iwslG~~l~~l~~g~~p~~~~ 222 (329)
.|+||+++|.|+++..||...
T Consensus 233 aW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 233 AWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp HHHHHHHHHHHHHSS-STCCC
T ss_pred HHHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-22 Score=179.82 Aligned_cols=250 Identities=31% Similarity=0.487 Sum_probs=186.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|+|+.||++.+. ..+|+|.+..... ......+|..++..+.+ +++++.+.+.+......+++++++
T Consensus 8 l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 8 LGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNH----PPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccC----CcceeeEEEEEecCCEEEEEEecC
Confidence 689999999999887 6789998874332 24556677777777732 227999999997777789999999
Q ss_pred -CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
++++.+++..... ..++...+..++.|++.++.++|+.+++|||+||+||++.
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~------------------------- 135 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD------------------------- 135 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec-------------------------
Confidence 8899877765431 1588999999999999999999999999999999999994
Q ss_pred CCCCC-CeEEeeCCCCcccCCC---------CCcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 155 MPKSS-AIKVIDFGSTTYERPD---------QNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 155 ~~~~~-~~~l~Dfg~~~~~~~~---------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
... .++++|||.+...... .....||..|+|||.+.+ ..+....|+||+|++++++++|..||..
T Consensus 136 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~ 213 (384)
T COG0515 136 --RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213 (384)
T ss_pred --CCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 333 5889999987644332 245679999999999988 5788999999999999999999999876
Q ss_pred Cch----hHHHHHHHHHhCC-CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHH
Q 020235 222 HEN----LEHLAMMERVLGP-LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296 (329)
Q Consensus 222 ~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
... ......+.....+ ....... .. .......+.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~--------------------------~~~~~~~~~ 252 (384)
T COG0515 214 EKNSSATSQTLKIILELPTPSLASPLSP---------------SN--------------------------PELISKAAS 252 (384)
T ss_pred CCccccHHHHHHHHHhcCCcccccccCc---------------cc--------------------------cchhhHHHH
Confidence 553 1222222221111 0000000 00 011235688
Q ss_pred HHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 297 HLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 297 ~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
+++..|+..+|..|.+..+...++|....
T Consensus 253 ~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 253 DLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 99999999999999999988887665543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-24 Score=204.13 Aligned_cols=228 Identities=26% Similarity=0.393 Sum_probs=157.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
+..|+||.||+++++.|.+.||.|+-+ +..... + ++... +.++++ |+-
T Consensus 91 isngAygavylvrh~~trqrfa~kiNk-q~lilR---n---ilt~a-----~npfvv--------------------gDc 138 (1205)
T KOG0606|consen 91 ISNGAYGAVYLVRHKETRQRFAMKINK-QNLILR---N---ILTFA-----GNPFVV--------------------GDC 138 (1205)
T ss_pred eccCCCCceeeeeccccccchhhcccc-cchhhh---c---ccccc-----CCccee--------------------chh
Confidence 357999999999999999999996533 211000 0 11111 223322 443
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
...+...+ .++. +++.+++|||+-||+|||+||+|.+|..-|.++++|||+++-...+-.. . ...+.
T Consensus 139 ~tllk~~g--~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at-n--l~eg~ 205 (1205)
T KOG0606|consen 139 ATLLKNIG--PLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT-N--LKEGH 205 (1205)
T ss_pred hhhcccCC--CCcc--------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc-h--hhhcc
Confidence 44444433 2222 2278899999999999999999999988888888888776443222110 0 00000
Q ss_pred eEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCCh
Q 020235 161 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (329)
+.- .++ +-.....+||+.|.|||++..++|+..+|+|++|+++|+++.|..||.+..+++.+..+.......|+
T Consensus 206 I~k----~t~--Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 206 IEK----DTH--EFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hHH----HHH--HhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 000 011 11123458999999999999999999999999999999999999999998888877766665444443
Q ss_pred hHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC---CHHHHh
Q 020235 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---TAREAL 317 (329)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---t~~~ll 317 (329)
. .+....+++++|.++|+.+|..|. .+-++.
T Consensus 280 ~----------------------------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk 313 (1205)
T KOG0606|consen 280 E----------------------------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVK 313 (1205)
T ss_pred c----------------------------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhh
Confidence 2 123566899999999999999997 577888
Q ss_pred cCCCCCCC
Q 020235 318 RHPFFTRD 325 (329)
Q Consensus 318 ~hp~f~~~ 325 (329)
+|+||+.=
T Consensus 314 ~h~ff~~L 321 (1205)
T KOG0606|consen 314 QHGFFQLL 321 (1205)
T ss_pred hccceeec
Confidence 99999853
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=204.68 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=168.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||++.|=.|.+|.+++ | .|+||++-+.. .....+.+++.-.+.. ...+||++.+..+..+++..|+|=+|...
T Consensus 31 LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~---l~~~pn~lPfqk~~~t~kAAylvRqyvkh 105 (1431)
T KOG1240|consen 31 LGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIKFA---LMKAPNCLPFQKVLVTDKAAYLVRQYVKH 105 (1431)
T ss_pred cCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHHHH---hhcCCcccchHHHHHhhHHHHHHHHHHhh
Confidence 7999999999998775 4 38999875432 1122222222222211 12558999999998889999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|+|.+.... -+..-+.++|+.|++.||..+|..||+|||||.+|||+.+=..+.++||..-+-...+.+ +
T Consensus 106 nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD-----N-- 176 (1431)
T KOG1240|consen 106 NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED-----N-- 176 (1431)
T ss_pred hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC-----C--
Confidence 9999998764 478888999999999999999999999999999999998888877777753322111111 0
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC----------C-CCCccchHhHHHHHHHHHh-CCCCCCCCchhH
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL----------G-WTYPCDIWSVGCILVELCT-GEALFQTHENLE 226 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (329)
. +||+.-.-.. ..-..|.|||.+... + .+++=||||+||+++||++ |++||.-
T Consensus 177 P----adf~fFFDTS------rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----- 241 (1431)
T KOG1240|consen 177 P----ADFTFFFDTS------RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----- 241 (1431)
T ss_pred c----ccceEEEecC------CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----
Confidence 0 2333221111 112369999988641 2 5677899999999999987 7898841
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
-++...... ..+..+.....++ +..++++|..|++.|
T Consensus 242 --SQL~aYr~~--------------------------~~~~~e~~Le~Ie---------------d~~~Rnlil~Mi~rd 278 (1431)
T KOG1240|consen 242 --SQLLAYRSG--------------------------NADDPEQLLEKIE---------------DVSLRNLILSMIQRD 278 (1431)
T ss_pred --HHHHhHhcc--------------------------CccCHHHHHHhCc---------------CccHHHHHHHHHccC
Confidence 111111100 0111111111121 235788999999999
Q ss_pred CCCCCCHHHHhcC
Q 020235 307 PTDRLTAREALRH 319 (329)
Q Consensus 307 P~~R~t~~~ll~h 319 (329)
|++|++|++.|+-
T Consensus 279 Ps~RlSAedyL~~ 291 (1431)
T KOG1240|consen 279 PSKRLSAEDYLQK 291 (1431)
T ss_pred chhccCHHHHHHh
Confidence 9999999999863
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=184.55 Aligned_cols=158 Identities=22% Similarity=0.217 Sum_probs=115.5
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccc------hhhHHhHHHHHHHHHHHHhhCCCCCcee-eeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCV-QIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~-~l~~~~~~~~~~~lv 72 (329)
||+|+||+||+|+++. +++.+|||++... ........+|+.++..+. |++++ .++.. +..++|
T Consensus 26 IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-----h~~iv~~l~~~----~~~~LV 96 (365)
T PRK09188 26 LKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-----GIGVVPQLLAT----GKDGLV 96 (365)
T ss_pred EeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-----CCCCCcEEEEc----CCcEEE
Confidence 6999999999999876 6778899986522 123455778999999994 45555 44432 457999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCC-CCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~di-kp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||+ |++|.. +.. .. ...++.+++.+|.|||++||+|||| ||+|||+
T Consensus 97 mE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---------------------- 145 (365)
T PRK09188 97 RGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---------------------- 145 (365)
T ss_pred EEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE----------------------
Confidence 9999 888862 211 11 1457889999999999999999999 9999999
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC-----------CcccccCCCCchhHHhcCC------CCCccchH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ-----------NYIVSTRHYRAPEVILGLG------WTYPCDIW 203 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~------~~~~~Diw 203 (329)
+.+..++|+|||+++...... ....+++.|+|||.+.... .+..+|-|
T Consensus 146 -----~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 146 -----GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred -----cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 344568999999987554433 2235677899999886432 33446665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=159.22 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=100.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh---------------------------HHhHHHHHHHHHHHHhhCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------------------REAAMIEIEVLQQLAKHDKGG 53 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~~~~~ 53 (329)
||+|++|.||+|.+. +|+.||+|+++..... ......|...+..+.+.....
T Consensus 5 ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~ 83 (190)
T cd05147 5 ISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPC 83 (190)
T ss_pred cccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
Confidence 799999999999987 8999999998743210 112234888899986543233
Q ss_pred CceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcccCCCCCcEEEeec
Q 020235 54 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 54 ~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~l-H~~~i~H~dikp~NIl~~~~ 131 (329)
|.+.. . ...++||||+ |+++....... ..++...+..++.|++.+|.++ |+.||+||||||+|||++
T Consensus 84 p~~~~------~-~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-- 152 (190)
T cd05147 84 PEPIL------L-KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-- 152 (190)
T ss_pred CcEEE------e-cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE--
Confidence 43321 1 1238999999 55554433222 3689999999999999999999 799999999999999993
Q ss_pred cccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccC
Q 020235 132 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 173 (329)
+..++|+|||.+...+
T Consensus 153 --------------------------~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 --------------------------DGKLYIIDVSQSVEHD 168 (190)
T ss_pred --------------------------CCcEEEEEccccccCC
Confidence 2459999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-21 Score=157.08 Aligned_cols=138 Identities=17% Similarity=0.164 Sum_probs=109.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC---c-eEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---H-ICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~---~-~~lv~e~ 75 (329)
||+|+||.||. +..++.. +||++... ........+|+.++..+.+....|+||++++++++++. . ..+|+||
T Consensus 10 LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 10 LGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred ecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 79999999995 7777766 69987743 22456788999999999776778899999999999873 4 3478999
Q ss_pred C---CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 76 L---GSSLYDFLRKNNYRSFPIDLVREIARQLLECI-AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 76 ~---~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L-~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+ +++|.+++.+. .+++. ..++.+++.++ +|||+++|+||||||+|||++..+
T Consensus 87 ~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~------------------- 142 (210)
T PRK10345 87 DGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRIS------------------- 142 (210)
T ss_pred CCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccC-------------------
Confidence 5 58999999763 35655 35678888777 999999999999999999996543
Q ss_pred cccCCCCCCeEEeeCCCC
Q 020235 152 FKRMPKSSAIKVIDFGST 169 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~ 169 (329)
..+..++|+|++.+
T Consensus 143 ----~~~~~~~LiDg~G~ 156 (210)
T PRK10345 143 ----ESEVIPVVCDNIGE 156 (210)
T ss_pred ----CCCCcEEEEECCCC
Confidence 34567999995443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.7e-21 Score=153.37 Aligned_cols=177 Identities=18% Similarity=0.176 Sum_probs=131.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHH-----hHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE-----AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
|++|+||+|+++.. .+.+++.+.+........ .+.+|+.++.++.+ +++++.++++ +..+++|+|
T Consensus 10 l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~----~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 10 LKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDG----LPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCC----CCCCCEEEEE----cCEEEEEee
Confidence 68999999998855 677888887775544333 46789999999943 3566666664 346999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCC-CCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL-KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~di-kp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+ |.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||+
T Consensus 80 I~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv------------------------- 125 (218)
T PRK12274 80 LAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV------------------------- 125 (218)
T ss_pred ecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE-------------------------
Confidence 9 8787644321 1 1346789999999999999999999 7999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCCCc----------------ccccCCCCchhHHhcC-CCC-CccchHhHHHHHHHHHhC
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQNY----------------IVSTRHYRAPEVILGL-GWT-YPCDIWSVGCILVELCTG 215 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~~~----------------~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~~l~~l~~g 215 (329)
..++.++|+|||.+....+.... ...++.+++|+...-. ..+ ...++++.|+-+|.++|+
T Consensus 126 --~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~ 203 (218)
T PRK12274 126 --QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTR 203 (218)
T ss_pred --cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhc
Confidence 44566999999999865544310 1246778888765543 344 667999999999999999
Q ss_pred CCCCCCCc
Q 020235 216 EALFQTHE 223 (329)
Q Consensus 216 ~~p~~~~~ 223 (329)
..|.-+.+
T Consensus 204 ~~~~~~~~ 211 (218)
T PRK12274 204 RVLHWEDN 211 (218)
T ss_pred cCCccccC
Confidence 98875543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-20 Score=154.16 Aligned_cols=135 Identities=17% Similarity=0.122 Sum_probs=99.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh---------------------------HHhHHHHHHHHHHHHhhCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---------------------------REAAMIEIEVLQQLAKHDKGG 53 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~~~~~~~ 53 (329)
||+|++|.||+|.+. +|+.||+|+++..... ......|...+..+.+..-..
T Consensus 5 ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (190)
T cd05145 5 ISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPV 83 (190)
T ss_pred eecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 799999999999987 8999999998753110 112246778888886533222
Q ss_pred CceeeeccccccCCceEEEeecC-CCCHH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEee
Q 020235 54 NRCVQIRNWFDYRNHICIVFEKL-GSSLY-DFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVS 130 (329)
Q Consensus 54 ~~i~~l~~~~~~~~~~~lv~e~~-~~~l~-~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~ 130 (329)
|. .+.. ...++||||+ |+++. ..+.. ..++...+..++.|++.+|.++|+ .||+|+||||+||+++
T Consensus 84 p~---~~~~----~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 84 PE---PILL----KKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred ce---EEEe----cCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 22 2221 1248999999 55333 33433 257888999999999999999999 9999999999999993
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~ 174 (329)
+..++|+|||.+.....
T Consensus 153 ---------------------------~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 ---------------------------DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ---------------------------CCCEEEEEcccceecCC
Confidence 45699999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.1e-21 Score=161.85 Aligned_cols=188 Identities=21% Similarity=0.309 Sum_probs=142.3
Q ss_pred CCCCceeeecccccc---------------------------CCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHH
Q 020235 51 KGGNRCVQIRNWFDY---------------------------RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 103 (329)
Q Consensus 51 ~~~~~i~~l~~~~~~---------------------------~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~ 103 (329)
..||||+.+...|.+ +..+|+||..+..+|..++.... .+.....-++.|
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHH
Confidence 578999999988853 23589999999999999998765 677788889999
Q ss_pred HHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC---------
Q 020235 104 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP--------- 174 (329)
Q Consensus 104 l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~--------- 174 (329)
+++|+.|||++||.|||+|.+|||+.-+. +.-..++++|||.+--...
T Consensus 350 lLEav~hL~~hgvAhRDlKSDNiL~Eldd-----------------------D~~P~LVvaDFGCcLAd~~hGlqlpy~S 406 (598)
T KOG4158|consen 350 LLEAVTHLHKHGVAHRDLKSDNILLELDD-----------------------DEIPQLVVADFGCCLADDNHGLQLPYES 406 (598)
T ss_pred HHHHHHHHHHccchhhcccccceEEEecC-----------------------CCCcEEEEcccceeeecccccccccccc
Confidence 99999999999999999999999995432 4456678899997532211
Q ss_pred CCCcccccCCCCchhHHhcCC-----C-CCccchHhHHHHHHHHHhCCCCCCCCchhH--HHHHHHHHhCCCChhHHHhh
Q 020235 175 DQNYIVSTRHYRAPEVILGLG-----W-TYPCDIWSVGCILVELCTGEALFQTHENLE--HLAMMERVLGPLPQHMLKRV 246 (329)
Q Consensus 175 ~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 246 (329)
......|.-..||||+...-+ . -.++|.|+.|.+.||++....||.+...+. ....-
T Consensus 407 ~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq--------------- 471 (598)
T KOG4158|consen 407 DEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ--------------- 471 (598)
T ss_pred ccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh---------------
Confidence 112234667789999987543 2 368999999999999999999998743321 00000
Q ss_pred hhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 247 DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+...+.+++.+...+++++..+|+.||++|+++
T Consensus 472 ----------------------------------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 472 ----------------------------------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred ----------------------------------hhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 111223345567789999999999999999984
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.3e-21 Score=158.41 Aligned_cols=159 Identities=13% Similarity=0.149 Sum_probs=113.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHh----------HHHHHHHHHHHHhhCCCCCceeeecccccc-----
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----------AMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----- 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----- 65 (329)
||.|+||.||++.. ++..+|+|+++......+. ..+|+..+.++.+ ++++....++..
T Consensus 39 l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-----~GI~~~~d~~~~~~~~~ 111 (232)
T PRK10359 39 FRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-----EGLASLNDFYLLAERKT 111 (232)
T ss_pred ecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-----CCCCcceEeeeeccccc
Confidence 68999999999755 4668999998743222221 4578888888855 555555554332
Q ss_pred ---CCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 66 ---RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 66 ---~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
.+..+++|||+ |.+|.++.. +++ ....+++.+|..+|..|++|+|+||+||+++
T Consensus 112 ~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~------------ 169 (232)
T PRK10359 112 LRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS------------ 169 (232)
T ss_pred ccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe------------
Confidence 34689999999 778877631 333 2456899999999999999999999999993
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
.++ ++|+|||.+........ .........++.++|+||||+++..+.
T Consensus 170 ---------------~~g-i~liDfg~~~~~~e~~a---------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 ---------------KNG-LRIIDLSGKRCTAQRKA---------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ---------------CCC-EEEEECCCcccccchhh---------HHHHHHHhHhcccccccceeEeehHHH
Confidence 344 99999998865532221 111344456778999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=179.68 Aligned_cols=189 Identities=24% Similarity=0.365 Sum_probs=147.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||.|+||.||+|.... |+.||+|+=+....+.-. ...+++.+|. ...-+.|..+...+...+..+||++|. -|+
T Consensus 706 ~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfY--I~~q~~~RLk--~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 706 IGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFY--ICLQVMERLK--PQMLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred eccccceEEEEeecCC-CcEEEEEeecCCCceeee--ehHHHHHhhc--hhhhcchHHHHHHHccCCcceeeeecccccc
Confidence 6999999999999887 999999986644333322 2233344443 112255666666666778889999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++... +.+++..+..++.|++..++.||.++|+|+||||+|.|+.+.- .....+.
T Consensus 781 lld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~--------------------~~~~~~~ 838 (974)
T KOG1166|consen 781 LLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREI--------------------CADSDSK 838 (974)
T ss_pred HHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeeccc--------------------CCCCccc
Confidence 99999843 4799999999999999999999999999999999999995421 0112356
Q ss_pred CeEEeeCCCCcccCC--CC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCC
Q 020235 160 AIKVIDFGSTTYERP--DQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~--~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 216 (329)
.++|||||.+.-... +. ....+|..+-++|...+.+.+..+|.|.|+.+++.|+-|+
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 799999999853322 22 3457899999999999999999999999999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.5e-20 Score=149.37 Aligned_cols=233 Identities=16% Similarity=0.169 Sum_probs=166.9
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
.+...|..|++++..++ +++|+++-.+ .....+..|.-.+..+ .||||..+++.+....++.++..|+ -
T Consensus 199 ~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrif-----shpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 199 AESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIF-----SHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred ccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeee-----cCCchhhhhhhccCCCCceEeeeeccc
Confidence 34566889999886544 6778776322 1223344566666666 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++|+..+......-++..++.+.+..++.|+.|||+.. |.--.+....++++.+-
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl----------------------- 328 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL----------------------- 328 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-----------------------
Confidence 99999999876566788899999999999999999865 44446778888885431
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCC---CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWT---YPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.-++..+|-.++... ....-.|.||+||.+...+-+ ..+|+|||++++||+.|+..||..-.+++....+.
T Consensus 329 --tarismad~kfsfqe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia 402 (448)
T KOG0195|consen 329 --TARISMADTKFSFQE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA 402 (448)
T ss_pred --hhheecccceeeeec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh
Confidence 122333333332211 112336789999999887633 57899999999999999999998777665432211
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
- +.....++...+..+..+++-|+..||.+||.
T Consensus 403 l-----------------------------------------------eglrv~ippgis~hm~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 403 L-----------------------------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPK 435 (448)
T ss_pred h-----------------------------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCC
Confidence 0 00111223456778999999999999999999
Q ss_pred HHHHh
Q 020235 313 AREAL 317 (329)
Q Consensus 313 ~~~ll 317 (329)
++.++
T Consensus 436 fdmiv 440 (448)
T KOG0195|consen 436 FDMIV 440 (448)
T ss_pred cceeh
Confidence 87653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=148.74 Aligned_cols=136 Identities=21% Similarity=0.185 Sum_probs=100.9
Q ss_pred CCCccceEEEEEE-ecCCCceEEEEEeccchh-------------------------hHHhHHHHHHHHHHHHhhCCCCC
Q 020235 1 MGEGTFGQVLECW-DRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAKHDKGGN 54 (329)
Q Consensus 1 Lg~G~~g~V~~a~-~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~~~~~~~~ 54 (329)
||+|++|.||+|. +..+|+.||+|+++.... ......+|...+..+.+. ..
T Consensus 36 Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~---~i 112 (237)
T smart00090 36 ISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA---GV 112 (237)
T ss_pred eccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc---CC
Confidence 7999999999998 667899999999874321 012245789999998642 22
Q ss_pred ceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CcccCCCCCcEEEeecc
Q 020235 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHTDLKPENVLLVSSE 132 (329)
Q Consensus 55 ~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~-i~H~dikp~NIl~~~~~ 132 (329)
.++..+.. ...++||||+ |.++....... .......+..++.|++.+|.+||+.| ++|+||||+||+++
T Consensus 113 ~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~--- 183 (237)
T smart00090 113 PVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH--- 183 (237)
T ss_pred CCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE---
Confidence 33344332 2348999999 65665544222 24566677899999999999999999 99999999999993
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccC
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 173 (329)
+..++|+|||.+....
T Consensus 184 -------------------------~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 -------------------------DGKVVIIDVSQSVELD 199 (237)
T ss_pred -------------------------CCCEEEEEChhhhccC
Confidence 3569999999987533
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.8e-20 Score=162.06 Aligned_cols=173 Identities=30% Similarity=0.473 Sum_probs=128.4
Q ss_pred ceEEEeecC-CCCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 68 HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 68 ~~~lv~e~~-~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
++++.|++| ..+|.++|.+. .....+....+.++.|++.|+.| +|.+|+|+||.||++..++
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~------------- 393 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD------------- 393 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-------------
Confidence 689999999 89999999743 33456778889999999999999 9999999999999995444
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC---------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-C
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-G 215 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g 215 (329)
.++|.|||+........ ...+||..||+||.+.++.|+.++||||||++++++++ -
T Consensus 394 --------------q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f 459 (516)
T KOG1033|consen 394 --------------QLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQF 459 (516)
T ss_pred --------------hhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHh
Confidence 46666666654332222 34579999999999999999999999999999999987 2
Q ss_pred CCCCCCCchhHHHHHHHHHh-CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 216 EALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
..++ +.......+. |.+|+..+.+ -+.
T Consensus 460 ~T~~------er~~t~~d~r~g~ip~~~~~d----------------------------------------------~p~ 487 (516)
T KOG1033|consen 460 STQF------ERIATLTDIRDGIIPPEFLQD----------------------------------------------YPE 487 (516)
T ss_pred ccHH------HHHHhhhhhhcCCCChHHhhc----------------------------------------------CcH
Confidence 3322 2222222221 2333222111 123
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcCCCC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~hp~f 322 (329)
-.+|+.+|+...|.+||++.+.-.|+|.
T Consensus 488 e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 488 EYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 4579999999999999988888888875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=155.44 Aligned_cols=195 Identities=18% Similarity=0.236 Sum_probs=147.1
Q ss_pred CCCceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-cccCCCCCcEEEe
Q 020235 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-IHTDLKPENVLLV 129 (329)
Q Consensus 52 ~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i-~H~dikp~NIl~~ 129 (329)
.|.|+.++++.+-++...+.|.+|| .|+|.|.+.... ..++.......+.+++.||.|+|...| +|+.++..|.++
T Consensus 5 ~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv- 82 (484)
T KOG1023|consen 5 DHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV- 82 (484)
T ss_pred chhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee-
Confidence 4678999999999999999999999 999999998844 568888889999999999999997765 999999999999
Q ss_pred eccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC---C----CC
Q 020235 130 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL---G----WT 197 (329)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---~----~~ 197 (329)
+..+.+||+|||+........ ....-...|.|||.+... . .+
T Consensus 83 --------------------------d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~ 136 (484)
T KOG1023|consen 83 --------------------------DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALT 136 (484)
T ss_pred --------------------------eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccccccccc
Confidence 677889999999987764311 111234479999999864 1 46
Q ss_pred CccchHhHHHHHHHHHhCCCCCCCCch----hHHHHHHHH-HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHh
Q 020235 198 YPCDIWSVGCILVELCTGEALFQTHEN----LEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 272 (329)
Q Consensus 198 ~~~DiwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
++.|+||+|++++++++.+.||..... .+....+.+ ...++.+..
T Consensus 137 ~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i------------------------------ 186 (484)
T KOG1023|consen 137 QKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSI------------------------------ 186 (484)
T ss_pred ccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcch------------------------------
Confidence 789999999999999999999976322 122333332 000111111
Q ss_pred hhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 273 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
.. .. ...+.+..++.+||..+|.+||+++++-
T Consensus 187 --------~~----~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 187 --------EL----LN-ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred --------hh----hh-hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 00 00 1223688899999999999999998874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.4e-17 Score=138.24 Aligned_cols=130 Identities=22% Similarity=0.280 Sum_probs=100.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|++|.||++.+ .|..+++|+...... ......+|..++..+.+ ++++....++.+.+..++
T Consensus 4 l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~i~~p~~~~~~~~~~~l 76 (211)
T PRK14879 4 IKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARK-----AGVNVPAVYFVDPENFII 76 (211)
T ss_pred cccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHH-----CCCCCCeEEEEeCCCCEE
Confidence 79999999999977 567799997653211 12345678888888854 333333333445567899
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
+|||+ |++|.+.+.... . ....++.+++.+|.++|+.|++|+|++|.|||+.
T Consensus 77 v~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~--------------------- 129 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS--------------------- 129 (211)
T ss_pred EEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE---------------------
Confidence 99999 889999987532 2 7788999999999999999999999999999993
Q ss_pred ccccCCCCCCeEEeeCCCCcc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
+..++++|||.+..
T Consensus 130 -------~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 -------GGKIYLIDFGLAEF 143 (211)
T ss_pred -------CCCEEEEECCcccC
Confidence 34589999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=8.8e-20 Score=171.22 Aligned_cols=249 Identities=20% Similarity=0.307 Sum_probs=183.9
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+|+.|-.+.+.. +...+|.|.+.... ........|..+-..+ ..|.|++.+++........++++++.
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~----s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKL----SKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccc----cccccccccCCccCCCcccccccCcc
Confidence 6899999999887743 34567777665332 2222333355444444 23789999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
|+++.+.+........+...+..++.|+..++.|+| ..++.|+|+||+|.+++.
T Consensus 104 ~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~------------------------ 159 (601)
T KOG0590|consen 104 DGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE------------------------ 159 (601)
T ss_pred cccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc------------------------
Confidence 889888884333235777888999999999999999 999999999999999944
Q ss_pred CCCCC-CeEEeeCCCCcccCC-CC-----Ccccc-cCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 155 MPKSS-AIKVIDFGSTTYERP-DQ-----NYIVS-TRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 155 ~~~~~-~~~l~Dfg~~~~~~~-~~-----~~~~g-t~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.. .+++.|||.|..... .. ...+| ++.|+|||...+..+ .+..|+||.|+++..+++|..||......
T Consensus 160 ---s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 160 ---SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred ---CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 33 678888888765544 22 23468 999999999998654 58899999999999999999999765443
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.... ..|.+.. .......+...+....+++.+++..
T Consensus 237 ~~~~-----------------------------~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~k~l~~ 272 (601)
T KOG0590|consen 237 DGRY-----------------------------SSWKSNK---------------GRFTQLPWNSISDQAHDLLHKILKE 272 (601)
T ss_pred cccc-----------------------------eeecccc---------------cccccCccccCChhhhhcccccccC
Confidence 2000 0000000 0000111345667788999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~ 324 (329)
+|..|.+.+++-.+||+..
T Consensus 273 ~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 273 NPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred Cchhccccccccccccccc
Confidence 9999999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.9e-17 Score=135.02 Aligned_cols=128 Identities=21% Similarity=0.247 Sum_probs=96.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|++|.||++.. ++..+++|...... .......+|..++..+.+... .++..+. ...+..++
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i---~~p~~~~--~~~~~~~l 74 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGV---NTPVVYD--VDPDNKTI 74 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCC---CCCEEEE--EECCCCEE
Confidence 79999999999974 56789999854211 112445578889988865322 2333333 24556789
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||++ |++|.+.+.... . .++.+++.+|.+||+.|++|+|++|.||+++
T Consensus 75 v~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~--------------------- 124 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR--------------------- 124 (199)
T ss_pred EEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE---------------------
Confidence 99999 899998876532 1 7889999999999999999999999999993
Q ss_pred ccccCCCCCCeEEeeCCCCccc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
+..++++|||.+...
T Consensus 125 -------~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 125 -------DDKLYLIDFGLGKYS 139 (199)
T ss_pred -------CCcEEEEECCCCcCC
Confidence 456899999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=130.55 Aligned_cols=131 Identities=25% Similarity=0.259 Sum_probs=95.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----------------------hHHhHHHHHHHHHHHHhhCCCCCcee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLAKHDKGGNRCV 57 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~~~~~~i~ 57 (329)
||+|+||.||++... +|+.||||+++.... .......|..++..+.+.. ..++
T Consensus 23 i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~---i~v~ 98 (198)
T cd05144 23 IGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG---FPVP 98 (198)
T ss_pred cccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC---CCCC
Confidence 689999999999875 789999998763210 0112456777787775432 1233
Q ss_pred eeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 58 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
..++ ....++||||+ |++|...... .....++.+++.++.++|+.|++|+||||+||++
T Consensus 99 ~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill-------- 158 (198)
T cd05144 99 KPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV-------- 158 (198)
T ss_pred ceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE--------
Confidence 3332 23458999999 7777654321 3456788899999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~ 174 (329)
+.+..++|+|||.+.....
T Consensus 159 -------------------~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 -------------------DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred -------------------cCCCcEEEEECCccccCCC
Confidence 4566799999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.8e-16 Score=126.42 Aligned_cols=134 Identities=23% Similarity=0.263 Sum_probs=91.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh---HHh----------------------HHHHHHHHHHHHhhCCCCCc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY---REA----------------------AMIEIEVLQQLAKHDKGGNR 55 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~---~~~----------------------~~~e~~~l~~l~~~~~~~~~ 55 (329)
||+|+||+||+|.+. +++.||+|+++..... ... ...|...+..+.... ..
T Consensus 5 lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~---~~ 80 (187)
T cd05119 5 IGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG---VP 80 (187)
T ss_pred cccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC---CC
Confidence 799999999999887 7899999988742211 010 124555565654422 12
Q ss_pred eeeeccccccCCceEEEeecC-CCCHH-HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeecc
Q 020235 56 CVQIRNWFDYRNHICIVFEKL-GSSLY-DFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 56 i~~l~~~~~~~~~~~lv~e~~-~~~l~-~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~ 132 (329)
++..+.. ...++||||+ ++.+. ..+.... .. ..+..++.+++.++.++|+ .|++|+||||+||++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---- 148 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---- 148 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE----
Confidence 3333322 2358999999 53321 1222111 11 5678899999999999999 999999999999999
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~ 174 (329)
. +..++|+|||.+.....
T Consensus 149 -----------------------~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 -----------------------D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -----------------------E-CCcEEEEECcccccccC
Confidence 3 45689999999865433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.7e-16 Score=144.89 Aligned_cols=126 Identities=23% Similarity=0.251 Sum_probs=94.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----h-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----K-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||+||++.+... .+++|+.... . .......+|..++..+.+ ++++....+..+....++
T Consensus 341 iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~-----~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 341 IGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR-----AGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred eccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc-----cCCCeeEEEEEeCCCCEE
Confidence 69999999999976543 3444432211 0 112456679999988843 455544444445567789
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||||+ |++|.+++. ....++.+++.+|.+||+.|++|||+||+|||+.
T Consensus 414 v~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~--------------------- 462 (535)
T PRK09605 414 VMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR--------------------- 462 (535)
T ss_pred EEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE---------------------
Confidence 99999 999998885 2467889999999999999999999999999992
Q ss_pred ccccCCCCCCeEEeeCCCCcc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
+..++|+|||.+..
T Consensus 463 -------~~~~~liDFGla~~ 476 (535)
T PRK09605 463 -------DDRLYLIDFGLGKY 476 (535)
T ss_pred -------CCcEEEEeCccccc
Confidence 24589999999875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.1e-15 Score=125.85 Aligned_cols=132 Identities=20% Similarity=0.202 Sum_probs=95.6
Q ss_pred CC-CccceEEEEEEecCCCceEEEEEeccc--------------hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc
Q 020235 1 MG-EGTFGQVLECWDRERKEMVAIKIVRGI--------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 65 (329)
Q Consensus 1 Lg-~G~~g~V~~a~~~~~~~~vaiK~~~~~--------------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~ 65 (329)
|| .||.|+||.+... +..+|||.+... ........+|+.++..+.+... .++..+.....
T Consensus 39 lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi---~vP~pl~~~~~ 113 (239)
T PRK01723 39 VGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGL---PVPRPIAARVV 113 (239)
T ss_pred eecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCC---CCceeEeeeee
Confidence 46 7999999999664 677899987521 1223456779999999966432 23444443222
Q ss_pred -CC---ceEEEeecC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCC
Q 020235 66 -RN---HICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDY 139 (329)
Q Consensus 66 -~~---~~~lv~e~~-~-~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~ 139 (329)
.. ..++|||++ | .+|.+++... .++... +.+++.+|.+||+.||+|+||||+|||+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv----------- 175 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL----------- 175 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE-----------
Confidence 22 236999999 5 5898888653 355543 5689999999999999999999999999
Q ss_pred cCccCCCCCCCccccCCCCCCeEEeeCCCCcc
Q 020235 140 KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
..+..++|+|||.+..
T Consensus 176 ----------------~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 176 ----------------DPDGKFWLIDFDRGEL 191 (239)
T ss_pred ----------------cCCCCEEEEECCCccc
Confidence 3445799999999875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.9e-16 Score=140.13 Aligned_cols=245 Identities=21% Similarity=0.274 Sum_probs=176.5
Q ss_pred CCC--ccceEEEEEEe--cCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGE--GTFGQVLECWD--RERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~--G~~g~V~~a~~--~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
+|+ |.+|.||.+.. ..++..+|+|.-+. ........++|...-+.+ ..|.+.++.+..++..+..++-+
T Consensus 122 ~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i----~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 122 TGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKI----DSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhccccc----CccccccccCcccccCCcceeee
Confidence 577 99999999998 88899999997321 112233344455555444 45678888899999999999999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE----CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~----~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|.|+.++.++..... .-++...++..+.+... ||.++|+.+++|.|+||.||++..+
T Consensus 198 E~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~------------------ 258 (524)
T KOG0601|consen 198 ELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSD------------------ 258 (524)
T ss_pred ccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccc------------------
Confidence 999999999888754 34788889999988888 9999999999999999999999544
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC---C-----cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ---N-----YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~-----~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
...++++|||......... . ...|...|++||++.+ -++...|+++||.++.+-.++..+...
T Consensus 259 --------~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 259 --------WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred --------cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 0445666666655444333 0 1145667999999877 578999999999999988887655433
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.... ....+.+.. .| .++-+.-+.++...+.+
T Consensus 330 g~~~-~W~~~r~~~--ip---------------------------------------------~e~~~~~s~~l~~~~~~ 361 (524)
T KOG0601|consen 330 GKNS-SWSQLRQGY--IP---------------------------------------------LEFCEGGSSSLRSVTSQ 361 (524)
T ss_pred CCCC-Ccccccccc--Cc---------------------------------------------hhhhcCcchhhhhHHHH
Confidence 2110 000000000 11 11122345566668999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
|+..+|-.|++++.+.+|+++.+.
T Consensus 362 ~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 362 MLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hcCcchhhhhHHHHHhccccccch
Confidence 999999999999999999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-16 Score=148.79 Aligned_cols=275 Identities=21% Similarity=0.266 Sum_probs=185.8
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCH
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSL 80 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l 80 (329)
-+|.++.++.+.-..+|..+++|.......-.......+..-..+ .....+|.++.....+......+|+++|+ +++|
T Consensus 813 qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~-~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~ 891 (1205)
T KOG0606|consen 813 QSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNI-LITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDL 891 (1205)
T ss_pred cCCCCcccccCCccccccccchhhhccchhhccccccccCCccCc-cccCCCCceecccCCCCCCCCcchhhHHhccCCc
Confidence 367888888887777776677775543221111101111111111 01123466665555555667899999999 8899
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC-CCCCCcccc-CCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT-PKDSSYFKR-MPKS 158 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~ 158 (329)
...++... ..+...++..+..+..++++||+..+.|+|++|.|+++..++...+++++..... ..+...... ..+.
T Consensus 892 ~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~ 969 (1205)
T KOG0606|consen 892 PSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSS 969 (1205)
T ss_pred hhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccccc
Confidence 99988765 5777788888999999999999999999999999999999999999999833222 111111100 0110
Q ss_pred CCeEEeeCCCCcccC---C----CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 159 SAIKVIDFGSTTYER---P----DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~---~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.+ -+++...... . ......||+-|.+||.+.+...+..+|+|++|+++++.++|.+||........+..+
T Consensus 970 ~~~--~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni 1047 (1205)
T KOG0606|consen 970 GTP--RRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENI 1047 (1205)
T ss_pred Ccc--ccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhcc
Confidence 111 1122111110 0 113357899999999999999999999999999999999999999887665554433
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.... ..|++- ....+..+.+++...+..+|.+|.
T Consensus 1048 ~~~~-----------------------~~~p~g-----------------------~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1048 LNRD-----------------------IPWPEG-----------------------PEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred ccCC-----------------------CCCCCC-----------------------ccccChhhhhhhhhhhccCchhcc
Confidence 3322 223221 124567899999999999999999
Q ss_pred CHH---HHhcCCCCCCCCc
Q 020235 312 TAR---EALRHPFFTRDHL 327 (329)
Q Consensus 312 t~~---~ll~hp~f~~~~~ 327 (329)
++. ++-.||||+.++.
T Consensus 1082 ~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CcccccccccCCccCCCCc
Confidence 887 8889999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.61 E-value=9.6e-15 Score=114.19 Aligned_cols=129 Identities=25% Similarity=0.339 Sum_probs=102.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|.++.||++.... ..+++|....... ......|...+..+.+. ...+++++......+..+++|||+ +..
T Consensus 6 i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~---~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 6 LKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARK---GLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHc---CCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 6899999999998754 6799998875433 45677899999999764 356777778777778899999999 555
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~---~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+..+ +......++.+++.+|..+|.. +++|+|++|+||++.
T Consensus 80 ~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~--------------------------- 123 (155)
T cd05120 80 LDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD--------------------------- 123 (155)
T ss_pred cccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---------------------------
Confidence 5433 4456667889999999999974 799999999999994
Q ss_pred CCCCeEEeeCCCCcc
Q 020235 157 KSSAIKVIDFGSTTY 171 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~ 171 (329)
+...++++|||.+..
T Consensus 124 ~~~~~~l~Df~~~~~ 138 (155)
T cd05120 124 DGKILGIIDWEYAGY 138 (155)
T ss_pred CCcEEEEEecccccC
Confidence 345689999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-16 Score=132.85 Aligned_cols=196 Identities=19% Similarity=0.285 Sum_probs=134.4
Q ss_pred CCCceeeeccccccCC-----ceEEEeecC-CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCC
Q 020235 52 GGNRCVQIRNWFDYRN-----HICIVFEKL-GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDL 121 (329)
Q Consensus 52 ~~~~i~~l~~~~~~~~-----~~~lv~e~~-~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~di 121 (329)
.|.|+++++.++.+.+ .+.++.||+ .|++.++|++ ..+..++...+++++.|+++||.|||+.. |+|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 3467999999987654 589999999 9999999986 33456888999999999999999999875 999999
Q ss_pred CCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc-------CCCCCcccccCCCCchhHHhcC
Q 020235 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE-------RPDQNYIVSTRHYRAPEVILGL 194 (329)
Q Consensus 122 kp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~-------~~~~~~~~gt~~y~aPE~~~~~ 194 (329)
..+-|++..+|.+ ++.--...... ....+...+-++|.|||.=..-
T Consensus 205 Tc~tifiq~ngLI---------------------------kig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~t 257 (458)
T KOG1266|consen 205 TCDTIFIQHNGLI---------------------------KIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTT 257 (458)
T ss_pred chhheeecCCceE---------------------------EecccCccccchhhhhhhHhhhhccccCCccccCCcCccc
Confidence 9999999554433 32111100000 0011223456789999876555
Q ss_pred CCCCccchHhHHHHHHHHHhCCCC-CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhh
Q 020235 195 GWTYPCDIWSVGCILVELCTGEAL-FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 273 (329)
Q Consensus 195 ~~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
..+.++|||++|.+..+|..+..- -.+.........+......+
T Consensus 258 n~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~l----------------------------------- 302 (458)
T KOG1266|consen 258 NTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGL----------------------------------- 302 (458)
T ss_pred ccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeec-----------------------------------
Confidence 677889999999999999887542 22211111111111111000
Q ss_pred hccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
...--++++.+|++-.|..||++++++.||-+-+++
T Consensus 303 -----------------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 303 -----------------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred -----------------cCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 011234578999999999999999999999876654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.2e-13 Score=125.98 Aligned_cols=142 Identities=18% Similarity=0.212 Sum_probs=93.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh-----------------------------------------HHhHHHH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY-----------------------------------------REAAMIE 39 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-----------------------------------------~~~~~~e 39 (329)
||+|++|.||+|+.+ +|+.||||+.+..-.. .-.+.+|
T Consensus 125 lasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 125 LAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred eeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 689999999999865 6899999997632100 0012335
Q ss_pred HHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHhcCCc
Q 020235 40 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE-CIAFMHDLCMI 117 (329)
Q Consensus 40 ~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~-~L~~lH~~~i~ 117 (329)
...+..+.....+++++..-.-+.+..+..++||||+ |.++.++..... ...+. ..++..++. .+..+|..|++
T Consensus 204 a~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~~---~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 204 AANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLDR---KALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCCH---HHHHHHHHHHHHHHHHhCCce
Confidence 5555555544444444322222223345679999999 888888765421 11222 334444444 46789999999
Q ss_pred ccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCC
Q 020235 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174 (329)
Q Consensus 118 H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~ 174 (329)
|+|+||.||++ ..++.++++|||.+....+
T Consensus 280 H~D~hPgNilv---------------------------~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFV---------------------------LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEE---------------------------CCCCcEEEEeCCCeeECCH
Confidence 99999999999 4556799999999876544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.9e-14 Score=130.85 Aligned_cols=143 Identities=18% Similarity=0.270 Sum_probs=89.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----------------------------------hHHh------HHHH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------------------YREA------AMIE 39 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~------~~~e 39 (329)
||+|++|.||+|+.+.+|+.||||+.+..-. .... ..+|
T Consensus 127 lasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~E 206 (537)
T PRK04750 127 LASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMRE 206 (537)
T ss_pred hcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHH
Confidence 6899999999999998899999999873210 0111 1234
Q ss_pred HHHHHHHHhhCCCCC--ceeeeccccccCCceEEEeecC-CCCHHHHH--HhCCC--CCCCHHHHHHHHHHHHHHHHHHH
Q 020235 40 IEVLQQLAKHDKGGN--RCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNY--RSFPIDLVREIARQLLECIAFMH 112 (329)
Q Consensus 40 ~~~l~~l~~~~~~~~--~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l--~~~~~--~~l~~~~~~~~~~~l~~~L~~lH 112 (329)
.....++.....+.+ .|+..+. +.....++||||+ |+.+.++- ...+. ..+.+..+..++.|+ .
T Consensus 207 a~N~~~~~~~f~~~~~v~VP~v~~--d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 207 AANASQLRRNFEDSDMLYVPEVYW--DYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHccCCCCeecceeec--ccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 444444443322222 2233332 2345678999999 88987753 22210 012233333344444 4
Q ss_pred hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC
Q 020235 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175 (329)
Q Consensus 113 ~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 175 (329)
..|++|+|+||.||++..+| ..++.++++|||.+....+.
T Consensus 278 ~~GffHaDpHPGNIlv~~~g-----------------------~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 278 RDGFFHADMHPGNIFVSYDP-----------------------PENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred hCCeeeCCCChHHeEEecCC-----------------------CCCCeEEEEecceEEECCHH
Confidence 69999999999999996544 23457999999998766554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-12 Score=102.41 Aligned_cols=134 Identities=18% Similarity=0.240 Sum_probs=95.4
Q ss_pred CCCccceEEEEEEecC------CCceEEEEEeccc-----------------------hhhHHh----HHHHHHHHHHHH
Q 020235 1 MGEGTFGQVLECWDRE------RKEMVAIKIVRGI-----------------------KKYREA----AMIEIEVLQQLA 47 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~------~~~~vaiK~~~~~-----------------------~~~~~~----~~~e~~~l~~l~ 47 (329)
||+|--+.||.|.... .+..+|||+.+.. ...... +.+|...|.++.
T Consensus 5 i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~rl~ 84 (197)
T cd05146 5 ISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKRMQ 84 (197)
T ss_pred cccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 6889999999997653 3578999998510 011122 237999999998
Q ss_pred hhCCCCCceeeeccccccCCceEEEeecCCCC-H-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCcccCCCCC
Q 020235 48 KHDKGGNRCVQIRNWFDYRNHICIVFEKLGSS-L-YDFLRKNNYRSFPIDLVREIARQLLECIAFM-HDLCMIHTDLKPE 124 (329)
Q Consensus 48 ~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~-l-~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~l-H~~~i~H~dikp~ 124 (329)
...-. ++..+.+ ..-++||||++++ + ...+... .++...+..+..+++.+|..+ |+.|++|+|+++.
T Consensus 85 ~~Gv~---vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~---~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~ 154 (197)
T cd05146 85 KAGIP---CPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA---KLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEY 154 (197)
T ss_pred HcCCC---CCeEEEe----cCCEEEEEEcCCCCccchhhhcc---ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 76544 4444433 4568999999543 2 1223322 355566778889999999988 8999999999999
Q ss_pred cEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc
Q 020235 125 NVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 125 NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
|||+. ++.++|||||.+...
T Consensus 155 NIL~~----------------------------~~~v~iIDF~qav~~ 174 (197)
T cd05146 155 NMLWH----------------------------DGKVWFIDVSQSVEP 174 (197)
T ss_pred HEEEE----------------------------CCcEEEEECCCceeC
Confidence 99993 245899999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.2e-12 Score=103.14 Aligned_cols=125 Identities=17% Similarity=0.134 Sum_probs=88.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
|++|.++.||+++.. +..+++|+............+|..++..+.+.. .+++++.... ...++|||++ |.+
T Consensus 6 l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~----~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 6 LKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAG----IGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred cCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhC----CCCceEEEeC--CCCeEEEEecCCCc
Confidence 578999999999764 678999987644322334567888888886532 2344444432 3358999999 666
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM-----IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i-----~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+.+. . . ....+..+++.+|..||+.++ +|+|++|.||+++
T Consensus 78 l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~------------------------- 122 (170)
T cd05151 78 LLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD------------------------- 122 (170)
T ss_pred cccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-------------------------
Confidence 5432 0 1 113456789999999999885 9999999999993
Q ss_pred CCCCCCeEEeeCCCCcc
Q 020235 155 MPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~ 171 (329)
+..++++||+.+..
T Consensus 123 ---~~~~~liDf~~a~~ 136 (170)
T cd05151 123 ---DGRLWLIDWEYAGM 136 (170)
T ss_pred ---CCeEEEEecccccC
Confidence 34589999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.6e-10 Score=101.77 Aligned_cols=165 Identities=17% Similarity=0.242 Sum_probs=123.2
Q ss_pred eEEEEEEecCCCceEEEEEeccchhh-HHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC--CCC
Q 020235 7 GQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL--GSS 79 (329)
Q Consensus 7 g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~--~~~ 79 (329)
.+.|+|+...+|..|++|++...... ......-++..+++ .|+|++++.++|.+ +..+++|++|+ .++
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-----~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-----CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-----ccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 56799999999999999998422111 11122335667777 56999999999984 34799999998 678
Q ss_pred HHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 80 LYDFLRKNN-------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 80 l~~~l~~~~-------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
|.+...... +...++..+|.++.|+..||.++|+.|+.-+-|.|.+||+
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv------------------ 426 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV------------------ 426 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe------------------
Confidence 887764311 2336788999999999999999999999999999999999
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCC
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 217 (329)
..+.+++|...|.......+.. +| + .--++-|.=.||.+++.|+||..
T Consensus 427 ---------~G~~RIriS~C~i~Dvl~~d~~---------~~--l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 427 ---------TGKMRIRISGCGIMDVLQEDPT---------EP--L---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ---------eCcceEEEecccceeeecCCCC---------cc--h---hHHhhhhHHHHHHHHHHHhhccc
Confidence 4555788877777665554431 11 1 12366799999999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.8e-12 Score=115.23 Aligned_cols=240 Identities=20% Similarity=0.157 Sum_probs=162.7
Q ss_pred CCCccceEEEEEEec-CCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR-ERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||.|.|+.|+.+..+ .++..+++|..... .......+.|+.+...+. .|.+++.....+......++-.|||
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~----~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILG----SHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhh----cccccCCCCCCccccccccCchhhh
Confidence 688999999998766 67788999987632 233445566777777764 3455666666677777788999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++...+.-. ..+.+...+++..|++.++.++|+..++|+|+||+||++.+++
T Consensus 349 ~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~----------------------- 403 (524)
T KOG0601|consen 349 EGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG----------------------- 403 (524)
T ss_pred cCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-----------------------
Confidence 77766555322 2477888899999999999999999999999999999996542
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCC--chhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYR--APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
...++.|||......-......++..+. +|+......+..++|++|||..+.+.+++...-..... ...+.+
T Consensus 404 ---~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~~ 477 (524)
T KOG0601|consen 404 ---FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIRS 477 (524)
T ss_pred ---hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccccc---ceeeec
Confidence 3356666666654222222223344455 44444555788999999999999998887643221111 011111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..-+. .......+..+...|+..++..|+.+
T Consensus 478 ~~~p~-------------------------------------------------~~~~~~~~q~~~kv~~~~~~~~~~l~ 508 (524)
T KOG0601|consen 478 GDTPN-------------------------------------------------LPGLKLQLQVLLKVMINPDRKRRPSA 508 (524)
T ss_pred ccccC-------------------------------------------------CCchHHhhhhhhhhhcCCccccchhh
Confidence 10000 01122456677888999999999999
Q ss_pred HHHhcCCCCCC
Q 020235 314 REALRHPFFTR 324 (329)
Q Consensus 314 ~~ll~hp~f~~ 324 (329)
.++..|+-|.+
T Consensus 509 ~~l~~~~~~~~ 519 (524)
T KOG0601|consen 509 VELSLHSEFYR 519 (524)
T ss_pred hhhcccchhhh
Confidence 99988876643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.3e-10 Score=87.68 Aligned_cols=140 Identities=24% Similarity=0.201 Sum_probs=100.8
Q ss_pred CCccceEEEEEEecCCCceEEEEEecc---------chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
-+|+-+.|+++.+ .|+...||.-.. .+..+.+...|...+.++.......|. ++ +.+...-.|+
T Consensus 16 kQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~---l~--~~D~~~~~i~ 88 (229)
T KOG3087|consen 16 KQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPR---LI--FIDTYGGQIY 88 (229)
T ss_pred eccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCce---EE--EEecCCCeEE
Confidence 4688899999854 577778885321 223456667799999888765433333 22 3344556789
Q ss_pred eecCCC--CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~~~--~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||..| ++.+++................+..+-..+.-||..+|+|+||..+||++.+.+
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~------------------ 150 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG------------------ 150 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC------------------
Confidence 999955 899999876543333344467788888889999999999999999999997653
Q ss_pred ccccCCCCCCeEEeeCCCCccc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
....+.++|||++...
T Consensus 151 ------~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 151 ------NQITPILIDFGLSSVS 166 (229)
T ss_pred ------CcCceEEEeecchhcc
Confidence 4455799999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=6.2e-10 Score=87.08 Aligned_cols=127 Identities=20% Similarity=0.215 Sum_probs=92.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc---------chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG---------IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
+++|+-+.++.+.+. |..+++|.--. ..-...+..+|..++..+.... -+++.++++ +.+...|
T Consensus 4 i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~G---V~~P~v~dv--D~~~~~I 76 (204)
T COG3642 4 IKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAG---VPVPIVYDV--DPDNGLI 76 (204)
T ss_pred hhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcC---CCCCeEEEE--cCCCCEE
Confidence 468999999999653 44577775321 1223456677999999887643 344555544 4566789
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
+|||. |..|.+.+... . ..++..+-.-+.-||..||+|+|+.++||++..
T Consensus 77 ~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~-------------------- 127 (204)
T COG3642 77 VMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSG-------------------- 127 (204)
T ss_pred EEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeC--------------------
Confidence 99999 77777788764 1 345566666678899999999999999999943
Q ss_pred ccccCCCCCCeEEeeCCCCcc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
..+.+||||++..
T Consensus 128 --------~~i~~IDfGLg~~ 140 (204)
T COG3642 128 --------GRIYFIDFGLGEF 140 (204)
T ss_pred --------CcEEEEECCcccc
Confidence 3399999999875
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.3e-10 Score=93.82 Aligned_cols=105 Identities=17% Similarity=0.141 Sum_probs=68.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC---CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~---~~~~lv~e~ 75 (329)
||.|..+.||++.... |..+++|....... .......|..++..+.... ..+++++.+.... +..++|||+
T Consensus 6 l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~---~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 6 LSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTG---VPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred cCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCC---CCCCCEEEECCCCCccCCceEEEEE
Confidence 6889999999998754 57899998764332 3456778999998886632 2344455544432 367899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH 112 (329)
+ |.++.+.+.. ..++..+...++.+++.+|..||
T Consensus 82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALH 116 (223)
T ss_pred eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence 9 6666554321 12455555556666666666665
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.2e-09 Score=90.52 Aligned_cols=141 Identities=18% Similarity=0.063 Sum_probs=96.2
Q ss_pred EEEEEecCCCceEEEEEeccchh------------hHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEee
Q 020235 9 VLECWDRERKEMVAIKIVRGIKK------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFE 74 (329)
Q Consensus 9 V~~a~~~~~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e 74 (329)
|.++. ..|+.+.||....... ....+.+|...+..+....-..|..+.+...-.. ....+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44543 3567899997653221 1114678999998887766555554444321111 235789999
Q ss_pred cCCC--CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 75 KLGS--SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 75 ~~~~--~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
++++ +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.+..
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~------------------- 176 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFP------------------- 176 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEecccc-------------------
Confidence 9943 7988886432234566777889999999999999999999999999999963100
Q ss_pred ccCCCCCCeEEeeCCCCcc
Q 020235 153 KRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~ 171 (329)
.......+.+|||+.+..
T Consensus 177 -~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 177 -GREEDLKLSVIDLHRAQI 194 (268)
T ss_pred -CCCCCceEEEEECCcccc
Confidence 002346799999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=5.1e-10 Score=90.00 Aligned_cols=127 Identities=26% Similarity=0.311 Sum_probs=78.8
Q ss_pred EEEEEEecCCCceEEEEEeccc---------------------------hhhHHhHHHHHHHHHHHHhhCCCCCceeeec
Q 020235 8 QVLECWDRERKEMVAIKIVRGI---------------------------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60 (329)
Q Consensus 8 ~V~~a~~~~~~~~vaiK~~~~~---------------------------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~ 60 (329)
.||.|... .|..+|+|+.+.. ........+|...|..+.... -+++..+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~G---v~vP~p~ 76 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAG---VPVPKPY 76 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT----SS--EE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCC---ccCCcEE
Confidence 38888764 4679999998521 011234456888888886543 3455555
Q ss_pred cccccCCceEEEeecCC--CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCcccCCCCCcEEEeeccccccC
Q 020235 61 NWFDYRNHICIVFEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAF-MHDLCMIHTDLKPENVLLVSSEYIKVP 137 (329)
Q Consensus 61 ~~~~~~~~~~lv~e~~~--~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~-lH~~~i~H~dikp~NIl~~~~~~~~~~ 137 (329)
.+. .-++||||++ |.....+.... ++......++.+++..+.. +|..||+|+|+.+.|||+.
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~-------- 141 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD-------- 141 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE--------
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee--------
Confidence 432 3479999996 64444444432 2344566677777775444 6799999999999999994
Q ss_pred CCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccC
Q 020235 138 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 173 (329)
.+ .+.|||||.+....
T Consensus 142 -------------------~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 -------------------DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp -------------------TT-CEEE--GTTEEETT
T ss_pred -------------------cc-eEEEEecCcceecC
Confidence 22 69999999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=100.28 Aligned_cols=165 Identities=17% Similarity=0.252 Sum_probs=119.3
Q ss_pred EEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCHHHHHHhCCC
Q 020235 11 ECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY 89 (329)
Q Consensus 11 ~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~ 89 (329)
.+..+.++.+|.+...+.... ......+-+..++.+ -||+|++++..++.++..|||+|.+. .|...+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-----RHP~Il~yL~t~e~~~~~ylvTErV~-Pl~~~lk~--- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-----RHPNILSYLDTTEEEGTLYLVTERVR-PLETVLKE--- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-----cCchhhhhhhhhcccCceEEEeeccc-cHHHHHHH---
Confidence 356677888888888764332 234455667778888 56999999999999999999999983 23455554
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCC
Q 020235 90 RSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168 (329)
Q Consensus 90 ~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~ 168 (329)
+....+..-+.||+.||.||| ..+++|++|.-..|++ ...+..+|.+|..
T Consensus 101 --l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---------------------------n~~GeWkLggle~ 151 (690)
T KOG1243|consen 101 --LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---------------------------NESGEWKLGGLEL 151 (690)
T ss_pred --hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---------------------------cCCCcEEEeeeEE
Confidence 346677788999999999998 7789999999999999 5556677777776
Q ss_pred CcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC
Q 020235 169 TTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG 215 (329)
Q Consensus 169 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 215 (329)
+....... ....-...|..|+.+.... -..|.|-|||++++++.|
T Consensus 152 v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 152 VSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 54332222 1222223456666433322 346999999999999998
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.5e-11 Score=109.48 Aligned_cols=154 Identities=21% Similarity=0.340 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHH-hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCc-
Q 020235 101 ARQLLECIAFMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 178 (329)
Q Consensus 101 ~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~- 178 (329)
+.+++.||.|+| +.+++|++|.|++|.+.. ++..||+.|+.+....++...
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na---------------------------~~~wkl~Gf~f~v~~~~~~~~p 157 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNA---------------------------NGDWKLAGFSFCVNANGPTEYP 157 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeecc---------------------------CcceeeccchhhhccCCCCccc
Confidence 345568999999 568999999999999954 445566666554433332111
Q ss_pred -----------ccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhh
Q 020235 179 -----------IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRV 246 (329)
Q Consensus 179 -----------~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (329)
......|.|||++.....+.++|++||||.+|.+.. |+.-+.+... ...............
T Consensus 158 ~~~yd~~lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~~~~~~~~~~------ 230 (700)
T KOG2137|consen 158 FSEYDPPLPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSFSRNLLNAGA------ 230 (700)
T ss_pred cccCCCCCChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCC-cchhhhhhccccccc------
Confidence 123446999999999888899999999999999985 4444433222 112222221111110
Q ss_pred hhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 247 DRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
. .+...+..++++-|.+++..++..||++..++..|||.+.-
T Consensus 231 ------------~--------------------------~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 231 ------------F--------------------------GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred ------------c--------------------------cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 0 11134667899999999999999999999999999998754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.7e-08 Score=79.21 Aligned_cols=142 Identities=11% Similarity=0.101 Sum_probs=103.3
Q ss_pred CCccceEEEEEEecCCCceEEEEEecc----c---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEE
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRG----I---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 72 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~----~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv 72 (329)
|.||.+.|+..... |+.+-+|.-.. . ......+.+|...+..+....-..|.++ +.+.-.. .-.-+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56999999998654 34677887541 0 2345677899999999988655444444 2222112 2357999
Q ss_pred eecCC--CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKLG--SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~~--~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
+|-++ .+|.+++....-.+.+......++.+++..+.-||+.|+.|+|+.+.||+++.+
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~------------------- 164 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE------------------- 164 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-------------------
Confidence 99885 689888876543345777778899999999999999999999999999999532
Q ss_pred ccccCCCCCCeEEeeCCCCcc
Q 020235 151 YFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
....+.+|||..++.
T Consensus 165 ------g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 165 ------GKAEAGFLDLEKSRR 179 (216)
T ss_pred ------CCeeEEEEEhhccch
Confidence 123499999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.2e-08 Score=89.23 Aligned_cols=187 Identities=14% Similarity=0.188 Sum_probs=116.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc------cccc-CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN------WFDY-RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~------~~~~-~~~~~lv~ 73 (329)
||+|+-+.+|..-.-.+ . +.|++..-....+. .....+... ..+|-+..-.. +..+ +..+.++|
T Consensus 19 LgqGgea~ly~l~e~~d--~-VAKIYh~Pppa~~a--qk~a~la~~----p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 19 LGQGGEADLYTLGEVRD--Q-VAKIYHAPPPAAQA--QKVAELAAT----PDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred ccCCccceeeecchhhc--h-hheeecCCCchHHH--HHHHHhccC----CCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 79999999998844332 2 45887632221111 111122221 12222211011 1112 22478889
Q ss_pred ecC--CCCHHHHHH----hCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 74 EKL--GSSLYDFLR----KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 74 e~~--~~~l~~~l~----~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+.. ...+.++++ +....-..+..+++....++.+..-||..|.+-+|++++|+|+++++.+.+.|-
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVds-------- 161 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDS-------- 161 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcc--------
Confidence 998 335555554 222334678889999999999999999999999999999999976655444321
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhC-CCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTG-EALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g-~~p~~~ 221 (329)
....|++-|.-. ...+|...|++||.-. +..-+...|.|.||+++|+++.| +.||.+
T Consensus 162 -----------Dsfqi~~ng~~~------~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 162 -----------DSFQINANGTLH------LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred -----------cceeeccCCceE------ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 112222222111 1246788999999876 23456789999999999999875 899976
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.5e-08 Score=89.35 Aligned_cols=144 Identities=17% Similarity=0.238 Sum_probs=92.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----------------------------------h------HHhHHHH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------------------Y------REAAMIE 39 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------------------------------~------~~~~~~e 39 (329)
|++++-|.||+|+.+. |+.||||+.+..-. . .-.+.+|
T Consensus 133 iAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~E 211 (517)
T COG0661 133 IASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRRE 211 (517)
T ss_pred hhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHH
Confidence 5789999999999875 99999999752100 0 0111235
Q ss_pred HHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcc
Q 020235 40 IEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118 (329)
Q Consensus 40 ~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H 118 (329)
...+.++.+...+.+.+..-.=+++..+...++|||+ |..+.++..-.. ...+...+...+.++. +..+=..|++|
T Consensus 212 A~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffH 288 (517)
T COG0661 212 AANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccc
Confidence 5556666665555555433333445567789999999 777777743222 2466544443333322 23333489999
Q ss_pred cCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC
Q 020235 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175 (329)
Q Consensus 119 ~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 175 (329)
.|.+|.||++. .++.+.+.|||......+.
T Consensus 289 aDpHpGNi~v~---------------------------~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 289 ADPHPGNILVR---------------------------SDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred cCCCccceEEe---------------------------cCCcEEEEcCcceecCCHH
Confidence 99999999994 4566777888877665554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.2e-07 Score=78.11 Aligned_cols=115 Identities=25% Similarity=0.286 Sum_probs=85.3
Q ss_pred hHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEeecC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Q 020235 32 YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFEKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECI 108 (329)
Q Consensus 32 ~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~e~~-~-~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L 108 (329)
......+|...+..+....-..|..+.+...-.. ....++|+|.+ + .+|.+++.... ..+......++.+++..+
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLI 131 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHH
Confidence 3456778999888887766555554444322111 13568999999 4 47999988744 266677788999999999
Q ss_pred HHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc
Q 020235 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 109 ~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
.-||..||+|+|+++.|||+..+ .....+.+|||+.+...
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~------------------------~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPD------------------------DGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCC------------------------CCceeEEEEcchhceeC
Confidence 99999999999999999999543 13457999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.2e-06 Score=71.03 Aligned_cols=122 Identities=15% Similarity=0.272 Sum_probs=92.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-----------------hhHHhHHHHHHHHHHHH-hhCCCCCceeeeccc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-----------------KYREAAMIEIEVLQQLA-KHDKGGNRCVQIRNW 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~-~~~~~~~~i~~l~~~ 62 (329)
||+|+.-.||.-- .+. ..+||++.... .......+|+.....+. .......+|++++++
T Consensus 9 i~~G~~R~cy~HP--~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 9 IAQGGERDCYQHP--DDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred cccCCCceEEECC--CCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 6899999999763 333 35789987543 23566778888888887 666677899999999
Q ss_pred cccCCceEEEeecC-------CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecc
Q 020235 63 FDYRNHICIVFEKL-------GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 63 ~~~~~~~~lv~e~~-------~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~ 132 (329)
.+++--..+|+|.. ..+|.+++... .++. .+...+.++ .++|-..+|+.+|++|.||++..++
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~~~Iv~~dl~~~NIv~~~~~ 155 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLDHHIVIRDLNPHNIVVQRRD 155 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHHcCCeecCCCcccEEEEecC
Confidence 99999999999987 23788888654 3665 444444444 4567789999999999999997654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-06 Score=72.18 Aligned_cols=129 Identities=28% Similarity=0.346 Sum_probs=87.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-----------------------hhhHHhHHHHHHHHHHHHhhCCCCCcee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-----------------------KKYREAAMIEIEVLQQLAKHDKGGNRCV 57 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~~e~~~l~~l~~~~~~~~~i~ 57 (329)
||-|--|.||.|.+. .|.++|+|.=+.. ...+..+.+|.++|.++.... -.++
T Consensus 99 IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G---~~VP 174 (304)
T COG0478 99 IGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG---VKVP 174 (304)
T ss_pred cccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC---CCCC
Confidence 688999999999876 5789999974310 112345678999999996542 2344
Q ss_pred eeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 58 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
.-+++ +.-.+|||+. |..|... +++...+..++..++.-+.-.-..|++|+|+.+=||++
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~-------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV-------- 235 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRL-------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILV-------- 235 (304)
T ss_pred Ccccc----ccceeeeehcccceeecc-------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEE--------
Confidence 44433 4567899999 5444322 12233444445555554554558999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcc
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
..++.+++|||-.+..
T Consensus 236 -------------------~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 -------------------TEDGDIVVIDWPQAVP 251 (304)
T ss_pred -------------------ecCCCEEEEeCccccc
Confidence 4566799999987754
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.4e-06 Score=71.88 Aligned_cols=134 Identities=17% Similarity=0.172 Sum_probs=91.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------------------------hHHhHHHHHHHHHHHHhhCCCCCc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAKHDKGGNR 55 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~~~~~~~~~ 55 (329)
|++|--+.||+|.. .++..+|+|+++.... ......+|..-|.++...+ -.
T Consensus 56 istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG---Vr 131 (268)
T COG1718 56 ISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG---VR 131 (268)
T ss_pred ecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC---CC
Confidence 56788899999975 4578999999862110 1123345777788876643 33
Q ss_pred eeeeccccccCCceEEEeecCCCC--HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeecc
Q 020235 56 CVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSE 132 (329)
Q Consensus 56 i~~l~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~ 132 (329)
+++-+.+. .-.||||++|.. -...|+.- .+....+..+..+++..+.-|-. .++||+||..=|||+.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~--- 201 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH--- 201 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE---
Confidence 44444443 347999999544 22222221 23333677788888888887776 8999999999999993
Q ss_pred ccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccC
Q 020235 133 YIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 173 (329)
.+.+.|||+|.|....
T Consensus 202 -------------------------~~~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -------------------------DGEPYIIDVSQAVTID 217 (268)
T ss_pred -------------------------CCeEEEEECccccccC
Confidence 4569999999987544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=70.93 Aligned_cols=105 Identities=17% Similarity=0.219 Sum_probs=62.0
Q ss_pred cCCCceEEEEEeccchhhH----------HhHHHHHHHHHHHHhhCCCC---CceeeeccccccCCceEEEeecC-CCCH
Q 020235 15 RERKEMVAIKIVRGIKKYR----------EAAMIEIEVLQQLAKHDKGG---NRCVQIRNWFDYRNHICIVFEKL-GSSL 80 (329)
Q Consensus 15 ~~~~~~vaiK~~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~---~~i~~l~~~~~~~~~~~lv~e~~-~~~l 80 (329)
...|+.+++|..+...... ....+.+..+..+....-.. +.++.....+......+++|||+ |..|
T Consensus 51 ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l 130 (229)
T PF06176_consen 51 EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVEL 130 (229)
T ss_pred EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeec
Confidence 4456778888766322111 11223344344443322111 12333333333445678999999 7777
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEe
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~ 129 (329)
.+... +++ .+...+..++.-+|+.|++|+|.+|.|+++.
T Consensus 131 ~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 131 NDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS 169 (229)
T ss_pred ccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE
Confidence 66532 332 2335577789999999999999999999994
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.3e-08 Score=93.46 Aligned_cols=236 Identities=17% Similarity=0.106 Sum_probs=155.8
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCc-eeeeccccccCCceEEEeecC-CC-
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRNWFDYRNHICIVFEKL-GS- 78 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~-i~~l~~~~~~~~~~~lv~e~~-~~- 78 (329)
+.|+++.+++.+...+...+ .+.+... .....++++|.++ ++|+ .+..++-++.+...++.++++ ++
T Consensus 251 vK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~-----n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 251 VKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKV-----NNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHc-----cCCCCcccccccCCcccccchhhhhhcCCc
Confidence 56788888988877665544 7776643 3334577788888 5566 666677777788999999999 44
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+...-..... ..+...+...+...-..+|+++|+.-=+|+| ||+.. +
T Consensus 321 s~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s----------------------------~ 367 (829)
T KOG0576|consen 321 SSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS----------------------------E 367 (829)
T ss_pred cccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----ccccc----------------------------c
Confidence 2222111110 1244445566677778889999988778888 88763 3
Q ss_pred CCeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
...+..||+........ .+...+|+.++|||+.....+....|.|++|+-..++.-|-+|-.+.-.. . ...|
T Consensus 368 ~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~----~~~g 441 (829)
T KOG0576|consen 368 EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV--L----PMIG 441 (829)
T ss_pred cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc--c----CCCC
Confidence 45677888877666655 45678999999999999999999999999998777777777665431000 0 0000
Q ss_pred CCC-hhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHH-HHHHHhcccCCCCCCCHH
Q 020235 237 PLP-QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT-HLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 237 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ll~~~l~~dP~~R~t~~ 314 (329)
.-| ..+ .+.+.. .+..+. ++...|+...|..|++..
T Consensus 442 ~~p~s~~-----------------------L~~~~a-------------------w~~~~~~~~~~~~~~g~P~~pkv~m 479 (829)
T KOG0576|consen 442 NGPNSPM-----------------------LTDKSA-------------------WSPVFHRDFPAPCLNGLPPTPKVHM 479 (829)
T ss_pred CCCCccc-----------------------cchhhh-------------------cCcccccCCcccccCCCCCCCcchh
Confidence 000 000 000000 000111 467789999999999999
Q ss_pred HHhcCCCCCCCCcC
Q 020235 315 EALRHPFFTRDHLR 328 (329)
Q Consensus 315 ~ll~hp~f~~~~~~ 328 (329)
.++-|.+|++=.+|
T Consensus 480 gacfsKvfngCpl~ 493 (829)
T KOG0576|consen 480 GACFSKVFNGCPLR 493 (829)
T ss_pred hHHHHHHhccCccc
Confidence 99999999886664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.1e-06 Score=69.37 Aligned_cols=70 Identities=13% Similarity=0.179 Sum_probs=49.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|..+.||+. .+..+++|.... ........+|..++..+....- .+++.+.+.+..+...+||+++ |.
T Consensus 9 i~~G~t~~~y~~----~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~gl---pvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 9 TGEGGNGESYTH----KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGI---PTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred ecCCCCcceeEe----cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCC---CCCceEEEEecCCeeeeeeeecCCc
Confidence 689999999984 244678898764 2334556889999999865332 2455566666677788999999 54
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.8e-06 Score=70.45 Aligned_cols=79 Identities=22% Similarity=0.235 Sum_probs=52.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
|++|..+.||++.... ..+++|..... ........|..++..+.......|.+.............+++|+++ |..
T Consensus 5 l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~ 81 (239)
T PF01636_consen 5 LSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRP 81 (239)
T ss_dssp EEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEE
T ss_pred CCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecccc
Confidence 4678899999998765 47899987754 4566777899999888765432333332211222334579999999 666
Q ss_pred HHH
Q 020235 80 LYD 82 (329)
Q Consensus 80 l~~ 82 (329)
+..
T Consensus 82 ~~~ 84 (239)
T PF01636_consen 82 LDD 84 (239)
T ss_dssp HHH
T ss_pred ccc
Confidence 666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=4e-06 Score=77.53 Aligned_cols=144 Identities=14% Similarity=0.129 Sum_probs=87.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--------------------------------hhhHHhHH------HHHHH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--------------------------------KKYREAAM------IEIEV 42 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--------------------------------~~~~~~~~------~e~~~ 42 (329)
||.-+.|.|++|+-+. |+.||||+=+.. +...+... +|.+-
T Consensus 169 iaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~N 247 (538)
T KOG1235|consen 169 IAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKN 247 (538)
T ss_pred hhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHh
Confidence 5778899999999887 999999974310 00011111 22222
Q ss_pred HHHHHhhCCC-----CCceeeeccccccCCceEEEeecC-CCCHH--HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 020235 43 LQQLAKHDKG-----GNRCVQIRNWFDYRNHICIVFEKL-GSSLY--DFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114 (329)
Q Consensus 43 l~~l~~~~~~-----~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~--~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~ 114 (329)
..++.+.... --.|++++..+ .....|+|||+ |..+. +.+.+. .++...+...+.+... ..+=..
T Consensus 248 ae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~--~qIf~~ 320 (538)
T KOG1235|consen 248 AERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYL--EQIFKT 320 (538)
T ss_pred HHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHH--HHHHhc
Confidence 2222221111 12255555544 45689999999 65443 444554 3777766655555544 333357
Q ss_pred CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC
Q 020235 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175 (329)
Q Consensus 115 ~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 175 (329)
|++|+|-+|.||++..++ ..+..+.+-|||+.......
T Consensus 321 GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CCccCCCCCCcEEEecCC-----------------------CCCccEEEEcccccccccHH
Confidence 899999999999996543 34677899999997654443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=3.5e-05 Score=60.37 Aligned_cols=127 Identities=24% Similarity=0.261 Sum_probs=84.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||.|.+|.||++.+. |..+|+|+-+ .+..+.....|.+++..+... ..-+.++.+.+ .++.|||. |..
T Consensus 30 L~KG~~s~Vyl~~~~--~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~----~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 30 LAKGTTSVVYLGEWR--GGEVALKVRR-RDSPRRNLEKEAKILEILAGE----GVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhcccccEEEEeecc--CceEEEEEec-CCcchhhHHHHHHHHHHhhhc----CCCceEEEech----hhhhhhhhcCcc
Confidence 689999999999775 4579999765 456677888999999888432 22344444433 23459999 668
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC-C-CcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLK-P-ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dik-p-~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|.+.-... +.. -+..++..---|-..||-|+.|. | .||++ .
T Consensus 99 L~~~~~~~-----~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----------------------------~ 141 (201)
T COG2112 99 LGKLEIGG-----DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----------------------------N 141 (201)
T ss_pred hhhhhhcc-----cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEe----------------------------c
Confidence 77665421 222 23445555444567899999886 3 35555 2
Q ss_pred CCCeEEeeCCCCcccCCC
Q 020235 158 SSAIKVIDFGSTTYERPD 175 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~ 175 (329)
...+.||||..|+....+
T Consensus 142 ~~~~~iIDFd~At~k~~p 159 (201)
T COG2112 142 DRDVYIIDFDSATFKKKP 159 (201)
T ss_pred CCcEEEEEccchhhccCC
Confidence 336999999999854443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.4e-05 Score=64.70 Aligned_cols=72 Identities=15% Similarity=0.067 Sum_probs=49.3
Q ss_pred Cccc-eEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCH
Q 020235 3 EGTF-GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSL 80 (329)
Q Consensus 3 ~G~~-g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l 80 (329)
.|.. +.||++... +..+.+|+..... .....+|..++..+... ..+++++.+....+.-++||+++ |.++
T Consensus 8 ~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~----~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 8 EGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK----LPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred CCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc----CCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444 789999654 3578889876432 33566799999888653 33566666666666789999999 6555
Q ss_pred HH
Q 020235 81 YD 82 (329)
Q Consensus 81 ~~ 82 (329)
..
T Consensus 80 ~~ 81 (244)
T cd05150 80 AA 81 (244)
T ss_pred hH
Confidence 53
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.99 E-value=5.2e-05 Score=74.83 Aligned_cols=199 Identities=24% Similarity=0.295 Sum_probs=118.1
Q ss_pred HHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020235 38 IEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112 (329)
Q Consensus 38 ~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH 112 (329)
.|...+..+ .|+|+..++.+--... ...+..++| ..++.+.+..-. .++...++.+..++..||.++|
T Consensus 231 ~e~~~l~k~-----~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 231 IELESLSKI-----AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHhh-----ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH
Confidence 344455555 3355555544432211 233445666 777777777654 6888999999999999999999
Q ss_pred hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEe--eCCCCcccCCCCCc--ccccCCCCch
Q 020235 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI--DFGSTTYERPDQNY--IVSTRHYRAP 188 (329)
Q Consensus 113 ~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--Dfg~~~~~~~~~~~--~~gt~~y~aP 188 (329)
+.. -.+..+..... -....+....+.+. ||+........... ..-+..+-+|
T Consensus 304 ~~~-------l~~v~L~~s~~-----------------~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~ 359 (1351)
T KOG1035|consen 304 SLS-------LEHVVLSASSS-----------------KESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNAD 359 (1351)
T ss_pred Hhc-------cceeEEecccc-----------------cccccCccceeecchhhhcccccCCCcccchhhcCccccccc
Confidence 883 34444422100 00001223334444 77666554443321 2234456778
Q ss_pred hHHhcCCCCC--ccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCC
Q 020235 189 EVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 266 (329)
Q Consensus 189 E~~~~~~~~~--~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
|......... ..|+|++|.....+..|..+-...... .....
T Consensus 360 e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~------~~~l~------------------------------ 403 (1351)
T KOG1035|consen 360 EDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP------VSLLD------------------------------ 403 (1351)
T ss_pred cccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch------hhhhc------------------------------
Confidence 7777665544 479999999988887765432110000 00000
Q ss_pred chHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 267 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
........+.+.+|+.-++++|+.+.+++.|||.+-.
T Consensus 404 ----------------------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 404 ----------------------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred ----------------------cccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 0011156778899999999999999999999998653
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0001 Score=62.05 Aligned_cols=71 Identities=14% Similarity=0.097 Sum_probs=42.3
Q ss_pred CCCccce-EEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhh-CCCCCceeeeccccccC---CceEEEeec
Q 020235 1 MGEGTFG-QVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDYR---NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g-~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~~i~~l~~~~~~~---~~~~lv~e~ 75 (329)
|+.|+.. .||++. ..+++|..+. ........+|..++..+... .- .++..+...+.. ...+++|++
T Consensus 5 ~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v---~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 5 VDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPL---PVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCC---CCCceeecCCCccCCCcceEEEEe
Confidence 3555555 589872 2467887653 33345678899999888643 22 234444433322 245889999
Q ss_pred C-CCCH
Q 020235 76 L-GSSL 80 (329)
Q Consensus 76 ~-~~~l 80 (329)
+ |.++
T Consensus 76 i~G~~l 81 (235)
T cd05155 76 LEGETA 81 (235)
T ss_pred ecCCCC
Confidence 8 6444
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00026 Score=57.22 Aligned_cols=112 Identities=21% Similarity=0.288 Sum_probs=74.2
Q ss_pred CCCccc-eEEEEEEecCCCceEEEEEecc---c------------h-------hhHHhHHHHHHHHHHHHhhCCCCCcee
Q 020235 1 MGEGTF-GQVLECWDRERKEMVAIKIVRG---I------------K-------KYREAAMIEIEVLQQLAKHDKGGNRCV 57 (329)
Q Consensus 1 Lg~G~~-g~V~~a~~~~~~~~vaiK~~~~---~------------~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~ 57 (329)
||.|.. |.||+++. .|+.+|+|+.+. . . ........|.....++.....++.--+
T Consensus 45 Lg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Av 122 (207)
T PF13095_consen 45 LGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAV 122 (207)
T ss_pred cCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEE
Confidence 789999 99999954 578999999321 0 0 112345578888888877544222237
Q ss_pred eeccccccC------------------CceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Q 020235 58 QIRNWFDYR------------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119 (329)
Q Consensus 58 ~l~~~~~~~------------------~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~ 119 (329)
++++++.-. ....||.|+....- .+... -+.+|.+-+..+|+.||+-+
T Consensus 123 kc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~k~gI~~~ 188 (207)
T PF13095_consen 123 KCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILHKLGIVPR 188 (207)
T ss_pred EeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHHHCCeeec
Confidence 777776211 13567777762221 12222 34567777899999999999
Q ss_pred CCCCCcEEE
Q 020235 120 DLKPENVLL 128 (329)
Q Consensus 120 dikp~NIl~ 128 (329)
|+++.|..=
T Consensus 189 Dv~~~ny~~ 197 (207)
T PF13095_consen 189 DVKPRNYRG 197 (207)
T ss_pred cCccccccC
Confidence 999999973
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.0001 Score=66.97 Aligned_cols=175 Identities=22% Similarity=0.253 Sum_probs=105.2
Q ss_pred hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-CceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Q 020235 31 KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109 (329)
Q Consensus 31 ~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~ 109 (329)
.+....+....+++.+ .|++.....++.+.. ....+|+|+++.++.+.+.... +-.... +
T Consensus 24 ~~s~~ilgr~~~lktl-----~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~---l~~~s~----------~- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSL-----QHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN---LKDESL----------L- 84 (725)
T ss_pred CcHHHHhhhhHHHHhh-----cCccceeeEeeecCccceEEEEehhhccchHHHHHhcc---cchhhh----------c-
Confidence 3455566677778777 447777777776543 4689999999999999998753 111000 0
Q ss_pred HHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchh
Q 020235 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPE 189 (329)
Q Consensus 110 ~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE 189 (329)
+|+ +.+.||+. ++| ..... | |
T Consensus 85 -------~~~-~~~~~~~~----------------------------------~td-~~~t~-------------~--~- 105 (725)
T KOG1093|consen 85 -------AHG-VLHLNIIY----------------------------------ITD-HFLTK-------------Y--P- 105 (725)
T ss_pred -------ccc-cceehhhh----------------------------------ccc-ccccc-------------C--C-
Confidence 232 22233333 122 00000 0 0
Q ss_pred HHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchH
Q 020235 190 VILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 269 (329)
Q Consensus 190 ~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (329)
.+..+++||||+|.++.++..|...+......+....+.+.... +........+.
T Consensus 106 ----~~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~-d~~~~~~a~e~-------------------- 160 (725)
T KOG1093|consen 106 ----SPIGPKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTD-DQELLSTAMEH-------------------- 160 (725)
T ss_pred ----CCCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccC-chhHHHHHHHH--------------------
Confidence 01225999999999999999988877655555555544443321 11111111000
Q ss_pred HHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 270 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
.+.-..+..+.+++.+|+...|..||...++..++-|++
T Consensus 161 ----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 161 ----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred ----------------HHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 001123456888999999999999999999999988764
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00066 Score=61.24 Aligned_cols=72 Identities=24% Similarity=0.233 Sum_probs=49.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc------c--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG------I--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~------~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||.|.++.||++.....++.++||.-.. . .....+...|.+.|..+..... ..+++++.+- ....++|
T Consensus 34 lggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p--~~VPkV~~~D--~~~~~lV 109 (401)
T PRK09550 34 IGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVP--DLVPKVYHYD--EELAVTV 109 (401)
T ss_pred cCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCC--CCCCeEEEEC--CCCCEEE
Confidence 6899999999999865445799997431 1 1234556778888887754322 3567776663 3557899
Q ss_pred eecC
Q 020235 73 FEKL 76 (329)
Q Consensus 73 ~e~~ 76 (329)
||++
T Consensus 110 ME~L 113 (401)
T PRK09550 110 MEDL 113 (401)
T ss_pred EecC
Confidence 9998
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00045 Score=60.53 Aligned_cols=134 Identities=20% Similarity=0.248 Sum_probs=90.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-----------------------c----hhhHHhHHHHHHHHHHHHhhCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-----------------------I----KKYREAAMIEIEVLQQLAKHDKGG 53 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----------------------~----~~~~~~~~~e~~~l~~l~~~~~~~ 53 (329)
|..|--+.||.|... +|..+|||+++. . .-.+..+.+|+.-|.++.......
T Consensus 152 iSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~ 230 (520)
T KOG2270|consen 152 ISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPC 230 (520)
T ss_pred cccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 456778899999754 577899999851 0 011234567888899987765444
Q ss_pred CceeeeccccccCCceEEEeecCCCC--HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcEEEee
Q 020235 54 NRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 54 ~~i~~l~~~~~~~~~~~lv~e~~~~~--l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NIl~~~ 130 (329)
|--+-+. .-.|||+++|.+ ....|... .++...+..+-.+++.-+.-|- .+++||.||.==|+|+
T Consensus 231 PePIlLk-------~hVLVM~FlGrdgw~aPkLKd~---~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-- 298 (520)
T KOG2270|consen 231 PEPILLK-------NHVLVMEFLGRDGWAAPKLKDA---SLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-- 298 (520)
T ss_pred CCceeee-------cceEeeeeccCCCCcCcccccc---cCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE--
Confidence 4333332 236999999533 22333332 4677777777777776665554 6789999999999998
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccC
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~ 173 (329)
-.+.++|||.+.+....
T Consensus 299 --------------------------hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 --------------------------HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred --------------------------ECCEEEEEEccccccCC
Confidence 34669999998876544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00047 Score=68.72 Aligned_cols=75 Identities=15% Similarity=0.079 Sum_probs=48.6
Q ss_pred CCCccceEEEEEEecCCC--ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC---CceEEEe
Q 020235 1 MGEGTFGQVLECWDRERK--EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~--~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~---~~~~lv~ 73 (329)
|+.|.++.+|+......+ ..+++|+..... .......+|..++..+..+ ....+++.+.++.+. +..|+||
T Consensus 46 l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~--~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 46 FGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEH--TDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred eCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhc--CCCCCCcEEEEecCCCcCCCceEEE
Confidence 467888999998765432 467788764322 1234567899999888531 112346666665543 4689999
Q ss_pred ecCC
Q 020235 74 EKLG 77 (329)
Q Consensus 74 e~~~ 77 (329)
|++.
T Consensus 124 E~v~ 127 (822)
T PLN02876 124 EYLE 127 (822)
T ss_pred EecC
Confidence 9993
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00073 Score=56.81 Aligned_cols=72 Identities=15% Similarity=0.305 Sum_probs=43.7
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
|..|-...+|++.... .++.|++|+............+|..++..+..... .++++...+. .+||||+ |.
T Consensus 6 l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl----~P~v~~~~~~----~~l~e~i~G~ 77 (235)
T cd05157 6 FTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL----APKLYATFQN----GLIYEFIPGR 77 (235)
T ss_pred cCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC----CCeEEEEeCC----cEEEEeeCCC
Confidence 4678888999996543 35678899765432222233468888888865432 3344433322 4799998 54
Q ss_pred CH
Q 020235 79 SL 80 (329)
Q Consensus 79 ~l 80 (329)
++
T Consensus 78 ~l 79 (235)
T cd05157 78 TL 79 (235)
T ss_pred cC
Confidence 43
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0023 Score=56.49 Aligned_cols=71 Identities=13% Similarity=0.040 Sum_probs=42.0
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc---ccccCCceEEEeecC
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEKL 76 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~---~~~~~~~~~lv~e~~ 76 (329)
+.|....+|++... +..+++|++. .........|..++..+....-..|.++...+ +....+..++++++.
T Consensus 31 ~~G~~n~~y~v~t~--~g~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 31 AEGIENSNFFLTTT--QGEYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred ccccccceEEEEeC--CCcEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 45666789998643 3368899875 22234455677778777654333343332110 112245678999998
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0033 Score=55.22 Aligned_cols=73 Identities=12% Similarity=0.005 Sum_probs=42.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc---ccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~---~~~~~~~~~lv~e~~ 76 (329)
++.|....+|++... +..+++|+.... ........|..++..+....-..|.++...+ +....+..+++++++
T Consensus 30 ~~~G~~n~~y~v~t~--~~~~vLK~~~~~-~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 30 IAEGVENSNYLLTTD--VGRYILTLYEKR-VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cCCccccceEEEEeC--CCcEEEEEecCC-CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 345666789998643 335778987542 2234556677888887654322233322211 112245678999998
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00098 Score=56.88 Aligned_cols=69 Identities=13% Similarity=0.007 Sum_probs=42.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhH-HhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR-EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
+..|-.+.+|++. .+++.+++|......... .....|..++..+..... .|. ++.... -++|++++ |.
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~---~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APK---PILVNE----HWLLVEWLEGE 73 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCc---eEEEeC----CEEEEEeccCc
Confidence 3568888999996 446678899755322111 134668889988865432 233 333322 36899998 54
Q ss_pred C
Q 020235 79 S 79 (329)
Q Consensus 79 ~ 79 (329)
.
T Consensus 74 ~ 74 (256)
T TIGR02721 74 V 74 (256)
T ss_pred c
Confidence 4
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0015 Score=57.00 Aligned_cols=72 Identities=11% Similarity=0.025 Sum_probs=45.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc------cccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~------~~~~~~~~lv~e 74 (329)
|..|....+|++... +..+++|+... ........|..++..+....-. +++.+.. ....+..++|++
T Consensus 22 i~~G~~n~~y~v~~~--~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~---vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 22 ISAGIENTNYFVTTD--SGRYVLTLFEK--VSAEELPFFLALLDHLAERGLP---VPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred ccCccccceEEEEeC--CCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCC---CCccccCCCCcEeeeeCCceEEEEE
Confidence 345767889998543 34688998764 3345667788888888664322 3333221 123456789999
Q ss_pred cC-CCC
Q 020235 75 KL-GSS 79 (329)
Q Consensus 75 ~~-~~~ 79 (329)
++ |..
T Consensus 95 ~i~G~~ 100 (296)
T cd05153 95 FLAGEH 100 (296)
T ss_pred eCCCCC
Confidence 99 544
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0052 Score=54.48 Aligned_cols=81 Identities=20% Similarity=0.191 Sum_probs=50.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec----c---c-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR----G---I-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~----~---~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
+|.|.-..||++.+...++-|+||.-. . . .....+...|...|.......+ ..+++++.+ +.....+|
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P--~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVP--HLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCc--cccCeEEEE--ccccceeh
Confidence 689999999999976444679999642 1 0 2234555678888876654322 245655543 34455689
Q ss_pred eecC--CCCHHHHHH
Q 020235 73 FEKL--GSSLYDFLR 85 (329)
Q Consensus 73 ~e~~--~~~l~~~l~ 85 (329)
||++ ...+...+-
T Consensus 79 MEdL~~~~ilR~~Li 93 (370)
T TIGR01767 79 MEDLSHHKIARKGLI 93 (370)
T ss_pred HhhCccchHHHHHHH
Confidence 9998 444545554
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0048 Score=53.99 Aligned_cols=71 Identities=13% Similarity=0.085 Sum_probs=43.6
Q ss_pred CCccceEEEEEEecC------CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 2 GEGTFGQVLECWDRE------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 2 g~G~~g~V~~a~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
..|-...+|++.... +++.+++|+.............|..++..+.... . .++++..+.. .+|+++
T Consensus 7 ~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g-~---~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 7 SGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERN-L---GPKLYGIFPN----GRIEEF 78 (302)
T ss_pred cCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCC-C---CCceEEEeCC----Cchhhe
Confidence 456667899997543 2578899987644333345567888888886643 2 2344444432 357888
Q ss_pred C-CCCH
Q 020235 76 L-GSSL 80 (329)
Q Consensus 76 ~-~~~l 80 (329)
+ |..+
T Consensus 79 i~G~~l 84 (302)
T cd05156 79 IPSRTL 84 (302)
T ss_pred eCCCcC
Confidence 7 4433
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0066 Score=54.53 Aligned_cols=80 Identities=24% Similarity=0.298 Sum_probs=51.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec----cc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR----GI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~----~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||.|.-.-||++.+...++-|+||.-. .. .....+...|...|.......+ ..+++++.+ +.....+||
T Consensus 37 igdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 37 IGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred cCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEEE--CcHHhhHHH
Confidence 689999999999885435568899632 11 2335666778888887766432 246666544 344556788
Q ss_pred ecC--CCCHHHHH
Q 020235 74 EKL--GSSLYDFL 84 (329)
Q Consensus 74 e~~--~~~l~~~l 84 (329)
|++ ...|...+
T Consensus 113 EdL~~~~ilR~~L 125 (409)
T PRK12396 113 EDLSDHTILRTAL 125 (409)
T ss_pred HhCcccHHHHHHH
Confidence 887 33444444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.019 Score=50.93 Aligned_cols=67 Identities=13% Similarity=0.195 Sum_probs=38.6
Q ss_pred CCccceEEEEEEecCC---CceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 2 GEGTFGQVLECWDRER---KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
..|-...+|++..... +..|++|+.......--.-..|..++..+....- . ++++.++..+ +|.+|+
T Consensus 23 ~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl-~---P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 23 SGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGF-G---AKLLGVFGNG----MIQSFI 92 (330)
T ss_pred CCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCC-C---CceeEEeCCc----Eeehhh
Confidence 3567778898865432 2378899875432222223468888888865432 1 3344444322 467777
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.017 Score=50.39 Aligned_cols=102 Identities=16% Similarity=0.142 Sum_probs=68.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc---cCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---YRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~---~~~~~~lv~e~~- 76 (329)
||+|..+.||...... + .+++|..+ ..........|...+..+.... ...+++.++.+. ..+..++|||++
T Consensus 22 i~~G~~~~vy~~~~~~-~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~--~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 22 ISEQPYAALWALYDSQ-G-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSG--TVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred cCCccceeEEEEEcCC-C-CEEEEEec-ccccchHHHHHHHHHHHHccCC--CCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 6899999999995432 3 46678744 2223457788999999986532 134566665544 346789999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~ 114 (329)
|.++.+. ..+......+..+++.+|.-||+.
T Consensus 97 G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 97 GVSVEAP-------ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred CEecCCC-------CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 6666541 123444556677888999999974
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0073 Score=48.81 Aligned_cols=83 Identities=27% Similarity=0.283 Sum_probs=59.5
Q ss_pred HHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC-CCHHHH---HHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q 020235 39 EIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG-SSLYDF---LRKNNYRSFPIDLVREIARQLLECIAFMHD- 113 (329)
Q Consensus 39 e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~-~~l~~~---l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~- 113 (329)
|.-++..+. +..+++++++++.. ++|.|+.+ +++... +... ...++....+++.+++..+.+++.
T Consensus 9 E~lll~~l~----~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~ 78 (188)
T PF12260_consen 9 EPLLLQLLQ----GSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHG 78 (188)
T ss_pred HHHHHHHcC----CCCCCCCeeeECCC----EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcC
Confidence 566666663 33488999998843 67899984 444321 1111 136888999999999999999996
Q ss_pred --cCCcccCCCCCcEEEeec
Q 020235 114 --LCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 114 --~~i~H~dikp~NIl~~~~ 131 (329)
..+.-.|++|+|+-+.++
T Consensus 79 ~~~~~~lcDv~~~nfgv~~~ 98 (188)
T PF12260_consen 79 PLGFFYLCDVSPDNFGVNDD 98 (188)
T ss_pred CCCcEEEeecchHHeEEeCC
Confidence 348889999999999543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.11 Score=46.13 Aligned_cols=71 Identities=13% Similarity=0.039 Sum_probs=42.1
Q ss_pred cceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc--ccccCCceEEEeecC
Q 020235 5 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN--WFDYRNHICIVFEKL 76 (329)
Q Consensus 5 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~--~~~~~~~~~lv~e~~ 76 (329)
.-..||++... ++..+++|+.+...........|...+..+....-..+.-+..-+ ....++..+.|+++.
T Consensus 37 ~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 44668988643 356789998764444566677888888888663321111111111 122245678899988
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.061 Score=48.74 Aligned_cols=70 Identities=16% Similarity=0.137 Sum_probs=45.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-----ch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-----IK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||.|.-..||++.+. ++.++||.-.. .. ....+...|...|..+.... ...+++++.+.+ +.-+++
T Consensus 40 iggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 40 VGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred cCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CCCEEE
Confidence 588999999999873 34588997541 11 13445556777776664321 136777777765 446778
Q ss_pred eecC
Q 020235 73 FEKL 76 (329)
Q Consensus 73 ~e~~ 76 (329)
||++
T Consensus 114 ME~L 117 (418)
T PLN02756 114 MRYL 117 (418)
T ss_pred Eeec
Confidence 9999
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.037 Score=48.40 Aligned_cols=62 Identities=11% Similarity=-0.021 Sum_probs=35.8
Q ss_pred EEEEEecCCCceEEEEEecc---chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--ceEEEeecC
Q 020235 9 VLECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HICIVFEKL 76 (329)
Q Consensus 9 V~~a~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--~~~lv~e~~ 76 (329)
+|..... ++.+++. ... .........+|..++..+.... .-++..+..+.++. ..|.||+++
T Consensus 41 t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~---vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 41 TFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVD---VPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCC---CCCcccccccccCCCCCceEEEEEe
Confidence 3555333 6778888 331 1122333345777777775432 23455566666555 789999999
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.041 Score=47.49 Aligned_cols=46 Identities=26% Similarity=0.141 Sum_probs=29.4
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhh
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH 49 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~ 49 (329)
++|--..|+.+. ..+|..+++|.-+. ........+|..++..+..+
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhc
Confidence 344445666663 33467888897653 23345668899999998653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0014 Score=67.18 Aligned_cols=139 Identities=13% Similarity=0.007 Sum_probs=99.8
Q ss_pred Cceeeecccccc--CCceEEEeecC-CCCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCC
Q 020235 54 NRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYR--SFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKP 123 (329)
Q Consensus 54 ~~i~~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~--~l~~~~~~~~~~~l~~~L~~lH~~~-----i~H~dikp 123 (329)
+++......... ...-+..++++ +|.+.+.|-++..+ .+...-+...-.+.+.+..-+|++. -+|+++|+
T Consensus 1289 ~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf 1368 (2724)
T KOG1826|consen 1289 YLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKF 1368 (2724)
T ss_pred eeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhh
Confidence 444444433332 34578899999 99999999764322 2334444444445477777777432 69999999
Q ss_pred CcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCcc
Q 020235 124 ENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPC 200 (329)
Q Consensus 124 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~ 200 (329)
-|.++ ..+..+++.++|+.+..++.. ....+++.|++|+....-.++.++
T Consensus 1369 ~lpmI---------------------------Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rs 1421 (2724)
T KOG1826|consen 1369 TLPMI---------------------------VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRS 1421 (2724)
T ss_pred hccce---------------------------ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHH
Confidence 99999 567778999999988555544 334667788999988887888889
Q ss_pred chHhHHHHHHHHHhCCCCC
Q 020235 201 DIWSVGCILVELCTGEALF 219 (329)
Q Consensus 201 DiwslG~~l~~l~~g~~p~ 219 (329)
|+|..|+-+|...-|..+|
T Consensus 1422 dilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1422 DILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHHHhcccHHH
Confidence 9999999999887777766
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.012 Score=51.17 Aligned_cols=113 Identities=20% Similarity=0.228 Sum_probs=73.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-------------------c----hhhHHhHHHHHHHHHHHHhhCCCCCcee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-------------------I----KKYREAAMIEIEVLQQLAKHDKGGNRCV 57 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-------------------~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~ 57 (329)
||-|--+.||.+.+.. |+..++|+=+. . ...+-.+.+|...++.+..+.-. ++
T Consensus 100 IGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp---VP 175 (465)
T KOG2268|consen 100 IGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP---VP 175 (465)
T ss_pred cccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC---CC
Confidence 5778889999998764 67788885321 0 01133446788888888765433 33
Q ss_pred eeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEe
Q 020235 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129 (329)
Q Consensus 58 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~ 129 (329)
+-++ .+.-++||++. |..|...-.- .+..+ +...+..-+--|..+|++|+|..-=||++.
T Consensus 176 kpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 176 KPID----HNRHCVVMELVDGYPLRQVRHV-----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred Cccc----ccceeeHHHhhcccceeeeeec-----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 3332 34568899998 7676544321 22333 334444445667789999999999999994
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.14 Score=44.94 Aligned_cols=65 Identities=11% Similarity=0.166 Sum_probs=37.3
Q ss_pred eEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecc---ccccCCceEEEeecC
Q 020235 7 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN---WFDYRNHICIVFEKL 76 (329)
Q Consensus 7 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~---~~~~~~~~~lv~e~~ 76 (329)
-.||++... +..+++|++... ......|...+..+....-..|.++...+ +...++..++|++++
T Consensus 10 ~~v~~v~t~--~g~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i 77 (313)
T TIGR02906 10 RNVYKVETD--SGNKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWI 77 (313)
T ss_pred ccEEEEEeC--CCCeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhc
Confidence 358888643 335889987532 23445577777777654333333333211 112355789999999
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.022 Score=50.86 Aligned_cols=70 Identities=14% Similarity=0.075 Sum_probs=40.9
Q ss_pred CCccceEEEEEEecC----CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 2 GEGTFGQVLECWDRE----RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 2 g~G~~g~V~~a~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
-.|-...+|++.... +++.|++|+.......--.-..|..++..+..... .| ++++.+..+ .|.+|+
T Consensus 45 ~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl-~P---~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 45 KGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQ-GP---RLLGRFPNG----RVEEFIH 116 (344)
T ss_pred CCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCC-CC---ceEEEECCc----eEEEeeC
Confidence 357778899986432 24678999876432222223568888888866432 23 334444332 467777
Q ss_pred CCC
Q 020235 77 GSS 79 (329)
Q Consensus 77 ~~~ 79 (329)
+.+
T Consensus 117 g~~ 119 (344)
T PLN02236 117 ART 119 (344)
T ss_pred CCC
Confidence 433
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.031 Score=45.90 Aligned_cols=88 Identities=14% Similarity=0.235 Sum_probs=53.7
Q ss_pred EEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHH
Q 020235 22 AIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVR 98 (329)
Q Consensus 22 aiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~ 98 (329)
.+|+++.... ....+..+..++.+. ..|+++.. ++.-.+.++.|.| .... ...
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Arm-------hGilrL~N--Dn~~~yGvIlE~Cy~~~i-----------~~~---- 144 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARM-------HGILRLKN--DNNYKYGVILERCYKIKI-----------NFS---- 144 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHh-------hheeEeec--CCCceeEEEEeeccCccc-----------chh----
Confidence 4555553222 344556778888887 45777773 2344678999999 3221 011
Q ss_pred HHHHHHHHHHHHHH--hcCCcccCCCCCcEEEeeccc
Q 020235 99 EIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEY 133 (329)
Q Consensus 99 ~~~~~l~~~L~~lH--~~~i~H~dikp~NIl~~~~~~ 133 (329)
.++.-=+.+|.-.| +.+..|+|..|+||+.+..|.
T Consensus 145 N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~ 181 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGY 181 (308)
T ss_pred HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCC
Confidence 11111146678889 456999999999999944443
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.062 Score=48.24 Aligned_cols=60 Identities=25% Similarity=0.359 Sum_probs=41.5
Q ss_pred eEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCcccCCCCCcEEEeec
Q 020235 69 ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF-MHDLCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 69 ~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~-lH~~~i~H~dikp~NIl~~~~ 131 (329)
..++-+|. |.++..++.... .++...+++..-.+.||-- +--.+++|.|++|.||++.-+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 45555666 888888887654 5555556665555555443 335679999999999999654
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.18 Score=51.70 Aligned_cols=77 Identities=17% Similarity=0.104 Sum_probs=43.9
Q ss_pred ccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhh--CCCCCceeeec-cc----ccc-CC--ceEEEe
Q 020235 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH--DKGGNRCVQIR-NW----FDY-RN--HICIVF 73 (329)
Q Consensus 4 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~--~~~~~~i~~l~-~~----~~~-~~--~~~lv~ 73 (329)
|....+|++.. .+|..+++|+.+.. ........|...+..+... ....|.++... +- ... ++ ..+.++
T Consensus 35 s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~vrLl 112 (1013)
T PRK06148 35 GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRLLRLL 112 (1013)
T ss_pred CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEEEEEE
Confidence 34577888864 34667999998753 2334445566777777654 22234433322 11 111 12 567889
Q ss_pred ecC-CCCHHH
Q 020235 74 EKL-GSSLYD 82 (329)
Q Consensus 74 e~~-~~~l~~ 82 (329)
+|. |..+.+
T Consensus 113 ~~l~G~~l~~ 122 (1013)
T PRK06148 113 SWLPGTPLAE 122 (1013)
T ss_pred eccCCCcHHh
Confidence 999 655544
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.25 Score=43.36 Aligned_cols=65 Identities=15% Similarity=0.206 Sum_probs=35.7
Q ss_pred cceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc------cccCCceEEEeecC
Q 020235 5 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHICIVFEKL 76 (329)
Q Consensus 5 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~------~~~~~~~~lv~e~~ 76 (329)
.-+.||++.- . +..+++|.+... .........++..+... +.+.++++... ...++..+++|++.
T Consensus 18 ~~~~v~~v~T-~-~G~~~Lk~~~~~---~~~l~~~~~~~~~L~~~--G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi 88 (309)
T TIGR02904 18 VTGKLFKVYT-D-QGVFALKKLYAD---RNTIESFVSQIQVLSEK--GFSRIVPVYPTKDGSYYLFHGHFLYYLMPWL 88 (309)
T ss_pred ccCcEEEEEe-C-CCCEEEEEeccc---hHhHHHHHHHHHHHHHc--CCCcCCceeecCCCCeeeEECCEEEEEeCCc
Confidence 3568899854 3 346889988733 22333344555555432 33343444221 12345569999998
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.69 Score=40.93 Aligned_cols=74 Identities=19% Similarity=0.128 Sum_probs=45.1
Q ss_pred cceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCc-eeeecc----ccccCCceEEEeecC-CC
Q 020235 5 TFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQIRN----WFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 5 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~-i~~l~~----~~~~~~~~~lv~e~~-~~ 78 (329)
.-..+|++.... |+ +++|+.... ........|+..+..+.......+- ++.+=+ .+..+...+.+++|+ |.
T Consensus 37 ~eN~~f~~~~~~-g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTED-GR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecC-CC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 345688886543 33 489998876 6677888899999988775432221 122211 111223788899999 54
Q ss_pred CHH
Q 020235 79 SLY 81 (329)
Q Consensus 79 ~l~ 81 (329)
.+.
T Consensus 114 ~~~ 116 (331)
T COG2334 114 PLE 116 (331)
T ss_pred CcC
Confidence 444
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.33 Score=44.01 Aligned_cols=70 Identities=16% Similarity=0.147 Sum_probs=37.8
Q ss_pred CCccceEEEEEEecCCC-c-----eEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 2 GEGTFGQVLECWDRERK-E-----MVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~-~-----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
..|-...+|++...... . .|+++........--.-.+|..++..+.... .-+++++.+.. ++|.||
T Consensus 59 ~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~g----lgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 59 NNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNN----FGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred CCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCC----CCCeEEEecCC----EEEEEE
Confidence 45777889999654321 1 2444432211111122245888888885432 33555665543 588888
Q ss_pred C-CCC
Q 020235 76 L-GSS 79 (329)
Q Consensus 76 ~-~~~ 79 (329)
+ |..
T Consensus 131 IeGr~ 135 (383)
T PTZ00384 131 VEGNT 135 (383)
T ss_pred ecccc
Confidence 8 443
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.51 E-value=0.11 Score=46.05 Aligned_cols=105 Identities=13% Similarity=0.248 Sum_probs=68.7
Q ss_pred cCCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 65 YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 65 ~~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
..-..|++|++.|+++.-. . .....++..++.+.+..++-+.+. ..-|||+...||||
T Consensus 297 e~~y~yl~~kdhgt~is~i-k-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI--------------- 355 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-K-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI--------------- 355 (488)
T ss_pred CceEEEEEEecCCceeeee-e-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---------------
Confidence 3457889999988877432 2 245677888888888777766643 58999999999999
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHH
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVG 206 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 206 (329)
+ ++.+.||||..++...++.- +.-..+--|-.+.|.. +.+-+||-+-
T Consensus 356 ------------d-~GnvtLIDfklsRl~~~q~~--isy~rldhp~lF~G~d-d~QFeIYrlM 402 (488)
T COG5072 356 ------------D-EGNVTLIDFKLSRLSYSQGI--ISYNRLDHPDLFNGVD-DYQFEIYRLM 402 (488)
T ss_pred ------------e-cCceEEEEeeeeecccCCce--eeccccCchhhhcCcc-ceeeeHHHHH
Confidence 4 56789999998875444321 1111223444555433 4556666544
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.17 Score=43.47 Aligned_cols=48 Identities=23% Similarity=0.358 Sum_probs=34.0
Q ss_pred HHHHHHHHHHHHHHHhc--CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc
Q 020235 98 REIARQLLECIAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 98 ~~~~~~l~~~L~~lH~~--~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
...+..+-.++.-.+.. -++|+|+.|+|++. ...+.++||||..|...
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---------------------------t~~~~l~LIDWEyAg~~ 184 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL---------------------------TDKGGLFLIDWEYAGLN 184 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEE---------------------------cCCCcEEEEecccCCCc
Confidence 33444555555555544 58999999999999 34467999999887653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.31 E-value=0.091 Score=46.04 Aligned_cols=98 Identities=16% Similarity=0.067 Sum_probs=50.0
Q ss_pred eEEEeecCCCCHH---HHHHhCCCCCCCHHHHHHHHHHHHHHHH---HHH-hcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 69 ICIVFEKLGSSLY---DFLRKNNYRSFPIDLVREIARQLLECIA---FMH-DLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 69 ~~lv~e~~~~~l~---~~l~~~~~~~l~~~~~~~~~~~l~~~L~---~lH-~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
-.+|++++.++.. .......+...-.+-++.++.|++.-.- -|- -...+|.||||+|||+.++.......+|-
T Consensus 246 nIIIfPLA~~Sadkv~~~~~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 325 (434)
T PF05445_consen 246 NIIIFPLARCSADKVTESNAAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGN 325 (434)
T ss_pred cEEEEehhhcchhhcCHHHHHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECC
Confidence 4678888733322 2222222222334456777777765321 122 23489999999999996543211111110
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~ 175 (329)
... .=.+...++|.||..+...+-.
T Consensus 326 ~~~---------vF~Epi~~~LnDFDfSqv~~i~ 350 (434)
T PF05445_consen 326 RNY---------VFKEPIRCCLNDFDFSQVANII 350 (434)
T ss_pred eEE---------EecccceeeecccCHHHhcccc
Confidence 000 0022345688888887654443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=92.90 E-value=0.07 Score=39.59 Aligned_cols=43 Identities=23% Similarity=0.370 Sum_probs=32.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQL 46 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l 46 (329)
||+|+.|.||+|+.+. |+.||||+.+. .-......++.++..+
T Consensus 19 lasASiaQVh~a~l~~-g~~VaVKV~rP--~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 19 LASASIAQVHRARLKD-GEEVAVKVQRP--GIEEQIEADLRILRRL 61 (119)
T ss_pred hhheehhhheeeeecc-cchhhhhhcch--HHHHHHHHHHHHHHHH
Confidence 6899999999998765 89999998773 3344555566666655
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 329 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-84 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-78 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-77 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-77 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-77 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-77 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 9e-64 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-47 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-46 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 3e-46 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-46 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-45 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-45 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-40 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-40 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 3e-39 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-36 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 8e-36 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-27 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-27 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-27 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-26 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-26 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-26 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-26 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-26 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-26 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-26 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-26 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-26 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-26 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-26 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-26 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-26 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-26 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-26 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-26 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-26 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-26 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-26 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-26 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-26 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-26 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-26 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-26 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-26 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-26 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-26 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-26 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-25 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-25 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-25 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-25 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-25 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-24 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-24 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-22 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-22 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-22 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-22 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-22 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-21 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-21 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-21 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-21 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-21 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-21 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-21 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-21 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-21 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-21 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-21 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-21 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-21 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-21 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-21 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-21 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-21 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-21 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-21 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-21 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-21 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-21 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-21 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-21 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-21 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-21 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-21 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-21 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-21 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-21 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-21 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-21 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-21 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-21 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-21 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-21 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-21 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-21 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-21 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-21 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-21 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-21 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-21 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-21 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-21 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-21 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-21 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-21 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-21 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-21 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-21 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-21 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-21 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-21 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-21 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-20 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-20 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-20 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-20 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-20 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-20 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-20 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-20 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-20 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-20 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-20 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-20 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-20 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-20 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-19 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-19 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-19 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-19 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-19 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-18 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-18 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-18 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-18 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-16 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-16 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-16 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-16 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-16 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 9e-16 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 9e-16 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-16 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 9e-16 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 9e-16 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-16 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-15 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-15 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-15 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-15 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-15 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-15 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-15 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-15 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-15 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-15 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 9e-15 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-14 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-14 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-14 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-14 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-14 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-14 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-14 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-14 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-14 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-14 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-14 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-14 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-13 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-13 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-13 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-13 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-13 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-13 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-13 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-12 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-12 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-12 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-12 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-12 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-12 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-12 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-12 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-12 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-12 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-12 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-12 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-12 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-09 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 8e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 5e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-06 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-06 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-06 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-06 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-05 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-05 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 4e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-05 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-05 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-05 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-05 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 9e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-05 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 9e-05 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 9e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-04 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-04 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-04 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 8e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 482 bits (1242), Expect = e-172
Identities = 129/325 (39%), Positives = 190/325 (58%), Gaps = 11/325 (3%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
MG+GTFG+VL C + K+ A+K+VR IKKY +A IE ++L+++ D N V+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
F Y +H+C++FE LG SLY+ + +NNY F I+ ++ ++L+ + ++ + + HTD
Sbjct: 103 GKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTD 162
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LL + K + K KS+ IK+IDFG T++ I+
Sbjct: 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQI--YRTKSTGIKLIDFGCATFKSDYHGSII 220
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
+TR YRAPEVIL LGW D+WS GC+L EL TG LF+THE++EHLAMME ++ P+P+
Sbjct: 221 NTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPK 280
Query: 241 HMLKRVDR-HAEKYVRRG--RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ML + + KYV + +L WPE A+S SIK V K L +I +
Sbjct: 281 NMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL------FCD 334
Query: 298 LLQGLLRYDPTDRLTAREALRHPFF 322
L +L+ DPT R + E L+H F
Sbjct: 335 FLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 476 bits (1227), Expect = e-170
Identities = 148/326 (45%), Positives = 209/326 (64%), Gaps = 15/326 (4%)
Query: 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEG FG+V+EC D + VA+KIV+ + +Y EAA EI+VL+ L D RCVQ
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQ 81
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ WF++ HICIVFE LG S YDF+++N + F +D +R++A Q+ + + F+H + H
Sbjct: 82 MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTH 141
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V S+Y + + K +R + IKV+DFGS TY+ +
Sbjct: 142 TDLKPENILFVQSDYTEAYNPKIKRD--------ERTLINPDIKVVDFGSATYDDEHHST 193
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E G +F TH++ EHLAMMER+LGPL
Sbjct: 194 LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P+HM+++ + KY RLDW E +++ + K P + ++ Q V+H L L
Sbjct: 254 PKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHER--LFDL 308
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
+Q +L YDP R+T REAL+HPFF
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFFDL 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 461 bits (1188), Expect = e-164
Identities = 143/326 (43%), Positives = 207/326 (63%), Gaps = 15/326 (4%)
Query: 1 MGEGTFGQVLECWDRER-KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQ 58
+GEGTFG+V+EC D R K VA+KI+R + KYREAA +EI VL+++ + DK CV
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 86
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +WF++ H+CI FE LG + ++FL++NN++ +P+ VR +A QL + F+H+ + H
Sbjct: 87 MSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTH 146
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
TDLKPEN+L V+SE+ + + S ++ K+++I+V DFGS T++
Sbjct: 147 TDLKPENILFVNSEFETLYNEHKSCE--------EKSVKNTSIRVADFGSATFDHEHHTT 198
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
IV+TRHYR PEVIL LGW PCD+WS+GCIL E G LFQTHEN EHL MME++LGP+
Sbjct: 199 IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
P HM+ R + KY +G L W E ++ +K K P ++ ++H L L
Sbjct: 259 PSHMIHRTRKQ--KYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHV--QLFDL 313
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTR 324
++ +L +DP R+T EAL HPFF
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-138
Identities = 109/335 (32%), Positives = 160/335 (47%), Gaps = 36/335 (10%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQI 59
+G+G+FGQV++ +D + + VA+K+VR K++ A EI +L+ L K DK + +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
F +RNHIC+ FE L +LY+ ++KN ++ F + LVR+ A +L+C+ +H +IH
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLKPEN+LL S IKVIDFGS+ YE
Sbjct: 225 DLKPENILLKQ-------------------------QGRSGIKVIDFGSSCYEHQRVYTY 259
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
+ +R YRAPEVILG + P D+WS+GCIL EL TG L + + LA M +LG
Sbjct: 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319
Query: 240 QHMLKRVDRHAEKYVRRGRLDWPEG----------AASRESIKSVMKLPRLQNLIMQHVD 289
Q +L R +G + R + P +
Sbjct: 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKG 379
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L+ L +DP R+T +ALRHP+ R
Sbjct: 380 CDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 382 bits (983), Expect = e-133
Identities = 109/342 (31%), Positives = 171/342 (50%), Gaps = 43/342 (12%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGG-NRCVQI 59
+G+G+FGQV++ +DR +E VAIKI++ K + A IE+ +L+ + KHD V +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHL 121
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMI 117
+ F +RNH+C+VFE L +LYD LR N+R ++L R+ A+Q+ + F+ +L +I
Sbjct: 122 KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSII 181
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+LL + PK SAIK++DFGS+
Sbjct: 182 HCDLKPENILLCN-------------------------PKRSAIKIVDFGSSCQLGQRIY 216
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+ +R YR+PEV+LG+ + D+WS+GCILVE+ TGE LF ++ + + VLG
Sbjct: 217 QYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-LQNLIMQHVDHSAG--- 293
P H+L + + + + + W + R L N++ G
Sbjct: 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336
Query: 294 -----------DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L+ +L YDP R+ AL+H FF +
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKK 378
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 369 bits (950), Expect = e-128
Identities = 101/344 (29%), Positives = 164/344 (47%), Gaps = 51/344 (14%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGN 54
+G G F V D VA+KIVRG K Y EAA EI++LQ++ D G N
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 55 RCVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
+++ + F+++ H+ +VFE LG +L ++K +R P+ V++I++QLL + +
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 146
Query: 111 MHDLC-MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
MH C +IHTD+KPENVL+ + + IK+ D G+
Sbjct: 147 MHRRCGIIHTDIKPENVLMEIVDSPE---------------------NLIQIKIADLGNA 185
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------ 223
+ + TR YR+PEV+LG W DIWS C++ EL TG+ LF+ E
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245
Query: 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283
+ +H+A + +LG LP ++L+ + RG L S +K L+++
Sbjct: 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN----------ISKLKFWPLEDV 295
Query: 284 IM---QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ + A +++ L +L+ DP R A + HP+
Sbjct: 296 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-107
Identities = 100/361 (27%), Positives = 168/361 (46%), Gaps = 49/361 (13%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---GGNRCV 57
+G G F V WD + K+ VA+K+V+ + Y E A+ EI +L+ + D V
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 58 QIRNWFDYR----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
Q+ + F HIC+VFE LG L ++ K+NY+ P+ V++I +Q+L+ + ++H
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT 164
Query: 114 LC-MIHTDLKPENVLLVSSEY----------------------IKVPDYKSSLHTPKDSS 150
C +IHTD+KPEN+LL +E V ++ +
Sbjct: 165 KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNP 224
Query: 151 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 210
+ + +K+ D G+ + + TR YR+ EV++G G+ P DIWS C+
Sbjct: 225 LEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284
Query: 211 ELCTGEALFQTHENLE------HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEG 264
EL TG+ LF+ H E H+A++ +LG +P+ ++ E + ++G L
Sbjct: 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344
Query: 265 AASRESIKSVMKLPRLQNLIMQHVDHSAGD---LTHLLQGLLRYDPTDRLTAREALRHPF 321
+K L ++++ + S + T L +L P R TA E LRHP+
Sbjct: 345 ----------LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394
Query: 322 F 322
Sbjct: 395 L 395
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 3e-54
Identities = 94/341 (27%), Positives = 152/341 (44%), Gaps = 74/341 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGNRCV 57
GEG++G V +C +R+ ++VAIK + A+ EI +L+QL KH N V
Sbjct: 12 GEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KHP---N-LV 65
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ F + + +VFE ++ L + R P LV+ I Q L+ + F H I
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H D+KPEN +L++ K S IK+ DFG + P
Sbjct: 125 HRDVKPEN-ILIT--------------------------KHSVIKLCDFGFARLLTGPSD 157
Query: 177 NY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
Y V+TR YR+PE+++G Y P D+W++GC+ EL +G L+ +++ L ++
Sbjct: 158 YYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216
Query: 233 RVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-----IMQ 286
+ LG +P+H S S +K+P +++
Sbjct: 217 KTLGDLIPRH-------------------QQVF--STNQYFSGVKIPDPEDMEPLELKFP 255
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
++ + A L L+G L DPT+RLT + L HP+F
Sbjct: 256 NISYPALGL---LKGCLHMDPTERLTCEQLLHHPYFENIRE 293
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-54
Identities = 87/343 (25%), Positives = 141/343 (41%), Gaps = 76/343 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGNR 55
GEG++G V++C +++ +VAIK +KK AM EI++L+QL +H+ N
Sbjct: 34 GEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK---IAMREIKLLKQL-RHE---N- 85
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
V + + +VFE + ++ D L +V++ Q++ I F H
Sbjct: 86 LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHN 144
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
+IH D+KPEN +LVS +S +K+ DFG + T P
Sbjct: 145 IIHRDIKPEN-ILVS--------------------------QSGVVKLCDFGFARTLAAP 177
Query: 175 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ Y V+TR YRAPE+++G Y D+W++GC++ E+ GE LF +++ L
Sbjct: 178 GEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH 236
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-----IM 285
+ LG L + ++LP ++
Sbjct: 237 IMMCLGNLIPR------------------HQELFNKNPVFAG--VRLPEIKEREPLERRY 276
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ DL + L DP R E L H FF D
Sbjct: 277 PKLSEVVIDL---AKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-49
Identities = 85/344 (24%), Positives = 145/344 (42%), Gaps = 85/344 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCV 57
GEGT+G+V + D E VAIK +R ++ E A+ E+ +L++L +H N +
Sbjct: 43 GEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QHR---N-II 96
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++++ + + + ++FE + L ++ KN + +++ QL+ + F H +
Sbjct: 97 ELKSVIHHNHRLHLIFEYAENDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H DLKP+N LL+S ++ +K+ DFG + + P +
Sbjct: 155 HRDLKPQN-LLLSVS---------------------DASETPVLKIGDFGLARAFGIPIR 192
Query: 177 NY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ + T YR PE++LG Y DIWS+ CI E+ LF ++ L +
Sbjct: 193 QFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251
Query: 233 RVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP------------R 279
VLG P WP V LP
Sbjct: 252 EVLGLPDDT-------------------TWPG----------VTALPDWKQSFPKFRGKT 282
Query: 280 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
L+ ++ +D D LL +L DP R++A+ AL HP+F+
Sbjct: 283 LKRVLGALLDDEGLD---LLTAMLEMDPVKRISAKNALEHPYFS 323
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-48
Identities = 86/345 (24%), Positives = 147/345 (42%), Gaps = 81/345 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQI 59
G G+FG V + + E+VAIK V K++ RE ++++++L H N V++
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE-----LQIMRKL-DHC---N-IVRL 112
Query: 60 RNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRS--FPIDLVREIARQLLECIAFM 111
R +F ++ +V + + ++Y R + P+ V+ QL +A++
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H + H D+KP+N+LL D P ++ +K+ DFGS
Sbjct: 173 HSFGICHRDIKPQNLLL-------------------D-------PDTAVLKLCDFGSAKQ 206
Query: 172 ERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228
+ + + +R+YRAPE+I G +T D+WS GC+L EL G+ +F ++ L
Sbjct: 207 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 266
Query: 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-----LQNL 283
+ +VLG + ++ ++ + ++ K P+ +
Sbjct: 267 VEIIKVLGTPTREQIREMNPNYTEF----------------------KFPQIKAHPWTKV 304
Query: 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
A L LL Y PT RLT EA H FF D LR
Sbjct: 305 FRPRTPPEAIAL---CSRLLEYTPTARLTPLEACAHSFF--DELR 344
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-48
Identities = 86/349 (24%), Positives = 141/349 (40%), Gaps = 88/349 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQL--AKHDKGG 53
G G +G V + D VA+K VR G + + E+ +L++L +H
Sbjct: 18 GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP--- 74
Query: 54 N----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
N V + D + +VFE + L +L K P + ++++ RQ L +
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 168
F+H C++H DLKPEN +LV+S +K+ DFG +
Sbjct: 135 FLHANCIVHRDLKPEN-ILVTSG--------------------------GTVKLADFGLA 167
Query: 169 TTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
Y +V T YRAPEV+L + P D+WSVGCI E+ + LF + +
Sbjct: 168 RIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
Query: 227 HLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL----- 280
L + ++G P DWP + LPR
Sbjct: 227 QLGKIFDLIGLPPED-------------------DWPR----------DVSLPRGAFPPR 257
Query: 281 --QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ + ++ ++ S LL +L ++P R++A AL+H + +D
Sbjct: 258 GPRPVQSVVPEMEESGAQ---LLLEMLTFNPHKRISAFRALQHSYLHKD 303
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-48
Identities = 94/347 (27%), Positives = 151/347 (43%), Gaps = 86/347 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQI 59
G G+FG V + E E VAIK V K++ RE +++++ + KH N V +
Sbjct: 49 GNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRIV-KHP---N-VVDL 97
Query: 60 RNWF------DYRNHICIVFEKLGSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFM 111
+ +F + +V E + ++Y R ++ P+ L++ QLL +A++
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYI 157
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H + + H D+KP+N+LL P S +K+IDFGS
Sbjct: 158 HSIGICHRDIKPQNLLL--------------------------DPPSGVLKLIDFGSAKI 191
Query: 172 ERPDQNYI--VSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLE 226
+ + + +R+YRAPE+I G T DIWS GC++ EL G+ LF ++
Sbjct: 192 LIAGEPNVSYICSRYYRAPELIFG--ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR-----LQ 281
L + +VLG + +K ++ + ++ K P+
Sbjct: 250 QLVEIIKVLGTPSREQIKTMNPNYMEH----------------------KFPQIRPHPFS 287
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ A DL + LL Y P+ RLTA EAL HPFF D LR
Sbjct: 288 KVFRPRTPPDAIDL---ISRLLEYTPSARLTAIEALCHPFF--DELR 329
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-48
Identities = 66/344 (19%), Positives = 125/344 (36%), Gaps = 99/344 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G +V + + + K++ AIK V + ++ EI L +L + ++ ++
Sbjct: 37 GSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ--HSDKIIR 92
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ +I +V E L +L+K +S + + +LE + +H ++H
Sbjct: 93 LYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVH 150
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
+DLKP N L+V +K+IDFG +PD
Sbjct: 151 SDLKPANFLIVDGM----------------------------LKLIDFGIANQMQPDTTS 182
Query: 179 IVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGEALFQTH 222
+V T +Y PE I + + D+WS+GCIL + G+ FQ
Sbjct: 183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
N ++ + ++ P +++P+
Sbjct: 243 IN--QISKLHAIIDP------------------NHEIEFPD------------------- 263
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ D +L+ L+ DP R++ E L HP+
Sbjct: 264 ----IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 300
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-47
Identities = 92/335 (27%), Positives = 147/335 (43%), Gaps = 71/335 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCV 57
GEGT+G V + +RE E+VA+K VR + E +A+ EI +L++L KH N V
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KHK---N-IV 64
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ + + +VFE L + N ++V+ QLL+ + F H ++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H DLKP+N LL++ +K+ +FG + + P +
Sbjct: 124 HRDLKPQN-LLINRN--------------------------GELKLANFGLARAFGIPVR 156
Query: 177 NY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 231
Y V T YR P+V+ G Y D+WS GCI EL G LF ++ + L +
Sbjct: 157 CYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215
Query: 232 ERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHV 288
R+LG P + WP K P +L ++ +
Sbjct: 216 FRLLGTPTEE-------------------QWP-SMTKLPDYKPYPMYPATTSLVNVVPKL 255
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+ + DL LQ LL+ +P R++A EAL+HP+F+
Sbjct: 256 NATGRDL---LQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-47
Identities = 90/334 (26%), Positives = 139/334 (41%), Gaps = 71/334 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCV 57
GEGT+G V + + E A+K +R ++K E + EI +L++L KH N V
Sbjct: 11 GEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KHS---N-IV 63
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ + + + +VFE L L L + QLL IA+ HD ++
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H DLKP+N LL++ E +K+ DFG + + P +
Sbjct: 123 HRDLKPQN-LLINRE--------------------------GELKIADFGLARAFGIPVR 155
Query: 177 NY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
Y + T YRAP+V++G Y DIWSVGCI E+ G LF + L +
Sbjct: 156 KYTHEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIF 214
Query: 233 RVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHVD 289
R+LG P + +WP + ++ +D
Sbjct: 215 RILGTPNSK-------------------NWP-NVTELPKYDPNFTVYEPLPWESFLKGLD 254
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
S D LL +L+ DP R+TA++AL H +F
Sbjct: 255 ESGID---LLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 7e-47
Identities = 67/344 (19%), Positives = 126/344 (36%), Gaps = 99/344 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G +V + + E+K++ AIK V + ++ EI L +L + ++ ++
Sbjct: 18 GSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ--HSDKIIR 73
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ +I +V E L +L+K +S + + +LE + +H ++H
Sbjct: 74 LYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVH 131
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
+DLKP N L+V +K+IDFG +PD
Sbjct: 132 SDLKPANFLIVDGM----------------------------LKLIDFGIANQMQPDTTS 163
Query: 179 I-----VSTRHYRAPEVILGLG-----------WTYPCDIWSVGCILVELCTGEALFQTH 222
+ V T +Y PE I + + D+WS+GCIL + G+ FQ
Sbjct: 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
N ++ + ++ P +++P+
Sbjct: 224 IN--QISKLHAIIDP------------------NHEIEFPD------------------- 244
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ D +L+ L+ DP R++ E L HP+
Sbjct: 245 ----IPEKDLQD---VLKCCLKRDPKQRISIPELLAHPYVQIQT 281
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-46
Identities = 89/334 (26%), Positives = 146/334 (43%), Gaps = 70/334 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQLAKHDKGGNRCV 57
GEGT+G V + D + +VA+K +R + E A+ EI +L++L H N V
Sbjct: 30 GEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HHP---N-IV 82
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + +VFE + L L +N ++ QLL +A H ++
Sbjct: 83 SLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRIL 141
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H DLKP+N LL++S+ A+K+ DFG + + P +
Sbjct: 142 HRDLKPQN-LLINSD--------------------------GALKLADFGLARAFGIPVR 174
Query: 177 NY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+Y V T YRAP+V++G Y DIWS+GCI E+ TG+ LF + + L +
Sbjct: 175 SYTHEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233
Query: 233 RVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL--IMQHVD 289
+LG P P+ +WP+ + ++ + I+
Sbjct: 234 SILGTPNPR-------------------EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC 274
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
D LL +L +DP R++AR+A+ HP+F
Sbjct: 275 QEGID---LLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-46
Identities = 91/346 (26%), Positives = 144/346 (41%), Gaps = 88/346 (25%)
Query: 2 GEGTFGQVLECWD-RERKEMVAIKIVRGIKKYRE----AAMIEIEVLQQL--AKHDKGGN 54
GEG +G+V + D + VA+K VR ++ E + + E+ VL+ L +H N
Sbjct: 20 GEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHP---N 75
Query: 55 ----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V + D + +VFE + L +L K P + ++++ QLL + F
Sbjct: 76 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-ST 169
+H ++H DLKP+N +LV+S IK+ DFG +
Sbjct: 136 LHSHRVVHRDLKPQN-ILVTSS--------------------------GQIKLADFGLAR 168
Query: 170 TYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
Y +V T YRAPEV+L + P D+WSVGCI E+ + LF+ +++
Sbjct: 169 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 227
Query: 228 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL------ 280
L + V+G P + DWP + LPR
Sbjct: 228 LGKILDVIGLPGEE-------------------DWPR----------DVALPRQAFHSKS 258
Query: 281 -QNL--IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
Q + + +D D LL L ++P R++A AL HP+F
Sbjct: 259 AQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSHPYFQ 301
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-45
Identities = 90/341 (26%), Positives = 148/341 (43%), Gaps = 75/341 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G GT+ V + ++ VA+K V+ G A+ EI ++++L KH+ N
Sbjct: 14 GNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS---TAIREISLMKEL-KHE---N-I 65
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNY----RSFPIDLVREIARQLLECIAFMH 112
V++ + N + +VFE + + L ++ R ++LV+ QLL+ +AF H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTY 171
+ ++H DLKP+N LL++ K +K+ DFG + +
Sbjct: 126 ENKILHRDLKPQN-LLIN--------------------------KRGQLKLGDFGLARAF 158
Query: 172 ERPDQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEH 227
P + V T YRAP+V++G TY DIWS GCIL E+ TG+ LF + E
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ 217
Query: 228 LAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
L ++ ++G P WP ++ ++L
Sbjct: 218 LKLIFDIMGTPNES-------------------LWP-SVTKLPKYNPNIQQRPPRDLRQV 257
Query: 287 HVDHSAGDLT----HLLQGLLRYDPTDRLTAREALRHPFFT 323
H+ L L GLL+ +P RL+A++AL HP+F
Sbjct: 258 LQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-45
Identities = 77/335 (22%), Positives = 143/335 (42%), Gaps = 60/335 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G + +V E + E V +KI++ +KK + EI++L+ L N + +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP---N-IITLA 97
Query: 61 NWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ +VFE + ++ DF K Y++ +R ++L+ + + H + ++H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMH 153
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
D+KP NV++ D + K +++ID+G + P Q Y
Sbjct: 154 RDVKPHNVMI-------------------DHEHRK-------LRLIDWGLAEFYHPGQEY 187
Query: 179 I--VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG-EALFQTHENLEHLAMMERV 234
V++R+++ PE+++ + Y D+WS+GC+L + E F H+N + L + +V
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 247
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR--LQNLIMQHVDHSA 292
LG Y+ + ++ + + R + + H
Sbjct: 248 LGT-ED---------LYDYIDKYNIELD-----PRFNDILGRHSRKRWERFVHSENQHLV 292
Query: 293 GDLT-HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
L LLRYD RLTAREA+ HP+F
Sbjct: 293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-45
Identities = 68/344 (19%), Positives = 124/344 (36%), Gaps = 99/344 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G +V + + + K++ AIK V + ++ EI L +L +H + ++
Sbjct: 65 GSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD---KIIR 120
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ +I +V E L +L+K +S + + +LE + +H ++H
Sbjct: 121 LYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVH 178
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
+DLKP N L+V +K+IDFG +PD
Sbjct: 179 SDLKPANFLIVDGM----------------------------LKLIDFGIANQMQPDTTS 210
Query: 179 IVS-----TRHYRAPEVILGLGW-----------TYPCDIWSVGCILVELCTGEALFQTH 222
+V +Y PE I + + D+WS+GCIL + G+ FQ
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
N ++ + ++ P +++P
Sbjct: 271 IN--QISKLHAIIDP------------------NHEIEFP-------------------- 290
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
D DL +L+ L+ DP R++ E L HP+
Sbjct: 291 ------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-45
Identities = 87/333 (26%), Positives = 137/333 (41%), Gaps = 68/333 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
GEGT+ V + + +VA+K +R G A+ E+ +L+ L KH N
Sbjct: 11 GEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC---TAIREVSLLKDL-KHA---N-I 62
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V + + + +VFE L L +L + V+ QLL +A+ H +
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
+H DLKP+N LL++ + +K+ DFG + P
Sbjct: 122 LHRDLKPQN-LLIN--------------------------ERGELKLADFGLARAKSIPT 154
Query: 176 QNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ Y V T YR P+++LG Y D+W VGCI E+ TG LF E L +
Sbjct: 155 KTYDNEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI 213
Query: 232 ERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
R+LG P + WP ++ E R + L+ H
Sbjct: 214 FRILGTPTEE-------------------TWPGILSNEEFKTYNYPKYRAEALL-SHAPR 253
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
D LL LL+++ +R++A +A++HPFF
Sbjct: 254 LDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-44
Identities = 82/341 (24%), Positives = 144/341 (42%), Gaps = 82/341 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYRE----AAMIEIEVLQQLAKHDKGGNR 55
GEG F V + D+ ++VAIK ++ + ++ A+ EI++LQ+L H N
Sbjct: 19 GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP---N- 73
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ + + F ++++I +VF+ + + L + K+N ++ L+ + ++H
Sbjct: 74 IIGLLDAFGHKSNISLVFDFMETDLEVII-KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERP 174
++H DLKP N LL+ +K+ DFG + ++ P
Sbjct: 133 ILHRDLKPNN-LLLDEN--------------------------GVLKLADFGLAKSFGSP 165
Query: 175 DQNY--IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
++ Y V TR YRAPE++ G Y D+W+VGCIL EL +L+ L
Sbjct: 166 NRAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224
Query: 231 MERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL------ 283
+ LG P + WP+ + LP
Sbjct: 225 IFETLGTPTEE-------------------QWPD----------MCSLPDYVTFKSFPGI 255
Query: 284 -IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+ + DL L+QGL ++P R+TA +AL+ +F+
Sbjct: 256 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-43
Identities = 58/328 (17%), Positives = 99/328 (30%), Gaps = 88/328 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G++G+V + +E + A+K K R + E+ +++ +H CV+
Sbjct: 66 GHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP----CCVR 121
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ + + E G SL S P V R L +A +H ++H
Sbjct: 122 LEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVH 180
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 177
D+KP N+ L K+ DFG
Sbjct: 181 LDVKPANIFL---------------------------GPRGRCKLGDFGLLVELGTAGAG 213
Query: 178 Y-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
Y APE++ G + D++S+G ++E+ L E + L +
Sbjct: 214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-RQGYLPP 271
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ S E L
Sbjct: 272 EFTAGL------------------------SSE-------------------------LR 282
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTR 324
+L +L DP R TA L P +
Sbjct: 283 SVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-43
Identities = 91/342 (26%), Positives = 145/342 (42%), Gaps = 66/342 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G+GTFG V ++ VAIK V ++ E++++Q L N VQ+++
Sbjct: 32 GQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDL-AVLHHPN-IVQLQS 86
Query: 62 WF-----DYRNHIC--IVFEKLGSSLYDFLRKNNYR--SFPIDLVREIARQLLECIAFMH 112
+F R I +V E + +L+ R R + P L++ QL+ I +H
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH 146
Query: 113 DLCM--IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+ H D+KP NVL+ + +K+ DFGS
Sbjct: 147 LPSVNVCHRDIKPHNVLV-------------------N-------EADGTLKLCDFGSAK 180
Query: 171 YERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
P + + + +R+YRAPE+I G +T DIWSVGCI E+ GE +F+ +
Sbjct: 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ 240
Query: 228 LAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
L + RVLG + +L++++ H + + K N+
Sbjct: 241 LHEIVRVLGCPSREVLRKLNPSHTDVDLYN------------------SKGIPWSNVFSD 282
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
H A + LL LL+Y P +R+ EAL HP+F D L
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF--DELH 322
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 67/335 (20%), Positives = 118/335 (35%), Gaps = 76/335 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---------KG 52
G+G FGQV++ + AIK +R ++ + E+ +L L H
Sbjct: 15 GQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLE 73
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V+ ++ + I E +LYD + N + D + RQ+LE ++++
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYI 132
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVIDFGS 168
H +IH DLKP N+ + S +K+ D F K + +S I +D +
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGD-------------FGLAKNVHRSLDILKLDSQN 179
Query: 169 TTYERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEH 227
+ + T Y A EV+ G G D++S+G I E+ F T +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---FSTGMERVN 236
Query: 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 287
+ K +R +++P + + +I
Sbjct: 237 IL----------------------KKLRSVSIEFPPDFDDNKM-------KVEKKIIRL- 266
Query: 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
L+ +DP R AR L +
Sbjct: 267 --------------LIDHDPNKRPGARTLLNSGWL 287
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-42
Identities = 79/328 (24%), Positives = 128/328 (39%), Gaps = 74/328 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG+F +C ++ + A+KI+ K+ EI L+ H N V++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKIIS--KRMEANTQKEITALKLCEGHP---N-IVKLHE 73
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
F + H +V E L G L++ R + F I R+L+ ++ MHD+ ++H D
Sbjct: 74 VFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-- 178
LKPEN+L + IK+IDFG + PD
Sbjct: 132 LKPENLLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQPLK 167
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
T HY APE++ G+ CD+WS+G IL + +G+ FQ+H+ +
Sbjct: 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD--------RSLTCT 219
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
++K+ +++G + A +V A D
Sbjct: 220 SAVEIMKK--------IKKGDFSFEGEAWK-------------------NVSQEAKD--- 249
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+QGLL DP RL + +
Sbjct: 250 LIQGLLTVDPNKRLKMSGLRYNEWLQDG 277
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-42
Identities = 67/348 (19%), Positives = 127/348 (36%), Gaps = 85/348 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G+ G V+ + VA+K + + + A++EI++L + H ++
Sbjct: 23 LGYGSSGTVVFQ-GSFQGRPVAVKRML--IDFCDIALMEIKLLTESDDH----PNVIRYY 75
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE-----IARQLLECIAFMHDLC 115
+ I E +L D + N + L +E + RQ+ +A +H L
Sbjct: 76 CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK 135
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH DLKP+N+L+ +S + ++ + ++ I + DFG
Sbjct: 136 IIHRDLKPQNILVSTSS--------------RFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 176 QNYIVSTRH-------YRAPEVILGLGW-------TYPCDIWSVGCIL-VELCTGEALFQ 220
Q+ + + +RAPE++ T DI+S+GC+ L G+ F
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF- 240
Query: 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRL 280
+ + I+ + L +
Sbjct: 241 ----------------------------------------GDKYSRESNIIRGIFSLDEM 260
Query: 281 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ L + + A D L+ ++ +DP R TA + LRHP F +
Sbjct: 261 KCLHDRSLIAEATD---LISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 69/328 (21%), Positives = 119/328 (36%), Gaps = 78/328 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G++ C + A+KI I K + EIE+L + +H N + +++
Sbjct: 31 GVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQHP---N-IITLKD 83
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+D ++ +V E + G L D + + + F + + + + ++H ++H D
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-- 178
LKP N+L V +I++ DFG R +
Sbjct: 142 LKPSNILYVDES-----------------------GNPESIRICDFGFAKQLRAENGLLM 178
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
T ++ APEV+ G+ CDIWS+G +L + TG F + ++ R+
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-- 236
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
G+ G + V +A D
Sbjct: 237 ------------------SGKFSLSGGYWN-------------------SVSDTAKD--- 256
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+ +L DP RLTA LRHP+
Sbjct: 257 LVSKMLHVDPHQRLTAALVLRHPWIVHW 284
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-41
Identities = 72/353 (20%), Positives = 130/353 (36%), Gaps = 85/353 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK------IVRGIKKYREAAMIEIEVLQQLAKHD---- 50
+G G G V D + + VAIK RE I+++++L HD
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-----IKIIRRL-DHDNIVK 72
Query: 51 ------KGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 104
G++ N + IV E + + L + L + + R QL
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE---EHARLFMYQL 129
Query: 105 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 164
L + ++H ++H DLKP N+ + + + +K+
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDL--------------------------VLKIG 163
Query: 165 DFG---STTYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEA 217
DFG + ++ + T+ YR+P ++L +T D+W+ GCI E+ TG+
Sbjct: 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPEGAASRESIKS 273
LF LE + ++ + + + + + Y+R +
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ---------- 273
Query: 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ + A D L+ +L + P DRLTA EAL HP+ +
Sbjct: 274 ----------LLPGISREAVD---FLEQILTFSPMDRLTAEEALSHPYMSIYS 313
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 6e-41
Identities = 83/362 (22%), Positives = 149/362 (41%), Gaps = 83/362 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY--RE------------------------- 34
G G+FG V E +D E + A+K V +Y RE
Sbjct: 16 GTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75
Query: 35 ---AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLR--KNNY 89
+ + K++ N + ++ ++ E + +L+ L+ +
Sbjct: 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSG 135
Query: 90 RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149
RS P++L+ QL + F+H L + H D+KP+N+L+
Sbjct: 136 RSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--------------------- 174
Query: 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYI--VSTRHYRAPEVILG-LGWTYPCDIWSVG 206
K + +K+ DFGS P + + + +R YRAPE++LG +T D+WS+G
Sbjct: 175 -----NSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229
Query: 207 CILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 266
C+ EL G+ LF +++ L + +++G + + R++ H
Sbjct: 230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH----------------Y 273
Query: 267 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ ++ + ++ + A D LL+ +LRY+P R+ EA+ HPFF DH
Sbjct: 274 TEVRFPTLKAKD-WRKILPEGTPSLAID---LLEQILRYEPDLRINPYEAMAHPFF--DH 327
Query: 327 LR 328
LR
Sbjct: 328 LR 329
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 58/341 (17%), Positives = 109/341 (31%), Gaps = 66/341 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G+G V ++ ++ AIK+ + + M E EVL++L H V++
Sbjct: 18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK----NIVKL 72
Query: 60 RNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLC 115
+ H ++ E SLY L + N P + R ++ + + +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H ++KP N++ V E S K+ DFG+ D
Sbjct: 133 IVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAARELEDD 169
Query: 176 QNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEALFQTHENL 225
+ + + T Y P++ D+WS+G TG F+ E
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 226 EHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
+M +++ P + V + G +DW S+ ++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ-------- 276
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
LT +L +L D +
Sbjct: 277 --------VLLTPVLANILEADQEKCWGFDQFFAETSDILH 309
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-40
Identities = 62/337 (18%), Positives = 116/337 (34%), Gaps = 86/337 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G G ++ VA+K + + + A E+++L++ +H N ++
Sbjct: 33 GHGAEGTIV-YRGMFDNRDVAVKRI--LPECFSFADREVQLLRESDEHP---N-VIRYFC 85
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
R I E ++L +++ + ++ ++ + +Q +A +H L ++H DL
Sbjct: 86 TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQQTTSGLAHLHSLNIVHRDL 144
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY--- 178
KP N+L+ P K + DFG ++
Sbjct: 145 KPHNILISM---------------PNAHGKIK-------AMISDFGLCKKLAVGRHSFSR 182
Query: 179 ---IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMM 231
+ T + APE++ TY DI+S GC+ + G F
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG----------- 231
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
K + R A + LD +H D
Sbjct: 232 ------------KSLQRQANILLGACSLDCLH--------------------PEKHEDVI 259
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
A + L++ ++ DP R +A+ L+HPFF +
Sbjct: 260 ARE---LIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 84/338 (24%), Positives = 155/338 (45%), Gaps = 30/338 (8%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
+G+G +G V + DR E+VA+K I + +A EI +L +L+ H+ N V
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE---N-IV 72
Query: 58 QIRNWF--DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ N D + +VF+ + + L+ +R N + + QL++ I ++H
Sbjct: 73 NLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQLIKVIKYLHSGG 129
Query: 116 MIHTDLKPENVLLVSSEYIKVPDY-----KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
++H D+KP N+LL + ++KV D+ ++ ++ + T
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 171 YERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
Y V+TR YRAPE++LG +T D+WS+GCIL E+ G+ +F + L
Sbjct: 190 Y--------VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE 241
Query: 230 MMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288
+ V+ ++ + A+ + + +++ I + K L+
Sbjct: 242 RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ A D LL LL+++P R++A +AL+HPF + H
Sbjct: 302 NEEALD---LLDKLLQFNPNKRISANDALKHPFVSIFH 336
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-40
Identities = 55/330 (16%), Positives = 107/330 (32%), Gaps = 71/330 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G FG V +C R + AIK + + A+ E+ L +H + V+
Sbjct: 20 GSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS---H-VVR 75
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC 115
+ + +H+ I E G SL D + +N F ++++ Q+ + ++H +
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 135
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H D+KP N+ + + + + K+ D G T
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLGHVT-RISS 186
Query: 176 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ A EV+ DI+++ +V E L + + +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ---- 242
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
G LP+ +P + +
Sbjct: 243 -GRLPR------------------------------------IP----------QVLSQE 255
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
T LL+ ++ DP R +A ++H
Sbjct: 256 FTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 76/330 (23%), Positives = 135/330 (40%), Gaps = 83/330 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQ 58
G G +G+VL C D+ AIKI+ + + ++ E+ VL+ L H N ++
Sbjct: 46 GSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHP---N-IMK 100
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ ++F+ + + +V E G L+D + F I +Q+L + ++H ++
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+LL S E K + IK++DFG + +
Sbjct: 159 HRDLKPENLLLESKE------------------------KDALIKIVDFGLSAVFENQKK 194
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
+ T +Y APEV+ + CD+WS+G IL L G F + E ++ +V
Sbjct: 195 MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKVE 250
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+G+ + ++V A D
Sbjct: 251 --------------------KGKYTFDSPE-------------------WKNVSEGAKD- 270
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ +L++D R++A++AL HP+
Sbjct: 271 --LIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 79/357 (22%), Positives = 137/357 (38%), Gaps = 97/357 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREA----AMIEIEVLQQLAKHDKGGN--- 54
G+GTFG+V + R+ + VA+K V ++ +E A+ EI++LQ L KH+ N
Sbjct: 26 GQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KHE---NVVN 80
Query: 55 -RCV---QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
+ + + + I +VF+ L L + F + ++ + + LL + +
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLYY 139
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 167
+H ++H D+K NVL + + +K+ DFG
Sbjct: 140 IHRNKILHRDMKAANVL---------------------------ITRDGVLKLADFGLAR 172
Query: 168 --STTYERPDQNY--IVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222
S Y V T YR PE++LG + P D+W GCI+ E+ T + Q +
Sbjct: 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232
Query: 223 ENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP--- 278
LA++ ++ G P+ WP V
Sbjct: 233 TEQHQLALISQLCGSITPE-------------------VWPN----------VDNYELYE 263
Query: 279 ----------RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
++++ + +V L+ LL DP R+ + +AL H FF D
Sbjct: 264 KLELVKGQKRKVKDRLKAYVRDPYA--LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-39
Identities = 81/331 (24%), Positives = 141/331 (42%), Gaps = 84/331 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+V+ C D+ + A+K++ K +E+ + E+++L+QL H N +
Sbjct: 35 GKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHP---N-IM 89
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ +F+ + + +V E G L+D + F I RQ+L I +MH +
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITYMHKNKI 147
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLKPEN+LL S K + I++IDFG +T+ +
Sbjct: 148 VHRDLKPENLLLESKS------------------------KDANIRIIDFGLSTHFEASK 183
Query: 177 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ T +Y APEV+ G + CD+WS G IL L +G F + ++++V
Sbjct: 184 KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKV 239
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
+G+ + + V SA D
Sbjct: 240 E--------------------KGKYTFELPQ-------------------WKKVSESAKD 260
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ +L Y P+ R++AR+AL H +
Sbjct: 261 ---LIRKMLTYVPSMRISARDALDHEWIQTY 288
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 71/336 (21%), Positives = 130/336 (38%), Gaps = 90/336 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ + V+I +
Sbjct: 71 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP---H-IVRIVD 122
Query: 62 WFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ R + IV E L G L+ ++ ++F EI + + E I ++H + +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
H D+KPEN+L S ++ +K+ DFG
Sbjct: 183 AHRDVKPENLLYTSKR------------------------PNAILKLTDFGFAKETTSHN 218
Query: 177 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ T +Y APEV+ + CD+WS+G I+ L G F ++ L
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--------- 269
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ M R +R G+ + W V
Sbjct: 270 --AISPGMKTR--------IRMGQYEFPNPEWS------------------------EVS 295
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ LL+ +PT R+T E + HP+ +
Sbjct: 296 EEVKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 328
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-39
Identities = 69/346 (19%), Positives = 120/346 (34%), Gaps = 87/346 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
GEG +V C + + A+KI+ R E+E+L Q H N +++
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR---N-VLELI 77
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+F+ + +VFEK+ G S+ + K R F + + + + F+H+ + H
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 178
DLKPEN+L + S +K+ DF + + + +
Sbjct: 136 DLKPENILCEHPN------------------------QVSPVKICDFDLGSGIKLNGDCS 171
Query: 179 ---------IVSTRHYRAPEVILGLGWTY-----PCDIWSVGCILVELCTGEALFQTHEN 224
+ Y APEV+ CD+WS+G IL L +G F
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
Query: 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPR 279
+ + + ++ G+ + W
Sbjct: 232 SDCGWDRGEACPACQNMLFES--------IQEGKYEFPDKDWA----------------- 266
Query: 280 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
H+ +A D L+ LL D RL+A + L+HP+
Sbjct: 267 -------HISCAAKD---LISKLLVRDAKQRLSAAQVLQHPWVQGC 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 61/338 (18%), Positives = 99/338 (29%), Gaps = 99/338 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKH------------ 49
G G FGQV + R + IK +K E A E++ L +L H
Sbjct: 20 GSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIVHYNGCWDG 75
Query: 50 DKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
+ + I E +L ++ K L E+ Q+ + +
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++H +I+ DLKP N+ LV + +K+ DFG
Sbjct: 136 DYIHSKKLINRDLKPSNIFLV---------------------------DTKQVKIGDFGL 168
Query: 169 TTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
T + D T Y +PE I + D++++G IL EL + T
Sbjct: 169 VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH---VCDTAFETS 225
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
R G + ++ + L+ +
Sbjct: 226 KFFTDLR-DGIISDIF------------------------DKK----------EKTLLQK 250
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
LL P DR E LR +
Sbjct: 251 ---------------LLSKKPEDRPNTSEILRTLTVWK 273
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 63/328 (19%), Positives = 119/328 (36%), Gaps = 79/328 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG V C + K+ K V+ + EI +L +H + +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RH----RNILHLHE 68
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
F+ + ++FE + G +++ + + + + Q+ E + F+H + H D
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-- 178
++PEN++ + +SS IK+I+FG +P N+
Sbjct: 128 IRPENIIYQT-------------------------RRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+ + Y APEV + D+WS+G ++ L +G F N + ++E ++
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIM--- 216
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
+ E A + + A D
Sbjct: 217 -----------------NAEYTFDEEA-------------------FKEISIEAMD---F 237
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ LL + R+TA EAL+HP+ +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKI 265
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 66/329 (20%), Positives = 112/329 (34%), Gaps = 79/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G F V +C + + A K + R + R + EI VL+ R +
Sbjct: 38 GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP----RVIN 93
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ ++ + I ++ E G ++ + V + +Q+LE + ++H ++
Sbjct: 94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKP+N+LL S IK++DFG +
Sbjct: 154 HLDLKPQNILLSSIY------------------------PLGDIKIVDFGMSRKIGHACE 189
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
I+ T Y APE++ T D+W++G I L T + F +N E +
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TYLNIS 246
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+ +D+ E V A D
Sbjct: 247 --------------------QVNVDYSEET-------------------FSSVSQLATD- 266
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTR 324
+Q LL +P R TA L H + +
Sbjct: 267 --FIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-38
Identities = 81/330 (24%), Positives = 135/330 (40%), Gaps = 83/330 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G+FG+VL+C DR ++ A+K++ K + E+E+L++L H N ++
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHP---N-IMK 85
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + IV E G L+D + K F I +Q+ I +MH ++
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+LL S E K IK+IDFG +T + +
Sbjct: 144 HRDLKPENILLESKE------------------------KDCDIKIIDFGLSTCFQQNTK 179
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
+ T +Y APEV+ G + CD+WS G IL L +G F + +++RV
Sbjct: 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVE 235
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
G+ + + + A D
Sbjct: 236 --------------------TGKYAFDLPQ-------------------WRTISDDAKD- 255
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ +L + P+ R+TA + L HP+ +
Sbjct: 256 --LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 81/345 (23%), Positives = 137/345 (39%), Gaps = 70/345 (20%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCV 57
+G G G V +D VAIK + R + A A E+ +++ + H N +
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHK---N-II 124
Query: 58 QIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ N F + + +V E + ++L ++ + + + Q+L I +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHL 180
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H +IH DLKP N+++ S +K++DFG
Sbjct: 181 HSAGIIHRDLKPSNIVVKSD---------------------------CTLKILDFGLART 213
Query: 172 ERPDQN---YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228
Y V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF + ++
Sbjct: 214 AGTSFMMTPY-VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272
Query: 229 AMMERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPE---GAASRESIKSVMKLPRLQ 281
+ LG +K++ YV L +P+ + L
Sbjct: 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS-----------LFPAD 321
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ + A D LL +L DP R++ +AL+HP+ +
Sbjct: 322 SEHNKLKASQARD---LLSKMLVIDPAKRISVDDALQHPYINVWY 363
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-38
Identities = 71/341 (20%), Positives = 132/341 (38%), Gaps = 94/341 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--------------GIKKYREAAMIEIEVLQQLA 47
G G +G+VL C ++ AIK+++ I+K+ E EI +L+ L
Sbjct: 45 GSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL- 103
Query: 48 KHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLE 106
H N +++ + F+ + + +V E G L++ + + F I +Q+L
Sbjct: 104 DHP---N-IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILS 157
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
I ++H ++H D+KPEN+LL + IK++DF
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKN------------------------SLLNIKIVDF 193
Query: 167 GSTTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224
G +++ D + T +Y APEV+ + CD+WS G I+ L G F +
Sbjct: 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252
Query: 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
+ ++++V +G+ +
Sbjct: 253 QD---IIKKVE--------------------KGKYYFDFND------------------- 270
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+++ A + L++ +L YD R TA EAL + +
Sbjct: 271 WKNISDEAKE---LIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-38
Identities = 75/330 (22%), Positives = 130/330 (39%), Gaps = 79/330 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G G+VLEC+ R + A+K++ K R+ E++ Q + + V I +
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQASGGP---H-IVCILD 89
Query: 62 WFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + + I+ E + G L+ +++ ++F EI R + I F+H +
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
H D+KPEN+L S E K + +K+ DFG + +
Sbjct: 150 AHRDVKPENLLYTSKE------------------------KDAVLKLTDFGFAKETTQNA 185
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
T +Y APEV+ + CD+WS+G I+ L G F ++
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA--------- 236
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
+ M +R +R G+ +P S V A
Sbjct: 237 --ISPGMKRR--------IRLGQYGFPNPEWS-------------------EVSEDAKQ- 266
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ LL+ DPT+RLT + + HP+ +
Sbjct: 267 --LIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-38
Identities = 77/352 (21%), Positives = 121/352 (34%), Gaps = 119/352 (33%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYR---------EAAMIEIEVLQQLAKHDKG 52
G+G F V C +RE + A+KI + + E E + L KH
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREASICHML-KHP-- 86
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLECIA 109
+ V++ + + +VFE + G+ L + R + + + RQ+LE +
Sbjct: 87 -H-IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 168
+ HD +IH D+KP VLL S E S+ +K+ FG +
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKE------------------------NSAPVKLGGFGVA 180
Query: 169 TTYERPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC-------TGEAL 218
V T H+ APEV+ + P D+W G IL + L T E L
Sbjct: 181 IQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERL 240
Query: 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKS 273
F+ + +G+ W
Sbjct: 241 FEG--------------------------------IIKGKYKMNPRQWS----------- 257
Query: 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
H+ SA D L++ +L DP +R+T EAL HP+
Sbjct: 258 -------------HISESAKD---LVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 71/379 (18%), Positives = 123/379 (32%), Gaps = 129/379 (34%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR------GIKKYREAAMIEIEVLQQLAKHDKGGNR 55
G+G++G V + + + + AIKI+ K E E+ ++++L H
Sbjct: 35 GQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HH----PN 89
Query: 56 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR------------------------ 90
++ ++ +IC+V E G L D L
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 91 --------------SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136
L+ I RQ+ + ++H+ + H D+KPEN L +++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK---- 205
Query: 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQNY------IVSTRHYRAPE 189
S IK++DFG S + + + T ++ APE
Sbjct: 206 ---------------------SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244
Query: 190 VILGLGWTY--PCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVD 247
V+ +Y CD WS G +L L G F N + +VL
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFP-GVN--DADTISQVL------------ 289
Query: 248 RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307
+L + + + A D LL LL +
Sbjct: 290 --------NKKLCFENPNYN-------------------VLSPLARD---LLSNLLNRNV 319
Query: 308 TDRLTAREALRHPFFTRDH 326
+R A AL+HP+ ++
Sbjct: 320 DERFDAMRALQHPWISQFS 338
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 72/329 (21%), Positives = 127/329 (38%), Gaps = 80/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V C ++ + K + + EI ++ QL H + + +
Sbjct: 60 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP----KLINLH 114
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F+ + + ++ E L G L+D + +Y V RQ E + MH+ ++H
Sbjct: 115 DAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMHEHSIVHL 173
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 178
D+KPEN++ + K+S++K+IDFG T PD+
Sbjct: 174 DIKPENIMCET-------------------------KKASSVKIIDFGLATKLNPDEIVK 208
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+T + APE++ + D+W++G + L +G + F ++LE ++ V
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK-- 263
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
R ++ E A V A D
Sbjct: 264 ------------------RCDWEFDEDA-------------------FSSVSPEAKD--- 283
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ LL+ +P RLT +AL HP+ DH
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 312
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-37
Identities = 83/362 (22%), Positives = 141/362 (38%), Gaps = 89/362 (24%)
Query: 2 GEGTFGQVLECWDRERK--EMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G GT+G V + ++ K + A+K + GI +A EI +L++L KH N +
Sbjct: 30 GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLREL-KHP---N-VI 81
Query: 58 QIRNWFDYRNHICI--VFE-------KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
++ F + +F+ + P +V+ + Q+L+ I
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG- 167
++H ++H DLKP N +LV E P+ +K+ D G
Sbjct: 142 HYLHANWVLHRDLKPAN-ILVMGEG----------------------PERGRVKIADMGF 178
Query: 168 STTYERPDQNY-----IVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQ 220
+ + P + +V T YRAPE++LG Y DIW++GCI EL T E +F
Sbjct: 179 ARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFH 237
Query: 221 ---------THENLEHLAMMERVLG-PLPQHMLKRVDRHAEKYVRRGRLDWPE------- 263
+ + L + V+G P + DW +
Sbjct: 238 CRQEDIKTSNPYHHDQLDRIFNVMGFPADK-------------------DWEDIKKMPEH 278
Query: 264 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
++ ++ L + +H HLLQ LL DP R+T+ +A++ P+F
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338
Query: 324 RD 325
D
Sbjct: 339 ED 340
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 83/341 (24%), Positives = 141/341 (41%), Gaps = 74/341 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCV 57
+G G +G V D+ E VAIK + R + A A E+ +L+ + +H+ N +
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHE---N-VI 86
Query: 58 QIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ + F +V + + L + F + ++ + Q+L+ + ++
Sbjct: 87 GLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK----FSEEKIQYLVYQMLKGLKYI 142
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H DLKP N+ + +K++DFG +
Sbjct: 143 HSAGVVHRDLKPGNLAVNED---------------------------CELKILDFGLARH 175
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ V TR YRAPEVIL DIWSVGCI+ E+ TG+ LF+ + L+ L
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235
Query: 231 MERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIM 285
+ +V G ++++ D+ A+ Y++ R D+ + +
Sbjct: 236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ--------------------LF 275
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
A D LL+ +L D RLTA +AL HPFF
Sbjct: 276 PRASPQAAD---LLEKMLELDVDKRLTAAQALTHPFFEPFR 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 65/332 (19%), Positives = 113/332 (34%), Gaps = 91/332 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
GEG+FG+ + E IK + K RE + E+ VL + KH VQ
Sbjct: 33 GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP----NIVQ 87
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
R F+ + IV + G L+ + F D + + Q+ + +HD ++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKIL 147
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+K +N+ L K +++ DFG
Sbjct: 148 HRDIKSQNIFL---------------------------TKDGTVQLGDFGIARVLNSTVE 180
Query: 178 Y---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM--ME 232
+ T +Y +PE+ + DIW++GC+L ELCT + F+ ++++L + +
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIIS 239
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
P+ H S +
Sbjct: 240 GSFPPVSLHY------------------------SYD----------------------- 252
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L L+ L + +P DR + L F +
Sbjct: 253 --LRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 82/339 (24%), Positives = 138/339 (40%), Gaps = 58/339 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCV 57
+G G G V +D + VAIK + R + A A E+ +++ + H N +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHK---N-II 87
Query: 58 QIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ N F + + IV E + ++L ++ + + Q+L I +
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER----MSYLLYQMLCGIKHL 143
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H +IH DLKP N+++ S +K+ D+ L +S+ T Y
Sbjct: 144 HSAGIIHRDLKPSNIVVKSDCTLKILDF--GLARTAGTSFM---------------MTPY 186
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
V TR+YRAPEVILG+G+ DIWSVGCI+ E+ G LF ++++ +
Sbjct: 187 --------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 287
LG +K++ YV + + L + +
Sbjct: 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEK--------LFPDVLFPADSEHNKL 290
Query: 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
A D LL +L D + R++ EAL+HP+ +
Sbjct: 291 KASQARD---LLSKMLVIDASKRISVDEALQHPYINVWY 326
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 80/346 (23%), Positives = 147/346 (42%), Gaps = 83/346 (23%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKG 52
+G G +G V +D + VA+K + + YRE + +L+ + KH+
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-----LRLLKHM-KHE-- 88
Query: 53 GNRCVQIRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 106
N + + + F + N + +V +G+ L + ++ D V+ + Q+L
Sbjct: 89 -N-VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQFLIYQILR 143
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
+ ++H +IH DLKP N+ + +K++DF
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNED---------------------------CELKILDF 176
Query: 167 GSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENL 225
G + + V+TR YRAPE++L + DIWSVGCI+ EL TG LF +++
Sbjct: 177 GLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236
Query: 226 EHLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRL 280
+ L ++ R++G +LK++ A Y++ ++++
Sbjct: 237 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFAN----------------- 279
Query: 281 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ + A D LL+ +L D R+TA +AL H +F + H
Sbjct: 280 ---VFIGANPLAVD---LLEKMLVLDSDKRITAAQALAHAYFAQYH 319
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-37
Identities = 58/335 (17%), Positives = 109/335 (32%), Gaps = 66/335 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G+G V ++ ++ AIK+ + + M E EVL++L H V++
Sbjct: 18 GQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHK----NIVKL 72
Query: 60 RNWFDYRN--HICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMHDLC 115
+ H ++ E SLY L + N P + R ++ + + +
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H ++KP N++ V E S K+ DFG+ D
Sbjct: 133 IVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDFGAARELEDD 169
Query: 176 QNY--IVSTRHYRAPEVILGLGWTYP--------CDIWSVGCILVELCTGEALFQTHENL 225
+ + + T Y P++ D+WS+G TG F+ E
Sbjct: 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP 229
Query: 226 EHLA-MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
+M +++ P + V + G +DW S+ ++
Sbjct: 230 RRNKEVMYKIITGKPSGAISGVQK-----AENGPIDWSGDMPVSCSLSRGLQ-------- 276
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319
LT +L +L D +
Sbjct: 277 --------VLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 75/348 (21%), Positives = 129/348 (37%), Gaps = 75/348 (21%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI------------EIEVLQQLAK 48
+ G++G V D E VAIK V I EI +L
Sbjct: 30 ISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-H 87
Query: 49 HDKGGNRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQ 103
H N + +R+ F + + +V E + + L + ++
Sbjct: 88 HP---N-ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYH 142
Query: 104 LLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKV 163
+L + +H+ ++H DL P N +L++ + I +
Sbjct: 143 ILLGLHVLHEAGVVHRDLHPGN-ILLADN--------------------------NDITI 175
Query: 164 IDFGSTTYERPDQN---YIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALF 219
DF + D N Y V+ R YRAPE+++ G+T D+WS GC++ E+ +ALF
Sbjct: 176 CDFNLAREDTADANKTHY-VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF 234
Query: 220 QTHENLEHLAMMERVLGPLPQHMLKRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLP 278
+ L + V+G + A Y+R + P + +V +P
Sbjct: 235 RGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVP-----ARAWTAV--VP 287
Query: 279 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
D A D L+ +L ++P R++ +ALRHP+F
Sbjct: 288 --------TADPVALD---LIAKMLEFNPQRRISTEQALRHPYFESLF 324
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 84/340 (24%), Positives = 142/340 (41%), Gaps = 59/340 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
+GEG +G V + E+VAIK + K A EI++L+ KH+ N +
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHE---N-IIT 73
Query: 59 IRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
I N + N + I+ E + + L+ + D ++ Q L + +H
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLRAVKVLHG 130
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+IH DLKP N+L+ S+ +KV D+ + + ++ + +
Sbjct: 131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------VEF-- 182
Query: 174 PDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
V+TR YRAPEV+L ++ D+WS GCIL EL +F + L ++
Sbjct: 183 ------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236
Query: 233 RVLG-PLPQHMLKRVD-RHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
++G P + L+ ++ A +Y++ + P
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK------------MFP-------- 276
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
V+ DL LQ +L +DP R+TA+EAL HP+ H
Sbjct: 277 RVNPKGIDL---LQRMLVFDPAKRITAKEALEHPYLQTYH 313
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 8e-37
Identities = 72/329 (21%), Positives = 120/329 (36%), Gaps = 80/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V +R A K V + +E EI+ + L +H V +
Sbjct: 166 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPT----LVNLH 220
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F+ N + +++E + G L++ + + D E RQ+ + + MH+ +H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHENNYVHL 279
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 178
DLKPEN++ + +S+ +K+IDFG T + P Q+
Sbjct: 280 DLKPENIMFTT-------------------------KRSNELKLIDFGLTAHLDPKQSVK 314
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
T + APEV G Y D+WSVG + L +G + F + E + V
Sbjct: 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVK-- 369
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ + A + D
Sbjct: 370 ------------------SCDWNMDDSA-------------------FSGISEDGKD--- 389
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ LL DP R+T +AL HP+ T +
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPGN 418
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 46/236 (19%), Positives = 89/236 (37%), Gaps = 28/236 (11%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR--CVQI 59
GEG F QV E + + + +K + A E + QL + K + ++
Sbjct: 74 GEGAFAQVYEATQGDLNDAKNKQKF-VLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKF 132
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFL---RKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ ++N +V E +L + + + + P LV A ++L I +HD
Sbjct: 133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE 192
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER-- 173
+IH D+KP+N +L + + + S + +ID G + +
Sbjct: 193 IIHGDIKPDNFILGNGFLEQDDEDDLSAG----------------LALIDLGQSIDMKLF 236
Query: 174 PDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
P + T ++ E++ W Y D + V + + G + +E E
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-36
Identities = 66/334 (19%), Positives = 120/334 (35%), Gaps = 85/334 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGGN 54
G G F V +C + + A K ++ + RE E+ +L+++ +H
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHP---- 68
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + + F+ + + ++ E + G L+DFL + D + +Q+L+ + ++H
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFLKQILDGVHYLHS 126
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ H DLKPEN++L+ + + IK+IDFG
Sbjct: 127 KRIAHFDLKPENIMLLD-----------------------KNVPNPRIKLIDFGIAHKIE 163
Query: 174 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 164 AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------------ 211
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
LG Q L + D+ E +
Sbjct: 212 ---LGETKQETLTN--------ISAVNYDFDEEY-------------------FSNTSEL 241
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A D ++ LL DP R+T ++L H +
Sbjct: 242 AKD---FIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-36
Identities = 82/345 (23%), Positives = 141/345 (40%), Gaps = 77/345 (22%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
+GEG +G V +D K VAIK + + EI++L + +H+ N +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE---N-IIG 89
Query: 59 IRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
I + + + IV + + + LY L+ + D + Q+L + ++H
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHS 146
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STT 170
++H DLKP N LL+++ +K+ DFG
Sbjct: 147 ANVLHRDLKPSN-LLLNTT--------------------------CDLKICDFGLARVAD 179
Query: 171 YERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ ++ V+TR YRAPE++L G+T DIWSVGCIL E+ + +F L+
Sbjct: 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
Query: 227 HLAMMERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQ 281
L + +LG Q L + + A Y+ + ++ W P
Sbjct: 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNR------------LFP--- 284
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ D A D LL +L ++P R+ +AL HP+ + +
Sbjct: 285 -----NADSKALD---LLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 134 bits (337), Expect = 2e-36
Identities = 40/355 (11%), Positives = 88/355 (24%), Gaps = 99/355 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRG--------IKKYREAAMIEIEVLQQLAKHDKGG 53
G V D ER E A+K+ +++ EA +L + + +
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 54 NRCVQIRNWFDYRNH-----------------ICIVFEKLGSSLYDFLRKNNYRS----- 91
R + + ++ ++ L ++
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGD 190
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
I + + QL+ A + ++H P+N+ ++
Sbjct: 191 EGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---------------------- 228
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCIL 209
+ + D + Y E + T+ + W +G +
Sbjct: 229 -----PDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283
Query: 210 VELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRE 269
+ F G + + R + + L + +
Sbjct: 284 YRVWCLFLPF----------------GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPD 327
Query: 270 SIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+K+ L+ L +D RL EA+ P F +
Sbjct: 328 FVKT------------------------LIGRFLNFDRRRRLLPLEAMETPEFLQ 358
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 71/334 (21%), Positives = 119/334 (35%), Gaps = 85/334 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGGN 54
G G F V +C ++ A K ++ + RE E+ +L+Q+ H
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHH---- 75
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + + ++ R + ++ E + G L+DFL + + +Q+L+ + ++H
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ H DLKPEN++L+ IK+IDFG
Sbjct: 134 KKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFGLAHEIE 170
Query: 174 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------------ 218
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
LG Q L + D+ E H
Sbjct: 219 ---LGDTKQETLAN--------ITSVSYDFDEEF-------------------FSHTSEL 248
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A D ++ LL + RLT +EALRHP+ T
Sbjct: 249 AKD---FIRKLLVKETRKRLTIQEALRHPWITPV 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 75/329 (22%), Positives = 120/329 (36%), Gaps = 83/329 (25%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G FG V +R IK + + E EIEVL+ L H ++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHP----NIIK 84
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFL--RKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
I F+ +++ IV E G L + + + ++ V E+ +Q++ +A+ H
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H DLKPEN+L + S IK+IDFG + D
Sbjct: 145 VVHKDLKPENILFQDTS------------------------PHSPIKIIDFGLAELFKSD 180
Query: 176 QNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
++ T Y APEV T+ CDIWS G ++ L TG F +LE +
Sbjct: 181 EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQ---- 234
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ ++ + + A
Sbjct: 235 ------------------QKATYKEPNYAVEC--------------------RPLTPQAV 256
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFF 322
D LL+ +L DP R +A + L H +F
Sbjct: 257 D---LLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-36
Identities = 86/340 (25%), Positives = 143/340 (42%), Gaps = 73/340 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREA--AMIEIEVLQQLAKHDKGGNRCVQ 58
G G +G V D VAIK + R + A A E+ +L+ + +H+ N +
Sbjct: 34 GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHE---N-VIG 88
Query: 59 IRNWF------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ + F D +V +G+ L ++ D ++ + Q+L+ + ++H
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE---DRIQFLVYQMLKGLRYIH 145
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+IH DLKP N+ + +K++DFG
Sbjct: 146 AAGIIHRDLKPGNLAVNED---------------------------CELKILDFGLARQA 178
Query: 173 RPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ V TR YRAPEVIL +T DIWSVGCI+ E+ TG+ LF+ ++L+ L +
Sbjct: 179 DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
Query: 232 ERVLGPLPQHMLKRV-DRHAEKYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
+V G P ++R+ A+ Y++ + D+ I+
Sbjct: 239 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS--------------------ILT 278
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ A + LL+ +L D R+TA EAL HP+F H
Sbjct: 279 NASPLAVN---LLEKMLVLDAEQRVTAGEALAHPYFESLH 315
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 82/343 (23%), Positives = 132/343 (38%), Gaps = 91/343 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--EIEVLQQLAKHDKG 52
G G G+V ++R+ + VAI+I+ ++ A + EIE+L++L H
Sbjct: 144 GSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHP-- 200
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
++I+N+FD IV E + G L+D + N + Q+L + ++
Sbjct: 201 --CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYL 255
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H+ +IH DLKPENVLL S E + IK+ DFG +
Sbjct: 256 HENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDFGHSKI 291
Query: 172 ERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ T Y APEV++ + G+ D WS+G IL +G F H
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT-- 349
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
+ + + G+ ++ +
Sbjct: 350 ------------QVSLKDQ--------ITSGKYNFIP-------------------EVWA 370
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 329
V A D L++ LL DP R T EALRHP+ + ++R
Sbjct: 371 EVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 410
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-36
Identities = 70/335 (20%), Positives = 118/335 (35%), Gaps = 85/335 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGN 54
G G F V +C ++ A K ++ + RE E+ +L+Q+ H
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHP---- 75
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + + ++ R + ++ E + G L+DFL + + +Q+L+ + ++H
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSFIKQILDGVNYLHT 133
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ H DLKPEN++L+ IK+IDFG
Sbjct: 134 KKIAHFDLKPENIMLLDKN-----------------------IPIPHIKLIDFGLAHEIE 170
Query: 174 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ I T + APE++ D+WS+G I L +G + F
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF------------ 218
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
LG Q L + D+ E
Sbjct: 219 ---LGDTKQETLAN--------ITAVSYDFDEEF-------------------FSQTSEL 248
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
A D ++ LL + RLT +EALRHP+ T
Sbjct: 249 AKD---FIRKLLVKETRKRLTIQEALRHPWITPVD 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 70/337 (20%), Positives = 116/337 (34%), Gaps = 97/337 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR----EAAMIEIEVLQQLAKHDKGGNRC 56
+G G++G+V + + A K I KY + EIE+++ L H
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMKSL-DH----PNI 68
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+++ F+ I +V E G L++ + F I + +L +A+ H L
Sbjct: 69 IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCHKLN 126
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+ H DLKPEN L ++ S +K+IDFG +P
Sbjct: 127 VAHRDLKPENFLFLTDS------------------------PDSPLKLIDFGLAARFKPG 162
Query: 176 QNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
+ V T +Y +P+V+ G + CD WS G ++ L G F +
Sbjct: 163 KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVM---- 216
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHV 288
+R G W +V
Sbjct: 217 ------------------LKIREGTFTFPEKDWL------------------------NV 234
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A L++ LL P R+T+ +AL H +F +
Sbjct: 235 SPQAES---LIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-36
Identities = 63/334 (18%), Positives = 118/334 (35%), Gaps = 85/334 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY-------REAAMIEIEVLQQLAKHDKGGN 54
G G F V +C ++ A K ++ + RE E+ +L+++ +H
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHP---- 74
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + ++ + + ++ E + G L+DFL + + E +Q+L + ++H
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHS 132
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
L + H DLKPEN++L+ IK+IDFG
Sbjct: 133 LQIAHFDLKPENIMLLDRN-----------------------VPKPRIKIIDFGLAHKID 169
Query: 174 PDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ I T + APE++ D+WS+G I L +G + F E +
Sbjct: 170 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL 226
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
V ++ + +
Sbjct: 227 ANVS--------------------AVNYEFEDEY-------------------FSNTSAL 247
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A D ++ LL DP R+T +++L+HP+
Sbjct: 248 AKD---FIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 1e-35
Identities = 72/334 (21%), Positives = 130/334 (38%), Gaps = 91/334 (27%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQI 59
+G G F +V R ++ A+K ++ +R++++ EI VL+++ KH+ N V +
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHE---N-IVTL 71
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ H +V + + G L+D + + + + +Q+L + ++H+ ++H
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLSAVKYLHENGIVH 129
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKPEN+L ++ E ++S I + DFG + E+
Sbjct: 130 RDLKPENLLYLTPE------------------------ENSKIMITDFGLSKMEQNGIMS 165
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHENLEHLAMMERVLG 236
T Y APEV+ ++ D WS+G I + LC G F E L E++
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC-GYPPFYE-ETESKL--FEKIK- 220
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
G + W + S
Sbjct: 221 -------------------EGYYEFESPFWD------------------------DISES 237
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A D + LL DP +R T +AL HP+ +
Sbjct: 238 AKD---FICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 82/335 (24%), Positives = 132/335 (39%), Gaps = 93/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G+FG+VL+C DR ++ A+K++ K + E+E+L++L H ++
Sbjct: 31 GKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHP----NIMK 85
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + IV E G L+D + K F I +Q+ I +MH ++
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+LL S E K IK+IDFG +T + +
Sbjct: 144 HRDLKPENILLESKE------------------------KDCDIKIIDFGLSTCFQQNTK 179
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
+ T +Y APEV+ G + CD+WS G IL L +G F +N +
Sbjct: 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDIL------ 231
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
K V G+ W +
Sbjct: 232 ----------------KRVETGKYAFDLPQWR------------------------TISD 251
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
A D L++ +L + P+ R+TA + L HP+ +
Sbjct: 252 DAKD---LIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 105/341 (30%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G+G F + E D + KE+ A KIV + K + + EI + + L H V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVV 78
Query: 58 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+F+ + + +V E SL + ++ ++ R RQ++ ++H +
Sbjct: 79 GFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRV 136
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
IH DLK N+ L + + K+ DFG +T E
Sbjct: 137 IHRDLKLGNLFL---------NEDLEV------------------KIGDFGLATKVEYDG 169
Query: 176 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ NYI APEV+ G ++ D+WS+GCI+ L G+ F+T L
Sbjct: 170 ERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL- 220
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
+ R +++ P+
Sbjct: 221 -------------KETYLR--------IKKNEYSIPK----------------------- 236
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
H++ A L+Q +L+ DPT R T E L FFT ++
Sbjct: 237 HINPVAAS---LIQKMLQTDPTARPTINELLNDEFFTSGYI 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 75/334 (22%), Positives = 126/334 (37%), Gaps = 95/334 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
+G G V C + ++ A+K+ +KK + ++ EI VL +L H N ++
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKV---LKKTVDKKIVRTEIGVLLRL-SHP---N-IIK 112
Query: 59 IRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ F+ I +V E G L+D + + Y + + +Q+LE +A++H+ ++
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQILEAVAYLHENGIV 170
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+L + + +K+ DFG +
Sbjct: 171 HRDLKPENLLYATPA------------------------PDAPLKIADFGLSKIVEHQVL 206
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELCTGEALFQTHENLEHLAMMERV 234
+ T Y APE++ G + D+WSVG I + LC G F + M R+
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC-GFEPFYDERGDQ--FMFRRI 263
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVD 289
L W V
Sbjct: 264 L--------------------NCEYYFISPWWD------------------------EVS 279
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+A D L++ L+ DP RLT +AL+HP+ T
Sbjct: 280 LNAKD---LVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 66/344 (19%), Positives = 116/344 (33%), Gaps = 110/344 (31%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G F V C + A KI+ + + + E + ++L +H N V+
Sbjct: 38 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHP---N-IVR 92
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + +VF+ + G L++ + + + +Q+LE IA+ H ++
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIV 150
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H +LKPEN+LL S K +A+K+ DFG +
Sbjct: 151 HRNLKPENLLLASKA------------------------KGAAVKLADFGLAIEVNDSEA 186
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALFQTHENLE 226
+ T Y +PEV+ ++ P DIW+ G IL + L L+
Sbjct: 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----- 241
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQ 281
++ G D W
Sbjct: 242 ---------------------------IKAGAYDYPSPEWD------------------- 255
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
V A L+ +L +P R+TA +AL+ P+
Sbjct: 256 -----TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 291
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-35
Identities = 85/377 (22%), Positives = 145/377 (38%), Gaps = 86/377 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKGG 53
G G++G V E +D+ K +VAIK + + + RE I +L +L HD
Sbjct: 62 GTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE-----IAILNRL-NHD--- 112
Query: 54 N----RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
+ + I + + + +V E S R Y + ++ + LL +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLT--ELHIKTLLYNLLVGVK 170
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++H ++H DLKP N L+ +KV D+ + + ++P S ++ +
Sbjct: 171 YVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
Query: 170 TYERPDQNYI---VSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCT----------- 214
+ + + + V TR YRAPE+IL +T D+WS+GCI EL
Sbjct: 231 PHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
Query: 215 GEALF--------------------QTHENLEHLAMMERVLGPLPQHMLKRV-DRHAEKY 253
LF T N + L ++ +LG + ++ + A++Y
Sbjct: 291 RGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY 350
Query: 254 VR----RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309
+R R D E + P A L L+ +L ++P
Sbjct: 351 IRIFPKREGTDLAE------------RFP--------ASSADAIHL---LKRMLVFNPNK 387
Query: 310 RLTAREALRHPFFTRDH 326
R+T E L HPFF
Sbjct: 388 RITINECLAHPFFKEVR 404
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 75/341 (21%), Positives = 125/341 (36%), Gaps = 105/341 (30%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G+G F + E D + KE+ A KIV + K + + EI + + L H V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH----QHVV 104
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+F+ + + +V E SL + ++ ++ R RQ++ ++H +
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRV 162
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
IH DLK N+ L + +K+ DFG +T E
Sbjct: 163 IHRDLKLGNLFL---------NEDLE------------------VKIGDFGLATKVEYDG 195
Query: 176 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ NYI APEV+ G ++ D+WS+GCI+ L G+ F+T L
Sbjct: 196 ERKKVLCGTPNYI-------APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCL- 246
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
+ R +++ P+
Sbjct: 247 -------------KETYLR--------IKKNEYSIPK----------------------- 262
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
H++ A L+Q +L+ DPT R T E L FFT ++
Sbjct: 263 HINPVA---ASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 70/345 (20%), Positives = 119/345 (34%), Gaps = 111/345 (32%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G F V C + A I+ + + + E + + L KH N V+
Sbjct: 20 GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHP---N-IVR 74
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + H ++F+ + G L++ + Y + +Q+LE + H + ++
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQILEAVLHCHQMGVV 132
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H +LKPEN+LL S K +A+K+ DFG + E Q
Sbjct: 133 HRNLKPENLLLASKL------------------------KGAAVKLADFGLAIEVEGEQQ 168
Query: 177 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALFQTHENL 225
+ T Y +PEV+ + P D+W+ G IL + L L+Q
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ----- 223
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRL 280
++ G D W
Sbjct: 224 ---------------------------QIKAGAYDFPSPEWD------------------ 238
Query: 281 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
V A D L+ +L +P+ R+TA EAL+HP+ +
Sbjct: 239 ------TVTPEAKD---LINKMLTINPSKRITAAEALKHPWISHR 274
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-35
Identities = 80/326 (24%), Positives = 128/326 (39%), Gaps = 80/326 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FGQV +C + +A KI++ K +E EI V+ QL H +Q+
Sbjct: 98 GGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHA----NLIQLY 152
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F+ +N I +V E + G L+D + +Y + +Q+ E I MH + ++H
Sbjct: 153 DAFESKNDIVLVMEYVDGGELFDRIIDESY-NLTELDTILFMKQICEGIRHMHQMYILHL 211
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY- 178
DLKPEN+L V+ + IK+IDFG +P +
Sbjct: 212 DLKPENILCVN-------------------------RDAKQIKIIDFGLARRYKPREKLK 246
Query: 179 -IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
T + APEV+ ++P D+WSVG I L +G + F LG
Sbjct: 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF---------------LGD 291
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
L + R D + Q + A +
Sbjct: 292 NDAETLNN--------ILACRWDLEDEE-------------------FQDISEEAKE--- 321
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFT 323
+ LL + + R++A EAL+HP+ +
Sbjct: 322 FISKLLIKEKSWRISASEALKHPWLS 347
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-34
Identities = 66/344 (19%), Positives = 116/344 (33%), Gaps = 110/344 (31%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G+G F V C + A KI+ + + + E + ++L +H N V+
Sbjct: 15 GKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHP---N-IVR 69
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + +VF+ + G L++ + + + +Q+LE IA+ H ++
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIV 127
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H +LKPEN+LL S K +A+K+ DFG +
Sbjct: 128 HRNLKPENLLLASKA------------------------KGAAVKLADFGLAIEVNDSEA 163
Query: 178 Y--IVSTRHYRAPEVILGLGWTYPCDIWSVGCIL-VELC--------TGEALFQTHENLE 226
+ T Y +PEV+ ++ P DIW+ G IL + L L+
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----- 218
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQ 281
++ G D W
Sbjct: 219 ---------------------------IKAGAYDYPSPEWD------------------- 232
Query: 282 NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
V A L+ +L +P R+TA +AL+ P+
Sbjct: 233 -----TVTPEAKS---LIDSMLTVNPKKRITADQALKVPWICNR 268
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 65/335 (19%), Positives = 101/335 (30%), Gaps = 92/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G+FG+V D++ A+K VR + E+ L R V +
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP----RIVPLYG 117
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+ I E L G SL +++ P D Q LE + ++H ++H D
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--------STTYE 172
+K +NVLL S + DFG
Sbjct: 176 VKADNVLL--------------------------SSDGSRAALCDFGHALCLQPDGLGKS 209
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+YI T + APEV++G DIWS C+++ + G H
Sbjct: 210 LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG----------CH----- 254
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
P Q+ +K+ I + A
Sbjct: 255 ----PWTQY---------------------------FRGPLCLKIASEPPPIREIPPSCA 283
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
+Q LR +P R +A E R +
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 65/338 (19%), Positives = 108/338 (31%), Gaps = 89/338 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G F +V VA+K V+ K R + EI++L+QL H N +
Sbjct: 41 GRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHP---N-VI 95
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ F N + IV E L ++ K R P V + QL + MH
Sbjct: 96 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
++H D+KP NV + + +K+ D G +
Sbjct: 156 RVMHRDIKPANVFIT---------------------------ATGVVKLGDLGLGRFFSS 188
Query: 174 PDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ +V T +Y +PE I G+ + DIWS+GC+L E+ ++ F + + ++
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLC 247
Query: 232 ERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+++ P P S E L+ L+
Sbjct: 248 KKIEQCDYPP--------------------LPSDHYSEE----------LRQLVNM---- 273
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ DP R
Sbjct: 274 -----------CINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 78/348 (22%), Positives = 123/348 (35%), Gaps = 107/348 (30%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV----------RGIKKYREAAMIEIEVLQQLAKHDK 51
G G V C + + A+KI+ +++ REA + E+++L++++ H
Sbjct: 26 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP- 84
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
N +Q+++ ++ +VF+ + L+D+L + R+I R LLE I
Sbjct: 85 --N-IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICA 139
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H L ++H DLKPEN+LL IK+ DFG +
Sbjct: 140 LHKLNIVHRDLKPENILLDD---------------------------DMNIKLTDFGFSC 172
Query: 171 YERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQTH 222
P + + T Y APE+I G+ D+WS G I+ L G F H
Sbjct: 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WH 231
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 277
ML+ + G W
Sbjct: 232 RK--------------QMLMLRM--------IMSGNYQFGSPEWD--------------- 254
Query: 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ D L+ L P R TA EAL HPFF +
Sbjct: 255 ---------DYSDTVKD---LVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 5e-34
Identities = 69/340 (20%), Positives = 122/340 (35%), Gaps = 104/340 (30%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G+G+F V VAIK++ + + K + E+++ QL KH +
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH----PSIL 74
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ N+F+ N++ +V E + +L+ + F + R Q++ + ++H +
Sbjct: 75 ELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGI 133
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
+H DL N+LL + IK+ DFG +T + P
Sbjct: 134 LHRDLTLSNLLL---------TRNMN------------------IKIADFGLATQLKMPH 166
Query: 176 Q---------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
+ NYI +PE+ D+WS+GC+ L G F T + +
Sbjct: 167 EKHYTLCGTPNYI-------SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTV- 217
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
++ L + V + P
Sbjct: 218 -------------KNTLNK--------VVLADYEMPS----------------------- 233
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ A D L+ LLR +P DRL+ L HPF +R+
Sbjct: 234 FLSIEAKD---LIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 65/343 (18%), Positives = 108/343 (31%), Gaps = 83/343 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
+G G FG V E ++ AIK +R + RE M E++ L +L +H
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHP---GIVRY 68
Query: 59 IRNWFD-----------YRNHICIVFEKL--GSSLYDFLRKNNYRSFP-IDLVREIARQL 104
W + + ++ I + L +L D++ + I Q+
Sbjct: 69 FNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 105 LECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVI 164
E + F+H ++H DLKP N+ + +KV D+ M + +
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV----------TAMDQDEEEQ-- 175
Query: 165 DFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224
+ V T+ Y +PE I G +++ DI+S+G IL EL F T
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP---FSTQME 232
Query: 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
VR K P L
Sbjct: 233 RVRTLTD----------------------VRNL------------------KFPPLFTQK 252
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
++Q +L P +R A + + F
Sbjct: 253 YP-------CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 63/346 (18%), Positives = 109/346 (31%), Gaps = 101/346 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G++G+ + + +++ K + ++ + E+ +L++L KH N V+
Sbjct: 15 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP---N-IVR 69
Query: 59 IRNWFDYR--NHICIVFEKL-GSSLYDFLR--KNNYRSFPIDLVREIARQLLECIAFMHD 113
+ R + IV E G L + + + V + QL + H
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 114 LC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++H DLKP NV L +K+ DFG
Sbjct: 130 RSDGGHTVLHRDLKPANVFLD---------------------------GKQNVKLGDFGL 162
Query: 169 TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
D ++ V T +Y +PE + + + DIWS+GC+L ELC F +
Sbjct: 163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQ 221
Query: 226 EHLAM--MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283
+ LA E +P S E
Sbjct: 222 KELAGKIREGKFRRIPYRY------------------------SDE-------------- 243
Query: 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 329
L ++ +L R + E L +P +H
Sbjct: 244 -----------LNEIITRMLNLKDYHRPSVEEILENPLI-LEHHHH 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 69/333 (20%), Positives = 107/333 (32%), Gaps = 64/333 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN----- 54
G G FG VL ++ E VAIK R K RE +EI+++++L H N
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP---NVVSAR 78
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKN-NYRSFPIDLVREIARQLLECIAFMH 112
+ + E G L +L + N +R + + + ++H
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+ +IH DLKPEN++L + K+ID G
Sbjct: 139 ENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDLGYAKEL 174
Query: 173 RPDQNY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ V T Y APE++ +T D WS G + E TG
Sbjct: 175 DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF-------------- 220
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
P + + K + ++K LP +L
Sbjct: 221 -------RPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGI---- 269
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
AG L LQ +L + R T + F
Sbjct: 270 LAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQ 302
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-33
Identities = 85/349 (24%), Positives = 134/349 (38%), Gaps = 103/349 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV-------RGIKKYREAAMI--EIEVLQQLAKHDKG 52
G G G+V ++R+ + VAIKI+ ++ A + EIE+L++L H
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHP-- 75
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
++I+N+FD ++ IV E + G L+D + N + Q+L + ++
Sbjct: 76 --CIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYL 130
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H+ +IH DLKPENVLL S E + IK+ DFG +
Sbjct: 131 HENGIIHRDLKPENVLLSSQE------------------------EDCLIKITDFGHSKI 166
Query: 172 ERPDQNY--IVSTRHYRAPEVILGL---GWTYPCDIWSVGCIL-VELCTGEALFQTHENL 225
+ T Y APEV++ + G+ D WS+G IL + L G F H
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS-GYPPFSEHRT- 224
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRL 280
+ + + G+ + W
Sbjct: 225 -------------QVSLKDQ--------ITSGKYNFIPEVWA------------------ 245
Query: 281 QNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHLRR 329
V A D L++ LL DP R T EALRHP+ + ++R
Sbjct: 246 ------EVSEKALD---LVKKLLVVDPKARFTTEEALRHPWLQDEDMKR 285
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 79/347 (22%), Positives = 126/347 (36%), Gaps = 108/347 (31%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---------RGIKKYREAAMIEIEVLQQLAKHDKG 52
G G V C R A+KI+ +++ REA E +L+Q+A H
Sbjct: 103 GRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH--- 159
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+ + + ++ + + +VF+ + L+D+L + R I R LLE ++F+
Sbjct: 160 -PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H DLKPEN+LL + I++ DFG + +
Sbjct: 217 HANNIVHRDLKPENILLDD---------------------------NMQIRLSDFGFSCH 249
Query: 172 ERPDQNY--IVSTRHYRAPEVILGL------GWTYPCDIWSVGCIL-VELCTGEALFQTH 222
P + + T Y APE++ G+ D+W+ G IL L G F H
Sbjct: 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA-GSPPF-WH 307
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKL 277
ML+ + G+ W
Sbjct: 308 RR--------------QILMLRM--------IMEGQYQFSSPEWD--------------- 330
Query: 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ D L+ LL+ DP RLTA +AL+HPFF R
Sbjct: 331 ---------DRSSTVKD---LISRLLQVDPEARLTAEQALQHPFFER 365
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 85/373 (22%), Positives = 141/373 (37%), Gaps = 86/373 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIK-IVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
G G++G V +D+ ++ VAIK + R + + I EI +L +L K D ++
Sbjct: 35 GRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSD---Y-IIR 89
Query: 59 IRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + + + IV E S L + + + + ++ I LL F+H+
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLLLGENFIHE 147
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPD------YKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+IH DLKP N LL +KV D S T + + K +
Sbjct: 148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQ 207
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTG----------- 215
T++ V TR YRAPE+IL +T DIWS GCI EL
Sbjct: 208 LTSH--------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR 259
Query: 216 EALFQ-----------------THENLEHLAMMERVLGPLPQHMLKRV-DRHAEKYVR-- 255
LF N + L ++ ++G + LK + KY++
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319
Query: 256 --RGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313
R ++ + K P + +L L+ +L+++P R+T
Sbjct: 320 PHRKPINLKQ------------KYP--------SISDDGINL---LESMLKFNPNKRITI 356
Query: 314 REALRHPFFTRDH 326
+AL HP+
Sbjct: 357 DQALDHPYLKDVR 369
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 67/334 (20%), Positives = 122/334 (36%), Gaps = 107/334 (32%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ V+I +
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP----HIVRIVD 78
Query: 62 WFD----YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ R + IV E L G L+ ++ ++F EI + + E I ++H + +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
H D+KPEN+L S ++ +K+ DFG
Sbjct: 139 AHRDVKPENLLYTSKR------------------------PNAILKLTDFG--------- 165
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
A E G + CD+WS+G I+ L G F ++
Sbjct: 166 ---------FAKET-TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-----------L 204
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLD-----WPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
+ M R +R G+ + W V
Sbjct: 205 AISPGMKTR--------IRMGQYEFPNPEWS------------------------EVSEE 232
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L++ LL+ +PT R+T E + HP+ +
Sbjct: 233 VKM---LIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+GT+G V D + +AIK + +Y + EI + + L KH VQ
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPID--LVREIARQLLECIAFMHDLCMI 117
F I I E++ G SL L ++ + + + +Q+LE + ++HD ++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS---TTYERP 174
H D+K +NVL+ S +K+ DFG+ P
Sbjct: 145 HRDIKGDNVLI--------------------------NTYSGVLKISDFGTSKRLAGINP 178
Query: 175 DQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGE 216
T Y APE+I G+ DIWS+GC ++E+ TG+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 69/329 (20%), Positives = 124/329 (37%), Gaps = 87/329 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G+G FG V +++ K ++A+K++ ++K + E+E+ L +H +
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPN----IL 72
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ +F + ++ E ++Y L+K F +L +++ H +
Sbjct: 73 RLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRV 130
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KPEN+LL S+ +K+ D+ S+H P +R D
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRT-------------DLCGTLD- 172
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
Y PE+I G D+WS+G + E G+ F+ +
Sbjct: 173 --------YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT------------- 211
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
Q KR + R +P+ V A D
Sbjct: 212 --YQETYKR--------ISRVEFTFPD-----------------------FVTEGARD-- 236
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+ LL+++P+ R RE L HP+ T +
Sbjct: 237 -LISRLLKHNPSQRPMLREVLEHPWITAN 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 68/329 (20%), Positives = 118/329 (35%), Gaps = 87/329 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G+G FG V +++ K ++A+K++ ++K + EIE+ L +H +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPN----IL 77
Query: 58 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ N+F R I ++ E LY L+K+ F +L + + + H+ +
Sbjct: 78 RMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKV 135
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KPEN+L+ +K+ D+ S+H P +R T D
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRR-------------TMCGTLD- 177
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
Y PE+I G D+W G + E G F + H R++
Sbjct: 178 --------YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP---SHTETHRRIV- 225
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
L +P + + D
Sbjct: 226 -------------------NVDLKFPP-----------------------FLSDGSKD-- 241
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+ LLRY P RL + + HP+ +
Sbjct: 242 -LISKLLRYHPPQRLPLKGVMEHPWVKAN 269
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 60/335 (17%), Positives = 121/335 (36%), Gaps = 91/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G+F V + D E VA ++ K R+ E E+L+ L +H V+
Sbjct: 35 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHP----NIVR 89
Query: 59 -IRNWFDY---RNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH- 112
+W + I +V E + S +L +L++ ++ I ++R RQ+L+ + F+H
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 113 -DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STT 170
+IH DLK +N+ + + ++K+ D G +T
Sbjct: 148 RTPPIIHRDLKCDNIFI--------------------------TGPTGSVKIGDLGLATL 181
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
++ T + APE+ + D+++ G ++E+ T E + +N +
Sbjct: 182 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QI 238
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
RV + + + P ++ +I
Sbjct: 239 YRRVTSGVKPASF-------------------------DKVAI----PEVKEIIEG---- 265
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+R + +R + ++ L H FF +
Sbjct: 266 -----------CIRQNKDERYSIKDLLNHAFFQEE 289
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 54/335 (16%), Positives = 101/335 (30%), Gaps = 79/335 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKY-REAAMIEIEVLQQLAKHDKGGNRCVQIR 60
GEG F V A+K + ++ RE A E ++ + H N +++
Sbjct: 38 GEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHP---N-ILRLV 92
Query: 61 NWF----DYRNHICIVFE-KLGSSLYDFL--RKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ ++ ++ +L++ + K+ D + + + + +H
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
H DLKP N+LL + D S + A ++
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSM---------------NQACIHVEGSRQALTL 197
Query: 174 PDQNYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILVELCTGEALFQ-THENLEHLA 229
D T YRAPE+ D+WS+GC+L + GE + + + +A
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ + +L P+ R S L L+
Sbjct: 258 L-----------------------AVQNQLSIPQS--PRHS-------SALWQLL----- 280
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
++ DP R L +
Sbjct: 281 ----------NSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 68/341 (19%), Positives = 119/341 (34%), Gaps = 103/341 (30%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAKHDKGG 53
+G G FG V VAIK V I + E E+ +L+++ G
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV-SSGFSG 109
Query: 54 NRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+++ +WF+ + ++ E+ L+DF+ + + +L R Q+LE +
Sbjct: 110 --VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHC 165
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H+ ++H D+K EN+L+ D + + +K+IDFGS
Sbjct: 166 HNCGVLHRDIKDENILI-------------------DLNRGE-------LKLIDFGSGAL 199
Query: 172 ERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLE 226
D Y TR Y PE I Y +WS+G +L ++ G+ F
Sbjct: 200 L-KDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILLYDMVCGDIPF------- 249
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
++ + RG++ +
Sbjct: 250 ----------------------EHDEEIIRGQVFFR------------------------ 263
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
+ + HL++ L P+DR T E HP+ L
Sbjct: 264 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 61/340 (17%), Positives = 110/340 (32%), Gaps = 101/340 (29%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI-----EIEVLQQLAKHDKGG 53
+G+G FG V + VAIK++ + + + E+ +L ++
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 54 NRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+++ +WF+ + +V E L+D++ + R Q++ I
Sbjct: 99 G-VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHC 155
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H ++H D+K EN+L+ D + K+IDFGS
Sbjct: 156 HSRGVVHRDIKDENILI-------------------DL-------RRGCAKLIDFGSGAL 189
Query: 172 ERPDQNYIVS--TRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLE 226
D+ Y TR Y PE I Y P +WS+G +L ++ G+ F
Sbjct: 190 -LHDEPYTDFDGTRVYSPPEWISRHQ--YHALPATVWSLGILLYDMVCGDIPF------- 239
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
++ + L +P
Sbjct: 240 ----------------------ERDQEILEAELHFPA----------------------- 254
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
H + D L++ L P+ R + E L P+
Sbjct: 255 ---HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 67/349 (19%), Positives = 106/349 (30%), Gaps = 110/349 (31%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGN------ 54
EG F V E D A+K + ++ A + E+ +++L+ H N
Sbjct: 37 AEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHP---NIVQFCS 93
Query: 55 RCVQIRNWFDYRNHICIVFEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ D ++ +L G + + + D V +I Q + MH
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 113 DL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+IH DLK EN+LL IK+ DFGS T
Sbjct: 154 RQKPPIIHRDLKVENLLLS---------------------------NQGTIKLCDFGSAT 186
Query: 171 YERPDQNYIVS-----------TRH----YRAPEVI---LGLGWTYPCDIWSVGCILVEL 212
+Y S TR+ YR PE+I DIW++GCIL L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 213 CTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIK 272
C + F+ L + G+ P
Sbjct: 247 CFRQHPFEDGAKLR---------------------------IVNGKYSIP---------- 269
Query: 273 SVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
H L++ +L+ +P +RL+ E +
Sbjct: 270 -------------PHDTQYT-VFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-30
Identities = 58/354 (16%), Positives = 119/354 (33%), Gaps = 94/354 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI----------------EIEVL 43
+G F +++ C + + A+K ++K R+ E++++
Sbjct: 40 NQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 44 QQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY------RSFPIDL 96
+ K++ C+ + + I++E + S+ F PI +
Sbjct: 98 TDI-KNE---Y-CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 97 VREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155
++ I + +L +++H+ + H D+KP N+L+ D
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM---------DKNGR------------- 190
Query: 156 PKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGWTY--PCDIWSVGCILVE 211
+K+ DFG + Y D+ S T + PE DIWS+G L
Sbjct: 191 -----VKLSDFGESEY-MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244
Query: 212 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 271
+ F +L + +R +++P
Sbjct: 245 MFYNVVPFSLKISL--------------VELFNN--------IRTKNIEYPLDRNHFLYP 282
Query: 272 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ K N + + D L+ LR +P +R+T+ +AL+H +
Sbjct: 283 LTNKKSTCSNN----FLSNEDID---FLKLFLRKNPAERITSEDALKHEWLADT 329
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-30
Identities = 49/367 (13%), Positives = 108/367 (29%), Gaps = 127/367 (34%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAM------IEIEVLQQLAKHDKGGNR 55
G+ LE D+E E + + ++ A+ + L + K+ K
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 56 CVQIRNWFD--------------------YRNHICIVFEKLGSSLYDFL-----RKNNYR 90
++ FD + ++ ++ S+L F + ++
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 91 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150
S ++ Q++ +A +H ++HT L+P +++L
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 240
Query: 151 YFKRMPKSSAIKVIDFGSTTYERPDQNYIVS--TRHYRAPEVILGLGW-----------T 197
+ + + F D +VS +R + PE+ T
Sbjct: 241 ------QRGGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMT 291
Query: 198 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG 257
+ D W++G ++ + + T + + +++ R
Sbjct: 292 FSFDAWALGLVIYWIWCADLPI-TKDAALGGS----------------------EWIFRS 328
Query: 258 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317
+ P+ LL+G LRY DRL +A+
Sbjct: 329 CKNIPQPVR------------------------------ALLEGFLRYPKEDRLLPLQAM 358
Query: 318 RHPFFTR 324
P + +
Sbjct: 359 ETPEYEQ 365
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 51/266 (19%), Positives = 92/266 (34%), Gaps = 70/266 (26%)
Query: 63 FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFP-IDLVREIARQLLECIAFMHDLCMIHTD 120
+ ++ I + +L D++ + + I Q+ E + F+H ++H D
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 121 LKPENVLLVSSEYIKVPDY---KSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
LKP N+ + +KV D+ + ++ + MP +
Sbjct: 190 LKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA---------------THT 234
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
V T+ Y +PE I G +++ DI+S+G IL EL F T MERV
Sbjct: 235 GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS---FSTQ--------MERV--- 280
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
++ VR + P K P+ ++
Sbjct: 281 ---RIITD--------VRNLKF--PLL--------FTQKYPQEHMMVQD----------- 308
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFT 323
+L PT+R A + + + F
Sbjct: 309 ----MLSPSPTERPEATDIIENAIFE 330
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-26
Identities = 50/363 (13%), Positives = 104/363 (28%), Gaps = 120/363 (33%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--------GIKKYREAAMIE------------IE 41
G+ LE D+E E + + IK+ +E +
Sbjct: 87 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 146
Query: 42 VLQQLAKHD--KGGNRCVQIRNWFDYRNH----ICIVFEKLGSSLYDFL-----RKNNYR 90
L+ + D K + IR D R+ ++ ++ S+L F + ++
Sbjct: 147 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 206
Query: 91 SFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150
S ++ Q++ +A +H ++HT L+P +++L
Sbjct: 207 SLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--------------------- 245
Query: 151 YFKRMPKSSAIKVIDFGSTTYE----RPDQNYIVSTRHYRAPEVILGLG-----WTYPCD 201
+ + + F + + A ++ T+ D
Sbjct: 246 ------QRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFD 299
Query: 202 IWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDW 261
W++G + + + T + L E + R +
Sbjct: 300 TWTLGLAIYWIWCADLPN-TDDAA--LGGSEWIF--------------------RSCKNI 336
Query: 262 PEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
P+ + LL+G LRY DRL +A+ P
Sbjct: 337 PQPVRA------------------------------LLEGFLRYPKEDRLLPLQAMETPE 366
Query: 322 FTR 324
+ +
Sbjct: 367 YEQ 369
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 70/340 (20%), Positives = 122/340 (35%), Gaps = 105/340 (30%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI----------EIEVLQQLAKHD 50
+G G FG V D+E+ + V +K ++ +K E I EI +L ++ +H
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAILSRV-EHA 89
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKLGSS--LYDFLRKNNYRSFPIDLVREIARQLLECI 108
+++ + F+ + +V EK GS L+ F+ ++ L I RQL+ +
Sbjct: 90 N----IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAV 143
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ +IH D+K EN+++ + IK+IDFGS
Sbjct: 144 GYLRLKDIIHRDIKDENIVI-------------------AEDF--------TIKLIDFGS 176
Query: 169 TTYERPDQNYIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENL 225
Y + + T Y APEV++G + P ++WS+G L L E
Sbjct: 177 AAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE--------- 227
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285
P L+ + P
Sbjct: 228 ------------NPFCELEE--------TVEAAIHPP----------------------- 244
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ +L L+ GLL+ P R T + + P+ T+
Sbjct: 245 ---YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-26
Identities = 63/331 (19%), Positives = 113/331 (34%), Gaps = 50/331 (15%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G G G V + + ++A K++ K I E++VL + I
Sbjct: 42 GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE--------CNSPYI 93
Query: 60 RNW---FDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-L 114
+ F I I E + G SL L+K P ++ +++ +++ + ++ +
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
++H D+KP N+L+ S IK+ DFG S
Sbjct: 152 KIMHRDVKPSNILVNSR---------------------------GEIKLCDFGVSGQLID 184
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
N V TR Y +PE + G ++ DIWS+G LVE+ G + E M
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 244
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ R R + + + + + S
Sbjct: 245 QVEGDAAETPPR----PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL- 299
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ + L +P +R ++ + H F R
Sbjct: 300 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-24
Identities = 68/349 (19%), Positives = 124/349 (35%), Gaps = 115/349 (32%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKHDKGGNRC 56
GEG++G+V E D E A+KI++ K R EI++L++L +H
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RH------- 65
Query: 57 VQIRN--------WFDYRNHICIVFE--KLGSS-LYDFLRKNNYRSFPIDLVREIARQLL 105
+N + + + + +V E G + D + + + FP+ QL+
Sbjct: 66 ---KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFCQLI 119
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
+ + ++H ++H D+KP N+LL + +K+
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLL---------TTGGT------------------LKISA 152
Query: 166 FG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEA 217
G + + T ++ PE+ GL T+ DIWS G L + TG
Sbjct: 153 LGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLY 211
Query: 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 277
F+ +N+ L + + +G P
Sbjct: 212 PFE-GDNIYKLF----------------------ENIGKGSYAIP--------------- 233
Query: 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
L+ LL+G+L Y+P R + R+ +H +F + H
Sbjct: 234 -----------GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 6e-24
Identities = 55/329 (16%), Positives = 109/329 (33%), Gaps = 31/329 (9%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV---RGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G V + E V ++ + + E+ V + H N V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHP---N-IVP 90
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
R F N + +V + S D + + + I + +L+ + ++H + +
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV 150
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H +K ++L+ + + +S+ S + +
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSN------LSMISHGQRQRVVHDF-----------PK 193
Query: 178 YIVSTRHYRAPEVI--LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
Y V + +PEV+ G+ DI+SVG EL G F+ + ++E++
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN 251
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
G +P + E + R G + + + H S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP-HF 310
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTR 324
H ++ L+ +P R +A L H FF +
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQ 339
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-24
Identities = 65/332 (19%), Positives = 112/332 (33%), Gaps = 90/332 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV-RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQ 58
G+G F +V VAIKI+ + + E+ +++ L H V+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHP----NIVK 78
Query: 59 IRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + ++ E G ++D+L + R RQ++ + + H ++
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLK EN+LL D + IK+ DFG +
Sbjct: 137 HRDLKAENLLL---------DADMN------------------IKIADFGFSNEFTVGGK 169
Query: 178 YIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
Y APE+ G + P D+WS+G IL L +G F +NL+ L
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKEL------ 222
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
+ V RG+ P + + D
Sbjct: 223 ----------------RERVLRGKYRIPF--------------------------YMSTD 240
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+LL+ L +P R T + ++ + H
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-24
Identities = 71/332 (21%), Positives = 123/332 (37%), Gaps = 90/332 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
GEG+FG+V + ++ VA+K + + +KK + EI L+ L +H +
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHP----HII 72
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ + I +V E G L+D++ + + D R +Q++ I + H ++
Sbjct: 73 KLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKPEN+LL D + +K+ DFG +
Sbjct: 131 HRDLKPENLLL---------DDNLN------------------VKIADFGLSNIMTDGNF 163
Query: 178 YIVS--TRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
S + +Y APEVI G + P D+WS G +L + G F E +
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD-DEFI--------- 213
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
++ K+ V P D +
Sbjct: 214 -----PNLFKK--------VNSCVYVMP--------------------------DFLSPG 234
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
L++ ++ DP R+T +E R P+F +
Sbjct: 235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 66/332 (19%), Positives = 113/332 (34%), Gaps = 89/332 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
GEG+F V+ + AIKI+ I K + E +V+ +L H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHP----FFV 93
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F + L ++RK SF R +++ + ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH DLKPEN+LL +I++ D+ ++ K + +
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTA----------KVLSP------ESKQARANS---- 191
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
V T Y +PE++ D+W++GCI+ +L G F N + ++++
Sbjct: 192 --FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGN--EYLIFQKII- 245
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ D+P + A D
Sbjct: 246 -------------------KLEYDFP-----------------------EKFFPKARD-- 261
Query: 297 HLLQGLLRYDPTDRLT------AREALRHPFF 322
L++ LL D T RL HPFF
Sbjct: 262 -LVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-23
Identities = 69/328 (21%), Positives = 108/328 (32%), Gaps = 79/328 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG D+ KE+VA+K + E EI + L +H V+ +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHP----NIVRFKE 83
Query: 62 WFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
H+ I+ E G LY+ + F D R +QLL +++ H + + H D
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRD 141
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NY 178
LK EN LL D S R +K+ DFG +
Sbjct: 142 LKLENTLL-------------------DGSPAPR------LKICDFGYSKSSVLHSQPKS 176
Query: 179 IVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
V T Y APEV+L + D+WS G L + G F+
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPRDY-------- 227
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
R + + + P+ + + H
Sbjct: 228 ----------RKTIQRILSVKYSIPDDI------------------------RISPECCH 253
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+ + DP R++ E H +F ++
Sbjct: 254 LISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 58/236 (24%), Positives = 94/236 (39%), Gaps = 43/236 (18%)
Query: 2 GEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V + W R + VAIK + + R+A ++E+ L ++ H V++
Sbjct: 17 GRGAFGVVCKAKW---RAKDVAIKQIES-ESERKAFIVELRQLSRV-NHP----NIVKLY 67
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS-FPIDLVREIARQLLECIAFMHDLC--- 115
N +C+V E G SLY+ L + Q + +A++H +
Sbjct: 68 GA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH DLKP N+LLV+ + +K+ DFG+ +
Sbjct: 126 LIHRDLKPPNLLLVAGGTV--------------------------LKICDFGTACDIQTH 159
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ + APEV G ++ CD++S G IL E+ T F M
Sbjct: 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 2e-22
Identities = 75/334 (22%), Positives = 121/334 (36%), Gaps = 95/334 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G GTFG+V + VA+KI+ + I+ I EI+ L+ +H +
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHP----HII 74
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ +V E + G L+D++ K+ R + +Q+L + + H +
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRHMV 132
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLKPENVLL D + K+ DFG + +
Sbjct: 133 VHRDLKPENVLL---------DAHMN------------------AKIADFGLSNMMSDGE 165
Query: 177 NYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ T +Y APEVI G + P DIWS G IL L G F E++
Sbjct: 166 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHV------ 216
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
+ K+ +R G P ++
Sbjct: 217 --------PTLFKK--------IRGGVFYIP--------------------------EYL 234
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ LL +L+ DP R T ++ H +F +D
Sbjct: 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 59/250 (23%), Positives = 92/250 (36%), Gaps = 54/250 (21%)
Query: 2 GEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI-----EIEVLQQLAKHD----- 50
G G FG+V W + VA+K R + I E ++ L KH
Sbjct: 16 GIGGFGKVYRAFW---IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIAL 71
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
+G C++ ++C+V E G L L + P D++ A Q+ +
Sbjct: 72 RGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMN 119
Query: 110 FMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
++HD +IH DLK N+L+ + +K+ DF
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKILKITDF 160
Query: 167 GSTTYERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
G + APEVI ++ D+WS G +L EL TGE F +
Sbjct: 161 GLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF---RGI 217
Query: 226 EHLAMMERVL 235
+ LA+ V
Sbjct: 218 DGLAVAYGVA 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 72/332 (21%), Positives = 121/332 (36%), Gaps = 87/332 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 57
G+G FG+V C R +M A K + IKK + AM E +L++ V
Sbjct: 193 GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK-VNS----RFVV 247
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ ++ ++ +C+V + G L + FP A ++ + +H +
Sbjct: 248 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
++ DLKPEN+LL +I++ D + + G T R
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA-------------------VHVPEGQTIKGR--- 345
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERVL 235
V T Y APEV+ +T+ D W++GC+L E+ G++ FQ + ++ + V
Sbjct: 346 ---VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 402
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
++ E S ++
Sbjct: 403 --------------------EVPEEYSER-FSPQAR------------------------ 417
Query: 296 THLLQGLLRYDPTDRL-----TAREALRHPFF 322
L LL DP +RL +ARE HP F
Sbjct: 418 -SLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 62/335 (18%), Positives = 115/335 (34%), Gaps = 93/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
GEG +G+V +R +E VA+KIV + I EI + + L H+ V+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE----NVVKF 70
Query: 60 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
N + E G L+D + + P + QL+ + ++H + + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 177
D+KPEN+LL D +K+ DFG +T + ++
Sbjct: 129 RDIKPENLLL-------------------DERD--------NLKISDFGLATVFRYNNRE 161
Query: 178 YIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+++ Y APE++ + P D+WS G +L + GE + +
Sbjct: 162 RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSD------ 213
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ Y W + +D
Sbjct: 214 --------SCQEYSDWKE-KKTY----LNPW------------------------KKIDS 236
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ LL +L +P+ R+T + + ++ +
Sbjct: 237 AP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-21
Identities = 66/335 (19%), Positives = 118/335 (35%), Gaps = 93/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRC- 56
G G FG+V C + +M A+K + IK + + E +L ++ D C
Sbjct: 198 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-----CP 252
Query: 57 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
V + F + + + + + G L+ L ++ F +R A +++ + MH+
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN 310
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+++ DLKP N+LL ++++ D + K +
Sbjct: 311 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------------------KPHAS 350
Query: 174 PDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ + +
Sbjct: 351 ------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
L ++ P
Sbjct: 405 MTL--------------------TMAVELP-----------------------DSFSPEL 421
Query: 293 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL+GLL+ D RL A+E PFF
Sbjct: 422 RS---LLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 58/356 (16%), Positives = 112/356 (31%), Gaps = 112/356 (31%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMIEIEVLQQLAKHDKGGNRCV-- 57
G+G++G V ++ A+K++ + + + + A R
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 58 QIRN-------------------WFDY-RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDL 96
Q+ D +H+ +VFE + + + D
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK---PLSEDQ 138
Query: 97 VREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156
R + L++ I ++H +IH D+KP N+L+
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-------------------GEDG----- 174
Query: 157 KSSAIKVIDFG-STTYERPDQNYIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCI 208
IK+ DFG S ++ D ++S + APE + + D+W++G
Sbjct: 175 ---HIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
Query: 209 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASR 268
L G+ F E + + + ++ L++P+
Sbjct: 230 LYCFVFGQCPFM-DERI--------------MCLHSK--------IKSQALEFPD----- 261
Query: 269 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
D + DL L+ +L +P R+ E HP+ TR
Sbjct: 262 ------------------QPDIAE-DLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 48/247 (19%), Positives = 79/247 (31%), Gaps = 56/247 (22%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--------EIEVLQQLAKHD--- 50
G+G FG V + + K +VAIK + E MI E+ ++ L H
Sbjct: 28 GKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIV 86
Query: 51 --KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLEC 107
G +V E + LY L + + +
Sbjct: 87 KLYGL--MHN---------PPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALG 134
Query: 108 IAFMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
I +M + ++H DL+ N+ L S + KV D
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLD----------------------ENAPVCAKVAD 172
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY--PCDIWSVGCILVELCTGEALFQTHE 223
FG + + ++ + APE I +Y D +S IL + TGE F +
Sbjct: 173 FGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF---D 229
Query: 224 NLEHLAM 230
+ +
Sbjct: 230 EYSYGKI 236
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 7e-21
Identities = 75/334 (22%), Positives = 121/334 (36%), Gaps = 95/334 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G GTFG+V VA+KI+ + I+ I EI+ L+ +H +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHP----HII 79
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + I +V E + G L+D++ KN R + +Q+L + + H +
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLKPENVLL D + K+ DFG + +
Sbjct: 138 VHRDLKPENVLL---------DAHMN------------------AKIADFGLSNMMSDGE 170
Query: 177 NYIVSTR----HYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
+ T +Y APEVI G + P DIWS G IL L G F +++
Sbjct: 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHV------ 221
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
+ K+ + G P +
Sbjct: 222 --------PTLFKK--------ICDGIFYTP--------------------------QYL 239
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ LL+ +L+ DP R T ++ H +F +D
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-21
Identities = 78/330 (23%), Positives = 121/330 (36%), Gaps = 91/330 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G+G+FG+V + D +++VAIKI+ + E I EI VL Q +
Sbjct: 31 GKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPY----VTKY 85
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + I+ E L G S D L + I R++L+ + ++H IH
Sbjct: 86 YGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIH 142
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYERPD 175
D+K NVLL +K+ DFG T +
Sbjct: 143 RDIKAANVLLSE---------------------------HGEVKLADFGVAGQLTDTQIK 175
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERV 234
+N V T + APEVI + DIWS+G +EL GE + H M +V
Sbjct: 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------PM--KV 227
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
L +P++ P L+ ++S
Sbjct: 228 LFLIPKN----------------------------------NPPTLEG------NYSK-P 246
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L ++ L +P+ R TA+E L+H F R
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFILR 276
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 62/335 (18%), Positives = 115/335 (34%), Gaps = 93/335 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
GEG +G+V +R +E VA+KIV + I EI + + L H+ V+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHEN----VVKF 70
Query: 60 RNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
N + E G L+D + + P + QL+ + ++H + + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLHGIGITH 128
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 177
D+KPEN+LL D +K+ DFG +T + ++
Sbjct: 129 RDIKPENLLL-------------------DERD--------NLKISDFGLATVFRYNNRE 161
Query: 178 YIVSTR----HYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+++ Y APE++ + P D+WS G +L + GE + +
Sbjct: 162 RLLNKMCGTLPYVAPELLKRRE--FHAEPVDVWSCGIVLTAMLAGELPWDQPSD------ 213
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ Y W + +D
Sbjct: 214 --------SCQEYSDWKE-KKTY----LNPW------------------------KKIDS 236
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325
+ LL +L +P+ R+T + + ++ +
Sbjct: 237 AP---LALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 62/336 (18%), Positives = 113/336 (33%), Gaps = 92/336 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIE--VLQQLAKHDKGGNRCV 57
G G FG+V C + ++ A K + +KK + +E +L + V
Sbjct: 194 GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK-VHS----RFIV 248
Query: 58 QIRNWFDYRNHICIVFE-----KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ F+ + +C+V + +Y+ N F Q++ + +H
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIVSGLEHLH 306
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+I+ DLKPENVLL +++ D A+++ + T
Sbjct: 307 QRNIIYRDLKPENVLLDDDGNVRISDL------------------GLAVELKAGQTKTKG 348
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMM 231
T + APE++LG + + D +++G L E+ F+ E +E+ +
Sbjct: 349 Y------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
+RVL + +P+ S S
Sbjct: 403 QRVL--------------------EQAVTYPDK-FSPASK-------------------- 421
Query: 292 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
+ LL+ DP RL + HP F
Sbjct: 422 -----DFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-20
Identities = 49/234 (20%), Positives = 93/234 (39%), Gaps = 54/234 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----------K 51
G GT+GQV + + ++ AIK++ E EI +L++ + H K
Sbjct: 33 GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
+ + W +V E S+ D ++ + + + I R++L ++
Sbjct: 93 KNPPGMDDQLW--------LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 167
+H +IH D+K +NVLL +++ +K++DFG
Sbjct: 145 LHQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSA 177
Query: 168 STTYERPDQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 216
+N + T ++ APEVI + + D+WS+G +E+ G
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 68/331 (20%), Positives = 119/331 (35%), Gaps = 92/331 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG++G V + +E ++VAIK V ++ + + EI ++QQ +
Sbjct: 38 GEGSYGSVYKAIHKETGQIVAIKQVP-VESDLQEIIKEISIMQQC--------DSPHVVK 88
Query: 62 WFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ + IV E S+ D +R N ++ D + I + L+ + ++H + I
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKI 147
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST---TYERP 174
H D+K N+LL + K+ DFG T
Sbjct: 148 HRDIKAGNILLNT---------------------------EGHAKLADFGVAGQLTDTMA 180
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMER 233
+N ++ T + APEVI +G+ DIWS+G +E+ G+ H M R
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH------PM--R 232
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ +P P + + +
Sbjct: 233 AIFMIPT----------------------------------NPPPTFRK-----PELWSD 253
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ T ++ L P R TA + L+HPF
Sbjct: 254 NFTDFVKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-20
Identities = 67/331 (20%), Positives = 119/331 (35%), Gaps = 93/331 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G G+FG+V+ +E A+KI+ + K ++ + E +LQ + V
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP----FLV 104
Query: 58 QIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F +++ +V E G ++ LR+ F R A Q++ ++H L +
Sbjct: 105 KLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLKPEN+L+ Y I+V DFG +
Sbjct: 163 IYRDLKPENLLIDQQGY---------------------------IQVTDFGFAKRVKGRT 195
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ T APE+IL G+ D W++G ++ E+ G F + + + E+++
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQ--PIQIYEKIV- 251
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
G++ +P H D
Sbjct: 252 -------------------SGKVRFP-----------------------SHFSSDLKD-- 267
Query: 297 HLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL+ LL+ D T R + H +F
Sbjct: 268 -LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 47/223 (21%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQIR 60
GEG+ G V ++ VA+K++ K+ R + E+ +++ +H +
Sbjct: 54 GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHF-------NVV 105
Query: 61 NWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ + ++ E L G +L D + + I + +L+ +A++H +
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQI---ATVCEAVLQALAYLHAQGV 162
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG---STTYER 173
IH D+K +++LL +K+ DFG + +
Sbjct: 163 IHRDIKSDSILLTL---------------------------DGRVKLSDFGFCAQISKDV 195
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
P + +V T ++ APEVI + DIWS+G +++E+ GE
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 46/223 (20%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQIR 60
G+G G V D + VAI+ + ++ ++ +I EI V+++ K+ I
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-------NIV 80
Query: 61 NWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
N+ D + + +V E L G SL D + + I + R+ L+ + F+H +
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQI---AAVCRECLQALEFLHSNQV 137
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST---TYER 173
IH D+K +N+LL ++K+ DFG T E+
Sbjct: 138 IHRDIKSDNILLGM---------------------------DGSVKLTDFGFCAQITPEQ 170
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
++ +V T ++ APEV+ + DIWS+G + +E+ GE
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 62/333 (18%), Positives = 116/333 (34%), Gaps = 86/333 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G G +G V + +++A+K +R +E + ++++ + V
Sbjct: 16 GRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP----FTVTF 71
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD-LCM 116
+ I E + +SL F ++ + ++ P D++ +IA +++ + +H L +
Sbjct: 72 YGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KP NVL+ + +K+ D+ S + A
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGIS----------GYLVDDVA-------KDID----- 169
Query: 177 NYIVSTRHYRAPEVILG----LGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLAMM 231
+ Y APE I G++ DIWS+G ++EL + + + L +
Sbjct: 170 ---AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV 226
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
V P P +L P S E
Sbjct: 227 --VEEPSP------------------QL--PADKFSAE---------------------- 242
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
L+ + +R T E ++HPFFT
Sbjct: 243 ---FVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 50/224 (22%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
MG GT GQV + R+ ++A+K +R G K+ + +++++V+ + VQ
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP----YIVQ 88
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMI 117
F + I E +G+ ++ P ++ ++ +++ + ++ + +I
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVI 147
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+KP N+LL IK+ D+ S R+ A ++
Sbjct: 148 HRDVKPSNILLDERGQIKLCDFGIS----------GRLVDDKA---------------KD 182
Query: 178 YIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILVELCTGE 216
Y APE I + D+WS+G LVEL TG+
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 9e-19
Identities = 72/346 (20%), Positives = 119/346 (34%), Gaps = 92/346 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G G F +V ++ ++ A+KI+ + K E + E +VL
Sbjct: 70 GRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVN-GDRR----WIT 124
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ F N++ +V E G L L K R P ++ R +++ I +H L
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVHRLGY 183
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H D+KP+N+LL +I++ D+ S L K+ G+
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCL------------------KLRADGTVR-----S 220
Query: 177 NYIVSTRHYRAPEVILGLGWTY-------PCDIWSVGCILVELCTGEALFQTHENLEHLA 229
V T Y +PE++ +G CD W++G E+ G+ F ++
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTA--E 277
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+++ + L P + V
Sbjct: 278 TYGKIVH------------------YKEHLSLPLVD--------------------EGVP 299
Query: 290 HSAGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 329
A D +Q LL P RL A + HPFF D LR
Sbjct: 300 EEARD---FIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-19
Identities = 72/335 (21%), Positives = 115/335 (34%), Gaps = 98/335 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIV--RGIKKYREAAMI--EIEVLQQLAKHDKGGNRCV 57
G G+FG V D E+VAIK + G + + I E+ LQ+L R
Sbjct: 63 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL--------RHP 114
Query: 58 QIRNWFD---YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ + +V E S D L + + + + L+ +A++H
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
MIH D+K N+LL +K+ DFG ++
Sbjct: 174 NMIHRDVKAGNILLSE---------------------------PGLVKLGDFGSASIMAP 206
Query: 174 PDQNYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHLA 229
N V T ++ APEVIL + + D+WS+G +EL + LF + A
Sbjct: 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------A 258
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
M L + Q+ + P LQ+
Sbjct: 259 M--SALYHIAQN----------------------------------ESPALQS------G 276
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
H + + + L+ P DR T+ L+H F R
Sbjct: 277 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 95/335 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
+G+G+FG+V+ + E+ A+KI++ E M+E VL K
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FL 404
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
Q+ + F + + V E + G L F A ++ + F+
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTT----- 499
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
T Y APE+I + D W+ G +L E+ G+A F+ + E + + ++
Sbjct: 500 -KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM 555
Query: 236 G---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
P+ M S+E++
Sbjct: 556 EHNVAYPKSM------------------------SKEAV--------------------- 570
Query: 293 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
+ +GL+ P RL R+ H FF
Sbjct: 571 ----AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 56/244 (22%), Positives = 93/244 (38%), Gaps = 49/244 (20%)
Query: 2 GEGTFGQVLE-CWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G+FG V W VA+KI+ + + E+ ++++L +H N V
Sbjct: 46 GAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHP---N-IV 97
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR-SFPIDLVREIARQLLECIAFMH--D 113
++ IV E L SLY L K+ R +A + + + ++H +
Sbjct: 98 LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H +LK N+L+ D Y +KV DFG + +
Sbjct: 158 PPIVHRNLKSPNLLV-------------------DKKY--------TVKVCDFGLSRLKA 190
Query: 174 PDQNYIVS---TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
S T + APEV+ D++S G IL EL T + + NL +
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW---GNLNPAQV 247
Query: 231 MERV 234
+ V
Sbjct: 248 VAAV 251
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 65/333 (19%), Positives = 116/333 (34%), Gaps = 97/333 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+V ++ + AIK ++ + + M+E VL +H
Sbjct: 26 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FLT 81
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + ++ V E L G L + F + A +++ + F+H +
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 139
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 173
++ DLK +N+LL +IK+ D+ M K + + + T
Sbjct: 140 VYRDLKLDNILLDKDGHIKIADFG--------------MCKEN----MLGDAKTNTFCGT 181
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
PD Y APE++LG + + D WS G +L E+ G++ F + E +
Sbjct: 182 PD---------YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS 229
Query: 234 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ P+ + +E+
Sbjct: 230 IRMDNPFYPRWL------------------------EKEAK------------------- 246
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALR-HPFF 322
LL L +P RL R +R HP F
Sbjct: 247 ------DLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 64/332 (19%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G++ +VL ++ + A+K+V+ + + E V +Q + H V
Sbjct: 18 GRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 73
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 74 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 131
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 167
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 224
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
++ + + ++ +++PR + A
Sbjct: 225 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 248
Query: 297 HLLQGLLRYDPTDRL------TAREALRHPFF 322
+L+ L DP +RL + HPFF
Sbjct: 249 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 64/336 (19%), Positives = 112/336 (33%), Gaps = 88/336 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G G +G V + + +++A+K +R +E + +++V+ + + VQ
Sbjct: 31 GRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP----YIVQF 86
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHD-LC 115
I E + +S F + P +++ +I ++ + + + L
Sbjct: 87 YGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY--ER 173
+IH D+KP N+LL S IK+ DFG + +
Sbjct: 147 IIHRDIKPSNILLDR---------------------------SGNIKLCDFGISGQLVDS 179
Query: 174 PDQNYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLEHL 228
+ R Y APE I G+ D+WS+G L EL TG + + + L
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQL 239
Query: 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288
+ V G PQ L + E S
Sbjct: 240 TQV--VKGDPPQ--LS---------------NSEEREFSPS------------------- 261
Query: 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ + L D + R +E L+HPF
Sbjct: 262 ------FINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-18
Identities = 69/340 (20%), Positives = 115/340 (33%), Gaps = 111/340 (32%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G G+FG+V R A+K+++ + + ++ E +L + H +
Sbjct: 15 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP----FII 69
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F I ++ + + G L+ LRK + FP + + A ++ + ++H +
Sbjct: 70 RMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STT 170
I+ DLKPEN+LL D H IK+ DFG T
Sbjct: 128 IYRDLKPENILL---------DKNG--H----------------IKITDFGFAKYVPDVT 160
Query: 171 YER---PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
Y PD Y APEV+ + D WS G ++ E+ G F N
Sbjct: 161 YTLCGTPD---------YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF-YDSN--T 208
Query: 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 287
+ E++L L +P
Sbjct: 209 MKTYEKIL--------------------NAELRFP-----------------------PF 225
Query: 288 VDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
+ D LL L+ D + RL + HP+F
Sbjct: 226 FNEDVKD---LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 5e-18
Identities = 63/332 (18%), Positives = 125/332 (37%), Gaps = 81/332 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G++ +VL ++ + A+++V+ + + E V +Q + H V
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH----PFLV 116
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ + F + + V E + G L R P + R + ++ + ++H+ +
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 174
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLK +NVLL S +IK+ DY M K + G TT
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYG--------------MCKEG----LRPGDTT------ 210
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ T +Y APE++ G + + D W++G ++ E+ G + F + ++
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE--- 267
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
++ + + ++ +++PR + A
Sbjct: 268 ---DYLFQVI------------------------LEKQIRIPR-------SLSVKAAS-- 291
Query: 297 HLLQGLLRYDPTDRL------TAREALRHPFF 322
+L+ L DP +RL + HPFF
Sbjct: 292 -VLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 52/244 (21%), Positives = 91/244 (37%), Gaps = 63/244 (25%)
Query: 2 GEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHDK----- 51
G G+FG V + W + VA+K++ + + E+ VL++ +H
Sbjct: 33 GSGSFGTVYKGKWHGD----VAVKMLN-VTAPTPQQLQAFKNEVGVLRKT-RHVNILLFM 86
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
G + IV + GSSLY L + F + + +IARQ + +
Sbjct: 87 GY--STA--------PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDY 135
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 167
+H +IH DLK N + + + +K+ DFG
Sbjct: 136 LHAKSIIHRDLKSNN-IFLHEDNT--------------------------VKIGDFGLAT 168
Query: 168 --STTYERPDQNYIVSTRHYRAPEVILGLGW---TYPCDIWSVGCILVELCTGEALFQTH 222
S + + + APEVI ++ D+++ G +L EL TG+ +
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
Query: 223 ENLE 226
N +
Sbjct: 229 NNRD 232
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-17
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRCVQIR 60
G+G FG+V + ++E + A K++ + I EIE+L H V++
Sbjct: 28 GDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPY----IVKLL 82
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + + I+ E G ++ + + + R ++ + RQ+LE + F+H +IH
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST---TYERPDQ 176
DLK NVL+ I++ DFG + +
Sbjct: 142 DLKAGNVLMTL---------------------------EGDIRLADFGVSAKNLKTLQKR 174
Query: 177 NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGE 216
+ + T ++ APEV++ + Y DIWS+G L+E+ E
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 69/337 (20%), Positives = 119/337 (35%), Gaps = 101/337 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+V+ + E+ A+KI++ + + + M+E VL K
Sbjct: 29 GKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP----FLT 84
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ + F + + V E + G L F A ++ + F+ +
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE---R 173
I+ DLK +NV+L S +IK+ D+ M K + I G TT
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFG--------------MCKEN----IWDGVTTKTFCGT 184
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
PD Y APE+I + D W+ G +L E+ G+A F E+ + + +
Sbjct: 185 PD---------YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDE--LFQS 232
Query: 234 VLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
++ P+ M S+E++
Sbjct: 233 IMEHNVAYPKSM------------------------SKEAV------------------- 249
Query: 291 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
+ +GL+ P RL R+ H FF
Sbjct: 250 ------AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 71/345 (20%), Positives = 119/345 (34%), Gaps = 97/345 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI--EIEVLQQLAKHDKGGNRCVQI 59
G G V + +KE VAIK + K + EI+ + Q H I
Sbjct: 24 GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHP-------NI 75
Query: 60 RNWFD---YRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLV---REIA---RQLLECIA 109
+++ ++ + +V + L G S+ D ++ + V IA R++LE +
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-- 167
++H IH D+K N+LL ++++ DFG
Sbjct: 136 YLHKNGQIHRDVKAGNILLGE---------------------------DGSVQIADFGVS 168
Query: 168 ---STTYERPDQ---NYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEA-LF 219
+T + V T + APEV+ G+ + DIWS G +EL TG A
Sbjct: 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
Query: 220 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 279
+ M +VL Q+ ++ + + +
Sbjct: 229 KYP------PM--KVLMLTLQNDPPSLETGVQDKEMLKKY-------GKS---------- 263
Query: 280 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
++ L+ DP R TA E LRH FF +
Sbjct: 264 ---------------FRKMISLCLQKDPEKRPTAAELLRHKFFQK 293
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-17
Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 60/254 (23%)
Query: 2 GEGTFGQVLE-CWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G+G FGQV W E VAI+++ + +A E+ +Q +H+ V
Sbjct: 42 GKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHEN----VV 92
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
H+ I+ G +LY +R ++ R+IA+++++ + ++H +
Sbjct: 93 LFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DLK +NV D + + DFG + Q
Sbjct: 152 LHKDLKSKNVFY---------DNGK-------------------VVITDFGLFSISGVLQ 183
Query: 177 NYIVS--------TRHYRAPEVILGLGWTYP---------CDIWSVGCILVELCTGEALF 219
+ APE+I L D++++G I EL E F
Sbjct: 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
Query: 220 QTHENLEHLAMMER 233
+T + M
Sbjct: 244 KTQPAEAIIWQMGT 257
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 66/333 (19%), Positives = 119/333 (35%), Gaps = 89/333 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G G FG+V + +++ A+K++ + K ++A E +++ A V
Sbjct: 78 GRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSP----WVV 132
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ F ++ +V E + G L + + P R +++ + +H +
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
IH D+KP+N+LL S ++K+ D+ + +M K ++ T PD
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTC----------MKMNKEGMVRCDTAVGT----PD- 234
Query: 177 NYIVSTRHYRAPEVILGLGWTYP----CDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
Y +PEV+ G CD WSVG L E+ G+ F ++L
Sbjct: 235 --------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLV--GTYS 283
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
+++ + L +P+ + K+
Sbjct: 284 KIMN------------------HKNSLTFPDDNDISKEAKN------------------- 306
Query: 293 GDLTHLLQGLLRYDPTDRLT---AREALRHPFF 322
L+ L D RL E RH FF
Sbjct: 307 -----LICAFLT-DREVRLGRNGVEEIKRHLFF 333
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 4e-17
Identities = 55/333 (16%), Positives = 113/333 (33%), Gaps = 93/333 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 56
G+G+FG+V + K+M A+K + + E E++++Q L
Sbjct: 24 GKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL--------EHP 75
Query: 57 --VQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
V + F + +V + LG L L++N F + V+ +L+ + ++ +
Sbjct: 76 FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN 133
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+IH D+KP+N+LL ++ + D+ + ++ +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIA-------------------AMLPRETQITT- 173
Query: 174 PDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ T+ Y APE+ G G+++ D WS+G EL G + + +
Sbjct: 174 -----MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ + +P +
Sbjct: 229 VHTFE--------------------TTVVTYPSAWSQ----------------------- 245
Query: 291 SAGDLTHLLQGLLRYDPTDRL-TAREALRHPFF 322
++ LL+ LL +P R + P+
Sbjct: 246 ---EMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 69/335 (20%), Positives = 117/335 (34%), Gaps = 96/335 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+V+ +E ++ A+K+++ I + + M E +L H
Sbjct: 32 GKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP----FLT 87
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
Q+ F + + V E + G L R F R A +++ + F+HD +
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALMFLHDKGI 145
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
I+ DLK +NVLL + K+ D+ M K I G TT
Sbjct: 146 IYRDLKLDNVLLDHEGHCKLADFG--------------MCKEG----ICNGVTT------ 181
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
T Y APE++ + + D W++G +L E+ G A F+ + + E +L
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAILN 238
Query: 237 ---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
P + ++
Sbjct: 239 DEVVYPTWL------------------------HEDAT---------------------- 252
Query: 294 DLTHLLQGLLRYDPTDRL------TAREALRHPFF 322
+L+ + +PT RL LRHPFF
Sbjct: 253 ---GILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 77/336 (22%), Positives = 122/336 (36%), Gaps = 100/336 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC- 56
G+GTFG+V+ ++ A+KI+R I E A + E VLQ R
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT--------RHP 65
Query: 57 --VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
++ F + +C V E G L F + R F + R +++ + ++H
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+++ D+K EN++L +IK+ D+ + K I G+T
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDF--------------GLCKEG----ISDGATM--- 162
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMM 231
T Y APEV+ + D W +G ++ E+ G F Q HE L L +M
Sbjct: 163 ---KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
E + P+ + S E+
Sbjct: 220 EEI--RFPRTL------------------------SPEAK-------------------- 233
Query: 292 AGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL GLL+ DP RL A+E + H FF
Sbjct: 234 -----SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 66/344 (19%), Positives = 124/344 (36%), Gaps = 90/344 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G G FG+V + ++ A+KI+ + K E A E +VL
Sbjct: 83 GRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-GDSK----WIT 137
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F N++ +V + G L L K R P ++ R +++ I +H L
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHY 196
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H D+KP+N+L+ + +I++ D+ S ++ + ++ T PD
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSC----------LKLMEDGTVQSSVAVGT----PD- 241
Query: 177 NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
Y +PE++ + + CD WS+G + E+ GE F E+L
Sbjct: 242 --------YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLV--ETY 290
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
+++ + R +P V
Sbjct: 291 GKIMN------------------HKERFQFP-----------------------TQVTDV 309
Query: 292 AGDLTHLLQGLLRYDPTDRLT---AREALRHPFFTR---DHLRR 329
+ + L++ L+ RL + +HPFF+ D++R
Sbjct: 310 SENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGIDWDNIRN 352
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 77/333 (23%), Positives = 122/333 (36%), Gaps = 94/333 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+VL + + A+K+++ I K +E M E VL + KH V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP----FLV 102
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + + V + + G L F R F R A ++ + ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
++ DLKPEN+LL S +I + D+ + K + I+ STT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFG--------------LCKEN----IEHNSTTST---- 198
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL- 235
T Y APEV+ + D W +G +L E+ G F + E M + +L
Sbjct: 199 --FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN 253
Query: 236 GPL--PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
PL ++ + +
Sbjct: 254 KPLQLKPNI------------------------TNSAR---------------------- 267
Query: 294 DLTHLLQGLLRYDPTDRL----TAREALRHPFF 322
HLL+GLL+ D T RL E H FF
Sbjct: 268 ---HLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 7e-17
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 8/128 (6%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G+FG + D E VAIK+ K+ + + E ++ + + +GG IR
Sbjct: 18 GSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMM----QGGVGIPTIR- 71
Query: 62 WF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
W ++ +V E LG SL D L R F + V +A Q++ I ++H IH D
Sbjct: 72 WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 130
Query: 121 LKPENVLL 128
+KP+N L+
Sbjct: 131 VKPDNFLM 138
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-17
Identities = 43/225 (19%), Positives = 90/225 (40%), Gaps = 34/225 (15%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDK-----GGNR 55
G+G FGQ ++ RE E++ +K + + + + E++V++ L +H G
Sbjct: 19 GKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGV-- 75
Query: 56 CVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ + + E + G +L ++ + +P A+ + +A++H +
Sbjct: 76 LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF---KRMPKSSAIKVIDFGSTTY 171
+IH DL N L+ ++ + V D F + M
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVAD-------------FGLARLMVDEKTQPEGLRSLKKP 174
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
+R + +V ++ APE+I G + D++S G +L E+
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 77/335 (22%), Positives = 126/335 (37%), Gaps = 95/335 (28%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAA--MIEIEVLQQLAKHDKGGNRC 56
+G+GTFG+V+ ++ A+KI++ I E A + E VLQ ++H
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP----FL 210
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DL 114
++ F + +C V E G L F + R F D R +++ + ++H +
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 268
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+++ DLK EN++L +IK+ D+ + K I G+T
Sbjct: 269 NVVYRDLKLENLMLDKDGHIKITDF--------------GLCKEG----IKDGATM---- 306
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALF--QTHENLEHLAMME 232
T Y APEV+ + D W +G ++ E+ G F Q HE L L +ME
Sbjct: 307 --KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
+ P+ + E+
Sbjct: 365 EI--RFPRTL------------------------GPEAK--------------------- 377
Query: 293 GDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL GLL+ DP RL A+E ++H FF
Sbjct: 378 ----SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 38/129 (29%), Positives = 61/129 (47%), Gaps = 8/129 (6%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+G G FG++ + E VAIK+ + +E +QL G+ Q+
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GSGDGIPQVY 71
Query: 61 NWF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+F + +V E LG SL D L R+F + V IA QL+ + ++H +I+
Sbjct: 72 -YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYR 129
Query: 120 DLKPENVLL 128
D+KPEN L+
Sbjct: 130 DVKPENFLI 138
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 8/128 (6%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G+FG++ + + E VAIK+ K+ + E ++ + L +GG +R
Sbjct: 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRIL----QGGTGIPNVR- 69
Query: 62 WF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
WF ++ +V + LG SL D L R + V +A Q++ + F+H +H D
Sbjct: 70 WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
Query: 121 LKPENVLL 128
+KP+N L+
Sbjct: 129 IKPDNFLM 136
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-16
Identities = 36/250 (14%), Positives = 75/250 (30%), Gaps = 60/250 (24%)
Query: 1 MGEGTFGQVLE-CWDRERKEMVAIKIVRGIKKYREAAMI----EIEVLQQLAKHD----- 50
+ E G++ + W + + +K+++ ++ + E L+ H
Sbjct: 18 LNENHSGELWKGRW---QGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRIF-SHPNVLPV 72
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G C H ++ + SLY+ L + + A + +A
Sbjct: 73 LGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA 125
Query: 110 FMHDL--CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
F+H L + L +V++ D ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMI-------------------DEDM--------TARISMAD 158
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYP---CDIWSVGCILVELCTGEALFQTHEN 224
+ + APE + D+WS +L EL T E F +
Sbjct: 159 VKFSF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF---AD 213
Query: 225 LEHLAMMERV 234
L ++ + +V
Sbjct: 214 LSNMEIGMKV 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 34/128 (26%), Positives = 56/128 (43%), Gaps = 8/128 (6%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG+FG + E + + VAIK + E + L G +
Sbjct: 19 GEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AGCTGIPNVY- 72
Query: 62 WF-DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+F H +V + LG SL D L R F + V A+Q+L + +H+ +++ D
Sbjct: 73 YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 131
Query: 121 LKPENVLL 128
+KP+N L+
Sbjct: 132 IKPDNFLI 139
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 6e-16
Identities = 51/242 (21%), Positives = 90/242 (37%), Gaps = 59/242 (24%)
Query: 2 GEGTFGQVLECWDR---ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G G + DR R V +K + G + + AM E + L ++ H
Sbjct: 89 AHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQAMAMAERQFLAEV-VHP----SI 141
Query: 57 VQIRNWFDYRNHIC-----IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
VQI N+ ++ + IV E + G SL + P+ ++L +++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----QKLPVAEAIAYLLEILPALSY 197
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG--- 167
+H + +++ DLKPEN++L + +K+ID G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ----------------------------LKLIDLGAVS 229
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227
Y+ T ++APE++ G T DI++VG L L ++
Sbjct: 230 RIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTR-NGRYVDG 283
Query: 228 LA 229
L
Sbjct: 284 LP 285
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 7e-16
Identities = 66/341 (19%), Positives = 127/341 (37%), Gaps = 106/341 (31%)
Query: 2 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAA--MIEIEVLQQLAKHDKGG 53
G+G +G+V + ++ A+K+++ ++ ++ A E +L+++
Sbjct: 26 GKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV------- 78
Query: 54 NRC---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
+ V + F + ++ E L G L F++ F D ++ +
Sbjct: 79 -KHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDTACFYLAEISMALG 135
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
+H +I+ DLKPEN++L ++K+ D+ K+S I G+
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC----KES--------------IHDGTV 177
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
T+ T Y APE+++ G D WS+G ++ ++ TG F T EN +
Sbjct: 178 THT------FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF-TGENRK--K 228
Query: 230 MMERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
++++L LP ++ ++E+
Sbjct: 229 TIDKILKCKLNLPPYL------------------------TQEAR--------------- 249
Query: 287 HVDHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL+ LL+ + RL A E HPFF
Sbjct: 250 ----------DLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 30/144 (20%), Positives = 58/144 (40%), Gaps = 22/144 (15%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG + + + E A +V+ + E++ Q++AK D + +
Sbjct: 46 GSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL 105
Query: 62 ---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQL 104
YR +V E+LG L +N +F V ++ ++
Sbjct: 106 DYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKSTVLQLGIRM 160
Query: 105 LECIAFMHDLCMIHTDLKPENVLL 128
L+ + ++H+ +H D+K N+LL
Sbjct: 161 LDVLEYIHENEYVHGDIKAANLLL 184
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 75/339 (22%), Positives = 125/339 (36%), Gaps = 104/339 (30%)
Query: 2 GEGTFGQVL---ECWDRERKEMVAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNR 55
G+G+FG+V + + +++ A+K+++ + R +E ++L ++
Sbjct: 33 GQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV--------N 84
Query: 56 C---VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
V++ F + ++ + L G L F R + F + V+ +L + +
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
H L +I+ DLKPEN+LL +IK+ D+ S K+S ID Y
Sbjct: 143 HSLGIIYRDLKPENILLDEEGHIKLTDFGLS----KES--------------IDHEKKAY 184
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
T Y APEV+ G T D WS G ++ E+ TG FQ + E M
Sbjct: 185 S------FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TM 235
Query: 232 ERVLG---PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288
+L +PQ + S E+
Sbjct: 236 TMILKAKLGMPQFL------------------------SPEAQ----------------- 254
Query: 289 DHSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL+ L + +P +RL E RH FF
Sbjct: 255 --------SLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 27/149 (18%), Positives = 54/149 (36%), Gaps = 29/149 (19%)
Query: 2 GEGTFGQV--------LECWDRERKEMVAIKI-------VRGIKKY-REAAMIEIEVLQQ 45
G + L C +K+ ++K+ + R A +++ ++
Sbjct: 51 TRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKK 110
Query: 46 LAKHDKGG-NRCVQIRNWF-----DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVRE 99
L C+ F YR +V LG SL L + V +
Sbjct: 111 LYSTPLLAIPTCM----GFGVHQDKYR---FLVLPSLGRSLQSALDVSPKHVLSERSVLQ 163
Query: 100 IARQLLECIAFMHDLCMIHTDLKPENVLL 128
+A +LL+ + F+H+ +H ++ EN+ +
Sbjct: 164 VACRLLDALEFLHENEYVHGNVTAENIFV 192
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-15
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 57/279 (20%)
Query: 2 GEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDN----I 73
Query: 57 VQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ + + ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICKGMEYLG 131
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
IH DL N+ LV +E +K+ DFG T
Sbjct: 132 TKRYIHRDLATRNI-LVENENR--------------------------VKIGDFGLTKVL 164
Query: 173 RPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
D+ + APE + ++ D+WS G +L EL T ++
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKS 219
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 264
A R++G Q + H + ++ RL P+G
Sbjct: 220 PPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 256
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 8e-15
Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 57/279 (20%)
Query: 2 GEGTFGQVLEC-WDRE---RKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G+G FG V C +D E+VA+K ++ +++ EIE+L+ L +HD
Sbjct: 50 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDN----I 104
Query: 57 VQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V+ + + R ++ ++ E GS L D+L+K+ R I L+ + Q+ + + ++
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYLQKHKERIDHIKLL-QYTSQICKGMEYLG 162
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
IH DL N+ LV +E +K+ DFG T
Sbjct: 163 TKRYIHRDLATRNI-LVENENR--------------------------VKIGDFGLTKVL 195
Query: 173 RPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226
D+ Y APE + ++ D+WS G +L EL T ++
Sbjct: 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-----KSKS 250
Query: 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 264
A R++G Q + H + ++ RL P+G
Sbjct: 251 PPAEFMRMIGNDKQGQMI--VFHLIELLKNNGRLPRPDG 287
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 69/338 (20%), Positives = 121/338 (35%), Gaps = 92/338 (27%)
Query: 2 GEGTFGQVL---ECWDRERKEMVAIKIVR-----GIKKYREAAMIEIEVLQQLAKHDKGG 53
G G +G+V + + ++ A+K+++ K E E +VL+ + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP--- 119
Query: 54 NRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V + F + ++ + + G L+ L + F V+ +++ + +H
Sbjct: 120 -FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLH 176
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
L +I+ D+K EN+LL S+ ++ + D+ S K+ V D Y+
Sbjct: 177 KLGIIYRDIKLENILLDSNGHVVLTDFGLS----KEF-------------VADETERAYD 219
Query: 173 RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLA 229
T Y AP+++ G G D WS+G ++ EL TG + F E
Sbjct: 220 ------FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
+ R+L + +P Q +
Sbjct: 274 ISRRIL--------------------KSEPPYP-----------------------QEMS 290
Query: 290 HSAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
A D L+Q LL DP RL A E H FF
Sbjct: 291 ALAKD---LIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 55/296 (18%), Positives = 107/296 (36%), Gaps = 57/296 (19%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN----RC 56
G+G FG+V W R E VA+KI ++ EI L +H+ N
Sbjct: 51 GKGRFGEVWRGKW---RGEEVAVKIFSSREERSWFREAEIYQTVML-RHE---NILGFIA 103
Query: 57 VQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-- 113
++ + +V + SL+D+L + + ++ + ++A +A +H
Sbjct: 104 ADNKD-NGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEI 159
Query: 114 ------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167
+ H DLK +N+L+ + + D ++ + P
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR-------- 211
Query: 168 STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCILVELCTGEALFQT 221
V T+ Y APEV+ DI+++G + E+ ++
Sbjct: 212 ------------VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259
Query: 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 277
HE+ + P + M K V ++ R + P S E+++ + K+
Sbjct: 260 HEDYQLPYYDLVPSDPSVEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKI 309
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 65/350 (18%), Positives = 109/350 (31%), Gaps = 104/350 (29%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD----------K 51
G FG V + E VA+KI K E+ L + KH+ +
Sbjct: 33 ARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKR 89
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
G + V + ++ SL DFL+ N + + IA + +A+
Sbjct: 90 GTSVDVDL----------WLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAY 136
Query: 111 MHD----------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160
+H+ + H D+K +NVLL ++
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLL-------------------KNNLT-------- 169
Query: 161 IKVIDFG-----STTYERPDQNYIVSTRHYRAPEVI-----LGLGWTYPCDIWSVGCILV 210
+ DFG D + V TR Y APEV+ D++++G +L
Sbjct: 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 211 ELCTGEALFQTHENLEHLAMMERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASR 268
EL + E++ E +G P + M + V ++ R
Sbjct: 230 ELASRCTAA-DGPVDEYMLPFEEEIGQHPSLEDMQEVVVH------KKKRPVLR------ 276
Query: 269 ESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318
+ + + L I + DH D RL+A
Sbjct: 277 DYWQKHAGMAMLCETIEECWDH---------------DAEARLSAGCVGE 311
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 48/258 (18%), Positives = 80/258 (31%), Gaps = 77/258 (29%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---------- 50
G+G +G+V W + E VA+KI + E+ L +H+
Sbjct: 17 GKGRYGEVWRGSW---QGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFIASDM 72
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
+ Q+ ++ SLYD+L+ + I + +A
Sbjct: 73 TSRHSSTQL----------WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLA 119
Query: 110 FMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 161
+H + H DLK +N+L+ K +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILV-----------KKNGQ----------------C 152
Query: 162 KVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCI 208
+ D G ST N V T+ Y APEV+ DIW+ G +
Sbjct: 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212
Query: 209 LVELCTGEALFQTHENLE 226
L E+ E+ +
Sbjct: 213 LWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 9e-14
Identities = 65/355 (18%), Positives = 110/355 (30%), Gaps = 114/355 (32%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD---------- 50
G+G +G+V W R E VA+K+ ++ EI + +H+
Sbjct: 46 GKGRYGEVWMGKW---RGEKVAVKVFFTTEEASWFRETEIYQTVLM-RHENILGFIAADI 101
Query: 51 KGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
KG Q+ ++ + SLYD+L+ + + ++A + +
Sbjct: 102 KGTGSWTQL----------YLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLC 148
Query: 110 FMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAI 161
+H + H DLK +N+L+ K +
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILV-----------KKNGT----------------C 181
Query: 162 KVIDFG-------STTYERPDQNYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCI 208
+ D G T N V T+ Y PEV+ D++S G I
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI 241
Query: 209 LVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYV-----RRGRLDWPE 263
L E+ E + LP H L D E ++ R +P
Sbjct: 242 LWEVARRCVSGGIVEEYQ-----------LPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 264 GAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318
+S E L ++ L+ + H +P RLTA +
Sbjct: 291 RWSSDEC------LRQMGKLMTECWAH---------------NPASRLTALRVKK 324
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 28/147 (19%), Positives = 55/147 (37%), Gaps = 25/147 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA---MIEIEVLQQLAKHDKGGNRCVQ 58
G+G FG + D E V +K E++ Q+ AK ++
Sbjct: 44 GQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 59 IRN---------WF--------DYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIA 101
+ YR ++ ++ GS L N + F V +++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGSDLQKIYEANA-KRFSRKTVLQLS 158
Query: 102 RQLLECIAFMHDLCMIHTDLKPENVLL 128
++L+ + ++H+ +H D+K N+LL
Sbjct: 159 LRILDILEYIHEHEYVHGDIKASNLLL 185
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 49/228 (21%)
Query: 2 GEGTFGQVLEC-WDRE---RKEMVAIKIVRGIKKYREAAMI-EIEVLQQLAKHDKGGNRC 56
G+G FG V C +D +VA+K ++ ++ EI++L+ L D
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDF----I 86
Query: 57 VQIRN--WFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V+ R + R + +V E G L DFL+++ R L+ + Q+ + + ++
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGC-LRDFLQRHRARLDASRLL-LYSSQICKGMEYLG 144
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+H DL N+ LV SE +K+ DFG
Sbjct: 145 SRRCVHRDLAARNI-LVESEAH--------------------------VKIADFGLAKLL 177
Query: 173 RPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT 214
D++Y V + APE + ++ D+WS G +L EL T
Sbjct: 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 8e-13
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 38/153 (24%)
Query: 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129
+V E + G +L +++ + +D Q+L+ I HD+ ++H D+KP+N+L
Sbjct: 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL-- 143
Query: 130 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTR 183
+ + +K+ DFG T+ + N+++ T
Sbjct: 144 -------------------------IDSNKTLKIFDFGIAKALSETSLTQT--NHVLGTV 176
Query: 184 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
Y +PE G DI+S+G +L E+ GE
Sbjct: 177 QYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 9e-13
Identities = 66/283 (23%), Positives = 107/283 (37%), Gaps = 65/283 (22%)
Query: 2 GEGTFGQVLEC-WDRER---KEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK---- 51
GEG FG+V C +D E E VA+K ++ + EIE+L+ L H+
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKY 88
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C + D N I ++ E GS L ++L KN + + + A Q+ + +
Sbjct: 89 KG--ICTE-----DGGNGIKLIMEFLPSGS-LKEYLPKNKNKINLKQQL-KYAVQICKGM 139
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ +H DL NV LV SE+ +K+ DFG
Sbjct: 140 DYLGSRQYVHRDLAARNV-LVESEHQ--------------------------VKIGDFGL 172
Query: 169 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
T D+ Y APE ++ + D+WS G L EL T +
Sbjct: 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDS 228
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 264
++ ++ + Q + R+ ++ G RL P
Sbjct: 229 DSSPMALFLKMIGPTHGQMTVTRL----VNTLKEGKRLPCPPN 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 1e-12
Identities = 35/153 (22%), Positives = 59/153 (38%), Gaps = 36/153 (23%)
Query: 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129
IV E + G +L D + E+ + + F H +IH D+KP N++
Sbjct: 93 IVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM-- 148
Query: 130 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTR 183
+ ++A+KV+DFG + ++ T
Sbjct: 149 -------------------------ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 184 HYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216
Y +PE G D++S+GC+L E+ TGE
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 1e-12
Identities = 35/150 (23%), Positives = 51/150 (34%), Gaps = 37/150 (24%)
Query: 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136
G L LR+ I RQ+ + H H D+KPEN+L+
Sbjct: 118 GVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV-------- 167
Query: 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG------STTYERPDQNYIVSTRHYRAPEV 190
+ D ++DFG + V T +Y APE
Sbjct: 168 --------SADD-----------FAYLVDFGIASATTDEKLTQL--GNTVGTLYYMAPER 206
Query: 191 ILGLGWTYPCDIWSVGCILVELCTGEALFQ 220
TY DI+++ C+L E TG +Q
Sbjct: 207 FSESHATYRADIYALTCVLYECLTGSPPYQ 236
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 48/240 (20%), Positives = 94/240 (39%), Gaps = 42/240 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-----GGNRC 56
G G +G+V E ++ VA+K ++ E + E V++++ KH G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLG--VC 285
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ I+ E G+ L D+LR+ N + ++ +A Q+ + ++
Sbjct: 286 TR-------EPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
IH +L N L+ + +KV D+ S +Y IK
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIK------------ 384
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE + ++ D+W+ G +L E+ T G + + + + ++E+
Sbjct: 385 ----------WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 53/249 (21%), Positives = 97/249 (38%), Gaps = 56/249 (22%)
Query: 2 GEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G FG V + + +K++ VAIK+++ K E M E +++ QL + V
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY----IV 73
Query: 58 QIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
++ + +V E G L+ FL ++ E+ Q+ + ++
Sbjct: 74 RL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMKYL 126
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
+ +H DL NVLLV+ Y K+ DFG +
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKIS---------------------------DFGLSKA 159
Query: 172 ERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 224
D +Y + + APE I ++ D+WS G + E + G+ ++ +
Sbjct: 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
Query: 225 LEHLAMMER 233
E +A +E+
Sbjct: 220 PEVMAFIEQ 228
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 51/255 (20%), Positives = 94/255 (36%), Gaps = 61/255 (23%)
Query: 2 GEGTFGQVLE-------CWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDK-- 51
G+GTF ++ + + + + V +K++ + Y E+ ++ +L H
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLV 75
Query: 52 ---GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLE 106
G CV + +V E K GS L +L+KN + + E+A+QL
Sbjct: 76 LNYG--VCVC-------GDENILVQEFVKFGS-LDTYLKKNKNCINILWKL-EVAKQLAA 124
Query: 107 CIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDF 166
+ F+ + +IH ++ +N+LL+ E K + IK+ D
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGN-------------------PPFIKLSDP 165
Query: 167 GSTTYERPDQNYIVSTRHYR------APEVIL-GLGWTYPCDIWSVGCILVELCT-GEAL 218
G + ++ + PE I D WS G L E+C+ G+
Sbjct: 166 GIS---I----TVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 219 FQTHENLEHLAMMER 233
++ L E
Sbjct: 219 LSALDSQRKLQFYED 233
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 64/343 (18%), Positives = 109/343 (31%), Gaps = 79/343 (23%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGN--RCV- 57
G G +G V + + VA+K+ + I + + +HD N R +
Sbjct: 22 GRGRYGAVYKGSL---DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHD---NIARFIV 74
Query: 58 -QIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD- 113
R D R +V E GS L +L + + +A + +A++H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGS-LXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 114 --------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
+ H DL NVL+ + + D+ S+ + ++A
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA----- 185
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGL-------GWTYPCDIWSVGCILVELCTGEAL 218
V T Y APEV+ G D++++G I E+
Sbjct: 186 -----------ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 219 FQTHENLEHLAM-MERVLGPLP--QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVM 275
E++ M + +G P + M V R + R +PE +
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR------EKQRPKFPEAWKENS-----L 283
Query: 276 KLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318
+ L+ I D D RLTA+ A
Sbjct: 284 AVRSLKETIEDCWDQ---------------DAEARLTAQXAEE 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 57/250 (22%), Positives = 102/250 (40%), Gaps = 58/250 (23%)
Query: 2 GEGTFGQVLE-CWDRERKEM-VAIKIVRG---IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G G FG V + + ++ VA+KI++ ++ + E V+QQL +
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPY----I 80
Query: 57 VQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V++ +V E +LG L +L++N R + E+ Q+ + +
Sbjct: 81 VRM-----IGICEAESWMLVMEMAELGP-LNKYLQQN--RHVKDKNIIELVHQVSMGMKY 132
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+ + +H DL NVLLV+ Y K+ DFG +
Sbjct: 133 LEESNFVHRDLAARNVLLVTQHYAKIS---------------------------DFGLSK 165
Query: 171 YERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 223
R D+NY + H + APE I ++ D+WS G ++ E + G+ ++ +
Sbjct: 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 224 NLEHLAMMER 233
E AM+E+
Sbjct: 226 GSEVTAMLEK 235
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 66/283 (23%), Positives = 105/283 (37%), Gaps = 67/283 (23%)
Query: 2 GEGTFGQVLEC-WDRE---RKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK---- 51
GEG FG+V +D EMVA+K ++ ++R EI++L+ L H+
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKY 98
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C + +V E LGS L D+L +++ L+ A+Q+ E +
Sbjct: 99 KG--CCED-----AGAASLQLVMEYVPLGS-LRDYLPRHSIG--LAQLL-LFAQQICEGM 147
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
A++H IH DL NV L+ ++ + +K+ DFG
Sbjct: 148 AYLHAQHYIHRDLAARNV-LLDNDRL--------------------------VKIGDFGL 180
Query: 169 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
Y APE + + Y D+WS G L EL T
Sbjct: 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT----HCDS 236
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEG 264
+E + Q + R+ + + RG RL P+
Sbjct: 237 SQSPPTKFLELIGIAQGQMTVLRL----TELLERGERLPRPDK 275
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 50/245 (20%), Positives = 94/245 (38%), Gaps = 52/245 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-----GGNRC 56
G G +G+V E ++ VA+K ++ E + E V++++ KH G C
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLG--VC 78
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ I+ E G+ L D+LR+ N + ++ +A Q+ + ++
Sbjct: 79 TR-------EPPFYIITEFMTYGN-LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
IH DL N LV ++ +KV DFG +
Sbjct: 131 NFIHRDLAARNC-LVGENHL--------------------------VKVADFGLSRLMTG 163
Query: 175 DQNYIVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228
D Y + APE + ++ D+W+ G +L E+ T G + + + +
Sbjct: 164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222
Query: 229 AMMER 233
++E+
Sbjct: 223 ELLEK 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 44/240 (18%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K VQ+
Sbjct: 276 GQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK----LVQL- 327
Query: 61 NWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
Y I IV E GS L DFL+ + + + ++A Q+ +A++ +
Sbjct: 328 ----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK------------ 429
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 430 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 65/240 (27%), Positives = 105/240 (43%), Gaps = 44/240 (18%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+G FG+V W+ + VAIK ++ EA + E +V+++L +H+K VQ+
Sbjct: 193 GQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKL-RHEK----LVQL- 244
Query: 61 NWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
Y I IV E GS L DFL+ + + + ++A Q+ +A++ +
Sbjct: 245 ----YAVVSEEPIYIVTEYMSKGS-LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H DL+ N+L+ + KV D+ + +D+ Y R IK
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIK------------ 346
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE L +T D+WS G +L EL T G + N E L +ER
Sbjct: 347 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.7 bits (146), Expect = 1e-10
Identities = 50/250 (20%), Positives = 77/250 (30%), Gaps = 62/250 (24%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR---------GIKKYREAAMIEIEVLQQLAKHDK 51
+GEG FG+V + VAIKI+ +K E + EI + ++L+
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 52 G------------GNRCVQ-------IRNWFDYRN-----------------HICIVFEK 75
CVQ ++ W Y + I + FE
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI-HTDLKPENVLLVSSEYI 134
G L K + + + I QL +A H DL NVLL +
Sbjct: 146 GGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK 201
Query: 135 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL 194
K LH + + +ID+ + ER ++ G
Sbjct: 202 K-------LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV--SMDEDLFTGD 252
Query: 195 GWTYPCDIWS 204
G Y DI+
Sbjct: 253 G-DYQFDIYR 261
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 61/240 (25%), Positives = 101/240 (42%), Gaps = 44/240 (18%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG+V +++ K VA+K ++ EA + E V++ L +HD + V++
Sbjct: 197 GAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKLH 249
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ I I+ E + SL DFL+ + P+ + + + Q+ E +AF+ IH
Sbjct: 250 AVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DL+ N+ LVS+ + K+ DFG D Y
Sbjct: 309 DLRAANI-LVSASLV--------------------------CKIADFGLARVIE-DNEYT 340
Query: 180 VSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
+ APE I +T D+WS G +L+E+ T G + N E + +ER
Sbjct: 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 52/249 (20%), Positives = 97/249 (38%), Gaps = 56/249 (22%)
Query: 2 GEGTFGQVLE-CWDRERKEM-VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G FG V + + +K++ VAIK+++ K E M E +++ QL + V
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPY----IV 399
Query: 58 QIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
++ + +V E G L+ FL ++ E+ Q+ + ++
Sbjct: 400 RL-----IGVCQAEALMLVMEMAGGGP-LHKFLVGKREEIPVSNVA-ELLHQVSMGMKYL 452
Query: 112 HDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
+ +H +L NVLLV+ Y K+ DFG +
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKIS---------------------------DFGLSKA 485
Query: 172 ERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 224
D +Y + + APE I ++ D+WS G + E + G+ ++ +
Sbjct: 486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 225 LEHLAMMER 233
E +A +E+
Sbjct: 546 PEVMAFIEQ 554
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 54/259 (20%), Positives = 96/259 (37%), Gaps = 59/259 (22%)
Query: 2 GEGTFGQVLE-CWDRERKEM--VAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G+G+FG V WD + VA+K ++ + + + E+ + L H
Sbjct: 27 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN--- 82
Query: 55 RCVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
+++ Y + +V E LGS L D LRK+ L A Q+ E +
Sbjct: 83 -LIRL-----YGVVLTPPMKMVTELAPLGS-LLDRLRKHQGHFLLGTLS-RYAVQVAEGM 134
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ IH DL N+LL + + +K+ DFG
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIG---------------------------DFGL 167
Query: 169 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221
+ ++ V H + APE + +++ D W G L E+ T G+ +
Sbjct: 168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227
Query: 222 HENLEHLAMMERVLGPLPQ 240
+ L +++ LP+
Sbjct: 228 LNGSQILHKIDKEGERLPR 246
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 62/245 (25%), Positives = 101/245 (41%), Gaps = 54/245 (22%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG+V ++ K VA+K ++ +A + E +++QL +H + V++
Sbjct: 22 GAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQL-QHQR----LVRL- 73
Query: 61 NWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
Y + I I+ E + GS L DFL+ + I+ + ++A Q+ E +AF+ +
Sbjct: 74 ----YAVVTQEPIYIITEYMENGS-LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
IH DL+ N+ LVS K+ DFG
Sbjct: 129 NYIHRDLRAANI-LVSDTLS--------------------------CKIADFGLARLIE- 160
Query: 175 DQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228
D Y + APE I +T D+WS G +L E+ T G + N E +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 229 AMMER 233
+ER
Sbjct: 221 QNLER 225
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 63/241 (26%), Positives = 97/241 (40%), Gaps = 46/241 (19%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V W + K VAIK +R E + E EV+ +L H K VQ+
Sbjct: 17 GSGQFGLVHLGYWLNKDK--VAIKTIREGAMSEEDFIEEAEVMMKL-SHPK----LVQLY 69
Query: 61 NWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ IC+V E + G L D+LR L+ + + E +A++ + C+IH
Sbjct: 70 GVCLEQAPICLVTEFMEHGC-LSDYLRTQRGLFAAETLL-GMCLDVCEGMAYLEEACVIH 127
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL N LV + IKV DFG T + D Y
Sbjct: 128 RDLAARNC-LVGENQV--------------------------IKVSDFGMTRFV-LDDQY 159
Query: 179 IVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232
ST + +PEV ++ D+WS G ++ E+ + G+ ++ N E + +
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
Query: 233 R 233
Sbjct: 220 T 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 7e-10
Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 46/241 (19%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V W + VA+K+++ + E + + +L H K V+
Sbjct: 17 GSGQFGVVKLGKWKGQYD--VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPK----LVKFY 69
Query: 61 NWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
I IV E G L ++LR + P L+ E+ + E +AF+ IH
Sbjct: 70 GVCSKEYPIYIVTEYISNGC-LLNYLRSHGKGLEPSQLL-EMCYDVCEGMAFLESHQFIH 127
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL N LV + +KV DFG T Y D Y
Sbjct: 128 RDLAARNC-LVDRDLC--------------------------VKVSDFGMTRYVL-DDQY 159
Query: 179 IVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232
+ S + APEV ++ D+W+ G ++ E+ + G+ + + N E + +
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
Query: 233 R 233
+
Sbjct: 220 Q 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 7e-10
Identities = 56/251 (22%), Positives = 93/251 (37%), Gaps = 58/251 (23%)
Query: 2 GEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK----- 51
G G G+V +R VAIK ++ ++ R + E ++ Q H
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLE 116
Query: 52 GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G + IV E + GS L FLR ++ + + LV + R + +
Sbjct: 117 G--VVTR-------GRLAMIVTEYMENGS-LDTFLRTHDGQFTIMQLV-GMLRGVGAGMR 165
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++ DL +H DL NV LV S + KV DFG +
Sbjct: 166 YLSDLGYVHRDLAARNV-LVDSNLV--------------------------CKVSDFGLS 198
Query: 170 TYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTH 222
D + +T + APE I ++ D+WS G ++ E+ GE +
Sbjct: 199 RVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
Query: 223 ENLEHLAMMER 233
N + ++ +E
Sbjct: 259 TNRDVISSVEE 269
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 9e-10
Identities = 56/246 (22%), Positives = 98/246 (39%), Gaps = 48/246 (19%)
Query: 2 GEGTFGQVLE-CW--DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G G FG+V +++ VAIK ++ +K R + E ++ Q H
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPN----I 108
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+++ + IV E + GS L FLRK++ + I LV + R + + ++ D+
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGS-LDSFLRKHDAQFTVIQLV-GMLRGIASGMKYLSDM 166
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H DL N+ L++S + KV DFG
Sbjct: 167 GYVHRDLAARNI-LINSNLV--------------------------CKVSDFGLGRVLED 199
Query: 175 DQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227
D +TR + +PE I +T D+WS G +L E+ + GE + N +
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 228 LAMMER 233
+ ++
Sbjct: 260 IKAVDE 265
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 48/249 (19%), Positives = 99/249 (39%), Gaps = 55/249 (22%)
Query: 2 GEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 55
G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPH---- 78
Query: 56 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
++ + + ++ + G L D++R++ L+ Q+ + +
Sbjct: 79 VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQIAKGMN 131
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSSAIKVID 165
++ D ++H DL NVL+ + +++K+ D+ + + + ++P IK
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP----IK--- 184
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 224
+ A E IL +T+ D+WS G + EL T G +
Sbjct: 185 -------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 225 LEHLAMMER 233
E +++E+
Sbjct: 226 SEISSILEK 234
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 53/247 (21%), Positives = 88/247 (35%), Gaps = 54/247 (21%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G G FG+V R +VA+K R + + E +L+Q H V++
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPN----IVRL 177
Query: 60 RNWFDY-----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ I IV E + G FLR R L+ ++ + ++
Sbjct: 178 -----IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLL-QMVGDAAAGMEYLES 231
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
C IH DL N LV+ + + +K+ DFG + E
Sbjct: 232 KCCIHRDLAARNC-LVTEKNV--------------------------LKISDFGMSREEA 264
Query: 174 PDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 226
D Y S + APE + ++ D+WS G +L E + G + + N +
Sbjct: 265 -DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
Query: 227 HLAMMER 233
+E+
Sbjct: 324 TREFVEK 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 46/241 (19%)
Query: 2 GEGTFGQVLEC-WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V W + VAIK+++ + + E +V+ L H+K VQ+
Sbjct: 33 GTGQFGVVKYGKWRGQYD--VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEK----LVQLY 85
Query: 61 NWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ I I+ E G L ++LR+ +R L+ E+ + + E + ++ +H
Sbjct: 86 GVCTKQRPIFIITEYMANGC-LLNYLREMRHRFQTQQLL-EMCKDVCEAMEYLESKQFLH 143
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DL N LV+ + + +KV DFG + Y D+ Y
Sbjct: 144 RDLAARNC-LVNDQGV--------------------------VKVSDFGLSRYVLDDE-Y 175
Query: 179 IVSTRH-----YRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMME 232
S + PEV++ ++ DIW+ G ++ E+ + G+ ++ N E +
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
Query: 233 R 233
+
Sbjct: 236 Q 236
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 54/252 (21%), Positives = 95/252 (37%), Gaps = 59/252 (23%)
Query: 2 GEGTFGQVLE-CW---DRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDK---- 51
G G FG+V + +++ VAIK ++ +K R + E ++ Q H
Sbjct: 53 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRL 111
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G + + I+ E + G+ L FLR+ + + LV + R + +
Sbjct: 112 EG--VISK-------YKPMMIITEYMENGA-LDKFLREKDGEFSVLQLV-GMLRGIAAGM 160
Query: 109 AFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++ ++ +H DL N+ LV+S + KV DFG
Sbjct: 161 KYLANMNYVHRDLAARNI-LVNSNLV--------------------------CKVSDFGL 193
Query: 169 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221
+ D +T + APE I +T D+WS G ++ E+ T GE +
Sbjct: 194 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
Query: 222 HENLEHLAMMER 233
N E + +
Sbjct: 254 LSNHEVMKAIND 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 53/249 (21%), Positives = 95/249 (38%), Gaps = 55/249 (22%)
Query: 2 GEGTFGQVLEC-WDRERKEM---VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNR 55
G G FG V + W E + + V IK++ ++ +A + + L H
Sbjct: 22 GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAH---- 76
Query: 56 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
V++ + + +V + LGS L D +R++ P L+ Q+ + +
Sbjct: 77 IVRL-----LGLCPGSSLQLVTQYLPLGS-LLDHVRQHRGALGPQLLL-NWGVQIAKGMY 129
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSSAIKVID 165
++ + M+H +L NVLL S ++V D+ + P D + P IK
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP----IK--- 182
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 224
+ A E I +T+ D+WS G + EL T G +
Sbjct: 183 -------------------WMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223
Query: 225 LEHLAMMER 233
E ++E+
Sbjct: 224 AEVPDLLEK 232
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 48/249 (19%), Positives = 99/249 (39%), Gaps = 55/249 (22%)
Query: 2 GEGTFGQVLEC-WDRERKEM---VAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 55
G G FG V + W E +++ VAIK +R K + + E V+ + +
Sbjct: 24 GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPH---- 78
Query: 56 CVQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
++ + + ++ + G L D++R++ L+ Q+ + +
Sbjct: 79 VCRL-----LGICLTSTVQLITQLMPFGC-LLDYVREHKDNIGSQYLL-NWCVQIAKGMN 131
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK----RMPKSSAIKVID 165
++ D ++H DL NVL+ + +++K+ D+ + + + ++P IK
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP----IK--- 184
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHEN 224
+ A E IL +T+ D+WS G + EL T G +
Sbjct: 185 -------------------WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 225 LEHLAMMER 233
E +++E+
Sbjct: 226 SEISSILEK 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 59/244 (24%), Positives = 95/244 (38%), Gaps = 47/244 (19%)
Query: 2 GEGTFGQVLE-CWDRERKE--MVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 24 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPH----I 78
Query: 57 VQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V++ N + I+ E LG L FL+ Y L+ A QL +A+
Sbjct: 79 VKL-----IGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLI-LYAYQLSTALAY 131
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK-------- 182
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229
+ APE I +T D+W G + E+ G FQ +N + +
Sbjct: 183 --------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228
Query: 230 MMER 233
+E
Sbjct: 229 RIEN 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 1e-07
Identities = 52/250 (20%), Positives = 94/250 (37%), Gaps = 59/250 (23%)
Query: 2 GEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
GEG FG+V E + + K VA+K + +E M E +++ L H
Sbjct: 21 GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPH----I 75
Query: 57 VQIRNWFDY----RNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
V++ I+ E G L +L +N + LV + Q+ + +A+
Sbjct: 76 VKL-----IGIIEEEPTWIIMELYPYGE-LGHYLERNKNSLKVLTLV-LYSLQICKAMAY 128
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+ + +H D+ N+ LV+S +K+ DFG +
Sbjct: 129 LESINCVHRDIAVRNI-LVASPEC--------------------------VKLGDFGLSR 161
Query: 171 YERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHE 223
Y + Y R +PE I +T D+W + E+ + G+ F E
Sbjct: 162 YIEDEDYY--KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE 219
Query: 224 NLEHLAMMER 233
N + + ++E+
Sbjct: 220 NKDVIGVLEK 229
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 38/144 (26%), Positives = 60/144 (41%), Gaps = 20/144 (13%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-----GGNRC 56
G+G FG V+ R K VA+K ++ +A + E V+ QL +H G
Sbjct: 202 GKGEFGDVMLGDYRGNK--VAVKCIKNDAT-AQAFLAEASVMTQL-RHSNLVQLLG--VI 255
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
V+ + + IV E GS L D+LR D + + + + E + ++
Sbjct: 256 VE------EKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 115 CMIHTDLKPENVLLVSSEYIKVPD 138
+H DL NVL+ KV D
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSD 332
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 58/245 (23%), Positives = 94/245 (38%), Gaps = 49/245 (20%)
Query: 2 GEGTFGQVLE-CW--DRERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDK----- 51
GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLI 457
Query: 52 GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G + N + I+ E LG L FL+ + L+ A QL +A
Sbjct: 458 G--VITE--------NPVWIIMELCTLGE-LRSFLQVRKFSLDLASLI-LYAYQLSTALA 505
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++ +H D+ NVL+ S++ +K+ D+ S + +DS+Y+K IK
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKASKGKLPIK------- 557
Query: 170 TYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228
+ APE I +T D+W G + E+ G FQ +N + +
Sbjct: 558 ---------------WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 602
Query: 229 AMMER 233
+E
Sbjct: 603 GRIEN 607
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 29/243 (11%), Positives = 50/243 (20%), Gaps = 65/243 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G Q + D VA+ V + + L ++
Sbjct: 40 GGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KP----GVA 94
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + R +V E + G SL + P+ +R + L H +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT---SPSPVGAIR-AMQSLAAAADAAHRAGV 150
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+ P V + + +
Sbjct: 151 ALSIDHPSRVRVSI---------------------------DGDVVLAYPA--------- 174
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
DI +G L L LA ER
Sbjct: 175 --------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
Query: 237 PLP 239
P
Sbjct: 220 GQP 222
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 59/244 (24%), Positives = 86/244 (35%), Gaps = 72/244 (29%)
Query: 2 GEGTFGQVLEC-WDRERKEM-VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK-----G 52
GEG FGQVL+ ++ M AIK ++ K E+EVL +L H G
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 93
Query: 53 GNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIA-------RQ 103
C R ++ + E G +L DFLRK+ + +Q
Sbjct: 94 --ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 104 LLEC---IA----FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156
LL +A ++ IH DL N+ LV Y+
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNI-LVGENYV---------------------- 180
Query: 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILV 210
K+ DFG + R Q V R A E + +T D+WS G +L
Sbjct: 181 ----AKIADFGLS---R-GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232
Query: 211 ELCT 214
E+ +
Sbjct: 233 EIVS 236
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 8e-07
Identities = 53/245 (21%), Positives = 90/245 (36%), Gaps = 58/245 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-----GGNRC 56
G+G FG V+ R K VA+K ++ +A + E V+ QL +H G
Sbjct: 30 GKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQLLG---V 82
Query: 57 VQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+ + + + IV E GS L D+LR D + + + + E + ++
Sbjct: 83 I-----VEEKGGLYIVTEYMAKGS-LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
+H DL NV LVS + + KV DFG T
Sbjct: 137 NFVHRDLAARNV-LVSEDNV--------------------------AKVSDFGLTKEA-- 167
Query: 175 DQNYIVSTRH---YR--APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228
+ APE + ++ D+WS G +L E+ + G + + +
Sbjct: 168 ---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224
Query: 229 AMMER 233
+E+
Sbjct: 225 PRVEK 229
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 53/248 (21%), Positives = 77/248 (31%), Gaps = 72/248 (29%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK--- 51
G G FG+V+E + VA+K+++ E M E++VL L H
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 52 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 107
G C ++ E G L +FLR+ I
Sbjct: 92 LLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 108 IAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
+ L IH DL N+ L++ I
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI-LLTHGRI----------------- 183
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYPCDIWSVG 206
K+ DFG + D NY+V APE I +T+ D+WS G
Sbjct: 184 ---------TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234
Query: 207 CILVELCT 214
L EL +
Sbjct: 235 IFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 61/296 (20%), Positives = 104/296 (35%), Gaps = 90/296 (30%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK--- 51
G G FG+V+E + VA+K+++ +EA M E++++ L +H+
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 52 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN--NYRSFPIDLVREIARQLL 105
G C + ++ E G L +FLR+ + P +
Sbjct: 115 LLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 106 ECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155
+ + F + M IH D+ NV L+++ ++
Sbjct: 165 DLLHFSSQVAQGMAFLASKNCIHRDVAARNV-LLTNGHV--------------------- 202
Query: 156 PKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILV 210
K+ DFG D NYIV + APE I +T D+WS G +L
Sbjct: 203 -----AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 211 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGA 265
E+ + L + P P + V+ K V+ G ++ P A
Sbjct: 258 EIFS-------------LGLN-----PYPGIL---VNSKFYKLVKDGYQMAQPAFA 292
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 49/246 (19%), Positives = 82/246 (33%), Gaps = 69/246 (28%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK--- 51
G G FGQV+E VA+K+++ + E M E+++L + H
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 52 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPIDLVREIARQ 103
G + ++ E K G +L +LR + + +
Sbjct: 96 LLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 104 LLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153
L I + + M IH DL N+ L+S + +
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNI-LLSEKNV------------------- 186
Query: 154 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYPCDIWSVGCI 208
+K+ DFG D +Y+ APE I +T D+WS G +
Sbjct: 187 -------VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 239
Query: 209 LVELCT 214
L E+ +
Sbjct: 240 LWEIFS 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 30/149 (20%), Positives = 52/149 (34%), Gaps = 23/149 (15%)
Query: 2 GEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK----- 51
G G FG V + +K A+K + I E + + E +++ H
Sbjct: 34 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLL 92
Query: 52 GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G +V K G L +F+R + DL+ Q+ + +
Sbjct: 93 G---IC-----LRSEGSPLVVLPYMKHGD-LRNFIRNETHNPTVKDLIG-FGLQVAKGMK 142
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPD 138
++ +H DL N +L +KV D
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVAD 171
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 31/121 (25%), Positives = 47/121 (38%), Gaps = 37/121 (30%)
Query: 100 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159
A + F+H+ IH D+K N+LL D ++ K S
Sbjct: 142 AANGI----NFLHENHHIHRDIKSANILL-------------------DEAF---TAKIS 175
Query: 160 AIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVGCILVELCT 214
DFG ++++R Y APE + G T DI+S G +L+E+ T
Sbjct: 176 -----DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIIT 229
Query: 215 G 215
G
Sbjct: 230 G 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 45/245 (18%), Positives = 82/245 (33%), Gaps = 58/245 (23%)
Query: 2 GEGTFGQVLE--CWDRERKEM-VAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK----- 51
G G FG V D + K++ A+K + I E + + E +++ H
Sbjct: 98 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLL 156
Query: 52 GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G +V K G L +F+R + DL+ Q+ + +
Sbjct: 157 G---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQVAKGMK 206
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-S 168
F+ +H DL N ++ ++ +KV DFG +
Sbjct: 207 FLASKKFVHRDLAARNC-MLDEKFT--------------------------VKVADFGLA 239
Query: 169 TTYERPDQNYIVSTRHYR------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221
+ + + + + A E + +T D+WS G +L EL T G +
Sbjct: 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299
Query: 222 HENLE 226
+
Sbjct: 300 VNTFD 304
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 57/333 (17%), Positives = 102/333 (30%), Gaps = 91/333 (27%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGN 54
G G FGQV+E VA+K+++ A M E+++L + H N
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL---N 87
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + ++ E +L +LR R+ + + AR
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--RNEFVPYKTKGARFR----QGKDY 141
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDY--KSSLHTPKDSSYFKRMPKSSA----------- 160
+ I DLK + SS+ + + SL ++ + + K
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 161 ------------------------------IKVIDFGSTTYERPDQNYIVSTRHYR---- 186
+K+ DFG D +Y+
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 261
Query: 187 -APEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP-QHMLK 244
APE I +T D+WS G +L E+ + LG P +
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFS--------------------LGASPYPGV-- 299
Query: 245 RVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 276
++D + ++ G R+ P+ + M
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYT--TPEMYQTML 330
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 24/156 (15%), Positives = 53/156 (33%), Gaps = 11/156 (7%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
+ F ++ E E ++ + +K E L++ + G Q
Sbjct: 84 IETSEFDKMDEY--LYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA---GVSVPQP- 137
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MIHT 119
+ Y ++ ++ L R V I ++E + ++ ++H
Sbjct: 138 --YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHA 195
Query: 120 DLKPENVLLVSS-EYIKVPDYKSSLHTPKDSSYFKR 154
DL N++ + +I + + H P SY +R
Sbjct: 196 DLSEYNIMYIDKVYFIDMGQAVTLRH-PMAESYLER 230
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 50/248 (20%), Positives = 90/248 (36%), Gaps = 72/248 (29%)
Query: 2 GEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK- 51
GEG FGQV+ R VA+K+++ ++ + + E+E+++ + KH
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137
Query: 52 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKN----NYRSFPIDLVREIA 101
G C Q + ++ E G +L ++L+ S+ E
Sbjct: 138 INLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 102 RQLLECIAFMHDLC--M--------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
+ ++ + + M IH DL NV LV+ + +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV-LVTEDNV----------------- 229
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVG 206
+K+ DFG Y +T + APE + +T+ D+WS G
Sbjct: 230 ---------MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 207 CILVELCT 214
+L E+ T
Sbjct: 281 VLLWEIFT 288
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 44/253 (17%), Positives = 82/253 (32%), Gaps = 60/253 (23%)
Query: 2 GEGTFGQVLEC---WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK----- 51
G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALI 88
Query: 52 GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIA 109
G + ++ G L F+R DL+ Q+ +
Sbjct: 89 G---IM-----LPPEGLPHVLLPYMCHGD-LLQFIRSPQRNPTVKDLI-SFGLQVARGME 138
Query: 110 FMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGST 169
++ + +H DL N ++ + +KV DFG
Sbjct: 139 YLAEQKFVHRDLAARNC-MLDESFT--------------------------VKVADFGLA 171
Query: 170 TYERPDQNYIVSTRHYR--------APEVILGLGWTYPCDIWSVGCILVELCT-GEALFQ 220
D+ Y +H A E + +T D+WS G +L EL T G ++
Sbjct: 172 RDIL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230
Query: 221 THENLEHLAMMER 233
+ + + +
Sbjct: 231 HIDPFDLTHFLAQ 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 57/251 (22%), Positives = 87/251 (34%), Gaps = 83/251 (33%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDK---- 51
GEG FG+V + K +VA+K ++ + R+ E E+L L +H
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRF 108
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECI 108
G C + + +VFE + G L FLR + + + ++A L
Sbjct: 109 FG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 109 AFMH-------------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155
+ L +H DL N LV +
Sbjct: 159 QLLAVASQVAAGMVYLAGLHFVHRDLATRNC-LVGQGLV--------------------- 196
Query: 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGLGWTYPCDIW 203
+K+ DFG + R I ST +YR PE IL +T D+W
Sbjct: 197 -----VKIGDFGMS---R----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 204 SVGCILVELCT 214
S G +L E+ T
Sbjct: 245 SFGVVLWEIFT 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 76/250 (30%)
Query: 2 GEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDK- 51
GEG FGQV+ + VA+K+++ ++ + + E+E+++ + KH
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 52 ----GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLL 105
G C Q + ++ E G +L ++LR R ++ +I R
Sbjct: 104 INLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYDINRVPE 151
Query: 106 ECIAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149
E + F + IH DL NV LV+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV--------------- 195
Query: 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWS 204
+K+ DFG Y +T + APE + +T+ D+WS
Sbjct: 196 -----------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 205 VGCILVELCT 214
G ++ E+ T
Sbjct: 245 FGVLMWEIFT 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 57/253 (22%), Positives = 90/253 (35%), Gaps = 86/253 (33%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDK---- 51
GEG FG+V + K +VA+K ++ R+ E E+L L +H+
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKF 82
Query: 52 -GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSF---------------P 93
G C + + +VFE K G L FLR + +
Sbjct: 83 YG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 94 IDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153
++ IA Q+ + ++ +H DL N LV + +
Sbjct: 133 SQML-HIASQIASGMVYLASQHFVHRDLATRNC-LVGANLL------------------- 171
Query: 154 RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR------------APEVILGLGWTYPCD 201
+K+ DFG + R + ST +YR PE I+ +T D
Sbjct: 172 -------VKIGDFGMS---R----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 217
Query: 202 IWSVGCILVELCT 214
+WS G IL E+ T
Sbjct: 218 VWSFGVILWEIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 7e-04
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 72/248 (29%)
Query: 2 GEGTFGQVLEC-------WDRERKEMVAIKIVRGIKKYREAA--MIEIEVLQQLAKHDKG 52
GEG FGQV+ + VA+K+++ ++ + + E+E+++ + KH
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149
Query: 53 GN---RCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 107
N C Q + ++ E G +L ++LR R ++ +I R E
Sbjct: 150 INLLGACTQ-------DGPLYVIVEYASKG-NLREYLRAR--RPPGMEYSYDINRVPEEQ 199
Query: 108 IAFMHDLCM----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
+ F + IH DL NV LV+ +
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV-LVTENNV----------------- 241
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTR-----HYRAPEVILGLGWTYPCDIWSVG 206
+K+ DFG Y +T + APE + +T+ D+WS G
Sbjct: 242 ---------MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 292
Query: 207 CILVELCT 214
++ E+ T
Sbjct: 293 VLMWEIFT 300
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 55/253 (21%), Positives = 87/253 (34%), Gaps = 77/253 (30%)
Query: 2 GEGTFGQVLEC-----WDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDK--- 51
G G FG+V+ VA+K+++ REA M E++++ QL H+
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 52 --GGNRCVQIRNWFDYRNHICIVFE--KLGSSLYDFLRKNNYRSFPIDLVREIARQLLEC 107
G C I ++FE G L ++LR + ++ E ++L E
Sbjct: 114 LLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 108 IAF----MHDLCM-----------------IHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146
DL +H DL NV LV+ +
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKV------------ 210
Query: 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYR-----APEVILGLGWTYPCD 201
+K+ DFG D NY+V APE + +T D
Sbjct: 211 --------------VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 256
Query: 202 IWSVGCILVELCT 214
+WS G +L E+ +
Sbjct: 257 VWSYGILLWEIFS 269
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 329 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.99 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.54 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.97 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.32 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.1 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.86 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.79 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.61 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.61 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.26 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.04 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 90.58 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-63 Score=433.89 Aligned_cols=244 Identities=27% Similarity=0.462 Sum_probs=212.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.||+.||||+++... ...+...+|+.++..+ .||||+++++++.+++.+|+||||| ||
T Consensus 82 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~ivmEy~~gg 156 (346)
T 4fih_A 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVVMEFLEGG 156 (346)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEECCCTTE
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence 799999999999999999999999996432 3345678899999999 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.+. .+++..++.++.|++.||+|||++||+||||||+|||+ +.+
T Consensus 157 ~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---------------------------~~~ 206 (346)
T 4fih_A 157 ALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---------------------------THD 206 (346)
T ss_dssp EHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTT
T ss_pred cHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---------------------------CCC
Confidence 999999874 49999999999999999999999999999999999999 566
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.+||+|||+|....... ...+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 207 g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 286 (346)
T 4fih_A 207 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 286 (346)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 779999999998664432 45689999999999999999999999999999999999999999887776666555432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+... .+..++.++++||.+||+.||++|||++|
T Consensus 287 ~~~~~----------------------------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e 320 (346)
T 4fih_A 287 PPRLK----------------------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAE 320 (346)
T ss_dssp CCCCS----------------------------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCC----------------------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 21110 12346789999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+|+||||++.
T Consensus 321 ~l~Hp~~~~~ 330 (346)
T 4fih_A 321 LLKHPFLAKA 330 (346)
T ss_dssp HTTCGGGGGC
T ss_pred HhcCHhhcCC
Confidence 9999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-63 Score=428.68 Aligned_cols=244 Identities=26% Similarity=0.424 Sum_probs=212.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+|+.||+|+++... .......+|+.++..+ .||||++++++|++++.+|+|||||
T Consensus 40 lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~yivmEy~ 114 (311)
T 4aw0_A 40 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEKLYFGLSYA 114 (311)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEEEEEEecC
Confidence 799999999999999999999999997432 2345677899999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 115 ~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl--------------------------- 165 (311)
T 4aw0_A 115 KNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--------------------------- 165 (311)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---------------------------
Confidence 999999998764 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~ 245 (311)
T 4aw0_A 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK 245 (311)
T ss_dssp CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 566779999999998654332 346899999999999999999999999999999999999999998877766666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+....+| ..++++++|||++||++||++|
T Consensus 246 i~~~~~~~p-------------------------------------------------~~~s~~~~dli~~lL~~dp~~R 276 (311)
T 4aw0_A 246 IIKLEYDFP-------------------------------------------------EKFFPKARDLVEKLLVLDATKR 276 (311)
T ss_dssp HHHTCCCCC-------------------------------------------------TTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHcCCCCCC-------------------------------------------------cccCHHHHHHHHHHccCCHhHC
Confidence 554322222 2457789999999999999999
Q ss_pred CCHHH------HhcCCCCCCCCc
Q 020235 311 LTARE------ALRHPFFTRDHL 327 (329)
Q Consensus 311 ~t~~~------ll~hp~f~~~~~ 327 (329)
||++| +++||||++.+-
T Consensus 277 ~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 277 LGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cChHHHcCCHHHHCCCCcCCCCH
Confidence 99988 589999998763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-62 Score=417.68 Aligned_cols=242 Identities=24% Similarity=0.431 Sum_probs=197.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+|+.||+|+++... .......+|+.++..+ .||||+++++++++++.+|+||||+
T Consensus 21 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~ivmEy~ 95 (275)
T 3hyh_A 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-----RHPHIIKLYDVIKSKDEIIMVIEYA 95 (275)
T ss_dssp EEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEEEEEEeCC
Confidence 799999999999999999999999997432 2345677899999999 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+ +
T Consensus 96 ~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---------------------------~ 146 (275)
T 3hyh_A 96 GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---------------------------D 146 (275)
T ss_dssp CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---------------------------C
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---------------------------C
Confidence 999999998765 69999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.+||+|||+|+...... ...+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 147 ~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~ 226 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN 226 (275)
T ss_dssp TTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 66779999999998655433 45689999999999999886 5799999999999999999999988776655555444
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...++| ...++++++||++||+.||++|||+
T Consensus 227 ~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dP~~R~s~ 257 (275)
T 3hyh_A 227 GVYTLP-------------------------------------------------KFLSPGAAGLIKRMLIVNPLNRISI 257 (275)
T ss_dssp TCCCCC-------------------------------------------------TTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCCCC-------------------------------------------------CCCCHHHHHHHHHHccCChhHCcCH
Confidence 322221 2357789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
+|+++||||+.+
T Consensus 258 ~eil~hpw~k~~ 269 (275)
T 3hyh_A 258 HEIMQDDWFKVD 269 (275)
T ss_dssp HHHHHCHHHHTT
T ss_pred HHHHcCcccccC
Confidence 999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-62 Score=432.53 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++.+|+.||||+++.. ....+...+|+.++..+ .||||+++++++++++.+|+|||||
T Consensus 32 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~yiVmEy~~ 106 (350)
T 4b9d_A 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-----KHPNIVQYRESFEENGSLYIVMDYCE 106 (350)
T ss_dssp C------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-----CCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 79999999999999999999999999743 23456678899999999 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
||+|.+++.......+++..++.++.|++.||+|||++||+||||||+|||+ +
T Consensus 107 gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---------------------------~ 159 (350)
T 4b9d_A 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---------------------------T 159 (350)
T ss_dssp TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---------------------------C
T ss_pred CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---------------------------C
Confidence 9999999987665678999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 160 ~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 239 (350)
T 4b9d_A 160 KDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS 239 (350)
T ss_dssp TTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc
Confidence 66779999999998765432 345799999999999999999999999999999999999999998877766665544
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...+. .+..++.++.+||.+||+.||++|||+
T Consensus 240 ~~~~~------------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~ 271 (350)
T 4b9d_A 240 GSFPP------------------------------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSV 271 (350)
T ss_dssp TCCCC------------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCC------------------------------------------------CCccCCHHHHHHHHHHccCChhHCcCH
Confidence 32111 123467789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
+|+|+||||++.
T Consensus 272 ~e~l~hp~~~~~ 283 (350)
T 4b9d_A 272 NSILEKGFIAKR 283 (350)
T ss_dssp HHHHTSHHHHTT
T ss_pred HHHhcCHHhhcC
Confidence 999999999764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=434.93 Aligned_cols=244 Identities=27% Similarity=0.462 Sum_probs=212.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|+++.||+.||||++.... ...+...+|+.++..+ .||||++++++|.+++.+|+||||| ||
T Consensus 159 iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIV~l~~~~~~~~~~~iVmEy~~gG 233 (423)
T 4fie_A 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-----QHENVVEMYNSYLVGDELWVVMEFLEGG 233 (423)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred eccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCCCceEEEEEECCEEEEEEeCCCCC
Confidence 799999999999999999999999997432 3355678899999999 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 234 ~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---------------------------~~~ 283 (423)
T 4fie_A 234 ALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---------------------------THD 283 (423)
T ss_dssp EHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---------------------------CTT
T ss_pred cHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---------------------------cCC
Confidence 999999875 49999999999999999999999999999999999999 566
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.+||+|||+|....... ...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 284 g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~ 363 (423)
T 4fie_A 284 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 363 (423)
T ss_dssp CCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC
Confidence 779999999998655432 45689999999999999999999999999999999999999999887776666554432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. ..+..++.++++||.+||+.||++|||++|
T Consensus 364 ~~~~----------------------------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e 397 (423)
T 4fie_A 364 PPRL----------------------------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAE 397 (423)
T ss_dssp CCCC----------------------------------------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCC----------------------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 1111 012346789999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+|+||||++.
T Consensus 398 ll~Hp~~~~~ 407 (423)
T 4fie_A 398 LLKHPFLAKA 407 (423)
T ss_dssp HTTCGGGGGC
T ss_pred HhcCHHhcCC
Confidence 9999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-61 Score=411.56 Aligned_cols=244 Identities=23% Similarity=0.428 Sum_probs=201.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~ 73 (329)
||+|+||+||+|.++.++..||+|++... ....+...+|+.++..+ .||||+++++++.+ ++.+|+||
T Consensus 34 iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 69999999999999999999999998643 23345677899999998 67999999999865 45689999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||| ||+|.+++.+.. .+++..++.++.|++.||+|||++| |+||||||+|||++
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--------------------- 165 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--------------------- 165 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES---------------------
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE---------------------
Confidence 999 999999998754 6999999999999999999999999 99999999999993
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.+||+|||+|+...... ...+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+......
T Consensus 166 -----~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~ 239 (290)
T 3fpq_A 166 -----GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp -----STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred -----CCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence 135679999999998654443 45689999999998875 69999999999999999999999997655443322
Q ss_pred H-HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 230 M-MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
. +.. +..|. ..+...++++.+||.+||+.||+
T Consensus 240 ~~i~~--~~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~~dP~ 272 (290)
T 3fpq_A 240 RRVTS--GVKPA---------------------------------------------SFDKVAIPEVKEIIEGCIRQNKD 272 (290)
T ss_dssp HHHTT--TCCCG---------------------------------------------GGGGCCCHHHHHHHHHHSCSSGG
T ss_pred HHHHc--CCCCC---------------------------------------------CCCccCCHHHHHHHHHHccCChh
Confidence 1 111 11111 11234567899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRD 325 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~ 325 (329)
+|||++|+|+||||+++
T Consensus 273 ~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 273 ERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp GSCCHHHHHTSGGGC--
T ss_pred HCcCHHHHhcCccccCC
Confidence 99999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-61 Score=417.36 Aligned_cols=243 Identities=28% Similarity=0.470 Sum_probs=202.7
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|++. .+++.||+|+++... .......+|+.++..+ .||||+++++++++++.+|+|||
T Consensus 32 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-----NHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-----CCTTEECEEEEEEETTEEEEEEC
T ss_pred EecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-----CCCCCCeEEEEEEECCEEEEEEE
Confidence 799999999999874 467899999997432 2234566788888777 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|| ||+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 107 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl------------------------- 159 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL------------------------- 159 (304)
T ss_dssp CCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE-------------------------
T ss_pred cCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE-------------------------
Confidence 99 999999998764 69999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 160 --~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~ 237 (304)
T 3ubd_A 160 --DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTM 237 (304)
T ss_dssp --CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHH
Confidence 56677999999999754332 2456899999999999999999999999999999999999999998887776666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+...++| ..+++++.+||++||+.||++|
T Consensus 238 i~~~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dP~~R 268 (304)
T 3ubd_A 238 ILKAKLGMP-------------------------------------------------QFLSPEAQSLLRMLFKRNPANR 268 (304)
T ss_dssp HHHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHcCCCCCC-------------------------------------------------CcCCHHHHHHHHHHcccCHHHC
Confidence 554322222 2457789999999999999999
Q ss_pred CCH-----HHHhcCCCCCCCC
Q 020235 311 LTA-----REALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~-----~~ll~hp~f~~~~ 326 (329)
||+ +|+++||||++.+
T Consensus 269 ~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 269 LGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp TTCSTTTHHHHHTSGGGTTCC
T ss_pred CCCCcCCHHHHHcCccccCCC
Confidence 984 7999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-60 Score=414.39 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=202.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++.+|+.||||+++... ...+|+.++..+ .||||+++++++.+++.+||||||| ||+
T Consensus 66 lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l-----~HpnIV~l~~~~~~~~~~~ivmEy~~gg~ 136 (336)
T 4g3f_A 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGL-----SSPRIVPLYGAVREGPWVNIFMELLEGGS 136 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTC-----CCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence 699999999999999999999999998532 234688888887 6799999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++ .++
T Consensus 137 L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---------------------------~~g 187 (336)
T 4g3f_A 137 LGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---------------------------SDG 187 (336)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---------------------------TTS
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---------------------------CCC
Confidence 999998764 699999999999999999999999999999999999994 333
Q ss_pred -CeEEeeCCCCcccCCCC--------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 160 -AIKVIDFGSTTYERPDQ--------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 160 -~~~l~Dfg~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 188 ~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~ 267 (336)
T 4g3f_A 188 SRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK 267 (336)
T ss_dssp CCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH
T ss_pred CEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 58999999997654432 235799999999999999999999999999999999999999987665444443
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.... .+ ....+..++..+.+||.+||+.||++|
T Consensus 268 i~~~~--~~--------------------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R 301 (336)
T 4g3f_A 268 IASEP--PP--------------------------------------------IREIPPSCAPLTAQAIQEGLRKEPVHR 301 (336)
T ss_dssp HHHSC--CG--------------------------------------------GGGSCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHcCC--CC--------------------------------------------chhcCccCCHHHHHHHHHHccCCHhHC
Confidence 33311 10 011234567899999999999999999
Q ss_pred CCHHHH-------------hcCCCCCCCC
Q 020235 311 LTAREA-------------LRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~l-------------l~hp~f~~~~ 326 (329)
||+.|+ ++|||+++.+
T Consensus 302 ~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 302 ASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999997 6799998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-59 Score=417.69 Aligned_cols=272 Identities=27% Similarity=0.466 Sum_probs=218.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~~l 71 (329)
||+|+||+||+|+++.||+.||||+++... .......+|+.++..+ .||||+++++++.. .+.+|+
T Consensus 62 lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~~~~~~~i 136 (398)
T 4b99_A 62 IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-----KHDNIIAIKDILRPTVPYGEFKSVYV 136 (398)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSSCTTTCCCEEE
T ss_pred EecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-----CCCCcceEeeeeecccccccCCEEEE
Confidence 799999999999999999999999997432 3345677899999998 67999999988653 468999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||||+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 137 vmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~----------------------- 191 (398)
T 4b99_A 137 VLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV----------------------- 191 (398)
T ss_dssp EEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE-----------------------
T ss_pred EEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc-----------------------
Confidence 99999888999997654 79999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
+.++.+||+|||+|+..... ....+||+.|||||++.+.. ++.++||||+||++|+|++|++||.+.+
T Consensus 192 ----~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~ 267 (398)
T 4b99_A 192 ----NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267 (398)
T ss_dssp ----CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred ----CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence 55667899999988754322 23568999999999998764 6899999999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
..+....+.+..+.++...+........ .+...- .... .. .........+.++.|||++|
T Consensus 268 ~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~-----------------~~-~~~~~~~~~s~~~~dLl~~m 328 (398)
T 4b99_A 268 YVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSL-PPRQ-----------------PV-PWETVYPGADRQALSLLGRM 328 (398)
T ss_dssp HHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSS-CCCC-----------------CC-CHHHHSTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcC-CCcC-----------------CC-CHHHhCCCCCHHHHHHHHHH
Confidence 9999999999999888765443322111 111110 0000 00 00111234678899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
|++||++||||+|+|+||||++.
T Consensus 329 L~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 329 LRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp SCSSTTTSCCHHHHTTSGGGTTT
T ss_pred CcCChhHCcCHHHHhcCHhhCcC
Confidence 99999999999999999999864
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=409.23 Aligned_cols=300 Identities=24% Similarity=0.352 Sum_probs=205.9
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++ .+++.||+|.+... .......+|+.++..+ .+||||+++++++++.+++|+||||+
T Consensus 29 lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~-~~~~~~~~E~~~l~~~----~~h~nIv~l~~~~~~~~~~~lvmE~~~ 103 (361)
T 4f9c_A 29 IGEGTFSSVYLATAQLQVGPEEKIALKHLIPT-SHPIRIAAELQCLTVA----GGQDNVMGVKYCFRKNDHVVIAMPYLE 103 (361)
T ss_dssp EEECSSEEEEEEEEEBTTSCEEEEEEEEECTT-SCHHHHHHHHHHHHHT----CSBTTBCCCSEEEEETTEEEEEEECCC
T ss_pred EecccCcEEEEEEEcccCCCCCEEEEEEEccc-cCHHHHHHHHHHHHHh----cCCCCCceEEEEEEECCEEEEEEeCCC
Confidence 799999999999875 46789999998743 3345677899988877 35799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeec-cccccCCCcCccCCCCCCCccccC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS-EYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++. .+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+++.|||++.....+..
T Consensus 104 g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~----- 173 (361)
T 4f9c_A 104 HESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI----- 173 (361)
T ss_dssp CCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC-----
T ss_pred cccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc-----
Confidence 899999984 48999999999999999999999999999999999999654 4444555554433221110
Q ss_pred CCCCCeEEeeCCCCc---------------ccCCCCCcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCC
Q 020235 156 PKSSAIKVIDFGSTT---------------YERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF 219 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~---------------~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~ 219 (329)
.+.+|+.+. .........+||+.|+|||++.+.. |+.++||||+||++|+|++|+.||
T Consensus 174 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 174 ------ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp ------GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred ------cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 000110000 0000113357999999999998764 899999999999999999999998
Q ss_pred C-CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhh-----------ccchhhHHHHhhh
Q 020235 220 Q-THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSV-----------MKLPRLQNLIMQH 287 (329)
Q Consensus 220 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~ 287 (329)
. +.++.+....+.+..|+.+....... ......... ..+.. ........ .............
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~--~~~~~~~~~--~~p~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKT--FGKSILCSK--EVPAQ--DLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHH--TTEEEEESS--CCCCC--CHHHHHHHHC----------------------
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhh--ccccccccc--cCcch--hhhHHHHhhccccccccccccccccccccccc
Confidence 5 45667788888888875433221111 000000000 00000 00000000 0000011111223
Q ss_pred ccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 288 ~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
+...+++++|||++||++||++|+||+|+|+||||++.++
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~l 361 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMSL 361 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC--
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 4567889999999999999999999999999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=391.70 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=186.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----------- 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----------- 67 (329)
||+|+||+||+|+++.+|+.||||+++.. ....+...+|+.++..+ .||||+++++++.+.+
T Consensus 13 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-----~HpnIV~~~~~~~~~~~~~~~~~~~~~ 87 (299)
T 4g31_A 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLEKNTTEKLQPSSPK 87 (299)
T ss_dssp EEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEEC----------C
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEecCccccccccCCC
Confidence 79999999999999999999999998643 23345678899999888 6799999999987544
Q ss_pred -ceEEEeecC-CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 68 -HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 68 -~~~lv~e~~-~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
.+|+||||| +|+|.+++..... ...+...++.++.|++.||+|||++||+||||||+|||+
T Consensus 88 ~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---------------- 151 (299)
T 4g31_A 88 VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---------------- 151 (299)
T ss_dssp EEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----------------
T ss_pred cEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE----------------
Confidence 479999999 9999999987542 124556788999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC---------------CcccccCCCCchhHHhcCCCCCccchHhHHHHH
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---------------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCIL 209 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l 209 (329)
+.++.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++
T Consensus 152 -----------~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 220 (299)
T 4g31_A 152 -----------TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLIL 220 (299)
T ss_dssp -----------CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred -----------CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHH
Confidence 455668888888876544321 234799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhHHHHHHHHHh-CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhc
Q 020235 210 VELCTGEALFQTHENLEHLAMMERVL-GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHV 288 (329)
Q Consensus 210 ~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (329)
|+|++ ||.+.. +....+.... ...|+.+
T Consensus 221 yell~---Pf~~~~--~~~~~~~~~~~~~~p~~~---------------------------------------------- 249 (299)
T 4g31_A 221 FELLY---PFSTQM--ERVRTLTDVRNLKFPPLF---------------------------------------------- 249 (299)
T ss_dssp HHHHS---CCSSHH--HHHHHHHHHHTTCCCHHH----------------------------------------------
T ss_pred HHHcc---CCCCcc--HHHHHHHHHhcCCCCCCC----------------------------------------------
Confidence 99995 776422 2222222221 2222211
Q ss_pred cCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 289 ~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
...++.+.+||++||+.||++|||+.|+++||||++.+
T Consensus 250 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 250 TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 12345678899999999999999999999999999865
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=417.25 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=216.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.+|+.||+|++.... ...+...+|+.++..+ .||||++++++|++.+.+|+||||| ||
T Consensus 165 lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~iv~E~~~gg 239 (573)
T 3uto_A 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEMVMIYEFMSGG 239 (573)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEEeecCCC
Confidence 699999999999999999999999987532 3456677899999998 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.. ...
T Consensus 240 ~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-------------------------~~~ 293 (573)
T 3uto_A 240 ELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-------------------------KRS 293 (573)
T ss_dssp BHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------SSC
T ss_pred cHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-------------------------CCC
Confidence 9999997543 36999999999999999999999999999999999999953 234
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
+.+||+|||+|....+.. ...+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 294 ~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~ 373 (573)
T 3uto_A 294 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373 (573)
T ss_dssp CCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC
T ss_pred CCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC
Confidence 679999999998776654 346899999999999999999999999999999999999999999888777766655443
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
.++... +..++.+++|||++||+.||.+|||+.|+
T Consensus 374 ~~~~~~---------------------------------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~ 408 (573)
T 3uto_A 374 NMDDSA---------------------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQA 408 (573)
T ss_dssp CCCSGG---------------------------------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCccc---------------------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 333211 23467889999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020235 317 LRHPFFTRDH 326 (329)
Q Consensus 317 l~hp~f~~~~ 326 (329)
|+||||+..+
T Consensus 409 l~Hpw~~~~~ 418 (573)
T 3uto_A 409 LEHPWLTPGN 418 (573)
T ss_dssp HHSTTTSCCC
T ss_pred hcCcCcCCCC
Confidence 9999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-56 Score=415.56 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=202.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.||+.||+|++++.. ........|..++..+.. ..||||++++++|++.+.+|+||||+
T Consensus 197 LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~--~~HP~IV~l~~~f~~~~~lylVmEy~ 274 (689)
T 3v5w_A 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDLM 274 (689)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhh--CCCCCEeEEEEEEEECCEEEEEEecC
Confidence 799999999999999999999999997432 122334445555544422 36899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 275 ~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl--------------------------- 325 (689)
T 3v5w_A 275 NGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--------------------------- 325 (689)
T ss_dssp CSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---------------------------
Confidence 999999998764 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.++.+||+|||+|....... ...+||+.|||||++.+ ..|+.++|+|||||++|+|++|++||.+.+..+.......
T Consensus 326 d~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~ 405 (689)
T 3v5w_A 326 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405 (689)
T ss_dssp CTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH
T ss_pred eCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 566779999999997665443 55789999999999964 5799999999999999999999999976443222111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
.... . ..++..++.++++||.+||+.||.+|+|
T Consensus 406 i~~~--------------------~--------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~ 439 (689)
T 3v5w_A 406 TLTM--------------------A--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGC 439 (689)
T ss_dssp HHHC--------------------C--------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTC
T ss_pred hcCC--------------------C--------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCC
Confidence 1100 0 0112356789999999999999999998
Q ss_pred ----HHHHhcCCCCCCCC
Q 020235 313 ----AREALRHPFFTRDH 326 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~ 326 (329)
++|+++||||++.+
T Consensus 440 ~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 440 LGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp SSSTHHHHTTSGGGTTCC
T ss_pred CCCCHHHHhcCccccCCC
Confidence 79999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=379.38 Aligned_cols=237 Identities=22% Similarity=0.325 Sum_probs=195.9
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|++. .++..||||+++.. ....+...+|+.++.++ .||||+++++++.+++.+++|||
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~~~~~~lV~E 95 (299)
T 4asz_A 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-----QHEHIVKFYGVCVEGDPLIMVFE 95 (299)
T ss_dssp EEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-----CCCCCccEEEEEeeCCEEEEEEE
Confidence 799999999999865 45789999999753 23456678899999888 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCc
Q 020235 75 KL-GSSLYDFLRKNN-----------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSS 142 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~-----------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~ 142 (329)
|| +|+|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 96 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl-------------- 161 (299)
T 4asz_A 96 YMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV-------------- 161 (299)
T ss_dssp CCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--------------
T ss_pred cCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE--------------
Confidence 99 999999997632 2468999999999999999999999999999999999999
Q ss_pred cCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CC
Q 020235 143 LHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GE 216 (329)
Q Consensus 143 ~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 216 (329)
+.+..+||+|||+|+...... ....||+.|||||++.+..|+.++|||||||++|||+| |+
T Consensus 162 -------------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 162 -------------GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 228 (299)
T ss_dssp -------------CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred -------------CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 455668999999987544332 23468999999999999999999999999999999998 89
Q ss_pred CCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHH
Q 020235 217 ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296 (329)
Q Consensus 217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
.||.+.+..+....+.+...+. .+..++.++.
T Consensus 229 ~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------------~p~~~~~~~~ 260 (299)
T 4asz_A 229 QPWYQLSNNEVIECITQGRVLQ------------------------------------------------RPRTCPQEVY 260 (299)
T ss_dssp CTTTTSCHHHHHHHHHHTCCCC------------------------------------------------CCTTCCHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCC------------------------------------------------CCccchHHHH
Confidence 9999877766655554422110 1234567899
Q ss_pred HHHHHhcccCCCCCCCHHHHh
Q 020235 297 HLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 297 ~ll~~~l~~dP~~R~t~~~ll 317 (329)
+||.+||+.||++|||+++++
T Consensus 261 ~li~~cl~~dP~~RPs~~~i~ 281 (299)
T 4asz_A 261 ELMLGCWQREPHMRKNIKGIH 281 (299)
T ss_dssp HHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHH
Confidence 999999999999999999984
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=375.18 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=190.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++. .||||+++.. ....+.+.+|+.++..+ .||||+++++++.. +.+++|||||
T Consensus 44 iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 44 IGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKT-----RHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred EeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 7999999999998653 4899998742 23345677899999888 67999999998764 5689999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 115 gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~--------------------------- 166 (307)
T 3omv_A 115 GSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH--------------------------- 166 (307)
T ss_dssp SCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---------------------------
T ss_pred CCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---------------------------
Confidence 999999998654 3699999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.+..+||+|||+|+...... ...+||+.|||||++.+. +|+.++|||||||++|||+||+.||.+.+.....
T Consensus 167 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~ 246 (307)
T 3omv_A 167 EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI 246 (307)
T ss_dssp TTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred CCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH
Confidence 45568888888887554321 345899999999999754 5899999999999999999999999876655443
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.......|. ....+..++..+.+||.+||+.||+
T Consensus 247 ~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~li~~cl~~dP~ 283 (307)
T 3omv_A 247 IFMVGRGYASPD-------------------------------------------LSKLYKNCPKAMKRLVADCVKKVKE 283 (307)
T ss_dssp HHHHHTTCCCCC-------------------------------------------STTSCTTSCHHHHHHHHHHTCSSST
T ss_pred HHHHhcCCCCCC-------------------------------------------cccccccchHHHHHHHHHHcCCCHh
Confidence 333221111110 0011234677899999999999999
Q ss_pred CCCCHHHH------hcCCCCC
Q 020235 309 DRLTAREA------LRHPFFT 323 (329)
Q Consensus 309 ~R~t~~~l------l~hp~f~ 323 (329)
+|||+++| |+|++-+
T Consensus 284 ~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 284 ERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp TSCCHHHHHHHHHHHHTTCCC
T ss_pred HCcCHHHHHHHHHHHhccCCC
Confidence 99999876 5677643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=380.97 Aligned_cols=239 Identities=22% Similarity=0.346 Sum_probs=193.6
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|+++ .+++.||||+++.. ....+.+.+|+.++..+ .||||+++++++.+++.+++|||
T Consensus 49 LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-----~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-----QHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEE
Confidence 799999999999864 46889999999753 33456678899999988 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 75 KL-GSSLYDFLRKNN-------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~-------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
|| +|+|.+++.... ..++++.++..++.|++.||+|||+++|+||||||+|||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl------------ 191 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------------ 191 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE------------
Confidence 99 999999997642 1358999999999999999999999999999999999999
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 214 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 214 (329)
+.+..+||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||+|
T Consensus 192 ---------------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~ 256 (329)
T 4aoj_A 192 ---------------GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTY 256 (329)
T ss_dssp ---------------ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ---------------CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcC
Confidence 455678899999887553322 33578999999999999999999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|+.||.+.+..+....+.+...+. .+..++++
T Consensus 257 G~~Pf~~~~~~~~~~~i~~g~~~~------------------------------------------------~p~~~~~~ 288 (329)
T 4aoj_A 257 GKQPWYQLSNTEAIDCITQGRELE------------------------------------------------RPRACPPE 288 (329)
T ss_dssp SCCTTCSSCHHHHHHHHHHTCCCC------------------------------------------------CCTTCCHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------------CcccccHH
Confidence 899999877766555544421110 12345678
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+.+||.+||+.||++|||++||+++
T Consensus 289 ~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 289 VYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=377.24 Aligned_cols=239 Identities=20% Similarity=0.235 Sum_probs=196.7
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|+.. .+++.||||+++.. ....+.+.+|+.++.++ .||||+++++++.+++.+++||
T Consensus 34 lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-----~HpNIV~l~g~~~~~~~~~lV~ 108 (308)
T 4gt4_A 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-----QHPNVVCLLGVVTKDQPLSMIF 108 (308)
T ss_dssp EEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred eccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-----CCCCCCCcceEEEECCEEEEEE
Confidence 799999999999863 46789999998743 23356778899999999 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCC
Q 020235 74 EKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPD 138 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~ 138 (329)
||| +|+|.++|.... ...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 109 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---------- 178 (308)
T 4gt4_A 109 SYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---------- 178 (308)
T ss_dssp ECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----------
T ss_pred EcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE----------
Confidence 999 999999997532 1358899999999999999999999999999999999999
Q ss_pred CcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHH
Q 020235 139 YKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELC 213 (329)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~ 213 (329)
+.+..+||+|||+++..... .....||+.|||||++.+..|+.++|||||||++|||+
T Consensus 179 -----------------~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~ 241 (308)
T 4gt4_A 179 -----------------YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 241 (308)
T ss_dssp -----------------CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -----------------CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHH
Confidence 45566888888888654322 23457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCch
Q 020235 214 T-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292 (329)
Q Consensus 214 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (329)
| |..||.+.+..+....+....... .++.++
T Consensus 242 t~g~~Pf~~~~~~~~~~~i~~~~~~~------------------------------------------------~p~~~~ 273 (308)
T 4gt4_A 242 SYGLQPYCGYSNQDVVEMIRNRQVLP------------------------------------------------CPDDCP 273 (308)
T ss_dssp TTTCCTTTTCCHHHHHHHHHTTCCCC------------------------------------------------CCTTCC
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------------Ccccch
Confidence 8 899999877766554443321110 123456
Q ss_pred hHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 293 ~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+.+|+.+||+.||++|||+++|+++
T Consensus 274 ~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 274 AWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 789999999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=381.99 Aligned_cols=302 Identities=36% Similarity=0.623 Sum_probs=239.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhC-CCCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
||+|+||+||+|.+..+++.||||+++...........|+.++..+.+.. .+++||+.+++.+...+..++|||+++++
T Consensus 105 LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 184 (429)
T 3kvw_A 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMN 184 (429)
T ss_dssp EEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCB
T ss_pred cccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCC
Confidence 69999999999999999999999999876666677788999999987643 36789999999999999999999999889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++ ..
T Consensus 185 L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~-------------------------~~ 239 (429)
T 3kvw_A 185 LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG-------------------------RS 239 (429)
T ss_dssp HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTT-------------------------SC
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCC-------------------------Cc
Confidence 99999987656799999999999999999999999999999999999994322 12
Q ss_pred CeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCC
Q 020235 160 AIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 239 (329)
.++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.+..+.++
T Consensus 240 ~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 240 GIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 38999999998777666677899999999999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHhhhhhhhhhhhcCCcCCCCCCC-chHH---------HhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 240 QHMLKRVDRHAEKYVRRGRLDWPEGAA-SRES---------IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
..++.........+...+...+..... .... .......+....+........+..+.+||++||++||++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~ 399 (429)
T 3kvw_A 320 QKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAV 399 (429)
T ss_dssp HHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTT
T ss_pred HHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhh
Confidence 888776544433332222111110000 0000 000001111122222233455788999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||++|+|+||||++...
T Consensus 400 Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 400 RMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp SCCHHHHHTSTTTC----
T ss_pred CCCHHHHhCChhhccCCC
Confidence 999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=372.46 Aligned_cols=315 Identities=40% Similarity=0.706 Sum_probs=241.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+||+|++..+++.||+|+++...........|..++..+.+....|+||+++++++...+..++|||+++++|
T Consensus 43 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L 122 (360)
T 3llt_A 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSL 122 (360)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBH
T ss_pred EcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCH
Confidence 69999999999999999999999999866666677778999999987655568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.+....-. ... ...............+..
T Consensus 123 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~ 200 (360)
T 3llt_A 123 YEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL-ITV-RRVTDGKKIQIYRTKSTG 200 (360)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE-EEE-ECTTTCCEEEEEEESCCC
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc-cch-hcccccccccccccCCCC
Confidence 999998765679999999999999999999999999999999999999642110000 000 000000000000023677
Q ss_pred eEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCCh
Q 020235 161 IKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (329)
++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....+++|.
T Consensus 201 ~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~ 280 (360)
T 3llt_A 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPK 280 (360)
T ss_dssp EEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCH
T ss_pred EEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCH
Confidence 99999999988777667778999999999999999999999999999999999999999999988999999999999998
Q ss_pred hHHHhhhhhhh-hhhhc--CCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 241 HMLKRVDRHAE-KYVRR--GRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 241 ~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
.+......... .+... ....|+............. ...+......+..+.+||.+||+.||++|||++|+|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL 354 (360)
T 3llt_A 281 NMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVK------KCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELL 354 (360)
T ss_dssp HHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHH------TCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhhhhhccCccccCcccceecCcccccchhhhhhhh------hcccccccchHHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 77665433221 11111 1223443333222221111 111112223457899999999999999999999999
Q ss_pred cCCCCC
Q 020235 318 RHPFFT 323 (329)
Q Consensus 318 ~hp~f~ 323 (329)
+||||+
T Consensus 355 ~hp~f~ 360 (360)
T 3llt_A 355 KHKFLE 360 (360)
T ss_dssp TSGGGC
T ss_pred cCcccC
Confidence 999996
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=372.89 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEE
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv 72 (329)
||+|+||+||+|.+..+ ++.||||.++... .......+|+.++..+. +||||+++++++.. ++.+++|
T Consensus 72 LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~----hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEECCTTSCCEEE
T ss_pred EecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcC----CCCcEEEEEEEEEecCCEEEEE
Confidence 79999999999987654 3689999987432 33456778999999993 45899999998865 5679999
Q ss_pred eecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccC
Q 020235 73 FEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 137 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~ 137 (329)
|||| +|+|.++|+... ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~-------- 219 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-------- 219 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC--------
Confidence 9999 999999997632 23488999999999999999999999999999999999994
Q ss_pred CCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHH
Q 020235 138 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 212 (329)
.+..+||+|||+|+...... ....||+.|||||++.+..|+.++|||||||++|||
T Consensus 220 -------------------~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El 280 (353)
T 4ase_A 220 -------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280 (353)
T ss_dssp -------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHH
Confidence 45568888888887554432 235789999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCchhHHH-HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 213 CT-GEALFQTHENLEHL-AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 213 ~~-g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
+| |..||.+.+..+.. ..+.+...+ ..++.
T Consensus 281 ~t~G~~Pf~~~~~~~~~~~~i~~g~~~------------------------------------------------~~p~~ 312 (353)
T 4ase_A 281 FSLGASPYPGVKIDEEFCRRLKEGTRM------------------------------------------------RAPDY 312 (353)
T ss_dssp TTTSCCSSTTCCCSHHHHHHHHHTCCC------------------------------------------------CCCTT
T ss_pred HhCCCCCCCCCCHHHHHHHHHHcCCCC------------------------------------------------CCCcc
Confidence 98 99999876543332 222221111 01234
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.++++.++|.+||+.||++|||+++|++|
T Consensus 313 ~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 313 TTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 56789999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=368.79 Aligned_cols=251 Identities=26% Similarity=0.453 Sum_probs=213.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+++.+|+.||+|+++.... ......+|+.++..+ .||||+++++++.+.+..++||
T Consensus 20 LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lv~ 94 (361)
T 2yab_A 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-----LHPNIITLHDVYENRTDVVLIL 94 (361)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-----CCcCCCcEEEEEEeCCEEEEEE
Confidence 6999999999999999999999999875322 235677899998888 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ |++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+..++
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-------------------- 152 (361)
T 2yab_A 95 ELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-------------------- 152 (361)
T ss_dssp ECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------------------
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC--------------------
Confidence 999 999999997653 699999999999999999999999999999999999995432
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.....++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 153 ---~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~ 229 (361)
T 2yab_A 153 ---IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229 (361)
T ss_dssp ---SSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred ---CCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 122379999999998665443 446799999999999998999999999999999999999999998777666665
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+......++... +...+..+.+||.+||+.||++|
T Consensus 230 i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dP~~R 264 (361)
T 2yab_A 230 ITAVSYDFDEEF---------------------------------------------FSQTSELAKDFIRKLLVKETRKR 264 (361)
T ss_dssp HHTTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhcCCCCCchh---------------------------------------------ccCCCHHHHHHHHHHCCCChhHC
Confidence 555433333322 23467789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||+..+
T Consensus 265 ~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 265 LTIQEALRHPWITPVD 280 (361)
T ss_dssp CCHHHHHTSTTTSCSS
T ss_pred cCHHHHhcCcCcCCCc
Confidence 9999999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=361.62 Aligned_cols=243 Identities=24% Similarity=0.383 Sum_probs=207.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.+..+|+.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 23 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~lv~e~~~ 97 (328)
T 3fe3_A 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-----NHPNIVKLFEVIETEKTLYLIMEYAS 97 (328)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCEEEEEEECCC
Confidence 699999999999999999999999987432 2345567899999888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+ +
T Consensus 98 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---------------------------~ 148 (328)
T 3fe3_A 98 GGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---------------------------D 148 (328)
T ss_dssp TCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------C
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---------------------------c
Confidence 999999998754 69999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+....... ...+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 66779999999987655433 446799999999999988875 789999999999999999999988776655544443
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.....| ...+..+.+||++||+.||.+|||+
T Consensus 229 ~~~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dP~~R~t~ 259 (328)
T 3fe3_A 229 GKYRIP-------------------------------------------------FYMSTDCENLLKRFLVLNPIKRGTL 259 (328)
T ss_dssp CCCCCC-------------------------------------------------TTSCHHHHHHHHHHCCSSTTTSCCH
T ss_pred CCCCCC-------------------------------------------------CCCCHHHHHHHHHHCCCChhHCcCH
Confidence 222211 2346789999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+++++||||+..+
T Consensus 260 ~eil~h~~~~~~~ 272 (328)
T 3fe3_A 260 EQIMKDRWINAGH 272 (328)
T ss_dssp HHHTTCTTTTTTC
T ss_pred HHHhcCHhhcCCC
Confidence 9999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=358.96 Aligned_cols=275 Identities=28% Similarity=0.433 Sum_probs=219.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|+++ +++.||+|+++... .......+|+.++..+ .|+||+++++++.+++..++||||+.
T Consensus 29 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 29 VGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-----HHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-----CCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred ccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-----CCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 699999999999986 48899999987432 2235667899999888 57999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.
T Consensus 103 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---------------------------~~ 154 (311)
T 3niz_A 103 KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---------------------------NS 154 (311)
T ss_dssp EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------------CT
T ss_pred CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---------------------------CC
Confidence 89999988754 458999999999999999999999999999999999999 55
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 155 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 155 DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp TCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred CCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 6679999999987654332 34578999999999987 4589999999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+..++..+....+...... ........ . .........+.++.+||++||++||++|||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--------------~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 295 (311)
T 3niz_A 235 ILGTPNPREWPQVQELPLWKQ-RTFQVFEK--------------K----PWSSIIPGFCQEGIDLLSNMLCFDPNKRISA 295 (311)
T ss_dssp HHCCCCTTTSGGGTTSHHHHS-CCCCCCCC--------------C----CHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHCCCChHHhhhhhccchhhh-cccccccC--------------C----cHHHhCcccCHHHHHHHHHHcCCChhHCCCH
Confidence 888766554444332221110 00000000 0 0111223467789999999999999999999
Q ss_pred HHHhcCCCCCCCCcC
Q 020235 314 REALRHPFFTRDHLR 328 (329)
Q Consensus 314 ~~ll~hp~f~~~~~~ 328 (329)
+|+++||||++.+.+
T Consensus 296 ~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 296 RDAMNHPYFKDLDPQ 310 (311)
T ss_dssp HHHHTSGGGTTSCTT
T ss_pred HHHhcCcccccCCcc
Confidence 999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=358.58 Aligned_cols=275 Identities=28% Similarity=0.506 Sum_probs=218.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~ 69 (329)
||+|+||+||+|+++.+++.||+|++.... .......+|+.++..+... .|+||+++++++.+.. ..
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~h~niv~~~~~~~~~~~~~~~~~ 94 (308)
T 3g33_A 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--EHPNVVRLMDVCATSRTDREIKV 94 (308)
T ss_dssp ECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHH--CCTTBCCEEEEEEECCSSSEEEE
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhc--CCCCeEEeeeeeeccCCCCceeE
Confidence 699999999999999999999999987322 1234566788888877532 4699999999987654 58
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++|||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 95 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~--------------------- 153 (308)
T 3g33_A 95 TLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV--------------------- 153 (308)
T ss_dssp EEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---------------------
T ss_pred EEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---------------------
Confidence 99999998899999998765569999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 154 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 227 (308)
T 3g33_A 154 ------TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ 227 (308)
T ss_dssp ------CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred ------cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 556679999999987665443 346789999999999999999999999999999999999999999888888
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+..+.++...+......... .++. .............+..+.+||.+||+.||
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~-------~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRG-------AFPP---------------RGPRPVQSVVPEMEESGAQLLLEMLTFNP 285 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGG-------GSCC---------------CCCCCHHHHSCSCCHHHHHHHHHHTCSST
T ss_pred HHHHHHHhCCCChhhccchhhcccc-------ccCC---------------CCCCcHHHhCccccHHHHHHHHHHhcCCC
Confidence 8888888877665433221110000 0000 00011112234577899999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCC
Q 020235 308 TDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~R~t~~~ll~hp~f~~~~ 326 (329)
++|||+.|+|+||||++.+
T Consensus 286 ~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 286 HKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTSCCHHHHHTSTTC----
T ss_pred ccCCCHHHHhcCccccCCC
Confidence 9999999999999999865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-51 Score=375.66 Aligned_cols=281 Identities=26% Similarity=0.439 Sum_probs=219.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||+||+|.++.+++.||||++... ........+|+.++..+ .|+||+++++++... ..+|+
T Consensus 70 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~l 144 (464)
T 3ttj_A 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKTLEEFQDVYL 144 (464)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred eecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEccCCccccCCeEEE
Confidence 69999999999999999999999999742 33455667899999888 679999999998654 46799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+++++.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 145 v~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll----------------------- 197 (464)
T 3ttj_A 145 VMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 197 (464)
T ss_dssp EEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred EEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE-----------------------
Confidence 999998788888754 48999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 198 ----~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 198 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp ----CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 556679999999998665543 44689999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..|.++++.+.........+...... +... .... .++.. ............+..+.+||++||++||++
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~---~~~~~-~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPK-YAGL--TFPK---LFPDS-LFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCC-CCCC--CHHH---HSCGG-GSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccc-cCCC--ChHH---hCccc-ccccccccccccCHHHHHHHHHHcCCChhh
Confidence 999999999888888776666655443211 1110 0000 00000 000000001123668999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
|||++|+|+||||+.
T Consensus 347 R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 347 RISVDDALQHPYINV 361 (464)
T ss_dssp SCCHHHHHTSTTTGG
T ss_pred CCCHHHHhcChhhhh
Confidence 999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=364.46 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+++++++.+.+.+|+||||+
T Consensus 31 lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~----~~hp~Iv~l~~~~~~~~~~~lv~E~~ 106 (353)
T 3txo_A 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA----RNHPFLTQLFCCFQTPDRLFFVMEFV 106 (353)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHT----TTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhc----cCCCceeeEEEEEEeCCEEEEEEeCC
Confidence 699999999999999999999999987432 2334456677777766 25799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 107 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl--------------------------- 157 (353)
T 3txo_A 107 NGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL--------------------------- 157 (353)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---------------------------
Confidence 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55667999999998754332 244679999999999999889999999999999999999999999887776666555
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
......| ...+..+.+||++||+.||.+|||
T Consensus 238 ~~~~~~p-------------------------------------------------~~~~~~~~~li~~lL~~dP~~R~~ 268 (353)
T 3txo_A 238 NDEVVYP-------------------------------------------------TWLHEDATGILKSFMTKNPTMRLG 268 (353)
T ss_dssp HCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSSGGGSTT
T ss_pred cCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhhCHHHccC
Confidence 4322222 235678999999999999999999
Q ss_pred H------HHHhcCCCCCCCC
Q 020235 313 A------REALRHPFFTRDH 326 (329)
Q Consensus 313 ~------~~ll~hp~f~~~~ 326 (329)
+ .++++||||++.+
T Consensus 269 ~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 269 SLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp SGGGTCTHHHHTSGGGTTCC
T ss_pred CcccCCHHHHhhCCcccCCC
Confidence 8 8999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=359.47 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=205.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|+++... .......+|..++..+ .||+|+++++++.+.+.+++||||+
T Consensus 13 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~l~~~~~~~~~~~lv~E~~ 87 (337)
T 1o6l_A 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-----CCCcCcceEEEEEeCCEEEEEEeCC
Confidence 699999999999999999999999987432 2344566788888766 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--------------------------- 138 (337)
T 1o6l_A 88 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--------------------------- 138 (337)
T ss_dssp TTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---------------------------
Confidence 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+.
T Consensus 139 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 218 (337)
T 1o6l_A 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 55667899999988753322 245689999999999999899999999999999999999999998876655444433
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
...... +...+.++.+||.+||+.||++||
T Consensus 219 ~~~~~~-------------------------------------------------p~~~s~~~~~li~~lL~~dP~~R~g 249 (337)
T 1o6l_A 219 MEEIRF-------------------------------------------------PRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HCCCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred cCCCCC-------------------------------------------------CCCCCHHHHHHHHHHhhcCHHHhcC
Confidence 321111 124567899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 250 ~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 250 GGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp CSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHcCCCcCCCC
Confidence 999999999998765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=365.74 Aligned_cols=300 Identities=36% Similarity=0.664 Sum_probs=230.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhC-CCCCceeeeccccccCCceEEEeecCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~l~~~~~~~~~~~lv~e~~~~~ 79 (329)
||+|+||+||+|.++.+++.||||+++...........|+.++..+.++. ..+++++.+.+++...+..++|||+++++
T Consensus 62 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 141 (382)
T 2vx3_A 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN 141 (382)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCB
T ss_pred EeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCC
Confidence 69999999999999999999999999866555667778999998886543 23456999999999999999999999889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH--~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||+.. +.
T Consensus 142 L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-------------------------~~ 196 (382)
T 2vx3_A 142 LYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-------------------------PK 196 (382)
T ss_dssp HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-------------------------TT
T ss_pred HHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-------------------------CC
Confidence 999999876557999999999999999999999 579999999999999943 23
Q ss_pred CCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
+..++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+..+.
T Consensus 197 ~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp SCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred CCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 56799999999988776666778999999999999999999999999999999999999999999998999999999998
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCC------------CCCCC-chHHHhhh-ccchhhHH-HHhhhccCchhHHHHHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDW------------PEGAA-SRESIKSV-MKLPRLQN-LIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~-~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~ll~~~ 302 (329)
++..++.........+.......| ..... .-...... ...+.... .........+..+.+||++|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 888776654332222211111111 00000 00000000 00000000 00000011235799999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
|++||++|||++|+|+||||++.
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=357.25 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=208.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|+++... .......+|..++..+ .||||+++++++.+.+.+++||||+
T Consensus 14 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~Iv~~~~~~~~~~~~~lv~e~~ 88 (318)
T 1fot_A 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQQIFMIMDYI 88 (318)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-----CCCCCceEeEEEEeCCEEEEEEeCC
Confidence 699999999999999999999999987432 2234556677777766 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 89 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--------------------------- 139 (318)
T 1fot_A 89 EGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--------------------------- 139 (318)
T ss_dssp CSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---------------------------
T ss_pred CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---------------------------
Confidence 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.++|+|||.+..........+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 219 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 219 (318)
T ss_dssp CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred cCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 55677999999999876665566789999999999999999999999999999999999999998877665555444322
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC----
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---- 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---- 311 (329)
...| ...+.++.++|++||+.||++|+
T Consensus 220 ~~~p-------------------------------------------------~~~~~~~~~li~~lL~~dp~~R~~~~~ 250 (318)
T 1fot_A 220 LRFP-------------------------------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQ 250 (318)
T ss_dssp CCCC-------------------------------------------------TTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CCCC-------------------------------------------------CCCCHHHHHHHHHHhccCHHHcCCCcC
Confidence 1111 23567899999999999999999
Q ss_pred -CHHHHhcCCCCCCCC
Q 020235 312 -TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 251 ~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 251 NGTEDVKNHPWFKEVV 266 (318)
T ss_dssp TTTHHHHTSGGGSSCC
T ss_pred CCHHHHhcCccccCCC
Confidence 999999999998764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=356.19 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=212.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++.+++.||+|++..... ......+|+.++..+ .||||+++++++.+.+..++||
T Consensus 19 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~ 93 (326)
T 2y0a_A 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEVYENKTDVILIL 93 (326)
T ss_dssp EECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCCEEEEEE
Confidence 6999999999999999999999999874321 245677899999988 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+|||+..++
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------------------- 151 (326)
T 2y0a_A 94 ELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-------------------- 151 (326)
T ss_dssp ECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS--------------------
T ss_pred EcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC--------------------
Confidence 999 899999997653 699999999999999999999999999999999999995433
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 152 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 228 (326)
T 2y0a_A 152 ---VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 228 (326)
T ss_dssp ---SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred ---CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH
Confidence 223479999999997664332 446799999999999998999999999999999999999999988776665555
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.......+... ....+..+.+||++||+.||++|
T Consensus 229 ~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~L~~dP~~R 263 (326)
T 2y0a_A 229 VSAVNYEFEDEY---------------------------------------------FSNTSALAKDFIRRLLVKDPKKR 263 (326)
T ss_dssp HHHTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHhcCCCcCccc---------------------------------------------cccCCHHHHHHHHHHccCChhhC
Confidence 554433333221 12456789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||++..
T Consensus 264 pt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 264 MTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCHHHHHHSTTTSCCS
T ss_pred CCHHHHhcCCCccCCc
Confidence 9999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=353.12 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=207.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|.+..+++.||+|++.... .......+|+.++..+ .||||+++++++.+++..++||||+ ++
T Consensus 28 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (297)
T 3fxz_A 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (297)
T ss_dssp EEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-----CCCCCCeEeEEEEECCEEEEEEECCCCC
Confidence 699999999999999999999999986432 3345567888888887 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+ +.+
T Consensus 103 ~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---------------------------~~~ 152 (297)
T 3fxz_A 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---------------------------GMD 152 (297)
T ss_dssp BHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTT
T ss_pred CHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---------------------------CCC
Confidence 999999875 49999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred CCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 679999999987655433 34579999999999999999999999999999999999999998876655444433322
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. ......+..+.+||.+||+.||++|||+++
T Consensus 233 ~~~~----------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (297)
T 3fxz_A 233 TPEL----------------------------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKE 266 (297)
T ss_dssp SCCC----------------------------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCC----------------------------------------------CCccccCHHHHHHHHHHccCChhHCcCHHH
Confidence 1110 001245678999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||+...
T Consensus 267 ll~h~~~~~~~ 277 (297)
T 3fxz_A 267 LLQHQFLKIAK 277 (297)
T ss_dssp HTTCGGGGGCC
T ss_pred HhhChhhcccC
Confidence 99999998654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=356.37 Aligned_cols=313 Identities=46% Similarity=0.850 Sum_probs=240.8
Q ss_pred CCCccceEEEEEEe-cCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhC-CCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWD-RERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHD-KGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||+||+|.+ +.+++.||+|+++..........+|+.++..+.+.. ..+++++.+++++.+.+..++|||++++
T Consensus 22 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 101 (339)
T 1z57_A 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL 101 (339)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCC
T ss_pred EecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCC
Confidence 68999999999998 567899999999866666677888999999998753 3456799999999999999999999999
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+...+.....+.+.. .......+
T Consensus 102 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~--------~~~~~~~~ 173 (339)
T 1z57_A 102 STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK--------RDERTLIN 173 (339)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC------------CEEEEESC
T ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc--------cccccccC
Confidence 9999998876567899999999999999999999999999999999999965432111110000 00001125
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (329)
..++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.+..+++
T Consensus 174 ~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 253 (339)
T 1z57_A 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL 253 (339)
T ss_dssp CCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSC
T ss_pred CCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 67999999999887776677789999999999999899999999999999999999999999988888888899999999
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
|..++...... .+.......|.............. .............+..+.+||.+||+.||.+|||++|+++
T Consensus 254 p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 254 PKHMIQKTRKR--KYFHHDRLDWDEHSSAGRYVSRAC---KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp CHHHHHHCSCG--GGEETTEECCCTTSHHHHHHHHHC---CCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHhhccch--hHHhhccccccccccccchhhhcC---cchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 98877754321 222222333433221111111100 0000111112334678999999999999999999999999
Q ss_pred CCCCCCCC
Q 020235 319 HPFFTRDH 326 (329)
Q Consensus 319 hp~f~~~~ 326 (329)
||||++..
T Consensus 329 hp~f~~~~ 336 (339)
T 1z57_A 329 HPFFDLLK 336 (339)
T ss_dssp SGGGGGGG
T ss_pred CHHHHHHh
Confidence 99998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=360.49 Aligned_cols=249 Identities=22% Similarity=0.397 Sum_probs=214.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|.++.+++.||+|++...........+|+.++..+ .||||+++++++.+.+..++||||+ +++
T Consensus 13 lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~e~~~g~~ 87 (321)
T 1tki_A 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-----CCCCCCeEeEEEecCCEEEEEEEeCCCCC
Confidence 6999999999999999999999999986655566678899999888 5799999999999999999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++. ..+.
T Consensus 88 L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-------------------------~~~~ 141 (321)
T 1tki_A 88 IFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-------------------------RRSS 141 (321)
T ss_dssp HHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------SSCC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-------------------------CCCC
Confidence 999997643 35899999999999999999999999999999999999943 1256
Q ss_pred CeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 160 AIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 142 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 221 (321)
T 1tki_A 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp CEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred CEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCC
Confidence 79999999998765544 3457899999999999988899999999999999999999999987776666665554433
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
++... +...+.++.+||.+||+.||++|||+.|++
T Consensus 222 ~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 256 (321)
T 1tki_A 222 FDEEA---------------------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp CCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CChhh---------------------------------------------hccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 33221 124567899999999999999999999999
Q ss_pred cCCCCCCC
Q 020235 318 RHPFFTRD 325 (329)
Q Consensus 318 ~hp~f~~~ 325 (329)
+||||++.
T Consensus 257 ~hp~~~~~ 264 (321)
T 1tki_A 257 QHPWLKQK 264 (321)
T ss_dssp HSHHHHSC
T ss_pred cChhhccC
Confidence 99999765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=361.02 Aligned_cols=272 Identities=28% Similarity=0.519 Sum_probs=219.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
||+|+||.||+|.++.+|+.||||++... ........+|+.++..+ .|+||+++++++.... ..|+
T Consensus 33 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~l 107 (367)
T 1cm8_A 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDETLDDFTDFYL 107 (367)
T ss_dssp C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred eeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCcCCCCceeeEecCCccccCceEEE
Confidence 79999999999999999999999998532 23345667899999988 5699999999987653 4699
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 108 v~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll----------------------- 161 (367)
T 1cm8_A 108 VMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----------------------- 161 (367)
T ss_dssp EEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-----------------------
T ss_pred EEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE-----------------------
Confidence 9999999999999874 59999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 162 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 237 (367)
T 1cm8_A 162 ----NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 237 (367)
T ss_dssp ----CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ----cCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55667999999999877766666789999999999987 6799999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.++.+.+..+.... ..+...- ...+. ..........+..+.+||.+||+.||++
T Consensus 238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~ll~~mL~~dP~~ 298 (367)
T 1cm8_A 238 IMKVTGTPPAEFVQRLQSDEAKNYMKGL-PELEK------------------KDFASILTNASPLAVNLLEKMLVLDAEQ 298 (367)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHS-CCCCC------------------CCGGGTCTTCCHHHHHHHHHHSCSSTTT
T ss_pred HHHhcCCCCHHHHHHhhhHHHHHHHHhC-CCCCC------------------CCHHHHCCCCCHHHHHHHHHHccCChhH
Confidence 99999999988776543322 1111110 00000 0011122346788999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|||++++|+||||++.+
T Consensus 299 R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 299 RVTAGEALAHPYFESLH 315 (367)
T ss_dssp SCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHhcChHHHhhc
Confidence 99999999999998743
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=356.22 Aligned_cols=277 Identities=29% Similarity=0.500 Sum_probs=216.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||+||+|.++.+++.||+|+++... .......+|+.++..+ .|+||+++++++.+++..++||||+.+
T Consensus 13 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~~ 87 (317)
T 2pmi_A 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-----KHENIVRLYDVIHTENKLTLVFEFMDN 87 (317)
T ss_dssp ------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-----CBTTBCCEEEEECCTTEEEEEEECCCC
T ss_pred ECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-----CCCCcceEEEEEEECCeEEEEEEecCC
Confidence 799999999999999999999999987432 2335667899988888 569999999999999999999999988
Q ss_pred CHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 79 SLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 79 ~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~-------------------------- 141 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI-------------------------- 141 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--------------------------
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE--------------------------
Confidence 9999987532 2358999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 142 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 220 (317)
T 2pmi_A 142 -NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220 (317)
T ss_dssp -CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred -cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 556679999999987654332 345789999999999874 589999999999999999999999999888888888
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHH-HHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN-LIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.++...+..+........ . ..... ...+.. .........+..+.+||.+||+.||++
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 284 (317)
T 2pmi_A 221 IFDIMGTPNESLWPSVTKLPKYNP-N--IQQRP-------------PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDM 284 (317)
T ss_dssp HHHHHCSCCTTTCGGGGGCTTCCT-T--CCCCC-------------CCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCChhHhhhhhhhhhccc-c--ccccc-------------chhHHHhhcccccccCCHHHHHHHHHHCCCCccc
Confidence 888888877766555433221100 0 00000 000111 111223456789999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||++|+++||||++.
T Consensus 285 Rpt~~e~l~hp~f~~~ 300 (317)
T 2pmi_A 285 RLSAKQALHHPWFAEY 300 (317)
T ss_dssp SCCHHHHTTSGGGGGG
T ss_pred CCCHHHHhCChhhhcc
Confidence 9999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=359.83 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=206.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..||+|+++++++.+.+.+|+||||+
T Consensus 25 lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~----~~hp~iv~l~~~~~~~~~~~lv~E~~ 100 (345)
T 1xjd_A 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQTKENLFFVMEYL 100 (345)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhc----CCCCCCCcEEEEEEeCCEEEEEEeCC
Confidence 699999999999999999999999997532 2334556777777765 25699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 101 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--------------------------- 151 (345)
T 1xjd_A 101 NGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--------------------------- 151 (345)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---------------------------
Confidence 999999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 152 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 152 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 5566789999998875432 2245689999999999999999999999999999999999999998877665555443
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+..+.+||.+||+.||++|||
T Consensus 232 ~~~~~~-------------------------------------------------p~~~s~~~~~li~~lL~~dp~~R~~ 262 (345)
T 1xjd_A 232 MDNPFY-------------------------------------------------PRWLEKEAKDLLVKLFVREPEKRLG 262 (345)
T ss_dssp HCCCCC-------------------------------------------------CTTSCHHHHHHHHHHSCSSGGGSBT
T ss_pred hCCCCC-------------------------------------------------CcccCHHHHHHHHHHhcCCHhHcCC
Confidence 321111 1235678999999999999999999
Q ss_pred HH-HHhcCCCCCCCC
Q 020235 313 AR-EALRHPFFTRDH 326 (329)
Q Consensus 313 ~~-~ll~hp~f~~~~ 326 (329)
+. ++++||||++.+
T Consensus 263 ~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 263 VRGDIRQHPLFREIN 277 (345)
T ss_dssp TBSCGGGSGGGTTCC
T ss_pred ChHHHHcCccccCCC
Confidence 98 999999999865
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=365.59 Aligned_cols=317 Identities=31% Similarity=0.562 Sum_probs=231.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCC---CCCceeeeccccc----cCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK---GGNRCVQIRNWFD----YRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~---~~~~i~~l~~~~~----~~~~~~lv~ 73 (329)
||+|+||+||+|++..+++.||+|+++..........+|+.++..+.+... +|++|+++++.+. .....++||
T Consensus 45 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~ 124 (397)
T 1wak_A 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVF 124 (397)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEE
Confidence 689999999999999999999999998766667778899999999976432 3678999999887 567899999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccC------CCcCccCCC
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVP------DYKSSLHTP 146 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~------~~~~~~~~~ 146 (329)
|++++++.+.+.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++..... ++......+
T Consensus 125 e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~ 204 (397)
T 1wak_A 125 EVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204 (397)
T ss_dssp CCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------
T ss_pred eccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCC
Confidence 99988888888876556799999999999999999999998 99999999999999866521110 000000000
Q ss_pred CCC----------------CccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHH
Q 020235 147 KDS----------------SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILV 210 (329)
Q Consensus 147 ~~~----------------~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ 210 (329)
... ...........++|+|||.+...........||+.|+|||++.+..++.++|||||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (397)
T 1wak_A 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAF 284 (397)
T ss_dssp ------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHH
Confidence 000 0000011234799999999987776666678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCc------hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 211 ELCTGEALFQTHE------NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 211 ~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
+|++|..||.+.+ .......+.+..+.+|..++....-....+...+.............. ......
T Consensus 285 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 357 (397)
T 1wak_A 285 ELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF-------EVLVEK 357 (397)
T ss_dssp HHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH-------HHHHHT
T ss_pred HHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh-------Hhhhhh
Confidence 9999999997654 456677788888988877654432222222222211111100000000 000000
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
.......+..+.+||.+||+.||++|||++|+|+||||++
T Consensus 358 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 358 YEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp SCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 1112335678999999999999999999999999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=352.94 Aligned_cols=272 Identities=28% Similarity=0.484 Sum_probs=216.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|.++.+++.||+|+++... .......+|+.++..+ .|+||+++++++.+++..++||||++
T Consensus 10 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 84 (292)
T 3o0g_A 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred ecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-----CCCCEeeEEeEEEeCCEEEEEEecCC
Confidence 699999999999999999999999987432 2335667788888887 57999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+.+.... ..+++..++.++.|++.||+|||++||+||||||+||++ +.
T Consensus 85 ~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---------------------------~~ 136 (292)
T 3o0g_A 85 QDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---------------------------NR 136 (292)
T ss_dssp EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CT
T ss_pred CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---------------------------cC
Confidence 78888877644 469999999999999999999999999999999999999 55
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCC-CCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEAL-FQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~ 232 (329)
++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..| |.+.+..+....+.
T Consensus 137 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~ 216 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216 (292)
T ss_dssp TSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHH
T ss_pred CCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHH
Confidence 6679999999987654332 3457899999999998766 79999999999999999987766 66667777788888
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+.++...+.......+.. .. ...+. ...........+..+++||++||+.||++|||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 276 (292)
T 3o0g_A 217 RLLGTPTEEQWPSMTKLPDYK-PY--PMYPA-----------------TTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp HHHCCCCTTTCTTGGGSTTCC-CC--CCCCT-----------------TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHhCCCChhhhhhhccccccc-cc--ccccC-----------------CcchhhcccccChHHHHHHHHHhccChhhCCC
Confidence 888877765544433221110 00 00000 00011122346788999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
++|+++||||++.
T Consensus 277 ~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcCcccccC
Confidence 9999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=351.06 Aligned_cols=272 Identities=28% Similarity=0.460 Sum_probs=212.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|++ .+++.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..++|||++.
T Consensus 10 lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred cccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-----CCCCEeeeeeEEccCCeEEEEEEecC
Confidence 69999999999998 5788999999864322 235566788888877 57999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.
T Consensus 84 ~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---------------------------~~ 135 (288)
T 1ob3_A 84 QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------------NR 135 (288)
T ss_dssp EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------CT
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------cC
Confidence 89999998643 468999999999999999999999999999999999999 55
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp TSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 6679999999887554322 345789999999999764 589999999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+..+...+....+..... . ...... . ..........+..+.+||++||+.||++|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~-~--~~~~~~-------------~----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 275 (288)
T 1ob3_A 216 ILGTPNSKNWPNVTELPKYD-P--NFTVYE-------------P----LPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (288)
T ss_dssp HHCCCCTTTSTTGGGSTTCC-T--TCCCCC-------------C----CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHCCCChhhchhhhcccccc-c--cccccc-------------C----ccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 87776654443322211100 0 000000 0 00011224567889999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+++++||||++.|
T Consensus 276 ~e~l~hp~f~~~n 288 (288)
T 1ob3_A 276 KQALEHAYFKENN 288 (288)
T ss_dssp HHHHTSGGGGC--
T ss_pred HHHhcCcchhhcC
Confidence 9999999999865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=363.41 Aligned_cols=282 Identities=27% Similarity=0.464 Sum_probs=206.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+. .|+||+++++++... ..+|+||||
T Consensus 17 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~----~h~niv~l~~~~~~~~~~~~~lv~e~ 92 (388)
T 3oz6_A 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----GHENIVNLLNVLRADNDRDVYLVFDY 92 (388)
T ss_dssp -------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTT----TCTTBCCEEEEEECTTSSCEEEEEEC
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhcc----CCCCCCeeeeEEecCCCCEEEEEecc
Confidence 79999999999999999999999998632 333455677888888873 479999999998754 479999999
Q ss_pred CCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 76 LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 76 ~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 93 ~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~-------------------------- 143 (388)
T 3oz6_A 93 METDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN-------------------------- 143 (388)
T ss_dssp CSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC--------------------------
T ss_pred cCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc--------------------------
Confidence 988999999874 589999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCC------------------------CCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP------------------------DQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILV 210 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ 210 (329)
.++.++|+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 144 -~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 222 (388)
T 3oz6_A 144 -AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222 (388)
T ss_dssp -TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred -CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence 445566677776653321 1133579999999999987 56899999999999999
Q ss_pred HHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhh-hhhh----cCCcCCCCCCCchHHHhhhccchhhHHHH-
Q 020235 211 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVR----RGRLDWPEGAASRESIKSVMKLPRLQNLI- 284 (329)
Q Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 284 (329)
+|++|++||.+.+..+....+....+.++.+.+........ .+.. ............. +......
T Consensus 223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~ 293 (388)
T 3oz6_A 223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIF---------TKWKNLLL 293 (388)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCH---------HHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhC---------cchhhhcc
Confidence 99999999999999999999999888887766544322110 0000 0000000000000 0000000
Q ss_pred -hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 285 -MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 285 -~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
.......+..+.+||++||+.||++|||++|+|+||||+.-
T Consensus 294 ~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 294 KINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred cccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 11123567889999999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=361.29 Aligned_cols=276 Identities=28% Similarity=0.482 Sum_probs=215.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh--HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||+||+|+++.+++.||+|+++..... .....+|+.++..+ .|+||+++++++.+.+..++||||+++
T Consensus 10 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (324)
T 3mtl_A 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-----KHANIVTLHDIIHTEKSLTLVFEYLDK 84 (324)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-----CCTTBCCEEEEEECSSCEEEEEECCSE
T ss_pred EcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-----CCCCCCeeeeEEeeCCEEEEEeccccc
Confidence 69999999999999999999999998743321 12345688888777 579999999999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.+
T Consensus 85 ~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---------------------------~~~ 136 (324)
T 3mtl_A 85 DLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---------------------------NER 136 (324)
T ss_dssp EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---------------------------CTT
T ss_pred CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---------------------------CCC
Confidence 9999998754 468999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 137 ~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 137 GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp CCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 679999999887554332 33578999999999987 56899999999999999999999999999988889999998
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.++...++........... .++. .............+..+.+||.+||+.||++|||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~----~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 277 (324)
T 3mtl_A 217 LGTPTEETWPGILSNEEFKTY----NYPK---------------YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAE 277 (324)
T ss_dssp HCCCCTTTSTTGGGCHHHHHT----CCCC---------------CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hCCCChHhchhhhcchhhccc----cccc---------------ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHH
Confidence 888776554433221110000 0000 000111122345678899999999999999999999
Q ss_pred HHhcCCCCCCCCcC
Q 020235 315 EALRHPFFTRDHLR 328 (329)
Q Consensus 315 ~ll~hp~f~~~~~~ 328 (329)
|+++||||++...+
T Consensus 278 e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 278 DAMKHPFFLSLGER 291 (324)
T ss_dssp HHTTSGGGGGGCST
T ss_pred HHhcChhhhhcccc
Confidence 99999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=358.48 Aligned_cols=182 Identities=24% Similarity=0.325 Sum_probs=148.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHH--HHHHHhhCCCCCceeeeccccccCC----ceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEV--LQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~--l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e 74 (329)
||+|+||+||+|++ +|+.||||+++.... .....|.++ +..+ .||||+++++++.+++ .+|||||
T Consensus 11 iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~--~~~~~e~Ei~~~~~l-----~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREE--RSWFREAEIYQTVML-----RHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEECSSSEEEEEEE--TTEEEEEEEECGGGH--HHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EeeCCCeEEEEEEE--CCEEEEEEEECccch--hhHHHHHHHHHHhcC-----CCCCCCcEEEEEEecCCCceEEEEEec
Confidence 79999999999987 588999999975433 233334333 3334 6799999999987654 5899999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~--------~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
|+ +|+|.+++... .+++..+.+++.|++.||+|||++ +|+||||||+|||+
T Consensus 82 y~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl----------------- 141 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----------------- 141 (303)
T ss_dssp CCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE-----------------
T ss_pred CCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE-----------------
Confidence 99 99999999875 499999999999999999999987 99999999999999
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC------CCCCccchHhHHHHHHHH
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l 212 (329)
+.++.+||+|||+|+...... ...+||+.|||||++.+. .++.++|||||||++|||
T Consensus 142 ----------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El 211 (303)
T 3hmm_A 142 ----------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp ----------CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence 566778999999987554332 234799999999999765 366789999999999999
Q ss_pred HhCCCCCCC
Q 020235 213 CTGEALFQT 221 (329)
Q Consensus 213 ~~g~~p~~~ 221 (329)
+||.+||..
T Consensus 212 ~tg~~~~~~ 220 (303)
T 3hmm_A 212 ARRCSIGGI 220 (303)
T ss_dssp HHTBCBTTB
T ss_pred HHCCCCCCc
Confidence 999888754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=366.99 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=210.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.++.+|+.||+|++.... .......+|+.++..+ .||||+++++++.+++..++||||+
T Consensus 19 LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-----KHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-----CBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 699999999999999999999999987532 2345567899999888 5699999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
|++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++.+ .
T Consensus 94 gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~------------------------~ 147 (444)
T 3soa_A 94 GGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK------------------------L 147 (444)
T ss_dssp CCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS------------------------S
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc------------------------C
Confidence 899999998764 69999999999999999999999999999999999999542 2
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 148 ~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 148 KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 45679999999997665543 345799999999999998999999999999999999999999988777666666555
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.....+.. .+...+..+.+||.+||+.||++|||+
T Consensus 228 ~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rpta 262 (444)
T 3soa_A 228 GAYDFPSP---------------------------------------------EWDTVTPEAKDLINKMLTINPSKRITA 262 (444)
T ss_dssp TCCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCcc---------------------------------------------ccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 43333221 123467789999999999999999999
Q ss_pred HHHhcCCCCCC
Q 020235 314 REALRHPFFTR 324 (329)
Q Consensus 314 ~~ll~hp~f~~ 324 (329)
.|+|+||||++
T Consensus 263 ~e~L~hp~~~~ 273 (444)
T 3soa_A 263 AEALKHPWISH 273 (444)
T ss_dssp HHHHHSCTTHH
T ss_pred HHHhcCccccC
Confidence 99999999964
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=359.76 Aligned_cols=243 Identities=28% Similarity=0.445 Sum_probs=209.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|+++... .......+|..++..+ .||+|+++++++.+.+.+|+||||+
T Consensus 49 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 123 (350)
T 1rdq_E 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 699999999999999999999999987432 2234566788887776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 124 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--------------------------- 174 (350)
T 1rdq_E 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--------------------------- 174 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---------------------------
Confidence 999999998754 59999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.++|+|||.+..........+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 175 ~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T 1rdq_E 175 DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 55667999999999877666666789999999999999999999999999999999999999998877665555444422
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC---
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT--- 312 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t--- 312 (329)
..+| ...+..+.++|.+||+.||.+||+
T Consensus 255 ~~~p-------------------------------------------------~~~~~~~~~li~~lL~~dp~~R~~~~~ 285 (350)
T 1rdq_E 255 VRFP-------------------------------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp CCCC-------------------------------------------------TTCCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred CCCC-------------------------------------------------CCCCHHHHHHHHHHhhcCHHhccCCcc
Confidence 1111 235678999999999999999998
Q ss_pred --HHHHhcCCCCCCCC
Q 020235 313 --AREALRHPFFTRDH 326 (329)
Q Consensus 313 --~~~ll~hp~f~~~~ 326 (329)
++++++||||++.+
T Consensus 286 ~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 286 NGVNDIKNHKWFATTD 301 (350)
T ss_dssp TTTHHHHTSGGGTTCC
T ss_pred CCHHHHHhCcCcCCCC
Confidence 99999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=368.35 Aligned_cols=300 Identities=26% Similarity=0.440 Sum_probs=200.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-----cCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----YRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-----~~~~~~lv 72 (329)
||+|+||+||+|+++.+++.||||++... ....+...+|+.++..+ .|+||+++++++. ..+.+|+|
T Consensus 61 lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~~~~~~~~~lv 135 (458)
T 3rp9_A 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-----NHDHVVKVLDIVIPKDVEKFDELYVV 135 (458)
T ss_dssp -------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred eeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-----CCCCCCceEEEEecCCcccCceEEEE
Confidence 79999999999999999999999998642 23345677899999998 6799999999984 34679999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+++.|||++..........
T Consensus 136 ~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 213 (458)
T 3rp9_A 136 LEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213 (458)
T ss_dssp ECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCC
T ss_pred EeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccc
Confidence 9999999999998753 69999999999999999999999999999999999999766666666666554432221110
Q ss_pred c---cCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh-cCCCCCccchHhHHHHHHHHHh-----------CCC
Q 020235 153 K---RMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCT-----------GEA 217 (329)
Q Consensus 153 ~---~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~l~~-----------g~~ 217 (329)
. .........+++|+.+..........+||+.|+|||++. +..++.++|||||||++|+|++ |++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p 293 (458)
T 3rp9_A 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293 (458)
T ss_dssp CCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCC
T ss_pred cccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccc
Confidence 0 000111122333333322222334567899999999874 5569999999999999999998 777
Q ss_pred CCCCCc--------------------hhHHHHHHHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhcc
Q 020235 218 LFQTHE--------------------NLEHLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMK 276 (329)
Q Consensus 218 p~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
+|.+.+ ..+....+.+..|.++.+.+..+..... .+...- ....
T Consensus 294 ~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~-------------- 358 (458)
T 3rp9_A 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIF-PKRE-------------- 358 (458)
T ss_dssp SCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTS-CCCC--------------
T ss_pred cCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhc-CCCC--------------
Confidence 776643 2466777888888888776665433221 111110 0000
Q ss_pred chhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 277 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
...........+.++.+||++||++||++|||++|+|+||||++.+
T Consensus 359 ----~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 359 ----GTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp ----CCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ----CCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 0001112234578899999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=359.54 Aligned_cols=279 Identities=27% Similarity=0.467 Sum_probs=214.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|+++.+++.||+|+++.... ......+|+.++..+ .|+||+++++++.+++..++||||+.
T Consensus 42 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (329)
T 3gbz_A 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-----QHRNIIELKSVIHHNHRLHLIFEYAE 116 (329)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-----CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-----CCCCcceEEEEEecCCEEEEEEecCC
Confidence 6999999999999999999999999874322 234456788888887 57999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+..++. ..
T Consensus 117 ~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~----------------------~~ 172 (329)
T 3gbz_A 117 NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA----------------------SE 172 (329)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC---------------------------
T ss_pred CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC----------------------Cc
Confidence 89999998865 5999999999999999999999999999999999999965431 34
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
...++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.+
T Consensus 173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 252 (329)
T 3gbz_A 173 TPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE 252 (329)
T ss_dssp CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHH
Confidence 4569999999987654332 345789999999999875 489999999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.++...+........... .++. ....... .......+.++.+||.+||+.||++|||+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~-----~~~~-----------~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 313 (329)
T 3gbz_A 253 VLGLPDDTTWPGVTALPDWKQ-----SFPK-----------FRGKTLK---RVLGALLDDEGLDLLTAMLEMDPVKRISA 313 (329)
T ss_dssp HHCCCCTTTSTTGGGSTTCCT-----TCCC-----------CCCCCHH---HHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HhCCCchhhhhhhhhhhhhhh-----hhhh-----------hccccHh---hhcccccCHHHHHHHHHHccCChhhCCCH
Confidence 877766544433222111000 0000 0000111 11223467889999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
+|+++||||++.+.
T Consensus 314 ~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 314 KNALEHPYFSHNDF 327 (329)
T ss_dssp HHHHTSGGGSSSCS
T ss_pred HHHhCCcccCCCCC
Confidence 99999999998763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=361.07 Aligned_cols=253 Identities=21% Similarity=0.384 Sum_probs=200.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..||||+++++++.+.+.+++||||+
T Consensus 60 LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~----~~hp~Iv~l~~~~~~~~~~~lV~E~~ 135 (396)
T 4dc2_A 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIEYV 135 (396)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHH----TTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhc----CCCCCcCeeEEEEEECCEEEEEEEcC
Confidence 699999999999999999999999997532 1223456788888776 25799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|..++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 136 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--------------------------- 186 (396)
T 4dc2_A 136 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--------------------------- 186 (396)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---------------------------
Confidence 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||++..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||......+....
T Consensus 187 ~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-- 264 (396)
T 4dc2_A 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-- 264 (396)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------
T ss_pred CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--
Confidence 5667799999999875322 22456899999999999999999999999999999999999999965322110000
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.....+.. ...... ..++...+.++.+||++||+.||++|||
T Consensus 265 ----~~~~~~~~--------~i~~~~--------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~ 306 (396)
T 4dc2_A 265 ----NTEDYLFQ--------VILEKQ--------------------------IRIPRSLSVKAASVLKSFLNKDPKERLG 306 (396)
T ss_dssp ----CCHHHHHH--------HHHHCC--------------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTT
T ss_pred ----hhHHHHHH--------HHhccc--------------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCC
Confidence 00000000 000000 1122346788999999999999999998
Q ss_pred H------HHHhcCCCCCCCC
Q 020235 313 A------REALRHPFFTRDH 326 (329)
Q Consensus 313 ~------~~ll~hp~f~~~~ 326 (329)
+ +++++||||++.+
T Consensus 307 ~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 307 CHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp CSTTTHHHHHHHSTTTTTCC
T ss_pred CCCCCCHHHHhcCccccCCC
Confidence 5 7999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=356.77 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=204.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ ..|++|+.+++++.+.+.+|+||||+
T Consensus 28 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~l~~~~~~~~~~~lv~E~~ 103 (353)
T 2i0e_A 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQTMDRLYFVMEYV 103 (353)
T ss_dssp EEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCT----TCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhc----CCCCEEeeEEEEEEcCCEEEEEEeCC
Confidence 699999999999999999999999987532 2233445566665444 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 104 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--------------------------- 154 (353)
T 2i0e_A 104 NGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--------------------------- 154 (353)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---------------------------
Confidence 899999998754 59999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 155 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 155 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 5566789999998875332 2245689999999999999999999999999999999999999998877666555554
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
......| ...+.++.+||.+||+.||++||+
T Consensus 235 ~~~~~~p-------------------------------------------------~~~s~~~~~li~~lL~~dP~~R~~ 265 (353)
T 2i0e_A 235 EHNVAYP-------------------------------------------------KSMSKEAVAICKGLMTKHPGKRLG 265 (353)
T ss_dssp HCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSCTTSCTT
T ss_pred hCCCCCC-------------------------------------------------CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 4221111 235678999999999999999994
Q ss_pred -----HHHHhcCCCCCCCC
Q 020235 313 -----AREALRHPFFTRDH 326 (329)
Q Consensus 313 -----~~~ll~hp~f~~~~ 326 (329)
++++++||||+..+
T Consensus 266 ~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 266 CGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp CSTTHHHHHHTSGGGTTCC
T ss_pred CCCCCHHHHhcCccccCCC
Confidence 69999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=358.22 Aligned_cols=248 Identities=26% Similarity=0.413 Sum_probs=209.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 37 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 699999999999999999999999997432 2335567899999988 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+.+.... .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 112 gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~------------------------ 165 (362)
T 2bdw_A 112 GGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------------------ 165 (362)
T ss_dssp SCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS------------------------
T ss_pred CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC------------------------
Confidence 899999997654 689999999999999999999999999999999999995432
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 166 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~ 245 (362)
T 2bdw_A 166 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 245 (362)
T ss_dssp TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 34569999999998665443 3457999999999999989999999999999999999999999887766655555443
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....+.. .+..++..+.+||.+||+.||++|||+.
T Consensus 246 ~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~ 280 (362)
T 2bdw_A 246 AYDYPSP---------------------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITAD 280 (362)
T ss_dssp CCCCCTT---------------------------------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCcc---------------------------------------------cccCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 3222211 1234567899999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
++|+||||..
T Consensus 281 e~l~hp~~~~ 290 (362)
T 2bdw_A 281 QALKVPWICN 290 (362)
T ss_dssp HHTTSHHHHT
T ss_pred HHhcCcccCC
Confidence 9999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=358.39 Aligned_cols=271 Identities=27% Similarity=0.496 Sum_probs=203.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||.||+|.++.+|+.||||++... ........+|+.++..+ .|+||+++++++... ...++
T Consensus 37 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~~~~~~~l 111 (367)
T 2fst_X 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSLEEFNDVYL 111 (367)
T ss_dssp CC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEecCCccccCCeEEE
Confidence 79999999999999999999999998642 23345667899999888 579999999988654 56899
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+++++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 112 v~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----------------------- 165 (367)
T 2fst_X 112 VTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----------------------- 165 (367)
T ss_dssp EEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE-----------------------
Confidence 9999999999998763 59999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 166 ----~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~ 241 (367)
T 2fst_X 166 ----NEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241 (367)
T ss_dssp ----CTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ----CCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55667999999999876666566789999999999987 5789999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.++.+.+..+.... ..+...- ...+. .. ........+..+.+||++||+.||++
T Consensus 242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~-~~~~~--------------~~----~~~~~~~~~~~~~dLl~~mL~~dP~~ 302 (367)
T 2fst_X 242 ILRLVGTPGAELLKKISSESARNYIQSL-TQMPK--------------MN----FANVFIGANPLAVDLLEKMLVLDSDK 302 (367)
T ss_dssp HHHHHCSCCHHHHTTCCCHHHHHHHHTS-CCCCC--------------CC----HHHHTTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHHHhCCCCHHHHHHhhhHHHHHHHhcc-CCCCC--------------CC----HHHHCCCCCHHHHHHHHHhCCCCccc
Confidence 99999998877766543221 1111110 00000 00 11112345778999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||+.++|+||||++.
T Consensus 303 R~t~~e~L~hp~~~~~ 318 (367)
T 2fst_X 303 RITAAQALAHAYFAQY 318 (367)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CcCHHHHhcChhhhhc
Confidence 9999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=353.20 Aligned_cols=249 Identities=29% Similarity=0.519 Sum_probs=186.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|.++.+++.||+|++... ......+|+.++..+. .|+||+++++++.+++..++||||+ +++
T Consensus 19 lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~----~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCE----GHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred cccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhc----CCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 79999999999999999999999998743 3456678888888873 4799999999999999999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+..++ .+.
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~------------------------~~~ 146 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN------------------------DNL 146 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----------------------------C
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC------------------------Ccc
Confidence 999998864 699999999999999999999999999999999999996432 234
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh-------HHHH
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL-------EHLA 229 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-------~~~~ 229 (329)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. +...
T Consensus 147 ~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 226 (325)
T 3kn6_A 147 EIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226 (325)
T ss_dssp EEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHH
T ss_pred cEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHH
Confidence 69999999997654433 3457899999999999999999999999999999999999999764431 1111
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.......+. ..+..++..+.+||.+||+.||++
T Consensus 227 ~i~~~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~ 261 (325)
T 3kn6_A 227 KIKKGDFSFEG---------------------------------------------EAWKNVSQEAKDLIQGLLTVDPNK 261 (325)
T ss_dssp HHTTTCCCCCS---------------------------------------------HHHHTSCHHHHHHHHHHHCCCTTT
T ss_pred HHHcCCCCCCc---------------------------------------------ccccCCCHHHHHHHHHHCCCChhH
Confidence 11111001110 112346778999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|||++++++||||++..
T Consensus 262 Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 262 RLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCTTTSTTCGGGCTTC
T ss_pred CCCHHHHhcChhhccCc
Confidence 99999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=361.77 Aligned_cols=287 Identities=26% Similarity=0.489 Sum_probs=208.0
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc--ccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~--~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++ .+++.||+|++... .......+|+.++..+ .|+||+++++++ .....+++||||+
T Consensus 29 lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~lv~e~~ 102 (405)
T 3rgf_A 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLREL-----KHPNVISLQKVFLSHADRKVWLLFDYA 102 (405)
T ss_dssp CC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHC-----CCTTBCCCCEEEEETTTTEEEEEEECC
T ss_pred eeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhc-----CCCCeeeEeeEEecCCCCeEEEEEeCC
Confidence 799999999999966 56889999998743 3345677899999999 579999999999 4577899999999
Q ss_pred CCCHHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 77 GSSLYDFLRKN-------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 77 ~~~l~~~l~~~-------~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+++|.+++... ....+++..++.++.|++.||.|||++||+||||||+|||+...+
T Consensus 103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~----------------- 165 (405)
T 3rgf_A 103 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----------------- 165 (405)
T ss_dssp SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS-----------------
T ss_pred CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC-----------------
Confidence 88999988632 112489999999999999999999999999999999999995432
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.+..++|+|||.+....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 166 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 166 ------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp ------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred ------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 355789999999997655321 345789999999999875 4899999999999999999999999765
Q ss_pred ch---------hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchh
Q 020235 223 EN---------LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293 (329)
Q Consensus 223 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (329)
+. .+....+....+.++...|..+............+. ....................+.
T Consensus 240 ~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 308 (405)
T 3rgf_A 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFR-----------RNTYTNCSLIKYMEKHKVKPDS 308 (405)
T ss_dssp C------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCC-----------GGGGTTCCHHHHHHTTTCCTTS
T ss_pred cccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhcc-----------ccCCCcchhhhhHhhcCCCCCH
Confidence 43 366777888888777665554433221110000000 0001111122222222334577
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 294 DLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 294 ~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
.+.+||++||++||++|||++|+|+||||++..+
T Consensus 309 ~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 309 KAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred HHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 8999999999999999999999999999988653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=362.84 Aligned_cols=244 Identities=24% Similarity=0.416 Sum_probs=207.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... ........|..++..+ .||||+++++++.+.+.+|+||||+
T Consensus 77 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~~~lV~E~~ 151 (410)
T 3v8s_A 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-----NSPWVVQLFYAFQDDRYLYMVMEYM 151 (410)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEEeCC
Confidence 699999999999999999999999987422 1233456788888877 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 152 ~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl--------------------------- 201 (410)
T 3v8s_A 152 PGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL--------------------------- 201 (410)
T ss_dssp TTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---------------------------
Confidence 99999999875 48999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCC----CCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG----WTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 566779999999987655443 3568999999999998765 78999999999999999999999998777666
Q ss_pred HHHHHHHh--CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 228 LAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 228 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
...+.... ...|. ...++..+++||++||+.
T Consensus 282 ~~~i~~~~~~~~~p~-----------------------------------------------~~~~s~~~~~li~~lL~~ 314 (410)
T 3v8s_A 282 YSKIMNHKNSLTFPD-----------------------------------------------DNDISKEAKNLICAFLTD 314 (410)
T ss_dssp HHHHHTHHHHCCCCT-----------------------------------------------TCCCCHHHHHHHHHHSSC
T ss_pred HHHHHhccccccCCC-----------------------------------------------cccccHHHHHHHHHHccC
Confidence 65554421 11110 124678899999999999
Q ss_pred CCCC--CCCHHHHhcCCCCCCCC
Q 020235 306 DPTD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~--R~t~~~ll~hp~f~~~~ 326 (329)
+|.+ |+|++++++||||++.+
T Consensus 315 ~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 315 REVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp GGGCTTSSCHHHHHTSGGGCCSS
T ss_pred hhhhCCCCCHHHHhcCccccCCC
Confidence 9999 99999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=351.78 Aligned_cols=253 Identities=21% Similarity=0.384 Sum_probs=199.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... .......+|..++..+ ..||||+++++++.+.+.+++||||+
T Consensus 17 lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~----~~hp~iv~l~~~~~~~~~~~lv~e~~ 92 (345)
T 3a8x_A 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFLVGLHSCFQTESRLFFVIEYV 92 (345)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHT----TTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhc----CCCCccCeEEEEEEeCCEEEEEEeCC
Confidence 699999999999999999999999997532 2234456677777765 35799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 93 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll--------------------------- 143 (345)
T 3a8x_A 93 NGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL--------------------------- 143 (345)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---------------------------
Confidence 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||...........
T Consensus 144 ~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-- 221 (345)
T 3a8x_A 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-- 221 (345)
T ss_dssp CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC--------
T ss_pred CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--
Confidence 5566789999998875322 22456899999999999999999999999999999999999999965321110000
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.....+... ...... ..+...+..+.+||.+||+.||++|||
T Consensus 222 ----~~~~~~~~~--------i~~~~~--------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~ 263 (345)
T 3a8x_A 222 ----NTEDYLFQV--------ILEKQI--------------------------RIPRSLSVKAASVLKSFLNKDPKERLG 263 (345)
T ss_dssp -----CHHHHHHH--------HHHCCC--------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred ----ccHHHHHHH--------HHcCCC--------------------------CCCCCCCHHHHHHHHHHhcCCHhHCCC
Confidence 000000000 000001 112346778999999999999999999
Q ss_pred H------HHHhcCCCCCCCC
Q 020235 313 A------REALRHPFFTRDH 326 (329)
Q Consensus 313 ~------~~ll~hp~f~~~~ 326 (329)
+ +++++||||++.+
T Consensus 264 ~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 264 CHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CCTTTHHHHHHTSGGGTTCC
T ss_pred CCCcCCHHHHhcCCccCCCC
Confidence 5 8999999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=361.85 Aligned_cols=273 Identities=29% Similarity=0.477 Sum_probs=210.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv 72 (329)
||+|+||.||+|+++.+++.||||++... ........+|+.++..+ .|+||+++++++... +.+|+|
T Consensus 34 lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~~~~~~~~~~~~~~lv 108 (432)
T 3n9x_A 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-----KSDYIIRLYDLIIPDDLLKFDELYIV 108 (432)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCTTTCCCEEEE
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-----CCCCcceEEEEEecCCCCcCCeEEEE
Confidence 69999999999999999999999998742 23346677899999998 569999999998766 579999
Q ss_pred eecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 73 FEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 73 ~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 109 ~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~----------------------- 163 (432)
T 3n9x_A 109 LEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLN----------------------- 163 (432)
T ss_dssp EECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC-----------------------
T ss_pred EecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEEC-----------------------
Confidence 9999889999998753 699999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCC-------------------------CCcccccCCCCchhHHh-cCCCCCccchHhHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPD-------------------------QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVG 206 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~-------------------------~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG 206 (329)
.++.++|+|||.+...... ....+||+.|+|||++. ...++.++||||||
T Consensus 164 ----~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG 239 (432)
T 3n9x_A 164 ----QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239 (432)
T ss_dssp ----TTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred ----CCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHH
Confidence 4556777777777654322 13457899999999874 55699999999999
Q ss_pred HHHHHHHh-----------CCCCCCCCc-----------------hhHHHHHHHHHhCCCChhHHHhhhhhh-hhhhhcC
Q 020235 207 CILVELCT-----------GEALFQTHE-----------------NLEHLAMMERVLGPLPQHMLKRVDRHA-EKYVRRG 257 (329)
Q Consensus 207 ~~l~~l~~-----------g~~p~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 257 (329)
|++|+|++ |.++|.+.+ ..+....+.+..|.++.+.+..+.... ..+....
T Consensus 240 ~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 319 (432)
T 3n9x_A 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLF 319 (432)
T ss_dssp HHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS
T ss_pred HHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhC
Confidence 99999998 445554433 356677788888988877665432211 1111111
Q ss_pred CcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 258 RLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
....+ ..........+..+.+||++||+.||++|||++|+|+||||++.+
T Consensus 320 ~~~~~-------------------~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 320 PHRKP-------------------INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp CCCCC-------------------CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CCCCC-------------------CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 00000 001112234678999999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=346.41 Aligned_cols=274 Identities=31% Similarity=0.554 Sum_probs=214.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.+..+|+.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 11 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (311)
T 4agu_A 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-----KHPNLVNLLEVFRRKRRLHLVFEYCD 85 (311)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-----CCCCccchhheeecCCeEEEEEEeCC
Confidence 699999999999999999999999886432 2245566799999888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||++ +
T Consensus 86 ~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---------------------------~ 136 (311)
T 4agu_A 86 HTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---------------------------T 136 (311)
T ss_dssp EEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------C
T ss_pred CchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---------------------------c
Confidence 777777776543 68999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 216 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216 (311)
T ss_dssp TTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 56679999999987655332 34578999999999987 568999999999999999999999999998888888888
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+..+...+......... .+........+... ..........+..+.+||++||+.||++|||
T Consensus 217 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 217 KTLGDLIPRHQQVFSTN--QYFSGVKIPDPEDM----------------EPLELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp HHHCSCCHHHHHHHHTC--GGGTTCCCCCCSSC----------------CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred HHhcccccccccccccc--cccccCcCCCcccc----------------chhhhhcccccHHHHHHHHHHccCChhhcCC
Confidence 88888776554432211 11111111111100 0011112356788999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++++++||||++..
T Consensus 279 ~~ell~hp~f~~~~ 292 (311)
T 4agu_A 279 CEQLLHHPYFENIR 292 (311)
T ss_dssp HHHHHTSGGGTTCC
T ss_pred HHHHhcChHHHhcc
Confidence 99999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=349.48 Aligned_cols=313 Identities=45% Similarity=0.851 Sum_probs=239.9
Q ss_pred CCCccceEEEEEEecCCC-ceEEEEEeccchhhHHhHHHHHHHHHHHHhhCC-CCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERK-EMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK-GGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||+||+|.++.++ +.||+|+++..........+|+.++..+.+... .+.+++.+.+++...+..++|||++++
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (355)
T 2eu9_A 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK 106 (355)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCC
T ss_pred eeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCC
Confidence 699999999999998777 689999998766667777889999999987543 345588889999999999999999988
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
++.+.+.......+++..++.++.|++.||.|||++||+||||||+|||+...+...+.+.. .........+
T Consensus 107 ~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~--------~~~~~~~~~~ 178 (355)
T 2eu9_A 107 NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------KSCEEKSVKN 178 (355)
T ss_dssp BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC---------CCCEEEESC
T ss_pred ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc--------ccccccccCC
Confidence 99999887665679999999999999999999999999999999999999654322221111 0111112356
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 238 (329)
..++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.+..++.
T Consensus 179 ~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 258 (355)
T 2eu9_A 179 TSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI 258 (355)
T ss_dssp CCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 78999999999887776677789999999999999899999999999999999999999999988888888999999999
Q ss_pred ChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
|..++....... +...+...|+.............. .. ..........+..+.+||.+||+.||++|||++++++
T Consensus 259 p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 259 PSHMIHRTRKQK--YFYKGGLVWDENSSDGRYVKENCK--PL-KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp CHHHHHHCSCGG--GEETTEECCCTTSHHHHHHHHHCC--CG-GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cHHHhhhccchh--hhcccccccccccchhccccccCC--cc-cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 988876543221 122222233322211111111000 00 0000111223568999999999999999999999999
Q ss_pred CCCCCCCC
Q 020235 319 HPFFTRDH 326 (329)
Q Consensus 319 hp~f~~~~ 326 (329)
||||++..
T Consensus 334 hp~f~~~~ 341 (355)
T 2eu9_A 334 HPFFAGLT 341 (355)
T ss_dssp SGGGGGCC
T ss_pred ChhhcCCC
Confidence 99999764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=354.82 Aligned_cols=271 Identities=28% Similarity=0.485 Sum_probs=217.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCce------EE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI------CI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~------~l 71 (329)
||+|+||+||+|.++.+|+.||+|++... ........+|+.++..+ .|+||+++++++...+.. ++
T Consensus 50 lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~~l 124 (371)
T 4exu_A 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPASSLRNFYDFYL 124 (371)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSSTTCCCCEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-----CCCCchhhhhheeccCCcccceeEEE
Confidence 69999999999999999999999998743 23345667899999888 579999999999877654 99
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||++++|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 125 v~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----------------------- 177 (371)
T 4exu_A 125 VMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----------------------- 177 (371)
T ss_dssp EEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-----------------------
T ss_pred EEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE-----------------------
Confidence 999998898888743 48999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 178 ----~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 253 (371)
T 4exu_A 178 ----NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 253 (371)
T ss_dssp ----CTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ----CCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 55667999999999877776667789999999999987 6789999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+.++.++...+............... ............+..+.+||.+||+.||++|
T Consensus 254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 315 (371)
T 4exu_A 254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT------------------PRKDFTQLFPRASPQAADLLEKMLELDVDKR 315 (371)
T ss_dssp HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCC------------------CCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHhCCCcHHHHHHhhhhhhhhhhhccCCC------------------cchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence 9999998887776654322211110000000 0011122234567899999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||++++++||||+..
T Consensus 316 pt~~ell~hp~f~~~ 330 (371)
T 4exu_A 316 LTAAQALTHPFFEPF 330 (371)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred CCHHHHhcCcccccC
Confidence 999999999999853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=354.38 Aligned_cols=297 Identities=33% Similarity=0.554 Sum_probs=228.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCC------CCCceeeeccccccCC----ceE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRCVQIRNWFDYRN----HIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~------~~~~i~~l~~~~~~~~----~~~ 70 (329)
||+|+||+||+|.++.+++.||+|++...........+|+.++..+.+... .|+||+++++++...+ ..+
T Consensus 27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 106 (373)
T 1q8y_A 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 106 (373)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred eeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEE
Confidence 699999999999999999999999998766666777889999999875321 2589999999987654 899
Q ss_pred EEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+|||+++++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 107 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~---------------- 170 (373)
T 1q8y_A 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS---------------- 170 (373)
T ss_dssp EEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET----------------
T ss_pred EEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC----------------
Confidence 99999999999999986656799999999999999999999998 9999999999999965431
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc------
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------ 223 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~------ 223 (329)
......++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+
T Consensus 171 -----~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 -----PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp -----TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred -----CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 023346899999999877766666789999999999999999999999999999999999999998654
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+....+.+..+.+|..++.........+...+.......... .................+..+.+||++||
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-------WPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-------CCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccc-------cchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 45567778888899998776654322222221111111000000 00001111111222345678999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
+.||++|||++++++||||++.
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~ 340 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDT 340 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTC
T ss_pred ccCccccCCHHHHhhChhhhcc
Confidence 9999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=358.23 Aligned_cols=250 Identities=26% Similarity=0.481 Sum_probs=209.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+ ++
T Consensus 59 LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~lv~E~~~gg 133 (387)
T 1kob_A 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMVLILEFLSGG 133 (387)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-----CCcCCCeEEEEEEeCCEEEEEEEcCCCC
Confidence 699999999999999999999999987532 2344567888888877 5799999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++. ...
T Consensus 134 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-------------------------~~~ 187 (387)
T 1kob_A 134 ELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-------------------------KKA 187 (387)
T ss_dssp BHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------TTC
T ss_pred cHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-------------------------CCC
Confidence 9999987643 36899999999999999999999999999999999999943 234
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 188 ~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~ 267 (387)
T 1kob_A 188 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267 (387)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred CceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 679999999998765543 335799999999999998999999999999999999999999988776655554444322
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+. .....++..+.+||.+||+.||++|||+.++
T Consensus 268 ~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~el 302 (387)
T 1kob_A 268 EFDE---------------------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302 (387)
T ss_dssp CCCS---------------------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCc---------------------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 2111 0112457789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020235 317 LRHPFFTRDH 326 (329)
Q Consensus 317 l~hp~f~~~~ 326 (329)
++||||++..
T Consensus 303 l~hp~~~~~~ 312 (387)
T 1kob_A 303 LEHPWLKGDH 312 (387)
T ss_dssp HTSTTTSSCC
T ss_pred hhCccccCCc
Confidence 9999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=354.91 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=194.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++.+++.||+|++...........+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 28 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~~~~ 102 (361)
T 3uc3_A 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAIIMEYASGGE 102 (361)
T ss_dssp ESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-----CCCCCCcEEEEEeeCCEEEEEEEeCCCCC
Confidence 7999999999999999999999999986665567778899999888 5799999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.+ ...
T Consensus 103 L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~-------------------------~~~ 155 (361)
T 3uc3_A 103 LYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS-------------------------PAP 155 (361)
T ss_dssp HHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSS-------------------------SSC
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC-------------------------CCc
Confidence 999997654 69999999999999999999999999999999999999432 233
Q ss_pred CeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcCCCCCc-cchHhHHHHHHHHHhCCCCCCCCchhHHHHH-HHHHh
Q 020235 160 AIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGLGWTYP-CDIWSVGCILVELCTGEALFQTHENLEHLAM-MERVL 235 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~ 235 (329)
.++|+|||.+...... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....... +....
T Consensus 156 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 235 (361)
T 3uc3_A 156 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL 235 (361)
T ss_dssp CEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHH
T ss_pred eEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence 5999999998743322 245679999999999998887655 8999999999999999999976543221111 11111
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.. ....+. ....+..+.+||++||+.||++|||+.+
T Consensus 236 ~~--------------------~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~e 271 (361)
T 3uc3_A 236 SV--------------------KYSIPD------------------------DIRISPECCHLISRIFVADPATRISIPE 271 (361)
T ss_dssp TT--------------------CCCCCT------------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred cC--------------------CCCCCC------------------------cCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 10 000000 1235678999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||.+.
T Consensus 272 ll~hp~f~~~ 281 (361)
T 3uc3_A 272 IKTHSWFLKN 281 (361)
T ss_dssp HHTSHHHHTT
T ss_pred HHhCcchhcC
Confidence 9999999543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=351.74 Aligned_cols=250 Identities=28% Similarity=0.413 Sum_probs=205.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++|||
T Consensus 32 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~e 106 (351)
T 3c0i_A 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-----KHPHIVELLETYSSDGMLYMVFE 106 (351)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEE
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999986422 1245677899999888 57999999999999999999999
Q ss_pred cC-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 75 KL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 75 ~~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+ +++|.+.+... .+..+++..++.++.|++.||.|||++||+||||||+|||+..++
T Consensus 107 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~------------------- 167 (351)
T 3c0i_A 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------- 167 (351)
T ss_dssp CCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS-------------------
T ss_pred CCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC-------------------
Confidence 99 89998888642 223589999999999999999999999999999999999995432
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...
T Consensus 168 -----~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~ 241 (351)
T 3c0i_A 168 -----NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLF 241 (351)
T ss_dssp -----TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHH
T ss_pred -----CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHH
Confidence 33559999999997665443 345799999999999998999999999999999999999999987432 223
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.......+.. .+..++..+.+||.+||+.||+
T Consensus 242 ~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP~ 276 (351)
T 3c0i_A 242 EGIIKGKYKMNPR---------------------------------------------QWSHISESAKDLVRRMLMLDPA 276 (351)
T ss_dssp HHHHHTCCCCCHH---------------------------------------------HHTTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHcCCCCCCcc---------------------------------------------ccccCCHHHHHHHHHHCCCChh
Confidence 3222221111111 1234577899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRD 325 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~ 325 (329)
+|||+.++++||||++.
T Consensus 277 ~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 277 ERITVYEALNHPWLKER 293 (351)
T ss_dssp TSCCHHHHHTSHHHHTH
T ss_pred HCcCHHHHhcChhhcCC
Confidence 99999999999999763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-51 Score=359.12 Aligned_cols=242 Identities=26% Similarity=0.407 Sum_probs=200.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|++.... .......+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 17 lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~~~~lv~E~~ 91 (336)
T 3h4j_B 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-----RHPHIIKLYDVITTPTDIVMVIEYA 91 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEEEEEEECC
Confidence 699999999999999999999999987432 1234567888888877 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+ +
T Consensus 92 ~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---------------------------~ 142 (336)
T 3h4j_B 92 GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---------------------------D 142 (336)
T ss_dssp CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---------------------------C
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---------------------------c
Confidence 999999987754 69999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........
T Consensus 143 ~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~---- 218 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK---- 218 (336)
T ss_dssp TTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----
T ss_pred CCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----
Confidence 56679999999987655443 45679999999999988776 689999999999999999999997543211000
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
....+.. ..+...+..+.+||++||+.||.+|||+
T Consensus 219 -------------------~i~~~~~--------------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~ 253 (336)
T 3h4j_B 219 -------------------KVNSCVY--------------------------VMPDFLSPGAQSLIRRMIVADPMQRITI 253 (336)
T ss_dssp -------------------CCCSSCC--------------------------CCCTTSCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -------------------HHHcCCC--------------------------CCcccCCHHHHHHHHHHcCCChhHCcCH
Confidence 0000000 1123457789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
+|+++||||+..
T Consensus 254 ~eil~hp~~~~~ 265 (336)
T 3h4j_B 254 QEIRRDPWFNVN 265 (336)
T ss_dssp HHHTTCHHHHTT
T ss_pred HHHHhChhhccC
Confidence 999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=344.83 Aligned_cols=251 Identities=27% Similarity=0.463 Sum_probs=210.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+++.+|+.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 94 (321)
T 2a2a_A 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-----LHHNVITLHDVYENRTDVVLIL 94 (321)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred eeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-----CCCCcceEEEEEecCCEEEEEE
Confidence 6999999999999999999999999874321 245677899999888 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++..++
T Consensus 95 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~-------------------- 152 (321)
T 2a2a_A 95 ELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-------------------- 152 (321)
T ss_dssp CCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------------------
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC--------------------
Confidence 999 899999998753 689999999999999999999999999999999999995433
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 153 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 229 (321)
T 2a2a_A 153 ---IPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 229 (321)
T ss_dssp ---SSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred ---CCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 122369999999997655433 345789999999999998999999999999999999999999988776665554
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.......+... ....+..+.+||.+||+.||++|
T Consensus 230 i~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~l~~dp~~R 264 (321)
T 2a2a_A 230 ITSVSYDFDEEF---------------------------------------------FSHTSELAKDFIRKLLVKETRKR 264 (321)
T ss_dssp HHTTCCCCCHHH---------------------------------------------HTTCCHHHHHHHHTTSCSSTTTS
T ss_pred HHhcccccChhh---------------------------------------------hcccCHHHHHHHHHHcCCChhhC
Confidence 444333322211 23456789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||+...
T Consensus 265 ps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 265 LTIQEALRHPWITPVD 280 (321)
T ss_dssp CCHHHHHHSTTTSCSS
T ss_pred cCHHHHhcCccccCCC
Confidence 9999999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=357.11 Aligned_cols=291 Identities=18% Similarity=0.203 Sum_probs=200.8
Q ss_pred CCCc--cceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEG--TFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G--~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+| +||+||+|+++.+++.||+|+++... .......+|+.++..+ .|+||+++++++.+.+..++||||
T Consensus 33 lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~ 107 (389)
T 3gni_B 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-----NHPNIVPYRATFIADNELWVVTSF 107 (389)
T ss_dssp EEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-----CCCCCCcEeEEEEECCEEEEEEEc
Confidence 6889 99999999999999999999997532 3345566799999888 579999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~------------------------- 162 (389)
T 3gni_B 108 MAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS------------------------- 162 (389)
T ss_dssp CTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC-------------------------
T ss_pred cCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc-------------------------
Confidence 9 89999999886555799999999999999999999999999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccC----------CCCCcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 155 MPKSSAIKVIDFGSTTYER----------PDQNYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~----------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
.++.++|+|||.+.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 163 --~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 240 (389)
T 3gni_B 163 --VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240 (389)
T ss_dssp --TTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred --CCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence 45567777777653221 11233478999999999987 57899999999999999999999999876
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
+.......+.... .+. .................................................++..+.+||++|
T Consensus 241 ~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 241 PATQMLLEKLNGT--VPC-LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp CSTTHHHHC-----------------------------------------------------------CCHHHHHHHHHH
T ss_pred CHHHHHHHHhcCC--CCc-cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 6554433322211 110 0000000000000000000000000000000000000111112223456788999999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
|+.||++|||++++|+||||++..
T Consensus 318 L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 318 LQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp TCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred hhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=362.19 Aligned_cols=247 Identities=23% Similarity=0.385 Sum_probs=206.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... ........|..++..+ .|++|+++++++.+.+.+++||||+
T Consensus 82 LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~~~~~lV~Ey~ 156 (437)
T 4aw2_A 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-----DSKWITTLHYAFQDDNNLYLVMDYY 156 (437)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-----CTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEeeCCEEEEEEecC
Confidence 699999999999999999999999987422 1223356788888777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 157 ~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--------------------------- 208 (437)
T 4aw2_A 157 VGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM--------------------------- 208 (437)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---------------------------
Confidence 999999998743 369999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.+||+|||++....... ...+||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 288 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence 566779999999987554433 2357999999999997 4568999999999999999999999999877766
Q ss_pred HHHHHHHHh--CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 227 HLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 227 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
....+.... ...|. .....+.++++||++||+
T Consensus 289 ~~~~i~~~~~~~~~p~----------------------------------------------~~~~~s~~~~dLi~~lL~ 322 (437)
T 4aw2_A 289 TYGKIMNHKERFQFPT----------------------------------------------QVTDVSENAKDLIRRLIC 322 (437)
T ss_dssp HHHHHHTHHHHCCCCS----------------------------------------------SCCCSCHHHHHHHHTTSS
T ss_pred HHHhhhhccccccCCc----------------------------------------------ccccCCHHHHHHHHHHhc
Confidence 665554321 11110 112467889999999999
Q ss_pred cCCCC--CCCHHHHhcCCCCCCCC
Q 020235 305 YDPTD--RLTAREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~--R~t~~~ll~hp~f~~~~ 326 (329)
.+|++ |++++++++||||++.+
T Consensus 323 ~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 323 SREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ccccccCCCCHHHHhCCCccCCCC
Confidence 99988 99999999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=352.53 Aligned_cols=244 Identities=27% Similarity=0.406 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh----HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY----REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++..... ......|..++ .....|++|+++++.+.+.+.+|+||||+
T Consensus 46 lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~l----l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 121 (373)
T 2r5t_A 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL----LKNVKHPFLVGLHFSFQTADKLYFVLDYI 121 (373)
T ss_dssp EECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CC----BCCCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHH----HHhCCCCCCCCEEEEEEeCCEEEEEEeCC
Confidence 69999999999999999999999999754321 12222333321 12247899999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 122 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--------------------------- 172 (373)
T 2r5t_A 122 NGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL--------------------------- 172 (373)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---------------------------
Confidence 899999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCC---CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 173 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 173 DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 5566799999999875322 2345689999999999999999999999999999999999999998877766555444
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... ....+..+.+||.+||+.||.+|++
T Consensus 253 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~lL~~dp~~R~~ 283 (373)
T 2r5t_A 253 NKPLQL-------------------------------------------------KPNITNSARHLLEGLLQKDRTKRLG 283 (373)
T ss_dssp HSCCCC-------------------------------------------------CSSSCHHHHHHHHHHTCSSGGGSTT
T ss_pred hcccCC-------------------------------------------------CCCCCHHHHHHHHHHcccCHHhCCC
Confidence 321111 1245678999999999999999998
Q ss_pred H----HHHhcCCCCCCCC
Q 020235 313 A----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~----~~ll~hp~f~~~~ 326 (329)
+ .++++||||+..+
T Consensus 284 ~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 284 AKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp TTTTHHHHHTSGGGTTCC
T ss_pred CCCCHHHHhCCccccCCC
Confidence 6 6999999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=353.81 Aligned_cols=247 Identities=26% Similarity=0.435 Sum_probs=200.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.+++.||+|++.... ....+|+.++..+. .||||+++++++.+++..|+||||+ |++
T Consensus 30 lG~G~~g~V~~~~~~~~~~~~avK~~~~~~---~~~~~E~~~l~~~~----~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSK---RDPTEEIEILLRYG----QHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEETTT---CCCHHHHHHHHHHT----TSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEccc---CChHHHHHHHHHhc----CCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 699999999999999999999999987543 23456888887772 5799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||+.+.. ....
T Consensus 103 L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~-----------------------~~~~ 157 (342)
T 2qr7_A 103 LLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPE 157 (342)
T ss_dssp HHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-----------------------CSGG
T ss_pred HHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC-----------------------CCcC
Confidence 999998754 689999999999999999999999999999999999984321 1224
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc---hhHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE---NLEHLAMMER 233 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~---~~~~~~~~~~ 233 (329)
.++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+....+..
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 237 (342)
T 2qr7_A 158 SIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS 237 (342)
T ss_dssp GEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH
T ss_pred eEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc
Confidence 59999999997654332 34578999999999998889999999999999999999999997632 2222222222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
....++. ..+..++..+.+||++||+.||++|||+
T Consensus 238 ~~~~~~~---------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~ 272 (342)
T 2qr7_A 238 GKFSLSG---------------------------------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTA 272 (342)
T ss_dssp CCCCCCS---------------------------------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCH
T ss_pred CCcccCc---------------------------------------------cccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 1111110 1123467889999999999999999999
Q ss_pred HHHhcCCCCCC
Q 020235 314 REALRHPFFTR 324 (329)
Q Consensus 314 ~~ll~hp~f~~ 324 (329)
.++++||||.+
T Consensus 273 ~~il~hp~~~~ 283 (342)
T 2qr7_A 273 ALVLRHPWIVH 283 (342)
T ss_dssp HHHTTSHHHHT
T ss_pred HHHhcCCeecC
Confidence 99999999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=354.16 Aligned_cols=281 Identities=27% Similarity=0.458 Sum_probs=212.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+||+++++++...+ ..++
T Consensus 33 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~~~l 107 (371)
T 2xrw_A 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIIGLLNVFTPQKSLEEFQDVYI 107 (371)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSCCSTTTCCEEEE
T ss_pred eEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-----CCCCccceEEeeccccccccccceEE
Confidence 69999999999999999999999998742 23345667899888888 6799999999887654 7899
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+.++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 108 v~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~----------------------- 160 (371)
T 2xrw_A 108 VMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 160 (371)
T ss_dssp EEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-----------------------
T ss_pred EEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE-----------------------
Confidence 999998889998863 48999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...
T Consensus 161 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 161 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp ----CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 456679999999987655432 34578999999999999999999999999999999999999999998888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.++++.+.........+..... .+... +.+........+. ........+..+.+||++||+.||++
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRP-KYAGY--SFEKLFPDVLFPA----DSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSC-CCCCC--CHHHHSCGGGSCC----SSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCc-ccccc--chhhhcccccCcc----cccccccccHHHHHHHHHHCcCChhh
Confidence 88888888887777766555544443321 11110 0111000000000 00011123668999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
|||++++++||||+.
T Consensus 310 R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 310 RISVDEALQHPYINV 324 (371)
T ss_dssp SCCHHHHHHSHHHHT
T ss_pred CCCHHHHhCCcchhh
Confidence 999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=356.74 Aligned_cols=249 Identities=30% Similarity=0.458 Sum_probs=205.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.++.+|+.||+|+++... .......+|+.++..+ .|+||+++++++.+.+..++||||+ ++
T Consensus 97 lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-----DHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp CC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 799999999999999999999999987533 3455677899888888 6799999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+.. ..+
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-------------------------~~~ 225 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-------------------------RDA 225 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-------------------------TTT
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-------------------------CCC
Confidence 9999987643 35899999999999999999999999999999999999954 234
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 226 ~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 305 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305 (373)
T ss_dssp TEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred CcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence 569999999998665543 345799999999999988899999999999999999999999998777666655554332
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
.++.. .....+..+.+||.+||+.||.+|||+.++
T Consensus 306 ~~~~~---------------------------------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~ 340 (373)
T 2x4f_A 306 DLEDE---------------------------------------------EFQDISEEAKEFISKLLIKEKSWRISASEA 340 (373)
T ss_dssp CSCSG---------------------------------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCChh---------------------------------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 22211 112456789999999999999999999999
Q ss_pred hcCCCCCCC
Q 020235 317 LRHPFFTRD 325 (329)
Q Consensus 317 l~hp~f~~~ 325 (329)
++||||++.
T Consensus 341 l~hp~~~~~ 349 (373)
T 2x4f_A 341 LKHPWLSDH 349 (373)
T ss_dssp HHSHHHHCH
T ss_pred hcCcCcCCC
Confidence 999999865
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=348.73 Aligned_cols=277 Identities=26% Similarity=0.459 Sum_probs=217.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--------CCce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------~~~~ 69 (329)
||+|+||+||+|+++.+|+.||+|++.... .......+|+.++..+ .|+||+++++++.+ .+..
T Consensus 25 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~~ 99 (351)
T 3mi9_A 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKASPYNRCKGSI 99 (351)
T ss_dssp CSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEEC--------CEE
T ss_pred EecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-----cCCCcccHhheeeccccccccCCceE
Confidence 799999999999999999999999886432 2234567899999888 57999999998876 4578
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++||||+++++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 100 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~--------------------- 157 (351)
T 3mi9_A 100 YLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--------------------- 157 (351)
T ss_dssp EEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------
T ss_pred EEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---------------------
Confidence 9999999889988887654 358999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus 158 ------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 158 ------TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp ------CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 45567899999988654321 1335789999999999864 589999999999999999999999999
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+.......+.+..+.++...+......... ......... .......... ...+..+.+||.+
T Consensus 232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~~li~~ 294 (351)
T 3mi9_A 232 NTEQHQLALISQLCGSITPEVWPNVDNYELY----EKLELVKGQ-----------KRKVKDRLKA--YVRDPYALDLIDK 294 (351)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCGGG----TSSCCCSSC-----------CCCHHHHHHH--HHCCHHHHHHHHH
T ss_pred CChHHHHHHHHHHhCCCChhhccccccchhh----ccccccccc-----------ccCHHHHhhh--ccCChHHHHHHHH
Confidence 9988889999999988887665544321110 000000000 0000000000 1135679999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
||+.||++|||++|+++||||++...
T Consensus 295 ~L~~dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 295 LLVLDPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGSSSC
T ss_pred HhcCChhhCCCHHHHhCCCCcCCCCC
Confidence 99999999999999999999988654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=356.93 Aligned_cols=270 Identities=29% Similarity=0.546 Sum_probs=214.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc----------------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---------------- 64 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~---------------- 64 (329)
||+|+||+||+|.+..+|+.||+|++.... ....+|+.++..+ .|+||+++++++.
T Consensus 15 lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~~~~~ 86 (383)
T 3eb0_A 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVL-----DHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86 (383)
T ss_dssp EECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTC-----CCTTBCCEEEEEEEC--------------
T ss_pred EEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHc-----CCCCccchhheeeecCccccccccccccc
Confidence 699999999999999999999999987542 2334688888888 6799999999884
Q ss_pred ----------------------cCCceEEEeecCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccC
Q 020235 65 ----------------------YRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120 (329)
Q Consensus 65 ----------------------~~~~~~lv~e~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~d 120 (329)
.....++||||++++|.+.+.. .....+++..++.++.|++.||.|||++||+|||
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~D 166 (383)
T 3eb0_A 87 NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRD 166 (383)
T ss_dssp -----------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred ccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCc
Confidence 3345899999998888888764 2234699999999999999999999999999999
Q ss_pred CCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC-CC
Q 020235 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WT 197 (329)
Q Consensus 121 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~ 197 (329)
|||+|||++. .+..++|+|||.+....... ....||+.|+|||++.+.. ++
T Consensus 167 ikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 220 (383)
T 3eb0_A 167 IKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYT 220 (383)
T ss_dssp CCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred cCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCC
Confidence 9999999942 34679999999997654333 4467899999999998754 89
Q ss_pred CccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccc
Q 020235 198 YPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 277 (329)
Q Consensus 198 ~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (329)
.++|||||||++|+|++|+.||.+.+..+....+.+..+.++.+.+......... ..++..
T Consensus 221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~------~~~~~~------------- 281 (383)
T 3eb0_A 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE------VRFPTL------------- 281 (383)
T ss_dssp THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--------CCCCCC-------------
T ss_pred cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc------ccCCcc-------------
Confidence 9999999999999999999999999999999999999998887655543221111 011100
Q ss_pred hhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
....+........+..+.+||++||+.||++|||+.|+++||||++
T Consensus 282 -~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 282 -KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp -CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred -CcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 0011112233456788999999999999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=350.31 Aligned_cols=271 Identities=27% Similarity=0.487 Sum_probs=215.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||.||+|.++.+|+.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..++|||
T Consensus 18 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e 92 (346)
T 1ua2_A 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGHKSNISLVFD 92 (346)
T ss_dssp EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECCTTCCEEEEE
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-----CCCCCCeEEEEEeeCCceEEEEE
Confidence 6999999999999999999999999874221 123566899999888 57999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 75 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 75 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
|+.++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 93 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~-------------------------- 145 (346)
T 1ua2_A 93 FMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL-------------------------- 145 (346)
T ss_dssp CCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--------------------------
T ss_pred cCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE--------------------------
Confidence 99779999887643 458899999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 146 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~ 224 (346)
T 1ua2_A 146 -DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224 (346)
T ss_dssp -CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 456678999999887654332 345789999999999765 488999999999999999999999999888888888
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+.++...|.......+...... .+. ..........+..+.+||.+||+.||++|
T Consensus 225 i~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R 283 (346)
T 1ua2_A 225 IFETLGTPTEEQWPDMCSLPDYVTFKS---FPG------------------IPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283 (346)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCCCCCC---CCC------------------CCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HHHHcCCCChhhhhhhccCcccccccc---cCC------------------CChHHhhccCCHHHHHHHHHHhccChhhC
Confidence 888877766554443322111110000 000 00111234567899999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||++|+++||||++.
T Consensus 284 pt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 284 ITATQALKMKYFSNR 298 (346)
T ss_dssp CCHHHHHTSGGGTSS
T ss_pred CCHHHHhcChhhhcC
Confidence 999999999999875
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=345.40 Aligned_cols=246 Identities=25% Similarity=0.434 Sum_probs=205.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|+++.+|+.||||++.... .......+|+.++..+ .|+||+++++++...+..++||||+ ++
T Consensus 53 lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-----QHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred eccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 699999999999999999999999987432 2345567888888877 5799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..+..++.|++.||.|||++||+||||||+||++ +.+
T Consensus 128 ~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---------------------------~~~ 177 (321)
T 2c30_A 128 ALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---------------------------TLD 177 (321)
T ss_dssp BHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTT
T ss_pred CHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------CCC
Confidence 999998764 59999999999999999999999999999999999999 456
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 257 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP 257 (321)
T ss_dssp CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred CcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence 679999999887654432 34579999999999999889999999999999999999999998776655444333321
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+... .....+..+.++|.+||+.||++|||+++
T Consensus 258 ~~~~~----------------------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 291 (321)
T 2c30_A 258 PPKLK----------------------------------------------NSHKVSPVLRDFLERMLVRDPQERATAQE 291 (321)
T ss_dssp CCCCT----------------------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCcC----------------------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 11000 01235678999999999999999999999
Q ss_pred HhcCCCCCCCCc
Q 020235 316 ALRHPFFTRDHL 327 (329)
Q Consensus 316 ll~hp~f~~~~~ 327 (329)
+++||||.+..+
T Consensus 292 ll~hp~~~~~~~ 303 (321)
T 2c30_A 292 LLDHPFLLQTGL 303 (321)
T ss_dssp HHTSGGGGGCCC
T ss_pred HhcChhhccCCC
Confidence 999999987653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=349.41 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=210.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+. .|++|+++++++.+.+..++||||+
T Consensus 37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~~iv~~~~~~~~~~~~~lv~e~~~ 112 (327)
T 3lm5_A 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK----SCPRVINLHEVYENTSEIILILEYAA 112 (327)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTT----TCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhcc----CCCCEEEEEEEEEeCCeEEEEEEecC
Confidence 699999999999999999999999987532 22456678888888873 5689999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.. .
T Consensus 113 ~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~------------------------~ 168 (327)
T 3lm5_A 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI------------------------Y 168 (327)
T ss_dssp TEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB------------------------T
T ss_pred CCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC------------------------C
Confidence 8899999876555679999999999999999999999999999999999999531 1
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 169 ~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 248 (327)
T 3lm5_A 169 PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV 248 (327)
T ss_dssp TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc
Confidence 25679999999998665443 3457999999999999999999999999999999999999999987777666655554
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....+... ....+..+.+||.+||+.||++|||++
T Consensus 249 ~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (327)
T 3lm5_A 249 NVDYSEET---------------------------------------------FSSVSQLATDFIQSLLVKNPEKRPTAE 283 (327)
T ss_dssp CCCCCTTT---------------------------------------------TTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ccccCchh---------------------------------------------hcccCHHHHHHHHHHcCCChhhCcCHH
Confidence 43332211 124567899999999999999999999
Q ss_pred HHhcCCCCCCCCcC
Q 020235 315 EALRHPFFTRDHLR 328 (329)
Q Consensus 315 ~ll~hp~f~~~~~~ 328 (329)
++++||||++.+..
T Consensus 284 ~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 284 ICLSHSWLQQWDFE 297 (327)
T ss_dssp HHTTCGGGCCCCTT
T ss_pred HHhCCHhhcccccc
Confidence 99999999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=345.79 Aligned_cols=243 Identities=24% Similarity=0.419 Sum_probs=198.1
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .+++.||+|+++... .......+|+.++..+ .|+||+++++++.+.+..++|
T Consensus 25 lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv 99 (327)
T 3a62_A 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-----KHPFIVDLIYAFQTGGKLYLI 99 (327)
T ss_dssp EEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-----CCTTBCCEEEEEECSSCEEEE
T ss_pred EEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-----CCCCccceeEEEEcCCEEEEE
Confidence 699999999999985 688999999987532 2234456788999888 579999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill----------------------- 154 (327)
T 3a62_A 100 LEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML----------------------- 154 (327)
T ss_dssp EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE-----------------------
T ss_pred EeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE-----------------------
Confidence 9999 899999998754 68999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.....
T Consensus 155 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 230 (327)
T 3a62_A 155 ----NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230 (327)
T ss_dssp ----CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ----CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 55667899999988654322 23457999999999999989999999999999999999999999887766555
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+.....| ...+..+.+||.+||+.||+
T Consensus 231 ~~i~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~L~~dp~ 261 (327)
T 3a62_A 231 DKILKCKLNLP-------------------------------------------------PYLTQEARDLLKKLLKRNAA 261 (327)
T ss_dssp HHHHHTCCCCC-------------------------------------------------TTSCHHHHHHHHHHSCSCGG
T ss_pred HHHHhCCCCCC-------------------------------------------------CCCCHHHHHHHHHHHhcCHh
Confidence 54444322221 23467899999999999999
Q ss_pred CCC-----CHHHHhcCCCCCCCC
Q 020235 309 DRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 309 ~R~-----t~~~ll~hp~f~~~~ 326 (329)
+|| |+.++++||||++.+
T Consensus 262 ~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 262 SRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp GSTTSSTTTHHHHHHSGGGSSCC
T ss_pred hccCCCCCCHHHHHcCCcccCCC
Confidence 999 889999999998764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=352.67 Aligned_cols=243 Identities=23% Similarity=0.422 Sum_probs=202.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 23 LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~~~lv~e~~ 97 (384)
T 4fr4_A 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-----EHPFLVNLWYSFQDEEDMFMVVDLL 97 (384)
T ss_dssp EECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCCEEEEEEecC
Confidence 699999999999999999999999987432 2235566788888887 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 98 ~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll--------------------------- 148 (384)
T 4fr4_A 98 LGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL--------------------------- 148 (384)
T ss_dssp TTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---------------------------
Confidence 999999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH---H
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLE---H 227 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~ 227 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.. ..++.++|||||||++|+|++|..||...+... .
T Consensus 149 ~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~ 228 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI 228 (384)
T ss_dssp CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH
T ss_pred CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 566779999999997654433 45689999999999974 458899999999999999999999997543321 1
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+...... .+...+..+.+||.+||+.||
T Consensus 229 ~~~~~~~~~~-------------------------------------------------~p~~~s~~~~~li~~lL~~dP 259 (384)
T 4fr4_A 229 VHTFETTVVT-------------------------------------------------YPSAWSQEMVSLLKKLLEPNP 259 (384)
T ss_dssp HHHHHHCCCC-------------------------------------------------CCTTSCHHHHHHHHHHSCSSG
T ss_pred HHHHhhcccC-------------------------------------------------CCCcCCHHHHHHHHHHhcCCH
Confidence 1111111111 123456789999999999999
Q ss_pred CCCCC-HHHHhcCCCCCCCC
Q 020235 308 TDRLT-AREALRHPFFTRDH 326 (329)
Q Consensus 308 ~~R~t-~~~ll~hp~f~~~~ 326 (329)
++||+ ++++++||||++.+
T Consensus 260 ~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 260 DQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp GGSCCSHHHHHTSGGGTTCC
T ss_pred hHhcccHHHHHcChhhhcCC
Confidence 99998 89999999999865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=349.89 Aligned_cols=249 Identities=25% Similarity=0.435 Sum_probs=192.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|+++.+++.||+|+++... ..+...+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 61 lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRL-----SHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhC-----CCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 699999999999999999999999988543 345667899999988 5799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+... ..+.
T Consensus 135 L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~------------------------~~~~ 188 (349)
T 2w4o_A 135 LFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP------------------------APDA 188 (349)
T ss_dssp HHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS------------------------STTC
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC------------------------CCCC
Confidence 999997654 68999999999999999999999999999999999999532 2367
Q ss_pred CeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH-HHHHHHHHhC
Q 020235 160 AIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE-HLAMMERVLG 236 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~ 236 (329)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 189 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~ 268 (349)
T 2w4o_A 189 PLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268 (349)
T ss_dssp CEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred CEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence 79999999987655433 34578999999999999899999999999999999999999997655433 2222222111
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+. ......+..+.+||++||+.||++|||+.++
T Consensus 269 ~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 303 (349)
T 2w4o_A 269 YFIS---------------------------------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303 (349)
T ss_dssp CCCT---------------------------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred ccCC---------------------------------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 1110 1123457789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020235 317 LRHPFFTRDH 326 (329)
Q Consensus 317 l~hp~f~~~~ 326 (329)
++||||++..
T Consensus 304 l~hp~~~~~~ 313 (349)
T 2w4o_A 304 LQHPWVTGKA 313 (349)
T ss_dssp HHSTTTTSTT
T ss_pred hcCcccCCCc
Confidence 9999998764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=348.05 Aligned_cols=278 Identities=31% Similarity=0.471 Sum_probs=212.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-------ceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-------HICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-------~~~lv~ 73 (329)
||+|+||+||+|.++.+++.||||++............++..+..+ .|+||+++++++...+ ..++||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~~~lv~ 105 (360)
T 3e3p_A 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-----HHPNIVQLQSYFYTLGERDRRDIYLNVVM 105 (360)
T ss_dssp --------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-----CCTTBCCEEEEEEEECSSCTTCEEEEEEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-----CCCCcccHHHhhhccccccccceeEEEEe
Confidence 7999999999999999999999999876554445555666667777 6799999999986533 389999
Q ss_pred ecCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 74 EKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMH--DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 74 e~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH--~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
||+.+++...+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++.
T Consensus 106 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~------------------- 166 (360)
T 3e3p_A 106 EYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE------------------- 166 (360)
T ss_dssp ECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-------------------
T ss_pred ecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-------------------
Confidence 9997787776653 23346899999999999999999999 999999999999999952
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+...
T Consensus 167 -------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 239 (360)
T 3e3p_A 167 -------ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239 (360)
T ss_dssp -------TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred -------CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH
Confidence 25679999999998665443 3457899999999997655 8999999999999999999999999999989
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+.+..+.++.+++.............. .................+..+.+||.+||+.|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 302 (360)
T 3e3p_A 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYN-----------------SKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302 (360)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGC-----------------CCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSS
T ss_pred HHHHHHHHcCCCCHHHHHhcccchhhccccc-----------------cccCCcccccchhhccccHHHHHHHHHHhccC
Confidence 9999999999988887766533221111000 00011112222233446789999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~~ 326 (329)
|++|||+.|+++||||++..
T Consensus 303 P~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 303 PEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp GGGSCCHHHHTTSGGGGGGG
T ss_pred ccccCCHHHHhcCccccccC
Confidence 99999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=348.42 Aligned_cols=271 Identities=29% Similarity=0.523 Sum_probs=218.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~ 73 (329)
||+|+||.||+|.+..+++.||+|++... ........+|+.++..+ .|+||+++++++... ...++||
T Consensus 35 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~iv~ 109 (364)
T 3qyz_A 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIEQMKDVYIVQ 109 (364)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred eecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-----CCCCCccceeEEecCCccccceEEEEE
Confidence 69999999999999999999999998743 23346677899999988 579999999988654 4789999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 110 e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------------------- 161 (364)
T 3qyz_A 110 DLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL------------------------- 161 (364)
T ss_dssp ECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-------------------------
T ss_pred cccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE-------------------------
Confidence 99988999999875 49999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 162 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 162 --NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp --CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred --CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 556679999999987654332 33478999999998765 458999999999999999999999999999999
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhh-hhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAE-KYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
....+....+.++.+.+........ .+.... + .+... .........+..+.+||.+||++
T Consensus 240 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--------------~~~~~-~~~~~~~~~~~~~~~li~~~L~~ 300 (364)
T 3qyz_A 240 QLNHILGILGSPSQEDLNCIINLKARNYLLSL----P--------------HKNKV-PWNRLFPNADSKALDLLDKMLTF 300 (364)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTS----C--------------CCCCC-CHHHHCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhc----C--------------CccCC-CHHHhCCCCCHHHHHHHHHHcCC
Confidence 9999999998888766554322111 111000 0 00000 00112235678899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~ 325 (329)
||++|||++++++||||++.
T Consensus 301 dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 301 NPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp STTTSCCHHHHHTSGGGTTT
T ss_pred ChhhCCCHHHHhcCcchhhc
Confidence 99999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=357.77 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=203.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||+|+++... ........|..++..+ .|++|+++++++.+.+.+|+||||+
T Consensus 69 lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-----~hp~Iv~l~~~~~~~~~~~lVmE~~ 143 (412)
T 2vd5_A 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-----DRRWITQLHFAFQDENYLYLVMEYY 143 (412)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-----CTTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeCCEEEEEEcCC
Confidence 699999999999999999999999997432 1223456788888776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 144 ~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl--------------------------- 195 (412)
T 2vd5_A 144 VGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL--------------------------- 195 (412)
T ss_dssp CSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---------------------------
Confidence 999999998743 369999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhc-------CCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.. ..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 275 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST 275 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH
Confidence 566779999999987655433 23589999999999983 4689999999999999999999999998777
Q ss_pred hHHHHHHHHHh--CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 225 LEHLAMMERVL--GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 225 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
.+....+.... ...| ......+.++++||++|
T Consensus 276 ~~~~~~i~~~~~~~~~p----------------------------------------------~~~~~~s~~~~dli~~l 309 (412)
T 2vd5_A 276 AETYGKIVHYKEHLSLP----------------------------------------------LVDEGVPEEARDFIQRL 309 (412)
T ss_dssp HHHHHHHHTHHHHCCCC--------------------------------------------------CCCHHHHHHHHTT
T ss_pred HHHHHHHHhcccCcCCC----------------------------------------------ccccCCCHHHHHHHHHH
Confidence 66555544321 1111 01134678899999999
Q ss_pred cccCCCCC---CCHHHHhcCCCCCCCC
Q 020235 303 LRYDPTDR---LTAREALRHPFFTRDH 326 (329)
Q Consensus 303 l~~dP~~R---~t~~~ll~hp~f~~~~ 326 (329)
|+ +|.+| +|++++++||||++.+
T Consensus 310 L~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 310 LC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp SS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred cC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 99 99998 4999999999998865
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=348.15 Aligned_cols=246 Identities=24% Similarity=0.374 Sum_probs=198.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|.++.+++.||+|++.... ...+...+|+.++..+ .|+||+++++++.+++..++||||+ +
T Consensus 15 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~e~~~~ 89 (323)
T 3tki_A 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQYLFLEYCSG 89 (323)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCeEEEEEEcCCC
Confidence 699999999999999999999999986432 2235667899999888 5799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+ +.
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---------------------------~~ 140 (323)
T 3tki_A 90 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---------------------------DE 140 (323)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------CT
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---------------------------eC
Confidence 89999987653 69999999999999999999999999999999999999 55
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
++.++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+........
T Consensus 141 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~ 220 (323)
T 3tki_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220 (323)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH
T ss_pred CCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 6679999999987543221 34579999999999988775 67899999999999999999999765443211111
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
........ ......+..+.+||.+||+.||++||
T Consensus 221 ~~~~~~~~----------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~ 254 (323)
T 3tki_A 221 WKEKKTYL----------------------------------------------NPWKKIDSAPLALLHKILVENPSARI 254 (323)
T ss_dssp HHTTCTTS----------------------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HhcccccC----------------------------------------------CccccCCHHHHHHHHHHccCChhhCc
Confidence 00000000 00134567899999999999999999
Q ss_pred CHHHHhcCCCCCCCC
Q 020235 312 TAREALRHPFFTRDH 326 (329)
Q Consensus 312 t~~~ll~hp~f~~~~ 326 (329)
|+.|+++||||++..
T Consensus 255 t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 255 TIPDIKKDRWYNKPL 269 (323)
T ss_dssp CHHHHTTCTTTTCCC
T ss_pred CHHHHhhChhhcccc
Confidence 999999999998643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=341.05 Aligned_cols=266 Identities=25% Similarity=0.407 Sum_probs=196.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|.++.+++.||+|++.... .......+|+.++..+ ..|+||+++++++.+.+..++||||+ ++
T Consensus 21 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~----~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 96 (316)
T 2ac3_A 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC----QGHRNVLELIEFFEEEDRFYLVFEKMRGG 96 (316)
T ss_dssp CCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHT----CCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred ecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHh----cCCCCeeeEEEEEeeCCEEEEEEEcCCCC
Confidence 799999999999999999999999987532 3356677898888775 26799999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++ ..
T Consensus 97 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~------------------------~~ 150 (316)
T 2ac3_A 97 SILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN------------------------QV 150 (316)
T ss_dssp BHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS------------------------SS
T ss_pred cHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC------------------------Cc
Confidence 9999998754 689999999999999999999999999999999999995432 22
Q ss_pred CCeEEeeCCCCcccCCC----------CCcccccCCCCchhHHhc-----CCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 159 SAIKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILG-----LGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
..++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp CSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 34899999987654321 123458999999999975 458899999999999999999999997654
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+..... ......... ........+...++ .......+..+.+||++||
T Consensus 231 ~~~~~~~~----~~~~~~~~~----~~~~~i~~~~~~~~----------------------~~~~~~~~~~~~~li~~~L 280 (316)
T 2ac3_A 231 GSDCGWDR----GEACPACQN----MLFESIQEGKYEFP----------------------DKDWAHISCAAKDLISKLL 280 (316)
T ss_dssp CSCSCC--------CCHHHHH----HHHHHHHHCCCCCC----------------------HHHHTTSCHHHHHHHHHHS
T ss_pred cccccccc----cccchhHHH----HHHHHHhccCcccC----------------------chhcccCCHHHHHHHHHHh
Confidence 22100000 000000000 00000000111110 0112346778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
+.||++|||++++++||||++..
T Consensus 281 ~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 281 VRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CSSTTTSCCHHHHHHSTTCC---
T ss_pred hCChhhCCCHHHHhcChhhcCCC
Confidence 99999999999999999998753
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=361.86 Aligned_cols=243 Identities=26% Similarity=0.438 Sum_probs=198.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+.+++++.+.+.+++||||+
T Consensus 156 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~~~~lv~e~~ 230 (446)
T 4ejn_A 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-----RHPFLTALKYSFQTHDRLCFVMEYA 230 (446)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-----SCTTSCCEEEEEEETTEEEEEECCC
T ss_pred EeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-----CCCeEeeEEEEEeeCCEEEEEEeeC
Confidence 699999999999999999999999987421 1223344566666555 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++.... .+++..++.++.|++.||+|||+ +||+||||||+|||+
T Consensus 231 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll-------------------------- 282 (446)
T 4ejn_A 231 NGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML-------------------------- 282 (446)
T ss_dssp SSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE--------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE--------------------------
Confidence 899999998754 68999999999999999999998 999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 283 -~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 283 -DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp -CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred -CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 45667999999998754332 24567999999999999999999999999999999999999999887766555444
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
......+| ...+..+.+||.+||+.||.+||
T Consensus 362 ~~~~~~~p-------------------------------------------------~~~~~~~~~li~~~L~~dP~~R~ 392 (446)
T 4ejn_A 362 LMEEIRFP-------------------------------------------------RTLGPEAKSLLSGLLKKDPKQRL 392 (446)
T ss_dssp HHCCCCCC-------------------------------------------------TTSCHHHHHHHHHHTCSSTTTST
T ss_pred HhCCCCCC-------------------------------------------------ccCCHHHHHHHHHHcccCHHHhC
Confidence 33221111 23567899999999999999999
Q ss_pred -----CHHHHhcCCCCCCCC
Q 020235 312 -----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -----t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 393 ~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 393 GGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp TCSTTTHHHHHTSGGGTTCC
T ss_pred CCCCCCHHHHHhCccccCCC
Confidence 999999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=373.28 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=206.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+++.||||+++... ........|..++..+ ..|++|+.+++++++.+.+|+||||+
T Consensus 349 LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~l~~~~~~~~~~~lV~E~~ 424 (674)
T 3pfq_A 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----GKPPFLTQLHSCFQTMDRLYFVMEYV 424 (674)
T ss_dssp SSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCT----TCCTTBCCEEEECBCSSEEEEEEECC
T ss_pred EccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhc----cCCCeEEEEEEEEEeCCEEEEEEeCc
Confidence 799999999999999999999999987432 2233445566666554 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 425 ~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl--------------------------- 475 (674)
T 3pfq_A 425 NGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML--------------------------- 475 (674)
T ss_dssp CSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---------------------------
Confidence 999999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 476 ~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 476 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 55667999999998753322 245689999999999999999999999999999999999999999877766655554
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.....+| ...+.++.+||++||+.||++|++
T Consensus 556 ~~~~~~p-------------------------------------------------~~~s~~~~~li~~lL~~dP~~R~~ 586 (674)
T 3pfq_A 556 EHNVAYP-------------------------------------------------KSMSKEAVAICKGLMTKHPGKRLG 586 (674)
T ss_dssp SSCCCCC-------------------------------------------------TTSCHHHHHHHHHHSCSSSTTCTT
T ss_pred hCCCCCC-------------------------------------------------ccCCHHHHHHHHHHccCCHHHCCC
Confidence 4222221 245778999999999999999999
Q ss_pred H-----HHHhcCCCCCCCC
Q 020235 313 A-----REALRHPFFTRDH 326 (329)
Q Consensus 313 ~-----~~ll~hp~f~~~~ 326 (329)
+ ++|++||||++.+
T Consensus 587 ~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 587 CGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp CSTTHHHHHHSSGGGSSCC
T ss_pred CCCCcHHHHhcCccccCCC
Confidence 7 9999999999865
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=345.28 Aligned_cols=274 Identities=28% Similarity=0.468 Sum_probs=214.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|+++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~ 107 (331)
T 4aaa_A 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-----RHENLVNLLEVCKKKKRWYLVFEFVD 107 (331)
T ss_dssp GGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-----CCCCEeeEEEEeecCCEEEEEEecCC
Confidence 799999999999999999999999986432 2344566799999888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++ +
T Consensus 108 ~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---------------------------~ 158 (331)
T 4aaa_A 108 HTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---------------------------S 158 (331)
T ss_dssp EEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------------------C
T ss_pred cchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---------------------------c
Confidence 666666655443 69999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 56679999999987554332 345789999999999876 68899999999999999999999999998888888888
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...+..++............ .....+... ...........++..+.+||.+||+.||++|||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVF----AGVRLPEIK--------------EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGG----TTCCCCCCS--------------SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhCCCChhhhhHhhhcccc----ccccCcccc--------------ccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 88888776654433221110 000111000 000011122356788999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++|+|+||||+..+
T Consensus 301 ~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 301 CAELLHHDFFQMDG 314 (331)
T ss_dssp GGGGGGSHHHHGGG
T ss_pred HHHHhcCchhccCC
Confidence 99999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=341.42 Aligned_cols=241 Identities=24% Similarity=0.360 Sum_probs=191.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|+++.+++.||||++.... ........|+..+..+ ..|+||+++++++.+++..++|||+++
T Consensus 65 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~----~~h~~iv~l~~~~~~~~~~~lv~e~~~ 140 (311)
T 3p1a_A 65 LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV----GQHPCCVRLEQAWEEGGILYLQTELCG 140 (311)
T ss_dssp EEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEEEETTEEEEEEECCC
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHh----cCCCcEEEEEEEEEeCCEEEEEEeccC
Confidence 699999999999999999999999886432 2223334444444444 367999999999999999999999999
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++ .
T Consensus 141 ~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~---------------------------~ 192 (311)
T 3p1a_A 141 PSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---------------------------P 192 (311)
T ss_dssp CBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---------------------------G
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC---------------------------C
Confidence 99999988754 4699999999999999999999999999999999999994 4
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+..++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+.+..... .+..
T Consensus 193 ~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~-- 266 (311)
T 3p1a_A 193 RGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLRQ-- 266 (311)
T ss_dssp GGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHTT--
T ss_pred CCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHhc--
Confidence 5568999999887654433 33568999999999887 78999999999999999999977665422211 1100
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+..+. ......+..+.+||.+||+.||++|||+++
T Consensus 267 ~~~~~---------------------------------------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 301 (311)
T 3p1a_A 267 GYLPP---------------------------------------------EFTAGLSSELRSVLVMMLEPDPKLRATAEA 301 (311)
T ss_dssp TCCCH---------------------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred cCCCc---------------------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 11111 112346778999999999999999999999
Q ss_pred HhcCCCCCC
Q 020235 316 ALRHPFFTR 324 (329)
Q Consensus 316 ll~hp~f~~ 324 (329)
+++||||++
T Consensus 302 ll~hp~~~~ 310 (311)
T 3p1a_A 302 LLALPVLRQ 310 (311)
T ss_dssp HHTSGGGSC
T ss_pred HHhCccccC
Confidence 999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=368.86 Aligned_cols=249 Identities=27% Similarity=0.445 Sum_probs=205.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|++.... .......+|..++..+ .|+||+++++++.+.+.+|+||||+
T Consensus 192 LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~~l~lVmEy~ 266 (576)
T 2acx_A 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-----NSRFVVSLAYAYETKDALCLVLTLM 266 (576)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-----CCCCEeeEEEEEeeCCEEEEEEEcC
Confidence 699999999999999999999999987432 2234567899999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 267 ~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl--------------------------- 319 (576)
T 2acx_A 267 NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL--------------------------- 319 (576)
T ss_dssp CSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---------------------------
Confidence 9999999987655569999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.+
T Consensus 320 d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~ 399 (576)
T 2acx_A 320 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 399 (576)
T ss_dssp CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH
T ss_pred eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH
Confidence 556679999999987665433 345899999999999998899999999999999999999999987543211111111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC--
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL-- 311 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~-- 311 (329)
.....+ ..++..++.++.+||++||+.||.+||
T Consensus 400 ~i~~~~---------------------------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~ 434 (576)
T 2acx_A 400 LVKEVP---------------------------------------------EEYSERFSPQARSLCSQLLCKDPAERLGC 434 (576)
T ss_dssp HHHHCC---------------------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred Hhhccc---------------------------------------------ccCCccCCHHHHHHHHHhccCCHHHcCCC
Confidence 100000 011234677899999999999999999
Q ss_pred ---CHHHHhcCCCCCCCC
Q 020235 312 ---TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ---t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 435 ~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 435 RGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp SSSHHHHHHTSGGGTTCC
T ss_pred CCCCHHHHHhChhhccCC
Confidence 899999999999865
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=357.63 Aligned_cols=248 Identities=27% Similarity=0.482 Sum_probs=193.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||||++... ....+|+.++.++ ..|+||+++++++.. .+.+|+||||+
T Consensus 70 LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~----~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHh----cCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 69999999999999999999999998742 3456777777655 256899999998875 66899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++..
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~------------------------ 197 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------------------ 197 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS------------------------
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC------------------------
Confidence 8999999987654569999999999999999999999999999999999999532
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH----HHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE----HLA 229 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----~~~ 229 (329)
..++.++|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... ...
T Consensus 198 ~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 277 (400)
T 1nxk_A 198 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277 (400)
T ss_dssp STTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred CCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence 125779999999998655433 45678999999999998899999999999999999999999997654321 111
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.. +.+..+. ..+..++.++.+||++||+.||++
T Consensus 278 ~i~~-----------------------~~~~~~~----------------------~~~~~~s~~~~~li~~~L~~dP~~ 312 (400)
T 1nxk_A 278 RIRM-----------------------GQYEFPN----------------------PEWSEVSEEVKMLIRNLLKTEPTQ 312 (400)
T ss_dssp HHHH-----------------------TCCCCCT----------------------TTTTTSCHHHHHHHHTTSCSSGGG
T ss_pred HHHc-----------------------CcccCCC----------------------cccccCCHHHHHHHHHHCCCChhH
Confidence 1111 1111110 012346788999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||+.++++||||.+.
T Consensus 313 Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 313 RMTITEFMNHPWIMQS 328 (400)
T ss_dssp SCCHHHHHHSHHHHTT
T ss_pred CcCHHHHhcCccccCC
Confidence 9999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=344.72 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---------------------------hHHhHHHHHHHHHHHHhhCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------------------------YREAAMIEIEVLQQLAKHDKGG 53 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~~l~~~~~~~ 53 (329)
||+|+||.||+|+++.+++.||+|++..... ..+...+|+.++..+ .|
T Consensus 21 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h 95 (298)
T 2zv2_A 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL-----DH 95 (298)
T ss_dssp EEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC-----CC
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC-----CC
Confidence 6999999999999999999999999874321 124467799998888 57
Q ss_pred Cceeeecccccc--CCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEee
Q 020235 54 NRCVQIRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 54 ~~i~~l~~~~~~--~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~ 130 (329)
+||+++++++.+ .+..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+|||+
T Consensus 96 ~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~-- 170 (298)
T 2zv2_A 96 PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV-- 170 (298)
T ss_dssp TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE--
T ss_pred CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE--
Confidence 999999999886 56899999999 7888776443 369999999999999999999999999999999999999
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC---CCCccchHh
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG---WTYPCDIWS 204 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Diws 204 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++||||
T Consensus 171 -------------------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 225 (298)
T 2zv2_A 171 -------------------------GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWA 225 (298)
T ss_dssp -------------------------CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHH
T ss_pred -------------------------CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHh
Confidence 455679999999987654432 3457999999999998765 367899999
Q ss_pred HHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 205 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 205 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
|||++|+|++|..||.+.+.......+.......+ .
T Consensus 226 lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-----------------------~--------------------- 261 (298)
T 2zv2_A 226 MGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP-----------------------D--------------------- 261 (298)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-----------------------S---------------------
T ss_pred HHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC-----------------------C---------------------
Confidence 99999999999999987655443333222111111 0
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
....+..+.+||.+||+.||++|||+.++++||||++
T Consensus 262 ---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 262 ---QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp ---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred ---ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 1245678999999999999999999999999999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=356.23 Aligned_cols=271 Identities=28% Similarity=0.503 Sum_probs=213.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~~lv~e 74 (329)
||+|+||.||+|+++.+++.||||++.... ....+|+.++..+ .|+||+++++++.. ...+++|||
T Consensus 62 lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l-----~hpniv~l~~~~~~~~~~~~~~~~~lv~e 133 (420)
T 1j1b_A 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKDEVYLNLVLD 133 (420)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTC-----CCTTBCCEEEEEEEEETTTTEEEEEEEEE
T ss_pred EeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHc-----CCCCccceeeEEeccCCCCcceeEEeehh
Confidence 699999999999999999999999987532 2345789999888 67999999888743 235789999
Q ss_pred cCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 75 KLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 75 ~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|+.+++.+.+.. .....+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 134 ~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~---------------------- 191 (420)
T 1j1b_A 134 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---------------------- 191 (420)
T ss_dssp CCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET----------------------
T ss_pred cccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC----------------------
Confidence 998788877753 22346999999999999999999999999999999999999952
Q ss_pred ccCCCCCCeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
....+||+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 192 ----~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~ 267 (420)
T 1j1b_A 192 ----DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267 (420)
T ss_dssp ----TTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----CCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 2345799999999765433 2446789999999999775 68999999999999999999999999998888899
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.++.+.+......... +.++.. ....+...+....+.++.+||++||+.||++
T Consensus 268 ~i~~~lg~p~~~~~~~~~~~~~~------~~~p~~--------------~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~ 327 (420)
T 1j1b_A 268 EIIKVLGTPTREQIREMNPNYTE------FKFPQI--------------KAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 327 (420)
T ss_dssp HHHHHHCSCCHHHHHHHCSCCCC------CCCCCC--------------CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhCCCCHHHHHhhChhhhh------hccCcc--------------CCCCHHHhcCCCCCHHHHHHHHHhccCChhH
Confidence 99999988877655443221111 111110 0001111122345778999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||+.|+++||||++.
T Consensus 328 R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 328 RLTPLEACAHSFFDEL 343 (420)
T ss_dssp SCCHHHHHTSGGGGGG
T ss_pred CCCHHHHhCCHhhccc
Confidence 9999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=334.73 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=209.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|.++.++..||+|++... ........+|+.++..+ .|+||+++++++.+.+..++||||+ ++
T Consensus 17 lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (277)
T 3f3z_A 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-----DHPNIIRLYETFEDNTDIYLVMELCTGG 91 (277)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCeEEEEEeccCCC
Confidence 68999999999999999999999998743 23345677899998888 5799999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++..+ +.+
T Consensus 92 ~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~------------------------~~~ 145 (277)
T 3f3z_A 92 ELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD------------------------SPD 145 (277)
T ss_dssp BHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS------------------------STT
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC------------------------CCC
Confidence 9999988754 58999999999999999999999999999999999999432 345
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
..++|+|||.+....... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+..+....+.+...
T Consensus 146 ~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 224 (277)
T 3f3z_A 146 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTF 224 (277)
T ss_dssp CCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred CcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 679999999987655443 345799999999998764 89999999999999999999999998777666665555444
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
..+...+ ...+..+.++|.+||+.||++|||+.++
T Consensus 225 ~~~~~~~---------------------------------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 225 TFPEKDW---------------------------------------------LNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp CCCHHHH---------------------------------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCchhh---------------------------------------------hcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4433211 2356789999999999999999999999
Q ss_pred hcCCCCCC
Q 020235 317 LRHPFFTR 324 (329)
Q Consensus 317 l~hp~f~~ 324 (329)
++||||++
T Consensus 260 l~h~~~~~ 267 (277)
T 3f3z_A 260 LEHEWFEK 267 (277)
T ss_dssp TTSHHHHH
T ss_pred hcCHHHhc
Confidence 99999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=362.91 Aligned_cols=248 Identities=31% Similarity=0.520 Sum_probs=209.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.++.+++.||+|++... ........+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 30 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~ 104 (486)
T 3mwu_A 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDSSSFYIVGELYT 104 (486)
T ss_dssp EECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-----CCCCcCeEEEEEEcCCEEEEEEEcCC
Confidence 69999999999999999999999998632 22345677899999998 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||+... .
T Consensus 105 ~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~------------------------~ 158 (486)
T 3mwu_A 105 GGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK------------------------E 158 (486)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS------------------------S
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC------------------------C
Confidence 899999987654 69999999999999999999999999999999999999543 2
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+..++|+|||.+....... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 237 (486)
T 3mwu_A 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (486)
T ss_dssp TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 45679999999998665443 34579999999999887 5899999999999999999999999987776666555543
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....+.. .+..++..+.+||++||+.||++|||+.
T Consensus 238 ~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ 272 (486)
T 3mwu_A 238 KYAFDLP---------------------------------------------QWRTISDDAKDLIRKMLTFHPSLRITAT 272 (486)
T ss_dssp CCCSCSG---------------------------------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCc---------------------------------------------ccCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 3222211 1234677899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++|+||||++.
T Consensus 273 ~~l~hp~~~~~ 283 (486)
T 3mwu_A 273 QCLEHPWIQKY 283 (486)
T ss_dssp HHHHCHHHHHT
T ss_pred HHhcCHhhccC
Confidence 99999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=344.74 Aligned_cols=246 Identities=31% Similarity=0.534 Sum_probs=204.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|.++.+|+.||||+++... .......+|+.++..+. .|+||+.+++++...+..++
T Consensus 102 lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~~~l 177 (365)
T 2y7j_A 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA----GHPHIITLIDSYESSSFMFL 177 (365)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEEEEEBSSEEEE
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeEEEEEEeeCCEEEE
Confidence 689999999999999999999999986432 11345567888888872 56999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 178 v~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---------------------- 233 (365)
T 2y7j_A 178 VFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---------------------- 233 (365)
T ss_dssp EECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----------------------
T ss_pred EEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----------------------
Confidence 99999 889999998653 68999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC------CCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.
T Consensus 234 -----~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 234 -----DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp -----CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 556679999999887655433 345799999999999743 5788999999999999999999999876
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
+.......+.......+... +...+..+.+||.+|
T Consensus 309 ~~~~~~~~i~~~~~~~~~~~---------------------------------------------~~~~~~~~~~li~~~ 343 (365)
T 2y7j_A 309 RQILMLRMIMEGQYQFSSPE---------------------------------------------WDDRSSTVKDLISRL 343 (365)
T ss_dssp SHHHHHHHHHHTCCCCCHHH---------------------------------------------HSSSCHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcc---------------------------------------------cccCCHHHHHHHHHH
Confidence 66555544444322222111 134567899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
|+.||++|||+.++++||||++
T Consensus 344 L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 344 LQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SCSSTTTSCCHHHHHHSGGGCC
T ss_pred cCCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999974
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=335.02 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=209.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+++..++||||+
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~ 88 (284)
T 3kk8_A 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-----QHPNIVRLHDSIQEESFHYLVFDLVT 88 (284)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred hcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-----CCCCcCeEEEEEEcCCEEEEEEecCC
Confidence 689999999999999999999999987432 2234566788888888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+.+.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++
T Consensus 89 ~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------------------ 142 (284)
T 3kk8_A 89 GGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------------------ 142 (284)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS------------------------
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC------------------------
Confidence 889998887754 689999999999999999999999999999999999995432
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
....++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 143 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (284)
T 3kk8_A 143 KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222 (284)
T ss_dssp TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc
Confidence 34559999999997665443 3457899999999999999999999999999999999999999887766655554443
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....+.. .....+..+.+||.+||+.||++|||++
T Consensus 223 ~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ 257 (284)
T 3kk8_A 223 AYDYPSP---------------------------------------------EWDTVTPEAKSLIDSMLTVNPKKRITAD 257 (284)
T ss_dssp CCCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred cccCCch---------------------------------------------hhcccCHHHHHHHHHHcccChhhCCCHH
Confidence 3222211 0124567899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
++++||||++.+
T Consensus 258 ~~l~h~~~~~~~ 269 (284)
T 3kk8_A 258 QALKVPWICNRE 269 (284)
T ss_dssp HHTTSHHHHSCC
T ss_pred HHhcCccccCCh
Confidence 999999998765
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=361.01 Aligned_cols=242 Identities=28% Similarity=0.401 Sum_probs=204.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 24 LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~~~~~~~~~~~lv~E~~ 98 (476)
T 2y94_A 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQVISTPSDIFMVMEYV 98 (476)
T ss_dssp EECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEeCC
Confidence 699999999999999999999999987432 1234567788888777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 99 ~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll--------------------------- 149 (476)
T 2y94_A 99 SGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL--------------------------- 149 (476)
T ss_dssp SSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---------------------------
Confidence 999999997653 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.
T Consensus 150 ~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 229 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229 (476)
T ss_dssp CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 556679999999987665433 44679999999999998775 689999999999999999999998766655444333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +...+..+.+||++||+.||++|||
T Consensus 230 ~~~~~~-------------------------------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt 260 (476)
T 2y94_A 230 DGIFYT-------------------------------------------------PQYLNPSVISLLKHMLQVDPMKRAT 260 (476)
T ss_dssp TTCCCC-------------------------------------------------CTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred cCCcCC-------------------------------------------------CccCCHHHHHHHHHHcCCCchhCcC
Confidence 221111 1234668999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020235 313 AREALRHPFFTRD 325 (329)
Q Consensus 313 ~~~ll~hp~f~~~ 325 (329)
+.++++||||++.
T Consensus 261 ~~eil~hp~~~~~ 273 (476)
T 2y94_A 261 IKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHTCHHHHTT
T ss_pred HHHHHhCHHhhhc
Confidence 9999999999764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=335.61 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=199.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.++..+|+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+ +
T Consensus 30 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~~ 104 (285)
T 3is5_A 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-----DHPNIIKIFEVFEDYHNMYIVMETCEG 104 (285)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCCSC
T ss_pred eccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-----CCchHHhHHHheecCCeEEEEEEeCCC
Confidence 699999999999999999999999987533 2346677899999888 5799999999999999999999999 8
Q ss_pred CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 78 SSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 78 ~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++|.+.+... ....+++..++.++.|++.||.|||++||+|+||||+||++...
T Consensus 105 ~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~------------------------ 160 (285)
T 3is5_A 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT------------------------ 160 (285)
T ss_dssp CBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS------------------------
T ss_pred CcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC------------------------
Confidence 8999998642 22469999999999999999999999999999999999999532
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+..++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.......
T Consensus 161 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~ 239 (285)
T 3is5_A 161 SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY 239 (285)
T ss_dssp STTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc
Confidence 345679999999997654433 44578999999999864 688999999999999999999999987665443332222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.....+. .....+..+.+||.+||+.||++|||+
T Consensus 240 ~~~~~~~----------------------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~ 273 (285)
T 3is5_A 240 KEPNYAV----------------------------------------------ECRPLTPQAVDLLKQMLTKDPERRPSA 273 (285)
T ss_dssp CCCCCCC------------------------------------------------CCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred CCccccc----------------------------------------------ccCcCCHHHHHHHHHHccCChhhCcCH
Confidence 1111100 012356789999999999999999999
Q ss_pred HHHhcCCCCCC
Q 020235 314 REALRHPFFTR 324 (329)
Q Consensus 314 ~~ll~hp~f~~ 324 (329)
.|+++||||++
T Consensus 274 ~e~l~hp~f~~ 284 (285)
T 3is5_A 274 AQVLHHEWFKQ 284 (285)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCHHhhc
Confidence 99999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=344.70 Aligned_cols=270 Identities=29% Similarity=0.515 Sum_probs=214.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc------eEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH------ICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~------~~l 71 (329)
||+|+||.||+|.++.+|+.||||++... ........+|+.++..+ .|+||+++++++...+. .++
T Consensus 32 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~l 106 (353)
T 3coi_A 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-----QHENVIGLLDVFTPASSLRNFYDFYL 106 (353)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSGGGCCCCEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-----CCCCcccHhheEecccccccceeEEE
Confidence 69999999999999999999999998642 22345667888888888 57999999999887654 499
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+++++|.+++.. .+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 107 v~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~----------------------- 159 (353)
T 3coi_A 107 VMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----------------------- 159 (353)
T ss_dssp EEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE-----------------------
T ss_pred EeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE-----------------------
Confidence 999998888777643 48999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 160 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 235 (353)
T 3coi_A 160 ----NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ 235 (353)
T ss_dssp ----CTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred ----CCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 55667999999999877666566788999999999987 5789999999999999999999999999888888888
Q ss_pred HHHHhCCCChhHHHhhhhhhhh-hhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEK-YVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+..+.++.+++..+.+.... +... ....+ ...........+..+.+||.+||+.||++
T Consensus 236 i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------------------~~~~~~~~~~~~~~~~~li~~~L~~dp~~ 296 (353)
T 3coi_A 236 ILKVTGVPGTEFVQKLNDKAAKSYIQS-LPQTP------------------RKDFTQLFPRASPQAADLLEKMLELDVDK 296 (353)
T ss_dssp HHHHHCBCCHHHHTTCSCHHHHHHHHT-SCBCS------------------SCCTTTTCTTSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHhCCCCHHHHHHHhhHHHHHHHHh-CcCCC------------------CccHHHhcCCcCHHHHHHHHHHcCCCccc
Confidence 8888888887776554332211 1110 00000 00011122356788999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||++++++||||+..
T Consensus 297 Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 297 RLTAAQALTHPFFEPF 312 (353)
T ss_dssp SCCHHHHHTSGGGTTT
T ss_pred CCCHHHHhcCcchhhc
Confidence 9999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=363.13 Aligned_cols=247 Identities=29% Similarity=0.498 Sum_probs=205.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++.++..||+|++.... .......+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 45 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-----DHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 699999999999999999999999987532 2345667899988888 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||+... .
T Consensus 120 ~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~------------------------~ 173 (494)
T 3lij_A 120 GGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK------------------------E 173 (494)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS------------------------S
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC------------------------C
Confidence 899999887654 68999999999999999999999999999999999999543 2
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
....++|+|||.+....... ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 174 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~ 252 (494)
T 3lij_A 174 KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252 (494)
T ss_dssp TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 34569999999987655433 34579999999999864 6899999999999999999999999988777666665554
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
...++... +..++..+.+||++||+.||.+|||+.
T Consensus 253 ~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ 287 (494)
T 3lij_A 253 KYTFDSPE---------------------------------------------WKNVSEGAKDLIKQMLQFDSQRRISAQ 287 (494)
T ss_dssp CCCCCSGG---------------------------------------------GTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCchh---------------------------------------------cccCCHHHHHHHHHHCCCChhhCccHH
Confidence 33322211 234677899999999999999999999
Q ss_pred HHhcCCCCCC
Q 020235 315 EALRHPFFTR 324 (329)
Q Consensus 315 ~ll~hp~f~~ 324 (329)
++|+||||++
T Consensus 288 e~l~hp~~~~ 297 (494)
T 3lij_A 288 QALEHPWIKE 297 (494)
T ss_dssp HHHTCHHHHH
T ss_pred HHhcCccccc
Confidence 9999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=361.37 Aligned_cols=248 Identities=27% Similarity=0.461 Sum_probs=207.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--------------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--------------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR 66 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~ 66 (329)
||+|+||+||+|.++.+++.||+|++.... .......+|+.++..+ .||||+++++++.+.
T Consensus 44 lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~ 118 (504)
T 3q5i_A 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-----DHPNIIKLFDVFEDK 118 (504)
T ss_dssp EEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-----CCTTBCCEEEEEECS
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEEcC
Confidence 699999999999999999999999987532 2245667899999888 579999999999999
Q ss_pred CceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 67 NHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 67 ~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
+..++||||+ +++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||+..++
T Consensus 119 ~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------------- 183 (504)
T 3q5i_A 119 KYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN------------- 183 (504)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-------------
T ss_pred CEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-------------
Confidence 9999999999 899999997754 699999999999999999999999999999999999995432
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE 223 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 223 (329)
....++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+
T Consensus 184 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~ 251 (504)
T 3q5i_A 184 -----------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN 251 (504)
T ss_dssp -----------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 23469999999998665543 44679999999999875 68999999999999999999999999887
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+....+.......+... +..++..+.+||++||
T Consensus 252 ~~~~~~~i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L 286 (504)
T 3q5i_A 252 DQDIIKKVEKGKYYFDFND---------------------------------------------WKNISDEAKELIKLML 286 (504)
T ss_dssp HHHHHHHHHHCCCCCCHHH---------------------------------------------HTTSCHHHHHHHHHHT
T ss_pred HHHHHHHHHcCCCCCCccc---------------------------------------------cCCCCHHHHHHHHHHc
Confidence 7776666655433333211 2346778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
++||.+|||++++|+||||++.
T Consensus 287 ~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 287 TYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCChhHCCCHHHHhcCHhhhhc
Confidence 9999999999999999999653
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=363.82 Aligned_cols=248 Identities=30% Similarity=0.511 Sum_probs=210.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 34 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~ 108 (484)
T 3nyv_A 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-----DHPNIMKLYEFFEDKGYFYLVGEVY 108 (484)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCCEEEEEEecC
Confidence 69999999999999999999999998643 23456677899999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+.+.... .+++..++.++.|++.||.|||++||+||||||+|||+...
T Consensus 109 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~------------------------ 162 (484)
T 3nyv_A 109 TGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK------------------------ 162 (484)
T ss_dssp CSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------------------------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC------------------------
Confidence 999999998754 69999999999999999999999999999999999999532
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
..+..++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.+
T Consensus 163 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 241 (484)
T 3nyv_A 163 SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK 241 (484)
T ss_dssp STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 245679999999997665544 34579999999999987 689999999999999999999999998877766665554
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
.....+.. .+..++..+.+||++||+.||++|||+
T Consensus 242 ~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~ 276 (484)
T 3nyv_A 242 GKYTFELP---------------------------------------------QWKKVSESAKDLIRKMLTYVPSMRISA 276 (484)
T ss_dssp CCCCCCSG---------------------------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCCCc---------------------------------------------ccccCCHHHHHHHHHHCCCChhHCcCH
Confidence 33222211 123467789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
+++|+||||++.
T Consensus 277 ~e~l~h~~~~~~ 288 (484)
T 3nyv_A 277 RDALDHEWIQTY 288 (484)
T ss_dssp HHHHTSHHHHHH
T ss_pred HHHhhChhhccc
Confidence 999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=359.62 Aligned_cols=245 Identities=23% Similarity=0.377 Sum_probs=203.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||+|++.... ........|..++..+ .|++|+++++++.+.+.+|+||||+
T Consensus 193 LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-----~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-----HSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEeeCCEEEEEEEec
Confidence 699999999999999999999999997432 2234567799999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl------------------------- 322 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL------------------------- 322 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-------------------------
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE-------------------------
Confidence 999999998643 3468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch----hH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN----LE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~----~~ 226 (329)
+.++.++|+|||.+....... ...+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+. .+
T Consensus 323 --~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~ 400 (543)
T 3c4z_A 323 --DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE 400 (543)
T ss_dssp --CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH
T ss_pred --eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH
Confidence 556679999999987654433 235899999999999999999999999999999999999999987532 12
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+..... .++...+..+.+||++||+.|
T Consensus 401 ~~~~i~~~~~-------------------------------------------------~~p~~~s~~~~~li~~lL~~d 431 (543)
T 3c4z_A 401 LKQRVLEQAV-------------------------------------------------TYPDKFSPASKDFCEALLQKD 431 (543)
T ss_dssp HHHHHHHCCC-------------------------------------------------CCCTTSCHHHHHHHHHHSCSS
T ss_pred HHHHHhhccc-------------------------------------------------CCCcccCHHHHHHHHHhccCC
Confidence 2221111110 112346778999999999999
Q ss_pred CCCCCC-----HHHHhcCCCCCCCC
Q 020235 307 PTDRLT-----AREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~t-----~~~ll~hp~f~~~~ 326 (329)
|++||+ ++++++||||++.+
T Consensus 432 P~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 432 PEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp GGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HhHCCCCcccCHHHHHcCccccCCC
Confidence 999996 58999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=335.76 Aligned_cols=243 Identities=25% Similarity=0.447 Sum_probs=202.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (279)
T 3fdn_A 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDATRVYLILEYA 91 (279)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-----CCCCCcchhheEecCCEEEEEEecC
Confidence 699999999999999999999999986432 1234456677777777 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||++
T Consensus 92 ~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili--------------------------- 142 (279)
T 3fdn_A 92 PLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--------------------------- 142 (279)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---------------------------
Confidence 889999998754 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|..||...+..+....+...
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 222 (279)
T 3fdn_A 143 GSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222 (279)
T ss_dssp CTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC
Confidence 556679999999876554433 4457899999999999988999999999999999999999999887666555544443
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....| ...+..+.+||.+||+.||++|||++
T Consensus 223 ~~~~~-------------------------------------------------~~~~~~~~~li~~~l~~~p~~Rps~~ 253 (279)
T 3fdn_A 223 EFTFP-------------------------------------------------DFVTEGARDLISRLLKHNPSQRPMLR 253 (279)
T ss_dssp CCCCC-------------------------------------------------TTSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCC-------------------------------------------------CcCCHHHHHHHHHHhccChhhCCCHH
Confidence 22222 23466899999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020235 315 EALRHPFFTRDH 326 (329)
Q Consensus 315 ~ll~hp~f~~~~ 326 (329)
++++||||++..
T Consensus 254 e~l~h~~~~~~~ 265 (279)
T 3fdn_A 254 EVLEHPWITANS 265 (279)
T ss_dssp HHHHCHHHHHHC
T ss_pred HHhhCccccCCc
Confidence 999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=336.41 Aligned_cols=276 Identities=28% Similarity=0.469 Sum_probs=217.5
Q ss_pred CCCccceEEEEEEec-CCCceEEEEEeccchh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-----cCCceEE
Q 020235 1 MGEGTFGQVLECWDR-ERKEMVAIKIVRGIKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----YRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-----~~~~~~l 71 (329)
||+|+||.||+|++. .+++.||+|+++.... ......+|+.++..+.. ..|+||+++++++. .....++
T Consensus 19 lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~h~~i~~~~~~~~~~~~~~~~~~~l 96 (326)
T 1blx_A 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSRTDRETKLTL 96 (326)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred ecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhc--cCCCCeEeeeeeeeecccCCCceEEE
Confidence 689999999999995 6789999999874321 22355678888887743 25699999999886 5678999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+++++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 97 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili----------------------- 153 (326)
T 1blx_A 97 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----------------------- 153 (326)
T ss_dssp EEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred EEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE-----------------------
Confidence 999998899999998765569999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 154 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 229 (326)
T 1blx_A 154 ----TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 229 (326)
T ss_dssp ----CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ----cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 456678999999987654332 34578999999999999899999999999999999999999999988888777
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....+.++...+.......... +. ..............+..+.+||.+||+.||++
T Consensus 230 ~i~~~~~~~~~~~~~~~~~~~~~~-------~~---------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 287 (326)
T 1blx_A 230 KILDVIGLPGEEDWPRDVALPRQA-------FH---------------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287 (326)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGG-------SC---------------CCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHHcCCCCcccCccccccchhh-------hc---------------ccCcchhhhccccCCHHHHHHHHHHcCCCccc
Confidence 777777665543322110000000 00 00000112233457788999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||+.++++||||++.+.
T Consensus 288 Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 288 RISAYSALSHPYFQDLER 305 (326)
T ss_dssp SCCHHHHHTSGGGTTCCC
T ss_pred CCCHHHHhcCccccccch
Confidence 999999999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=349.68 Aligned_cols=270 Identities=32% Similarity=0.552 Sum_probs=211.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~lv~e 74 (329)
||+|+||+||+|++..+++ +|+|++.... ....+|+.++..+ .|+||+++++++...+ .+++|||
T Consensus 48 lG~G~~g~V~~a~~~~~~~-~aikk~~~~~---~~~~~E~~il~~l-----~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 48 IGNGSFGVVFQAKLVESDE-VAIKKVLQDK---RFKNRELQIMRIV-----KHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEETTEEEEEEEETTTEE-EEEEEEECCT---TSCCHHHHHHHTC-----CCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred EeeCCCeEEEEEEECCCCe-EEEEEEecCc---chHHHHHHHHHhC-----CCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 6999999999999988776 8888876432 2234688898888 5799999999985433 4899999
Q ss_pred cCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 75 KLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 75 ~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|+.+++...+.. .....+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~----------------------- 175 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD----------------------- 175 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-----------------------
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc-----------------------
Confidence 997777666542 1224699999999999999999999999999999999999994
Q ss_pred ccCCCCCCeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+...
T Consensus 176 ---~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~ 252 (394)
T 4e7w_A 176 ---PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252 (394)
T ss_dssp ---TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 14567899999999765333 2456789999999999775 48999999999999999999999999999999999
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.++.+.+....... .... ++. .........+....+.++.+||.+||+.||++
T Consensus 253 ~i~~~~g~p~~~~~~~~~~~~---~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (394)
T 4e7w_A 253 EIIKVLGTPSREQIKTMNPNY---MEHK---FPQ--------------IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSA 312 (394)
T ss_dssp HHHHHHCCCCHHHHHHHCGGG---SSSC---CCC--------------CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHHhCCCCHHHHHhhChhh---hhhc---ccc--------------ccCCcHHHhccccCCHHHHHHHHHHhCCChhh
Confidence 999999988876655432211 1110 000 00011111223346789999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||+.++++||||++.
T Consensus 313 R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 313 RLTAIEALCHPFFDEL 328 (394)
T ss_dssp SCCHHHHHTSGGGSTT
T ss_pred CCCHHHHhcChhhhhh
Confidence 9999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=343.21 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=202.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|++..+++.||||++.... .......+|+.++..+ .|+||+++++++.+++..++||||+
T Consensus 62 lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~ 136 (348)
T 1u5q_A 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREHTAWLVMEYC 136 (348)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCeEEEEEecC
Confidence 699999999999999999999999986432 2234567899999888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.|++.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 137 ~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~--------------------------- 188 (348)
T 1u5q_A 137 LGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS--------------------------- 188 (348)
T ss_dssp SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---------------------------
T ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---------------------------
Confidence 888988886533 3689999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.++.++|+|||.+...... ....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.+..+....+.+
T Consensus 189 ~~~~~kL~DfG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 267 (348)
T 1u5q_A 189 EPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267 (348)
T ss_dssp TTTEEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecCCC-CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 4556899999988765543 3457999999999996 45688999999999999999999999987766554443333
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
...+.. .....+..+.+||.+||+.||++|||+
T Consensus 268 ~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~ 300 (348)
T 1u5q_A 268 NESPAL-----------------------------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTS 300 (348)
T ss_dssp SCCCCC-----------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred cCCCCC-----------------------------------------------CCCCCCHHHHHHHHHHcccChhhCcCH
Confidence 211100 012346689999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+++++||||.+..
T Consensus 301 ~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 301 EVLLKHRFVLRER 313 (348)
T ss_dssp HHHTTCHHHHSCC
T ss_pred HHHhhChhhhccC
Confidence 9999999997654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=334.11 Aligned_cols=251 Identities=24% Similarity=0.449 Sum_probs=206.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++.+++.||+|++..... ..+...+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~ 87 (283)
T 3bhy_A 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-----RHPNIITLHDIFENKTDVVLIL 87 (283)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred hcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-----CCCCeeehhheecCCCeEEEEE
Confidence 6899999999999999999999999874321 245677899999888 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|++ +++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++..++
T Consensus 88 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-------------------- 145 (283)
T 3bhy_A 88 ELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN-------------------- 145 (283)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS--------------------
T ss_pred eecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC--------------------
Confidence 999 899999997653 689999999999999999999999999999999999996543
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
..+..++|+|||.+....... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....
T Consensus 146 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 222 (283)
T 3bhy_A 146 ---VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTN 222 (283)
T ss_dssp ---SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred ---CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHH
Confidence 234479999999987654433 345689999999999988999999999999999999999999988766554444
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.......+.. .....+..+.++|.+||+.||++|
T Consensus 223 ~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~li~~~l~~dp~~R 257 (283)
T 3bhy_A 223 ISAVNYDFDEE---------------------------------------------YFSNTSELAKDFIRRLLVKDPKRR 257 (283)
T ss_dssp HHTTCCCCCHH---------------------------------------------HHTTCCHHHHHHHHTTSCSSGGGS
T ss_pred hHhcccCCcch---------------------------------------------hcccCCHHHHHHHHHHccCCHhHC
Confidence 43322222211 122456789999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||+.++++||||++..
T Consensus 258 ps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 258 MTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCHHHHHHCHHHHHHH
T ss_pred cCHHHHHhCHHHHHHH
Confidence 9999999999998653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=336.71 Aligned_cols=278 Identities=25% Similarity=0.500 Sum_probs=206.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|++..+++.||+|+++.. ......+|+.++..+. +|+||+++++++.+ ....++||||+ +
T Consensus 44 lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~----~~~~i~~~~~~~~~~~~~~~~lv~e~~~~ 117 (330)
T 3nsz_A 44 LGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLR----GGPNIITLADIVKDPVSRTPALVFEHVNN 117 (330)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCCEEEEEECCCC
T ss_pred ecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcC----CCCCEEEeeeeeccCCCCceEEEEeccCc
Confidence 69999999999999999999999998743 3466788999999993 46999999999987 67899999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.. +++..++.++.|++.||.|||++||+||||||+|||++. .
T Consensus 118 ~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~--------------------------~ 166 (330)
T 3nsz_A 118 TDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--------------------------E 166 (330)
T ss_dssp CCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------------------T
T ss_pred hhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC--------------------------C
Confidence 999988753 899999999999999999999999999999999999953 2
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCC-CchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQT-HENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~-~~~~~~~~~~~~ 233 (329)
+..++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.+
T Consensus 167 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~ 246 (330)
T 3nsz_A 167 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246 (330)
T ss_dssp TTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHH
Confidence 2368999999997654433 44578999999999987 5689999999999999999999999954 344455555555
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHH-HhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL-IMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..+.. ........ ....... ................. .......++..+.+||.+||+.||++|||
T Consensus 247 ~~~~~--~~~~~~~~--------~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 313 (330)
T 3nsz_A 247 VLGTE--DLYDYIDK--------YNIELDP---RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313 (330)
T ss_dssp HHCHH--HHHHHHHH--------TTCCCCT---HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC
T ss_pred hcCCc--hhhhHHHH--------hcccccc---chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC
Confidence 54431 11111110 0000000 00000000000000000 01112236789999999999999999999
Q ss_pred HHHHhcCCCCCCCCcC
Q 020235 313 AREALRHPFFTRDHLR 328 (329)
Q Consensus 313 ~~~ll~hp~f~~~~~~ 328 (329)
++|+|+||||++....
T Consensus 314 a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 314 AREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHTSGGGTTCC--
T ss_pred HHHHhcCccHhhhccC
Confidence 9999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=340.68 Aligned_cols=273 Identities=25% Similarity=0.425 Sum_probs=209.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh------------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccc----
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD---- 64 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~---- 64 (329)
||+|+||.||+|.+.. ++.||+|++..... ......+|+.++..+ .|+||+++++++.
T Consensus 30 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~ 103 (362)
T 3pg1_A 30 ISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-----HHPNILGLRDIFVHFEE 103 (362)
T ss_dssp EEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEEEECCT
T ss_pred eccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-----CCcCccceeeeEEeccC
Confidence 6999999999999865 88999999863211 125677899999988 5799999999883
Q ss_pred -cCCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 65 -YRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 65 -~~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
.....++||||++++|.+.+.... ..+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 104 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~--------------- 167 (362)
T 3pg1_A 104 PAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--------------- 167 (362)
T ss_dssp TTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------
T ss_pred CCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---------------
Confidence 345789999999889999988643 468999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCC
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQ 220 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~ 220 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 168 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 168 ------------ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp ------------CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ------------cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 556679999999987544333 34578999999999987 568999999999999999999999999
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhh-hhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDR-HAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 299 (329)
+.+..+....+.+..+.++......... ....+........+.. .........+..+.+||
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~li 297 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR------------------AWTAVVPTADPVALDLI 297 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC------------------CHHHHSTTSCHHHHHHH
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh------------------hHHhhCCCCCHHHHHHH
Confidence 9988888888888888776554332211 1111211111111110 01122345677899999
Q ss_pred HHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 300 QGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 300 ~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
.+||+.||++|||+.++++||||++.
T Consensus 298 ~~~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 298 AKMLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHhcCChhhCCCHHHHHcCchhhhc
Confidence 99999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=341.17 Aligned_cols=236 Identities=27% Similarity=0.459 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||+||+|+++.+++.||+|+++.... ......+|+.++..+ .|+||+++++++.+.+..++
T Consensus 32 lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~Iv~~~~~~~~~~~~~l 106 (335)
T 3dls_A 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-----EHANIIKVLDIFENQGFFQL 106 (335)
T ss_dssp CSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-----CCTTBCCEEEEEECSSEEEE
T ss_pred EEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEeeCCEEEE
Confidence 7999999999999999999999999875321 234566799999888 57999999999999999999
Q ss_pred EeecC-CC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 72 VFEKL-GS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 72 v~e~~-~~-~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|||++ ++ +|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 107 v~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll--------------------- 163 (335)
T 3dls_A 107 VMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI--------------------- 163 (335)
T ss_dssp EEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------
T ss_pred EEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---------------------
Confidence 99998 44 9999998764 69999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 164 ------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 237 (335)
T 3dls_A 164 ------AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV 237 (335)
T ss_dssp ------CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT
T ss_pred ------cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH
Confidence 556779999999998665543 34579999999999998876 789999999999999999999996522110
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
.... ..+...+..+.+||.+||+.|
T Consensus 238 -----------------------------~~~~--------------------------~~~~~~~~~l~~li~~~L~~d 262 (335)
T 3dls_A 238 -----------------------------EAAI--------------------------HPPYLVSKELMSLVSGLLQPV 262 (335)
T ss_dssp -----------------------------TTCC--------------------------CCSSCCCHHHHHHHHHHTCSS
T ss_pred -----------------------------hhcc--------------------------CCCcccCHHHHHHHHHHccCC
Confidence 0000 001235678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~ 325 (329)
|++|||++++++||||++.
T Consensus 263 P~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 263 PERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp GGGSCCHHHHHHCTTTTCC
T ss_pred hhhCcCHHHHhcCccccCC
Confidence 9999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=336.28 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=205.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|+++.+|+.||+|+++.... ......+|+.++..+ .|+||+++++++.+.+..++|||++ ++
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (304)
T 2jam_A 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-----KHENIVTLEDIYESTTHYYLVMQLVSGG 91 (304)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred ccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-----CCCCeeehhhhcccCCEEEEEEEcCCCc
Confidence 6999999999999999999999999875432 334567899999888 5799999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++..+ +.+
T Consensus 92 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~------------------------~~~ 145 (304)
T 2jam_A 92 ELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP------------------------EEN 145 (304)
T ss_dssp BHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS------------------------STT
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC------------------------CCC
Confidence 9999997654 68999999999999999999999999999999999999432 345
Q ss_pred CCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.+....
T Consensus 146 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 225 (304)
T 2jam_A 146 SKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE 225 (304)
T ss_dssp CCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred CCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence 678999999987654432 3356899999999999988999999999999999999999999877665554444432222
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
.+. ......+..+.+||.+||+.||++|||+.+++
T Consensus 226 ~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 226 FES---------------------------------------------PFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp CCT---------------------------------------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCc---------------------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 111 01234567899999999999999999999999
Q ss_pred cCCCCCCC
Q 020235 318 RHPFFTRD 325 (329)
Q Consensus 318 ~hp~f~~~ 325 (329)
+||||++.
T Consensus 261 ~h~~~~~~ 268 (304)
T 2jam_A 261 SHPWIDGN 268 (304)
T ss_dssp TSHHHHSS
T ss_pred cCccccCC
Confidence 99999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=354.86 Aligned_cols=251 Identities=30% Similarity=0.469 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh---------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK---------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||+||+|.++.+++.||+|++..... ......+|+.++..+ .||||+++++++.. +..++
T Consensus 143 LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~-~~~~l 216 (419)
T 3i6u_A 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIKNFFDA-EDYYI 216 (419)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-----CCTTBCCCCEEEES-SEEEE
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-----CCCCEeeEEEEEec-CceEE
Confidence 6999999999999999999999999874321 122456899999998 67999999999864 45899
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+..+
T Consensus 217 v~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~------------------- 275 (419)
T 3i6u_A 217 VLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ------------------- 275 (419)
T ss_dssp EEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-------------------
T ss_pred EEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC-------------------
Confidence 99999 889988887653 69999999999999999999999999999999999999543
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..+..++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......
T Consensus 276 -----~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 350 (419)
T 3i6u_A 276 -----EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350 (419)
T ss_dssp -----SSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred -----CCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence 234569999999998765543 34679999999999864 46788999999999999999999999764332
Q ss_pred H-HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 E-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
. ....+.......++ ..+..++..+.+||.+||+
T Consensus 351 ~~~~~~i~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~L~ 385 (419)
T 3i6u_A 351 VSLKDQITSGKYNFIP---------------------------------------------EVWAEVSEKALDLVKKLLV 385 (419)
T ss_dssp CCHHHHHHTTCCCCCH---------------------------------------------HHHTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHhcCCCCCCc---------------------------------------------hhhcccCHHHHHHHHHHcc
Confidence 1 11111111111111 1123467789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCcC
Q 020235 305 YDPTDRLTAREALRHPFFTRDHLR 328 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~~~ 328 (329)
.||++|||++++++||||++.+.+
T Consensus 386 ~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 386 VDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp SSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred CChhHCcCHHHHhCCcccCChhHH
Confidence 999999999999999999987543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=332.29 Aligned_cols=244 Identities=25% Similarity=0.424 Sum_probs=204.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++|||++
T Consensus 22 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 96 (284)
T 2vgo_A 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-----RHPNILRMYNYFHDRKRIYLMLEFA 96 (284)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-----CCCCEeeEEEEEEcCCEEEEEEEeC
Confidence 689999999999999999999999986432 1234567788888887 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 97 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--------------------------- 147 (284)
T 2vgo_A 97 PRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM--------------------------- 147 (284)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---------------------------
Confidence 889999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++.++|+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+...
T Consensus 148 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 227 (284)
T 2vgo_A 148 GYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227 (284)
T ss_dssp CTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc
Confidence 455678999999886554332 4457899999999999988999999999999999999999999876655443333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... +...+..+.++|.+||+.||.+|||++
T Consensus 228 ~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ 258 (284)
T 2vgo_A 228 DLKF-------------------------------------------------PPFLSDGSKDLISKLLRYHPPQRLPLK 258 (284)
T ss_dssp CCCC-------------------------------------------------CTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred ccCC-------------------------------------------------CCcCCHHHHHHHHHHhhcCHhhCCCHH
Confidence 1111 123567899999999999999999999
Q ss_pred HHhcCCCCCCCCc
Q 020235 315 EALRHPFFTRDHL 327 (329)
Q Consensus 315 ~ll~hp~f~~~~~ 327 (329)
++++||||++...
T Consensus 259 ~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 259 GVMEHPWVKANSR 271 (284)
T ss_dssp HHHTCHHHHHHCC
T ss_pred HHhhCHHHHhhcc
Confidence 9999999986543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=329.12 Aligned_cols=249 Identities=30% Similarity=0.515 Sum_probs=205.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~ 70 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+. .|+||+++++++.+.+..+
T Consensus 25 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~ 100 (298)
T 1phk_A 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLKDTYETNTFFF 100 (298)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSSEEE
T ss_pred ecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhc----CCCCEeeeeeeeccCCeEE
Confidence 689999999999999999999999986432 22345667888888883 4799999999999999999
Q ss_pred EEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+|||++ +++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 101 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--------------------- 157 (298)
T 1phk_A 101 LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--------------------- 157 (298)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------
T ss_pred EEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---------------------
Confidence 999999 899999998753 68999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHh------cCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL------GLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++.++|+|||.+....... ....||+.|+|||++. ...++.++||||||+++|+|++|..||.+
T Consensus 158 ------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 158 ------DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp ------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 456679999999987655433 3457899999999986 34578999999999999999999999988
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+.......+.......+.. ....++..+.++|.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~l~~li~~ 266 (298)
T 1phk_A 232 RKQMLMLRMIMSGNYQFGSP---------------------------------------------EWDDYSDTVKDLVSR 266 (298)
T ss_dssp SSHHHHHHHHHHTCCCCCTT---------------------------------------------TGGGSCHHHHHHHHH
T ss_pred ccHHHHHHHHhcCCcccCcc---------------------------------------------cccccCHHHHHHHHH
Confidence 76655544444322211110 012356789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
||+.||++|||+.++++||||++...
T Consensus 267 ~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 267 FLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HccCCcccCCCHHHHHhChHhhhccc
Confidence 99999999999999999999997643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=334.54 Aligned_cols=273 Identities=26% Similarity=0.442 Sum_probs=209.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc--------------c
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--------------Y 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~--------------~ 65 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++. .
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~~~~ 93 (320)
T 2i6l_A 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-----DHDNIVKVFEILGPSGSQLTDDVGSLTE 93 (320)
T ss_dssp CC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECTTSCBCCC----CCS
T ss_pred eccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-----CCCCeeEEEEeccccccccccccccccc
Confidence 799999999999999999999999987433 3345667899888888 5799999988763 4
Q ss_pred CCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 66 RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 66 ~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
.+..++||||++++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 94 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~--------------- 155 (320)
T 2i6l_A 94 LNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--------------- 155 (320)
T ss_dssp CSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET---------------
T ss_pred cCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC---------------
Confidence 4688999999988999999753 5899999999999999999999999999999999999952
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCC------CCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCC
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEAL 218 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p 218 (329)
.+..++|+|||.+...... .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 156 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (320)
T 2i6l_A 156 -----------EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224 (320)
T ss_dssp -----------TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred -----------CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCC
Confidence 3456899999988765432 133467889999999876 5689999999999999999999999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.+.........+.........+....... ...........++..+.+|
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l 285 (320)
T 2i6l_A 225 FAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTE-------------------PHKPLTQLLPGISREAVDF 285 (320)
T ss_dssp SCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTS-------------------CCCCHHHHSTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccC-------------------CCCChhHhcchhhHHHHHH
Confidence 999888877777777766666555444333222221110000 0000112234567899999
Q ss_pred HHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 299 LQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
|++||+.||++|||++++++||||+...
T Consensus 286 i~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 286 LEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp HHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HHHHcCCCccccCCHHHHhCCccccccc
Confidence 9999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=334.69 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=189.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----------- 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----------- 67 (329)
||+|+||.||+|+++.+++.||||+++.. ....+...+|+.++..+ .||||+++++++.+..
T Consensus 14 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-----EHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-----CCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred ecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 69999999999999999999999998743 23456677899999888 5799999999875432
Q ss_pred ----------------------------------------------ceEEEeecC-CCCHHHHHHhCCC-CCCCHHHHHH
Q 020235 68 ----------------------------------------------HICIVFEKL-GSSLYDFLRKNNY-RSFPIDLVRE 99 (329)
Q Consensus 68 ----------------------------------------------~~~lv~e~~-~~~l~~~l~~~~~-~~l~~~~~~~ 99 (329)
..++||||+ +++|.+++.+... ...++..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 389999999 9999999987542 2245567899
Q ss_pred HHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC---
Q 020235 100 IARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--- 176 (329)
Q Consensus 100 ~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--- 176 (329)
++.|++.||.|||++||+||||||+|||+ ..++.++|+|||.+.......
T Consensus 169 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---------------------------~~~~~~kL~DfG~a~~~~~~~~~~ 221 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFF---------------------------TMDDVVKVGDFGLVTAMDQDEEEQ 221 (332)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------------CTTCCEEECCCTTCEECSCC----
T ss_pred HHHHHHHHHHHHHhCCeeecCCCcccEEE---------------------------eCCCCEEEeecCcccccccchhhc
Confidence 99999999999999999999999999999 455668888888876554431
Q ss_pred ------------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh-CCCChhHH
Q 020235 177 ------------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL-GPLPQHML 243 (329)
Q Consensus 177 ------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 243 (329)
....||+.|+|||++.+..++.++|||||||++|+|++|..|+.. ....+.... +..+..
T Consensus 222 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~-- 294 (332)
T 3qd2_B 222 TVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLL-- 294 (332)
T ss_dssp ----------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHH--
T ss_pred cccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcc--
Confidence 234699999999999999999999999999999999998776421 111111111 111111
Q ss_pred HhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q 020235 244 KRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323 (329)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~ 323 (329)
....++.+.+||.+||+.||++|||++++++||||+
T Consensus 295 --------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 295 --------------------------------------------FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp --------------------------------------------HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred --------------------------------------------cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhh
Confidence 112345678999999999999999999999999998
Q ss_pred CC
Q 020235 324 RD 325 (329)
Q Consensus 324 ~~ 325 (329)
+.
T Consensus 331 ~~ 332 (332)
T 3qd2_B 331 NL 332 (332)
T ss_dssp CC
T ss_pred cC
Confidence 63
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=331.28 Aligned_cols=244 Identities=25% Similarity=0.437 Sum_probs=178.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 19 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (278)
T 3cok_A 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-----KHPSILELYNYFEDSNYVYLVLEMC 93 (278)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-----CCCCeEeEEEEEccCCeEEEEEecC
Confidence 6899999999999999999999999874322 124566788887777 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 94 ~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili--------------------------- 145 (278)
T 3cok_A 94 HNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL--------------------------- 145 (278)
T ss_dssp TTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---------------------------
T ss_pred CCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---------------------------
Confidence 889999998653 468999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 225 (278)
T 3cok_A 146 TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225 (278)
T ss_dssp CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC
T ss_pred cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh
Confidence 556679999999987654322 23578999999999998889999999999999999999999997644322111000
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
.... ..+...+..+.++|.+||+.||++|||
T Consensus 226 -----------------------~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps 256 (278)
T 3cok_A 226 -----------------------LADY--------------------------EMPSFLSIEAKDLIHQLLRRNPADRLS 256 (278)
T ss_dssp -----------------------SSCC--------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred -----------------------hccc--------------------------CCccccCHHHHHHHHHHcccCHhhCCC
Confidence 0000 011235678999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++++++||||.+..
T Consensus 257 ~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 257 LSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHTTSTTTC---
T ss_pred HHHHhcCccccCCC
Confidence 99999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=342.98 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=201.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.++.+++.||+|++... ........+|+.++..+ .|+||+++++++.+.+..++|||
T Consensus 34 lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e 108 (345)
T 3hko_A 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-----HHPNIARLYEVYEDEQYICLVME 108 (345)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEEE
T ss_pred eeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-----CCCCcceeehhhccCCeEEEEEe
Confidence 69999999999999999999999998643 23345677899999988 57999999999999999999999
Q ss_pred cC-CCCHHHHHHhCC--------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 020235 75 KL-GSSLYDFLRKNN--------------------------------------YRSFPIDLVREIARQLLECIAFMHDLC 115 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~--------------------------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~ 115 (329)
|+ +++|.+++.... ...+++..++.++.|++.||+|||++|
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 188 (345)
T 3hko_A 109 LCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188 (345)
T ss_dssp CCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99 999999985210 112357788899999999999999999
Q ss_pred CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCch
Q 020235 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAP 188 (329)
Q Consensus 116 i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aP 188 (329)
|+|+||||+||+++.+ ....++|+|||.+...... .....||+.|+||
T Consensus 189 ivH~Dlkp~NIll~~~-------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP 243 (345)
T 3hko_A 189 ICHRDIKPENFLFSTN-------------------------KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243 (345)
T ss_dssp EECCCCCGGGEEESCS-------------------------SSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred ccccCCChhhEEEecC-------------------------CCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence 9999999999999432 2237999999998754321 1345789999999
Q ss_pred hHHhc--CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCC
Q 020235 189 EVILG--LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAA 266 (329)
Q Consensus 189 E~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
|++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------------------- 298 (345)
T 3hko_A 244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP------------------------- 298 (345)
T ss_dssp HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------
T ss_pred hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------
Confidence 99976 568899999999999999999999998877766555444432221110
Q ss_pred chHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 267 SRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
.....+..+.+||.+||+.||++|||+.++++||||++..
T Consensus 299 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 299 --------------------NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp --------------------GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred --------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 0123567899999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=329.20 Aligned_cols=245 Identities=23% Similarity=0.418 Sum_probs=196.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~ 73 (329)
||+|+||+||+|.+..++..||+|++... ........+|+.++..+ .|+||+++++++.. ....++||
T Consensus 34 lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred ccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-----CCCCeeeeeeeeccccCCCceEEEEE
Confidence 69999999999999999999999998743 23345566788888877 57999999998764 45799999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||+ +++|.+++.... .+++..++.++.|++.||.|||++| ++|+||||+||+++
T Consensus 109 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--------------------- 165 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--------------------- 165 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---------------------
T ss_pred EecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE---------------------
Confidence 999 889999998753 6899999999999999999999999 99999999999993
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........
T Consensus 166 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 239 (290)
T 1t4h_A 166 -----GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 239 (290)
T ss_dssp -----STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred -----CCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHH
Confidence 145679999999987655443 34578999999998875 58999999999999999999999998755433222
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
..... +..+. ......+..+.++|.+||+.||++
T Consensus 240 ~~~~~-~~~~~---------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~ 273 (290)
T 1t4h_A 240 RRVTS-GVKPA---------------------------------------------SFDKVAIPEVKEIIEGCIRQNKDE 273 (290)
T ss_dssp HHHTT-TCCCG---------------------------------------------GGGGCCCHHHHHHHHHHSCSSGGG
T ss_pred HHHhc-cCCcc---------------------------------------------ccCCCCCHHHHHHHHHHccCChhh
Confidence 11110 00010 112234568999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||++++++||||+++
T Consensus 274 Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 274 RYSIKDLLNHAFFQEE 289 (290)
T ss_dssp SCCHHHHHTSGGGC--
T ss_pred CCCHHHHhhCcccccC
Confidence 9999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=335.23 Aligned_cols=248 Identities=22% Similarity=0.407 Sum_probs=199.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~~lv~e 74 (329)
||+|+||.||+|++..+++.||+|++...........+|+.++..+. .|+||+++++++.. .+..++|||
T Consensus 32 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 107 (326)
T 2x7f_A 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS----HHRNIATYYGAFIKKNPPGMDDQLWLVME 107 (326)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHC----CSTTBCCEEEEEEECC--CCCCEEEEEEE
T ss_pred eccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhcc----CCCCeeeeeeEEeeccCccccceEEEEEE
Confidence 68999999999999999999999999866556677788999998883 56899999999876 568999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~------------------------- 162 (326)
T 2x7f_A 108 FCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL------------------------- 162 (326)
T ss_dssp CCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE-------------------------
T ss_pred cCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE-------------------------
Confidence 99 7899999987654568999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
..++.++|+|||.+...... .....||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..
T Consensus 163 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 240 (326)
T 2x7f_A 163 --TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240 (326)
T ss_dssp --CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred --cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH
Confidence 45667899999988765432 23457899999999997 456889999999999999999999999876655
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
.....+.....+. ......+..+.+||.+||..
T Consensus 241 ~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~l~~ 273 (326)
T 2x7f_A 241 RALFLIPRNPAPR-----------------------------------------------LKSKKWSKKFQSFIESCLVK 273 (326)
T ss_dssp HHHHHHHHSCCCC-----------------------------------------------CSCSCSCHHHHHHHHHHCCS
T ss_pred HHHHHhhcCcccc-----------------------------------------------CCccccCHHHHHHHHHHhcc
Confidence 4433322211100 00123567899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||++|||++++++||||++..
T Consensus 274 dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 274 NHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SGGGSCCHHHHHTSHHHHCCT
T ss_pred ChhhCCCHHHHhhChHHhhCc
Confidence 999999999999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.41 Aligned_cols=271 Identities=29% Similarity=0.473 Sum_probs=208.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-----CceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-----NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-----~~~~lv~ 73 (329)
||+|+||.||+|.++.+|+.||||++... ........+|+.++..+ .|+||+++++++... ...++||
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-----KHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-----cCCCcCCeeeeecccccCccceEEEEE
Confidence 69999999999999999999999998643 22345566899999888 579999999876653 6899999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 94 e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~------------------------- 145 (353)
T 2b9h_A 94 ELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI------------------------- 145 (353)
T ss_dssp CCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-------------------------
T ss_pred eccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE-------------------------
Confidence 99988999999874 59999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------------CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCC
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------------NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALF 219 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------------~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~ 219 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 146 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 146 --NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp --CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred --cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 455668888888876544221 12468999999998875 56899999999999999999999999
Q ss_pred CCCchhHHHHHHHHHhCCCChhHH-Hhhh-hhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHH
Q 020235 220 QTHENLEHLAMMERVLGPLPQHML-KRVD-RHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297 (329)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
.+.+..+....+....+.++.... .... .....+ .......+ ...........+..+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~--~~~~~~~~~~~~~~~~~ 284 (353)
T 2b9h_A 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREY-----------------IKSLPMYP--AAPLEKMFPRVNPKGID 284 (353)
T ss_dssp CCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHH-----------------HHTSCCCC--CCCHHHHSTTSCHHHHH
T ss_pred CCCCcHHHHHHHHHHhCCCchhccccccccchhhHH-----------------hhcccCCC--CcchhhhcccCCHHHHH
Confidence 998887777777777766542110 0000 000000 00000000 00011223456788999
Q ss_pred HHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 298 LLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 298 ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
||.+||+.||++|||++++++||||++.
T Consensus 285 li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 285 LLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 9999999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=341.78 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=194.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.+.. ++.||||++.... .......+|+.++..+.+ +++||+++++++..++.+++|||+.+
T Consensus 64 LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~---~~~~iv~~~~~~~~~~~~~lv~E~~~ 139 (390)
T 2zmd_A 64 IGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYIYMVMECGN 139 (390)
T ss_dssp EECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHccc---CCCeEEEEEEEEecCCEEEEEEecCC
Confidence 6999999999999875 8899999986432 334567789999999954 45899999999999999999999669
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+.
T Consensus 140 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---------------------------- 189 (390)
T 2zmd_A 140 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---------------------------- 189 (390)
T ss_dssp EEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----------------------------
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----------------------------
Confidence 99999998864 689999999999999999999999999999999999992
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhc-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+..++|+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 2458999999987665432 34579999999999975 3588999999999999999999999976
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
..... ..+.....+.. ...+ +...+..+.+||.+
T Consensus 270 ~~~~~--~~~~~~~~~~~------------------~~~~--------------------------~~~~~~~~~~li~~ 303 (390)
T 2zmd_A 270 IINQI--SKLHAIIDPNH------------------EIEF--------------------------PDIPEKDLQDVLKC 303 (390)
T ss_dssp CCCHH--HHHHHHHCTTS------------------CCCC--------------------------CCCSCHHHHHHHHH
T ss_pred hhHHH--HHHHHHhCccc------------------cCCC--------------------------CccchHHHHHHHHH
Confidence 43321 11111111100 0000 12235679999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
||+.||++|||+.++++||||+..
T Consensus 304 ~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 304 CLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred HcccChhhCCCHHHHhhCcCcccc
Confidence 999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=335.33 Aligned_cols=243 Identities=29% Similarity=0.449 Sum_probs=204.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 49 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 123 (335)
T 2owb_A 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDNDFVFVVLELC 123 (335)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCeEEEEEecC
Confidence 699999999999999999999999987432 3345567788888877 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 124 ~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~--------------------------- 174 (335)
T 2owb_A 124 RRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--------------------------- 174 (335)
T ss_dssp TTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---------------------------
T ss_pred CCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---------------------------
Confidence 899999988753 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+.
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 254 (335)
T 2owb_A 175 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 254 (335)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh
Confidence 45667999999998765432 234578999999999999889999999999999999999999998766554443333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... ....+..+.+||.+||+.||++|||
T Consensus 255 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~dp~~Rps 285 (335)
T 2owb_A 255 KNEYSI-------------------------------------------------PKHINPVAASLIQKMLQTDPTARPT 285 (335)
T ss_dssp HTCCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCCCC-------------------------------------------------CccCCHHHHHHHHHHccCChhHCcC
Confidence 321111 1234567899999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++++++||||++..
T Consensus 286 ~~ell~~~~~~~~~ 299 (335)
T 2owb_A 286 INELLNDEFFTSGY 299 (335)
T ss_dssp GGGGGGSHHHHTSC
T ss_pred HHHHhcCccccCCC
Confidence 99999999998653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=329.92 Aligned_cols=263 Identities=20% Similarity=0.277 Sum_probs=195.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.++.+++.||+|++... ........+|+..+..+ ..|+||+++++++.+.+..++||||+
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l----~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL----GQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHS----CSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHh----CCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 68999999999999999999999998743 23345566677777666 25699999999999999999999999
Q ss_pred CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 ~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++.....+....... .
T Consensus 95 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~--------~ 166 (289)
T 1x8b_A 95 GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD--------W 166 (289)
T ss_dssp TCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------------------
T ss_pred CCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc--------c
Confidence 889999998632 135899999999999999999999999999999999999987654333222211100 1
Q ss_pred CCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
......++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...+... .+.+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~ 242 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQ 242 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHT
T ss_pred cCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHc
Confidence 1245679999999998765543 34689999999999876 46689999999999999999998775433211 1111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
+.. +......+..+.++|.+||+.||++|||+
T Consensus 243 --~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 274 (289)
T 1x8b_A 243 --GRL----------------------------------------------PRIPQVLSQEFTELLKVMIHPDPERRPSA 274 (289)
T ss_dssp --TCC----------------------------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred --CCC----------------------------------------------CCCCcccCHHHHHHHHHHhCCCcccCCCH
Confidence 000 01123457789999999999999999999
Q ss_pred HHHhcCCCCCCCCc
Q 020235 314 REALRHPFFTRDHL 327 (329)
Q Consensus 314 ~~ll~hp~f~~~~~ 327 (329)
.++++||||++...
T Consensus 275 ~~ll~h~~~~~~~~ 288 (289)
T 1x8b_A 275 MALVKHSVLLSASR 288 (289)
T ss_dssp HHHHTCTTC-----
T ss_pred HHHhhChHhhhhcc
Confidence 99999999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=336.00 Aligned_cols=244 Identities=27% Similarity=0.448 Sum_probs=192.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.+. +++.||+|++.... .......+|+.++..+.+ ++++|+++++++.+++..++|||+.+
T Consensus 17 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~~~~~~~lv~e~~~ 92 (343)
T 3dbq_A 17 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYIYMVMECGN 92 (343)
T ss_dssp ESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTT---TCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred EecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhh---cCCceEEEeeeEeeCCEEEEEEeCCC
Confidence 799999999999885 58899999987432 233566789999999964 34899999999999999999999779
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+.
T Consensus 93 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~---------------------------- 142 (343)
T 3dbq_A 93 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---------------------------- 142 (343)
T ss_dssp EEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----------------------------
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----------------------------
Confidence 99999998864 689999999999999999999999999999999999993
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhc-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 2348999999987665433 24579999999999975 5688999999999999999999999976
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
..... ..+.....+. .... .+...+..+.+||.+
T Consensus 223 ~~~~~--~~~~~~~~~~------------------~~~~--------------------------~~~~~~~~l~~li~~ 256 (343)
T 3dbq_A 223 IINQI--SKLHAIIDPN------------------HEIE--------------------------FPDIPEKDLQDVLKC 256 (343)
T ss_dssp CCSHH--HHHHHHHCTT------------------SCCC--------------------------CCCCSCHHHHHHHHH
T ss_pred hhhHH--HHHHHHhcCC------------------cccC--------------------------CcccCCHHHHHHHHH
Confidence 43221 1111111110 0001 112345679999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
||+.||++|||+.++++||||+.
T Consensus 257 ~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 257 CLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HcCCChhHCCCHHHHHhCccccc
Confidence 99999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=329.30 Aligned_cols=243 Identities=29% Similarity=0.449 Sum_probs=203.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 23 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~ 97 (294)
T 2rku_A 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-----AHQHVVGFHGFFEDNDFVFVVLELC 97 (294)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeeeccCCEEEEEEecC
Confidence 699999999999999999999999986432 2345566788888777 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 98 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~--------------------------- 148 (294)
T 2rku_A 98 RRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--------------------------- 148 (294)
T ss_dssp TTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---------------------------
Confidence 899999988754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+..++.++|+||||+++|+|++|..||...+..+....+.
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 228 (294)
T 2rku_A 149 NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK 228 (294)
T ss_dssp CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 55667899999998765432 234578999999999999889999999999999999999999998766544333322
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... ....+..+.++|.+||+.||++|||
T Consensus 229 ~~~~~~-------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps 259 (294)
T 2rku_A 229 KNEYSI-------------------------------------------------PKHINPVAASLIQKMLQTDPTARPT 259 (294)
T ss_dssp TTCCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hccCCC-------------------------------------------------ccccCHHHHHHHHHHcccChhhCcC
Confidence 211111 1234568999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++++++||||++..
T Consensus 260 ~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 260 INELLNDEFFTSGY 273 (294)
T ss_dssp GGGGGGSHHHHTSC
T ss_pred HHHHhhChheecCC
Confidence 99999999998653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=342.90 Aligned_cols=285 Identities=21% Similarity=0.329 Sum_probs=202.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|.++.+++.||+|++... ........+|+.++..+ .|+||+++++++.+++..++||||+ +
T Consensus 41 lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 115 (360)
T 3eqc_A 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEISICMEHMDG 115 (360)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-----CCCCEEEEeEEEEECCEEEEEEECCCC
Confidence 69999999999999999999999998753 23345567788887777 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.... .+++..+..++.|++.||.|||++ ||+|+||||+||++ +
T Consensus 116 ~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---------------------------~ 166 (360)
T 3eqc_A 116 GSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---------------------------N 166 (360)
T ss_dssp CBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---------------------------C
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---------------------------C
Confidence 89999998754 589999999999999999999986 99999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCC-CCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERP-DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
.++.++|+|||.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 167 ~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 246 (360)
T 3eqc_A 167 SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 246 (360)
T ss_dssp TTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---
T ss_pred CCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccc
Confidence 566799999998864432 2234578999999999999999999999999999999999999998766554433222211
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHH-HhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRES-IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..........................+ ...... ........ ........++.++.+||++||+.||++|||++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 320 (360)
T 3eqc_A 247 EGDAAETPPRPRTPGRPLNKFGMDSRP--PMAIFELLDYIVNEP----PPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320 (360)
T ss_dssp -----------------------------CCCHHHHHHHHHHSC----CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHH
T ss_pred cccCCCCCCCcccCCCcccccccCCCC--cccchhhhhHHhccC----CCCCCcccccHHHHHHHHHHhhcChhhCCCHH
Confidence 111110000000000000000000000 000000 00000000 00001123577899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++++||||++.
T Consensus 321 ell~hp~~~~~ 331 (360)
T 3eqc_A 321 QLMVHAFIKRS 331 (360)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChHhhcc
Confidence 99999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=328.62 Aligned_cols=247 Identities=23% Similarity=0.428 Sum_probs=182.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHH--hHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYRE--AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~--~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||+||+|.+..+++.||+|+++....... ....|...+ + ....|+||+++++++.+++..++||||+++
T Consensus 15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~--~--~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 90 (290)
T 3fme_A 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS--M--RTVDCPFTVTFYGALFREGDVWICMELMDT 90 (290)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHH--H--TTCCCTTBCCEEEEEECSSSEEEEEECCSE
T ss_pred cCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHH--H--HhCCCCeEEEEeeeeeccCCEEEEEehhcc
Confidence 6999999999999999999999999875322222 222222221 1 223789999999999999999999999988
Q ss_pred CHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 79 SLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 79 ~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|.+++.. .....+++..++.++.|++.||.|||++ |++|+||||+||++
T Consensus 91 ~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~--------------------------- 143 (290)
T 3fme_A 91 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI--------------------------- 143 (290)
T ss_dssp EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---------------------------
T ss_pred chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---------------------------
Confidence 99888764 1234699999999999999999999998 99999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHH----hcCCCCCccchHhHHHHHHHHHhCCCCCCCCch-hHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~ 228 (329)
+.+..++|+|||.+....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ....
T Consensus 144 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 223 (290)
T 3fme_A 144 NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL 223 (290)
T ss_dssp CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH
T ss_pred CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH
Confidence 455678999999887654433 334789999999997 455688999999999999999999999976332 2222
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
........+. . .....+..+.++|.+||+.||+
T Consensus 224 ~~~~~~~~~~----------------------~-------------------------~~~~~~~~~~~li~~~l~~~p~ 256 (290)
T 3fme_A 224 KQVVEEPSPQ----------------------L-------------------------PADKFSAEFVDFTSQCLKKNSK 256 (290)
T ss_dssp HHHHHSCCCC----------------------C-------------------------CTTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHhccCCCC----------------------c-------------------------ccccCCHHHHHHHHHHhhcChh
Confidence 2111111000 0 0123567899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRD 325 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~ 325 (329)
+|||+.++++||||+..
T Consensus 257 ~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 257 ERPTYPELMQHPFFTLH 273 (290)
T ss_dssp GSCCHHHHTTSHHHHHH
T ss_pred hCcCHHHHHhCcccccC
Confidence 99999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=326.34 Aligned_cols=243 Identities=27% Similarity=0.395 Sum_probs=194.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++|||++
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 93 (276)
T 2h6d_A 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-----RHPHIIKLYQVISTPTDFFMVMEYV 93 (276)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-----CCCCEeEEEEEEecCCeEEEEEecc
Confidence 689999999999999999999999987432 1234566788888777 5799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 94 ~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~--------------------------- 144 (276)
T 2h6d_A 94 SGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL--------------------------- 144 (276)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---------------------------
Confidence 889999998754 58999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 224 (276)
T 2h6d_A 145 DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR 224 (276)
T ss_dssp CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 455678999999887655433 34578999999999988765 589999999999999999999998765544433333
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... ....+..+.++|.+||+.||++|||
T Consensus 225 ~~~~~~-------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rps 255 (276)
T 2h6d_A 225 GGVFYI-------------------------------------------------PEYLNRSVATLLMHMLQVDPLKRAT 255 (276)
T ss_dssp HCCCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCcccC-------------------------------------------------chhcCHHHHHHHHHHccCChhhCCC
Confidence 221111 1234567999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++++++||||++.-
T Consensus 256 ~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 256 IKDIREHEWFKQDL 269 (276)
T ss_dssp HHHHHHSHHHHTTC
T ss_pred HHHHHhChhhccCc
Confidence 99999999998753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=348.67 Aligned_cols=254 Identities=15% Similarity=0.108 Sum_probs=184.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeecc-------ccccC---
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRN-------WFDYR--- 66 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~-------~~~~~--- 66 (329)
||+|+||+||+|+++.+++.||+|++.... .......+|+.++..+.. .|||+++++. .+...
T Consensus 70 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~---~hp~iv~~~~~~~~p~d~~~~~~~~ 146 (371)
T 3q60_A 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG---ESPEEARDRRRLLLPSDAVAVQSQP 146 (371)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-------------CBCCCCEEEEETTSC
T ss_pred ccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc---cChhhhhhceeEEeeehheecCCCC
Confidence 699999999999999999999999998632 334555678777777754 5688776543 22221
Q ss_pred --------------CceEEEeecCCCCHHHHHHhCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCcccCCCCCcE
Q 020235 67 --------------NHICIVFEKLGSSLYDFLRKNNYRSFPIDLV------REIARQLLECIAFMHDLCMIHTDLKPENV 126 (329)
Q Consensus 67 --------------~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~------~~~~~~l~~~L~~lH~~~i~H~dikp~NI 126 (329)
...|+||||+.++|.+++.... ..++.... ..++.|++.||+|||++||+||||||+||
T Consensus 147 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NI 225 (371)
T 3q60_A 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL 225 (371)
T ss_dssp SSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred CeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHE
Confidence 3489999999999999998642 12444444 56779999999999999999999999999
Q ss_pred EEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc--CCCCCccchHh
Q 020235 127 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG--LGWTYPCDIWS 204 (329)
Q Consensus 127 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Diws 204 (329)
|+ +.++.++|+|||.+...........+|+.|+|||++.+ ..++.++||||
T Consensus 226 ll---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwS 278 (371)
T 3q60_A 226 FI---------------------------MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQ 278 (371)
T ss_dssp EE---------------------------CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHH
T ss_pred EE---------------------------CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHH
Confidence 99 55667999999999876655445667799999999987 67999999999
Q ss_pred HHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 205 VGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 205 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
|||++|+|++|+.||.+...... .... .. .......... .
T Consensus 279 lG~il~elltg~~Pf~~~~~~~~--------~~~~--------~~--~~~~~~~~~~----------------------~ 318 (371)
T 3q60_A 279 LGLSIYRVWCLFLPFGLVTPGIK--------GSWK--------RP--SLRVPGTDSL----------------------A 318 (371)
T ss_dssp HHHHHHHHHHSSCSTTBCCTTCT--------TCCC--------BC--CTTSCCCCSC----------------------C
T ss_pred HHHHHHHHHhCCCCCCCcCcccc--------cchh--------hh--hhhhcccccc----------------------c
Confidence 99999999999999976432100 0000 00 0000000000 0
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
.......+..+.+||.+||+.||++|||+.++++||||++.
T Consensus 319 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 00123467889999999999999999999999999999764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=333.66 Aligned_cols=250 Identities=31% Similarity=0.481 Sum_probs=198.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++..++ .++
T Consensus 18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~-~~l 91 (322)
T 2ycf_A 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-----NHPCIIKIKNFFDAED-YYI 91 (322)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-----CCTTBCCEEEEEESSS-EEE
T ss_pred EecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-----CCCCCceEeeEEcCCc-eEE
Confidence 699999999999999999999999986432 1123456799999888 6799999999987655 899
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus 92 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------------------ 151 (322)
T 2ycf_A 92 VLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------ 151 (322)
T ss_dssp EEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------------------
T ss_pred EEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------------------
Confidence 99999 889999987643 689999999999999999999999999999999999995432
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
....++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..||......
T Consensus 152 ------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 152 ------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp ------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred ------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 23469999999998765443 2346899999999985 456889999999999999999999999764432
Q ss_pred -HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 -EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.....+........+ ......+..+.+||.+||+
T Consensus 226 ~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~ 260 (322)
T 2ycf_A 226 VSLKDQITSGKYNFIP---------------------------------------------EVWAEVSEKALDLVKKLLV 260 (322)
T ss_dssp SCHHHHHHHTCCCCCH---------------------------------------------HHHTTSCHHHHHHHHHHSC
T ss_pred HHHHHHHHhCccccCc---------------------------------------------hhhhhcCHHHHHHHHHHcc
Confidence 111112211111111 1123457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCCc
Q 020235 305 YDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
.||++|||++++++||||++...
T Consensus 261 ~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 261 VDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp SSTTTSCCHHHHHTSGGGCCHHH
T ss_pred cCHhhCCCHHHHhhCcCcCCHHH
Confidence 99999999999999999987653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=329.71 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=200.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.+|+.||+|++.... ......+|+.++..+ .|+||+++++++...+..++||||+ +++
T Consensus 37 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 110 (314)
T 3com_A 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQC-----DSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110 (314)
T ss_dssp CC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred eccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhC-----CCCCCccEEEEEEeCCEEEEEeecCCCCC
Confidence 799999999999999999999999987533 345677899888888 6799999999999999999999999 789
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++ +.++
T Consensus 111 L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---------------------------~~~~ 162 (314)
T 3com_A 111 VSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---------------------------NTEG 162 (314)
T ss_dssp HHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTTC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---------------------------CCCC
Confidence 999997433 368999999999999999999999999999999999999 4556
Q ss_pred CeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 160 AIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
.++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.......+.....
T Consensus 163 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 242 (314)
T 3com_A 163 HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP 242 (314)
T ss_dssp CEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred CEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC
Confidence 78999999986554332 345789999999999998899999999999999999999999987665443332222111
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
+.. ......+..+.+||.+||+.||.+|||+.++
T Consensus 243 ~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~l 276 (314)
T 3com_A 243 PTF----------------------------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQL 276 (314)
T ss_dssp CCC----------------------------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred ccc----------------------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 000 0012346789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020235 317 LRHPFFTRDH 326 (329)
Q Consensus 317 l~hp~f~~~~ 326 (329)
++||||++..
T Consensus 277 l~~~~~~~~~ 286 (314)
T 3com_A 277 LQHPFVRSAK 286 (314)
T ss_dssp TTSHHHHTCC
T ss_pred HhCHHHhcCC
Confidence 9999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=325.71 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=199.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+++..++|||++ +
T Consensus 15 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (276)
T 2yex_A 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQYLFLEYCSG 89 (276)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-----CCCCceeeeeEEEcCCEEEEEEEecCC
Confidence 689999999999999999999999986432 2345667788888777 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||++ ..
T Consensus 90 ~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---------------------------~~ 140 (276)
T 2yex_A 90 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---------------------------DE 140 (276)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------CT
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---------------------------cc
Confidence 89999886543 68999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHH-HHH
Q 020235 158 SSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEH-LAM 230 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-~~~ 230 (329)
++.++|+|||.+...... .....||+.|+|||++.+..+ +.++|+||||+++|+|++|..||........ ...
T Consensus 141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 220 (276)
T 2yex_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220 (276)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH
T ss_pred CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 567899999988654322 134578999999999988765 6789999999999999999999976543211 111
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....... ......+..+.++|.+||+.||++|
T Consensus 221 ~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 253 (276)
T 2yex_A 221 WKEKKTYL-----------------------------------------------NPWKKIDSAPLALLHKILVENPSAR 253 (276)
T ss_dssp HHTTCTTS-----------------------------------------------TTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred hhhccccc-----------------------------------------------CchhhcCHHHHHHHHHHCCCCchhC
Confidence 11000000 0012456789999999999999999
Q ss_pred CCHHHHhcCCCCCCCCc
Q 020235 311 LTAREALRHPFFTRDHL 327 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~~ 327 (329)
||++++++||||++...
T Consensus 254 ps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 254 ITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp CCHHHHTTCTTTTCCCC
T ss_pred CCHHHHhcCccccChhh
Confidence 99999999999997654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=354.33 Aligned_cols=242 Identities=18% Similarity=0.262 Sum_probs=188.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeec-------cccccCC--
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-------NWFDYRN-- 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~-------~~~~~~~-- 67 (329)
||+|+||+||+|+++.+|+.||||++... ....+...+|+.++..+.. ..||||++++ +++++.+
T Consensus 81 lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~--l~hpniv~~~~~~~~~~~~~~~~~~~ 158 (377)
T 3byv_A 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG--IKNQKQAKVHLRFIFPFDLVKDPQKK 158 (377)
T ss_dssp EEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTT--CCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred eecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccc--cCCHHHHHHHhhhhhhhhhhhccCCc
Confidence 69999999999999999999999998632 2334566778866655532 2679999888 4444433
Q ss_pred ---------------ceEEEeecCCCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEE
Q 020235 68 ---------------HICIVFEKLGSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVL 127 (329)
Q Consensus 68 ---------------~~~lv~e~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl 127 (329)
..++||||++|+|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIl 238 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238 (377)
T ss_dssp SEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred cccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 3899999999999999986421 11234788889999999999999999999999999999
Q ss_pred EeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-----------CC
Q 020235 128 LVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-----------GW 196 (329)
Q Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~ 196 (329)
+ +.++.++|+|||.+...........| +.|+|||++.+. .+
T Consensus 239 l---------------------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~ 290 (377)
T 3byv_A 239 L---------------------------DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLM 290 (377)
T ss_dssp E---------------------------CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred E---------------------------cCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccC
Confidence 9 55567999999999876555455678 999999999987 79
Q ss_pred CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhcc
Q 020235 197 TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMK 276 (329)
Q Consensus 197 ~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (329)
+.++|||||||++|+|++|+.||.+.+......
T Consensus 291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~----------------------------------------------- 323 (377)
T 3byv_A 291 TFSFDAWALGLVIYWIWCADLPITKDAALGGSE----------------------------------------------- 323 (377)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCCC------CCSG-----------------------------------------------
T ss_pred ChhhhHHHHHHHHHHHHHCCCCCcccccccchh-----------------------------------------------
Confidence 999999999999999999999996533211000
Q ss_pred chhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 277 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
........++..+.+||.+||+.||++|||+.++++||||++.
T Consensus 324 ------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 324 ------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp ------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred ------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 0000113456789999999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=338.04 Aligned_cols=247 Identities=25% Similarity=0.409 Sum_probs=197.5
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||.||+|++. .+++.||+|+++... .......+|+.++..+. .|++|+.+++++.+.+..++|
T Consensus 62 lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----QSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHH----TCTTBCCEEEEEEETTEEEEE
T ss_pred eccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHcc----CCCceeEEEEEEeeCceEEEE
Confidence 699999999999984 578999999987422 23455667999998884 468999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 138 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----------------------- 192 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----------------------- 192 (355)
T ss_dssp ECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred eecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE-----------------------
Confidence 9999 899999998754 68999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcC--CCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||......
T Consensus 193 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~ 268 (355)
T 1vzo_A 193 ----DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 268 (355)
T ss_dssp ----CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred ----CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc
Confidence 556678999999887543322 235799999999999863 4789999999999999999999999754322
Q ss_pred HHHHHHHHH-hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 226 EHLAMMERV-LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 226 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.....+.+. ... ........+..+.+||.+||+
T Consensus 269 ~~~~~~~~~~~~~----------------------------------------------~~~~~~~~~~~~~~li~~~L~ 302 (355)
T 1vzo_A 269 NSQAEISRRILKS----------------------------------------------EPPYPQEMSALAKDLIQRLLM 302 (355)
T ss_dssp CCHHHHHHHHHHC----------------------------------------------CCCCCTTSCHHHHHHHHHHTC
T ss_pred chHHHHHHHHhcc----------------------------------------------CCCCCcccCHHHHHHHHHHhh
Confidence 111111110 000 001123456789999999999
Q ss_pred cCCCCCC-----CHHHHhcCCCCCCCC
Q 020235 305 YDPTDRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~-----t~~~ll~hp~f~~~~ 326 (329)
.||.+|| |++++++||||++.+
T Consensus 303 ~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 303 KDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp SSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred hCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 9999999 999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=327.40 Aligned_cols=245 Identities=24% Similarity=0.454 Sum_probs=199.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-----hhHHhHHHHHHHHHHHHhhCCCCCceeeecccc--ccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~--~~~~~~~lv~ 73 (329)
||+|+||.||+|.+..+++.||+|+++... .......+|+.++..+ .|+||+++++++ .+.+..++||
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv~ 87 (305)
T 2wtk_C 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-----RHKNVIQLVDVLYNEEKQKMYMVM 87 (305)
T ss_dssp EEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECC---CEEEEE
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-----CCCCeeEEEEEEEcCCCCeEEEEe
Confidence 689999999999999999999999987432 2345667788888877 579999999988 4556899999
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
||+.+++.+++.......+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 88 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~------------------------- 142 (305)
T 2wtk_C 88 EYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL------------------------- 142 (305)
T ss_dssp ECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-------------------------
T ss_pred hhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE-------------------------
Confidence 9996668888887665679999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+..+
T Consensus 143 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (305)
T 2wtk_C 143 --TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220 (305)
T ss_dssp --CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred --cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Confidence 456678999999887654322 2346899999999998754 3679999999999999999999998766554
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+.+..... ....+..+.+||.+||+.|
T Consensus 221 ~~~~i~~~~~~~-------------------------------------------------~~~~~~~l~~li~~~l~~d 251 (305)
T 2wtk_C 221 LFENIGKGSYAI-------------------------------------------------PGDCGPPLSDLLKGMLEYE 251 (305)
T ss_dssp HHHHHHHCCCCC-------------------------------------------------CSSSCHHHHHHHHHHTCSS
T ss_pred HHHHHhcCCCCC-------------------------------------------------CCccCHHHHHHHHHHccCC
Confidence 444333321111 1235678999999999999
Q ss_pred CCCCCCHHHHhcCCCCCCCC
Q 020235 307 PTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 307 P~~R~t~~~ll~hp~f~~~~ 326 (329)
|++|||++++++||||++..
T Consensus 252 p~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 252 PAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp TTTSCCHHHHHHSHHHHSCC
T ss_pred hhhCCCHHHHhcCcccccCC
Confidence 99999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=338.64 Aligned_cols=252 Identities=29% Similarity=0.493 Sum_probs=175.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+++.||+|++..... ...|+..+... ..|+|++++++++.. ....++||||+
T Consensus 37 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~----~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 108 (336)
T 3fhr_A 37 LGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQA----SGGPHIVCILDVYENMHHGKRCLLIIMECM 108 (336)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHh----cCCCChHHHHHHHhhccCCCceEEEEEecc
Confidence 6999999999999999999999999875332 23333333333 267899999998876 45689999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..++.++.|++.||.|||++||+||||||+||++..+
T Consensus 109 ~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~------------------------ 164 (336)
T 3fhr_A 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK------------------------ 164 (336)
T ss_dssp TTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS------------------------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec------------------------
Confidence 8899999998765679999999999999999999999999999999999999543
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
..+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.............
T Consensus 165 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 244 (336)
T 3fhr_A 165 EKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRR 244 (336)
T ss_dssp STTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred CCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHh
Confidence 235569999999997655433 4467899999999998888899999999999999999999999764433211111100
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
. .......+ ...+..++..+.+||.+||+.||++|||++
T Consensus 245 ~-------------------~~~~~~~~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 283 (336)
T 3fhr_A 245 I-------------------RLGQYGFP----------------------NPEWSEVSEDAKQLIRLLLKTDPTERLTIT 283 (336)
T ss_dssp -------------------------CCC----------------------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred h-------------------hccccccC----------------------chhhccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 0 00000000 011234677899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++++||||++.
T Consensus 284 ell~hp~~~~~ 294 (336)
T 3fhr_A 284 QFMNHPWINQS 294 (336)
T ss_dssp HHHHSHHHHTG
T ss_pred HHhcCcccccc
Confidence 99999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=324.78 Aligned_cols=248 Identities=31% Similarity=0.520 Sum_probs=204.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++|||++
T Consensus 30 lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~ 104 (287)
T 2wei_A 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-----DHPNIMKLFEILEDSSSFYIVGELYT 104 (287)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-----cCCCccEEEEEEeCCCeEEEEEEccC
Confidence 689999999999999999999999986432 2345677899888888 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+.+.... .+++..++.++.|++.||.|||++|++|+||||+||+++.+ .
T Consensus 105 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~------------------------~ 158 (287)
T 2wei_A 105 GGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK------------------------E 158 (287)
T ss_dssp SCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS------------------------S
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC------------------------C
Confidence 899999887654 68999999999999999999999999999999999999543 2
Q ss_pred CCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
....++|+|||.+....... ....||+.|+|||++.+. ++.++|+||||+++|+|++|..||.+.+..+....+...
T Consensus 159 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (287)
T 2wei_A 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG 237 (287)
T ss_dssp TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 34579999999987665443 345689999999998764 889999999999999999999999887665544444332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
....+. .....++..+.++|++||+.||++|||+.
T Consensus 238 ~~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ 272 (287)
T 2wei_A 238 KYAFDL---------------------------------------------PQWRTISDDAKDLIRKMLTFHPSLRITAT 272 (287)
T ss_dssp CCCCCS---------------------------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCc---------------------------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHH
Confidence 211110 00124567899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++++||||++.
T Consensus 273 ell~hp~~~~~ 283 (287)
T 2wei_A 273 QCLEHPWIQKY 283 (287)
T ss_dssp HHHHSHHHHHH
T ss_pred HHhcCHHHhcc
Confidence 99999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=332.21 Aligned_cols=271 Identities=21% Similarity=0.349 Sum_probs=200.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... .......+|+.++..+ .|+||+++++++...+ ..++||||+
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (319)
T 4euu_A 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETTTRHKVLIMEFC 91 (319)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred ecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCcceEEEEeecCCCceEEEEEeCC
Confidence 699999999999999999999999987432 2345567899999988 5799999999887654 889999999
Q ss_pred -CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+|||+....
T Consensus 92 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~---------------------- 149 (319)
T 4euu_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---------------------- 149 (319)
T ss_dssp TTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT----------------------
T ss_pred CCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC----------------------
Confidence 8999999986432 2389999999999999999999999999999999999984322
Q ss_pred CCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHh--------cCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL--------GLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+....++|+|||.+....... ....||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 150 -~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 150 -DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp -TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred -CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 344568999999998665443 3457999999999987 46789999999999999999999999975332
Q ss_pred h-HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 225 L-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
. .....+.+.....|...+..+.... .....|... + ..........+..+.++|++||
T Consensus 229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~-----~~~~~~~~~----------~------~~~~~~~~~~~~~l~~ll~~~L 287 (319)
T 4euu_A 229 PRRNKEVMYKIITGKPSGAISGVQKAE-----NGPIDWSGD----------M------PVSCSLSRGLQVLLTPVLANIL 287 (319)
T ss_dssp GGGCHHHHHHHHHHCCTTCCEEEECST-----TCCEEEESS----------C------CTTCSSCHHHHHHHHHHHHHHS
T ss_pred cchhHHHHHHHhcCCCcccchhhhccc-----CCccccCcc----------C------CcccccchhHHHHhHHHHHHhc
Confidence 1 1122222222222221111110000 000111000 0 0000112335668999999999
Q ss_pred ccCCCCCCCHHHHhcCC
Q 020235 304 RYDPTDRLTAREALRHP 320 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp 320 (329)
+.||++|||++|+++||
T Consensus 288 ~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 288 EADQEKCWGFDQFFAET 304 (319)
T ss_dssp CCCTTTSCCHHHHHHHH
T ss_pred cCChhhhccHHHhhhcc
Confidence 99999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=327.12 Aligned_cols=247 Identities=25% Similarity=0.425 Sum_probs=197.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+ ++
T Consensus 27 lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 101 (302)
T 2j7t_A 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-----DHPYIVKLLGAYYHDGKLWIMIEFCPGG 101 (302)
T ss_dssp EECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECC-CEEEEEECCTTE
T ss_pred eccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-----CCCCEeeeeeeeeeCCeEEEEEEeCCCC
Confidence 699999999999999999999999987432 3345667888888888 5799999999999999999999999 88
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++ +.+
T Consensus 102 ~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---------------------------~~~ 153 (302)
T 2j7t_A 102 AVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---------------------------TLE 153 (302)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---------------------------CTT
T ss_pred cHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---------------------------CCC
Confidence 9999987643 358999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCC---CCCcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERP---DQNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++|+|||.+..... ......||+.|+|||++. ...++.++||||||+++|+|++|..||...+.......
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 233 (302)
T 2j7t_A 154 GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 233 (302)
T ss_dssp SCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 6789999997643211 123357899999999984 55688999999999999999999999987766554433
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.....+.. ......+..+.++|.+||+.||++|
T Consensus 234 ~~~~~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~R 267 (302)
T 2j7t_A 234 IAKSDPPTL----------------------------------------------LTPSKWSVEFRDFLKIALDKNPETR 267 (302)
T ss_dssp HHHSCCCCC----------------------------------------------SSGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HhccCCccc----------------------------------------------CCccccCHHHHHHHHHHcccChhhC
Confidence 333211100 0012356689999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
||++++++||||++..
T Consensus 268 ps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 268 PSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CCHHHHTTSTTTTTCC
T ss_pred CCHHHHhcChHHhhhc
Confidence 9999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=323.84 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=197.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+++++++...+..++|||++ ++
T Consensus 30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 104 (295)
T 2clq_A 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-----KHKNIVQYLGSFSENGFIKIFMEQVPGG 104 (295)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred EeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-----CCCCEeeEeeEEEeCCcEEEEEEeCCCC
Confidence 699999999999999999999999987533 2345667788888887 6799999999999999999999999 89
Q ss_pred CHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+|.+++..... ..+++..++.++.|++.||.|||++|++|+||||+||+++. .
T Consensus 105 ~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~--------------------------~ 158 (295)
T 2clq_A 105 SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--------------------------Y 158 (295)
T ss_dssp EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------------------T
T ss_pred CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC--------------------------C
Confidence 99999987532 34678899999999999999999999999999999999952 2
Q ss_pred CCCeEEeeCCCCcccCCC---CCcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
++.++|+|||.+...... .....||+.|+|||++.+.. ++.++||||||+++|+|++|..||.............
T Consensus 159 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (295)
T 2clq_A 159 SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV 238 (295)
T ss_dssp TCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH
T ss_pred CCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh
Confidence 567899999998765432 23457899999999998653 7899999999999999999999996543322111100
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +......+..+.++|.+||+.||++|||
T Consensus 239 ~~~~~~----------------------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps 272 (295)
T 2clq_A 239 GMFKVH----------------------------------------------PEIPESMSAEAKAFILKCFEPDPDKRAC 272 (295)
T ss_dssp HHHCCC----------------------------------------------CCCCTTSCHHHHHHHHHTTCSSTTTSCC
T ss_pred cccccc----------------------------------------------ccccccCCHHHHHHHHHHccCChhhCCC
Confidence 100000 0112345678999999999999999999
Q ss_pred HHHHhcCCCCCCCCc
Q 020235 313 AREALRHPFFTRDHL 327 (329)
Q Consensus 313 ~~~ll~hp~f~~~~~ 327 (329)
++++++||||+....
T Consensus 273 ~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 273 ANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHHTSGGGCC---
T ss_pred HHHHhcChhhhhccc
Confidence 999999999987654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=325.15 Aligned_cols=242 Identities=29% Similarity=0.447 Sum_probs=202.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.||+|++.... .......+|+.++..+ .|++|+++++++.+.+..++||||+ +
T Consensus 30 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 104 (303)
T 3a7i_A 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-----DSPYVTKYYGSYLKDTKLWIIMEYLGG 104 (303)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCCeEEEEEEeCCC
Confidence 689999999999999999999999987432 3346677888888887 6699999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||++ +.
T Consensus 105 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---------------------------~~ 154 (303)
T 3a7i_A 105 GSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---------------------------SE 154 (303)
T ss_dssp EEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CT
T ss_pred CcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---------------------------CC
Confidence 8999998763 59999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
++.++|+|||.+....... ....||+.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+.+.
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234 (303)
T ss_dssp TSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred CCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC
Confidence 5678999999886554332 3457899999999999988999999999999999999999999876654433322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ .....++..+.+||.+||+.||++|||+.
T Consensus 235 ~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 266 (303)
T 3a7i_A 235 NPP------------------------------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAK 266 (303)
T ss_dssp CCC------------------------------------------------CCCSSCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCccccCHHHHHHHHHHcCCChhhCcCHH
Confidence 100 01234567899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
++++||||.+.
T Consensus 267 ~ll~~~~~~~~ 277 (303)
T 3a7i_A 267 ELLKHKFILRN 277 (303)
T ss_dssp HHTTCHHHHHH
T ss_pred HHhhChhhhcC
Confidence 99999999654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=332.38 Aligned_cols=245 Identities=23% Similarity=0.337 Sum_probs=193.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc----eEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH----ICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~----~~lv 72 (329)
||+|+||.||+|+++.+++.||+|+++.... ......+|+.++..+ .|+||+++++++..... .|+|
T Consensus 20 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~~~~~lv 94 (311)
T 3ork_A 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEAETPAGPLPYIV 94 (311)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-----CCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-----CCCCcceEEEeeeccCCCCcccEEE
Confidence 6999999999999999999999999975322 223455676666666 67999999999876543 4999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 95 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---------------------- 150 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---------------------- 150 (311)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----------------------
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc----------------------
Confidence 9999 899999998754 689999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 151 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 151 -----ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp -----TTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -----CCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 45568999999887554332 2346899999999999999999999999999999999999999887665
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+......... ..+.. ......+..+.++|.+||+.
T Consensus 226 ~~~~~~~~~~-~~~~~--------------------------------------------~~~~~~~~~l~~li~~~l~~ 260 (311)
T 3ork_A 226 SVAYQHVRED-PIPPS--------------------------------------------ARHEGLSADLDAVVLKALAK 260 (311)
T ss_dssp HHHHHHHHCC-CCCHH--------------------------------------------HHSTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCC-CCCcc--------------------------------------------cccCCCCHHHHHHHHHHHhc
Confidence 5443333221 11110 11234677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~ 324 (329)
||++||++.++++|+|++.
T Consensus 261 dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 261 NPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SGGGSCSSHHHHHHHHHHH
T ss_pred CHhhChhhHHHHHHHHHHH
Confidence 9999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=323.79 Aligned_cols=245 Identities=26% Similarity=0.389 Sum_probs=188.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-------------CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-------------RN 67 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-------------~~ 67 (329)
||+|+||.||+|++..+++.||+|++...........+|+.++..+ .|+|++++++++.+ .+
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 88 (303)
T 1zy4_A 14 LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-----NHQYVVRYYAAWLERRNFVKPMTAVKKKS 88 (303)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEECCCCCC------CEE
T ss_pred eccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-----CchHHHHHHHHHHhhcchhhhhcccccCC
Confidence 6899999999999999999999999986655566777899888888 57999999887643 46
Q ss_pred ceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCC
Q 020235 68 HICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTP 146 (329)
Q Consensus 68 ~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~ 146 (329)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~----------------- 150 (303)
T 1zy4_A 89 TLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFID----------------- 150 (303)
T ss_dssp EEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC-----------------
T ss_pred ceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEc-----------------
Confidence 789999999 889999998744 3578899999999999999999999999999999999994
Q ss_pred CCCCccccCCCCCCeEEeeCCCCcccCCC-----------------CCcccccCCCCchhHHhcC-CCCCccchHhHHHH
Q 020235 147 KDSSYFKRMPKSSAIKVIDFGSTTYERPD-----------------QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCI 208 (329)
Q Consensus 147 ~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~ 208 (329)
.++.++|+|||.+...... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 151 ----------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (303)
T 1zy4_A 151 ----------ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220 (303)
T ss_dssp ----------TTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHH
T ss_pred ----------CCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHH
Confidence 4556777777777654321 1334689999999999875 68999999999999
Q ss_pred HHHHHhCCCCCCCCch-hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhh
Q 020235 209 LVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH 287 (329)
Q Consensus 209 l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (329)
+|+|++ ||..... ......+.......|+ ..
T Consensus 221 l~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------------~~ 252 (303)
T 1zy4_A 221 FFEMIY---PFSTGMERVNILKKLRSVSIEFPP---------------------------------------------DF 252 (303)
T ss_dssp HHHHHS---CCSSHHHHHHHHHHHHSTTCCCCT---------------------------------------------TC
T ss_pred HHHHHh---ccCCchhHHHHHHhccccccccCc---------------------------------------------cc
Confidence 999997 5543221 1111111111111110 11
Q ss_pred ccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 288 VDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 288 ~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
....+..+.++|++||+.||.+|||++++++||||+...
T Consensus 253 ~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 253 DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred cccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 233456789999999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=328.18 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=180.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+++++++...+..++||||+ +
T Consensus 23 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~ 97 (303)
T 2vwi_A 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-----HHPNIVSYYTSFVVKDELWLVMKLLSG 97 (303)
T ss_dssp CC---CCCEEEEEC----CEEEEECCC----------------CCCCC-----CCTTBCCEEEEEESSSCEEEEEECCTT
T ss_pred eccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-----CCCCEeeEEEEEeecCCcEEEehhccC
Confidence 799999999999999999999999986432 2234455676666666 5799999999999999999999999 8
Q ss_pred CCHHHHHHh------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 78 SSLYDFLRK------NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 78 ~~l~~~l~~------~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 98 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----------------------- 154 (303)
T 2vwi_A 98 GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL----------------------- 154 (303)
T ss_dssp CBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE-----------------------
T ss_pred CchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE-----------------------
Confidence 999999974 122458999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC--------CCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCC
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTH 222 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 222 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 155 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 155 ----GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230 (303)
T ss_dssp ----CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence 45566888888877544322 123468999999999976 56899999999999999999999999876
Q ss_pred chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHh
Q 020235 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGL 302 (329)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 302 (329)
..............+.... ..........++..+.++|.+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~~li~~~ 271 (303)
T 2vwi_A 231 PPMKVLMLTLQNDPPSLET---------------------------------------GVQDKEMLKKYGKSFRKMISLC 271 (303)
T ss_dssp CGGGHHHHHHTSSCCCTTC--------------------------------------------CCCCCCCHHHHHHHHHH
T ss_pred chhhHHHHHhccCCCcccc---------------------------------------ccccchhhhhhhHHHHHHHHHH
Confidence 5543322111110000000 0000111234677899999999
Q ss_pred cccCCCCCCCHHHHhcCCCCCCCC
Q 020235 303 LRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 303 l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
|+.||.+|||++++++||||++..
T Consensus 272 l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 272 LQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCSSGGGSCCHHHHHTSTTC----
T ss_pred ccCChhhCcCHHHHhhChhhhcCC
Confidence 999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=319.83 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=200.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc--ccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--DYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~--~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.||+|++... ....+...+|+.++..+ .|+||+++++++ ...+..++||||
T Consensus 14 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv~e~ 88 (279)
T 2w5a_A 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTNTTLYIVMEY 88 (279)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEEGGGTEEEEEEEC
T ss_pred ccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEecCCCceEEEEEeC
Confidence 68999999999999999999999998743 23445677899999888 569999999977 446789999999
Q ss_pred C-CCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 76 L-GSSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 76 ~-~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+ +++|.+++.... ...+++..++.++.|++.||.|||++| ++|+||||+||++
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~------------------- 149 (279)
T 2w5a_A 89 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL------------------- 149 (279)
T ss_dssp CTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE-------------------
T ss_pred CCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE-------------------
Confidence 9 889999997532 235899999999999999999999999 9999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+.
T Consensus 150 --------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 150 --------DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp --------CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --------cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 456679999999987665443 234689999999999998899999999999999999999999987665
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.+....+.....+ ......+..+.++|.+||+
T Consensus 222 ~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~ 253 (279)
T 2w5a_A 222 KELAGKIREGKFR------------------------------------------------RIPYRYSDELNEIITRMLN 253 (279)
T ss_dssp HHHHHHHHHTCCC------------------------------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHhhcccc------------------------------------------------cCCcccCHHHHHHHHHHcC
Confidence 5444333332110 0112356789999999999
Q ss_pred cCCCCCCCHHHHhcCCCCCCCC
Q 020235 305 YDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
.||++|||+.++++|+|+++..
T Consensus 254 ~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 254 LKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SSGGGSCCHHHHHTSTTCCGGG
T ss_pred CCcccCCCHHHHHhChhhhhhc
Confidence 9999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=317.69 Aligned_cols=237 Identities=27% Similarity=0.400 Sum_probs=198.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+.. ++.||+|++.......+...+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 18 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 18 IGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEECSSCEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ecCCCccEEEEEEecC-CCeEEEEEecccccCHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 6999999999999874 67799999986665667788899999988 5699999999999999999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++ .+.
T Consensus 92 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---------------------------~~~ 143 (269)
T 4hcu_A 92 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---------------------------ENQ 143 (269)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---------------------------GGG
T ss_pred HHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---------------------------CCC
Confidence 999997654 3589999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....+|+.|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus 144 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~ 223 (269)
T 4hcu_A 144 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 223 (269)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC
Confidence 68999999887554432 23456778999999999999999999999999999999 99999887665544443332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..... ....+..+.+++.+||+.||++|||+.
T Consensus 224 ~~~~~------------------------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~ 255 (269)
T 4hcu_A 224 FRLYK------------------------------------------------PRLASTHVYQIMNHCWRERPEDRPAFS 255 (269)
T ss_dssp CCCCC------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCCC------------------------------------------------CCcCCHHHHHHHHHHccCCcccCcCHH
Confidence 11110 123467899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++|
T Consensus 256 ~ll~~ 260 (269)
T 4hcu_A 256 RLLRQ 260 (269)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=320.61 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=187.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|++ +++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 45 lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 45 IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-----RHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp EEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred eecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEECCceEEEEecCC
Confidence 69999999999976 57889999987532 2334567899999988 5799999999999999999999999
Q ss_pred CCCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 GSSLYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 ~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++..... ..+++..++.++.|++.||.|||++| |+||||||+||++
T Consensus 118 ~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll------------------------- 172 (309)
T 3p86_A 118 RGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV------------------------- 172 (309)
T ss_dssp TCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE-------------------------
T ss_pred CCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE-------------------------
Confidence 8899999986431 23899999999999999999999999 9999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....
T Consensus 173 --~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~ 250 (309)
T 3p86_A 173 --DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250 (309)
T ss_dssp --CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred --eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 556679999999987554432 345799999999999999999999999999999999999999987666544333
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....... ......+..+.+||.+||+.||++|
T Consensus 251 ~~~~~~~~-----------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~R 283 (309)
T 3p86_A 251 VGFKCKRL-----------------------------------------------EIPRNLNPQVAAIIEGCWTNEPWKR 283 (309)
T ss_dssp HHHSCCCC-----------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhcCCCC-----------------------------------------------CCCccCCHHHHHHHHHHccCChhhC
Confidence 32211110 0123456789999999999999999
Q ss_pred CCHHHHhc
Q 020235 311 LTAREALR 318 (329)
Q Consensus 311 ~t~~~ll~ 318 (329)
||++++++
T Consensus 284 ps~~~ll~ 291 (309)
T 3p86_A 284 PSFATIMD 291 (309)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=328.20 Aligned_cols=241 Identities=26% Similarity=0.467 Sum_probs=199.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++.+++.||+|++..... ......+|+.++..+.+ .+++++++++++...+..++||
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp CSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEEECSSEEEEEE
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhcc---CCCCceEEEEEEecCCcEEEEE
Confidence 7999999999999999999999999875321 22456679999999854 4699999999999999999999
Q ss_pred ecC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 74 EKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 74 e~~-~-~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|++ + ++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 128 e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~--------------------- 184 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--------------------- 184 (320)
T ss_dssp ECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET---------------------
T ss_pred EcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC---------------------
Confidence 999 4 89999998754 6899999999999999999999999999999999999941
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
.+..++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..
T Consensus 185 -----~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---- 255 (320)
T 3a99_A 185 -----NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---- 255 (320)
T ss_dssp -----TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH----
T ss_pred -----CCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh----
Confidence 34568999999987655433 34578999999999987765 68899999999999999999999652210
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.. +. . ......+..+.+||.+||+.||++
T Consensus 256 --~~--~~---------------------~--------------------------~~~~~~~~~~~~li~~~l~~dp~~ 284 (320)
T 3a99_A 256 --IR--GQ---------------------V--------------------------FFRQRVSSECQHLIRWCLALRPSD 284 (320)
T ss_dssp --HH--CC---------------------C--------------------------CCSSCCCHHHHHHHHHHTCSSGGG
T ss_pred --hc--cc---------------------c--------------------------cccccCCHHHHHHHHHHccCChhh
Confidence 00 00 0 011245678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCCc
Q 020235 310 RLTAREALRHPFFTRDHL 327 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~~ 327 (329)
|||++++++||||++...
T Consensus 285 Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 285 RPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp SCCHHHHHTSGGGSSCCC
T ss_pred CcCHHHHhcCHhhcCccC
Confidence 999999999999998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=321.96 Aligned_cols=243 Identities=21% Similarity=0.321 Sum_probs=191.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|++..+++.||+|++... ........+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 93 (294)
T 4eqm_A 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-----SHQNIVSMIDVDEEDDCYYLVMEYI 93 (294)
T ss_dssp EEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CBTTBCCEEEEEECSSEEEEEEECC
T ss_pred EccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-----CCCCCceEEEeeeeCCeEEEEEeCC
Confidence 68999999999999999999999998532 22334566788887777 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 94 ~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~--------------------------- 144 (294)
T 4eqm_A 94 EGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI--------------------------- 144 (294)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------------------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---------------------------
Confidence 889999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+.....
T Consensus 145 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~ 224 (294)
T 4eqm_A 145 DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH 224 (294)
T ss_dssp CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH
T ss_pred CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 556679999999987655432 2356899999999999999999999999999999999999999876654432221
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
. ....+.. .......++..+.++|.+||+.||++||
T Consensus 225 ~--~~~~~~~------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~ 260 (294)
T 4eqm_A 225 I--QDSVPNV------------------------------------------TTDVRKDIPQSLSNVILRATEKDKANRY 260 (294)
T ss_dssp H--SSCCCCH------------------------------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred h--hccCCCc------------------------------------------chhcccCCCHHHHHHHHHHhcCCHhHcc
Confidence 1 1111110 0111234677899999999999999999
Q ss_pred CHHHHhcCCC
Q 020235 312 TAREALRHPF 321 (329)
Q Consensus 312 t~~~ll~hp~ 321 (329)
+..+.+.+.|
T Consensus 261 ~~~~~l~~~l 270 (294)
T 4eqm_A 261 KTIQEMKDDL 270 (294)
T ss_dssp SSHHHHHHHH
T ss_pred ccHHHHHHHH
Confidence 5544444433
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=323.42 Aligned_cols=245 Identities=21% Similarity=0.257 Sum_probs=195.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+||+|.+..+++.||+|++.... ......+|+.++..+. .|++|+.+++++.+++..++|||+++++|
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~lv~e~~~~~L 91 (330)
T 2izr_A 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLG----SGDGIPQVYYFGPCGKYNAMVLELLGPSL 91 (330)
T ss_dssp CCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHC----SCTTSCCEEEEEEETTEEEEEEECCCCBH
T ss_pred eeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhh----CCCCCCEEEEEEecCCccEEEEEeCCCCH
Confidence 799999999999999999999999987432 3446778999999983 56899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. .....
T Consensus 92 ~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~----------------------~~~~~ 148 (330)
T 2izr_A 92 EDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN----------------------KTQQV 148 (330)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG----------------------TCTTS
T ss_pred HHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC----------------------CCCce
Confidence 99998753 46999999999999999999999999999999999999965442 12234
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH---H
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE---H 227 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~ 227 (329)
++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+ .
T Consensus 149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~ 228 (330)
T 2izr_A 149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER 228 (330)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence 8999999987543322 34579999999999999999999999999999999999999998754322 2
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.....+.+.. ......+ .+.+++..||+.||
T Consensus 229 ~~~i~~~~~~~~~~--------------------------------------------~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 229 YQKIGDTKRATPIE--------------------------------------------VLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp HHHHHHHHHHSCHH--------------------------------------------HHTTTCH-HHHHHHHHHHHCCT
T ss_pred HHHHHhhhccCCHH--------------------------------------------HHhccCh-HHHHHHHHHHhCCC
Confidence 22222211111110 0011233 89999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+|||++++++
T Consensus 264 ~~RP~~~~l~~ 274 (330)
T 2izr_A 264 FEKPDYDYLRK 274 (330)
T ss_dssp TCCCCHHHHHH
T ss_pred CCCCCHHHHHH
Confidence 99999988875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=317.59 Aligned_cols=238 Identities=21% Similarity=0.321 Sum_probs=201.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|.++.++..||+|++.......+...+|+.++..+ .|+||+++++++.+.+..++|||++ +++
T Consensus 21 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 95 (288)
T 3kfa_A 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYIITEFMTYGN 95 (288)
T ss_dssp SGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSEEEEEECCTTEE
T ss_pred cCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCCEEEEEEcCCCCc
Confidence 7999999999999999999999999987666677788999999999 5799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++ .++
T Consensus 96 L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---------------------------~~~ 148 (288)
T 3kfa_A 96 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---------------------------ENH 148 (288)
T ss_dssp HHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---------------------------GGG
T ss_pred HHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---------------------------CCC
Confidence 99999986656799999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.......+...
T Consensus 149 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~ 228 (288)
T 3kfa_A 149 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 228 (288)
T ss_dssp CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence 68999999887665443 22356788999999999999999999999999999999 99999876554433332221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ......+..+.++|.+||+.||++|||++
T Consensus 229 ~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 260 (288)
T 3kfa_A 229 YRM------------------------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFA 260 (288)
T ss_dssp CCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHH
Confidence 111 01124567899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 261 ~~~~ 264 (288)
T 3kfa_A 261 EIHQ 264 (288)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=331.61 Aligned_cols=245 Identities=20% Similarity=0.282 Sum_probs=197.9
Q ss_pred CCCccceEEEEEE-----ecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|. +..+++.||+|+++.. ........+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 79 LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~lv~ 153 (367)
T 3l9p_A 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGVSLQSLPRFILL 153 (367)
T ss_dssp CCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-----CCCCCCeEEEEEecCCCCEEEE
Confidence 7999999999999 4567789999998642 33344567898888888 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 74 EKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 154 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--------------- 218 (367)
T 3l9p_A 154 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--------------- 218 (367)
T ss_dssp ECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---------------
T ss_pred EeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC---------------
Confidence 999 8999999986431 3488999999999999999999999999999999999995432
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccC-----CCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYER-----PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 221 (329)
.+..++|+|||.+.... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 219 ---------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 219 ---------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp ---------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 34569999999986432 12234567899999999999999999999999999999998 9999988
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..+....+.......+ ....+..+.+||.+
T Consensus 290 ~~~~~~~~~i~~~~~~~~------------------------------------------------~~~~~~~l~~li~~ 321 (367)
T 3l9p_A 290 KSNQEVLEFVTSGGRMDP------------------------------------------------PKNCPGPVYRIMTQ 321 (367)
T ss_dssp CCHHHHHHHHHTTCCCCC------------------------------------------------CTTCCHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCC------------------------------------------------CccCCHHHHHHHHH
Confidence 766554443333211110 12356689999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f 322 (329)
||+.||++|||++++++|.++
T Consensus 322 ~l~~dP~~Rps~~eil~~l~~ 342 (367)
T 3l9p_A 322 CWQHQPEDRPNFAIILERIEY 342 (367)
T ss_dssp HTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCHhHCcCHHHHHHHHHH
Confidence 999999999999999988654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=315.07 Aligned_cols=237 Identities=22% Similarity=0.311 Sum_probs=197.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++ ++..||+|+++..........+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 16 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (268)
T 3sxs_A 16 LGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-----SHPKLVKFYGVCSKEYPIYIVTEYISNGC 89 (268)
T ss_dssp EEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred eccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCceEEEEEccCCCc
Confidence 699999999999876 466799999987665667788999999998 5699999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++ +.++
T Consensus 90 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---------------------------~~~~ 141 (268)
T 3sxs_A 90 LLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---------------------------DRDL 141 (268)
T ss_dssp HHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---------------------------CTTC
T ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---------------------------CCCC
Confidence 999998753 358999999999999999999999999999999999999 5566
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 142 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~ 221 (268)
T 3sxs_A 142 CVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG 221 (268)
T ss_dssp CEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred CEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcC
Confidence 79999999887655443 22345677999999999889999999999999999999 99999876665544333222
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..... +...++.+.++|.+||+.||++|||+.
T Consensus 222 ~~~~~------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (268)
T 3sxs_A 222 HRLYR------------------------------------------------PHLASDTIYQIMYSCWHELPEKRPTFQ 253 (268)
T ss_dssp CCCCC------------------------------------------------CTTSCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCC------------------------------------------------CCcChHHHHHHHHHHcCCChhhCcCHH
Confidence 11110 123466899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++|
T Consensus 254 ~ll~~ 258 (268)
T 3sxs_A 254 QLLSS 258 (268)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=316.94 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=197.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|.+..+++.||+|++... .......+|+.++..+. .+++++.+++++.+....++|||+++++|
T Consensus 18 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~~lv~e~~~~~L 92 (298)
T 1csn_A 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR-SDAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGLHNVLVIDLLGPSL 92 (298)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEECC-TTSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EeecCCEEEEEEEECCCCcEEEEEEeccC-CccHHHHHHHHHHHHHh----cCCCCCeEEeecCCCceeEEEEEecCCCH
Confidence 68999999999999999999999998743 33455678888888883 45788888999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. .....
T Consensus 93 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~----------------------~~~~~ 149 (298)
T 1csn_A 93 EDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----------------------KNANM 149 (298)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS----------------------TTTTC
T ss_pred HHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC----------------------CCCCe
Confidence 99998754 35899999999999999999999999999999999999965431 23445
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch---hHH
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN---LEH 227 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~---~~~ 227 (329)
++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+. ...
T Consensus 150 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 229 (298)
T 1csn_A 150 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 229 (298)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred EEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHH
Confidence 9999999987554321 345689999999999998999999999999999999999999987432 222
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.......+ .......++..+.+++.+||+.||
T Consensus 230 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp 265 (298)
T 1csn_A 230 YERIGEKKQSTP--------------------------------------------LRELCAGFPEEFYKYMHYARNLAF 265 (298)
T ss_dssp HHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred HHHHHhhccCcc--------------------------------------------HHHHHhhCcHHHHHHHHHHhcCCc
Confidence 222222111111 011123467789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||++++++
T Consensus 266 ~~RP~~~~l~~ 276 (298)
T 1csn_A 266 DATPDYDYLQG 276 (298)
T ss_dssp TCCCCHHHHHH
T ss_pred ccCCCHHHHHH
Confidence 99999998865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=333.09 Aligned_cols=263 Identities=20% Similarity=0.381 Sum_probs=202.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhH------------------HhHHHHHHHHHHHHhhCCCCCceeeeccc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR------------------EAAMIEIEVLQQLAKHDKGGNRCVQIRNW 62 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------------~~~~~e~~~l~~l~~~~~~~~~i~~l~~~ 62 (329)
||+|+||.||+|.+ +++.||+|++....... ....+|+.++..+ .|+||++++++
T Consensus 39 lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~ 111 (348)
T 2pml_X 39 LNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-----KNEYCLTCEGI 111 (348)
T ss_dssp EECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-----CCTTBCCCSEE
T ss_pred EcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-----CCCCcceEEEE
Confidence 69999999999998 89999999987432211 6677899998888 57999999999
Q ss_pred cccCCceEEEeecC-CCCHHHH------HHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeecccc
Q 020235 63 FDYRNHICIVFEKL-GSSLYDF------LRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYI 134 (329)
Q Consensus 63 ~~~~~~~~lv~e~~-~~~l~~~------l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~ 134 (329)
+.+.+..++||||+ +++|.++ +.......+++..++.++.|++.||.|||+ +|++|+||||+||++
T Consensus 112 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~------ 185 (348)
T 2pml_X 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM------ 185 (348)
T ss_dssp EESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE------
T ss_pred EeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE------
Confidence 99999999999999 7899998 655434679999999999999999999999 999999999999999
Q ss_pred ccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcC-CCCC-ccchHhHHHHHHH
Q 020235 135 KVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGL-GWTY-PCDIWSVGCILVE 211 (329)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~ 211 (329)
+.++.++|+|||.+...... .....||+.|+|||++.+. .++. ++|||||||++|+
T Consensus 186 ---------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 244 (348)
T 2pml_X 186 ---------------------DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244 (348)
T ss_dssp ---------------------CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHH
T ss_pred ---------------------cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHH
Confidence 55667999999998765433 2445789999999999887 5665 9999999999999
Q ss_pred HHhCCCCCCCCch-hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++|..||...+. .+....+.......+.. ..... .+............
T Consensus 245 l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~-------~~~~~~~~~~~~~~ 294 (348)
T 2pml_X 245 MFYNVVPFSLKISLVELFNNIRTKNIEYPLD-----------------------RNHFL-------YPLTNKKSTCSNNF 294 (348)
T ss_dssp HHHSSCSSCCSSCSHHHHHHHTSCCCCCCCS-----------------------SSSST-------TTTCC--------C
T ss_pred HHhCCCCCCCCCcHHHHHHHHhccCcCCccc-----------------------hhhhh-------ccccccccccchhh
Confidence 9999999987665 33333322221111110 00000 00000000111245
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCc
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~~~~ 327 (329)
.+..+.+||.+||+.||.+|||++++++||||++.+.
T Consensus 295 ~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 295 LSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 6788999999999999999999999999999998753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=326.30 Aligned_cols=240 Identities=19% Similarity=0.301 Sum_probs=194.4
Q ss_pred CCCccceEEEEEEec-------CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|++. .++..||+|+++... .......+|+.++..+. .|+||+++++++.+.+..|+
T Consensus 89 LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG----KHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp ESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSC----CCTTBCCEEEEECSSSSCEE
T ss_pred EeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhc----CCCCEeeEEEEEccCCCEEE
Confidence 799999999999874 345689999987532 23456678988888882 46999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-------- 236 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-------- 236 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--------
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--------
Confidence 99999 889999998753 1347889999999999999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+
T Consensus 237 -------------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e 297 (370)
T 2psq_A 237 -------------------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297 (370)
T ss_dssp -------------------CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 556678999999987554322 22356788999999999999999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+.+..+....+.....+ ..+..
T Consensus 298 llt~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~ 329 (370)
T 2psq_A 298 IFTLGGSPYPGIPVEELFKLLKEGHRM------------------------------------------------DKPAN 329 (370)
T ss_dssp HHTTSCCSSTTCCGGGHHHHHHTTCCC------------------------------------------------CCCTT
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCCCC------------------------------------------------CCCCC
Confidence 999 99999876554433322221100 01124
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
++..+.++|.+||+.||++|||+.+++++
T Consensus 330 ~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 330 CTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56789999999999999999999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=323.42 Aligned_cols=237 Identities=23% Similarity=0.286 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|+++.+++ .||||+++.. ........+|+.++..+ .|+||+++++++.+++..++||||
T Consensus 57 lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~ 131 (325)
T 3kul_A 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-----DHPNIIRLEGVVTRGRLAMIVTEY 131 (325)
T ss_dssp EEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECGGGCCEEEEEC
T ss_pred EEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEeCCccEEEeeC
Confidence 6999999999999986655 4999998753 33345677898888888 579999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 132 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll-------------------------- 184 (325)
T 3kul_A 132 MENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV-------------------------- 184 (325)
T ss_dssp CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------------------------
T ss_pred CCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--------------------------
Confidence 9 889999997653 369999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+.+..++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 185 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 185 -DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp -CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred -CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 556679999999987665432 12245678999999999899999999999999999999 9999988766554
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+....... ....++..+.++|.+||..||
T Consensus 264 ~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~dp 295 (325)
T 3kul_A 264 ISSVEEGYRLP------------------------------------------------APMGCPHALHQLMLDCWHKDR 295 (325)
T ss_dssp HHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCC------------------------------------------------CCCCcCHHHHHHHHHHccCCh
Confidence 44433321110 012456789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 296 ~~Rps~~eil~ 306 (325)
T 3kul_A 296 AQRPRFSQIVS 306 (325)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=316.07 Aligned_cols=237 Identities=22% Similarity=0.338 Sum_probs=196.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||++.++ ++..||+|++...........+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 32 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 105 (283)
T 3gen_A 32 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFIITEYMANGC 105 (283)
T ss_dssp CC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEEEECCCTTCB
T ss_pred cCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-----CCCCEeeEEEEEecCCCeEEEEeccCCCc
Confidence 799999999999876 567899999986655667788899999888 5799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++ +.+.
T Consensus 106 L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---------------------------~~~~ 157 (283)
T 3gen_A 106 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---------------------------NDQG 157 (283)
T ss_dssp HHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---------------------------CTTS
T ss_pred HHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---------------------------cCCC
Confidence 999997633 359999999999999999999999999999999999999 5566
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+....+.+.
T Consensus 158 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~ 237 (283)
T 3gen_A 158 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237 (283)
T ss_dssp CEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT
T ss_pred CEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc
Confidence 79999999987654432 23356778999999999899999999999999999998 99999887765554444332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..... ....+..+.++|.+||+.||++|||+.
T Consensus 238 ~~~~~------------------------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ 269 (283)
T 3gen_A 238 LRLYR------------------------------------------------PHLASEKVYTIMYSCWHEKADERPTFK 269 (283)
T ss_dssp CCCCC------------------------------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred cCCCC------------------------------------------------CCcCCHHHHHHHHHHccCChhHCcCHH
Confidence 21111 123456899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++|
T Consensus 270 ~ll~~ 274 (283)
T 3gen_A 270 ILLSN 274 (283)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=317.75 Aligned_cols=239 Identities=18% Similarity=0.271 Sum_probs=192.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-chhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|.++.+++.||+|++.. .........+|+.++..+ .|+||+++++++.+++..++||||+ ++
T Consensus 18 lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 92 (310)
T 3s95_A 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-----EHPNVLKFIGVLYKDKRLNFITEYIKGG 92 (310)
T ss_dssp EECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred ecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCcCcccEEEEEecCCeeEEEEEecCCC
Confidence 6999999999999999999999998764 334456677899988888 5799999999999999999999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.+
T Consensus 93 ~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---------------------------~~~ 144 (310)
T 3s95_A 93 TLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---------------------------REN 144 (310)
T ss_dssp BHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---------------------------CTT
T ss_pred cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---------------------------CCC
Confidence 9999998744 468999999999999999999999999999999999999 455
Q ss_pred CCeEEeeCCCCcccCCCC-----------------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 159 SAIKVIDFGSTTYERPDQ-----------------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 145 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 568888888876543322 135789999999999999999999999999999999999999865
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
....... .. ... ...........++..+.++|.+
T Consensus 225 ~~~~~~~---------~~--------------------------~~~-----------~~~~~~~~~~~~~~~l~~li~~ 258 (310)
T 3s95_A 225 YLPRTMD---------FG--------------------------LNV-----------RGFLDRYCPPNCPPSFFPITVR 258 (310)
T ss_dssp TSCBCTT---------SS--------------------------BCH-----------HHHHHHTCCTTCCTTHHHHHHH
T ss_pred hhhhHHH---------Hh--------------------------hhh-----------hccccccCCCCCCHHHHHHHHH
Confidence 3221000 00 000 0000011123456789999999
Q ss_pred hcccCCCCCCCHHHHhc
Q 020235 302 LLRYDPTDRLTAREALR 318 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~ 318 (329)
||+.||++|||+.++++
T Consensus 259 ~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 259 CCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=325.57 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=192.3
Q ss_pred CCCccceEEEEEE-----ecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-ceEEE
Q 020235 1 MGEGTFGQVLECW-----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-~~~lv 72 (329)
||+|+||.||+|+ +..+++.||+|+++... .......+|+.++..+ ..|+||+++++++.+.+ ..++|
T Consensus 30 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hpniv~~~~~~~~~~~~~~iv 105 (359)
T 3vhe_A 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI----GHHLNVVNLLGACTKPGGPLMVI 105 (359)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSTTSCCEEE
T ss_pred ecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhh----cCCcceeeeeeeeecCCCceEEE
Confidence 6999999999998 56677999999997532 2345677899999988 35699999999987754 59999
Q ss_pred eecC-CCCHHHHHHhCCC--------------------------------------------------------------
Q 020235 73 FEKL-GSSLYDFLRKNNY-------------------------------------------------------------- 89 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~-------------------------------------------------------------- 89 (329)
|||+ +++|.+++.....
T Consensus 106 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (359)
T 3vhe_A 106 VEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDL 185 (359)
T ss_dssp EECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CT
T ss_pred EEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccch
Confidence 9999 8999999986532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCC
Q 020235 90 --RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG 167 (329)
Q Consensus 90 --~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg 167 (329)
..+++..++.++.|++.||.|||++||+||||||+|||++ .++.++|+|||
T Consensus 186 ~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---------------------------~~~~~kl~Dfg 238 (359)
T 3vhe_A 186 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---------------------------EKNVVKICDFG 238 (359)
T ss_dssp TTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------------GGGCEEECCCG
T ss_pred hccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---------------------------CCCcEEEEecc
Confidence 1288999999999999999999999999999999999994 44568888888
Q ss_pred CCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChh
Q 020235 168 STTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQH 241 (329)
Q Consensus 168 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 241 (329)
.+....... ....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+............+
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-- 316 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR-- 316 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--
T ss_pred ceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--
Confidence 887543332 23467889999999999999999999999999999998 9999987654433222222111100
Q ss_pred HHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 242 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.....+..+.++|.+||+.||++|||+.++++|
T Consensus 317 ---------------------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ---------------------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 012356789999999999999999999999876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=318.33 Aligned_cols=246 Identities=27% Similarity=0.443 Sum_probs=191.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||.||+|.+. +++.||+|++... ........+|+.++..+.+ .+++|+++++++.+.+..++|||+.+
T Consensus 36 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~---~~~~iv~~~~~~~~~~~~~lv~e~~~ 111 (313)
T 3cek_A 36 IGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ---HSDKIIRLYDYEITDQYIYMVMECGN 111 (313)
T ss_dssp EECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGG---GCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred ecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccc---cCCceEEEEEEeecCCEEEEEEecCC
Confidence 699999999999986 4889999998643 2334566789999999965 35899999999999999999999779
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 112 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---------------------------- 161 (313)
T 3cek_A 112 IDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV---------------------------- 161 (313)
T ss_dssp EEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----------------------------
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----------------------------
Confidence 99999998764 689999999999999999999999999999999999993
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhc-----------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILG-----------LGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 162 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 2458999999887654432 23468999999999976 3678899999999999999999999976
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
...... .+.....+. .... .....+..+.++|.+
T Consensus 242 ~~~~~~--~~~~~~~~~------------------~~~~--------------------------~~~~~~~~l~~li~~ 275 (313)
T 3cek_A 242 IINQIS--KLHAIIDPN------------------HEIE--------------------------FPDIPEKDLQDVLKC 275 (313)
T ss_dssp CCSHHH--HHHHHHCTT------------------SCCC--------------------------CCCCSCHHHHHHHHH
T ss_pred HHHHHH--HHHHHHhcc------------------cccC--------------------------CcccchHHHHHHHHH
Confidence 433211 111111100 0000 112345679999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||+.||++|||+.++++||||+...
T Consensus 276 ~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 276 CLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HccCCcccCcCHHHHhcCccccCCC
Confidence 9999999999999999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=336.63 Aligned_cols=249 Identities=22% Similarity=0.282 Sum_probs=188.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+|+. ....+++.||||++.... .....+|+.++..+ ..|+||+++++++.+.+..++|||+++++|
T Consensus 32 LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l----~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L 104 (432)
T 3p23_A 32 LGHGAEGTIVY-RGMFDNRDVAVKRILPEC--FSFADREVQLLRES----DEHPNVIRYFCTEKDRQFQYIAIELCAATL 104 (432)
T ss_dssp EEECGGGCEEE-EEESSSSEEEEEEECTTT--EEECHHHHHHHHHS----CCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred eecCcCEEEEE-EEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhc----cCCCCcCeEEEEEecCCEEEEEEECCCCCH
Confidence 69999999764 445678999999987432 23456788888877 257999999999999999999999998899
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ...++..+..++.|++.||.|||++||+||||||+|||+..++. .....
T Consensus 105 ~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~----------------------~~~~~ 161 (432)
T 3p23_A 105 QEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA----------------------HGKIK 161 (432)
T ss_dssp HHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT----------------------TTBCC
T ss_pred HHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC----------------------CCcee
Confidence 99998754 23455567789999999999999999999999999999954321 23456
Q ss_pred eEEeeCCCCcccCCCC------CcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 020235 161 IKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAM 230 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 230 (329)
++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus 162 ~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~- 240 (432)
T 3p23_A 162 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI- 240 (432)
T ss_dssp EEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-
T ss_pred EEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-
Confidence 8899999987665332 33579999999999974 457789999999999999999 999996543322111
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
..+.... .... .....+..+.+||.+||+.||++|
T Consensus 241 ---~~~~~~~-------------------~~~~-----------------------~~~~~~~~~~~li~~~L~~dP~~R 275 (432)
T 3p23_A 241 ---LLGACSL-------------------DCLH-----------------------PEKHEDVIARELIEKMIAMDPQKR 275 (432)
T ss_dssp ---HTTCCCC-------------------TTSC-----------------------TTCHHHHHHHHHHHHHSCSSGGGS
T ss_pred ---HhccCCc-------------------cccC-----------------------ccccccHHHHHHHHHHHhCCHhhC
Confidence 1111000 0000 001234568899999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||+.++++||||.+.
T Consensus 276 ps~~evl~hp~f~~~ 290 (432)
T 3p23_A 276 PSAKHVLKHPFFWSL 290 (432)
T ss_dssp CCHHHHHTSTTTCCH
T ss_pred CCHHHHHhCccccCh
Confidence 999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=321.94 Aligned_cols=245 Identities=18% Similarity=0.236 Sum_probs=181.2
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCce-----
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI----- 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~----- 69 (329)
||+|+||+||+|+++.++. .||+|+++.. ........+|+.++..+ .|+||+++++++......
T Consensus 31 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-----DHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-----CCTTBCCCCEEEECC-------C
T ss_pred ecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-----CCCceehhhceeeccccccCCCc
Confidence 6999999999999887765 8999998743 23345667888888887 679999999998876654
Q ss_pred -EEEeecC-CCCHHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 70 -CIVFEKL-GSSLYDFLRKNN----YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 70 -~lv~e~~-~~~l~~~l~~~~----~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli--------------- 170 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML--------------- 170 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---------------
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---------------
Confidence 9999999 889999996532 1258999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCC
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEA 217 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~ 217 (329)
+.++.++|+|||.+....... ....+++.|+|||.+.+..++.++|||||||++|+|++ |..
T Consensus 171 ------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 171 ------------AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp ------------CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ------------cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCC
Confidence 455679999999987654432 22346778999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHH
Q 020235 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297 (329)
Q Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (329)
||.+.+..+....+...... ......+..+.+
T Consensus 239 p~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~ 270 (323)
T 3qup_A 239 PYAGIENAEIYNYLIGGNRL------------------------------------------------KQPPECMEEVYD 270 (323)
T ss_dssp TTTTCCGGGHHHHHHTTCCC------------------------------------------------CCCTTCCHHHHH
T ss_pred CccccChHHHHHHHhcCCCC------------------------------------------------CCCCccCHHHHH
Confidence 99876665443333221110 001245678999
Q ss_pred HHHHhcccCCCCCCC-------HHHHhcCCCCCCC
Q 020235 298 LLQGLLRYDPTDRLT-------AREALRHPFFTRD 325 (329)
Q Consensus 298 ll~~~l~~dP~~R~t-------~~~ll~hp~f~~~ 325 (329)
||.+||+.||++||| ++++++|||+...
T Consensus 271 li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 271 LMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999999999999999 7889999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=338.04 Aligned_cols=238 Identities=21% Similarity=0.318 Sum_probs=200.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.++..||||+++......+...+|+.++..+ .|+||+++++++.+.+..++||||+ +++
T Consensus 228 lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~l~~~~~~~~~~~lv~E~~~~g~ 302 (495)
T 1opk_A 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYIITEFMTYGN 302 (495)
T ss_dssp SGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred ecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-----CCCCEeeEEEEEecCCcEEEEEEccCCCC
Confidence 7999999999999999999999999986655667788999999999 5799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++ .+.
T Consensus 303 L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---------------------------~~~ 355 (495)
T 1opk_A 303 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---------------------------ENH 355 (495)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------------------GGG
T ss_pred HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---------------------------CCC
Confidence 99999886656799999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 356 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~ 435 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435 (495)
T ss_dssp CEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred cEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 68888888887654332 22345678999999999889999999999999999999 99999876654433322221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... ..+..++..+.+||.+||+.||++|||+.
T Consensus 436 ~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 467 (495)
T 1opk_A 436 YRM------------------------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFA 467 (495)
T ss_dssp CCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHH
Confidence 100 01224567899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 468 el~~ 471 (495)
T 1opk_A 468 EIHQ 471 (495)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=322.61 Aligned_cols=240 Identities=19% Similarity=0.279 Sum_probs=196.4
Q ss_pred CCCccceEEEEEEecCC-------CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRER-------KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||+||+|++..+ +..||+|+++... .......+|+.++..+ ..|+||+++++++.+.+..++
T Consensus 77 LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEE
T ss_pred EecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHh----cCCchhhhheeeeccCCceEE
Confidence 69999999999997543 3579999987532 2335677899999888 256999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------- 224 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-------- 224 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--------
Confidence 99999 889999998754 1358999999999999999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+
T Consensus 225 -------------------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 285 (382)
T 3tt0_A 225 -------------------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 285 (382)
T ss_dssp -------------------CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred -------------------cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHH
Confidence 456679999999987654332 23456788999999999999999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+.+..+....+.+..... ....
T Consensus 286 llt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 317 (382)
T 3tt0_A 286 IFTLGGSPYPGVPVEELFKLLKEGHRMD------------------------------------------------KPSN 317 (382)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCCC------------------------------------------------CCSS
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCC------------------------------------------------CCcc
Confidence 999 999998766554443333221110 0124
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.+||.+||+.||++|||+++++++
T Consensus 318 ~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 318 CTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56789999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.30 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=177.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhH--HhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYR--EAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+|+.||+|++....... .....|...+.. ...|+||+++++++.+.+..++||||+++
T Consensus 33 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~----~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (318)
T 2dyl_A 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLK----SHDCPYIVQCFGTFITNTDVFIAMELMGT 108 (318)
T ss_dssp C------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHH----TTTCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred eeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHH----hcCCCceeeEEEEEecCCcEEEEEeccCC
Confidence 799999999999999999999999987533221 222233332222 13679999999999999999999999977
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
.+..+..... ..+++..++.++.|++.||.|||++ |++|+||||+||++ +.
T Consensus 109 ~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---------------------------~~ 160 (318)
T 2dyl_A 109 CAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---------------------------DE 160 (318)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---------------------------CT
T ss_pred cHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---------------------------CC
Confidence 7776665432 4689999999999999999999995 99999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCch-hHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHEN-LEHLA 229 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~ 229 (329)
++.++|+|||.+....... ....||+.|+|||++. ...++.++|||||||++|+|++|..||..... .+...
T Consensus 161 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 240 (318)
T 2dyl_A 161 RGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT 240 (318)
T ss_dssp TSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH
T ss_pred CCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH
Confidence 6678999999886554332 3457899999999995 44688999999999999999999999976432 22222
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.....+. .+ .....+..+.++|.+||+.||.+
T Consensus 241 ~~~~~~~~~----------------------~~------------------------~~~~~~~~l~~li~~~l~~dp~~ 274 (318)
T 2dyl_A 241 KVLQEEPPL----------------------LP------------------------GHMGFSGDFQSFVKDCLTKDHRK 274 (318)
T ss_dssp HHHHSCCCC----------------------CC------------------------SSSCCCHHHHHHHHHHTCSCTTT
T ss_pred HHhccCCCC----------------------CC------------------------ccCCCCHHHHHHHHHHccCChhH
Confidence 222211110 00 01235678999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
|||++++++||||++.
T Consensus 275 Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 275 RPKYNKLLEHSFIKRY 290 (318)
T ss_dssp SCCHHHHTTSHHHHHH
T ss_pred CcCHHHHhhCHHHHhc
Confidence 9999999999999753
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=319.07 Aligned_cols=242 Identities=24% Similarity=0.449 Sum_probs=192.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++.+++.||+|++..... ......+|+.++..+.... .|+||+++++++.+.+..++||
T Consensus 39 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-~h~~i~~~~~~~~~~~~~~~v~ 117 (312)
T 2iwi_A 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG-GHPGVIRLLDWFETQEGFMLVL 117 (312)
T ss_dssp EEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSC-CCSSBCCEEEEC-----CEEEE
T ss_pred EEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccC-CCCCeeeEEEEEecCCeEEEEE
Confidence 6899999999999999999999999874321 2334457888888885422 5799999999999999999999
Q ss_pred ec-C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 74 EK-L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 74 e~-~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|+ + +++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 118 e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---------------------- 173 (312)
T 2iwi_A 118 ERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID---------------------- 173 (312)
T ss_dssp ECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE----------------------
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe----------------------
Confidence 99 5 899999998754 689999999999999999999999999999999999995
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCC-CccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWT-YPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..++.++|+|||.+....... ....||..|+|||++.+..+. .++|||||||++|+|++|+.||.....
T Consensus 174 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----- 244 (312)
T 2iwi_A 174 ----LRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----- 244 (312)
T ss_dssp ----TTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred ----CCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence 144568999999887655443 445789999999999877664 589999999999999999999965221
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.... . ......+..+.++|.+||+.||++
T Consensus 245 -~~~~~-----------------------~--------------------------~~~~~~~~~~~~li~~~l~~~p~~ 274 (312)
T 2iwi_A 245 -ILEAE-----------------------L--------------------------HFPAHVSPDCCALIRRCLAPKPSS 274 (312)
T ss_dssp -HHHTC-----------------------C--------------------------CCCTTSCHHHHHHHHHHTCSSTTT
T ss_pred -Hhhhc-----------------------c--------------------------CCcccCCHHHHHHHHHHccCChhh
Confidence 00000 0 011235678999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|||++++++||||++..
T Consensus 275 Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 275 RPSLEEILLDPWMQTPA 291 (312)
T ss_dssp SCCHHHHHHSTTTCC--
T ss_pred CcCHHHHhcChhhcCch
Confidence 99999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=311.62 Aligned_cols=241 Identities=21% Similarity=0.258 Sum_probs=192.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhh--------HHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKY--------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||+||+|++..+++.||+|++...... .....+|+.++..+ .|+||+++++++.+.. ++|
T Consensus 27 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~--~lv 99 (287)
T 4f0f_A 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-----NHPNIVKLYGLMHNPP--RMV 99 (287)
T ss_dssp CCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-----CCTTBCCEEEEETTTT--EEE
T ss_pred cccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-----CCCCchhhheeecCCC--eEE
Confidence 79999999999999999999999998643221 14567788888887 5799999999987665 799
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++| |+|+||||+||+++.++.
T Consensus 100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~---------------- 162 (287)
T 4f0f_A 100 MEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE---------------- 162 (287)
T ss_dssp EECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT----------------
T ss_pred EEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC----------------
Confidence 9999 899999987654 46899999999999999999999999 999999999999954331
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHh--cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVIL--GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH 227 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 227 (329)
.....++|+|||.+...........||+.|+|||++. ...++.++|||||||++|+|++|..||...+....
T Consensus 163 ------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~ 236 (287)
T 4f0f_A 163 ------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI 236 (287)
T ss_dssp ------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH
T ss_pred ------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH
Confidence 2233489999999987666656678999999999984 34578899999999999999999999976544322
Q ss_pred --HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 228 --LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 228 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
...+.. .+..+ ......+..+.++|.+||+.
T Consensus 237 ~~~~~~~~-~~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~ 269 (287)
T 4f0f_A 237 KFINMIRE-EGLRP----------------------------------------------TIPEDCPPRLRNVIELCWSG 269 (287)
T ss_dssp HHHHHHHH-SCCCC----------------------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHhc-cCCCC----------------------------------------------CCCcccCHHHHHHHHHHhcC
Confidence 111111 11000 11234567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||++|||++++++
T Consensus 270 dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 270 DPKKRPHFSYIVK 282 (287)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=309.87 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=185.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+. ++.||+|+++.... ..+...+|+.++..+ .|+||+++++++.+++..++||||
T Consensus 15 lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~ 87 (271)
T 3dtc_A 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-----KHPNIIALRGVCLKEPNLCLVMEF 87 (271)
T ss_dssp EEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHC-----CCTTBCCEEEEECCC--CEEEEEC
T ss_pred eccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-----CCCCEeeEEEEEecCCceEEEEEc
Confidence 689999999999875 78899999874322 235567788888888 579999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC---MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~---i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+ +++|.+++... .+++..++.++.|++.||.|||++| ++|+||||+||+++....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~------------------ 146 (271)
T 3dtc_A 88 ARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE------------------ 146 (271)
T ss_dssp CTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS------------------
T ss_pred CCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc------------------
Confidence 9 89999998653 5999999999999999999999999 899999999999954210
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.....+..++|+|||.+....... ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.......
T Consensus 147 -~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 225 (271)
T 3dtc_A 147 -NGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG 225 (271)
T ss_dssp -SSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH
T ss_pred -cccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh
Confidence 000236779999999997655443 345789999999999998999999999999999999999999987665443332
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....... ......+..+.++|.+||+.||++|
T Consensus 226 ~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~R 258 (271)
T 3dtc_A 226 VAMNKLAL-----------------------------------------------PIPSTCPEPFAKLMEDCWNPDPHSR 258 (271)
T ss_dssp HHTSCCCC-----------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhcCCCCC-----------------------------------------------CCCcccCHHHHHHHHHHhcCCcccC
Confidence 22111100 0123456789999999999999999
Q ss_pred CCHHHHhcC
Q 020235 311 LTAREALRH 319 (329)
Q Consensus 311 ~t~~~ll~h 319 (329)
||+.++++|
T Consensus 259 ps~~e~l~~ 267 (271)
T 3dtc_A 259 PSFTNILDQ 267 (271)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=327.72 Aligned_cols=237 Identities=21% Similarity=0.366 Sum_probs=194.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|.++.+++.||+|+++.. ........+|+.++..+ .|+||+++++++...+..++||||+ +
T Consensus 122 lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~lv~e~~~~ 196 (377)
T 3cbl_A 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-----SHPNIVRLIGVCTQKQPIYIVMELVQG 196 (377)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-----CCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred eccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEecCCCcEEEEEcCCC
Confidence 69999999999999999999999998743 22334667899998888 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+ +.
T Consensus 197 g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---------------------------~~ 248 (377)
T 3cbl_A 197 GDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---------------------------TE 248 (377)
T ss_dssp CBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------CT
T ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---------------------------cC
Confidence 99999998643 358999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 231 (329)
++.++|+|||.+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 249 ~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~ 328 (377)
T 3cbl_A 249 KNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328 (377)
T ss_dssp TCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH
T ss_pred CCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 5678889998886543322 12235678999999998889999999999999999998 99999876655443332
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
...... . .+...+..+.++|.+||+.||++||
T Consensus 329 ~~~~~~----------------------~--------------------------~~~~~~~~l~~li~~cl~~dP~~Rp 360 (377)
T 3cbl_A 329 EKGGRL----------------------P--------------------------CPELCPDAVFRLMEQCWAYEPGQRP 360 (377)
T ss_dssp HTTCCC----------------------C--------------------------CCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HcCCCC----------------------C--------------------------CCCCCCHHHHHHHHHHcCCCchhCc
Confidence 221100 0 0123466899999999999999999
Q ss_pred CHHHHhc
Q 020235 312 TAREALR 318 (329)
Q Consensus 312 t~~~ll~ 318 (329)
|++++++
T Consensus 361 s~~~i~~ 367 (377)
T 3cbl_A 361 SFSTIYQ 367 (377)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 9999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=307.95 Aligned_cols=237 Identities=26% Similarity=0.388 Sum_probs=196.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+. +++.||+|++.......+...+|+.++..+ .|+||+++++++.+.+..++|||++ +++
T Consensus 16 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 16 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred ecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 689999999999987 567899999987655567788899999888 5799999999999999999999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++ .+.
T Consensus 90 L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---------------------------~~~ 141 (267)
T 3t9t_A 90 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---------------------------ENQ 141 (267)
T ss_dssp HHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---------------------------GGG
T ss_pred HHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---------------------------CCC
Confidence 999998754 3589999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||++.+..++.++|+||||+++|+|++ |..||.+.+..+....+...
T Consensus 142 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~ 221 (267)
T 3t9t_A 142 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221 (267)
T ss_dssp CEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred CEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcC
Confidence 68899999887554321 23456778999999998899999999999999999999 89999876655444333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .....+..+.+++.+||+.||++|||++
T Consensus 222 ~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 253 (267)
T 3t9t_A 222 FRLY------------------------------------------------KPRLASTHVYQIMNHCWRERPEDRPAFS 253 (267)
T ss_dssp CCCC------------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CcCC------------------------------------------------CCccCcHHHHHHHHHHccCChhhCcCHH
Confidence 1110 0123466899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
+++++
T Consensus 254 ~ll~~ 258 (267)
T 3t9t_A 254 RLLRQ 258 (267)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=310.71 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=189.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+||+|++..+++.||+|++... .......+|..++..+.+ ++++..+..++...+..++|||+++++|
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~~~~~~lv~e~~~~~L 91 (296)
T 4hgt_A 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK-TKHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYNVMVMELLGPSL 91 (296)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTT----STTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred ecCCCCeEEEEEEEcCCCceEEEEeeccc-ccchHHHHHHHHHHHhcC----CCCCCeeeeecCCCCceEEEEEccCCCH
Confidence 69999999999999999999999987643 234456789999988843 3455555666677889999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+... +.+..
T Consensus 92 ~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~------------------------~~~~~ 146 (296)
T 4hgt_A 92 EDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------------KKGNL 146 (296)
T ss_dssp HHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG------------------------GGTTC
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc------------------------CCCCe
Confidence 99998643 369999999999999999999999999999999999999422 23456
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH---H
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE---H 227 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~ 227 (329)
++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+... .
T Consensus 147 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 4hgt_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhh
Confidence 8899999886544322 24578999999999999999999999999999999999999997643321 1
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.......+ .......++..+.++|.+||+.||
T Consensus 227 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p 262 (296)
T 4hgt_A 227 YERISEKKMSTP--------------------------------------------IEVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred hhhhhcccccch--------------------------------------------hhhhhccCCHHHHHHHHHHHhcCC
Confidence 111111110000 011123456789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||++++++
T Consensus 263 ~~Rpt~~~l~~ 273 (296)
T 4hgt_A 263 DDKPDYSYLRQ 273 (296)
T ss_dssp TCCCCHHHHHH
T ss_pred CCCCCHHHHHH
Confidence 99999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=309.52 Aligned_cols=244 Identities=23% Similarity=0.276 Sum_probs=190.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|++..+++.||+|++.... ......+|+.++..+.+ ++++..+..+....+..++||||++++|
T Consensus 17 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~----~~~i~~~~~~~~~~~~~~lv~e~~~~~L 91 (296)
T 3uzp_A 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQG----GVGIPTIRWCGAEGDYNVMVMELLGPSL 91 (296)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTT----STTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhc----CCCCCccccccCCCCceEEEEEecCCCH
Confidence 689999999999999999999999987533 34457789999999853 2344555555567788999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++..+ +.+..
T Consensus 92 ~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~------------------------~~~~~ 146 (296)
T 3uzp_A 92 EDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------------KKGNL 146 (296)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------------------------GGTTC
T ss_pred HHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC------------------------CCCCe
Confidence 99998543 469999999999999999999999999999999999999421 24456
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh---HH
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL---EH 227 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~ 227 (329)
++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..
T Consensus 147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 226 (296)
T 3uzp_A 147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 226 (296)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence 8899999886544322 3457899999999999999999999999999999999999999764321 12
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.......+ .......++..+.+++.+||+.||
T Consensus 227 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~l~~li~~~l~~dp 262 (296)
T 3uzp_A 227 YERISEKKMSTP--------------------------------------------IEVLCKGYPSEFATYLNFCRSLRF 262 (296)
T ss_dssp HHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHHHHHHHTSCT
T ss_pred hhhhcccccCCc--------------------------------------------hHHHHhhCCHHHHHHHHHHHhcCc
Confidence 222111110111 011123466789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||++++++
T Consensus 263 ~~Rps~~~l~~ 273 (296)
T 3uzp_A 263 DDKPDYSYLRQ 273 (296)
T ss_dssp TCCCCHHHHHH
T ss_pred CcCCCHHHHHH
Confidence 99999998875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=328.47 Aligned_cols=235 Identities=23% Similarity=0.313 Sum_probs=192.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-CceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-~~~~lv~e~~-~~ 78 (329)
||+|+||.||++.++ ++.||||+++... ..+...+|+.++..+ .|+||+++++++... +..++||||+ ++
T Consensus 201 lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp EEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTC-----CCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred ecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhc-----cCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 699999999999875 6789999998543 456778899999888 679999999987655 4799999999 89
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+ +.+
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---------------------------~~~ 325 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---------------------------SED 325 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---------------------------CTT
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---------------------------CCC
Confidence 99999987654457999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
+.++|+|||.+...........++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+....+.+....
T Consensus 326 ~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~ 405 (450)
T 1k9a_A 326 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 405 (450)
T ss_dssp SCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC
T ss_pred CCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 67999999998765544444467889999999999999999999999999999998 99999876554443333221100
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
..+..++..+.++|.+||+.||++|||+.+++
T Consensus 406 ------------------------------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~ 437 (450)
T 1k9a_A 406 ------------------------------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLR 437 (450)
T ss_dssp ------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------------------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 01234567899999999999999999999987
Q ss_pred c
Q 020235 318 R 318 (329)
Q Consensus 318 ~ 318 (329)
+
T Consensus 438 ~ 438 (450)
T 1k9a_A 438 E 438 (450)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=311.97 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=194.6
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+ ..+++.||+|+++... ...+...+|+.++..+ ..|+||+++++++.+++..++||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL----GNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred hCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhc----ccCCCeeeEEEEEecCCCcEEEE
Confidence 69999999999985 4677899999987532 2346677899999888 35699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 74 EKL-GSSLYDFLRKNNY----------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~----------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~------- 179 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT------- 179 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-------
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc-------
Confidence 999 8899999987542 2489999999999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 180 --------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 239 (313)
T 1t46_A 180 --------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (313)
T ss_dssp --------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --------------------CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHH
Confidence 44568888888887655443 23456788999999999899999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+.................+ ....
T Consensus 240 llt~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~ 272 (313)
T 1t46_A 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRML-----------------------------------------------SPEH 272 (313)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCC-----------------------------------------------CCTT
T ss_pred HHhCCCCCCCcccchhHHHHHhccCCCCC-----------------------------------------------Cccc
Confidence 998 9999987654433222222110000 0123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.++|.+||+.||.+|||+.+++++
T Consensus 273 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 273 APAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 56789999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=330.54 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=189.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+||.+ ...+|+.||||++... ..+...+|+.++..+. .||||+++++++.+++..++|||+++++|
T Consensus 23 LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~----~HpnIv~~~~~~~~~~~~~lv~E~~~gsL 95 (434)
T 2rio_A 23 LGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESD----DHPNVIRYYCSETTDRFLYIALELCNLNL 95 (434)
T ss_dssp EEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHT----TSTTBCCEEEEEECSSEEEEEECCCSEEH
T ss_pred EeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhcc----CCCCcCeEEEEEecCCeEEEEEecCCCCH
Confidence 699999999875 4567999999998743 2445678998888762 56999999999999999999999998899
Q ss_pred HHHHHhCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 81 YDFLRKNNYRS-----FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 81 ~~~l~~~~~~~-----l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
.+++....... .++..++.++.|++.||+|||++||+||||||+|||++.++...... ...
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~--------------~~~ 161 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ--------------QTG 161 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC--------------TTC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc--------------ccC
Confidence 99998754211 12234577999999999999999999999999999997654211100 001
Q ss_pred CCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhc-------CCCCCccchHhHHHHHHHHHh-CCCCCC
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGCILVELCT-GEALFQ 220 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~p~~ 220 (329)
..+..++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 345679999999998665432 23479999999999976 568899999999999999999 999997
Q ss_pred CCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHH
Q 020235 221 THENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300 (329)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 300 (329)
...... ..+.......+. .. . ......+.++.+||.
T Consensus 242 ~~~~~~--~~i~~~~~~~~~------------------~~------------------~------~~~~~~~~~~~~li~ 277 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDE------------------MK------------------C------LHDRSLIAEATDLIS 277 (434)
T ss_dssp STTTHH--HHHHHTCCCCCC------------------CT------------------T------CCCHHHHHHHHHHHH
T ss_pred CchhhH--HHHhcCCCCccc------------------cc------------------c------cccccchHHHHHHHH
Confidence 643322 111111111000 00 0 001124568999999
Q ss_pred HhcccCCCCCCCHHHHhcCCCCCCC
Q 020235 301 GLLRYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 301 ~~l~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
+||+.||++|||+.++++||||...
T Consensus 278 ~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 278 QMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred HHhhCChhhCCCHHHHHhCCccCCc
Confidence 9999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=311.32 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=192.8
Q ss_pred CCCccceEEEEEEecCCC-------ceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERK-------EMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||+||+|.++.++ ..||+|++.... ...+...+|+.++..+ .|+||+++++++.+++..++|
T Consensus 16 lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv 90 (289)
T 4fvq_A 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-----SHKHLVLNYGVCVCGDENILV 90 (289)
T ss_dssp EEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-----CCTTBCCEEEEECCTTCCEEE
T ss_pred eccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEEeCCCCEEE
Confidence 689999999999998877 469999986432 3446677888888888 579999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.++..+..
T Consensus 91 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~-------------- 155 (289)
T 4fvq_A 91 QEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG-------------- 155 (289)
T ss_dssp EECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT--------------
T ss_pred EECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc--------------
Confidence 9999 899999998754 348999999999999999999999999999999999999876543332
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhC-CCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTG-EALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~ 229 (329)
....++|+|||.+...... ....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+.....
T Consensus 156 -----~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~- 228 (289)
T 4fvq_A 156 -----NPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL- 228 (289)
T ss_dssp -----BCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-
T ss_pred -----ccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-
Confidence 2234899999998755433 23468899999999987 6689999999999999999995 4555443332221
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
......... ....+..+.++|.+||+.||++
T Consensus 229 ~~~~~~~~~-------------------------------------------------~~~~~~~l~~li~~~l~~dp~~ 259 (289)
T 4fvq_A 229 QFYEDRHQL-------------------------------------------------PAPKAAELANLINNCMDYEPDH 259 (289)
T ss_dssp HHHHTTCCC-------------------------------------------------CCCSSCTTHHHHHHHSCSSGGG
T ss_pred HHhhccCCC-------------------------------------------------CCCCCHHHHHHHHHHcCCChhH
Confidence 111111111 1223557889999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||++++++|
T Consensus 260 Rps~~~ll~~ 269 (289)
T 4fvq_A 260 RPSFRAIIRD 269 (289)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=315.83 Aligned_cols=239 Identities=19% Similarity=0.320 Sum_probs=193.4
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+. .+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~ 105 (314)
T 2ivs_A 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-----NHPHVIKLYGACSQDGPLLLIV 105 (314)
T ss_dssp EEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred ecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-----CCCceeeEEEEEecCCceEEEE
Confidence 689999999999873 456899999987432 2345567788888877 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEee
Q 020235 74 EKL-GSSLYDFLRKNNY----------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~----------------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~ 130 (329)
||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~- 184 (314)
T 2ivs_A 106 EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA- 184 (314)
T ss_dssp ECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE-
T ss_pred eecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEc-
Confidence 999 8999999987532 2388999999999999999999999999999999999994
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhH
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 205 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (329)
.+..++|+|||.+....... ....+|+.|+|||++.+..++.++|||||
T Consensus 185 --------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 238 (314)
T 2ivs_A 185 --------------------------EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238 (314)
T ss_dssp --------------------------TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred --------------------------CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHH
Confidence 44568889999887554432 23356788999999999889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 206 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 206 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
||++|+|++ |..||.+.+.......+......
T Consensus 239 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------- 271 (314)
T 2ivs_A 239 GVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM----------------------------------------------- 271 (314)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC-----------------------------------------------
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC-----------------------------------------------
Confidence 999999999 99999876554433222221100
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.....++..+.++|.+||+.||++|||+.+++++
T Consensus 272 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 272 -ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0112456789999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=317.91 Aligned_cols=239 Identities=21% Similarity=0.305 Sum_probs=193.9
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|++. .+++.||+|+++... .......+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 55 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~ 129 (343)
T 1luf_A 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGVCAVGKPMCLLF 129 (343)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred eeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEccCCceEEEE
Confidence 689999999999987 456899999987432 2345667899888888 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEee
Q 020235 74 EKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~----------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~ 130 (329)
||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 130 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~- 208 (343)
T 1luf_A 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG- 208 (343)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred ecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEC-
Confidence 999 889999998742 14689999999999999999999999999999999999994
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhH
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSV 205 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (329)
.++.++|+|||.+...... .....+|+.|+|||++.+..++.++|||||
T Consensus 209 --------------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 262 (343)
T 1luf_A 209 --------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 262 (343)
T ss_dssp --------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred --------------------------CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH
Confidence 4456888999987644322 133467889999999999899999999999
Q ss_pred HHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 206 GCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 206 G~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
||++|+|++ |..||.+.+..+....+......
T Consensus 263 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~----------------------------------------------- 295 (343)
T 1luf_A 263 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----------------------------------------------- 295 (343)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------------------------
T ss_pred HHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC-----------------------------------------------
Confidence 999999999 99999876655444333221100
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.....++..+.++|.+||+.||++|||+.+++++
T Consensus 296 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 296 -ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 0112356789999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=317.36 Aligned_cols=241 Identities=21% Similarity=0.296 Sum_probs=191.8
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+ ..++..||+|++.... .......+|+.++..+ ..||||+++++++...+..++||
T Consensus 53 lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL----GSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhh----cCCCCeeeEEEEEeeCCccEEEE
Confidence 69999999999997 3456789999987432 2345677899999888 25699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeec
Q 020235 74 EKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~---------------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~ 131 (329)
||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~-- 206 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-- 206 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEE--
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEc--
Confidence 999 8999999987542 2378999999999999999999999999999999999994
Q ss_pred cccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHH
Q 020235 132 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 206 (329)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 206 (329)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++||||||
T Consensus 207 -------------------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 261 (344)
T 1rjb_A 207 -------------------------HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 261 (344)
T ss_dssp -------------------------TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred -------------------------CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHH
Confidence 44568888888887554332 234578889999999998999999999999
Q ss_pred HHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHh
Q 020235 207 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285 (329)
Q Consensus 207 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
|++|+|++ |..||.+.................
T Consensus 262 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------------------------- 294 (344)
T 1rjb_A 262 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------------------------------------------- 294 (344)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-----------------------------------------------
T ss_pred HHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC-----------------------------------------------
Confidence 99999998 999998765443332222211000
Q ss_pred hhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 286 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
......+..+.+||.+||+.||.+|||+.++++|
T Consensus 295 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 295 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 0012346789999999999999999999999876
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=320.89 Aligned_cols=237 Identities=22% Similarity=0.320 Sum_probs=183.9
Q ss_pred CCCccceEEEEEEec---CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDR---ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~---~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|+++ .++..||||+++.. ........+|+.++..+ .|+||+++++++.+.+..++||||
T Consensus 53 lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~lv~e~ 127 (373)
T 2qol_A 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-----DHPNIIRLEGVVTKSKPVMIVTEY 127 (373)
T ss_dssp EEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCceEEEEeC
Confidence 699999999999887 46778999998743 23445677898888888 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 128 ~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------------------------- 180 (373)
T 2qol_A 128 MENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI-------------------------- 180 (373)
T ss_dssp CTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------------------------
T ss_pred CCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE--------------------------
Confidence 9 899999998653 468999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+.+..++|+|||.+........ ...+|..|+|||++.+..++.++|||||||++|+|++ |..||...+..+.
T Consensus 181 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 181 -NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp -CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred -cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 5566789999998876544321 1234678999999999999999999999999999998 9999987665544
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+....... .....+..+.++|.+||+.||
T Consensus 260 ~~~i~~~~~~~------------------------------------------------~~~~~~~~l~~li~~cl~~dp 291 (373)
T 2qol_A 260 IKAVDEGYRLP------------------------------------------------PPMDCPAALYQLMLDCWQKDR 291 (373)
T ss_dssp HHHHHTTEECC------------------------------------------------CCTTCBHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCC------------------------------------------------CCccccHHHHHHHHHHhCcCh
Confidence 33332211110 012356789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 292 ~~RPs~~~i~~ 302 (373)
T 2qol_A 292 NNRPKFEQIVS 302 (373)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999998875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=330.12 Aligned_cols=242 Identities=25% Similarity=0.379 Sum_probs=198.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++. +..||||+++......+...+|+.++..+ .|+||+++++++. .+..++||||+ +++
T Consensus 196 lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~l~~~~~-~~~~~lv~e~~~~g~ 268 (454)
T 1qcf_A 196 LGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTL-----QHDKLVKLHAVVT-KEPIYIITEFMAKGS 268 (454)
T ss_dssp EECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSSCEEEECCCTTCB
T ss_pred cccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhC-----CCCCEeeEEEEEe-CCccEEEEeecCCCc
Confidence 6999999999998864 67899999986655667788999999888 5799999999986 56799999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+ +.+.
T Consensus 269 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---------------------------~~~~ 321 (454)
T 1qcf_A 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---------------------------SASL 321 (454)
T ss_dssp HHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---------------------------CTTC
T ss_pred HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---------------------------CCCC
Confidence 9999985433358899999999999999999999999999999999999 5566
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||.+....... ....+|..|+|||++....++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 322 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 401 (454)
T 1qcf_A 322 VCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401 (454)
T ss_dssp CEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred cEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 79999999987654321 22346778999999998899999999999999999999 99999887766555444432
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .+..++..+.++|.+||+.||++|||++
T Consensus 402 ~~~~------------------------------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ 433 (454)
T 1qcf_A 402 YRMP------------------------------------------------RPENCPEELYNIMMRCWKNRPEERPTFE 433 (454)
T ss_dssp CCCC------------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 1111 0123567899999999999999999999
Q ss_pred HHhc--CCCCCC
Q 020235 315 EALR--HPFFTR 324 (329)
Q Consensus 315 ~ll~--hp~f~~ 324 (329)
++++ ..+++.
T Consensus 434 ~i~~~L~~~~~~ 445 (454)
T 1qcf_A 434 YIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHHHTSSSS
T ss_pred HHHHHHHHHHhc
Confidence 9875 344443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=318.49 Aligned_cols=248 Identities=15% Similarity=0.216 Sum_probs=187.8
Q ss_pred CCCccceEEEEEEecCC-----CceEEEEEeccchhhHHhHHHHHHHHHHHHh----------hCCCCCceeeecccccc
Q 020235 1 MGEGTFGQVLECWDRER-----KEMVAIKIVRGIKKYREAAMIEIEVLQQLAK----------HDKGGNRCVQIRNWFDY 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~----------~~~~~~~i~~l~~~~~~ 65 (329)
||+|+||.||+|.++.+ ++.||+|++.... .....|+.++..+.+ ....|+||+++++++..
T Consensus 43 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp CCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC---HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EecCCCeEEEEeeecCccccccccceEEEEeeccc---hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 79999999999998765 5789999987532 234455665555432 23468999999998876
Q ss_pred C----CceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 66 R----NHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 66 ~----~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
. ...++||||++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 120 ~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~----------- 187 (364)
T 3op5_A 120 DKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY----------- 187 (364)
T ss_dssp EETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-----------
T ss_pred ccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-----------
Confidence 4 5689999999999999998753 46999999999999999999999999999999999999952
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
..+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 188 --------------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~e 253 (364)
T 3op5_A 188 --------------KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQ 253 (364)
T ss_dssp --------------SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHH
Confidence 145678999999886543221 23459999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhHHHHH-HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhh--c
Q 020235 212 LCTGEALFQTHENLEHLAM-MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQH--V 288 (329)
Q Consensus 212 l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 288 (329)
|++|+.||.+......... ....... .+....... .
T Consensus 254 l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~ 292 (364)
T 3op5_A 254 WLTGHLPWEDNLKDPKYVRDSKIRYRE-----------------------------------------NIASLMDKCFPA 292 (364)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHHH-----------------------------------------CHHHHHHHHSCT
T ss_pred HHhCCCCccccccCHHHHHHHHHHhhh-----------------------------------------hHHHHHHHhccc
Confidence 9999999975332222111 1111000 000111111 1
Q ss_pred cCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 289 DHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 289 ~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
...+..+.+++..||..||++|||++++++
T Consensus 293 ~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 293 ANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 345778999999999999999999998874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=320.05 Aligned_cols=255 Identities=22% Similarity=0.235 Sum_probs=186.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e~~ 76 (329)
||+|+||+||+|++. ++.||+|++............|+.++..+ .|+||+++++++.... ..++||||+
T Consensus 32 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~~~~~~~~~~lv~e~~ 104 (322)
T 3soc_A 32 KARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGM-----KHENILQFIGAEKRGTSVDVDLWLITAFH 104 (322)
T ss_dssp EECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTC-----CCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred ecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcC-----CCCCchhhcceeccCCCCCceEEEEEecC
Confidence 699999999999875 78999999986555455555677666666 6799999999988754 479999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL----------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~----------~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
+++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||+
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill----------------- 164 (322)
T 3soc_A 105 EKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----------------- 164 (322)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE-----------------
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE-----------------
Confidence 88999999875 499999999999999999999999 99999999999999
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC-----CCCCccchHhHHHHHHHHHhC
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTG 215 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~l~~g 215 (329)
+.+..++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 165 ----------~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg 234 (322)
T 3soc_A 165 ----------KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234 (322)
T ss_dssp ----------CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ----------CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhC
Confidence 556679999999986544322 235789999999999873 355678999999999999999
Q ss_pred CCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHH
Q 020235 216 EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295 (329)
Q Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (329)
+.||.+....................... ........... +.... .....+..+
T Consensus 235 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------------------~~~~~--~~~~~~~~l 288 (322)
T 3soc_A 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQ------EVVVHKKKRPV------------------LRDYW--QKHAGMAML 288 (322)
T ss_dssp BTTSSSCCCCCCCTTHHHHCSSCCHHHHH------HHHTTSCCCCC------------------CCGGG--GSSHHHHHH
T ss_pred CCCCCCCcchhccchhhhhccCCchhhhh------hhhhcccCCCC------------------ccccc--cccchHHHH
Confidence 99997654321111111111111110000 00000000000 00000 011234569
Q ss_pred HHHHHHhcccCCCCCCCHHHHhc
Q 020235 296 THLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 296 ~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.+||.+||+.||++|||+.++++
T Consensus 289 ~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 289 CETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=317.09 Aligned_cols=245 Identities=20% Similarity=0.269 Sum_probs=194.0
Q ss_pred CCCccceEEEEEE-----ecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECW-----DRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~-----~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|. +..+++.||+|++... ........+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 38 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~ 112 (327)
T 2yfx_A 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-----NHQNIVRCIGVSLQSLPRFILM 112 (327)
T ss_dssp CC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred EcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-----CCCCCCeEEEEEcCCCCcEEEE
Confidence 7999999999999 5567889999998642 23345667788888888 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 74 EKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+|||++.++
T Consensus 113 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~--------------- 177 (327)
T 2yfx_A 113 ELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--------------- 177 (327)
T ss_dssp ECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---------------
T ss_pred ecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---------------
Confidence 999 9999999987532 3488999999999999999999999999999999999995432
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCC
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQT 221 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 221 (329)
.+..++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 178 ---------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 178 ---------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp ---------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 3456999999988643222 233467889999999999899999999999999999998 9999987
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..+....+....... ....++..+.++|.+
T Consensus 249 ~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~ 280 (327)
T 2yfx_A 249 KSNQEVLEFVTSGGRMD------------------------------------------------PPKNCPGPVYRIMTQ 280 (327)
T ss_dssp CCHHHHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHH
T ss_pred cCHHHHHHHHhcCCCCC------------------------------------------------CCCCCCHHHHHHHHH
Confidence 66544333322211110 012356789999999
Q ss_pred hcccCCCCCCCHHHHhcCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFF 322 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f 322 (329)
||+.||.+|||+.++++|.|+
T Consensus 281 ~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 281 CWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HTCSSGGGSCCHHHHHHHHHH
T ss_pred HhcCChhhCcCHHHHHHHHHH
Confidence 999999999999999998765
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=317.04 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=188.5
Q ss_pred CCCccceEEEEEEecCCCce----EEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEM----VAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.+..+++. ||+|.+.... .......+|+.++..+ .|+||+++++++. ++..++|||
T Consensus 21 lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~~v~e 94 (325)
T 3kex_A 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-----DHAHIVRLLGLCP-GSSLQLVTQ 94 (325)
T ss_dssp EECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-----CCTTBCCEEEEEC-BSSEEEEEE
T ss_pred eeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-----CCCCcCeEEEEEc-CCccEEEEE
Confidence 69999999999999888775 7777765322 2234556788888777 6799999999886 567999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 95 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~------------------------- 148 (325)
T 3kex_A 95 YLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL------------------------- 148 (325)
T ss_dssp CCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE-------------------------
T ss_pred eCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE-------------------------
Confidence 99 899999998643 368999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+.++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 149 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 226 (325)
T 3kex_A 149 --KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV 226 (325)
T ss_dssp --SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH
T ss_pred --CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH
Confidence 455678999999987654432 23457789999999999899999999999999999999 9999987665544
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+....... .....+..+.++|.+||+.||
T Consensus 227 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~~l~~dp 258 (325)
T 3kex_A 227 PDLLEKGERLA------------------------------------------------QPQICTIDVYMVMVKCWMIDE 258 (325)
T ss_dssp HHHHHTTCBCC------------------------------------------------CCTTBCTTTTHHHHHHTCSCT
T ss_pred HHHHHcCCCCC------------------------------------------------CCCcCcHHHHHHHHHHcCCCh
Confidence 33332211110 012245568889999999999
Q ss_pred CCCCCHHHHhcC
Q 020235 308 TDRLTAREALRH 319 (329)
Q Consensus 308 ~~R~t~~~ll~h 319 (329)
.+|||+.++++|
T Consensus 259 ~~Rps~~el~~~ 270 (325)
T 3kex_A 259 NIRPTFKELANE 270 (325)
T ss_dssp TTSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=316.28 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=174.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~ 78 (329)
||+|+||.||+|.++.+++.||+|+++.... .......|...+.. ...|+||+++++++.+.+..++||||+.+
T Consensus 30 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~----~~~h~niv~~~~~~~~~~~~~lv~e~~~~ 105 (327)
T 3aln_A 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMR----SSDCPYIVQFYGALFREGDCWICMELMST 105 (327)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHS----SCCCTTBCCEEEEEECSSEEEEEECCCSE
T ss_pred eccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHH----cCCCCcEeeeeeEEEeCCceEEEEeecCC
Confidence 6899999999999999999999999975322 22333344442222 23779999999999999999999999977
Q ss_pred CHHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 79 SLYDFLRK---NNYRSFPIDLVREIARQLLECIAFMHDL-CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 79 ~l~~~l~~---~~~~~l~~~~~~~~~~~l~~~L~~lH~~-~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+|.+++.. .....+++..+..++.|++.||.|||+. ||+|+||||+||+++
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~------------------------- 160 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD------------------------- 160 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE-------------------------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc-------------------------
Confidence 88888863 2234689999999999999999999998 999999999999994
Q ss_pred CCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHH----hcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVI----LGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.++.++|+|||.+....... ....||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.+...
T Consensus 161 --~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 236 (327)
T 3aln_A 161 --RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-- 236 (327)
T ss_dssp --TTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------
T ss_pred --CCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--
Confidence 45568999999887654433 234789999999998 45568999999999999999999999997543210
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+...... .....+ .......+..+.+||.+||+.||+
T Consensus 237 ~~~~~~~~~-------------------~~~~~~----------------------~~~~~~~~~~l~~li~~~l~~dp~ 275 (327)
T 3aln_A 237 DQLTQVVKG-------------------DPPQLS----------------------NSEEREFSPSFINFVNLCLTKDES 275 (327)
T ss_dssp ---CCCCCS-------------------CCCCCC----------------------CCSSCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHhcC-------------------CCCCCC----------------------CcccccCCHHHHHHHHHHhhCChh
Confidence 000000000 000000 001134577899999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 020235 309 DRLTAREALRHPFFTRD 325 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~~ 325 (329)
+|||+.++++||||.+.
T Consensus 276 ~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 276 KRPKYKELLKHPFILMY 292 (327)
T ss_dssp GSCCHHHHTTSHHHHHH
T ss_pred hCcCHHHHHhChHHHHh
Confidence 99999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=318.61 Aligned_cols=246 Identities=16% Similarity=0.233 Sum_probs=181.7
Q ss_pred CCCccceEEEEEEecC---CCceEEEEEeccchhh------------HHhHHHHHHHHHHHHhhCCCCCceeeecccccc
Q 020235 1 MGEGTFGQVLECWDRE---RKEMVAIKIVRGIKKY------------REAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~ 65 (329)
||+|+||.||+|.++. ++..+|+|++...... .....+|+..+..+ .|+||+++++++.+
T Consensus 45 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-----~h~ni~~~~~~~~~ 119 (345)
T 2v62_A 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-----DYLGIPLFYGSGLT 119 (345)
T ss_dssp C------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-----SCCCCCCEEEEEEE
T ss_pred EeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-----cccCcceeeccccc
Confidence 7999999999999987 7889999998753221 01122233333333 67999999999887
Q ss_pred ----CCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 66 ----RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 66 ----~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
....++||||++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 120 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------- 188 (345)
T 2v62_A 120 EFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN--------- 188 (345)
T ss_dssp ESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSS---------
T ss_pred ccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCC---------
Confidence 67899999999999999998654 689999999999999999999999999999999999996432
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
...++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 189 ----------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 252 (345)
T 2v62_A 189 ----------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLR 252 (345)
T ss_dssp ----------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred ----------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 2378999999886543211 33478999999999999999999999999999999
Q ss_pred HHhCCCCCCCC--chhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhcc
Q 020235 212 LCTGEALFQTH--ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289 (329)
Q Consensus 212 l~~g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (329)
|++|..||.+. +...............+....... ...
T Consensus 253 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~ 292 (345)
T 2v62_A 253 WLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWA----------------------------------------PSG 292 (345)
T ss_dssp HHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHS----------------------------------------CTT
T ss_pred HHhCCCCccccccccHHHHHHHHhhcccccHHHHhhc----------------------------------------ccc
Confidence 99999999652 222222222222222222211100 011
Q ss_pred CchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 290 HSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 290 ~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
..+..+.++|.+||+.||++|||++++++
T Consensus 293 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 293 SSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp SCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 46778999999999999999999998875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=316.25 Aligned_cols=237 Identities=21% Similarity=0.265 Sum_probs=185.2
Q ss_pred CCCccceEEEEEEecCCCce----EEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEM----VAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|++..+++. ||+|.++... .......+|+.++..+ .|+||+++++++.++. .++|++
T Consensus 23 lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~-~~~v~e 96 (327)
T 3poz_A 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-----CBTTBCCEEEEEESSS-EEEEEE
T ss_pred EeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEeEEEEEEecCC-eEEEEE
Confidence 69999999999999877765 5888775322 3346677899999988 5699999999998755 778899
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~----------------------- 152 (327)
T 3poz_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT----------------------- 152 (327)
T ss_dssp CCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-----------------------
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECC-----------------------
Confidence 98 999999998754 46899999999999999999999999999999999999954
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 153 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 228 (327)
T 3poz_A 153 ----PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp ----TTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ----CCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH
Confidence 4458888888886554332 22346778999999999999999999999999999999 9999987655443
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+....... .....+..+.+++.+||+.||
T Consensus 229 ~~~~~~~~~~~------------------------------------------------~~~~~~~~~~~li~~~l~~~p 260 (327)
T 3poz_A 229 SSILEKGERLP------------------------------------------------QPPICTIDVYMIMVKCWMIDA 260 (327)
T ss_dssp HHHHHTTCCCC------------------------------------------------CCTTBCHHHHHHHHHHTCSCG
T ss_pred HHHHHcCCCCC------------------------------------------------CCccCCHHHHHHHHHHcCCCh
Confidence 33222211100 012356689999999999999
Q ss_pred CCCCCHHHHhcC
Q 020235 308 TDRLTAREALRH 319 (329)
Q Consensus 308 ~~R~t~~~ll~h 319 (329)
++|||+.+++++
T Consensus 261 ~~Rps~~ell~~ 272 (327)
T 3poz_A 261 DSRPKFRELIIE 272 (327)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCCCHHHHHHH
Confidence 999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=328.21 Aligned_cols=244 Identities=27% Similarity=0.348 Sum_probs=195.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.+ ..||||+++......+...+|+.++..+ .|+||+++++++.+ +..++||||+ +++
T Consensus 192 lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~-~~~~iv~e~~~~gs 264 (452)
T 1fmk_A 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 264 (452)
T ss_dssp EEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred ecCCCCeEEEEEEECCC-ceEEEEEeccCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEcC-CceEEEehhhcCCC
Confidence 69999999999998754 5699999986555567788999999999 57999999999876 6789999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++ .+.
T Consensus 265 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---------------------------~~~ 317 (452)
T 1fmk_A 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---------------------------ENL 317 (452)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------------GGG
T ss_pred HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---------------------------CCC
Confidence 99999754334689999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.+.
T Consensus 318 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~ 397 (452)
T 1fmk_A 318 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397 (452)
T ss_dssp CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 68888888887654322 22346778999999999899999999999999999999 99999887665544433321
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .+..++..+.++|.+||+.||++|||++
T Consensus 398 ~~~~------------------------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ 429 (452)
T 1fmk_A 398 YRMP------------------------------------------------CPPECPESLHDLMCQCWRKEPEERPTFE 429 (452)
T ss_dssp CCCC------------------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC------------------------------------------------CCCCCCHHHHHHHHHHccCChhhCcCHH
Confidence 1100 0123567899999999999999999999
Q ss_pred HHhc--CCCCCCCC
Q 020235 315 EALR--HPFFTRDH 326 (329)
Q Consensus 315 ~ll~--hp~f~~~~ 326 (329)
++++ ..+++..+
T Consensus 430 ~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 430 YLQAFLEDYFTSTE 443 (452)
T ss_dssp HHHHHHHTTTSCSC
T ss_pred HHHHHHHHHhccCC
Confidence 9987 46666544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=308.05 Aligned_cols=237 Identities=24% Similarity=0.309 Sum_probs=181.3
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+..+ +..||+|++... ........+|+.++..+ .|+||+++++++. ++..++||||
T Consensus 23 lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~-~~~~~lv~e~ 96 (281)
T 1mp8_A 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-ENPVWIIMEL 96 (281)
T ss_dssp EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred eeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCccceEEEEEc-cCccEEEEec
Confidence 69999999999998654 457999998743 23345567788888877 5799999999984 5678999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~------------------------ 151 (281)
T 1mp8_A 97 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS------------------------ 151 (281)
T ss_dssp CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE------------------------
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECC------------------------
Confidence 9 889999998753 35899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 152 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~ 228 (281)
T 1mp8_A 152 ---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 228 (281)
T ss_dssp ---TTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred ---CCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH
Confidence 4458888888876554432 22346778999999999899999999999999999996 999998766544433
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+...... ......+..+.++|.+||+.||++
T Consensus 229 ~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~~ 260 (281)
T 1mp8_A 229 RIENGERL------------------------------------------------PMPPNCPPTLYSLMTKCWAYDPSR 260 (281)
T ss_dssp HHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHccCChhh
Confidence 32221100 011245678999999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||+.+++++
T Consensus 261 Rps~~~l~~~ 270 (281)
T 1mp8_A 261 RPRFTELKAQ 270 (281)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.73 Aligned_cols=237 Identities=24% Similarity=0.327 Sum_probs=191.5
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++ .++..||+|+++.. ........+|+.++..+ .|+||+++++++ ..+..++|||++
T Consensus 18 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~-~~~~~~lv~e~~ 91 (287)
T 1u59_A 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVC-QAEALMLVMEMA 91 (287)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEE-ESSSEEEEEECC
T ss_pred ccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-----CCCCEeEEEEEe-cCCCcEEEEEeC
Confidence 699999999999864 46788999999753 23456677899999988 579999999998 456799999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 92 ~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~------------------------- 145 (287)
T 1u59_A 92 GGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN------------------------- 145 (287)
T ss_dssp TTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-------------------------
T ss_pred CCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcC-------------------------
Confidence 889999997543 45899999999999999999999999999999999999954
Q ss_pred CCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 146 --~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 223 (287)
T 1u59_A 146 --RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 223 (287)
T ss_dssp --TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred --CCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence 3457888888876554332 22346788999999998889999999999999999998 99999876655443
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.....+ ..+...+..+.++|.+||+.||+
T Consensus 224 ~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~~p~ 255 (287)
T 1u59_A 224 AFIEQGKRM------------------------------------------------ECPPECPPELYALMSDCWIYKWE 255 (287)
T ss_dssp HHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HHHhcCCcC------------------------------------------------CCCCCcCHHHHHHHHHHcCCChh
Confidence 333221100 01124567899999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+.++++|
T Consensus 256 ~Rps~~~l~~~ 266 (287)
T 1u59_A 256 DRPDFLTVEQR 266 (287)
T ss_dssp GSCCHHHHHHH
T ss_pred hCcCHHHHHHH
Confidence 99999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.89 Aligned_cols=253 Identities=24% Similarity=0.320 Sum_probs=188.0
Q ss_pred CCCccceEEEEEE----ecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEe
Q 020235 1 MGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~ 73 (329)
||+|+||+||+|+ +..+++.||+|++.... .......+|+.++..+ .|+||+++++++.. ....++||
T Consensus 18 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~ 92 (295)
T 3ugc_A 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSAGRRNLKLIM 92 (295)
T ss_dssp EEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECHHHHTSCEEEE
T ss_pred eeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecCCCCceEEEE
Confidence 6999999999998 56789999999987533 3345667899999888 57999999998754 45799999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.
T Consensus 93 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~---------------------- 149 (295)
T 3ugc_A 93 EYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---------------------- 149 (295)
T ss_dssp ECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE----------------------
T ss_pred EeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcC----------------------
Confidence 999 899999998754 35899999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+..++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus 150 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~- 223 (295)
T 3ugc_A 150 -----ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE- 223 (295)
T ss_dssp -----TTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-
T ss_pred -----CCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH-
Confidence 4458888888887554332 2234677899999999999999999999999999999999998653221
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
.....+..+..... .............. .....++..+.++|.+||+.|
T Consensus 224 ----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~d 272 (295)
T 3ugc_A 224 ----FMRMIGNDKQGQMI-VFHLIELLKNNGRL--------------------------PRPDGCPDEIYMIMTECWNNN 272 (295)
T ss_dssp ----HHHHHCTTCCTHHH-HHHHHHHHHTTCCC--------------------------CCCTTCCHHHHHHHHHHSCSS
T ss_pred ----HHhhhcCccccchh-HHHHHHHHhccCcC--------------------------CCCcCcCHHHHHHHHHHcCCC
Confidence 11112211110000 00000001011111 112346778999999999999
Q ss_pred CCCCCCHHHHhc
Q 020235 307 PTDRLTAREALR 318 (329)
Q Consensus 307 P~~R~t~~~ll~ 318 (329)
|++|||+.++++
T Consensus 273 p~~Rps~~el~~ 284 (295)
T 3ugc_A 273 VNQRPSFRDLAL 284 (295)
T ss_dssp GGGSCCHHHHHH
T ss_pred hhhCCCHHHHHH
Confidence 999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=310.99 Aligned_cols=240 Identities=19% Similarity=0.293 Sum_probs=193.4
Q ss_pred CCCccceEEEEEEec-------CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDR-------ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|.+. .++..||+|+++... .......+|+.++..+ ..|+||+++++++.+.+..++
T Consensus 43 lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI----GKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSCCEE
T ss_pred EeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHh----hcCCCEeeEEEEEccCCceEE
Confidence 699999999999975 456789999987432 2345567899999888 256999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~--------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-------- 190 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-------- 190 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--------
Confidence 99999 8899999986531 248899999999999999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+
T Consensus 191 -------------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 251 (334)
T 2pvf_A 191 -------------------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 251 (334)
T ss_dssp -------------------CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred -------------------cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHH
Confidence 456678999999887654432 22356788999999998889999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |..||.+....+....+....... ....
T Consensus 252 llt~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~ 283 (334)
T 2pvf_A 252 IFTLGGSPYPGIPVEELFKLLKEGHRMD------------------------------------------------KPAN 283 (334)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHHTCCCC------------------------------------------------CCTT
T ss_pred HHhCCCCCcCcCCHHHHHHHHhcCCCCC------------------------------------------------CCcc
Confidence 999 999998766554443333221110 0123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.++|.+||+.||.+|||+.+++++
T Consensus 284 ~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 284 CTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 56789999999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=310.86 Aligned_cols=238 Identities=21% Similarity=0.304 Sum_probs=187.5
Q ss_pred CCCccceEEEEEEecCCC----ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.++.++ ..||+|+++.. ........+|+.++..+ .|+||+++++++.+.+..++|||
T Consensus 52 lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEecCCCcEEEEe
Confidence 699999999999987654 45999998743 23344567888888888 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 127 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------------------- 180 (333)
T 1mqb_A 127 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV------------------------- 180 (333)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------------------
T ss_pred CCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE-------------------------
Confidence 99 889999998753 468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~ 226 (329)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 181 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 258 (333)
T 1mqb_A 181 --NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258 (333)
T ss_dssp --CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred --CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 556678999999887654432 12245778999999999899999999999999999998 999998766544
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+....... .....+..+.++|.+||+.|
T Consensus 259 ~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~~ 290 (333)
T 1mqb_A 259 VMKAINDGFRLP------------------------------------------------TPMDCPSAIYQLMMQCWQQE 290 (333)
T ss_dssp HHHHHHTTCCCC------------------------------------------------CCTTCBHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCcCC------------------------------------------------CcccCCHHHHHHHHHHcCCC
Confidence 433332211000 01235678999999999999
Q ss_pred CCCCCCHHHHhcC
Q 020235 307 PTDRLTAREALRH 319 (329)
Q Consensus 307 P~~R~t~~~ll~h 319 (329)
|++|||+++++++
T Consensus 291 p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 291 RARRPKFADIVSI 303 (333)
T ss_dssp TTTSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999998764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=324.83 Aligned_cols=247 Identities=20% Similarity=0.285 Sum_probs=193.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|++..+++.||||++.... .......|..++..+.+ ++++..+..++...+..++||||++++|
T Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~----~~~i~~i~~~~~~~~~~~lvme~~g~sL 89 (483)
T 3sv0_A 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQG----GTGIPNVRWFGVEGDYNVLVMDLLGPSL 89 (483)
T ss_dssp CEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTT----STTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcC----CCCCCeEEEEEeeCCEEEEEEECCCCCH
Confidence 799999999999999999999999887433 34457789999988843 3556666666777889999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+... +.+..
T Consensus 90 ~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~------------------------~~~~~ 144 (483)
T 3sv0_A 90 EDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG------------------------RRANQ 144 (483)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG------------------------GGTTC
T ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC------------------------CCCCe
Confidence 99998643 469999999999999999999999999999999999999421 24567
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
++|+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........
T Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (483)
T 3sv0_A 145 VYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (483)
T ss_dssp EEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHH
T ss_pred EEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHH
Confidence 8999999987554432 245799999999999999999999999999999999999999987543222111
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+... .............++.++.+||..||+.||++|
T Consensus 225 ~~~i~~-----------------------------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~R 263 (483)
T 3sv0_A 225 YEKISE-----------------------------------------KKVATSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (483)
T ss_dssp HHHHHH-----------------------------------------HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCC
T ss_pred HHHHhh-----------------------------------------ccccccHHHHhcCCcHHHHHHHHHHhcCChhhC
Confidence 111100 000001111123456789999999999999999
Q ss_pred CCHHHHhc
Q 020235 311 LTAREALR 318 (329)
Q Consensus 311 ~t~~~ll~ 318 (329)
|++.+|++
T Consensus 264 Ps~~el~~ 271 (483)
T 3sv0_A 264 PDYSYLKR 271 (483)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99987764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=308.86 Aligned_cols=238 Identities=26% Similarity=0.334 Sum_probs=192.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc---------------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------------- 65 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------------- 65 (329)
||+|+||.||+|.++.+++.||+|++.... ....+|+.++..+ .|+||+++++++..
T Consensus 19 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 19 IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKL-----DHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp EECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHC-----CCTTBCCEEEEEEEEEEC---------CC
T ss_pred eccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhC-----CCCCEEEEeeeEeccccCccccccccccc
Confidence 699999999999999999999999987542 4567899999888 57999999988754
Q ss_pred -CCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCcc
Q 020235 66 -RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSL 143 (329)
Q Consensus 66 -~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~ 143 (329)
....++||||+ +++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~------------- 157 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD------------- 157 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE-------------
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC-------------
Confidence 45689999999 789999998754457999999999999999999999999999999999999954
Q ss_pred CCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 144 HTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 144 ~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+..++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..|+..
T Consensus 158 --------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 158 --------------TKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp --------------TTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred --------------CCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 4458888888877554432 345789999999999998999999999999999999999988742
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.. .....+.. +. .....+..+.++|.+
T Consensus 224 ~~--~~~~~~~~--~~-------------------------------------------------~~~~~~~~~~~li~~ 250 (284)
T 2a19_B 224 TS--KFFTDLRD--GI-------------------------------------------------ISDIFDKKEKTLLQK 250 (284)
T ss_dssp HH--HHHHHHHT--TC-------------------------------------------------CCTTSCHHHHHHHHH
T ss_pred HH--HHHHHhhc--cc-------------------------------------------------ccccCCHHHHHHHHH
Confidence 11 00000000 00 012356678999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||+.||++|||+.++++|.+.-...
T Consensus 251 ~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 251 LLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HccCChhhCcCHHHHHHHHHHHhhC
Confidence 9999999999999999987654443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=305.99 Aligned_cols=236 Identities=26% Similarity=0.379 Sum_probs=193.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++ +++.||+|.+.......+...+|+.++..+ .|+||+++++++. .+..++|||++ +++
T Consensus 21 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~-~~~~~~v~e~~~~~~ 93 (279)
T 1qpc_A 21 LGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVT-QEPIYIITEYMENGS 93 (279)
T ss_dssp EEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred ecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhC-----CCcCcceEEEEEc-CCCcEEEEecCCCCC
Confidence 689999999999876 467899999986655567788899999998 5699999999886 45689999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++ +.+.
T Consensus 94 L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---------------------------~~~~ 146 (279)
T 1qpc_A 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---------------------------SDTL 146 (279)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------CTTS
T ss_pred HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---------------------------cCCC
Confidence 9999975432358999999999999999999999999999999999999 4556
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||.+....... ....++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....+.+.
T Consensus 147 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 226 (279)
T 1qpc_A 147 SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (279)
T ss_dssp CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred CEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc
Confidence 78999999887655433 23356778999999998889999999999999999999 99999876655443333221
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... .....+..+.+++.+||+.||++|||++
T Consensus 227 ~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 258 (279)
T 1qpc_A 227 YRMV------------------------------------------------RPDNCPEELYQLMRLCWKERPEDRPTFD 258 (279)
T ss_dssp CCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCCC------------------------------------------------CcccccHHHHHHHHHHhccChhhCCCHH
Confidence 1100 0123567899999999999999999999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 259 ~l~~ 262 (279)
T 1qpc_A 259 YLRS 262 (279)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=309.56 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=190.9
Q ss_pred CCCccceEEEEEEe-----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC-CceEEE
Q 020235 1 MGEGTFGQVLECWD-----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR-NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~-----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~-~~~~lv 72 (329)
||+|+||+||+|.+ ..+++.||+|+++... .......+|+.++..+. .|+||+++++++... ...++|
T Consensus 35 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEECCTTSCCEEE
T ss_pred EcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcc----cCCCeeeEEEEEecCCCceEEE
Confidence 68999999999985 4567899999987532 23345678999998883 569999999988765 459999
Q ss_pred eecC-CCCHHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccC
Q 020235 73 FEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 137 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~--------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~ 137 (329)
|||+ +++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-------- 182 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-------- 182 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--------
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC--------
Confidence 9999 8899999987542 1278999999999999999999999999999999999994
Q ss_pred CCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHH
Q 020235 138 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 212 (329)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 183 -------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l 243 (316)
T 2xir_A 183 -------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243 (316)
T ss_dssp -------------------GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHH
Confidence 44568888888887554432 234678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc
Q 020235 213 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291 (329)
Q Consensus 213 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
++ |..||.+................. ......
T Consensus 244 ~t~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~ 276 (316)
T 2xir_A 244 FSLGASPYPGVKIDEEFCRRLKEGTRM-----------------------------------------------RAPDYT 276 (316)
T ss_dssp HTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------------------------------------CCCTTC
T ss_pred HhCCCCCCcccchhHHHHHHhccCccC-----------------------------------------------CCCCCC
Confidence 98 999998755433222111111000 001235
Q ss_pred hhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 292 AGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 292 ~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+..+.++|.+||+.||.+|||+.++++|
T Consensus 277 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 277 TPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6689999999999999999999999876
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=309.36 Aligned_cols=238 Identities=24% Similarity=0.338 Sum_probs=184.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|++..... ......+|+.++..+ .|+||+++++++..++..++|||++
T Consensus 42 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 116 (309)
T 2h34_A 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-----QEPHVVPIHDFGEIDGQLYVDMRLI 116 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-----CCCCeeEEEEEEeeCCeEEEEEEec
Confidence 6899999999999999999999999875322 235566788888777 5699999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... .+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 117 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~--------------------------- 167 (309)
T 2h34_A 117 NGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV--------------------------- 167 (309)
T ss_dssp CCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------
T ss_pred CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---------------------------
Confidence 889999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.......+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 247 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI 247 (309)
T ss_dssp CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH
T ss_pred cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh
Confidence 455678999999887654432 2356899999999999888999999999999999999999999875543221111
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.. ..+.+ ......++..+.++|.+||+.||++||
T Consensus 248 ~~-~~~~~---------------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp 281 (309)
T 2h34_A 248 NQ-AIPRP---------------------------------------------STVRPGIPVAFDAVIARGMAKNPEDRY 281 (309)
T ss_dssp HS-CCCCG---------------------------------------------GGTSTTCCTHHHHHHHHHTCSSGGGSC
T ss_pred cc-CCCCc---------------------------------------------cccCCCCCHHHHHHHHHhccCCHHHHH
Confidence 11 00000 011234567899999999999999999
Q ss_pred -CHHHHhc
Q 020235 312 -TAREALR 318 (329)
Q Consensus 312 -t~~~ll~ 318 (329)
|++++++
T Consensus 282 ~s~~~l~~ 289 (309)
T 2h34_A 282 VTCGDLSA 289 (309)
T ss_dssp SSHHHHHH
T ss_pred HhHHHHHH
Confidence 8888764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=301.98 Aligned_cols=235 Identities=15% Similarity=0.136 Sum_probs=188.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~e~ 75 (329)
||+|+||+||+|+++ ++.||+|++.... .......+|+.++..+ .|+||+++++++.+. +..++||||
T Consensus 18 lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (271)
T 3kmu_A 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-----SHPNVLPVLGACQSPPAPHPTLITHW 90 (271)
T ss_dssp EEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-----SCTTEECEEEEECTTTSSSCEEEEEC
T ss_pred hcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCchhheEEEEccCCCCCeEeeecc
Confidence 689999999999885 7889999987532 2334566777777666 579999999999877 789999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+ +++|.+++.......+++..++.++.|++.||.|||++| ++|+||||+||++
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~------------------------ 146 (271)
T 3kmu_A 91 MPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI------------------------ 146 (271)
T ss_dssp CTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE------------------------
T ss_pred cCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE------------------------
Confidence 9 889999998866556899999999999999999999999 9999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCC---ccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTY---PCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+.++.++|+|||.+..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||.+.+..+...
T Consensus 147 ---~~~~~~~l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 221 (271)
T 3kmu_A 147 ---DEDMTARISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM 221 (271)
T ss_dssp ---CTTSCEEEEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH
T ss_pred ---cCCcceeEEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH
Confidence 4555678887777654332 2347899999999998866554 7999999999999999999998766655433
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....... ..+...+..+.++|.+||+.||++
T Consensus 222 ~~~~~~~~~-----------------------------------------------~~~~~~~~~~~~li~~~l~~~p~~ 254 (271)
T 3kmu_A 222 KVALEGLRP-----------------------------------------------TIPPGISPHVSKLMKICMNEDPAK 254 (271)
T ss_dssp HHHHSCCCC-----------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHhcCCCC-----------------------------------------------CCCCCCCHHHHHHHHHHcCCChhh
Confidence 332211110 012345678999999999999999
Q ss_pred CCCHHHHhc
Q 020235 310 RLTAREALR 318 (329)
Q Consensus 310 R~t~~~ll~ 318 (329)
|||++++++
T Consensus 255 Rps~~~il~ 263 (271)
T 3kmu_A 255 RPKFDMIVP 263 (271)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.05 Aligned_cols=269 Identities=21% Similarity=0.344 Sum_probs=197.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC--ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN--HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~--~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|+++... .......+|+.++..+ .|+||+++++++...+ ..++||||+
T Consensus 17 LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~~~~~~lv~e~~ 91 (396)
T 4eut_A 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEEETTTRHKVLIMEFC 91 (396)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECTTTCCEEEEECCC
T ss_pred EEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-----CCCCCCeEEEeeccCCCCeeEEEEecC
Confidence 699999999999999999999999987432 2345567899999988 5799999999987654 789999999
Q ss_pred -CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 77 -GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 77 -~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+....
T Consensus 92 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------------------- 149 (396)
T 4eut_A 92 PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---------------------- 149 (396)
T ss_dssp TTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT----------------------
T ss_pred CCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC----------------------
Confidence 899999997643 22389999999999999999999999999999999999984322
Q ss_pred CCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc--------CCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG--------LGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.+..++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 150 -~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~ 228 (396)
T 4eut_A 150 -DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (396)
T ss_dssp -TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred -CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence 344568999999997665443 34579999999999875 4577899999999999999999999965332
Q ss_pred h-HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 225 L-EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 225 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
. .....+.+.....|...+..+... ..+...|.... + .........+..+.++|.+||
T Consensus 229 ~~~~~~~~~~~~~~~p~~~~~~~~~~-----~~~~~~~~~~~----------~------~~~~l~~~~~~~l~~ll~~~L 287 (396)
T 4eut_A 229 PRRNKEVMYKIITGKPSGAISGVQKA-----ENGPIDWSGDM----------P------VSCSLSRGLQVLLTPVLANIL 287 (396)
T ss_dssp TTTCHHHHHHHHHSCCTTCCEEEECS-----TTCCEEEESSC----------C------TTCSSCHHHHHHHHHHHHHHS
T ss_pred ccchHHHHHHHhcCCCcccchhheec-----cCCCcccCccC----------C------cccccchHHHhhchHHHHHhh
Confidence 1 112222333322222211111110 00111111100 0 000112234667999999999
Q ss_pred ccCCCCCCCHHHHhc
Q 020235 304 RYDPTDRLTAREALR 318 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~ 318 (329)
++||++|||++++++
T Consensus 288 ~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 288 EADQEKCWGFDQFFA 302 (396)
T ss_dssp CCCTTTSCCHHHHHH
T ss_pred ccChhhhccHHHHHH
Confidence 999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=302.95 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=188.4
Q ss_pred CCCccceEEEEEEecC---CCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRE---RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|.+.. ++..||+|++... ........+|+.++..+ .|+||+++++++.+ +..++|||+
T Consensus 20 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~-~~~~~v~e~ 93 (281)
T 3cc6_A 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-----DHPHIVKLIGIIEE-EPTWIIMEL 93 (281)
T ss_dssp EEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-----CCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-----CCCCcceEEEEEcC-CCCEEEEec
Confidence 6899999999998654 3457999998753 23456677899999999 57999999999875 456899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 94 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~------------------------ 148 (281)
T 3cc6_A 94 YPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS------------------------ 148 (281)
T ss_dssp CTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEE------------------------
T ss_pred CCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECC------------------------
Confidence 9 899999998643 35899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
+..++|+|||.+....... ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+...
T Consensus 149 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~ 225 (281)
T 3cc6_A 149 ---PECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG 225 (281)
T ss_dssp ---TTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH
T ss_pred ---CCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH
Confidence 3457888888876554432 23456788999999999899999999999999999998 999998665544433
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....... .....+..+.++|.+||+.||++
T Consensus 226 ~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~~p~~ 257 (281)
T 3cc6_A 226 VLEKGDRLP------------------------------------------------KPDLCPPVLYTLMTRCWDYDPSD 257 (281)
T ss_dssp HHHHTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHhcCCCCC------------------------------------------------CCCCCCHHHHHHHHHHccCCchh
Confidence 332221110 01235668999999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||+.+++++
T Consensus 258 Rps~~ell~~ 267 (281)
T 3cc6_A 258 RPRFTELVCS 267 (281)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=302.65 Aligned_cols=237 Identities=20% Similarity=0.266 Sum_probs=188.1
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCce-EEEee
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHI-CIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~-~lv~e 74 (329)
||+|+||+||+|.+..+++ .||+|++.... ...+...+|+.++..+ .|+||+++++++.+.+.. ++|||
T Consensus 29 lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-----NHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSSSCCEEEEC
T ss_pred eccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEecCCCCcEEEEe
Confidence 6999999999999765544 79999987432 2345667888888888 579999999999876654 99999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++
T Consensus 104 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili------------------------- 157 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML------------------------- 157 (298)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-------------------------
T ss_pred cccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE-------------------------
Confidence 99 999999998643 468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC-------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC-CCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD-------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~ 225 (329)
+.++.++|+|||.+...... .....+|+.|+|||.+.+..++.++|||||||++|+|++| .+||...+..
T Consensus 158 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~ 235 (298)
T 3pls_A 158 --DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF 235 (298)
T ss_dssp --CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG
T ss_pred --cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH
Confidence 45567899999988654332 1334678899999999998999999999999999999994 5556554444
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+....... .....+..+.+++.+||+.
T Consensus 236 ~~~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~ 267 (298)
T 3pls_A 236 DLTHFLAQGRRLP------------------------------------------------QPEYCPDSLYQVMQQCWEA 267 (298)
T ss_dssp GHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHhhcCCCCC------------------------------------------------CCccchHHHHHHHHHHccC
Confidence 3333222211110 0123567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||.+|||+.++++
T Consensus 268 ~p~~Rps~~~ll~ 280 (298)
T 3pls_A 268 DPAVRPTFRVLVG 280 (298)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999998875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=305.16 Aligned_cols=236 Identities=26% Similarity=0.402 Sum_probs=180.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.+. ++.||+|++.. ........+|+.++..+ .|+||+++++++.+ ..++||||+ +++
T Consensus 16 lg~G~~g~V~~~~~~--~~~vavK~~~~-~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~--~~~lv~e~~~~~~ 85 (307)
T 2eva_A 16 VGRGAFGVVCKAKWR--AKDVAIKQIES-ESERKAFIVELRQLSRV-----NHPNIVKLYGACLN--PVCLVMEYAEGGS 85 (307)
T ss_dssp EECCSSSEEEEEEET--TEEEEEEECSS-TTHHHHHHHHHHHHHHC-----CCTTBCCEEEBCTT--TTEEEEECCTTCB
T ss_pred eecCCCceEEEEEEC--CeeEEEEEecC-hhHHHHHHHHHHHHhcC-----CCCCcCeEEEEEcC--CcEEEEEcCCCCC
Confidence 699999999999875 67899999874 33456678899999888 57999999998874 589999999 899
Q ss_pred HHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 80 LYDFLRKNNY-RSFPIDLVREIARQLLECIAFMHD---LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 80 l~~~l~~~~~-~~l~~~~~~~~~~~l~~~L~~lH~---~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|.+++..... ..++...+..++.|++.||.|||+ +||+||||||+||+++.+
T Consensus 86 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~------------------------ 141 (307)
T 2eva_A 86 LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG------------------------ 141 (307)
T ss_dssp HHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETT------------------------
T ss_pred HHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCC------------------------
Confidence 9999986532 236888999999999999999999 899999999999999532
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
...++|+|||.+...........||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 142 --~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~ 219 (307)
T 2eva_A 142 --GTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219 (307)
T ss_dssp --TTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT
T ss_pred --CCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc
Confidence 223799999998766655555679999999999999899999999999999999999999997543322111101101
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
+..+ ......+..+.++|.+||+.||++|||+++
T Consensus 220 ~~~~----------------------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 253 (307)
T 2eva_A 220 GTRP----------------------------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEE 253 (307)
T ss_dssp TCCC----------------------------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCC----------------------------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 1100 012345678999999999999999999999
Q ss_pred Hhc
Q 020235 316 ALR 318 (329)
Q Consensus 316 ll~ 318 (329)
+++
T Consensus 254 ll~ 256 (307)
T 2eva_A 254 IVK 256 (307)
T ss_dssp HHH
T ss_pred HHH
Confidence 987
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=312.81 Aligned_cols=240 Identities=22% Similarity=0.280 Sum_probs=189.5
Q ss_pred CCCccceEEEEEEecCCCceE--EEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMV--AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~v--aiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.++..+ |+|.+... ........+|+.++..+ ..|+||+++++++.+.+..++||||+
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l----~~hp~iv~~~~~~~~~~~~~lv~e~~ 108 (327)
T 1fvr_A 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL----GHHPNIINLLGACEHRGYLYLAIEYA 108 (327)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTC----CCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred eecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhc----cCCCchhhhceeeeeCCceEEEEecC
Confidence 699999999999999888765 99988742 22334566788877766 35699999999999999999999999
Q ss_pred -CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 77 -GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 77 -~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
+++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 109 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~------------ 176 (327)
T 1fvr_A 109 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG------------ 176 (327)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred CCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc------------
Confidence 889999998643 24689999999999999999999999999999999999994
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
.++.++|+|||.+....... ....+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 177 ---------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 241 (327)
T 1fvr_A 177 ---------------ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241 (327)
T ss_dssp ---------------GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ---------------CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCC
Confidence 44568888888876433222 23456788999999999889999999999999999998 9999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+...... ......+..+.++
T Consensus 242 f~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~l 273 (327)
T 1fvr_A 242 YCGMTCAELYEKLPQGYRL------------------------------------------------EKPLNCDDEVYDL 273 (327)
T ss_dssp TTTCCHHHHHHHGGGTCCC------------------------------------------------CCCTTBCHHHHHH
T ss_pred CCCCcHHHHHHHhhcCCCC------------------------------------------------CCCCCCCHHHHHH
Confidence 9876654433222111000 0012356789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
|.+||+.||.+|||+++++++
T Consensus 274 i~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 274 MRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=311.58 Aligned_cols=239 Identities=22% Similarity=0.311 Sum_probs=193.5
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.++ .+++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~ 107 (322)
T 1p4o_A 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVSQGQPTLVIM 107 (322)
T ss_dssp EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred eccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-----CCCCEeeeEEEEccCCccEEEE
Confidence 689999999999887 467899999987432 2334566788888777 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 74 EKL-GSSLYDFLRKNN--------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~--------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
|++ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 108 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---------------- 171 (322)
T 1p4o_A 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---------------- 171 (322)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----------------
T ss_pred EeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE----------------
Confidence 999 889999997521 1346899999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
+.++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 172 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 240 (322)
T 1p4o_A 172 -----------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240 (322)
T ss_dssp -----------CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred -----------cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCc
Confidence 456679999999887544322 22356888999999999899999999999999999999 8999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+...... ......+..+.++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~l 272 (322)
T 1p4o_A 241 YQGLSNEQVLRFVMEGGLL------------------------------------------------DKPDNCPDMLFEL 272 (322)
T ss_dssp TTTSCHHHHHHHHHTTCCC------------------------------------------------CCCTTCCHHHHHH
T ss_pred cccCCHHHHHHHHHcCCcC------------------------------------------------CCCCCCCHHHHHH
Confidence 9876655443332221100 0012356789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
|.+||+.||++|||+.++++|
T Consensus 273 i~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 273 MRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=305.18 Aligned_cols=235 Identities=23% Similarity=0.329 Sum_probs=188.3
Q ss_pred CCCccceEEEEEE--ecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECW--DRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~--~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|. .+.+++.||+|+++... .......+|+.++..+ .|+||+++++++ ..+..++|||+
T Consensus 25 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~-~~~~~~lv~e~ 98 (291)
T 1xbb_A 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGIC-EAESWMLVMEM 98 (291)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEE-ESSSEEEEEEC
T ss_pred cccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEE-CCCCcEEEEEe
Confidence 6899999999995 45678899999987432 2245667888888888 579999999998 56778999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... .+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 99 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~------------------------ 152 (291)
T 1xbb_A 99 AELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT------------------------ 152 (291)
T ss_dssp CTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE------------------------
T ss_pred CCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeC------------------------
Confidence 9 899999998754 6899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+..++|+|||.+........ ...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+..+.
T Consensus 153 ---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 229 (291)
T 1xbb_A 153 ---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229 (291)
T ss_dssp ---TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred ---CCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 34578888888775544331 1245678999999998889999999999999999999 9999987665543
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.....+ ......+..+.++|.+||+.||
T Consensus 230 ~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~li~~~l~~dp 261 (291)
T 1xbb_A 230 TAMLEKGERM------------------------------------------------GCPAGCPREMYDLMNLCWTYDV 261 (291)
T ss_dssp HHHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSST
T ss_pred HHHHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcCCCh
Confidence 3332221100 0112456789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+.++++
T Consensus 262 ~~Rps~~~l~~ 272 (291)
T 1xbb_A 262 ENRPGFAAVEL 272 (291)
T ss_dssp TTSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.75 Aligned_cols=236 Identities=21% Similarity=0.269 Sum_probs=184.5
Q ss_pred CCCccceEEEEEEecCCCceE----EEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMV----AIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|++..+++.+ |+|.+... ........+|+.++..+ .|+||+++++++.++. .++|++
T Consensus 23 lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~-~~~v~~ 96 (327)
T 3lzb_A 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTST-VQLITQ 96 (327)
T ss_dssp EEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-----CBTTBCCCCEEEESSS-EEEEEC
T ss_pred eeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-----CCCCeeEEEEEEecCC-ceEEEE
Confidence 699999999999998887755 66766432 23456677898888888 5699999999998765 788889
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 97 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~----------------------- 152 (327)
T 3lzb_A 97 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT----------------------- 152 (327)
T ss_dssp CCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-----------------------
T ss_pred ecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcC-----------------------
Confidence 98 999999998754 36899999999999999999999999999999999999954
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 153 ----~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 228 (327)
T 3lzb_A 153 ----PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228 (327)
T ss_dssp ----TTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred ----CCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 4458888888887654332 22346778999999999999999999999999999999 9999987665543
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+....... .....+..+.++|.+||+.||
T Consensus 229 ~~~~~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~dp 260 (327)
T 3lzb_A 229 SSILEKGERLP------------------------------------------------QPPICTIDVYMIMRKCWMIDA 260 (327)
T ss_dssp HHHHHTTCCCC------------------------------------------------CCTTBCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCC------------------------------------------------CCccCCHHHHHHHHHHcCCCh
Confidence 33322211110 012356689999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
.+|||+.++++
T Consensus 261 ~~Rps~~ell~ 271 (327)
T 3lzb_A 261 DSRPKFRELII 271 (327)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=306.36 Aligned_cols=235 Identities=23% Similarity=0.320 Sum_probs=182.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-cCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||++.++ |+.||+|+++.. ...+...+|+.++..+ .|+|++++++++. ..+..++||||+ ++
T Consensus 29 lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 29 IGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp EEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EecCCCceEEEEEEc--CCEEEEEEecch-hHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 689999999999774 789999998753 3456677888888887 5799999999854 445899999999 78
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++ +.+
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---------------------------~~~ 153 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---------------------------SED 153 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---------------------------CTT
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---------------------------eCC
Confidence 99999986542347899999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
+.++|+|||.+...........+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..+....+.+...
T Consensus 154 ~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~- 232 (278)
T 1byg_A 154 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK- 232 (278)
T ss_dssp SCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC-
T ss_pred CcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-
Confidence 67999999998866655555578889999999999899999999999999999998 9999977554333222211100
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
.......+..+.++|.+||+.||++|||+.+++
T Consensus 233 -----------------------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 265 (278)
T 1byg_A 233 -----------------------------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 265 (278)
T ss_dssp -----------------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----------------------------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 001234567899999999999999999999987
Q ss_pred c
Q 020235 318 R 318 (329)
Q Consensus 318 ~ 318 (329)
+
T Consensus 266 ~ 266 (278)
T 1byg_A 266 E 266 (278)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=312.42 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=190.9
Q ss_pred CCCccceEEEEEEecCCCc-----eEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKE-----MVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|.+..+++ .||+|.+.... .......+|+.++..+ ..|+||+++++++.+.+..++||
T Consensus 54 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~h~~iv~~~~~~~~~~~~~lv~ 129 (333)
T 2i1m_A 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL----GQHENIVNLLGACTHGGPVLVIT 129 (333)
T ss_dssp EEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred eccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhh----cCCCCeeeEEEEEecCCceEEEE
Confidence 6999999999999877664 79999987532 3345677899999888 24699999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 74 EKL-GSSLYDFLRKNN------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+|||++.++
T Consensus 130 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-------- 201 (333)
T 2i1m_A 130 EYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-------- 201 (333)
T ss_dssp ECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG--------
T ss_pred ecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC--------
Confidence 999 889999997531 23579999999999999999999999999999999999996544
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT- 214 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~- 214 (329)
.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 202 -------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 262 (333)
T 2i1m_A 202 -------------------VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSL 262 (333)
T ss_dssp -------------------EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred -------------------eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcC
Confidence 46777777765433222 23456788999999999899999999999999999998
Q ss_pred CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhH
Q 020235 215 GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294 (329)
Q Consensus 215 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (329)
|..||.+.........+.......+ .....+..
T Consensus 263 g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~ 295 (333)
T 2i1m_A 263 GLNPYPGILVNSKFYKLVKDGYQMA-----------------------------------------------QPAFAPKN 295 (333)
T ss_dssp SCCSSTTCCSSHHHHHHHHHTCCCC-----------------------------------------------CCTTCCHH
T ss_pred CCCCCcccchhHHHHHHHhcCCCCC-----------------------------------------------CCCCCCHH
Confidence 9999987654433332222111100 01224567
Q ss_pred HHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 295 LTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 295 ~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
+.++|.+||+.||.+|||+.+++++
T Consensus 296 l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 296 IYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccChhhCcCHHHHHHH
Confidence 9999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=317.92 Aligned_cols=244 Identities=15% Similarity=0.154 Sum_probs=184.3
Q ss_pred CCCccceEEEEEEecCC--------CceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceee--------------
Q 020235 1 MGEGTFGQVLECWDRER--------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ-------------- 58 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~-------------- 58 (329)
||+|+||.||+|+++.+ ++.||+|++... ....+|+.++..+. |+|+++
T Consensus 50 lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAA-----KPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp EEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHC-----CHHHHHHHHHHTTCTTCSCC
T ss_pred ecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhc-----ccchhhhhhhhccCCccCcc
Confidence 68999999999999874 889999998743 45678888888883 455554
Q ss_pred -ecccccc-CCceEEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 59 -IRNWFDY-RNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 59 -l~~~~~~-~~~~~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
+++++.. ++..++||||++++|.+++.......+++..++.++.|++.||.|||++||+||||||+|||++.++
T Consensus 121 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~---- 196 (352)
T 2jii_A 121 TCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED---- 196 (352)
T ss_dssp CCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE----
T ss_pred chhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC----
Confidence 5555554 6789999999999999999976344799999999999999999999999999999999999995432
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 206 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 206 (329)
...++|+|||.+....... ....||+.|+|||++.+..++.++||||||
T Consensus 197 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 255 (352)
T 2jii_A 197 ---------------------QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLG 255 (352)
T ss_dssp ---------------------EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ---------------------CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHH
Confidence 1257888888876443221 234789999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCc-hhHHHHHHHH-HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 207 CILVELCTGEALFQTHE-NLEHLAMMER-VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 207 ~~l~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
|++|+|++|+.||.... .......... .....+. ... .
T Consensus 256 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~--------------------~ 295 (352)
T 2jii_A 256 YCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP--------------------FVG--------------------P 295 (352)
T ss_dssp HHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC--------------------EEC--------------------T
T ss_pred HHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh--------------------hhh--------------------h
Confidence 99999999999997653 2222221111 1111100 000 0
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
...+..++..+.+||.+||+.||++|||++++++
T Consensus 296 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 296 CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 0001245778999999999999999999999865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=338.19 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=200.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~~lv 72 (329)
||+|+||+||+|.++.+|+.||+|+++.. ........+|+.++..+ .||||+++++++.. .+..++|
T Consensus 22 LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-----~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-----NHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-----CBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCceeeeecccccccCCCeEEEE
Confidence 79999999999999999999999998743 33355677899999998 56999999888765 6788999
Q ss_pred eecC-CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 73 FEKL-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
|||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+|+||||+||+++.++
T Consensus 97 mEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g------------------ 158 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP------------------ 158 (676)
T ss_dssp EECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS------------------
T ss_pred EEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC------------------
Confidence 9999 999999998743 23588999999999999999999999999999999999996532
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
....++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 159 ------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~- 231 (676)
T 3qa8_A 159 ------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ- 231 (676)
T ss_dssp ------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-
T ss_pred ------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-
Confidence 23458999999998765443 345799999999999988999999999999999999999999976433211
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
............. .......+...+.. ...........++..+.+||.+||++||+
T Consensus 232 -----~~~~i~~~~~~~~---~~~~~l~g~~~~~~----------------~lp~p~~l~~~ls~~L~dLI~~mL~~DP~ 287 (676)
T 3qa8_A 232 -----WHGKVREKSNEHI---VVYDDLTGAVKFSS----------------VLPTPNHLSGILAGKLERWLQCMLMWHQR 287 (676)
T ss_dssp -----SSTTCC------C---CSCCCCSSSCCCCS----------------SSCCSCCCCGGGHHHHHHHHHHHSCSSCC
T ss_pred -----hhhhhhcccchhh---hhhhhhcccccccc----------------ccCCchhhchhhhHHHHHHHHHHccCCHh
Confidence 0000000000000 00000000111100 00011112334678899999999999999
Q ss_pred CCCCHHHHhcCCCCCC
Q 020235 309 DRLTAREALRHPFFTR 324 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~~ 324 (329)
+|||++++++||||+.
T Consensus 288 kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 288 QRGTDPQNPNVGCFQA 303 (676)
T ss_dssp ---CCTTCCCCTTHHH
T ss_pred hCcCHHHHhcCHHHHH
Confidence 9999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=310.13 Aligned_cols=234 Identities=26% Similarity=0.476 Sum_probs=181.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++.+++.||+|+++.. ....+|+.++.+. ..|+||+++++++.. ....++||||+
T Consensus 26 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~----~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 26 LGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHh----ccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 68999999999999999999999998742 3456778877555 267999999998876 67899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.......+++..++.++.|++.||.|||++||+|+||||+||+++..
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~------------------------ 153 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------------------ 153 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS------------------------
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC------------------------
Confidence 8899999998765679999999999999999999999999999999999999532
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
..+..++|+|||.+..... ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~-------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-- 212 (299)
T 3m2w_A 154 RPNAILKLTDFGFAKETTG-------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-- 212 (299)
T ss_dssp STTCCEEECCCTTCEECTT-------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--
T ss_pred CCCCcEEEecccccccccc-------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--
Confidence 1256799999999864322 3477899999999999999999999976443221000000
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
....+.... .......++..+.+||.+||+.||++|||+++
T Consensus 213 -----------------~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 213 -----------------RIRMGQYEF----------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp -----------------SSCTTCCSS----------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred -----------------HHhhccccC----------------------CchhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence 000000000 00112346788999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 020235 316 ALRHPFFTRDH 326 (329)
Q Consensus 316 ll~hp~f~~~~ 326 (329)
+++||||++..
T Consensus 254 ~l~hp~~~~~~ 264 (299)
T 3m2w_A 254 FMNHPWIMQST 264 (299)
T ss_dssp HHTSHHHHTGG
T ss_pred HhcChhhcccc
Confidence 99999997653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.80 Aligned_cols=254 Identities=22% Similarity=0.261 Sum_probs=191.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|.++ +++.||+|++.... .......+|+.++..+ .|+||+++++++.+.+..++||||+ ++
T Consensus 47 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 47 IGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFC-----RHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp SCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-----CCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred eecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 799999999999965 68899999887432 2345567788888777 5799999999999999999999999 89
Q ss_pred CHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 79 SLYDFLRKNNY--RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 79 ~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||++ +
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---------------------------~ 173 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---------------------------D 173 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---------------------------C
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---------------------------C
Confidence 99999865432 348899999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+.+.....
T Consensus 174 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~ 253 (321)
T 2qkw_B 174 ENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253 (321)
T ss_dssp TTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH
T ss_pred CCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH
Confidence 56678999999887543221 2346899999999999889999999999999999999999999764332110000
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
.. .......+..... ..+... .......+..+.+++.+||+.||++||
T Consensus 254 ~~----------------~~~~~~~~~~~~~-------------~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rp 301 (321)
T 2qkw_B 254 EW----------------AVESHNNGQLEQI-------------VDPNLA---DKIRPESLRKFGDTAVKCLALSSEDRP 301 (321)
T ss_dssp HH----------------THHHHTTTCCCSS-------------SSSSCT---TCSCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred HH----------------hhhccccccHHHh-------------cChhhc---cccCHHHHHHHHHHHHHHcCCCcccCc
Confidence 00 0000000000000 000000 001123456799999999999999999
Q ss_pred CHHHHhcC
Q 020235 312 TAREALRH 319 (329)
Q Consensus 312 t~~~ll~h 319 (329)
|++++++|
T Consensus 302 s~~ell~~ 309 (321)
T 2qkw_B 302 SMGDVLWK 309 (321)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=304.26 Aligned_cols=240 Identities=26% Similarity=0.387 Sum_probs=181.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.+..+++.||+|+++.. ........+|+.++..+ .|+||+++++++...+..++|||++
T Consensus 40 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~ 114 (310)
T 2wqm_A 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-----NHPNVIKYYASFIEDNELNIVLELA 114 (310)
T ss_dssp EECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEcCCcEEEEEecC
Confidence 68999999999999999999999998742 23345667888888888 5799999999999999999999999
Q ss_pred -CCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 77 -GSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 77 -~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 115 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~------------------------- 169 (310)
T 2wqm_A 115 DAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI------------------------- 169 (310)
T ss_dssp CSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------------------------
T ss_pred CCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE-------------------------
Confidence 8899999975 123468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh--HHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL--EHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~ 228 (329)
+.++.++|+|||.+....... ....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.... ...
T Consensus 170 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 247 (310)
T 2wqm_A 170 --TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 247 (310)
T ss_dssp --CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH
T ss_pred --cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH
Confidence 455678999999887554332 2346899999999999989999999999999999999999999754321 111
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+... ..+. ......+..+.++|.+||+.||+
T Consensus 248 ~~~~~~--~~~~---------------------------------------------~~~~~~~~~l~~li~~~l~~dp~ 280 (310)
T 2wqm_A 248 KKIEQC--DYPP---------------------------------------------LPSDHYSEELRQLVNMCINPDPE 280 (310)
T ss_dssp HHHHTT--CSCC---------------------------------------------CCTTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhhcc--cCCC---------------------------------------------CcccccCHHHHHHHHHHcCCChh
Confidence 111110 0000 00123567899999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+++++++
T Consensus 281 ~Rps~~~il~~ 291 (310)
T 2wqm_A 281 KRPDVTYVYDV 291 (310)
T ss_dssp GSCCHHHHHHH
T ss_pred hCCCHHHHHHH
Confidence 99999999863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=303.21 Aligned_cols=237 Identities=17% Similarity=0.227 Sum_probs=187.0
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccc-cccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-FDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~-~~~~~~~~lv~e 74 (329)
||+|+||+||+|.+..+ ...+|+|.+.... .......+|+.++..+ .|+||++++++ +..++..++|||
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEECCSSSCCEEEEE
T ss_pred eeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeeEEEcCCCceEEEEe
Confidence 69999999999987543 3468999987432 3345667888888888 57999999998 556678999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 108 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~------------------------- 161 (298)
T 3f66_A 108 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML------------------------- 161 (298)
T ss_dssp CCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-------------------------
T ss_pred CCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE-------------------------
Confidence 99 889999997643 468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....||+.|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..
T Consensus 162 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~ 239 (298)
T 3f66_A 162 --DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 239 (298)
T ss_dssp --CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT
T ss_pred --CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH
Confidence 455678888888886543322 23457788999999999999999999999999999999 66777765554
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+...... ....+..+.+++.+||+.
T Consensus 240 ~~~~~~~~~~~~~~------------------------------------------------~~~~~~~l~~li~~~l~~ 271 (298)
T 3f66_A 240 DITVYLLQGRRLLQ------------------------------------------------PEYCPDPLYEVMLKCWHP 271 (298)
T ss_dssp THHHHHHTTCCCCC------------------------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHhcCCCCCC------------------------------------------------CccCCHHHHHHHHHHcCC
Confidence 43333222211110 123456899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||++|||+.++++
T Consensus 272 ~p~~Rps~~ell~ 284 (298)
T 3f66_A 272 KAEMRPSFSELVS 284 (298)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999885
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=311.39 Aligned_cols=237 Identities=28% Similarity=0.387 Sum_probs=171.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc--------ccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF--------DYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~--------~~~~~~~l 71 (329)
||+|+||.||+|+++.+++.||+|++... ........+|+.++..+. .|+||+++++++ ......++
T Consensus 36 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~----~h~~iv~~~~~~~~~~~~~~~~~~~~~l 111 (337)
T 3ll6_A 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS----GHPNIVQFCSAASIGKEESDTGQAEFLL 111 (337)
T ss_dssp EECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHT----TSTTBCCEEEEEEECTTTSTTSSEEEEE
T ss_pred EccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhc----cCCChhhccccccccccccccCCceEEE
Confidence 69999999999999999999999988543 233456678889998883 479999999887 34556899
Q ss_pred EeecCCCCHHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCC
Q 020235 72 VFEKLGSSLYDFLRK-NNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKD 148 (329)
Q Consensus 72 v~e~~~~~l~~~l~~-~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~ 148 (329)
||||++++|.+++.. .....+++..++.++.|++.||.|||++| |+|+||||+|||++
T Consensus 112 v~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~------------------- 172 (337)
T 3ll6_A 112 LTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS------------------- 172 (337)
T ss_dssp EEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC-------------------
T ss_pred EEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC-------------------
Confidence 999999999999875 22236999999999999999999999999 99999999999994
Q ss_pred CCccccCCCCCCeEEeeCCCCcccCCCC---------------CcccccCCCCchhHH---hcCCCCCccchHhHHHHHH
Q 020235 149 SSYFKRMPKSSAIKVIDFGSTTYERPDQ---------------NYIVSTRHYRAPEVI---LGLGWTYPCDIWSVGCILV 210 (329)
Q Consensus 149 ~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---------------~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~ 210 (329)
.++.++|+|||.+....... ....||+.|+|||++ .+..++.++|||||||++|
T Consensus 173 --------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~ 244 (337)
T 3ll6_A 173 --------NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY 244 (337)
T ss_dssp --------TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHH
T ss_pred --------CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHH
Confidence 45567778888776544322 134689999999998 4556889999999999999
Q ss_pred HHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 211 ELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 211 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
+|++|..||.......... .. ...+ ....
T Consensus 245 el~~g~~p~~~~~~~~~~~---~~------------------------~~~~------------------------~~~~ 273 (337)
T 3ll6_A 245 LLCFRQHPFEDGAKLRIVN---GK------------------------YSIP------------------------PHDT 273 (337)
T ss_dssp HHHHSSCCC---------------------------------------CCCC------------------------TTCC
T ss_pred HHHhCCCCCcchhHHHhhc---Cc------------------------ccCC------------------------cccc
Confidence 9999999996533221100 00 0000 0123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+..+.+||.+||+.||++|||+.++++|
T Consensus 274 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 274 QYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp SSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34568899999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=330.06 Aligned_cols=244 Identities=27% Similarity=0.350 Sum_probs=199.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||.||+|.++.+ ..||||+++......+...+|+.++..+ .|+||+++++++.+ +..++||||+ +++
T Consensus 275 lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~E~~~l~~l-----~hpniv~~~~~~~~-~~~~lv~e~~~~gs 347 (535)
T 2h8h_A 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 347 (535)
T ss_dssp EEECSSEEEEEEEETTT-EEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEEEECCCTTEE
T ss_pred cccCCCeEEEEEEECCC-ceEEEEEeCCCCCCHHHHHHHHHHHHhC-----CCCCEeeEEEEEee-ccceEeeehhcCCc
Confidence 69999999999998764 5699999986555567788999999999 57999999999876 6799999999 889
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++ .+.
T Consensus 348 L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---------------------------~~~ 400 (535)
T 2h8h_A 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---------------------------ENL 400 (535)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------------GGG
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---------------------------CCC
Confidence 99999754334589999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.++|+|||++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+....+.+.
T Consensus 401 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~ 480 (535)
T 2h8h_A 401 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480 (535)
T ss_dssp CEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 68999999887654321 22346778999999999899999999999999999999 99999887665544433321
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
... .....++..+.+||.+||+.||++|||++
T Consensus 481 ~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 512 (535)
T 2h8h_A 481 YRM------------------------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFE 512 (535)
T ss_dssp CCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 110 01123567899999999999999999999
Q ss_pred HHhcC--CCCCCCC
Q 020235 315 EALRH--PFFTRDH 326 (329)
Q Consensus 315 ~ll~h--p~f~~~~ 326 (329)
+|++. .+|...+
T Consensus 513 ~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 513 YLQAFLEDYFTSTE 526 (535)
T ss_dssp HHHHHHHTSSCCCS
T ss_pred HHHHHHHHHhhccC
Confidence 99874 6666544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=332.86 Aligned_cols=235 Identities=23% Similarity=0.325 Sum_probs=189.9
Q ss_pred CCCccceEEEEEEe--cCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWD--RERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~--~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+ +.+++.||||+++... .......+|+.++..+ .|+||++++++++. +..++||||
T Consensus 377 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~l~~~~~~-~~~~lv~E~ 450 (635)
T 4fl3_A 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLVMEM 450 (635)
T ss_dssp EEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-SSEEEEEEC
T ss_pred eccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEec-CCEEEEEEc
Confidence 69999999999954 4667899999987532 2346778899999999 57999999999864 568999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 451 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~------------------------ 504 (635)
T 4fl3_A 451 AELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT------------------------ 504 (635)
T ss_dssp CTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE------------------------
T ss_pred cCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC------------------------
Confidence 9 899999998754 6899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
+..++|+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.
T Consensus 505 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~ 581 (635)
T 4fl3_A 505 ---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581 (635)
T ss_dssp ---TTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred ---CCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 4458888888876554332 22346778999999999999999999999999999998 9999988776655
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+..... .+..++.++.+||.+||+.||
T Consensus 582 ~~~i~~~~~~~------------------------------------------------~p~~~~~~l~~li~~cl~~dP 613 (635)
T 4fl3_A 582 TAMLEKGERMG------------------------------------------------CPAGCPREMYDLMNLCWTYDV 613 (635)
T ss_dssp HHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSST
T ss_pred HHHHHcCCCCC------------------------------------------------CCCCCCHHHHHHHHHHcCCCH
Confidence 44443321110 112356789999999999999
Q ss_pred CCCCCHHHHhc
Q 020235 308 TDRLTAREALR 318 (329)
Q Consensus 308 ~~R~t~~~ll~ 318 (329)
++|||+++|++
T Consensus 614 ~~RPs~~~l~~ 624 (635)
T 4fl3_A 614 ENRPGFAAVEL 624 (635)
T ss_dssp TTSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=307.62 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=180.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||+|+||+||+|.+ +++.||+|++... .......|.+++.... ..|+||+++++++.+ ....++||||+
T Consensus 16 lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 16 VGKGRYGEVWRGSW--QGENVAVKIFSSR--DEKSWFRETELYNTVM---LRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp EEECSSEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHTC---CCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred eccCCCcEEEEEEE--CCEEEEEEEeccc--cchhhHHHHHHHHHhh---ccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 69999999999977 6889999998743 2344556767666632 267999999988543 45789999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH--------~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+++|.+++... .+++..++.++.|++.||+||| ++||+||||||+|||+
T Consensus 89 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill------------------- 146 (301)
T 3q4u_A 89 EMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV------------------- 146 (301)
T ss_dssp TTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE-------------------
T ss_pred cCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE-------------------
Confidence 88999999654 5999999999999999999999 9999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC------CCCCccchHhHHHHHHHHHh
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL------GWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~l~~ 214 (329)
+.+..++|+|||.+....... ....||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 147 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~t 218 (301)
T 3q4u_A 147 --------KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218 (301)
T ss_dssp --------CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHh
Confidence 455678999999886544332 224799999999999876 34478999999999999999
Q ss_pred C----------CCCCCCCchhH-HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHH
Q 020235 215 G----------EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283 (329)
Q Consensus 215 g----------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
| ..||....... ....+....... ......+.
T Consensus 219 g~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~-------------------- 261 (301)
T 3q4u_A 219 RMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVD-----------------QQRPNIPN-------------------- 261 (301)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTS-----------------CCCCCCCG--------------------
T ss_pred hhcCccccccccccccccCCCCcchhhhhHHHhcc-----------------CCCCCCCh--------------------
Confidence 9 77875432110 011111110000 00000000
Q ss_pred HhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 284 IMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 284 ~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.......+..+.+||.+||+.||++|||+.++++
T Consensus 262 -~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 262 -RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp -GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 0011234568999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=304.28 Aligned_cols=239 Identities=18% Similarity=0.252 Sum_probs=182.8
Q ss_pred CCCccceEEEEEEecC---CCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ce
Q 020235 1 MGEGTFGQVLECWDRE---RKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~---~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~ 69 (329)
||+|+||.||+|.+.. +++.||+|+++... .......+|+.++..+ .|+||+++++++.+.+ ..
T Consensus 42 lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-----SHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEC-------CE
T ss_pred eeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-----CCCCeeeeeEEEeeccccCCccc
Confidence 6999999999998765 56689999987432 2335567788888888 5799999999987654 45
Q ss_pred EEEeecC-CCCHHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 70 CIVFEKL-GSSLYDFLRKN----NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 70 ~lv~e~~-~~~l~~~l~~~----~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
++||||+ +++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---------------- 180 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---------------- 180 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE----------------
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----------------
Confidence 9999999 89999999642 23468999999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 218 (329)
+.++.++|+|||.+....... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus 181 -----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 181 -----------RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp -----------CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred -----------cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 455678999999887554332 23456788999999999999999999999999999999 8999
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.....+ .....++..+.++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~------------------------------------------------~~~~~~~~~l~~l 281 (313)
T 3brb_A 250 YPGVQNHEMYDYLLHGHRL------------------------------------------------KQPEDCLDELYEI 281 (313)
T ss_dssp STTCCGGGHHHHHHTTCCC------------------------------------------------CCBTTCCHHHHHH
T ss_pred CccCCHHHHHHHHHcCCCC------------------------------------------------CCCccccHHHHHH
Confidence 9876654433322221100 0112456789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
|.+||+.||++|||+.+++++
T Consensus 282 i~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 282 MYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=305.45 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=191.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+ +++.||+|++... ........+|+.++..+ .|+||+++++++.+.+..++||||
T Consensus 39 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 39 MGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-----QHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp EEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEEEC
T ss_pred cccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-----CCCCeEEEEEEEecCCceEEEEEe
Confidence 68999999999976 5788999998642 22345677899999888 579999999999999999999999
Q ss_pred C-CCCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 76 L-GSSLYDFLRKNN-YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 76 ~-~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
+ +++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||++
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili------------------------- 166 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL------------------------- 166 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-------------------------
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE-------------------------
Confidence 9 999999997532 2458999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........
T Consensus 167 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 167 --DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp --CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred --cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 556678999999887554432 23468999999999876 4789999999999999999999999875543222
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+........+ ..+.... ........+..+.+++.+||+.||.
T Consensus 244 ~~~~~~~~~~~~~~--------~~~~~~~--------------------------~~~~~~~~~~~l~~li~~cl~~~p~ 289 (307)
T 2nru_A 244 LDIKEEIEDEEKTI--------EDYIDKK--------------------------MNDADSTSVEAMYSVASQCLHEKKN 289 (307)
T ss_dssp THHHHHHHTTSCCH--------HHHSCSS--------------------------CSCCCHHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHhhhhhhhh--------hhhcccc--------------------------ccccchHHHHHHHHHHHHHcCCCcc
Confidence 22222111100000 0000000 0001123456799999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+++++++
T Consensus 290 ~Rps~~~l~~~ 300 (307)
T 2nru_A 290 KRPDIKKVQQL 300 (307)
T ss_dssp TSCCHHHHHHH
T ss_pred cCcCHHHHHHH
Confidence 99999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=304.08 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=191.3
Q ss_pred CCCccceEEEEEE----ecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECW----DRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||.||+|+ +..+++.||+|++.... .......+|+.++..+ .|+||+++++++.+. +..++|
T Consensus 29 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv 103 (302)
T 4e5w_A 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-----YHENIVKYKGICTEDGGNGIKLI 103 (302)
T ss_dssp EEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-----CCTTBCCEEEEEEC---CCEEEE
T ss_pred cCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-----CCCCeeeeeeEEecCCCceEEEE
Confidence 6999999999998 57789999999987432 2335667899998888 579999999998876 679999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 104 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~--------------------- 161 (302)
T 4e5w_A 104 MEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES--------------------- 161 (302)
T ss_dssp EECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE---------------------
T ss_pred EEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcC---------------------
Confidence 9999 889999996543 35899999999999999999999999999999999999954
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 162 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~--- 232 (302)
T 4e5w_A 162 ------EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP--- 232 (302)
T ss_dssp ------TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH---
T ss_pred ------CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch---
Confidence 4458888888887655433 2345788899999999988999999999999999999999987432
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
........++........ ........... ...+..++..+.+||.+||+.
T Consensus 233 --~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~ 282 (302)
T 4e5w_A 233 --MALFLKMIGPTHGQMTVT--RLVNTLKEGKR--------------------------LPCPPNCPDEVYQLMRKCWEF 282 (302)
T ss_dssp --HHHHHHHHCSCCGGGHHH--HHHHHHHTTCC--------------------------CCCCTTCCHHHHHHHHHTTCS
T ss_pred --hhHHhhccCCcccccCHH--HHHHHHhccCC--------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 122223333333221110 00000000000 111234677899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||.+|||+.++++
T Consensus 283 dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 283 QPSNRTSFQNLIE 295 (302)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHH
Confidence 9999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=328.06 Aligned_cols=243 Identities=17% Similarity=0.237 Sum_probs=180.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCC-----------------CCCceeee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDK-----------------GGNRCVQI 59 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~-----------------~~~~i~~l 59 (329)
||+|+||+||+|++..+|+.||||+++.... ..+...+|+.++..+.+..+ ..++...+
T Consensus 86 LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (413)
T 3dzo_A 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 165 (413)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----
T ss_pred cccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCcc
Confidence 6999999999999999999999999873221 13445667777766643110 00011111
Q ss_pred cccccc-----CCceEEEeecCCCCHHHHHH-----hCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEe
Q 020235 60 RNWFDY-----RNHICIVFEKLGSSLYDFLR-----KNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLV 129 (329)
Q Consensus 60 ~~~~~~-----~~~~~lv~e~~~~~l~~~l~-----~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~ 129 (329)
...+.. ....+++|+.++++|.+++. ......+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl- 244 (413)
T 3dzo_A 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL- 244 (413)
T ss_dssp -----------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred ccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE-
Confidence 111111 23578999999999999995 2222347788889999999999999999999999999999999
Q ss_pred eccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHH----------hcCCCCCc
Q 020235 130 SSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVI----------LGLGWTYP 199 (329)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~ 199 (329)
+.++.+||+|||.+..........+| +.|+|||++ ....++.+
T Consensus 245 --------------------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~ 297 (413)
T 3dzo_A 245 --------------------------DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA 297 (413)
T ss_dssp --------------------------CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH
T ss_pred --------------------------ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCch
Confidence 55566999999998776655556678 999999999 44457889
Q ss_pred cchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchh
Q 020235 200 CDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPR 279 (329)
Q Consensus 200 ~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (329)
+|||||||++|+|++|+.||.+.+.......
T Consensus 298 ~DvwSlGvil~elltg~~Pf~~~~~~~~~~~------------------------------------------------- 328 (413)
T 3dzo_A 298 FDTWTLGLAIYWIWCADLPNTDDAALGGSEW------------------------------------------------- 328 (413)
T ss_dssp HHHHHHHHHHHHHHHSSCCCCTTGGGSCSGG-------------------------------------------------
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchhhhHHH-------------------------------------------------
Confidence 9999999999999999999976443210000
Q ss_pred hHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q 020235 280 LQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
.......++..+.+||.+||+.||++|||+.++++||||++
T Consensus 329 ----~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 329 ----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp ----GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 00001235678999999999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.13 Aligned_cols=257 Identities=20% Similarity=0.228 Sum_probs=190.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh--hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK--YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||.||+|++. +++.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..++||||+ +
T Consensus 38 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~ 111 (326)
T 3uim_A 38 LGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMA-----VHRNLLRLRGFCMTPTERLLVYPYMAN 111 (326)
T ss_dssp EECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTC-----CCTTBCCCCEEECCSSCCEEEEECCTT
T ss_pred EecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhc-----cCCCccceEEEEecCCceEEEEEeccC
Confidence 699999999999854 688999999875322 222456788877776 5799999999999999999999999 8
Q ss_pred CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 78 SSLYDFLRKNN--YRSFPIDLVREIARQLLECIAFMHDL---CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 78 ~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~L~~lH~~---~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
++|.+++.... ...+++..+..++.|++.||.|||++ ||+|+||||+|||+
T Consensus 112 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~------------------------ 167 (326)
T 3uim_A 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL------------------------ 167 (326)
T ss_dssp CBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE------------------------
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE------------------------
Confidence 89999998643 23489999999999999999999999 99999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
+.+..++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 168 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-- 242 (326)
T 3uim_A 168 ---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN-- 242 (326)
T ss_dssp ---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT--
T ss_pred ---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc--
Confidence 556679999999987654332 23458999999999998889999999999999999999999995211100
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
....... +.............. .... .........+..+.+++.+||+.||+
T Consensus 243 --------~~~~~~~----~~~~~~~~~~~~~~~-------------~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~ 294 (326)
T 3uim_A 243 --------DDDVMLL----DWVKGLLKEKKLEAL-------------VDVD---LQGNYKDEEVEQLIQVALLCTQSSPM 294 (326)
T ss_dssp --------TSCSBHH----HHHTTTTSSCCSTTS-------------SCTT---CTTSCCHHHHHHHHHHHHHHTCSCGG
T ss_pred --------ccchhHH----HHHHHHhhchhhhhh-------------cChh---hccccCHHHHHHHHHHHHHHhCcCCc
Confidence 0000000 000000000000000 0000 00011223456899999999999999
Q ss_pred CCCCHHHHhcCC
Q 020235 309 DRLTAREALRHP 320 (329)
Q Consensus 309 ~R~t~~~ll~hp 320 (329)
+|||++++++|-
T Consensus 295 ~Rps~~ell~~L 306 (326)
T 3uim_A 295 ERPKMSEVVRML 306 (326)
T ss_dssp GSCCHHHHHHHH
T ss_pred cCCCHHHHHHHh
Confidence 999999999873
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=313.17 Aligned_cols=238 Identities=18% Similarity=0.227 Sum_probs=181.0
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccc-ccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-DYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~-~~~~~~~lv~e 74 (329)
||+|+||+||+|.+..+ +..||+|.++... .......+|+.++..+ .|+||+++++++ ..++..++|||
T Consensus 97 LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-----CCTTBCCCCEEECCCSSCCEEEEE
T ss_pred eeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-----CCCCcceEEEEEEcCCCCeEEEEE
Confidence 69999999999987543 3468999886432 3345667788888777 579999999975 45678999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 172 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll------------------------- 225 (373)
T 3c1x_A 172 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------------------------- 225 (373)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------------------
T ss_pred CCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE-------------------------
Confidence 99 889999997644 458899999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
+.+..++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..
T Consensus 226 --~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 226 --DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp --CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred --CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 455678999999887543322 22356778999999999999999999999999999999 78888765544
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+..... .+...+..+.++|.+||+.
T Consensus 304 ~~~~~~~~~~~~~------------------------------------------------~p~~~~~~l~~li~~cl~~ 335 (373)
T 3c1x_A 304 DITVYLLQGRRLL------------------------------------------------QPEYCPDPLYEVMLKCWHP 335 (373)
T ss_dssp CHHHHHHTTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCCCC------------------------------------------------CCCCCCHHHHHHHHHHcCC
Confidence 3332222211000 0123566899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 020235 306 DPTDRLTAREALRH 319 (329)
Q Consensus 306 dP~~R~t~~~ll~h 319 (329)
||++|||+.+++++
T Consensus 336 dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 336 KAEMRPSFSELVSR 349 (373)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=300.74 Aligned_cols=238 Identities=24% Similarity=0.357 Sum_probs=178.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|.+.. .||+|+++... .......+|+.++..+ .|+||+.++++. .....++||||+
T Consensus 32 lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~-~~~~~~lv~e~~~ 102 (289)
T 3og7_A 32 IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYS-TAPQLAIVTQWCE 102 (289)
T ss_dssp EEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred ecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhC-----CCCcEEEEEeec-cCCccEEEEEecC
Confidence 6999999999997654 49999987432 2345567788888877 579999999854 556789999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~--------------------------- 154 (289)
T 3og7_A 103 GSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH--------------------------- 154 (289)
T ss_dssp EEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---------------------------
T ss_pred CCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---------------------------
Confidence 899999997544 4689999999999999999999999999999999999994
Q ss_pred CCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHh---cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.++.++|+|||.+....... ....||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.+..+..
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 234 (289)
T 3og7_A 155 EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 234 (289)
T ss_dssp TTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH
T ss_pred CCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH
Confidence 44568888888886544321 2346899999999997 556888999999999999999999999876655443
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..........+. .......++..+.+||.+||+.||+
T Consensus 235 ~~~~~~~~~~~~-------------------------------------------~~~~~~~~~~~l~~li~~~l~~~p~ 271 (289)
T 3og7_A 235 IEMVGRGSLSPD-------------------------------------------LSKVRSNCPKRMKRLMAECLKKKRD 271 (289)
T ss_dssp HHHHHHTSCCCC-------------------------------------------TTSSCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHhcccccCcc-------------------------------------------hhhccccCCHHHHHHHHHHccCChh
Confidence 332222111100 0001224567899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||++++++
T Consensus 272 ~Rps~~ell~ 281 (289)
T 3og7_A 272 ERPSFPRILA 281 (289)
T ss_dssp GSCCHHHHHH
T ss_pred hCCCHHHHHH
Confidence 9999999985
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.62 Aligned_cols=236 Identities=24% Similarity=0.326 Sum_probs=189.1
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|.++ .++..||||+++.. ....+...+|+.++..+ .|+||+++++++.. +..++||||+
T Consensus 344 LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~hpniv~l~~~~~~-~~~~lv~E~~ 417 (613)
T 2ozo_A 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-EALMLVMEMA 417 (613)
T ss_dssp EEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-----CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred EecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-----CCCCEeeEEEEecc-CCeEEEEEeC
Confidence 699999999999876 35677999998753 23456778899999888 67999999999876 5699999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 418 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~------------------------- 471 (613)
T 2ozo_A 418 GGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN------------------------- 471 (613)
T ss_dssp TTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE-------------------------
T ss_pred CCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcC-------------------------
Confidence 899999997643 46899999999999999999999999999999999999954
Q ss_pred CCCCCeEEeeCCCCcccCCCCC------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQN------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
+..++|+|||++........ ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 472 --~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~ 549 (613)
T 2ozo_A 472 --RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549 (613)
T ss_dssp --TTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH
T ss_pred --CCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 44578888888875543321 1235678999999999899999999999999999998 99999887766544
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+.... ..+..++..+.+||.+||+.||+
T Consensus 550 ~~i~~~~~~------------------------------------------------~~p~~~~~~l~~li~~cl~~dP~ 581 (613)
T 2ozo_A 550 AFIEQGKRM------------------------------------------------ECPPECPPELYALMSDCWIYKWE 581 (613)
T ss_dssp HHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHTTCSSTT
T ss_pred HHHHcCCCC------------------------------------------------CCCCcCCHHHHHHHHHHcCCChh
Confidence 433332110 01124567899999999999999
Q ss_pred CCCCHHHHhc
Q 020235 309 DRLTAREALR 318 (329)
Q Consensus 309 ~R~t~~~ll~ 318 (329)
+|||+.++++
T Consensus 582 ~RPs~~~l~~ 591 (613)
T 2ozo_A 582 DRPDFLTVEQ 591 (613)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=311.35 Aligned_cols=253 Identities=22% Similarity=0.272 Sum_probs=190.1
Q ss_pred CCCccceEEEEEE----ecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc--cCCceEEEe
Q 020235 1 MGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD--YRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~--~~~~~~lv~ 73 (329)
||+|+||.||+|+ +..+++.||+|++.... .......+|+.++..+ .|+||+++++++. +.+..++||
T Consensus 31 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~~~lv~ 105 (327)
T 3lxl_A 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-----HSDFIVKYRGVSYGPGRQSLRLVM 105 (327)
T ss_dssp EEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSSCEEEEEE
T ss_pred ccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-----CCCceeEEEEEEecCCCceEEEEE
Confidence 6999999999998 56789999999987543 3345567899999888 6699999998775 456799999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 106 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~---------------------- 162 (327)
T 3lxl_A 106 EYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES---------------------- 162 (327)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE----------------------
T ss_pred eecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECC----------------------
Confidence 999 999999998643 25899999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
++.++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 163 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~ 237 (327)
T 3lxl_A 163 -----EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF 237 (327)
T ss_dssp -----TTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred -----CCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh
Confidence 4457888888877554332 22357788999999999889999999999999999999999996533221
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
... .......+. .... ........ .......++..+.+||.+||+.|
T Consensus 238 ~~~--~~~~~~~~~--~~~~---~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~d 284 (327)
T 3lxl_A 238 LRM--MGCERDVPA--LSRL---LELLEEGQ--------------------------RLPAPPACPAEVHELMKLCWAPS 284 (327)
T ss_dssp HHH--CC----CCH--HHHH---HHHHHTTC--------------------------CCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hhh--ccccccccc--HHHH---HHHhhccc--------------------------CCCCCCcccHHHHHHHHHHcCCC
Confidence 100 000000000 0000 00000000 00112346788999999999999
Q ss_pred CCCCCCHHHHhcC
Q 020235 307 PTDRLTAREALRH 319 (329)
Q Consensus 307 P~~R~t~~~ll~h 319 (329)
|++|||+++++++
T Consensus 285 P~~Rps~~ell~~ 297 (327)
T 3lxl_A 285 PQDRPSFSALGPQ 297 (327)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=311.97 Aligned_cols=265 Identities=21% Similarity=0.242 Sum_probs=179.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccc-----ccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWF-----DYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~-----~~~~~~~lv~e~ 75 (329)
||+|+||.||+|++ +++.||+|+++... ......|.++... ....|+||+++++.+ ......++||||
T Consensus 21 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~---~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 93 (336)
T 3g2f_A 21 IGRGRYGAVYKGSL--DERPVAVKVFSFAN--RQNFINEKNIYRV---PLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93 (336)
T ss_dssp EEECSSEEEEEEEE--TTEEEEEEEEEGGG--HHHHHHHHHHHTS---TTCCCTTBCCEEEEEEEECTTSCEEEEEEECC
T ss_pred cccCCCeEEEEEEE--CCeEEEEEEeeccc--hhhHHHHHHHHHH---HhccCcchhhheecccccccCCCceEEEEEec
Confidence 69999999999965 67899999987443 2333334333322 123679999998633 334478999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCcccCCCCCcEEEeeccccccCCCcCccCC
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL---------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHT 145 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~---------~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~ 145 (329)
+ +++|.+++.... .++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 94 ~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill----------------- 153 (336)
T 3g2f_A 94 YPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV----------------- 153 (336)
T ss_dssp CTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE-----------------
T ss_pred CCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE-----------------
Confidence 9 899999998754 68999999999999999999999 99999999999999
Q ss_pred CCCCCccccCCCCCCeEEeeCCCCcccCCCC-----------CcccccCCCCchhHHhc-------CCCCCccchHhHHH
Q 020235 146 PKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----------NYIVSTRHYRAPEVILG-------LGWTYPCDIWSVGC 207 (329)
Q Consensus 146 ~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~ 207 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+ ..++.++|||||||
T Consensus 154 ----------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 223 (336)
T 3g2f_A 154 ----------KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223 (336)
T ss_dssp ----------CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHH
T ss_pred ----------cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHH
Confidence 455678888998886543221 23468999999999987 34667899999999
Q ss_pred HHHHHHhCCCCCCCCch-hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhh
Q 020235 208 ILVELCTGEALFQTHEN-LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286 (329)
Q Consensus 208 ~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (329)
++|+|++|..||..... .+....+....+..+.. .......... ......+... .
T Consensus 224 il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~--------------------~ 279 (336)
T 3g2f_A 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF--EDMQVLVSRE--KQRPKFPEAW--------------------K 279 (336)
T ss_dssp HHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCH--HHHHHHHTTS--CCCCCCCTTC--------------------C
T ss_pred HHHHHHhcCCcCCCccchhHHHHhhhcccCCCchH--HHHHhhhccc--ccCCCCCccc--------------------c
Confidence 99999999766643221 11111111111111110 0000000000 0000011000 0
Q ss_pred hccCchhHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCCCC
Q 020235 287 HVDHSAGDLTHLLQGLLRYDPTDRLTAREA------LRHPFFTRDH 326 (329)
Q Consensus 287 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l------l~hp~f~~~~ 326 (329)
.....+..+.+||.+||+.||++|||+.++ +-++|-+++.
T Consensus 280 ~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 280 ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 011245679999999999999999999999 4478877654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=305.70 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=179.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC----CceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR----NHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~----~~~~lv~e~~ 76 (329)
||+|+||.||+|.++ ++.||+|++.... ......|.+++.... ..|+||+++++++... ...++||||+
T Consensus 45 lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~e~~~~~~~~---~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 45 IGKGRYGEVWMGKWR--GEKVAVKVFFTTE--EASWFRETEIYQTVL---MRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEETTEEEEEEEET--TEEEEEEEEEGGG--HHHHHHHHHHHTSTT---CCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred eecCCCeEEEEEEEC--CceEEEEEEeccc--cchhhhHHHHHHHHh---hcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 699999999999875 8899999987433 333344555444332 2679999999998876 7899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL--------CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~--------~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 118 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill------------------- 175 (337)
T 3mdy_A 118 ENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV------------------- 175 (337)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE-------------------
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE-------------------
Confidence 88999999875 499999999999999999999998 99999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCc------cchHhHHHHHHHHHh
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYP------CDIWSVGCILVELCT 214 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~~l~~ 214 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+...... +|||||||++|+|++
T Consensus 176 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~t 247 (337)
T 3mdy_A 176 --------KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR 247 (337)
T ss_dssp --------CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHT
T ss_pred --------CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHh
Confidence 455678999999886544332 23479999999999988776665 999999999999999
Q ss_pred C----------CCCCCCCchhH-HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHH
Q 020235 215 G----------EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNL 283 (329)
Q Consensus 215 g----------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (329)
| ..||....... ....+.... ........
T Consensus 248 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~ 287 (337)
T 3mdy_A 248 RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIV----------------------------------------CIKKLRPS 287 (337)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH----------------------------------------TTSCCCCC
T ss_pred ccCcccccccccccHhhhcCCCCchhhhHHHH----------------------------------------hhhccCcc
Confidence 9 55554321110 000000000 00000000
Q ss_pred Hh--hhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 284 IM--QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 284 ~~--~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.+ .....++..+.+||.+||+.||++|||+.++++|
T Consensus 288 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 00 0012356679999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.10 Aligned_cols=238 Identities=21% Similarity=0.273 Sum_probs=182.0
Q ss_pred CCCccceEEEEEEecC-CC--ceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-RK--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~--~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|.+.. ++ ..||+|+++.. ....+...+|+.++..+ .|+||+++++++.++. .++||
T Consensus 26 lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~-~~~v~ 99 (291)
T 1u46_A 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVLTPP-MKMVT 99 (291)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSS-CEEEE
T ss_pred ecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-----CCCCcccEEEEEccCC-ceeeE
Confidence 7999999999998653 33 36899998743 23345667898998888 5799999999988765 89999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus 100 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~---------------------- 156 (291)
T 1u46_A 100 ELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---------------------- 156 (291)
T ss_dssp ECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE----------------------
T ss_pred ecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcC----------------------
Confidence 999 899999998643 35899999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
+..++|+|||.+....... ....+|..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 157 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 157 -----RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp -----TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -----CCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 4458888888876654432 22356778999999998889999999999999999999 99999877665
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.......+ ....++..+.++|.+||+.
T Consensus 232 ~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~~l~~ 264 (291)
T 1u46_A 232 QILHKIDKEGERLP-----------------------------------------------RPEDCPQDIYNVMVQCWAH 264 (291)
T ss_dssp HHHHHHHTSCCCCC-----------------------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHccCCCCC-----------------------------------------------CCcCcCHHHHHHHHHHccC
Confidence 44433322111111 0124567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 020235 306 DPTDRLTAREALRH 319 (329)
Q Consensus 306 dP~~R~t~~~ll~h 319 (329)
||++|||+.+++++
T Consensus 265 ~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 265 KPEDRPTFVALRDF 278 (291)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=303.93 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=189.3
Q ss_pred CCCccceEEEEEEe----cCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEE
Q 020235 1 MGEGTFGQVLECWD----RERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv 72 (329)
||+|+||+||++.+ ..+++.||+|+++... .......+|+.++..+ .|+||+++++++.+ ...+++|
T Consensus 39 lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-----YHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTTTEEEEE
T ss_pred ecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-----CCcchhhEEEEEecCCCceEEEE
Confidence 69999999987754 4578999999997542 3345677899999998 57999999999987 4678999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++... .+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 114 ~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~----------------------- 167 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL----------------------- 167 (318)
T ss_dssp ECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-----------------------
T ss_pred EecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE-----------------------
Confidence 9999 88999999875 39999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.+..++|+|||.+....... ....||..|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 168 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~ 243 (318)
T 3lxp_A 168 ----DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTK 243 (318)
T ss_dssp ----CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred ----cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchh
Confidence 456678999999987665433 2345778899999999988999999999999999999999999653221
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
. ............. .... .....+. .......++..+.+||.+||+.
T Consensus 244 ~-----~~~~~~~~~~~~~--~~~~-~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~ 290 (318)
T 3lxp_A 244 F-----LELIGIAQGQMTV--LRLT-ELLERGE-------------------------RLPRPDKCPAEVYHLMKNCWET 290 (318)
T ss_dssp H-----HHHHCSCCHHHHH--HHHH-HHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCS
T ss_pred h-----hhhhcccccchhH--HHHH-HHHhccc-------------------------CCCCCccccHHHHHHHHHHcCC
Confidence 1 1111111110000 0000 0000000 0111234677899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||++|||++++++
T Consensus 291 dP~~Rps~~ell~ 303 (318)
T 3lxp_A 291 EASFRPTFENLIP 303 (318)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CcccCcCHHHHHH
Confidence 9999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=309.90 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=161.5
Q ss_pred CCCccceEEEEE-----EecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLEC-----WDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+| .+..+++.||+|+++.. .......|..++..+.+ ..|++++.+++.+...+..++||||
T Consensus 73 lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~--~~~~~iv~~~~~~~~~~~~~lv~e~ 148 (365)
T 3e7e_A 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKP--SMQHMFMKFYSAHLFQNGSVLVGEL 148 (365)
T ss_dssp EEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCG--GGGGGBCCEEEEEECSSCEEEEECC
T ss_pred eeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhh--hhhhhhhhhheeeecCCCcEEEEec
Confidence 689999999999 46778999999998753 34566778888888743 3468999999999999999999999
Q ss_pred C-CCCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 76 L-GSSLYDFLRKN---NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 76 ~-~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+ +++|.+++... ....+++..++.++.|++.||+|||++||+||||||+|||++.+... .
T Consensus 149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~----------------~ 212 (365)
T 3e7e_A 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE----------------Q 212 (365)
T ss_dssp CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC----------------C
T ss_pred cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC----------------c
Confidence 9 89999999752 23469999999999999999999999999999999999999542100 0
Q ss_pred cccCCCCCCeEEeeCCCCcccC---CC--CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 152 FKRMPKSSAIKVIDFGSTTYER---PD--QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~---~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
......+..++|+|||.+.... .. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 0001236789999999996432 11 1345799999999999999999999999999999999999999954
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=303.77 Aligned_cols=239 Identities=20% Similarity=0.265 Sum_probs=185.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc----cCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD----YRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~----~~~~~~lv~e~ 75 (329)
||+|+||.||+|.++.+++.||+|++... ........+|+.++..+ .|+||+++++++. .....++||||
T Consensus 37 lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 111 (317)
T 2buj_A 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-----NHPNILRLVAYCLRERGAKHEAWLLLPF 111 (317)
T ss_dssp EEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEEEETTEEEEEEEEEC
T ss_pred ecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-----CCCCeeeEEEEEEeccCCCceeEEEEEe
Confidence 69999999999999999999999988642 33455667888888887 6799999999886 34589999999
Q ss_pred C-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 76 L-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 76 ~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
+ +++|.+++... ....+++..++.++.|++.||.|||++||+|+||||+||++
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~------------------------ 167 (317)
T 2buj_A 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL------------------------ 167 (317)
T ss_dssp CTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------------------
T ss_pred CCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE------------------------
Confidence 9 88999999862 23468999999999999999999999999999999999999
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------------CcccccCCCCchhHHhcCC---CCCccchHhHHHHHHHHHhCCC
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------------NYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEA 217 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------------~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l~~g~~ 217 (329)
..+..++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++|..
T Consensus 168 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 244 (317)
T 2buj_A 168 ---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244 (317)
T ss_dssp ---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCC
Confidence 455678999999876543221 1234689999999987654 6899999999999999999999
Q ss_pred CCCCCchh--HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHH
Q 020235 218 LFQTHENL--EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295 (329)
Q Consensus 218 p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (329)
||...... .....+.. .... ......+..+
T Consensus 245 p~~~~~~~~~~~~~~~~~------------------------~~~~------------------------~~~~~~~~~l 276 (317)
T 2buj_A 245 PYDMVFQKGDSVALAVQN------------------------QLSI------------------------PQSPRHSSAL 276 (317)
T ss_dssp TTHHHHHTTSCHHHHHHC------------------------C--C------------------------CCCTTSCHHH
T ss_pred ChhhhhcccchhhHHhhc------------------------cCCC------------------------CccccCCHHH
Confidence 99431100 00000000 0000 0012356789
Q ss_pred HHHHHHhcccCCCCCCCHHHHhcC
Q 020235 296 THLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 296 ~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
.++|.+||+.||.+|||+++++++
T Consensus 277 ~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 277 WQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcChhhCCCHHHHHHH
Confidence 999999999999999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=310.86 Aligned_cols=261 Identities=20% Similarity=0.226 Sum_probs=183.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---------hhHHhHHHHHHHHHHHHhhC---------------------
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHD--------------------- 50 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~--------------------- 50 (329)
||+|+||+||+|++ +|+.||||++.... .......+|+.++..+....
T Consensus 28 lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~ 105 (336)
T 2vuw_A 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQG 105 (336)
T ss_dssp EEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEES
T ss_pred ecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecC
Confidence 69999999999987 68999999997432 12266788999999886311
Q ss_pred CCCCceeeecccccc-------------CCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcC
Q 020235 51 KGGNRCVQIRNWFDY-------------RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLC 115 (329)
Q Consensus 51 ~~~~~i~~l~~~~~~-------------~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~ 115 (329)
..||||+++++++.+ .+..|+||||+ +|++.+.+.+ ..+++..++.++.|++.||+||| ++|
T Consensus 106 ~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ 182 (336)
T 2vuw_A 106 SYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR 182 (336)
T ss_dssp SCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 115777777777775 78999999999 7766565544 35899999999999999999999 999
Q ss_pred CcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCC
Q 020235 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG 195 (329)
Q Consensus 116 i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (329)
|+||||||+|||++.++... .+++.. ............+||+|||.+...... ..+||+.|+|||++.+..
T Consensus 183 ivHrDlKp~NILl~~~~~~~-~~~~~~------~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~~g~~ 253 (336)
T 2vuw_A 183 FEHRDLHWGNVLLKKTSLKK-LHYTLN------GKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLFTGDG 253 (336)
T ss_dssp CBCSCCCGGGEEEEECSCSE-EEEEET------TEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGGCCCS
T ss_pred EeECCCCHHHEEEeccCCcc-eeeecc------CccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhhcCCC
Confidence 99999999999997654100 000000 000000012237999999999866543 458999999999998876
Q ss_pred CCCccchHhHHHH-HHHHHhCCCCCCCCchhH-HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhh
Q 020235 196 WTYPCDIWSVGCI-LVELCTGEALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKS 273 (329)
Q Consensus 196 ~~~~~DiwslG~~-l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (329)
+.++||||||++ .++++.|..||.+..... ....+...... ....
T Consensus 254 -~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----------------------~~~~---------- 300 (336)
T 2vuw_A 254 -DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF----------------------KTKC---------- 300 (336)
T ss_dssp -SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC----------------------SSCC----------
T ss_pred -ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc----------------------Cccc----------
Confidence 889999998777 677888999884311100 11111110000 0000
Q ss_pred hccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q 020235 274 VMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL-RHPFFT 323 (329)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll-~hp~f~ 323 (329)
........+.++.+||++||++| ||+|+| +||||+
T Consensus 301 ----------~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 ----------NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ----------CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ----------chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 00011235778999999999987 999999 999996
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=297.45 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=188.6
Q ss_pred CCCccceEEEEEE----ecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC--CceEEEe
Q 020235 1 MGEGTFGQVLECW----DRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR--NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~----~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~--~~~~lv~ 73 (329)
||+|+||.||+|+ +..+++.||+|++.... .......+|+.++..+ .|+||+++++++... ...++||
T Consensus 49 lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~lv~ 123 (326)
T 2w1i_A 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-----QHDNIVKYKGVCYSAGRRNLKLIM 123 (326)
T ss_dssp EECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECC----CCEEEE
T ss_pred eccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEEecCCCceEEEE
Confidence 6999999999998 46789999999987532 3345677899998888 569999999987654 3789999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|++ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++.
T Consensus 124 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~---------------------- 180 (326)
T 2w1i_A 124 EYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN---------------------- 180 (326)
T ss_dssp CCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE----------------------
T ss_pred ECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcC----------------------
Confidence 999 889999998754 35899999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
++.++|+|||.+....... ....++..|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 181 -----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~-- 253 (326)
T 2w1i_A 181 -----ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-- 253 (326)
T ss_dssp -----TTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--
T ss_pred -----CCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--
Confidence 3457888888887654432 123467789999999998899999999999999999999999864211
Q ss_pred HHHHHHHHhCCCCh-hH-HHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 227 HLAMMERVLGPLPQ-HM-LKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 227 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
...+..+..+. .+ ...+.+.. ...... .....++..+.++|.+||+
T Consensus 254 ---~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------------------------~~~~~~~~~l~~li~~cl~ 301 (326)
T 2w1i_A 254 ---EFMRMIGNDKQGQMIVFHLIELL---KNNGRL--------------------------PRPDGCPDEIYMIMTECWN 301 (326)
T ss_dssp ---HHHHHHCTTCCTHHHHHHHHHHH---HTTCCC--------------------------CCCTTCCHHHHHHHHHHSC
T ss_pred ---HHHHhhccccchhhhHHHHHHHh---hcCCCC--------------------------CCCCcccHHHHHHHHHHcC
Confidence 11111221111 10 00000000 000000 1123467789999999999
Q ss_pred cCCCCCCCHHHHhc
Q 020235 305 YDPTDRLTAREALR 318 (329)
Q Consensus 305 ~dP~~R~t~~~ll~ 318 (329)
.||++|||+.++++
T Consensus 302 ~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 302 NNVNQRPSFRDLAL 315 (326)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=319.81 Aligned_cols=236 Identities=25% Similarity=0.305 Sum_probs=189.2
Q ss_pred CCCccceEEEEEEecCC---CceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRER---KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~---~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|.+..+ +..||+|.+... ........+|+.++..+ .||||+++++++. ++..++||||
T Consensus 398 LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEe-cCceEEEEEc
Confidence 69999999999998654 467999988643 23345677899999888 6799999999985 4678999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 472 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~------------------------ 526 (656)
T 2j0j_A 472 CTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS------------------------ 526 (656)
T ss_dssp CTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE------------------------
T ss_pred CCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeC------------------------
Confidence 9 899999998653 35899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
++.++|+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 527 ---~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~ 603 (656)
T 2j0j_A 527 ---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 603 (656)
T ss_dssp ---TTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred ---CCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 4458888888887654432 12346778999999999899999999999999999997 999998876665544
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....... .+..++..+.++|.+||+.||++
T Consensus 604 ~i~~~~~~~------------------------------------------------~~~~~~~~l~~li~~~l~~dP~~ 635 (656)
T 2j0j_A 604 RIENGERLP------------------------------------------------MPPNCPPTLYSLMTKCWAYDPSR 635 (656)
T ss_dssp HHHHTCCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCCC------------------------------------------------CCccccHHHHHHHHHHcCCChhH
Confidence 443321110 11235678999999999999999
Q ss_pred CCCHHHHhc
Q 020235 310 RLTAREALR 318 (329)
Q Consensus 310 R~t~~~ll~ 318 (329)
|||+.++++
T Consensus 636 RPs~~el~~ 644 (656)
T 2j0j_A 636 RPRFTELKA 644 (656)
T ss_dssp SCCHHHHHH
T ss_pred CcCHHHHHH
Confidence 999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=299.66 Aligned_cols=243 Identities=21% Similarity=0.272 Sum_probs=183.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e~~ 76 (329)
||+|+||.||+|.+ +++.||+|+++.. ......+|.+++..+. ..|+||+++++++.... ..++||||+
T Consensus 50 lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~---l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 50 IGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVM---LRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSC---CCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred ecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhh---cCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 68999999999987 4889999998743 3445667877777642 26799999999988765 899999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH--------DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH--------~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+++|.+++.+. .+++..++.++.|++.||.||| +.||+|+||||+||++
T Consensus 123 ~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll------------------- 180 (342)
T 1b6c_B 123 EHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV------------------- 180 (342)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE-------------------
T ss_pred CCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE-------------------
Confidence 88999999875 4999999999999999999999 8999999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCC------CCCccchHhHHHHHHHHHh
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~l~~ 214 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 181 --------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~t 252 (342)
T 1b6c_B 181 --------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252 (342)
T ss_dssp --------CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --------CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHh
Confidence 455678999999886554432 3347899999999998763 3368999999999999999
Q ss_pred C----------CCCCCCCchhH-HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCC-cCCCCCCCchHHHhhhccchhhHH
Q 020235 215 G----------EALFQTHENLE-HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGR-LDWPEGAASRESIKSVMKLPRLQN 282 (329)
Q Consensus 215 g----------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 282 (329)
| ..||....... ....+.+... .... ...+.
T Consensus 253 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~------------------- 295 (342)
T 1b6c_B 253 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC------------------EQKLRPNIPN------------------- 295 (342)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHT------------------TSCCCCCCCG-------------------
T ss_pred ccCcCCcccccccCccccCcCcccHHHHHHHHH------------------HHHhCCCCcc-------------------
Confidence 9 67776532210 0001111000 0000 00000
Q ss_pred HHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 283 ~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
. .........+.++|.+||+.||++|||+.++++|
T Consensus 296 ~--~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 296 R--WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp G--GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred c--ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 0 0012235679999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=296.59 Aligned_cols=234 Identities=21% Similarity=0.282 Sum_probs=183.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||.||+|.++. .+|+|++.... ...+...+|+.++..+ .|+||+++++++.+.+..++||||+
T Consensus 41 lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~iv~e~~~ 112 (319)
T 2y4i_B 41 IGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-----RHENVVLFMGACMSPPHLAIITSLCK 112 (319)
T ss_dssp CCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-----CCTTBCCCCEEEECSSCEEEECBCCC
T ss_pred eccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-----CCCCEeEEEEEEecCCceEEEeeccc
Confidence 7999999999998764 48999987432 2234455677777777 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++
T Consensus 113 ~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~--------------------------- 164 (319)
T 2y4i_B 113 GRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD--------------------------- 164 (319)
T ss_dssp SEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---------------------------
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe---------------------------
Confidence 899999997643 4689999999999999999999999999999999999993
Q ss_pred CCCCeEEeeCCCCcccCCC--------CCcccccCCCCchhHHhc---------CCCCCccchHhHHHHHHHHHhCCCCC
Q 020235 157 KSSAIKVIDFGSTTYERPD--------QNYIVSTRHYRAPEVILG---------LGWTYPCDIWSVGCILVELCTGEALF 219 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~--------~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~l~~g~~p~ 219 (329)
++.++|+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 165 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 243 (319)
T 2y4i_B 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243 (319)
T ss_dssp ---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 346888999887644211 123468999999999975 34788999999999999999999999
Q ss_pred CCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHH
Q 020235 220 QTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299 (329)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 299 (329)
.+.+.......+.....+.. .....+..+.++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~~~l~~li 276 (319)
T 2y4i_B 244 KTQPAEAIIWQMGTGMKPNL-----------------------------------------------SQIGMGKEISDIL 276 (319)
T ss_dssp SSCCHHHHHHHHHTTCCCCC-----------------------------------------------CCSSCCTTHHHHH
T ss_pred CCCCHHHHHHHhccCCCCCC-----------------------------------------------CcCCCCHHHHHHH
Confidence 87665544433322111100 0113456799999
Q ss_pred HHhcccCCCCCCCHHHHhc
Q 020235 300 QGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 300 ~~~l~~dP~~R~t~~~ll~ 318 (329)
.+||..||++|||+.++++
T Consensus 277 ~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 277 LFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHCSSTTTSCCHHHHHH
T ss_pred HHHhcCChhhCcCHHHHHH
Confidence 9999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.28 Aligned_cols=214 Identities=14% Similarity=0.021 Sum_probs=166.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh----hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK----YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|++..+++.||+|++..... ......+|+.++..+ .|+||+++++++.+.+..|+||||+
T Consensus 39 lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~hp~iv~~~~~~~~~~~~~lv~e~~ 113 (286)
T 3uqc_A 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-----DKPGVARVLDVVHTRAGGLVVAEWI 113 (286)
T ss_dssp EEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-----CCCCcceeeEEEEECCcEEEEEEec
Confidence 6999999999999999999999999975422 235667788887776 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++... .....+..++.|++.||.|||++||+||||||+|||++.
T Consensus 114 ~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~------------------------- 164 (286)
T 3uqc_A 114 RGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI------------------------- 164 (286)
T ss_dssp CEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEET-------------------------
T ss_pred CCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcC-------------------------
Confidence 89999999542 455678889999999999999999999999999999954
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH-H
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER-V 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~ 234 (329)
++.++|+++ .|++ +++.++|||||||++|+|++|+.||.+.+..+......+ .
T Consensus 165 --~g~~kl~~~-----------------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 218 (286)
T 3uqc_A 165 --DGDVVLAYP-----------------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218 (286)
T ss_dssp --TSCEEECSC-----------------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT
T ss_pred --CCCEEEEec-----------------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh
Confidence 445666533 2344 378999999999999999999999986543210000000 0
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.. ..........+..+.++|.+||+.||++| |+.
T Consensus 219 ~~~~-------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~ 254 (286)
T 3uqc_A 219 AGQP-------------------------------------------IEPADIDRDIPFQISAVAARSVQGDGGIR-SAS 254 (286)
T ss_dssp TSCB-------------------------------------------CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHH
T ss_pred ccCC-------------------------------------------CChhhcccCCCHHHHHHHHHHcccCCccC-CHH
Confidence 0000 00111234567789999999999999999 999
Q ss_pred HHhc
Q 020235 315 EALR 318 (329)
Q Consensus 315 ~ll~ 318 (329)
++++
T Consensus 255 el~~ 258 (286)
T 3uqc_A 255 TLLN 258 (286)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=319.83 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=181.9
Q ss_pred CCCccceEEEEEEecC-CCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCc-----eEEE
Q 020235 1 MGEGTFGQVLECWDRE-RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNH-----ICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~-----~~lv 72 (329)
||+|+||.||+|.++. +++.||||++... ........+|+.++..+ .|+||+++++++...+. .|+|
T Consensus 88 lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~iv~~~~~~~~~~~~~~~~~~lv 162 (681)
T 2pzi_A 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-----VHPSIVQIFNFVEHTDRHGDPVGYIV 162 (681)
T ss_dssp EEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-----CCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred EeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-----CCCCcCeEeeeEeecCCCCCceeEEE
Confidence 6899999999999976 7899999988643 23344566788888777 57999999999987665 7999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ |++|.+++.. .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 163 ~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---------------------- 216 (681)
T 2pzi_A 163 MEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---------------------- 216 (681)
T ss_dssp EECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC----------------------
T ss_pred EEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe----------------------
Confidence 9999 8899887654 589999999999999999999999999999999999993
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
. ..++|+|||.+...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+....
T Consensus 217 -----~-~~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~------ 282 (681)
T 2pzi_A 217 -----E-EQLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD------ 282 (681)
T ss_dssp -----S-SCEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS------
T ss_pred -----C-CcEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc------
Confidence 3 26899999999876554 456799999999999875 488999999999999999999988642110
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
..+.. .+ ....+..+.++|.+||+.||++||
T Consensus 283 -----~~~~~-----------------------------------~~---------~~~~~~~l~~li~~~l~~dP~~R~ 313 (681)
T 2pzi_A 283 -----GLPED-----------------------------------DP---------VLKTYDSYGRLLRRAIDPDPRQRF 313 (681)
T ss_dssp -----SCCTT-----------------------------------CH---------HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred -----ccccc-----------------------------------cc---------ccccCHHHHHHHhhhccCChhhCC
Confidence 00000 00 001245788999999999999999
Q ss_pred CHHHHhcCCCC
Q 020235 312 TAREALRHPFF 322 (329)
Q Consensus 312 t~~~ll~hp~f 322 (329)
|+.+.+.|+|+
T Consensus 314 ~~~~~l~~~l~ 324 (681)
T 2pzi_A 314 TTAEEMSAQLT 324 (681)
T ss_dssp SSHHHHHHHHH
T ss_pred CHHHHHHHHHH
Confidence 98888888775
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-34 Score=269.92 Aligned_cols=178 Identities=20% Similarity=0.121 Sum_probs=125.4
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccc-----------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceE
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGI-----------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 70 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~-----------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~ 70 (329)
+.|+.|.+..++...+|+.+|+|++... ....+...+|+++|.++ ..|+||+++++++++++..|
T Consensus 243 ~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~----~~~~~i~~~~~~~ed~~~~y 318 (569)
T 4azs_A 243 YAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQP----PAGFDAPAVLAHGENAQSGW 318 (569)
T ss_dssp C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSC----CTTCCCCCEEEEEECSSEEE
T ss_pred ccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhc----CCCCCeeEEEEEEEECCEEE
Confidence 4677888888888888999999998642 12334567788888877 45689999999999999999
Q ss_pred EEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
|||||+ |++|.++|.+.. ++++. .|+.||+.||+|+|++||+||||||+|||+
T Consensus 319 LVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL--------------------- 372 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV--------------------- 372 (569)
T ss_dssp EEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---------------------
T ss_pred EEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---------------------
Confidence 999999 999999998764 56654 578999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE 216 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 216 (329)
+.++.+||+|||+|+...... ...+||+.|||||++.+. +...+|+||+|++++.+.++.
T Consensus 373 ------~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 373 ------DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp ------CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred ------CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 556679999999987655433 346899999999999874 677899999999987765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.2e-28 Score=224.78 Aligned_cols=173 Identities=20% Similarity=0.191 Sum_probs=138.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||++ +..++.+|+|+..... ...+...+|+.++..+ .|+||+.+..+....+..|+
T Consensus 344 LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 344 IGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-----KDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ----CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-----GGGTCCCCCEEEEETTTTEE
T ss_pred EeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-----CCCCcCceEEEEEeCCccEE
Confidence 799999999999 4456789999864321 1134467899999999 45888855555556777899
Q ss_pred EeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 72 VFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||||+ +++|.+++.. +..++.|++.||.|||++||+||||||+|||+
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl---------------------- 464 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF---------------------- 464 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE----------------------
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE----------------------
Confidence 99999 8999999865 55899999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC----------CcccccCCCCchhHHhc--CCCCCccchHhHHHHHHHHHhCCCC
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILG--LGWTYPCDIWSVGCILVELCTGEAL 218 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p 218 (329)
+. .++|+|||.++...... ....||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+
T Consensus 465 -----~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r 537 (540)
T 3en9_A 465 -----DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR 537 (540)
T ss_dssp -----SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred -----CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence 33 79999999998776642 24579999999999987 5688889999999988888877776
Q ss_pred C
Q 020235 219 F 219 (329)
Q Consensus 219 ~ 219 (329)
|
T Consensus 538 Y 538 (540)
T 3en9_A 538 Y 538 (540)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.6e-24 Score=185.09 Aligned_cols=147 Identities=24% Similarity=0.334 Sum_probs=112.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------------------hHHhHHHHHHHHHHHHhhCCCCCceeeecc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~ 61 (329)
||+|+||.||+|.+ .+|+.||+|+++.... ......+|+.++..+. | +.+.+
T Consensus 98 iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-------~-~~v~~ 168 (282)
T 1zar_A 98 MGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-------G-LAVPK 168 (282)
T ss_dssp EEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-------T-SSSCC
T ss_pred eccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-------C-CCcCe
Confidence 68999999999999 7899999999864221 2445678999999984 2 33444
Q ss_pred ccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 62 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
++.. +..++||||+ |++|.+ +. . .....++.|++.||.|||++||+||||||+|||+
T Consensus 169 ~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl------------ 226 (282)
T 1zar_A 169 VYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV------------ 226 (282)
T ss_dssp EEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE------------
T ss_pred EEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE------------
Confidence 4433 5679999999 889887 42 1 2345799999999999999999999999999999
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc----------CCCCCccchHh
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG----------LGWTYPCDIWS 204 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws 204 (329)
+ ++.++|+|||.+. .+..++|||.+.. ..++..+|+|.
T Consensus 227 ---------------~-~~~vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 227 ---------------S-EEGIWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp ---------------E-TTEEEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred ---------------E-CCcEEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 4 4569999999986 3556899999864 23555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.4e-21 Score=163.63 Aligned_cols=131 Identities=17% Similarity=0.143 Sum_probs=100.7
Q ss_pred CCCccceEEEEEEecCCCce--EEEEEeccchh-------------------------hHHhHHHHHHHHHHHHhhCCCC
Q 020235 1 MGEGTFGQVLECWDRERKEM--VAIKIVRGIKK-------------------------YREAAMIEIEVLQQLAKHDKGG 53 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~~~-------------------------~~~~~~~e~~~l~~l~~~~~~~ 53 (329)
||+|+||.||+|.+..+|+. ||||+++.... ......+|+.++..+.+....+
T Consensus 55 ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 134 (258)
T 1zth_A 55 ISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSV 134 (258)
T ss_dssp EEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 68999999999998778888 99998753211 0125678999999997754333
Q ss_pred CceeeeccccccCCceEEEeecCC--C----CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCCCcE
Q 020235 54 NRCVQIRNWFDYRNHICIVFEKLG--S----SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH-DLCMIHTDLKPENV 126 (329)
Q Consensus 54 ~~i~~l~~~~~~~~~~~lv~e~~~--~----~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH-~~~i~H~dikp~NI 126 (329)
|.+... +..++||||++ | .|.+.... .++..+..++.|++.+|.||| +.||+||||||+||
T Consensus 135 p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NI 202 (258)
T 1zth_A 135 PQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNI 202 (258)
T ss_dssp CCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSE
T ss_pred CeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 443321 35789999994 3 67766432 335567889999999999999 99999999999999
Q ss_pred EEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCccc
Q 020235 127 LLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172 (329)
Q Consensus 127 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~ 172 (329)
|+ .. .++|+|||.+...
T Consensus 203 Ll---------------------------~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 203 MY---------------------------ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EE---------------------------SS--SEEECCCTTCEET
T ss_pred EE---------------------------cC--cEEEEECcccccC
Confidence 99 33 7999999998753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=6.1e-17 Score=143.17 Aligned_cols=138 Identities=17% Similarity=0.165 Sum_probs=93.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-----------------------hHHhHHHHHHHHHHHHhhCCCCCcee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-----------------------YREAAMIEIEVLQQLAKHDKGGNRCV 57 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~~~~~~i~ 57 (329)
||+|++|.||+|.+. +|+.||||+++.... .+....+|...+.++.+.... ++
T Consensus 103 IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~---vp 178 (397)
T 4gyi_A 103 IGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP---VP 178 (397)
T ss_dssp EEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS---CC
T ss_pred eeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC---CC
Confidence 699999999999875 589999998752100 011234577778888653322 22
Q ss_pred eeccccccCCceEEEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 58 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
..+.. +..+|||||+ |++|..+. ....+..++.|++.+|.+||+.||+||||||.|||+..+|...-
T Consensus 179 ~p~~~----~~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 179 EPIAQ----SRHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CEEEE----ETTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred eeeec----cCceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 22221 2237999999 66764332 22235678899999999999999999999999999987663111
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcc
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~ 171 (329)
.+ .....+.||||+.+..
T Consensus 247 ~~-----------------~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 247 PS-----------------SITLTPIIIXFPQMVS 264 (397)
T ss_dssp TT-----------------SEEEEEEECCCTTCEE
T ss_pred cc-----------------ccccceEEEEeCCccc
Confidence 00 1112489999998764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-11 Score=104.35 Aligned_cols=100 Identities=11% Similarity=0.061 Sum_probs=73.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
++.|+.+.||++... ++.+++|+..... .......+|..++..+.. +..+++++.+..+.+..|+|||++ |.
T Consensus 22 ~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~----~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 22 TEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG----KLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp CSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred ccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc----CCCCCeEEEEEecCCceEEEEEecCCe
Confidence 356778899999643 6789999976421 223457789999998854 245777777778888999999999 77
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~ 113 (329)
++.+.+. +......++.+++.+|..||+
T Consensus 96 ~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 96 LCSEEYE-------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred ehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence 8876521 122234678889999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=2e-10 Score=96.92 Aligned_cols=96 Identities=14% Similarity=0.126 Sum_probs=64.7
Q ss_pred CccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHH
Q 020235 3 EGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 81 (329)
Q Consensus 3 ~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~ 81 (329)
.|..+.||++.. .+|..+++|+.... .......|..++..+.+. ...+++++.+...++..++|||++ |.++.
T Consensus 30 gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~---~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~ 103 (264)
T 1nd4_A 30 GCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATT---GVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 103 (264)
T ss_dssp TTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTT---TCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred CCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhC---CCCCCeEEEeccCCCCCEEEEEecCCcccC
Confidence 456699999964 45677999987643 234567899999988653 123666777777777899999999 76663
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 020235 82 DFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114 (329)
Q Consensus 82 ~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~ 114 (329)
.. ..+. ..++.+++..|..||+.
T Consensus 104 --~~-----~~~~---~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 104 --SS-----HLAP---AEKVSIMADAMRRLHTL 126 (264)
T ss_dssp --TS-----CCCH---HHHHHHHHHHHHHHTTS
T ss_pred --cC-----cCCH---hHHHHHHHHHHHHHhCC
Confidence 11 1221 24556666777777754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=1.4e-09 Score=96.49 Aligned_cols=104 Identities=16% Similarity=0.148 Sum_probs=71.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEec--cch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC---CceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVR--GIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR---NHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~---~~~~lv~ 73 (329)
|+.|.++.||++... +..+++|+.. ... .......+|..++..+.... ..+++++.++.+. +..|+||
T Consensus 46 l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~---vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 46 FKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTD---VPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp CCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSS---SCCCCEEEEECCTTTTSSCEEEE
T ss_pred cCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCC---CCCCcEEEECCCCCccCCeEEEE
Confidence 578999999999754 4578899865 322 22346678999999996532 3466666666655 4589999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~ 113 (329)
|++ |..+.+.. -..++......++.+++..|..||+
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhC
Confidence 999 65553311 1236777888899999999999997
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.99 E-value=9.1e-10 Score=95.34 Aligned_cols=181 Identities=19% Similarity=0.251 Sum_probs=113.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC---ceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN---HICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~---~~~lv~e~~- 76 (329)
++.|..+.||++. ..+++|+... ........+|..++..+.... . ..++..+......+ ..|+||+++
T Consensus 28 ~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~-~-v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 28 SGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKL-P-LPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSS-S-SCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred cCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcC-C-CCCCceEeecCCCCCCCcceEEEcccC
Confidence 3578889999873 4588998653 233556778999998884421 1 12444444433332 458999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD------------------------------------------- 113 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~------------------------------------------- 113 (329)
|.++.+.... .++..+...++.+++..|..||+
T Consensus 100 G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 100 GVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 7666543322 36777777777788887777775
Q ss_pred ---------------cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCc
Q 020235 114 ---------------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178 (329)
Q Consensus 114 ---------------~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 178 (329)
..++|+|++|.||+++.+ ....+.++||+.+....+..-
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-------------------------~~~~~~~iD~~~~~~~~~~~D- 229 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-------------------------KNTICGIIDFGDAAISDPDND- 229 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-------------------------TTEEEEECCCTTCEEECTTHH-
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCC-------------------------CCCEEEEEeCCCCccCChHHH-
Confidence 136999999999999531 033467899988765433210
Q ss_pred ccccCCC---CchhHHhc--CCCC------------CccchHhHHHHHHHHHhCCCCC
Q 020235 179 IVSTRHY---RAPEVILG--LGWT------------YPCDIWSVGCILVELCTGEALF 219 (329)
Q Consensus 179 ~~gt~~y---~aPE~~~~--~~~~------------~~~DiwslG~~l~~l~~g~~p~ 219 (329)
....... ..|+.... ..|. ...+.|+++.++|.+.+|..+|
T Consensus 230 l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 230 FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0001111 23332211 0111 1258999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=6.9e-07 Score=77.20 Aligned_cols=99 Identities=18% Similarity=0.098 Sum_probs=59.0
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-cCCceEEEeecC-CCC
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIVFEKL-GSS 79 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-~~~~~~lv~e~~-~~~ 79 (329)
+.|....||++ +..+++|+.. .........+|..++..+.++.. ..++..+.+.. ..+..++||+++ |.+
T Consensus 28 ~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~--v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 28 GEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVK--VNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCS--SBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred CCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCC--CCCCCeEeecccCCCceEEEEeccCCeE
Confidence 56777889988 4568889854 23335567789999999965311 23445544442 456678999999 766
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH 112 (329)
+.+..-. .++......+..++...|..||
T Consensus 100 l~~~~~~----~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 100 LGEDGMA----VLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp CHHHHHT----TSCHHHHHHHHHHHHHHHHHHH
T ss_pred Cchhhhh----hCCHHHHHHHHHHHHHHHHHHh
Confidence 6553211 1333344444444444444444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.38 E-value=1.9e-06 Score=72.80 Aligned_cols=94 Identities=13% Similarity=0.192 Sum_probs=63.5
Q ss_pred eEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHHHHH
Q 020235 7 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR 85 (329)
Q Consensus 7 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l~ 85 (329)
+.||+......+..+++|+-... .......|..++..+... --+++++.+..+++..++||+++ |.++.+...
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~----vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~ 112 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAF----MPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLE 112 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTT----SCCCCEEEEEEETTEEEEEEECCCSEEHHHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccC----CCcCeEEEEEEECCeEEEEEEeeCCcccccccc
Confidence 46899887777788999986532 344567799999888542 23677777888888999999999 777766654
Q ss_pred hCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020235 86 KNNYRSFPIDLVREIARQLLECIAFMH 112 (329)
Q Consensus 86 ~~~~~~l~~~~~~~~~~~l~~~L~~lH 112 (329)
... .....+..++...|.-||
T Consensus 113 ~~~------~~~~~~~~~l~~~L~~Lh 133 (272)
T 4gkh_A 113 EYP------DSGENIVDALAVFLRRLH 133 (272)
T ss_dssp HCG------GGHHHHHHHHHHHHHHHH
T ss_pred CCH------HHHHHHHHHHHHHHHHhc
Confidence 321 112234455555555555
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=8e-06 Score=73.15 Aligned_cols=73 Identities=21% Similarity=0.235 Sum_probs=45.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||.|..+.||++....+++.+++|...... ........|..++..+.... ...++.++.+ +....++|
T Consensus 38 lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 38 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTTEEE
T ss_pred CCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCccEEE
Confidence 688999999999876667889999764211 11234567888888875431 1234455443 33456899
Q ss_pred eecCC
Q 020235 73 FEKLG 77 (329)
Q Consensus 73 ~e~~~ 77 (329)
||++.
T Consensus 114 mE~l~ 118 (397)
T 2olc_A 114 MEDLS 118 (397)
T ss_dssp ECCCT
T ss_pred EEeCC
Confidence 99993
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.17 E-value=3.5e-05 Score=67.20 Aligned_cols=73 Identities=14% Similarity=0.195 Sum_probs=41.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeec-c--ccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~-~--~~~~~~~~~lv~e~~- 76 (329)
|+.|..+.||++... +..+++|+.... ......|..++..+....-..|.++... + +....+..++||+++
T Consensus 40 l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 40 IQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp CC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred ccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 345678899999753 335889988752 2334457777777765433334333311 1 112456789999999
Q ss_pred CC
Q 020235 77 GS 78 (329)
Q Consensus 77 ~~ 78 (329)
|.
T Consensus 115 G~ 116 (346)
T 2q83_A 115 GR 116 (346)
T ss_dssp CB
T ss_pred Cc
Confidence 54
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.6e-05 Score=70.03 Aligned_cols=75 Identities=9% Similarity=0.054 Sum_probs=48.9
Q ss_pred CCccceEEEEEEecC------CCceEEEEEeccch---h-hHHhHHHHHHHHHHHHhh-CCCCCceeeeccccccC---C
Q 020235 2 GEGTFGQVLECWDRE------RKEMVAIKIVRGIK---K-YREAAMIEIEVLQQLAKH-DKGGNRCVQIRNWFDYR---N 67 (329)
Q Consensus 2 g~G~~g~V~~a~~~~------~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~~~-~~~~~~i~~l~~~~~~~---~ 67 (329)
+.|..+.+|++.... ++..+++|+..... . .......|..++..+... . ..+++++.+..+. +
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~---vpvP~v~~~~~~~~~~g 106 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTD---VPVPRVRWIETTGDVLG 106 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCC---SCCCCEEEEECSSTTTS
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCC---CCCCcEEEEccCCCccC
Confidence 578888999986531 15678899865432 0 124567899999988765 2 2345555554443 4
Q ss_pred ceEEEeecC-CCC
Q 020235 68 HICIVFEKL-GSS 79 (329)
Q Consensus 68 ~~~lv~e~~-~~~ 79 (329)
..++|||++ |..
T Consensus 107 ~~~~v~e~l~G~~ 119 (357)
T 3ats_A 107 TPFFLMDYVEGVV 119 (357)
T ss_dssp SCEEEEECCCCBC
T ss_pred CceEEEEecCCCC
Confidence 578999999 544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00041 Score=62.46 Aligned_cols=72 Identities=17% Similarity=0.180 Sum_probs=42.4
Q ss_pred CCCccceEEEEEEecCCCceEEEEEecc-----chh---hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRG-----IKK---YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~-----~~~---~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||.|..+.||++.. +++.++||.... ... .......|.+++..+.... ...+++++.+. ....++|
T Consensus 42 l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 42 VGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp CCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTTTEEE
T ss_pred ccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCccEEE
Confidence 57899999999954 467799994221 011 0123344555555443321 13455555543 4667999
Q ss_pred eecC-CC
Q 020235 73 FEKL-GS 78 (329)
Q Consensus 73 ~e~~-~~ 78 (329)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 65
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00055 Score=58.62 Aligned_cols=66 Identities=12% Similarity=-0.011 Sum_probs=39.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
|+.|....+|++ ..+++|+.............|..++..+...... ++++... .+.-+++++++ +|
T Consensus 26 l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~----P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 26 RLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS----PEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp EESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS----CCEEEEC--TTTCCEEEECCTTC
T ss_pred cCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC----CceEEEE--CCCCEEEEeecCCC
Confidence 356888999999 4578898764322112234688888888664422 3444433 33346889998 54
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0015 Score=56.33 Aligned_cols=74 Identities=11% Similarity=0.063 Sum_probs=41.8
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeec-c--ccccCCceEEEeecC-C
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR-N--WFDYRNHICIVFEKL-G 77 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~-~--~~~~~~~~~lv~e~~-~ 77 (329)
+.|....+|++... +..+++|+.... ........|..++..+....-..|.++... + +....+..+++++++ |
T Consensus 31 ~~G~~n~~~~v~~~--~g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G 107 (322)
T 2ppq_A 31 AEGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEG 107 (322)
T ss_dssp CC---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCC
T ss_pred CCCcccceEEEEeC--CccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCC
Confidence 56777889999653 236889987742 223445678888888876543333333211 0 111235678999999 5
Q ss_pred C
Q 020235 78 S 78 (329)
Q Consensus 78 ~ 78 (329)
.
T Consensus 108 ~ 108 (322)
T 2ppq_A 108 M 108 (322)
T ss_dssp B
T ss_pred c
Confidence 3
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0029 Score=54.66 Aligned_cols=70 Identities=14% Similarity=0.173 Sum_probs=44.4
Q ss_pred ccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc-----cccCCceEEEeecCC
Q 020235 4 GTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW-----FDYRNHICIVFEKLG 77 (329)
Q Consensus 4 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~-----~~~~~~~~lv~e~~~ 77 (329)
|....||++... +|+.+++|+.+...........|..++..+....-. ++..+.. ...++..++||++++
T Consensus 36 g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~---vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 36 SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVP---VAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCS---BCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCe---ecceeecCCcEEEEECCEEEEEEEecC
Confidence 666789988543 355789999864333345666788888888764322 3333332 122456688999993
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0023 Score=51.40 Aligned_cols=98 Identities=13% Similarity=0.017 Sum_probs=58.4
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
.+|.++|...+ .++++.++|.++.|.+.+|.-+-. ..-..+=+-|..|++..+|
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG------------------------ 87 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG------------------------ 87 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS------------------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC------------------------
Confidence 47999998765 689999999999999998877621 1111233446778875444
Q ss_pred CCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh
Q 020235 157 KSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 214 (329)
.|.+.+ +.+. .....+.|||... ...+.+.=|+|||+++|.-+-
T Consensus 88 ---~V~f~~-~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 88 ---AVTLAP-AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---CEEECC-C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ceeccc-cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 343332 1100 1122466777653 234567789999999998774
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0033 Score=54.48 Aligned_cols=68 Identities=10% Similarity=0.007 Sum_probs=38.3
Q ss_pred EEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHHHHH
Q 020235 9 VLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFL 84 (329)
Q Consensus 9 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~~~l 84 (329)
+|++... ++..+++|...... ......|..++..+....- .+++++.+....+ +++||++ +..+.+.+
T Consensus 35 ~~r~~~~-~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~---~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l 103 (333)
T 3csv_A 35 YQRLRSP-TGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDI---SAPEIYAEEHARG--LLLIEDLGDALFTEVI 103 (333)
T ss_dssp CEEEECT-TCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTC---BCCCEEEEETTTT--EEEECCCCSCBHHHHH
T ss_pred EEEEEcC-CCCeEEEEECCCCC--CccccHHHHHHHHHHhCCC---CCCceeeecCCCC--EEEEeeCCCcchHHHh
Confidence 6677532 25567777644221 1345668888888876432 3444444322222 7899998 55555443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.86 E-value=0.013 Score=50.91 Aligned_cols=69 Identities=13% Similarity=0.127 Sum_probs=43.5
Q ss_pred CCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccc------cccCCceEEEeec
Q 020235 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNW------FDYRNHICIVFEK 75 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~------~~~~~~~~lv~e~ 75 (329)
|.|....||++... +| .+++|+..... ...|..++..+.... .+.++..+.. ....+..++||++
T Consensus 32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g--~~~vp~pi~~~~G~~~~~~~g~~~~l~~~ 102 (339)
T 3i1a_A 32 GADTNAFAYQADSE-SK-SYFIKLKYGYH-----DEINLSIIRLLHDSG--IKEIIFPIHTLEAKLFQQLKHFKIIAYPF 102 (339)
T ss_dssp TSCSSCEEEEEECS-SC-EEEEEEEECSS-----CCHHHHHHHHHHHTT--CCSSCCCCCCTTSCSSEECSSEEEEEEEC
T ss_pred cCccccceEEEEeC-CC-CEEEEEecCcc-----chHHHHHHHHHHhcC--CcccccceecCCCCEEEEECCEEEEEEec
Confidence 44446889999643 34 78999876433 256788888886643 2324444332 1235678999999
Q ss_pred C-CCC
Q 020235 76 L-GSS 79 (329)
Q Consensus 76 ~-~~~ 79 (329)
+ |..
T Consensus 103 i~G~~ 107 (339)
T 3i1a_A 103 IHAPN 107 (339)
T ss_dssp CCCCB
T ss_pred cCCCc
Confidence 9 543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0035 Score=55.40 Aligned_cols=67 Identities=13% Similarity=0.140 Sum_probs=39.7
Q ss_pred CCccceEEEEEEecC-------CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 2 GEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 2 g~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
..|-...+|++.... +++.+++|+.-..........+|..++..+..... .++++..+.+ .+|||
T Consensus 59 sGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv----~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 59 SGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSL----GPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp -----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTS----SCCEEEEETT----EEEEE
T ss_pred CCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCC----CCeEEEEcCC----ccEEE
Confidence 457778889997642 34678999864322223444579999988876542 2555555544 28999
Q ss_pred cC
Q 020235 75 KL 76 (329)
Q Consensus 75 ~~ 76 (329)
|+
T Consensus 131 ~i 132 (379)
T 3feg_A 131 YI 132 (379)
T ss_dssp CC
T ss_pred Ee
Confidence 98
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0067 Score=53.39 Aligned_cols=68 Identities=22% Similarity=0.152 Sum_probs=38.9
Q ss_pred CCCccceEEEEEEecCC--------CceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRER--------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
|+.|....+|++..... +..+++|+.............|..++..+..... +++++.... -++|
T Consensus 41 l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~----~P~~~~~~~----~~~v 112 (369)
T 3c5i_A 41 ILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI----APQLLNTFN----GGRI 112 (369)
T ss_dssp C----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS----SCCEEEEET----TEEE
T ss_pred eCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC----CCceEEecC----CcEE
Confidence 45677889999976431 2678899865432211123568888888866432 334443332 2689
Q ss_pred eecC
Q 020235 73 FEKL 76 (329)
Q Consensus 73 ~e~~ 76 (329)
|+++
T Consensus 113 ~e~i 116 (369)
T 3c5i_A 113 EEWL 116 (369)
T ss_dssp EECC
T ss_pred EEEe
Confidence 9998
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.017 Score=48.88 Aligned_cols=69 Identities=13% Similarity=0.078 Sum_probs=45.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
+|.|..+.||+++. .+|+.|++|+...... .......|...|..+.... ...+++.+.+ +.-++|||+.
T Consensus 23 ~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~--~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 23 RGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSF--GSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCST--TCCSCCEEEE----ETTEEEEECC
T ss_pred cCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhC--CCCcceEEec----cCceEEEEee
Confidence 47899999999975 4678899998653322 2234567999998885431 1224444443 2347899998
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.57 E-value=0.027 Score=51.05 Aligned_cols=68 Identities=12% Similarity=0.058 Sum_probs=41.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
|+.|-...+|++....++..+++|+..........-..|..++..+.... ..++++..+.. .+|++|+
T Consensus 116 lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~g----l~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 116 INGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKN----IAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp ECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSS----SBCCEEEEETT----EEEEECC
T ss_pred cCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcC----CCCCEEEEeCC----eEEEEee
Confidence 35677889999987554577889987532111111147888898885532 23556665532 3599998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.032 Score=50.22 Aligned_cols=67 Identities=12% Similarity=0.117 Sum_probs=43.2
Q ss_pred CCCccceEEEEEEecC-------CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
|+.|....||++.... ++..+++|+.... ........|..++..+..... .+++++.+.+ .+|+
T Consensus 81 l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~----~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 81 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHL----GPKLYGIFSG----GRLE 151 (429)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTS----SSCEEEEETT----EEEE
T ss_pred eCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCC----CCcEEEEeCC----CEEE
Confidence 3567789999997642 2567899987431 111344579999988876432 2445555443 3889
Q ss_pred ecC
Q 020235 74 EKL 76 (329)
Q Consensus 74 e~~ 76 (329)
+|+
T Consensus 152 e~l 154 (429)
T 1nw1_A 152 EYI 154 (429)
T ss_dssp CCC
T ss_pred EEe
Confidence 998
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.26 E-value=0.021 Score=49.03 Aligned_cols=94 Identities=21% Similarity=0.176 Sum_probs=67.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
|+.|....+|++.. ++..+++|+.... .......|...+..+.... ...+++.+.+....+..++|||++ |..
T Consensus 44 l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 44 LYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp ECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46788999999975 4667889986632 3556678999999886631 245667777766678899999999 544
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i 116 (329)
+. . ....++...|.-||+.+.
T Consensus 118 ~~------------~----~~~~~lG~~LA~LH~~~~ 138 (312)
T 3jr1_A 118 NK------------Q----SSFTIFAEKIAQLHQIQG 138 (312)
T ss_dssp CC------------T----THHHHHHHHHHHHHHCCC
T ss_pred CC------------c----hhHHHHHHHHHHHHcCCC
Confidence 21 1 234678888999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=90.58 E-value=2.1 Score=38.13 Aligned_cols=69 Identities=14% Similarity=0.058 Sum_probs=42.1
Q ss_pred CCccceEEEEEEecCC-------CceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 2 GEGTFGQVLECWDRER-------KEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 2 g~G~~g~V~~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
..|-...+|++..... ++.+++|+..........-.+|..++..+..... .+++++.+. -++|++
T Consensus 79 sGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi----~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 79 FSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINI----APNIIADFP----EGRIEE 150 (424)
T ss_dssp CCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTS----SCCEEEEET----TEEEEE
T ss_pred CCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCC----CCCEEEEcC----CCEEEE
Confidence 4577788899976521 5678999864322111222478888888866432 344444332 278999
Q ss_pred cC-CC
Q 020235 75 KL-GS 78 (329)
Q Consensus 75 ~~-~~ 78 (329)
|+ |.
T Consensus 151 fI~G~ 155 (424)
T 3mes_A 151 FIDGE 155 (424)
T ss_dssp CCCSE
T ss_pred EeCCc
Confidence 99 53
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 329 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-52 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-44 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-42 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-38 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-34 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-31 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-31 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-30 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-29 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-28 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-27 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-27 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-26 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-23 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-23 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-12 | |
| d1nw1a_ | 395 | d.144.1.8 (A:) Choline kinase {Caenorhabditis eleg | 1e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-52
Identities = 67/328 (20%), Positives = 112/328 (34%), Gaps = 44/328 (13%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G G G V + + ++A K++ R + E++VL + V
Sbjct: 15 GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP----YIVGF 69
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC-MI 117
F I I E + G SL L+K P ++ +++ +++ + ++ + ++
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREKHKIM 127
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQ 176
H D+KP N+L+ S IK+ DFG S
Sbjct: 128 HRDVKPSNILVNSRGE---------------------------IKLCDFGVSGQLIDSMA 160
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
N V TR Y +PE + G ++ DIWS+G LVE+ G + E M +
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
R G P A V + P L D
Sbjct: 221 GDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQD-- 276
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ L +P +R ++ + H F R
Sbjct: 277 -FVNKCLIKNPAERADLKQLMVHAFIKR 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (423), Expect = 1e-49
Identities = 69/329 (20%), Positives = 124/329 (37%), Gaps = 80/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V C ++ + K + + EI ++ QL H + + +
Sbjct: 38 GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP----KLINLH 92
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F+ + + ++ E L G L+D + +Y+ V RQ E + MH+ ++H
Sbjct: 93 DAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEHSIVHL 151
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--N 177
D+KPEN++ K+S++K+IDFG T PD+
Sbjct: 152 DIKPENIMC-------------------------ETKKASSVKIIDFGLATKLNPDEIVK 186
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+T + APE++ + D+W++G + L +G + F ++LE L ++R
Sbjct: 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE 246
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ V A+
Sbjct: 247 FDEDAFSSVSPEAK---------------------------------------------D 261
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRDH 326
++ LL+ +P RLT +AL HP+ DH
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWLKGDH 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-49
Identities = 71/332 (21%), Positives = 132/332 (39%), Gaps = 80/332 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G G+VL+ +++ +E A+K+++ K R E+E+ + ++ V+I +
Sbjct: 21 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP----HIVRIVD 72
Query: 62 WFDY----RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ R + IV E L G L+ ++ ++F EI + + E I ++H + +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
H D+KPEN+L S ++ +K+ DFG
Sbjct: 133 AHRDVKPENLLYTS------------------------KRPNAILKLTDFGFAKETTSHN 168
Query: 177 NY--IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ T +Y APEV+ + CD+WS+G I+ L G F ++ L M+
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT- 227
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
+R G+ ++P S S +
Sbjct: 228 ------------------RIRMGQYEFPNPEWSEVS----------------------EE 247
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ L++ LL+ +PT R+T E + HP+ +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 163 bits (414), Expect = 2e-48
Identities = 72/330 (21%), Positives = 122/330 (36%), Gaps = 80/330 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G G FG V +R A K V + +E EI+ + L +H V +
Sbjct: 35 GTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP----TLVNLH 89
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ F+ N + +++E + G L++ + + + D E RQ+ + + MH+ +H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENNYVHL 148
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLKPEN++ + +S+ +K+IDFG T + P Q+
Sbjct: 149 DLKPENIMFTT-------------------------KRSNELKLIDFGLTAHLDPKQSVK 183
Query: 180 VST--RHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
V+T + APEV G Y D+WSVG + L +G + F + E L ++
Sbjct: 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN 243
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ + D
Sbjct: 244 MDDSAFSGISE---------------------------------------------DGKD 258
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
++ LL DP R+T +AL HP+ T +
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWLTPGNA 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-48
Identities = 74/333 (22%), Positives = 140/333 (42%), Gaps = 45/333 (13%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCV- 57
G+GTFG+V + R+ + VA+K V + + A+ EI++LQ L + +
Sbjct: 19 GQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC 78
Query: 58 --QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ + + I +VF+ L L N F + ++ + + LL + ++H
Sbjct: 79 RTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK 137
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H D+K NVL+ +K+ D+ + + +
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLA-------------------RAFSLAKNSQPNRY 178
Query: 176 QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
N V T YR PE++LG + P D+W GCI+ E+ T + Q + LA++ ++
Sbjct: 179 TNR-VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
G + + VD + + + L + ++ +K+ ++ P +LI +
Sbjct: 238 CGSITPEVWPNVDNY--ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-------- 287
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
LL DP R+ + +AL H FF D +
Sbjct: 288 -------LLVLDPAQRIDSDDALNHDFFWSDPM 313
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 3e-47
Identities = 81/328 (24%), Positives = 136/328 (41%), Gaps = 45/328 (13%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
GEG +G V +D K VAIK + + Y + + EI++L + + G +
Sbjct: 17 GEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIR 76
Query: 60 RNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + +V +G+ LY L+ + D + Q+L + ++H ++H
Sbjct: 77 APTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHR 133
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DLKP N+LL ++ +K+ D+ + D + +
Sbjct: 134 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL---------------------TEY 172
Query: 180 VSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
V+TR YRAPE++L G+T DIWSVGCIL E+ + +F L+ L + +LG
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 232
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
Q L + R L P K N + + D A D L
Sbjct: 233 SQEDLNCIIN---LKARNYLLSLPH------------KNKVPWNRLFPNADSKALD---L 274
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTRDH 326
L +L ++P R+ +AL HP+ + +
Sbjct: 275 LDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (406), Expect = 3e-47
Identities = 100/339 (29%), Positives = 156/339 (46%), Gaps = 45/339 (13%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNR 55
G G F V D VA+KIVRG K Y EAA EI++LQ++ D G N
Sbjct: 22 GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81
Query: 56 CVQIRNWFDYRN----HICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFM 111
+++ + F+++ H+ +VFE LG +L ++K +R P+ V++I++QLL + +M
Sbjct: 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 141
Query: 112 HDLCMI-HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
H C I HTD+KPENVL+ + IK+ D G+
Sbjct: 142 HRRCGIIHTDIKPENVLMEIVDS---------------------PENLIQIKIADLGNAC 180
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------N 224
+ + TR YR+PEV+LG W DIWS C++ EL TG+ LF+ E +
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284
+H+A + +LG LP ++L+ + RG L S L +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLR-------NISKLKFWPLEDVLTEK 293
Query: 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPFFT 323
+ A +++ L +L+ DP R A + HP+
Sbjct: 294 YKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLK 332
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-46
Identities = 73/333 (21%), Positives = 137/333 (41%), Gaps = 58/333 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNR 55
GEG F V + D+ ++VAIK ++ + A+ EI++LQ+L H
Sbjct: 7 GEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHP----N 61
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+ + + F ++++I +VF+ + + L ++ N+ P ++ L+ + ++H
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEYLHQHW 120
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
++H DLKP N+LL + +K+ D+ + + +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY----------------------- 157
Query: 176 QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ V TR YRAPE++ G + D+W+VGCIL EL +L+ L +
Sbjct: 158 -THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
LG + WP+ + + + + I D
Sbjct: 217 LGTPTEE------------------QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDHL 327
L +QGL ++P R+TA +AL+ +F+
Sbjct: 259 L---IQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-46
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 54/328 (16%)
Query: 2 GEGTFGQVLECWDRE-RKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGN--- 54
GEG +G+V + D + VA+K VR G + + + E+ VL+ L +
Sbjct: 16 GEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL 75
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
V + D + +VFE + L +L K P + ++++ QLL + F+H
Sbjct: 76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
++H DLKP+N+L+ SS IK+ D +
Sbjct: 136 RVVHRDLKPQNILVTSSGQIKLAD-------------------------FGLARIYSFQM 170
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+V T YRAPEV+L + P D+WSVGCI E+ + LF+ +++ L + V
Sbjct: 171 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 230
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
+G + DWP A ++ + +D D
Sbjct: 231 IGLPGEE------------------DWPRDVALPRQAFHSKSAQPIEKFV-TDIDELGKD 271
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFF 322
LL L ++P R++A AL HP+F
Sbjct: 272 ---LLLKCLTFNPAKRISAYSALSHPYF 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-46
Identities = 61/325 (18%), Positives = 117/325 (36%), Gaps = 79/325 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G+G FG V +++ K ++A+K++ + + ++ ++ H + N +++
Sbjct: 15 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN-ILRLYG 73
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+F + ++ E ++Y L+K F +L +++ H +IH D
Sbjct: 74 YFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSKRVIHRD 131
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
+KPEN+LL S+ +K+ D+ S+H P +
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSRRT--------------------------TLC 165
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
T Y PE+I G D+WS+G + E G+ F+ + E + RV P
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+ + L+
Sbjct: 226 FVTE-------------------------------------------------GARDLIS 236
Query: 301 GLLRYDPTDRLTAREALRHPFFTRD 325
LL+++P+ R RE L HP+ T +
Sbjct: 237 RLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 4e-46
Identities = 80/336 (23%), Positives = 144/336 (42%), Gaps = 65/336 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G+FG V + + E+VAIK V K+++ E++++++L H V++R
Sbjct: 29 GNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---ELQIMRKL-DHC----NIVRLRY 80
Query: 62 WF------DYRNHICIVFEKLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHD 113
+F ++ +V + + ++Y R ++ P+ V+ QL +A++H
Sbjct: 81 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
+ H D+KP+N+LL P ++ +K+ DFGS
Sbjct: 141 FGICHRDIKPQNLLL--------------------------DPDTAVLKLCDFGSAKQLV 174
Query: 174 PDQNY--IVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+ + +R+YRAPE+I G +T D+WS GC+L EL G+ +F ++ L
Sbjct: 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ +VLG + ++ ++ + ++ +P+ +K +
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEF------KFPQ-----------IKAHPWTKVFRPRTPP 277
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
A L LL Y PT RLT EA H FF
Sbjct: 278 EAIA---LCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 4e-46
Identities = 88/325 (27%), Positives = 142/325 (43%), Gaps = 53/325 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
GEGT+G V + ++ E+VA+K +R + A+ EI +L++L + V+
Sbjct: 11 GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-----IVK 65
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + N + +VFE L L F+ + P+ L++ QLL+ +AF H ++H
Sbjct: 66 LLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLH 125
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKP+N+L+ + IK+ D+ + + +
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------------------------TH 161
Query: 179 IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
V T YRAPE++LG ++ DIWS+GCI E+ T ALF ++ L + R LG
Sbjct: 162 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGT 221
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ + WP + + S K R + V D
Sbjct: 222 PDEVV------------------WPGVTSMPDYKPSFPKWARQD--FSKVVPPLDEDGRS 261
Query: 298 LLQGLLRYDPTDRLTAREALRHPFF 322
LL +L YDP R++A+ AL HPFF
Sbjct: 262 LLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (390), Expect = 1e-45
Identities = 68/334 (20%), Positives = 115/334 (34%), Gaps = 81/334 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----------GIKKYREAAMIEIEVLQQLAKHDK 51
G G V C + + A+KI+ +++ REA + E+++L++++ H
Sbjct: 12 GRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP- 70
Query: 52 GGNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAF 110
+Q+++ ++ +VF+ + L+D+L + + R+I R LLE I
Sbjct: 71 ---NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICA 125
Query: 111 MHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTT 170
+H L ++H DLKPEN+LL IK+ D+ S +D G
Sbjct: 126 LHKLNIVHRDLKPENILLDDDMNIKLTDFGFS-------------------CQLDPGEKL 166
Query: 171 YERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
E ++ G+ D+WS G I+ L G F + + L M
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM 226
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+
Sbjct: 227 IMSGNYQFGSPEWDDYSD------------------------------------------ 244
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFFTR 324
+ L+ L P R TA EAL HPFF +
Sbjct: 245 ---TVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-45
Identities = 57/330 (17%), Positives = 111/330 (33%), Gaps = 79/330 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG V C + K+ K V+ + EI +L +H + +
Sbjct: 14 GRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHR----NILHLHE 68
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
F+ + ++FE + G +++ + + + + Q+ E + F+H + H D
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY-- 178
++PEN++ + + K+I+FG +P N+
Sbjct: 128 IRPENIIYQTRRSSTI-------------------------KIIEFGQARQLKPGDNFRL 162
Query: 179 IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPL 238
+ + Y APEV + D+WS+G ++ L +G F N + + +
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF 222
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298
+ K + +
Sbjct: 223 DEEAFKEISI---------------------------------------------EAMDF 237
Query: 299 LQGLLRYDPTDRLTAREALRHPFFTRDHLR 328
+ LL + R+TA EAL+HP+ + R
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIER 267
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 65/330 (19%), Positives = 118/330 (35%), Gaps = 81/330 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+G FG+V + ++E + A K++ ++ E M+EI++L H V++
Sbjct: 21 GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPN----IVKLL 75
Query: 61 NWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+ F Y N++ I+ E D + R ++ + +Q L+ + ++HD +IH D
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LK N+L IK+ D+ S + + +
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR------------------------DSFI 171
Query: 181 STRHYRAPEVILGL-----GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235
T ++ APEV++ + Y D+WS+G L+E+ E + L + +
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
P L P +S +
Sbjct: 232 PP--------------------TLAQPSRWSS--------------------------NF 245
Query: 296 THLLQGLLRYDPTDRLTAREALRHPFFTRD 325
L+ L + R T + L+HPF T D
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 151 bits (383), Expect = 4e-44
Identities = 69/329 (20%), Positives = 133/329 (40%), Gaps = 56/329 (17%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G + +V E + E V +KI++ ++ EI++L+ L + + +
Sbjct: 44 GRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGP----NIITLAD 97
Query: 62 WF--DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+VFE + + + +R ++L+ + + H + ++H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-- 176
D+KP NV++ + +++ID+G + P Q
Sbjct: 153 RDVKPHNVMIDH--------------------------EHRKLRLIDWGLAEFYHPGQEY 186
Query: 177 NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERV 234
N V++R+++ PE+++ + Y D+WS+GC+L + + F H+N + L + +V
Sbjct: 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV 246
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
LG Y+ + ++ S + R + QH+ +
Sbjct: 247 LGT----------EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP--E 294
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFT 323
L LLRYD RLTAREA+ HP+F
Sbjct: 295 ALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 3e-43
Identities = 65/329 (19%), Positives = 119/329 (36%), Gaps = 81/329 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
G G F +V+ D+ +++VAIK + ++ + EI VL ++ KH V +
Sbjct: 18 GTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHP----NIVAL 72
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ ++ H+ ++ + + G L+D + + + + + Q+L+ + ++HDL ++H
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLGIVH 130
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKPEN+L S + + S I + DFG + E P
Sbjct: 131 RDLKPENLLYYS------------------------LDEDSKIMISDFGLSKMEDPGSVL 166
Query: 179 --IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
T Y APEV+ ++ D WS+G I L G F + + + +
Sbjct: 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY 226
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+
Sbjct: 227 EFDSPYWDDISD---------------------------------------------SAK 241
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRD 325
++ L+ DP R T +AL+HP+ D
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-42
Identities = 59/328 (17%), Positives = 110/328 (33%), Gaps = 79/328 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQI 59
GEG +G+V +R +E VA+KIV E EI + + L H+ V+
Sbjct: 14 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE----NVVKF 68
Query: 60 RNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
N + E G L+D + + P + QL+ + ++H + + H
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
D+KPEN+LL + +K+ D+ + ++ N
Sbjct: 127 RDIKPENLLLDERDNLKISDFGLATVFRYNN----------------------RERLLNK 164
Query: 179 IVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+ T Y APE++ + P D+WS G +L + GE + + +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKK 223
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+ K++D
Sbjct: 224 TYLNPWKKIDSAPL---------------------------------------------A 238
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRD 325
LL +L +P+ R+T + + ++ +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 3e-42
Identities = 68/332 (20%), Positives = 113/332 (34%), Gaps = 88/332 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G+FG V D E+VAIK + + + + E+ LQ+L +H +
Sbjct: 24 GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP----NTI 78
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
Q R + + +V E S D L + + + + L+ +A++H MI
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H D+K N+LL +K+ DFGS + P +
Sbjct: 138 HRDVKAGNILLSEPGL---------------------------VKLGDFGSASIMAPANS 170
Query: 178 YIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ V T ++ APEVIL + + D+WS+G +EL + + L + +
Sbjct: 171 F-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
P Q W E
Sbjct: 230 ESPALQSG-----------------HWSE------------------------------Y 242
Query: 295 LTHLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
+ + L+ P DR T+ L+H F R+
Sbjct: 243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-42
Identities = 73/329 (22%), Positives = 127/329 (38%), Gaps = 40/329 (12%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNR-CV 57
G G G V +D VAIK + + + + A E+ +++ + +
Sbjct: 26 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVF 85
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ + + +V E + ++L ++ + + + Q+L I +H +I
Sbjct: 86 TPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIKHLHSAGII 141
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKP N+++ S +K+ D T
Sbjct: 142 HRDLKPSNIVVKSDCTLKILD-------------------------FGLARTAGTSFMMT 176
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
V TR+YRAPEVILG+G+ DIWSVGCI+ E+ + LF + ++ + LG
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
+K++ YV P+ A L + + A D
Sbjct: 237 PCPEFMKKLQPTVRNYVEN----RPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD--- 289
Query: 298 LLQGLLRYDPTDRLTAREALRHPFFTRDH 326
LL +L DP R++ +AL+HP+ +
Sbjct: 290 LLSKMLVIDPAKRISVDDALQHPYINVWY 318
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 9e-42
Identities = 65/327 (19%), Positives = 113/327 (34%), Gaps = 80/327 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIR 60
G+G G V D + VAI+ + + +E + EI V+++ K+ V
Sbjct: 29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP----NIVNYL 83
Query: 61 NWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + + + +V E L G SL D + + + + R+ L+ + F+H +IH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
D+K +N+LL +K+ D+ + S M
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM------------------------ 176
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
V T ++ APEV+ + DIWS+G + +E+ GE + L L ++ P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-- 234
Query: 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
L PE ++ L
Sbjct: 235 ------------------ELQNPEKLSA--------------------------IFRDFL 250
Query: 300 QGLLRYDPTDRLTAREALRHPFFTRDH 326
L D R +A+E L+H F
Sbjct: 251 NRCLDMDVEKRGSAKELLQHQFLKIAK 277
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-42
Identities = 81/330 (24%), Positives = 138/330 (41%), Gaps = 53/330 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA-KHDKGGNRCV 57
G G +G V D VAIK + + + + A E+ +L+ + ++ G
Sbjct: 27 GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 86
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
D +V +G+ L ++ D ++ + Q+L+ + ++H +I
Sbjct: 87 TPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGII 143
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKP N+ + + +K++DFG +
Sbjct: 144 HRDLKPGNLAV---------------------------NEDCELKILDFGLARQADSEMT 176
Query: 178 YIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
V TR YRAPEVIL + +T DIWSVGCI+ E+ TG+ LF+ ++L+ L + +V G
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
P ++R+ K +G + + + I+ + A +
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS---------------ILTNASPLAVN-- 279
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
LL+ +L D R+TA EAL HP+F H
Sbjct: 280 -LLEKMLVLDAEQRVTAGEALAHPYFESLH 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-41
Identities = 74/330 (22%), Positives = 140/330 (42%), Gaps = 53/330 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLA-KHDKGGNRCV 57
G G +G V +D + VA+K + + + E+ +L+ + ++ G
Sbjct: 27 GSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 86
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
+ N + +V +G+ L + ++ + D V+ + Q+L + ++H +I
Sbjct: 87 TPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADII 143
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
H DLKP N+ + + +K++DFG + +
Sbjct: 144 HRDLKPSNLA---------------------------VNEDCELKILDFGLARHTDDEMT 176
Query: 178 YIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
V+TR YRAPE++L + DIWSVGCI+ EL TG LF ++++ L ++ R++G
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+LK++ + + + P+ + + + A D
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFAN---------------VFIGANPLAVD-- 279
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
LL+ +L D R+TA +AL H +F + H
Sbjct: 280 -LLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-40
Identities = 59/332 (17%), Positives = 120/332 (36%), Gaps = 91/332 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G+F V + D E VA ++ K R+ E E+L+ L +H V+
Sbjct: 18 GRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHP----NIVR 72
Query: 59 IRNWF----DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + + I +V E + +L +L++ + I ++R RQ+L+ + F+H
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT 130
Query: 114 LC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTY 171
+IH DLK +N+ + + ++K+ D G T
Sbjct: 131 RTPPIIHRDLKCDNIFITG--------------------------PTGSVKIGDLGLATL 164
Query: 172 ERPDQNY-IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
+R ++ T + APE+ + D+++ G ++E+ T E + +N +
Sbjct: 165 KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY- 222
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
R V+ D
Sbjct: 223 -----------------RRVTSGVKPASFD----------------------------KV 237
Query: 291 SAGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ ++ +++G +R + +R + ++ L H FF
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 5e-40
Identities = 66/331 (19%), Positives = 117/331 (35%), Gaps = 85/331 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGN 54
G G F V +C ++ A K ++ + RE E+ +L+++ +H
Sbjct: 19 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHP---- 73
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
+ + ++ + + ++ E + G L+DFL + S + E +Q+L + ++H
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS 131
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
L + H DLKPEN++L+ R IK+IDFG
Sbjct: 132 LQIAHFDLKPENIMLLD-----------------------RNVPKPRIKIIDFGLAHKID 168
Query: 174 PDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
I T + APE++ D+WS+G I L +G + F E LA +
Sbjct: 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV 228
Query: 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291
V A+
Sbjct: 229 SAVNYEFEDEYFSNTSALAK---------------------------------------- 248
Query: 292 AGDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
++ LL DP R+T +++L+HP+
Sbjct: 249 -----DFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 4e-39
Identities = 60/328 (18%), Positives = 107/328 (32%), Gaps = 81/328 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG+F V+ + AIKI+ +E + + + + V++
Sbjct: 17 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF-FVKLYF 75
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
F + L ++RK SF R +++ + ++H +IH D
Sbjct: 76 TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
LKPEN+LL +I++ D+ ++ +S + N V
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARA----------------------NSFV 171
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
T Y +PE++ D+W++GCI+ +L G F+ + ++ P+
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+P+ L++
Sbjct: 232 KF------------------FPK-------------------------------ARDLVE 242
Query: 301 GLLRYDPTDRLTAREA------LRHPFF 322
LL D T RL E HPFF
Sbjct: 243 KLLVLDATKRLGCEEMEGYGPLKAHPFF 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (340), Expect = 3e-38
Identities = 78/325 (24%), Positives = 128/325 (39%), Gaps = 55/325 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
GEGT+G V + + E A+K +R K + EI +L++L + V+
Sbjct: 11 GEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELKHSN-----IVK 64
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + + + +VFE L L L + QLL IA+ HD ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKP+N+L+ +K+ D+ + + +
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKY------------------------TH 159
Query: 179 IVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+ T YRAP+V++G ++ DIWSVGCI E+ G LF + L + R+LG
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT 219
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
V + + P ++ +D S DL
Sbjct: 220 PNSKNWPNVTELP-----------------KYDPNFTVYEPLPWESFLKGLDESGIDL-- 260
Query: 298 LLQGLLRYDPTDRLTAREALRHPFF 322
L +L+ DP R+TA++AL H +F
Sbjct: 261 -LSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-38
Identities = 62/327 (18%), Positives = 109/327 (33%), Gaps = 85/327 (25%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G+G+FG+V ++ + AIK ++ + E M+E VL +H
Sbjct: 11 GKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP----FLT 66
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + ++ V E L G L ++ F + A +++ + F+H +
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGI 124
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
++ DLK +N+LL +IK+ D+ +
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT------------------------ 160
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
N T Y APE++LG + + D WS G +L E+ G++ F + E
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF-------- 212
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+R +P +
Sbjct: 213 ---------------HSIRMDNPFYPRWLEK--------------------------EAK 231
Query: 297 HLLQGLLRYDPTDRLTAR-EALRHPFF 322
LL L +P RL R + +HP F
Sbjct: 232 DLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 61/336 (18%), Positives = 107/336 (31%), Gaps = 96/336 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G++G+ + + +++ K + + ++ + E+ +L++L KH V+
Sbjct: 13 GTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPN----IVR 67
Query: 59 IRNWFDYR--NHICIVFEKL-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHD 113
+ R + IV E G L + K + + V + QL + H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 114 L-----CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGS 168
++H DLKP NV L + +K+ DFG
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQN---------------------------VKLGDFGL 160
Query: 169 TTYERPDQNY---IVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
D ++ V T +Y +PE + + + DIWS+GC+L ELC F
Sbjct: 161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285
E +R G+ S E
Sbjct: 221 ELAGK-----------------------IREGKFRRIPYRYSDE---------------- 241
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRHPF 321
L ++ +L R + E L +P
Sbjct: 242 ---------LNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-37
Identities = 79/330 (23%), Positives = 138/330 (41%), Gaps = 55/330 (16%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
GEGT+G V + +RE E+VA+K VR + +A+ EI +L++L + V+
Sbjct: 11 GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN-----IVR 65
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + + +VFE L + N P ++V+ QLL+ + F H ++H
Sbjct: 66 LHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHSRNVLH 124
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNY 178
DLKP+N+L+ + +K+ ++ + + +
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCY------------------------SA 160
Query: 179 IVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEA-LFQTHENLEHLAMMERVLG 236
V T YR P+V+ G + D+WS GCI EL LF ++ + L + R+LG
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ + + + K P +L+ +A
Sbjct: 221 TPTEEQWPSMTKLPD-------------------YKPYPMYPATTSLVNVVPKLNA-TGR 260
Query: 297 HLLQGLLRYDPTDRLTAREALRHPFFTRDH 326
LLQ LL+ +P R++A EAL+HP+F+
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-37
Identities = 61/330 (18%), Positives = 109/330 (33%), Gaps = 93/330 (28%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR-------GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G G FG V VAIK V G +E+ +L++++ G
Sbjct: 13 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG-- 70
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+++ +WF+ + ++ E+ F + +L R Q+LE + H+
Sbjct: 71 -VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYER 173
++H D+K EN+L+ + +K+IDFG +
Sbjct: 130 GVLHRDIKDENILIDLNRGE--------------------------LKLIDFGSGALLKD 163
Query: 174 PDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
TR Y PE I +WS+G +L ++ G+ F+ E
Sbjct: 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------- 215
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
+ RG++ + + +S
Sbjct: 216 ---------------------IIRGQVFFRQRVSS------------------------- 229
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRHPFF 322
+ HL++ L P+DR T E HP+
Sbjct: 230 -ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 2e-36
Identities = 57/328 (17%), Positives = 102/328 (31%), Gaps = 64/328 (19%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G+FG + D E VAIK+ +K IE ++ + + IR
Sbjct: 16 GSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGG----VGIPTIRW 70
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
++ +V E LG SL D + R F + V +A Q++ I ++H IH D+
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDV 129
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
KP+N L+ + + D K+ + + I + +
Sbjct: 130 KPDNFLMGLGKKGNLVYII-------DFGLAKKYRDARTHQHIPYRENKN-------LTG 175
Query: 182 TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQH 241
T Y + LG+ + D+ S+G +L+ G +Q + ER
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-------- 227
Query: 242 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301
+ ++ I + L
Sbjct: 228 ---------------------------------ISEKKMSTPIEVLCKGYPSEFATYLNF 254
Query: 302 LLRYDPTDRLTA---REALRHPFFTRDH 326
D+ R+ R+ F +
Sbjct: 255 CRSLRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (313), Expect = 4e-34
Identities = 48/244 (19%), Positives = 87/244 (35%), Gaps = 38/244 (15%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
GEG+FG + E + + VAIK + E + LA +
Sbjct: 14 GEGSFGVIFEGTNLLNNQQVAIKFEP-RRSDAPQLRDEYRTYKLLAGC----TGIPNVYY 68
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
+ H +V + LG SL D L R F + V A+Q+L + +H+ +++ D+
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDI 127
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG----------STTY 171
KP+N L+ ++ I V+DFG
Sbjct: 128 KPDNFLIGR----------------------PNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 172 ERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231
++ + T Y + LG + D+ ++G + + G +Q + +
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 232 ERVL 235
ER+
Sbjct: 226 ERIG 229
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (313), Expect = 5e-34
Identities = 61/330 (18%), Positives = 106/330 (32%), Gaps = 91/330 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G+FG+V R A+K+++ K E E +L + H +
Sbjct: 13 GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THP----FII 67
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ F I ++ + + L + + R FP + + A ++ + ++H +I
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLHSKDII 126
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
+ DLKPEN+LL + + IK+ DFG Y
Sbjct: 127 YRDLKPENILLDKNGH---------------------------IKITDFGFAKYVPDVTY 159
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+ T Y APEV+ + D WS G ++ E+ G F
Sbjct: 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY---------------DS 204
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
++ + L +P D+
Sbjct: 205 NTMKTYEK--------ILNAELRFPPFFNE--------------------------DVKD 230
Query: 298 LLQGLLRYDPTDRL-----TAREALRHPFF 322
LL L+ D + RL + HP+F
Sbjct: 231 LLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 125 bits (315), Expect = 8e-34
Identities = 66/333 (19%), Positives = 124/333 (37%), Gaps = 89/333 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G FG+V C + +M A+K + +K+ A+ E +L ++ D V
Sbjct: 13 GRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFIV 70
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ F + + + + + G L+ L ++ F +R A +++ + MH+ +
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFV 128
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPD 175
++ DLKP N+LL + +++ D G + + +
Sbjct: 129 VYRDLKPANILLDEHGH---------------------------VRISDLGLACDFSKKK 161
Query: 176 QNYIVSTRHYRAPEVIL-GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234
+ V T Y APEV+ G+ + D +S+GC+L +L G + F+ H+ + +
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGD 294
L ++ P+ + +
Sbjct: 222 LTM--------------------AVELPDSFSP--------------------------E 235
Query: 295 LTHLLQGLLRYDPTDRLT-----AREALRHPFF 322
L LL+GLL+ D RL A+E PFF
Sbjct: 236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-33
Identities = 62/331 (18%), Positives = 111/331 (33%), Gaps = 90/331 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G+GTFG+V+ ++ A+KI+R K + E VLQ +H
Sbjct: 14 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RH----PFLT 68
Query: 58 QIRNWFDYRNHICIVFEK-LGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ F + +C V E G L+ L + F + R +++ + ++H +
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSRDV 126
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
++ D+K EN++L +IK+ D+ D +
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM------------------------ 162
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
T Y APEV+ + D W +G ++ E+ G F ++ +
Sbjct: 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ 216
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ + +P + +
Sbjct: 217 -----------------ILMEEIRFPRTLSP--------------------------EAK 233
Query: 297 HLLQGLLRYDPTDRL-----TAREALRHPFF 322
LL GLL+ DP RL A+E + H FF
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-33
Identities = 56/320 (17%), Positives = 105/320 (32%), Gaps = 84/320 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G+G FG V+ R K VA+K ++ +A + E V+ QL +H VQ+
Sbjct: 16 GKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHS----NLVQLLG 67
Query: 62 WF-DYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHT 119
+ + + IV E + SL D+LR D + + + + E + ++ +H
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127
Query: 120 DLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYI 179
DL NVL+ + + KV DFG T Q+
Sbjct: 128 DLAARNVLV---------------------------SEDNVAKVSDFGLTKEASSTQDTG 160
Query: 180 VSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLP 239
+ APE + ++ D+WS G +L E+ + + L+ +
Sbjct: 161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------- 209
Query: 240 QHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLL 299
+ + ++D P+G + ++
Sbjct: 210 ----------VPRVEKGYKMDAPDGCPP--------------------------AVYEVM 233
Query: 300 QGLLRYDPTDRLTAREALRH 319
+ D R + +
Sbjct: 234 KNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 118 bits (296), Expect = 3e-31
Identities = 66/330 (20%), Positives = 108/330 (32%), Gaps = 91/330 (27%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G+FG+V+ +E A+KI+ K K E + E +LQ +
Sbjct: 50 GTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP----FLVK 105
Query: 58 QIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMI 117
++ D N ++ G ++ LR+ F R A Q++ ++H L +I
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLI 163
Query: 118 HTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQN 177
+ DLKPEN+L+ Y I+V DFG +
Sbjct: 164 YRDLKPENLLIDQQGY---------------------------IQVTDFGFAKRVKGRTW 196
Query: 178 YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237
+ T APE+IL G+ D W++G ++ E+ G F + ++ +
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVR 256
Query: 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTH 297
P H DL
Sbjct: 257 FPSHFSS-------------------------------------------------DLKD 267
Query: 298 LLQGLLRYDPTDRL-----TAREALRHPFF 322
LL+ LL+ D T R + H +F
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-31
Identities = 62/327 (18%), Positives = 114/327 (34%), Gaps = 86/327 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRCVQ 58
G G+FG V + + VA+K++ + +A E+ VL++ R V
Sbjct: 17 GSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT--------RHVN 65
Query: 59 IRNWFDY--RNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
I + Y + IV + GSSLY L + F + + +IARQ + + ++H
Sbjct: 66 ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAKS 124
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+IH DLK N+ L +K+ D+ + + S +
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF--------------------- 163
Query: 176 QNYIVSTRHYRAPEVILGLG---WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
+ + + APEVI +++ D+++ G +L EL TG+ + N + + M
Sbjct: 164 -EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM- 221
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSA 292
V RG L + + +
Sbjct: 222 ---------------------VGRGYLSPD---------------------LSKVRSNCP 239
Query: 293 GDLTHLLQGLLRYDPTDRLTAREALRH 319
+ L+ L+ +R + L
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (289), Expect = 7e-31
Identities = 48/264 (18%), Positives = 88/264 (33%), Gaps = 37/264 (14%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G +V D VA+K++R + E + L H V
Sbjct: 16 GFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP----AIV 70
Query: 58 QIRNWFDYRNH----ICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
+ + + IV E + G +L D + E+ + + F H
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALNFSH 128
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
+IH D+KP N+++ ++ +KV D+ + + +
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT----------------- 171
Query: 173 RPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232
++ T Y +PE G D++S+GC+L E+ TGE F +
Sbjct: 172 ----AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 233 RVLGPLPQHMLKRVDRHAEKYVRR 256
R P + + + V +
Sbjct: 228 REDPIPPSARHEGLSADLDAVVLK 251
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (285), Expect = 2e-30
Identities = 61/325 (18%), Positives = 111/325 (34%), Gaps = 80/325 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG+V + + VA+K ++ +A + E +++QL +H R V++
Sbjct: 22 GAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----RLVRLYA 75
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
+ I I+ E + SL DFL+ + I+ + ++A Q+ E +AF+ + IH D
Sbjct: 76 VVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
L+ N+L+ + K+ D+ + + +
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-----------------------AK 171
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQ 240
+ APE I +T D+WS G +L E+ T + +
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------------ 219
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
+ R R+ P+ +L L++
Sbjct: 220 ---------IQNLERGYRMVRPDNCPE--------------------------ELYQLMR 244
Query: 301 GLLRYDPTDRLTAREALR--HPFFT 323
+ P DR T FFT
Sbjct: 245 LCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 5e-30
Identities = 58/324 (17%), Positives = 105/324 (32%), Gaps = 78/324 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G+G FG+V VAIK ++ EA + E +V+++L + VQ+
Sbjct: 26 GQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHE-----KLVQLYA 79
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
+ SL DFL+ + + + ++A Q+ +A++ + +H DL
Sbjct: 80 VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
+ N+L+ + KV D+ + + ++
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTARQG-----------------------AKF 176
Query: 182 TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQH 241
+ APE L +T D+WS G +L EL T + +
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------------NRE 222
Query: 242 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301
+L +V+R R+ P L L+
Sbjct: 223 VLDQVERGY-------RMPCPPECPE--------------------------SLHDLMCQ 249
Query: 302 LLRYDPTDRLTAREALR--HPFFT 323
R +P +R T +FT
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 7e-29
Identities = 60/330 (18%), Positives = 117/330 (35%), Gaps = 85/330 (25%)
Query: 2 GEGTFGQVLECWDRERK--EMVAIKIVR---GIKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G G FG V + + + +K + VA+KI++ ++ + E V+QQL +
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP----YI 70
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V++ + + + ++ L +L++N R + E+ Q+ + ++ +
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DL NVLLV+ Y K+ D+ S D +Y+K
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ--------------------- 167
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMERVL 235
+ + APE I ++ D+WS G ++ E G+ ++ + E AM+E+
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE 227
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
R+ P G ++
Sbjct: 228 ----------------------RMGCPAGCPR--------------------------EM 239
Query: 296 THLLQGLLRYDPTDRLTARE---ALRHPFF 322
L+ YD +R LR+ ++
Sbjct: 240 YDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 57/318 (17%), Positives = 102/318 (32%), Gaps = 76/318 (23%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG V + K+ VAIK +R E + E EV+ +L H + VQ+
Sbjct: 14 GSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP----KLVQLYG 67
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
+ IC+VFE + + F + + + + E +A++ + C+IH DL
Sbjct: 68 VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
N L+ ++ IKV D+ + D
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-----------------------TKF 164
Query: 182 TRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGPLPQH 241
+ +PEV ++ D+WS G ++ E+ + + + + +
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------------- 211
Query: 242 MLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301
E RL P A++ + ++
Sbjct: 212 --------VEDISTGFRLYKPRLAST--------------------------HVYQIMNH 237
Query: 302 LLRYDPTDRLTAREALRH 319
+ P DR LR
Sbjct: 238 CWKERPEDRPAFSRLLRQ 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 107 bits (268), Expect = 1e-27
Identities = 50/288 (17%), Positives = 107/288 (37%), Gaps = 31/288 (10%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G +G+V E ++ VA+K ++ E + E V++++ KH VQ+
Sbjct: 26 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP----NLVQLLG 80
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTD 120
I+ E + +L D+LR+ N + ++ +A Q+ + ++ IH D
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140
Query: 121 LKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIV 180
L N L+ + +KV D+ S D+
Sbjct: 141 LAARNCLVGENHLVKVADFGLSRLMTGDTYT-----------------------AHAGAK 177
Query: 181 STRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--AMMERVLGPL 238
+ APE + ++ D+W+ G +L E+ T +L + + +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 237
Query: 239 PQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQ 286
P+ ++V + D P A ++ +++ + + + + +
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 56/337 (16%), Positives = 101/337 (29%), Gaps = 95/337 (28%)
Query: 2 GEGTFGQVLECWDRE--RKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCV 57
GEG FGQVL+ ++ + AIK ++ K E+EVL +L H +
Sbjct: 19 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP----NII 74
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVREIAR 102
+ ++R ++ + E +L DFLRK+ + + A
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 103 QLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIK 162
+ + ++ IH DL N+L+ + K+ D+ S
Sbjct: 135 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK------------ 182
Query: 163 VIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH 222
+ + A E + +T D+WS G +L E+ +
Sbjct: 183 -------------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 223 ENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQN 282
L EK + RL+ P
Sbjct: 230 MTCAEL---------------------YEKLPQGYRLEKPLNCDD--------------- 253
Query: 283 LIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319
++ L++ R P +R + + L
Sbjct: 254 -----------EVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-27
Identities = 57/349 (16%), Positives = 108/349 (30%), Gaps = 105/349 (30%)
Query: 2 GEGTFGQVLECWDRERKE-----MVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G G FG+V+ + VA+K+++ REA M E++++ QL H+
Sbjct: 46 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE---- 101
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYR---------------------SF 92
V + I ++FE L ++LR +
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 93 PIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152
+ + A Q+ + + F+ +H DL NVL+ + +K+ D+ + DS+Y
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221
Query: 153 KRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212
R + APE + +T D+WS G +L E+
Sbjct: 222 VRG----------------------NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259
Query: 213 CT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRES 270
+ G + + K ++ G ++D P A
Sbjct: 260 FSLGVNPYPGIPVDANF----------------------YKLIQNGFKMDQPFYATE--- 294
Query: 271 IKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319
++ ++Q +D R +
Sbjct: 295 -----------------------EIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 6e-27
Identities = 58/329 (17%), Positives = 109/329 (33%), Gaps = 62/329 (18%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G+G FG+V + R E VA+KI ++ EI L +H+
Sbjct: 12 GKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNK 68
Query: 62 WFDYRNHICIVFEKL-GSSLYDFLRKNNY-----RSFPIDLVREIARQLLECIAFMHDLC 115
+ +V + SL+D+L + + +A +E +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 128
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+ H DLK +N+L+ + + D + V +T
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADL--------------------GLAVRHDSATDTIDIA 168
Query: 176 QNYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229
N+ V T+ Y APEV+ DI+++G + E+ ++ HE+ +
Sbjct: 169 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228
Query: 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVD 289
P + M K V ++ R + P S E+++ + K
Sbjct: 229 YDLVPSDPSVEEMRKVVCE------QKLRPNIPNRWQSCEALRVMAK------------- 269
Query: 290 HSAGDLTHLLQGLLRYDPTDRLTAREALR 318
+++ + RLTA +
Sbjct: 270 --------IMRECWYANGAARLTALRIKK 290
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 8e-27
Identities = 67/331 (20%), Positives = 113/331 (34%), Gaps = 85/331 (25%)
Query: 2 GEGTFGQVLECWDRERKE--MVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGNRCV 57
G G FG V + R RK+ VAIK+++ K E M E +++ QL + V
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----YIV 72
Query: 58 QIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
++ + +V E G L+ FL P+ V E+ Q+ + ++ +
Sbjct: 73 RLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DL NVLLV+ Y K+ D+ S D SY+
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--------------------- 169
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE-LCTGEALFQTHENLEHLAMMERVL 235
+ + APE I ++ D+WS G + E L G+ ++ + E +A +E+
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229
Query: 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDL 295
R++ P P L L+
Sbjct: 230 ----------------------RMECPPECP-----------PELYALMSD--------- 247
Query: 296 THLLQGLLRYDPTDRLTARE---ALRHPFFT 323
Y DR +R +++
Sbjct: 248 ------CWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 2e-26
Identities = 47/244 (19%), Positives = 94/244 (38%), Gaps = 30/244 (12%)
Query: 2 GEGTFGQVLECWDR---ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRC 56
G G FG+V + +R+ VAIK ++ +K R + E ++ Q H
Sbjct: 35 GAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPN----V 89
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ + + I+ E + + D + N F + + + R + + ++ D+
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 149
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DL N+L+ S+ KV D+ S + ++ ++
Sbjct: 150 VHRDLAARNILVNSNLVCKVSDFGLS-------------------RFLEDDTSDPTYTSA 190
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVL 235
+ APE I +T D+WS G ++ E+ + GE + N + + +E+
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 236 GPLP 239
P
Sbjct: 251 RLPP 254
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-26
Identities = 44/253 (17%), Positives = 91/253 (35%), Gaps = 34/253 (13%)
Query: 2 GEGTFGQVLECWDR----ERKEMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNR 55
G G FG+V + + +++ VAIK ++ +K R + E ++ Q + H
Sbjct: 16 GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH-----N 70
Query: 56 CVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC 115
+++ + I+ E + + D + F + + + R + + ++ ++
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN 130
Query: 116 MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPD 175
+H DL N+L+ S+ KV D+ S D
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT-------------------- 170
Query: 176 QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL--AMMER 233
+ + APE I +T D+WS G ++ E+ T + + A+ +
Sbjct: 171 -SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 234 VLGPLPQHMLKRV 246
P P +
Sbjct: 230 FRLPTPMDCPSAI 242
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-26
Identities = 61/342 (17%), Positives = 113/342 (33%), Gaps = 98/342 (28%)
Query: 2 GEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G G FG+V+E + VA+K+++ REA M E++VL L H
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM---- 87
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRK----------------NNYRSFPIDLV 97
V + ++ E L +FLR+ ++ + ++ +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 98 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157
+ Q+ + +AF+ IH DL N+LL K+ D+ + DS+Y
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV---- 203
Query: 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217
+ + APE I +T+ D+WS G L EL + +
Sbjct: 204 ------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
Query: 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRG-RLDWPEGAASRESIKSVMK 276
++ K ++ G R+ PE
Sbjct: 246 SPYPGMPVDSKFY---------------------KMIKEGFRMLSPE------------- 271
Query: 277 LPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318
H+ ++ +++ DP R T ++ ++
Sbjct: 272 -------------HAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 3e-26
Identities = 51/319 (15%), Positives = 102/319 (31%), Gaps = 78/319 (24%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61
G G FG V R + + VAIK+++ + + E +V+ L H+ + VQ+
Sbjct: 13 GTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHE----KLVQLYG 66
Query: 62 WFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDL 121
+ I I+ E + + + F + E+ + + E + ++ +H DL
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 122 KPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVS 181
N L+ +KV D+ S + D
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-----------------------SKF 163
Query: 182 TRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGPLPQ 240
+ PEV++ ++ DIW+ G ++ E+ + G+ ++ N E + + L
Sbjct: 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----- 218
Query: 241 HMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQ 300
RL P A+ + ++
Sbjct: 219 -----------------RLYRPHLASE--------------------------KVYTIMY 235
Query: 301 GLLRYDPTDRLTAREALRH 319
+R T + L +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 1e-25
Identities = 44/323 (13%), Positives = 82/323 (25%), Gaps = 76/323 (23%)
Query: 2 GEGTFGQVLECWDRE---RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRC 56
G G FG V + +K A+K + I + E +++ H N
Sbjct: 36 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP---NVL 91
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
+ +V + +N + + + Q+ + + F+
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H DL N +L +KV D+ + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA----------------- 194
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ A E + +T D+WS G +L EL T A N +
Sbjct: 195 ---KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-------- 243
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
++ RL PE + L
Sbjct: 244 -------------TVYLLQGRRLLQPE--------------------------YCPDPLY 264
Query: 297 HLLQGLLRYDPTDRLTAREALRH 319
++ R + E +
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-25
Identities = 62/337 (18%), Positives = 112/337 (33%), Gaps = 90/337 (26%)
Query: 2 GEGTFGQVLECWD---RERKEMVAIKIVRGIK-----KYREAAMIEIEVLQQLAKHDKGG 53
G G +G+V + ++ A+K+++ K E E +VL+ + +
Sbjct: 33 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS---- 88
Query: 54 NRCVQIRNWFDYRNHICIVFE-KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMH 112
V + F + ++ + G L+ L + F V+ +++ + +H
Sbjct: 89 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH 146
Query: 113 DLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYE 172
L +I+ D+K EN+LL S+ ++ + D+ S E
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-----------------------VADE 183
Query: 173 RPDQNYIVSTRHYRAPEVILGL--GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230
T Y AP+++ G G D WS+G ++ EL TG + F A
Sbjct: 184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 243
Query: 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290
+ R + + +P+ ++
Sbjct: 244 ISR-------------------RILKSEPPYPQEMSA----------------------- 261
Query: 291 SAGDLTHLLQGLLRYDPTDRL-----TAREALRHPFF 322
L+Q LL DP RL A E H FF
Sbjct: 262 ---LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 1e-23
Identities = 53/342 (15%), Positives = 103/342 (30%), Gaps = 97/342 (28%)
Query: 2 GEGTFGQVLECWDR-------ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKG 52
GEG FGQV+ R VA+K+++ +K + E+E+++ + KH
Sbjct: 22 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH--- 78
Query: 53 GNRCVQIRNWFDYRNHICIVFEKL-GSSLYDFLR--------------KNNYRSFPIDLV 97
+ + + ++ E +L ++L+ N +
Sbjct: 79 -KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 98 REIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157
A Q+ + ++ IH DL NVL+ +K+ D+ + Y K
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT-- 195
Query: 158 SSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA 217
+ APE + +T+ D+WS G +L E+ T
Sbjct: 196 --------------------NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
Query: 218 LFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKL 277
+E L + R+D P +
Sbjct: 236 SPYPGVPVEEL---------------------FKLLKEGHRMDKPSNCTN---------- 264
Query: 278 PRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319
+L +++ P+ R T ++ +
Sbjct: 265 ----------------ELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 96.5 bits (239), Expect = 1e-23
Identities = 53/347 (15%), Positives = 97/347 (27%), Gaps = 104/347 (29%)
Query: 2 GEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
GEG FG+V + E MVA+K+++ + E ++ +
Sbjct: 22 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP----- 76
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS---------------------- 91
V++ +C++FE + L +FLR + +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 92 FPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151
IARQ+ +A++ + +H DL N L+ + +K+ D+ S + Y
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211
+ PE I +T D+W+ G +L E
Sbjct: 197 KADGN----------------------DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234
Query: 212 LCTGEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESI 271
+ + E + L PE
Sbjct: 235 IFSYGLQPYYGMAHEEV---------------------IYYVRDGNILACPENCPL---- 269
Query: 272 KSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318
+L +L++ P DR + R
Sbjct: 270 ----------------------ELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 3e-23
Identities = 49/326 (15%), Positives = 94/326 (28%), Gaps = 85/326 (26%)
Query: 2 GEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAA--------MIEIEVLQQLAKHDKGG 53
G G FG V + E V I + IK+ REA + E V+ + +
Sbjct: 18 GSGAFGTVYKGLWIPEGEKVKIPVA--IKELREATSPKANKEILDEAYVMASV-DNP--- 71
Query: 54 NRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD 113
++ I L D++R++ + + Q+ + + ++ D
Sbjct: 72 -HVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED 129
Query: 114 LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYER 173
++H DL NVL+ + +++K+ D+ + + +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA------------------- 170
Query: 174 PDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233
+ A E IL +T+ D+WS G + EL T + +
Sbjct: 171 ---EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----- 222
Query: 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAG 293
+ + RL P
Sbjct: 223 ----------------SSILEKGERLPQPPICTI-------------------------- 240
Query: 294 DLTHLLQGLLRYDPTDRLTAREALRH 319
D+ ++ D R RE +
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 3e-23
Identities = 41/247 (16%), Positives = 89/247 (36%), Gaps = 35/247 (14%)
Query: 2 GEGTFGQVLECWDRE---RKEMVAIKIVR----GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G+G+FG V + VA+K ++ + + + E+ + L H
Sbjct: 17 GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRN--- 72
Query: 55 RCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDL 114
+++ + +V E + + F + + A Q+ E + ++
Sbjct: 73 -LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 115 CMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERP 174
IH DL N+LL + + +K+ D+ P++ ++
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM-------------------- 170
Query: 175 DQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMER 233
Q + + APE + +++ D W G L E+ T G+ + + L +++
Sbjct: 171 -QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
Query: 234 VLGPLPQ 240
LP+
Sbjct: 230 EGERLPR 236
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 3e-23
Identities = 55/343 (16%), Positives = 107/343 (31%), Gaps = 96/343 (27%)
Query: 2 GEGTFGQVLECWDR-----ERKEMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G+G+FG V E + E + VAIK V + R + E V+++ H
Sbjct: 29 GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH----- 83
Query: 55 RCVQIRNWFDYRNHICIVFEKL-GSSLYDFLRKNNYRS--------FPIDLVREIARQLL 105
V++ ++ E + L +LR + + ++A ++
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 106 ECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVID 165
+ +A+++ +H DL N ++ +K+ D+ + + Y K
Sbjct: 144 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK--------- 194
Query: 166 FGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225
+ + +PE + +T D+WS G +L E+ T +
Sbjct: 195 -------------GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285
E + + G LD P
Sbjct: 242 EQV---------------------LRFVMEGGLLDKP----------------------- 257
Query: 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR------HPFF 322
D+ L L++ +Y+P R + E + P F
Sbjct: 258 ---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 4e-23
Identities = 53/323 (16%), Positives = 88/323 (27%), Gaps = 81/323 (25%)
Query: 2 GEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRC 56
GEG FG V + + VAIK + RE + E ++Q H
Sbjct: 16 GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP----HI 70
Query: 57 VQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCM 116
V++ N + I+ E + S + + A QL +A++
Sbjct: 71 VKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 117 IHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ 176
+H D+ NVL+ S++ +K+ D+ S + + Y
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK--------------------- 168
Query: 177 NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236
+ APE I +T D+W G + E+ +
Sbjct: 169 --GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------- 218
Query: 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLT 296
+ RL P L
Sbjct: 219 -------------IGRIENGERLPMPPNCPP--------------------------TLY 239
Query: 297 HLLQGLLRYDPTDRLTAREALRH 319
L+ YDP+ R E
Sbjct: 240 SLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 5e-21
Identities = 54/341 (15%), Positives = 104/341 (30%), Gaps = 95/341 (27%)
Query: 2 GEGTFGQVLECWDRERK-----EMVAIKIVR--GIKKYREAAMIEIEVLQQLAKHDKGGN 54
G G FGQV+E VA+K+++ A M E+++L + H
Sbjct: 22 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH----L 77
Query: 55 RCVQIRN-WFDYRNHICIVFEKL-GSSLYDFLRKNNY--------------RSFPIDLVR 98
V + + ++ E +L +LR ++ +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 99 EIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158
+ Q+ + + F+ IH DL N+LL +K+ D+ + KD Y ++
Sbjct: 138 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK---- 193
Query: 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEAL 218
+ APE I +T D+WS G +L E+ + A
Sbjct: 194 ------------------GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 235
Query: 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLP 278
+ + +R+
Sbjct: 236 PYPGVK-------------IDEEFCRRLK------------------------------- 251
Query: 279 RLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319
+ M+ D++ ++ + +P+ R T E + H
Sbjct: 252 --EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.7 bits (149), Expect = 5e-12
Identities = 32/217 (14%), Positives = 62/217 (28%), Gaps = 39/217 (17%)
Query: 1 MGEGTFGQVLECWDRERKEMVAIKIVR-GIKKYREAAMIEIEVLQQLAKHDKGGNR-CVQ 58
MGEG V C+ + E +K + G +++ + R +
Sbjct: 8 MGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 59 IRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIH 118
+ + + L + + ++ E+ +LE +A + ++H
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRGIVH 126
Query: 119 TDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFG-STTYERPDQN 177
DL NVL+ I +IDF S
Sbjct: 127 GDLSQYNVLVSEEG----------------------------IWIIDFPQSVEVGEEGWR 158
Query: 178 YIVSTRHYRAPEVIL---GLGWTYPCDIWSVGCILVE 211
I+ R I+ + DI S +++
Sbjct: 159 EIL----ERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} Length = 395 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Score = 41.0 bits (95), Expect = 1e-04
Identities = 21/133 (15%), Positives = 39/133 (29%), Gaps = 5/133 (3%)
Query: 35 AAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSLYDFLRKNNYRSFPI 94
A + ++ + C ++ W + + N +
Sbjct: 143 AKRVAKVHQLEVPIWKEPDYLCEALQRWLKQLTGTVDAEHRFDLPEECGVSSVNC----L 198
Query: 95 DLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK-DSSYFK 153
DL RE+ + H DL+ N+LL + + S T +S
Sbjct: 199 DLARELEFLRAHISLSKSPVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSA 258
Query: 154 RMPKSSAIKVIDF 166
P + +IDF
Sbjct: 259 FNPADPRLVLIDF 271
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 329 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.25 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.02 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.41 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.75 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.67 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-61 Score=406.91 Aligned_cols=242 Identities=25% Similarity=0.438 Sum_probs=208.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||+|++.... .......+|+.++..+ .||||+++++++.+++..++||||+
T Consensus 14 iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~ivmEy~ 88 (263)
T d2j4za1 14 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-----RHPNILRLYGYFHDATRVYLILEYA 88 (263)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-----CCCCCCeEEEEEEECCEEEEEEeec
Confidence 799999999999999999999999986422 2345667899999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 89 ~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill--------------------------- 139 (263)
T d2j4za1 89 PLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL--------------------------- 139 (263)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---------------------------
Confidence 899999998754 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 234 (329)
+.++.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 140 ~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 219 (263)
T d2j4za1 140 GSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 219 (263)
T ss_dssp CTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred cCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 556678999999987665443 4567999999999999999999999999999999999999999887766655544332
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.... ++..+.++.+||.+||+.||++|||++
T Consensus 220 ~~~~-------------------------------------------------p~~~s~~~~~li~~~L~~dp~~R~t~~ 250 (263)
T d2j4za1 220 EFTF-------------------------------------------------PDFVTEGARDLISRLLKHNPSQRPMLR 250 (263)
T ss_dssp CCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC-------------------------------------------------CccCCHHHHHHHHHHccCCHhHCcCHH
Confidence 2111 123567899999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
|+|+||||++.
T Consensus 251 eil~hp~~~~~ 261 (263)
T d2j4za1 251 EVLEHPWITAN 261 (263)
T ss_dssp HHHTCHHHHHH
T ss_pred HHHcCcCcCCc
Confidence 99999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-60 Score=406.82 Aligned_cols=244 Identities=26% Similarity=0.414 Sum_probs=209.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.+|+.||||+++... ...+...+|+.++..+ .||||+++++++.+++.+|+||||| |+
T Consensus 28 iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ivmEy~~gg 102 (293)
T d1yhwa1 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-----KNPNIVNYLDSYLVGDELWVVMEYLAGG 102 (293)
T ss_dssp CCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred EecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-----CCCCEeeEeEEEEECCEEEEEEEecCCC
Confidence 799999999999999999999999987433 3456678899999988 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+ +.+
T Consensus 103 ~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---------------------------~~~ 152 (293)
T d1yhwa1 103 SLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---------------------------GMD 152 (293)
T ss_dssp BHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTT
T ss_pred cHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---------------------------CCC
Confidence 999988775 49999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 159 SAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.+||+|||.+....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 153 ~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 232 (293)
T d1yhwa1 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (293)
T ss_dssp CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred CcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 679999999998654432 44679999999999999999999999999999999999999998877666554444322
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
.+.. ..+..++..+++||.+||+.||++|||++|
T Consensus 233 ~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 266 (293)
T d1yhwa1 233 TPEL----------------------------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKE 266 (293)
T ss_dssp SCCC----------------------------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCCC----------------------------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 1110 012346778999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+|+||||+..
T Consensus 267 il~Hp~~~~~ 276 (293)
T d1yhwa1 267 LLQHQFLKIA 276 (293)
T ss_dssp HTTCGGGGGC
T ss_pred HhcCHhhCCC
Confidence 9999999753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-60 Score=405.79 Aligned_cols=245 Identities=24% Similarity=0.374 Sum_probs=201.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|+++.+|+.||+|+++... ...+...+|+.++..+ .||||+++++++.+++..|+||||+ +
T Consensus 13 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~~~~~~~~~~~ivmEy~~g 87 (271)
T d1nvra_ 13 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRREGNIQYLFLEYCSG 87 (271)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-----CCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-----CCCCEeeEeeeeccCceeEEEEeccCC
Confidence 799999999999999999999999987432 2345677899999888 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+ +.
T Consensus 88 g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---------------------------~~ 138 (271)
T d1nvra_ 88 GELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---------------------------DE 138 (271)
T ss_dssp EEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---------------------------CT
T ss_pred CcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---------------------------CC
Confidence 99999987543 69999999999999999999999999999999999999 45
Q ss_pred CCCeEEeeCCCCcccCCC-----CCcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPD-----QNYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLAMM 231 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 231 (329)
++.+||+|||.|...... ....+||+.|||||++.+..+ +.++|||||||++|+|++|+.||...+........
T Consensus 139 ~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~ 218 (271)
T d1nvra_ 139 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218 (271)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH
T ss_pred CCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 567999999998765332 234679999999999998876 57899999999999999999999765543222211
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
........ ..+..++.++.+||++||+.||++||
T Consensus 219 ~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~ 252 (271)
T d1nvra_ 219 WKEKKTYL----------------------------------------------NPWKKIDSAPLALLHKILVENPSARI 252 (271)
T ss_dssp HHTTCTTS----------------------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSC
T ss_pred HhcCCCCC----------------------------------------------CccccCCHHHHHHHHHHcCCChhHCc
Confidence 11111100 01234577899999999999999999
Q ss_pred CHHHHhcCCCCCCC
Q 020235 312 TAREALRHPFFTRD 325 (329)
Q Consensus 312 t~~~ll~hp~f~~~ 325 (329)
|++|+++||||++.
T Consensus 253 t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 253 TIPDIKKDRWYNKP 266 (271)
T ss_dssp CHHHHTTCTTTTCC
T ss_pred CHHHHhcCHhhCcC
Confidence 99999999999854
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-59 Score=407.93 Aligned_cols=249 Identities=26% Similarity=0.453 Sum_probs=198.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|+++.+++.||||++.... .......+|+.++..+ .||||+++++++.+++.+|+||||| |
T Consensus 17 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~lvmE~~~g 91 (307)
T d1a06a_ 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-----KHPNIVALDDIYESGGHLYLIMQLVSG 91 (307)
T ss_dssp SBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-----CCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 799999999999999999999999987432 2344567899999888 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||+... +.
T Consensus 92 g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------------------~~ 145 (307)
T d1a06a_ 92 GELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------------------DE 145 (307)
T ss_dssp CBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS------------------------ST
T ss_pred CcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc------------------------CC
Confidence 99999998754 69999999999999999999999999999999999999532 34
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
++.+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+..
T Consensus 146 ~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~ 225 (307)
T d1a06a_ 146 DSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE 225 (307)
T ss_dssp TCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTC
T ss_pred CceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccC
Confidence 6779999999998665443 44689999999999999999999999999999999999999998877666555554432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHH
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTARE 315 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ 315 (329)
..++.. ....+++++.+||.+||+.||++|||++|
T Consensus 226 ~~~~~~---------------------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e 260 (307)
T d1a06a_ 226 YEFDSP---------------------------------------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQ 260 (307)
T ss_dssp CCCCTT---------------------------------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCc---------------------------------------------cccCCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 222211 12346778999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020235 316 ALRHPFFTRD 325 (329)
Q Consensus 316 ll~hp~f~~~ 325 (329)
+++||||++.
T Consensus 261 il~hp~~~~~ 270 (307)
T d1a06a_ 261 ALQHPWIAGD 270 (307)
T ss_dssp HHHSTTTTSS
T ss_pred HhcCHhhCCC
Confidence 9999999854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=403.46 Aligned_cols=244 Identities=25% Similarity=0.414 Sum_probs=208.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+|+.||||+++.. ........+|+.++..+ .||||+++++++.+++.+|+||||+
T Consensus 16 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~ivmEy~ 90 (288)
T d1uu3a_ 16 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-----DHPFFVKLYFTFQDDEKLYFGLSYA 90 (288)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-----CSTTBCCEEEEEECSSEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-----CCCCeeEEEEEEEECCEEEEEEEcc
Confidence 69999999999999999999999998742 22345677899999988 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 91 ~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll--------------------------- 141 (288)
T d1uu3a_ 91 KNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL--------------------------- 141 (288)
T ss_dssp TTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------
T ss_pred CCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---------------------------
Confidence 899999988764 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++|+|||.|....... ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 142 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 142 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK 221 (288)
T ss_dssp CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHH
Confidence 556679999999997654332 335799999999999999999999999999999999999999998777665554
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+....+ +..+++++++||++||+.||++|
T Consensus 222 i~~~~~~~-------------------------------------------------p~~~s~~~~~li~~~L~~dP~~R 252 (288)
T d1uu3a_ 222 IIKLEYDF-------------------------------------------------PEKFFPKARDLVEKLLVLDATKR 252 (288)
T ss_dssp HHTTCCCC-------------------------------------------------CTTCCHHHHHHHHTTSCSSGGGS
T ss_pred HHcCCCCC-------------------------------------------------CccCCHHHHHHHHHHccCCHhHC
Confidence 44322111 12457789999999999999999
Q ss_pred CCHHH------HhcCCCCCCCCc
Q 020235 311 LTARE------ALRHPFFTRDHL 327 (329)
Q Consensus 311 ~t~~~------ll~hp~f~~~~~ 327 (329)
||++| +++||||++.+.
T Consensus 253 ~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 253 LGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp TTSGGGTCHHHHHTSGGGTTCCC
T ss_pred cCHHHHcCCHHHHcCCccCCCCH
Confidence 99988 588999998764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=401.96 Aligned_cols=253 Identities=25% Similarity=0.463 Sum_probs=214.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|+++.+|+.||||+++... ...+...+|+.++..+ .||||+++++++.+.+.+|+||
T Consensus 18 lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~iv~ 92 (293)
T d1jksa_ 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-----QHPNVITLHEVYENKTDVILIL 92 (293)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-----CCTTBCCEEEEEECSSEEEEEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEE
Confidence 799999999999999999999999986421 2246678899999999 5799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||| +|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+..++
T Consensus 93 E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~-------------------- 150 (293)
T d1jksa_ 93 ELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-------------------- 150 (293)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS--------------------
T ss_pred EcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC--------------------
Confidence 999 899999998754 699999999999999999999999999999999999996554
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
.....+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 151 ---~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 227 (293)
T d1jksa_ 151 ---VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227 (293)
T ss_dssp ---SSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ---CcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 334569999999998765443 446799999999999999999999999999999999999999998877776666
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+....++... ....+..+++||++||+.||++|
T Consensus 228 i~~~~~~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dP~~R 262 (293)
T d1jksa_ 228 VSAVNYEFEDEY---------------------------------------------FSNTSALAKDFIRRLLVKDPKKR 262 (293)
T ss_dssp HHTTCCCCCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSSGGGS
T ss_pred HHhcCCCCCchh---------------------------------------------cCCCCHHHHHHHHHHccCChhHC
Confidence 555433333221 23467789999999999999999
Q ss_pred CCHHHHhcCCCCCCCCcC
Q 020235 311 LTAREALRHPFFTRDHLR 328 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~~~ 328 (329)
||++|+++||||++.+.+
T Consensus 263 ~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 263 MTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp CCHHHHHHSTTTCC----
T ss_pred cCHHHHhcCcccCCCChh
Confidence 999999999999987654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=402.85 Aligned_cols=246 Identities=25% Similarity=0.463 Sum_probs=207.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc-hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI-KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.+++.||+|+++.. ....+...+|+.++..+ .||||+++++++.+++.+++||||| +|
T Consensus 20 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~~~~~~~~~~~lvmEy~~~g 94 (288)
T d2jfla1 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-----DHPNIVKLLDAFYYENNLWILIEFCAGG 94 (288)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-----CCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-----CCCCCCeEEEEEeeCCeEEEEEecCCCC
Confidence 79999999999999999999999998753 34456778899999998 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.+.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.+
T Consensus 95 ~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---------------------------~~~ 146 (288)
T d2jfla1 95 AVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---------------------------TLD 146 (288)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------CTT
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---------------------------CCC
Confidence 9999987643 369999999999999999999999999999999999999 556
Q ss_pred CCeEEeeCCCCcccCCC---CCcccccCCCCchhHHh-----cCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 159 SAIKVIDFGSTTYERPD---QNYIVSTRHYRAPEVIL-----GLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.+||+|||+|...... .....||+.|+|||++. ...|+.++|||||||++|+|++|+.||.+.+..+....
T Consensus 147 ~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~ 226 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226 (288)
T ss_dssp SCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred CCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 67999999998654332 23467999999999985 44588999999999999999999999988777665555
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+...+.. ..+...+.++.+||++||+.||++|
T Consensus 227 i~~~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dp~~R 260 (288)
T d2jfla1 227 IAKSEPPTL----------------------------------------------AQPSRWSSNFKDFLKKCLEKNVDAR 260 (288)
T ss_dssp HHHSCCCCC----------------------------------------------SSGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHcCCCCCC----------------------------------------------CccccCCHHHHHHHHHHccCChhHC
Confidence 444221110 0012457789999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
||++|+++||||+..
T Consensus 261 ~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 261 WTTSQLLQHPFVTVD 275 (288)
T ss_dssp CCHHHHTTSGGGCCC
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-58 Score=408.80 Aligned_cols=250 Identities=28% Similarity=0.442 Sum_probs=215.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.+|+.||||++.... ...+...+|+.++..+ .||||+++++++.+++.+|+||||| ||
T Consensus 34 lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ivmE~~~gg 108 (350)
T d1koaa2 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-----RHPTLVNLHDAFEDDNEMVMIYEFMSGG 108 (350)
T ss_dssp EEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-----CCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 799999999999999999999999987532 3356677899999999 5799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+.. ..+
T Consensus 109 ~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-------------------------~~~ 162 (350)
T d1koaa2 109 ELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-------------------------KRS 162 (350)
T ss_dssp BHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------TTS
T ss_pred CHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-------------------------CCC
Confidence 9999996543 35999999999999999999999999999999999999943 234
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
+.+||+|||++....... ....||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 163 ~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~ 242 (350)
T d1koaa2 163 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 242 (350)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 679999999998766554 346799999999999999999999999999999999999999998887777766665443
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
.++... ...++.++++||.+||+.||++|||++|+
T Consensus 243 ~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dP~~R~t~~ei 277 (350)
T d1koaa2 243 NMDDSA---------------------------------------------FSGISEDGKDFIRKLLLADPNTRMTIHQA 277 (350)
T ss_dssp CSCCGG---------------------------------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCccc---------------------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 332211 12457789999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020235 317 LRHPFFTRDH 326 (329)
Q Consensus 317 l~hp~f~~~~ 326 (329)
|+||||++.+
T Consensus 278 l~hp~~~~~~ 287 (350)
T d1koaa2 278 LEHPWLTPGN 287 (350)
T ss_dssp HHSTTTSCTT
T ss_pred hcCcccCCCC
Confidence 9999998765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=411.17 Aligned_cols=285 Identities=22% Similarity=0.326 Sum_probs=204.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|+++.+|+.||+|+++.. ........+|+.++..+ .||||+++++++.+.+++|+||||+ |
T Consensus 14 iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~~~~iVmEy~~g 88 (322)
T d1s9ja_ 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-----NSPYIVGFYGAFYSDGEISICMEHMDG 88 (322)
T ss_dssp EECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-----CCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 79999999999999999999999998743 23356677899998888 6799999999999999999999999 8
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++|.+++.+.. .+++..++.++.|++.||+|||+ +||+||||||+|||+ .
T Consensus 89 g~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---------------------------~ 139 (322)
T d1s9ja_ 89 GSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---------------------------N 139 (322)
T ss_dssp EEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---------------------------C
T ss_pred CcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---------------------------C
Confidence 99999998754 69999999999999999999997 599999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCC-CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH-HHHH
Q 020235 157 KSSAIKVIDFGSTTYERPD-QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM-MERV 234 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~ 234 (329)
.++.+||+|||+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.... ....
T Consensus 140 ~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~ 219 (322)
T d1s9ja_ 140 SRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219 (322)
T ss_dssp TTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----
T ss_pred CCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHh
Confidence 5667999999998755433 3456899999999999999999999999999999999999999987655432221 1111
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
.+.... ....................+ ............... .........|.++.|||.+||+.||.+||||+
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ 293 (322)
T d1s9ja_ 220 EGDAAE-TPPRPRTPGRPLSSYGMDSRP--PMAIFELLDYIVNEP---PPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293 (322)
T ss_dssp ---------------------------C--CCCHHHHHHHHHTSC---CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred cCCccc-CCccccccccccccccccccc--chhHHHHHhhhhccC---CccCccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 111110 000000000000000000000 000000000000000 00001123578999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020235 315 EALRHPFFTRD 325 (329)
Q Consensus 315 ~ll~hp~f~~~ 325 (329)
|+|+||||++.
T Consensus 294 e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 294 QLMVHAFIKRS 304 (322)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhCHhhCcC
Confidence 99999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-58 Score=402.21 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=210.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.||+.||+|++++.. .......+|+.++..+ .||||+++++++.+.+.+|+||||+
T Consensus 13 lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~~~~iv~ey~ 87 (337)
T d1o6la_ 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-----RHPFLTALKYAFQTHDRLCFVMEYA 87 (337)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-----CCCCEEEEEeeeccccccccceecc
Confidence 799999999999999999999999997432 2345667899998887 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 88 ~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl--------------------------- 138 (337)
T d1o6la_ 88 NGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--------------------------- 138 (337)
T ss_dssp TTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---------------------------
Confidence 999999998865 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.+||+|||.|+...... ...+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+.
T Consensus 139 ~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~ 218 (337)
T d1o6la_ 139 DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence 566779999999997654322 44689999999999999999999999999999999999999999887766555444
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC-
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL- 311 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~- 311 (329)
.....+ +...++++++||++||++||++|+
T Consensus 219 ~~~~~~-------------------------------------------------p~~~s~~~~dli~~~L~~dP~~R~~ 249 (337)
T d1o6la_ 219 MEEIRF-------------------------------------------------PRTLSPEAKSLLAGLLKKDPKQRLG 249 (337)
T ss_dssp HCCCCC-------------------------------------------------CTTSCHHHHHHHHHHTCSSTTTSTT
T ss_pred cCCCCC-------------------------------------------------CccCCHHHHHHHHhhccCCchhhcc
Confidence 432222 234677899999999999999999
Q ss_pred ----CHHHHhcCCCCCCCC
Q 020235 312 ----TAREALRHPFFTRDH 326 (329)
Q Consensus 312 ----t~~~ll~hp~f~~~~ 326 (329)
|+.++++||||++.+
T Consensus 250 ~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 250 GGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp CSTTTHHHHHTSGGGTTCC
T ss_pred cccccHHHHHcCcccccCC
Confidence 499999999998864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-58 Score=407.92 Aligned_cols=249 Identities=26% Similarity=0.475 Sum_probs=214.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~ 78 (329)
||+|+||+||+|+++.+|+.||||+++... .......+|+.++..+ .||||+++++++.+++.+|+||||| |+
T Consensus 37 lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~ivmE~~~gg 111 (352)
T d1koba_ 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-----HHPKLINLHDAFEDKYEMVLILEFLSGG 111 (352)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-----CSTTBCCEEEEEECSSEEEEEEECCCCC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-----CCCCCCcEEEEEEECCEEEEEEEcCCCC
Confidence 799999999999999999999999987543 3345567899999888 6799999999999999999999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+.+.... .++++..++.++.||+.||+|||++||+||||||+|||++. ..+
T Consensus 112 ~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-------------------------~~~ 165 (352)
T d1koba_ 112 ELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-------------------------KKA 165 (352)
T ss_dssp BHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------TTC
T ss_pred hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-------------------------cCC
Confidence 9998876543 46999999999999999999999999999999999999943 245
Q ss_pred CCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhC
Q 020235 159 SAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLG 236 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 236 (329)
+.+||+|||+|....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+...
T Consensus 166 ~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~ 245 (352)
T d1koba_ 166 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 245 (352)
T ss_dssp CCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCC
T ss_pred CeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 679999999998776654 345799999999999999999999999999999999999999998888777766665443
Q ss_pred CCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHH
Q 020235 237 PLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREA 316 (329)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~l 316 (329)
.++... ...++.++.+||++||++||.+|||++|+
T Consensus 246 ~~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~ei 280 (352)
T d1koba_ 246 EFDEDA---------------------------------------------FSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280 (352)
T ss_dssp CCCSST---------------------------------------------TTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CCCccc---------------------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 333211 23467789999999999999999999999
Q ss_pred hcCCCCCCC
Q 020235 317 LRHPFFTRD 325 (329)
Q Consensus 317 l~hp~f~~~ 325 (329)
|+||||+..
T Consensus 281 l~Hp~~~~~ 289 (352)
T d1koba_ 281 LEHPWLKGD 289 (352)
T ss_dssp HTSTTTSSC
T ss_pred hcCHhhCCC
Confidence 999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-58 Score=399.17 Aligned_cols=243 Identities=26% Similarity=0.420 Sum_probs=213.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+|+.||||+++... ...+...+|+.++..+ .||||+++++++.+.+.+|+||||+
T Consensus 12 lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~ivmE~~ 86 (316)
T d1fota_ 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-----THPFIIRMWGTFQDAQQIFMIMDYI 86 (316)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-----CBTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-----cCcChhheeeeEeeCCeeeeEeeec
Confidence 799999999999999999999999987422 2345667898888888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|+++..++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 87 ~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl--------------------------- 137 (316)
T d1fota_ 87 EGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--------------------------- 137 (316)
T ss_dssp CSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---------------------------
T ss_pred CCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---------------------------
Confidence 899999998765 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.+||+|||.|..........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.+..
T Consensus 138 ~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 217 (316)
T d1fota_ 138 DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 217 (316)
T ss_dssp CTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC
T ss_pred cCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence 56677999999999887777777899999999999999999999999999999999999999999877766665555432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC----
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---- 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---- 311 (329)
...| ...+.++.++|.+||+.||.+|+
T Consensus 218 ~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dp~~R~~~~r 248 (316)
T d1fota_ 218 LRFP-------------------------------------------------PFFNEDVKDLLSRLITRDLSQRLGNLQ 248 (316)
T ss_dssp CCCC-------------------------------------------------TTSCHHHHHHHHHHTCSCTTTCTTSST
T ss_pred CCCC-------------------------------------------------CCCCHHHHHHHHHHhhhCHHhccccch
Confidence 2222 23567899999999999999996
Q ss_pred -CHHHHhcCCCCCCCC
Q 020235 312 -TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 249 ~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 249 NGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TTTHHHHTSGGGSSCC
T ss_pred hhHHHHHcCcccccCC
Confidence 999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-58 Score=391.66 Aligned_cols=242 Identities=24% Similarity=0.429 Sum_probs=199.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~ 73 (329)
||+|+||+||+|+++.+++.||+|.+... ....+...+|+.++.++ .||||+++++++.+ ...+|+||
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-----QHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-----CCCCeeeEEEEEeeccccCCEEEEEE
Confidence 79999999999999999999999998643 23345567899999888 67999999999864 35689999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCCCcEEEeeccccccCCCcCccCCCCCCC
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLC--MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSS 150 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~--i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 150 (329)
||+ +++|.+++.+.. .+++..++.++.|++.||+|||+++ |+||||||+|||++
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--------------------- 148 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--------------------- 148 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---------------------
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee---------------------
Confidence 999 999999998754 6999999999999999999999999 99999999999993
Q ss_pred ccccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH-
Q 020235 151 YFKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHL- 228 (329)
Q Consensus 151 ~~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~- 228 (329)
..++.+||+|||++....... ...+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.......
T Consensus 149 -----~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~ 222 (270)
T d1t4ha_ 149 -----GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY 222 (270)
T ss_dssp -----STTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred -----CCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHH
Confidence 235679999999998655543 45689999999999876 5999999999999999999999999765543322
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.. +..|. ..+...++++.+||++||+.||+
T Consensus 223 ~~i~~--~~~~~---------------------------------------------~~~~~~~~~~~~li~~~l~~dp~ 255 (270)
T d1t4ha_ 223 RRVTS--GVKPA---------------------------------------------SFDKVAIPEVKEIIEGCIRQNKD 255 (270)
T ss_dssp HHHTT--TCCCG---------------------------------------------GGGGCCCHHHHHHHHHHSCSSGG
T ss_pred HHHHc--CCCCc---------------------------------------------ccCccCCHHHHHHHHHHccCCHh
Confidence 22111 11111 11234567899999999999999
Q ss_pred CCCCHHHHhcCCCCC
Q 020235 309 DRLTAREALRHPFFT 323 (329)
Q Consensus 309 ~R~t~~~ll~hp~f~ 323 (329)
+|||++|+|+||||+
T Consensus 256 ~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 256 ERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GSCCHHHHHTSGGGC
T ss_pred HCcCHHHHhCCcccC
Confidence 999999999999996
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=400.46 Aligned_cols=272 Identities=26% Similarity=0.471 Sum_probs=214.6
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh------hHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK------YREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|+++.+|+.||||+++.... ......+|+.++..+ .||||+++++++.+++++++|||
T Consensus 6 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-----SHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-----CCTTBCCEEEEECCTTCCEEEEE
T ss_pred eccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-----CCCCEeEEEeeeccCCceeehhh
Confidence 7999999999999999999999999874322 124567899999998 67999999999999999999999
Q ss_pred cCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 75 KLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 75 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
|+.+++...+.... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 81 ~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli-------------------------- 133 (299)
T d1ua2a_ 81 FMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL-------------------------- 133 (299)
T ss_dssp CCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--------------------------
T ss_pred hhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe--------------------------
Confidence 99544444444322 468999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.+||+|||.+....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 134 -~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~ 212 (299)
T d1ua2a_ 134 -DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 212 (299)
T ss_dssp -CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred -cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHH
Confidence 566778999999987655433 345799999999998754 579999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+.++...+.......... .+.. ... ..........+.++.|||++||+.||++|
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~------~~~~-----------~~~----~~~~~~~~~~s~~~~dll~~~L~~dP~~R 271 (299)
T d1ua2a_ 213 IFETLGTPTEEQWPDMCSLPDYV------TFKS-----------FPG----IPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271 (299)
T ss_dssp HHHHHCCCCTTTSSSTTSSTTCC------CCCC-----------CCC----CCHHHHCTTCCHHHHHHHHHHHCSSTTTS
T ss_pred HHHhcCCCChhhccchhccchhh------hhcc-----------CCC----CChHHhcccCCHHHHHHHHHHccCChhhC
Confidence 99988877654333221111000 0000 000 00112234567889999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 020235 311 LTAREALRHPFFTRDH 326 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~~ 326 (329)
|||+|+|+||||++..
T Consensus 272 ~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 272 ITATQALKMKYFSNRP 287 (299)
T ss_dssp CCHHHHHTSGGGTSSS
T ss_pred cCHHHHhCCHhhCCCC
Confidence 9999999999999765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-58 Score=398.35 Aligned_cols=244 Identities=27% Similarity=0.386 Sum_probs=203.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||||+++... ...+...+|+.++..+ .||||+++++++.+++..|+|||||
T Consensus 23 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-----RHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEECCEEEEEEEec
Confidence 799999999999999999999999987532 2234567899999888 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
++++..++.... .+++..++.++.|++.||.|||++||+||||||+|||++
T Consensus 98 ~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~-------------------------- 149 (309)
T d1u5ra_ 98 LGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS-------------------------- 149 (309)
T ss_dssp SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--------------------------
T ss_pred CCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC--------------------------
Confidence 777766665543 699999999999999999999999999999999999994
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhc---CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILG---LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
.++.+||+|||.+...... ....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+....+.
T Consensus 150 -~~~~~Kl~DFG~a~~~~~~-~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~ 227 (309)
T d1u5ra_ 150 -EPGLVKLGDFGSASIMAPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (309)
T ss_dssp -TTTEEEECCCTTCBSSSSB-CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred -CCCCEEEeecccccccCCC-CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 4566899999998765543 34589999999999964 358899999999999999999999998877666555444
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
+...+.+. ....+..+.+||.+||+.||++|||
T Consensus 228 ~~~~~~~~-----------------------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt 260 (309)
T d1u5ra_ 228 QNESPALQ-----------------------------------------------SGHWSEYFRNFVDSCLQKIPQDRPT 260 (309)
T ss_dssp HSCCCCCS-----------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hCCCCCCC-----------------------------------------------CCCCCHHHHHHHHHHCcCChhHCcC
Confidence 42211110 1235778999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
++|+|+||||.+..
T Consensus 261 ~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 261 SEVLLKHRFVLRER 274 (309)
T ss_dssp HHHHTTCHHHHSCC
T ss_pred HHHHHhCHHhcCCC
Confidence 99999999997653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-57 Score=401.80 Aligned_cols=243 Identities=28% Similarity=0.445 Sum_probs=213.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.+|+.||||++.... ...+...+|+.++..+ .||||+++++++.+.+..++||||+
T Consensus 49 lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~~v~e~~ 123 (350)
T d1rdqe_ 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-----NFPFLVKLEFSFKDNSNLYMVMEYV 123 (350)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECC
T ss_pred eecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-----CCCcEeecccccccccccccccccc
Confidence 799999999999999999999999986422 2235567899988887 6799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 124 ~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl--------------------------- 174 (350)
T d1rdqe_ 124 AGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI--------------------------- 174 (350)
T ss_dssp TTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred cccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---------------------------
Confidence 999999998764 69999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHh
Q 020235 156 PKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVL 235 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (329)
+.++.+||+|||.+...........||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 175 ~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~ 254 (350)
T d1rdqe_ 175 DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254 (350)
T ss_dssp CTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC
Confidence 56677999999999887777677889999999999999999999999999999999999999999877766655554432
Q ss_pred CCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC----
Q 020235 236 GPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL---- 311 (329)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~---- 311 (329)
...| ..+++++.+||++||+.||.+|+
T Consensus 255 ~~~p-------------------------------------------------~~~s~~~~~li~~~L~~dP~kR~~~~r 285 (350)
T d1rdqe_ 255 VRFP-------------------------------------------------SHFSSDLKDLLRNLLQVDLTKRFGNLK 285 (350)
T ss_dssp CCCC-------------------------------------------------TTCCHHHHHHHHHHSCSCTTTCTTSST
T ss_pred CCCC-------------------------------------------------ccCCHHHHHHHHHHhhhCHHhcccccc
Confidence 2221 24577899999999999999995
Q ss_pred -CHHHHhcCCCCCCCC
Q 020235 312 -TAREALRHPFFTRDH 326 (329)
Q Consensus 312 -t~~~ll~hp~f~~~~ 326 (329)
|++++++||||++.+
T Consensus 286 ~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 286 NGVNDIKNHKWFATTD 301 (350)
T ss_dssp TTTHHHHTSGGGTTCC
T ss_pred ccHHHHHcCccccCCC
Confidence 999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-58 Score=391.28 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=193.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~ 75 (329)
||+|+||+||+|+++.+|+.||+|++... ....+...+|+.++..+ .||||+++++++.+ .+.+|+||||
T Consensus 12 iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~~~ivmEy 86 (269)
T d2java1 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-----KHPNIVRYYDRIIDRTNTTLYIVMEY 86 (269)
T ss_dssp EEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-----CCTTBCCEEEEEEC----CEEEEEEC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-----CCCCEeeEEEEEEeCCCCEEEEEEec
Confidence 79999999999999999999999998643 23345567788888877 67999999998854 5678999999
Q ss_pred C-CCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 76 L-GSSLYDFLRKN--NYRSFPIDLVREIARQLLECIAFMHDLC-----MIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 76 ~-~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~L~~lH~~~-----i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
| +|+|.+++.+. ....+++..++.++.|++.||+|||++| |+||||||+|||+
T Consensus 87 ~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll------------------- 147 (269)
T d2java1 87 CEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL------------------- 147 (269)
T ss_dssp CTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE-------------------
T ss_pred CCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc-------------------
Confidence 9 99999998642 2346999999999999999999999977 9999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCch
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHEN 224 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~ 224 (329)
+.++.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 148 --------~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 148 --------DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp --------CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred --------CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 556679999999987655433 346799999999999999999999999999999999999999988776
Q ss_pred hHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcc
Q 020235 225 LEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLR 304 (329)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~ 304 (329)
.+....+.....+ ..+..+++++.+||++||+
T Consensus 220 ~~~~~~i~~~~~~------------------------------------------------~~~~~~s~~l~~li~~~L~ 251 (269)
T d2java1 220 KELAGKIREGKFR------------------------------------------------RIPYRYSDELNEIITRMLN 251 (269)
T ss_dssp HHHHHHHHHTCCC------------------------------------------------CCCTTSCHHHHHHHHHHTC
T ss_pred HHHHHHHHcCCCC------------------------------------------------CCCcccCHHHHHHHHHHcC
Confidence 6655444332111 0122457789999999999
Q ss_pred cCCCCCCCHHHHhcCCCC
Q 020235 305 YDPTDRLTAREALRHPFF 322 (329)
Q Consensus 305 ~dP~~R~t~~~ll~hp~f 322 (329)
.||++|||++|+++|||+
T Consensus 252 ~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 252 LKDYHRPSVEEILENPLI 269 (269)
T ss_dssp SSGGGSCCHHHHHTSTTC
T ss_pred CChhHCcCHHHHHhCCcC
Confidence 999999999999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-58 Score=399.05 Aligned_cols=249 Identities=22% Similarity=0.397 Sum_probs=217.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|.++.+++.||+|+++..........+|+.++..+ .||||+++++++++++.+|+||||| |++
T Consensus 13 lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-----~HpnIv~~~~~~~~~~~~~lvmE~~~gg~ 87 (321)
T d1tkia_ 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-----RHRNILHLHESFESMEELVMIFEFISGLD 87 (321)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-----CCTTBCCEEEEEEETTEEEEEECCCCCCB
T ss_pred EecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-----CCCCCCeEEEEEEECCEEEEEEecCCCCc
Confidence 6999999999999999999999999987666666778999999888 6799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++. ....
T Consensus 88 L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-------------------------~~~~ 141 (321)
T d1tkia_ 88 IFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-------------------------RRSS 141 (321)
T ss_dssp HHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-------------------------SSCC
T ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-------------------------CCce
Confidence 999997653 35899999999999999999999999999999999999953 2345
Q ss_pred CeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHHHhCC
Q 020235 160 AIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
.++|+|||.+....... ....||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+..+....+.+....
T Consensus 142 ~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 221 (321)
T d1tkia_ 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221 (321)
T ss_dssp CEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCC
T ss_pred EEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 78999999998765544 3457899999999999999999999999999999999999999998887777777665544
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
++... +..++.++++||++||+.||++|||++|++
T Consensus 222 ~~~~~---------------------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 222 FDEEA---------------------------------------------FKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp CCHHH---------------------------------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CChhh---------------------------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 44332 224577899999999999999999999999
Q ss_pred cCCCCCCC
Q 020235 318 RHPFFTRD 325 (329)
Q Consensus 318 ~hp~f~~~ 325 (329)
+||||++.
T Consensus 257 ~hp~~~~~ 264 (321)
T d1tkia_ 257 QHPWLKQK 264 (321)
T ss_dssp HSHHHHSC
T ss_pred cCHhhccC
Confidence 99999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=392.60 Aligned_cols=274 Identities=32% Similarity=0.519 Sum_probs=221.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|.++.+|+.||+|+++... .......+|+.+++++ .||||+++++++.+++.+|+||||++
T Consensus 10 lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~Hp~Iv~~~~~~~~~~~~~iv~e~~~ 84 (298)
T d1gz8a_ 10 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-----NHPNIVKLLDVIHTENKLYLVFEFLH 84 (298)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-----CCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEEeccccccccceeEEEeecC
Confidence 799999999999999999999999986432 2345677899999888 67999999999999999999999998
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+++.+++.......+++..++.++.|++.||+|||++||+||||||+|||+ +.
T Consensus 85 ~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---------------------------~~ 137 (298)
T d1gz8a_ 85 QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---------------------------NT 137 (298)
T ss_dssp EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------CT
T ss_pred CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---------------------------cc
Confidence 888888876665679999999999999999999999999999999999999 56
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+..++|+|||.|....... ....||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+....+.+
T Consensus 138 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 6778999999987665433 3458999999999988776 47899999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.+....+.......+.. ...+... ...........+.++.|||++||+.||++|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~---------------~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~ 277 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYK-----PSFPKWA---------------RQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCC-----TTSCCCC---------------CCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hcCCCchhhccccccccccc-----ccccccc---------------ccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 88776655444332211110 0000000 000111223567889999999999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020235 314 REALRHPFFTRDH 326 (329)
Q Consensus 314 ~~ll~hp~f~~~~ 326 (329)
+|+++||||++.+
T Consensus 278 ~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 278 KAALAHPFFQDVT 290 (298)
T ss_dssp HHHHTSGGGTTCC
T ss_pred HHHhCCHhhccCC
Confidence 9999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-56 Score=382.61 Aligned_cols=246 Identities=30% Similarity=0.524 Sum_probs=208.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHIC 70 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~ 70 (329)
||+|+||+||+|+++.+|+.||||+++... ...+...+|+.++..+. .||||+++++++++++.+|
T Consensus 11 iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~----~hpnIv~~~~~~~~~~~~~ 86 (277)
T d1phka_ 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS----GHPNIIQLKDTYETNTFFF 86 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHT----TCTTBCCEEEEEECSSEEE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhc----CCCCeEEEEeecccCcceE
Confidence 799999999999999999999999986432 12345778999999993 4799999999999999999
Q ss_pred EEeecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 71 IVFEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 71 lv~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 87 ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill--------------------- 143 (277)
T d1phka_ 87 LVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL--------------------- 143 (277)
T ss_dssp EEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------
T ss_pred EEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---------------------
Confidence 999999 899999998754 69999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhc------CCCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILG------LGWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++.+||+|||.+....... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+
T Consensus 144 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 144 ------DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp ------CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 566779999999998765543 44679999999999974 2468899999999999999999999998
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.+..+....+.+....++.. .....|+++++||.+
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~---------------------------------------------~~~~~s~~~~~li~~ 252 (277)
T d1phka_ 218 RKQMLMLRMIMSGNYQFGSP---------------------------------------------EWDDYSDTVKDLVSR 252 (277)
T ss_dssp SSHHHHHHHHHHTCCCCCTT---------------------------------------------TGGGSCHHHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCCCCc---------------------------------------------ccccCCHHHHHHHHH
Confidence 87766665555432221110 123467899999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTR 324 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~ 324 (329)
||+.||++|||++|||+||||++
T Consensus 253 ~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 253 FLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HccCChhHCcCHHHHHcCHHHHH
Confidence 99999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=387.19 Aligned_cols=275 Identities=28% Similarity=0.472 Sum_probs=216.6
Q ss_pred CCCccceEEEEEEecCC-CceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-----cCCceEE
Q 020235 1 MGEGTFGQVLECWDRER-KEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-----YRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-----~~~~~~l 71 (329)
||+|+||+||+|+++.+ ++.||||+++... .......+|+.++..+.. ..||||+++++++. .....++
T Consensus 15 LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~--~~HpnIv~~~~~~~~~~~~~~~~~~~ 92 (305)
T d1blxa_ 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET--FEHPNVVRLFDVCTVSRTDRETKLTL 92 (305)
T ss_dssp EEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHH--TCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred EecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhh--cCCCCcceeeeeecccccccCceEEE
Confidence 79999999999999765 6779999986432 223456688888888754 25799999999885 3457999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
+||++.+.+..+........+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 93 ~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi----------------------- 149 (305)
T d1blxa_ 93 VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----------------------- 149 (305)
T ss_dssp EEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred EEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE-----------------------
Confidence 999996655555555555679999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
+..+.++|+|||.+....... ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+...
T Consensus 150 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 225 (305)
T d1blxa_ 150 ----TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225 (305)
T ss_dssp ----CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ----cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 556678999999887554333 45689999999999999999999999999999999999999999999888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..+.++...++............ .............+..+.|||++||++||++
T Consensus 226 ~i~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 283 (305)
T d1blxa_ 226 KILDVIGLPGEEDWPRDVALPRQAFHS----------------------KSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 283 (305)
T ss_dssp HHHHHHCCCCGGGSCTTCSSCGGGSCC----------------------CCCCCGGGTCCSCCHHHHHHHHHHSCSSTTT
T ss_pred HHHHhhCCCchhcccccccchhhhhcc----------------------ccccchhhccccCCHHHHHHHHHHCcCChhH
Confidence 888888876654332211111000000 0000112234567889999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
||||+|+|+||||++.+
T Consensus 284 R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 284 RISAYSALSHPYFQDLE 300 (305)
T ss_dssp SCCHHHHHTSGGGTTCC
T ss_pred CcCHHHHhcChhhcCch
Confidence 99999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=391.18 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=206.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||||+++... ........|..++... ..||||+++++++.+++.+|+||||+
T Consensus 10 iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~----~~hp~Iv~~~~~~~~~~~~yivmEy~ 85 (320)
T d1xjda_ 10 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA----WEHPFLTHMFCTFQTKENLFFVMEYL 85 (320)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHH----TTCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHh----CCCCcEEEEEEEEccCCceeEEEeec
Confidence 799999999999999999999999997432 2233455666665542 26799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 86 ~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~--------------------------- 136 (320)
T d1xjda_ 86 NGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL--------------------------- 136 (320)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---------------------------
T ss_pred CCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---------------------------
Confidence 999999998754 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMME 232 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 232 (329)
+.++.++|+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 566778999999987554332 34679999999999999999999999999999999999999999877766655554
Q ss_pred HHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 233 RVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
...... +..++.++.+||++||+.||++|||
T Consensus 217 ~~~~~~-------------------------------------------------p~~~s~~~~dli~~~L~~dP~~R~s 247 (320)
T d1xjda_ 217 MDNPFY-------------------------------------------------PRWLEKEAKDLLVKLFVREPEKRLG 247 (320)
T ss_dssp HCCCCC-------------------------------------------------CTTSCHHHHHHHHHHSCSSGGGSBT
T ss_pred cCCCCC-------------------------------------------------CccCCHHHHHHHHHhcccCCCCCcC
Confidence 321111 1235778999999999999999999
Q ss_pred HH-HHhcCCCCCCCC
Q 020235 313 AR-EALRHPFFTRDH 326 (329)
Q Consensus 313 ~~-~ll~hp~f~~~~ 326 (329)
+. ++++||||++.+
T Consensus 248 ~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 248 VRGDIRQHPLFREIN 262 (320)
T ss_dssp TBSCGGGSGGGTTCC
T ss_pred HHHHHHhCchhccCC
Confidence 95 899999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.2e-56 Score=394.34 Aligned_cols=249 Identities=25% Similarity=0.405 Sum_probs=202.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||.||+|+++.||+.||||++.... .......+|...+..+.+ ..||||+++++++.+.+.+|+||||+
T Consensus 12 lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~--~~hpnIv~l~~~~~~~~~~~ivmE~~ 89 (364)
T d1omwa3 12 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST--GDCPFIVCMSYAFHTPDKLSFILDLM 89 (364)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSS--SCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhc--CCCCcEEEEEEEEEECCEEEEEEEec
Confidence 799999999999999999999999986422 122334455555555432 36799999999999999999999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
|++|.+++.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 90 ~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl--------------------------- 140 (364)
T d1omwa3 90 NGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--------------------------- 140 (364)
T ss_dssp CSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------
T ss_pred CCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---------------------------
Confidence 999999998764 68999999999999999999999999999999999999
Q ss_pred CCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
+.++.+||+|||+|....... ....||+.|+|||++.. ..|+.++|||||||++|+|++|+.||.+.+..+.......
T Consensus 141 ~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 220 (364)
T d1omwa3 141 DEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220 (364)
T ss_dssp CSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH
T ss_pred cCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 556679999999988655443 45689999999999974 5689999999999999999999999987544332221111
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCC-
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT- 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t- 312 (329)
.....+ ..+..+++++++||.+||+.||++|||
T Consensus 221 ~~~~~~----------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 221 TLTMAV----------------------------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp SSSCCC----------------------------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred cccCCC----------------------------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCC
Confidence 111100 112346788999999999999999999
Q ss_pred ----HHHHhcCCCCCCCC
Q 020235 313 ----AREALRHPFFTRDH 326 (329)
Q Consensus 313 ----~~~ll~hp~f~~~~ 326 (329)
|+++++||||++.+
T Consensus 255 ~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 255 LGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp SSSTHHHHHTSGGGTTCC
T ss_pred cccCHHHHHcCccccCCC
Confidence 79999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=399.19 Aligned_cols=252 Identities=27% Similarity=0.473 Sum_probs=202.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc----CCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY----RNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~----~~~~~lv~e~~ 76 (329)
||+|+||+||+|+++.+++.||||+++.. ....+|+.++.++ ..||||++++++|++ .+.+|+|||||
T Consensus 20 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~----~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRA----SQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHH----TTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred eeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHh----cCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 69999999999999999999999998743 3456788887666 257999999999875 46799999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
||+|.+++.+.....+++..++.++.|++.||+|||++||+||||||+|||++..
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~------------------------ 147 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK------------------------ 147 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS------------------------
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc------------------------
Confidence 8999999987655679999999999999999999999999999999999999543
Q ss_pred CCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
.....+||+|||++....... ...+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 148 ~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~ 227 (335)
T d2ozaa1 148 RPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227 (335)
T ss_dssp STTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred cccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 245679999999998655443 456899999999999998999999999999999999999999977554433222222
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
... .+...++. ..+..++.++.+||++||+.||++|||+
T Consensus 228 ~i~-------------------~~~~~~~~----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~ 266 (335)
T d2ozaa1 228 RIR-------------------MGQYEFPN----------------------PEWSEVSEEVKMLIRNLLKTEPTQRMTI 266 (335)
T ss_dssp CCC-------------------SCSSSCCT----------------------THHHHSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHh-------------------cCCCCCCC----------------------cccccCCHHHHHHHHHHccCChhHCcCH
Confidence 110 01111110 0112357789999999999999999999
Q ss_pred HHHhcCCCCCCC
Q 020235 314 REALRHPFFTRD 325 (329)
Q Consensus 314 ~~ll~hp~f~~~ 325 (329)
.|+++||||.+.
T Consensus 267 ~eil~hp~~~~~ 278 (335)
T d2ozaa1 267 TEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHSHHHHTT
T ss_pred HHHHcCHHhhCC
Confidence 999999999654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=389.64 Aligned_cols=272 Identities=28% Similarity=0.504 Sum_probs=219.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC------ceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN------HICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~------~~~l 71 (329)
||+|+||+||+|.++.+|+.||||+++.. ....+...+|+.++..+ .|+||+++++++...+ ++|+
T Consensus 26 lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpniv~l~~~~~~~~~~~~~~~~~l 100 (346)
T d1cm8a_ 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-----RHENVIGLLDVFTPDETLDDFTDFYL 100 (346)
T ss_dssp C------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-----CBTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-----CCCCeeEEEEEeccCccccccceEEE
Confidence 79999999999999999999999999743 23345678899999998 5699999999987654 5799
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||++.+|..++... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 101 v~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~----------------------- 154 (346)
T d1cm8a_ 101 VMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----------------------- 154 (346)
T ss_dssp EEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-----------------------
T ss_pred EEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc-----------------------
Confidence 9999999998888764 59999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++++|||.+...........||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......
T Consensus 155 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~ 230 (346)
T d1cm8a_ 155 ----NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE 230 (346)
T ss_dssp ----CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ----ccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence 667789999999999888777778999999999999875 468999999999999999999999999999999999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+....+.++..++.................... ..........++.+.|||++||+.||++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (346)
T d1cm8a_ 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEK------------------KDFASILTNASPLAVNLLEKMLVLDAEQR 292 (346)
T ss_dssp HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCC------------------CCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred HHhccCCCcHHHHhhhcchhhhhhhccCCcccc------------------cchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence 999999988877665433222111111100000 00111223567889999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
|||+|+|+||||++.
T Consensus 293 ~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 293 VTAGEALAHPYFESL 307 (346)
T ss_dssp CCHHHHHHSGGGTTT
T ss_pred cCHHHHhcChhhCcC
Confidence 999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-55 Score=377.17 Aligned_cols=270 Identities=29% Similarity=0.462 Sum_probs=213.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLG 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~ 77 (329)
||+|+||+||+|+++ +|+.||||+++... .......+|+.++..+ .||||+++++.+.+++..+++|++++
T Consensus 10 iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 10 IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-----KHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-----CCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred EecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-----CCCcEEeeeeecccCCceeEEEEeeh
Confidence 799999999999986 78999999997532 2245677899998888 57999999999999999999999996
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
+.+...+.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.
T Consensus 84 ~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---------------------------~~ 135 (286)
T d1ob3a_ 84 QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---------------------------NR 135 (286)
T ss_dssp EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------CT
T ss_pred hhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---------------------------cC
Confidence 66666665433 469999999999999999999999999999999999999 56
Q ss_pred CCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 233 (329)
++.+||+|||.+....... ....|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+...++.+
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 136 EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp TSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 6779999999987655432 345789999999999865 468999999999999999999999999888888888888
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCH
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTA 313 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~ 313 (329)
..+.++...+................. + ..........+..+.|||++||++||++|||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-------------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 216 ILGTPNSKNWPNVTELPKYDPNFTVYE-P-------------------LPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCC-C-------------------CCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hhCCCChhhccchhhhhhccccccccc-C-------------------cchhhhcccCCHHHHHHHHHHccCChhHCcCH
Confidence 888777655544333221111000000 0 00112234567899999999999999999999
Q ss_pred HHHhcCCCCCC
Q 020235 314 REALRHPFFTR 324 (329)
Q Consensus 314 ~~ll~hp~f~~ 324 (329)
+|+|+||||++
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcccCc
Confidence 99999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=378.89 Aligned_cols=240 Identities=25% Similarity=0.451 Sum_probs=199.7
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch-------hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK-------KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|+++.+|+.||||+++... .......+|+.++..+.+ .|+||+++++++.+.+..++||
T Consensus 12 lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~---~h~nIv~~~~~~~~~~~~~lv~ 88 (273)
T d1xwsa_ 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS---GFSGVIRLLDWFERPDSFVLIL 88 (273)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCS---SSCSBCCEEEEEECSSEEEEEE
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhcc---CCCCccEEEEEEeeCCeEEEEE
Confidence 799999999999999999999999987432 112345689999999853 4799999999999999999999
Q ss_pred ecC-C-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 74 EKL-G-SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 74 e~~-~-~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|++ + +++.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 89 e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~--------------------- 145 (273)
T d1xwsa_ 89 ERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL--------------------- 145 (273)
T ss_dssp ECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET---------------------
T ss_pred EeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec---------------------
Confidence 999 4 68888887654 6999999999999999999999999999999999999952
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC-CcccccCCCCchhHHhcCCC-CCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ-NYIVSTRHYRAPEVILGLGW-TYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
.+..++|+|||.+....... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.
T Consensus 146 -----~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----- 215 (273)
T d1xwsa_ 146 -----NRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----- 215 (273)
T ss_dssp -----TTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred -----CCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----
Confidence 33568999999997655443 45689999999999988775 5778999999999999999999975221
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
+.+. ... ....++.++.+||++||+.||++
T Consensus 216 -i~~~-----------------------~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~ 245 (273)
T d1xwsa_ 216 -IIRG-----------------------QVF--------------------------FRQRVSSECQHLIRWCLALRPSD 245 (273)
T ss_dssp -HHHC-----------------------CCC--------------------------CSSCCCHHHHHHHHHHTCSSGGG
T ss_pred -Hhhc-----------------------ccC--------------------------CCCCCCHHHHHHHHHHccCCHhH
Confidence 1110 000 12346788999999999999999
Q ss_pred CCCHHHHhcCCCCCCCC
Q 020235 310 RLTAREALRHPFFTRDH 326 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~~ 326 (329)
|||++|+++||||++..
T Consensus 246 R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 246 RPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp SCCHHHHHTSGGGSSCC
T ss_pred CcCHHHHhcCHhhCCCC
Confidence 99999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=384.40 Aligned_cols=271 Identities=28% Similarity=0.504 Sum_probs=214.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc------CCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY------RNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~------~~~~~lv~e 74 (329)
||+|+||+||+|+++.+|+.||||++.... ....+|+.++..+ .|+||+++++++.. ..++++|||
T Consensus 28 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l-----~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 28 IGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKL-----DHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHC-----CCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred EeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhc-----CCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 799999999999999999999999997543 2345799999888 67999999998843 346899999
Q ss_pred cCCCCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 75 KLGSSLYDFLRK--NNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 75 ~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
|+++++.+.+.. .....+++..++.++.|++.||+|||++||+||||||+|||++.
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~---------------------- 157 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP---------------------- 157 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT----------------------
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec----------------------
Confidence 997766655542 22346999999999999999999999999999999999999942
Q ss_pred ccCCCCCCeEEeeCCCCcccCCC--CCcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPD--QNYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
....+||+|||.+...... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+...
T Consensus 158 ----~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~ 233 (350)
T d1q5ka_ 158 ----DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233 (350)
T ss_dssp ----TTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred ----CCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence 2346899999998765443 3456899999999998764 68999999999999999999999999999889999
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+..|..+.+.+........... .+.. .............++++.|||++||++||++
T Consensus 234 ~i~~~~g~~~~~~~~~~~~~~~~~~------~~~~--------------~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 293 (350)
T d1q5ka_ 234 EIIKVLGTPTREQIREMNPNYTEFK------FPQI--------------KAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 293 (350)
T ss_dssp HHHHHHCCCCHHHHHHHCC---CCC------CCCC--------------CCCCGGGTSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HHHHHhCCChHHhhhhhccchhhcc------cccc--------------ccCchhhhcccCCCHHHHHHHHHHccCChhH
Confidence 9999999988776654432211110 0000 0000011112346778999999999999999
Q ss_pred CCCHHHHhcCCCCCCC
Q 020235 310 RLTAREALRHPFFTRD 325 (329)
Q Consensus 310 R~t~~~ll~hp~f~~~ 325 (329)
||||+|+|+||||++.
T Consensus 294 R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 294 RLTPLEACAHSFFDEL 309 (350)
T ss_dssp SCCHHHHHTSGGGGGG
T ss_pred CcCHHHHhcCHhhccc
Confidence 9999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-54 Score=370.76 Aligned_cols=245 Identities=20% Similarity=0.299 Sum_probs=203.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++.+++.||||+++......+...+|+.++..+ .||||+++++++.+++..++||||+ +|+
T Consensus 25 iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 99 (287)
T d1opja_ 25 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLLGVCTREPPFYIITEFMTYGN 99 (287)
T ss_dssp TTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-----CCCCEecCCccEeeCCeeEEEeecccCcc
Confidence 7999999999999999999999999987666677888999999999 6799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++ .++
T Consensus 100 l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~---------------------------~~~ 152 (287)
T d1opja_ 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---------------------------ENH 152 (287)
T ss_dssp HHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------------GGG
T ss_pred hHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEEC---------------------------CCC
Confidence 99999887666799999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCC-chhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTH-ENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~ 234 (329)
.+||+|||.++...... ....||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+...
T Consensus 153 ~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~ 232 (287)
T d1opja_ 153 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 232 (287)
T ss_dssp CEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred cEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC
Confidence 68899999887665543 2245788999999999999999999999999999999976665443 333222222111
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ ..+...+..+.+||.+||+.||++|||++
T Consensus 233 ~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 264 (287)
T d1opja_ 233 YRM------------------------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFA 264 (287)
T ss_dssp CCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHH
Confidence 100 11234677899999999999999999999
Q ss_pred HHhc--CCCCCCC
Q 020235 315 EALR--HPFFTRD 325 (329)
Q Consensus 315 ~ll~--hp~f~~~ 325 (329)
++++ ..++++.
T Consensus 265 ei~~~L~~~~~~~ 277 (287)
T d1opja_ 265 EIHQAFETMFQES 277 (287)
T ss_dssp HHHHHHHHTTSSS
T ss_pred HHHHHHHHHHHhC
Confidence 9976 3555543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=377.99 Aligned_cols=281 Identities=26% Similarity=0.423 Sum_probs=213.9
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc------cCCceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD------YRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~------~~~~~~l 71 (329)
||+|+||+||+|+++.||+.||||+++.. ........+|+.++..+ .||||++++++|. +.+++|+
T Consensus 25 LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-----~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-----NHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp CSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred eecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-----CCCCeeEEEEEEecccccccCceeEE
Confidence 79999999999999999999999999743 23345677899999888 6799999999985 3468999
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
||||+.+++.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 100 v~Ey~~~~l~~~~~~----~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~----------------------- 152 (355)
T d2b1pa1 100 VMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----------------------- 152 (355)
T ss_dssp EEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-----------------------
T ss_pred EEeccchHHHHhhhc----CCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc-----------------------
Confidence 999997777766643 58999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLA 229 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 229 (329)
..+..++++|||.+....... ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+......
T Consensus 153 ----~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~ 228 (355)
T d2b1pa1 153 ----KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_dssp ----CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence 556678999999877555433 44579999999999999999999999999999999999999999998888888
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+....+.++.+.+.........+........ . ....... . ..............+.++.|||++||++||++
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~---~-~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 301 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA-G--LTFPKLF---P-DSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCC-C--CCHHHHS---C-GGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCcccc-c--ccccccc---c-cccccccccccccCCHHHHHHHHHHCcCChhH
Confidence 88888888888777776666555544432111 1 0111000 0 00000001112235778999999999999999
Q ss_pred CCCHHHHhcCCCCCC
Q 020235 310 RLTAREALRHPFFTR 324 (329)
Q Consensus 310 R~t~~~ll~hp~f~~ 324 (329)
||||+|||+||||+.
T Consensus 302 R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 302 RISVDDALQHPYINV 316 (355)
T ss_dssp SCCHHHHHTSTTTGG
T ss_pred CcCHHHHhcCcccCC
Confidence 999999999999985
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=372.10 Aligned_cols=276 Identities=26% Similarity=0.434 Sum_probs=208.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--------CCce
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--------RNHI 69 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--------~~~~ 69 (329)
||+|+||+||+|+++.+|+.||||++... ........+|+.++..+ .|+|++.+++++.. .+++
T Consensus 18 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-----KHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-----CCTTBCCEEEEEEC----------CE
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-----cCCCccceEeeeecccccccccCceE
Confidence 79999999999999999999999998643 23345677899999998 56899999887754 4578
Q ss_pred EEEeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 70 CIVFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 70 ~lv~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
++|||++++.+........ ..+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 93 ~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl--------------------- 150 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--------------------- 150 (318)
T ss_dssp EEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---------------------
T ss_pred EEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---------------------
Confidence 9999999666655554433 468999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCC
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQT 221 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~ 221 (329)
+.++.++|+|||++....... ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 151 ------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 151 ------TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp ------CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 556678888888886443321 335799999999999865 689999999999999999999999999
Q ss_pred CchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHH
Q 020235 222 HENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQG 301 (329)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 301 (329)
.++......+.+..+.+++..+............. ... ........... ....+..+.|||.+
T Consensus 225 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-----------~~~~~~~~~~~--~~~~~~~~~dLl~~ 287 (318)
T d3blha1 225 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE----LVK-----------GQKRKVKDRLK--AYVRDPYALDLIDK 287 (318)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTCCCC-----------CCS-----------SCCBCHHHHHH--HHHCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHhcCCCChhhccccchhhhhhhhc----ccc-----------cccccchhhhc--cccCCHHHHHHHHH
Confidence 99888888999988887765433321111000000 000 00000111111 11235678999999
Q ss_pred hcccCCCCCCCHHHHhcCCCCCCCC
Q 020235 302 LLRYDPTDRLTAREALRHPFFTRDH 326 (329)
Q Consensus 302 ~l~~dP~~R~t~~~ll~hp~f~~~~ 326 (329)
||++||++||||+|+|+||||+...
T Consensus 288 mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 288 LLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred HCcCChhHCcCHHHHHcChhhccCC
Confidence 9999999999999999999998653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=361.58 Aligned_cols=237 Identities=26% Similarity=0.397 Sum_probs=190.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++ +++.||||+++......+...+|+.++..+ .||||+++++++.+++..++||||+ +|+
T Consensus 13 iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 13 IGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-----SHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred EeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-----CCCCcccccceeccCCceEEEEEecCCCc
Confidence 699999999999986 467899999987666677889999999999 6799999999999999999999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++ .+.
T Consensus 87 L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~---------------------------~~~ 138 (263)
T d1sm2a_ 87 LSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---------------------------ENQ 138 (263)
T ss_dssp HHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC---------------------------GGG
T ss_pred HHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec---------------------------CCC
Confidence 999987654 4689999999999999999999999999999999999994 455
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+....+...
T Consensus 139 ~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~ 218 (263)
T d1sm2a_ 139 VIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 218 (263)
T ss_dssp CEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT
T ss_pred CeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc
Confidence 68888888887554432 23568999999999999999999999999999999999 56777665555544444432
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..... +...+.++.+|+.+||+.||++|||++
T Consensus 219 ~~~~~------------------------------------------------p~~~~~~l~~li~~cl~~~p~~Rps~~ 250 (263)
T d1sm2a_ 219 FRLYK------------------------------------------------PRLASTHVYQIMNHCWKERPEDRPAFS 250 (263)
T ss_dssp CCCCC------------------------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCC------------------------------------------------ccccCHHHHHHHHHHccCCHhHCcCHH
Confidence 21110 123466899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++|
T Consensus 251 ~il~~ 255 (263)
T d1sm2a_ 251 RLLRQ 255 (263)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=371.34 Aligned_cols=271 Identities=28% Similarity=0.518 Sum_probs=207.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC-----ceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN-----HICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~-----~~~lv~ 73 (329)
||+|+||+||+|+++.+|+.||||+++... ...+..++|+.++..+ .||+++++++++.... ..++++
T Consensus 16 LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-----~hp~iv~~~~~~~~~~~~~~~~~~l~~ 90 (345)
T d1pmea_ 16 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-----RHENIIGINDIIRAPTIEQMKDVYLVT 90 (345)
T ss_dssp CC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-----CCTTBCCCCEEECCSSTTTCCCEEEEE
T ss_pred EeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-----CCCCCCcEEEEEeeccccccceEEEEE
Confidence 799999999999999999999999997432 3345678899999999 6699999999886543 467776
Q ss_pred ecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 74 EKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 74 e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 91 ~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl------------------------- 142 (345)
T d1pmea_ 91 HLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL------------------------- 142 (345)
T ss_dssp ECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE-------------------------
T ss_pred eecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE-------------------------
Confidence 66699999999875 49999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCC------CCcccccCCCCchhHHhc-CCCCCccchHhHHHHHHHHHhCCCCCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILG-LGWTYPCDIWSVGCILVELCTGEALFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 226 (329)
+.++.+||+|||.+...... ....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+
T Consensus 143 --~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 143 --NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp --CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred --CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH
Confidence 55667899999988654332 234578999999999854 457899999999999999999999999988887
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhh-hhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHA-EKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
...........+............ ...... . ..... ..........+..+.+||++||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--------------~~~~~-~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLS----L--------------PHKNK-VPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT----S--------------CCCCC-CCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhccccc----C--------------CccCC-CCHHHhCCCCCHHHHHHHHHHccC
Confidence 777777777666554322211100 000000 0 00000 000112335677899999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 020235 306 DPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 306 dP~~R~t~~~ll~hp~f~~~ 325 (329)
||++||||+|+|+||||++.
T Consensus 282 dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 282 NPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp STTTSCCHHHHHTSGGGTTT
T ss_pred ChhHCcCHHHHhcCHhhccC
Confidence 99999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-53 Score=374.75 Aligned_cols=272 Identities=26% Similarity=0.466 Sum_probs=215.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccC------CceEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYR------NHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~------~~~~l 71 (329)
||+|+||+||+|+++.+|+.||||+++... ...+...+|+.++..+ .|+|++++++++... ...++
T Consensus 26 LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-----~h~~iv~~~~~~~~~~~~~~~~~~~i 100 (348)
T d2gfsa1 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-----KHENVIGLLDVFTPARSLEEFNDVYL 100 (348)
T ss_dssp CGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-----CCTTBCCCSEEECSCSSTTTCCCCEE
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEeeccccccCceEEE
Confidence 799999999999999999999999987432 3345677899999998 679999999987532 34555
Q ss_pred EeecCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 72 VFEKLGSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 72 v~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
++++++++|.+++... ++++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 101 ~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi----------------------- 154 (348)
T d2gfsa1 101 VTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----------------------- 154 (348)
T ss_dssp EEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred EEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc-----------------------
Confidence 5554599999999654 59999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
+.++.++++|||.+...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......
T Consensus 155 ----~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~ 230 (348)
T d2gfsa1 155 ----NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230 (348)
T ss_dssp ----CTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ----cccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5667789999999987777767778999999999987765 67999999999999999999999999999988999
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+..+..+.+....................+.. .........+..++|||++||+.||.+|
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~s~~~~dli~~mL~~dP~~R 292 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKM------------------NFANVFIGANPLAVDLLEKMLVLDSDKR 292 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCC------------------CHHHHSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCc------------------chhhhcCCCCHHHHHHHHHHCcCChhhC
Confidence 9998888877665543222221111111111110 0011123567889999999999999999
Q ss_pred CCHHHHhcCCCCCCC
Q 020235 311 LTAREALRHPFFTRD 325 (329)
Q Consensus 311 ~t~~~ll~hp~f~~~ 325 (329)
|||+|+|+||||++-
T Consensus 293 ~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 293 ITAAQALAHAYFAQY 307 (348)
T ss_dssp CCHHHHHTSGGGTTT
T ss_pred cCHHHHhcCHhhCCC
Confidence 999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-53 Score=373.01 Aligned_cols=276 Identities=25% Similarity=0.473 Sum_probs=205.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc--CCceEEEeecC-C
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY--RNHICIVFEKL-G 77 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~--~~~~~lv~e~~-~ 77 (329)
||+|+||+||+|+++.+|+.||||+++... .+...+|+.++..+. .|+||+++++++.. ...+++||||+ +
T Consensus 43 LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~----~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 43 LGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLR----GGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHT----TSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhcc----CCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 799999999999999999999999987533 456788999999883 47999999999874 45799999999 7
Q ss_pred CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCC
Q 020235 78 SSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPK 157 (329)
Q Consensus 78 ~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (329)
++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++. .
T Consensus 117 ~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~--------------------------~ 165 (328)
T d3bqca1 117 TDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--------------------------E 165 (328)
T ss_dssp CBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET--------------------------T
T ss_pred CcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC--------------------------C
Confidence 7876543 35999999999999999999999999999999999999953 2
Q ss_pred CCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcC-CCCCccchHhHHHHHHHHHhCCCCCCCCc-hhHHHHHHHH
Q 020235 158 SSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGL-GWTYPCDIWSVGCILVELCTGEALFQTHE-NLEHLAMMER 233 (329)
Q Consensus 158 ~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~~~~~~~~~ 233 (329)
+..++|+|||.|....... ...+||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||.... ..+....+..
T Consensus 166 ~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~ 245 (328)
T d3bqca1 166 HRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 245 (328)
T ss_dssp TTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHH
T ss_pred CCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHH
Confidence 3458999999997665433 456789999999998875 47999999999999999999999997643 4455556666
Q ss_pred HhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhH-HHHhhhccCchhHHHHHHHHhcccCCCCCCC
Q 020235 234 VLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQ-NLIMQHVDHSAGDLTHLLQGLLRYDPTDRLT 312 (329)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 312 (329)
..++.....+... ........+. ............ ..........+.++.|||++||++||++|||
T Consensus 246 ~~g~~~~~~~~~~------~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 312 (328)
T d3bqca1 246 VLGTEDLYDYIDK------YNIELDPRFN-------DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 312 (328)
T ss_dssp HHCHHHHHHHHHH------TTCCCCGGGG-------GTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HHCCchhhhhhhh------cccccCcccc-------hhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC
Confidence 6654322111110 0000000000 000000000000 0011112346788999999999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020235 313 AREALRHPFFTRDH 326 (329)
Q Consensus 313 ~~~ll~hp~f~~~~ 326 (329)
|+|+|+||||+++.
T Consensus 313 a~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 313 AREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTSGGGTTSC
T ss_pred HHHHhcCcccCCCC
Confidence 99999999999864
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=367.64 Aligned_cols=242 Identities=26% Similarity=0.376 Sum_probs=199.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++ +++.||||+++......+...+|+.++.++ .||||+++++++.+ +..++||||+ +|+
T Consensus 21 iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~ 93 (272)
T d1qpca_ 21 LGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQL-----QHQRLVRLYAVVTQ-EPIYIITEYMENGS 93 (272)
T ss_dssp EEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEEEEECCTTCB
T ss_pred EecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhC-----CCCCEeEEEeeecc-CCeEEEEEeCCCCc
Confidence 799999999999976 567899999987666677789999999999 56999999998754 5679999999 999
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
|.+++.......+++..+..++.|++.||+|||+++|+||||||+|||+ +.+.
T Consensus 94 L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---------------------------~~~~ 146 (272)
T d1qpca_ 94 LVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---------------------------SDTL 146 (272)
T ss_dssp HHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---------------------------CTTS
T ss_pred HHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---------------------------eccc
Confidence 9998865443458999999999999999999999999999999999999 5667
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC-CCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||+|....... ....||+.|+|||++.+..++.++|||||||++|+|+|| .+||...+..+....+...
T Consensus 147 ~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~ 226 (272)
T d1qpca_ 147 SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226 (272)
T ss_dssp CEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 78999999987665433 345688999999999988999999999999999999995 5566555554444333321
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+. .+..++.++.+|+.+||+.||++|||++
T Consensus 227 ~~~~------------------------------------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ 258 (272)
T d1qpca_ 227 YRMV------------------------------------------------RPDNCPEELYQLMRLCWKERPEDRPTFD 258 (272)
T ss_dssp CCCC------------------------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCC------------------------------------------------CcccChHHHHHHHHHHcCCCHhHCcCHH
Confidence 1110 1134567899999999999999999999
Q ss_pred HHhc--CCCCCC
Q 020235 315 EALR--HPFFTR 324 (329)
Q Consensus 315 ~ll~--hp~f~~ 324 (329)
++++ |+||++
T Consensus 259 ei~~~L~~~fts 270 (272)
T d1qpca_ 259 YLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHhhhhhhc
Confidence 9998 788864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=357.32 Aligned_cols=237 Identities=22% Similarity=0.338 Sum_probs=202.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++ +++.||||+++......+...+|+.++..+ .||||+++++++.+++.+++||||+ +|+
T Consensus 12 iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-----~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 12 LGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-----SHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTC-----CCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhc-----CCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 799999999999985 678899999987666778889999999988 6799999999999999999999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
+.+++.... ..+++..+.+++.|++.||.|||++||+||||||+||++ +.+.
T Consensus 86 l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---------------------------~~~~ 137 (258)
T d1k2pa_ 86 LLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---------------------------NDQG 137 (258)
T ss_dssp HHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---------------------------CTTC
T ss_pred HHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---------------------------cCCC
Confidence 999876644 358999999999999999999999999999999999999 5566
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|+| |+.||.+.+..+....+.+.
T Consensus 138 ~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~ 217 (258)
T d1k2pa_ 138 VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217 (258)
T ss_dssp CEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred cEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC
Confidence 78999999987544332 23568999999999999999999999999999999998 89999988776665554442
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..... +...+..+.+||++||+.||++|||++
T Consensus 218 ~~~~~------------------------------------------------p~~~~~~l~~li~~cl~~dP~~RPt~~ 249 (258)
T d1k2pa_ 218 LRLYR------------------------------------------------PHLASEKVYTIMYSCWHEKADERPTFK 249 (258)
T ss_dssp CCCCC------------------------------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCC------------------------------------------------cccccHHHHHHHHHHccCCHhHCcCHH
Confidence 21111 123456899999999999999999999
Q ss_pred HHhcC
Q 020235 315 EALRH 319 (329)
Q Consensus 315 ~ll~h 319 (329)
++++|
T Consensus 250 eil~~ 254 (258)
T d1k2pa_ 250 ILLSN 254 (258)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=363.33 Aligned_cols=270 Identities=28% Similarity=0.450 Sum_probs=212.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+++.+++.||||+++... .......+|+.+++.+ .|+||+++++++.+....++|++++
T Consensus 10 LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~~~~iv~~~~~ 84 (292)
T d1unla_ 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-----KHKNIVRLHDVLHSDKKLTLVFEFCD 84 (292)
T ss_dssp EEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEECSSEEEEEEECCS
T ss_pred EecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-----CcCCEEeeccccccccceeEEeeecc
Confidence 799999999999999999999999986432 3356677899998887 6799999999999999999999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
++++..++... ..+++..++.++.|++.||+|||++||+||||||+|||+ +
T Consensus 85 ~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---------------------------~ 135 (292)
T d1unla_ 85 QDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---------------------------N 135 (292)
T ss_dssp EEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---------------------------C
T ss_pred ccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---------------------------c
Confidence 77776666554 368999999999999999999999999999999999999 5
Q ss_pred CCCCeEEeeCCCCcccCCCC---CcccccCCCCchhHHhcCC-CCCccchHhHHHHHHHHHhCCCCC-CCCchhHHHHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ---NYIVSTRHYRAPEVILGLG-WTYPCDIWSVGCILVELCTGEALF-QTHENLEHLAMM 231 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~-~~~~~~~~~~~~ 231 (329)
.+..++|+|||.+....... ....+++.|+|||++.... ++.++|||||||++|+|++|+.|| .+.+..+....+
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~ 215 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_dssp TTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHH
T ss_pred cCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 56679999999998665443 2345778899999998765 689999999999999999999885 455566667777
Q ss_pred HHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCC
Q 020235 232 ERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRL 311 (329)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 311 (329)
....++++...+.......... .... ..............+..+.|||++||++||++||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~----~~~~----------------~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 275 (292)
T d1unla_ 216 FRLLGTPTEEQWPSMTKLPDYK----PYPM----------------YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI 275 (292)
T ss_dssp HHHHCCCCTTTCTTGGGSTTCC----CCCC----------------CCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred HhhcCCCChhhhhhhhhccccc----cccc----------------ccccchhhhccccCCHHHHHHHHHHccCChhHCc
Confidence 7777776654433322211110 0000 0001111122345678899999999999999999
Q ss_pred CHHHHhcCCCCCC
Q 020235 312 TAREALRHPFFTR 324 (329)
Q Consensus 312 t~~~ll~hp~f~~ 324 (329)
||+|+|+||||++
T Consensus 276 sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 276 SAEEALQHPYFSD 288 (292)
T ss_dssp CHHHHTTSGGGSS
T ss_pred CHHHHhcChhhcC
Confidence 9999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=362.95 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=192.8
Q ss_pred CCCccceEEEEEEec--CCCceEEEEEeccch---hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDR--ERKEMVAIKIVRGIK---KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~--~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|.++ .+++.||||+++... ...+...+|+.++.++ .||||+++++++++ +..++||||
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-----DNPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEES-SSEEEEEEC
T ss_pred cccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-----CCCCCceEEEEecc-CCEEEEEEc
Confidence 799999999999864 456789999986422 2345678899999888 67999999999865 457899999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +|+|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 89 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~------------------------ 142 (277)
T d1xbba_ 89 AELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT------------------------ 142 (277)
T ss_dssp CTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE------------------------
T ss_pred CCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccc------------------------
Confidence 9 999999998764 6999999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
++.++|+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..+.
T Consensus 143 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~ 219 (277)
T d1xbba_ 143 ---QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219 (277)
T ss_dssp ---TTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH
T ss_pred ---cCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH
Confidence 4457888888876544332 22468899999999999999999999999999999997 8999988766554
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+...+ ..+..++.++.+||.+||+.||
T Consensus 220 ~~~i~~~~~~------------------------------------------------~~p~~~~~~~~~li~~cl~~dp 251 (277)
T d1xbba_ 220 TAMLEKGERM------------------------------------------------GCPAGCPREMYDLMNLCWTYDV 251 (277)
T ss_dssp HHHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSST
T ss_pred HHHHHcCCCC------------------------------------------------CCCcccCHHHHHHHHHHcCCCH
Confidence 4443321111 0123456789999999999999
Q ss_pred CCCCCHHHH---hcCCCCC
Q 020235 308 TDRLTAREA---LRHPFFT 323 (329)
Q Consensus 308 ~~R~t~~~l---l~hp~f~ 323 (329)
++|||++++ |+|+|+.
T Consensus 252 ~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 252 ENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTSCCHHHHHHHHHHHHHH
T ss_pred hHCcCHHHHHHHhhCHHhh
Confidence 999999998 4676653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=362.55 Aligned_cols=238 Identities=23% Similarity=0.349 Sum_probs=187.6
Q ss_pred CCCccceEEEEEEecCCCc---eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERKE---MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||+||+|+++.+++ .||||.+... ....+...+|+.++..+ .||||+++++++.+++.+++||||
T Consensus 34 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~~~~~iv~Ey 108 (299)
T d1jpaa_ 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-----DHPNVIHLEGVVTKSTPVMIITEF 108 (299)
T ss_dssp EEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-----CCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCCccEEEEEeeCCEEEEEEEe
Confidence 7999999999999987765 5889987643 33445678899999888 679999999999999999999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 109 ~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl-------------------------- 161 (299)
T d1jpaa_ 109 MENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV-------------------------- 161 (299)
T ss_dssp CTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--------------------------
T ss_pred cCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE--------------------------
Confidence 9 999999888654 468999999999999999999999999999999999999
Q ss_pred CCCCCCeEEeeCCCCcccCCCCC--------cccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQN--------YIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~~--------~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
+.++.+||+|||+++....... ...||+.|+|||.+.+..++.++|||||||++|+|+| |..||.+.+..
T Consensus 162 -~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 -NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp -CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 5667789999998876544321 1357889999999999999999999999999999998 89999887766
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+...+.+ +..++..+.+||.+||+.
T Consensus 241 ~~~~~i~~~~~~~~------------------------------------------------~~~~~~~l~~li~~cl~~ 272 (299)
T d1jpaa_ 241 DVINAIEQDYRLPP------------------------------------------------PMDCPSALHQLMLDCWQK 272 (299)
T ss_dssp HHHHHHHTTCCCCC------------------------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCCCCC------------------------------------------------CccchHHHHHHHHHHcCC
Confidence 55544433211110 123567899999999999
Q ss_pred CCCCCCCHHHHhcC
Q 020235 306 DPTDRLTAREALRH 319 (329)
Q Consensus 306 dP~~R~t~~~ll~h 319 (329)
||++|||++|++++
T Consensus 273 ~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 273 DRNHRPKFGQIVNT 286 (299)
T ss_dssp STTTSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=361.93 Aligned_cols=240 Identities=25% Similarity=0.343 Sum_probs=194.2
Q ss_pred CCCccceEEEEEEecCC--CceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRER--KEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~--~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.+ +..||||+++.. ....+...+|+.++.++ .||||+++++++.+ +.+++||||+
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-----DNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-----CCTTBCCEEEEEES-SSEEEEEECC
T ss_pred EecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-----CCCCEeeEeeeecc-CeEEEEEEeC
Confidence 69999999999987643 457999998743 23356678899999998 67999999999875 4689999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRM 155 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (329)
+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 91 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~------------------------- 144 (285)
T d1u59a_ 91 GGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN------------------------- 144 (285)
T ss_dssp TTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEE-------------------------
T ss_pred CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeecc-------------------------
Confidence 899999986543 46999999999999999999999999999999999999954
Q ss_pred CCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHH
Q 020235 156 PKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHL 228 (329)
Q Consensus 156 ~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 228 (329)
+..+||+|||+++...... ....||+.|+|||++....++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 145 --~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~ 222 (285)
T d1u59a_ 145 --RHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 222 (285)
T ss_dssp --TTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH
T ss_pred --CCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 4457888888876554432 23468899999999999899999999999999999998 99999887666554
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..+.+...+ ..+..++.++.+||.+||+.||+
T Consensus 223 ~~i~~~~~~------------------------------------------------~~p~~~~~~l~~li~~cl~~~p~ 254 (285)
T d1u59a_ 223 AFIEQGKRM------------------------------------------------ECPPECPPELYALMSDCWIYKWE 254 (285)
T ss_dssp HHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHTTCSSGG
T ss_pred HHHHcCCCC------------------------------------------------CCCCcCCHHHHHHHHHHcCCCHh
Confidence 444332111 01234567899999999999999
Q ss_pred CCCCHHHH---hcCCCC
Q 020235 309 DRLTAREA---LRHPFF 322 (329)
Q Consensus 309 ~R~t~~~l---l~hp~f 322 (329)
+|||+.++ |+|+|+
T Consensus 255 ~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 255 DRPDFLTVEQRMRACYY 271 (285)
T ss_dssp GSCCHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHHHH
Confidence 99999888 567776
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=357.97 Aligned_cols=239 Identities=24% Similarity=0.338 Sum_probs=188.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc---hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI---KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL- 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~- 76 (329)
||+|+||+||+|+.+. .||||+++.. ....+...+|+.++.++ .||||+++++++. ++.+++||||+
T Consensus 16 lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~~~~~-~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 16 IGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-----RHVNILLFMGYST-APQLAIVTQWCE 86 (276)
T ss_dssp EEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTC-----CCTTBCCEEEEEC-SSSCEEEEECCC
T ss_pred EeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhC-----CCCCEeeeeEEEe-ccEEEEEEecCC
Confidence 6999999999997543 5999998643 33345667899999888 6799999999865 45789999999
Q ss_pred CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCC
Q 020235 77 GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMP 156 (329)
Q Consensus 77 ~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (329)
+|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||+ +
T Consensus 87 ~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---------------------------~ 138 (276)
T d1uwha_ 87 GSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---------------------------H 138 (276)
T ss_dssp EEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------------------------E
T ss_pred CCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---------------------------c
Confidence 899999998654 369999999999999999999999999999999999999 4
Q ss_pred CCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcC---CCCCccchHhHHHHHHHHHhCCCCCCCCchhHHH
Q 020235 157 KSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGL---GWTYPCDIWSVGCILVELCTGEALFQTHENLEHL 228 (329)
Q Consensus 157 ~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 228 (329)
.+..+||+|||+|....... ....||+.|||||++.+. .|+.++|||||||++|+|++|+.||.+.+.....
T Consensus 139 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~ 218 (276)
T d1uwha_ 139 EDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218 (276)
T ss_dssp TTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred CCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH
Confidence 55678999999887654322 335789999999999753 4789999999999999999999999886665443
Q ss_pred HHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCC
Q 020235 229 AMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPT 308 (329)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~ 308 (329)
..........|. .......++..+.+||.+||+.||+
T Consensus 219 ~~~~~~~~~~p~-------------------------------------------~~~~~~~~~~~l~~li~~cl~~dp~ 255 (276)
T d1uwha_ 219 IFMVGRGYLSPD-------------------------------------------LSKVRSNCPKAMKRLMAECLKKKRD 255 (276)
T ss_dssp HHHHHHTSCCCC-------------------------------------------GGGSCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHhcCCCCCc-------------------------------------------chhccccchHHHHHHHHHHcCCCHh
Confidence 333222111110 0111234677899999999999999
Q ss_pred CCCCHHHHhcC
Q 020235 309 DRLTAREALRH 319 (329)
Q Consensus 309 ~R~t~~~ll~h 319 (329)
+|||+++++++
T Consensus 256 ~RPt~~~il~~ 266 (276)
T d1uwha_ 256 ERPLFPQILAS 266 (276)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=367.40 Aligned_cols=241 Identities=21% Similarity=0.299 Sum_probs=194.5
Q ss_pred CCCccceEEEEEEecCCCc-----eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRERKE-----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|+++.+++ .||+|.+... ........+|+.++..+ ..||||+++++++.+.+.+++||
T Consensus 45 lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l----~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 45 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL----GSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHh----cCCCcEeEEEEEEeeCCeEEEEE
Confidence 6999999999999876543 6999998643 23345667899998888 35799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeec
Q 020235 74 EKL-GSSLYDFLRKNNY---------------------RSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSS 131 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~---------------------~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~ 131 (329)
||| +|+|.+++..... ..+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill--- 197 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--- 197 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---
Confidence 999 9999999976431 247889999999999999999999999999999999999
Q ss_pred cccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHH
Q 020235 132 EYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVG 206 (329)
Q Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 206 (329)
+.++.+||+|||+|+...... ....||+.|||||++.+..++.++||||||
T Consensus 198 ------------------------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~G 253 (325)
T d1rjba_ 198 ------------------------THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG 253 (325)
T ss_dssp ------------------------ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred ------------------------ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchh
Confidence 455668899999887654443 234679999999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHh
Q 020235 207 CILVELCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIM 285 (329)
Q Consensus 207 ~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (329)
|++|+|++ |..||.+.+..+....+.+....+
T Consensus 254 vil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~----------------------------------------------- 286 (325)
T d1rjba_ 254 ILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------------------------------------------- 286 (325)
T ss_dssp HHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-----------------------------------------------
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------------------
Confidence 99999997 899998766544443332211111
Q ss_pred hhccCchhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 286 QHVDHSAGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 286 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
..+...+.++.+||.+||+.||++|||++||++|
T Consensus 287 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 287 DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0123456789999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-52 Score=360.11 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=190.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccch----hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIK----KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv 72 (329)
||+|+||+||+|+++.+|+.||||+++... .......+|+.++..+ .||||+++++++...+ ..|+|
T Consensus 15 lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-----~hpniv~~~~~~~~~~~~~~~~~lv 89 (277)
T d1o6ya_ 15 LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-----NHPAIVAVYDTGEAETPAGPLPYIV 89 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-----CCCCCCcccceeeeccCCCceEEEE
Confidence 699999999999999999999999997432 2344567899888877 6799999999987654 48999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ |++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 90 mE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---------------------- 145 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---------------------- 145 (277)
T ss_dssp EECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE----------------------
T ss_pred EECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC----------------------
Confidence 9999 899999987764 699999999999999999999999999999999999994
Q ss_pred cccCCCCCCeEEeeCCCCcccCCC------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPD------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
.+...+++|||.+...... ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 146 -----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 146 -----ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp -----TTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -----ccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 4556788888876543322 13457999999999999999999999999999999999999999887766
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+....++. .....++..+.+||.+||+.
T Consensus 221 ~~~~~~~~~~~~~~~---------------------------------------------~~~~~~s~~l~~li~~~L~~ 255 (277)
T d1o6ya_ 221 SVAYQHVREDPIPPS---------------------------------------------ARHEGLSADLDAVVLKALAK 255 (277)
T ss_dssp HHHHHHHHCCCCCGG---------------------------------------------GTSSSCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhcCCCCCc---------------------------------------------hhccCCCHHHHHHHHHHccC
Confidence 554443332111111 11235678899999999999
Q ss_pred CCCCCC-CHHHHhcCCCC
Q 020235 306 DPTDRL-TAREALRHPFF 322 (329)
Q Consensus 306 dP~~R~-t~~~ll~hp~f 322 (329)
||++|| |++++ .|+|.
T Consensus 256 dp~~R~~sa~~l-~~~l~ 272 (277)
T d1o6ya_ 256 NPENRYQTAAEM-RADLV 272 (277)
T ss_dssp SGGGSCSSHHHH-HHHHH
T ss_pred CHhHCHhHHHHH-HHHHH
Confidence 999999 55554 56554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=356.43 Aligned_cols=245 Identities=26% Similarity=0.334 Sum_probs=196.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
||+|+||+||+|+++.+ +.||||+++......+...+|+.++.++ .|+||+++++++.+ +..++||||+ +|+
T Consensus 25 iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l-----~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~ 97 (285)
T d1fmka3 25 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-----RHEKLVQLYAVVSE-EPIYIVTEYMSKGS 97 (285)
T ss_dssp EEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEEEECCCTTCB
T ss_pred EeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhc-----ccCCEeEEEEEEec-CCeEEEEEecCCCc
Confidence 79999999999998765 5699999987666677888999999998 67999999999854 5689999999 899
Q ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCC
Q 020235 80 LYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSS 159 (329)
Q Consensus 80 l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (329)
+.+++.......+++.+++.++.|++.||+|||++||+||||||+|||++ .++
T Consensus 98 l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---------------------------~~~ 150 (285)
T d1fmka3 98 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---------------------------ENL 150 (285)
T ss_dssp HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---------------------------GGG
T ss_pred hhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---------------------------CCC
Confidence 99998765445699999999999999999999999999999999999994 445
Q ss_pred CeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCC-CCCCCCchhHHHHHHHHH
Q 020235 160 AIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-ALFQTHENLEHLAMMERV 234 (329)
Q Consensus 160 ~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~ 234 (329)
.+||+|||++....... ....||+.|+|||++....++.++|||||||++|+|++|. +|+.+....+....+.+.
T Consensus 151 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~ 230 (285)
T d1fmka3 151 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 230 (285)
T ss_dssp CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 68888888887554332 2356899999999999999999999999999999999954 555555554444433322
Q ss_pred hCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHH
Q 020235 235 LGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAR 314 (329)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~ 314 (329)
..+ ..+..++.++.+||.+||+.||++|||++
T Consensus 231 ~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 262 (285)
T d1fmka3 231 YRM------------------------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFE 262 (285)
T ss_dssp CCC------------------------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCC------------------------------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHH
Confidence 111 01234567899999999999999999999
Q ss_pred HHhc--CCCCCCCCc
Q 020235 315 EALR--HPFFTRDHL 327 (329)
Q Consensus 315 ~ll~--hp~f~~~~~ 327 (329)
+|++ ++||++.+.
T Consensus 263 ~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 263 YLQAFLEDYFTSTEP 277 (285)
T ss_dssp HHHHHHHTTTSCSCC
T ss_pred HHHHHHhhhhcCCCC
Confidence 9998 899987654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=363.23 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=202.5
Q ss_pred CCCccceEEEEEEe---cCCCceEEEEEeccc-----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWD---RERKEMVAIKIVRGI-----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~---~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||+|+||+||+|++ +.+|+.||||+++.. ....+...+|+.++.++.| +|||+++++++++....+++
T Consensus 32 IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h----~pnIv~~~~~~~~~~~~~~v 107 (322)
T d1vzoa_ 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ----SPFLVTLHYAFQTETKLHLI 107 (322)
T ss_dssp EEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHT----CTTBCCEEEEEEETTEEEEE
T ss_pred EecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccC----CCeEEEeeeeeccCCceeee
Confidence 79999999999987 457899999998642 2234567789999999953 47999999999999999999
Q ss_pred eecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCc
Q 020235 73 FEKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSY 151 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 151 (329)
|||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 108 ~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill----------------------- 162 (322)
T d1vzoa_ 108 LDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----------------------- 162 (322)
T ss_dssp ECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-----------------------
T ss_pred eecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee-----------------------
Confidence 9999 999999998765 57899999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCC--CCCccchHhHHHHHHHHHhCCCCCCCCchh
Q 020235 152 FKRMPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLG--WTYPCDIWSVGCILVELCTGEALFQTHENL 225 (329)
Q Consensus 152 ~~~~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 225 (329)
+.++.++|+|||.+....... ....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..
T Consensus 163 ----~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 163 ----DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp ----CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred ----cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 556679999999887554332 3457899999999998654 678999999999999999999999876554
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+..... ....+...+..+.+||++||++
T Consensus 239 ~~~~~i~~~~~~~---------------------------------------------~~~~~~~~s~~~~~li~~~l~~ 273 (322)
T d1vzoa_ 239 NSQAEISRRILKS---------------------------------------------EPPYPQEMSALAKDLIQRLLMK 273 (322)
T ss_dssp CCHHHHHHHHHHC---------------------------------------------CCCCCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHHhcccC---------------------------------------------CCCCcccCCHHHHHHHHHHccc
Confidence 3333332221000 0011234678999999999999
Q ss_pred CCCCCC-----CHHHHhcCCCCCCCC
Q 020235 306 DPTDRL-----TAREALRHPFFTRDH 326 (329)
Q Consensus 306 dP~~R~-----t~~~ll~hp~f~~~~ 326 (329)
||++|| |++|+++||||++.+
T Consensus 274 dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 274 DPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 999999 589999999999866
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=346.29 Aligned_cols=237 Identities=20% Similarity=0.291 Sum_probs=185.1
Q ss_pred CCCccceEEEEEEecCCC----ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERK----EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~----~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.++.++ ..||||+++.. ........+|+.++..+ .||||+++++++.+.+..++|||
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-----~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-----SHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-----CCCCEeeeeEEEecCCceEEEEE
Confidence 799999999999987665 47999998643 23345567899999888 67999999999999999999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|+ ++++.+.+.... ..+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 90 ~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl------------------------- 143 (283)
T d1mqba_ 90 YMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV------------------------- 143 (283)
T ss_dssp CCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-------------------------
T ss_pred ecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE-------------------------
Confidence 99 888988887654 468999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCC-CCCCCchhH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEA-LFQTHENLE 226 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~-p~~~~~~~~ 226 (329)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|+|+++.. |+...+..+
T Consensus 144 --~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~ 221 (283)
T d1mqba_ 144 --NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221 (283)
T ss_dssp --CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred --CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH
Confidence 566779999999987654432 22457899999999999999999999999999999999654 454444433
Q ss_pred HHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccC
Q 020235 227 HLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYD 306 (329)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~d 306 (329)
....+.....+ ..+...+..+.+||.+||+.|
T Consensus 222 ~~~~i~~~~~~------------------------------------------------~~~~~~~~~l~~li~~cl~~~ 253 (283)
T d1mqba_ 222 VMKAINDGFRL------------------------------------------------PTPMDCPSAIYQLMMQCWQQE 253 (283)
T ss_dssp HHHHHHTTCCC------------------------------------------------CCCTTCBHHHHHHHHHHTCSS
T ss_pred HHHHHhccCCC------------------------------------------------CCchhhHHHHHHHHHHHCcCC
Confidence 33322221111 011235678999999999999
Q ss_pred CCCCCCHHHHhc
Q 020235 307 PTDRLTAREALR 318 (329)
Q Consensus 307 P~~R~t~~~ll~ 318 (329)
|++|||+.+|++
T Consensus 254 p~~RPt~~eil~ 265 (283)
T d1mqba_ 254 RARRPKFADIVS 265 (283)
T ss_dssp TTTSCCHHHHHH
T ss_pred HhHCcCHHHHHH
Confidence 999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=346.24 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=184.9
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeec
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEK 75 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~ 75 (329)
||+|+||.||+|++..++ ..||||.++.. ........+|+.++..+ .||||+++++++. ++.+++||||
T Consensus 15 iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~~~~~-~~~~~iv~E~ 88 (273)
T d1mp8a_ 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-----DHPHIVKLIGVIT-ENPVWIIMEL 88 (273)
T ss_dssp EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEe-cCeEEEEEEe
Confidence 799999999999987553 46899988643 33345677899999888 6799999999986 4678999999
Q ss_pred C-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcccc
Q 020235 76 L-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKR 154 (329)
Q Consensus 76 ~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (329)
+ +|++.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 89 ~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~------------------------ 143 (273)
T d1mp8a_ 89 CTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS------------------------ 143 (273)
T ss_dssp CTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE------------------------
T ss_pred ccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecC------------------------
Confidence 9 899999887654 46899999999999999999999999999999999999954
Q ss_pred CCCCCCeEEeeCCCCcccCCCC----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHH
Q 020235 155 MPKSSAIKVIDFGSTTYERPDQ----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLA 229 (329)
Q Consensus 155 ~~~~~~~~l~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 229 (329)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+...
T Consensus 144 ---~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~ 220 (273)
T d1mp8a_ 144 ---NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG 220 (273)
T ss_dssp ---TTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred ---CCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 4558888888887654332 23467899999999999999999999999999999998 899998877665544
Q ss_pred HHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCC
Q 020235 230 MMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTD 309 (329)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~ 309 (329)
.+.+...+ ..+..++..+.+||.+||+.||++
T Consensus 221 ~i~~~~~~------------------------------------------------~~~~~~~~~~~~li~~cl~~dp~~ 252 (273)
T d1mp8a_ 221 RIENGERL------------------------------------------------PMPPNCPPTLYSLMTKCWAYDPSR 252 (273)
T ss_dssp HHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHcCCCC------------------------------------------------CCCCCCCHHHHHHHHHHcCCCHhH
Confidence 43332111 012346778999999999999999
Q ss_pred CCCHHHHhcC
Q 020235 310 RLTAREALRH 319 (329)
Q Consensus 310 R~t~~~ll~h 319 (329)
|||+++|++|
T Consensus 253 Rps~~ei~~~ 262 (273)
T d1mp8a_ 253 RPRFTELKAQ 262 (273)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=347.56 Aligned_cols=241 Identities=21% Similarity=0.285 Sum_probs=181.6
Q ss_pred CCCccceEEEEEEecC-----CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEE
Q 020235 1 MGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv 72 (329)
||+|+||.||+|++.. +++.||||+++... ........|..++.++. +|++|+.+++++.. ++.+++|
T Consensus 21 iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~----~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 21 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG----HHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHC----CCTTBCCEEEEECSTTSCCEEE
T ss_pred EeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhc----CCCeEEEeeeeeccCCCeEEEE
Confidence 7999999999999754 45789999987432 23445566777777773 56888888887654 5579999
Q ss_pred eecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccC
Q 020235 73 FEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVP 137 (329)
Q Consensus 73 ~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~ 137 (329)
|||| +|+|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~-------- 168 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-------- 168 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC--------
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeEC--------
Confidence 9999 999999997542 13488999999999999999999999999999999999994
Q ss_pred CCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHH
Q 020235 138 DYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVEL 212 (329)
Q Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 212 (329)
.++.+||+|||+|+...... ....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 169 -------------------~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~el 229 (299)
T d1ywna1 169 -------------------EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 229 (299)
T ss_dssp -------------------GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHH
Confidence 45568888888886544322 235789999999999999999999999999999999
Q ss_pred HhC-CCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCc
Q 020235 213 CTG-EALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHS 291 (329)
Q Consensus 213 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (329)
++| .+||.+.+..+...........+ ..++..
T Consensus 230 lt~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------------------~~~~~~ 262 (299)
T d1ywna1 230 FSLGASPYPGVKIDEEFCRRLKEGTRM-----------------------------------------------RAPDYT 262 (299)
T ss_dssp HTTSCCSSTTCCCSHHHHHHHHHTCCC-----------------------------------------------CCCTTC
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCCC-----------------------------------------------CCCccC
Confidence 986 57887765444332222211000 012345
Q ss_pred hhHHHHHHHHhcccCCCCCCCHHHHhcC
Q 020235 292 AGDLTHLLQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 292 ~~~~~~ll~~~l~~dP~~R~t~~~ll~h 319 (329)
++++.++|.+||+.||++|||++|+++|
T Consensus 263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 263 TPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6789999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-51 Score=345.05 Aligned_cols=236 Identities=22% Similarity=0.311 Sum_probs=186.3
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccc-cCCceEEEeecC-CC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFD-YRNHICIVFEKL-GS 78 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~-~~~~~~lv~e~~-~~ 78 (329)
||+|+||.||+|+++ |..||||+++.. ...+...+|+.++.++ .||||+++++++. +.+.+++||||+ +|
T Consensus 15 lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~lv~ey~~~g 86 (262)
T d1byga_ 15 IGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQL-----RHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86 (262)
T ss_dssp EEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTC-----CCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred EecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhC-----CCCCEeeEEEEEEecCCcEEEEEeccCCC
Confidence 699999999999874 678999999753 4456778899998888 6799999999874 456789999999 99
Q ss_pred CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCC
Q 020235 79 SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKS 158 (329)
Q Consensus 79 ~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (329)
+|.+++.......+++..++.++.|++.||+|||+.+|+||||||+|||+ +.+
T Consensus 87 ~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---------------------------~~~ 139 (262)
T d1byga_ 87 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---------------------------SED 139 (262)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---------------------------CTT
T ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---------------------------cCC
Confidence 99999976543458999999999999999999999999999999999999 566
Q ss_pred CCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHHHHHHHHHhCC
Q 020235 159 SAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEHLAMMERVLGP 237 (329)
Q Consensus 159 ~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 237 (329)
+.++|+|||.+...........+|..|+|||++.+..++.++|||||||++|+|++ |++||...+..+....+.+...+
T Consensus 140 ~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~ 219 (262)
T d1byga_ 140 NVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219 (262)
T ss_dssp SCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC
T ss_pred CCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 77999999999887776666788999999999999999999999999999999998 78998876655444333221100
Q ss_pred CChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCCCCHHHHh
Q 020235 238 LPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDRLTAREAL 317 (329)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll 317 (329)
+.+...++.+.+||++||+.||.+|||+.+++
T Consensus 220 ------------------------------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~ 251 (262)
T d1byga_ 220 ------------------------------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251 (262)
T ss_dssp ------------------------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------------------------------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 11234567899999999999999999999998
Q ss_pred cC
Q 020235 318 RH 319 (329)
Q Consensus 318 ~h 319 (329)
++
T Consensus 252 ~~ 253 (262)
T d1byga_ 252 EQ 253 (262)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.9e-49 Score=351.08 Aligned_cols=297 Identities=32% Similarity=0.528 Sum_probs=223.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCC------CCCceeeeccccccC--CceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDK------GGNRCVQIRNWFDYR--NHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~------~~~~i~~l~~~~~~~--~~~~lv 72 (329)
||+|+||+||+|+++.+|+.||||+++......+...+|+.++..+.+... .+++|+++++++... ...+++
T Consensus 21 LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 100 (362)
T d1q8ya_ 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 100 (362)
T ss_dssp EEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEE
T ss_pred EeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeee
Confidence 799999999999999999999999998776666777889999999876432 357899999887643 456666
Q ss_pred eecC--CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCCCcEEEeeccccccCCCcCccCCCCCC
Q 020235 73 FEKL--GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD-LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDS 149 (329)
Q Consensus 73 ~e~~--~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~-~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 149 (329)
+.++ +++............+++..++.++.|++.||.|||+ .||+||||||+|||++.++..
T Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~--------------- 165 (362)
T d1q8ya_ 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP--------------- 165 (362)
T ss_dssp EEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT---------------
T ss_pred eeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc---------------
Confidence 6665 5566666666655678999999999999999999998 899999999999999765420
Q ss_pred CccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc------
Q 020235 150 SYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE------ 223 (329)
Q Consensus 150 ~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~------ 223 (329)
.....++++|||.+..........+||+.|+|||++.+..++.++|+||+||++++|++|+.||...+
T Consensus 166 ------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 166 ------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp ------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 12234899999999877777777889999999999999999999999999999999999999996542
Q ss_pred hhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhc
Q 020235 224 NLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLL 303 (329)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l 303 (329)
..+........+|..+..+..........+.............. .................+..+.|||++||
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~dll~~mL 312 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF-------WPLEDVLTEKYKFSKDEAKEISDFLSPML 312 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB-------CCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC-------CchhhhcccccccCcccCHHHHHHHHHHC
Confidence 23455666778888888776654433333322221111110000 00011111112223446778999999999
Q ss_pred ccCCCCCCCHHHHhcCCCCCCC
Q 020235 304 RYDPTDRLTAREALRHPFFTRD 325 (329)
Q Consensus 304 ~~dP~~R~t~~~ll~hp~f~~~ 325 (329)
++||.+||||+|+|+||||++.
T Consensus 313 ~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 313 QLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTC
T ss_pred CCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999855
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-50 Score=348.45 Aligned_cols=237 Identities=21% Similarity=0.262 Sum_probs=188.9
Q ss_pred CCCccceEEEEEEecCCCc----eEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERKE----MVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e 74 (329)
||+|+||+||+|.++.+|+ .||+|.++.. ....+...+|+.++..+ .||||+++++++.++ ..+++++
T Consensus 17 lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~l~g~~~~~-~~~~v~e 90 (317)
T d1xkka_ 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-----DNPHVCRLLGICLTS-TVQLITQ 90 (317)
T ss_dssp EEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-----CCTTBCCEEEEEESS-SEEEEEE
T ss_pred EecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-----CCCCEeeEEEEEecC-CeeEEEE
Confidence 7999999999999988876 5888887642 23456778999999998 679999999999865 4667777
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
++ +++|.+.+.... ..+++..++.++.|++.||.|||++||+||||||+|||++.
T Consensus 91 ~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~----------------------- 146 (317)
T d1xkka_ 91 LMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT----------------------- 146 (317)
T ss_dssp CCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE-----------------------
T ss_pred eccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC-----------------------
Confidence 77 999999888754 46899999999999999999999999999999999999954
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchhHH
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENLEH 227 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 227 (329)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|+| |.+||.+.+..+.
T Consensus 147 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~ 222 (317)
T d1xkka_ 147 ----PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 222 (317)
T ss_dssp ----TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH
T ss_pred ----CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence 4568888888887554332 22358999999999999999999999999999999998 8999987665554
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.+...+. .+...+..+.+|+.+||+.||
T Consensus 223 ~~~i~~~~~~~------------------------------------------------~p~~~~~~~~~li~~cl~~dP 254 (317)
T d1xkka_ 223 SSILEKGERLP------------------------------------------------QPPICTIDVYMIMVKCWMIDA 254 (317)
T ss_dssp HHHHHHTCCCC------------------------------------------------CCTTBCHHHHHHHHHHTCSSG
T ss_pred HHHHHcCCCCC------------------------------------------------CCcccCHHHHHHHHHhCCCCh
Confidence 44333321110 123456789999999999999
Q ss_pred CCCCCHHHHhcC
Q 020235 308 TDRLTAREALRH 319 (329)
Q Consensus 308 ~~R~t~~~ll~h 319 (329)
++|||+.++++|
T Consensus 255 ~~RPs~~eil~~ 266 (317)
T d1xkka_ 255 DSRPKFRELIIE 266 (317)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=339.44 Aligned_cols=239 Identities=19% Similarity=0.290 Sum_probs=189.4
Q ss_pred CCCccceEEEEEEecCCC-------ceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEE
Q 020235 1 MGEGTFGQVLECWDRERK-------EMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICI 71 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~-------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~l 71 (329)
||+|+||.||+|++..++ ..||||+++... .......+|...+.++ ..||||+++++++.+++..++
T Consensus 21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~----~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI----GKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp CC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEE
T ss_pred EeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHh----cCCCeEEecccccccCCeEEE
Confidence 799999999999986554 479999986533 3345566777777777 357999999999999999999
Q ss_pred EeecC-CCCHHHHHHhCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 72 VFEKL-GSSLYDFLRKNN--------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 72 v~e~~-~~~l~~~l~~~~--------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||||+ +|+|.+++.... ...+++.+++.++.|++.||+|||+++|+||||||+|||+
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl-------- 168 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-------- 168 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--------
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee--------
Confidence 99999 999999997543 2358999999999999999999999999999999999999
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
+.++.+||+|||.+....... ....||+.|+|||.+.+..|+.++|||||||++|+
T Consensus 169 -------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~e 229 (299)
T d1fgka_ 169 -------------------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWE 229 (299)
T ss_dssp -------------------CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred -------------------cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHH
Confidence 556678899999887554432 23568899999999999999999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |.+||.+.+.......+.....+ ..+..
T Consensus 230 ll~~g~~p~~~~~~~~~~~~i~~~~~~------------------------------------------------~~p~~ 261 (299)
T d1fgka_ 230 IFTLGGSPYPGVPVEELFKLLKEGHRM------------------------------------------------DKPSN 261 (299)
T ss_dssp HHTTSCCSSTTCCHHHHHHHHHTTCCC------------------------------------------------CCCSS
T ss_pred hccCCCCCCCCCCHHHHHHHHHcCCCC------------------------------------------------CCCcc
Confidence 998 78999876655443333221111 01234
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
++..+.+||.+||+.||++|||++||++
T Consensus 262 ~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 262 CTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5678999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=337.82 Aligned_cols=237 Identities=22% Similarity=0.274 Sum_probs=183.7
Q ss_pred CCCccceEEEEEEecCC-C--ceEEEEEeccc----hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRER-K--EMVAIKIVRGI----KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~-~--~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+++.+ + ..||||+++.. ....+...+|+.++..+ .||||+++++++.+ +..++||
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-----~H~nIv~~~g~~~~-~~~~lv~ 89 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-----DHRNLIRLYGVVLT-PPMKMVT 89 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-----CCTTBCCEEEEECS-SSCEEEE
T ss_pred EecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-----CCCCEEEEEEEEee-cchheee
Confidence 79999999999986533 2 46899998643 23345678899999998 67999999999976 4678999
Q ss_pred ecC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCcc
Q 020235 74 EKL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYF 152 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (329)
||+ ++++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus 90 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~---------------------- 146 (273)
T d1u46a_ 90 ELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---------------------- 146 (273)
T ss_dssp ECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEE----------------------
T ss_pred eeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccc----------------------
Confidence 999 899998887643 35999999999999999999999999999999999999954
Q ss_pred ccCCCCCCeEEeeCCCCcccCCCC------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHh-CCCCCCCCchh
Q 020235 153 KRMPKSSAIKVIDFGSTTYERPDQ------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCT-GEALFQTHENL 225 (329)
Q Consensus 153 ~~~~~~~~~~l~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 225 (329)
+..+||+|||++....... ....||..|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 147 -----~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 147 -----RDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp -----TTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred -----ccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 4458888888887654443 22357789999999999999999999999999999998 89999987777
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.+....++ .+..++..+.+||.+||..
T Consensus 222 ~~~~~i~~~~~~~~-----------------------------------------------~~~~~~~~l~~li~~cl~~ 254 (273)
T d1u46a_ 222 QILHKIDKEGERLP-----------------------------------------------RPEDCPQDIYNVMVQCWAH 254 (273)
T ss_dssp HHHHHHHTSCCCCC-----------------------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHhCCCCCC-----------------------------------------------CcccccHHHHHHHHHHcCC
Confidence 65554433211110 1234567899999999999
Q ss_pred CCCCCCCHHHHhc
Q 020235 306 DPTDRLTAREALR 318 (329)
Q Consensus 306 dP~~R~t~~~ll~ 318 (329)
||++|||+++|++
T Consensus 255 dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 255 KPEDRPTFVALRD 267 (273)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-48 Score=338.89 Aligned_cols=251 Identities=24% Similarity=0.308 Sum_probs=194.5
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||.||+|+++.+|+.||||++.... .......|..++..+. ++++|+.+..++.+++..++|||++++++
T Consensus 15 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~----~~~~i~~~~~~~~~~~~~~ivme~~~~~l 89 (299)
T d1ckia_ 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQ----GGVGIPTIRWCGAEGDYNVMVMELLGPSL 89 (299)
T ss_dssp EEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHST----TSTTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHcc----CCCcccEEEEEEecCCEEEEEEEEcCCch
Confidence 799999999999999999999999987533 3455678999988884 34567777778888899999999998888
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||+... +.+..
T Consensus 90 ~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~------------------------~~~~~ 144 (299)
T d1ckia_ 90 EDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG------------------------KKGNL 144 (299)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG------------------------GGTTC
T ss_pred hhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc------------------------CCCce
Confidence 88877644 469999999999999999999999999999999999998543 24566
Q ss_pred eEEeeCCCCcccCCCC----------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHHHHH
Q 020235 161 IKVIDFGSTTYERPDQ----------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEHLAM 230 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 230 (329)
++|+|||.|....... ....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~ 224 (299)
T d1ckia_ 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224 (299)
T ss_dssp EEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------
T ss_pred eeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH
Confidence 8999999987654322 335799999999999999999999999999999999999999987554433222
Q ss_pred HHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCCCCC
Q 020235 231 MERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDPTDR 310 (329)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R 310 (329)
+.+.... ............++.++.+||..||+.||++|
T Consensus 225 ~~~~~~~-----------------------------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~R 263 (299)
T d1ckia_ 225 YERISEK-----------------------------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDK 263 (299)
T ss_dssp HHHHHHH-----------------------------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCC
T ss_pred HHHhhcc-----------------------------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHC
Confidence 2111000 00000111123467789999999999999999
Q ss_pred CCHH---HHhcCCCC
Q 020235 311 LTAR---EALRHPFF 322 (329)
Q Consensus 311 ~t~~---~ll~hp~f 322 (329)
||++ ++|+|+|.
T Consensus 264 P~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 264 PDYSYLRQLFRNLFH 278 (299)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHH
Confidence 9986 45677654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-49 Score=340.12 Aligned_cols=238 Identities=21% Similarity=0.297 Sum_probs=193.4
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|+++ .+++.||||+++... ...+...+|+.++..+ .|+|++++++++.+.+..+++|
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~~~~~v~ 95 (301)
T d1lufa_ 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-----DNPNIVKLLGVCAVGKPMCLLF 95 (301)
T ss_dssp EEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-----CCCCcccceeeeccCCceEEEE
Confidence 799999999999875 356789999987432 3345678899999888 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEee
Q 020235 74 EKL-GSSLYDFLRKNN----------------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVS 130 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~----------------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~ 130 (329)
|++ +++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 96 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld- 174 (301)
T d1lufa_ 96 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG- 174 (301)
T ss_dssp ECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC-
T ss_pred EecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEEC-
Confidence 999 999999997532 12478889999999999999999999999999999999994
Q ss_pred ccccccCCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhH
Q 020235 131 SEYIKVPDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSV 205 (329)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 205 (329)
.+..+||+|||++....... ....||+.|+|||.+.+..++.++|||||
T Consensus 175 --------------------------~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~ 228 (301)
T d1lufa_ 175 --------------------------ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY 228 (301)
T ss_dssp --------------------------GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred --------------------------CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccc
Confidence 45568899999886443321 23568899999999999999999999999
Q ss_pred HHHHHHHHhCC-CCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHH
Q 020235 206 GCILVELCTGE-ALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLI 284 (329)
Q Consensus 206 G~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
||++|+|++|. +||.+.+..+....+.+...+
T Consensus 229 Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~----------------------------------------------- 261 (301)
T d1lufa_ 229 GVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL----------------------------------------------- 261 (301)
T ss_dssp HHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------------------------
T ss_pred hhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------------------------------------------
Confidence 99999999985 688877666554443322111
Q ss_pred hhhccCchhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 285 MQHVDHSAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 285 ~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
..+..++.++.+||.+||+.||++|||+.||++
T Consensus 262 -~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 262 -ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 012345678999999999999999999999964
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=336.98 Aligned_cols=240 Identities=24% Similarity=0.346 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEec-----CCCceEEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDR-----ERKEMVAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||.||+|+++ .+++.||||+++.. ........+|+.++..+ ..||||+++++++.+.+..++||
T Consensus 31 iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l----~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL----GNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHH----CCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhc----cCCCCEEEEEEEEeeCCEEEEEE
Confidence 799999999999863 46789999999743 23345567898899888 35799999999999999999999
Q ss_pred ecC-CCCHHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeecccccc
Q 020235 74 EKL-GSSLYDFLRKNN----------------YRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKV 136 (329)
Q Consensus 74 e~~-~~~l~~~l~~~~----------------~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~ 136 (329)
||| +++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~------- 179 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT------- 179 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE-------
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc-------
Confidence 999 999999998643 12588999999999999999999999999999999999994
Q ss_pred CCCcCccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHH
Q 020235 137 PDYKSSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVE 211 (329)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 211 (329)
.+..++++|||.+....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 180 --------------------~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~e 239 (311)
T d1t46a_ 180 --------------------HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWE 239 (311)
T ss_dssp --------------------TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred --------------------ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHH
Confidence 45567888888877654433 23578999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccC
Q 020235 212 LCT-GEALFQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDH 290 (329)
Q Consensus 212 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
|++ |.+||.+.+..+....+...-..+. .+..
T Consensus 240 llt~g~p~~~~~~~~~~~~~~i~~~~~~~-----------------------------------------------~~~~ 272 (311)
T d1t46a_ 240 LFSLGSSPYPGMPVDSKFYKMIKEGFRML-----------------------------------------------SPEH 272 (311)
T ss_dssp HHTTTCCSSTTCCSSHHHHHHHHHTCCCC-----------------------------------------------CCTT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhcCCCCC-----------------------------------------------Cccc
Confidence 998 6777777665544433322211100 0123
Q ss_pred chhHHHHHHHHhcccCCCCCCCHHHHhc
Q 020235 291 SAGDLTHLLQGLLRYDPTDRLTAREALR 318 (329)
Q Consensus 291 ~~~~~~~ll~~~l~~dP~~R~t~~~ll~ 318 (329)
.+..+.+||.+||+.||++|||+++|++
T Consensus 273 ~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 273 APAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5678999999999999999999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=342.15 Aligned_cols=240 Identities=21% Similarity=0.265 Sum_probs=191.8
Q ss_pred CCCccceEEEEEEecCCCce--EEEEEeccc--hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEM--VAIKIVRGI--KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~--vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~ 76 (329)
||+|+||+||+|.++.++.. ||||.++.. ....+...+|+.++..+ ..||||+++++++.+++..++||||+
T Consensus 18 iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l----~~HpnIv~~~~~~~~~~~~~iV~ey~ 93 (309)
T d1fvra_ 18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL----GHHPNIINLLGACEHRGYLYLAIEYA 93 (309)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTC----CCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhc----cCCCCEeeEEEEEecCCeeEEEEEec
Confidence 79999999999999988764 677877532 22345677888888877 24799999999999999999999999
Q ss_pred -CCCHHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcC
Q 020235 77 -GSSLYDFLRKN--------------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKS 141 (329)
Q Consensus 77 -~~~l~~~l~~~--------------~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~ 141 (329)
+|+|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 94 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~------------- 160 (309)
T d1fvra_ 94 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------------- 160 (309)
T ss_dssp TTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE-------------
T ss_pred CCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE-------------
Confidence 99999999753 23468999999999999999999999999999999999999
Q ss_pred ccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCC--CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCC-CC
Q 020235 142 SLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ--NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGE-AL 218 (329)
Q Consensus 142 ~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p 218 (329)
+.+..+||+|||.+....... ....||..|+|||.+.+..++.++|||||||++|+|++|. +|
T Consensus 161 --------------~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p 226 (309)
T d1fvra_ 161 --------------GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 226 (309)
T ss_dssp --------------CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred --------------cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCC
Confidence 455668999999887554433 2346899999999999999999999999999999999965 67
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.+...+ ..+...++++.+|
T Consensus 227 ~~~~~~~~~~~~i~~~~~~------------------------------------------------~~~~~~~~~~~~l 258 (309)
T d1fvra_ 227 YCGMTCAELYEKLPQGYRL------------------------------------------------EKPLNCDDEVYDL 258 (309)
T ss_dssp TTTCCHHHHHHHGGGTCCC------------------------------------------------CCCTTBCHHHHHH
T ss_pred CCCCCHHHHHHHHHhcCCC------------------------------------------------CCCccCCHHHHHH
Confidence 8776655544333221100 1123456789999
Q ss_pred HHHhcccCCCCCCCHHHHhcC
Q 020235 299 LQGLLRYDPTDRLTAREALRH 319 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~h 319 (329)
|.+||+.||++|||+++|++|
T Consensus 259 i~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 259 MRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999976
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=339.69 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=199.7
Q ss_pred CCCccceEEEEEEecC-----CCceEEEEEeccch--hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-----RKEMVAIKIVRGIK--KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
||+|+||+||+|.++. ++..||||+++... .......+|+.++.++ .|+||+++++++..+...++||
T Consensus 28 lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~~~~~lv~ 102 (308)
T d1p4oa_ 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-----NCHHVVRLLGVVSQGQPTLVIM 102 (308)
T ss_dssp EEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-----CCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-----CCCCEeeeeeEEecCCceeEEE
Confidence 7999999999998863 35789999997432 2234467888888887 6799999999999999999999
Q ss_pred ecC-CCCHHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccC
Q 020235 74 EKL-GSSLYDFLRKN--------NYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLH 144 (329)
Q Consensus 74 e~~-~~~l~~~l~~~--------~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~ 144 (329)
||+ +|+|.+++... .-..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 103 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---------------- 166 (308)
T d1p4oa_ 103 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---------------- 166 (308)
T ss_dssp ECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----------------
T ss_pred eecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee----------------
Confidence 999 99999998642 11246888999999999999999999999999999999999
Q ss_pred CCCCCCccccCCCCCCeEEeeCCCCcccCCCC-----CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhC-CCC
Q 020235 145 TPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQ-----NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTG-EAL 218 (329)
Q Consensus 145 ~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~p 218 (329)
+.+..+||+|||++....... ....||+.|+|||.+.+..++.++|||||||++|+|++| .+|
T Consensus 167 -----------d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 167 -----------AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp -----------CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred -----------cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCC
Confidence 566779999999987554432 234689999999999999999999999999999999998 588
Q ss_pred CCCCchhHHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHH
Q 020235 219 FQTHENLEHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHL 298 (329)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (329)
|.+.+..+....+.+...+ ..+...+..+.++
T Consensus 236 ~~~~~~~~~~~~i~~~~~~------------------------------------------------~~p~~~~~~l~~l 267 (308)
T d1p4oa_ 236 YQGLSNEQVLRFVMEGGLL------------------------------------------------DKPDNCPDMLFEL 267 (308)
T ss_dssp TTTSCHHHHHHHHHTTCCC------------------------------------------------CCCTTCCHHHHHH
T ss_pred CCCCCHHHHHHHHHhCCCC------------------------------------------------CCcccchHHHHHH
Confidence 8877666554443321111 0112456789999
Q ss_pred HHHhcccCCCCCCCHHHHhc------CCCCCCCC
Q 020235 299 LQGLLRYDPTDRLTAREALR------HPFFTRDH 326 (329)
Q Consensus 299 l~~~l~~dP~~R~t~~~ll~------hp~f~~~~ 326 (329)
|.+||+.||++|||+++|++ +|+|++.+
T Consensus 268 i~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 268 MRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCC
Confidence 99999999999999999997 78887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-47 Score=329.97 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=193.8
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecCCCCH
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKLGSSL 80 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~~~~l 80 (329)
||+|+||+||+|+++.+|+.||||+++... ......+|+.++..+. ++++++.+++++..+...++|||+++++|
T Consensus 13 iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~----~~~~i~~~~~~~~~~~~~~~vme~~~~~l 87 (293)
T d1csna_ 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLA----GCTGIPNVYYFGQEGLHNVLVIDLLGPSL 87 (293)
T ss_dssp EEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTT----TCTTCCCEEEEEEETTEEEEEEECCCCBH
T ss_pred EecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhc----CCCCCCEEEEEeecCCccEEEEEecCCCH
Confidence 799999999999999999999999986432 3445677888888884 34788888999999999999999999999
Q ss_pred HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccccCCCCCC
Q 020235 81 YDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFKRMPKSSA 160 (329)
Q Consensus 81 ~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (329)
.+++.... ..++...+..++.|++.||+|||++||+||||||+|||+.+... .....
T Consensus 88 ~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~----------------------~~~~~ 144 (293)
T d1csna_ 88 EDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS----------------------KNANM 144 (293)
T ss_dssp HHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS----------------------TTTTC
T ss_pred HHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc----------------------ccCCc
Confidence 99987754 46899999999999999999999999999999999999964321 23567
Q ss_pred eEEeeCCCCcccCCC----------CCcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCchhHH---
Q 020235 161 IKVIDFGSTTYERPD----------QNYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHENLEH--- 227 (329)
Q Consensus 161 ~~l~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--- 227 (329)
++|+|||.|+..... .....||+.|||||++.+..++.++|||||||++|+|++|..||.+......
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 224 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence 999999999754332 1235799999999999999999999999999999999999999976443221
Q ss_pred HHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhcccCC
Q 020235 228 LAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRYDP 307 (329)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP 307 (329)
...+.......+ ..+.....++++.+++..|+..+|
T Consensus 225 ~~~i~~~~~~~~--------------------------------------------~~~l~~~~p~~l~~ii~~~~~~~~ 260 (293)
T d1csna_ 225 YERIGEKKQSTP--------------------------------------------LRELCAGFPEEFYKYMHYARNLAF 260 (293)
T ss_dssp HHHHHHHHHHSC--------------------------------------------HHHHTTTSCHHHHHHHHHHHHCCT
T ss_pred HHHHHhccCCCC--------------------------------------------hHHhcCCCCHHHHHHHHHHhcCCc
Confidence 111111110000 011123456789999999999999
Q ss_pred CCCCCHHHHh
Q 020235 308 TDRLTAREAL 317 (329)
Q Consensus 308 ~~R~t~~~ll 317 (329)
++||+.+.+.
T Consensus 261 ~~rP~y~~l~ 270 (293)
T d1csna_ 261 DATPDYDYLQ 270 (293)
T ss_dssp TCCCCHHHHH
T ss_pred ccCcCHHHHH
Confidence 9999876553
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=332.86 Aligned_cols=244 Identities=16% Similarity=0.179 Sum_probs=190.3
Q ss_pred CCCccceEEEEEEecCCC---ceEEEEEecc--chhhHHhHHHHHHHHHHHHhhCCCCCceeeecccccc-CCceEEEee
Q 020235 1 MGEGTFGQVLECWDRERK---EMVAIKIVRG--IKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDY-RNHICIVFE 74 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~---~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~-~~~~~lv~e 74 (329)
||+|+||+||+|++..++ ..||||+++. .....+...+|+.++.++ .||||+++++++.. ++..++|||
T Consensus 35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-----~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-----SHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-----CCTTBCCCCEEEEETTTEEEEEEE
T ss_pred EeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-----CCCCEeEEeEEEEecCCceEEEEE
Confidence 699999999999986543 3689999864 333446678999999988 67999999998754 568999999
Q ss_pred cC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCcCccCCCCCCCccc
Q 020235 75 KL-GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPKDSSYFK 153 (329)
Q Consensus 75 ~~-~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (329)
|| +++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||+
T Consensus 110 ~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl------------------------- 163 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------------------------- 163 (311)
T ss_dssp CCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-------------------------
T ss_pred EeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE-------------------------
Confidence 99 999999887644 457888999999999999999999999999999999999
Q ss_pred cCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCCCCCccchHhHHHHHHHHHhCCCCCCCCc-hh
Q 020235 154 RMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLGWTYPCDIWSVGCILVELCTGEALFQTHE-NL 225 (329)
Q Consensus 154 ~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-~~ 225 (329)
+.+..+||+|||.+....... ....||+.|+|||.+....++.++||||||+++|+|++|..||.... ..
T Consensus 164 --~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~ 241 (311)
T d1r0pa_ 164 --DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241 (311)
T ss_dssp --CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----
T ss_pred --CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH
Confidence 556678888888887544332 22468899999999999999999999999999999999777775422 21
Q ss_pred HHHHHHHHHhCCCChhHHHhhhhhhhhhhhcCCcCCCCCCCchHHHhhhccchhhHHHHhhhccCchhHHHHHHHHhccc
Q 020235 226 EHLAMMERVLGPLPQHMLKRVDRHAEKYVRRGRLDWPEGAASRESIKSVMKLPRLQNLIMQHVDHSAGDLTHLLQGLLRY 305 (329)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~ 305 (329)
+....+.....+ ..+...++.+.+||.+||+.
T Consensus 242 ~~~~~i~~g~~~------------------------------------------------~~p~~~~~~l~~li~~cl~~ 273 (311)
T d1r0pa_ 242 DITVYLLQGRRL------------------------------------------------LQPEYCPDPLYEVMLKCWHP 273 (311)
T ss_dssp -CHHHHHTTCCC------------------------------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred HHHHHHHcCCCC------------------------------------------------CCcccCcHHHHHHHHHHcCC
Confidence 111111111000 01123567899999999999
Q ss_pred CCCCCCCHHHHhcC------CCCCCC
Q 020235 306 DPTDRLTAREALRH------PFFTRD 325 (329)
Q Consensus 306 dP~~R~t~~~ll~h------p~f~~~ 325 (329)
||++|||+.||++| +|..+.
T Consensus 274 dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 274 KAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred CHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 99999999999988 666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=330.50 Aligned_cols=184 Identities=24% Similarity=0.313 Sum_probs=149.0
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCC----ceEEEeecC
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRN----HICIVFEKL 76 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~----~~~lv~e~~ 76 (329)
||+|+||+||+|+. +|+.||||+++... .....+|.+++... ...||||+++++++.+.+ .+|+||||+
T Consensus 11 iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~--~~~~~~e~ei~~~~---~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~ 83 (303)
T d1vjya_ 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTV---MLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EECCSSSEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHTST---TCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EeeCCCeEEEEEEE--CCEEEEEEEECccc--hhHHHHHHHHHHHh---hCCCCcCcceEEEEEeCCCcceEEEEEEecc
Confidence 69999999999975 58899999987543 23344454443221 126899999999987543 689999999
Q ss_pred -CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------cCCcccCCCCCcEEEeeccccccCCCcCccCCCC
Q 020235 77 -GSSLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHD--------LCMIHTDLKPENVLLVSSEYIKVPDYKSSLHTPK 147 (329)
Q Consensus 77 -~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~--------~~i~H~dikp~NIl~~~~~~~~~~~~~~~~~~~~ 147 (329)
+|+|.+++.+. .+++.....++.|++.||+|||+ +||+||||||+|||+
T Consensus 84 ~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl------------------- 141 (303)
T d1vjya_ 84 EHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV------------------- 141 (303)
T ss_dssp TTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE-------------------
T ss_pred cCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE-------------------
Confidence 99999999885 49999999999999999999996 599999999999999
Q ss_pred CCCccccCCCCCCeEEeeCCCCcccCCCC-------CcccccCCCCchhHHhcCC------CCCccchHhHHHHHHHHHh
Q 020235 148 DSSYFKRMPKSSAIKVIDFGSTTYERPDQ-------NYIVSTRHYRAPEVILGLG------WTYPCDIWSVGCILVELCT 214 (329)
Q Consensus 148 ~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~l~~ 214 (329)
+.++.+||+|||++....... ....||+.|+|||++.+.. ++.++|||||||++|+|++
T Consensus 142 --------~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~t 213 (303)
T d1vjya_ 142 --------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp --------CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred --------cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhh
Confidence 556678999999887553322 3357999999999987653 5678999999999999999
Q ss_pred CCCCCCC
Q 020235 215 GEALFQT 221 (329)
Q Consensus 215 g~~p~~~ 221 (329)
|..||..
T Consensus 214 g~~~~~~ 220 (303)
T d1vjya_ 214 RCSIGGI 220 (303)
T ss_dssp TBCBTTB
T ss_pred CCCCCCc
Confidence 9988854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.8e-25 Score=177.58 Aligned_cols=156 Identities=22% Similarity=0.264 Sum_probs=106.1
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccchh-------------------hHHhHHHHHHHHHHHHhhCCCCCceeeecc
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGIKK-------------------YREAAMIEIEVLQQLAKHDKGGNRCVQIRN 61 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~ 61 (329)
||+|+||+||+|.+. +|+.||||+++.... ......+|...+..+ .+.+++..++
T Consensus 8 IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~v~~~~~ 81 (191)
T d1zara2 8 MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-----QGLAVPKVYA 81 (191)
T ss_dssp EEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-----TTSSSCCEEE
T ss_pred eeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-----cCCCcceEEE
Confidence 799999999999885 688999998753110 112223456666666 3455665554
Q ss_pred ccccCCceEEEeecCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCCCcEEEeeccccccCCCc
Q 020235 62 WFDYRNHICIVFEKLGS-SLYDFLRKNNYRSFPIDLVREIARQLLECIAFMHDLCMIHTDLKPENVLLVSSEYIKVPDYK 140 (329)
Q Consensus 62 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~l~~~L~~lH~~~i~H~dikp~NIl~~~~~~~~~~~~~ 140 (329)
.. ..+++||++++ .+. .++...+..++.|++.+|+|||++||+||||||+|||++.
T Consensus 82 ~~----~~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~---------- 138 (191)
T d1zara2 82 WE----GNAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---------- 138 (191)
T ss_dssp EE----TTEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET----------
T ss_pred ec----CCEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC----------
Confidence 32 23799999943 321 2455567789999999999999999999999999999953
Q ss_pred CccCCCCCCCccccCCCCCCeEEeeCCCCcccCCCCCcccccCCCCch--h---HHhcCCCCCccchHhHHHH
Q 020235 141 SSLHTPKDSSYFKRMPKSSAIKVIDFGSTTYERPDQNYIVSTRHYRAP--E---VILGLGWTYPCDIWSVGCI 208 (329)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DiwslG~~ 208 (329)
..++|||||.|.....+... .|... + ......|+.++|+||+.--
T Consensus 139 ------------------~~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 139 ------------------EGIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp ------------------TEEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred ------------------CCEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence 23899999998765433211 01111 0 0123468899999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.25 E-value=2.1e-06 Score=70.16 Aligned_cols=74 Identities=8% Similarity=-0.025 Sum_probs=49.7
Q ss_pred ccceEEEEEEecCCCceEEEEEeccch-hhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCCHH
Q 020235 4 GTFGQVLECWDRERKEMVAIKIVRGIK-KYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSSLY 81 (329)
Q Consensus 4 G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~l~ 81 (329)
|+.+.||++. .+++.+++|+..... .......+|...+..+.. +--+++++.+.+.++..++||++. |.++.
T Consensus 25 ~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~----~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~ 98 (263)
T d1j7la_ 25 MSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG----KLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp CSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT----TSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred CCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc----cCCCCcEEEEEecCCceEEEEEeccccccc
Confidence 3346899885 345667889876432 223445678888887743 233567777777788899999999 66665
Q ss_pred HH
Q 020235 82 DF 83 (329)
Q Consensus 82 ~~ 83 (329)
+.
T Consensus 99 ~~ 100 (263)
T d1j7la_ 99 EE 100 (263)
T ss_dssp HH
T ss_pred cc
Confidence 43
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.02 E-value=1.7e-05 Score=68.79 Aligned_cols=72 Identities=21% Similarity=0.235 Sum_probs=45.2
Q ss_pred CCCccceEEEEEEecCCCceEEEEEeccc--------hhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEE
Q 020235 1 MGEGTFGQVLECWDRERKEMVAIKIVRGI--------KKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIV 72 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~~~~~vaiK~~~~~--------~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv 72 (329)
||.|....||++.+..+++.+++|.-... .....+...|...+..+.... ...+++++.+ ++...++|
T Consensus 34 ig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~--p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp CCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTTEEE
T ss_pred eCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC--CCCcceEEEE--cCCCCEEE
Confidence 68899999999998877888999964321 112234566888887775432 1345555544 34456789
Q ss_pred eecC
Q 020235 73 FEKL 76 (329)
Q Consensus 73 ~e~~ 76 (329)
||++
T Consensus 110 mE~L 113 (392)
T d2pula1 110 MEDL 113 (392)
T ss_dssp ECCC
T ss_pred Eecc
Confidence 9999
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.66 E-value=5.2e-05 Score=61.21 Aligned_cols=68 Identities=12% Similarity=0.079 Sum_probs=47.7
Q ss_pred ceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEeecC-CCC
Q 020235 6 FGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVFEKL-GSS 79 (329)
Q Consensus 6 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~e~~-~~~ 79 (329)
-+.||++... ++..+++|...... ......|...+..+.... ..+++++....+++..++||+++ |.+
T Consensus 24 ~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~g---vpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 24 DAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTG---VPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp SCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTT---CCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred CCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcC---CCCCceeeecccccceEEEEEeeeccc
Confidence 3678999754 45668889866432 345667888888886543 23667777777788899999999 544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.41 E-value=0.00035 Score=58.52 Aligned_cols=70 Identities=16% Similarity=0.191 Sum_probs=46.4
Q ss_pred eEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeec--cccccCCceEEEeecCC
Q 020235 7 GQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIR--NWFDYRNHICIVFEKLG 77 (329)
Q Consensus 7 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~--~~~~~~~~~~lv~e~~~ 77 (329)
..||++... +|..|++|+.+...........|...+..+.......+..+..- ..+..++..+.++++.+
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 479999753 57889999988655556777889999999877543333222221 12234556888899883
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.75 E-value=0.0022 Score=53.08 Aligned_cols=50 Identities=12% Similarity=0.070 Sum_probs=30.2
Q ss_pred CccceEEEEEEecCCCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCc
Q 020235 3 EGTFGQVLECWDRERKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNR 55 (329)
Q Consensus 3 ~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~ 55 (329)
.|--.+.|++... +..+++|+.... ........|+.++..+.......|.
T Consensus 28 ~G~~N~ny~v~t~--~g~yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 28 EGVENSNFLLHTT--KDPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp C---EEEEEEEES--SCCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCcccCeEEEEEC--CCcEEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccc
Confidence 4555778998654 345899998643 2344556688888888876544443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.67 E-value=0.002 Score=55.34 Aligned_cols=67 Identities=12% Similarity=0.126 Sum_probs=43.4
Q ss_pred CCCccceEEEEEEecC-------CCceEEEEEeccchhhHHhHHHHHHHHHHHHhhCCCCCceeeeccccccCCceEEEe
Q 020235 1 MGEGTFGQVLECWDRE-------RKEMVAIKIVRGIKKYREAAMIEIEVLQQLAKHDKGGNRCVQIRNWFDYRNHICIVF 73 (329)
Q Consensus 1 Lg~G~~g~V~~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~i~~l~~~~~~~~~~~lv~ 73 (329)
|+.|-.-.+|++.... .++.|++++.-. ........+|..+++.+.... ..+++++++.+ ++|+
T Consensus 50 l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~g----l~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 50 IKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERH----LGPKLYGIFSG----GRLE 120 (395)
T ss_dssp ECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTT----SSSCEEEEETT----EEEE
T ss_pred cCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCC----CCCeEEEEcCC----ceEE
Confidence 4567888899998653 245677777653 222334457888888886643 24566666653 5788
Q ss_pred ecC
Q 020235 74 EKL 76 (329)
Q Consensus 74 e~~ 76 (329)
+|+
T Consensus 121 efi 123 (395)
T d1nw1a_ 121 EYI 123 (395)
T ss_dssp CCC
T ss_pred EEe
Confidence 888
|